PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Manavalan, APC; Kober, A; Metso, J; Lang, I; Becker, T; Hasslitzer, K; Zandl, M; Fanaee-Danesh, E; Pippal, JB; Sachdev, V; Kratky, D; Stefulj, J; Jauhiainen, M; Panzenboeck, U				Manavalan, Anil Paul Chirackal; Kober, Alexandra; Metso, Jari; Lang, Ingrid; Becker, Tatjana; Hasslitzer, Karin; Zandl, Martina; Fanaee-Danesh, Elham; Pippal, Jyotsna Brijesh; Sachdev, Vinay; Kratky, Dagmar; Stefulj, Jasminka; Jauhiainen, Matti; Panzenboeck, Ute			Phospholipid Transfer Protein Is Expressed in Cerebrovascular Endothelial Cells and Involved in High Density Lipoprotein Biogenesis and Remodeling at the Blood- Brain Barrier*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cholesterol; Endothelium; HDL; Nuclear Receptors; A; Blood-Brain Barrier; Cholesterol Efflux; LXRs; Pre- HDL	LIVER-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; ENHANCES CHOLESTEROL EFFLUX; APOLIPOPROTEIN-A-I; ALZHEIMERS-DISEASE; LIPID-METABOLISM; STEROL TRANSPORT; HDL CHOLESTEROL; TRANSGENIC MICE; RISK-FACTOR	Background: Liver X receptor activation promotes formation of HDL-like particles at the blood-brain barrier (BBB). Results: Cerebrovascular endothelial cells express phospholipid transfer protein (PLTP) that transfers phospholipids, remodels HDL, and supports cellular cholesterol efflux. Conclusion: PLTP is involved in HDL genesis and remodeling at the BBB. Significance: We demonstrate a direct role of PLTP in HDL metabolism at the blood-brain interface. Phospholipid transfer protein (PLTP) is a key protein involved in biogenesis and remodeling of plasma HDL. Several neuroprotective properties have been ascribed to HDL. We reported earlier that liver X receptor (LXR) activation promotes cellular cholesterol efflux and formation of HDL-like particles in an established in vitro model of the blood-brain barrier (BBB) consisting of primary porcine brain capillary endothelial cells (pBCEC). Here, we report PLTP synthesis, regulation, and its key role in HDL metabolism at the BBB. We demonstrate that PLTP is highly expressed and secreted by pBCEC. In a polarized in vitro model mimicking the BBB, pBCEC secreted phospholipid-transfer active PLTP preferentially to the basolateral (brain parenchymal) compartment. PLTP expression levels and phospholipid transfer activity were enhanced (up to 2.5-fold) by LXR activation using 24(S)-hydroxycholesterol (a cerebral cholesterol metabolite) or TO901317 (a synthetic LXR agonist). TO901317 administration elevated PLTP activity in BCEC from C57/BL6 mice. Preincubation of HDL3 with human plasma-derived active PLTP resulted in the formation of smaller and larger HDL particles and enhanced the capacity of the generated HDL particles to remove cholesterol from pBCEC by up to 3-fold. Pre--HDL, detected by two-dimensional crossed immunoelectrophoresis, was generated from HDL3 in pBCEC-derived supernatants, and their generation was markedly enhanced (1.9-fold) upon LXR activation. Furthermore, RNA interference-mediated PLTP silencing (up to 75%) reduced both apoA-I-dependent (67%) and HDL3-dependent (30%) cholesterol efflux from pBCEC. Based on these findings, we propose that PLTP is actively involved in lipid transfer, cholesterol efflux, HDL genesis, and remodeling at the BBB.	[Manavalan, Anil Paul Chirackal; Kober, Alexandra; Becker, Tatjana; Hasslitzer, Karin; Zandl, Martina; Fanaee-Danesh, Elham; Pippal, Jyotsna Brijesh; Panzenboeck, Ute] Med Univ Graz, Inst Pathophysiol & Immunol, A-8010 Graz, Austria; [Lang, Ingrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Sachdev, Vinay; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Metso, Jari; Jauhiainen, Matti] Biomedicum, Natl Inst Hlth & Welf, FI-00290 Helsinki, Finland; [Stefulj, Jasminka] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb 10000, Croatia	Medical University of Graz; Medical University of Graz; Medical University of Graz; Finland National Institute for Health & Welfare; University of Helsinki; Rudjer Boskovic Institute	Panzenboeck, U (corresponding author), Med Univ Graz, Inst Pathophysiol & Immunol, Heinrichstr 31a, A-8010 Graz, Austria.	ute.panzenboeck@medunigraz.at	Stefulj, Jasminka/A-1267-2011; Kratky, Dagmar/ABF-5699-2021; Sachdev, Vinay/D-1029-2018	Sachdev, Vinay/0000-0002-6221-4376; Kratky, Dagmar/0000-0003-1357-7573; Panzenbock, Ute/0000-0002-0545-6758; Zandl-Lang, Martina/0000-0003-0522-4372; Lang-Olip, Ingrid/0000-0003-0403-4884	Austrian Science Fund [DK-MCD W1226-B18, P24783 B19, SFB LIPOTOX F30, P38223P]; Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation [365]; Austrian Science Fund (FWF) [F 3004] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund Grants DK-MCD W1226-B18 (to U. P. and D. K.), P24783 B19 (to U. P.), and SFB LIPOTOX F30 and P38223P (to D. K.), by the Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation 365 (to U. P.).	Albers JJ, 1996, INT J CLIN LAB RES, V26, P262, DOI 10.1007/BF02602960; Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Ashida Y, 1999, SCAND J CLIN LAB INV, V59, P663, DOI 10.1080/00365519950185166; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bowman G. L., 2012, CURR GERONTOL GERIAT, V2012; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Desrumaux C, 2004, FASEB J, V18, P296, DOI 10.1096/fj.04-2400fje; Desrumaux C, 2013, NEUROPSYCHOPHARMACOL, V38, P817, DOI 10.1038/npp.2012.247; Dong WJ, 2009, J NEUROSCI RES, V87, P3176, DOI 10.1002/jnr.22137; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Huuskonen J, 1998, J LIPID RES, V39, P2021; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Janis MT, 2005, BIOCHEM BIOPH RES CO, V331, P333, DOI 10.1016/j.bbrc.2005.03.164; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Koch S, 2001, J LIPID RES, V42, P1143; Kontush A, 2004, BRAIN PATHOL, V14, P433; Kontush A, 2008, ARTERIOSCL THROM VAS, V28, P1418, DOI 10.1161/ATVBAHA.108.169714; Kratzer I, 2007, J CONTROL RELEASE, V117, P301, DOI 10.1016/j.jconrel.2006.11.020; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; MarquesVidal P, 1997, ATHEROSCLEROSIS, V133, P87, DOI 10.1016/S0021-9150(97)00120-2; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Norata GD, 2005, INT J MOL MED, V16, P717; Olesen OF, 2000, BIOCHEM BIOPH RES CO, V270, P62, DOI 10.1006/bbrc.2000.2372; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Oram JF, 2008, J BIOL CHEM, V283, P11541, DOI 10.1074/jbc.M800117200; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Panzenboeck U, 2006, INT J BIOCHEM CELL B, V38, P1314, DOI 10.1016/j.biocel.2006.01.013; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Riemens SC, 1998, DIABETOLOGIA, V41, P929, DOI 10.1007/s001250051009; Robciuc MR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-59; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P2466, DOI 10.1210/jc.2011-2969; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P437, DOI 10.1210/jc.2011-1942; Schweinzer C, 2011, J ALZHEIMERS DIS, V27, P341, DOI 10.3233/JAD-2011-110854; Settasatian N, 2001, J BIOL CHEM, V276, P26898, DOI 10.1074/jbc.M010708200; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; TU AY, 1993, J BIOL CHEM, V268, P23098; Tu AY, 2001, DIABETES, V50, P1851, DOI 10.2337/diabetes.50.8.1851; Tzotzas T, 2009, OBES REV, V10, P403, DOI 10.1111/j.1467-789X.2009.00586.x; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; Vuletic S, 2005, J NEUROSCI RES, V80, P406, DOI 10.1002/jnr.20458; Vuletic S, 2003, J LIPID RES, V44, P1113, DOI 10.1194/jlr.M300046-JLR200; Vuletic S, 2009, BBA-MOL CELL RES, V1793, P584, DOI 10.1016/j.bbamcr.2009.01.010; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang H., 2013, J ALZHEIMERS DIS, DOI 10.3233/JAD-130812; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001	61	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4683	4698		10.1074/jbc.M113.499129	http://dx.doi.org/10.1074/jbc.M113.499129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24369175	Green Published, hybrid			2022-12-25	WOS:000331607900016
J	Wang, W; Ma, T; Lian, KH; Zhang, Y; Tian, HM; Ji, KH; Li, GQ				Wang, Wei; Ma, Ting; Lian, Kehui; Zhang, Yue; Tian, Huimei; Ji, Kaihua; Li, Guoqiang			Genetic Analysis of Benzothiophene Biodesulfurization Pathway of Gordonia terrae Strain C-6	PLOS ONE			English	Article							MYCOBACTERIUM-GOODII X7B; RHODOCOCCUS-ERYTHROPOLIS; DESULFURIZING BACTERIUM; FOSSIL-FUELS; DIBENZOTHIOPHENE; IDENTIFICATION; IGTS8; OVEREXPRESSION; MONOOXYGENASE; ALKANIVORANS	Sulfur can be removed from benzothiophene (BT) by some bacteria without breaking carbon-carbon bonds. However, a clear mechanism for BT desulfurization and its genetic components have not been reported in literatures so far. In this study, we used comparative transcriptomics to study differential expression of genes in Gordonia terrae C-6 cultured with BT or sodium sulfate as the sole source of sulfur. We found that 135 genes were up-regulated with BT relative to sodium sulfate as the sole sulfur source. Many of these genes encode flavin-dependent monooxygenases, alkane sulfonate monooxygenases and desulfinase, which perform similar functions to those involved in the 4S pathway of dibenzothiophene (DBT) biodesulfurization. Three of the genes were found to be located in the same operon, designated bdsABC. Cell extracts of pET28a-bdsABC transfected E. coli Rosetta (DE3) converted BT to a phenolic compound, identified as o-hydroxystyrene. These results advance our understanding of enzymes involved in the BT biodesulfurization pathway.	[Wang, Wei; Ma, Ting; Lian, Kehui; Zhang, Yue; Tian, Huimei; Ji, Kaihua; Li, Guoqiang] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Wang, Wei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Wang, Wei] Tianjin Key Lab Microbial Funct Genom, Tianjin, Peoples R China	Nankai University; Nankai University	Li, GQ (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	gqli@nankai.edu.cn		Wang, Wei/0000-0002-6660-8540	National Natural Science Foundation of China [31000056, 31170075, 31070078, 31370121]; Natural Science Foundation of Tianjin, China [09JCZDJC18000, 11JCZDJC16100, 11JCZDJC16600]; National High Technology Research and Development Program of China [2013AA064402]; Funds for National basic science personnel training [J1103503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Funds for National basic science personnel training	This work was supported by the National Natural Science Foundation of China (Grant No. 31000056, 31170075, 31070078, and 31370121), the Natural Science Foundation of Tianjin, China (Grant No. 09JCZDJC18000, 11JCZDJC16100, and 11JCZDJC16600), National High Technology Research and Development Program of China (2013AA064402) and Funds for National basic science personnel training(Grant No. J1103503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2013, MOL BIOSYST, V9, P2530, DOI 10.1039/c3mb70132h; Aggarwal S, 2012, MOL BIOSYST, V8, P2724, DOI 10.1039/c2mb25127b; Aggarwal S, 2011, FEMS MICROBIOL LETT, V315, P115, DOI 10.1111/j.1574-6968.2010.02179.x; Dinamarca MA, 2010, BIORESOURCE TECHNOL, V101, P2375, DOI 10.1016/j.biortech.2009.11.086; Chen H, 2009, BIORESOURCE TECHNOL, V100, P2085, DOI 10.1016/j.biortech.2008.10.010; Chi YS, 2011, GREEN CHEM, V13, P1224, DOI 10.1039/c0gc00745e; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Davoodi-Dehaghani F, 2010, BIORESOURCE TECHNOL, V101, P1102, DOI 10.1016/j.biortech.2009.08.058; DENOME SA, 1994, J BACTERIOL, V176, P6707, DOI 10.1128/JB.176.21.6707-6716.1994; DENOME SA, 1993, APPL ENVIRON MICROB, V59, P2837, DOI 10.1128/AEM.59.9.2837-2843.1993; Gilbert SC, 1998, MICROBIOL-UK, V144, P2545, DOI 10.1099/00221287-144-9-2545; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Hasan Z, 2012, J HAZARD MATER, V205, P216, DOI 10.1016/j.jhazmat.2011.12.059; Ishii Y, 2000, BIOCHEM BIOPH RES CO, V270, P81, DOI 10.1006/bbrc.2000.2370; KODAMA K, 1973, AGR BIOL CHEM TOKYO, V37, P45, DOI 10.1080/00021369.1973.10860640; Konishi J, 2000, FEMS MICROBIOL LETT, V187, P151, DOI 10.1016/S0378-1097(00)00186-5; Kulkarni PS, 2010, GREEN CHEM, V12, P1139, DOI 10.1039/c002113j; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WC, 2006, J BIOL CHEM, V281, P32534, DOI 10.1074/jbc.M602974200; Lei BF, 1996, J BACTERIOL, V178, P5699, DOI 10.1128/jb.178.19.5699-5705.1996; Li FL, 2005, APPL ENVIRON MICROB, V71, P276, DOI 10.1128/AEM.71.1.276-281.2005; Li GQ, 2008, APPL ENVIRON MICROB, V74, P971, DOI 10.1128/AEM.02319-07; Li JC, 2009, BIORESOURCE TECHNOL, V100, P2594, DOI 10.1016/j.biortech.2008.12.009; Li YG, 2009, BIORESOURCE TECHNOL, V100, P5092, DOI 10.1016/j.biortech.2009.05.064; Matsubara T, 2001, APPL ENVIRON MICROB, V67, P1179, DOI 10.1128/AEM.67.3.1179-1184; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Monticello DJ, 2000, CURR OPIN BIOTECH, V11, P540, DOI 10.1016/S0958-1669(00)00154-3; Pawelec B, 2011, CATAL SCI TECHNOL, V1, P23, DOI 10.1039/c0cy00049c; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Tanaka Y, 2002, APPL MICROBIOL BIOT, V59, P325, DOI 10.1007/s00253-002-0985-9; Tanaka Y, 2001, CURR MICROBIOL, V43, P187, DOI 10.1007/s002840010285; Wang W, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00381-13, DOI 10.1128/GEN0MEA.00381-13.PUBMED:23788548]; Xu P, 2009, ADV BIOCHEM ENG BIOT, V113, P255, DOI 10.1007/10_2008_16	36	26	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84386	10.1371/journal.pone.0084386	http://dx.doi.org/10.1371/journal.pone.0084386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367657	gold, Green Submitted, Green Published			2022-12-25	WOS:000328741900045
J	Foley, DL; Mackinnon, A; Watts, GF; Shaw, JE; Magliano, DJ; Castle, DJ; McGrath, JJ; Waterreus, A; Morgan, VA; Galletly, CA				Foley, Debra L.; Mackinnon, Andrew; Watts, Gerald F.; Shaw, Jonathan E.; Magliano, Dianna J.; Castle, David J.; McGrath, John J.; Waterreus, Anna; Morgan, Vera A.; Galletly, Cherrie A.			Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; AUSTRALIAN NATIONAL-SURVEY; DRUG-NAIVE PATIENTS; METABOLIC RISK; SCHIZOPHRENIA; 1ST-EPISODE; MORTALITY; ANTIPSYCHOTICS; OBESITY; PEOPLE	Individuals with psychosis are more likely than the general community to develop obesity and to die prematurely from heart disease. Interventions to improve cardiovascular outcomes are best targeted at the earliest indicators of risk, at the age they first emerge. We investigated which cardiometabolic risk indicators distinguished those with psychosis from the general population, by age by gender, and whether obesity explained the pattern of observed differences. Data was analyzed from an epidemiologically representative sample of 1,642 Australians with psychosis aged 18-64 years and a national comparator sample of 8,866 controls aged 25-64 years from the general population. Cubic b-splines were used to compare cross sectional age trends by gender for mean waist circumference, body mass index [BMI], blood pressure, fasting blood glucose, triglycerides, LDL, HDL, and total cholesterol in our psychosis and control samples. At age 25 individuals with psychosis had a significantly higher mean BMI, waist circumference, triglycerides, glucose [women only], and diastolic blood pressure and significantly lower HDL-cholesterol than controls. With the exception of triglycerides at age 60+ in men, and glucose in women at various ages, these differences were present at every age. Differences in BMI and waist circumference between samples, although dramatic, could not explain all differences in diastolic blood pressure, HDL-cholesterol or triglycerides but did explain differences in glucose. Psychosis has the hallmarks of insulin resistance by at least age 25. The entire syndrome, not just weight, should be a focus of intervention to reduce mortality from cardiovascular disease.	[Foley, Debra L.; Mackinnon, Andrew] Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic 3010, Australia; [Foley, Debra L.; Mackinnon, Andrew] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic 3010, Australia; [Watts, Gerald F.] Univ Western Australia, Lipid Disorders Clin, Metab Res Ctr, Nedlands, WA 6009, Australia; [Watts, Gerald F.] Univ Western Australia, Dept Internal Med, Royal Perth Hosp, Nedlands, WA 6009, Australia; [Watts, Gerald F.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Shaw, Jonathan E.; Magliano, Dianna J.] Baker IDI Heart & Diabet Inst, Dept Clin Diabet & Epidemiol, Melbourne, Vic, Australia; [Castle, David J.] St Vincents Hosp, Melbourne, Vic, Australia; [Castle, David J.] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia; [McGrath, John J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Waterreus, Anna; Morgan, Vera A.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia; [Galletly, Cherrie A.] Univ Adelaide, Discipline Psychiat, Sch Med, Adelaide, SA 5005, Australia; [Galletly, Cherrie A.] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; University of Melbourne; University of Queensland; University of Western Australia; University of Adelaide	Foley, DL (corresponding author), Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic 3010, Australia.	foley.debra@gmail.com	Shaw, Jonathan/E-7388-2010; Morgan, Vera/U-4851-2019; McGrath, John Joseph/G-5493-2010	Shaw, Jonathan/0000-0002-6187-2203; McGrath, John Joseph/0000-0002-4792-6068; Waterreus, Anna/0000-0002-1648-7701; Magliano, Dianna/0000-0002-9507-6096; Mackinnon, Andrew/0000-0003-0831-9801; Watts, Gerald/0000-0003-2276-1524	Australian Government Department of Health and Ageing; Commonwealth Dept of Health and Aged Care; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca; Aventis Pharmaceutical; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly [Aust] Pty Ltd; GlaxoSmithKline; Janssen-Cilag [Aust] Pty Ltd; Merck Lipha s.a.; Merck Sharp Dohme [Aust]; Novartis Pharmaceutical [Aust] Pty Ltd.; Novo Nordisk Pharmaceutical Pty Ltd; Pharmacia and Upjohn Pty Ltd; Pfizer Pty Ltd; Roche Diagnostics; Sanofi Synthelabo [Aust] Pty Ltd.; Servier Laboratories [Aust] Pty Ltd; BioRad Laboratories Pty Ltd; HITECH Pathology Pty Ltd; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia [Northern Territory]; Queensland Health; South Australian Department of Human Services; Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Victorian OIS program; Health Department of Western Australia; Colonial Foundation [Australia]	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Dept of Health and Aged Care; Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca(AstraZeneca); Aventis Pharmaceutical; Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly [Aust] Pty Ltd(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag [Aust] Pty Ltd; Merck Lipha s.a.; Merck Sharp Dohme [Aust](Merck & Company); Novartis Pharmaceutical [Aust] Pty Ltd.; Novo Nordisk Pharmaceutical Pty Ltd(Novo Nordisk); Pharmacia and Upjohn Pty Ltd; Pfizer Pty Ltd(Pfizer); Roche Diagnostics; Sanofi Synthelabo [Aust] Pty Ltd.; Servier Laboratories [Aust] Pty Ltd; BioRad Laboratories Pty Ltd; HITECH Pathology Pty Ltd; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia [Northern Territory]; Queensland Health; South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA)); Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Victorian OIS program; Health Department of Western Australia; Colonial Foundation [Australia]	The psychosis survey [the SHIP study] was funded by the Australian Government Department of Health and Ageing under contract to The University of Western Australia. The general population survey [the AusDiab study] was funded by The Commonwealth Dept of Health and Aged Care, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Aventis Pharmaceutical, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly [Aust] Pty Ltd, GlaxoSmithKline, Janssen-Cilag [Aust] Pty Ltd, Merck Lipha s.a., Merck Sharp & Dohme [Aust], Novartis Pharmaceutical [Aust] Pty Ltd., Novo Nordisk Pharmaceutical Pty Ltd, Pharmacia and Upjohn Pty Ltd, Pfizer Pty Ltd, Roche Diagnostics, Sanofi Synthelabo [Aust] Pty Ltd., Servier Laboratories [Aust] Pty Ltd, BioRad Laboratories Pty Ltd, HITECH Pathology Pty Ltd, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia [Northern Territory], Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services, Victorian Department of Human Services, the Victorian OIS program and Health Department of Western Australia. Drs Foley and Mackinnon were supported by the Colonial Foundation [Australia]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; [Anonymous], AUSDIAB REP 2000; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Cohen D, 2011, NEUROPSYCHOPHARMACOL, V36, P2368, DOI 10.1038/npp.2011.94; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; De Hert M, 2011, BRIT J PSYCHIAT, V199, P99, DOI 10.1192/bjp.bp.110.084665; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Galletly CA, 2012, AUST NZ J PSYCHIAT, V46, P753, DOI 10.1177/0004867412453089; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Mitchell AJ, 2012, PSYCHOL MED, V42, P125, DOI 10.1017/S003329171100105X; Morgan VA, 2012, AUST NZ J PSYCHIAT, V46, P735, DOI 10.1177/0004867412449877; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Moser DJ, 2002, AM J PSYCHIAT, V159, P1201, DOI 10.1176/appi.ajp.159.7.1201; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Newson R., 2000, STATA TECHNICAL B, V57, P20; Nielsen J, 2010, NEUROPSYCHOPHARMACOL, V35, P1997, DOI 10.1038/npp.2010.78; Polymeropoulos MH, 2009, SCHIZOPHR RES, V108, P134, DOI 10.1016/j.schres.2008.11.025; Remington G, 1998, BRIT J PSYCHIAT, V172, P66, DOI 10.1192/S0007125000297687; Remington G, 2011, J CLIN PSYCHIAT, V72, P1042, DOI 10.4088/JCP.09m05866yel; Remington G, 2010, SCHIZOPHRENIA BULL, V36, P900, DOI 10.1093/schbul/sbq083; Roberts LW, 2000, AM J PSYCHIAT, V157, P67, DOI 10.1176/ajp.157.1.67; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Stroup TS, 2011, AM J PSYCHIAT, V168, P947, DOI 10.1176/appi.ajp.2011.10111609; Tauscher J, 2001, CNS DRUGS, V15, P671, DOI 10.2165/00023210-200115090-00001; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; World Health Organization, 2008, ICD 10 INT STAT CLAS; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	38	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82606	10.1371/journal.pone.0082606	http://dx.doi.org/10.1371/journal.pone.0082606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367528	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300044
J	Hanafusa, S; Kawaguchi, T; Umezaki, Y; Tomioka, K; Yoshii, T				Hanafusa, Shiho; Kawaguchi, Tomoaki; Umezaki, Yujiro; Tomioka, Kenji; Yoshii, Taishi			Sexual Interactions Influence the Molecular Oscillations in DN1 Pacemaker Neurons in Drosophila melanogaster	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; CLOCK NEURONS; CIRCADIAN CLOCK; PERIOD; RHYTHMS; LIGHT; TEMPERATURE; GENE; CRYPTOCHROME; DRIVE	Circadian rhythms can synchronize to environmental time cues, such as light, temperature, humidity, and food availability. Previous studies have suggested that these rhythms can also be entrained by social interactions. Here, we used Drosophila melanogaster as a model to study the influence of socio-sexual interactions on the circadian clock in behavior and pacemaker neurons. If two flies of opposite sex were paired and kept in a small space, the daily activity patterns of the two flies were clearly different from the sum of the activity of single male and female flies. Compared with single flies, paired flies were more active in the night and morning, were more active during females' active phase, and were less active during males' active phase. These behavioral phenotypes are related to courtship behavior, but not to the circadian clock. Nevertheless, in male-female pairs of flies with clocks at different speeds ( wild-type and per(S) flies), clock protein cycling in the DN1 pacemaker neurons in the male brain were slightly influenced by their partners. These results suggest that sexual interactions between male-female couples can serve as a weak zeitgeber for the DN1 pacemaker neurons, but the effect is not sufficient to alter rhythms of behavioral activity.	[Hanafusa, Shiho; Kawaguchi, Tomoaki; Umezaki, Yujiro; Tomioka, Kenji; Yoshii, Taishi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Okayama University	Yoshii, T (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	yoshii@okayama-u.ac.jp	Yoshii, Taishi/C-2766-2015; Tomioka, Kenji/B-2632-2011	Yoshii, Taishi/0000-0002-7057-7986; Tomioka, Kenji/0000-0001-7951-8950	Sumitomo Foundation; Inamori Foundation; Ryobi Teien Memory Foundation;  [KAKENHI 23870021];  [25840121];  [KAKENHI 19657027];  [23657056]; Grants-in-Aid for Scientific Research [23657056] Funding Source: KAKEN	Sumitomo Foundation; Inamori Foundation; Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Inamori Foundation, Ryobi Teien Memory Foundation and research grants from Grants-in-Aid for Scientific Research (KAKENHI 23870021 and 25840121 to TY, and KAKENHI 19657027 and 23657056 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam S, 2008, J INSECT PHYSIOL, V54, P1205, DOI 10.1016/j.jinsphys.2008.05.001; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0035; Bywalez W, 2012, CHRONOBIOL INT, V29, P395, DOI 10.3109/07420528.2012.668505; Castillo-Ruiz A, 2012, PROG BRAIN RES, V199, P267, DOI 10.1016/B978-0-444-59427-3.00016-2; Choi C, 2010, CURR BIOL, V20, pR322, DOI 10.1016/j.cub.2010.02.036; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamasaka Y, 2010, GENES CELLS, V15, P1240, DOI 10.1111/j.1365-2443.2010.01456.x; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kistenpfennig C, 2012, J BIOL RHYTHM, V27, P117, DOI 10.1177/0748730411434390; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Lone SR, 2012, J BIOL RHYTHM, V27, P107, DOI 10.1177/0748730411434384; Lone SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028336; Lone SR, 2011, J EXP BIOL, V214, P3742, DOI 10.1242/jeb.057554; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84495	10.1371/journal.pone.0084495	http://dx.doi.org/10.1371/journal.pone.0084495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367668	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300145
J	Hicks, SL; Sharma, R; Khan, AN; Berna, CM; Waldecker, A; Talbot, K; Kennard, C; Turner, MR				Hicks, Stephen L.; Sharma, Rakesh; Khan, Amad N.; Berna, Claire M.; Waldecker, Andrea; Talbot, Kevin; Kennard, Chris; Turner, Martin R.			An Eye-Tracking Version of the Trail-Making Test	PLOS ONE			English	Article							EXECUTIVE DYSFUNCTION; PART-B; DISEASE; FMRI; AGE	The neurodegenerative disorder amyotrophic lateral sclerosis may render patients unable to speak or write, so that objective assessment of cognitive impairment, which is commonly of a dysexecutive nature, is challenging. There is therefore a need to develop other methods of assessment that utilize other relatively unaffected motor systems. In this proof-of-principle study a novel eye-tracking version of the trail-making test was compared with performance on the standard written version in a group of healthy volunteers. There was good correlation for speed between both versions of Part B (R-2=0.73), suggesting that this is a viable method to objectively assess cognitive impairment in disorders where patients are unable to speak or write.	[Hicks, Stephen L.; Sharma, Rakesh; Khan, Amad N.; Berna, Claire M.; Waldecker, Andrea; Talbot, Kevin; Kennard, Chris; Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of Oxford	Turner, MR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	martin.turner@ndcn.ox.ac.uk		Turner, Martin/0000-0003-0267-3180; Talbot, Kevin/0000-0001-5490-1697	Rhodes Foundation; Wellcome Trust; Medical Research Council; Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship; NIHR Biomedical Research Centre, Oxford; MRC [MR/K01014X/1, G0701923] Funding Source: UKRI; Medical Research Council [MR/K01014X/1, G0701923] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish	Rhodes Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association	This work was supported by the Rhodes Foundation (RS), Wellcome Trust (SH, CB, CK), Medical Research Council & Motor Neuron Disease Association Lady Edith Wolfson Clinician Fellowship (MRT), and the NIHR Biomedical Research Centre, Oxford (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; ABRAHAMS S, 2013, AMYOTROPH LATERAL SC; Antoniades CA, 2010, J NEUROL, V257, P1890, DOI 10.1007/s00415-010-5632-2; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Army Individual Test Battery, 1994, MAN DIR SCOR; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; D'Elia L., 1989, COLOR TRAILS 1 2; Drapeau CE, 2007, PERCEPT MOTOR SKILL, V104, P785, DOI 10.2466/PMS.104.3.785-791; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; HARTIKAINEN P, 1993, J NEURAL TRANSM-PARK, V6, P127, DOI 10.1007/BF02261006; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kilani M, 2004, AMYOTROPH LATERAL SC, V5, P46, DOI 10.1080/14660820310017560; KOLIND S, 2013, AMYOTROPH LATERAL SC; Kuhlman A, 2006, J CLIN EXP NEUROPSYC, V28, P126, DOI 10.1080/13803390590929289; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	25	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84061	10.1371/journal.pone.0084061	http://dx.doi.org/10.1371/journal.pone.0084061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367626	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300126
J	Saridaki, Z; Tzardi, M; Sfakianaki, M; Papadaki, C; Voutsina, A; Kalykaki, A; Messaritakis, I; Mpananis, K; Mavroudis, D; Stathopoulos, E; Georgoulias, V; Souglakos, J				Saridaki, Zacharenia; Tzardi, Maria; Sfakianaki, Maria; Papadaki, Chara; Voutsina, Alexandra; Kalykaki, Aristea; Messaritakis, Ippokratis; Mpananis, Kyriakos; Mavroudis, Dimitris; Stathopoulos, Efstathios; Georgoulias, Vassilis; Souglakos, John			BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients' Outcome	PLOS ONE			English	Article							CETUXIMAB PLUS IRINOTECAN; BRAF V600E MUTATION; COLON-CANCER; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; SURVIVAL; KRAS; EXPRESSION	Background: To prospectively evaluate the usefulness of the BRAFV600E mutation detection in daily clinical practice in patients with metastatic Colorectal Cancer (mCRC). Patients and Methods: 504 mCRC patients treated with systemic chemotherapy +/- biologics were analyzed. Results: A statistically significant higher incidence of the BRAF mutation was observed in patients with ECOG-PS 2 (p=0.001), multiple metastatic sites (p=0.002),> 65 years old (p=0.004), primary tumors located in the colon (p<0.001), high-grade tumors (p=0.001) and in those with mucinous features (p=0.037). Patients with BRAFV600E mutated tumors had a statistically significantly reduced progression-free survival (PFS) compared to wild-type (wt) ones (4.1 and 11.6 months, respectively; p<0.001) and overall survival (OS) (14.0 vs. 34.6 months, respectively; p<0.001). In the multivariate analysis the BRAFV600E mutation emerged as an independent factor associated with reduced PFS (HR: 4.1, 95% CI 2.7-6.2; p<0.001) and OS (HR: 5.9, 95% CI 3.7-9.5; p<0.001). Among the 273 patients treated with salvage cetuximab or panitumumab, the BRAFV600E mutation was correlated with reduced PFS (2.2 vs. 6.0 months; p<0.0001) and OS (4.3 vs. 17.4 months; p<0.0001). Conclusions: The presence of BRAFV600E-mutation in mCRC characterizes a subgroup of patients with distinct biologic, clinical and pathological features and is associated with very poor patients' prognosis.	[Saridaki, Zacharenia; Sfakianaki, Maria; Papadaki, Chara; Voutsina, Alexandra; Kalykaki, Aristea; Messaritakis, Ippokratis; Mpananis, Kyriakos; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Saridaki, Zacharenia; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria; Stathopoulos, Efstathios] Univ Gen Hosp, Pathol Lab, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Souglakos, J (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019	Messaritakis, Ippokratis/0000-0003-1877-500X; PAPADAKI, CHARA/0000-0002-4591-3757	Cretan Association for Biomedical Research (CABR); Hellenic Society for Medical Oncology (HeSMO); CABR	Cretan Association for Biomedical Research (CABR); Hellenic Society for Medical Oncology (HeSMO); CABR	This work was partly supported by a grant from the Cretan Association for Biomedical Research (CABR) and the Hellenic Society for Medical Oncology (HeSMO). Z.S., I.M. and A.V. are recipients of a CABR post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Oliner KS, 2013, J CLIN ONCOL, V31; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Pentheroudakis G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-49; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Saridaki Z, 2010, BRIT J CANCER, V102, P1762, DOI 10.1038/sj.bjc.6605694; Saridaki Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015980; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wang L, 2003, CANCER RES, V63, P5209	23	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84604	10.1371/journal.pone.0084604	http://dx.doi.org/10.1371/journal.pone.0084604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367680	gold, Green Submitted, Green Published			2022-12-25	WOS:000328740300151
J	Selden, C; Spearman, CW; Kahn, D; Miller, M; Figaji, A; Erro, E; Bundy, J; Massie, I; Chalmers, SA; Arendse, H; Gautier, A; Sharratt, P; Fuller, B; Hodgson, H				Selden, Clare; Spearman, Catherine Wendy; Kahn, Delawir; Miller, Malcolm; Figaji, Anthony; Erro, Eloy; Bundy, James; Massie, Isobel; Chalmers, Sherri-Ann; Arendse, Hiram; Gautier, Aude; Sharratt, Peter; Fuller, Barry; Hodgson, Humphrey			Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in a Translational Setting	PLOS ONE			English	Article							ACUTE HEPATIC-FAILURE; HEPG2 CELLS; ALGINATE; SUPPORT; BIOREACTOR; SYSTEM; MODEL; TRIAL; LINES; THROMBOELASTOGRAPHY	Liver failure is an increasing problem. Donor-organ shortage results in patients dying before receiving a transplant. Since the liver can regenerate, alternative therapies providing temporary liver-support are sought. A bioartificial-liver would temporarily substitute function in liver failure buying time for liver regeneration/organ-procurement. Our aim: to develop a prototype bioartificial-liver-machine (BAL) comprising a human liver-derived cell-line, cultured to phenotypic competence and deliverable in a clinical setting to sites distant from its preparation. The objective of this study was to determine whether its use would improve functional parameters of liver failure in pigs with acute liver failure, to provide proof-of-principle. HepG2cells encapsulated in alginate-beads, proliferated in a fluidised-bed-bioreactor providing a biomass of 4-6x10(10) cells, were transported from preparation-laboratory to point-of-use operating theatre (6000miles) under perfluorodecalin at ambient temperature. Irreversible ischaemic liver failure was induced in anaesthetised pigs, after portal-systemic-shunt, by hepatic-artery-ligation. Biochemical parameters, intracranial pressure, and functional-clotting were measured in animals connected in an extracorporeal bioartificial-liver circuit. Efficacy was demonstrated comparing outcomes between animals connected to a circuit containing alginate-encapsulated cells (Cell-bead BAL), and those connected to circuit containing alginate capsules without cells (Empty-bead BAL). Cells of the biomass met regulatory standards for sterility and provenance. All animals developed progressive liver-failure after ischaemia induction. Efficacy of BAL was demonstrated since animals connected to a functional biomass (+cells) had significantly smaller rises in intracranial pressure, lower ammonia levels, more bilirubin conjugation, improved acidosis and clotting restoration compared to animals connected to the circuit without cells. In the +cell group, human proteins accumulated in pigs' plasma. Delivery of biomass using a short-term cold-chain enabled transport and use without loss of function over 3days. Thus, a fluidised-bed bioreactor containing alginate-encapsulated HepG2cell-spheroids improved important parameters of acute liver failure in pigs. The system can readily be up-scaled and transported to point-of-use justifying development at clinical scale.	[Selden, Clare; Erro, Eloy; Bundy, James; Massie, Isobel; Chalmers, Sherri-Ann; Gautier, Aude; Hodgson, Humphrey] UCL, Sch Med, Inst Liver & Digest Hlth, London, England; [Spearman, Catherine Wendy] Univ Cape Town, Dept Med, Div Hepatol, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Kahn, Delawir; Arendse, Hiram] Univ Cape Town, Dept Surg, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Miller, Malcolm] Univ Cape Town, Dept Anaesthet, Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Figaji, Anthony] Univ Cape Town, Dept Neurosurg, Red Cross Childrens Hosp, ZA-7925 Cape Town, Western Cape, South Africa; [Sharratt, Peter] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Fuller, Barry] UCL, Sch Med, Div Surg & Intervent Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cambridge; University of London; University College London; UCL Medical School	Selden, C (corresponding author), UCL, Sch Med, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England.	c.selden@ucl.ac.uk	Miller, Malcolm/AAR-5783-2021; Figaji, Anthony/ADH-9410-2022; Spearman, C.Wendy/R-8173-2019	Miller, Malcolm/0000-0001-6137-7723; Figaji, Anthony/0000-0002-3357-6490; Erro Barbarin, Eloy/0000-0002-3558-4216; Spearman, Catherine Wendy/0000-0003-3199-301X; Selden, Angela/0000-0003-2648-443X	National Institute for Health Research [NEAT L002]; Liver Group Charity: BXHJ; Peter Stebbings Memorial Trust; Weston Foundation; Eranda Foundation; Wellcome Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); Liver Group Charity: BXHJ; Peter Stebbings Memorial Trust; Weston Foundation; Eranda Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	National Institute for Health Research: NEAT L002 (http://www.nihr.ac.uk/Pages/default.aspx); Liver Group Charity: BXHJ.(http://www.ucl.ac.uk/livergroup/); Peter Stebbings Memorial Trust; Weston Foundation, (http://www.garfieldweston.org/); Eranda Foundation; Wellcome Trust, (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banares R, 2010, J HEPATOL, V52, pS459; BODE BP, 1994, ANN SURG, V220, P411, DOI 10.1097/00000658-199410000-00001; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; CAI ZH, 1988, ARTIF ORGANS, V12, P388, DOI 10.1111/j.1525-1594.1988.tb02793.x; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Chang SJ, 1999, J BIOMAT SCI-POLYM E, V10, P531; Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x; Coward SM, 2005, ARTIF ORGANS, V29, P152, DOI 10.1111/j.1525-1594.2005.29026.x; David B, 2004, INT J ARTIF ORGANS, V27, P284, DOI 10.1177/039139880402700404; Detry O, 2007, HEPATO-GASTROENTEROL, V54, P2109; DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4; Erro E, 2011, J HEPATOL, V54, pS427; Erro E, 2010, J HEPATOL, V52, pS322, DOI 10.1016/S0168-8278(10)60827-6; Erro E, 2009, INT J ARTIF ORGANS, V32, P407; Erro E, 2013, BIORESEARCH OPEN ACC, V2, P1, DOI 10.1089/biores.2012.0286; Hillebrand DJ, 2010, J HEPATOL, V52, pS323, DOI 10.1016/S0168-8278(10)60830-6; Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5; Klein SM, 2000, ANESTH ANALG, V91, P1091, DOI 10.1097/00000539-200011000-00009; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; Massie I, 2012, TISSUE ENG C; Massie I, 2011, TISSUE ENG PART C-ME, V17, P765, DOI [10.1089/ten.tec.2010.0394, 10.1089/ten.TEC.2010.0394]; Massie I, 2011, CRYOLETTERS, V32, P158; Mavri-Damelin D, 2008, BIOTECHNOL BIOENG, V99, P644, DOI 10.1002/bit.21599; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; Miyashita T, 2003, SURG TODAY, V33, P743, DOI 10.1007/s00595-003-2599-y; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Nibourg GAA, 2012, EXPERT OPIN BIOL TH, V12, P905, DOI 10.1517/14712598.2012.685714; Nieuwoudt M, 2006, BIOMATERIALS, V27, P3836, DOI 10.1016/j.biomaterials.2006.02.013; Nyberg SL, 2012, LIVER TRANSPLANT, V18, pS10, DOI 10.1002/lt.23506; Poyck PPC, 2007, INT J ARTIF ORGANS, V30, P183, DOI 10.1177/039139880703000302; Rahman TM, 2004, ARTIF ORGANS, V28, P476, DOI 10.1111/j.1525-1594.2004.07259.x; Rahman TM, 2000, INT J EXP PATHOL, V81, P145; Rifai Kinan, 2011, Liver Int, V31 Suppl 3, P13, DOI 10.1111/j.1478-3231.2011.02595.x; Roussel JC, 2008, AM J TRANSPLANT, V8, P1101, DOI 10.1111/j.1600-6143.2008.02210.x; Sauer IM, 2003, J HEPATOL, V39, P649, DOI 10.1016/S0168-8278(03)00348-9; Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x; Selden C, 2000, INT J ARTIF ORGANS, V23, P774, DOI 10.1177/039139880002301107; Sosef MN, 2002, TRANSPLANTATION, V73, P204, DOI 10.1097/00007890-200201270-00009; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Stange J, 2011, LIVER TRANSPLANT, V17, P705, DOI 10.1002/lt.22237; STARZL TE, 1975, AM J SURG, V129, P587, DOI 10.1016/0002-9610(75)90323-2; Stevens AC, 2001, HEPATOLOGY, V34, p299A; Tomori T, 2010, BLOOD COAGUL FIBRIN, V21, P20, DOI 10.1097/MBC.0b013e32833113e9; Van de Kerkhove MP, 2002, INT J ARTIF ORGANS, V25, P950, DOI 10.1177/039139880202501009; WOOD RP, 1993, TRANSPLANT P, V25, P53	45	29	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82312	10.1371/journal.pone.0082312	http://dx.doi.org/10.1371/journal.pone.0082312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367515	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300031
J	Shapter, FM; Cross, M; Ablett, G; Malory, S; Chivers, IH; King, GJ; Henry, RJ				Shapter, Frances M.; Cross, Michael; Ablett, Gary; Malory, Sylvia; Chivers, Ian H.; King, Graham J.; Henry, Robert J.			High-Throughput Sequencing and Mutagenesis to Accelerate the Domestication of Microlaena stipoides as a New Food Crop	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; RICE DOMESTICATION; MUTATIONS; GRASSES; BARLEY; POPULATION; DISCOVERY; RELATIVES; GENETICS; GENES	Global food demand, climatic variability and reduced land availability are driving the need for domestication of new crop species. The accelerated domestication of a rice-like Australian dryland polyploid grass, Microlaena stipoides (Poaceae), was targeted using chemical mutagenesis in conjunction with high throughput sequencing of genes for key domestication traits. While M. stipoides has previously been identified as having potential as a new grain crop for human consumption, only a limited understanding of its genetic diversity and breeding system was available to aid the domestication process. Next generation sequencing of deeply-pooled target amplicons estimated allelic diversity of a selected base population at 14.3 SNP/Mb and identified novel, putatively mutation-induced polymorphisms at about 2.4 mutations/Mb. A 97% lethal dose (LD97) of ethyl methanesulfonate treatment was applied without inducing sterility in this polyploid species. Forward and reverse genetic screens identified beneficial alleles for the domestication trait, seed-shattering. Unique phenotypes observed in the M2 population suggest the potential for rapid accumulation of beneficial traits without recourse to a traditional cross-breeding strategy. This approach may be applicable to other wild species, unlocking their potential as new food, fibre and fuel crops.	[Shapter, Frances M.; Cross, Michael; Ablett, Gary; Malory, Sylvia; Chivers, Ian H.; King, Graham J.] So Cross Univ, Lismore, NSW 2480, Australia; [Chivers, Ian H.] Native Seeds Pty Ltd, Sandringham, Vic, Australia; [Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia	Southern Cross University; University of Queensland	Shapter, FM (corresponding author), So Cross Univ, Lismore, NSW 2480, Australia.	frances.shapter@scu.edu.au	Shapter, Frances M/A-3094-2014; Henry, Robert J/B-5824-2008; King, Graham J/AAW-3368-2020	Shapter, Frances M/0000-0001-8562-6034; Henry, Robert J/0000-0002-4060-0292; King, Graham J/0000-0002-5975-6051	Australian Research Council [LP0776409]	Australian Research Council(Australian Research Council)	Funding for this research was provided by the Australian Research Council Linkage program (Project number LP0776409,www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Aoki D, 2009, WEED BIOL MANAG, V9, P225, DOI 10.1111/j.1445-6664.2009.00343.x; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Cordeiro G, 2006, ANAL BIOCHEM, V355, P145, DOI 10.1016/j.ab.2006.03.026; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; DAVIS C, 2005, RURAL IND RES DEV CO, P1; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Fitzgerald TL, 2011, P NATL ACAD SCI USA, V108, P21140, DOI 10.1073/pnas.1115203108; Greene EA, 2003, GENETICS, V164, P731; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; Henry R., 2010, PLANT RESOURCES FOOD; Huxtable CHA, 1990, THESIS U NEW ENGLAND; Izawa T, 2009, CURR OPIN PLANT BIOL, V12, P185, DOI 10.1016/j.pbi.2009.01.004; Kellogg EA, 2009, RICE, V2, P1, DOI 10.1007/s12284-009-9022-2; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; King GJ, 1995, J MOL EVOL, V41, P732; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Malory S, 2011, PLANT BIOTECHNOL J, V9, P1131, DOI 10.1111/j.1467-7652.2011.00640.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MESKEN M, 1968, EUPHYTICA, V17, P363, DOI 10.1007/BF00056237; MUNDY J, 1983, CARLSBERG RES COMMUN, V48, P81, DOI 10.1007/BF02906171; Murray BG, 2005, ANN BOT-LONDON, V96, P1293, DOI 10.1093/aob/mci281; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Pienaar E, 2006, COMPUT BIOL CHEM, V30, P102, DOI 10.1016/j.compbiolchem.2005.11.002; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sexton T, 2013, MOL MARKERS PLANTS, P35; Shapter FM, 2009, J CEREAL SCI, V49, P4, DOI 10.1016/j.jcs.2008.06.013; Shapter F. M., 2008, Plant Genetic Resources Characterization and Utilization, V6, P85, DOI 10.1017/S1479262108986512; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Tindale NormanB., 1977, STONE TOOLS CULTURAL; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Turner Fred, 1895, AUSTR GRASSES; van Harten A.M., 1998, MUTATION BREEDING TH; Vaughan DA, 2007, ANN BOT-LONDON, V100, P893, DOI 10.1093/aob/mcm224	50	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82641	10.1371/journal.pone.0082641	http://dx.doi.org/10.1371/journal.pone.0082641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367532	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300048
J	Shiotani, A; Murao, T; Fujita, Y; Fujimura, Y; Sakakibara, T; Nishio, K; Haruma, K				Shiotani, Akiko; Murao, Takahisa; Fujita, Yoshihiko; Fujimura, Yoshinori; Sakakibara, Takashi; Nishio, Kazuto; Haruma, Ken			Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding	PLOS ONE			English	Article							PEPTIC-ULCER; INJURY; RISK; DRUGS; GENE; RATS	Background: Aspirin-induced enteropathy is now increasingly being recognized although the pathogenesis of small intestinal damage induced by aspirin is not well understood and related risk factors have not been established. Aim: To investigate pharmacogenomic profile of low dose aspirin (LDA)-induced small bowel bleeding. Methods: Genome-wide analysis of single nucleotide polymorphisms (SNPs) was performed using the Affymetrix DMET (TM) Plus Premier Pack. Genotypes of candidate genes associated with small bowel bleeding were determined using TaqMan SNP Genotyping Assay kits and direct sequencing. Results: In the validation study in overall 37 patients with small bowel bleeding and 400 controls, 4 of 27 identified SNPs: CYP4F11 (rs1060463) GG (p=0.003), CYP2D6 (rs28360521) GG (p=0.02), CYP24A1 (rs4809957) T allele (p=0.04), and GSTP1 (rs1695) G allele (p=0.04) were significantly more frequent in the small bowel bleeding group compared to the controls. After adjustment for significant factors, CYP2D6 (rs28360521) GG (OR 4.11, 95% CI. 1.62 -10.4) was associated with small bowel bleeding. Conclusions: CYP4F11 and CYP2D6 SNPs may identify patients at increased risk for aspirin-induced small bowel bleeding.	[Shiotani, Akiko; Murao, Takahisa; Haruma, Ken] Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama, Japan; [Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka, Japan; [Fujimura, Yoshinori; Sakakibara, Takashi] Sakakibara Heart Inst Okayama, Dept Gastroenterol, Okayama, Japan	Kawasaki Medical School; Kindai University (Kinki University)	Shiotani, A (corresponding author), Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama, Japan.	shiotani@med.kawasaki-m.ac.jp			Kawasaki Medical School [23590930, 23B-11, 24B-80, 25B-36]	Kawasaki Medical School	This study was supported by Grant-in-Aid for Scientific Research (C) 23590930 and Research Project Grant (23B-11, 24B-80, and 25B-36) from Kawasaki Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Cooke GE, 2006, EXPERT OPIN DRUG SAF, V5, P815, DOI 10.1517/14740338.5.6.815; Dagle JM, 2011, J PEDIATR-US, V159, P104, DOI 10.1016/j.jpeds.2011.01.002; Dai XM, 2009, REV CARDIOVASC MED, V10, P14; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Endo H, 2009, J GASTROENTEROL, V44, P544, DOI 10.1007/s00535-009-0040-z; Endo H, 2009, DIGESTION, V79, P44, DOI 10.1159/000204465; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Hirata Y, 2011, SCAND J GASTROENTERO, V46, P803, DOI 10.3109/00365521.2011.568522; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; KENT TH, 1969, AM J PATHOL, V54, P237; Nadatani Y, 2013, SCAND J GASTROENTERO, V48, P320, DOI 10.3109/00365521.2012.758771; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Shiotani A, 2008, J GASTROENTEROL, V43, P581, DOI 10.1007/s00535-008-2206-5; Shiotani A, 2012, DIGEST LIVER DIS, V44, P201, DOI 10.1016/j.dld.2011.10.005; Shiotani A, 2011, DIGEST DIS SCI, V56, P465, DOI 10.1007/s10620-010-1382-3; Shiotani A, 2010, J GASTROEN HEPATOL, V25, pS31, DOI 10.1111/j.1440-1746.2009.06212.x; Shiotani A, 2009, J GASTROENTEROL, V44, P126, DOI 10.1007/s00535-008-2290-6; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Tan VP, 2009, CARDIOVASC REVASCULA, V10, P36, DOI 10.1016/j.carrev.2008.11.001; van Oijen MGH, 2006, DIGEST DIS SCI, V51, P2348, DOI 10.1007/s10620-006-9475-8; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; WAX J, 1970, GASTROENTEROLOGY, V58, P772; WHITTLE BJR, 1995, BRIT J PHARMACOL, V116, P2286, DOI 10.1111/j.1476-5381.1995.tb15066.x; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	32	22	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84244	10.1371/journal.pone.0084244	http://dx.doi.org/10.1371/journal.pone.0084244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367646	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300134
J	Sommese, RF; Nag, S; Sutton, S; Miller, SM; Spudich, JA; Ruppel, KM				Sommese, Ruth F.; Nag, Suman; Sutton, Shirley; Miller, Susan M.; Spudich, James A.; Ruppel, Kathleen M.			Effects of Troponin T Cardiomyopathy Mutations on the Calcium Sensitivity of the Regulated Thin Filament and the Actomyosin Cross-Bridge Kinetics of Human beta-Cardiac Myosin	PLOS ONE			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; PYRENE-LABELED TROPOMYOSIN; DILATED CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; MUSCLE-CONTRACTION; TRANSGENIC MICE; F-ACTIN; BINDING; MUTANTS; DISEASE	w Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) lead to significant cardiovascular morbidity and mortality worldwide. Mutations in the genes encoding the sarcomere, the force-generating unit in the cardiomyocyte, cause familial forms of both HCM and DCM. This study examines two HCM-causing (I79N, E163K) and two DCM-causing (R141W, R173W) mutations in the troponin T subunit of the troponin complex using human beta-cardiac myosin. Unlike earlier reports using various myosin constructs, we found that none of these mutations affect the maximal sliding velocities or maximal Ca2+-activated ADP release rates involving the thin filament human b-cardiac myosin complex. Changes in Ca2+ sensitivity using the human myosin isoform do, however, mimic changes seen previously with non-human myosin isoforms. Transient kinetic measurements show that these mutations alter the kinetics of Ca2+ induced conformational changes in the regulatory thin filament proteins. These changes in calcium sensitivity are independent of active, cycling human b-cardiac myosin.	[Sommese, Ruth F.; Nag, Suman; Sutton, Shirley; Spudich, James A.; Ruppel, Kathleen M.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Miller, Susan M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ruppel, Kathleen M.] Stanford Univ, Dept Pediat Cardiol, Sch Med, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	jspudich@stanford.edu; kruppel@stanford.edu			National Institutes of Health [GM33289]; Human Frontier Science Program Research Grant Program [RGP0054/2009-C]; Stanford Interdisciplinary Graduate Fellowship; Stanford Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Research Grant Program; Stanford Interdisciplinary Graduate Fellowship; Stanford Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM33289 and Human Frontier Science Program Research Grant Program (RGP0054/2009-C) to J.A.S., Stanford Interdisciplinary Graduate Fellowship awarded to R. F. S., and Stanford Dean's Postdoctoral Fellowship to S.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P4239, DOI 10.1007/s00018-012-1111-5; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRACEFFA P, 1980, J BIOL CHEM, V255, P1296; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Hershberger R, 2013, FAMILIAL DILATED CAR; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; HOFMANN PA, 1987, AM J PHYSIOL, V253, pC541, DOI 10.1152/ajpcell.1987.253.4.C541; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; ISHII Y, 1991, J BIOL CHEM, V266, P6894; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kobayashi M, 2013, J BIOL CHEM; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lakdawala NK, 2012, CIRC-CARDIOVASC GENE, V5, P503, DOI 10.1161/CIRCGENETICS.112.962761; Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; McDonald KS, 2002, NEWS PHYSIOL SCI, V17, P185, DOI 10.1152/nips.01396.2002; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; PAN BS, 1992, J BIOL CHEM, V267, P23052; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2011, J BIOL CHEM, V286, P1005, DOI 10.1074/jbc.M110.168583; Ramaraj R, 2008, CARDIOL REV, V16, P172, DOI 10.1097/CRD.0b013e318178e525; Redwood C, 2000, CIRC RES, V86, P1146; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; Sich NM, 2010, J BIOL CHEM, V285, P39150, DOI 10.1074/jbc.M110.142232; Sivaramakrishnan S, 2009, J CARDIOVASC TRANSL, V2, P426, DOI 10.1007/s12265-009-9129-2; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Stehle R, 2010, J MOL CELL CARDIOL, V48, P843, DOI 10.1016/j.yjmcc.2009.12.020; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; WU CW, 1976, BIOCHEMISTRY-US, V15, P2863, DOI 10.1021/bi00658a025; Wynne J BE, 1992, BRAUNWALDS HEART DIS, P1394; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	72	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83403	10.1371/journal.pone.0083403	http://dx.doi.org/10.1371/journal.pone.0083403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367593	Green Published, gold			2022-12-25	WOS:000328740300103
J	Dillahunt-Aspillaga, C; Jorgensen-Smith, T; Ehlke, S; Sosinski, M; Monroe, D; Thor, J				Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Ehlke, Sarah; Sosinski, Melanie; Monroe, Douglas; Thor, Jennifer			Traumatic Brain Injury: Unmet Support Needs of Caregivers and Families in Florida	PLOS ONE			English	Article							INDIVIDUALS; VALIDATION; MANAGEMENT; QUALITY; CARERS; PEOPLE; ADULTS; SCALE; LIFE	Sustaining a Traumatic Brain Injury results in familial strain due to the significant impact the injury has upon the role and function of individuals and their families at home and in the community. Using the Stress Process Model of Caregiving, a caregiver needs assessment survey was developed and conducted to better understand the needs of individuals with a Traumatic Brain Injury and their caregivers. Survey results indicate that caregivers experience many challenges including unmet needs in areas of relational supports such as maintaining relationships, long-term emotional and financial support for themselves and the survivor, and the need for a patient or caregiver advocate. Implications for future practice are presented.	[Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Thor, Jennifer] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA; [Monroe, Douglas] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Ehlke, Sarah] Univ N Carolina, Dept Psychol, Wilmington, NC 28401 USA; [Sosinski, Melanie] Univ S Florida, Dept Social Work, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] Brain Injury Assoc Florida Inc, Tallahassee, FL USA; [Monroe, Douglas] WellFlorida Council Inc, Gainesville, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Wilmington; State University System of Florida; University of South Florida	Dillahunt-Aspillaga, C (corresponding author), Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA.	cdillahuntas@usf.edu		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023; Jorgensen Smith, Tammy/0000-0001-6769-7269				Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Family Caregiver Alliance, 2012, FCA FAM CAR ALL NAT; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hassan STS, 2012, HEALTHMED, V6, P2423; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Reinhard S, 2008, PATIENT SAFETY QUALI; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WellFlorida Council Inc, 2012, WHAT IS TRAUM BRAIN; WellFlorida Council Inc, 2007, TRAUM BRAIN INJ STAT; WellFlorida Council Inc, 2010, TBI STAT FLOR; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	37	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82896	10.1371/journal.pone.0082896	http://dx.doi.org/10.1371/journal.pone.0082896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358236	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700039
J	Choudhary, G; Jankowich, M; Wu, WC				Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih			Prevalence and Clinical Characteristics Associated with Pulmonary Hypertension in African-Americans	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; ARTERY SYSTOLIC PRESSURE; UNITED-STATES; RISK-FACTORS; HEART; DYSFUNCTION; SPIROMETRY; MORTALITY; OBESITY; DETERMINANTS	Background: Pulmonary hypertension (PH) is associated with increased mortality and morbidity. It is frequently associated with cardiopulmonary diseases that are prevalent in African Americans (AAs). However, the prevalence or determinants of PH in the AA population is not known. Methods: We conducted a cross-sectional study to estimate the prevalence of PH (defined as trans-tricuspid gradient >= 35 mm Hg) and associated clinical characteristics in AAs using the Jackson Heart Study cohort (n=3,282) who underwent echocardiography and had a measurable trans-tricuspid regurgitant jet. Echocardiography is frequently used for screening for PH despite its limitations in estimating accurate PA systolic pressures. Overall and age-adjusted gender-specific prevalence were estimated and modified Poisson regression was used to identify independent clinical, spirometric, and echocardiographic characteristics associated with PH. Results: The mean age of the study population was 56.1 +/- 12.6 years with 67.5% female. The prevalence of PH was 6.8%, with higher prevalence in female AAs (age-adjusted prevalence: Men 4.9%, 95% CI 3.6-6.2%; Women 7.7%, 95% CI 6.6-8.8%). Pulmonary hypertension prevalence increased with age (Prevalence Ratio: 10.0, 95% CI 4.0-25.1, >65 versus <45 years old), presence of obesity, higher pulse pressure, diabetes, obstructive or restrictive spirometry pattern, and severe left heart valvular disease. Also, PH was significantly associated with left atrial size and left ventricular ejection fraction. Conclusions: Pulmonary hypertension is prevalent in AAs, more in women than in men. The identified cardiopulmonary risk factors that increase the prevalence of PH may assist in diagnosis and management of these at-risk subjects in the AA population.	[Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih] Brown Univ, Warren Alpert Med Sch, Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02912 USA; [Choudhary, Gaurav; Jankowich, Matthew; Wu, Wen-Chih] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Choudhary, G (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02912 USA.	Gaurav_choudhary@brown.edu	Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service [IBX000711A]; Research Enhancement Award Program grant [REA 08-263]; VA Health Services Research and Development Service (W-CW); National Heart, Lung, and Blood Institute [N01-HC-95170, N01-HC-95171, N01HC-95172]; National Institute on Minority Health and Health Disparities; National Institute on Biomedical Imaging and Bioengineering; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095170, N01HC095171, N01HC095172] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Research Enhancement Award Program grant; VA Health Services Research and Development Service (W-CW); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development: Biomedical Laboratory Research and Development Service (MERIT Review Award to GC, IBX000711A); Research Enhancement Award Program grant (REA 08-263) from the VA Health Services Research and Development Service (W-CW). The Jackson Heart Study is supported by contracts N01-HC-95170, N01-HC-95171, N01HC-95172 from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities, with additional support from the National Institute on Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON SV, 1992, ANN INTERN MED, V116, P888, DOI 10.7326/0003-4819-116-11-888; Bogaard Harm J, 2012, Pulm Circ, V2, P148, DOI 10.4103/2045-8932.97592; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; Corp Stata S, 2010, MULT IMP AN US STATA; Enea I, 2010, G ITAL CARDIOL, V11, P402, DOI 10.1714/567.6728; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Fulop T, 2012, SLEEP MED, V13, P1039, DOI 10.1016/j.sleep.2012.06.005; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Guglin M, 2012, INT J CLIN PRACT, V66, P13, DOI 10.1111/ijcp.12008; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Kjaergaard J, 2007, AM J CARDIOL, V99, P1146, DOI 10.1016/j.amjcard.2006.11.052; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Leung CC, 2010, AM J CARDIOL, V106, P284, DOI 10.1016/j.amjcard.2010.02.039; Mannino DM, 2012, INT J TUBERC LUNG D, V16, P1405, DOI 10.5588/ijtld.12.0054; Mannino DM, 2005, INT J TUBERC LUNG D, V9, P613; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubin DB, 2004, MULTIPLE IMPUTATION; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Samdarshi TE, 2009, AM HEART J, V158, P209, DOI 10.1016/j.ahj.2009.05.020; Scarlata S, 2008, RESP MED, V102, P1349, DOI 10.1016/j.rmed.2008.02.021; Setiawan VW, 2006, CANCER EPIDEM BIOMAR, V15, P1849, DOI 10.1158/1055-9965.EPI-06-0307; Shah SJ, 2012, JAMA-J AM MED ASSOC, V308, P1366, DOI 10.1001/jama.2012.12347; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Sweeney L, 2009, EUR J MED RES, V14, P433, DOI 10.1186/2047-783X-14-10-433; Taraseviciute A, 2006, EUR J MED RES, V11, P198; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	33	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84264	10.1371/journal.pone.0084264	http://dx.doi.org/10.1371/journal.pone.0084264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358351	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700159
J	Limburg, KE; Hayden, TA; Pine, WE; Yard, MD; Kozdon, R; Valley, JW				Limburg, Karin E.; Hayden, Todd A.; Pine, William E., III; Yard, Michael D.; Kozdon, Reinhard; Valley, John W.			Of Travertine and Time: Otolith Chemistry and Microstructure Detect Provenance and Demography of Endangered Humpback Chub in Grand Canyon, USA	PLOS ONE			English	Article							COLORADO RIVER; ADAPTIVE MANAGEMENT; GILA-CYPHA; TEMPERATURE; VARIABILITY; DELTA-C-13; CARBON; WATER; MICROCHEMISTRY; POPULATION	We developed a geochemical atlas of the Colorado River in Grand Canyon and in its tributary, the Little Colorado River, and used it to identify provenance and habitat use by Federally Endangered humpback chub, Gila cypha. Carbon stable isotope ratios (delta C-13) discriminate best between the two rivers, but fine scale analysis in otoliths requires rare, expensive instrumentation. We therefore correlated other tracers (SrSr, Ba, and Se in ratio to Ca) to delta C-13 that are easier to quantify in otoliths with other microchemical techniques. Although the Little Colorado River's water chemistry varies with major storm events, at base flow or near base flow (conditions occurring 84% of the time in our study) its chemistry differs sufficiently from the mainstem to discriminate one from the other. Additionally, when fish egress from the natal Little Colorado River to the mainstem, they encounter cold water which causes the otolith daily growth increments to decrease in size markedly. Combining otolith growth increment analysis and microchemistry permitted estimation of size and age at first egress; size at first birthday was also estimated. Emigrants < 1 year old averaged 51.2 +/- 4.4 (SE) days and 35.5 +/- 3.6 mm at egress; older fish that had recruited to the population averaged 100 +/- 7.8 days old and 51.0 +/- 2.2 mm at egress, suggesting that larger, older emigrants recruit better. Back-calculated size at age 1 was unimodal and large (78.2 +/- 3.3 mm) in Little Colorado caught fish but was bimodally distributed in Colorado mainstem caught fish (49.9 +/- 3.6 and 79 +/- 4.9 mm) suggesting that humpback chub can also rear in the mainstem. The study demonstrates the coupled usage of the two rivers by this fish and highlights the need to consider both rivers when making management decisions for humpback chub recovery.	[Limburg, Karin E.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Hayden, Todd A.] Great Lakes Fishery Commiss, Ann Arbor, MI USA; [Pine, William E., III] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Yard, Michael D.] US Geol Survey, Grand Canyon Monitoring & Res Ctr, Southwest Biol Sci Ctr, Flagstaff, AZ USA; [Kozdon, Reinhard; Valley, John W.] Univ Wisconsin, Dept Geosci, Madison, WI USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Limburg, KE (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	klimburg@esf.edu	Valley, John W./B-3466-2011; Kozdon, Reinhard/J-9468-2014	Valley, John W./0000-0003-3530-2722; Kozdon, Reinhard/0000-0001-6347-456X; Limburg, Karin/0000-0003-3716-8555	United States Bureau of Reclamation (USBOR); National Science Foundation; National Institutes of Health/National Institute of General Medical Sciences [DMR-0936384]; WiscSIMS [NSF-EAR 1053466]	United States Bureau of Reclamation (USBOR); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WiscSIMS	This project was funded by the United States Bureau of Reclamation (USBOR) through a cooperative agreement to the University of Florida as part of the Near Shore Ecology Project. This work is based in part upon research conducted at the Cornell High Energy Synchrotron Source (CHESS) which is supported by the National Science Foundation and the National Institutes of Health/National Institute of General Medical Sciences under NSF award DMR-0936384. WiscSIMS is partly supported by NSF-EAR 1053466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Ben-Tzvi O, 2007, LIMNOL OCEANOGR-METH, V5, P97, DOI 10.4319/lom.2007.5.97; Brandes JA, 2009, LIMNOL OCEANOGR-METH, V7, P730, DOI 10.4319/lom.2009.7.730; Brophy D, 2004, MAR BIOL, V144, P779, DOI 10.1007/s00227-003-1240-3; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Clarkson RW, 2000, COPEIA, P402; Coggins Jr L.G., 2009, 20091075 US GEOL SUR; Coggins LG, 2011, T AM FISH SOC, V140, P456, DOI 10.1080/00028487.2011.572009; Coggins LG, 2006, N AM J FISH MANAGE, V26, P233, DOI 10.1577/M05-075.1; Converse YK, 1998, REGUL RIVER, V14, P267, DOI 10.1002/(SICI)1099-1646(199805/06)14:3<267::AID-RRR501>3.0.CO;2-5; Crossey LJ, 2009, GEOL SOC AM BULL, V121, P1034, DOI 10.1130/B26394.1; Dodrill M. J., 2012, THESIS U FLORIDA GAI; Dolnick E, 2002, GREAT UNKNOWN J WESL; Du J, 2002, THESIS MACMASTER U H; Elsdon TS, 2005, MAR ECOL PROG SER, V285, P233, DOI 10.3354/meps285233; Ferreira T, 2012, IMAGEJ USERGUIDE; Ferry JM, 2010, GEOCHIM COSMOCHIM AC, V74, P6517, DOI 10.1016/j.gca.2010.08.039; Finch C, 2012, THESIS U FLORIDA GAI; Gorman OT, 1999, ENVIRON BIOL FISH, V55, P115, DOI 10.1023/A:1007450826743; HAMMAN RL, 1982, PROG FISH CULT, V44, P213, DOI 10.1577/1548-8659(1982)44[213:SACOHC]2.0.CO;2; Hayden TA, 2012, RIVER RES APPL, DOI [10.1002/rra.2627, DOI 10.1002/RRA.2627)]; Hendrickson DA, 1997, PRELIMINARY STUDY UT; HOFF GR, 1995, B MAR SCI, V56, P578; Johnson BE, 1968, GROUNDWATER ATLAS ST; KAEDING LR, 1983, T AM FISH SOC, V112, P577, DOI 10.1577/1548-8659(1983)112<577:LHAEOT>2.0.CO;2; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; Kozdon R, 2009, CHEM GEOL, V258, P327, DOI 10.1016/j.chemgeo.2008.10.032; Limburg KE, 2007, X-RAY SPECTROM, V36, P336, DOI 10.1002/xrs.980; Limburg KE, 2011, P NATL ACAD SCI USA, V108, pE177, DOI 10.1073/pnas.1100684108; LORAH MM, 1988, WATER RESOUR RES, V24, P1541, DOI 10.1029/WR024i009p01541; Lorenzen K, 2000, CAN J FISH AQUAT SCI, V57, P2374, DOI 10.1139/cjfas-57-12-2374; Ludsin SA, 1997, ECOL APPL, V7, P1024; Melis TS, 2012, RIVER RES APPL, V28, P764, DOI 10.1002/rra.1503; Melis TS, 2005, P INT C RES OP RIV M; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Paukert CP, 2006, T AM FISH SOC, V135, P539, DOI 10.1577/T05-204.1; Pentecost A., 2005, TRAVERTINE; Pine WE, 2013, N AM J FISH MANAGE, V33, P626, DOI 10.1080/02755947.2013.788587; Pulwarty RS, 2001, J ENVIRON MANAGE, V63, P307, DOI 10.1006/jema.2001.0494; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHWARTZ DW, 1965, AM ANTIQUITY, V30, P278, DOI 10.2307/278809; Shannon JP, 2001, ISOT ENVIRON HEALT S, V37, P179, DOI 10.1080/10256010108033294; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; Stevens LE, 1999, COLORADO RIVER BENTH, V13, P129; Stone DM, 2006, AM MIDL NAT, V155, P123, DOI 10.1674/0003-0031(2006)155[0123:OOEHCG]2.0.CO;2; Taylor HE, 1996, 96614 US GEOL SURV; Tohse H, 2008, AQUAT BIOL, V1, P259, DOI 10.3354/ab00029; Topping DJ, 2000, WATER RESOUR RES, V36, P515, DOI 10.1029/1999WR900285; Trammell M., 2012, NPSGRCANRR2012586; U.S. Bureau of Reclamation (USBOR), 2012, COL RIV BAS WAT SUPP; United States Department of the Interior (USDOI), 1973, FED REGISTER, V32, P4001; United States Department of the Interior (USDOI), 1994, FED REGISTER, V59, P13376; USFWS (U.S. Fish and Wildlife Service), 2011, FIN BIOL OP OP GLEN; USGS (United States Geological Survey), 2013, MICR REF MAT ACC; Valdez RA, 1999, SOUTHWEST NAT, V44, P384; Valdez RA, 1995, TR25008 BIOWEST INC; Van Haverbeke DR, 2013, J FISH WILDL MANAG, V4, P163, DOI 10.3996/082012-JFWM-071; Voichick N, 2007, US GEOLOGICAL SURVEY, V251; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Walters C, 2000, CONSERV ECOL, V4, part. no.; Walther BD, 2012, J FISH BIOL, V81, P796, DOI 10.1111/j.1095-8649.2012.03371.x; Weidel BC, 2007, CAN J FISH AQUAT SCI, V64, P1641, DOI 10.1139/F07-157; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wright SA, 2009, RIVER RES APPL, V25, P675, DOI 10.1002/rra.1179; Yard MD, 2011, T AM FISH SOC, V140, P471, DOI 10.1080/00028487.2011.572011	67	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84235	10.1371/journal.pone.0084235	http://dx.doi.org/10.1371/journal.pone.0084235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358346	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700157
J	Manson, JH; Gervais, MM; Kline, MA				Manson, Joseph H.; Gervais, Matthew M.; Kline, Michelle A.			Defectors Cannot Be Detected during "Small Talk'' with Strangers	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; THIN SLICES; EVOLUTION; RECIPROCITY; COOPERATION; BEHAVIOR; TRUSTWORTHINESS; SELECTION; ACCURACY; COVER	To account for the widespread human tendency to cooperate in one-shot social dilemmas, some theorists have proposed that cooperators can be reliably detected based on ethological displays that are difficult to fake. Experimental findings have supported the view that cooperators can be distinguished from defectors based on "thin slices'' of behavior, but the relevant cues have remained elusive, and the role of the judge's perspective remains unclear. In this study, we followed triadic conversations among unacquainted same-sex college students with unannounced dyadic one-shot prisoner's dilemmas, and asked participants to guess the PD decisions made toward them and among the other two participants. Two other sets of participants guessed the PD decisions after viewing videotape of the conversations, either with foreknowledge (informed), or without foreknowledge (naive), of the post-conversation PD. Only naive video viewers approached better-than-chance prediction accuracy, and they were significantly accurate at predicting the PD decisions of only opposite-sexed conversation participants. Four ethological displays recently proposed to cue defection in one-shot social dilemmas (arms crossed, lean back, hand touch, and face touch) failed to predict either actual defection or guesses of defection by any category of observer. Our results cast doubt on the role of "greenbeard'' signals in the evolution of human prosociality, although they suggest that eavesdropping may be more informative about others' cooperative propensities than direct interaction.	[Manson, Joseph H.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Manson, JH (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	jmanson@anthro.ucla.edu			International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	This work was supported by International Society for Human Ethology (http://www.ishe.org) and UCLA Academic Senate Faculty Grants Program (http://www.senate.ucla.edu/committees/cor/fgp/frg-guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Bonnefon J-F, 2012, J EXP PSYCHOL, DOI 1037/a0028930; Boone RT, 2003, J NONVERBAL BEHAV, V27, P163, DOI 10.1023/A:1025341931128; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brosig J, 2002, J ECON BEHAV ORGAN, V47, P275, DOI 10.1016/S0167-2681(01)00211-6; Brown W.M., 2003, EVOL PSYCHOL-US, V1, P42, DOI DOI 10.1177/147470490300100104; Centorrino S, 2011, 669 IDEI; Cleckley H., 1988, MASK SANITY, V5th; DAWES RM, 1977, J PERS SOC PSYCHOL, V35, P1, DOI 10.1037/0022-3514.35.1.1; Dawkins R., 1982, pi; Dawkins R, 1976, SELFISH GENE; De Neys W, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0037; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; DeSteno D, 2012, PSYCHOL SCI, V23, P1549, DOI 10.1177/0956797612448793; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; FEHR E, 2005, ANAL KRITIK, V27, P73; Fehr E, 2003, CSEIFO WORKING PAPER, V859, DOI [10.2139/ssrn.382950, DOI 10.2139/SSRN.382950]; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fetchenhauer D, 2010, EVOL HUM BEHAV, V31, P80, DOI 10.1016/j.evolhumbehav.2009.06.009; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fowler KA, 2009, PSYCHOL ASSESSMENT, V21, P68, DOI 10.1037/a0014938; Frank R. H., 1988, PASSIONS REASON STRA; FRANK RH, 1987, AM ECON REV, V77, P593; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; Frank RH, 2005, ANAL KRITIK, V27, P85; Gervais MM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2773; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Haselton M. G., 2006, EVOLUTION SOCIAL PSY, P15, DOI [DOI 10.4324/9780203782965, 10.4324/9780203782965]; Hayashi N, 1999, RATION SOC, V11, P27, DOI 10.1177/104346399011001002; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2006, COGN SYST RES, V7, P220, DOI 10.1016/j.cogsys.2005.11.010; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hirshleifer J., 1987, LATEST BEST ESSAYS E, P307; Kaplan HS, 2009, PHILOS T R SOC B, V364, P3289, DOI 10.1098/rstb.2009.0115; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Krasnow MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01747; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Little AC, 2013, PERS INDIV DIFFER, V54, P507, DOI 10.1016/j.paid.2012.10.018; Manson JH, 2013, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.qm689, DOI 10.5061/DRYAD.QM689]; Mehu M., 2007, J EVOLUT PSYCHOL, V5, P183, DOI [DOI 10.1556/JEP.2007.1011, 10.1556/JEP.2007.1011]; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Oda R, 2009, HUM NATURE-INT BIOS, V20, P331, DOI 10.1007/s12110-009-9070-8; Pontari BA, 2000, J PERS SOC PSYCHOL, V78, P1092, DOI 10.1037//0022-3514.78.6.1092; Price ME, 2006, J ORGAN BEHAV, V27, P201, DOI 10.1002/job.347; Reed LI, 2012, EVOL HUM BEHAV, V33, P200, DOI 10.1016/j.evolhumbehav.2011.09.003; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schug J, 2010, EVOL HUM BEHAV, V31, P87, DOI 10.1016/j.evolhumbehav.2009.09.006; Smeesters D, 2003, J PERS SOC PSYCHOL, V84, P972, DOI 10.1037/0022-3514.84.5.972; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vanneste S, 2007, EVOL HUM BEHAV, V28, P272, DOI 10.1016/j.evolhumbehav.2007.02.005; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; Vogt S, 2013, EVOL HUM BEHAV, DOI [10.1016/j.evolhumbehav.2013.03.003, DOI 10.1016/J.EV0LHUMBEHAV.2013.03.003]; Von Eye A., 2005, ANAL RATER AGREEMENT; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809; Yamagishi T, 2003, EVOL HUM BEHAV, V24, P290, DOI 10.1016/S1090-5138(03)00035-7; Yamagishi T., 1999, ASIAN J SOC PSYCHOL, V2, P145, DOI [DOI 10.1111/1467-839X.00030, 10.1111/1467-839X.00030]; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009	67	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82531	10.1371/journal.pone.0082531	http://dx.doi.org/10.1371/journal.pone.0082531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358201	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700080
J	Zhang, ZY; Zhang, X; Wang, SF; Xin, WW; Tang, JX; Wang, QL				Zhang, Zhiyong; Zhang, Xin; Wang, Sufang; Xin, Wanwan; Tang, Juxiang; Wang, Qinglian			Effect of Mechanical Stress on Cotton Growth and Development	PLOS ONE			English	Article							PLANT-RESPONSE; HEIGHT GROWTH; ALLOCATION; WIND; THIGMOMORPHOGENESIS; VIBRATION; PATTERNS; BIOMASS; TOUCH	Agricultural crops experience diverse mechanical stimuli, which may affect their growth and development. This study was conducted to investigate the effects of mechanical stresses caused by hanging labels from the flower petioles (HLFP) on plant shape and cotton yields in four cotton varieties: CCRI 41, DP 99B, CCRC 21, and BAI 1. HLFP significantly reduced plant height by between 7.8% and 36.5% in all four lines and also significantly reduced the number of fruiting positions per plant in the CCRI 41, DP 99B and CCRC 21 lines. However, the number of fruiting positions in BAI 1 was unaffected. HLFP also significantly reduced the boll weight for all four cultivars and the seed cotton yields for CCRI 41, DP 99B and BAI 1. Conversely, it significantly increased the seed cotton yield for CCRC 21 by 11.2%. HLFP treatment did not significantly affect the boll count in the fruiting branches of the 1st and 2nd layers in any variety, but did significantly reduce those on the 3rd and 4th fruiting branch layers for CCRI 41 and DP 99B. Similar trends were observed for the number of bolls per FP. In general, HLFP reduced plant height and boll weight. However, the lines responded differently to HLFP treatment in terms of their total numbers of fruiting positions, boll numbers, seed cotton yields, etc. Our results also suggested that HFLP responses might be delayed for some agronomy traits of some cotton genotypes, and that hanging labels from early-opening flowers might influence the properties related with those that opened later on.	[Zhang, Zhiyong; Zhang, Xin; Wang, Sufang; Xin, Wanwan; Tang, Juxiang; Wang, Qinglian] Henan Inst Sci & Technol, Sch Life Sci & Technol, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology	Zhang, ZY (corresponding author), Henan Inst Sci & Technol, Sch Life Sci & Technol, Xinxiang, Henan, Peoples R China.	z_zy123@163.com	Zhang, Xin/ABI-7149-2020		NSFC (National Natural Science Foundation of China) [31271648]; Science and Technology Innovation Talents Project of Henan Province of China [114100510008]	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Talents Project of Henan Province of China	This research was supported by the NSFC (National Natural Science Foundation of China, 31271648) and Science and Technology Innovation Talents Project of Henan Province of China (114100510008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anten NPR, 2006, PHYSIOL PLANTARUM, V128, P274, DOI 10.1111/j.1399-3054.2006.00736.x; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; BIDDINGTON NL, 1985, ANN BOT-LONDON, V55, P109, DOI 10.1093/oxfordjournals.aob.a086869; BOYER N, 1967, CR ACAD SCI D NAT, V264, P2114; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chehab EW, 2009, J EXP BOT, V60, P43, DOI 10.1093/jxb/ern315; DANN IR, 1990, SCI HORTIC-AMSTERDAM, V43, P37, DOI 10.1016/0304-4238(90)90034-C; Darwin C., 1906, MOVEMENTS HABITS CLI; Fiorani F, 2002, PLANT PHYSIOL, V129, P1382, DOI 10.1104/pp.001198; FRIZZELL JL, 1960, AGRON J, V52, P69, DOI 10.2134/agronj1960.00021962005200020003x; GARTNER BL, 1994, J EXP BOT, V45, P1647, DOI 10.1093/jxb/45.11.1647; Goodman AM, 1996, J EXP BOT, V47, P1499, DOI 10.1093/jxb/47.10.1499; GRACE J, 1977, J EXP BOT, V28, P268, DOI 10.1093/jxb/28.2.268; JACOBS M. R., 1954, AUSTRALIAN JOUR BOT, V2, P35, DOI 10.1071/BT9540035; JAFFE MJ, 1984, PHYSIOL PLANTARUM, V62, P73, DOI 10.1111/j.1399-3054.1984.tb05925.x; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; JAFFE MJ, 1980, BIOSCIENCE, V30, P239, DOI 10.2307/1307878; Kern KA, 2005, TREE PHYSIOL, V25, P1243, DOI 10.1093/treephys/25.10.1243; Latimer J. G., 1998, HortTechnology, V8, P529; [李忠光 LI Zhong-Guang], 2010, [植物生理学通讯, Plant Physiology Communications], V46, P135; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; MAKELA A, 1992, J THEOR BIOL, V159, P443, DOI 10.1016/S0022-5193(05)80690-3; Meng SX, 2006, J EXP BOT, V57, P3175, DOI 10.1093/jxb/erl079; Mitchell CA, 1996, HORTSCIENCE, V31, P31, DOI 10.21273/HORTSCI.31.1.31; Niklas KJ, 1998, ANN BOT-LONDON, V82, P147, DOI 10.1006/anbo.1998.0658; Onguso JM, 2006, SCI HORTIC-AMSTERDAM, V108, P359, DOI 10.1016/j.scienta.2006.02.013; Pigliucci M, 2002, INT J PLANT SCI, V163, P399, DOI 10.1086/339158; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Puijalon S, 2005, J EXP BOT, V56, P777, DOI 10.1093/jxb/eri063; Simons P, 1992, ACTION PLANT MOVEMEN; TURGEON R, 1971, SCIENCE, V174, P961, DOI 10.1126/science.174.4012.961; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YH, 2008, INT J PLANT SCI, V169, P503, DOI 10.1086/528750	35	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82256	10.1371/journal.pone.0082256	http://dx.doi.org/10.1371/journal.pone.0082256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24363813	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700051
J	Ono, W; Hayashi, Y; Yokoyama, W; Kuroda, T; Kishimoto, H; Ito, I; Kimura, K; Akaogi, K; Waku, T; Yanagisawa, J				Ono, Wakana; Hayashi, Yuki; Yokoyama, Wataru; Kuroda, Takao; Kishimoto, Hiroyuki; Ito, Ichiaki; Kimura, Keiji; Akaogi, Kensuke; Waku, Tsuyoshi; Yanagisawa, Junn			The Nucleolar Protein Myb-binding Protein 1A ( MYBBP1A) Enhances p53 Tetramerization and Acetylation in Response to Nucleolar Disruption*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Nucleolus; p300; p53; Post-translational Modification; Stress Response	CELL-CYCLE ARREST; DNA-BINDING; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES P53; OLIGOMERIZATION DOMAIN; BREAST-CANCER; ACTINOMYCIN-D; RNA SYNTHESIS; MDM2	Background: Nucleolar disruption is involved in cellular stress response and is sufficient for p53 activation. p53 tetramerization is crucial to exert its activity. Results: The nucleolar protein MYBBP1A enhanced p53 tetramerization by directly interacting with p53. Conclusion: p53 tetramerization by MYBBP1A is indispensable for activating p53 under nucleolar stress. Significance: This is the first report to describe the possible mechanism underlying p53 tetramerization in cells under nucleolar stress. Tetramerization of p53 is crucial to exert its biological activity, and nucleolar disruption is sufficient to activate p53. We previously demonstrated that nucleolar stress induces translocation of the nucleolar protein MYBBP1A from the nucleolus to the nucleoplasm and enhances p53 activity. However, whether and how MYBBP1A regulates p53 tetramerization in response to nucleolar stress remain unclear. In this study, we demonstrated that MYBBP1A enhances p53 tetramerization, followed by acetylation under nucleolar stress. We found that MYBBP1A has two regions that directly bind to lysine residues of the p53 C-terminal regulatory domain. MYBBP1A formed a self-assembled complex that provided a molecular platform for p53 tetramerization and enhanced p300-mediated acetylation of the p53 tetramer. Moreover, our results show that MYBBP1A functions to enhance p53 tetramerization that is necessary for p53 activation, followed by cell death with actinomycin D treatment. Thus, we suggest that MYBBP1A plays a pivotal role in the cellular stress response.	[Ono, Wakana; Hayashi, Yuki; Yokoyama, Wataru; Kishimoto, Hiroyuki; Kimura, Keiji; Akaogi, Kensuke; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kuroda, Takao] Doshisha Univ, Grad Sch Brain Sci, Kyoto 6190225, Japan; [Kishimoto, Hiroyuki; Ito, Ichiaki; Yanagisawa, Junn] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Waku, Tsuyoshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tsukuba; Doshisha University; University of Tsukuba; University of Tokyo	Waku, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	twaku@mol.f.u-tokyo.ac.jp; junny@agbi.tsukuba.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science.	Akaogi K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-65; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MEEK DW, 2009, COLD SPRING HARB PER, V1; Meng XB, 2007, J BIOL CHEM, V282, P1570, DOI 10.1074/jbc.M607520200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ono W, 2013, BIOCHEM BIOPH RES CO, V434, P659, DOI 10.1016/j.bbrc.2013.04.006; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Prives C, 1999, J PATHOL, V187, P112; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Warnock LJ, 2008, CANCER BIOL THER, V7, P1483, DOI 10.4161/cbt.7.9.6473; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zambetti GP, 2007, J CELL PHYSIOL, V213, P370, DOI 10.1002/jcp.21217; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	79	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4928	4940		10.1074/jbc.M113.474049	http://dx.doi.org/10.1074/jbc.M113.474049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375404	Green Published, hybrid			2022-12-25	WOS:000331607900039
J	Imam, M; Singh, S; Kaushik, NK; Chauhan, VS				Imam, Maryam; Singh, Shailja; Kaushik, Naveen Kumar; Chauhan, Virander Singh			Plasmodium falciparum Merozoite Surface Protein 3 OLIGOMERIZATION, SELF-ASSEMBLY, AND HEME COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Erythrocyte; Heme; Infectious Diseases; Malaria	HISTIDINE-RICH PROTEIN; MALARIA VACCINE; CELL INTERACTIONS; FIBRIL FORMATION; BINDING SITES; INVASION; ERYTHROCYTES; PARASITE; PEPTIDE; PEROXIDASE	Merozoite surface protein 3 of Plasmodium falciparum, a 40-kDa protein that also binds heme, has been biophysically characterized for its tendency to form highly elongated oligomers. This study aims to systematically analyze the regions in MSP3 sequence involved in oligomerization and correlate its aggregation tendency with its high affinity for binding with heme. Through size exclusion chromatography, dynamic light scattering, and transmission electron microscopy, we have found that MSP3, previously known to form elongated oligomers, actually forms self-assembled filamentous structures that possess amyloid-like characteristics. By expressing different regions of MSP3, we observed that the previously described leucine zipper region at the C terminus of MSP3 may not be the only structural element responsible for oligomerization and that other peptide segments like MSP3(192-196) (YILGW) may also be required. MSP3 aggregates on incubation were transformed to long unbranched amyloid fibrils. Using immunostaining methods, we found that 5-15-m-long fibrillar structures stained by anti-MSP3 antibodies were attached to the merozoite surface and also associated with erythrocyte membrane. We also found MSP3 to bind several molecules of heme by UV spectrophotometry, HPLC, and electrophoresis. This study suggested that its ability to bind heme is somehow related to its inherent characteristics to form oligomers. Moreover, heme interaction with a surface protein like MSP3, which does not participate in hemozoin formation, may suggest a protective role against the heme released from unprocessed hemoglobin released after schizont egress. These studies point to the other roles that MSP3 may play during the blood stages of the parasite, in addition to be an important vaccine candidate.	[Imam, Maryam; Singh, Shailja; Kaushik, Naveen Kumar; Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, POB 110504,Aruna Asaf Ali Marg, New Delhi 110067, India.	virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019	Kaushik, Naveen Kumar/0000-0002-4710-4662	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India fellowship; Innovative Young Biotechnologist Award, Department of Biotechnology; Indian Council of Medical Research, India	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India fellowship; Innovative Young Biotechnologist Award, Department of Biotechnology; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Department of Biotechnology.; Supported by a Council of Scientific and Industrial Research, Government of India fellowship.; Supported by an Innovative Young Biotechnologist Award, Department of Biotechnology.; Supported by the Indian Council of Medical Research, India.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; AFT RL, 1984, J BIOL CHEM, V259, P301; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; BANNISTER LH, 1977, B WORLD HEALTH ORGAN, V55, P163; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Chauhan VS, 2010, HUM VACCINES, V6, P757, DOI 10.4161.hv.6.9.12468; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Clark ME, 2007, ENVIRON MICROBIOL, V9, P2844, DOI 10.1111/j.1462-2920.2007.01398.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dworkin M, 1999, BIOESSAYS, V21, P590, DOI 10.1002/(SICI)1521-1878(199907)21:7<590::AID-BIES7>3.0.CO;2-E; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huy NT, 2003, J BIOCHEM, V133, P693, DOI 10.1093/jb/mvg089; Imam M, 2011, CLIN VACCINE IMMUNOL, V18, P1221, DOI 10.1128/CVI.00064-11; Khodarahmi R, 2010, ARCH BIOCHEM BIOPHYS, V494, P205, DOI 10.1016/j.abb.2009.12.010; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Low A, 2007, BIOPOLYMERS, V87, P12, DOI 10.1002/bip.20764; Lundberg KM, 1997, CHEM BIOL, V4, P345, DOI 10.1016/S1074-5521(97)90125-3; Mashima R, 2002, J BIOL CHEM, V277, P14514, DOI 10.1074/jbc.M109386200; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Murali J, 2003, BIOCHEM CELL BIOL, V81, P51, DOI 10.1139/O03-009; Naiki H, 1999, METHOD ENZYMOL, V309, P305; OEUVRAY C, 1994, BLOOD, V84, P1594; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Puentes A, 2005, BIOCHIMIE, V87, P461, DOI 10.1016/j.biochi.2005.01.001; Ravi LB, 2005, NEUROBIOL DIS, V19, P28, DOI 10.1016/j.nbd.2004.11.004; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Schneider EL, 2005, BIOCHEMISTRY-US, V44, P979, DOI 10.1021/bi048570p; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Suliman HB, 2002, FREE RADICAL BIO MED, V32, P246, DOI 10.1016/S0891-5849(01)00797-3; Summers CA, 2000, PROTEIN SCI, V9, P2001, DOI 10.1110/ps.9.10.2001; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Walker JR, 2007, MOL MICROBIOL, V63, P629, DOI 10.1111/j.1365-2958.2006.05494.x; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yang XD, 2010, BIOCHIMIE, V92, P1287, DOI 10.1016/j.biochi.2010.06.001; Zhang XC, 2012, BIOCHEMISTRY-US, V51, P1380, DOI 10.1021/bi201880s	73	19	19	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3856	3868		10.1074/jbc.M113.520239	http://dx.doi.org/10.1074/jbc.M113.520239			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362023	Green Published, hybrid			2022-12-25	WOS:000331403800003
J	Liu, YQ; Sanchez-Tillo, E; Lu, XQ; Huang, L; Clem, B; Telang, S; Jenson, AB; Cuatrecasas, M; Chesney, J; Postigo, A; Dean, DC				Liu, Yongqing; Sanchez-Tillo, Ester; Lu, Xiaoqin; Huang, Li; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Cuatrecasas, Miriam; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.			The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with miR200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cancer Biology; Cell Signaling; Epithelial Mesenchymal Transition; Senescence	CELL SELF-RENEWAL; G(1) CONTROL; STEM-CELLS; H-RAS; CANCER; GENE; PROTEIN; GROWTH; EMT; PROLIFERATION	Ras mutations are frequent in cancer cells where they drive proliferation and resistance to apoptosis. However in primary cells, mutant Ras instead can cause oncogene-induced senescence, a tumor suppressor function linked to repression of the polycomb factor Bmi1, which normally regulates cell cycle inhibitory cyclin-dependent kinase inhibitors (cdki). It is unclear how Ras causes repression of Bmi1 in primary cells to suppress tumor formation while inducing the gene in cancer cells to drive tumor progression. Ras also induces the EMT transcription factor ZEB1 to trigger tumor invasion and metastasis. Beyond its well-documented role in EMT, ZEB1 is important for maintaining repression of cdki. Indeed, heterozygous mutation of ZEB1 is sufficient for elevated cdki expression, leading to premature senescence of primary cells. A similar phenotype is evident with Bmi1 mutation. We show that activation of Rb1 in response to mutant Ras causes dominant repression of ZEB1 in primary cells, but loss of the Rb1 pathway is a hallmark of cancer cells and in the absence of such Rb1 repression Ras induces ZEB1 in cancer cells. ZEB1 represses miR-200 in the context of a mutual repression loop. Because miR-200 represses Bmi1, induction of ZEB1 leads to induction of Bmi1. Rb1 pathway status then dictates the opposing effects of mutant Ras on the ZEB1-miR-200 loop in primary versus cancer cells. This loop not only triggers EMT, surprisingly we show it acts downstream of Ras to regulate Bmi1 expression and thus the critical decision between oncogene-induced senescence and tumor initiation.	[Liu, Yongqing; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, James Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Liu, Yongqing; Lu, Xiaoqin; Huang, Li; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Liu, Yongqing; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Birth Defects Ctr, Louisville, KY 40202 USA; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Grp Transcript Regulat Gene Express, Barcelona 08036, Spain; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, CIBERehd, Barcelona 08036, Spain; [Postigo, Antonio] ICREA, Barcelona 08010, Spain; [Cuatrecasas, Miriam] Ctr Diagnost Biomed CDB Hosp Clin, Dept Pathol, Barcelona, Spain; [Cuatrecasas, Miriam] IDIBAPS, Hosp Clin, Tumor Bank, Barcelona 08036, Spain; [Huang, Li] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Zhejiang University	Postigo, A (corresponding author), IDIBAPS, Grp Transcript Regulat Gene Express, Villarroel 170, Barcelona 08036, Spain.	idib412@clinic.ub.es; dcdean01@louisville.edu	Cuatrecasas, Miriam/C-9156-2019	Cuatrecasas, Miriam/0000-0003-3063-0110; Postigo, Antonio/0000-0003-4605-2634	National Institutes of Health [EY019113, EY018603, EY015636]; Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program [P20 RR017702-09]; FOT; AVON-SAU; AECC; ACMCB; Fundacio La Marato de TV3;  [MEC/MICINN-BFU2010-15163]; NATIONAL CANCER INSTITUTE [R01CA149438] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017702] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018603, R21EY019113, R24EY015636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program; FOT; AVON-SAU; AECC; ACMCB; Fundacio La Marato de TV3; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	These studies were supported by Grants EY019113 and EY018603 from the National Institutes of Health (to D. C. D.), Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program Grant P20 RR017702-09) (to Y. L.), NIH Core Grant EY015636, and FOT, AVON-SAU, AECC, MEC/MICINN-BFU2010-15163, ACMCB, and Fundacio La Marato de TV3 (to A. P.).	Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jun T., 1999, SCI STKE, V13, P1; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Liu YF, 2013, STAT INTERFACE, V6, P1; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; To MD, 2005, CELL CYCLE, V4, P1185, DOI 10.4161/cc.4.9.2039; Wang Z., 2011, PLOS ONE, V6; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007	54	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4116	4125		10.1074/jbc.M113.533505	http://dx.doi.org/10.1074/jbc.M113.533505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371144	Green Published, hybrid			2022-12-25	WOS:000331403800025
J	Goltz, D; Pleger, B; Thiel, S; Villringer, A; Muller, MM				Goltz, Dominique; Pleger, Burkhard; Thiel, Sabrina; Villringer, Arno; Mueller, Matthias M.			Sustained Spatial Attention to Vibrotactile Stimulation in the Flutter Range: Relevant Brain Regions and Their Interaction	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; SELECTIVE ATTENTION; TACTILE STIMULI; CEREBRAL LATERALIZATION; PARIETAL CORTEX; WORKING-MEMORY; NEURAL CODES; TIME-COURSE; SI; ACTIVATION	The present functional magnetic resonance imaging (fMRI) study was designed to get a better understanding of the brain regions involved in sustained spatial attention to tactile events and to ascertain to what extent their activation was correlated. We presented continuous 20 Hz vibrotactile stimuli (range of flutter) concurrently to the left and right index fingers of healthy human volunteers. An arrow cue instructed subjects in a trial-by-trial fashion to attend to the left or right index finger and to detect rare target events that were embedded in the vibrotactile stimulation streams. We found blood oxygen level-dependent (BOLD) attentional modulation in primary somatosensory cortex (SI), mainly covering Brodmann area 1, 2, and 3b, as well as in secondary somatosensory cortex (SII), contralateral to the to-beattended hand. Furthermore, attention to the right (dominant) hand resulted in additional BOLD modulation in left posterior insula. All of the effects were caused by an increased activation when attention was paid to the contralateral hand, except for the effects in left SI and insula. In left SI, the effect was related to a mixture of both a slight increase in activation when attention was paid to the contralateral hand as well as a slight decrease in activation when attention was paid to the ipsilateral hand (i. e., the tactile distraction condition). In contrast, the effect in left posterior insula was exclusively driven by a relative decrease in activation in the tactile distraction condition, which points to an active inhibition when tactile information is irrelevant. Finally, correlation analyses indicate a linear relationship between attention effects in intrahemispheric somatosensory cortices, since attentional modulation in SI and SII were interrelated within one hemisphere but not across hemispheres. All in all, our results provide a basis for future research on sustained attention to continuous vibrotactile stimulation in the range of flutter.	[Goltz, Dominique; Pleger, Burkhard; Thiel, Sabrina; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Goltz, Dominique; Mueller, Matthias M.] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany	Max Planck Society; Leipzig University; Leipzig University; Humboldt University of Berlin	Muller, MM (corresponding author), Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany.	m.mueller@rz.uni-leipzig.de		Villringer, Arno/0000-0003-2604-2404	Deutsche Forschungsgemeinschaft [MU 972/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft supported the work (www.dfg.de; grant nummer MU 972/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2009, BIOL PSYCHOL, V81, P77, DOI 10.1016/j.biopsycho.2009.02.001; Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Auksztulewicz R, 2011, EUR J NEUROSCI, V34, P839, DOI 10.1111/j.1460-9568.2011.07797.x; Backes WH, 2000, CLIN NEUROPHYSIOL, V111, P1738, DOI 10.1016/S1388-2457(00)00420-X; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Burton H, 2000, J CLIN NEUROPHYSIOL, V17, P575, DOI 10.1097/00004691-200011000-00004; Burton H, 2008, HUM BRAIN MAPP, V29, P207, DOI 10.1002/hbm.20384; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eimer M, 2003, CLIN NEUROPHYSIOL, V114, P1298, DOI 10.1016/S1388-2457(03)00107-X; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Galazky I, 2009, J NEUROL SCI, V279, P93, DOI 10.1016/j.jns.2008.12.006; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Giabbiconi CM, 2007, NEUROIMAGE, V35, P255, DOI 10.1016/j.neuroimage.2006.11.022; Giabbiconi CM, 2004, COGNITIVE BRAIN RES, V20, P58, DOI 10.1016/j.cogbrainres.2004.01.004; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Hamalainen H, 2000, NEUROREPORT, V11, P1673; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; Hsiao SS, 1993, CORTEX J NEUROPHYSIO, V70, P444; HYVARINEN J, 1980, J NEUROPHYSIOL, V43, P870, DOI 10.1152/jn.1980.43.4.870; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P523, DOI 10.1113/jphysiol.1978.sp012517; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Johansen-Berg H, 2000, FRONT BIOSCI-LANDMRK, V5, pD894, DOI 10.2741/berg; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Katus T, 2012, J COGNITIVE NEUROSCI, V24, P1596, DOI 10.1162/jocn_a_00234; Keitel C, 2011, EXP BRAIN RES, V213, P321, DOI 10.1007/s00221-011-2667-2; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Meador KJ, 1998, NEUROLOGY, V51, P721, DOI 10.1212/WNL.51.3.721; Meador KJ, 2002, J INT NEUROPSYCH SOC, V8, P349, DOI 10.1017/S1355617702813169; MICHIE PT, 1987, PSYCHOPHYSIOLOGY, V24, P449, DOI 10.1111/j.1469-8986.1987.tb00316.x; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Moore CI, 2013, J COGNITIVE NEUROSCI, V25, P49, DOI 10.1162/jocn_a_00315; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Nelson AJ, 2004, COGNITIVE BRAIN RES, V19, P174, DOI 10.1016/j.cogbrainres.2003.11.013; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; PONS TP, 1986, J COMP NEUROL, V248, P313, DOI 10.1002/cne.902480303; Preuschhof C, 2006, J NEUROSCI, V26, P13231, DOI 10.1523/JNEUROSCI.2767-06.2006; Ragert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016150; Regan D, 1989, HUMAN BRAIN ELECTROP, Vxxiv; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Saupe K, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.058.2009; Schweizer R, 2000, SOMATOSENS MOT RES, V17, P309; Spitzer B, 2013, HUM BRAIN MAPP; Spitzer B, 2010, J NEUROSCI, V30, P4496, DOI 10.1523/JNEUROSCI.6041-09.2010; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Sterr A, 2007, NEUROREPORT, V18, P607, DOI 10.1097/WNR.0b013e3280b07c34; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Tommerdahl M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-29; Tommerdahl M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-11; Tommerdahl M, 1999, J NEUROPHYSIOL, V82, P16, DOI 10.1152/jn.1999.82.1.16; Wacker E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024860; WARREN S, 1986, J NEUROPHYSIOL, V56, P598, DOI 10.1152/jn.1986.56.3.598; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Zopf R, 2004, COGNITIVE BRAIN RES, V20, P491, DOI 10.1016/j.cogbrainres.2004.02.014	73	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84196	10.1371/journal.pone.0084196	http://dx.doi.org/10.1371/journal.pone.0084196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367642	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900037
J	Liu, J; Qu, B; Hu, BX; Jiang, N; Wang, DB				Liu, Jie; Qu, Bo; Hu, Bingxue; Jiang, Nan; Wang, Dongbo			The Quality of Life of Men Who Have Sex with Men in China: Reliability and Validity Testing of the SF-36 Questionnaire	PLOS ONE			English	Article							36 HEALTH SURVEY; MEDICAL OUTCOMES; SCALING ASSUMPTIONS; HIV PREVENTION; PREVALENCE; VALIDATION; SYPHILIS; VIRUS; AIDS; RESPONSIVENESS	Objective: The aim of the study was to assess the psychometric properties of the 36-Item Short Form Health Survey (SF-36) in the men who have sex with men (MSM) population in China. Methods: A cross-sectional survey was conducted among 373 MSM from September to December, 2012, in Zhengzhou and Huludao City, China. Internal reliability of the questionnaire was calculated by Cronbach's alpha coefficient. Validity was analyzed through construct validity, divisional validity, and collective validity testing. Results: The overall Cronbach's alpha coefficient of the SF-36 questionnaire was 0.943, while the Cronbach's alpha coefficients for each of the dimensions were all > 0.70. Results showed that the SF-36 questionnaire was reliable and valid. Conclusions: This study provided evidence that the SF-36 is an acceptable, valid and reliable instrument in evaluating the quality of life of MSM in Mainland China.	[Liu, Jie; Qu, Bo; Hu, Bingxue; Jiang, Nan; Wang, Dongbo] China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China.	qubo6666@163.com	JIANG, NAN/AHB-1945-2022		National Natural Science Foundation of China [81273186, 71103200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 81273186 and 71103200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bing EG, 2000, QUAL LIFE RES, V9, P55, DOI 10.1023/A:1008919227665; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; Bouhnik AD, 2006, JAIDS-J ACQ IMM DEF, V42, P597, DOI 10.1097/01.qai.0000221674.76327.d7; Call SA, 2000, QUAL LIFE RES, V9, P977, DOI 10.1023/A:1016668802328; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chen GZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-58; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Clark TJ, 2002, EUR J OBSTET GYN R B, V104, P96, DOI 10.1016/S0301-2115(02)00076-3; Clayson DJ, 2006, PHARMACOECONOMICS, V24, P751, DOI 10.2165/00019053-200624080-00003; DeBoer JB, 1996, QUAL LIFE RES, V5, P339, DOI 10.1007/BF00433918; Drabkin AS, 2013, AIDS PATIENT CARE ST, V27, P333, DOI 10.1089/apc.2012.0313; Eriksson LE, 2007, INT J STD AIDS, V18, P207, DOI 10.1258/095646207780132442; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; Hu J, 2010, DIABETES RES CLIN PR, V88, P273, DOI 10.1016/j.diabres.2010.03.005; Jafari H, 2008, J POSTGRAD MED, V54, P273; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Leung YY, 2010, RHEUMATOLOGY, V49, P1495, DOI 10.1093/rheumatology/keq112; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Lim LLY, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-52; Lubeck DP, 1997, QUAL LIFE RES, V6, P494, DOI 10.1023/A:1018404014821; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Meng YJ, 2008, PUBLIC HEALTH, V122, P404, DOI 10.1016/j.puhe.2007.06.007; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Najafi M, 2009, J CARDIOVASC MED, V10, P316, DOI 10.2459/JCM.0b013e328326291a; Nightingale VR, 2011, AIDS BEHAV, V15, P1870, DOI 10.1007/s10461-011-9980-4; Ou FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038861; Riley ED, 2003, QUAL LIFE RES, V12, P1051, DOI 10.1023/A:1026166021386; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Sandfort TGM, 2003, ARCH SEX BEHAV, V32, P15, DOI 10.1023/A:1021885127560; Setia MS, 2010, INT J PUBLIC HEALTH, V55, P687, DOI 10.1007/s00038-010-0173-0; Smith MY, 1996, QUAL LIFE RES, V5, P47, DOI 10.1007/BF00435968; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; SUN YM, 2012, MODERN PREVENTIVE ME, P1012; Tate D, 2003, AIDS PATIENT CARE ST, V17, P115, DOI 10.1089/108729103763807936; Valenti Marco, 2008, Int J Med Sci, V5, P24; WACHTEL T, 1992, ANN INTERN MED, V116, P129, DOI 10.7326/0003-4819-116-2-129; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watkins R E, 2000, Asia Pac J Public Health, V12, P118; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032312; Xia JunRui, 2010, Modern Preventive Medicine, V37, P3812; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Yu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050762; Zhou Biao, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1193; 2009, DAILY CHINA, P1012	51	10	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83362	10.1371/journal.pone.0083362	http://dx.doi.org/10.1371/journal.pone.0083362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367592	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900017
J	Protopsaltis, I; Ploumidis, A; Sergentanis, TN; Constantoulakis, P; Tzirogiannis, K; Kyprianidou, C; Papazafiropoulou, AK; Melidonis, A; Delakas, D				Protopsaltis, Ioannis; Ploumidis, Achilles; Sergentanis, Theodoros N.; Constantoulakis, Padelis; Tzirogiannis, Kostantinos; Kyprianidou, Chrysoula; Papazafiropoulou, Athanasia K.; Melidonis, Andreas; Delakas, Dimitrios			Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR BINDING PROTEIN-3; URINARY-TRACT SYMPTOMS; BODY-MASS INDEX; METABOLIC SYNDROME; INSULIN-RESISTANCE; WAIST CIRCUMFERENCE; GLUCOSE-TOLERANCE; IGF-I; CANCER	Benign prostatic hyperplasia (BPH) represents a pattern of non-malignant growth of prostatic fibromuscular stroma. Metabolic disturbances such us pre-diabetes and metabolic syndrome may have a role in BPH pathophysiology. A potential explanation for the above relationship involves the insulin-like growth factor (IGF) axis as well as IGF binding proteins, (IGFBPs) of which the most abundant form is IGFBP-3. Therefore, the aim of the present study was to investigate the association between intra-prostatic levels of IGF-1, IGF-2 as well as to evaluate the role of locally expressed IGFBP-3 in BPH development in pre-diabetes. A total of 49 patients admitted to the Urology department of a tertiary urban Greek hospital, for transurethral prostate resection, or prostatectomy and with pre-diabetes [impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) or both] were finally included. The majority of the sample consisted of subjects with IGT (51.0%), followed by IFG and IGT (32.7%) and isolated IFG (16.3%). For all participants a clinical examination was performed and blood samples were collected. In addition, total prostate (TP) volume or transitional zone (TZ) volume were estimated by transrectal ultrasonography. The results of the multivariate analysis regarding TP volume showed that higher PSA (p<0.001), larger waist circumference (p=0.007) and higher IGFBP-3 expression levels (p<0.001) independently predicted higher TP volume. The results regarding the volume of the TZ showed that higher PSA (p<0.001), larger waist circumference (p<0.001) and higher IGFBP-3 expression levels (p=0.024) were independently associated with higher TZ volume. Our findings show that intra-prostatic levels of IGFBP-3, PSA and waist circumference, but not overall obesity, are positively associated with prostate volume. IGFBP-3 seems to be a multifunctional protein, which can potentiate or inhibit IGF activity.	[Protopsaltis, Ioannis; Tzirogiannis, Kostantinos; Melidonis, Andreas] Tzanio Gen Hosp Piraeus, Ctr Diabet, Piraeus, Greece; [Ploumidis, Achilles; Delakas, Dimitrios] Asklipieio Gen Hosp, Dept Urol, Voula, Greece; [Sergentanis, Theodoros N.] Natl Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Constantoulakis, Padelis; Kyprianidou, Chrysoula] Dept Mol Pathol & Genet, Locus Medicus Lab, Athens, Greece; [Papazafiropoulou, Athanasia K.] Gen Hosp Nikaia Ag Panteleimon, Dept Internal Med 3, Piraeus, Greece; [Papazafiropoulou, Athanasia K.] Gen Hosp Nikaia Ag Panteleimon, Ctr Diabet, Piraeus, Greece	Athens Medical School; National & Kapodistrian University of Athens	Papazafiropoulou, AK (corresponding author), Gen Hosp Nikaia Ag Panteleimon, Dept Internal Med 3, Piraeus, Greece.	pathan@ath.forthnet.gr	Sergentanis, Theodoros N./AAD-8303-2019	Sergentanis, Theodoros N./0000-0002-9355-5528				Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Bieche I, 2001, ONCOGENE, V20, P6955, DOI 10.1038/sj.onc.1204739; Boon T A, 2001, Curr Urol Rep, V2, P297, DOI 10.1007/s11934-001-0067-z; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Bub JD, 2006, BIOCHEM BIOPH RES CO, V340, P1158, DOI 10.1016/j.bbrc.2005.12.103; Butt AJ, 2002, ENDOCRINOLOGY, V143, P2693, DOI 10.1210/en.143.7.2693; Chokkalingam AP, 2002, PROSTATE, V52, P98, DOI 10.1002/pros.10096; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; COHEN P, 1994, J CLIN ENDOCR METAB, V79, P1410, DOI 10.1210/jc.79.5.1410; COHEN P, 1994, J ENDOCRINOL, V142, P407, DOI 10.1677/joe.0.1420407; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1986, DOI 10.1210/jc.84.6.1986; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; CONOVER CA, 1991, ENDOCRINOLOGY, V129, P710, DOI 10.1210/endo-129-2-710; Dagogo-Jack S, 2009, J CLIN ENDOCR METAB, V94, P2031, DOI 10.1210/jc.2008-1348; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; de Cremoux P, 2003, ENDOCR-RELAT CANCER, V10, P409, DOI 10.1677/erc.0.0100409; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Gao Y, 2012, UROLOGY, V79, P194, DOI 10.1016/j.urology.2011.07.1399; Giovannucci E, 2003, HORM METAB RES, V35, P694, DOI 10.1055/s-2004-814147; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; Grant ES, 1998, J CLIN ENDOCR METAB, V83, P3252, DOI 10.1210/jc.83.9.3252; Gupta A, 2006, UROLOGY, V68, P1198, DOI 10.1016/j.urology.2006.09.034; Hammarsten J, 1999, BLOOD PRESSURE, V8, P29, DOI 10.1080/080370599438365; Hammarsten J, 1998, PROSTATE CANCER P D, V1, P157, DOI 10.1038/sj.pcan.4500221; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Haynes JM, 2001, CELL SIGNAL, V13, P703, DOI 10.1016/S0898-6568(01)00205-4; Hong GS, 2010, KOREAN J UROL, V51, P631, DOI 10.4111/kju.2010.51.9.631; Janssen I, 2004, AM J CLIN NUTR, V79, P379; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KIRBY R, 1996, TXB BENIGN PROSTATIC, P85; KIRBY R, 1996, TXB BENIGN PROSTATIC, P23; Kuo CS, 2002, DIABETES NUTR METAB, V15, P101; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Liao L, 2006, ENDOCRINOLOGY, V147, P3877, DOI 10.1210/en.2005-1537; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Monti S, 1998, STEROIDS, V63, P362, DOI 10.1016/S0039-128X(98)00034-8; Monti S, 2001, J CLIN ENDOCR METAB, V86, P1700, DOI 10.1210/jc.86.4.1700; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; NEELY EK, 1991, ACTA PAEDIATR SCAND, P116; Neuhouser ML, 2008, PROSTATE, V68, P1477, DOI 10.1002/pros.20819; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Park SH, 2005, CLIN SCI, V108, P553, DOI 10.1042/CS20040331; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-2799; PARTIN AW, 1991, J UROLOGY, V145, P405, DOI 10.1016/S0022-5347(17)38353-2; Poirier P, 2005, HYPERTENSION, V45, P363, DOI 10.1161/01.HYP.0000155463.90018.dc; Pollak M, 2000, EUR J CANCER, V36, P1224, DOI 10.1016/S0959-8049(00)00102-7; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Roberts RO, 2003, AM J EPIDEMIOL, V157, P784, DOI 10.1093/aje/kwf054; Rohrmann S, 2005, INT J OBESITY, V29, P310, DOI 10.1038/sj.ijo.0802881; Sarma AV, 2002, UROLOGY, V59, P362, DOI 10.1016/S0090-4295(01)01546-1; Schenk JM, 2009, PROSTATE, V69, P1303, DOI 10.1002/pros.20974; SHAPIRO E, 1992, J UROLOGY, V147, P1293, DOI 10.1016/S0022-5347(17)37546-8; Shibata Y, 2000, PROSTATE, V42, P45; Stattin P, 2001, SCAND J UROL NEPHROL, V35, P122; STEINER MS, 1993, UROLOGY, V42, P99, DOI 10.1016/0090-4295(93)90352-B; Temml C, 2009, UROLOGY, V73, P544, DOI 10.1016/j.urology.2008.10.027; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Vikram A, 2010, PROSTATE, V70, P79, DOI 10.1002/pros.21041; Wahrenberg H, 2005, BRIT MED J, V330, P1363, DOI 10.1136/bmj.38429.473310.AE; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zappala G, 2009, BIOCHEM BIOPH RES CO, V382, P785, DOI 10.1016/j.bbrc.2009.03.112; Zucchetto A, 2005, INT J OBESITY, V29, P798, DOI 10.1038/sj.ijo.0802979	70	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e81411	10.1371/journal.pone.0081411	http://dx.doi.org/10.1371/journal.pone.0081411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367483	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900003
J	Garcia, AF; Lopes, JLS; Costa, AJ; Wallace, BA; Araujo, APU				Garcia, Assuero F.; Lopes, Jose L. S.; Costa-Filho, Antonio J.; Wallace, Bonnie A.; Araujo, Ana P. U.			Membrane Interactions of S100A12 (Calgranulin C)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; SECONDARY STRUCTURE; STABILITY; DOMAIN; ZINC; TRANSLOCATION; SPECTROSCOPY; ACTIVATION; MIGRATION; MUTANTS	S100A12 (Calgranulin C) is a small acidic calcium-binding peripheral membrane protein with two EF-hand structural motifs. It is expressed in macrophages and lymphocytes and highly up-regulated in several human inflammatory diseases. In pigs, S100A12 is abundant in the cytosol of granulocytes, where it is believed to be involved in signal modulation of inflammatory process. In this study, we investigated the interaction of the porcine S100A12 with phospholipid bilayers and the effect that ions (Ca2+, Zn2+ or both together) have in modifying protein-lipid interactions. More specifically, we intended to address issues such as: (1) is the protein-membrane interaction modulated by the presence of ions? (2) is the protein overall structure affected by the presence of the ions and membrane models simultaneously? (3) what are the specific conformational changes taking place when ions and membranes are both present? (4) does the protein have any kind of molecular preferences for a specific lipid component? To provide insight into membrane interactions and answer those questions, synchrotron radiation circular dichroism spectroscopy, fluorescence spectroscopy, and surface plasmon resonance were used. The use of these combined techniques demonstrated that this protein was capable of interacting both with lipids and with ions in solution, and enabled examination of changes that occur at different levels of structure organization. The presence of both Ca2+ and Zn2+ ions modify the binding, conformation and thermal stability of the protein in the presence of lipids. Hence, these studies examining molecular interactions of porcine S100A12 in solution complement the previously determined crystal structure information on this family of proteins, enhancing our understanding of its dynamics of interaction with membranes.	[Garcia, Assuero F.; Lopes, Jose L. S.; Costa-Filho, Antonio J.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Garcia, Assuero F.; Costa-Filho, Antonio J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil; [Lopes, Jose L. S.; Wallace, Bonnie A.] Univ London, Inst Struct & Mol Biol, Birkbeck Coll, London, England	Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; Birkbeck University London	Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.	anapaula@ifsc.usp.br	Araujo, Ana Paula U/I-6664-2012; Costa-Filho, Antonio J/D-3153-2012; Lopes, Jose L S/D-3213-2012; Costa-Filho, Antonio José/AAZ-1808-2020; Lopes, Jose Luiz S/AAC-2917-2021; Wallace, B A/C-3753-2008	Araujo, Ana Paula U/0000-0001-5455-084X; Costa-Filho, Antonio J/0000-0001-6730-8737; Lopes, Jose L S/0000-0003-1281-0521; Wallace, B A/0000-0001-9649-5092	Brazilian INCT-INBEQMeDI; FAPESP; CNPq [573607/2008-7, 2010/17662-8, 2012/20367-3]; UK Biotechnology and Biological Sciences Research Council (BBRSC); BBSRC; EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA) [226716]; BBSRC [BB/G530417/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530417/1] Funding Source: researchfish	Brazilian INCT-INBEQMeDI; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Biotechnology and Biological Sciences Research Council (BBRSC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by research grants from the Brazilian INCT-INBEQMeDI, FAPESP and CNPq (to APUA grant number 573607/2008-7 and AJCF - grant numbers 2010/17662-8 and 2012/20367-3), and the UK Biotechnology and Biological Sciences Research Council (BBRSC) (to BAW), CNPq Fellowships (to JLSL and AFG), and paired UK/Brazil Partnering grants from the CNPq and BBSRC. SRCD measurements at the ISA synchtroron (Aarhus, Denmark) were enabled by beamtime grants (to BAW and JLSL). Access to the CD1 beamline at ISA is acknowledged under the EU Integrated Infrastructure Initiative (I3), European Light Sources Activities (ELISA), grant agreement number 226716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAUDIER J, 1983, BIOCHEMISTRY-US, V22, P3360, DOI 10.1021/bi00283a009; Bauer MC, 2008, PROTEIN SCI, V17, P760, DOI 10.1110/ps.073381108; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; CALISSANO P, 1974, BIOCHEMISTRY-US, V13, P4553, DOI 10.1021/bi00719a013; DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; FUJII T, 1995, J BIOCHEM-TOKYO, V117, P999, DOI 10.1093/oxfordjournals.jbchem.a124833; Garcia AF, 2008, BIOPHYS CHEM, V134, P246, DOI 10.1016/j.bpc.2008.02.013; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2002, J CELL SCI, V115, P3149; Kathir KM, 2007, BBA-BIOMEMBRANES, V1768, P3080, DOI 10.1016/j.bbamem.2007.09.007; KILHOFFER MC, 1981, BIOCHEMISTRY-US, V20, P4407, DOI 10.1021/bi00518a027; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lopes JLS, 2009, BBA-BIOMEMBRANES, V1788, P2252, DOI 10.1016/j.bbamem.2009.06.026; Malmendal A, 2005, BIOCHEMISTRY-US, V44, P6502, DOI 10.1021/bi050088z; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Mozsolits H, 2002, BIOPOLYMERS, V66, P3, DOI 10.1002/bip.10200; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; RICHMAN PG, 1979, J BIOL CHEM, V254, P5372; Rouleau P, 2003, CLIN IMMUNOL, V107, P46, DOI 10.1016/S1521-6616(02)00043-8; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Sivaraja V, 2001, BIOPHYS J, V1, P1832; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Venyaminov SY, 2004, ANAL BIOCHEM, V334, P97, DOI 10.1016/j.ab.2004.07.032; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; WENDT B, 1988, EUR J BIOCHEM, V175, P439, DOI 10.1111/j.1432-1033.1988.tb14214.x; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zimmer D. B., 2010, CARDIOVASC PSYCHIAT, V2010, DOI DOI 10.1155/2010/728052; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	53	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82555	10.1371/journal.pone.0082555	http://dx.doi.org/10.1371/journal.pone.0082555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367524	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000328740300040
J	Penelo, E; Negrete, A; Portell, M; Raich, RM				Penelo, Eva; Negrete, America; Portell, Mariona; Raich, Rosa M.			Psychometric Properties of the Eating Disorder Examination Questionnaire (EDE-Q) and Norms for Rural and Urban Adolescent Males and Females in Mexico	PLOS ONE			English	Article							BODY SHAPE MODEL; CONFIRMATORY FACTOR-ANALYSIS; SOCIOCULTURAL INFLUENCES; SCOFF QUESTIONNAIRE; SPANISH VERSION; VALIDITY; RELIABILITY; WOMEN; INTERVIEW	Aims: To contribute new evidence to the controversy about the factor structure of the Eating Disorder Examination Questionnaire (EDE-Q) and to provide, for the first time, norms based on a large adolescent Mexican community sample, regarding sex and area of residence (urban/rural). Methods: A total of 2928 schoolchildren (1544 females and 1384 males) aged 11-18 were assessed with the EDE-Q and other disordered eating questionnaire measures. Results: Confirmatory factor analysis of the attitudinal items of the EDE-Q did not support the four theorized subscales, and a two-factor solution, Restraint and Eating-Shape-Weight concern, showed better fit than the other models examined (RMSEA =.054); measurement invariance for this two-factor model across sex and area of residence was found. Satisfactory internal consistency (omega =.80) and two-week test-retest reliability (ICCa =.84;. =. 56), and evidence for convergent validity with external measures was obtained. The highest attitudinal EDE-Q scores were found for urban females and the lowest scores were found for rural males, whereas the occurrence of key eating disorder behavioural features and compensatory behaviours was similar in both areas of residence. Conclusions: This study reveals satisfactory psychometric properties and provides population norms of the EDE-Q, which may help clinicians and researchers to interpret the EDE-Q scores of adolescents from urban and rural areas in Mexico.	[Penelo, Eva] Univ Autonoma Barcelona, Lab Estadist Aplicada, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Negrete, America] Univ Autonoma Nayarit, Acad Instrumental, Programa Acad Psicol, Tepic, Nayarit, Mexico; [Negrete, America; Portell, Mariona; Raich, Rosa M.] Univ Autonoma Barcelona, Unitat Avaluacio & Intervencio Imatge Corporal, E-08193 Barcelona, Spain; [Portell, Mariona] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Raich, Rosa M.] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Raich, RM (corresponding author), Univ Autonoma Barcelona, Unitat Avaluacio & Intervencio Imatge Corporal, E-08193 Barcelona, Spain.	rosa.raich@uab.cat	Portell, Mariona/L-5295-2014	Portell, Mariona/0000-0002-5939-6842; Raich, Rosa M./0000-0001-7819-3357; Penelo, Eva/0000-0001-6796-7660	Spanish Ministry of Economy and Competitivity [PSI2010-22067]; Catalonian Government	Spanish Ministry of Economy and Competitivity(Spanish Government); Catalonian Government	This research was partly supported by grants PSI2010-22067 from the Spanish Ministry of Economy and Competitivity, and 2009-SGR-1450 from the Catalonian Government. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Aardoom JJ, 2012, EAT BEHAV, V13, P305, DOI 10.1016/j.eatbeh.2012.09.002; Allen KL, 2011, EAT BEHAV, V12, P143, DOI 10.1016/j.eatbeh.2011.01.005; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; APA, 1994, DIAGN STAT MAN MENT; Barnes J, 2012, EAT BEHAV, V13, P379, DOI 10.1016/j.eatbeh.2012.05.001; Becker AE, 2010, INT J EAT DISORDER, V43, P171, DOI 10.1002/eat.20675; Berg KC, 2012, INT J EAT DISORDER, V45, P428, DOI 10.1002/eat.20931; Bojorquez I, 2004, EUR EAT DISORD REV, V12, P197, DOI 10.1002/erv.571; Brown T. A., 2015, CONFIRMATORY FACTOR, VSecond; Byrne BM, 2008, PSICOTHEMA, V20, P872; Carter JC, 2001, BEHAV RES THER, V39, P625, DOI 10.1016/S0005-7967(00)00033-4; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; *CONEVAL, 2010, POBR INGR MEX; Darcy AM, 2013, BODY IMAGE, V10, P399, DOI 10.1016/j.bodyim.2013.01.008; DOMENECH JM, 2008, SPSS MACROBONFE BONF; ESCOTO MC, 2008, REV MEX PSICOL, V25, P99; Espinoza P, 2010, BODY IMAGE, V7, P70, DOI 10.1016/j.bodyim.2009.09.002; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn Christopher G., 1993, P317; FINNER H, 1993, J AM STAT ASSOC, V88, P920, DOI 10.2307/2290782; Franco Paredes Karina, 2011, Rev. Mex. de trastor. aliment, V2, P148; Franco Paredes Karina, 2010, Rev. Mex. de trastor. aliment, V1, P90; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Garner DM, 1991, EATING DISORDER INVE; Giovazolias T, 2013, EUR J PSYCHOL ASSESS, V29, P189, DOI 10.1027/1015-5759/a000138; *GOB EST NAYAR ORG, 2012, PLAN EST DES NAYAR 2; Grilo CM, 2013, OBES SURG, V23, P657, DOI 10.1007/s11695-012-0840-8; Hay PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001541; Hidalgo-Rasmussen Carlos Alejandro, 2011, Rev. Mex. de trastor. aliment, V2, P71; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Holmqvist K, 2010, EUR EAT DISORD REV, V18, P133, DOI 10.1002/erv.965; Hrabosky JI, 2008, OBESITY, V16, P763, DOI 10.1038/oby.2008.3; *INEGI, 2010, POBL 3 AN MAS MUN ED; *INEGI, 2010, TOT ESC ED BAS MED S; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; JORESKOG KG, 1975, J AM STAT ASSOC, V70, P631, DOI 10.2307/2285946; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; Luck AJ, 2002, BRIT MED J, V325, P755, DOI 10.1136/bmj.325.7367.755; MALONEY MJ, 1988, J AM ACAD CHILD PSY, V27, P541, DOI 10.1097/00004583-198809000-00004; MANCILLA JM, 2003, REV THOMSON PSICOLOG, V1, P167; Marsh HW, 2013, DEV PSYCHOL, V49, P1194, DOI 10.1037/a0026913; McDonald RP, 1999, TEST THEORY UNIFIED; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2004, INT J EAT DISORDER, V36, P195, DOI 10.1002/eat.20017; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nunez-Navarro A, 2012, EUR EAT DISORD REV, V20, P23, DOI 10.1002/erv.1146; Pelaez-Fernandez MA, 2013, PSICOTHEMA, V25, P107, DOI 10.7334/psicothema2012.18; Penelo E, 2012, EUR J PSYCHOL ASSESS, V28, P76, DOI 10.1027/1015-5759/a000093; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Reas DL, 2006, BEHAV RES THER, V44, P43, DOI 10.1016/j.brat.2005.01.004; Ro O, 2010, NORD J PSYCHIAT, V64, P428, DOI 10.3109/08039481003797235; Sanchez-Armass O, 2012, SALUD PUBLICA MEXICO, V54, P375, DOI 10.1590/S0036-36342012000400007; *SEDESOL, 2012, DIR GEN ADJ PLAN MIC; Statistics IS, 2010, STAT PACK SOC SCI VE; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Toro J, 2005, EUR EAT DISORD REV, V13, P351, DOI 10.1002/erv.650; TORO J, 1994, ACTA PSYCHIAT SCAND, V89, P147, DOI 10.1111/j.1600-0447.1994.tb08084.x; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vazquez R, 2000, SALUD MENT, V23, P18; Villarroel AM, 2011, J PSYCHOPATHOL BEHAV, V33, P121, DOI 10.1007/s10862-009-9177-6; WHITAKER WH, 1983, J RES RURAL ED, V1, P71; White HJ, 2014, INT J EAT DISORDER, V47, P99, DOI 10.1002/eat.22199; Yucel B, 2011, EUR EAT DISORD REV, V19, P509, DOI 10.1002/erv.1104	68	58	59	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83245	10.1371/journal.pone.0083245	http://dx.doi.org/10.1371/journal.pone.0083245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367587	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300098
J	Seegelke, C; Hughes, CML; Schack, T				Seegelke, Christian; Hughes, Charmayne Mary Lee; Schack, Thomas			Simulating My Own or Others Action Plans? - Motor Representations, Not Visual Representations Are Recalled in Motor Memory	PLOS ONE			English	Article							MANUAL OBSTACLE AVOIDANCE; END-STATE COMFORT; INDIVIDUAL-DIFFERENCES; MIRROR NEURONS; OBJECT; PERCEPTION; COGNITION; KINEMATICS; IMITATION; REVEALS	Action plans are not generated from scratch for each movement, but features of recently generated plans are recalled for subsequent movements. This study investigated whether the observation of an action is sufficient to trigger plan recall processes. Participant dyads performed an object manipulation task in which one participant transported a plunger from an outer platform to a center platform of different heights (first move). Subsequently, either the same (intra-individual task condition) or the other participant (inter-individual task condition) returned the plunger to the outer platform (return moves). Grasp heights were inversely related to center target height and similar irrespective of direction (first vs. return move) and task condition (intra-vs. inter-individual). Moreover, participants' return move grasp heights were highly correlated with their own, but not with their partners' first move grasp heights. Our findings provide evidence that a simulated action plan resembles a plan of how the observer would execute that action (based on a motor representation) rather than a plan of the actually observed action (based on a visual representation).	[Seegelke, Christian; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Seegelke, Christian; Schack, Thomas] Res Inst Cognit & Robot CoR Lab, Bielefeld, Germany; [Seegelke, Christian; Schack, Thomas] Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Hughes, Charmayne Mary Lee] Tech Univ Munich, Dept Sport & Hlth Sci, Inst Movement Sci, D-80290 Munich, Germany	University of Bielefeld; Technical University of Munich	Seegelke, C (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany.	Christian.seegelke@uni-bielefeld.de	Seegelke, Christian/AAH-9410-2019	Seegelke, Christian/0000-0001-9624-6395	German Research Foundation (DFG) [EC 277]; Honda Research Institute Europe	German Research Foundation (DFG)(German Research Foundation (DFG)); Honda Research Institute Europe	This research was funded by the German Research Foundation (DFG; EC 277). Christian Seegelke gratefully acknowledges the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Becchio C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00117; Belot M, 2013, P NATL ACAD SCI USA, V110, P2763, DOI 10.1073/pnas.1209981110; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2002, ATTENTION PERFORM, V19, P315; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Dragovic M, 2004, ACTA NEUROPSYCHIATR, V16, P212, DOI 10.1111/j.0924-2708.2004.00087.x; Edwards MG, 2003, BRAIN COGNITION, V53, P495, DOI 10.1016/S0278-2626(03)00210-0; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Griffiths D, 2009, Q J EXP PSYCHOL, V62, P2450, DOI 10.1080/17470210903103059; Hughes CML, 2012, EXP BRAIN RES, V219, P391, DOI 10.1007/s00221-012-3100-1; Hughes CML, 2012, J MOTOR BEHAV, V44, P195, DOI 10.1080/00222895.2012.672483; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Mason AH, 2005, EXP BRAIN RES, V163, P173, DOI 10.1007/s00221-004-2157-x; Meulenbroek RGJ, 2007, EXP BRAIN RES, V180, P333, DOI 10.1007/s00221-007-0861-z; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Poljac E, 2009, PSYCHOL RES-PSYCH FO, V73, P407, DOI 10.1007/s00426-008-0151-9; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Rosenbaum DA, 2006, PSYCHON B REV, V13, P918, DOI 10.3758/BF03194019; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Schutz C, 2011, MOTOR CONTROL, V15, P321, DOI 10.1123/mcj.15.3.321; Seegelke C, 2012, EXP BRAIN RES, V222, P125, DOI 10.1007/s00221-012-3203-8; Seegelke C, 2011, EXP BRAIN RES, V215, P65, DOI 10.1007/s00221-011-2872-z; van der Wel RPRD, 2007, J EXP PSYCHOL HUMAN, V33, P1117, DOI 10.1037/0096-1523.33.5.1117; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Weigelt M, 2007, EXP BRAIN RES, V179, P191, DOI 10.1007/s00221-006-0780-4; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	46	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84662	10.1371/journal.pone.0084662	http://dx.doi.org/10.1371/journal.pone.0084662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367689	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300155
J	Sun, Y; Yan, JY; Mao, HY; Zhang, L; Lyu, QF; Wu, ZH; Zheng, W; Feng, C; Zhang, YJ				Sun, Yi; Yan, JuYing; Mao, HaiYan; Zhang, Lei; Lyu, QinFeng; Wu, ZhongHua; Zheng, Wei; Feng, Cen; Zhang, YanJun			Characterization of the Complete Genome of Chikungunya in Zhejiang, China, Using a Modified Virus Discovery Method Based on cDNA-AFLP	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; IDENTIFICATION; CORONAVIRUS; OUTBREAK; INDIA	Background: Chikungunya (CHIK) virus is a mosquito-borne emerging pathogen presenting great health challenges worldwide, particularly in tropical zones. Here we report a newly detected strain of CHIK, Zhejiang/chik-sy/2012, in China, a nonindigenous region for CHIK, using a modified approach based on the classic cDNA-AFLP. We then performed etiological and phylogenetic analyses to better understand its molecular characterization and phylogenetic pattern, and also to aid in further evaluating its persistence in Southeast Asia. Methods: By using this modified procedure, we determined for the first time the complete genome sequence of the chikungunya virus strain, Zhejiang/chik-sy/2012, isolated in 2012 from a patient in Zhejiang, China. Sequence analyses revealed that this positive single strand of RNA is 12,017 bp long. We found no single amino acid mutation in A226V, D284E and A316V. Phylogenetic analysis showed that our strain shared the greatest homology with a strain isolated in Taiwan, which was derived from a strain from Indonesia. Chik-sy/2012 is in a different clade from other CHIK viruses found in China previously. Conclusions: A modified cDNA-AFLP in virus discovery was used to isolate the first CHIK and the first complete genome sequence of virus strain chik-sy/2012 in 2012 from a patient with CHIK fever in Zhejiang, China. The infection displayed great phylogenetic distance from viruses detected in Guangdong, China, in 2008 and 2010, since they were derived from another evolutionary lineage. Additional molecular epidemiology data are needed to further understand, monitor and evaluate CHIK in China.	[Sun, Yi; Yan, JuYing; Mao, HaiYan; Zhang, Lei; Zhang, YanJun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Lyu, QinFeng; Wu, ZhongHua; Zheng, Wei] Zhejiang Int Travel Healthcare Ctr, Hangzhou, Zhejiang, Peoples R China; [Feng, Cen] Zhejiang Normal Univ, Jinhua, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Normal University	Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	yjzhang@cdc.zj.cn			Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation; General Administration of Quality Supervision, Inspection and Quarantine of P.R.C [20100043]	Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation; General Administration of Quality Supervision, Inspection and Quarantine of P.R.C	This work was funded by Zhejiang Provincial Program for the Cultivation of High-level Innoative Health talents, Youth Project of Zhejiang CDC Foundation and General Administration of Quality Supervision, Inspection and Quarantine of P.R.C (20100043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hedrick PW, 2011, GENETICS POPULATION, P111; Holmes KV, 1996, FIELDS VIROLOGY, P1075; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Li XF, 2012, J VIROL, V86, P8904, DOI 10.1128/JVI.01289-12; Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]; Zheng K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-8	16	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83014	10.1371/journal.pone.0083014	http://dx.doi.org/10.1371/journal.pone.0083014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367579	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300090
J	Weng, ZH; Ertle, J; Zheng, SP; Lauenstein, T; Mueller, S; Bockisch, A; Gerken, G; Yang, DL; Schlaak, JF				Weng, Zhihong; Ertle, Judith; Zheng, Shaoping; Lauenstein, Thomas; Mueller, Stefan; Bockisch, Andreas; Gerken, Guido; Yang, Dongliang; Schlaak, Joerg F.			A New Model to Estimate Prognosis in Patients with Hepatocellular Carcinoma after Yttrium-90 Radioembolization	PLOS ONE			English	Article							UNITED-STATES; LIVER-CANCER; SURVIVAL; CRITERIA; RECOMMENDATIONS; MANAGEMENT; SELECTION; FUTURE	Aims: The current prognostic model to estimate the survival in hepatocellular carcinoma (HCC) patients treated with transarterial hepatic selective internal radiotherapy (SIRT) is not fully characterized. The aim of this study was to establish a new scoring model including assessment of both tumor responses and therapy-induced systemic changes in HCC patients to predict survival at an early time point post-SIRT. Methods and materials: Between 2008 and 2012, 149 HCC patients treated with SIRT were included into this study. CT images and biomarkers in blood tested at one month post-SIRT were analyzed and correlated with clinical outcome. Tumor responses were assessed by RECIST 1.1, mRECIST, and Choi criteria. Kaplan-Meier methods were used to estimate survival curves. Cox regression was used in uni- and multivariable survival analyses and in the establishment of a prognostic model. Results: A multivariate proportional hazards model was created based on the tumor response, the number of tumor nodules, the score of the model for end stage liver disease (MELD), and the serum C-reactive protein levels which were independent predictors of survival in HCC patients at one month post-SIRT. This prognostic model accurately differentiated the outcome of patients with different risk scores in this cohort (P<0.001). The model also had the ability to assign a predicted survival probability for individual patients. Conclusions: A new model to predict survival of HCC patients mainly based on tumor responses and therapy-induced systemic changes provides reliable prognosis and accurately discriminates the survival at an early time point after SIRT in these patients.	[Weng, Zhihong; Ertle, Judith; Gerken, Guido; Schlaak, Joerg F.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Weng, Zhihong; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Lauenstein, Thomas] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Mueller, Stefan; Bockisch, Andreas] Univ Hosp Essen, Inst Nucl Med, Essen, Germany	University of Duisburg Essen; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen; University of Duisburg Essen	Schlaak, JF (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	joerg.schlaak@uni-due.de		Schlaak, Joerg/0000-0002-9499-1014	Deutsche Forschungsgemeinschaft [TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; ATTALI P, 1987, CANCER, V59, P2108, DOI 10.1002/1097-0142(19870615)59:12<2108::AID-CNCR2820591225>3.0.CO;2-3; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Coldwell D, 2011, AM J CLIN ONCOL-CANC, V34, P337, DOI 10.1097/COC.0b013e3181ec61bb; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Gillmore R, 2011, J HEPATOL, V55, P1309, DOI 10.1016/j.jhep.2011.03.007; Hamami ME, 2009, J NUCL MED, V50, P688, DOI 10.2967/jnumed.108.058347; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Kennedy A, 2012, AM J CLIN ONCOL-CANC, V35, P81, DOI 10.1097/COC.0b013e3181ec60b8; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pencina MJ, 2012, STAT MED, V31, P1543, DOI 10.1002/sim.4508; Piscaglia F, 2010, DIGEST LIVER DIS, V42, pS258, DOI 10.1016/S1590-8658(10)60514-2; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yang JD, 2012, HEPATOLOGY, V56, P614, DOI 10.1002/hep.25680	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82225	10.1371/journal.pone.0082225	http://dx.doi.org/10.1371/journal.pone.0082225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367506	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300022
J	Maradonna, F; Gioacchini, G; Falcinelli, S; Bertotto, D; Radaelli, G; Olivotto, I; Carnevali, O				Maradonna, Francesca; Gioacchini, Giorgia; Falcinelli, Silvia; Bertotto, Daniela; Radaelli, Giuseppe; Olivotto, Ike; Carnevali, Oliana			Probiotic Supplementation Promotes Calcification in Danio rerio Larvae: A Molecular Study	PLOS ONE			English	Article							MATRIX GLA PROTEIN; LACTIC-ACID BACTERIA; BONE-RESORBING CELLS; GENE-EXPRESSION; TELEOST FISH; DICENTRARCHUS-LABRAX; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; SPARUS-AURATA	A growing number of studies have been showing that dietary probiotics can exert beneficial health effects in both humans and animals. We previously demonstrated that dietary supplementation with Lactobacillus rhamnosus - a component of the human gut microflora - enhances reproduction, larval development, and the biomineralization process in Danio rerio (zebrafish). The aim of this study was to identify the pathways affected by L. rhamnosus during zebrafish larval development. Our morphological and histochemical findings show that L. rhamnosus accelerates bone deposition through stimulation of the expression of key genes involved in ossification, e.g. runt-related transcription factor 2 (runx2), Sp7 transcription factor (sp7), matrix Gla protein (mgp), and bone gamma-carboxyglutamate (gla) protein (bglap) as well as through inhibition of sclerostin (sost), a bone formation inhibitor. Western blot analysis of mitogen-activated protein kinase 1 and 3-(Mapk1 and Mapk3), which are involved in osteoblast and osteocyte differentiation, documented an increase in Mapk1 16 days post fertilization (dpf) and of Mapk3 23 dpf in individuals receiving L. rhamnosus supplementation. Interestingly, a reduction of sost detected in the same individuals suggests that the probiotic may help treat bone disorders.	[Maradonna, Francesca; Gioacchini, Giorgia; Falcinelli, Silvia; Olivotto, Ike; Carnevali, Oliana] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Bertotto, Daniela; Radaelli, Giuseppe] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy; [Carnevali, Oliana] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Marche Polytechnic University; University of Padua	Carnevali, O (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	o.carnevali@univpm.it	Gioacchini, Giorgia/AAU-3581-2021; Olivotto, Ike/K-9397-2014; Maradonna, Francesca/AAU-3017-2021; Maradonna, Francesca/AAU-5167-2021; Carnevali, Oliana/P-2751-2015	Olivotto, Ike/0000-0002-0906-4225; Maradonna, Francesca/0000-0001-6677-1017; Carnevali, Oliana/0000-0001-5994-0572; Gioacchini, Giorgia/0000-0003-1187-7302; RADAELLI, Giuseppe/0000-0003-0176-1701; BERTOTTO, Daniela/0000-0002-1370-8679	"Fondi di Ateneo'' Universita' Politecnica delle Marche	"Fondi di Ateneo'' Universita' Politecnica delle Marche	This work was supported by "Fondi di Ateneo 2012'' Universita' Politecnica delle Marche grant awarded to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelli L, 2009, ANN NY ACAD SCI, V1163, P340, DOI 10.1111/j.1749-6632.2008.03670.x; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Apschner A, 2011, METHOD CELL BIOL, V105, P239, DOI 10.1016/B978-0-12-381320-6.00010-2; Avella MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045572; Avella MA, 2010, AM J PHYSIOL-REG I, V298, pR359, DOI 10.1152/ajpregu.00300.2009; BENJAMIN M, 1988, ANAT EMBRYOL, V178, P461, DOI 10.1007/BF00306053; BENJAMIN M, 1990, J ANAT, V169, P153; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Carnevali O, 2013, GEN COMP ENDOCR, V188, P297, DOI 10.1016/j.ygcen.2013.02.022; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; DELMAS PD, 1990, J BONE MINER RES, V5, P5, DOI 10.1002/jbmr.5650050104; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gioacchini G, 2013, REPROD FERT DEVELOP, V25, P1115, DOI 10.1071/RD12187; Gioacchini G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094243; Gioacchini G, 2010, REPRODUCTION, V140, P953, DOI 10.1530/REP-10-0145; Giorgini E, 2010, ANAL BIOANAL CHEM, V398, P3063, DOI 10.1007/s00216-010-4234-2; HALE JE, 1988, J BIOL CHEM, V263, P5820; Hall Brian K., 2007, P13; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Karsenty G, 2000, TRENDS ENDOCRIN MET, V11, P437, DOI 10.1016/S1043-2760(00)00322-2; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krossoy C, 2009, J ANAT, V215, P663, DOI 10.1111/j.1469-7580.2009.01153.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamari F, 2013, AQUACULTURE, V376, P137, DOI 10.1016/j.aquaculture.2012.11.016; Lauzon HL, 2010, J APPL MICROBIOL, V108, P624, DOI 10.1111/j.1365-2672.2009.04454.x; Lewiecki EM, 2011, DISCOV MED, V12, P263; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Lian JB, 2003, CALCIFIED TISSUE INT, V72, P631, DOI 10.1007/s00223-002-1058-x; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Lombardo F, 2011, FISH AQUACULT J FAJ, V33; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Matsushita T, 2009, HUM MOL GENET, V18, P227, DOI 10.1093/hmg/ddn339; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McNulty MS, 2012, GENE EXPR PATTERNS, V12, P228, DOI 10.1016/j.gep.2012.04.003; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Oliva-Teles A, 2012, J FISH DIS, V35, P83, DOI 10.1111/j.1365-2761.2011.01333.x; Palermo FA, 2011, GEN COMP ENDOCR, V171, P293, DOI 10.1016/j.ygcen.2011.02.009; Pearse AGE, 1985, HISTOCHEMISTRY THEOR, P1512; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Picchietti S, 2009, FISH SHELLFISH IMMUN, V26, P368, DOI 10.1016/j.fsi.2008.10.008; Pinto JP, 2003, BONE, V32, P201, DOI 10.1016/S8756-3282(02)00981-X; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Price PA, 2000, ARTERIOSCL THROM VAS, V20, P317, DOI 10.1161/01.ATV.20.2.317; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Standen BT, 2013, FISH SHELLFISH IMMUN, V35, P1097, DOI 10.1016/j.fsi.2013.07.018; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Witten PE, 2010, J APPL ICHTHYOL, V26, P257, DOI 10.1111/j.1439-0426.2010.01416.x; Witten PE, 2010, J APPL ICHTHYOL, V26, P225, DOI 10.1111/j.1439-0426.2010.01410.x; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Witten PE, 2001, J MORPHOL, V250, P197, DOI 10.1002/jmor.1065.abs; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027324	74	43	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83155	10.1371/journal.pone.0083155	http://dx.doi.org/10.1371/journal.pone.0083155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358259	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700050
J	Xiao, HX; Liu, L; Zhu, QY; Tan, ZW; Yu, WB; Tang, X; Zhan, DW; Du, YH; Wang, HB; Liu, D; Li, ZX; Yuen, KY; Ho, DD; Gao, GF; Chen, ZW				Xiao, Haixia; Liu, Li; Zhu, Qingyu; Tan, Zhiwu; Yu, Wenbo; Tang, Xian; Zhan, Dawei; Du, Yanhua; Wang, Haibo; Liu, Di; Li, Zhixin; Yuen, Kwok-Yung; Ho, David D.; Gao, George F.; Chen, Zhiwei			A Replicating Modified Vaccinia Tiantan Strain Expressing an Avian-Derived Influenza H5N1 Hemagglutinin Induce Broadly Neutralizing Antibodies and Cross-Clade Protective Immunity in Mice	PLOS ONE			English	Article							A H5N1; PANDEMIC INFLUENZA; RECOMBINANT VECTOR; RHESUS-MONKEYS; HOST-RANGE; VIRUS; IMMUNOGENICITY; MVA; TRANSMISSION; ATTENUATION	To combat the possibility of a zoonotic H5N1 pandemic in a timely fashion, it is necessary to develop a vaccine that would confer protection against homologous and heterologous human H5N1 influenza viruses. Using a replicating modified vaccinia virus Tian Tan strain (MVTT) as a vaccine vector, we constructed MVTTHA-QH and MVTTHA-AH, which expresses the H5 gene of a goose-derived Qinghai strain A/Bar-headed Goose/Qinghai/1/2005 or human-derived Anhui Strain A/Anhui/1/2005. The immunogenicity profiles of both vaccine candidates were evaluated. Vaccination with MVTTHA-QH induced a significant level of neutralizing antibodies (Nabs) against a homologous strain and a wide range of H5N1 pseudoviruses (clades 1, 2.1, 2.2, 2.3.2, and 2.3.4). Neutralization tests (NT) and Haemagglutination inhibition (HI) antibodies inhibit the live autologous virus as well as a homologous A/Xingjiang/1/2006 and a heterologous A/Vietnam/1194/2004, representing two human isolates from clade 2.2 and clade 1, respectively. Importantly, mice vaccinated with intranasal MVTTHA-QH were completely protected from challenge with lethal dosages of A/Bar-headed Goose/Qinghai/1/2005 and the A/Viet Nam/1194/2004, respectively, but not control mice that received a mock MVTTS vaccine. However, MVTTHA-AH induced much lower levels of NT against its autologous strain. Our results suggest that it is feasible to use the H5 gene from A/Bar-headed Goose/Qinghai/1/2005 to construct an effective vaccine, when using MVTT as a vector, to prevent infections against homologous and genetically divergent human H5N1 influenza viruses.	[Xiao, Haixia; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China; [Liu, Li; Tan, Zhiwu; Yu, Wenbo; Tang, Xian; Du, Yanhua; Wang, Haibo; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Xiao, Haixia; Liu, Di; Li, Zhixin; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Li; Yuen, Kwok-Yung; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Liu, Li; Yuen, Kwok-Yung; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Qingyu; Zhan, Dawei] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Ho, David D.] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY USA; [Ho, David D.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Hong Kong; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Hong Kong; University of Hong Kong; Academy of Military Medical Sciences - China; Academia Sinica - Taiwan; Rockefeller University; University of Hong Kong	Gao, GF (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China.	gaof@im.ac.cn; zchenai@hku.hk	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019; Gao, George Fu/ABD-5229-2021; Liu, Di/G-6135-2014; Liu, Di/ABD-2729-2021; Xiao, Haixia/AAZ-3374-2020	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; Xiao, Haixia/0000-0003-0032-5430; Yuen, Kwok-yung/0000-0002-2083-1552; Yu, Wenbo/0000-0002-9237-272X	National High-Tech R&D Project (Project 863) of China [2006AA02A205]; National Basic Research Program (Project 973) of China [2005CB523001, 2006CB504208]; National Key Technologies R&D Program of China [2006BAD06A01]; National Natural Sciences Foundation of China [30599434]; Hong Kong Research Grant Council [HK-RGC762208]; NIH [3 U19 AI051915-05S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National High-Tech R&D Project (Project 863) of China; National Basic Research Program (Project 973) of China(National Basic Research Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National High-Tech R&D Project (Project 863) of China (2006AA02A205), National Basic Research Program (Project 973) of China (2005CB523001 and 2006CB504208), the National Key Technologies R&D Program of China (2006BAD06A01), the National Natural Sciences Foundation of China (30599434), Hong Kong Research Grant Council (HK-RGC762208) and NIH (3 U19 AI051915-05S1). GFG is a distinguished young investigator of the National Natural Science Foundation of China (grant number 30525010). DL is supported by the China Postdoctoral Fellowship (number 20070420542). ZC is supported by the University Development Fund of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Barouch DH, 2001, J VIROL, V75, P5151, DOI 10.1128/JVI.75.11.5151-5158.2001; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jin LHC Q, 1977, SCI CHINA, V27, P562; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Minor PD, 2010, CLIN INFECT DIS, V50, P560, DOI 10.1086/650171; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Seth A, 1998, P NATL ACAD SCI USA, V95, P10112, DOI 10.1073/pnas.95.17.10112; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Steel J, 2011, BIODRUGS, V25, P285, DOI 10.2165/11593870-000000000-00000; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; Vajo Z, 2008, PEDIATR INFECT DIS J, V27, P1052, DOI 10.1097/INF.0b013e3181861dd7; Webster RG, 2005, ARCH VIROL, P117; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhu JH, 1996, ARCH VIROL, V141, P1055, DOI 10.1007/BF01718609; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	42	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83274	10.1371/journal.pone.0083274	http://dx.doi.org/10.1371/journal.pone.0083274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358269	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700055
J	Foster, CR; Daniel, LL; Daniels, CR; Dalal, S; Singh, M; Singh, K				Foster, Cerrone R.; Daniel, Laura L.; Daniels, Christopher R.; Dalal, Suman; Singh, Mahipal; Singh, Krishna			Deficiency of Ataxia Telangiectasia Mutated Kinase Modulates Cardiac Remodeling Following Myocardial Infarction: Involvement in Fibrosis and Apoptosis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; MYOCYTE APOPTOSIS; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; ATM; DYSFUNCTION; MICE; PHOSPHORYLATION; P53	Ataxia telangiectasia mutated kinase (ATM) is a cell cycle checkpoint protein activated in response to DNA damage. We recently reported that ATM plays a protective role in myocardial remodeling following beta-adrenergic receptor stimulation. Here we investigated the role of ATM in cardiac remodeling using myocardial infarction (MI) as a model. Methods and Results: Left ventricular (LV) structure, function, apoptosis, fibrosis, and protein levels of apoptosis-and fibrosis-related proteins were examined in wild-type (WT) and ATM heterozygous knockout (hKO) mice 7 days post-MI. Infarct sizes were similar in both MI groups. However, infarct thickness was higher in hKO-MI group. Two dimensional M-mode echocardiography revealed decreased percent fractional shortening (% FS) and ejection fraction (EF) in both MI groups when compared to their respective sham groups. However, the decrease in % FS and EF was significantly greater in WT-MI vs hKO-MI. LV end systolic and diastolic diameters were greater in WT-MI vs hKO-MI. Fibrosis, apoptosis, and a-smooth muscle actin staining was significantly higher in hKO-MI vs WT-MI. MMP-2 protein levels and activity were increased to a similar extent in the infarct regions of both groups. MMP-9 protein levels were increased in the non-infarct region of WT-MI vs WT-sham. MMP-9 protein levels and activity were significantly lower in the infarct region of WT vs hKO. TIMP-2 protein levels similarly increased in both MI groups, whereas TIMP-4 protein levels were significantly lower in the infarct region of hKO group. Phosphorylation of p53 protein was higher, while protein levels of manganese superoxide dismutase were significantly lower in the infarct region of hKO vs WT. In vitro, inhibition of ATM using KU-55933 increased oxidative stress and apoptosis in cardiac myocytes.	[Foster, Cerrone R.; Daniel, Laura L.; Daniels, Christopher R.; Dalal, Suman; Singh, Mahipal; Singh, Krishna] E Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, James H Quillen Vet Affairs Med Ctr, Johnson City, TN 37614 USA	East Tennessee State University	Singh, K (corresponding author), E Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, James H Quillen Vet Affairs Med Ctr, Johnson City, TN 37614 USA.	singhk@etsu.edu	Daniel, Laura/K-2428-2015	Daniel, Laura/0000-0003-3143-5915	National Institutes of Health [R21HL-091405, R21HL-092459]; Merit Review award from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [BX000640]; institutional Research and Improvement funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091405, R21HL092459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review award from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; institutional Research and Improvement funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health (Grant numbers R21HL-091405 and R21HL-092459), a Merit Review award (number BX000640) from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development, and institutional Research and Improvement funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2012, HEART FAIL CLIN, V8, P79, DOI 10.1016/j.hfc.2011.08.010; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y; Chen YJ, 2005, AM J PHYSIOL-HEART C, V288, pH133, DOI 10.1152/ajpheart.00851.2003; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Colucci WS, 1997, AM J CARDIOL, V80, pL15, DOI 10.1016/S0002-9149(97)00845-X; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; Daniels CR, 2012, AM J PHYSIOL-HEART C, V303, pH1459, DOI 10.1152/ajpheart.00401.2012; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Foster CR, 2012, EXP PHYSIOL, V97, P506, DOI [10.1113/expphysiol.2011.061812, 10.1111/j.1469-445X.2011.01034.x]; Foster CR, 2011, MOL CELL BIOCHEM, V353, P13, DOI 10.1007/s11010-011-0769-6; Frangogiannis NG, 2000, CARDIOVASC RES, V48, P89, DOI 10.1016/S0008-6363(00)00158-9; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; Krishnamurthy P, 2009, MOL CELL BIOCHEM, V322, P53, DOI 10.1007/s11010-008-9939-6; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; Li YW, 2007, AM J PHYSIOL-HEART C, V292, pH946, DOI 10.1152/ajpheart.00361.2006; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Lin CS, 2012, ORAL ONCOL, V48, P1152, DOI 10.1016/j.oraloncology.2012.05.020; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mishra PK, 2010, CELL BIOCHEM BIOPHYS, V57, P67, DOI 10.1007/s12013-010-9084-1; Mukherjee R, 2006, AM J PHYSIOL-HEART C, V291, pH2216, DOI 10.1152/ajpheart.01343.2005; Mukherjee R, 2012, J SURG RES, V172, P59, DOI 10.1016/j.jss.2010.06.015; Obal D, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0305-1; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Su Y, 2000, ANN INTERN MED, V133, P770, DOI 10.7326/0003-4819-133-10-200011210-00009; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; WILLEMS IEMG, 1994, AM J PATHOL, V145, P868; Yan MS, 2002, CANCER RES, V62, P5153; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513	51	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83513	10.1371/journal.pone.0083513	http://dx.doi.org/10.1371/journal.pone.0083513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358288	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700127
J	Katara, GK; Jaiswal, MK; Kulshrestha, A; Kolli, B; Gilman-Sachs, A; Beaman, KD				Katara, G. K.; Jaiswal, M. K.; Kulshrestha, A.; Kolli, B.; Gilman-Sachs, A.; Beaman, K. D.			Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages	ONCOGENE			English	Article						a2V-ATPase; a2NTD; tumor-associated macrophages; M2 macrophages; invasion assay; angiogenesis	N-TERMINUS DOMAIN; H+-ATPASE; V-ATPASE; A2 ISOFORM; IN-VITRO; CANCER; POLARIZATION; ACTIVATION; CELLS; ATP6L	Macrophage polarization contributes to distinct human pathologies. In tumors, a polarized M2 phenotype called tumor-associated macrophages (TAMs) are associated with promotion of invasion and angiogenesis. In cancer cells, vacuolar ATPase (V-ATPase), a multi-subunit enzyme, is expressed on the plasma/vesicular membranes and critically influences the metastatic behavior. In addition, the soluble, cleaved N-terminal domain of a2 isoform of V-ATPase (a2NTD) is associated with in vitro induction of pro-tumorigenic properties in monocytes. This activity of a2 isoform of V-ATPase (a2V) caused us to investigate its role in cancer progression through the evaluation of the immunomodulatory properties of a2NTD. Here, we present direct evidence that surface expression of V-ATPase is associated with macrophage polarization in tumor tissue. Macrophages from BALB/c mice (peritoneal/bone marrow derived) were stimulated with recombinant a2NTD in both ex vivo and in vivo systems and evaluated for TAM characteristics. a2V was highly expressed in tumor tissues (breast and skin) as well as on the surface of tumor cell lines. The a2NTD-stimulated macrophages (a2M Phi) acquired TAM phenotype, which was characterized by elevated expression of mannose receptor-1, Arginase-1, interleukin-10 and transforming growth factor-beta. a2M Phi also exhibited increased production of other tumorigenic factors including matrix metalloproteinase-9 and vascular endothelial growth factor. Further, a2M Phi were cocultured with mouse B-16F0 melanoma cells for their functional characterization. The coculture of these a2M Phi subsequently increased the invasion and angiogenesis of less invasive B-16F0 cells. When cocultured with naive T cells, a2M Phi significantly inhibited T-cell activation. The present data establish the role of V-ATPase in modulating a macrophage phenotype towards TAMs through the action of a2NTD, suggesting it to be a potential therapeutic target in cancer.	[Katara, G. K.; Jaiswal, M. K.; Kulshrestha, A.; Kolli, B.; Gilman-Sachs, A.; Beaman, K. D.] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, 3333 Green Bay Rd, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science	Beaman, KD (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kenneth.beaman@rosalindfranklin.edu			Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA	Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA	We thank Robert Dickinson for technical assistance and the Rosalind Franklin University of Medicine and Science Flow Cytometry Core Facility. This work was supported by grants from the Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.	De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; Derks R, 2004, HUM IMMUNOL, V65, P676, DOI 10.1016/j.humimm.2004.04.006; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Jaiswal MK, 2012, REPRODUCTION, V143, P713, DOI 10.1530/REP-12-0036; Kwong C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22978; Kwong C, 2011, J IMMUNOL, V186, P1781, DOI 10.4049/jimmunol.1002998; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Matlack R, 2006, IMMUNOLOGY, V117, P386, DOI 10.1111/j.1365-2567.2005.02312.x; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Ntrivalas E, 2007, HUM IMMUNOL, V68, P469, DOI 10.1016/j.humimm.2007.02.010; Ntrivalas E, 2007, AM J REPROD IMMUNOL, V57, P201, DOI 10.1111/j.1600-0897.2006.00463.x; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	25	33	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5649	5654		10.1038/onc.2013.532	http://dx.doi.org/10.1038/onc.2013.532			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24362525				2022-12-25	WOS:000346088700009
J	Li, M; Andersson-Lendahl, M; Sejersen, T; Arner, A				Li, Mei; Andersson-Lendahl, Monika; Sejersen, Thomas; Arner, Anders			Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment	FASEB JOURNAL			English	Article						Danio rerio; Duchenne muscular dystrophy; skeletal muscle; therapy	DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; NONSENSE MUTATIONS; MDX MOUSE; MODEL; SUPPRESSION; PATHOLOGY; EMBRYO; PTC124; GENE	Sapje zebrafish carry a mutation in the dystrophin gene, which results in a premature stop codon, and a severe muscle phenotype. They display several of the structural characteristics of Duchenne muscular dystrophy (DMD). Ataluren (PTC124) is proposed to cause readthrough of premature stop codons and has been introduced as a potential treatment of genetic disorders. Clinical trials in DMD have shown promise, although with complex dose dependency. We have established physiology techniques, enabling high resolution of contractile function in skeletal muscle of zebrafish larvae. We aimed to provide a mechanical analysis of sapje larval muscle and examine effects of ataluren. Homozygous 5 d postfertilization (dpf) sapje larvae exhibited structural defects with 50% decrease in active tension. Ataluren (0.1-1 mu M, 3-5 dpf) improved contractile function (similar to 60% improvement of force at 0.5 mu M) and dystrophin expression. Controls were not affected. Higher doses (5 mu M, 35 mu M) impaired contractile function, an effect also observed in controls, suggesting unspecific negative effects at high concentrations. In summary, Sapje larvae exhibit impaired contractile performance and provide a relevant DMD model for functional studies. Ataluren significantly improves skeletal muscle function in the sapje larvae, most likely reflecting an observed increase in dystrophin expression. The bell-shaped dose dependence in sapje resembles that previously reported in clinical DMD studies.-Li, M., Andersson-Lendahl, M., Sejersen, T., Arner, A. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.	[Li, Mei; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Andersson-Lendahl, Monika] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Sejersen, Thomas] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Li, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Von Eulers 5 8, SE-17177 Stockholm, Sweden.	anders.arner@ki.se	Andersson Lendahl, Monika/ABE-5981-2021	Sejersen, Thomas/0000-0001-5961-7097; Andersson Lendahl, Monika/0000-0002-5690-8515	Swedish Research Council [2009-4302]; Association Francaise Contre les Myopathies [16304]; Strategic Research Programme in Stem Cells and Regenerative Medicine (StratRegen; Karolinska Institutet); PTC Therapeutics	Swedish Research Council(Swedish Research CouncilEuropean Commission); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Strategic Research Programme in Stem Cells and Regenerative Medicine (StratRegen; Karolinska Institutet); PTC Therapeutics	This study was supported by grants from the Swedish Research Council (2009-4302), the Association Francaise Contre les Myopathies (16304), and the Strategic Research Programme in Stem Cells and Regenerative Medicine (StratRegen; Karolinska Institutet). T.S. has received economic support from PTC Therapeutics to perform a part of an initial phase 2b study of ataluren for DMD, and he is currently a member of the scientific advisory board for a PTC Therapeutics phase 3 study of ataluren for DMD. The authors appreciate the competent help with zebrafish handling and breeding from Mr. Kent Ivarsen (CMB zebrafish facility, Karolinska Institutet).	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Berger J, 2010, NEUROMUSCULAR DISORD, V20, P826, DOI 10.1016/j.nmd.2010.08.004; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CULLEN MJ, 1975, J NEUROL SCI, V24, P179, DOI 10.1016/0022-510X(75)90232-4; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Dou Y, 2008, J GEN PHYSIOL, V131, P445, DOI 10.1085/jgp.200809982; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Granato M, 1996, DEVELOPMENT, V123, P399; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; LEV AA, 1987, J BIOL CHEM, V262, P15817; Li M, 2013, J GEN PHYSIOL, V141, P335, DOI 10.1085/jgp.201210915; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; O'Brien KF, 2001, MOL GENET METAB, V74, P75, DOI 10.1006/mgme.2001.3220; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Sparrow J, 2008, ADV EXP MED BIOL, V642, P192; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; Tan L, 2011, J INHERIT METAB DIS, V34, P443, DOI 10.1007/s10545-010-9265-5; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Zucconi E, 2010, NEUROMUSCULAR DISORD, V20, P64, DOI 10.1016/j.nmd.2009.10.011	30	35	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1593	1599		10.1096/fj.13-240044	http://dx.doi.org/10.1096/fj.13-240044			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371125	Bronze			2022-12-25	WOS:000335344300008
J	Wu, DD; Zhang, FQ; Hao, F; Chun, J; Xu, XM; Cui, MZ				Wu, Daniel Dongwei; Zhang, Fuqiang; Hao, Feng; Chun, Jerold; Xu, Xuemin; Cui, Mei-Zhen			Matricellular Protein Cyr61 Bridges Lysophosphatidic Acid and Integrin Pathways Leading to Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Migration; Protein Kinases; Signal Transduction; Signaling; Vascular Biology	FOCAL ADHESION KINASE; IMMEDIATE-EARLY GENE; SMOOTH-MUSCLE-CELLS; TISSUE GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; BETA(1)A INTEGRINS; ENDOTHELIAL-CELLS; RECEPTOR; EXPRESSION	Background: The molecular mechanism of smooth muscle cell (SMC) migration, a crucial event in atherosclerosis, is not well understood. Results: The de novo matricellular protein Cyr61 bridges lysophosphatidic acid (LPA) and integrin pathways, activating focal adhesion kinase (FAK) and leading to cell migration. Conclusion: The LPA-Cyr61-integrin-FAK axis controls SMC migration. Significance: This study provides new insights into mechanisms underlying cell migration-related disorders. Lysophosphatidic acid (LPA), a potent bioactive lipid found in atherosclerotic lesions, markedly induces smooth muscle cell (SMC) migration, which is an important process in atherogenesis. Therefore, understanding the mechanism of LPA-induced SMC migration is important. Several microarray databases suggest that the matricellular protein Cyr61 is highly induced by LPA. We hypothesized that Cyr61 mediates LPA-induced cell migration. Our data show that LPA induced temporal and spatial expression of Cyr61, which promptly accumulated in the cellular Golgi apparatus and then translocated to the extracellular matrix. Cyr61 antibody blockade and siRNA inhibition both diminished LPA-induced SMC migration, indicating a novel regulatory role of Cyr61. SMCs derived from LPA receptor 1 (LPA(1)) knock-out mice lack the ability of Cyr61 induction and cell migration, supporting the concept that LPA(1) is required for Cyr61 expression and migration. By contrast, PPAR was not found to be involved in LPA-mediated effects. Furthermore, focal adhesion kinase (FAK), a nonreceptor tyrosine kinase important for regulating cell migration, was activated by LPA at a late time frame coinciding with Cyr61 accumulation. Interestingly, knockdown of Cyr61 blocked LPA-induced FAK activation, indicating that an LPA-Cyr61-FAK axis leads to SMC migration. Our results further demonstrate that plasma membrane integrins 61 and 3 transduced the LPA-Cyr61 signal toward FAK activation and migration. Taken together, these data reveal that de novo Cyr61 in the extracellular matrix bridges LPA and integrin pathways, which in turn, activate FAK, leading to cell migration. The current study provides new insights into mechanisms underlying cell migration-related disorders, including atherosclerosis, restenosis, and cancers.	[Wu, Daniel Dongwei; Zhang, Fuqiang; Hao, Feng; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Zhang, Fuqiang] Jilin Univ, Coll Pharm, Dept Med Bioengn, Changchun 130021, Peoples R China; [Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Mol & Cellular Neurosci Dept, La Jolla, CA 92037 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University; Scripps Research Institute	Cui, MZ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	Chun, Jerold/Y-4670-2019	xu, xuemin/0000-0002-7426-272X; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL107466, AG026640, NS082092]; American Health Assistance Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS082092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039596, R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107466 (to M. Z. C.), AG026640 (to X. X.), and NS082092 (to J. C.). This work was also supported by an American Health Assistance Foundation Grant (to X. X.)	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bennett G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-50; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; JAMIESON JD, 1966, P NATL ACAD SCI USA, V55, P424, DOI 10.1073/pnas.55.2.424; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim J, 2006, CELL SIGNAL, V18, P1695, DOI 10.1016/j.cellsig.2006.01.009; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Marek I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-102; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480; Sakai T, 1998, J BIOL CHEM, V273, P19378, DOI 10.1074/jbc.273.31.19378; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Stortelers C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-387; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Terada N, 2012, PROSTATE, V72, P966, DOI 10.1002/pros.21501; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Witzenbichler B, 1999, J CLIN INVEST, V104, P1469, DOI 10.1172/JCI7251; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	53	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5774	5783		10.1074/jbc.M113.533042	http://dx.doi.org/10.1074/jbc.M113.533042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24371135	Green Published, hybrid			2022-12-25	WOS:000332015500037
J	Ouyang, WM; Torigoe, C; Fang, H; Xie, T; Frucht, DM				Ouyang, Weiming; Torigoe, Chikako; Fang, Hui; Xie, Tao; Frucht, David M.			Anthrax Lethal Toxin Inhibits Translation of Hypoxia-inducible Factor 1 alpha and Causes Decreased Tolerance to Hypoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Bacterial Pathogenesis; Hypoxia; Hypoxia-inducible Factor; Infectious Diseases; MAP kinases (MAPKs); mTOR; Protein Stability; Toxins; Translation	HIPPEL-LINDAU PROTEIN; INNATE IMMUNITY; BACILLUS-ANTHRACIS; SIGNALING PATHWAYS; KEY MEDIATOR; FACTOR-1-ALPHA; HIF-1-ALPHA; KINASE; FAMILY; HIF	Background: Hypoxia is proposed as a mediator of anthrax lethal factor (LT)-induced pathology. Results: LT inhibits hypoxia-inducible factor 1 (HIF-1) translation and causes increased cellular toxicity in response to hypoxic stress. Conclusion: LT reduces HIF-1 translation, dysregulating host responses to hypoxia. Significance: Inhibition of HIF-1 translation is a novel mechanism underlying LT-induced pathology. Hypoxia is considered to be a contributor to the pathology associated with administration of anthrax lethal toxin (LT). However, we report here that serum lactate levels in LT-treated mice are reduced, a finding inconsistent with the anaerobic metabolism expected to occur during hypoxia. Reduced lactate levels are also observed in the culture supernatants of LT-treated cells. LT inhibits the accumulation of hypoxia-inducible factor (HIF)-1, a subunit of HIF-1, the master regulator directing cellular responses to hypoxia. The toxin has no effect on the transcription or protein turnover of HIF-1, but instead it acts to inhibit HIF-1 translation. LT treatment diminishes phosphorylation of eIF4B, eIF4E, and rpS6, critical components of the intracellular machinery required for HIF-1 translation. Moreover, blockade of MKK1/2-ERK1/2, but not p38 or JNK signaling, lowers HIF-1 protein levels in both normoxic and hypoxic conditions, consistent with a role for MKK1 and MKK2 as the major targets of LT responsible for the inhibition of HIF-1 translation. The physiological importance of the LT-induced translation blockade is demonstrated by the finding that LT treatment decreases the survival of hepatocyte cell lines grown in hypoxic conditions, an effect that is overcome by preinduction of HIF-1. Taken together, these data support a role for LT in dysregulating HIF-1 and thereby disrupting homeostatic responses to hypoxia, an environmental characteristic of certain tissues at baseline and/or during disseminated infection with Bacillus anthracis.	[Ouyang, Weiming; Torigoe, Chikako; Fang, Hui; Xie, Tao; Frucht, David M.] US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA.	david.frucht@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by a Medical Countermeasures Grant from the Food and Drug Administration.	Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abraham RT, 2003, CURR TOP MICROBIOL, V279, P299; Adams JM, 2009, ACTA PHYSIOL HUNG, V96, P19, DOI 10.1556/APhysiol.96.2009.1.2; Alfano RW, 2010, MOL CANCER THER, V9, P190, DOI 10.1158/1535-7163.MCT-09-0694; Artenstein AW, 2012, CLIN INFECT DIS, V54, P1148, DOI 10.1093/cid/cis017; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; Bodart JF, 2002, CELL CYCLE, V1, P10, DOI 10.4161/cc.1.1.95; Bromberg-White JL, 2008, METHOD ENZYMOL, V438, P355, DOI 10.1016/S0076-6879(07)38025-7; Bromberg-White JL, 2011, INVEST OPHTH VIS SCI, V52, P8979, DOI 10.1167/iovs.11-7651; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Czibik G, 2009, CTS-CLIN TRANSL SCI, V2, P33, DOI 10.1111/j.1752-8062.2008.00077.x; D'Osualdo A, 2012, PIGM CELL MELANOMA R, V25, P5, DOI 10.1111/j.1755-148X.2011.00942.x; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Frankel AE, 2009, FRONT BIOSCI, V14, P4516, DOI 10.2741/3544; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Golden HB, 2009, FRONT BIOSCI-LANDMRK, V14, P2335, DOI 10.2741/3382; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Malyshev I Iu, 2012, Patol Fiziol Eksp Ter, P42; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Zhang J, 2010, PLOS ONE, V5; Zhou J, 2006, MOL BIOL CELL, V17, P1549, DOI 10.1091/mbc.E05-08-0770	58	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4180	4190		10.1074/jbc.M113.530006	http://dx.doi.org/10.1074/jbc.M113.530006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366872	hybrid, Green Published			2022-12-25	WOS:000331403800031
J	Wang, H; Chen, Y; Lin, P; Li, L; Zhou, GS; Liu, GC; Logsdon, C; Jin, JP; Abbruzzese, JL; Tan, TH; Wang, HM				Wang, Hua; Chen, Yue; Lin, Ping; Li, Lei; Zhou, Guisheng; Liu, Guangchao; Logsdon, Craig; Jin, Jianping; Abbruzzese, James L.; Tan, Tse-Hua; Wang, Huamin			The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; MAP Kinases (MAPKs); Pancreatic Cancer; Proteasome; Protein Phosphatase; Serine Threonine Protein Kinase; CUL7 Ubiquitin Ligase; Fbxw8; HPK1; PP4	STE20-RELATED PROTEIN-KINASE; CASPASE-MEDIATED CLEAVAGE; ADAPTER PROTEINS; POSITIVE REGULATOR; TUMOR-SUPPRESSOR; HPK1; ACTIVATION; TARGETS; CUL7; CRK	HPK1, a member of mammalian Ste20-like serine/threonine kinases, is lost in >95% pancreatic cancer through proteasome-mediated degradation. However, the mechanism of HPK1 loss has not been defined. The aims of this study are to identify the ubiquitin ligase and to examine the mechanisms that targets HPK1 degradation. We found that the CUL7/Fbxw8 ubiquitin ligase targeted HPK1 for degradation via the 26 S proteasome. The ubiquitination of HPK1 required its kinase activity and autophosphorylation. Wild-type protein phosphatase 4 (PP4), but not the phosphatase-dead PP4 mutant, PP4-RL, inhibits the interaction of Fbxw8 with HPK1 and Fbxw8-mediated ubiquitination of HPK1. In addition, we showed that Thr-355 of HPK1 is a key PP4 dephosphorylation site, through which CUL7/Fbxw8 ubiquitin ligase and PP4 regulates HPK1 stability. Knockdown of Fbxw8 restores endogenous HPK1 protein expression and inhibits cell proliferation of pancreatic cancer cells. Our study demonstrated that targeted degradation of HPK1 by the CUL7/Fbxw8 ubiquitin ligase constitutes a negative-feedback loop to restrain the activity of HPK1 and that CUL7/Fbxw8 ubiquitin ligase promotes pancreatic cancer cell proliferation. CUL7/Fbxw8 ubiquitin ligase-mediated HPK1 degradation revealed a direct link and novel role of CUL7/Fbxw8 ubiquitin ligase in the MAPK pathway, which plays a critical role in cell proliferation and differentiation.	[Wang, Hua; Abbruzzese, James L.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Chen, Yue; Lin, Ping; Li, Lei; Liu, Guangchao; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lin, Ping] Harbin Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Harbin 150081, Peoples R China; [Li, Lei] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Zhou, Guisheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Jin, Jianping] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harbin Medical University; Naval Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; National Health Research Institutes - Taiwan	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 085, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hmwang@mdanderson.org	Tan, Tse-Hua/ABD-7080-2021; Tan, Tse-Hua/E-3983-2010; Jin, Jianping/K-5002-2018	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Jin, Jianping/0000-0003-4175-9104	National Institutes of Health [1R21CA149544-01A1]; G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA149544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health though Grant 1R21CA149544-01A1 and by the G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center.	Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chen-Deutsch X, 2012, CELL CYCLE, V11, P1364, DOI 10.4161/cc.19765; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jung P, 2007, P NATL ACAD SCI USA, V104, P11388, DOI 10.1073/pnas.0609467104; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Paradis V, 2013, GUT, V62, P911, DOI 10.1136/gutjnl-2012-302091; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2007, J BIOL CHEM, V282, P34693, DOI 10.1074/jbc.M707425200; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Wang H, 2009, CANCER RES, V69, P1063, DOI 10.1158/0008-5472.CAN-08-1751; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang ZW, 2012, EMBO REP, V13, P36, DOI 10.1038/embor.2011.231; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	40	36	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4009	4017		10.1074/jbc.M113.520106	http://dx.doi.org/10.1074/jbc.M113.520106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362026	Green Published, hybrid			2022-12-25	WOS:000331403800016
J	Li, TT; Liu, MX; Feng, X; Wang, Z; Das, I; Xu, YP; Zhou, X; Sun, YP; Guan, KL; Xiong, Y; Lei, QY				Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Das, Indrani; Xu, Yanping; Zhou, Xin; Sun, Yiping; Guan, Kun-Liang; Xiong, Yue; Lei, Qun-Ying			Glyceraldehyde-3-phosphate Dehydrogenase Is Activated by Lysine 254 Acetylation in Response to Glucose Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Growth; Glycolysis; Histone Deacetylase; Lung Cancer; Metabolism; Acetylation; GAPDH; HDAC5; PCAF; Tumorigenesis	URACIL DNA GLYCOSYLASE; GENE-EXPRESSION; CANCER CELLS; GAPDH; PROTEIN; APOPTOSIS; PET; RNA	Background: Glyceraldehyde-3-phosphate dehydrogenase is a pivotal glycolytic enzyme and implicated in many human cancers. Results: GAPDH acetylation promotes its activity in response to glucose via the action of PCAF and HDAC5. Conclusion: GAPDH acetylation promotes cell proliferation and tumor growth. Significance: This study demonstrates a critical role of GAPDH acetylation in tumor growth and provides potential therapy target for cancer. The altered metabolism in most tumor cells consists of elevated glucose uptake and increased glycolysis even in the presence of high oxygen tension. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an obligatory enzyme in glycolysis. Here, we report that acetylation at lysine 254 (K254) increases GAPDH activity in response to glucose. Furthermore, acetylation of GAPDH (K254) is reversibly regulated by the acetyltransferase PCAF and the deacetylase HDAC5. Substitution of K254 to glutamine compromises the ability of GAPDH to support cell proliferation and tumor growth. Our study reveals a mechanism of GAPDH enzyme activity regulation by acetylation and its critical role in cellular regulation.	[Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Lei, Qun-Ying] Fudan Univ, Minist Educ, Key Lab Mol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Lei, Qun-Ying] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Guan, Kun-Liang; Xiong, Yue; Lei, Qun-Ying] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Das, Indrani] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92037 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Lei, QY (corresponding author), Fudan Univ, Minist Educ, Key Lab Mol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn	Lei, Qun-Ying/J-1390-2017; Zhou, Xin/AAD-6937-2019; Guan, Kun-Liang/ADK-7088-2022; Liu, Mengxi/N-7308-2019	Lei, Qun-Ying/0000-0002-8547-8518; 	ABC 973 [2011CB910600, 2009CB918401]; NSFC [31071192, 81225016, 31271454]; Shanghai Key Basic Research Program [12JC1401100]; "100 Talents" Program of Shanghai Health [XBR2011041]; Shanghai Education Commission; Shanghai Outstanding Academic Leader [13XD1400600]; 985 Program, the Shanghai Leading Academic Discipline Project [B110]	ABC 973; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Program; "100 Talents" Program of Shanghai Health; Shanghai Education Commission; Shanghai Outstanding Academic Leader; 985 Program, the Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by 973 (Grant 2011CB910600, 2009CB918401), NSFC (Grant 31071192, 81225016, 31271454), Shanghai Key Basic Research Program (12JC1401100), "100 Talents" Program of Shanghai Health (Grant XBR2011041), Scholar of "Dawn" Program of Shanghai Education Commission, and Shanghai Outstanding Academic Leader (Grant No. 13XD1400600) (to Q. Y. L.). This work was also supported by the 985 Program, the Shanghai Leading Academic Discipline Project (Project Number B110).	ALEXANDERBRIDGES M, 1992, ADV ENZYME REGUL, V32, P149; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Detterbeck FC, 2004, CHEST, V126, P1656, DOI 10.1378/chest.126.5.1656; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Joo HY, 2012, BIOCHEM BIOPH RES CO, V424, P681, DOI 10.1016/j.bbrc.2012.07.006; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lu HZ, 2002, MOL THER, V6, P783, DOI 10.1006/mthe.2002.0813; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nicholls C, 2012, P NATL ACAD SCI USA, V109, P13308, DOI 10.1073/pnas.1206672109; Puzone R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-97; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; STRAUSS LG, 1991, J NUCL MED, V32, P623; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	30	61	65	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3775	3785		10.1074/jbc.M113.531640	http://dx.doi.org/10.1074/jbc.M113.531640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362262	Green Published, hybrid			2022-12-25	WOS:000331368700057
J	Ko, S; Kawasaki, I; Shim, YH				Ko, Sunhee; Kawasaki, Ichiro; Shim, Yhong-Hee			PAB-1, a Caenorhabditis elegans Poly(A)-Binding Protein, Regulates mRNA Metabolism in germline by Interacting with CGH-1 and CAR-1	PLOS ONE			English	Article							TRANSLATION INITIATION; PROCESSING BODIES; C-ELEGANS; BINDING PROTEINS; P-BODIES; COMPONENT; GRANULES; GENE; COMPLEX; CYTOKINESIS	Poly(A)-binding proteins are highly conserved among eukaryotes and regulate stability of mRNA and translation. Among C. elegans homologues, pab-1 mutants showed defects in germline mitotic proliferation. Unlike pab-1 mutants, pab-1 RNAi at every larval stage caused arrest of germline development at the following stage, indicating that pab-1 is required for the entire postembryonic germline development. This idea is supported by the observations that the mRNA level of pab-1 increased throughout postembryonic development and its protein expression was germline-enriched. PAB-1 localized to P granules and the cytoplasm in the germline. PAB-1 colocalized with CGH-1 and CAR-1 and affected their localization, suggesting that PAB-1 is a component of processing (P)-bodies that interacts with them. The mRNA and protein levels of representative germline genes, rec-8, GLP-1, rme-2, and msp-152, were decreased after pab-1 RNAi. Although the mRNA level of msp-152 was increased in cgh-1 mutant, it was also significantly reduced by pab-1 RNAi. Our results suggest that PAB-1 positively regulates the mRNA levels of germline genes, which is likely facilitated by the interaction of PAB-1 with other P-body components, CGH-1 and CAR-1.	[Ko, Sunhee; Kawasaki, Ichiro; Shim, Yhong-Hee] Konkuk Univ, Inst KU Biotechnol, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Shim, YH (corresponding author), Konkuk Univ, Inst KU Biotechnol, Dept Biosci & Biotechnol, Seoul, South Korea.	yshim@konkuk.ac.kr	Shim, Yhong-hee/D-6691-2011; Kawasaki, Ichiro/D-6864-2011	Shim, Yhong-hee/0000-0002-8660-4176; Kawasaki, Ichiro/0000-0003-1722-0993	National Research Foundation of Korea (NRF) [2010-0011182, NRF-2013R1A1A2009090, 2010-0009509, NRF-2013R1A1A2009820]; Konkuk University, Korea; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Konkuk University, Korea; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) to Y. H. Shim (2010-0011182 and NRF-2013R1A1A2009090) and I. Kawasaki (2010-0009509 and NRF-2013R1A1A2009820), and by the 2012 KU Brain Pool Program of Konkuk University, Korea to I. Kawasaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BLOBEL G, 1973, P NATL ACAD SCI USA, V102, P367; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; BRENNER S, 1974, GENETICS, V77, P71; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; CONTRERAS V, 2011, PLOS ONE, P1012, DOI DOI 10.1371/J0URNAL.P0NE; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Evans Thomas C, 2005, WormBook, P1, DOI 10.1895/wormbook.1.34.1; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P1012; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Ko S, 2010, MOL CELLS, V30, P167, DOI 10.1007/s10059-010-0103-2; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; KUMSTA C, 2012, PLOS ONE, P1012, DOI DOI 10.1371/J0URNAL.P0NE.0035428; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee Min-Ho, 2006, WormBook, P1; LEFRERE V, 1990, GENE, V96, P219, DOI 10.1016/0378-1119(90)90256-Q; Maciejowski J, 2005, GENETICS, V169, P1997, DOI 10.1534/genetics.104.040121; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Navarro RE, 2005, GENESIS, V42, P172, DOI 10.1002/gene.20136; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Nousch M, 2013, ADV EXP MED BIOL, V757, P205, DOI 10.1007/978-1-4614-4015-4_8; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Scheckel C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002742; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Sun YY, 2011, PROTEIN CELL, V2, P918, DOI 10.1007/s13238-011-1119-x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Yoon S, 2012, CELL CYCLE, V11, P1354, DOI 10.4161/cc.19755; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	55	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84798	10.1371/journal.pone.0084798	http://dx.doi.org/10.1371/journal.pone.0084798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367695	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900066
J	Koyama, T; Arias, JF; Iwabu, Y; Yokoyama, M; Fujita, H; Sato, H; Tokunaga, K				Koyama, Takayoshi; Arias, Juan Fernando; Iwabu, Yukie; Yokoyama, Masaru; Fujita, Hideaki; Sato, Hironori; Tokunaga, Kenzo			APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; RIBONUCLEOPROTEIN COMPLEXES; ANTIRETROVIRAL DEFENSE; ADAPTIVE EVOLUTION; VIRUS-REPLICATION; CRYSTAL-STRUCTURE; INSERTION; PROTEIN; ELEMENT	Alu and LINE-1 (L1), which constitute similar to 11% and similar to 17% of the human genome, respectively, are transposable non-LTR retroelements. They transpose not only in germ cells but also in somatic cells, occasionally causing cancer. We have previously demonstrated that antiretroviral restriction factors, human APOBEC3 (hA3) proteins (A-H), differentially inhibit L1 retrotransposition. In this present study, we found that hA3 members also restrict Alu retrotransposition at differential levels that correlate with those observed previously for L1 inhibition. Through deletion analyses based on the best-characterized hA3 member human APOBEC3G (hA3G), its N-terminal 30 amino acids were required for its inhibitory activity against Alu retrotransposition. The inhibitory effect of hA3G on Alu retrotransposition was associated with its oligomerization that was affected by the deletion of its N-terminal 30 amino acids. Through structural modeling, the amino acids 24 to 28 of hA3G were predicted to be located at the interface of the dimer. The mutation of these residues resulted in abrogated hA3G oligomerization, and consistently abolished the inhibitory activity of hA3G against Alu retrotransposition. Importantly, the anti-L1 activity of hA3G was also associated with hA3G oligomerization. These results suggest that the inhibitory activities of hA3G against Alu and L1 retrotransposition might involve a common mechanism.	[Koyama, Takayoshi; Arias, Juan Fernando; Iwabu, Yukie; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nagasaki International University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	tokunaga@nih.go.jp	Arias, Juan F/ABI-5762-2020; Tokunaga, Kenzo/Q-9914-2018	Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor and Welfare of Japan [H24-005, H24-008, H25-010]; Ministry of Education, Science, Technology, Sports and Culture of Japan [22590428]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS project no. H24-005, H24-008 and H25-010), and from the Ministry of Education, Science, Technology, Sports and Culture of Japan (22590428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Claverie-Martin F, 2005, J HUM GENET, V50, P370, DOI 10.1007/s10038-005-0265-5; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; ECONOMOUPACHNIS A, 1985, P NATL ACAD SCI USA, V82, P2857, DOI 10.1073/pnas.82.9.2857; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Khatua AK, 2010, VIROLOGY, V400, P68, DOI 10.1016/j.virol.2010.01.021; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MIKI Y, 1992, CANCER RES, V52, P643; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zheng YH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-112	83	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84228	10.1371/journal.pone.0084228	http://dx.doi.org/10.1371/journal.pone.0084228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367644	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900039
J	van Kralingen, C; Kho, DT; Costa, J; Angel, CE; Graham, ES				van Kralingen, Christa; Kho, Dan Ting; Costa, Jessica; Angel, Catherine Elizabeth; Graham, E. Scott			Exposure to Inflammatory Cytokines IL-1 beta and TNF alpha Induces Compromise and Death of Astrocytes; Implications for Chronic Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN NEURONS; REAL-TIME; CEREBROSPINAL-FLUID; SPINAL-CORD; BRAIN; CELLS; EXPRESSION; DIFFERENTIATION; CHEMOKINES	Background: Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier. Methods: We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death. Results: Inflammatory activation (IL-1 beta or TNF alpha) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48h post cytokine treatment. However, significant cell loss was not observed until at least 72h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1 beta or TNF alpha treatment. Conclusions: Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1 beta or TNF alpha is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.	[van Kralingen, Christa; Kho, Dan Ting; Costa, Jessica; Graham, E. Scott] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand; [Angel, Catherine Elizabeth] Univ Auckland, Fac Sci, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Graham, ES (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand.	s.graham@auckland.ac.nz		Kho, Dan/0000-0001-7193-2954; Graham, Scott/0000-0002-2925-9126; Angel, Catherine/0000-0003-1737-8539	ESG from New Zealand Lottery Health; HRC	ESG from New Zealand Lottery Health; HRC	Funding for this study was obtained by ESG from New Zealand Lottery Health and HRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Farkas E, 2006, MICROVASC RES, V72, P113, DOI 10.1016/j.mvr.2006.05.007; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Graham ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072011; Grimsey NL, 2012, J BIOMOL SCREEN, V17, P386, DOI 10.1177/1087057111428985; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Kikuchi S, 2003, J NEUROSCI RES, V71, P591, DOI 10.1002/jnr.10479; Kleine TO, 2003, BRAIN RES BULL, V61, P327, DOI 10.1016/S0361-9230(03)00096-0; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lu W, 2005, DEV BRAIN RES, V155, P127, DOI 10.1016/j.devbrainres.2005.01.004; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Minami M, 2001, YAKUGAKU ZASSHI, V121, P875, DOI 10.1248/yakushi.121.875; Miyazono M, 1996, J COMP NEUROL, V376, P603, DOI 10.1002/(SICI)1096-9861(19961223)376:4<603::AID-CNE8>3.0.CO;2-5; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Pommepuy I, 2003, ONCOLOGY-BASEL, V64, P459, DOI 10.1159/000070307; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Trojanowski JQ, 1997, EXP NEUROL, V144, P92, DOI 10.1006/exnr.1996.6393; Unsworth CF, 2010, J NEUROSCI METH, V194, P154, DOI 10.1016/j.jneumeth.2010.09.022; Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041; Xi BA, 2011, JALA-J LAB AUTOM, V16, P415, DOI 10.1016/j.jala.2011.09.002; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; ZELLER M, 1995, INT J DEV NEUROSCI, V13, P437, DOI 10.1016/0736-5748(95)00025-C	47	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84269	10.1371/journal.pone.0084269	http://dx.doi.org/10.1371/journal.pone.0084269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367648	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900041
J	Heinrichs, J; Dong, SS; Schafer-Verwimp, A; Pocs, T; Feldberg, K; Czumaj, A; Schmidt, AR; Reitner, J; Renner, MAM; Hentschel, J; Stech, M; Schneider, H				Heinrichs, Jochen; Dong, Shanshan; Schaefer-Verwimp, Alfons; Pocs, Tamas; Feldberg, Kathrin; Czumaj, Aleksandra; Schmidt, Alexander R.; Reitner, Joachim; Renner, Matt A. M.; Hentschel, Joern; Stech, Michael; Schneider, Harald			Molecular Phylogeny of the Leafy Liverwort Lejeunea (Porellales): Evidence for a Neotropical Origin, Uneven Distribution of Sexual Systems and Insufficient Taxonomy	PLOS ONE			English	Article							CHLOROPLAST DNA-SEQUENCES; LATITUDINAL DIVERSITY GRADIENT; TUMIDA SPECIES GROUP; CRYPTIC SPECIATION; MYRIOCOLEA-IRRORATA; ENDEMIC LIVERWORT; TROPICAL AMERICA; L. DUMORT.; JUNGERMANNIOPSIDA; BIOGEOGRAPHY	Background: Lejeunea is a largely epiphytic, subcosmopolitan liverwort genus with a complex taxonomic history. Species circumscriptions and their relationships are subject to controversy; biogeographic history and diversification through time are largely unknown. Methodology and Results: We employed sequences of two chloroplast regions (trnL-trnF, rbcL) and the nuclear ribosomal ITS region of 332 accessions to explore the phylogeny of the Harpalejeunea-Lejeunea-Microlejeunea complex. Lejeunea forms a well-supported clade that splits into two main lineages corresponding to L. subg. Lejeunea and L. subg. Crossotolejeunea. Neotropical accessions dominate early diverging lineages of both main clades of Lejeunea. This pattern suggests an origin in the Neotropics followed by several colonizations from the Neotropics into the Paleotropics and vice versa. Most Afro-Madagascan clades are related to Asian clades. Several temperate Lejeunea radiations were detected. Eighty two of the 91 investigated Lejeunea species could be identified to species level. Of these 82 species, 54 were represented by multiple accessions (25 para-or polyphyletic, 29 monophyletic). Twenty nine of the 36 investigated species of L. subg. Lejeunea were monoicous and 7 dioicous. Within L. subg. Crossotolejeunea, 15 of the 46 investigated species were monoicous and 31 dioicous. Some dioicous as well as some monoicous species have disjunct ranges. Conclusions/Significance: We present the first global phylogeny of Lejeunea and the first example of a Neotropical origin of a Pantropical liverwort genus. Furthermore, we provide evidence for the Neotropics as a cradle of Lejeunea lineages and detect post-colonization radiations in Asia, Australasia, Afro-Madagascar and Europe. Dioicy/monoicy shifts are likely non-randomly distributed. The presented phylogeny points to the need of integrative taxonomical studies to clarify many Lejeunea binomials. Most importantly, it provides a framework for future studies on the diversification of this lineage in space and time, especially in the context of sexual systems in Lejeuneaceae.	[Heinrichs, Jochen; Feldberg, Kathrin] Univ Munich, Fac Biol, Munich, Germany; [Heinrichs, Jochen; Dong, Shanshan; Czumaj, Aleksandra] Univ Gottingen, Dept Systemat Bot, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Pocs, Tamas] Eszterhazy Coll, Dept Bot, Inst Biol, Eger, Hungary; [Schmidt, Alexander R.; Reitner, Joachim] Univ Gottingen, Courant Res Ctr Geobiol, D-37073 Gottingen, Germany; [Renner, Matt A. M.] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia; [Hentschel, Joern] Univ Jena, Dept Systemat Bot, Herbarium Haussknecht, Jena, Germany; [Hentschel, Joern] Univ Jena, Bot Garden, Jena, Germany; [Stech, Michael] Naturalis Biodivers Ctr, Leiden, Netherlands; [Stech, Michael] Leiden Univ, Leiden, Netherlands; [Schneider, Harald] Nat Hist Museum, London SW7 5BD, England	University of Munich; University of Gottingen; University of Gottingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Natural History Museum London	Heinrichs, J (corresponding author), Univ Munich, Fac Biol, Munich, Germany.	jheinrichs@lmu.de	Schneider, Harald/B-6681-2008; Renner, Matt A. M./H-6322-2011; Czumaj, Aleksandra/AAP-1122-2020	Schneider, Harald/0000-0002-4548-7268; Renner, Matt A. M./0000-0003-2286-7257; Czumaj, Aleksandra/0000-0002-3072-6334	Deutsche Forschungsgemeinschaft [HE 3584/2]; China Scholarship Council [2010697001]; German Excellence Initiative [120]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); German Excellence Initiative	This study was supported by the Deutsche Forschungsgemeinschaft [HE 3584/2 and 4]. SD got support from the China Scholarship Council (scholarship number 2010697001). This is publication number 120 from the Courant Research Centre Geobiology that is funded by the German Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng Claudine, 2005, Lindbergia, V30, P43; Ahonen I., 2005, Acta Botanica Hungarica, V47, P225, DOI 10.1556/ABot.47.2005.3-4.2; BONNER C. E. B., 1960, BRYOLOGIST, V63, P217; Bystriakova N, 2011, BOT J LINN SOC, V165, P1, DOI 10.1111/j.1095-8339.2010.01092.x; Cooper ED, 2012, BIOL J LINN SOC, V107, P425, DOI 10.1111/j.1095-8312.2012.01946.x; Cooper ED, 2012, MOL PHYLOGENET EVOL, V65, P10, DOI 10.1016/j.ympev.2012.05.008; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Devos N, 2011, TAXON, V60, P1623, DOI 10.1002/tax.606007; Devos N, 2011, NEW PHYTOL, V192, P225, DOI 10.1111/j.1469-8137.2011.03783.x; Dong SS, 2013, PHYTOTAXA, V85, P41, DOI 10.11646/phytotaxa.85.2.2; Dong SS, 2012, MOL PHYLOGENET EVOL, V65, P582, DOI 10.1016/j.ympev.2012.07.009; Evans A. W., 1904, B TORREY BOT CLUB, V31, P183, DOI [http://dx.doi.org/10.2307/2478687, DOI 10.2307/2478687]; Feldberg K, 2004, PLANT SYST EVOL, V249, P247, DOI 10.1007/s00606-004-0221-4; Feldberg K, 2007, J BIOGEOGR, V34, P688, DOI 10.1111/j.1365-2699.2006.01623.x; Feldberg K, 2010, MOL PHYLOGENET EVOL, V55, P293, DOI 10.1016/j.ympev.2009.11.009; Feldberg K, 2011, BRYOLOGIST, V114, P686, DOI 10.1639/0007-2745-114.4.686; Feldberg K, 2010, CRYPTOGAMIE BRYOL, V31, P141; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forrest LL, 2011, BRYOLOGIST, V114, P102, DOI 10.1639/0007-2745-114.1.102; Fuselier L, 2009, BIOL J LINN SOC, V98, P745, DOI 10.1111/j.1095-8312.2009.01319.x; Glenny D., 1998, TUHINGA, V10, P119; Gottsche CM, 1844, NEES AB ESENBECK CG; Gradstein S.R., 2009, MEMOIRS NEW YORK BOT, V76, P140; Gradstein SR, 2006, BOT J LINN SOC, V151, P293, DOI 10.1111/j.1095-8339.2006.00531.x; Gradstein SR, 2013, PHYTOTAXA, V100, P6, DOI 10.11646/phytotaxa.100.1.2; Gradstein S. Robbert, 2001, Memoirs of the New York Botanical Garden, V86, P1; GRADSTEIN SR, 1983, ACTA BOT HUNG, V29, P127; Gradstein SR, 2004, J HATTORI BOT LAB, P235; GROLLE R, 1971, T BRIT BRYOL SOC, V6, P258, DOI 10.1179/006813871804146229; GROLLE R, 1966, Journal of the Hattori Botanical Laboratory, V29, P75; Grolle R, 2000, J BRYOL, V22, P103, DOI 10.1179/jbr.2000.22.2.103; GROLLE R., 1969, MONOGRAPHIAE BIOL, V19, P562; Grolle R., 1984, STUTTGARTER BEITRA B, V108, P1; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hartmann FA, 2006, INT J PLANT SCI, V167, P1205, DOI 10.1086/508023; Heinrichs J, 2005, PLANT SYST EVOL, V250, P105, DOI 10.1007/s00606-004-0220-5; Heinrichs J, 2005, TAXON, V54, P317, DOI 10.2307/25065360; Heinrichs J., 2002, BRYOPHYTORUM BIBLIOT, V58, P1; Heinrichs J, 2007, TAXON, V56, P31, DOI 10.2307/25065733; Heinrichs J, 2014, PLANT SYST EVOL, V300, P63, DOI 10.1007/s00606-013-0860-4; Heinrichs J, 2012, PHYTOTAXA, V69, P7, DOI 10.11646/phytotaxa.69.1.3; Heinrichs J, 2012, PHYTOTAXA, V66, P55, DOI 10.11646/phytotaxa.66.1.9; Heinrichs J, 2012, CRYPTOGAMIE BRYOL, V33, P81, DOI 10.7872/cryb.v33.iss1.2012.081; Heinrichs J, 2012, MOL PHYLOGENET EVOL, V62, P973, DOI 10.1016/j.ympev.2011.11.029; Heinrichs J, 2011, AM J BOT, V98, P1252, DOI 10.3732/ajb.1100115; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Heinrichs J, 2010, CRYPTOGAMIE BRYOL, V31, P67; Heinrichs J, 2009, J SYST EVOL, V47, P497, DOI 10.1111/j.1759-6831.2009.00028.x; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hennequin S, 2010, BOT J LINN SOC, V164, P113, DOI 10.1111/j.1095-8339.2010.01076.x; Hentschel J, 2006, PLANT SYST EVOL, V258, P211, DOI 10.1007/s00606-006-0408-y; Hentschel J, 2007, MOL PHYLOGENET EVOL, V45, P693, DOI 10.1016/j.ympev.2007.05.005; Hentschel J, 2009, MOL PHYLOGENET EVOL, V52, P142, DOI 10.1016/j.ympev.2008.12.021; Hepperle D., 2004, SEQASSEM SEQUENCE AN; Herzog T., 1926, GEOGRAPHIE MOOSE; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutsemekers V, 2012, MOL PHYLOGENET EVOL, V62, P748, DOI 10.1016/j.ympev.2011.11.014; Ilkiu-Borges AL, 2005, NOVA HEDWIGIA, V80, P45, DOI 10.1127/0029-5035/2005/0080-0045; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; JONES EW, 1968, T BRIT BRYOL SOC, V5, P548, DOI 10.1179/006813868804146863; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Kraichak E, 2012, AM J BOT, V99, P1436, DOI 10.3732/ajb.1200120; Kreier HP, 2010, MOL PHYLOGENET EVOL, V57, P1260, DOI 10.1016/j.ympev.2010.10.002; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee Gaik Ee, 2013, Polish Botanical Journal, V58, P59, DOI 10.2478/pbj-2013-0007; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Libert M-A., 1820, ANN GEN SCI PHYS, V6, P372; Longton RE, 1983, NEW MANUAL BRYOLOGY, P386; Maddison DR, 2004, MESQUITE VERSION 2 7; Marshall CR, 2006, SCIENCE, V314, P66, DOI 10.1126/science.1133351; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Merckx VSFT, 2013, AM J BOT, V100, P712, DOI 10.3732/ajb.1200330; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; MIZUTANI M, 1971, Journal of the Hattori Botanical Laboratory, V34, P445; Moreau CS, 2013, EVOLUTION, DOI [10.111/evo.12105, DOI 10.111/EV0.12105]; Patino J, 2013, J BRYOL IN PRESS; Paton J. A., 1999, LIVERWORT FLORA BRIT; Perrie LR, 2012, NEW ZEAL J BOT, V50, P475; POCS T., 2011, ACTA BIOL PLANTARUM, V1, P53; Pohjamo M, 2008, BIOL CONSERV, V141, P1204, DOI 10.1016/j.biocon.2008.02.016; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Reiner-Drehwald M.E., 2000, TROPICAL BRYOLOGY, V19, P81, DOI DOI 10.11646/BDE.19.1.14; Reiner-Drehwald M. E., 1999, BRYOPHYT BIBLIOTH, V54, P1; Reiner-Drehwald ME, 2008, NOVA HEDWIGIA, V87, P175, DOI 10.1127/0029-5035/2008/0087-0175; Reiner-Drehwald ME, 2012, CRYPTOGAMIE BRYOL, V33, P33, DOI 10.7872/cryb.v33.iss1.2012.033; Reiner-Drehwald ME, 2010, NOVA HEDWIGIA, P117; Reiner-Drehwald ME, 2008, NOVA HEDWIGIA, V87, P387, DOI 10.1127/0029-5035/2008/0087-0387; Reiner-Drehwald ME, 2010, NOVA HEDWIGIA, V91, P519, DOI 10.1127/0029-5035/2010/0091-0519; Reiner-Drehwald ME, 2005, SYST BOT, V30, P687, DOI 10.1600/036364405775097860; Reiner-Drehwald ME, 2005, CRYPTOGAMIE BRYOL, V26, P59; Reiner-Drehwald ME, 2004, J BRYOL, V26, P103, DOI 10.1179/037366804225021056; Reiner-Drehwald ME, 2000, J HATTORI BOT LAB, P1; Reiner-Drehwald ME, 2000, NOVA HEDWIGIA, V71, P447; Reiner-Drehwald ME, 1995, THESIS; Renner Matt A. M., 2013, Polish Botanical Journal, V58, P193, DOI 10.2478/pbj-2013-0018; Renner MAM, 2013, AUST SYST BOT, V26, P13, DOI 10.1071/SB12016; Renner MAM, 2011, AUST SYST BOT, V24, P10, DOI 10.1071/SB10047; Renner MAM, 2010, AUST SYST BOT, V23, P443, DOI 10.1071/SB10037; Renner MAM, 2009, NOVA HEDWIGIA, V89, P335, DOI 10.1127/0029-5035/2009/0089-0335; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Rouhan G, 2012, SYST BOT, V37, P331, DOI 10.1600/036364412X635386; Rubasinghe SCK, 2011, BRYOLOGIST, V114, P116, DOI 10.1639/0007-2745-114.1.116; Schaumann F, 2005, PLANT SYST EVOL, V252, P27, DOI 10.1007/s00606-004-0279-z; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schiffner V., 1893, NATURL PFLANZ, V1, P97; Schneider H, 2013, J SYST EVOL, V51, P61, DOI 10.1111/j.1759-6831.2012.00234.x; Schneider H, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P61, DOI 10.1007/978-3-642-12425-9_4; Schuster R. M, 1980, HEPATICAE ANTHOCEROT; Schuster R. M, 1994, J HATTORI BOT LAB, V75, P211; Spruce R, 1884, T P BOT SOC EDINBURG, V15, P1, DOI DOI 10.5962/BHL.TITLE.115637; Stephani F., 1898, SPECIES HEPATICARUM, V1; Sukkharak P, 2011, TAXON, V60, P1607, DOI 10.1002/tax.606006; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szweykowski J, 2005, PLANT SYST EVOL, V253, P133, DOI 10.1007/s00606-005-0301-0; van Zanten B. O., 1988, NOVA HEDWIGIA S, V90, P41; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; Vana J, 2012, PHYTOKEYS, V10, P13, DOI 10.3897/phytokeys.10.2654; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A, 2006, MOL PHYLOGENET EVOL, V40, P73, DOI 10.1016/j.ympev.2006.02.013; Vanderpoorten A, 2010, BIOL REV, V85, P471, DOI 10.1111/j.1469-185X.2009.00111.x; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wigginton M. J., 2004, SCRIPTA BOT BELGICA, V30, P1; Wilson R, 2007, BIOLOGY LETT, V3, P566, DOI 10.1098/rsbl.2007.0287; Wilson R, 2007, MOL PHYLOGENET EVOL, V43, P270, DOI 10.1016/j.ympev.2006.10.017; Ye W, 2013, J SYST EVOL, V51, P468, DOI 10.1111/j.1759-6831.2012.00238.x; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yu Y, 2013, SYST BOT, V38, P553, DOI 10.1600/036364413X670304; Zhu RL, 2003, ANN BOT FENN, V40, P101; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	138	50	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82547	10.1371/journal.pone.0082547	http://dx.doi.org/10.1371/journal.pone.0082547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367522	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300038
J	Husemoen, LLN; Skaaby, T; Jorgensen, T; Thyssen, JP; Meldgaard, M; Szecsi, PB; Stender, S; Johansen, JD; Linneberg, A				Husemoen, Lise Lotte N.; Skaaby, Tea; Jorgensen, Torben; Thyssen, Jacob P.; Meldgaard, Michael; Szecsi, Pal B.; Stender, Steen; Johansen, Jeanne Duus; Linneberg, Allan			No Association between Loss-of-Function Mutations in filaggrin and Diabetes, Cardiovascular Disease, and All-Cause Mortality	PLOS ONE			English	Article							ATOPIC-DERMATITIS; FUNCTION VARIANTS; RISK; GENE; REGISTER	Background: Common loss-of-function mutations in the filaggrin gene (FLG) are a major predisposing risk factor for atopic disease due to reduced epidermal filaggrin protein levels. We previously observed an association between these mutations and type 2 diabetes and hypothesized that an inherited impairment of skin barrier functions could facilitate low-grade inflammation and hence increase the risk of diabetes and cardiovascular disease. We examined the association between loss-of-function mutations in FLG and diabetes, stroke, ischemic heart disease (IHD), and all-cause mortality in the general population. Methods: The R501X and 2282del4 loss-of function mutations in FLG were genotyped in four Danish study populations including a total of 13373 adults aged 15-77 years. Two of the studies also genotyped the R2447X mutation. By linkage to Danish national central registers we obtained information for all participants on dates of diagnoses of diabetes, stroke, and IHD, as well as all-cause mortality. Data were analyzed by Cox proportional hazard models and combined by fixed effect meta-analyses. Results: In meta-analyses combining the results from the four individual studies, carriage of loss-of-function mutations in FLG was not associated with incident diabetes (hazard ratio (HR) (95% confidence intervals (CI)) = 0.95 (0.73, 1.23), stroke (HR (95% CI) = 1.27 (0.97, 1.65), ischemic heart disease (HR (95% CI) = 0.92 (0.71, 1.19), and all-cause mortality (HR (95% CI) = 1.02 (0.83, 1.25)). Similar results were obtained when including prevalent cases in logistic regression models. Conclusion: Our results suggest that loss-of-function mutations in FLG are not associated with type 2 diabetes, cardiovascular disease, and all-cause mortality. However, larger studies with longer follow-up are needed to exclude any associations.	[Husemoen, Lise Lotte N.; Skaaby, Tea; Jorgensen, Torben; Linneberg, Allan] Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Thyssen, Jacob P.; Johansen, Jeanne Duus] Copenhagen Univ Hosp Gentofte, Dept Dermato Allergol, Natl Allergy Res Ctr, Hellerup, Denmark; [Meldgaard, Michael; Szecsi, Pal B.; Stender, Steen] Copenhagen Univ Hosp Gentofte, Dept Clin Biochem, Hellerup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Husemoen, LLN (corresponding author), Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark.	lloh@regionh.dk	Johansen, Jeanne/AAM-6382-2021; Thyssen, Jacob/ABD-8517-2020; Jørgensen, Torben/Z-1335-2018	Johansen, Jeanne/0000-0002-3537-8463; stender, steen/0000-0003-1037-1158; Linneberg, Allan/0000-0002-0994-0184; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Szecsi, Pal/0000-0003-3446-0411; Skaaby, Tea/0000-0003-0031-5726; Jorgensen, Torben/0000-0001-9453-2830	Health Insurance Foundation [2010B131]	Health Insurance Foundation	The study was supported by the Health Insurance Foundation grant No. 2010B131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Husemoen LLN, 2013, APPROACH EUR J CLIN; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Meldgaard M, 2012, CLIN CHIM ACTA, V413, P1488, DOI 10.1016/j.cca.2012.06.014; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Olesen AB, 2001, LANCET, V357, P1749, DOI 10.1016/S0140-6736(00)04896-0; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rasmussen SL, 1998, J HYPERTENS, V16, P1415, DOI 10.1097/00004872-199816100-00004; Rosenbauer J, 2003, DIABETOLOGIA, V46, P784, DOI 10.1007/s00125-003-1108-6; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Thuesen BH, 2013, INT J EPIDEMIOL; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84293	10.1371/journal.pone.0084293	http://dx.doi.org/10.1371/journal.pone.0084293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367652	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300136
J	Agaku, IT; Vardavas, CI				Agaku, Israel T.; Vardavas, Constantine I.			Disparities and Trends in Indoor Exposure to Secondhand Smoke among US Adolescents: 2000-2009	PLOS ONE			English	Article							MULTIUNIT HOUSING RESIDENTS; LARGE-HUB AIRPORTS; UNITED-STATES; HOME	Introduction: Secondhand smoke (SHS) exposure causes disease and death among nonsmokers. With a plethora of smokefree legislation implemented and a steady decrease in cigarette consumption noted over the past decade in the U.S., this study assessed trends in indoor SHS exposure among U.S. adolescents in grades 6-12 during 2000-2009. Methods: Data were obtained from the 2000-2009 National Youth Tobacco Survey -a national survey of U. S. middle and high school students. SHS exposure within an indoor area within the past seven days was self-reported. Trends in indoor SHS exposure during 2000-2009 were assessed overall and by socio-demographic characteristics, using the Wald's test in a binary logistic regression. Within-group comparisons were performed using chi-squared statistics (p<0.05). Results: The proportion of U.S. middle and high school students who were exposed to indoor SHS declined from 65.5% in 2000 to 40.5% in 2009 (p<0.05 for linear trend). Significant declines were also observed across all population subgroups. Between 2000 and 2009, prevalence of indoor SHS exposure declined significantly among both middle (58.5% to 34.3%) and high school (71.5% to 45.4%) students. Prevalence of indoor SHS exposure was significantly higher among girls (44.0% in 2009) compared to boys (37.2% in 2009) during each survey year. Similarly, prevalence of indoor SHS exposure during 20002009 was highest among non-Hispanic whites (44.2% in 2009) and lowest among non-Hispanic Asians (30.2% in 2009). During each survey year, prevalence was highest among the oldest age group ($ 18 years) and lowest among the youngest (9-11 years). Also, prevalence was significantly higher among current cigarette smokers (83.8% in 2009) compared to nonsmokers (34.0% in 2009). Conclusion: Significant declines in indoor SHS exposure among U.S. middle and high school students occurred during 2000-2009. While the results are encouraging, additional efforts are needed to further reduce youth indoor SHS exposure.	[Agaku, Israel T.; Vardavas, Constantine I.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Ctr Global Tobacco Control, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Agaku, IT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Ctr Global Tobacco Control, 665 Huntington Ave, Boston, MA 02115 USA.	iagaku@post.harvard.edu	Vardavas, Constantine/O-4961-2016; Vardavas, Constantine I/G-7598-2011	Vardavas, Constantine/0000-0003-0171-9570; 				Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Alpert HR, 2011, TOB CONTROL, V20, P207, DOI 10.1136/tc.2010.038711; Arrazola Rene A., 2012, Morbidity and Mortality Weekly Report, V61, P581; Behm I, 2012, TOB CONTROL, V21, P6, DOI 10.1136/tc.2010.041376; Cartmell KB, 2011, PUBLIC HEALTH REP, V126, P575, DOI 10.1177/003335491112600414; Centers for Disease Control and Prevention, 2013, STAT TOB ACT TRACK E; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P1484; Head P, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120079; Hopkins Maggie, 2012, Morbidity and Mortality Weekly Report, V61, P914; King Brian, 2012, Morbidity and Mortality Weekly Report, V61, P948; King BA, 2013, NICOTINE TOB RES, V15, P1316, DOI 10.1093/ntr/nts254; King BA, 2010, NICOTINE TOB RES, V12, P1133, DOI 10.1093/ntr/ntq162; King BA, 2010, NICOTINE TOB RES, V12, P598, DOI 10.1093/ntr/ntq053; Kline RL, 2000, TOB CONTROL, V9, P201, DOI 10.1136/tc.9.2.201; Marshall LaTisha, 2006, Morbidity and Mortality Weekly Report, V55, P1; Rodu B, 2012, J COMMUN HEALTH, V37, P468, DOI 10.1007/s10900-011-9464-5; Tynan M., 2011, Morbidity and Mortality Weekly Report, V60, P472; U.S. Census Bureau, 2011, SCH ENR CURR POP SUR; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Department of Housing and Urban Development, 2009, NONSM POL PUBL HOUS; Winickoff JP, 2010, NEW ENGL J MED, V362, P2319, DOI 10.1056/NEJMhle1000941	22	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83058	10.1371/journal.pone.0083058	http://dx.doi.org/10.1371/journal.pone.0083058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358249	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700045
J	Alibekova, R; Huang, JP; Chen, YH				Alibekova, Raushan; Huang, Jian-Pei; Chen, Yi-Hua			Adequate Prenatal Care Reduces the Risk of Adverse Pregnancy Outcomes in Women with History of Infertility: A Nationwide Population-Based Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; PERINATAL OUTCOMES; ANTENATAL CARE; SINGLETON PREGNANCIES; MATERNAL FACTORS; COHORT; CHALLENGES; CONCEPTION	Objectives: To investigate the effects of various measures of prenatal care on adverse pregnancy outcomes in women with a history of infertility. Study Design: A retrospective cohort study. Methods: Data were derived by linking 2 large nationwide population-based datasets, the National Health Insurance Research Database and Taiwan Birth Certificate Registry. The study sample included 15,056 women with an infertility diagnosis and 60,224 randomly selected women without infertility matched to the study sample by maternal age. A conditional logistic regression analysis was performed for the analysis. Results: Women diagnosed with infertility respectively had 1.39 (95% CI, 1.06 similar to 1.83), 1.15 (95% CI, 1.08 similar to 1.24), 1.13 (95% CI, 1.08 similar to 1.18), and 1.08 (95% CI, 1.05 similar to 1.12) higher odds of having very low birth weight (VLBW) babies, preterm births, labor complications, and cesarean sections (CSs) compared to women without infertility. Inadequate numbers of total and major prenatal visits and late initiation of prenatal care increased the risks of adverse pregnancy outcomes in women with infertility, especially the risk of a VLBW baby. However, no significant associations were found for the risks of adverse birth outcomes in infertile women with adequate prenatal care compared to fertile women with adequate care. Conclusions: Study findings suggest that adequate prenatal care can reduce the risk of adverse pregnancy outcomes in women with infertility.	[Alibekova, Raushan; Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Jian-Pei] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	Taipei Medical University; Mackay Memorial Hospital	Chen, YH (corresponding author), Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan.	yichen251@yahoo.com.tw		Chen, Yi-Hua/0000-0003-2464-2537				Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Beeckman K, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-213; Brown SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-196; Chen L M, 2001, Matern Child Health J, V5, P35, DOI 10.1023/A:1011345801673; Chung K, 2006, FERTIL STERIL, V86, P1634, DOI 10.1016/j.fertnstert.2006.04.038; Cooper AR, 2011, FERTIL STERIL, V96, P1100, DOI 10.1016/j.fertnstert.2011.08.038; Cox RG, 2011, MATERN CHILD HLTH J, V15, P931, DOI 10.1007/s10995-009-0542-6; D.O.H, 2010, MAT HLTH HDB; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Heaman Maureen I, 2008, BMC Pregnancy Childbirth, V8, P15, DOI 10.1186/1471-2393-8-15; Herbert DL, 2012, FERTIL STERIL, V97, P630, DOI 10.1016/j.fertnstert.2011.12.033; Herbst MA, 2003, AM J OBSTET GYNECOL, V189, P930, DOI 10.1067/S0002-9378(03)01055-X; Kitsantas P, 2012, WOMEN HEALTH ISS, V22, pE455, DOI 10.1016/j.whi.2012.06.003; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V271, P1340, DOI 10.1001/jama.271.17.1340; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lin HC, 2009, J CLIN PSYCHIAT, V70, P1297, DOI 10.4088/JCP.09m05087; Liu K, 2011, J OBSTET GYNAECOL CA, V33, P1165, DOI 10.1016/S1701-2163(16)35087-3; Ludwig AK, 2006, HUM REPROD, V21, P713, DOI 10.1093/humrep/dei390; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; Pandian Z, 2001, HUM REPROD, V16, P2593, DOI 10.1093/humrep/16.12.2593; Partridge S, 2012, AM J PERINATOL; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Raatikainen K, 2012, HUM REPROD, V27, P1162, DOI 10.1093/humrep/des015; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Schieve LA, 2007, MATERN CHILD HLTH J, V11, P517, DOI 10.1007/s10995-007-0202-7; Segev Y, 2011, J WOMENS HEALTH, V20, P853, DOI 10.1089/jwh.2010.2603; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005; Welmerink DB, 2010, FERTIL STERIL, V94, P2580, DOI 10.1016/j.fertnstert.2010.03.005; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84237	10.1371/journal.pone.0084237	http://dx.doi.org/10.1371/journal.pone.0084237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358347	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700088
J	Johnson, ZI; Wheeler, BJ; Blinebry, SK; Carlson, CM; Ward, CS; Hunt, DE				Johnson, Zackary I.; Wheeler, Benjamin J.; Blinebry, Sara K.; Carlson, Christina M.; Ward, Christopher S.; Hunt, Dana E.			Dramatic Variability of the Carbonate System at a Temperate Coastal Ocean Site (Beaufort, North Carolina, USA) Is Regulated by Physical and Biogeochemical Processes on Multiple Timescales	PLOS ONE			English	Article							ACIDIFICATION; IMPACTS; SEAWATER; PH; ESTUARINE; RESPONSES; DYNAMICS; PCO(2); SINKS; RIVER	Increasing atmospheric carbon dioxide (CO2) from anthropogenic sources is acidifying marine environments resulting in potentially dramatic consequences for the physical, chemical and biological functioning of these ecosystems. If current trends continue, mean ocean pH is expected to decrease by similar to 0.2 units over the next similar to 50 years. Yet, there is also substantial temporal variability in pH and other carbon system parameters in the ocean resulting in regions that already experience change that exceeds long-term projected trends in pH. This points to short-term dynamics as an important layer of complexity on top of long-term trends. Thus, in order to predict future climate change impacts, there is a critical need to characterize the natural range and dynamics of the marine carbonate system and the mechanisms responsible for observed variability. Here, we present pH and dissolved inorganic carbon (DIC) at time intervals spanning 1 hour to >1 year from a dynamic, coastal, temperate marine system (Beaufort Inlet, Beaufort NC USA) to characterize the carbonate system at multiple time scales. Daily and seasonal variation of the carbonate system is largely driven by temperature, alkalinity and the balance between primary production and respiration, but high frequency change (hours to days) is further influenced by water mass movement (e. g. tides) and stochastic events (e. g. storms). Both annual (similar to 0.3 units) and diurnal (similar to 0.1 units) variability in coastal ocean acidity are similar in magnitude to 50 year projections of ocean acidity associated with increasing atmospheric CO2. The environmental variables driving these changes highlight the importance of characterizing the complete carbonate system rather than just pH. Short-term dynamics of ocean carbon parameters may already exert significant pressure on some coastal marine ecosystems with implications for ecology, biogeochemistry and evolution and this shorter term variability layers additive effects and complexity, including extreme values, on top of long-term trends in ocean acidification.	[Johnson, Zackary I.; Wheeler, Benjamin J.; Blinebry, Sara K.; Carlson, Christina M.; Ward, Christopher S.; Hunt, Dana E.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	Duke University	Johnson, ZI (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA.	zij@duke.edu	Johnson, Zackary I/E-4601-2011; Hunt, Dana/A-2051-2012	Johnson, Zackary I/0000-0003-0793-8512; Hunt, Dana/0000-0002-8801-9624	US-NSF [0959630, 1031064]; Repass Family; Division Of Ocean Sciences [1031064] Funding Source: National Science Foundation	US-NSF(National Science Foundation (NSF)); Repass Family; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by US-NSF# 0959630 to ZIJ and DEH and 1031064 to ZIJ (http://www.nsf.gov) and by the Repass Family to the Duke University Marine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Bates NR, 1998, NATURE, V395, P58, DOI 10.1038/25703; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boyd PW, 2011, NAT GEOSCI, V4, P273, DOI 10.1038/ngeo1150; Bozec Y, 2011, MAR CHEM, V126, P13, DOI 10.1016/j.marchem.2011.03.003; Burkholder J, 2004, P NATL ACAD SCI USA, V101, P9291, DOI 10.1073/pnas.0306842101; Byrne RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040999; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Dai MH, 2009, LIMNOL OCEANOGR, V54, P735, DOI 10.4319/lo.2009.54.3.0735; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Kitidis V, 2012, CONT SHELF RES, V42, P30, DOI 10.1016/j.csr.2012.04.012; Knauss JA, 2005, INTRO PHYS OCEANOGRA; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Van Heuven, 2011, ORNLCDIAC105B USDA C; WAKITA M, 2013, BIOGEOSCIENCES DISCU, V10, P8283, DOI DOI 10.5194/BGD-10-8283-2013; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	42	42	42	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85117	10.1371/journal.pone.0085117	http://dx.doi.org/10.1371/journal.pone.0085117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358377	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700111
J	Wang, XG; Liu, XX; Ge, HL; Yang, Q; Liu, XL; Shi, DM; Zhou, YJ				Wang, Xinguo; Liu, Xuxia; Ge, Hailong; Yang, Qing; Liu, Xiaoli; Shi, Dongmei; Zhou, Yujie			Positive Association of Coronary Calcium Detected by Computed Tomography Coronary Angiography with Periprocedural Myocardial Infarction	PLOS ONE			English	Article							CARDIAC TROPONIN ELEVATION; PLAQUE COMPOSITION; INTRAVASCULAR ULTRASOUND; INTERVENTION; IMPACT; CT	Background: Periprocedural myocardial infarction (PMI) may occur in approximately 5% to 30% of patients undergoing percutaneous coronary intervention. Whether the morphology of coronary plaque calcium affects the occurrence of PMI is unknown. Materials and Methods: A total of 616 subjects with stable angina and normal baseline cardiac troponin I levels who had undergone computed tomography angiography (CTA) were referred to elective percutaneous coronary intervention. The morphology of coronary calcium was determined by CTA analysis. PMI was defined as an elevation in 24-h post-procedural cardiac troponin I levels of. 5 times the upper limit of normal with either symptoms of myocardial ischemia, new ischemic electrocardiographic changes, or documented complications during the procedure. Logistic regression was performed to identify the effect of the morphology of coronary calcium on the occurrence of PMI. Results: According to the presence or morphology of coronary calcium as shown by CTA, 210 subjects were grouped in the heavy calcification group, 258 in the mild calcification group, 40 in the spotty calcification group and 108 in the control group. The dissection rate was significantly higher in the heavy calcification group than in the control group (7.1 % vs. 1.9%, p = 0.03). The occurrence of PMI in the heavy calcification group was significantly higher than that in the control group (OR 4.38, 95% CI 1.80-10.65, p = 0.001). After multivariate adjustment, the risk of PMI still remained significantly higher in the heavy calcification group than in the control group (OR 4.04, 95% CI 1.50-10.89, p = 0.003). Conclusions: The morphology of coronary calcium determined by CTA may help to predict the subsequent occurrence of PMI. A large amount of coronary calcium may be predictive of PMI.	[Wang, Xinguo; Ge, Hailong; Yang, Qing; Liu, Xiaoli; Shi, Dongmei; Zhou, Yujie] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Liu, Xuxia; Zhou, Yujie] Minist Educ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Liu, Xuxia; Zhou, Yujie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Zhou, YJ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China.	azzyj12@163.com	Zhou, Yu/HHN-3071-2022; Liu, Xiaoli/HGE-7614-2022		Beijing Postdoctoral Scientific [2012ZZ-41]	Beijing Postdoctoral Scientific	This work was supported by the Beijing Postdoctoral Scientific grant (No. 2012ZZ-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Babu GG, 2011, EUR HEART J, V32, P23, DOI 10.1093/eurheartj/ehq393; Bose D, 2008, BASIC RES CARDIOL, V103, P587, DOI 10.1007/s00395-008-0745-9; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020; Iakovou I, 2003, J AM COLL CARDIOL, V42, P1900, DOI 10.1016/j.jacc.2003.06.012; Kitagawa T, 2007, AM HEART J, V154, P1191, DOI 10.1016/j.ahj.2007.07.020; Kodama T, 2012, JACC-CARDIOVASC INTE, V5, P636, DOI 10.1016/j.jcin.2012.02.016; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mehran R, 2000, CIRCULATION, V101, P604, DOI 10.1161/01.CIR.101.6.604; Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Testa L, 2009, QJM-INT J MED, V102, P369, DOI 10.1093/qjmed/hcp005; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; Uetani T, 2010, JACC-CARDIOVASC IMAG, V3, P19, DOI 10.1016/j.jcmg.2009.09.016; van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033; Watabe H, 2012, J AM COLL CARDIOL, V59, P1881, DOI 10.1016/j.jacc.2012.01.051; Zemanek D, 2013, INT J CARDIOL, V2015; Zhao L, 2011, EUR J RADIOL, V77, P436, DOI 10.1016/j.ejrad.2009.09.006	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82835	10.1371/journal.pone.0082835	http://dx.doi.org/10.1371/journal.pone.0082835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358229	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700033
J	Jeong, SH; Lee, DH; Kim, BY; Choi, SW; Lee, JB; Park, SY; Choi, IS; Song, CS				Jeong, Seung-Hwan; Lee, Dong-Hun; Kim, Byoung-Yoon; Choi, Soo-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon			Immunization with a Thermostable Newcastle Disease Virus K148/08 Strain Originated from Wild Mallard Duck Confers Protection against Lethal Viscerotropic Velogenic Newcastle Disease Virus Infection in Chickens	PLOS ONE			English	Article							VACCINATION; BIRDS	Newcastle disease (ND) is one of the most devastating poultry infections because of its worldwide distribution and accompanying economical threat. In the present study, we characterized the ND virus (NDV) K148/08 strain from wild mallard duck, with regard to safety, thermostability, immunogenicity, and protective efficacy against velogenic ND viral infection. The NDV K148/08 strain offered enhanced immunogenicity and safety relative to commercially available vaccine strains. The NDV K148/08 strain was safe in 1-day-old SPF chicks after vaccination using a coarse or cabinet-type fine sprayer. We demonstrated that the NDV K148/08 strain elicited high levels of antibody responses and provided protective efficacy against lethal NDV challenge. In addition, the thermostability of the NDV K148/08 strain was as high as that of the thermostable V4 strain. Therefore, the NDV K148/08 strain may be useful to ensure NDV vaccine performance and effectiveness in developing countries, especially in remote areas without cold chains.	[Jeong, Seung-Hwan; Lee, Dong-Hun; Kim, Byoung-Yoon; Choi, Soo-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea	Konkuk University	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea.	songcs@konkuk.ac.kr	Lee, Dong-hun/H-5082-2019	Lee, Dong-Hun/0000-0002-0820-7378	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [610001-03-1-SU000]	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by grant no. 610001-03-1-SU000 from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D J, 1974, Avian Pathol, V3, P269, DOI 10.1080/03079457409353840; Alexander D.J., 2008, LAB MANUAL ISOLATION, V4th, P135; Alexander DJ, 2008, POULTRY DIS, P75; ALLAN WH, 1976, RES VET SCI, V20, P101, DOI 10.1016/S0034-5288(18)33487-8; BEARD CW, 1967, J INFECT DIS, V117, P55, DOI 10.1093/infdis/117.1.55; BEARD CW, 1993, AVIAN DIS, V37, P222, DOI 10.2307/1591478; Bermudez AJ, 2009, DIS POULTRY, P17; Burmester BR, 1947, POULTRY SCI, V26, P614, DOI [10.3382/ps.0260614, DOI 10.3382/PS.0260614]; GODDARD RD, 1988, VACCINE, V6, P530, DOI 10.1016/0264-410X(88)90106-5; GOUGH R E, 1976, Avian Pathology, V5, P81, DOI 10.1080/03079457608418174; Kim BY, 2012, INFECT GENET EVOL, V12, P478, DOI 10.1016/j.meegid.2011.12.004; Kristensen D, 2011, VACCINE, V29, P7122, DOI 10.1016/j.vaccine.2011.05.070; LOMNICZI B, 1975, ARCH VIROL, V47, P249, DOI 10.1007/BF01317812; Pharmacopoeia E, 2004, INFECT BRONCHITIS LI, V1; REED L. J., 1938, AMER JOUR HYG, V27, P493; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Shim JB, 2011, AVIAN PATHOL, V40, P565, DOI 10.1080/03079457.2011.616187; SPRADBROW PB, 1995, VET MICROBIOL, V46, P21, DOI 10.1016/0378-1135(95)00066-J; Stephan GT, 2008, LAB MAUNAL ISOLATION, P195; STEPHENS P, 1968, AUST VET J, V44, P29, DOI 10.1111/j.1751-0813.1967.tb04764.x; Takada A, 1996, VET MICROBIOL, V50, P17, DOI 10.1016/0378-1135(96)00004-1; Villegas P, 1998, POULTRY SCI, V77, P1143, DOI 10.1093/ps/77.8.1143; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83161	10.1371/journal.pone.0083161	http://dx.doi.org/10.1371/journal.pone.0083161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358260	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700108
J	Jung, AS; Koo, BK; Chong, SH; Kim, K; Choi, DK; Vu, TTT; Nguyen, MT; Jeong, B; Ryu, HB; Kim, I; Jang, YJ; Robinson, RC; Choe, H				Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Kim, Kyunhoo; Choi, Dong Kyu; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Kim, Injune; Jang, Yeon Jin; Robinson, Robert Charles; Choe, Han			Soluble Expression of Human Leukemia Inhibitory Factor with Protein Disulfide Isomerase in Escherichia coli and Its Simple Purification	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; LOW-TEMPERATURE INCREASES; FACTOR LIF; RECOMBINANT PROTEINS; CRYSTAL-STRUCTURE; STEM-CELLS; HUMAN PDI; DIFFERENTIATION; CLONING; GENE	Human leukemia inhibitory factor (hLIF) is a multifunctional cytokine that is essential for maintaining the pluripotency of embryonic stem cells. hLIF may be also be useful in aiding fertility through its effects on increasing the implantation rate of fertilized eggs. Thus these applications in biomedical research and clinical medicine create a high demand for bioactive hLIF. However, production of active hLIF is problematic since eukaryotic cells demonstrate limited expression and prokaryotic cells produce insoluble protein. Here, we have adopted a hybrid protein disulfide isomerase design to increase the solubility of hLIF in Escherichia coli. Low temperature expression of hLIF fused to the b'a' domain of protein disulfide isomerase (PDIb'a') increased the soluble expression in comparison to controls. A simple purification protocol for bioactive hLIF was established that includes removal of the PDIb'a' domain by cleavage by TEV protease. The resulting hLIF, which contains one extra glycine residue at the N-terminus, was highly pure and demonstrated endotoxin levels below 0.05 EU/mu g. The presence of an intramolecular disulfide bond was identified using mass spectroscopy. This purified hLIF effectively maintained the pluripotency of a murine embryonic stem cell line. Thus we have developed an effective method to produce a pure bioactive version of hLIF in E. coli for use in biomedical research.	[Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Jang, Yeon Jin; Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; [Jung, A. Song; Koo, Bon-Kyung; Chong, Seon-Ha; Thu Trang Thi Vu; Minh Tan Nguyen; Jeong, Boram; Ryu, Han-Bong; Jang, Yeon Jin; Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea; [Kim, Kyunhoo; Choi, Dong Kyu; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Robinson, Robert Charles] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Robinson, Robert Charles] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	University of Ulsan; University of Ulsan; Korea Advanced Institute of Science & Technology (KAIST); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Robinson, Robert/G-9702-2011; Nguyen, Minh Tan/AAH-7865-2019; Kim, Injune/C-1710-2011	Robinson, Robert/0000-0001-6367-6903; Kim, Injune/0000-0001-9244-815X; choe, han/0000-0003-4604-647X	National Research Foundation [2008-0062286]; Korea government	National Research Foundation; Korea government(Korean Government)	This work was supported by the MRC grant (2008-0062286) of National Research Foundation funded by the Korea government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chodorowska Grazyna, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P189; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GEARING DP, 1989, BIO-TECHNOL, V7, P1157; GOUGH NM, 1988, P NATL ACAD SCI USA, V85, P2623, DOI 10.1073/pnas.85.8.2623; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HILTON DJ, 1988, ANAL BIOCHEM, V173, P359, DOI 10.1016/0003-2697(88)90200-X; HILTON DJ, 1992, TRENDS BIOCHEM SCI, V17, P72, DOI 10.1016/0968-0004(92)90505-4; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Imaizumi K, 2013, PROTEIN EXPRES PURIF, V90, P20, DOI 10.1016/j.pep.2013.04.006; Imsoonthornruksa S, 2011, J BIOTECHNOL, V151, P295, DOI 10.1016/j.jbiotec.2010.12.020; Joo HJ, 2012, BLOOD, V120, P2733, DOI 10.1182/blood-2012-04-421610; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZJ, 2001, PROTEIN EXPRES PURIF, V21, P438, DOI 10.1006/prep.2001.1395; Lin JE, 2011, PROTEIN PEPTIDE LETT, V18, P690, DOI 10.2174/092986611795446058; Liu Y, 2005, PROTEIN EXPRES PURIF, V44, P155, DOI 10.1016/j.pep.2005.03.030; METCALF D, 1990, BLOOD, V76, P50; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SAMAL BB, 1995, BBA-GENE STRUCT EXPR, V1260, P27, DOI 10.1016/0167-4781(94)00172-Y; SCHMELZER CH, 1993, ARCH BIOCHEM BIOPHYS, V302, P484, DOI 10.1006/abbi.1993.1243; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; Sims NA, 2012, GROWTH FACTORS, V30, P76, DOI 10.3109/08977194.2012.656760; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Tomala M, 2010, PROTEIN EXPRES PURIF, V73, P51, DOI 10.1016/j.pep.2010.04.002; Vasina JA, 1997, PROTEIN EXPRES PURIF, V9, P211, DOI 10.1006/prep.1996.0678; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Weickert MJ, 1997, APPL ENVIRON MICROB, V63, P4313, DOI 10.1128/AEM.63.11.4313-4320.1997; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yi AR, 2009, J MICROBIOL BIOTECHN, V19, P829, DOI 10.4014/jmb.0812.683	48	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83781	10.1371/journal.pone.0083781	http://dx.doi.org/10.1371/journal.pone.0083781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358310	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700138
J	Zhang, ZH; Khoo, AA; Mihalek, I				Zhang, Zong Hong; Khoo, Aik Aun; Mihalek, Ivana			Cube - An Online Tool for Comparison and Contrasting of Protein Sequences	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; AMINO-ACID SUBSTITUTIONS; WEB SERVER; EVOLUTIONARY ANALYSIS; LAC REPRESSOR; SPECIFICITY; DIVERGENCE; CONSERVATION; PREDICTION; GENE	When comparing sequences of similar proteins, two kinds of questions can be asked, and the related two kinds of inference made. First, one may ask to what degree they are similar, and then, how they differ. In the first case one may tentatively conclude that the conserved elements common to all sequences are of central and common importance to the protein's function. In the latter case the regions of specialization may be discriminative of the function or binding partners across subfamilies of related proteins. Experimental efforts - mutagenesis or pharmacological intervention - can then be pointed in either direction, depending on the context of the study. Cube simplifies this process for users that already have their favorite sets of sequences, and helps them collate the information by visualization of the conservation and specialization scores on the sequence and on the structure, and by spreadsheet tabulation. All information can be visualized on the spot, or downloaded for reference and later inspection. Server homepage: http://eopsf.org/cube	[Zhang, Zong Hong; Khoo, Aik Aun; Mihalek, Ivana] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Mihalek, I (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	ivanam@bii.a-star.edu.sg			Biomedical Research Council of the Agency for Science, Technology and Research, Singapore	Biomedical Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Biomedical Research Council of the Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhiman S, 2005, NUCLEIC ACIDS RES, V33, pD197, DOI 10.1093/nar/gki067; Adikesavan AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002244; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bharatham K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024382; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Carro A, 2006, NUCLEIC ACIDS RES, V34, pW110, DOI 10.1093/nar/gkl203; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pW242, DOI 10.1093/nar/gks559; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Innis C, 2000, PROTEIN ENG, V13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mihalek I, 2006, PROTEINS, V63, P87, DOI 10.1002/prot.20866; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; MILLER JH, 1977, J MOL BIOL, V109, P275, DOI 10.1016/S0022-2836(77)80034-X; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Ye K, 2008, BIOINFORMATICS, V24, P18, DOI 10.1093/bioinformatics/btm537; Zhang ZH, 2012, NUCLEIC ACIDS RES, V40, pD490, DOI 10.1093/nar/gkr1129	45	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79480	10.1371/journal.pone.0079480	http://dx.doi.org/10.1371/journal.pone.0079480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24363790	Green Published, gold, Green Submitted			2022-12-25	WOS:000327313100026
J	Giusti, A; Leprince, P; Mazzucchelli, G; Thome, JP; Lagadic, L; Ducrot, V; Joaquim-Justo, C				Giusti, Arnaud; Leprince, Pierre; Mazzucchelli, Gabriel; Thome, Jean-Pierre; Lagadic, Laurent; Ducrot, Virginie; Joaquim-Justo, Celia			Proteomic Analysis of the Reproductive Organs of the Hermaphroditic Gastropod Lymnaea stagnalis Exposed to Different Endocrine Disrupting Chemicals	PLOS ONE			English	Article							MUSSEL MYTILUS-EDULIS; SYDNEY ROCK OYSTER; HALIOTIS-DIVERSICOLOR-SUPERTEXTA; PROTEIN EXPRESSION SIGNATURES; PROSOBRANCH SNAILS MOLLUSCA; SACCOSTREA-GLOMERATA; PLACOPECTEN-MAGELLANICUS; TESTOSTERONE LEVELS; SEX STEROIDS; BISPHENOL-A	Many studies have reported perturbations of mollusc reproduction following exposure to low concentrations (ng/L range) of endocrine disrupting chemicals (EDCs). However, the mechanisms of action of these molecules on molluscs are still poorly understood. Investigation of the modifications of protein expression in organisms exposed to chemicals using proteomic methods can provide a broader and more comprehensive understanding of adverse impacts of pollution on organisms than conventional biochemical biomarkers (e.g., heat-shock proteins, metallothioneins, GST, EROD). In this study we have investigated the impacts of four chemicals, which exhibit different endocrine disrupting properties in vertebrates, on the proteome of the hermaphroditic freshwater pulmonate gastropod Lymnaea stagnalis after 21 days of exposure. Testosterone, tributyltin, chlordecone and cyproterone acetate were chosen as tested compounds as they can induce adverse effects on the reproduction of this snail. The 2D-DIGE method was used to identify proteins whose expression was affected by these compounds. In addition to modifying the expression of proteins involved in the structure and function of the cytoskeleton, chemicals had impacts on the expression of proteins involved in the reproduction of L. stagnalis. Exposure to 19.2 mu g/L of chlordecone increased the abundance of ovipostatin, a peptide transmitted during mating through seminal fluid, which reduces oviposition in this species. The expression of yolk ferritin, the vitellogenin equivalent in L. stagnalis, was reduced after exposure to 94.2 ng Sn/L of tributyltin. The identification of yolk ferritin and the modification of its expression in snails exposed to chemicals were refined using western blot analysis. Our results showed that the tested compounds influenced the abundance of yolk ferritin in the reproductive organs. Alteration in proteins involved in reproductive pathways (e.g., ovipostatin and yolk ferritin) could constitute relevant evidence of interaction of EDCs with reproductive pathways that are under the control of the endocrine system of L. stagnalis.	[Giusti, Arnaud; Thome, Jean-Pierre; Joaquim-Justo, Celia] Univ Liege, CART, Lab Anim Ecol & Ecotoxicol, Liege, Belgium; [Giusti, Arnaud; Lagadic, Laurent; Ducrot, Virginie] INRA, Ecol & Sante Ecosyst UMR0985, Equipe Ecotoxicol & Qualite Milieux Aquat, F-35042 Rennes, France; [Leprince, Pierre] Univ Liege, GIGA Neurosci, Liege, Belgium; [Mazzucchelli, Gabriel] Univ Liege, GIGA R, Lab Mass Spectrometry, Liege, Belgium	University of Liege; INRAE; University of Liege; University of Liege	Giusti, A (corresponding author), Univ Liege, CART, Lab Anim Ecol & Ecotoxicol, Liege, Belgium.	Arnaud.Giusti@ulg.ac.be		Mazzucchelli, Gabriel/0000-0002-8757-8133; Leprince, pierre/0000-0002-7233-6553; Lagadic, Laurent/0000-0002-2469-8541	FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture); Belgian FNRS-FRFC grant [2.4.585.10.F]; FRSM grant [3.4559.11]	FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); Belgian FNRS-FRFC grant(Fonds de la Recherche Scientifique - FNRS); FRSM grant(Fonds de la Recherche Scientifique - FNRS)	This work was financially supported by a FNRS-F.R.I.A. grant (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture), a Belgian FNRS-FRFC grant Number: 2.4.585.10.F and a FRSM grant nr 3.4559.11. http://www.frs-fnrs.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese M, 2013, J CELL PHYSIOL, V228, P547, DOI 10.1002/jcp.24161; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andrew MN, 2008, AQUAT TOXICOL, V88, P39, DOI 10.1016/j.aquatox.2008.03.003; Andrew MN, 2010, ECOTOXICOLOGY, V19, P1440, DOI 10.1007/s10646-010-0529-5; Andrew-Priestley MN, 2012, AQUAT TOXICOL, V120, P99, DOI 10.1016/j.aquatox.2012.03.020; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Apraiz I, 2006, MOL CELL PROTEOMICS, V5, P1274, DOI 10.1074/mcp.M500333-MCP200; Apraiz I, 2009, MAR POLLUT BULL, V58, P1815, DOI 10.1016/j.marpolbul.2009.08.004; BARTLETT MS, 1946, J ROY STAT SOC B, V8, P128; Bauer B, 1997, ENVIRON POLLUT, V96, P299, DOI 10.1016/S0269-7491(97)00049-3; Belgers JDM, 2011, CHEMOSPHERE, V85, P1017, DOI 10.1016/j.chemosphere.2011.07.025; Benachour N, 2007, TOXICOL APPL PHARM, V222, P129, DOI 10.1016/j.taap.2007.03.033; Benninghoff AD, 2007, TOXICOL SCI, V95, P1, DOI 10.1093/toxsci/kfl157; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Beyret E, 2011, DEV BIOL, V355, P215, DOI 10.1016/j.ydbio.2011.04.021; Bjorkblom C, 2011, ENVIRON TOXICOL, V28, P229; BOTTKE W, 1986, CELL TISSUE RES, V243, P397; Bottke W, 1979, DEV BIOL, V186, P71; Bottke W, 1988, DEV GENES EVOL, V197, P377; Bouetard A, 2012, ECOTOXICOLOGY, V21, P2222, DOI 10.1007/s10646-012-0977-1; Bradley BP, 2002, MAR ENVIRON RES, V54, P373, DOI 10.1016/S0141-1136(02)00115-0; Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027; Cao A, 2009, AQUACULTURE, V295, P149, DOI 10.1016/j.aquaculture.2009.06.044; Chora S, 2009, AQUAT TOXICOL, V94, P300, DOI 10.1016/j.aquatox.2009.07.014; Collodoro M, 2012, J PROTEOMICS, V75, P4555, DOI 10.1016/j.jprot.2012.04.032; Coutellec MA, 2006, ECOTOXICOLOGY, V15, P199, DOI 10.1007/s10646-005-0049-x; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech P, 2001, AQUAT TOXICOL, V53, P103, DOI 10.1016/S0166-445X(00)00169-7; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Damodaran Senthilkumar, 2007, Genomics Proteomics & Bioinformatics, V5, P152, DOI 10.1016/S1672-0229(08)60002-9; Damstra T., 2002, GLOBAL ASSESSMENT ST; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Donohoe RM, 1996, AQUAT TOXICOL, V36, P31, DOI 10.1016/S0166-445X(96)00799-0; Dowling VA, 2006, PROTEOMICS, V6, P5597, DOI 10.1002/pmic.200600274; Ducrot V, 2010, ECOTOXICOLOGY, V19, P1312, DOI 10.1007/s10646-010-0518-8; Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Francis F, 2010, J INSECT PHYSIOL, V56, P575, DOI 10.1016/j.jinsphys.2009.12.001; Gauthier-Clerc S, 2006, GEN COMP ENDOCR, V145, P133, DOI 10.1016/j.ygcen.2005.08.004; GERAERTS WPM, 1976, GEN COMP ENDOCR, V28, P350, DOI 10.1016/0016-6480(76)90187-8; Giusti A, 2013, ENVIRON TOXICOL CHEM, V32, P1740, DOI 10.1002/etc.2234; Giusti A, 2013, ENVIRON TOXICOL CHEM, V32, P1552, DOI 10.1002/etc.2200; Gomes T, 2009, ECOTOXICOLOGY, V18, P1104, DOI 10.1007/s10646-009-0359-5; Gooding MP, 2004, INVERTEBR BIOL, V123, P237; HAMMOND B, 1979, P NATL ACAD SCI USA, V76, P6641, DOI 10.1073/pnas.76.12.6641; Harries JE, 1999, ENVIRON TOXICOL CHEM, V18, P932, DOI 10.1002/etc.5620180517; Hoffer J., 2012, QUANTIFYING SEXUAL C; Horiguchi T, 2012, MAR ENVIRON RES, V76, P56, DOI 10.1016/j.marenvres.2011.09.002; ISO ISO, 2004, 147SC ISO TC, P31; Koene JM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00167; Koene JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010117; Lavado R, 2006, AQUAT TOXICOL, V78, pS65, DOI 10.1016/j.aquatox.2006.02.018; Leroy D, 2010, ECOTOX ENVIRON SAFE, V73, P343, DOI 10.1016/j.ecoenv.2009.11.006; Leung KMY, 2007, CHEMOSPHERE, V66, P1358, DOI 10.1016/j.chemosphere.2006.06.051; Leung PTY, 2011, AQUAT TOXICOL, V105, P49, DOI 10.1016/j.aquatox.2011.05.010; Liu WG, 2008, NEW ZEAL J MAR FRESH, V42, P417, DOI 10.1080/00288330809509970; Manduzio H, 2005, PROTEOMICS, V5, P4958, DOI 10.1002/pmic.200401328; Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008; Matozzo V, 2008, ENVIRON TOXICOL PHAR, V26, P38, DOI 10.1016/j.etap.2008.01.001; McDonagh B, 2005, AQUAT TOXICOL, V73, P315, DOI 10.1016/j.aquatox.2005.03.020; Miura Y, 2005, ELECTROPHORESIS, V26, P2786, DOI 10.1002/elps.200500172; OECD, 2010, DET REV PAP MOLL LIF; OECD, 2009, TEST 229 FISH SHORT; OECD, 2000, GUID DOC AQ TOX TEST; OECD (Organisation for Economic Co-operation and Development), 2012, GUID DOC STAND TEST; Oehlmann J, 2000, ECOTOXICOLOGY, V9, P383, DOI 10.1023/A:1008972518019; Oehlmann J, 1998, HYDROBIOLOGIA, V378, P199, DOI 10.1023/A:1003218411850; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Ortiz-Zarragoitia M, 2010, ECOTOX ENVIRON SAFE, V73, P693, DOI 10.1016/j.ecoenv.2010.04.002; Pascoal S, 2012, MOL ECOL; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Raudrant D, 2003, DRUGS, V63, P463, DOI 10.2165/00003495-200363050-00003; Rittschof D, 2005, MAR POLLUT BULL, V50, P369, DOI 10.1016/j.marpolbul.2005.02.008; Rodriguez-Ortega MJ, 2003, PROTEOMICS, V3, P1535, DOI 10.1002/pmic.200300491; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Saitoh M, 2001, BIOCHEM BIOPH RES CO, V289, P198, DOI 10.1006/bbrc.2001.5952; Sanchez BC, 2011, ENVIRON TOXICOL CHEM, V30, P274, DOI 10.1002/etc.402; Shepard JL, 2000, MAR ENVIRON RES, V50, P337, DOI 10.1016/S0141-1136(00)00065-9; Sternberg RM, 2010, ECOTOXICOLOGY, V19, P4, DOI 10.1007/s10646-009-0397-z; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Thompson EL, 2012, ENVIRON POLLUT, V170, P102, DOI 10.1016/j.envpol.2012.06.015; Thompson EL, 2012, AQUAT TOXICOL, V109, P202, DOI 10.1016/j.aquatox.2011.09.018; Tillmann M, 2001, ECOTOXICOLOGY, V10, P373, DOI 10.1023/A:1012279231373; US-EPA, 1997, EPA360R96012, P120; Wang C, 2004, AQUACULTURE, V238, P483, DOI 10.1016/j.aquaculture.2004.05.024; Wang CD, 2003, INVERTEBR REPROD DEV, V44, P89, DOI 10.1080/07924259.2003.9652559; Wang CD, 2006, AQUACULTURE, V256, P423, DOI 10.1016/j.aquaculture.2006.01.017; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wright PC, 2012, THERIOGENOLOGY, V77, P738, DOI 10.1016/j.theriogenology.2011.11.012; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhou J, 2010, DEV COMP IMMUNOL, V34, P1059, DOI 10.1016/j.dci.2010.05.006; Zhou J, 2010, CHEMOSPHERE, V79, P595, DOI 10.1016/j.chemosphere.2010.01.052; Zhou X, 2007, BIOCHEM BIOPH RES CO, V362, P126, DOI 10.1016/j.bbrc.2007.07.179	94	15	15	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81086	10.1371/journal.pone.0081086	http://dx.doi.org/10.1371/journal.pone.0081086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24363793	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900114
J	Li, L; Puliyappadam, V; Chakraborty, S; Rehman, A; Vemireddy, V; Saha, D; Souza, RF; Hatanpaa, KJ; Koduru, P; Burma, S; Boothman, DA; Habib, AA				Li, L.; Puliyappadam, V. T.; Chakraborty, S.; Rehman, A.; Vemireddy, V.; Saha, D.; Souza, R. F.; Hatanpaa, K. J.; Koduru, P.; Burma, S.; Boothman, D. A.; Habib, A. A.			EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma	ONCOGENE			English	Article						EGFRvIII; glioblastoma; EGFR wild type; Met; antagonistic interaction; temozolomide	GROWTH-FACTOR RECEPTOR; C-MET; SIGNALING NETWORKS; AUTOCRINE LOOP; BRAIN-TUMORS; CELLS; GLIOMA; EXPRESSION; CANCER; RADIORESISTANCE	Epidermal growth factor receptor (EGFR)vIII is the most common EGFR mutant found in glioblastoma (GBM). EGFRvIII does not bind ligand, is highly oncogenic and is usually coexpressed with EGFR wild type (EGFRwt). EGFRvIII activates Met, and Met contributes to EGFRvIII-mediated oncogenicity and resistance to treatment. Here, we report that addition of EGF results in a rapid loss of EGFRvIII-driven Met phosphorylation in glioma cells. Met is associated with EGFRvIII in a physical complex. Addition of EGF results in a dissociation of the EGFRvIII-Met complex with a concomitant loss of Met phosphorylation. Consistent with the abrogation of Met activation, addition of EGF results in the inhibition of EGFRvIII-mediated resistance to chemotherapy. Thus, our study suggests that ligand in the milieu of EGFRvIII-expressing GBM cells is likely to influence the EGFRvIII-Met interaction and resistance to treatment, and highlights a novel antagonistic interaction between EGFRwt and EGFRvIII in glioma cells.	[Li, L.; Puliyappadam, V. T.; Chakraborty, S.; Rehman, A.; Vemireddy, V.; Habib, A. A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75216 USA; [Saha, D.; Burma, S.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75216 USA; [Souza, R. F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75216 USA; [Souza, R. F.] Univ Texas SW Med Ctr Dallas, Esophagal Dis Ctr, Dallas, TX 75216 USA; [Hatanpaa, K. J.; Koduru, P.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75216 USA; [Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75216 USA; [Boothman, D. A.; Habib, A. A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75216 USA; [Habib, A. A.] VA North Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Habib, AA (corresponding author), Univ Texas SW Med Ctr Dallas, North Texas VA Hlth care Syst, Dept Neurol, Mail Code 151,4500 South Lancaster Rd, Dallas, TX 75235 USA.	Amyn.Habib@UTSouthwestern.edu	Boothman, David/Q-7776-2019		NIH [RO1N5062080, RO1 CA139217]; National Institutes of Health [RO1 CA149461, R01-DK63621, R01-CA134571]; National Aeronautics and Space Administration [NNX13AI13G]; Cancer Prevention and Research Institute of Texas [RP100644]; Office of Medical Research, Departments of Veterans Affairs (RFS); NATIONAL CANCER INSTITUTE [R01CA139217, R01CA149461, R01CA134571, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; Office of Medical Research, Departments of Veterans Affairs (RFS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grant RO1N5062080 to AAH and by RO1 CA139217 to DAB. SB is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX13AI13G) and the Cancer Prevention and Research Institute of Texas (RP100644). This work was also supported by the Office of Medical Research, Departments of Veterans Affairs (RFS) and the National Institutes of Health (R01-DK63621, R01-CA134571 to RFS).	Abounader R, 2001, FASEB J, V15, P108, DOI 10.1096/fj.01-0421fje; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chumbalkar V, 2011, J PROTEOME RES, V10, P1343, DOI 10.1021/pr101075e; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Garnett J, 2013, NEOPLASIA, V15, P73, DOI 10.1593/neo.121536; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jiwani AJ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-53; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Karpel-Massler G, 2009, MOL CANCER RES, V7, P1000, DOI 10.1158/1541-7786.MCR-08-0479; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li L, 2014, ONCOGENE, V33, P4253, DOI 10.1038/onc.2013.400; Lorimer IAJ, 2002, CURR CANCER DRUG TAR, V2, P91, DOI 10.2174/1568009023333926; Luwor RB, 2004, ONCOGENE, V23, P6095, DOI 10.1038/sj.onc.1207870; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Puliyappadamba VT, 2013, CELL REP, V4, P764, DOI 10.1016/j.celrep.2013.07.025; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xu L, 2010, ONCOGENE, V29, P2616, DOI 10.1038/onc.2010.16; Zhang Y, 2013, CLIN CANCER RES, V19, P1433, DOI 10.1158/1078-0432.CCR-12-2832; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	33	37	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					129	134		10.1038/onc.2013.534	http://dx.doi.org/10.1038/onc.2013.534			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24362532	Green Accepted			2022-12-25	WOS:000349740100012
J	Han, J; Hou, W; Goldstein, LA; Stolz, DB; Watkins, SC; Rabinowich, H				Han, Jie; Hou, Wen; Goldstein, Leslie A.; Stolz, Donna B.; Watkins, Simon C.; Rabinowich, Hannah			A Complex between Atg7 and Caspase-9 A NOVEL MECHANISM OF CROSS-REGULATION BETWEEN AUTOPHAGY AND APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Caspase; Cell Death; Cellular Regulation	MEDIATED CLEAVAGE; CELL-DEATH; IN-VITRO; BECLIN 1; ACTIVATION; TRAIL; PATHWAY; DEGRADATION; INVOLVEMENT; MODULATION	Background: Several cross-talk mechanisms between autophagy and apoptosis have been identified, where the same protein plays a central role in the opposing processes. Results: This study identified a novel cross-talk mechanism involving an Atg7caspase-9 complex. Conclusion: Atg7 and caspase-9 mutually regulate each other's activity. Significance: The Atg7caspase-9 complex may determine the balance between autophagy and apoptosis in response to stress. Several cross-talk mechanisms between autophagy and apoptosis have been identified, in which certain co-regulators are shared, allowing the same protein to participate in these opposing processes. Our studies suggest that caspase-9 is a novel co-regulator of apoptosis and autophagy and that its caspase catalytic activity is dispensable for its autophagic role. We provide evidence that caspase-9 facilitates the early events leading to autophagosome formation; that it forms a complex with Atg7; that Atg7 is not a direct substrate for caspase-9 proteolytic activity; and that, depending on the cellular context, Atg7 represses the apoptotic capability of caspase-9, whereas the latter enhances the Atg7-mediated formation of light chain 3-II. The repression of caspase-9 apoptotic activity is mediated by its direct interaction with Atg7, and it is not related to the autophagic function of Atg7. We propose that the Atg7caspase-9 complex performs a dual function of linking caspase-9 to the autophagic process while keeping in check its apoptotic activity.	[Han, Jie; Hou, Wen; Goldstein, Leslie A.; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17c,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA134776]; Department of Defense [W81XWH-12-1-0228]; Pennsylvania Breast and Cervical Cancer Research Initiative; NATIONAL CANCER INSTITUTE [R01CA134776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Pennsylvania Breast and Cervical Cancer Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA134776. This work was also supported by Department of Defense Grant W81XWH-12-1-0228 and the Pennsylvania Breast and Cervical Cancer Research Initiative (to H. R.).	Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hou W, 2008, AUTOPHAGY, V4, P940, DOI 10.4161/auto.6769; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Hu Q, 2013, J BIOL CHEM, V288, P15142, DOI 10.1074/jbc.M112.441568; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Jeong HS, 2011, BBA-MOL CELL RES, V1813, P80, DOI 10.1016/j.bbamcr.2010.09.016; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li H, 2011, CANCER RES, V71, P3625, DOI 10.1158/0008-5472.CAN-10-4475; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; White EJ, 2011, AM J CANCER RES, V1, P362; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	61	69	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6485	6497		10.1074/jbc.M113.536854	http://dx.doi.org/10.1074/jbc.M113.536854			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24362031	Green Published, hybrid			2022-12-25	WOS:000332389400016
J	Chaturvedi, R; Singha, PK; Dey, S				Chaturvedi, Ratna; Singha, Prajjal Kanti; Dey, Satyahari			Water Soluble Bioactives of Nacre Mediate Antioxidant Activity and Osteoblast Differentiation	PLOS ONE			English	Article							PINCTADA-MAXIMA; MATRIX PROTEIN; PEARL OYSTER; ORGANIC MATRIX; OXIDATIVE STRESS; BONE-FORMATION; IMPLANTS; STIMULATION; EVOLUTION; FRACTION	The water soluble matrix of nacre is a proven osteoinductive material. In spite of the differences in the biomolecular compositions of nacre obtained from multiple species of oysters, the common biochemical properties of those principles substantiate their biological activity. However, the mechanism by which nacre stimulates bone differentiation remains largely unknown. Since the positive impact of antioxidants on bone metabolism is well acknowledged, in this study we investigated the antioxidant potential of a water soluble matrix (WSM) obtained from the nacre of the marine oyster Pinctada fucata, which could regulate its osteoblast differentiation activity. Enhanced levels of ALP activity observed in pre-osteoblast cells upon treatment with WSM, suggested the induction of bone differentiation events. Furthermore, bone nodule formation and up-regulation of bone differentiation marker transcripts, i.e. collagen type-1 and osteocalcin by WSM confirmed its ability to induce differentiation of the preosteoblasts into mature osteoblasts. Remarkably, same WSM fraction upon pre-treatment lowered the H2O2 and UV-B induced oxidative damages in keratinocytes, thus indicating the antioxidant potential of WSM. This was further confirmed from the in vitro scavenging of ABTS and DPPH free radicals and inhibition of lipid peroxidation by WSM. Together, these results indicate that WSM poses both antioxidant potential and osteoblast differentiation property. Thus, bioactivities associated with nacre holds potential in the development of therapeutics for bone regeneration and against oxidative stress induced damages in cells.	[Chaturvedi, Ratna; Dey, Satyahari] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Singha, Prajjal Kanti] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Texas System; University of Texas Health San Antonio	Chaturvedi, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	ratna.ch@gmail.com	Chaturvedi, Ratna/B-1570-2015	Chaturvedi, Ratna/0000-0002-4979-9525	Ministry of Human Resource Development (MHRD); IIT Kharagpur, India	Ministry of Human Resource Development (MHRD)(Ministry of Human Resource Development (MHRD), Government of India); IIT Kharagpur, India	Ministry of Human Resource Development (MHRD) and IIT Kharagpur, India, provided fellowship to carry out the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1; Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao G, 1996, Zhongguo Zhong Yao Za Zhi, V21, P635; Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236; Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; Furuhashi T, 2010, COMP BIOCHEM PHYS B, V155, P195, DOI 10.1016/j.cbpb.2009.11.007; GU WZ, 1988, J TRADIT CHIN MED, V8, P247; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098; Kroger N, 2009, SCIENCE, V325, P1351, DOI 10.1126/science.1177055; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2; Lee K, 2012, MOL BIOL REP, V39, P3211, DOI 10.1007/s11033-011-1088-4; Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5; Liu YC, 2006, FISHERIES SCI, V72, P388, DOI 10.1111/j.1444-2906.2006.01161.x; Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marie B, 2009, MATER RES SOC SYMP P, V1187, P3; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miyamoto H, 2013, ZOOL SCI, V30, P801, DOI 10.2108/zsj.30.801; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Noguchi T, 2007, FISHERIES SCI, V73, P1177, DOI 10.1111/j.1444-2906.2007.01450.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parhami F, 2003, PROSTAG LEUKOTR ESS, V68, P373, DOI 10.1016/S0952-3278(03)00061-9; Parhami F, 2000, ARTERIOSCL THROM VAS, V20, P2346, DOI 10.1161/01.ATV.20.11.2346; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809; SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; TAN W, 1988, SENOIR MED J, V8, P109; Torita A, 2007, FISHERIES SCI, V73, P1388, DOI 10.1111/j.1444-2906.2007.01482.x; WANG D, 1994, CHINESE HERBAL MED, V25, P203; Wang Jian-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P220; Wang Jian-jun, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1838; Wang XY, 2011, COMP BIOCHEM PHYS B, V158, P173, DOI 10.1016/j.cbpb.2010.11.004; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wu YY, 2013, J FUNCT FOODS, V5, P527, DOI 10.1016/j.jff.2013.01.016; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6; ZHOU Y, 2007, COMP BIOCH PHYSL B, V148, P158	65	33	36	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84584	10.1371/journal.pone.0084584	http://dx.doi.org/10.1371/journal.pone.0084584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367677	Green Submitted, gold, Green Published			2022-12-25	WOS:000328741900056
J	Hassaballah, AI; Hassan, MA; Mardi, AN; Hamdi, M				Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd			An Inverse Finite Element Method for Determining the Tissue Compressibility of Human Left Ventricular Wall during the Cardiac Cycle	PLOS ONE			English	Article							RAPID FILLING PHASE; MYOCARDIAL STIFFNESS; FIBER; ARCHITECTURE; MODEL; CONTRACTION; MUSCLE; HEART	The determination of the myocardium's tissue properties is important in constructing functional finite element (FE) models of the human heart. To obtain accurate properties especially for functional modeling of a heart, tissue properties have to be determined in vivo. At present, there are only few in vivo methods that can be applied to characterize the internal myocardium tissue mechanics. This work introduced and evaluated an FE inverse method to determine the myocardial tissue compressibility. Specifically, it combined an inverse FE method with the experimentally-measured left ventricular (LV) internal cavity pressure and volume versus time curves. Results indicated that the FE inverse method showed good correlation between LV repolarization and the variations in the myocardium tissue bulk modulus K (K = 1/compressibility), as well as provided an ability to describe in vivo human myocardium material behavior. The myocardium bulk modulus can be effectively used as a diagnostic tool of the heart ejection fraction. The model developed is proved to be robust and efficient. It offers a new perspective and means to the study of living-myocardium tissue properties, as it shows the variation of the bulk modulus throughout the cardiac cycle.	[Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia; [Hassaballah, Abdallah I.; Hassan, Mohsen A.; Mardi, Azizi N.; Hamdi, Mohd] Univ Malaya, Fac Engn, Ctr Adv Mfg & Mat Proc, Kuala Lumpur, Malaysia; [Hassan, Mohsen A.] Assiut Univ, Fac Engn, Dept Mech Engn, Assiut, Egypt	Universiti Malaya; Universiti Malaya; Egyptian Knowledge Bank (EKB); Assiut University	Hassaballah, AI (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia.	abdallahhassaballah@yahoo.com	Hassan, Mohsen A./J-9534-2012; Hassaballah, Abdallah/B-8467-2014; Abd Shukor, Mohd Hamdi/B-9093-2010	Hassan, Mohsen A./0000-0001-8599-7732; Abd Shukor, Mohd Hamdi/0000-0003-2123-3041; Hasaballa, Abdallah/0000-0003-4579-9576	Ministry of Higher Education, Malaysia [HIR-MOHE-D000001-16001]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was supported by the High Impact Research (HIR) Grant (HIR-MOHE-D000001-16001) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002369; Augenstein KF, 2006, LECT NOTES COMPUT SC, V4190, P628; Bagnoli P, 2011, INT J ARTIF ORGANS, V34, P44, DOI 10.5301/IJAO.2011.6313; Balaraman K, 2006, 010252 SAE; Bettendorff-Bakman DE, 2008, J THEOR BIOL, V250, P581, DOI 10.1016/j.jtbi.2007.10.033; Bettendorff-Bakman DE, 2006, J THEOR BIOL, V238, P303, DOI 10.1016/j.jtbi.2005.05.009; Chen JJ, 2005, AM J PHYSIOL-HEART C, V289, pH1898, DOI 10.1152/ajpheart.00041.2005; Courneya CAM, 2010, CARDIOVASCULAR PHYSL; Dent CL, 2000, ULTRASOUND MED BIOL, V26, P375, DOI 10.1016/S0301-5629(99)00144-1; Dorri F., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P319, DOI 10.1080/10255840600960546; Eriksson T, 2013, MATH MECH SOLIDS; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Evans S, 2012, COMPUT METHOD BIOMEC, V15, P1, DOI 10.1080/10255842.2012.650321; Fung YC, 1994, J BIOMECH ENG-T ASME, V61, P1007, DOI [10.1115/1.2901550, DOI 10.1115/1.2901550]; Hall J. E., 2011, GUYTON HALL TXB MED; Hassaballah AIM, 2013, J APPL MATH IN PRESS; Hassan MA, 2012, J MECH BEHAV BIOMED, V5, P99, DOI 10.1016/j.jmbbm.2011.08.011; Helm P, 2005, ANN NY ACAD SCI, V1047, P296, DOI 10.1196/annals.1341.026; Kerckhoffs RCP, 2003, ANN BIOMED ENG, V31, P536, DOI 10.1114/1.1566447; Kerckhoffs RCP, 2012, MECH RES COMMUN, V42, P40, DOI 10.1016/j.mechrescom.2011.11.004; Klabunde R., 2011, CARDIOVASCULAR PHYSL; Kohl P, 2011, CARDIAC MECHANOELECT; Kolipaka A, 2010, MAGN RESON MED, V64, P862, DOI 10.1002/mrm.22467; Kroon W, 2007, LECT NOTES COMPUT SC, V4466, P340, DOI 10.1007/978-3-540-72907-5_35; Le Rolle V, 2008, ARTIF INTELL MED, V44, P201, DOI 10.1016/j.artmed.2008.06.001; Lee LC, 2013, J APPL PHYSL; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Lombaert H, 2012, IEEE T MED IMAGING, V31, P1436, DOI 10.1109/TMI.2012.2192743; Lombaert H, 2011, LECT NOTES COMPUT SC, V6666, P171, DOI 10.1007/978-3-642-21028-0_22; Marchesseau S, 2012, J MECH BEHAV BIOMEDI; Martina JR, 2013, ARTIFICIAL ORGANS; Masugata H, 2000, CLIN CARDIOL, V23, P115, DOI 10.1002/clc.4960230209; Niederer SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000371; Perie D, 2013, BMC CARDIOVASC DISOR, V13, P1; Rohmer D, 2006, RECONSTRUCTION VISUA; Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030; Shim J, 2012, J BIOMECH, V45, P832, DOI 10.1016/j.jbiomech.2011.11.024; Stevens C, 2003, J BIOMECH, V36, P737, DOI 10.1016/S0021-9290(02)00452-9; Stouffer G, 2011, CARDIOVASCULAR HEMOD; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301; Veress AI, 2005, MEASUREMENT STRAIN L; Wang VY, 2009, MED IMAGE ANAL, V13, P773, DOI 10.1016/j.media.2009.07.006; Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772; Xu ZH, 2010, ACTA MATER, V58, P5972, DOI 10.1016/j.actamat.2010.07.013; Yettram AL, 1998, MED ENG PHYS, V20, P103, DOI 10.1016/S1350-4533(98)00009-5; Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864, DOI 10.1152/ajpheart.1996.271.5.H1864; Zenker S, 2007, PLOS COMPUT BIOL, V3, P2072, DOI 10.1371/journal.pcbi.0030204; Zhong L, 2007, J MECH MED BIOL, V7, P107, DOI 10.1142/S0219519407002182	49	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82703	10.1371/journal.pone.0082703	http://dx.doi.org/10.1371/journal.pone.0082703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367544	gold, Green Submitted, Green Published			2022-12-25	WOS:000328741900011
J	Lata, S; Ronsard, L; Sood, V; Dar, SA; Ramachandran, VG; Das, S; Banerjea, AC				Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla; Banerjea, Akhil C.			Effect on HIV-1 Gene Expression, Tat-Vpr Interaction and Cell Apoptosis by Natural Variants of HIV-1 Tat Exon 1 and Vpr from Northern India	PLOS ONE			English	Article							VIRUS TYPE-1 VPR; FUNCTIONAL-CHARACTERIZATION; SUBTYPE-B; T-CELLS; PROTEIN; RECOMBINATION; RNA; STRAINS; CYCLE; TRANSACTIVATION	Background: Since HIV-1 Tat and Vpr genes are involved in promoter transactivation, apoptosis, etc, we carried out studies to find out nature and extent of natural variation in the two genes from seropositive patients from Northern India and determined their functional implications. Methods: HIV-1 tat exon 1 and vpr were amplified from the genomic DNA isolated from the blood of HIV-1 infected individuals using specific primers by Polymerase Chain reaction (PCR) and subjected to extensive genetic analysis (CLUSTAL W, Simplot etc). Their expression was monitored by generating myc fusion clones. Tat exon 1 and Vpr variants were co-transfected with the reporter gene construct (LTR-luc) and their transactivation potential was monitored by measuring luciferase activity. Apoptosis and cell cycle analysis was done by Propidium Iodide (PI) staining followed by FACS. Results: Exon 1 of tat was amplified from 21 samples and vpr was amplified from 16 samples. One of the Tat exon 1 variants showed phylogenetic relatedness to subtype B & C and turned out to be a unique recombinant. Two of the Vpr variants were B/C/D recombinants. These natural variations were found to have no impact on the stability of Tat and Vpr. These variants differed in their ability to transactivate B LTR and C LTR promoters. B/C recombinant Tat showed better cooperative interaction with Vpr. B/C/D recombination in Vpr was found to have no effect on its co-operativity with Tat. Recombinant Tat (B/C) induced more apoptosis than wild type B and C Tat. The B/C/D recombination in Vpr did not affect its G2 arrest induction potential but reduced its apoptosis induction ability. Conclusions: Extensive sequence and region-specific variations were observed in Tat and Vpr genes from HIV-1 infected individuals from Northern India. These variations have functional implications & therefore important for the pathogenicity of virus.	[Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla] Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India; [Lata, Sneh; Ronsard, Larance; Sood, Vikas; Dar, Sajad A.; Ramachandran, Vishnampettai G.; Das, Shukla] Guru Teg Bahadur Hosp, Delhi 110095, India; [Ronsard, Larance; Sood, Vikas; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi 110067, India	University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ramachandran, VG (corresponding author), Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India.	rama_88@yahoo.com; akhil@nii.res.in	Ronsard, Larance/H-2731-2019; Dar, Sajad Ahmad/L-1065-2019; Sood, Vikas/HDM-3074-2022	Ronsard, Larance/0000-0002-5307-1940; Dar, Sajad Ahmad/0000-0003-2499-8701; 	Council of Scientific and Industrial Research, New Delhi, India; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This study was supported by Council of Scientific and Industrial Research, New Delhi, India and Indian Council of Medical Research (HIV/50/142/9/2011-ECD), Government of India, to the corresponding author, National Institute of Immunology, New Delhi, India for the period of 3 years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Chiu YL, 2002, MOL CELL, V10, P585, DOI 10.1016/S1097-2765(02)00630-5; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Dey SS, 2012, J BIOL CHEM, V287, P7945, DOI 10.1074/jbc.M111.302653; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; Fang ZM, 2010, AIDS RES HUM RETROV, V26, P359, DOI 10.1089/aid.2009.0192; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; GOLOVKINA TV, 1994, J VIROL, V68, P5019, DOI 10.1128/JVI.68.8.5019-5026.1994; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jeang K., 1996, HUMAN RETROVIRUSES A, P3; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klostermeier D, 1997, BIOPHYS CHEM, V63, P87, DOI 10.1016/S0301-4622(96)02243-0; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kuiken C, 2000, HIV SEQUENCE COMPEND; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCloskey TW, 1997, J IMMUNOL, V158, P1014; Metzger AU, 1997, BIOCHEM BIOPH RES CO, V241, P31, DOI 10.1006/bbrc.1997.7770; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Neogi U, 2008, ARCH VIROL, V153, P1961, DOI 10.1007/s00705-008-0210-y; Neogi U, 2012, AIDS RES HUM RETROV, V28, P952, DOI [10.1089/aid.2011.0380, 10.1089/AID.2011.0380]; Neogi Ujjwal, 2009, AIDS Res Ther, V6, P28, DOI 10.1186/1742-6405-6-28; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Ott M, 1998, J IMMUNOL, V160, P2872; Ouyang YB, 2012, CURR HIV RES, V10, P151, DOI 10.2174/157016212799937236; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RAPPAPORT J, 1989, New Biologist, V1, P101; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Robertson DL, 1999, HUMAN RETROVIRUSES A, P492; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; RUBEN S, 1989, J VIROL, V63, P1; SADAIE MR, 1988, P NATL ACAD SCI USA, V85, P9224, DOI 10.1073/pnas.85.23.9224; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; SEIGEL LJ, 1986, VIROLOGY, V148, P226, DOI 10.1016/0042-6822(86)90419-8; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; SODROSKI J, 1985, SCIENCE, V227, P171, DOI 10.1126/science.2981427; Sorgel S, 2012, VIROLOGY, V432, P444, DOI 10.1016/j.virol.2012.06.027; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; TUMAS KM, 1993, VIROLOGY, V192, P587, DOI 10.1006/viro.1993.1075; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verhoef K, 1999, J VIROL, V73, P2781, DOI 10.1128/JVI.73.4.2781-2789.1999; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82128	10.1371/journal.pone.0082128	http://dx.doi.org/10.1371/journal.pone.0082128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367500	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900006
J	Pence, BW; Whetten, K; Shirey, KG; Yao, J; Thielman, NM; Whetten, R; Itemba, D; Maro, V				Pence, Brian W.; Whetten, Kathryn; Shirey, Kristen G.; Yao, Jia; Thielman, Nathan M.; Whetten, Rachel; Itemba, Dafrosa; Maro, Venance			Factors Associated with Change in Sexual Transmission Risk Behavior over 3 Years among HIV-Infected Patients in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INCONSISTENT CONDOM USE; MALE CIRCUMCISION TRIAL; TRAUMATIC LIFE EVENTS; HOUSEHOLD DYSFUNCTION; GENDER-DIFFERENCES; CHILDHOOD ABUSE; HEALTH-STATUS; DEPRESSION; WOMEN	Background: The reduction of HIV transmission risk behaviors among those infected with HIV remains a major global health priority. Psychosocial characteristics have proven to be important correlates of sexual transmission risk behaviors in high-income countries, but little attention has focused on the influence of psychosocial and psychological factors on sexual transmission risk behaviors in African cohorts. Methodology and Principal Findings: The CHAT Study enrolled a representative sample of 499 HIV-infected patients in established HIV care and 267 newly diagnosed HIV-infected individuals from the Kilimanjaro Region of Tanzania. Participants completed in-person interviews every 6 months for 3 years. Using logistic random effects models to account for repeated observations, we assessed sociodemographic, physical health, and psychosocial predictors of self-reported unprotected sexual intercourse. Among established patients, the proportion reporting any recent unprotected sex was stable, ranging between 6-13% over 3 years. Among newly diagnosed patients, the proportion reporting any unprotected sex dropped from 43% at baseline to 11-21% at 6-36 months. In multivariable models, higher odds of reported unprotected sex was associated with female gender, younger age, being married, better physical health, and greater post-traumatic stress symptoms. In addition, within-individual changes in post-traumatic stress over time coincided with increases in unprotected sex. Conclusions and Significance: Changes in post-traumatic stress symptomatology were associated with changes in sexual transmission risk behaviors in this sample of HIV-infected adults in Tanzania, suggesting the importance of investing in appropriate mental health screening and intervention services for HIV-infected patients, both to improve mental health and to support secondary prevention efforts.	[Pence, Brian W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Whetten, Kathryn; Shirey, Kristen G.; Yao, Jia; Whetten, Rachel] Duke Univ, Ctr Hlth Policy & Inequal Res, Duke Global Hlth Inst, Sanford Sch Publ Policy, Durham, NC USA; [Shirey, Kristen G.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Duke Global Hlth Inst, Durham, NC USA; [Thielman, Nathan M.] Duke Univ, Dept Med, Div Infect Dis, Duke Global Hlth Inst, Durham, NC USA; [Itemba, Dafrosa] Tanzania Women Res Fdn, Moshi, Tanzania; [Maro, Venance] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Pence, BW (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	bpence@aya.yale.edu; k.whetten@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	National Institute of Mental Health [5R01MH078756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078756] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant 5R01MH078756 from the National Institute of Mental Health (www.nimh.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; [Anonymous], 2012, GLOB REP UNAIDS REP; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogart LM, 2005, AIDS BEHAV, V9, P325, DOI 10.1007/s10461-005-9006-1; Boone MR, 2013, AIDS BEHAV, V17, P1883, DOI 10.1007/s10461-012-0167-4; Chuang CH, 2006, AIDS BEHAV, V10, P201, DOI 10.1007/s10461-005-9046-6; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Deribe Kebede, 2009, East Afr J Public Health, V6, P248; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fox JE, 2012, PUBLIC HEALTH REP, V127, P5, DOI 10.1177/00333549121270S203; Galvan FH, 2004, AIDS BEHAV, V8, P441, DOI 10.1007/s10461-004-7328-z; Hamburger ME, 2004, AIDS BEHAV, V8, P333, DOI 10.1023/B:AIBE.0000044080.04397.97; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kalichman SC, 2008, PSYCHOSOM MED, V70, P593, DOI 10.1097/PSY.0b013e3181773bce; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; KILPATRICK DG, 1993, POSTTRAUMATIC STRESS; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Leserman J, 1997, PSYCHOSOM MED, V59, P152, DOI 10.1097/00006842-199703000-00007; Leserman J, 2008, AIDS PATIENT CARE ST, V22, P403, DOI 10.1089/apc.2007.0175; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Matovu JKB, 2007, REPROD HEALTH MATTER, V15, P68, DOI 10.1016/S0968-8080(07)29306-1; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Myers HF, 2006, AIDS BEHAV, V10, P191, DOI 10.1007/s10461-005-9054-6; Nakimuli-Mpungu E, 2011, AIDS BEHAV; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; NIH, 2012, RFAMH13040 NIH; O'Cleirigh C, 2012, JAIDS-J ACQ IMM DEF, V59, P331, DOI 10.1097/QAI.0b013e31824aed80; Pence BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036304; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Pence BW, 2010, PSYCHOSOM MED, V72, P720, DOI 10.1097/PSY.0b013e3181e9eef3; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reisner SL, 2009, AIDS CARE, V21, P1481, DOI 10.1080/09540120902893258; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sikkema KJ, 2008, JAIDS-J ACQ IMM DEF, V47, P506, DOI 10.1097/QAI.0b013e318160d727; Sikkema KJ, 2011, JAIDS-J ACQ IMM DEF, V57, P230, DOI 10.1097/QAI.0b013e3182167e7a; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Walusaga HA, 2012, AIDS PATIENT CARE ST, V26, P694, DOI 10.1089/apc.2012.0208; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Weathers FW, 1996, MEASUREMENT STRESS T; Weiss NH, 2013, AIDS CARE; Wong FY, 2008, AIDS EDUC PREV, V20, P56, DOI 10.1521/aeap.2008.20.1.56; Wyatt GE, 2004, AIDS BEHAV, V8, P453, DOI 10.1007/s10461-004-7329-y	57	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82974	10.1371/journal.pone.0082974	http://dx.doi.org/10.1371/journal.pone.0082974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367575	gold, Green Published			2022-12-25	WOS:000328740300086
J	Wu, C; Huang, R; Chen, JJ; Gu, Q; Zhu, B; Wang, J; Zhang, K; Chen, QJ; Xiong, CC; Liu, Y; Li, JQ; Zhou, YH; Ding, YT				Wu, Chao; Huang, Rui; Chen, Jianjun; Gu, Qin; Zhu, Bin; Wang, Jun; Zhang, Kui; Chen, Quanjiao; Xiong, Chaochao; Liu, Yong; Li, Jiequan; Zhou, Yi-Hua; Ding, Yitao			Avian Influenza A(H7N9) Virus Screening in Patients with Fever and Flu-Like Symptoms in a Tertiary Hospital in an Area with Confirmed Cases	PLOS ONE			English	Article							A H7N9 VIRUS	Novel avian influenza A(H7N9) virus was isolated in fatal patients in Yangtze River Delta of China in March 2013. We aimed to screen the virus in febrile patients in a tertiary hospital in an area with confirmed cases. Throat-swab specimens collected from consecutive patients with fever (>= 38 degrees C) and flu-like symptoms from April 15 to April 25, 2013 were subjected to detect novel avian influenza A(H7N9) virus with real-time PCR. The clinical outcomes in the patients and close contacts were followed up. Of total 200 patients screened, one (0.5%) was positive for avian influenza A(H7N9) virus and 199 others were negative. The infected patient experienced respiratory failure and had diffuse infiltrates in the right lower lobe in chest CT images. He received symptomatic and antibacterial treatments as well as oseltamivir. His condition was substantially improved within three days after admission; avian influenza A(H7N9) virus was not detected after 5 days' antiviral therapy. The hemagglutinin inhibition test showed that the serum titers against avian influenza A(H7N9) virus increased from <1:20 at the early phase to 1:80 at the convalescent phase. Follow-up of 23 close contacts showed that none of them developed fever and other symptoms within two weeks. Our findings suggest that although the infection rate of avian influenza A(H7N9) virus in patients with fever and flu-like symptoms is rare, the screening is valuable to rapidly define the infection, which will be critical to improve the clinical outcomes.	[Wu, Chao; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Rui] Nanjing Univ Chinese Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jianjun; Chen, Quanjiao; Xiong, Chaochao] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Gu, Qin] Nanjing Univ, Sch Med, Dept Intens Care Units, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Bin] Nanjing Univ, Sch Med, Dept Radiol, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Jun] Nanjing Univ, Sch Med, Dept Emergency Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Kui; Liu, Yong; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jiequan] Nanjing Municipal Ctr Dis Control, Nanjing, Jiangsu, Peoples R China; [Liu, Yong; Zhou, Yi-Hua; Ding, Yitao] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Ding, YT (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	dtchaowu@126.com	liu, yong/AAD-1467-2019; Liu, Yong/GWQ-6163-2022; Wu, Chao/H-3195-2019	Xiong, Chaochao/0000-0003-3506-6117	Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154]; Jiangsu Science and Technology Department [BL2012034]	Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Science and Technology Department	This study was supported by Jiangsu Province's Outstanding Medical Academic Leader Program (No. LJ201154) and a Special Grant from Jiangsu Science and Technology Department (No. BL2012034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai Cheng-liang, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P443; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen JJ, 2009, VIRUS RES, V146, P19, DOI 10.1016/j.virusres.2009.08.010; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073362; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hsieh SM, 2013, J INFECTION, V67, P494, DOI 10.1016/j.jinf.2013.08.003; Lo YC, 2013, EUROSURVEILLANCE, V18, P2; Wang Y, 2013, AM J RESP CRIT CARE, V188, P115, DOI 10.1164/rccm.201305-0936LE; WHO, 2013, HUM INF AV INFL A H7; World Health Organization, 2013, INT WHO SURV REC HUM; Xie L, 2013, EUR J CLIN MICROBIOL; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Zheng LY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-17; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	17	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82613	10.1371/journal.pone.0082613	http://dx.doi.org/10.1371/journal.pone.0082613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367529	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300045
J	Abelson, S; Shamai, Y; Berger, L; Skorecki, K; Tzukerman, M				Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl; Tzukerman, Maty			Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations	PLOS ONE			English	Article							CLEAR-CELL; CLINICOPATHOLOGICAL ANALYSIS; TUMOR MICROENVIRONMENT; CARCINOMA; PLASTICITY; FIBROBLASTS; METHYLATION; EVOLUTION; HALLMARKS; MARKER	Intratumoral heterogeneity challenges existing paradigms for anti-cancer therapy. We have previously demonstrated that the human embryonic stem cells (hESC)-derived cellular microenvironment in immunocompromised mice, enables functional distinction of heterogeneous tumor cells, including cells which do not grow into a tumor in a conventional direct tumor xenograft platform. We have identified and characterized six cancer cell subpopulations each clonally expanded from a single cell, derived from human ovarian clear cell carcinoma of a single tumor, to demonstrate striking intratumoral phenotypic heterogeneity that is dynamically dependent on the tumor growth microenvironment. These cancer cell subpopulations, characterized as cancer stem cell subpopulations, faithfully recapitulate the full spectrum of histological phenotypic heterogeneity known for human ovarian clear cell carcinoma. Each of the six subpopulations displays a different level of morphologic and tumorigenic differentiation wherein growth in the hESC-derived microenvironment favors growth of CD44+/aldehyde dehydrogenase positive pockets of self-renewing cells that sustain tumor growth through a process of tumorigenic differentiation into CD44-/aldehyde dehydrogenase negative derivatives. Strikingly, these derivative cells display microenvironment-dependent plasticity with the capacity to restore self-renewal markers and CD44 expression. In the current study, we delineate the distinct gene expression and epigenetic profiles of two such subpopulations, representing extremes of phenotypic heterogeneity in terms of niche-dependent self-renewal and tumorigenic differentiation. By combining Gene Set Enrichment, Gene Ontology and Pathway-focused array analyses with methylation status, we propose a suite of robust differences in tumor self-renewal and differentiation pathways that underlie the striking intratumoral phenotypic heterogeneity which characterize this and other solid tumor malignancies.	[Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl] Technion Israel Inst Technol, Rambam Med Ctr, Rappaport Fac Med, Haifa, Israel; [Abelson, Sagi; Shamai, Yeela; Berger, Liron; Skorecki, Karl] Technion Israel Inst Technol, Rambam Med Ctr, Res Inst, Haifa, Israel; [Skorecki, Karl; Tzukerman, Maty] Rambam Med Ctr, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	Skorecki, K (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Rappaport Fac Med, Haifa, Israel.	skorecki@techunix.technion.ac.il; bimaty@techunix.technion.ac.il	Abelson, Sagi/ABG-3403-2021	Abelson, Sagi/0000-0003-1747-3819	Daniel M. Soref Charitable Trust; Skirball Foundation; Israel Science Foundation [453/06, 62/10]	Daniel M. Soref Charitable Trust; Skirball Foundation; Israel Science Foundation(Israel Science Foundation)	Finnancial support for this research was provided by the Daniel M. Soref Charitable Trust, the Skirball Foundation and by a research grant from the Israel Science Foundation (grant No. 453/06MT and grant No. 62/10 MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Berry NB, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-8; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Burgos-Ojeda D, 2013, CANCER RES, V73, P3555, DOI 10.1158/0008-5472.CAN-12-2845; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; CZERNOBILSKY B, 1970, CANCER-AM CANCER SOC, V25, P762, DOI 10.1002/1097-0142(197004)25:4<762::AID-CNCR2820250404>3.0.CO;2-3; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeLair D, 2011, AM J SURG PATHOL, V35, P36, DOI 10.1097/PAS.0b013e3181ff400e; Ebben JD, 2010, EXPERT OPIN THER TAR, V14, P621, DOI 10.1517/14712598.2010.485186; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Folkman J, 2004, CANCER BIOL THER, V3, P338, DOI 10.4161/cbt.3.3.708; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YL, 2011, DIGEST DIS SCI, V56, P681, DOI 10.1007/s10620-010-1369-0; Jamil S, 2013, INT J ONCOL, V43, P831, DOI 10.3892/ijo.2013.2014; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lucci A, 1998, ANTICANCER RES, V18, P475; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Medina V, 2009, CLIN TRANSL ONCOL, V11, P199, DOI 10.1007/s12094-009-0341-y; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; MONTAG AG, 1989, INT J GYNECOL PATHOL, V8, P85, DOI 10.1097/00004347-198906000-00001; Nishimura K, 2012, PATHOBIOLOGY, V79, P290, DOI 10.1159/000337296; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Ringel MD, 2002, J CLIN ENDOCR METAB, V87, P2399, DOI 10.1210/jc.87.5.2399; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schwartz DR, 2002, CANCER RES, V62, P4722; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Tan DSP, 2007, J CLIN PATHOL, V60, P355, DOI 10.1136/jcp.2006.040030; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Tzukerman M, 2003, P NATL ACAD SCI USA, V100, P13507, DOI 10.1073/pnas.2235551100; van der Horst G, 2012, MOL CANCER RES, V10, P995, DOI 10.1158/1541-7786.MCR-12-0274; van Vlerken LE, 2012, J MOL MED, V90, P791, DOI 10.1007/s00109-012-0917-9; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; You A, 2011, J CANCER RES CLIN, V137, P621, DOI 10.1007/s00432-010-0916-6; Young LC, 2001, CLIN CANCER RES, V7, P1798; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	64	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83651	10.1371/journal.pone.0083651	http://dx.doi.org/10.1371/journal.pone.0083651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358304	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700068
J	Li, X; Chen, W; Zhang, L; Liu, WB; Fei, Z				Li, Xia; Chen, Wei; Zhang, Lei; Liu, Wen-bo; Fei, Zhou			Inhibition of Store-Operated Calcium Entry Attenuates MPP+-Induced Oxidative Stress via Preservation of Mitochondrial Function in PC12 Cells: Involvement of Homer1a	PLOS ONE			English	Article							MODEL; PROTECTS; ACTIVATION; APOPTOSIS; DISEASE; STIM1; NADH	The process of store-operated calcium entry (SOCE), whereby the release of intracellular Ca2+ from endoplasmic reticulum (ER) activates Ca2+ influx channels in the plasma membrane, has been demonstrated to impact a diverse range of cell functions. In the present study, we investigated the potential protective effect of SOCE inhibition against 1-methyl-4-phenylpyridinium (MPP+) injury by using pharmacological antagonists or specific small interfering RNA (siRNA) in PC12 cells. The results showed that both antagonists (15 mu M MRS-1845 and 50 mu M ML-9) and stromal interacting molecule-1 (STIM1) targeted siRNA (Si-STIM1) significantly increased cell viability, decreased apoptotic cell death and reduced intracellular reactive oxygen species (ROS) production and lipid peroxidation in MPP+ injured PC12 cells. SOCE inhibition also prevented MPP+ induced mitochondrial dysfunction and activation of mitochondrial related apoptotic factors, while had no effect on mitochondrial biogenesis. Moreover, inhibition of SOCE by antagonists and siRNA increased the expression levels of Homer1a mRNA and protein, and knockdown of Homer1a expression by specific siRNA partly reversed the protective effects induced by SOCE inhibition in PC12 cells. All these results indicated that SOCE inhibition protected PC12 cells against MPP+ insult through upregulation of Homer1a expression, and SOCE might be an ideal target for investigating therapeutic strategy against neuronal injury in PD patients.	[Li, Xia; Zhang, Lei; Liu, Wen-bo; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Chen, Wei] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	fmmuzhoufei@163.com			National Natural Science Foundation of China [30930093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 30930093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Ding F, 2012, APOPTOSIS, V17, P579, DOI 10.1007/s10495-012-0708-3; Esteves AR, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/693761; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; GARCIAGARCIA A, 2013, TOXICOL SCI; Henke N, 2012, J BIOL CHEM, V287, P42042, DOI 10.1074/jbc.M112.417212; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Jellinger KA, 2001, ADV NEUROL, V86, P55; Kurosaki T, 2010, PROG BIOPHYS MOL BIO, V103, P51, DOI 10.1016/j.pbiomolbio.2010.02.004; Lee CS, 2005, NEUROCHEM INT, V46, P169, DOI 10.1016/j.neuint.2004.07.007; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Lynch D, 2008, MITOCHONDRION, V8, P109, DOI 10.1016/j.mito.2007.09.002; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Ryazantseva M, 2013, BIOCHIMIE, V95, P1506, DOI 10.1016/j.biochi.2013.04.009; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Song XY, 2013, NEUROSCIENCE, V242, P28, DOI 10.1016/j.neuroscience.2013.02.049; Steinbeck JA, 2011, EXP NEUROL, V232, P185, DOI 10.1016/j.expneurol.2011.08.022; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Zeng X, 2013, NEUROSCI LETT, V543, P183, DOI 10.1016/j.neulet.2013.03.030; Zhang LL, 2012, FOOD CHEM TOXICOL, V50, P2591, DOI 10.1016/j.fct.2012.05.045	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83638	10.1371/journal.pone.0083638	http://dx.doi.org/10.1371/journal.pone.0083638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358303	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700067
J	Mannaerts, I; Schroyen, B; Verhulst, S; Van Lommel, L; Schuit, F; Nyssen, M; van Grunsven, LA				Mannaerts, Inge; Schroyen, Ben; Verhulst, Stefaan; Van Lommel, Leentje; Schuit, Frans; Nyssen, Marc; van Grunsven, Leo A.			Gene Expression Profiling of Early Hepatic Stellate Cell Activation Reveals a Role for Igfbp3 in Cell Migration	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; BREAST-CANCER CELLS; HISTONE DEACETYLASE INHIBITOR; LIVER FIBROSIS; VALPROIC ACID; EXTRACELLULAR-MATRIX; DISTINCT ROLES; IN-VITRO; GROWTH; INSULIN	Background: Scarring of the liver is the result of prolonged exposure to exogenous or endogenous stimuli. At the onset of fibrosis, quiescent hepatic stellate cells (HSCs) activate and transdifferentiate into matrix producing, myofibroblast-like cells. Aim and methods: To identify key players during early HSC activation, gene expression profiling was performed on primary mouse HSCs cultured for 4, 16 and 64 hours. Since valproic acid (VPA) can partly inhibit HSC activation, we included VPA-treated cells in the profiling experiments to facilitate this search. Results: Gene expression profiling confirmed early changes for known genes related to HSC activation such as alpha smooth muscle actin (Acta2), lysyl oxidase (Lox) and collagen, type I, alpha 1 (Col1a1). In addition we noticed that, although genes which are related to fibrosis change between 4 and 16 hours in culture, most gene expression changes occur between 16 and 64 hours. Insulin-like growth factor binding protein 3 (Igfbp3) was identified as a gene strongly affected by VPA treatment. During normal HSC activation Igfbp3 is up regulated and this can thus be prevented by VPA treatment in vitro and in vivo. siRNA-mediated silencing of Igfbp3 in primary mouse HSCs induced matrix metalloproteinase (Mmp) 9 mRNA expression and strongly reduced cell migration. The reduced cell migration after Igfbp3 knock-down could be overcome by tissue inhibitor of metalloproteinase (TIMP) 1 treatment. Conclusion: Igfbp3 is a marker for culture-activated HSCs and plays a role in HSC migration. VPA treatment prevents Igfbp3 transcription during activation of HSCs in vitro and in vivo.	[Mannaerts, Inge; Schroyen, Ben; Verhulst, Stefaan; van Grunsven, Leo A.] Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium; [Van Lommel, Leentje; Schuit, Frans] Dept Cellular & Mol Med, Louvain, Belgium; [Nyssen, Marc] Vrije Univ Brussel, Fac Med & Pharmacy, Dept Biostat & Med Informat, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium.	leo.van.grunsven@vub.ac.be	Verhulst, Stefaan/AAH-7603-2020; van Grunsven, Leo/E-5839-2010; Mannaerts, Inge/F-2181-2015; Mannaerts, Inge/AAC-5487-2019	Verhulst, Stefaan/0000-0001-6566-6071; van Grunsven, Leo/0000-0002-0990-7034; Mannaerts, Inge/0000-0002-2235-2555; Mannaerts, Inge/0000-0002-2235-2555	Vrije Universiteit Brussel [GOA48, GOA78]; Fund for Scientific Research, Flanders (FWO-V) [G.0260.09]; Institute for the Promotion of Innovation through Science and Technology in Flanders	Vrije Universiteit Brussel; Fund for Scientific Research, Flanders (FWO-V)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The work was funded by the Vrije Universiteit Brussel through GOA48 and GOA78 and by the Fund for Scientific Research, Flanders (FWO-V) G.0260.09 to LAvG. SV received a Ph.D. grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasic AM, 2012, EUR J ENDOCRINOL, V166, P121, DOI 10.1530/EJE-11-0778; Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; BALLARDINI G, 1983, LIVER, V3, P58; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Baumkotter F, 2012, EXP BRAIN RES, V217, P389, DOI 10.1007/s00221-011-2878-6; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; CENACCHI G, 1983, VIRCHOWS ARCH B, V43, P75, DOI 10.1007/BF02932946; Chang YZ, 2008, HEPATOB PANCREAT DIS, V7, P401; Chen X, 2013, FEBS J, V280, P855, DOI 10.1111/febs.12074; Collard TJ, 2003, CARCINOGENESIS, V24, P393, DOI 10.1093/carcin/24.3.393; CORTES VL, 2012, J CELLULAR PHYSL; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fudge NJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-15; Gentilini A, 1998, J CELL PHYSIOL, V174, P240; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Himoto T, 2013, NUTR RES, V33, P27, DOI 10.1016/j.nutres.2012.11.007; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Knittel T, 1999, HISTOCHEM CELL BIOL, V112, P387, DOI 10.1007/s004180050421; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V287, pG795, DOI 10.1152/ajpgi.00009.2004; Lee MH, 2008, TOXICOL APPL PHARM, V226, P271, DOI 10.1016/j.taap.2007.09.014; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lin WH, 2011, J BIOL CHEM, V286, P29540, DOI 10.1074/jbc.M111.263111; Liu ZN, 2011, J HEPATOL, V54, P132, DOI 10.1016/j.jhep.2010.06.020; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Martin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045844; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Ragland M, 2009, AM J EPIDEMIOL, V170, P1344, DOI 10.1093/aje/kwp288; Raja, 2007, Front Biosci, V12, P2849; Reiss MJ, 2010, SURGERY, V147, P295, DOI 10.1016/j.surg.2009.10.016; Roeb E, 2000, FASEB J, V14, P1671; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Scharf JG, 1998, HEPATOLOGY, V27, P1275, DOI 10.1002/hep.510270513; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; SCHROYEN B, 2012, EUR J GASTROENTEROL; Selinski S, 2012, ARCH TOXICOL, V86, P195, DOI 10.1007/s00204-011-0747-5; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tsubaki J, 2002, ENDOCRINOLOGY, V143, P1778, DOI 10.1210/en.143.5.1778; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; Xue SN, 2012, EXP DIABETES RES, DOI 10.1155/2012/494579; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yang C, 2009, J AM PODIAT MED ASSN, V99, P489, DOI 10.7547/0990489; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012	62	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84071	10.1371/journal.pone.0084071	http://dx.doi.org/10.1371/journal.pone.0084071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358328	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700077
J	Nicholas, KJ; Zern, EK; Barnett, L; Smith, RM; Lorey, SL; Copeland, CA; Sadagopal, S; Kalams, SA				Nicholas, Katherine J.; Zern, Emily K.; Barnett, Louise; Smith, Rita M.; Lorey, Shelly L.; Copeland, Courtney A.; Sadagopal, Shanmugalakshmi; Kalams, Spyros A.			B Cell Responses to HIV Antigen Are a Potent Correlate of Viremia in HIV-1 Infection and Improve with PD-1 Blockade	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; CD4(+) T-CELLS; ELEVATED FREQUENCIES; EXPRESSION; ACTIVATION; RESPONSIVENESS; PERTURBATIONS; PROLIFERATION; PROGRESSION; LYMPHOCYTE	Infection with Human Immunodeficiency Virus Type 1 (HIV-1) induces defects of both cellular and humoral immune responses. Impaired CD4+ T cell help and B cell dysfunction may partially explain the low frequency of broadly neutralizing antibodies in HIV-infected individuals. To understand the extent of B cell dysfunction during HIV infection, we assessed the level of B cell activation at baseline and after stimulation with a variety of antigens. Increased levels of viremia were associated with higher baseline expression of the activation marker CD86 on B cells and with decreased ability of B cells to increase expression of CD86 after in vitro stimulation with inactivated HIV-1. In a series of cell isolation experiments B cell responses to antigen were enhanced in the presence of autologous CD4+ T cells. HIV infected individuals had a higher frequency of PD-1 expression on B cells compared to HIV-subjects and PD-1 blockade improved B cell responsiveness to HIV antigen, suggesting that inhibitory molecule expression during HIV-1 infection may contribute to some of the observed B cell defects. Our findings demonstrate that during chronic HIV infection, B cells are activated and lose full capacity to respond to antigen, but suppression of inhibitory pressures as well as a robust CD4+ T cell response may help preserve B cell function.	[Nicholas, Katherine J.; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Zern, Emily K.; Barnett, Louise; Smith, Rita M.; Lorey, Shelly L.; Sadagopal, Shanmugalakshmi; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA; [Copeland, Courtney A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Kalams, SA (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	s.kalams@vanderbilt.edu			National Institutes of Health [SAK P01 AI78064, KJN T32 AI1089554]; NIH [P30 AI54999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI010895, P30AI042851, P30AI054999, P01AI078064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (SAK P01 AI78064 and KJN T32 AI1089554). Flow cytometric cell acquisition or sorting was performed by the Vanderbilt-Meharry Center for AIDS Research Immunopathogenesis Core, an NIH funded program (P30 AI54999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bussmann BM, 2010, VIROLOGY, V397, P7, DOI 10.1016/j.virol.2009.11.003; Conrad JA, 2012, J VIROL, V86, P4213, DOI 10.1128/JVI.06000-11; Conrad JA, 2011, J IMMUNOL, V186, P6871, DOI 10.4049/jimmunol.1004234; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Forster R, 1997, BLOOD, V90, P520, DOI 10.1182/blood.V90.2.520.520_520_525; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; PAHWA R, 1987, P NATL ACAD SCI USA, V84, P3826, DOI 10.1073/pnas.84.11.3826; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; STEINHOFF MC, 1991, NEW ENGL J MED, V325, P1837, DOI 10.1056/NEJM199112263252603; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Valdez H, 2000, AIDS, V14, P11, DOI 10.1097/00002030-200001070-00002; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Walker BD, 2011, NAT MED, V17, P1194, DOI 10.1038/nm.2529	44	27	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84185	10.1371/journal.pone.0084185	http://dx.doi.org/10.1371/journal.pone.0084185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358343	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700156
J	Silva, IN; Tavares, AC; Ferreira, AS; Moreira, LM				Silva, Ines N.; Tavares, Andreia C.; Ferreira, Ana S.; Moreira, Leonilde M.			Stress Conditions Triggering Mucoid Morphotype Variation in Burkholderia Species and Effect on Virulence in Galleria mellonella and Biofilm Formation In Vitro	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; EXOPOLYSACCHARIDE BIOSYNTHESIS; COLONY MORPHOLOGY; SP NOV.; ADAPTATION; INFECTION; GENES; MULTIVORANS	Burkholderia cepacia complex (Bcc) bacteria are opportunistic pathogens causing chronic respiratory infections particularly among cystic fibrosis patients. During these chronic infections, mucoid-to-nonmucoid morphotype variation occurs, with the two morphotypes exhibiting different phenotypic properties. Here we show that in vitro, the mucoid clinical isolate Burkholderia multivorans D2095 gives rise to stable nonmucoid variants in response to prolonged stationary phase, presence of antibiotics, and osmotic and oxidative stresses. Furthermore, in vitro colony morphotype variation within other members of the Burkholderia genus occurred in Bcc and non-Bcc strains, irrespectively of their clinical or environmental origin. Survival to starvation and iron limitation was comparable for the mucoid parental isolate and the respective nonmucoid variant, while susceptibility to antibiotics and to oxidative stress was increased in the nonmucoid variants. Acute infection of Galleria mellonella larvae showed that, in general, the nonmucoid variants were less virulent than the respective parental mucoid isolate, suggesting a role for the exopolysaccharide in virulence. In addition, most of the tested nonmucoid variants produced more biofilm biomass than their respective mucoid parental isolate. As biofilms are often associated with increased persistence of pathogens in the CF lungs and are an indicative of different cell-to-cell interactions, it is possible that the nonmucoid variants are better adapted to persist in this host environment.	[Moreira, Leonilde M.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Silva, Ines N.; Tavares, Andreia C.; Ferreira, Ana S.; Moreira, Leonilde M.] Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Moreira, LM (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal.	lmoreira@tecnico.ulisboa.pt	Ferreira, Ana Sofia/F-7899-2014; de Fátima Morais Moreira, Leonilde/C-6744-2011; Silva, Inês/F-7876-2014	de Fátima Morais Moreira, Leonilde/0000-0002-6838-4245; Silva, Inês/0000-0002-4078-4706; Tavares, Andreia/0000-0002-8260-0776	FEDER; Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/118260/2010, PEst-OE/EQB/LA0023/2011]	FEDER(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by FEDER and Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/118260/2010; PEst-OE/EQB/LA0023/2011] and Post-doc fellowships to I.N.S. and A.S.F., respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chung JW, 2003, INFECT IMMUN, V71, P904, DOI 10.1128/IAI.71.2.904-909.2003; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Coenye T, 1999, INT J SYST BACTERIOL, V49, P1657, DOI 10.1099/00207713-49-4-1657; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x; Drevinek P, 2010, J CLIN MICROBIOL, V48, P34, DOI 10.1128/JCM.01433-09; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; GLASS S, 1986, J INFECTION, V13, P157, DOI 10.1016/S0163-4453(86)92953-1; Goris J, 2004, INT J SYST EVOL MICR, V54, P1677, DOI 10.1099/ijs.0.63101-0; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LARSEN GY, 1993, J CLIN MICROBIOL, V31, P788, DOI 10.1128/JCM.31.4.788-792.1993; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Moreira LM, 1997, ARCH MICROBIOL, V168, P92, DOI 10.1007/s002030050474; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Silva IN, 2011, MICROBIOL-SGM, V157, P3124, DOI 10.1099/mic.0.050989-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; SPEERT DP, 1990, J CLIN MICROBIOL, V28, P188, DOI 10.1128/JCM.28.2.188-194.1990; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tavares IM, 1999, RES MICROBIOL, V150, P105, DOI 10.1016/S0923-2508(99)80028-X; TERRY JM, 1991, INFECT IMMUN, V59, P471, DOI 10.1128/IAI.59.2.471-477.1991; Van Acker E, 2010, J CYST FIBROS, V9, P450, DOI 10.1016/j.jcf.2010.08.015; van Laer F, 1998, INFECT CONT HOSP EP, V19, P112; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	44	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82522	10.1371/journal.pone.0082522	http://dx.doi.org/10.1371/journal.pone.0082522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358195	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700074
J	Skogmar, S; Schon, T; Balcha, TT; Jemal, ZH; Tibesso, G; Bjork, J; Bjorkman, P				Skogmar, Sten; Schon, Thomas; Balcha, Taye Tolera; Jemal, Zelalem Habtamu; Tibesso, Gudeta; Bjork, Jonas; Bjorkman, Per			CD4 Cell Levels during Treatment for Tuberculosis (TB) in Ethiopian Adults and Clinical Markers Associated with CD4 Lymphocytopenia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INFECTION; COUNTS; COINFECTION; DEPLETION; DEATH; RISK	Background: The clinical correlations and significance of subnormal CD4 levels in HIV-negative patients with TB are unclear. We have determined CD4 cell levels longitudinally during anti-tuberculosis treatment (ATT) in patients, with and without HIV co-infection, and their associations with clinical variables. Method: Adults diagnosed with TB (maximum duration of ATT for 2 weeks, and with no history of antiretroviral therapy (ART) in HIV-positive subjects) were included consecutively in eight out-patient clinics in Ethiopia. Healthy individuals were recruited for comparison at one of the study health centers. Data on patient characteristics and physical findings were collected by trained nurses following a structured questionnaire at inclusion and on follow-up visits at 2 and 6 months. In parallel, peripheral blood CD4 cell levels were determined. The evolution of CD4 cell levels during ATT was assessed, and the association between clinical characteristics and low CD4 cell levels at baseline was investigated using regression analysis. Results: In total, 1116 TB patients were included (307 HIV-infected). Among 809 HIV-negative patients, 200 (25%) had subnormal CD4 cell counts (<500 cells/mm(3)), with <350 cells/mm(3) in 82 (10%) individuals. CD4 cell levels increased significantly during the course of ATT in both HIV+ and HIV-TB-patients, but did not reach the levels in healthy subjects (median 896 cells/mm(3)). Sputum smear status, signs of wasting (low mid upper arm circumference (MUAC)), and bedridden state were significantly associated with low CD4 cell counts. Conclusion: A high proportion of Ethiopian TB patients have subnormal CD4 cell counts before starting treatment. Low CD4 cell levels are associated with smear positive disease and signs of wasting. The continuous increase of CD4 cell counts during the course of ATT suggest a reversible impact of active TB on CD4 cell homeostasis, which may be considered in interpretation of CD4 cell counts in HIV/TB co-infected subjects.	[Skogmar, Sten; Balcha, Taye Tolera; Bjorkman, Per] Lund Univ, Fac Med, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden; [Schon, Thomas] Linkoping Univ, Fac Hlth Sci, Dept Med Microbiol, Linkoping, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden; [Balcha, Taye Tolera] Minist Hlth, Addis Ababa, Ethiopia; [Jemal, Zelalem Habtamu] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Tibesso, Gudeta] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs Ethiopia, Addis Ababa, Ethiopia; [Bjork, Jonas] Skane Univ Hosp, Res & Dev Unit, Lund, Sweden	Lund University; Linkoping University; Lund University; Skane University Hospital	Skogmar, S (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden.	sten.skogmar@med.lu.se		Bjork, Jonas/0000-0003-1883-2000	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society; Skane Regional Council; Marcus and Marianne Wallenberg foundation	Swedish International Development Cooperation Agency (SIDA); Swedish Civil Contingency Agency (MSB); Swedish Medical Society; Skane Regional Council; Marcus and Marianne Wallenberg foundation	The Swedish International Development Cooperation Agency (SIDA), the Swedish Civil Contingency Agency (MSB), the Swedish Medical Society, Skane Regional Council and Marcus and Marianne Wallenberg foundation have provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; Andersen AB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-66; Begtrup K, 1997, AM J EPIDEMIOL, V145, P629, DOI 10.1093/oxfordjournals.aje.a009160; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cingolani A, 2012, CLIN INFECT DIS, V54, P853, DOI 10.1093/cid/cir900; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Dieli F, 1999, J INFECT DIS, V180, P225, DOI 10.1086/314852; DJOMAND G, 1994, AIDS, V8, P843, DOI 10.1097/00002030-199406000-00019; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hood MLH, 2013, EUR J CLIN NUTR; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Jones BE, 1997, CLIN INFECT DIS, V24, P988, DOI 10.1093/clinids/24.5.988; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kim DK, 2008, EUR RESPIR J, V32, P1031, DOI 10.1183/09031936.00174907; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; Mupere E, 2012, ANN EPIDEMIOL, V22, P466, DOI 10.1016/j.annepidem.2012.04.007; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; TURETT GS, 1994, CHEST, V105, P1335, DOI 10.1378/chest.105.5.1335; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, HIV ASS OP CHAR; Wolday D, 2002, ETHIOPIAN MED J, V40, P11; World Health Organization, 2012, WHO POL COLL TB HIV; Zachariah R, T R SOC TROP MED HYG, V96, P291	29	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83270	10.1371/journal.pone.0083270	http://dx.doi.org/10.1371/journal.pone.0083270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358268	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700112
J	Davies, MA; Phiri, S; Wood, R; Wellington, M; Cox, V; Bolton-Moore, C; Timmerman, V; Moultrie, H; Ndirangu, J; Rabie, H; Technau, K; Giddy, J; Maxwell, N; Boulle, A; Keiser, O; Egger, M; Eley, B				Davies, Mary-Ann; Phiri, Sam; Wood, Robin; Wellington, Maureen; Cox, Vivian; Bolton-Moore, Carolyn; Timmerman, Venessa; Moultrie, Harry; Ndirangu, James; Rabie, Helena; Technau, Karl; Giddy, Janet; Maxwell, Nicola; Boulle, Andrew; Keiser, Olivia; Egger, Matthias; Eley, Brian		IeDEA Southern Africa Steering Grp	Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; SUB-SAHARAN AFRICA; TREATMENT PROGRAM; RETROSPECTIVE COHORT; EARLY-DIAGNOSIS; FOLLOW-UP; OUTCOMES; INFANTS; ADOLESCENTS; MORTALITY	Background: Since 2005, increasing numbers of children have started antiretroviral therapy (ART) in sub-Saharan Africa and, in recent years, WHO and country treatment guidelines have recommended ART initiation for all infants and very young children, and at higher CD4 thresholds for older children. We examined temporal changes in patient and regimen characteristics at ART start using data from 12 cohorts in 4 countries participating in the IeDEA-SA collaboration. Methodology/Principal Findings: Data from 30,300 ART-naive children aged <16 years at ART initiation who started therapy between 2005 and 2010 were analysed. We examined changes in median values for continuous variables using the Cuzick's test for trend over time. We also examined changes in the proportions of patients with particular disease severity characteristics (expressed as a binary variable e.g. WHO Stage III/V vs I/II) using logistic regression. Between 2005 and 2010 the number of children starting ART each year increased and median age declined from 63 months (2006) to 56 months (2010). Both the proportion of children <1 year and >10 years of age increased from 12 to 19% and 18 to 22% respectively. Children had less severe disease at ART initiation in later years with significant declines in the percentage with severe immunosuppression (81 to 63%), WHO Stage III/IV disease (75 to 62%), severe anemia (12 to 7%) and weight-for-age z-score<-3 (31 to 28%). Similar results were seen when restricting to infants with significant declines in the proportion with severe immunodeficiency (98 to 82%) and Stage III/IV disease (81 to 63%). First-line regimen use followed country guidelines. Conclusions/Significance: Between 2005 and 2010 increasing numbers of children have initiated ART with a decline in disease severity at start of therapy. However, even in 2010, a substantial number of infants and children started ART with advanced disease. These results highlight the importance of efforts to improve access to HIV diagnostic testing and ART in children.	[Davies, Mary-Ann; Maxwell, Nicola; Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Phiri, Sam] Kamuzu Cent Hosp, Lighthouse Trust Clin, Lilongwe, Malawi; [Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Gugulethu Community Hlth Ctr, ZA-7925 Cape Town, South Africa; [Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wellington, Maureen] Newlands Clin, Harare, Zimbabwe; [Cox, Vivian] Medecins Sans Frontieres South Africa, Cape Town, South Africa; [Cox, Vivian] Khayelitsha ART Programme, Cape Town, South Africa; [Bolton-Moore, Carolyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bolton-Moore, Carolyn] Univ N Carolina, Chapel Hill, NC USA; [Timmerman, Venessa] Univ Cape Town, Lung Inst, Knowledge Translat Unit, ZA-7925 Cape Town, South Africa; [Moultrie, Harry] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Harriet Shezi Childrens Clin, Chris Hani Baragwanath Hosp,Fac Hlth Sci, Johannesburg, South Africa; [Ndirangu, James] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Rabie, Helena] Univ Stellenbosch, Tygerberg Acad Hosp, ZA-7600 Stellenbosch, South Africa; [Technau, Karl] Rahima Moosa Mother & Child Hosp, Empilweni Serv & Res Unit, Johannesburg, South Africa; [Technau, Karl] Univ Witwatersrand, Johannesburg, South Africa; [Giddy, Janet] McCord Hosp, Sinikithemba Clin, Durban, South Africa; [Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Eley, Brian] Univ Cape Town, Red Cross Childrens Hosp, ZA-7925 Cape Town, South Africa; [Eley, Brian] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of North Carolina; University of North Carolina Chapel Hill; University of Cape Town; University of Witwatersrand; University of Kwazulu Natal; Stellenbosch University; University of Witwatersrand; University of Bern; University of Cape Town; University of Cape Town	Davies, MA (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	mary-ann.davies@uct.ac.za	Prozesky, Hans Walter/ABE-6956-2020; Moultrie, Harry/AFV-0903-2022; Boulle, Andrew/C-1413-2008; Rabie, Helena/ABH-1437-2020; Moultrie, Harry/H-1842-2014	Prozesky, Hans Walter/0000-0001-9715-3449; Moultrie, Harry/0000-0001-9722-0699; Boulle, Andrew/0000-0002-7713-8062; Rabie, Helena/0000-0001-6336-2963; Moultrie, Harry/0000-0001-9722-0699; Keiser, Olivia/0000-0001-8191-2789; Technau, Karl-Gunter/0000-0001-7367-7512; Egger, Matthias/0000-0001-7462-5132; Ndirangu, James/0000-0002-2768-5631; Bolton Moore, Carolyn/0000-0001-9103-7746	National Institutes of Health, National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development [2U01AI069924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (www.nih.gov) (National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; grant number 2U01AI069924; Pls: Egger and Davies). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Calmy AL, 2011, LANCET, V377, P1546, DOI 10.1016/S0140-6736(11)60363-2; Chakanyuka-Musanhu CC, 2013, 7 INT AIDS SOC C KUA; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, SAMJ S AFR MED J, V99, P653; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Division of AIDS, 2009, DIV AIDS TABL GRAD S; Eley B, 2006, SAMJ S AFR MED J, V96, P988; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE60, DOI 10.1097/QAI.0b013e3182303c7e; Fatti G, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-46; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; Heidari S, 2012, JAIDS-J ACQ IMM DEF, V59, P161, DOI 10.1097/QAI.0b013e3182427029; Iliff P, 2008, TROP MED INT HEALTH, V13, P1459, DOI 10.1111/j.1365-3156.2008.02178.x; Inwani I, 2009, JAIDS-J ACQ IMM DEF, V50, P492, DOI 10.1097/QAI.0b013e318198a8a4; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Jaspan HB, 2008, PEDIATR INFECT DIS J, V27, P993, DOI 10.1097/INF.0b013e31817acf7b; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Khamadi S, 2008, J TROP PEDIATRICS, V54, P370, DOI 10.1093/tropej/fmn036; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Lilian RR, 2012, J CLIN MICROBIOL, V50, P2373, DOI 10.1128/JCM.00431-12; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Malawi Ministry of Health, 2006, GUID US AN THER MAL; Malawi Ministry of Health, 2011, CLIN MAN HIV CHILDR; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; National Department of Health of South Africa, 2005, GUID MAN HIV INF CHI; National Department of Health of South Africa, 2012, CIRC MIN 2 2012 IN A; National Department of Health South Africa, 2010, GUID MAN HIV CHILDR; National Department of Health South Africa, 2004, NAT ANT TREATM GUID; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Patel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044914; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Sutcliffe CG, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-54; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Weigel R, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-80; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2006, WHO CHILD GROWTH STA; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033611	57	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81037	10.1371/journal.pone.0081037	http://dx.doi.org/10.1371/journal.pone.0081037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363808	Green Submitted, Green Published, gold			2022-12-25	WOS:000328705200015
J	Schmidt, GM; Richter, C				Schmidt, Gertraud Maria; Richter, Claudio			Coral Growth and Bioerosion of Porites lutea in Response to Large Amplitude Internal Waves	PLOS ONE			English	Article							REEF-BUILDING CORALS; GREAT-BARRIER-REEF; CLIMATE-CHANGE; ARABIAN GULF; CALCIFICATION; TEMPERATURE; RATES; PHOTOSYNTHESIS; ACIDIFICATION; COMMUNITIES	The Similan Islands (Thailand) in the Andaman Sea are exposed to large amplitude internal waves (LAIW), as evidenced by i.a. abrupt fluctuations in temperature of up to 10 degrees C at supertidal frequencies. Although LAIW have been shown to affect coral composition and framework development in shallow waters, the role of LAIW on coral growth is so far unknown. We carried out a long-term transplant experiment with live nubbins and skeleton slabs of the dominating coral Porites lutea to assess the net growth and bioerosion in LAIW-exposed and LAIW-protected waters. Depth-related, seasonal and interannual differences in LAIW-intensities on the exposed western sides of the islands allowed us to separate the effect of LAIW from other possible factors (e.g. monsoon) affecting the corals. Coral growth and bioerosion were inversely related to LAIW intensity, and positively related to coral framework development. Accretion rates of calcareous fouling organisms on the slabs were negligible compared to bioerosion, reflecting the lack of a true carbonate framework on the exposed W faces of the Similan Islands. Our findings show that LAIW may play an important, yet so far overlooked, role in controlling coral growth in tropical waters	[Schmidt, Gertraud Maria; Richter, Claudio] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schmidt, GM (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	gertraud.schmidt@awi.de	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896	German Research Foundation [RI 1074/7-1]; National Research Council of Thailand; German Federal Ministry for Education and Research [03F0608B]	German Research Foundation(German Research Foundation (DFG)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Funding for this study was provided by the German Research Foundation (RI 1074/7-1: Ocean-Reef Coupling in the Andaman Sea), the National Research Council of Thailand and the German Federal Ministry for Education and Research (Grant number 03F0608B, Bioacid 3.2.3, Coral calcification in marginal reefs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Alutoin S, 2001, MAR ENVIRON RES, V52, P289, DOI 10.1016/S0141-1136(01)00105-2; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; Behera SK, 2008, GEOPHYS RES LET, V35; Birkeland C., 1997, LIFE DEATH CORAL REE; BUDDEMEIER RW, 1974, J EXP MAR BIOL ECOL, V14, P179, DOI 10.1016/0022-0981(74)90024-0; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carreiro-Silva M, 2005, CORAL REEFS, V24, P214, DOI 10.1007/s00338-004-0445-3; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; CORTES J, 1985, B MAR SCI, V36, P339; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; Davies P.J., 1983, Coral Reefs, V2, P27, DOI 10.1007/BF00304729; DAVIES PS, 1989, MAR BIOL, V101, P389; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Edmunds PJ, 2008, MAR BIOL, V154, P153, DOI 10.1007/s00227-008-0910-6; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Forsman Z.H., 2003, THESIS U HOUSTON; Gattuso JP, 1999, AM ZOOL, V39, P160; Glynn Peter W., 1997, P68; GOREAU TF, 1963, ANN NY ACAD SCI, V109, P127, DOI 10.1111/j.1749-6632.1963.tb13465.x; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; HALLOCK P, 1988, PALAEOGEOGR PALAEOCL, V63, P275, DOI 10.1016/0031-0182(88)90100-9; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; Hassan M, 1997, THESIS U KIEL; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jackson C., 2004, ATLAS INTERNAL SOLIT; Jimenez C, 2010, REVMAR-REV CIENC MAR, V2, P95; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Leichter JJ, 2005, J PHYS OCEANOGR, V35, P1945, DOI 10.1175/JPO2808.1; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Manzello DP, 2009, P 11 INT COR REEF S, V1, P1299; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Osorno A, 2005, CORAL REEFS, V24, P292, DOI 10.1007/s00338-005-0478-2; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; Phongsuwan N, 2008, 10 YEARS BLEACHING F; ReakaKudla ML, 1996, CORAL REEFS, V15, P101; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl B, 2001, PALAEOGEOGR PALAEOCL, V175, P79, DOI 10.1016/S0031-0182(01)00387-X; Roder C, 2011, CORAL REEFS, V30, P57, DOI 10.1007/s00338-011-0722-x; Roder C, 2010, MAR ECOL PROG SER, V412, P113, DOI 10.3354/meps08707; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Schmidt GM, 2012, MAR ECOL PROG SER, V456, P113, DOI 10.3354/meps09682; SCOFFIN TP, 1980, B MAR SCI, V30, P475; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; Scotti A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021052; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TOMASCIK T, 1987, MAR BIOL, V94, P53, DOI 10.1007/BF00392900; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050207; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006	80	7	7	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e73236	10.1371/journal.pone.0073236	http://dx.doi.org/10.1371/journal.pone.0073236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363805	Green Published, Green Submitted, gold			2022-12-25	WOS:000328705200002
J	Parrish, JK; Sechler, M; Winn, RA; Jedlicka, P				Parrish, J. K.; Sechler, M.; Winn, R. A.; Jedlicka, P.			The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma	ONCOGENE			English	Article						Ewing sarcoma; microRNA; epigenetics; histone demethylase	ONCOGENIC TRANSCRIPTION; CELL-LINES; EXPRESSION; CHROMATIN; DIFFERENTIATION; SENSITIVITY; MICRORNAS; EPIGENOME; THERAPY; HYPOXIA	Ewing Sarcoma is a biologically aggressive bone and soft tissue malignancy affecting children and young adults. Ewing Sarcoma pathogenesis is driven by EWS/Ets fusion oncoproteins, of which EWS/Fli1 is the most common. We have previously shown that microRNAs (miRs) regulated by EWS/Fli1 contribute to the pro-oncogenic program in Ewing Sarcoma. Here we show that miR-22, an EWS/Fli1-repressed miR, is inhibitory to Ewing Sarcoma clonogenic and anchorage-independent cell growth, even at modest overexpression levels. Our studies further identify the H3K9me1/2 histone demethylase KDM3A (JMJD1A/JHDM2A) as a new miR-22-regulated gene. We show that KDM3A is overexpressed in Ewing Sarcoma, and that its depletion inhibits clonogenic and anchorage-independent growth in multiple patient-derived cell lines, and tumorigenesis in a xenograft model. KDM3A depletion further results in augmentation of the levels of the repressive H3K9me2 histone mark, and downregulation of pro-oncogenic factors in Ewing Sarcoma. Together, our studies identify the histone demethylase KDM3A as a new, miR-regulated, tumor promoter in Ewing Sarcoma.	[Parrish, J. K.; Jedlicka, P.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Sechler, M.; Jedlicka, P.] Univ Colorado Denver, Canc Biol Grad Program, Aurora, CO 80045 USA; [Winn, R. A.] Univ Illinois, Dept Med, Chicago, IL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jedlicka, P (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus,12800 E 19th Ave,MS 8104, Aurora, CO 80045 USA.	paul.jedlicka@ucdenver.edu			Boettcher Foundation's Webb-Waring Biomedical Research Program, Department of Defense Discovery Award [W81XWH-12-1-0296]; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado School of Medicine and Cancer Center; US Department of Veterans' Affairs;  [R01CA138528-2522717]; NATIONAL CANCER INSTITUTE [R01CA138528, P30CA046934] Funding Source: NIH RePORTER	Boettcher Foundation's Webb-Waring Biomedical Research Program, Department of Defense Discovery Award; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado School of Medicine and Cancer Center; US Department of Veterans' Affairs(US Department of Veterans Affairs); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kathrin Bernt and Tobias Neff for advice on histone mark analysis, Steve Lessnick for retroviral packaging constructs, Heide Ford for critical reading of the manuscript, and the University of Colorado Cancer Center DNA Sequencing, Flow Cytometry, and Functional Genomics core facilities. This work was supported by the Boettcher Foundation's Webb-Waring Biomedical Research Program, Department of Defense Discovery Award (W81XWH-12-1-0296), Alex's Lemonade Stand Foundation for Childhood Cancer, and funds from the University of Colorado School of Medicine and Cancer Center (to PJ); and Merit Award from the US Department of Veterans' Affairs and R01CA138528-2522717 (to RAW).	Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Franzetti GA, 2013, ONCOGENE, V32, P3915, DOI 10.1038/onc.2012.403; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Lawlor ER, 2012, CLIN CANCER RES, V18, P2768, DOI 10.1158/1078-0432.CCR-11-1921; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Li J, 2010, GYNECOL ONCOL, V119, P543, DOI 10.1016/j.ygyno.2010.08.034; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Wai DH, 2002, INT J ONCOL, V20, P441; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	45	62	64	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					257	262		10.1038/onc.2013.541	http://dx.doi.org/10.1038/onc.2013.541			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362521	Green Accepted			2022-12-25	WOS:000347790500013
J	Stampolidis, P; Ullrich, A; Lacobelli, S				Stampolidis, P.; Ullrich, A.; lacobelli, S.			LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention	ONCOGENE			English	Article						LGALS3BP; cancer biomarker; extracellular matrix; integrin signalling; therapeutic target	TUMOR-ASSOCIATED ANTIGEN; EXTRACELLULAR-MATRIX; MAC-2-BINDING PROTEIN; LUNG-CARCINOMA; CANCER; 90K; ACTIVATION; EXPRESSION; INTEGRINS; MARKER	The extracellular matrix protein lectin galactoside-binding soluble 3 binding protein (LGALS3BP) constitutes a negative prognostic marker of cancer onset and progression with increasing value in clinical application. Since its discovery, however, although the glycoprotein has been implicated in a growing number of disease-related processes, its actual role and mechanism of action have remained ambiguous, thus hindering opportunities for therapeutic development. In this study, we have determined that LGALS3BP constitutes a novel ligand for integrins alpha(5)beta(1), alpha(v)beta(1) and alpha(6)beta(1) and have identified that these newly established partnerships at the membrane level are responsible for exerting the molecule's involvement in cancer through manipulation of multiple canonical 'outside-in' integrin signalling events. We demonstrate that LGALS3BP-mediated integrin activation results into signal transmission via Akt, JNK and the Ras cascade via the Raf-ERK axis while p38 activity is kept at baseline levels. Transient cellular adherence to LGALS3BP favours survival and proliferation signalling while apoptosis is kept at bay. Sustained cellular exposure to LGALS3BP significantly supports viability, motility and migration. Importantly, an anti-LGALS3BP antibody, SP2 is capable of impeding these newly defined LGALS3BP-driven processes without, however, compromising cell viability. These novel findings reveal the mechanism of action of LGALS3BP during cellular adherence and warrant its further validation as a potential pharmacological target for anticancer therapies.	[Stampolidis, P.; Ullrich, A.] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [lacobelli, S.] MediaPharma Srl, Chieti, Italy	Max Planck Society	Stampolidis, P (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Am Klopferspitz 18, D-82152 Bavaria, Germany.	stampoli@biochem.mpg.de						Awasthi N, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-12; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Block AS, 2011, PROSTATE, V71, P711, DOI 10.1002/pros.21287; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; CARLIN CR, 1983, EXP CELL RES, V147, P359, DOI 10.1016/0014-4827(83)90218-5; Cesinaro AM, 2002, J INVEST DERMATOL, V119, P187, DOI 10.1046/j.1523-1747.2002.17642.x; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Faccio R, 2002, J CELL SCI, V115, P2919; Fomarini B, 2000, BLOOD, V96, P3282, DOI 10.1182/blood.V96.9.3282.h8003282_3282_3285; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huxley-Jones J, 2008, DRUG DISCOV TODAY, V13, P685, DOI 10.1016/j.drudis.2008.05.005; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; IACOBELLI S, 1994, BRIT J CANCER, V69, P172, DOI 10.1038/bjc.1994.29; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kashyap MK, 2010, CANCER BIOL THER, V10, P796, DOI 10.4161/cbt.10.8.12914; Koopmann J, 2004, CANCER-AM CANCER SOC, V101, P1609, DOI 10.1002/cncr.20469; Lacovazzi PA, 2001, CLIN CHEM LAB MED, V39, P961; Lee YJ, 2007, CLIN EXP RHEUMATOL, V25, pS41; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lu XJ, 2008, PERSPECT MED CHEM, V2, P57; Marchetti A, 2002, CANCER RES, V62, P2535; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Mould A. P., 2011, CURRENT PROTOCOLS CE; Mould A. Paul, 2009, V522, P195, DOI 10.1007/978-1-59745-413-1_13; NATOLI C, 1993, J ACQ IMMUN DEF SYND, V6, P370; Niland S, 2012, J ONCOL, V2012, DOI 10.1155/2012/125278; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ozaki Y, 2002, CANCER, V95, P1954, DOI 10.1002/cncr.10899; Park YP, 2007, INT J CANCER, V120, P813, DOI 10.1002/ijc.22369; Pelliccia P, 1999, J CLIN IMMUNOL, V19, P143, DOI 10.1023/A:1020562702083; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Ruegg C, 2003, CELL MOL LIFE SCI, V60, P1135, DOI 10.1007/s00018-003-2297-3; Sardana G, 2007, CLIN CHEM, V53, P429, DOI 10.1373/clinchem.2006.077370; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; SCAMBIA G, 1988, ANTICANCER RES, V8, P761; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Srirajaskanthan R, 2010, MOL CELL PROTEOMICS, V9, P656, DOI 10.1074/mcp.M900401-MCP200; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; Van Slambrouck S, 2009, INT J ONCOL, V34, P1717, DOI 10.3892/ijo_00000302; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Zhang Dong-Sheng, 2003, Ai Zheng, V22, P870; Zhang H, 2004, CANCER SCI, V95, P878, DOI 10.1111/j.1349-7006.2004.tb02197.x	51	39	42	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					39	52		10.1038/onc.2013.548	http://dx.doi.org/10.1038/onc.2013.548			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24362527				2022-12-25	WOS:000349740100004
J	An, B; Abbonante, V; Yigit, S; Balduini, A; Kaplan, DL; Brodsky, B				An, Bo; Abbonante, Vittorio; Yigit, Sezin; Balduini, Alessandra; Kaplan, David L.; Brodsky, Barbara			Definition of the Native and Denatured Type II Collagen Binding Site for Fibronectin Using a Recombinant Collagen System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix Proteins; Fibronectin; Protein Chimeras; Recombinant Protein Expression; Binding; Gelatin; Triple Helix	TRIPLE-HELICAL COLLAGEN; AMINO-ACID-SEQUENCE; CALF-SKIN COLLAGEN; STRUCTURAL-ANALYSIS; GLYCOPROTEIN-VI; ALPHA-CHAINS; PROTEIN; MATRIX; IDENTIFICATION; RECEPTORS	Background: Sequence requirements for triple-helical collagen to bind fibronectin are not fully understood. Results: Fibronectin affinity was conferred on a recombinant bacterial collagen by incorporating specific human collagen II sequences. Conclusion: The chimeric collagen defines the minimum collagen II sequence required for fibronectin affinity. Significance: This system is useful to investigate sequence/activity relationships for triple-helical collagen and to generate scalable bioactive materials. Interaction of collagen with fibronectin is important for extracellular matrix assembly and regulation of cellular processes. A fibronectin-binding region in collagen was identified using unfolded fragments, but it is not clear if the native protein binds fibronectin with the same primary sequence. A recombinant bacterial collagen is utilized to characterize the sequence requirement for fibronectin binding. Chimeric collagens were generated by inserting the putative fibronectin-binding region from human collagen into the bacterial collagen sequence. Insertion of a sufficient length of human sequence conferred fibronectin affinity. The minimum sequence requirement was identified as a 6-triplet sequence near the unique collagenase cleavage site and was the same in both triple-helix and denatured states. Denaturation of the chimeric collagen increased its affinity for fibronectin, as seen for mammalian collagens. The fibronectin binding recombinant collagen did not contain hydroxyproline, indicating hydroxyproline is not essential for binding. However, its absence may account, in part, for the higher affinity of the native chimeric protein and the lower affinity of the denatured protein compared with type II collagen. Megakaryocytes cultured on chimeric collagen with fibronectin affinity showed improved adhesion and differentiation, suggesting a strategy for generating bioactive materials in biomedical applications.	[An, Bo; Yigit, Sezin; Balduini, Alessandra; Kaplan, David L.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Abbonante, Vittorio; Balduini, Alessandra] Univ Pavia, San Matteo Fdn, IRCCS, Dept Mol Med,Biotechnol Res Labs, I-27100 Pavia, Italy	Tufts University; IRCCS Fondazione San Matteo; University of Pavia	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu; barbara.brodsky@tufts.edu	Balduini, Alessandra/K-6802-2016; Abbonante, Vittorio/K-4028-2016; BALDUINI, ALESSANDRA/AAC-3363-2022; An, Bo/N-3466-2014; Abbonante, Vittorio/AAA-9303-2020	Balduini, Alessandra/0000-0003-3145-1245; Abbonante, Vittorio/0000-0001-8066-9895; BALDUINI, ALESSANDRA/0000-0003-3145-1245; An, Bo/0000-0002-1031-3380; Abbonante, Vittorio/0000-0001-8066-9895	National Institutes of Health Grant [EB011620]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EB011620 (to B. B. and D. K.).	Akiyama S K, 1983, Monogr Pathol, V24, P55; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; Asselin J, 1999, BIOCHEM J, V339, P413, DOI 10.1042/0264-6021:3390413; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; FIETZEK PP, 1973, EUR J BIOCHEM, V38, P396, DOI 10.1111/j.1432-1033.1973.tb03072.x; Fox NE, 2005, EXP HEMATOL, V33, P94, DOI 10.1016/j.exphem.2004.10.002; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; GUIDRY C, 1990, J BIOL CHEM, V265, P19230; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Jiang F, 2002, BLOOD, V99, P3579, DOI 10.1182/blood.V99.10.3579; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Kielty C. M., 2002, CONNECTIVE TISSUE IT, P158; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LWEBUGAMUKASA JS, 1984, COLLAGEN REL RES, V4, P95; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Matsunaga T, 2012, ANN HEMATOL, V91, P1633, DOI 10.1007/s00277-012-1498-y; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Peng Y. Y., 2013, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34898; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Piez K.A., 1984, EXTRACELLULAR MATRIX; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stultz CM, 2003, BIOPHYS J, V85, P2198, DOI 10.1016/S0006-3495(03)74645-1; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	54	47	47	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4941	4951		10.1074/jbc.M113.530808	http://dx.doi.org/10.1074/jbc.M113.530808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375478	Green Published, hybrid			2022-12-25	WOS:000331607900040
J	Genini, S; Beltran, WA; Aguirre, GD				Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.			Up-Regulation of Tumor Necrosis Factor Superfamily Genes in Early Phases of Photoreceptor Degeneration	PLOS ONE			English	Article							CELL-DEATH; FRAMESHIFT MUTATION; BETA-SUBUNIT; TNF-ALPHA; APOPTOSIS; MECHANISMS; EXPRESSION; ROD; ACTIVATION; PATHWAY	We used quantitative real-time PCR to examine the expression of 112 genes related to retinal function and/or belonging to known pro-apoptotic, cell survival, and autophagy pathways during photoreceptor degeneration in three early-onset canine models of human photoreceptor degeneration, rod cone dysplasia 1 (rcd1), X-linked progressive retinal atrophy 2 (xlpra2), and early retinal degeneration (erd), caused respectively, by mutations in PDE6B, RPGRORF15, and STK38L. Notably, we found that expression and timing of differentially expressed (DE) genes correlated with the cell death kinetics. Gene expression profiles of rcd1 and xlpra2 were similar; however rcd1 was more severe as demonstrated by the results of the TUNEL and ONL thickness analyses, a greater number of genes that were DE, and the identification of altered expression that occurred at earlier time points. Both diseases differed from erd, where a smaller number of genes were DE. Our studies did not highlight the potential involvement of mitochondrial or autophagy pathways, but all three diseases were accompanied by the down-regulation of photoreceptor genes, and up-regulation of several genes that belong to the TNF superfamily, the extrinsic apoptotic pathway, and pro-survival pathways. These proteins were expressed by different retinal cells, including horizontal, amacrine, ON bipolar, and Muller cells, and suggest an interplay between the dying photoreceptors and inner retinal cells. Western blot and immunohistochemistry results supported the transcriptional regulation for selected proteins. This study highlights a potential role for signaling through the extrinsic apoptotic pathway in early cell death events and suggests that retinal cells other than photoreceptors might play a primary or bystander role in the degenerative process.	[Genini, Sem; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Genini, S (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA.	geninis@vet.upenn.edu; gda@vet.upenn.edu		Aguirre, Gustavo/0000-0002-5228-256X	Foundation Fighting Blindness (FFB), NIH [EY06855, EY017549, EY022012, 5P30EY001583-38]; Van Sloun Fund for Canine Genetic Research, Hope for Vision; Macula Vision Research Foundation; NATIONAL EYE INSTITUTE [R24EY022012, R01EY017549, R01EY006855, P30EY001583, U01EY006855] Funding Source: NIH RePORTER	Foundation Fighting Blindness (FFB), NIH; Van Sloun Fund for Canine Genetic Research, Hope for Vision; Macula Vision Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Foundation Fighting Blindness (FFB), NIH Grants EY06855, EY017549, EY022012, and 5P30EY001583-38, the Van Sloun Fund for Canine Genetic Research, Hope for Vision, and Macula Vision Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Genini S, 2012, ADV EXP MED BIOL, V723, P353, DOI 10.1007/978-1-4614-0631-0_46; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Gesslein B, 2010, MOL VIS, V16, P2317; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Ma JJ, 2009, EUR J OBSTET GYN R B, V146, P222, DOI 10.1016/j.ejogrb.2009.06.011; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855; Zhang BY, 2010, J IMMUNOL, V184, P4770, DOI 10.4049/jimmunol.0902713; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhang Q, 2003, INVEST OPHTH VIS SCI, V44, P4542, DOI 10.1167/iovs.02-1202	53	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e85408	10.1371/journal.pone.0085408	http://dx.doi.org/10.1371/journal.pone.0085408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367709	Green Published, gold			2022-12-25	WOS:000328741900077
J	Gorsic, LK; Stark, AL; Wheeler, HE; Wong, SS; Im, HK; Dolan, ME				Gorsic, Lidija K.; Stark, Amy L.; Wheeler, Heather E.; Wong, Shan S.; Im, Hae K.; Dolan, M. Eileen			EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells	PLOS ONE			English	Article							COMBINATORIAL BIOSYNTHESIS; INDUCED CYTOTOXICITY; CELLULAR GROWTH; MITHRAMYCIN; EXPRESSION; APOPTOSIS; TOXICITY; BINDING; TRANSFORMATION; CHEMOTHERAPY	Cisplatin, a commonly used chemotherapeutic, is associated with ototoxicity, renal toxicity and neurotoxicity, thus identifying means to increase the therapeutic index of cisplatin may allow for improved outcomes. A SNP (rs4343077) within EPS8, discovered through a genome wide association study of cisplatin-induced cytotoxicity and apoptosis in lymphoblastoid cell lines (LCLs), provided impetus to further study this gene. The purpose of this work was to evaluate the role of EPS8 in cellular susceptibility to cisplatin in cancerous and non-cancerous cells. We used EPS8 RNA interference to determine the effect of decreased EPS8 expression on LCL and A549 lung cancer cell sensitivity to cisplatin. EPS8 knockdown in LCLs resulted in a 7.9% increase in cisplatin-induced survival (P = 1.98x10(-7)) and an 8.7% decrease in apoptosis (P = 0.004) compared to control. In contrast, reduced EPS8 expression in lung cancer cells resulted in a 20.6% decrease in cisplatin-induced survival (P = 5.08x10(-5)). We then investigated an EPS8 inhibitor, mithramycin A, as a potential agent to increase the therapeutic index of cisplatin. Mithramycin A decreased EPS8 expression in LCLs resulting in decreased cellular sensitivity to cisplatin as evidenced by lower caspase 3/7 activation following cisplatin treatment (42.7%+/- 66.8% relative to control P = 0.0002). In 5 non-small-cell lung carcinoma (NSCLC) cell lines, mithramycin A also resulted in decreased EPS8 expression. Adding mithramycin to 4 NSCLC cell lines and a bladder cancer cell line, resulted in increased sensitivity to cisplatin that was significantly more pronounced in tumor cell lines than in LCL lines (p<0.0001). An EGFR mutant NSCLC cell line (H1975) showed no significant change in sensitivity to cisplatin with the addition of mithramycin treatment. Therefore, an inhibitor of EPS8, such as mithramycin A, could improve cisplatin treatment by increasing sensitivity of tumor relative to normal cells.	[Gorsic, Lidija K.; Stark, Amy L.; Wheeler, Heather E.; Wong, Shan S.; Dolan, M. Eileen] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Im, Hae K.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Wheeler, Heather/I-9279-2019	Wheeler, Heather/0000-0003-1365-9667	National Institute of Health, National Institute of General Medical Sciences [UO1GM61393]; National Institute of Health Clinical and Translational Science [TL1 RR25001]; National Institute of Health [T32CA009594]; NATIONAL CANCER INSTITUTE [F32CA165823, T32CA009594] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Institute of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health Clinical and Translational Science; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to National Institute of Health, National Institute of General Medical Sciences UO1GM61393 (MED), National Institute of Health Clinical and Translational Science Award TL1 RR25001 (ALS), National Institute of Health Cancer Biology Training Grant T32CA009594 (HEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2007, NUCLEIC ACIDS RES, V35, P2215, DOI 10.1093/nar/gkm037; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; BROWN JH, 1965, NEW ENGL J MED, V272, P111, DOI 10.1056/NEJM196501212720301; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Ding XF, 2013, ONCOL REP, V29, P697, DOI 10.3892/or.2012.2160; ELIAS EG, 1972, J BONE JOINT SURG AM, VA 54, P1730, DOI 10.2106/00004623-197254080-00013; Freeman DJ, 2009, MOL CANCER THER, V8, P1536, DOI 10.1158/1535-7163.MCT-08-0978; Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Huang RS, 2011, CLIN CANCER RES, V17, P5490, DOI 10.1158/1078-0432.CCR-11-0724; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Majee S, 1999, EUR J BIOCHEM, V260, P619, DOI 10.1046/j.1432-1327.1999.00159.x; MATOSKOVA B, 1995, MOL CELL BIOL, V15, P3805; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t; O'Donnell PH, 2010, PHARMACOGENET GENOM, V20, P327, DOI 10.1097/FPC.0b013e3283396c4e; Petrovic V, 2010, CANCER BIOL THER, V9, P1008, DOI 10.4161/cbt.9.12.11710; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; ROBINS PR, 1973, J LAB CLIN MED, V82, P576; Roos WP, 2012, CANC LETT; Ryan W G, 1969, Trans Assoc Am Physicians, V82, P353; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; Shukla SJ, 2008, PHARMACOGENET GENOM, V18, P253, DOI 10.1097/FPC.0b013e3282f5e605; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Wang HX, 2010, CARCINOGENESIS, V31, P1132, DOI 10.1093/carcin/bgq058; Wen YJ, 2012, HUM MOL GENET, V21, P1470, DOI 10.1093/hmg/ddr583; Wen YJ, 2011, PHARMACOGENET GENOM, V21, P476, DOI 10.1097/FPC.0b013e3283481967; Wheeler HE, 2013, PHARMACOGENOMICS J, V13, P35, DOI 10.1038/tpj.2011.38; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang TP, 2010, CHEM-BIOL INTERACT, V183, P181, DOI 10.1016/j.cbi.2009.09.018; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	43	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82220	10.1371/journal.pone.0082220	http://dx.doi.org/10.1371/journal.pone.0082220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367505	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900008
J	Carroll, SY; O'Mahony, SM; Grenham, S; Cryan, JF; Hyland, NP				Carroll, Siobhan Yvonne; O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis; Hyland, Niall Patrick			Disodium Cromoglycate Reverses Colonic Visceral Hypersensitivity and Influences Colonic Ion Transport in a Stress-Sensitive Rat Strain	PLOS ONE			English	Article							NEONATAL MATERNAL-DEPRIVATION; CONNECTIVE-TISSUE-TYPE; LONG-TERM ALTERATIONS; MOUSE MAST-CELLS; SODIUM CROMOGLYCATE; ANTIALLERGIC COMPOUNDS; HISTAMINE-RELEASE; RESTRAINT STRESS; FIBROBLASTS; ANAPHYLAXIS	The interface between psychiatry and stress-related gastrointestinal disorders (GI), such as irritable bowel syndrome (IBS), is well established, with anxiety and depression the most frequently occurring comorbid conditions. Moreover, stress-sensitive Wistar Kyoto (WKY) rats, which display anxiety-and depressive-like behaviors, exhibit GI disturbances akin to those observed in stress-related GI disorders. Additionally, there is mounting preclinical and clinical evidence implicating mast cells as significant contributors to the development of abdominal visceral pain in IBS. In this study we examined the effects of the rat connective tissue mast cell (CTMC) stabiliser, disodium cromoglycate (DSCG) on visceral hypersensitivity and colonic ion transport, and examined both colonic and peritoneal mast cells from stress-sensitive WKY rats. DSCG significantly decreased abdominal pain behaviors induced by colorectal distension in WKY animals independent of a reduction in colonic rat mast cell mediator release. We further demonstrated that mast cell-stimulated colonic ion transport was sensitive to inhibition by the mast cell stabiliser DSCG, an effect only observed in stress-sensitive rats. Moreover, CTMC-like mast cells were significantly increased in the colonic submucosa of WKY animals, and we observed a significant increase in the proportion of intermediate, or immature, peritoneal mast cells relative to control animals. Collectively our data further support a role for mast cells in the pathogenesis of stress-related GI disorders.	[Carroll, Siobhan Yvonne; O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis; Hyland, Niall Patrick] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Carroll, Siobhan Yvonne; Hyland, Niall Patrick] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [O'Mahony, Siobhain Mary; Grenham, Susan; Cryan, John Francis] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Cork; University College Cork	Hyland, NP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	n.hyland@ucc.ie	O'Mahony, Siobhain M./AAE-9167-2021; Cryan, John F./A-6950-2013	O'Mahony, Siobhain M./0000-0002-9597-9391; Cryan, John F./0000-0001-5887-2723; Hyland, Niall/0000-0003-0060-7390	Science Foundation Ireland [02/CE/B124, 07/CE/B1368]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland through a Centre Grant to the Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland (02/CE/B124 and 07/CE/B1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE F, 1983, DIGESTION, V28, P108, DOI 10.1159/000198972; ARRUZAZABALA MD, 1982, AGENTS ACTIONS, V12, P596, DOI 10.1007/BF01965066; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2008, GUT, V57, P582, DOI 10.1136/gut.2007.126680; Barreau F, 2004, GASTROENTEROLOGY, V127, P524, DOI 10.1053/j.gastro.2004.05.019; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Collins CB, 2007, POULTRY SCI, V86, P843, DOI 10.1093/ps/86.5.843; CROSSMAN DC, 1993, J APPL PHYSIOL, V75, P167, DOI 10.1152/jappl.1993.75.1.167; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; Dong Wen Zhu, 2004, Chin J Dig Dis, V5, P103, DOI 10.1111/j.1443-9573.2004.00168.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Eleno N, 1999, PULM PHARMACOL THER, V12, P55, DOI 10.1006/pupt.1999.0171; ENERBACK L, 1985, BIOCHEM J, V227, P661, DOI 10.1042/bj2270661; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P313, DOI 10.1111/apm.1966.66.3.313; Folks David G, 2004, Curr Psychiatry Rep, V6, P210, DOI 10.1007/s11920-004-0066-0; Gibney SM, 2010, NEUROSCIENCE, V165, P675, DOI 10.1016/j.neuroscience.2009.08.076; GIBSON S, 1987, IMMUNOLOGY, V62, P621; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Gunter WD, 2000, PHYSIOL BEHAV, V69, P379, DOI 10.1016/S0031-9384(99)00254-1; Hyland NP, 2009, GUT, V58, P1029, DOI 10.1136/gut.2008.167882; Inagaki N, 2001, BIOL PHARM BULL, V24, P829, DOI 10.1248/bpb.24.829; KANAKURA Y, 1988, BLOOD, V72, P877; La Jun-Ho, 2004, J Vet Sci, V5, P319; Larauche M, 2011, J NEUROGASTROENTEROL, V17, P213, DOI 10.5056/jnm.2011.17.3.213; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LOBO B, 2009, GASTROENTEROLOGY S1, V140, pS499; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Manchanda RK, 2011, PHARMACOL REP, V63, P54, DOI 10.1016/S1734-1140(11)70398-X; Martinez V, 2007, N-S ARCH PHARMACOL, V376, P205, DOI 10.1007/s00210-007-0195-1; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Michaloudi HC, 1999, J ANAT, V195, P577, DOI 10.1046/j.1469-7580.1999.19540577.x; MILLER HRP, 1972, AM J PATHOL, V69, P195; MOSS GF, 1970, TOXICOL APPL PHARM, V17, P691, DOI 10.1016/0041-008X(70)90043-8; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; O'Mahony CM, 2011, PHARMACOL BIOCHEM BE, V97, P690, DOI 10.1016/j.pbb.2010.11.012; O'Mahony SM, 2010, NEUROGASTROENT MOTIL, V22, P573, DOI 10.1111/j.1365-2982.2009.01432.x; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; O'Malley D, 2010, NEUROGASTROENT MOTIL, V22, P301, DOI 10.1111/j.1365-2982.2009.01412.x; O'Malley D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00190; Ohashi K, 2007, J VET MED SCI, V69, P1223, DOI 10.1292/jvms.69.1223; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Park JH, 2006, J GASTROEN HEPATOL, V21, P71, DOI 10.1111/j.1440-1746.2005.04143.x; PEARCE FL, 1982, J IMMUNOL, V128, P2481; PEARCE FL, 1982, AGENTS ACTIONS, V12, P183, DOI 10.1007/BF01965140; PERDUE MH, 1985, J ALLERGY CLIN IMMUN, V76, P498, DOI 10.1016/0091-6749(85)90733-X; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; Schemann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052104; SCOTT RB, 1993, DIGEST DIS SCI, V38, P396, DOI 10.1007/BF01316490; SHANAHAN F, 1986, INT ARCH ALLER A IMM, V80, P424, DOI 10.1159/000234092; Sugimoto Y, 1998, GEN PHARMACOL, V31, P613, DOI 10.1016/S0306-3623(98)00063-9; Tariq Mohammad, 2006, Inflammopharmacology, V14, P163, DOI 10.1007/s10787-006-1524-6; Trezena AG, 2003, MEDIAT INFLAMM, V12, P237, DOI 10.1080/09629350310001599684; van den Wijngaard R. M., 2009, NEUROGASTROENT MOTIL, V21, P1107, DOI DOI 10.1111/J.1365-2982.2009.01339.X.PUBMED:19523146; Vergnolle N, 1998, GASTROENTEROLOGY, V114, pA429; Zuo YX, 2003, PAIN, V105, P467, DOI 10.1016/S0304-3959(03)00261-6	62	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84718	10.1371/journal.pone.0084718	http://dx.doi.org/10.1371/journal.pone.0084718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367692	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300157
J	Charpentier, MJE; Drea, CM				Charpentier, Marie J. E.; Drea, Christine M.			Victims of Infanticide and Conspecific Bite Wounding in a Female-Dominant Primate: A Long-Term Study	PLOS ONE			English	Article							RING-TAILED LEMURS; BEZA-MAHAFALY-RESERVE; SEX-DIFFERENCES; SOCIAL RELATIONSHIPS; RISK-TAKING; SOUTHWESTERN MADAGASCAR; REPRODUCTIVE PARAMETERS; AGGRESSIVE COMPETITION; INBREEDING DEPRESSION; RINGTAILED LEMURS	The aggression animals receive from conspecifics varies between individuals across their lifetime. As poignantly evidenced by infanticide, for example, aggression can have dramatic fitness consequences. Nevertheless, we understand little about the sources of variation in received aggression, particularly in females. Using a female-dominant species renowned for aggressivity in both sexes, we tested for potential social, demographic, and genetic patterns in the frequency with which animals were wounded by conspecifics. Our study included 243 captive, ring-tailed lemurs (Lemur catta), followed from infancy to adulthood over a 35-year time span. We extracted injury, social, and life-history information from colony records and calculated neutral heterozygosity for a subset of animals, as an estimate of genetic diversity. Focusing on victims rather than aggressors, we used General Linear Models to explain bite-wound patterns at different life stages. In infancy, maternal age best predicted wounds received, as infants born to young mothers were the most frequent infanticide victims. In adulthood, sex best predicted wounds received, as males were three times more likely than females to be seriously injured. No relation emerged between wounds received and the other variables studied. Beyond the generally expected costs of adult male intrasexual aggression, we suggest possible additive costs associated with female-dominant societies - those suffered by young mothers engaged in aggressive disputes and those suffered by adult males aggressively targeted by both sexes. We propose that infanticide in lemurs may be a costly by-product of aggressively mediated, female social dominance. Accordingly, the benefits of female behavioral 'masculinization' accrued to females through priority of access to resources, may be partially offset by early costs in reproductive success. Understanding the factors that influence lifetime patterns of conspecific wounding is critical to evaluating the fitness costs associated with social living; however, these costs may vary substantially between societies.	[Charpentier, Marie J. E.; Drea, Christine M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27705 USA; [Charpentier, Marie J. E.; Drea, Christine M.] Duke Univ, Dept Biol, Durham, NC USA; [Charpentier, Marie J. E.] CEFE CNRS, UMR 5175, Montpellier, France	Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Charpentier, MJE (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27705 USA.	marie.charpentier@cefe.cnrs.fr	Charpentier, Marie JE/A-5108-2016	Charpentier, Marie/0000-0001-6530-5874	NSF [BCS-0409367, IOS-0719003]; Marie Curie outgoing fellowship	NSF(National Science Foundation (NSF)); Marie Curie outgoing fellowship(European Commission)	This research was supported by NSF grants (BCS-0409367 and IOS-0719003 to CMD) and a Marie Curie outgoing fellowship (to MJEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andrews J, 1998, FOLIA PRIMATOL, V69, P14, DOI 10.1159/000052694; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Arlet ME, 2009, PRIMATES, V50, P65, DOI 10.1007/s10329-008-0119-9; Baker RL, 1999, J INSECT BEHAV, V12, P213, DOI 10.1023/A:1020966817008; Belsley D., 1980, REGRESSION DIAGNOSTI, P292, DOI DOI 10.1002/0471725153; BERNSTEIN IS, 1986, AM J PRIMATOL, V10, P213, DOI 10.1002/ajp.1350100302; Boydston EE, 2001, ETHOLOGY, V107, P369, DOI 10.1046/j.1439-0310.2001.00672.x; Burbank VK., 1987, BEHAV SCI RES, V21, P70, DOI [10.1177/106939718702100103, DOI 10.1177/106939718702100103]; Castro N, 2006, AGGRESSIVE BEHAV, V32, P474, DOI 10.1002/ab.20147; Charpentier MJE, 2008, CONSERV GENET, V9, P1605, DOI 10.1007/s10592-007-9499-4; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Charpentier MJE, 2008, BEHAV GENET, V38, P151, DOI 10.1007/s10519-008-9191-6; CHENEY DL, 1977, BEHAV ECOL SOCIOBIOL, V2, P303, DOI 10.1007/BF00299742; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; De Waal FBM, 2007, CHIMPANZEE POLITICS, P235; Drea CM, 2008, J MORPHOL, V269, P451, DOI 10.1002/jmor.10594; Drea CM, 2007, HORM BEHAV, V51, P555, DOI 10.1016/j.yhbeh.2007.02.006; Drea CM, 2011, HORM BEHAV, V59, P417, DOI 10.1016/j.yhbeh.2010.09.011; Drea CM, 2005, INTEGR COMP BIOL, V45, P915, DOI 10.1093/icb/45.5.915; Drea CM, 2002, P ROY SOC B-BIOL SCI, V269, P1981, DOI 10.1098/rspb.2002.2109; Drews C, 1996, BEHAVIOUR, V133, P443, DOI 10.1163/156853996X00530; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Dunbar RIM, 1984, REPROD DECISIONS EC, P265; Eklund A, 1996, BEHAVIOUR, V133, P883, DOI 10.1163/156853996X00297; Erhart EM, 2008, INT J PRIMATOL, V29, P1227, DOI 10.1007/s10764-008-9287-0; FAIRBANKS LA, 1993, BEHAVIOUR, V124, P57, DOI 10.1163/156853993X00506; Fedigan LM, 1997, AM J PHYS ANTHROPOL, V102, P161, DOI 10.1002/(SICI)1096-8644(199702)102:2<161::AID-AJPA2>3.0.CO;2-1; Forster S, 2002, GUENONS DIVERSITY AD, P245; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; FRANK LG, 1995, NATURE, V377, P584, DOI 10.1038/377584b0; Glickman Stephen E., 1993, Perspectives in Ethology, V10, P87; Gould L, 2007, AM J PRIMATOL, V69, P1325, DOI 10.1002/ajp.20438; Gould L, 2003, AM J PHYS ANTHROPOL, V120, P182, DOI 10.1002/ajpa.10151; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Hausfater G, 2008, INFANTICIDE COMP EVO, P598; Hood LC, 1995, INT J PRIMATOL, V16, P997, DOI 10.1007/BF02696113; HOOD LC, 1994, AM J PRIMATOL, V33, P65, DOI 10.1002/ajp.1350330107; Hooley JM, 1983, PRIMATE SOCIAL RELAT, P142; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hrdy SB, 1984, INFANTICIDE COMP EVO; Huntingford F., 1987, ANIMAL CONFLICT, P460; Ichino S, 2005, AM J PRIMATOL, V67, P267, DOI 10.1002/ajp.20183; Isbell LA, 1991, BEHAV ECOL, V2, P143, DOI 10.1093/beheco/2.2.143; JOLLY A, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P85; Jolly A, 2000, INT J PRIMATOL, V21, P21, DOI 10.1023/A:1005467411880; Jolly A., 1966, LEMUR BEHAV MADAGASC, P187; Kaplan J, 1987, COMP BEHAV AFRICAN M, P127; KOYAMA N, 1991, PRIMATOLOGY TODAY, P173; Koyama N, 2002, PRIMATES, V43, P291, DOI 10.1007/BF02629604; Koyama N, 2001, PRIMATES, V42, P1, DOI 10.1007/BF02640684; Lindenfors P, 2011, ADV GENET, V75, P7, DOI 10.1016/B978-0-12-380858-5.00009-5; Lorenz K, 1966, AGGRESSION, P306; MARLER P, 1976, AM PSYCHOL, V31, P239, DOI 10.1037/0003-066X.31.3.239; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MOSES LE, 1992, AM J PRIMATOL, V28, P49, DOI 10.1002/ajp.1350280105; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nakamichi M, 1997, INT J PRIMATOL, V18, P73, DOI 10.1023/A:1026393223883; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Parga JA, 2005, ZOO BIOL, V24, P295, DOI 10.1002/zoo.20062; Parga JA, 2012, AM J PHYS ANTHROPOL, V147, P21, DOI 10.1002/ajpa.21603; Parmigiani S., 1994, INFANTICIDE PARENTAL, P496; Pereira ME, 1997, BEHAVIOUR, V134, P225, DOI 10.1163/156853997X00467; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Pereira Michael E., 1993, P285; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; RUTBERG AT, 1990, ANIM BEHAV, V40, P322, DOI 10.1016/S0003-3472(05)80927-3; Sauther Michelle L., 2006, P313, DOI 10.1007/978-0-387-34126-2_18; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Sauther ML, 2002, AM J PHYS ANTHROPOL, V117, P122, DOI 10.1002/ajpa.10016; SAUTHER ML, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P135; SAUTHER ML, 1991, AM J PHYS ANTHROPOL, V84, P463, DOI 10.1002/ajpa.1330840409; SHELLY TE, 1985, ANIM BEHAV, V33, P1211, DOI 10.1016/S0003-3472(85)80181-0; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Starling AP, 2010, HORM BEHAV, V57, P76, DOI 10.1016/j.yhbeh.2009.09.016; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; SUSSMAN RW, 1991, AM J PHYS ANTHROPOL, V84, P43, DOI 10.1002/ajpa.1330840105; SUSSMAN RW, 1995, EVOL ANTHROPOL, V3, P149; Takahata Y, 2008, PRIMATES, V49, P135, DOI 10.1007/s10329-007-0076-8; TAYLOR L, 1985, INT J PRIMATOL, V6, P601, DOI 10.1007/BF02692291; Tiira K, 2003, MOL ECOL, V12, P2399, DOI 10.1046/j.1365-294X.2003.01925.x; VICK LG, 1989, BEHAV ECOL SOCIOBIOL, V25, P3, DOI 10.1007/BF00299705; Wang XT, 2009, EVOL HUM BEHAV, V30, P77, DOI 10.1016/j.evolhumbehav.2008.09.006; WILSON AP, 1970, ANIM BEHAV, V18, P719, DOI 10.1016/0003-3472(70)90017-5; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Wrangham R, 1997, DEMONIC MALES APES O, P350	91	17	17	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82830	10.1371/journal.pone.0082830	http://dx.doi.org/10.1371/journal.pone.0082830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367560	Green Published, gold			2022-12-25	WOS:000328740300073
J	Cuny, C; Layer, F; Kock, R; Werner, G; Witte, W				Cuny, Christiane; Layer, Franziska; Koeck, Robin; Werner, Guido; Witte, Wolfgang			Methicillin Susceptible Staphylococcus aureus (MSSA) of Clonal Complex CC398, t571 from Infections in Humans Are Still Rare in Germany	PLOS ONE			English	Article							NEW-YORK; RESISTANT; ST398; EMERGENCE; GENE; MRSA; PREVALENCE; ANIMALS; PORCINE; ERM(T)	Methicillin-susceptible Staphylococcus aureus (MSSA) attributed to clonal complex (CC) 398 and exhibiting spa-type t571 received attention in Europe and in the USA for being associated with severe infections in humans. As this spa-type is exhibited by livestock-associated (LA) Methicillin-resistant S. aureus (MRSA) as well, it is important to discriminate LA- and human-derived strains by easy to perform, PCR-based methods. MSSA t571 contain phage int3 carrying scn and chp, whereas LA-MRSA t571 lack these markers. In contrast, pathogenicity island SaPIbov5 (detected by PCR bridging vwbbov and scn) is contained by LA-MRSA t571 and absent in the human MSSA subpopulation. Furthermore, MSSA t571 contain erm(T), the particular genomic arrangement of which was assessed by a PCR bridging erm(T) and the adjacent transposase gene. MSSA t571 are rare so far in Germany among isolates from infections in humans (0.14%) as well as among isolates from nasal colonization (0.13%). LA-MRSA t571 are also infrequent among MRSA isolated from carriage at admission to hospitals (0.1%) and also among isolates from infections in humans (0.013%).	[Cuny, Christiane; Layer, Franziska; Werner, Guido] Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany; [Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Witte, Wolfgang] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute; University of Munster; Robert Koch Institute	Cuny, C (corresponding author), Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany.	cunych@rki.de	Köck, Robin/AAC-1552-2019	Layer, Franziska/0000-0002-4613-6478	German Federal Ministry of Education and Research [01KI1014G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding came from Grant 01KI1014G from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, APPL ENVIRON MICROB, V76, P652, DOI 10.1128/AEM.01721-09; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Cuny C, 2013, INT J MED MICROBIO S, VS1438-4221; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P3275, DOI 10.1128/AAC.00171-13; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Holtfreter S, 2012, CLONAL DISTRIBUTION; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Meyer M., 1967, INT J SYST BACTERIOL, V17, P387; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vogel U, 2012, J CLIN MICROBIOL, V50, P1889, DOI 10.1128/JCM.00038-12; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	35	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83165	10.1371/journal.pone.0083165	http://dx.doi.org/10.1371/journal.pone.0083165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367584	Green Published, gold			2022-12-25	WOS:000328740300095
J	Dingle, BM; Liu, YY; Fatheree, NY; Min, J; Rhoads, JM; Tran, DQ				Dingle, Bridgette M.; Liu, Yuying; Fatheree, Nicole Y.; Min, Juleen; Rhoads, J. Marc; Tran, Dat Q.			FoxP3(+) Regulatory T Cells Attenuate Experimental Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; INTESTINAL HOMEOSTASIS; AUTOIMMUNE-DISEASES; LAMINA PROPRIA; ONTOGENY; THERAPY; RAT; TRANSPLANTATION; PREVENTION	Necrotizing enterocolitis (NEC) results from severe intestinal inflammation in premature infants. FoxP3(+) regulatory T cells (Tregs) are central to gut homeostasis. While Treg proportions are significantly reduced in the ileums of premature infants with NEC, it is unknown whether they play a critical function in preventing NEC. This study investigated Treg development in newborn rat pups and their role in experimental NEC induction. Utilizing an established rat model of experimental NEC, the ontogeny of T cells and Tregs in newborn pups was characterized by flow cytometry. To investigate the functions of Tregs, newborn pups were given Tregs harvested from adult rats prior to NEC induction to assess clinical improvement and mechanisms of immune regulation. The results revealed that there were few Treg numbers in the terminal ileums of newborn rats and 8-fold reduction after NEC. Adoptive transfer of Tregs significantly improved weight loss, survival from 53% to 88%, and NEC incidence from 87% to 35%. The Tregs modulated the immune response as manifested in reduced CD80 expression on antigen presenting cells and decreased T cell activation within the mesenteric lymph nodes. These findings suggest that while Tregs are present in the intestines, their numbers might be insufficient to dampen the excessive inflammatory state in NEC. Adoptive transfer of Tregs attenuates the severity of NEC by limiting the immune response. Strategies to enhance Tregs have a therapeutic potential in controlling the development of NEC.	[Dingle, Bridgette M.; Liu, Yuying; Fatheree, Nicole Y.; Min, Juleen; Rhoads, J. Marc; Tran, Dat Q.] Univ Texas Med Sch, Dept Pediat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Tran, DQ (corresponding author), Univ Texas Med Sch, Dept Pediat, Houston, TX USA.	dat.q.tran@uth.tmc.edu	Liu, Yuying/ABB-8417-2021	Liu, Yuying/0000-0003-3848-9254	National Institutes of Health [1R01HL113304-01]; Richard W. Mithoff Endowed Chair; Pediatric Department; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard W. Mithoff Endowed Chair; Pediatric Department; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Pediatric Department start-up fund and by a grant from the National Institutes of Health (1R01HL113304-01) to DQT and supplemented with funding from Richard W. Mithoff Endowed Chair (Kathleen A. Kennedy MD, MPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Collins CB, 2012, GUT, V61, P1154, DOI 10.1136/gutjnl-2011-300820; Davidson TS, 2011, EUR J IMMUNOL, V41, P2862, DOI 10.1002/eji.201141503; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Dvorak B, 2008, J PEDIATR GASTR NUTR, V47, P11, DOI 10.1097/MPG.0b013e3181788618; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Hardenberg G, 2011, SEMIN IMMUNOL, V23, P130, DOI 10.1016/j.smim.2011.01.012; Henry Marion C W, 2005, Semin Pediatr Surg, V14, P181, DOI 10.1053/j.sempedsurg.2005.05.007; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lan Q, 2012, J MOL CELL BIOL, V4, P409, DOI 10.1093/jmcb/mjs040; Liedel JL, 2011, PEDIATR RES, V69, P395, DOI 10.1203/PDR.0b013e3182114ec9; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Moraes-Vasconcelos D, 2008, J CLIN IMMUNOL, V28, pS11, DOI 10.1007/s10875-008-9176-5; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Neu Josef, 2008, Curr Gastroenterol Rep, V10, P450, DOI 10.1007/s11894-008-0084-x; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tayman C, 2011, PEDIATR RES, V70, P489, DOI 10.1203/PDR.0b013e31822d7ef2; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2009, HUM IMMUNOL, V70, P294, DOI 10.1016/j.humimm.2009.02.007; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	53	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82963	10.1371/journal.pone.0082963	http://dx.doi.org/10.1371/journal.pone.0082963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367573	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300084
J	Fujiyuki, T; Yoneda, M; Yasui, F; Kuraishi, T; Hattori, S; Kwon, H; Munekata, K; Kiso, Y; Kida, H; Kohara, M; Kai, C				Fujiyuki, Tomoko; Yoneda, Misako; Yasui, Fumihiko; Kuraishi, Takeshi; Hattori, Shosaku; Kwon, Hyun-jeong; Munekata, Keisuke; Kiso, Yuri; Kida, Hiroshi; Kohara, Michinori; Kai, Chieko			Experimental Infection of Macaques with a Wild Water Bird-Derived Highly Pathogenic Avian Influenza Virus (H5N1)	PLOS ONE			English	Article							A VIRUS; MODEL; TRANSMISSION; IMMUNITY; VACCINE	Highly pathogenic avian influenza virus (HPAIV) continues to threaten human health. Non-human primate infection models of human influenza are desired. To establish an animal infection model with more natural transmission and to determine the pathogenicity of HPAIV isolated from a wild water bird in primates, we administered a Japanese isolate of HPAIV (A/whooper swan/Hokkaido/1/2008, H5N1 clade 2.3.2.1) to rhesus and cynomolgus monkeys, in droplet form, via the intratracheal route. Infection of the lower and upper respiratory tracts and viral shedding were observed in both macaques. Inoculation of rhesus monkeys with higher doses of the isolate resulted in stronger clinical symptoms of influenza. Our results demonstrate that HPAIV isolated from a water bird in Japan is pathogenic in monkeys by experimental inoculation, and provide a new method for HPAIV infection of non-human primate hosts, a good animal model for investigation of HPAIV pathogenicity.	[Fujiyuki, Tomoko; Yoneda, Misako; Kwon, Hyun-jeong; Kiso, Yuri; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan; [Yasui, Fumihiko; Munekata, Keisuke; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Kuraishi, Takeshi; Hattori, Shosaku] Univ Tokyo, Amami Lab Injurious Anim, Inst Med Sci, Kagoshima, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan	University of Tokyo; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Hokkaido University	Kai, C (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan.	ckai@ims.u-tokyo.ac.jp	Fujiyuki, Tomoko Kaito/GYD-6398-2022	Fujiyuki, Tomoko Kaito/0000-0001-5533-4129	Ministry of Education, Science, Culture, and Sports, Japan	Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Science, Culture, and Sports, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gao RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013315; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Kida H, 2006, DEV BIOLOGICALS, V124, P69; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; SASLAW S, 1946, J EXP MED, V84, P113, DOI 10.1084/jem.84.2.113; Sirinonthanawech N, 2011, J MED VIROL, V83, P1418, DOI 10.1002/jmv.22146; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki E, 2008, J MED VIROL, V80, P1065, DOI 10.1002/jmv.21144; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; WHEELDON EB, 1992, LAB ANIM, V26, P29, DOI 10.1258/002367792780809020; Williams PD, 1997, TOXICOL METHOD, V7, P1; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	26	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83551	10.1371/journal.pone.0083551	http://dx.doi.org/10.1371/journal.pone.0083551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367600	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300109
J	Horanont, T; Phithakkitnukoon, S; Leong, TW; Sekimoto, Y; Shibasaki, R				Horanont, Teerayut; Phithakkitnukoon, Santi; Leong, Tuck W.; Sekimoto, Yoshihide; Shibasaki, Ryosuke			Weather Effects on the Patterns of People's Everyday Activities: A Study Using GPS Traces of Mobile Phone Users	PLOS ONE			English	Article								This study explores the effects that the weather has on people's everyday activity patterns. Temperature, rainfall, and wind speed were used as weather parameters. People's daily activity patterns were inferred, such as place visited, the time this took place, the duration of the visit, based on the GPS location traces of their mobile phones overlaid upon Yellow Pages information. Our analysis of 31,855 mobile phone users allowed us to infer that people were more likely to stay longer at eateries or food outlets, and (to a lesser degree) at retail or shopping areas when the weather is very cold or when conditions are calm (non-windy). When compared to people's regular activity patterns, certain weather conditions affected people's movements and activities noticeably at different times of the day. On cold days, people's activities were found to be more diverse especially after 10AM, showing greatest variations between 2PM and 6PM. A similar trend is observed between 10AM and midnight on rainy days, with people's activities found to be most diverse on days with heaviest rainfalls or on days when the wind speed was stronger than 4 km/h, especially between 10AM-1AM. Finally, we observed that different geographical areas of a large metropolis were impacted differently by the weather. Using data of urban infrastructure to characterize areas, we found strong correlations between weather conditions upon people's accessibility to trains. This study sheds new light on the influence of weather conditions on human behavior, in particular the choice of daily activities and how mobile phone data can be used to investigate the influence of environmental factors on urban dynamics.	[Horanont, Teerayut; Sekimoto, Yoshihide; Shibasaki, Ryosuke] Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo, Japan; [Phithakkitnukoon, Santi] Open Univ, Comp & Commun Dept, Milton Keynes MK7 6AA, Bucks, England; [Leong, Tuck W.] Univ Technol Sydney, Fac Engn & IT, Sydney, NSW 2007, Australia	University of Tokyo; Open University - UK; University of Technology Sydney	Horanont, T (corresponding author), Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo, Japan.	teerayut@iis.u-tokyo.ac.jp	Phithakkitnukoon, Santi/E-4204-2015; Leong, Tuck W/C-7936-2017	Phithakkitnukoon, Santi/0000-0002-5716-9363; Leong, Tuck W/0000-0002-1021-9001	DIAS (Data Integration and Analysis System); GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology	DIAS (Data Integration and Analysis System); GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology	This work was supported by the DIAS (Data Integration and Analysis System) and GRENE (Green Net- work of Excellence) project of Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2005, DOTF17007 IOW STAT U; Akhtari M, 2011, MICHIGAN J BUSINESS, V4, P51; [Anonymous], DOES IT FEEL; Calabrese F., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P312, DOI 10.1109/ITSC.2010.5625119; CHARRY JM, 1981, J PERS SOC PSYCHOL, V41, P185, DOI 10.1037/0022-3514.41.1.185; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Edwards C, 2010, NEW ELECTRON, V43, P19; Gonzalez MC, 2009, NATURE, V458, DOI 10.1038/nature07850; HOWARTH E, 1984, BRIT J PSYCHOL, V75, P15, DOI 10.1111/j.2044-8295.1984.tb02785.x; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Maze TH, 2005, TRANSPORT RES REC, P1; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Phithakkitnukoon S, 2012, PLOS ONE, V7; Phithakkitnukoon S, 2010, ACTIVITY AWARE MAP I, P14; Phithakkitnukoon S, 2012, PLOS ONE, V10; SAUNDERS EM, 1993, AM ECON REV, V83, P1337; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Statistics Bureau Ministry of Internal and Communications, 2006, 2006 EST ENT CENS; Tokyo Metropolitan Archaeological Centre, 1998, OW SIT 3; Trenberth KE, 2002, EFFECTS CHANGING CLI; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Zenrin: Maps to the Future, MAPS FUT TEL PACK	28	59	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81153	10.1371/journal.pone.0081153	http://dx.doi.org/10.1371/journal.pone.0081153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367481	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000328740300003
J	Kennedy, BE; LeBlanc, VG; Mailman, TM; Fice, D; Burton, I; Karakach, TK; Karten, B				Kennedy, Barry E.; LeBlanc, Veronique G.; Mailman, Tiffany M.; Fice, Debra; Burton, Ian; Karakach, Tobias K.; Karten, Barbara			Pre-Symptomatic Activation of Antioxidant Responses and Alterations in Glucose and Pyruvate Metabolism in Niemann-Pick Type C1-Deficient Murine Brain	PLOS ONE			English	Article							LIPID STORAGE DISORDER; N-TERMINAL KINASE; NCTR-BALB/C MICE; DISEASE TYPE-C; OXIDATIVE STRESS; RAT-BRAIN; CHOLESTEROL ACCUMULATION; DEHYDROGENASE ACTIVITY; NEURONAL CHOLESTEROL; HEME OXYGENASE-1	Niemann-Pick Type C (NPC) disease is an autosomal recessive neurodegenerative disorder caused in most cases by mutations in the NPC1 gene. NPC1-deficiency is characterized by late endosomal accumulation of cholesterol, impaired cholesterol homeostasis, and a broad range of other cellular abnormalities. Although neuronal abnormalities and glial activation are observed in nearly all areas of the brain, the most severe consequence of NPC1-deficiency is a near complete loss of Purkinje neurons in the cerebellum. The link between cholesterol trafficking and NPC pathogenesis is not yet clear; however, increased oxidative stress in symptomatic NPC disease, increases in mitochondrial cholesterol, and alterations in autophagy/mitophagy suggest that mitochondria play a role in NPC disease pathology. Alterations in mitochondrial function affect energy and neurotransmitter metabolism, and are particularly harmful to the central nervous system. To investigate early metabolic alterations that could affect NPC disease progression, we performed metabolomics analyses of different brain regions from age-matched wildtype and Npc1(-/-) mice at pre-symptomatic, early symptomatic and late stage disease by H-1-NMR spectroscopy. Metabolic profiling revealed markedly increased lactate and decreased acetate/acetyl-CoA levels in Npc1(-/-) cerebellum and cerebral cortex at all ages. Protein and gene expression analyses indicated a pre-symptomatic deficiency in the oxidative decarboxylation of pyruvate to acetyl-CoA, and an upregulation of glycolytic gene expression at the early symptomatic stage. We also observed a pre-symptomatic increase in several indicators of oxidative stress and antioxidant response systems in Npc1(-/-) cerebellum. Our findings suggest that energy metabolism and oxidative stress may present additional therapeutic targets in NPC disease, especially if intervention can be started at an early stage of the disease.	[Kennedy, Barry E.; LeBlanc, Veronique G.; Mailman, Tiffany M.; Fice, Debra; Karten, Barbara] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Burton, Ian; Karakach, Tobias K.] Natl Res Council Canada, Inst Marine Biosci, Halifax, NS, Canada	Dalhousie University; International Business Machines (IBM); National Research Council Canada	Karten, B (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	bkarten@dal.ca		Karakach, Tobias/0000-0003-2460-3781; Karten, Barbara/0000-0003-2395-3333	Nova Scotia Health Research Foundation (NSHRF) [MED-PROJECT-2010-6804]; Canadian Institutes of Health Research (CIHR) [MOP 110926]; NSHRF [MED-SS-2012-8683, RSH-84188]; CIHR	Nova Scotia Health Research Foundation (NSHRF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSHRF; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Nova Scotia Health Research Foundation (NSHRF; MED-PROJECT-2010-6804) and the Canadian Institutes of Health Research (CIHR; MOP 110926). BEK was supported by a postgraduate fellowship from the NSHRF (MED-SS-2012-8683). BK received salary support from the CIHR in regional partnership with the NSHRF (RSH-84188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bolton RJ, 2003, J COMPUT GRAPH STAT, V12, P121, DOI 10.1198/1061860031374; Brouns R, 2008, CLIN CHIM ACTA, V397, P27, DOI 10.1016/j.cca.2008.07.016; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1610, DOI 10.1089/ars.2011.4109; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Charman M, 2010, J LIPID RES, V51, P1023, DOI 10.1194/jlr.M002345; Choi JS, 2010, BIOCHEM BIOPH RES CO, V391, P147, DOI 10.1016/j.bbrc.2009.11.022; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2013, J INHERIT METAB DIS; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Correia SC, 2010, J NEUROCHEM, V112, P1, DOI 10.1111/j.1471-4159.2009.06443.x; Daszykowski M, 2005, CHEMOMETR INTELL LAB, V78, P19, DOI 10.1016/j.chemolab.2004.12.002; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; de Graaf RA, 2011, NMR BIOMED, V24, P958, DOI 10.1002/nbm.1761; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Fu R, 2013, HUM MOL GENET; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; GEKAKIS N, 1994, J BIOL CHEM, V269, P3348; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Hawes CM, 2010, J NEUROCHEM, V114, P311, DOI 10.1111/j.1471-4159.2010.06768.x; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huang JY, 2011, J FORMOS MED ASSOC, V110, P537, DOI 10.1016/S0929-6646(11)60080-6; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Karakach TK, 2009, ANAL CHIM ACTA, V636, P163, DOI 10.1016/j.aca.2009.01.048; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Karten B, 2005, BIOCHEM J, V387, P779, DOI 10.1042/BJ20041694; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kreft M, 2012, ASN NEURO, V4, DOI 10.1042/AN20120007; Kumar A, 2011, PEDIATR NEUROL, V44, P57, DOI 10.1016/j.pediatrneurol.2010.08.004; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; MacLellan DL, 2011, MOL BIOSYST, V7, P2181, DOI 10.1039/c1mb05080j; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; MORRIS MD, 1982, AM J PATHOL, V108, P140; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Quistorff B, 2011, P NATL ACAD SCI USA, V108, pE21, DOI 10.1073/pnas.1017750108; Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Reid PC, 2004, J LIPID RES, V45, P582, DOI 10.1194/jlr.D300032-JLR200; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Rothman DL, 2011, NMR BIOMED, V24, P943, DOI 10.1002/nbm.1772; Santos MS, 2001, DIABETES-METAB RES, V17, P223, DOI 10.1002/dmrr.200; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schousboe A, 2007, NEUROTOX RES, V12, P263, DOI 10.1007/BF03033909; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; SHIO H, 1982, AM J PATHOL, V108, P150; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Soanes KH, 2011, J PROTEOME RES, V10, P5102, DOI 10.1021/pr2005549; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Stacpoole PW, 2012, AGING CELL, V11, P371, DOI 10.1111/j.1474-9726.2012.00805.x; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Suzuki H, 2003, PEDIATR INT, V45, P1, DOI 10.1046/j.1442-200X.2003.01651.x; TRAXINGER RR, 1990, BIOCHEM INT, V22, P607; Tsang TM, 2009, NEUROCHEM RES, V34, P1261, DOI 10.1007/s11064-008-9904-5; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Verwaest KA, 2011, BBA-MOL BASIS DIS, V1812, P1371, DOI 10.1016/j.bbadis.2011.08.001; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; YANG SY, 1987, J BIOL CHEM, V262, P13027; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	115	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82685	10.1371/journal.pone.0082685	http://dx.doi.org/10.1371/journal.pone.0082685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367541	Green Published, gold			2022-12-25	WOS:000328740300056
J	Lengacher, S; Nehiri-Sitayeb, T; Steiner, N; Carneiro, L; Favrod, C; Preitner, F; Thorens, B; Stehle, JC; Dix, L; Pralong, F; Magistretti, PJ; Pellerin, L				Lengacher, Sylvain; Nehiri-Sitayeb, Touria; Steiner, Nadia; Carneiro, Lionel; Favrod, Celine; Preitner, Frederic; Thorens, Bernard; Stehle, Jean-Christophe; Dix, Laure; Pralong, Francois; Magistretti, Pierre J.; Pellerin, Luc			Resistance to Diet-Induced Obesity and Associated Metabolic Perturbations in Haploinsufficient Monocarboxylate Transporter 1 Mice	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; HIGH-FAT DIET; CELLULAR EXPRESSION; LACTATE; MOUSE; RAT; DEFICIENCY; LEPTIN; EXERCISE; MCT1	The monocarboxylate transporter 1 (MCT1 or SLC16A1) is a carrier of short-chain fatty acids, ketone bodies, and lactate in several tissues. Genetically modified C57BL/6J mice were produced by targeted disruption of the mct1 gene in order to understand the role of this transporter in energy homeostasis. Null mutation was embryonically lethal, but MCT1(+/-) mice developed normally. However, when fed high fat diet (HFD), MCT1(+/-) mice displayed resistance to development of diet-induced obesity (24.8% lower body weight after 16 weeks of HFD), as well as less insulin resistance and no hepatic steatosis as compared to littermate MCT1(+/+) mice used as controls. Body composition analysis revealed that reduced weight gain in MCT1(+/-) mice was due to decreased fat accumulation (50.0% less after 9 months of HFD) notably in liver and white adipose tissue. This phenotype was associated with reduced food intake under HFD (12.3% less over 10 weeks) and decreased intestinal energy absorption (9.6% higher stool energy content). Indirect calorimetry measurements showed similar to 15% increase in O-2 consumption and CO2 production during the resting phase, without any changes in physical activity. Determination of plasma concentrations for various metabolites and hormones did not reveal significant changes in lactate and ketone bodies levels between the two genotypes, but both insulin and leptin levels, which were elevated in MCT1(+/+) mice when fed HFD, were reduced in MCT1(+/-) mice under HFD. Interestingly, the enhancement in expression of several genes involved in lipid metabolism in the liver of MCT1(+/+) mice under high fat diet was prevented in the liver of MCT1(+/-) mice under the same diet, thus likely contributing to the observed phenotype. These findings uncover the critical role of MCT1 in the regulation of energy balance when animals are exposed to an obesogenic diet.	[Lengacher, Sylvain; Nehiri-Sitayeb, Touria; Steiner, Nadia; Carneiro, Lionel; Favrod, Celine; Pellerin, Luc] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Lengacher, Sylvain; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain & Mind Inst, Lausanne, Switzerland; [Preitner, Frederic; Thorens, Bernard] Univ Lausanne, Mouse Metab Evaluat Facil, Ctr Integrat Genom, Lausanne, Switzerland; [Stehle, Jean-Christophe; Dix, Laure] CHU Vaudois, Mouse Pathol Facil, Inst Univ Pathol, CH-1011 Lausanne, Switzerland; [Pralong, Francois] CHU Vaudois, Serv Endocrinol Diabetol & Metab, CH-1011 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pellerin, L (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Luc.Pellerin@unil.ch	Lengacher, Sylvain/C-2591-2009; Carneiro, Lionel/AAE-9251-2020; Pellerin, Luc/A-8912-2017	Lengacher, Sylvain/0000-0003-2190-9654; Carneiro, Lionel/0000-0001-8493-4879; Pellerin, Luc/0000-0002-1016-1970; Magistretti, Pierre Julius/0000-0002-6678-320X	Human Frontier Science Program [RG118/1998-B]; Swiss Fonds National de Recherche Scientifique [3100A0-100679, 31003A-112119, 31003A-125063, 31003A-140957]	Human Frontier Science Program(Human Frontier Science Program); Swiss Fonds National de Recherche Scientifique	TNS received the Bernard Beaufrere young investigator prize from the Institut Francais pour la Nutrition. This project, which was initiated in 1998, was initially supported by grant no RG118/1998-B from the Human Frontier Science Program to LP. Then, it received the continuous support from the Swiss Fonds National de Recherche Scientifique through grant nos 3100A0-100679, 31003A-112119, 31003A-125063 and 31003A-140957 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Alvaro A, 2008, IUBMB LIFE, V60, P757, DOI 10.1002/iub.110; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Cha SH, 2009, BIOCHEM BIOPH RES CO, V386, P212, DOI 10.1016/j.bbrc.2009.06.017; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Frederico MJS, 2011, SCAND J GASTROENTERO, V46, P1381, DOI 10.3109/00365521.2011.613945; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Hajduch E, 2000, FEBS LETT, V479, P89, DOI 10.1016/S0014-5793(00)01889-5; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Jang C, 2008, J CELL BIOL, V183, P11, DOI 10.1083/jcb.200807052; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; KATZ J, 1993, J BIOL CHEM, V268, P25509; Kim EJ, 2010, J MED FOOD, V13, P743, DOI 10.1089/jmf.2009.1350; Kokorovic A, 2009, J CELL MOL MED, V13, P4403, DOI 10.1111/j.1582-4934.2008.00596.x; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Maekawa F, 2008, J NEUROCHEM, V107, P789, DOI 10.1111/j.1471-4159.2008.05650.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Powell DR, 2006, OBES REV, V7, P89, DOI 10.1111/j.1467-789X.2006.00220.x; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; TRISCARI J, 1982, METABOLISM, V31, P223, DOI 10.1016/0026-0495(82)90057-9; van Dyken R, 2010, PSYCHONEUROENDOCRINO, V35, P1287, DOI 10.1016/j.psyneuen.2010.02.016; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; WINDER WW, 1975, CAN J PHYSIOL PHARM, V53, P86, DOI 10.1139/y75-011; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zambell KL, 2003, J NUTR, V133, P3509, DOI 10.1093/jn/133.11.3509; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	49	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82505	10.1371/journal.pone.0082505	http://dx.doi.org/10.1371/journal.pone.0082505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367518	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300035
J	Long, X; Stone, MD				Long, Xi; Stone, Michael D.			Kinetic Partitioning Modulates Human Telomere DNA G-Quadruplex Structural Polymorphism	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; G-QUARTET FORMATION; CRYSTAL-STRUCTURE; K+ SOLUTION; POTASSIUM SOLUTION; MOLECULE; FLUORESCENCE; REPEAT; SPECTROSCOPY; STABILITY	Telomeres are specialized chromatin structures found at the end of chromosomes and are crucial to the maintenance of eukaryotic genome stability. Human telomere DNA is comprised of the repeating sequence (T(2)AG(3))(n), which is predominantly double-stranded but terminates with a 3 ' single-stranded tail. The guanine-rich tail can fold into secondary structures known as a G-quadruplexes (GQs) that may exist as a polymorphic mixture of anti-parallel, parallel, and several hybrid topological isomers. Using single-molecule Forster resonance energy transfer (smFRET), we have reconstructed distributions of telomere DNA GQ conformations generated by an in situ refolding protocol commonly employed in single-molecule studies of GQ structure, or using a slow cooling DNA annealing protocol typically used in the preparation of GQ samples for ensemble biophysical analyses. We find the choice of GQ folding protocol has a marked impact on the observed distributions of DNA conformations under otherwise identical buffer conditions. A detailed analysis of the kinetics of GQ folding over timescales ranging from minutes to hours revealed the distribution of GQ structures generated by in situ refolding gradually equilibrates to resemble the distribution generated by the slow cooling DNA annealing protocol. Interestingly, conditions of low ionic strength, which promote transient GQ unfolding, permit the fraction of folded DNA molecules to partition into a distribution that more closely approximates the thermodynamic folding equilibrium. Our results are consistent with a model in which kinetic partitioning occurs during in situ folding at room temperature in the presence of K+ ions, producing a long-lived non-equilibrium distribution of GQ structures in which the parallel conformation predominates on the timescale of minutes. These results suggest that telomere DNA GQ folding kinetics, and not just thermodynamic stability, likely contributes to the physiological ensemble GQ structures.	[Long, Xi; Stone, Michael D.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Stone, Michael D.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Stone, MD (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	mds@ucsc.edu			NIH [GM095850]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the following grants: NIH GM095850 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti P, 2003, P NATL ACAD SCI USA, V100, P1569, DOI 10.1073/pnas.0335459100; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Antonacci C, 2007, BIOCHEMISTRY-US, V46, P4654, DOI 10.1021/bi602511p; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; Gray DM, 2008, CHIRALITY, V20, P431, DOI 10.1002/chir.20455; Gray RD, 2009, J PHYS CHEM B, V113, P2676, DOI 10.1021/jp809578f; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Jena PV, 2009, J AM CHEM SOC, V131, P12522, DOI 10.1021/ja903408r; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Li W, 2013, J AM CHEM SOC, V135, P6423, DOI 10.1021/ja4019176; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; LUSTIG AJ, 1992, NUCLEIC ACIDS RES, V20, P3021, DOI 10.1093/nar/20.12.3021; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Patel PK, 1999, NUCLEIC ACIDS RES, V27, P2457, DOI 10.1093/nar/27.12.2457; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sannohe Y, 2010, CURR PROTOC NUCL ACI; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Viglasky V, 2011, EUR BIOPHYS J BIOPHY, V40, P29, DOI 10.1007/s00249-010-0625-8; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100	36	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83420	10.1371/journal.pone.0083420	http://dx.doi.org/10.1371/journal.pone.0083420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367594	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300104
J	Martinelli, P; Sperduti, M; Devauchelle, AD; Kalenzaga, S; Gallarda, T; Lion, S; Delhommeau, M; Anssens, A; Amado, I; Meder, JF; Krebs, MO; Oppenheim, C; Piolino, P				Martinelli, Penelope; Sperduti, Marco; Devauchelle, Anne-Dominique; Kalenzaga, Sandrine; Gallarda, Thierry; Lion, Stephanie; Delhommeau, Marion; Anssens, Adele; Amado, Isabelle; Meder, Jean Francois; Krebs, Marie-Odile; Oppenheim, Catherine; Piolino, Pascale			Age-Related Changes in the Functional Network Underlying Specific and General Autobiographical Memory Retrieval: A Pivotal Role for the Anterior Cingulate Cortex	PLOS ONE			English	Article							WORKING-MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; EXECUTIVE FUNCTIONS; PERSONAL EVENTS; COUNTING STROOP; OLDER-ADULTS; SELF; NEUROANATOMY; BRAIN	Age-related changes in autobiographical memory (AM) recall are characterized by a decline in episodic details, while semantic aspects are spared. This deleterious effect is supposed to be mediated by an inefficient recruitment of executive processes during AM retrieval. To date, contrasting evidence has been reported on the neural underpinning of this decline, and none of the previous studies has directly compared the episodic and semantic aspects of AM in elderly. We asked 20 young and 17 older participants to recall specific and general autobiographical events (i.e., episodic and semantic AM) elicited by personalized cues while recording their brain activity by means of fMRI. At the behavioral level, we confirmed that the richness of episodic AM retrieval is specifically impoverished in aging and that this decline is related to the reduction of executive functions. At the neural level, in both age groups, we showed the recruitment of a large network during episodic AM retrieval encompassing prefrontal, cortical midline and posterior regions, and medial temporal structures, including the hippocampus. This network was very similar, but less extended, during semantic AM retrieval. Nevertheless, a greater activity was evidenced in the dorsal anterior cingulate cortex (dACC) during episodic, compared to semantic AM retrieval in young participants, and a reversed pattern in the elderly. Moreover, activity in dACC during episodic AM retrieval was correlated with inhibition and richness of memories in both groups. Our findings shed light on the direct link between episodic AM retrieval, executive control, and their decline in aging, proposing a possible neuronal signature. They also suggest that increased activity in dACC during semantic AM retrieval in the elderly could be seen as a compensatory mechanism underpinning successful AM performance observed in aging. These results are discussed in the framework of recently proposed models of neural reorganization in aging.	[Martinelli, Penelope; Sperduti, Marco; Kalenzaga, Sandrine; Delhommeau, Marion; Anssens, Adele; Piolino, Pascale] Univ Paris 05, Lab Memory & Cognit, Boulogne, France; [Martinelli, Penelope; Sperduti, Marco; Kalenzaga, Sandrine; Gallarda, Thierry; Delhommeau, Marion; Anssens, Adele; Amado, Isabelle; Krebs, Marie-Odile; Piolino, Pascale] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France; [Devauchelle, Anne-Dominique; Lion, Stephanie; Meder, Jean Francois; Oppenheim, Catherine] Univ Paris 05, Dept Radiol, Ctr Psychiat & Neurosci, INSERM,U894, Paris, France; [Gallarda, Thierry; Amado, Isabelle; Krebs, Marie-Odile] Ctr Hosp St Anne, Lab Physiopathol Psychiat Dis, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Piolino, P (corresponding author), Univ Paris 05, Lab Memory & Cognit, Boulogne, France.	pascale.piolino@parisdescartes.fr	Sperduti, Marco/AFN-4311-2022; Krebs, Marie-Odile/O-2104-2017; Piolino, pascale/F-8075-2014; Oppenheim, Catherine/N-1635-2018	Krebs, Marie-Odile/0000-0002-4715-9890; Piolino, pascale/0000-0002-7787-924X; Lion, Stephanie/0000-0003-4195-1892; Meder, Jean-Francois/0000-0002-0898-0133; Oppenheim, Catherine/0000-0003-3410-0862; Sperduti, Marco/0000-0002-0974-8811	National Hospital Clinical Research Program (NEMAUVI); Institut Universitaire de France; Ministry of Higher Education and Research of France	National Hospital Clinical Research Program (NEMAUVI); Institut Universitaire de France; Ministry of Higher Education and Research of France	This work was supported by the National Hospital Clinical Research Program (NEMAUVI to TG and PP), the Institut Universitaire de France (to PP), and the Ministry of Higher Education and Research of France (thesis funding to PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2011, NEUROPSYCHOLOGIA, V49, P3656, DOI 10.1016/j.neuropsychologia.2011.09.021; Addis DR, 2004, NEUROIMAGE, V23, P1460, DOI 10.1016/j.neuroimage.2004.08.007; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 1986, AUTOBIOGRAPHICAL MEM, P225; Baena E, 2010, NEUROPSYCHOLOGIA, V48, P319, DOI 10.1016/j.neuropsychologia.2009.09.021; Barsalou L.W., 1988, REMEMBERING RECONSID, P193, DOI [10.1017/CBO9780511664014.009, DOI 10.1017/CBO9780511664014.009]; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2001, J MEM LANG, V45, P493, DOI 10.1006/jmla.2001.2781; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Deltour J. J., 1993, ECHELLE VOCABULAIRE; Denkova E, 2006, NEUROSCI LETT, V407, P32, DOI 10.1016/j.neulet.2006.07.075; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P383, DOI 10.1093/arclin/acq037; Ford JH, 2011, NEUROPSYCHOLOGIA, V49, P2514, DOI 10.1016/j.neuropsychologia.2011.04.032; Gardini S, 2006, NEUROIMAGE, V30, P645, DOI 10.1016/j.neuroimage.2005.10.012; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Holland AC, 2011, NEUROPSYCHOLOGIA, V49, P3164, DOI 10.1016/j.neuropsychologia.2011.07.015; HOLLAND CA, 1990, Q J EXP PSYCHOL-A, V42, P441, DOI 10.1080/14640749008401232; Jacques PLS, 2012, NEUROBIOL AGING, V33, P1298, DOI 10.1016/j.neurobiolaging.2010.11.007; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2003, BRAIN, V126, P1511, DOI 10.1093/brain/awg157; Martinelli P, 2013, NEUROPSYCHOLOGY, V27, P69, DOI 10.1037/a0030453; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Nadel L., 2007, NEURAL PLASTICITY, V90472; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park D. C., 2005, COGNITIVE NEUROSCIEN, P218; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Picard L, 2012, CHILD DEV, V83, P1037, DOI 10.1111/j.1467-8624.2012.01736.x; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2008, HIPPOCAMPUS, V18, P445, DOI 10.1002/hipo.20406; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter-Lorenz P. A., 2005, COGNITIVE NEUROSCIEN, P186, DOI DOI 10.1093/ACPROF:OSO/9780195156744.003.0003; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Ros L, 2010, AGING NEUROPSYCHOL C, V17, P89, DOI 10.1080/13825580903042650; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sperduti M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00041; St Jacques PL, 2007, MEMORY, V15, P129, DOI 10.1080/09658210601119762; St-Laurent M, 2011, J COGNITIVE NEUROSCI, V23, P4150, DOI 10.1162/jocn_a_00079; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaidya JG, 2007, NEUROIMAGE, V37, P1346, DOI 10.1016/j.neuroimage.2007.06.015; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; Wechsler D, 2000, ECHELLE INTELLIGENCE; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	79	37	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82385	10.1371/journal.pone.0082385	http://dx.doi.org/10.1371/journal.pone.0082385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367516	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300032
J	Richel, O; De Vries, HJC; Dijkgraaf, MGW; Van Noesel, CJM; Prins, JM				Richel, Olivier; De Vries, Henry J. C.; Dijkgraaf, Marcel G. W.; Van Noesel, Carel J. M.; Prins, Jan M.			Risk Factors for the Presence of Anal Intraepithelial Neoplasia in HIV plus Men Who Have Sex with Men	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; POSITIVE MEN; CANCER PRECURSORS; HIGH PREVALENCE; HOMOSEXUAL-MEN; LESIONS; HPV; PROGRESSION; POPULATION	Objective: Anal Intraepithelial Neoplasia (AIN) is present in the majority of HIV+ men who have sex with men (MSM) and routine AIN-screening is subject of discussion. In this study we analysed a wide range of potential risk factors for AIN in order to target screening programs. Methods: We screened 311 HIV+ MSM by high resolution anoscopy, with biopsies of suspect lesions. HIV-parameters, previous sexual transmitted infections (STI's), anal pathology, sexual practices and substance use were analysed in relation to AIN by uni-and multivariable logistic regression. Results: AIN (any grade) was found in 175/311 MSM (56%), high grade (HG) AIN in 30%. In the univariable analysis, years since HIV diagnosis, years of antiretroviral therapy (cART) and anal XTC use decreased AIN risk, while a history of anogenital warts and use of GHB (gamma-hydroxybutyric acid) increased this risk. In the multivariable analysis three parameters remained significant: years of cART (OR=0.92 per year, p=0.003), anal XTC use (OR=0.10, p=0.002) and GHB use (OR=2.60, p=0.003). No parameters were significantly associated with HGAIN, but there was a trend towards increased risk with anal enema use prior to sex (>50 times ever; p=0.07) and with a history of AIN (p=0.06). CD4 count, STI's, anal pathology, smoking, number of sex partners and anal fisting were not associated with (HG) AIN. Conclusion: GHB use increases the risk for AIN, while duration of cART and anal XTC use are negatively correlated with AIN. Given the high prevalence of AIN in HIV+ MSM, these associations are not helpful to guide a screening program.	[Richel, Olivier; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [De Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Van Noesel, Carel J. M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Richel, Olivier; De Vries, Henry J. C.; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [De Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Cluster Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Richel, O (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands.	o.richel@amc.nl	de Vries, Henry/K-5963-2012; Prins, Jan M./AAF-4945-2020; Dijkgraaf, Marcel GW/G-6663-2011; Richel, Olivier/AAG-2314-2019	de Vries, Henry/0000-0001-9784-547X; Prins, Jan/0000-0002-5415-8933	Maurits and Anna de Cock Foundation	Maurits and Anna de Cock Foundation	This study received a grant for equipment needed for high resolution anoscopy from the Maurits and Anna de Cock Foundation, a non profit organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2010, AIDS, V24, P2355, DOI 10.1097/QAD.0b013e32833db9ea; Barker JC, 2007, J PSYCHOACTIVE DRUGS, V39, P115, DOI 10.1080/02791072.2007.10399870; Berry J Michael, 2004, Surg Oncol Clin N Am, V13, P355; Boyle NT, 2010, BRIT J PHARMACOL, V161, P17, DOI 10.1111/j.1476-5381.2010.00899.x; Chin-Hong PV, 2005, JNCI-J NATL CANCER I, V97, P896, DOI 10.1093/jnci/dji163; Ciobotaru B, 2007, DIS COLON RECTUM, V50, P1011, DOI 10.1007/s10350-006-0873-y; Conley L, 2010, J INFECT DIS, V202, P1567, DOI 10.1086/656775; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; De Vries HJC, 2008, SEX TRANSM DIS, V35, P203, DOI 10.1097/OLQ.0b013e31815abb08; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Kreuter A, 2005, J AM ACAD DERMATOL, V52, P603, DOI 10.1016/j.jaad.2004.11.026; Kreuter A, 2010, BRIT J DERMATOL, V162, P1269, DOI 10.1111/j.1365-2133.2010.09712.x; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Minkoff H, 2001, AIDS, V15, P2157, DOI 10.1097/00002030-200111090-00011; Ndimbie OK, 1996, GENITOURIN MED, V72, P213; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; Palefsky JM, 2001, J ACQ IMMUN DEF SYND, V28, P422, DOI 10.1097/00042560-200112150-00003; Palefsky JM, 1998, J ACQ IMMUN DEF SYND, V17, P320, DOI 10.1097/00042560-199804010-00005; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Piketty C, 2004, SEX TRANSM DIS, V31, P96, DOI 10.1097/01.OLQ.0000109515.75864.2B; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Richel O, 2010, BRIT J DERMATOL, V163, P1301, DOI 10.1111/j.1365-2133.2010.09982.x; Salit IE, 2009, INT PAP C 2009 MALM; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; Shia J, 2010, ARCH PATHOL LAB MED, V134, P1601, DOI 10.1043/2009-0668-RAR.1; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Watson AJM, 2006, ANZ J SURG, V76, P715, DOI 10.1111/j.1445-2197.2006.03837.x; Wilkin TJ, 2004, J INFECT DIS, V190, P1685, DOI 10.1086/424599	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84030	10.1371/journal.pone.0084030	http://dx.doi.org/10.1371/journal.pone.0084030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367625	gold, Green Submitted, Green Published			2022-12-25	WOS:000328740300125
J	Yazdanpanah, Y; Perelman, J; DiLorenzo, MA; Alves, J; Barros, H; Mateus, C; Pereira, J; Mansinho, K; Robine, M; Park, JE; Ross, EL; Losina, E; Walensky, RP; Noubary, F; Freedberg, KA; Paltiel, AD				Yazdanpanah, Yazdan; Perelman, Julian; DiLorenzo, Madeline A.; Alves, Joana; Barros, Henrique; Mateus, Ceu; Pereira, Joao; Mansinho, Kamal; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Noubary, Farzad; Freedberg, Kenneth A.; Paltiel, A. David			Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness	PLOS ONE			English	Article							MODEL PARAMETER-ESTIMATION; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC INFECTIONS; UNITED-STATES; VIRUS; TRANSMISSION; LOPINAVIR/RITONAVIR; UNCERTAINTY; POPULATIONS; PREVENTION	Objective: To compare the clinical outcomes and cost-effectiveness of routine HIV screening in Portugal to the current practice of targeted and on-demand screening. Design: We used Portuguese national clinical and economic data to conduct a model-based assessment. Methods: We compared current HIV detection practices to strategies of increasingly frequent routine HIV screening in Portuguese adults aged 18-69. We considered several subpopulations and geographic regions with varying levels of undetected HIV prevalence and incidence. Baseline inputs for the national case included undiagnosed HIV prevalence 0.16%, annual incidence 0.03%, mean population age 43 years, mean CD4 count at care initiation 292 cells/mu L, 63% HIV test acceptance, 78% linkage to care, and HIV rapid test cost (sic)6 under the proposed routine screening program. Outcomes included quality-adjusted survival, secondary HIV transmission, cost, and incremental cost-effectiveness. Results: One-time national HIV screening increased HIV-infected survival from 164.09 quality-adjusted life months (QALMs) to 166.83 QALMs compared to current practice and had an incremental cost-effectiveness ratio (ICER) of (sic)28,000 per quality-adjusted life year (QALY). Screening more frequently in higher-risk groups was cost-effective: for example screening annually in men who have sex with men or screening every three years in regions with higher incidence and prevalence produced ICERs of (sic)21,000/QALY and (sic)34,000/QALY, respectively. Conclusions: One-time HIV screening in the Portuguese national population will increase survival and is cost-effective by international standards. More frequent screening in higher-risk regions and subpopulations is also justified. Given Portugal's challenging economic priorities, we recommend prioritizing screening in higher-risk populations and geographic settings.	[Yazdanpanah, Yazdan] Univ Paris Diderot, Hop Bichat, Paris, France; [Yazdanpanah, Yazdan] Univ Paris 07, INSERM, U1137, ATIP Avenir Inserm Modelisat Aide Decis & Cout Ef, Paris, France; [Perelman, Julian; Alves, Joana; Mateus, Ceu; Pereira, Joao] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Barros, Henrique] Univ Porto, Inst Saude Publ, P-4100 Porto, Portugal; [Mansinho, Kamal] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Boston, MA USA; [DiLorenzo, Madeline A.; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [DiLorenzo, Madeline A.; Robine, Marion; Park, Ji-Eun; Ross, Eric L.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Ctr AIDS Res, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Paltiel, A. David] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Nova de Lisboa; Universidade do Porto; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston University; Boston University; Tufts Medical Center; Tufts University; Yale University	Yazdanpanah, Y (corresponding author), Univ Paris Diderot, Hop Bichat, Paris, France.	yazdan.yazdanpanah@bch.aphp.fr	Barros, Henrique/A-5488-2008; Mateus, Ceu/AAC-8146-2021; Mateus, Ceu/J-2554-2012; Barros, Henrique/Q-8609-2019; Alves, Joana/GXF-4738-2022; Alves, Joana/AGA-9322-2022; Alves, Joana/I-3308-2017; Perelman, Julian/B-4350-2013	Mateus, Ceu/0000-0001-6219-219X; Mateus, Ceu/0000-0001-6219-219X; Barros, Henrique/0000-0003-4699-6571; Alves, Joana/0000-0002-5736-6519; Alves, Joana/0000-0002-5736-6519; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290; Perelman, Julian/0000-0001-6634-9000; Ross, Eric/0000-0002-6025-2010	Coordenacao Nacional para Infeccao VIH/SIDA; Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS); National Institute of Allergy and Infectious Diseases [R37 AI42006]; National Institute of Mental Health [R01 MH065869]; National Institute on Drug Abuse [R01 DA015612]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Coordenacao Nacional para Infeccao VIH/SIDA; Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Sources of funding: Coordenacao Nacional para Infeccao VIH/SIDA, Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS), National Institute of Allergy and Infectious Diseases (R37 AI42006), National Institute of Mental Health (R01 MH065869), and the National Institute on Drug Abuse (R01 DA015612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADM CENTR SIST SA, 2007, CONT AN 2006 HOSP SN; [Anonymous], 2007, EFFICACY SAFETY MARA; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Edejer T, 2003, MAKING CHOICES HLTH; *EMIS, 1 EMIS; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Garattini L, 2011, EUR J HEALTH ECON, V12, P499, DOI 10.1007/s10198-011-0348-5; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; *HAS, 2009, DEP INF VIH FRANC ST; International Monetary Fund Country Report, 2013, WORLD EC OUTL DAT; Jauffret Roustide M, 2006, B EPIDEMIOLOGIQUE HE, V33, P244; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; *MIN SAUD, 2013, CAT APR PUBL SAUDE; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Organisation for Economic Co-operation and Development (OECD), 2011, HLTH GLANC 2011 OECD, DOI DOI 10.1787/HEALTH_; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; PERELMAN J, 2013, REV SAUDE P IN PRESS; *PORT NAT I STAT, 2011, PORT STAT DAT 2009 2; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RODRIGUES J, 2011, VIH PORT LISB PORT; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; *VIH SIDA, 2009, REC PORT TRAT INF VI; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; *WHO, 2010, SCAL HIV TEST COUNC; *WHO, 2009, CHOOSING INT AR COST; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132; 2012, PROGR NAC INF VIH SI	52	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84173	10.1371/journal.pone.0084173	http://dx.doi.org/10.1371/journal.pone.0084173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367639	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300131
J	Alvarez, TM; Paiva, JH; Ruiz, DM; Cairo, JPLF; Pereira, IO; Paixao, DAA; de Almeida, RF; Tonoli, CCC; Ruller, R; Santos, CR; Squina, FM; Murakami, MT				Alvarez, Thabata M.; Paiva, Joice H.; Ruiz, Diego M.; Cairo, Joao Paulo L. F.; Pereira, Isabela O.; Paixao, Douglas A. A.; de Almeida, Rodrigo F.; Tonoli, Celisa C. C.; Ruller, Roberto; Santos, Camila R.; Squina, Fabio M.; Murakami, Mario T.			Structure and Function of a Novel Cellulase 5 from Sugarcane Soil Metagenome	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; CRYSTAL-STRUCTURE; ERWINIA-CHRYSANTHEMI; HYDROLYSIS REACTION; ENDOGLUCANASE; FAMILIES; ADAPTATION; BACTERIA; FAMILY-5; COMPLEX	Cellulases play a key role in enzymatic routes for degradation of plant cell-wall polysaccharides into simple and economically-relevant sugars. However, their low performance on complex substrates and reduced stability under industrial conditions remain the main obstacle for the large-scale production of cellulose-derived products and biofuels. Thus, in this study a novel cellulase with unusual catalytic properties from sugarcane soil metagenome (CelE1) was isolated and characterized. The polypeptide deduced from the celE1 gene encodes a unique glycoside hydrolase domain belonging to GH5 family. The recombinant enzyme was active on both carboxymethyl cellulose and beta-glucan with an endo-acting mode according to capillary electrophoretic analysis of cleavage products. CelE1 showed optimum hydrolytic activity at pH 7.0 and 50 degrees C with remarkable activity at alkaline conditions that is attractive for industrial applications in which conventional acidic cellulases are not suitable. Moreover, its three-dimensional structure was determined at 1.8 angstrom resolution that allowed the identification of an insertion of eight residues in the beta 8-alpha 8 loop of the catalytic domain of CelE1, which is not conserved in its psychrophilic orthologs. This 8-residue-long segment is a prominent and distinguishing feature of thermotolerant cellulases 5 suggesting that it might be involved with thermal stability. Based on its unconventional characteristics, CelE1 could be potentially employed in biotechnological processes that require thermotolerant and alkaline cellulases.	[Alvarez, Thabata M.; Cairo, Joao Paulo L. F.; Pereira, Isabela O.; Paixao, Douglas A. A.; de Almeida, Rodrigo F.; Ruller, Roberto; Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Paiva, Joice H.; Ruiz, Diego M.; Tonoli, Celisa C. C.; Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil		Squina, FM (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	fabio.squina@bioethanol.org.br; mario.murakami@lnbio.cnpem.br	Squina, Fabio/J-8130-2012; Alvarez, Thabata/G-4117-2014; Cairo, João Paulo L Franco/A-3423-2013; Murakami, Mario T/C-2087-2012; Murakami, Mario T/F-5640-2016; Santos, Camila Ramos dos/F-7095-2013; Ruller, ROBERTO/D-1260-2014	Squina, Fabio/0000-0002-8154-7459; Cairo, João Paulo L Franco/0000-0002-4744-3111; Murakami, Mario T/0000-0002-0405-8010; Santos, Camila Ramos dos/0000-0003-0652-4211; Ruller, Roberto/0000-0001-7501-5176; Ruller, ROBERTO/0000-0002-5087-9493; de Oliveira Pereira, Isabela/0000-0002-8902-3115; Tonoli, Celisa/0000-0003-2580-5588	Brazilian Research Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/08312-6, 13/13309-0, 2008/58037-9, 2010/11469-1, 2012/18559-5, 2011/20977-3]; Brazilian Research Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478059/2009-4, 486841/2012-0]; Brazilian Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Brazilian Research Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian Research Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants number: 09/08312-6 and 13/13309-0 to MTM, 2008/58037-9 to FMS, 2010/11469-1 to TMA, 2012/18559-5 to RG, 2011/20977-3 to JPLFC; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants number 478059/2009-4 and 486841/2012-0 awarded to MTM; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070014; Badieyan S, 2012, PROTEIN ENG DES SEL, V25, P223, DOI 10.1093/protein/gzs010; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; Bischoff KM, 2006, BIOTECHNOL LETT, V28, P1761, DOI 10.1007/s10529-006-9153-0; Branden CI, 1991, CURR OPIN STRUC BIOL, V1, P978, DOI 10.1016/0959-440X(91)90094-A; Chapon V, 2001, J MOL BIOL, V310, P1055, DOI 10.1006/jmbi.2001.4787; Cohen R, 2005, APPL ENVIRON MICROB, V71, P2412, DOI 10.1128/AEM.71.5.2412-2417.2005; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P1926, DOI 10.1021/bi972162m; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Festucci-Buselli Reginaldo A., 2007, Braz. J. Plant Physiol., V19, P1, DOI 10.1590/S1677-04202007000100001; Cairo JPLF, 2013, INSECT BIOCHEM MOLEC, V43, P970, DOI 10.1016/j.ibmb.2013.07.007; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang CN, 2011, APPL MICROBIOL BIOT, V89, P315, DOI 10.1007/s00253-010-2842-6; Liu JA, 2011, APPL MICROBIOL BIOT, V89, P1083, DOI 10.1007/s00253-010-2828-4; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen NH, 2012, BIOSCI BIOTECH BIOCH, V76, P1075, DOI 10.1271/bbb.110786; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Pereira JH, 2009, ACTA CRYSTALLOGR D, V65, P744, DOI 10.1107/S0907444909012773; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Shaw A, 2002, J MOL BIOL, V320, P303, DOI 10.1016/S0022-2836(02)00387-X; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Sonan GK, 2007, BIOCHEM J, V407, P293, DOI 10.1042/BJ20070640; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varrot A, 2000, J MOL BIOL, V297, P819, DOI 10.1006/jmbi.2000.3567; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P723; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	42	36	36	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83635	10.1371/journal.pone.0083635	http://dx.doi.org/10.1371/journal.pone.0083635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358302	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700066
J	Budde, LE; Berger, C; Lin, YK; Wang, JJ; Lin, XB; Frayo, SE; Brouns, SA; Spencer, DM; Till, BG; Jensen, MC; Riddell, SR; Press, OW				Budde, Lihua E.; Berger, Carolina; Lin, Yukang; Wang, Jinjuan; Lin, Xubin; Frayo, Shani E.; Brouns, Shaunda A.; Spencer, David M.; Till, Brian G.; Jensen, Michael C.; Riddell, Stanley R.; Press, Oliver W.			Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma	PLOS ONE			English	Article							GENE-THERAPY; ENHANCED SURVIVAL; CLINICAL-TRIAL; ADVERSE EVENT; PHASE-I; LYMPHOCYTES; COSTIMULATION; PROLIFERATION; PERSISTENCE; DEATH	Modification of T cells with chimeric antigen receptors (CAR) has emerged as a promising treatment modality for human malignancies. Integration of co-stimulatory domains into CARs can augment the activation and function of genetically targeted T cells against tumors. However, the potential for insertional mutagenesis and toxicities due to the infused cells have made development of safe methods for removing transferred cells an important consideration. We have genetically modified human T cells with a lentiviral vector to express a CD20-CAR containing both CD28 and CD137 co-stimulatory domains, a "suicide gene'' relying on inducible activation of caspase 9 (iC9), and a truncated CD19 selectable marker. Rapid expansion (2000 fold) of the transduced T cells was achieved in 28 days after stimulation with artificial antigen presenting cells. Transduced T cells exhibited effective CD20-specific cytotoxic activity in vitro and in a mouse xenograft tumor model. Activation of the iC9 suicide switch resulted in efficient removal of transduced T cells both in vitro and in vivo. Our work demonstrates the feasibility and promise of this approach for treating CD20(+) malignancies in a safe and more efficient manner. A phase I clinical trial using this approach in patients with relapsed indolent B-NHL is planned.	[Budde, Lihua E.] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Budde, Lihua E.; Berger, Carolina; Lin, Yukang; Wang, Jinjuan; Lin, Xubin; Frayo, Shani E.; Brouns, Shaunda A.; Till, Brian G.; Jensen, Michael C.; Riddell, Stanley R.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Budde, Lihua E.; Till, Brian G.; Riddell, Stanley R.; Press, Oliver W.] Univ Washington, Dept Med, Seattle, WA USA; [Budde, Lihua E.; Till, Brian G.; Riddell, Stanley R.; Press, Oliver W.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Spencer, David M.] Baylor Coll Med, Houston, TX 77030 USA; [Spencer, David M.] Bellicum Pharmaceut Inc, Houston, TX USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany	City of Hope; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; Seattle Children's Hospital; Technical University of Munich	Press, OW (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	press@uw.edu		Press, Oliver/0000-0002-3147-8037	David and Patricia Giuliani Family Foundation; Lymphoma Research Foundation; Edson Foundation; Leukemia & Lymphoma Special Fellow Award for Clinical Research; NATIONAL CANCER INSTITUTE [K23CA154874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	David and Patricia Giuliani Family Foundation; Lymphoma Research Foundation; Edson Foundation; Leukemia & Lymphoma Special Fellow Award for Clinical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a major gift from the David and Patricia Giuliani Family Foundation (O.W.P.), a grant from the Lymphoma Research Foundation (O.W.P.), a pilot immunotherapy award from the Edson Foundation (L. E. B.), and a Leukemia & Lymphoma Special Fellow Award for Clinical Research (L. E. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PS, 2010, GENE THER, V17, P1244, DOI 10.1038/gt.2010.62; Berger C, 2004, BLOOD, V103, P1261, DOI 10.1182/blood-2003-08-2908; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Gerull S, 2007, HUM GENE THER, V18, P451, DOI 10.1089/hum.2006.039; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; James SE, 2009, BLOOD, V114, P5454, DOI 10.1182/blood-2009-08-232967; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shan DM, 1999, J IMMUNOL, V162, P6589; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tey SK, 2007, BIOL BLOOD MARROW TR, V13, P913, DOI 10.1016/j.bbmt.2007.04.005; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Wang J, 2007, HUM GENE THER, V18, P712, DOI 10.1089/hum.2007.028; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; ZHOU LJ, 1991, J IMMUNOL, V147, P1424	37	142	186	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82742	10.1371/journal.pone.0082742	http://dx.doi.org/10.1371/journal.pone.0082742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358223	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700029
J	Lee, JW; Kim, KS; An, HK; Kim, CH; Moon, HI; Lee, YC				Lee, Ji-Won; Kim, Kyoung-Sook; An, Hyun-Kyu; Kim, Cheorl-Ho; Moon, Hyung-In; Lee, Young-Choon			Dendropanoxide Induces Autophagy through ERK1/2 Activation in MG-63 Human Osteosarcoma Cells and Autophagy Inhibition Enhances Dendropanoxide-Induced Apoptosis	PLOS ONE			English	Article							DEATH; MECHANISMS; PATHWAYS; CANCER	Anticancer effects of dendropanoxide (DP) newly isolated from leaves and stem of Dendropanax morbifera Leveille were firstly investigated in this study. DP inhibited cell proliferation and induced apoptosis in dose-and time-dependent manner in MG-63 human osteosarcoma cells, which was dependent on the release of cytochrome c to the cytosol and the activation of caspases. Moreover, the DP-treated cells exhibited autophagy, as characterized by the punctuate patterns of microtubule-associated protein 1 light chain 3 (LC3) by confocal microscopy and the appearance of autophagic vacuoles by MDC staining. The expression levels of ATG7, Beclin-1 and LC3-II were also increased by DP treatment. Inhibition of autophagy by 3-methyladenine (3-MA) and wortmannin (Wort) significantly enhanced DP-induced apoptosis. DP treatment also caused a time-dependent increase in protein levels of extracellular signal-regulated kinase 1 and 2 (ERK1/2), and inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased DP-induced autophagy that was accompanied by an increased apoptosis and a decreased cell viability. These results indicate a cytoprotective function of autophagy against DP-induced apoptosis and suggest that the combination of DP treatment with autophagy inhibition may be a promising strategy for human osteosarcoma control. Taken together, this study demonstrated for the first time that DP could induce autophagy through ERK1/2 activation in human osteosarcoma cells and autophagy inhibition enhanced DP-induced apoptosis.	[Lee, Ji-Won; Kim, Kyoung-Sook; An, Hyun-Kyu; Moon, Hyung-In; Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Kyonggi Do, South Korea	Dong A University; Sungkyunkwan University (SKKU)	Moon, HI (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	himun68@dau.ac.kr; yclee@dau.ac.kr	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714	Dong-A University research fund	Dong-A University research fund	This work was supported by the Dong-A University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aredia Francesca, 2012, Cells, V1, P520, DOI 10.3390/cells1030520; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Choe YJ, 2012, ONCOL REP, V28, P2049, DOI 10.3892/or.2012.2034; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim HJ, 2013, INT J ONCOL, V42, P1985, DOI 10.3892/ijo.2013.1884; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Meschini S, 2008, AUTOPHAGY, V4, P1020, DOI 10.4161/auto.6952; Moon HI, 2011, HUM EXP TOXICOL, V30, P870, DOI 10.1177/0960327110382131; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Wang YY, 2013, TOXICOL IN VITRO, V27, P1928, DOI 10.1016/j.tiv.2013.06.001; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yu HY, 2012, J AGR FOOD CHEM, V60, P5400, DOI 10.1021/jf3014475; Yu HY, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/637512, DOI 10.1155/2012/637512]; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83611	10.1371/journal.pone.0083611	http://dx.doi.org/10.1371/journal.pone.0083611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358301	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700065
J	Marini, M; Sriram, N; Schnabel, K; Maliszewski, N; Devos, T; Ekehammar, B; Wiers, R; Cai, HJ; Somogyi, M; Shiomura, K; Schnall, S; Neto, F; Bar-Anan, Y; Vianello, M; Ayala, A; Dorantes, G; Park, J; Kesebir, S; Pereira, A; Tulbure, B; Ortner, T; Stepanikova, I; Greenwald, AG; Nosekl, BA				Marini, Maddalena; Sriram, Natarajan; Schnabel, Konrad; Maliszewski, Norbert; Devos, Thierry; Ekehammar, Bo; Wiers, Reinout; Cai HuaJian; Somogyi, Monika; Shiomura, Kimihiro; Schnall, Simone; Neto, Felix; Bar-Anan, Yoav; Vianello, Michelangelo; Ayala, Alfonso; Dorantes, Gabriel; Park, Jaihyun; Kesebir, Selin; Pereira, Antonio; Tulbure, Bogdan; Ortner, Tuulia; Stepanikova, Irena; Greenwald, Anthony G.; Nosekl, Brian A.			Overweight People Have Low Levels of Implicit Weight Bias, but Overweight Nations Have High Levels of Implicit Weight Bias	PLOS ONE			English	Article							ANTI-FAT BIAS; ASSOCIATION TEST; HEALTH-PROFESSIONALS; BODY-WEIGHT; OBESITY; STIGMA; ATTITUDES; DISCRIMINATION; PREJUDICE; BELIEFS	Although a greater degree of personal obesity is associated with weaker negativity toward overweight people on both explicit (i.e., self-report) and implicit (i.e., indirect behavioral) measures, overweight people still prefer thin people on average. We investigated whether the national and cultural context - particularly the national prevalence of obesity predicts attitudes toward overweight people independent of personal identity and weight status. Data were collected from a total sample of 338,121 citizens from 71 nations in 22 different languages on the Project Implicit website (https://implicit.harvard.edu/) between May 2006 and October 2010. We investigated the relationship of the explicit and implicit weight bias with the obesity both at the individual (i.e., across individuals) and national (i.e., across nations) level. Explicit weight bias was assessed with self-reported preference between overweight and thin people; implicit weight bias was measured with the Implicit Association Test (IAT). The national estimates of explicit and implicit weight bias were obtained by averaging the individual scores for each nation. Obesity at the individual level was defined as Body Mass Index (BMI) scores, whereas obesity at the national level was defined as three national weight indicators (national BMI, national percentage of overweight and underweight people) obtained from publicly available databases. Across individuals, greater degree of obesity was associated with weaker implicit negativity toward overweight people compared to thin people. Across nations, in contrast, a greater degree of national obesity was associated with stronger implicit negativity toward overweight people compared to thin people. This result indicates a different relationship between obesity and implicit weight bias at the individual and national levels.	[Marini, Maddalena; Sriram, Natarajan; Nosekl, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Marini, Maddalena] Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy; [Schnabel, Konrad] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Maliszewski, Norbert] Warsaw Univ, Dept Psychol, Warsaw, Poland; [Devos, Thierry] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Ekehammar, Bo] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Wiers, Reinout] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cai HuaJian] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Somogyi, Monika] Eotvos Lorand Univ, Dept Psychol, Budapest, Hungary; [Shiomura, Kimihiro] Ferris Univ, Yokohama, Kanagawa, Japan; [Schnall, Simone] Univ Cambridge, Dept Psychol, Cambridge, England; [Neto, Felix] Univ Porto, Fac Psicol & Ciencias Educ, P-4100 Porto, Portugal; [Bar-Anan, Yoav] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Vianello, Michelangelo] Univ Padua, Dept Appl Psychol, Padua, Italy; [Ayala, Alfonso] Inst Electoral Veracruzano, Xalapa, Veracruz, Mexico; [Dorantes, Gabriel] Univ Autonoma Estado Morelos, Fac Psicol, Cuernavaca, Morelos, Mexico; [Park, Jaihyun] CUNY, Baruch Coll, Dept Psychol, New York, NY 10021 USA; [Kesebir, Selin] London Business Sch, London NW1 4SA, England; [Pereira, Antonio] Univ Rio Grande Do Norte, Brain Inst Fed, Natal, RN, Brazil; [Tulbure, Bogdan] Transilvania Univ Brasov, Dept Psychol, Brasov, Romania; [Stepanikova, Irena] Salzburg Univ, Dept Psychol, Div Psychol Assessment, A-5020 Salzburg, Austria; [Stepanikova, Irena] Univ S Carolina, Sloan Coll, Columbia, SC 29208 USA; [Greenwald, Anthony G.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Virginia; Universita di Modena e Reggio Emilia; University of Potsdam; University of Warsaw; California State University System; San Diego State University; Stockholm University; University of Amsterdam; Chinese Academy of Sciences; Institute of Psychology, CAS; Eotvos Lorand University; University of Cambridge; Universidade do Porto; Ben Gurion University; University of Padua; Universidad Autonoma del Estado de Morelos; City University of New York (CUNY) System; Baruch College (CUNY); University of London; London Business School; Transylvania University of Brasov; Salzburg University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle	Marini, M (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	maddalena.marini@unimore.it	Bar-Anan, Yoav/AAM-7229-2021; Tulbure, Bogdan Tudor/H-4226-2015; Maliszewski, Norbert/D-9047-2015; Neto, Félix/H-6575-2013; Greenwald, Anthony G./AAB-2397-2020; Wiers, Reinout/AAB-4008-2021; Tulbure, Bogdan Tudor/AAF-4896-2021; Dorantes-Argandar, Gabriel/U-7805-2019; Kesebir, Selin/C-9905-2014; Pereira, Antonio/AAY-4372-2020; Vianello, Michelangelo/G-8919-2013; Ortner, Tuulia M./AAE-5157-2020	Tulbure, Bogdan Tudor/0000-0001-8101-1753; Neto, Félix/0000-0003-0112-880X; Greenwald, Anthony G./0000-0001-6865-8552; Wiers, Reinout/0000-0002-4312-9766; Tulbure, Bogdan Tudor/0000-0001-8101-1753; Dorantes-Argandar, Gabriel/0000-0001-9853-979X; Kesebir, Selin/0000-0002-3909-9445; Pereira, Antonio/0000-0002-0808-1058; Vianello, Michelangelo/0000-0002-1530-1469; Ortner, Tuulia M./0000-0002-5703-6915; Maliszewski, Norbert/0000-0001-6901-9509; Nosek, Brian/0000-0001-6797-5476	Project Implicit, Inc; University of Warsaw, Poland [BST164635]	Project Implicit, Inc; University of Warsaw, Poland	This project was supported by Project Implicit, Inc (http://projectimplicit.net/), a non-profit organization that includes in its mission "To develop and deliver methods for investigating and applying phenomena of implicit social cognition, including especially phenomena of implicit bias based on age, race, gender or other factors." The Polish sample was financed from a grant from the University of Warsaw, Poland (BST164635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1991, INT J EAT DISORDER, V10, P599; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Anderson-Fye EP, 2004, CULT MED PSYCHIAT, V28, P561, DOI 10.1007/s11013-004-1068-4; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Ashmore Jamile A, 2008, Eat Behav, V9, P203, DOI 10.1016/j.eatbeh.2007.09.006; Becker Anne, 1995, BODY SELF SOC VIEW F; Bessenoff GR, 2000, SOC COGNITION, V18, P329, DOI 10.1521/soco.2000.18.4.329; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Carr D, 2005, J HEALTH SOC BEHAV, V46, P244, DOI 10.1177/002214650504600303; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; DOLINSKI D, 1991, POLISH PSYCHOL B, V22, P43; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Fiske A.P., 1998, HDB SOCIAL PSYCHOL, P915; Fiske S.T., 1991, SOC COGNITION; FURNHAM A, 1993, J SOC PSYCHOL, V133, P317, DOI 10.1080/00224545.1993.9712149; FURNHAM A, 1992, PSYCHOL REP, V71, P1149, DOI 10.2466/PR0.71.8.1149-1150; Glashouwer KA, 2013, J BEHAV THER EXP PSY, V44, P105, DOI 10.1016/j.jbtep.2012.07.015; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Heine SJ, 2008, PSYCHOL SCI, V19, P309, DOI 10.1111/j.1467-9280.2008.02085.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; LERNER MJ, 1978, PSYCHOL BULL, V85, P1030, DOI 10.1037/0033-2909.85.5.1030; Lerner MJ, 1998, CRIT IS SOC, P1; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Popenoe R, 2004, FEEDING DESIRE FATNE; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Schwartz MB, 2006, OBESITY, V14, P440, DOI 10.1038/oby.2006.58; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; SOBO E, 1994, SWEETNESS FAT HLTH P; Tajfel H., 1986, PSYCHOL INTERGROUP R, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Teige-Mocigemba S., 2010, HDB IMPLICIT SOCIAL, P117; Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318; WAGNER CH, 1982, AM STAT, V36, P46, DOI 10.2307/2684093; WANG H, 1993, INTRO CROSS CULTURE; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003	55	56	56	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83543	10.1371/journal.pone.0083543	http://dx.doi.org/10.1371/journal.pone.0083543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358291	Green Published, gold			2022-12-25	WOS:000328737700060
J	Wehi, PM; Raubenheimer, D; Morgan-Richards, M				Wehi, Priscilla M.; Raubenheimer, David; Morgan-Richards, Mary			Tolerance for Nutrient Imbalance in an Intermittently Feeding Herbivorous Cricket, the Wellington Tree Weta	PLOS ONE			English	Article							FOOD SELECTION; LIFE-SPAN; ORGANISMAL STOICHIOMETRY; HEMIDEINA-CRASSIDENS; NUTRITIONAL ECOLOGY; MULTIPLE NUTRIENTS; GEOMETRIC ANALYSIS; INSECT HERBIVORE; SEXUAL SELECTION; NITROGEN-CONTENT	Organisms that regulate nutrient intake have an advantage over those that do not, given that the nutrient composition of any one resource rarely matches optimal nutrient requirements. We used nutritional geometry to model protein and carbohydrate intake and identify an intake target for a sexually dimorphic species, the Wellington tree weta (Hemideina crassidens). Despite pronounced sexual dimorphism in this large generalist herbivorous insect, intake targets did not differ by sex. In a series of laboratory experiments, we then investigated whether tree weta demonstrate compensatory responses for enforced periods of imbalanced nutrient intake. Weta pre-fed high or low carbohydrate: protein diets showed large variation in compensatory nutrient intake over short (<48 h) time periods when provided with a choice. Individuals did not strongly defend nutrient targets, although there was some evidence for weak regulation. Many weta tended to select high and low protein foods in a ratio similar to their previously identified nutrient optimum. These results suggest that weta have a wide tolerance to nutritional imbalance, and that the time scale of weta nutrient balancing could lie outside of the short time span tested here. A wide tolerance to imbalance is consistent with the intermittent feeding displayed in the wild by weta and may be important in understanding weta foraging patterns in New Zealand forests.	[Wehi, Priscilla M.; Morgan-Richards, Mary] Massey Univ, Inst Agr & Environm, Ecol Grp, Palmerston North, New Zealand; [Raubenheimer, David] Massey Univ, Inst Nat Sci, Palmerston North, New Zealand; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Massey University; Massey University; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Wehi, PM (corresponding author), Univ Otago, Ctr Sustainabil CSAFE, Dunedin, New Zealand.	priscilla.wehi@otago.ac.nz	Morgan-Richards, Mary/B-4444-2011	Raubenheimer, David/0000-0001-9050-1447; Wehi, Priscilla/0000-0001-9821-8160; Morgan-Richards, Mary/0000-0002-3913-9814	FRST postdoctoral fellowship [MAUX0905]; Massey University [MURF_11/0039]	FRST postdoctoral fellowship(New Zealand Foundation for Research, Science and Technology); Massey University	PMW was supported by FRST postdoctoral fellowship MAUX0905. MMR had Massey University Research Funding MURF_11/0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Bakr EM, 2005, J APPL ENTOMOL, V129, P173, DOI 10.1111/j.1439-0418.2005.00948.x; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Behmer ST, 2001, ANIM BEHAV, V61, P995, DOI 10.1006/anbe.2000.1695; Belovsky GE, 1997, EVOL ECOL, V11, P641, DOI 10.1023/A:1018430201230; BJORNDAL KA, 1991, ECOLOGY, V72, P1234, DOI 10.2307/1941097; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Daniel M.J., 1973, Proceedings of the New Zealand Ecological Society, V20, P21; Dewhurst R, 2013, THESIS MASSEY U PALM; Fanson BG, 2013, EVOL ECOL, V27, P937, DOI 10.1007/s10682-013-9638-y; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Griffin Melissa J., 2011, New Zealand Natural Sciences, V36, P11; Griffin MJ, 2011, NEW ZEAL J ECOL, V35, P302; Haw JM, 2001, NEW ZEAL J ECOL, V25, P61; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Houston AI, 2011, ECOL LETT, V14, P1101, DOI 10.1111/j.1461-0248.2011.01678.x; Innes J., 1979, New Zealand Journal of Ecology, V2, P85; Kelly CD, 2005, BEHAV ECOL, V16, P145, DOI 10.1093/beheco/arh141; Kelly CD, 2006, ANIM BEHAV, V72, P727, DOI 10.1016/j.anbehav.2006.02.007; Kelly CD, 2006, BEHAV ECOL SOCIOBIOL, V60, P175, DOI 10.1007/s00265-005-0154-0; Leisnham PT, 2003, NEW ZEAL J ECOL, V27, P191; Lemaitre JF, 2013, BEHAV ECOL, V24, P421, DOI 10.1093/beheco/ars179; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Morehouse NI, 2010, OIKOS, V119, P766, DOI 10.1111/j.1600-0706.2009.18569.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; Quinn JM, 2000, NEW ZEAL J MAR FRESH, V34, P253, DOI 10.1080/00288330.2000.9516931; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2001, ECOLOGY, V82, P422; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Spencer AM, 1995, THESIS VICTORIA U WE; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stringer Ian A.N., 2006, New Zealand Entomologist, V29, P5; Stringer Ian A.N., 2001, P399, DOI 10.1079/9780851994086.0399; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Warbrick-Smith J, 2009, ENTOMOL EXP APPL, V132, P65, DOI 10.1111/j.1570-7458.2009.00870.x; Wehi PM, 2013, NEW ZEAL J ECOL, V37, P75; Wehi PM, 2010, J INSECT PHYSIOL, V56, P1877, DOI 10.1016/j.jinsphys.2010.08.005; Zajitschek F, 2012, ECOL EVOL, V2, P1627, DOI 10.1002/ece3.288; Zajitschek F, 2009, ECOLOGY, V90, P1698, DOI 10.1890/08-0048.1	59	13	13	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84641	10.1371/journal.pone.0084641	http://dx.doi.org/10.1371/journal.pone.0084641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358369	Green Published, gold			2022-12-25	WOS:000328737700104
J	Xin, JG; Yang, HQ; Fan, NN; Zhao, BT; Ouyang, Z; Liu, ZM; Zhao, Y; Li, XP; Song, J; Yang, Y; Zou, QJ; Yan, QM; Zeng, YZ; Lai, LX				Xin, Jige; Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Li, Xiaoping; Song, Jun; Yang, Yi; Zou, Qingjian; Yan, Quanmei; Zeng, Yangzhi; Lai, Liangxue			Highly Efficient Generation of GGTA1 Biallelic Knockout Inbred Mini-Pigs with TALENs	PLOS ONE			English	Article							NUCLEAR TRANSFER; EMBRYO MICROINJECTION; GENE-KNOCKOUT; PIGS; RATS; LINE	Inbred mini-pigs are ideal organ donors for future human xenotransplantations because of their clear genetic background, high homozygosity, and high inbreeding endurance. In this study, we chose fibroblast cells from a highly inbred pig line called Banna mini-pig inbred line (BMI) as donor nuclei for nuclear transfer, combining with transcription activator-like effector nucleases (TALENs) and successfully generated alpha-1,3-galactosyltransferase (GGTA1) gene biallelic knockout (KO) pigs. To validate the efficiency of TALEN vectors, in vitro-transcribed TALEN mRNAs were microinjected into one-cell stage parthenogenetically activated porcine embryos. The efficiency of indel mutations at the GGTA1-targeting loci was as high as 73.1% (19/26) among the parthenogenetic blastocysts. TALENs were co-transfected into porcine fetal fibroblasts of BMI with a plasmid containing neomycin gene. The targeting efficiency reached 89.5% (187/209) among the survived cell clones after a 10 d selection. More remarkably 27.8% (58/209) of colonies were biallelic KO. Five fibroblast cell lines with biallelic KO were chosen as nuclear donors for somatic cell nuclear transfer (SCNT). Three miniature piglets with biallelic mutations of the GGTA1 gene were achieved. Gal epitopes on the surface of cells from all the three biallelic KO piglets were completely absent. The fibroblasts from the GGTA1 null piglets were more resistant to lysis by pooled complement-preserved normal human serum than those from wild-type pigs. These results indicate that a combination of TALENs technology with SCNT can generate biallelic KO pigs directly with high efficiency. The GGTA1 null piglets with inbred features created in this study can provide a new organ source for xenotransplantation research.	[Xin, Jige; Li, Xiaoping; Yang, Yi; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Song, Jun; Zou, Qingjian; Yan, Quanmei; Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Yang, Huaqiang; Fan, Nana; Zhao, Bentian; Ouyang, Zhen; Liu, Zhaoming; Zhao, Yu; Song, Jun; Zou, Qingjian; Yan, Quanmei; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Xin, Jige; Zeng, Yangzhi; Lai, Liangxue] Yunnan Agr Univ, Anim Sci & Technol Coll, Key Lab Banna Mini Pig Inbred Line Yunnan Prov, Kunming, Peoples R China	Jilin University; Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Yunnan Agricultural University	Lai, LX (corresponding author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China.	lai_liangxue@gibh.ac.cn	Song, Jun/A-3487-2013; Yang, Huaqiang/H-7644-2014; Yang, Huaqiang/AAU-6402-2021	Song, Jun/0000-0002-6128-6378; Yang, Huaqiang/0000-0002-4287-0026; 	National Natural Science Foundation of China [31071293, 31071172, 31272394]; Ministry of Science and Technology National Basic Research Program of China (973 program) [2011CB944203, 2009CB941001]; Science and Technology Program of Guangzhou [12S134060176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology National Basic Research Program of China (973 program); Science and Technology Program of Guangzhou	This work is supported by grants from the National Natural Science Foundation of China (31071293, 31071172), the Ministry of Science and Technology National Basic Research Program of China (973 program) (2011CB944203, 2009CB941001), the Science and Technology Program of Guangzhou (12S134060176), the National Natural Science Foundation of China (31272394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen YN, 2007, CHINESE MED J-PEKING, V120, P739, DOI 10.1097/00029330-200705010-00001; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Sun X, 2004, TRANSPL P, V36, P2488, DOI 10.1016/j.transproceed.2004.07.060; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yu P, 2004, TRANSPL P, V36, P2485, DOI 10.1016/j.transproceed.2004.07.055; YU P, 2006, J RAPID METH AUT MIC, P199; Zeng R, 2005, ANIM GENET, V36, P267, DOI 10.1111/j.1365-2052.2005.01277.x; Zhang L, 2005, TRANSPLANTATION, V79, P1128, DOI 10.1097/00007890-200505150-00031; Zhang L, 2004, TRANSPL P, V36, P2490, DOI 10.1016/j.transproceed.2004.07.064	26	59	82	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84250	10.1371/journal.pone.0084250	http://dx.doi.org/10.1371/journal.pone.0084250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358349	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700090
J	Hauzy, C; Nadin, G; Canard, E; Gounand, I; Mouquet, N; Ebenman, B				Hauzy, Celine; Nadin, Gregoire; Canard, Elsa; Gounand, Isabelle; Mouquet, Nicolas; Ebenman, Bo			Confronting the Paradox of Enrichment to the Metacommunity Perspective	PLOS ONE			English	Article							PREDATOR-PREY DYNAMICS; DENSITY-DEPENDENT DISPERSAL; METAPOPULATION DYNAMICS; FOOD WEBS; SPATIAL HETEROGENEITY; POPULATION-DYNAMICS; BIOLOGICAL-CONTROL; LAKE ECOSYSTEMS; NITROGEN-CYCLE; CROP PEST	Resource enrichment can potentially destabilize predator-prey dynamics. This phenomenon historically referred as the "paradox of enrichment" has mostly been explored in spatially homogenous environments. However, many predator-prey communities exchange organisms within spatially heterogeneous networks called metacommunities. This heterogeneity can result from uneven distribution of resources among communities and thus can lead to the spreading of local enrichment within metacommunities. Here, we adapted the original Rosenzweig-MacArthur predator-prey model, built to study the paradox of enrichment, to investigate the effect of regional enrichment and of its spatial distribution on predator-prey dynamics in metacommunities. We found that the potential for destabilization was depending on the connectivity among communities and the spatial distribution of enrichment. In one hand, we found that at low dispersal regional enrichment led to the destabilization of predator-prey dynamics. This destabilizing effect was more pronounced when the enrichment was uneven among communities. In the other hand, we found that high dispersal could stabilize the predator-prey dynamics when the enrichment was spatially heterogeneous. Our results illustrate that the destabilizing effect of enrichment can be dampened when the spatial scale of resource enrichment is lower than that of organismss movements (heterogeneous enrichment). From a conservation perspective, our results illustrate that spatial heterogeneity could decrease the regional extinction risk of species involved in specialized trophic interactions. From the perspective of biological control, our results show that the heterogeneous distribution of pest resource could favor or dampen outbreaks of pests and of their natural enemies, depending on the spatial scale of heterogeneity.	[Hauzy, Celine; Ebenman, Bo] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Hauzy, Celine] Univ Paris 06, Ecol & Evolut UMR7625, Paris, France; [Hauzy, Celine] INRA, Ecol Populat & Communautes USC2031, Paris, France; [Nadin, Gregoire] CNRS, UMR7598, Lab Jacques Louis, Paris, France; [Canard, Elsa; Gounand, Isabelle; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France	Linkoping University; UDICE-French Research Universities; Sorbonne Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Hauzy, C (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	celinehauzy@gmail.com	MOUQUET, Nicolas/AAL-1440-2021; Isabelle, Gounand/ABX-7866-2022	Mouquet, Nicolas/0000-0003-1840-6984; Gounand, Isabelle/0000-0002-0675-3973	Linkoping University	Linkoping University	CH and BE were supported by a Faculty grant from Linkoping University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Amarasekare P, 2007, SPATIAL DYNAMICS COM, P170; Amarasekare P, 2010, J ANIM ECOL, V79, P282, DOI 10.1111/j.1365-2656.2009.01607.x; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Cooper JK, 2012, ECOL LETT, V15, P856, DOI 10.1111/j.1461-0248.2012.01808.x; Cottingham KL, 2000, ECOL LETT, V3, P340, DOI 10.1046/j.1461-0248.2000.00158.x; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Genkai-Kato M, 1999, P ROY SOC B-BIOL SCI, V266, P1215, DOI 10.1098/rspb.1999.0765; Hanski I., 1999, METAPOPULATION ECOLO; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; Hauzy C, 2010, J THEOR BIOL, V266, P458, DOI 10.1016/j.jtbi.2010.07.008; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUFFAKER C. B., 1963, HILGARDIA, V34, P305; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; KARR JR, 1982, ECOLOGY, V63, P1975, DOI 10.2307/1940137; Kindvall O, 1996, ECOLOGY, V77, P207, DOI 10.2307/2265670; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kirk KL, 1998, ECOLOGY, V79, P2456, DOI 10.2307/176835; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; LUCKINBILL LS, 1973, ECOLOGY, V54, P1320, DOI 10.2307/1934194; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; Matthews DP, 2007, ECOLOGY, V88, P2848, DOI 10.1890/06-1107.1; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; MCCAULEY E, 1990, NATURE, V343, P455, DOI 10.1038/343455a0; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Nisbet R.M, 1993, PATCH DYNAMICS, P125; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; PERSSON L, 1993, OIKOS, V66, P193, DOI 10.2307/3544805; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Roy S, 2007, J BIOSCIENCES, V32, P421, DOI 10.1007/s12038-007-0040-1; Ruokolainen L, 2011, J THEOR BIOL, V291, P76, DOI 10.1016/j.jtbi.2011.09.004; SCHEFFER M, 1995, ECOLOGY, V76, P2270, DOI 10.2307/1941701; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schops K., 1998, P119; Steiner CF, 2005, ECOL LETT, V8, P819, DOI 10.1111/j.1461-0248.2005.00785.x; Thies C, 2008, AGR ECOSYST ENVIRON, V125, P266, DOI 10.1016/j.agee.2007.12.011; VEILLEUX BG, 1979, J ANIM ECOL, V48, P787, DOI 10.2307/4195; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x; WALDE SJ, 1994, J ANIM ECOL, V63, P337, DOI 10.2307/5552; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	65	6	6	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82969	10.1371/journal.pone.0082969	http://dx.doi.org/10.1371/journal.pone.0082969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358242	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700099
J	Ito, S; Gojoubori, T; Tsunoda, K; Yamaguchi, Y; Asano, M; Goke, E; Koshi, R; Sugano, N; Yoshinuma, N; Komiyama, K; Ito, K				Ito, Satoshi; Gojoubori, Takahiro; Tsunoda, Kou; Yamaguchi, Yoko; Asano, Masatake; Goke, Eiji; Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto; Komiyama, Kazuo; Ito, Koichi			Nicotine-Induced Expression of Low-Density Lipoprotein Receptor in Oral Epithelial Cells	PLOS ONE			English	Article							MEDIATED TOBACCO TOXICITY; HUMAN GINGIVAL; TRANSCRIPTIONAL REGULATION; PROMOTER ACTIVITY; GENE-REGULATION; SP1; METABOLISM; INTERLEUKIN-8; CHOLESTEROL; PATHWAY	Background: Nicotine use is one of the most important risk factors for the development of cardiovascular and periodontal diseases. Numerous reports have suggested the possible contribution of disturbed lipid metabolism for the development of both disease groups. Despite these observations, little is known about the relationship between tobacco smoking and the development of these diseases. Our previous microarray data revealed that nicotine induced low-density lipoprotein receptor (LDLR) expression in oral epithelial cells (OECs). The aim of the present study was to confirm nicotine-mediated LDLR induction and to elucidate the signaling mechanisms leading to the augmented expression of LDLR in OECs. Methods and Results: LDLR and nicotinic acetylcholine receptor (nAChR) subunit expression was detected by real-time PCR. The production of LDLR was demonstrated by immunofluorescence staining. nAChR-mediated LDLR induction was examined by pre-incubation of the cells with its specific inhibitor, a-bungarotoxin (alpha-BTX). The functional importance of transcription factor specific protein 1 (Sp1) was examined by luciferase assay, mithramycin pre-incubation or by small interfering RNA (siRNA) transfection. The specific binding of Sp1 to R3 region of LDLR 5'untranslated region was demonstrated with electrophoretic mobility shift assay (EMSA) and streptavidin-agarose precipitation assay followed by western blotting. The results confirmed that nicotine induced LDLR expression at the transcriptional level. Nicotine was sensed by nAChR and the signal was transduced by Sp1 which bound to the R3 region of LDLR gene. Augmented production of LDLR in the gingival epithelial cells was further demonstrated by immunofluorescence staining using the gingival tissues obtained from the smoking patients. Conclusions: Taken together, the results suggested that nicotine might contribute to the development of both cardiovascular and periodontal diseases by inducing the LDLR in OECs thereby disturbing lipid metabolism.	[Ito, Satoshi; Gojoubori, Takahiro; Tsunoda, Kou] Nihon Univ, Grad Sch Dent, Div Appl Oral Sci, Tokyo, Japan; [Yamaguchi, Yoko] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan; [Yamaguchi, Yoko] Nihon Univ, Sch Dent, Div Funct Morphol, Tokyo 101, Japan; [Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan; [Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Div Immunol & Pathobiol, Tokyo 101, Japan; [Goke, Eiji; Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo 101, Japan; [Koshi, Ryosuke; Sugano, Naoyuki; Yoshinuma, Naoto] Nihon Univ, Sch Dent, Div Adv Dent Treatment, Tokyo 101, Japan; [Ito, Koichi] Nihon Univ, Sch Dent, Tokyo 101, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University	Asano, M (corresponding author), Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan.	asano.masatake@nihon-u.ac.jp	Asano, Masatake/ABH-5102-2020		Nihon University; Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT) [S1001024, 23592778]; Health and Labour Sciences Research Grants; Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan	Nihon University; Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by: Nihon University Joint Research Grant for 2010-2012 (to Dr. Okayama and Dr. Imamura); a grant of Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT), 2010-2014 (S1001024) and 2011-2013 (23592778); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; The Promotion and Mutual Aid Corporation for Private Schools of Japan (2011); Grant-in-aid for Scientific Research (C) (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Ashakumary L, 1997, LIPIDS, V32, P311, DOI 10.1007/s11745-997-0038-8; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; BOOYSE FM, 1981, AM J PATHOL, V102, P229; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; Campos-Caro A, 2001, DNA CELL BIOL, V20, P657, DOI 10.1089/104454901753340640; Chattopadhyay K, 2008, INDIAN J MED RES, V127, P571; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; Dunckley T, 2003, J BIOL CHEM, V278, P15633, DOI 10.1074/jbc.M210389200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Johnson GK, 2010, J PERIODONTAL RES, V45, P583, DOI 10.1111/j.1600-0765.2009.01262.x; Kashiwagi Y, 2012, ARCH ORAL BIOL, V57, P483, DOI 10.1016/j.archoralbio.2011.10.007; Katz J, 2002, J PERIODONTOL, V73, P494, DOI 10.1902/jop.2002.73.5.494; KITA T, 2001, ANN NY ACAD SCI, V947, P196; Koshi R SN, 2007, NIHON U DENT J, V81, P571; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lax P, 2002, CELL CALCIUM, V32, P53, DOI 10.1016/S0143-4160(02)00076-3; Laxman Vandana K, 2008, J Contemp Dent Pract, V9, P97; Lee J, 2012, LIFE SCI, V91, P1058, DOI 10.1016/j.lfs.2012.06.032; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Losche W, 2000, J CLIN PERIODONTOL, V27, P537, DOI 10.1034/j.1600-051x.2000.027008537.x; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2001, J BIOL CHEM, V276, P19040, DOI 10.1074/jbc.M010735200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J DENT RES, V79, P939; Noack B, 2000, J PERIODONTOL, V71, P898, DOI 10.1902/jop.2000.71.6.898; Omagari D, 2011, CLIN EXP IMMUNOL, V165, P85, DOI 10.1111/j.1365-2249.2011.04404.x; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Peeters AV, 1998, J LIPID RES, V39, P1021; Sakiyama Y, 2010, J PERIODONTAL RES, V45, P216, DOI 10.1111/j.1600-0765.2009.01226.x; Santanam N, 2012, ATHEROSCLEROSIS, V225, P264, DOI 10.1016/j.atherosclerosis.2012.07.041; Scofield MD, 2010, NEUROSCIENCE, V170, P1056, DOI 10.1016/j.neuroscience.2010.08.007; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; Sun XJ, 2009, CANCER RES, V69, P6445, DOI 10.1158/0008-5472.CAN-09-1001; Suzuki K, 2010, J PERIODONTAL RES, V45, P488, DOI 10.1111/j.1600-0765.2009.01263.x; Valor LM, 2002, J BIOL CHEM, V277, P8866, DOI 10.1074/jbc.M110454200; van der Heide F, 2009, INFLAMM BOWEL DIS, V15, P1199, DOI 10.1002/ibd.20884; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017	56	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82563	10.1371/journal.pone.0082563	http://dx.doi.org/10.1371/journal.pone.0082563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358207	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700082
J	Wang, Z; Wang, YN; Sun, CL; Yang, D; Su, LD; Xie, YJ; Zhou, L; Wang, Y; Shen, Y				Wang, Zhen; Wang, Ya-Nan; Sun, Cheng-Long; Yang, Dong; Su, Li-Da; Xie, Ya-Jun; Zhou, Lin; Wang, Yin; Shen, Ying			C-Terminal Domain of ICA69 Interacts with PICK1 and Acts on Trafficking of PICK1-PKC alpha Complex and Cerebellar Plasticity	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; PDZ DOMAIN; CONTAINING PROTEIN; BINDING-PROTEIN; SUBUNIT GLUR2; PKC; DEPRESSION; PHOSPHORYLATION; RETENTION; LIGAND	Background: PICK1 (protein interacting with C-kinase 1) is a PKC (protein kinase C)-binding protein, which is essential for synaptic plasticity. The trafficking of PKC alpha-PICK1 complex to plasma membrane is critical for the internalization of GluR2 and induction of long-term depression. ICA69 (islet cell autoantigen 69 kDa) is identified as a major binding partner of PICK1. While heteromeric BAR domain complex is suggested to underlie the interaction between PICK1 and ICA69, the role of C-terminal domain of ICA69 (ICAC) in PICK1-ICA69 complex is unknown. Methodology/Principal Findings: We found that ICAC interacted with PICK1 and regulated the trafficking of PICK1-PKC alpha complex. ICAC and Delta ICAC (containing BAR domain) might function distinctly in the association of ICA69 with PICK1. While Delta ICAC domain inclined to form clusters, the distribution of ICAC was diffuse. The trafficking of PICK1 to plasma membrane mediated by activated PKC alpha was inhibited by ICA69. This action might ascribe to ICAC, because overexpression of ICAC, but not Delta ICAC, interrupted PKCa-mediated PICK1 trafficking. Notably, infusion of maltose binding protein (MBP) fusion protein, MBP-ICA69 or MBP-ICAC, in cerebellar Purkinje cells significantly inhibited the induction of long-term depression at parallel fiber-and climbing fiber-Purkinje cell synapses. Conclusions: Our experiments showed that ICAC is an important domain for the ICA69-PICK1 interaction and plays essential roles in PICK1-mediated neuronal plasticity.	[Wang, Zhen; Wang, Ya-Nan; Sun, Cheng-Long; Yang, Dong; Su, Li-Da; Xie, Ya-Jun; Zhou, Lin; Shen, Ying] Zhejiang Univ, Sch Med, Dept Neurobiol,Minist Hlth, Key Lab Med Neurobiol,Zhejiang Prov Key Lab Neuro, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yin] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Ningxia Medical University	Shen, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol,Minist Hlth, Key Lab Med Neurobiol,Zhejiang Prov Key Lab Neuro, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	shen, ying/HHS-5635-2022; Yang, Dong/AAE-7987-2020; Xie, Yajun/ABE-8877-2020; Xie, Yajun/AFS-3223-2022; Zhen, Wang/S-7244-2019	Yang, Dong/0000-0003-0612-1439; Xie, Yajun/0000-0003-2988-2708; wang, yanan/0000-0002-7433-3567	National Basic Research Program of the Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [31070945, 30960108, 31060140, 31271148]; National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund [30731160616]; New Century Talent Award of the Ministry of Education of China [NCET-07-0751]	National Basic Research Program of the Ministry of Science and Technology of China; National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund; New Century Talent Award of the Ministry of Education of China	This work was supported by grants from National Basic Research Program of the Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), National Foundation of Natural Science of China (31070945, 30960108, 31060140 and 31271148), National Foundation of Natural Science of China/Hong Kong Research Grants Council JRS fund (30731160616) and New Century Talent Award of the Ministry of Education of China (NCET-07-0751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianjoh FE, 2010, PAIN, V151, P226, DOI 10.1016/j.pain.2010.07.017; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Cao JY, 2011, J BIOL CHEM, V286, P27698, DOI 10.1074/jbc.M111.235333; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chung HJ, 2000, J NEUROSCI, V20, P7258; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Ji YF, 2011, BIOCHEM BIOPH RES CO, V405, P691, DOI 10.1016/j.bbrc.2011.01.105; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masukawa K, 2006, ACTA HISTOCHEM CYTOC, V39, P173, DOI 10.1267/ahc.06025; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Shao X, 2010, NEUROCHEM INT, V56, P962, DOI 10.1016/j.neuint.2010.04.006; Shen Y, 2005, NEURON, V46, P715, DOI 10.1016/j.neuron.2005.04.033; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x; Su LD, 2009, NEUROREPORT, V20, P502, DOI 10.1097/WNR.0b013e328328f397; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041499; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046012	42	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83862	10.1371/journal.pone.0083862	http://dx.doi.org/10.1371/journal.pone.0083862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358315	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700141
J	Zoppini, G; Galletti, A; Targher, G; Brangani, C; Pichiri, I; Negri, C; Stoico, V; Cacciatori, V; Bonora, E				Zoppini, Giacomo; Galletti, Anna; Targher, Giovanni; Brangani, Corinna; Pichiri, Isabella; Negri, Carlo; Stoico, Vincenzo; Cacciatori, Vittorio; Bonora, Enzo			Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients	PLOS ONE			English	Article							HYPOVITAMINOSIS-D; D DEFICIENCY; PREVALENCE; HEALTH	Objective: A correlation between glucose control and 25(OH) D metabolism has been suggested by previous studies. However, this correlation has not yet been evaluated considering the impact of chronic complications of type 2 diabetes, especially the presence of nephropathy. Thus, the aim of this study was to determine the correlation between A1C and 25(OH) D in a well characterized cohort of type 2 diabetic patients. Research Design and Methods: We cross-sectionally examined the association between A1C and serum 25(OH) D in 715 type 2 diabetic patients attending our clinic during the years 2011-2012. The average age was 68612 years (range 26-94 years). The relation between A1C and serum 25(OH) D levels was modelled by multiple linear regression analyses. Results: Serum 25(OH) D levels were inversely associated with A1C levels (r = -0.116, p = .003). This relation maintains its independence in the multivariate analysis after adjusting for age, sex, A1C, BMI, treatment and duration of diabetes and nephropathy. Conclusions: In type 2 diabetic patients, high A1C levels are associated with low concentrations of serum 25(OH) D independently of duration of diabetes, diabetic treatment and nephropathy. Future studies are needed to clarify the biological relation between glucose control and vitamin D metabolism in type 2 diabetes.	[Zoppini, Giacomo; Galletti, Anna; Targher, Giovanni; Brangani, Corinna; Pichiri, Isabella; Negri, Carlo; Stoico, Vincenzo; Cacciatori, Vittorio; Bonora, Enzo] Univ Verona, Dept Med, Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Zoppini, G (corresponding author), Univ Verona, Dept Med, Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy.	giacomo.zoppini@univr.it	Targher, Giovanni/AAB-9008-2019; zoppini, giacomo/AAA-9000-2022; Bonora, Enzo/AAA-5300-2022; raspolli, anna/AGF-5132-2022	Targher, Giovanni/0000-0002-4325-3900; zoppini, giacomo/0000-0003-1085-554X; BONORA, Enzo/0000-0003-1074-5164				Aksu NM, 2013, MED SCI MONITOR, V19, P264, DOI 10.12659/MSM.883880; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; BOUCHER BJ, 1995, DIABETOLOGIA, V38, P1239, DOI 10.1007/BF00422375; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hosseinpour F, 2003, BIOCHEM BIOPH RES CO, V303, P877, DOI 10.1016/S0006-291X(03)00442-X; Hutchinson MS, 2011, SCAND J CLIN LAB INV, V71, P399, DOI 10.3109/00365513.2011.575235; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Luo C, 2009, DIABETES VASC DIS RE, V6, P194, DOI 10.1177/1479164109337974; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Maxwell CS, 2011, NUTR REV, V69, P291, DOI 10.1111/j.1753-4887.2011.00393.x; Ozfirat Z, 2010, POSTGRAD MED J, V86, P18, DOI 10.1136/pgmj.2009.078626; Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x; Patel P, 2010, J DIABETES, V2, P36, DOI 10.1111/j.1753-0407.2009.00057.x; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Rajakumar K, 2012, DIABETES CARE, V35, P627, DOI 10.2337/dc11-1825; Stefanov M. V., 1996, Ukrainskii Biokhimicheskii Zhurnal, V68, P66; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tahrani AA, 2010, INT J CLIN PRACT, V64, P351, DOI 10.1111/j.1742-1241.2009.02221.x; Xuan Y, 2013, J DIABETES; Yu Jung Re, 2012, Chonnam Med J, V48, P108, DOI 10.4068/cmj.2012.48.2.108	23	35	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82733	10.1371/journal.pone.0082733	http://dx.doi.org/10.1371/journal.pone.0082733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358222	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700092
J	Riekhof, WR; Wu, WI; Jones, JL; Nikrad, M; Chan, MM; Loewen, CJR; Voelker, DR				Riekhof, Wayne R.; Wu, Wen-I; Jones, Jennifer L.; Nikrad, Mrinalini; Chan, Mallory M.; Loewen, Christopher J. R.; Voelker, Dennis R.			An Assembly of Proteins and Lipid Domains Regulates Transport of Phosphatidylserine to Phosphatidylserine Decarboxylase 2 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Endosomes; Glycerophospholipid; Lipid Transport; Membrane Biogenesis; Phosphatidic Acid; Phosphatidylethanolamine; Phosphatidylserine; Yeast	BINDING-PROTEINS; NULL ALLELE; FFAT MOTIF; YEAST; GENE; PHOSPHATIDYLETHANOLAMINE; MITOCHONDRIA; TRAFFICKING; METABOLISM; COMPLEXES	Background: The machinery for interorganelle phosphatidylserine (PtdSer) transport is poorly defined at the molecular level. Results: Molecular interaction studies identify specific protein-protein and protein-lipid interactions in PtdSer transport. Conclusion: A protein and lipid interaction network defines key participants in PS transport to the locus of PtdSer-decarboxylase 2. Significance: This study identifies important molecular participants involved in non-vesicular phospholipid traffic. Saccharomyces cerevisiae uses multiple biosynthetic pathways for the synthesis of phosphatidylethanolamine. One route involves the synthesis of phosphatidylserine (PtdSer) in the endoplasmic reticulum (ER), the transport of this lipid to endosomes, and decarboxylation by PtdSer decarboxylase 2 (Psd2p) to produce phosphatidylethanolamine. Several proteins and protein motifs are known to be required for PtdSer transport to occur, namely the Sec14p homolog PstB2p/Pdr17p; a PtdIns 4-kinase, Stt4p; and a C2 domain of Psd2p. The focus of this work is on defining the protein-protein and protein-lipid interactions of these components. PstB2p interacts with a protein encoded by the uncharacterized gene YPL272C, which we name Pbi1p (PstB2p-interacting 1). PstB2p, Psd2, and Pbi1p were shown to be lipid-binding proteins specific for phosphatidic acid. Pbi1p also interacts with the ER-localized Scs2p, a binding determinant for several peripheral ER proteins. A complex between Psd2p and PstB2p was also detected, and this interaction was facilitated by a cryptic C2 domain at the extreme N terminus of Psd2p (C2-1) as well the previously characterized C2 domain of Psd2p (C2-2). The predicted N-terminal helical region of PstB2p was necessary and sufficient for promoting the interaction with both Psd2p and Pbi1p. Taken together, these results support a model for PtdSer transport involving the docking of a PtdSer donor membrane with an acceptor via specific protein-protein and protein-lipid interactions. Specifically, our model predicts that this process involves an acceptor membrane complex containing the C2 domains of Psd2p, PstB2p, and Pbi1p that ligate to Scs2p and phosphatidic acid present in the donor membrane, forming a zone of apposition that facilitates PtdSer transfer.	[Riekhof, Wayne R.; Wu, Wen-I; Jones, Jennifer L.; Nikrad, Mrinalini; Chan, Mallory M.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Cell Biol Program, Denver, CO 80206 USA; [Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	National Jewish Health; University of British Columbia	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [5R37 GM32453, GM081461, F32 GM076798]; American Cancer Society [PF-06-288-01-CSM]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032453, F32GM076798, R37GM032453, R01GM081461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37 GM32453 and GM081461 (to D. R. V.) and F32 GM076798 (to W. R. R.). This work was also supported by American Cancer Society Great-West Postdoctoral Fellowship Award PF-06-288-01-CSM (to W. R. R.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kitamura H, 2002, J BIOL CHEM, V277, P33720, DOI 10.1074/jbc.M205672200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wu WI, 2004, J BIOL CHEM, V279, P6635, DOI 10.1074/jbc.M311570200; Wu WI, 2001, J BIOL CHEM, V276, P7114, DOI 10.1074/jbc.M010278200	38	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5809	5819		10.1074/jbc.M113.518217	http://dx.doi.org/10.1074/jbc.M113.518217			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24366873	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000332015500040
J	Asuni, AA; Gray, B; Bailey, J; Skipp, P; Perry, VH; O'Connor, V				Asuni, Ayodeji A.; Gray, Bryony; Bailey, Joanne; Skipp, Paul; Perry, V. Hugh; O'Connor, Vincent			Analysis of the Hippocampal Proteome in ME7 Prion Disease Reveals a Predominant Astrocytic Signature and Highlights the Brain-restricted Production of Clusterin in Chronic Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; Mass Spectrometry (MS); mRNA; Neurobiology; Prions; ME7; Neurodegeneration; Prion; iTRAQ	BOVINE SPONGIFORM ENCEPHALOPATHY; PRP KNOCKOUT MICE; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-J; PLASMA CLUSTERIN; NEUROLOGICAL DISORDERS; INFLAMMATORY RESPONSE; SYSTEMIC INFLAMMATION; REACTIVE ASTROCYTES; TRANSGENIC MICE	Prion diseases are characterized by accumulation of misfolded protein, gliosis, synaptic dysfunction, and ultimately neuronal loss. This sequence, mirroring key features of Alzheimer disease, is modeled well in ME7 prion disease. We used iTRAQ(TM)/mass spectrometry to compare the hippocampal proteome in control and late-stage ME7 animals. The observed changes associated with reactive glia highlighted some specific proteins that dominate the proteome in late-stage disease. Four of the up-regulated proteins (GFAP, high affinity glutamate transporter (EAAT-2), apo-J (Clusterin), and peroxiredoxin-6) are selectively expressed in astrocytes, but astrocyte proliferation does not contribute to their up-regulation. The known functional role of these proteins suggests this response acts against protein misfolding, excitotoxicity, and neurotoxic reactive oxygen species. A recent convergence of genome-wide association studies and the peripheral measurement of circulating levels of acute phase proteins have focused attention on Clusterin as a modifier of late-stage Alzheimer disease and a biomarker for advanced neurodegeneration. Since ME7 animals allow independent measurement of acute phase proteins in the brain and circulation, we extended our investigation to address whether changes in the brain proteome are detectable in blood. We found no difference in the circulating levels of Clusterin in late-stage prion disease when animals will show behavioral decline, accumulation of misfolded protein, and dramatic synaptic and neuronal loss. This does not preclude an important role of Clusterin in late-stage disease, but it cautions against the assumption that brain levels provide a surrogate peripheral measure for the progression of brain degeneration.	[Asuni, Ayodeji A.; Gray, Bryony; Bailey, Joanne; Perry, V. Hugh; O'Connor, Vincent] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Skipp, Paul] Univ Southampton, Ctr Prote Res, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton	Asuni, AA (corresponding author), Univ Southampton, Ctr Biol Sci, Fac Nat & Environm Sci, Bldg 85,Univ Rd,Highfield Campus, Southampton SO17 1BJ, Hants, England.	a.a.asuni@soton.ac.uk	Perry, V. Hugh/Y-2935-2019; Asuni, Ayodeji/F-4285-2011	Asuni, Ayodeji/0000-0003-3488-6893; O'Connor, Vincent/0000-0003-3185-5709	Medical Research Council [G0501636]; MRC [G0501636] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0501636.	Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Asuni AA, 2010, NEUROSCIENCE, V165, P662, DOI 10.1016/j.neuroscience.2009.10.047; Asuni AA, 2008, BRAIN RES, V1233, P1, DOI 10.1016/j.brainres.2008.07.083; Baig S, 2012, J ALZHEIMERS DIS, V28, P337, DOI 10.3233/JAD-2011-110473; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Brown AR, 2004, NEUROPATH APPL NEURO, V30, P555, DOI 10.1111/j.1365-2990.2004.00565.x; BURKEY BF, 1991, J LIPID RES, V32, P1039; CAMPBELL IL, 1994, J VIROL, V68, P2383, DOI 10.1128/JVI.68.4.2383-2387.1994; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Charnay Y, 2012, BRAIN RES BULL, V88, P434, DOI 10.1016/j.brainresbull.2012.05.006; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; Chung C, 2013, J NEUROCHEM, V126, P146, DOI 10.1111/jnc.12245; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2005, J VIROL, V79, P5174, DOI 10.1128/JVI.79.8.5174-5184.2005; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Filali H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-399; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Fukuda I, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-36; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Gray B. C., 2006, THESIS U SOUTHAMPTON; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Hazzaa SM, 2010, PATHOL ONCOL RES, V16, P101, DOI 10.1007/s12253-009-9196-3; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hilton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068062; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ijsselstijn L, 2011, J PROTEOME RES, V10, P2006, DOI 10.1021/pr101221h; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; JEFFREY M, 1995, NEUROPATH APPL NEURO, V21, P41, DOI 10.1111/j.1365-2990.1995.tb01027.x; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Larvie M., 2012, J BIOMED BIOTECHNOL, V2012, P1; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Lewicki H, 2003, J VIROL, V77, P3799, DOI 10.1128/JVI.77.6.3799-3808.2003; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; LIPTON SA, 1994, ANN NY ACAD SCI, V738, P382; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Luccarini I, 2012, NEUROSCI LETT, V506, P94, DOI 10.1016/j.neulet.2011.10.056; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Majer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003002; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Newsom DM, 2011, COMP IMMUNOL MICROB, V34, P387, DOI 10.1016/j.cimid.2011.06.001; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; PASINETTI GM, 1994, J COMP NEUROL, V339, P387, DOI 10.1002/cne.903390307; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prusiner SB, 1996, COLD SPRING HARB SYM, V61, P473; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schurmann B, 2011, J ALZHEIMERS DIS, V25, P421, DOI 10.3233/JAD-2011-110251; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Silajdzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050237; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Vranova HP, 2010, J NEURAL TRANSM, V117, P1177, DOI 10.1007/s00702-010-0462-z; Wagner W, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-38; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; WITTE DP, 1993, AM J PATHOL, V143, P763; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Xing YY, 2012, J ALZHEIMERS DIS, V29, P515, DOI 10.3233/JAD-2011-111844; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yu HR, 2010, PEDIATR CARDIOL, V31, P1151, DOI 10.1007/s00246-010-9769-7; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	112	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4532	4545		10.1074/jbc.M113.502690	http://dx.doi.org/10.1074/jbc.M113.502690			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366862	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000331403800060
J	Mazalouskas, MD; Godoy-Ruiz, R; Weber, DJ; Zimmer, DB; Honkanen, RE; Wadzinski, BE				Mazalouskas, Matthew D.; Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.; Honkanen, Richard E.; Wadzinski, Brian E.			Small G Proteins Rac1 and Ras Regulate Serine/Threonine Protein Phosphatase 5 (PP5).Extracellular Signal-Regulated Kinase (ERK) Complexes Involved in the Feedback Regulation of Raf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERK; MAP Kinases (MAPKs); Rac; Raf; Ras; S100 Proteins; MEK; PP5; Feedback Phosphorylation; Small G Protein	TETRATRICOPEPTIDE REPEAT DOMAIN; POSITIVE REGULATION; PHOSPHORYLATION; ACTIVATION; BINDING; EXPRESSION; PATHWAY; PP5; TRANSDUCTION; 2A	Background: PP5 binds HSP90 and regulates cell growth and stress-induced signaling pathways. Results: PP5 associates with ERKs in a manner facilitated, in part, by HSP90. Rac1 and Ras regulate PP5ERK1/2 complexes. Conclusion: PP5 and ERK play a role in the feedback phosphorylation of PP5-associated Raf1. Significance: Differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to oncogenic small G proteins may contribute to particular tumor traits. Serine/threonine protein phosphatase 5 (PP5, PPP5C) is known to interact with the chaperonin heat shock protein 90 (HSP90) and is involved in the regulation of multiple cellular signaling cascades that control diverse cellular processes, such as cell growth, differentiation, proliferation, motility, and apoptosis. Here, we identify PP5 in stable complexes with extracellular signal-regulated kinases (ERKs). Studies using mutant proteins reveal that the formation of PP5ERK1 and PP5ERK2 complexes partially depends on HSP90 binding to PP5 but does not require PP5 or ERK1/2 activity. However, PP5 and ERK activity regulates the phosphorylation state of Raf1 kinase, an upstream activator of ERK signaling. Whereas expression of constitutively active Rac1 promotes the assembly of PP5ERK1/2 complexes, acute activation of ERK1/2 fails to influence the phosphatase-kinase interaction. Introduction of oncogenic HRas (HRas(V12)) has no effect on PP5-ERK1 binding but selectively decreases the interaction of PP5 with ERK2, in a manner that is independent of PP5 and MAPK/ERK kinase (MEK) activity, yet paradoxically requires ERK2 activity. Additional studies conducted with oncogenic variants of KRas4B reveal that KRas(L61), but not KRas(V12), also decreases the PP5-ERK2 interaction. The expression of wild type HRas or KRas proteins fails to reduce PP5-ERK2 binding, indicating that the effect is specific to HRas(V12) and KRas(L61) gain-of-function mutations. These findings reveal a novel, differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to select oncogenic Ras variants and also support a role for PP5ERK complexes in regulating the feedback phosphorylation of PP5-associated Raf1.	[Mazalouskas, Matthew D.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.] Univ Maryland, Sch Med, Ctr Biomol Therapeut, Baltimore, MD 20102 USA; [Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 20102 USA; [Honkanen, Richard E.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	Vanderbilt University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of South Alabama	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 424 RRB, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu	Weber, David J/B-5349-2011; Godoy Ruiz, Raquel/GOH-1617-2022	Weber, David J/0000-0002-8824-1110; GODOY-RUIZ, RAQUEL/0000-0003-4569-0781	National Institutes of Health [GM051366, CA60750, T32 GM08554, CA107331]; Center for Biomolecular Therapeutics at the University of Maryland School of Medicine; Institute for Bioscience and Biotechnology Research; NATIONAL CANCER INSTITUTE [R01CA060750, R01CA107331, R29CA060750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, T32GM008554, T32GM007628, R01GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomolecular Therapeutics at the University of Maryland School of Medicine; Institute for Bioscience and Biotechnology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 (to B. E. W.), CA60750 (to R. E. H.), T32 GM08554 (to M. D. M.), and CA107331 (to D. J. W.). This work was also supported by funds from the Center for Biomolecular Therapeutics at the University of Maryland School of Medicine and the Institute for Bioscience and Biotechnology Research.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2011, J BIOL CHEM, V286, P40413, DOI 10.1074/jbc.M111.244053; AMBURGEY JC, 1995, J BIOMOL NMR, V6, P171, DOI 10.1007/BF00211781; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Chatterjee A, 2010, J BIOL CHEM, V285, P3872, DOI 10.1074/jbc.M109.088427; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chiang CW, 2011, BIOCHEM J, V433, P187, DOI 10.1042/BJ20100247; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Illert AL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373464; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nguyen LK, 2013, FEBS J, V280, P751, DOI 10.1111/j.1742-4658.2012.08522.x; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; Roberts MS, 2003, J BIOL CHEM, V278, P1975, DOI 10.1074/jbc.M208607200; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.137; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Swingle Mark, 2007, V365, P23; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Szomolay B, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-26; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Uversky Vladimir N, 2013, F1000 Biol Rep, V5, P1, DOI 10.3410/B5-1; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Wegner Adam M., 2007, V365, P61; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yung YV, 2000, J BIOL CHEM, V275, P15799, DOI 10.1074/jbc.M910060199; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005	78	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4219	4232		10.1074/jbc.M113.518514	http://dx.doi.org/10.1074/jbc.M113.518514			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371145	Green Published, hybrid			2022-12-25	WOS:000331403800034
J	Cook, MB; Matthews, CE; Gunja, MZ; Abid, Z; Freedman, ND; Abnet, CC				Cook, Michael B.; Matthews, Charles E.; Gunja, Munira Z.; Abid, Zaynah; Freedman, Neal D.; Abnet, Christian C.			Physical Activity and Sedentary Behavior in Relation to Esophageal and Gastric Cancers in the NIH-AARP Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; SQUAMOUS-CELL CARCINOMA; POPULATION-BASED COHORT; NATIONAL DEATH INDEX; SOCIOECONOMIC-STATUS; MASTER FILE; LIFE-STYLE; RISK; OBESITY; ASSOCIATION	Introduction: Body mass index is known to be positively associated with an increased risk of adenocarcinomas of the esophagus, yet there is there limited evidence on whether physical activity or sedentary behavior affects risk of histology- and site-specific upper gastrointestinal cancers. We used the NIH-AARP Diet and Health Study to assess these exposures in relation to esophageal adenocarcinoma (EA), esophageal squamous cell carcinoma (ESCC), gastric cardia adenocarcinoma (GCA), and gastric non-cardia adenocarcinoma (GNCA). Methods: Self-administered questionnaires were used to elicit physical activity and sedentary behavior exposures at various age periods. Cohort members were followed via linkage to the US Postal Service National Change of Address database, the Social Security Administration Death Master File, and the National Death Index. Cox proportional hazards regression models were used to estimate hazard ratios (HR) and 95 percent confidence intervals (95% CI) Results: During 4.8 million person years, there were a total of 215 incident ESCCs, 631 EAs, 453 GCAs, and 501 GNCAs for analysis. Strenuous physical activity in the last 12 months (HR>(5times/week vs.never)=0.58, 95% CI: 0.39, 0.88) and typical physical activity and sports during ages 15-18 years (p for trend=0.01) were each inversely associated with GNCA risk. Increased sedentary behavior was inversely associated with EA (HR5-6 hrs/day vs. <1 hr=0.57, 95% CI: 0.36, 0.92). There was no evidence that BMI was a confounder or effect modifier of any relationship. After adjustment for multiple testing, none of these results were deemed to be statistically significant at p<0.05. Conclusions: We find evidence for an inverse association between physical activity and GNCA risk. Associations between body mass index and adenocarcinomas of the esophagus do not appear to be related to physical activity and sedentary behavior.	[Cook, Michael B.; Matthews, Charles E.; Gunja, Munira Z.; Abid, Zaynah; Freedman, Neal D.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cook, MB (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	michael.cook@nih.gov	Abnet, Christian C/C-4111-2015; Cook, Michael B/A-5641-2009; matthews, Charles e/E-8073-2015; Freedman, Neal David/B-9741-2015	Abnet, Christian C/0000-0002-3008-7843; Cook, Michael B/0000-0002-0533-7302; matthews, Charles e/0000-0001-8037-3103; Freedman, Neal David/0000-0003-0074-1098	NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams JA, 2009, GUT, V58, P1437, DOI 10.1136/gut.2009.183285; Akiyama T, 2011, DIGESTION, V83, P142, DOI 10.1159/000321810; Ayazi S, 2009, J GASTROINTEST SURG, V13, P1440, DOI 10.1007/s11605-009-0930-7; Balbuena L, 2009, FUTURE ONCOL, V5, P1051, DOI 10.2217/FON.09.65; Batty GD, 2010, ANN EPIDEMIOL, V20, P661, DOI 10.1016/j.annepidem.2010.03.014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair A, 2005, ANN EPIDEMIOL, V15, P279, DOI 10.1016/j.annepidem.2004.08.008; BROWNSON RC, 1991, AM J PUBLIC HEALTH, V81, P639, DOI 10.2105/AJPH.81.5.639; Campbell PT, 2007, EUR J CANCER, V43, P593, DOI 10.1016/j.ejca.2006.11.011; Dar NA, 2013, CANCER SCI, V104, P1231, DOI 10.1111/cas.12210; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; DOSEMECI M, 1993, CANCER CAUSE CONTROL, V4, P313, DOI 10.1007/BF00051333; Dunton GF, 2009, INT J OBESITY, V33, P1427, DOI 10.1038/ijo.2009.174; Etemadi A, 2012, ANN ONCOL, V23, P1593, DOI 10.1093/annonc/mdr494; Hassler S, 2008, EUR J EPIDEMIOL, V23, P273, DOI 10.1007/s10654-008-9232-8; Hermansen SW, 2009, AM J EPIDEMIOL, V169, P901, DOI 10.1093/aje/kwn404; Hill ME, 2001, SOC SECUR BULL, V64, P45; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; Huang Xin-En, 2004, Asian Pac J Cancer Prev, V5, P419; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Jurek AM, 2008, INT J EPIDEMIOL, V37, P382, DOI 10.1093/ije/dym291; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Leitzmann MF, 2009, AM J PREV MED, V36, P112, DOI 10.1016/j.amepre.2008.09.033; Huerta JM, 2010, CANCER CAUSE CONTROL, V21, P657, DOI 10.1007/s10552-009-9493-x; NOMURA AMY, 1995, JPN J CANCER RES, V86, P916, DOI 10.1111/j.1349-7006.1995.tb03001.x; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; PAFFENBARGER RS, 1987, AM J CLIN NUTR, V45, P312, DOI 10.1093/ajcn/45.1.312; Pandeya N, 2011, J GASTROEN HEPATOL, V26, P1283, DOI 10.1111/j.1440-1746.2011.06726.x; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pukkala E, 1993, Eur J Cancer Prev, V2, P369, DOI 10.1097/00008469-199309000-00002; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; SEVERSON RK, 1989, AM J EPIDEMIOL, V130, P522, DOI 10.1093/oxfordjournals.aje.a115366; Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704; Soll-Johanning H, 2004, INT ARCH OCC ENV HEA, V77, P351, DOI 10.1007/s00420-004-0510-9; STUKONIS M, 1969, INT J CANCER, V4, P248, DOI 10.1002/ijc.2910040215; Vigen C, 2006, INT J CANCER, V118, P1004, DOI 10.1002/ijc.21419; Wannamethee SG, 2001, BRIT J CANCER, V85, P1311, DOI 10.1054/bjoc.2001.2096; Weiderpass E, 2003, J OCCUP ENVIRON MED, V45, P305, DOI 10.1097/01.jom.0000052963.43131.44; Wen XY, 2010, ASIAN PAC J CANCER P, V11, P1473; WHITTEMORE AS, 1985, JNCI-J NATL CANCER I, V74, P43; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Yun YH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-366; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761	46	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84805	10.1371/journal.pone.0084805	http://dx.doi.org/10.1371/journal.pone.0084805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367697	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900068
J	Qureshi, HY; Han, D; MacDonald, R; Paudel, HK				Qureshi, Hamid Y.; Han, Dong; MacDonald, Ryen; Paudel, Hemant K.			Overexpression of 14-3-3z Promotes Tau Phosphorylation at Ser(262) and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FTDP-17 MISSENSE MUTATIONS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROTEASOMAL DEGRADATION; REACTIVE ASTROCYTES; RECOMBINANT TAU; LUNG-CANCER; EXPRESSION; NEURODEGENERATION	b-amyloid peptide accumulation, tau hyperphosphorylation, and synapse loss are characteristic neuropathological symptoms of Alzheimer's disease (AD). Tau hyperphosphorylation is suggested to inhibit the association of tau with microtubules, making microtubules unstable and causing neurodegeneration. The mechanism of tau phosphorylation in AD brain, therefore, is of considerable significance. Although PHF-tau is phosphorylated at over 40 Ser/Thr sites, Ser(262) phosphorylation was shown to mediate b-amyloid neurotoxicity and formation of toxic tau lesions in the brain. In vitro, PKA is one of the kinases that phosphorylates tau at Ser(262), but the mechanism by which it phosphorylates tau in AD brain is not very clear. 14-3-3z is associated with neurofibrillary tangles and is upregulated in AD brain. In this study, we show that 14-3-3z promotes tau phosphorylation at Ser(262) by PKA in differentiating neurons. When overexpressed in rat hippocampal primary neurons, 14-3-3z causes an increase in Ser(262) phosphorylation, a decrease in the amount of microtubule-bound tau, a reduction in the amount of polymerized microtubules, as well as microtubule instability. More importantly, the level of pre-synaptic protein synaptophysin was significantly reduced. Downregulation of synaptophysin in 14-3-3z overexpressing neurons was mitigated by inhibiting the proteosome, indicating that 14-3-3z promotes proteosomal degradation of synaptophysin. When 14-3-3z overexpressing neurons were treated with the microtubule stabilizing drug taxol, tau Ser(262) phosphorylation decreased and synaptophysin level was restored. Our data demonstrate that overexpression of 14-3-3z accelerates proteosomal turnover of synaptophysin by promoting the destabilization of microtubules. Synaptophysin is involved in synapse formation and neurotransmitter release. Our results suggest that 14-3-3z may cause synaptic pathology by reducing synaptophysin levels in the brains of patients suffering from AD.	[Qureshi, Hamid Y.; Han, Dong; MacDonald, Ryen; Paudel, Hemant K.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [MacDonald, Ryen; Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research, and Alzheimer's Society of Canada	Canadian Institute for Health Research, and Alzheimer's Society of Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institute for Health Research, and Alzheimer's Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Allen B, 2002, J NEUROSCI, V22, P9340; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; Brennan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054491; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cassano S, 1996, J BIOL CHEM, V271, P29870, DOI 10.1074/jbc.271.47.29870; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Chen XQ, 2003, GLIA, V42, P315, DOI 10.1002/glia.10185; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Daly C, 1997, J NEUROSCI, V17, P2365; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huff LM, 2010, CANCER RES, V70, P5870, DOI 10.1158/0008-5472.CAN-09-4281; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P302, DOI 10.1007/s00401-004-0892-5; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leugers CJ, 2010, J BIOL CHEM, V285, P19125, DOI 10.1074/jbc.M110.105387; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lim F, 2001, MOL CELL NEUROSCI, V18, P702, DOI 10.1006/mcne.2001.1051; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Pirim I, 1998, INT J NEUROSCI, V95, P101, DOI 10.3109/00207459809000653; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Ramser EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013462; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Ren QG, 2007, FEBS LETT, V581, P1521, DOI 10.1016/j.febslet.2007.02.065; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Sironi JJ, 1998, FEBS LETT, V436, P471, DOI 10.1016/S0014-5793(98)01185-5; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Soulie C, 2004, NEUROSCI LETT, V365, P1, DOI 10.1016/j.neulet.2004.03.090; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; YAN GZ, 1995, J NEUROSCI, V15, P6200; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576	101	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84615	10.1371/journal.pone.0084615	http://dx.doi.org/10.1371/journal.pone.0084615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367683	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900059
J	Somasundaram, R; Nuij, VJAA; van der Woude, CJ; Kuipers, EJ; Peppelenbosch, MP; Fuhler, GM				Somasundaram, Rajesh; Nuij, Veerle J. A. A.; van der Woude, C. Janneke; Kuipers, Ernst J.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.			Peripheral Neutrophil Functions and Cell Signalling in Crohn's Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE-B; GM-CSF; PHOSPHATIDYLINOSITOL 3-KINASE; ULCERATIVE-COLITIS; REGULATED KINASE; NADPH OXIDASE; WHOLE-BLOOD; IN-VITRO	The role of the innate immunity in the pathogenesis of Crohn's disease (CD), an inflammatory bowel disease, is a subject of increasing interest. Neutrophils (PMN) are key members of the innate immune system which migrate to sites of bacterial infection and initiate the defence against microbes by producing reactive oxygen species (ROS), before undergoing apoptosis. It is believed that impaired innate immune responses contribute to CD, but it is as yet unclear whether intrinsic defects in PMN signal transduction and corresponding function are present in patients with quiescent disease. We isolated peripheral blood PMN from CD patients in remission and healthy controls (HC), and characterised migration, bacterial uptake and killing, ROS production and cell death signalling. Whereas IL8-induced migration and signalling were normal in CD, trans-epithelial migration was significantly impaired. Uptake and killing of E. coli were normal. However, an increased ROS production was observed in CD PMN after stimulation with the bacterial peptide analogue fMLP, which was mirrored by an increased fMLP-triggered ERK and AKT signal activation. Interestingly, cleavage of caspase-3 and caspase-8 during GMCSF-induced rescue from cell-death was decreased in CD neutrophils, but a reduced survival signal emanating from STAT3 and AKT pathways was concomitantly observed, resulting in a similar percentage of end stage apoptotic PMN in CD patients and HC. In toto, these data show a disturbed signal transduction activation and functionality in peripheral blood PMN from patients with quiescent CD, which point toward an intrinsic defect in innate immunity in these patients.	[Somasundaram, Rajesh; Nuij, Veerle J. A. A.; van der Woude, C. Janneke; Kuipers, Ernst J.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Fuhler, GM (corresponding author), Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	g.fuhler@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019; Fuhler, Gwenny/AAC-7122-2019; Kuipers, Ernst J/H-3293-2019	Fuhler, Gwenny/0000-0001-9221-4855; Kuipers, Ernst J/0000-0002-0633-3098; van der Woude, C.Janneke/0000-0003-3875-6957; Peppelenbosch, Maikel/0000-0001-9112-6028	Dutch Cancer Society [2010-4737]; ECCO	Dutch Cancer Society(KWF Kankerbestrijding); ECCO	GMF is supported by the Dutch Cancer Society (grant 2010-4737). MPP is supported by a personal ECCO grant. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biagioni C, 2006, EXP BIOL MED, V231, P186; Blake KM, 2004, CLIN EXP IMMUNOL, V136, P262, DOI 10.1111/j.1365-2249.2004.02429.x; Brandt E, 1998, EUR CYTOKINE NETW, V9, P647; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Burelout C, 2007, J LEUKOCYTE BIOL, V81, P1523, DOI 10.1189/jlb.0406256; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; Crepaldi L, 2002, INT IMMUNOL, V14, P1145, DOI 10.1093/intimm/dxf079; Epling-Burnette PK, 2001, J IMMUNOL, V166, P7486, DOI 10.4049/jimmunol.166.12.7486; Faber K.N., 2012, CLIN VACCINE IMMUNOL; Fiuza C, 2002, CLIN DIAGN LAB IMMUN, V9, P433, DOI 10.1128/CDLI.9.2.433-439.2002; Fortin CF, 2007, BIOGERONTOLOGY, V8, P173, DOI 10.1007/s10522-006-9067-1; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Fuhler GM, 2003, EXP HEMATOL, V31, P752, DOI 10.1016/S0301-472X(03)00188-7; Fuhler GM, 2003, BLOOD, V101, P1172, DOI 10.1182/blood.V101.3.1172; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Furebring M, 2006, SCAND J IMMUNOL, V63, P208, DOI 10.1111/j.1365-3083.2006.01724.x; GIONCHETTI P, 1994, DIGEST DIS SCI, V39, P550, DOI 10.1007/BF02088341; Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1; GRISHAM MB, 1988, DIGEST DIS SCI, V33, pS6, DOI 10.1007/BF01538126; Harbord MWN, 2006, ALIMENT PHARM THER, V24, P651, DOI 10.1111/j.1365-2036.2006.03016.x; Hayee B, 2011, DIGEST DIS SCI, V56, P1482, DOI 10.1007/s10620-010-1426-8; HOMBURG CHE, 1995, BLOOD, V85, P532; JONES SC, 1993, J GASTROEN HEPATOL, V8, P508, DOI 10.1111/j.1440-1746.1993.tb01643.x; Klionsky DJ, 2009, NEW ENGL J MED, V360, P1785, DOI 10.1056/NEJMcibr0810347; Kopprasch S, 1996, CLIN CHIM ACTA, V253, P145, DOI 10.1016/0009-8981(96)06365-6; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Liu LX, 1996, ANN NY ACAD SCI, V796, P21, DOI 10.1111/j.1749-6632.1996.tb32563.x; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marks DJB, 2010, CLIN REV ALLERG IMMU, V38, P20, DOI 10.1007/s12016-009-8133-2; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; McKenzie SJ, 1996, J CLIN INVEST, V98, P136, DOI 10.1172/JCI118757; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; MULHOLLAND MW, 1983, ANN SURG, V198, P673, DOI 10.1097/00000658-198312000-00001; Passalacqua S, 2011, J CLIN APHERESIS, V26, P332, DOI 10.1002/jca.20315; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rahman FZ, 2008, INFLAMM BOWEL DIS, V14, P1443, DOI 10.1002/ibd.20449; RHODES JM, 1983, GUT, V24, P73, DOI 10.1136/gut.24.1.73; Sakamoto C, 2003, INT J HEMATOL, V77, P60, DOI 10.1007/BF02982604; Schwarzmaier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062761; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Trottier MD, 2012, OBESITY, V20, P1057, DOI 10.1038/oby.2011.354; Uzel G, 2008, BLOOD, V111, P209, DOI 10.1182/blood-2007-04-082552; VERSPAGET HW, 1988, GUT, V29, P223, DOI 10.1136/gut.29.2.223; Zhou L, 2009, CELL MOL LIFE SCI, V66, P192, DOI 10.1007/s00018-008-8308-7	53	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84521	10.1371/journal.pone.0084521	http://dx.doi.org/10.1371/journal.pone.0084521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367671	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900052
J	Specogna, AV; Patten, SB; Turin, TC; Hill, MD				Specogna, Adrian V.; Patten, Scott B.; Turin, Tanvir C.; Hill, Michael D.			The Reliability and Sensitivity of the National Institutes of Health Stroke Scale for Spontaneous Intracerebral Hemorrhage in an Uncontrolled Setting	PLOS ONE			English	Article								Background and Purpose: The National Institutes of Health Stroke Scale (NIHSS) is commonly used to measure neurologic function and guide treatment after spontaneous intracerebral hemorrhage (ICH) in routine stroke clinics. We evaluated its reliability and sensitivity to detect change with consecutive and unique rater combinations in a real-world setting. Methods: Conservative measures of interrater reliability (unweighted Kappa (kappa), Intraclass Correlation Coefficient (ICC1.1) and sensitivity to detect change (Minimal Detectable Difference (MDD)) were estimated. Sixty-one repeated ratings were completed within 1 week after ICH by physicians and nurses with no investigator intervention. Results: Reliability (consistency) of the NIHSS total score was good for both physicians vs. nurses and nurses vs. nurses (ICC=0.78, 95%CI: 0.58-0.89 and ICC= 0.75, 95% CI: 0.55-0.87 respectively) in this scenario. Reliability (agreement) of items 1C and 9 were excellent (kappa>=0.61) for both rater comparisons, however, reliability was poor to fair on most remaining items (kappa:0.01-0.60), with item 11 being completely unreliable in this scenario (kappa<0.01). The MDD95 of the total NIHSS score was +/- 10 and +/- 11 points for physician vs. nurse and nurse vs. nurse comparisons. Conclusions: The reliability of the NIHSS is good overall for ICH even in an uncontrolled setting. However, on repeated measurements changes in total NIHSS score of at least >=10 points need to be observed for clinicians to be confident that real changes had occurred within 1 week after ICH.	[Specogna, Adrian V.; Patten, Scott B.; Turin, Tanvir C.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Hill, Michael D.] Foothills Prov Gen Hosp, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary	Specogna, AV (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada.	specogna@shaw.ca	Hill, Michael D/C-9073-2012; Patten, Scott/B-4434-2011; Turin, Tanvir C/L-7617-2016	Hill, Michael D/0000-0002-6269-1543; Patten, Scott/0000-0001-9871-4041; Turin, Tanvir C/0000-0002-7499-5050	Alberta Heritage Foundation for Medical Research; University of Calgary; Tomorrow's Research Cardiovascular Health Professional training program	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); University of Calgary; Tomorrow's Research Cardiovascular Health Professional training program	Adrian V. Specogna has received salary support awards from the Alberta Heritage Foundation for Medical Research, the University of Calgary, and the Tomorrow's Research Cardiovascular Health Professional training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Kasner SE, 2003, STROKE, V34, P568, DOI 10.1161/01.STR.0000052630.11159.25; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Portney LG, 2008, CORRELATION, V3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Specogna Adrian V, 2004, J Knee Surg, V17, P203; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	9	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84702	10.1371/journal.pone.0084702	http://dx.doi.org/10.1371/journal.pone.0084702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367691	Green Published, gold			2022-12-25	WOS:000328741900063
J	Chuffa, LGA; Fioruci-Fontanelli, BA; Mendes, LO; Favaro, WJ; Pinheiro, PFF; Martinez, M; Martinez, FE				Chuffa, Luiz Gustavo A.; Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.; Favaro, Wagner J.; Pinheiro, Patricia Fernanda F.; Martinez, Marcelo; Martinez, Francisco Eduardo			Characterization of Chemically Induced Ovarian Carcinomas in an Ethanol-Preferring Rat Model: Influence of Long-Term Melatonin Treatment	PLOS ONE			English	Article							SEX STEROID-RECEPTORS; INCESSANT OVULATION; EPITHELIAL-CELLS; PINEAL HORMONE; CANCER RISK; ADULT RATS; IN-VIVO; ALCOHOL; CARCINOGENESIS; INHIBITION	Ovarian cancer is the fourth most common cause of cancer deaths among women, and chronic alcoholism may exert co-carcinogenic effects. Because melatonin (mel) has oncostatic properties, we aimed to investigate and characterize the chemical induction of ovarian tumors in a model of ethanol-preferring rats and to verify the influence of mel treatment on the overall features of these tumors. After rats were selected to receive ethanol (EtOH), they were surgically injected with 100 mu g of 7,12-dimethyl-benz[a] anthracene (DMBA) plus sesame oil directly under the left ovarian bursa. At 260 days old, half of the animals received i.p. injections of 200 mu g mel/100 g b.w. for 60 days. Four experimental groups were established: Group C, rats bearing ovarian carcinomas (OC); Group C+EtOH, rats voluntarily consuming 10% (v/v) EtOH and bearing OC; Group C+M, rats bearing OC and receiving mel; and Group C+EtOH+M, rats with OC consuming EtOH and receiving mel. Estrous cycle and nutritional parameters were evaluated, and anatomopathological analyses of the ovarian tumors were conducted. The incidence of ovarian tumors was higher in EtOH drinking animals 120 days post-DMBA administration, and mel efficiently reduced the prevalence of some aggressive tumors. Although mel promoted high EtOH consumption, it was effective in synchronizing the estrous cycle and reducing ovarian tumor mass by 20%. While rats in the C group displayed cysts containing serous fluid, C+EtOH rats showed solid tumor masses. After mel treatment, the ovaries of these rats presented as soft and mobile tissues. EtOH consumption increased the incidence of serous papillary carcinomas and sarcomas but not clear cell carcinomas. In contrast, mel reduced the incidence of sarcomas, endometrioid carcinomas and cystic teratomas. Combination of DMBA with EtOH intake potentiated the incidence of OC with malignant histologic subtypes. We concluded that mel reduces ovarian masses and the incidence of adenocarcinomas in ethanol-deprived rats.	[Chuffa, Luiz Gustavo A.; Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.; Pinheiro, Patricia Fernanda F.; Martinez, Francisco Eduardo] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Anat, Botucatu, SP, Brazil; [Fioruci-Fontanelli, Beatriz A.; Mendes, Leonardo O.] Univ Estadual Campinas, UNICAMP, Inst Biol, Programa Posgrad Biol Celular & Estrutural, Campinas, SP, Brazil; [Favaro, Wagner J.] Univ Estadual Campinas, UNICAMP, Dept Anat Biol Celular & Fisiol & Biofis, Campinas, SP, Brazil; [Martinez, Marcelo] UFSCar Univ Fed Sao Carlos, Dept Morfol & Patol, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Carlos	Chuffa, LGA (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Anat, Botucatu, SP, Brazil.	guchuffa@yahoo.com.br	Mendes, Leonardo O Oliveira/V-4120-2018; Martinez, Francisco Eduardo/A-8090-2008; Chuffa, Luiz Gustavo/ABC-2781-2020; Chuffa, Luiz Gustavo/CAA-2741-2022; Chuffa, Luiz Gustavo A/A-4085-2010; Martinez, Francisco Eduardo/P-4804-2018; Fávaro, Wagner José/AAS-7463-2020	Mendes, Leonardo O Oliveira/0000-0001-9761-7653; Martinez, Francisco Eduardo/0000-0002-9317-344X; Chuffa, Luiz Gustavo/0000-0002-0199-3396; Chuffa, Luiz Gustavo A/0000-0002-0199-3396; Fávaro, Wagner José/0000-0001-5830-8938	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/19294-9, 2013/02466-7]; Primeiros Projetos (Prope/UNESP); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Primeiros Projetos (Prope/UNESP); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to give special thanks to FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Proc. n. 2011/19294-9 and 2013/02466-7), Primeiros Projetos 2013 (Prope/UNESP) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berstad P, 2008, BREAST CANCER RES TR, V108, P113, DOI 10.1007/s10549-007-9578-8; Chada S, 2003, CURR OPIN MOL THER, V5, P463; Chien JR, 2007, J CELL BIOCHEM, V102, P1117, DOI 10.1002/jcb.21552; Chuffa LGA, 2011, BRAZ J MED BIOL RES, V44, P217, DOI 10.1590/S0100-879X2011007500018; Chuffa LGA, 2013, REPROD TOXICOL, V39, P40, DOI 10.1016/j.reprotox.2013.04.001; Chuffa LGA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-108; Chuffa LGA, 2011, ALCOHOL CLIN EXP RES, V35, P1498, DOI 10.1111/j.1530-0277.2011.01486.x; Chuffa LGA, 2009, MATURITAS, V62, P21, DOI 10.1016/j.maturitas.2008.09.027; Conti A, 1995, J PINEAL RES, V19, P103, DOI 10.1111/j.1600-079X.1995.tb00177.x; Cos S, 2008, CURR CANCER DRUG TAR, V8, P691, DOI 10.2174/156800908786733469; Crespi F, 2012, BRAIN RES, V1452, P39, DOI 10.1016/j.brainres.2011.10.050; Crist KA, 2005, CARCINOGENESIS, V26, P951, DOI 10.1093/carcin/bgi039; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; FATHALLA MF, 1971, LANCET, V2, P163; Fisher SP, 2010, SLEEP, V33, P833, DOI 10.1093/sleep/33.6.833; Fleming JS, 2006, MOL CELL ENDOCRINOL, V247, P4, DOI 10.1016/j.mce.2005.09.014; GODWIN AK, 1992, J NATL CANCER I, V84, P592, DOI 10.1093/jnci/84.8.592; HILL SM, 1992, CANCER LETT, V64, P249, DOI 10.1016/0304-3835(92)90050-6; Hoyer PB, 2009, GYNECOL ONCOL, V112, P610, DOI 10.1016/j.ygyno.2008.12.013; Huang YP, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-21; Jacinto-Aleman LF, 2013, MED ORAL PATOL ORAL, V18, pE325, DOI 10.4317/medoral.18068; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Konishi I, 1999, ONCOLOGY-BASEL, V57, P45, DOI 10.1159/000055274; LAVECCHIA C, 1992, J CLIN EPIDEMIOL, V45, P1025, DOI 10.1016/0895-4356(92)90119-8; Lima MFP, 2004, BRAZ J MED BIOL RES, V37, P987, DOI 10.1590/S0100-879X2004000700007; Lissoni P, 2007, PATHOL BIOL, V55, P201, DOI 10.1016/j.patbio.2006.12.025; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; MARDONES J, 1983, NEUROBEH TOXICOL TER, V5, P171; Masana MI, 2001, SCI STKE, V107, ppe39; MELLO NK, 1983, SCIENCE, V221, P677, DOI 10.1126/science.6867739; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Murdoch WJ, 2008, ADV EXP MED BIOL, V622, P119, DOI 10.1007/978-0-387-68969-2_10; Nishida T, 1998, CANCER, V83, P965, DOI 10.1002/(SICI)1097-0142(19980901)83:5<965::AID-CNCR23>3.0.CO;2-S; NISHIDA T, 1986, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V38, P570; NISHIDA T, 1982, GANN, V73, P153; OZOLS RF, 2005, PRINCIPLES PRACTICE, P903; Peres R, 2011, ADDICT BIOL, V16, P580, DOI 10.1111/j.1369-1600.2011.00342.x; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; Rota M, 2012, GYNECOL ONCOL, V125, P758, DOI 10.1016/j.ygyno.2012.03.031; Sauer LA, 2001, BIOCHEM PHARMACOL, V61, P1455, DOI 10.1016/S0006-2952(01)00634-7; Schouten LJ, 2004, CANCER CAUSE CONTROL, V15, P201, DOI 10.1023/B:CACO.0000019512.71560.2b; Seitz Helmut K, 2013, Subcell Biochem, V67, P131, DOI 10.1007/978-94-007-5881-0_3; Srinivasan V, 2011, RECENT PATENTS ENDOC, V5, P109, DOI 10.2174/187221411799015408; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stewart SL, 2004, CANCER RES, V64, P8177, DOI 10.1158/0008-5472.CAN-04-1702; Treeck O, 2006, ONCOL REP, V15, P231; Tworoger SS, 2008, CANCER-AM CANCER SOC, V112, P1169, DOI 10.1002/cncr.23275; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Vanderhyden BC, 2005, CELL TISSUE RES, V322, P117, DOI 10.1007/s00441-005-1100-1; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Xi SC, 2001, PROSTATE, V46, P52	52	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81676	10.1371/journal.pone.0081676	http://dx.doi.org/10.1371/journal.pone.0081676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367487	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300008
J	Marcus, JL; Glidden, DV; Mayer, KH; Liu, AY; Buchbinder, SP; Amico, KR; McMahan, V; Kallas, EG; Montoya-Herrera, O; Pilotto, J; Grant, RM				Marcus, Julia L.; Glidden, David V.; Mayer, Kenneth H.; Liu, Albert Y.; Buchbinder, Susan P.; Amico, K. Rivet; McMahan, Vanessa; Kallas, Esper Georges; Montoya-Herrera, Orlando; Pilotto, Jose; Grant, Robert M.			No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis	PLOS ONE			English	Article							MALE CIRCUMCISION; UNITED-STATES; FOLLOW-UP; BEHAVIOR; INFECTION; MEN; PREVENTION; PARTICIPANTS; IMPACT; CHEMOPROPHYLAXIS	Objective: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but may be affected by reporting bias. We evaluated potential risk compensation using biomarkers of sexual risk behavior. Design and methods: Sexual practices were assessed at baseline and quarterly thereafter; perceived treatment assignment and PrEP efficacy beliefs were assessed at 12 weeks. Among participants with >= 1 follow-up behavioral assessment, sexual behavior, syphilis, and HIV infection were compared by perceived treatment assignment, actual treatment assignment, and perceived PrEP efficacy. Results: Overall, acute HIV infection and syphilis decreased during follow-up. Compared with participants believing they were receiving placebo, participants believing they were receiving FTC/TDF reported more receptive anal intercourse partners prior to initiating drug (12.8 vs. 7.7, P = 0.04). Belief in receiving FTC/TDF was not associated with an increase in receptive anal intercourse with no condom (ncRAI) from baseline through follow-up (risk ratio [RR] 0.9, 95% confidence interval [CI]: 0.6-1.4; P = 0.75), nor with a decrease after stopping study drug (RR 0.8, 95% CI: 0.5-1.3; P = 0.46). In the placebo arm, there were trends toward lower HIV incidence among participants believing they were receiving FTC/TDF (incidence rate ratio [IRR] 0.8, 95% CI: 0.4-1.8; P = 0.26) and also believing it was highly effective (IRR 0.5, 95% CI: 0.1-1.7; P = 0.12). Conclusions: There was no evidence of sexual risk compensation in iPrEx. Participants believing they were receiving FTC/TDF had more partners prior to initiating drug, suggesting that risk behavior was not a consequence of PrEP use.	[Marcus, Julia L.; McMahan, Vanessa; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Marcus, Julia L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Glidden, David V.; Liu, Albert Y.; Buchbinder, Susan P.; Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Liu, Albert Y.; Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Amico, K. Rivet] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Kallas, Esper Georges] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Montoya-Herrera, Orlando] Fdn Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador; [Pilotto, Jose] Hosp Geral Nova Iguacu, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; San Francisco Department of Public Health; University of Connecticut; Universidade de Sao Paulo	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	robert.grant@ucsf.edu	Pilotto, Jose Henrique/AAD-9773-2019; /AAE-4700-2020; Glidden, David/AAD-4730-2020	Pilotto, Jose Henrique/0000-0003-0521-8597; Amico, K Rivet/0000-0002-4458-6934; Grant, Robert/0000-0002-0851-7085; Kallas, Esper/0000-0003-2026-6925; Glidden, David/0000-0001-5888-1419	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1 AI64002]; Bill and Melinda Gates Foundation; Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI064002] Funding Source: NIH RePORTER	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, as a cooperative agreement (UO1 AI64002, to Dr. Grant), by the Bill and Melinda Gates Foundation, and by the Gladstone Institutes. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J., 1995, RISK, V1st ed.; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; Huebner DM, 2001, ANN BEHAV MED, V23, P304, DOI 10.1207/S15324796ABM2304_10; Kasparian NA, 2009, J BEHAV MED, V32, P406, DOI 10.1007/s10865-009-9219-2; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; Liu AY, 2013, J ACQUIR IMMUNE DEFI; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Martin JN, 2004, AIDS, V18, P787, DOI 10.1097/00002030-200403260-00010; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wilde GJS, 2001, TARGET RISK DEALING	39	165	167	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81997	10.1371/journal.pone.0081997	http://dx.doi.org/10.1371/journal.pone.0081997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367497	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300016
J	Rodriguez, E; Soler, MJ; Rap, O; Barrios, C; Orfila, MA; Pascual, J				Rodriguez, Eva; Soler, Maria J.; Rap, Oana; Barrios, Clara; Orfila, Maria A.; Pascual, Julio			Risk Factors for Acute Kidney Injury in Severe Rhabdomyolysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; RIFLE CRITERIA; HOSPITALIZED-PATIENTS; MECHANISMS; MYOGLOBIN	Background: Acute kidney injury (AKI) is a life-threatening complication of severe rhabdomyolysis. This study was conducted to assess risk factors for AKI and to develop a risk score for early prediction. Methods: Retrospective observational cohort study with a 9-year follow-up, carried out in an acute-care teaching-affiliated hospital. A total of 126 patients with severe rhabdomyolysis defined as serum creatine kinase (CK) > 5,000 IU/L fulfilled the inclusion criteria. Univariate and logistic regression analyses were performed to determine risk factors for AKI. Based on the values obtained for each variable, a risk score and prognostic probabilities were estimated to establish the risk for developing AKI. Results: The incidence of AKI was 58%. Death during hospitalization was significantly higher among patients with AKI, compared to patients without AKI (19.2% vs 3.6%, p = 0.008). The following variables were independently associated with AKI: peak CK (odds ratio [OR] 4.9, 95%CI 1.4-16.8), hypoalbuminemia (< 33 mg/dL, [OR 5.1, 95%CI 1.4-17-7]), metabolic acidosis (OR 5.3, 95%CI 1.4-20.3), and decreased prothrombin time (OR 4.4, 95% CI 1.3-14.5). A risk score for AKI was calculated for each patient, with an OR of 1.72 (95% CI 1.45-2.04). The discrimination value of the predictive model was established by means of a ROC curve, with the area under the curve of 0.871 (p<0.001). Conclusions: The identification of independent factors associated with AKI and a risk score for early prediction of this complication in patients with severe rhabdomyolysis may be useful in clinical practice, particularly to implement early preventive measures.	[Rodriguez, Eva; Soler, Maria J.; Rap, Oana; Barrios, Clara; Orfila, Maria A.; Pascual, Julio] Hosp Mar, Dept Nephrol, Barcelona, Spain; [Rodriguez, Eva; Soler, Maria J.; Barrios, Clara; Pascual, Julio] Inst Invest Med, Nephrol Res Grp, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Rodriguez, E (corresponding author), Hosp Mar, Dept Nephrol, Barcelona, Spain.	ERodriguezG@hospitaldelmar.cat	Soler, Maria Jose/ABC-4410-2021; Soler, Maria José/AAP-4454-2020; Barrios, Clara/AAF-6865-2021	Soler, Maria José/0000-0003-3621-0766; Rodriguez, Eva/0000-0002-4397-162X				Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Better OS, 2011, NAT REV NEPHROL, V7, P416, DOI 10.1038/nrneph.2011.56; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; CADNAPAPHORNCHAI P, 1980, AM J MED SCI, V280, P66, DOI 10.1097/00000441-198009000-00001; de Meijer AR, 2003, INTENS CARE MED, V29, P1121, DOI 10.1007/s00134-003-1800-5; Delaney KA, 2012, J EMERG MED, V42, P521, DOI 10.1016/j.jemermed.2011.03.008; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Goldfarb DS, 2002, AM J MED, V113, P260, DOI 10.1016/S0002-9343(02)01188-9; Hatamizadeh P, 2006, AM J KIDNEY DIS, V47, P428, DOI 10.1053/j.ajkd.2005.11.019; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Melli G, 2005, MEDICINE, V84, P377, DOI 10.1097/01.md.0000188565.48918.41; Mikkelsen TS, 2005, ACTA ANAESTH SCAND, V49, P859, DOI 10.1111/j.1399-6576.2005.00577.x; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Pinol V, 2004, DIS COLON RECTUM, V47, P1192, DOI 10.1007/s10350-004-0562-7; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; RON D, 1984, ARCH INTERN MED, V144, P277, DOI 10.1001/archinte.144.2.277; ROTH D, 1988, NEW ENGL J MED, V319, P673, DOI 10.1056/NEJM198809153191103; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Sharp LS, 2004, AM J SURG, V188, P801, DOI 10.1016/j.amjsurg.2004.08.050; SINGHAL PC, 1992, AM J MED, V92, P458, DOI 10.1016/0002-9343(92)90740-3; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; WOODROW G, 1995, RENAL FAILURE, V17, P467, DOI 10.3109/08860229509037610; ZAGER RA, 1989, LAB INVEST, V60, P619; ZAGER RA, 1989, AM J PHYSIOL, V256, pF446, DOI 10.1152/ajprenal.1989.256.3.F446	28	16	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82992	10.1371/journal.pone.0082992	http://dx.doi.org/10.1371/journal.pone.0082992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367578	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300089
J	Adachi, K; Osada, Y; Nakamura, R; Tamada, K; Hamano, S				Adachi, Keishi; Osada, Yoshio; Nakamura, Risa; Tamada, Koji; Hamano, Shinjiro			Unique T Cells with Unconventional Cytokine Profiles Induced in the Livers of Mice during Schistosoma mansoni Infection	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; HEPATITIS-B-VIRUS; NKT CELLS; IN-VIVO; GRANULOMATOUS PATHOLOGY; TH2 POLARIZATION; DENDRITIC CELLS; GERMINAL CENTER; HELPER-CELLS; RECEPTOR	During infection with Schistosoma, serious hepatic disorders are induced in the host. The liver possesses unique immune systems composed of specialized cells that differ from those of other immune competent organs or tissues. Host immune responses change dramatically during Schistosoma mansoni infection; in the early phase, Th1-related responses are induced, whereas during the late phase Th2 reactions dominate. Here, we describe unique T cell populations induced in the liver of mice during the period between Th1- and Th2-phases, which we term the transition phase. During this phase, varieties of immune cells including T lymphocytes increase in the liver. Subsets of CD4(+) T cells exhibit unique cytokine production profiles, simultaneously producing both IFN-gamma and IL-13 or both IFN-gamma and IL-4. Furthermore, cells triply positive for IFN-gamma, IL-13 and IL-4 also expand in the S. mansoni-infected liver. The induction of these unique cell populations does not occur in the spleen, indicating it is a phenomenon specific to the liver. In single hepatic CD4(+) T cells showing the unique cytokine profiles, both T-bet and GATA-3 are expressed. Thus, our studies show that S. mansoni infection triggers the induction of hepatic T cell subsets with unique cytokine profiles.	[Adachi, Keishi; Nakamura, Risa; Hamano, Shinjiro] Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Adachi, Keishi; Hamano, Shinjiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Osada, Yoshio] Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 755, Japan	Nagasaki University; Nagasaki University; University of Occupational & Environmental Health - Japan; Yamaguchi University	Hamano, S (corresponding author), Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	shinjiro@nagasaki-u.ac.jp	Hamano, Shinjiro/A-7932-2011; adachi, keishi/AAT-7471-2020	Hamano, Shinjiro/0000-0003-3881-8337; 	JSPS KAKENHI [24790402, 25670204]; Health Labour Sciences Research Grant [H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014]; Nagasaki University; MEXT	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Nagasaki University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research Number 24790402 (to K. A.), 25670204 (to S. H.), (http://www.jsps.go.jp/english/e-grants/index.html), a Health Labour Sciences Research Grant (H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014 to S. H.) (http://www.mhlw.go.jp/english/), and the Global COE Program, Nagasaki University, supported by MEXT (to S. H.) (http://www-sdc.med.nagasaki-u.ac.jp/gcoe/activities/publication/200901_e.html, http://www.jsps.go.jp/english/e-globalcoe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Adachi K, 2004, INT IMMUNOL, V16, P787, DOI 10.1093/intimm/dxh080; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Burdin N, 1998, J IMMUNOL, V161, P3271; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Fitzpatrick JM, 2009, INT J PARASITOL, V39, P267, DOI 10.1016/j.ijpara.2008.06.015; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hayashi N, 1999, J IMMUNOL, V163, P6702; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Jankovic D, 1999, J IMMUNOL, V163, P337; Kambayashi T, 2001, EUR J IMMUNOL, V31, P1523, DOI 10.1002/1521-4141(200105)31:5<1523::AID-IMMU1523>3.0.CO;2-S; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakahira M, 2011, INT IMMUNOL, V23, P761, DOI 10.1093/intimm/dxr087; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Osada Y, 2005, PARASITOL INT, V54, P29, DOI 10.1016/j.parint.2004.08.004; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; Soulard V, 2007, INFECT IMMUN, V75, P2511, DOI 10.1128/IAI.01818-06; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tsutsui H, 2000, IMMUNOL REV, V174, P192, DOI 10.1034/j.1600-0528.2002.017418.x; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	63	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82698	10.1371/journal.pone.0082698	http://dx.doi.org/10.1371/journal.pone.0082698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358216	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700089
J	Duval, A; Marinov, I; Bousquet, G; Gapihan, G; Starikovskaia, SM; Rousseau, A; Janin, A				Duval, Arnaud; Marinov, Ilya; Bousquet, Guilhem; Gapihan, Guillaume; Starikovskaia, Svetlana M.; Rousseau, Antoine; Janin, Anne			Cell Death Induced on Cell Cultures and Nude Mouse Skin by Non-Thermal, Nanosecond-Pulsed Generated Plasma	PLOS ONE			English	Article							PROTOPORPHYRIN-IX; ELECTRIC-FIELDS; APOPTOSIS; MEDICINE; COAGULATION; DERMATOLOGY; SELECTIVITY; LYMPHOMA; STRENGTH; NECROSIS	Non-thermal plasmas are gaseous mixtures of molecules, radicals, and excited species with a small proportion of ions and energetic electrons. Non-thermal plasmas can be generated with any high electro-magnetic field. We studied here the pathological effects, and in particular cell death, induced by nanosecond-pulsed high voltage generated plasmas homogeneously applied on cell cultures and nude mouse skin. In vitro, Jurkat cells and HMEC exhibited apoptosis and necrosis, in dose-dependent manner. In vivo, on nude mouse skin, cell death occurred for doses above 113 J/cm(2) for the epidermis, 281 J/cm(2) for the dermis, and 394 J/cm(2) for the hypodermis. Using electron microscopy, we characterized apoptosis for low doses and necrosis for high doses. We demonstrated that these effects were not related to thermal, photonic or pH variations, and were due to the production of free radicals. The ability of cold plasmas to generate apoptosis on cells in suspension and, without any sensitizer, on precise skin areas, opens new fields of application in dermatology for extracorporeal blood cell treatment and the eradication of superficial skin lesions.	[Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] INSERM, U728, Paris, France; [Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] Univ Paris Diderot, Sorbonne Paris Cite, Lab Pathol, UMR S 728, Paris, France; [Duval, Arnaud; Bousquet, Guilhem; Gapihan, Guillaume; Janin, Anne] Hop St Louis, AP HP, Dept Pathol, Paris, France; [Marinov, Ilya; Starikovskaia, Svetlana M.; Rousseau, Antoine] Univ Paris 11, CNRS, UPMC, Lab Phys Plasmas,Ecole Polytech, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Duval, A (corresponding author), INSERM, U728, Paris, France.	arnaudduval@sls.aphp.fr	Bousquet, Guilhem/O-2920-2015	Bousquet, Guilhem/0000-0001-5594-6694; rousseau, antoine/0000-0002-8965-5307				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Hoffmann M, 2012, INTERACT CARDIOV TH, V14, P239, DOI 10.1093/icvts/ivr109; Hoffmann M, 2010, INTERACT CARDIOV TH, V10, P502, DOI 10.1510/icvts.2009.223768; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Knobler R, 2009, J AM ACAD DERMATOL, V61, P652, DOI 10.1016/j.jaad.2009.02.039; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Laux CO, 2003, PLASMA SOURCES SCI T, V12, P125, DOI 10.1088/0963-0252/12/2/301; MARTIN A, 1995, ARCH DERMATOL RES, V287, P665; Martino M, 2012, EXPERT OPIN BIOL TH, V12, P1017, DOI 10.1517/14712598.2012.688025; Nastuta AV, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/10/105204; Paris P, 2005, J PHYS D APPL PHYS, V38, P3894, DOI 10.1088/0022-3727/38/21/010; Raizer Yu. P., 1991, GAS DISCHARGE PHYS; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Silve A, 2012, BIOELECTROCHEMISTRY, V87, P260, DOI 10.1016/j.bioelechem.2011.10.002; Smits T, 2009, BRIT J DERMATOL, V160, P849, DOI 10.1111/j.1365-2133.2008.09012.x; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; Yoo J-O, 2012, NEW INSIGHTS MECHANI	32	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83001	10.1371/journal.pone.0083001	http://dx.doi.org/10.1371/journal.pone.0083001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358244	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700101
J	Saxena, M; Dykes, SS; Malyarchuk, S; Wang, AE; Cardelli, JA; Pruitt, K				Saxena, M.; Dykes, S. S.; Malyarchuk, S.; Wang, A. E.; Cardelli, J. A.; Pruitt, K.			The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration	ONCOGENE			English	Article						SIRT1; SIRT2; TIAM1; Rac1-GTPase; Dishevelled; acetylation	NUCLEOTIDE EXCHANGE FACTOR; PREDICTS POOR-PROGNOSIS; HISTONE DEACETYLASE; BREAST-CANCER; HEPATOCELLULAR CARCINOMAS; COLORECTAL-CANCER; EPITHELIAL-CELLS; PROSTATE-CANCER; RHO GTPASES; SIRT1	Rac1-GTPases serve as intermediary cellular switches, which conduct transient and constitutive signals from upstream cues, including those from Ras oncoproteins. Although the sirtuin1 (SIRT1) deacetylase is overexpressed in several human cancers and has recently been linked to cancer cell motility as a context-dependent regulator of multiple pathways, its role in Rac1 activation has not been reported. Similarly, SIRT2 has been demonstrated to be upregulated in some cancers; however, studies have also reported its role in tumor suppression. Here, we demonstrate that SIRT1 and SIRT2 positively regulate the levels of Rac1-GTP and the activity of T-cell lymphoma invasion and metastasis 1 (TIAM1), a Rac guanine nucleotide exchange factor (GEF). Transient inhibition of SIRT1 and SIRT2 resulted in increased acetylation of TIAM1, whereas chronic SIRT2 knockdown resulted in enhanced acetylation of TIAM1. SIRT1 regulates Dishevelled (DVL) protein levels in cancer cells, and DVL along with TIAM1 are known to augment Rac activation; however, SIRT1 or 2 has not been previously linked with TIAM1. We found that diminished sirtuin activity led to the disruption of the DVL1-TIAM1 interaction. We hence propose a model for Rac activation where SIRT1/2 positively modulates the DVL/TIAM1/Rac axis and promotes sustained pathway activation.	[Saxena, M.; Malyarchuk, S.; Wang, A. E.; Pruitt, K.] LSU Hlth Shreveport, Dept Cellular & Mol Physiol, Shreveport, LA 71130 USA; [Dykes, S. S.; Cardelli, J. A.] LSU Hlth Shreveport, Dept Microbiol & Immunol, Shreveport, LA 71130 USA; [Cardelli, J. A.; Pruitt, K.] LSU Hlth Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Pruitt, K (corresponding author), LSU Hlth Shreveport, Dept Cellular & Mol Physiol, BRI F4-26,1501 Kings Hwy, Shreveport, LA 71130 USA.	kpruit@lsuhsc.edu			Feist-Weiller Cancer Center Idea Award; Carroll-Feist Predoctoral Fellowship Award; NATIONAL CANCER INSTITUTE [R01CA155223] Funding Source: NIH RePORTER	Feist-Weiller Cancer Center Idea Award; Carroll-Feist Predoctoral Fellowship Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Channing Der at University of North Carolina and Dr Sharon Dent at University of Texas MD Anderson Cancer Center for providing the plasmids. The work described here is funded by a Feist-Weiller Cancer Center Idea Award to KP. MS is supported by the Carroll-Feist Predoctoral Fellowship Award.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Adams HC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2637; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Byles V, 2010, INT J BIOL SCI, V6, P599; Cajanek L, 2013, MOL CELL BIOL, V33, P59, DOI 10.1128/MCB.00745-12; Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou HL, 2012, J CLIN PATHOL, V65, P1088, DOI 10.1136/jclinpath-2012-200940; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Krusche CA, 2005, BREAST CANCER RES TR, V90, P15, DOI 10.1007/s10549-004-1668-2; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liu HM, 2011, ONCOL REP, V25, P841, DOI 10.3892/or.2010.1122; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang SJ, 2012, J CELL BIOL, V199, P331, DOI 10.1083/jcb.201202041; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81	60	34	35	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					188	198		10.1038/onc.2013.549	http://dx.doi.org/10.1038/onc.2013.549			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362520	Green Accepted			2022-12-25	WOS:000347790500006
J	Roosjen, M; McColl, B; Kao, B; Gearing, LJ; Blewitt, ME; Vadolas, J				Roosjen, Mark; McColl, Bradley; Kao, Betty; Gearing, Linden J.; Blewitt, Marnie E.; Vadolas, Jim			Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal beta-like globin genes	FASEB JOURNAL			English	Article						RNA interference; beta-hemoglobinopathies; molecular mechanism; epigenetic repressor	CAUSES HEREDITARY PERSISTENCE; GAMMA-GLOBIN; THERAPEUTIC TARGET; NUCLEAR RECEPTORS; HEMOGLOBIN; DIFFERENTIATION; EXPRESSION; GENERATION; INDUCTION; HBS1L-MYB	The clinical symptoms of hemoglobin disorders such as beta-thalassemia and sickle cell anemia are significantly ameliorated by the persistent expression of gamma-globin after birth. This knowledge has driven the discovery of important regulators that silence gamma-globin postnatally. Improved understanding of the gamma- to beta-globin switching mechanism holds the key to devising targeted therapies for beta-hemoglobinopathies. To further investigate this mechanism, we used the murine erythroleukemic (MEL) cell line containing an intact 183-kb human beta-globin locus, in which the (G)gamma- and beta-globin genes are replaced by DsRed and eGFP fluorescent reporters, respectively. Following RNA interference (RNAi)-mediated knockdown of two key transcriptional regulators, Myb and BCL11A, we observed a derepression of gamma-globin, measured by DsRed fluorescence and qRT-PCR (P < 0.001). Interestingly, double knockdown of Myb and DNA methyltransferase 1 (DNMT1) resulted in a robust induction of epsilon-globin, (up to 20% of total beta-like globin species) compared to single knockdowns (P < 0.001). Conversely, double knockdowns of BCL11A and DNMT1 enhanced gamma-globin expression (up to 90% of total beta-like globin species) compared to single knockdowns (P < 0.001). Moreover, following RNAi treatment, expression of human beta-like globin genes mirrored the expression levels of their endogenous murine counterparts. These results demonstrate that Myb and BCL11A cooperate with DNMT1 to achieve developmental repression of embryonic and fetal beta-like globin genes in the adult erythroid environment.-Roosjen, M., McColl, B., Kao, B., Gearing, L. J., Blewitt, M. E., Vadolas, J. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal beta-like globin genes.	[Roosjen, Mark] Van Hall Larenstein Univ Appl Sci, Leeuwarden, Netherlands; [Roosjen, Mark; McColl, Bradley; Kao, Betty; Vadolas, Jim] Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Grp, Melbourne, Vic, Australia; [Gearing, Linden J.; Blewitt, Marnie E.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia; [Kao, Betty; Vadolas, Jim] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Gearing, Linden J.; Blewitt, Marnie E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Blewitt, Marnie E.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne	Vadolas, J (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Grp, Flemington Rd, Parkville, Vic 3052, Australia.	jim.vadolas@mcri.edu.au		Kao, Betty/0000-0003-0202-8018; Gearing, Linden/0000-0003-3508-3056; Blewitt, Marnie/0000-0002-2984-1474; Vadolas, Jim/0000-0002-3072-3512	Australia National Health and Medical Research Council; Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program, Thalassaemia Australia; Thalassaemia Society of New South Wales; Greek Conference	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program, Thalassaemia Australia; Thalassaemia Society of New South Wales; Greek Conference(Greek Ministry of Development-GSRT)	The Australia National Health and Medical Research Council, the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, Thalassaemia Australia, the Thalassaemia Society of New South Wales, and the Greek Conference supported this work. The authors declare no conflicts of interest.	Akpan I, 2010, EXP HEMATOL, V38, P989, DOI 10.1016/j.exphem.2010.08.001; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Atweh GF, 1999, BLOOD, V93, P1790; Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Boosalis MS, 2011, BLOOD CELL MOL DIS, V47, P107, DOI 10.1016/j.bcmd.2011.04.008; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Chan KSK, 2012, FASEB J, V26, P1736, DOI 10.1096/fj.11-199356; Costa FC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003155; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Olivieri NF, 1998, HUM MOL GENET, V7, P1655, DOI 10.1093/hmg/7.10.1655; Papadopoulos P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051272; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; REDDY PMS, 1993, MOL CELL BIOL, V13, P1093, DOI 10.1128/MCB.13.2.1093; Rees DC, 2011, HAEMATOL-HEMATOL J, V96, P488, DOI 10.3324/haematol.2011.041988; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Sankaran VG, 2010, ANN NY ACAD SCI, V1202, P64, DOI 10.1111/j.1749-6632.2010.05574.x; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Suzuki M, 2013, MOL CELL BIOL, V33, P1687, DOI 10.1128/MCB.01617-12; Tallack MR, 2013, CURR OPIN HEMATOL, V20, P193, DOI 10.1097/MOH.0b013e32835f59ba; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; van Dijk TB, 2010, BLOOD, V116, P4349, DOI 10.1182/blood-2010-03-274399; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	45	26	32	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1610	1620		10.1096/fj.13-242669	http://dx.doi.org/10.1096/fj.13-242669			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371119				2022-12-25	WOS:000335344300010
J	An, HT; Kim, J; Yoo, S; Ko, J				An, Hyoung-Tae; Kim, Jeonghan; Yoo, Seungmin; Ko, Jesang			Small Leucine Zipper Protein (sLZIP) Negatively Regulates Skeletal Muscle Differentiation via Interaction with alpha-Actinin-4*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Gene Transcription; Muscle; Myogenesis; Transcription Repressor; Actinin-4; sLZIP	CREATINE-KINASE GENE; MYOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; CELL MOTILITY; EXPRESSION; MEF2; ENHANCER; ALPHA; LOCALIZATION; ASSOCIATION	Background: Cooperation between transcription factors and myogenic regulatory factors is important for skeletal muscle differentiation. Results: sLZIP inhibits expression of muscle-specific genes during myogenesis via disruption of an association between -actinin-4 and MEF2. Conclusion: A novel myogenesis regulatory mechanism of sLZIP is characterized. Significance: sLZIP can be used as a therapeutic target for treatment of muscle diseases. The small leucine zipper protein (sLZIP) plays a role in transcriptional regulation in various types of cells. However, the role of sLZIP in myogenesis is unknown. We identified -actinin-4 (ACTN4) as a sLZIP-binding protein. ACTN4 functions as a transcriptional regulator of myocyte enhancer factor (MEF)2, which plays a critical role in expression of muscle-specific genes during skeletal muscle differentiation. We found that ACTN4 translocates to the nucleus, induces myogenic gene expression, and promotes myotube formation during myogenesis. The myogenic process is controlled by an association between myogenic factors and MEF2 transcription factors. ACTN4 increased expression of muscle-specific proteins via interaction with MEF2. However, sLZIP decreased myogenic gene expression and myotube formation during myogenesis via disruption of the association between ACTN4 and MEF2. ACTN4 increased the promoter activities of myogenic genes, whereas sLZIP abrogated the effect of ACTN4 on transcriptional activation of myogenic genes in myoblasts. The C terminus of sLZIP is required for interaction with the C terminus of ACTN4, based on deletion mutant analysis, and sLZIP plays a role in regulation of MEF2 transactivation via interaction with ACTN4. Our results indicate that sLZIP negatively regulates skeletal muscle differentiation via interaction with ACTN4 and that sLZIP can be used as a therapeutic target molecule for treatment of muscle hypertrophy and associated diseases.	[An, Hyoung-Tae; Kim, Jeonghan; Yoo, Seungmin; Ko, Jesang] Korea Univ, Div Life Sci, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Basic Research Laboratory Program through the National Research Foundation of Korea (NRF) [2009-0087099]; Ministry of Education, Science, and Technology	Basic Research Laboratory Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Research Laboratory Program (2009-0087099) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology.	ALBAGLICURIEL O, 1993, DIFFERENTIATION, V52, P201, DOI 10.1111/j.1432-0436.1993.tb00632.x; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; CassarMalek I, 1996, J BIOL CHEM, V271, P11392, DOI 10.1074/jbc.271.19.11392; CASSARMALEK I, 1994, ONCOGENE, V9, P2197; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; Kang H, 2011, J BIOL CHEM, V286, P42072, DOI 10.1074/jbc.M111.272302; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Lin Q, 1998, DEVELOPMENT, V125, P4565; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Passaquin AC, 1998, BRIT J PHARMACOL, V124, P1751, DOI 10.1038/sj.bjp.0702036; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Sumitani S, 2002, ENDOCRINOLOGY, V143, P820, DOI 10.1210/en.143.3.820; SUZUKI E, 1995, MOL CELL BIOL, V15, P3415; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1985, J CELL BIOL, V100, P1063, DOI 10.1083/jcb.100.4.1063; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	36	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4969	4979		10.1074/jbc.M113.515395	http://dx.doi.org/10.1074/jbc.M113.515395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375477	hybrid, Green Published			2022-12-25	WOS:000331607900042
J	Stafford, JH; Hao, GY; Best, AM; Sun, XK; Thorpe, PE				Stafford, Jason H.; Hao, Guiyang; Best, Anne M.; Sun, Xiankai; Thorpe, Philip E.			Highly Specific PET Imaging of Prostate Tumors in Mice with an Iodine-124-Labeled Antibody Fragment That Targets Phosphatidylserine	PLOS ONE			English	Article							ANNEXIN-V SCINTIGRAPHY; ANIONIC PHOSPHOLIPIDS; MONOCLONAL-ANTIBODY; INCREASED EXPOSURE; IN-VITRO; CHEMOTHERAPY; APOPTOSIS; SURFACE; PHOSPHATIDYLETHANOLAMINE; AGENT	Phosphatidylserine (PS) is an attractive target for imaging agents that identify tumors and assess their response to therapy. PS is absent from the surface of most cell types, but becomes exposed on tumor cells and tumor vasculature in response to oxidative stresses in the tumor microenvironment and increases in response to therapy. To image exposed PS, we used a fully human PS-targeting antibody fragment, PGN635 F(ab')2, that binds to complexes of PS and beta 2-glycoprotein I. PGN635 F(ab')(2) was labeled with the positron-emitting isotope iodine-124 (I-124) and the resulting probe was injected into nude mice bearing subcutaneous or orthotopic human PC3 prostate tumors. Biodistribution studies showed that I-124-PGN635 F(ab')(2) localized with remarkable specificity to the tumors with little uptake in other organs, including the liver and kidneys. Clear delineation of the tumors was achieved by PET 48 hours after injection. Radiation of the tumors with 15 Gy or systemic treatment of the mice with 10 mg/kg docetaxel increased localization in the tumors. Tumor-to-normal (T/N) ratios were inversely correlated with tumor growth measured over 28 days. These data indicate that I-124-PGN635 F(ab')(2) is a promising new imaging agent for predicting tumor response to therapy.	[Stafford, Jason H.; Best, Anne M.; Thorpe, Philip E.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Hao, Guiyang; Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stafford, JH (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	jason006@stanford.edu	Hao, Guiyang/D-5312-2011	Hao, Guiyang/0000-0001-6695-5123	NIH [U24 CA126608]; Cancer Center [5P30 CA 142543-03]; Gillson Longenbaugh Foundation; Peregrine Pharmaceuticals Inc., Tustin, CA; NATIONAL CANCER INSTITUTE [P30CA142543, U24CA126608] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Gillson Longenbaugh Foundation; Peregrine Pharmaceuticals Inc., Tustin, CA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (U24 CA126608) for the Small Animal Imaging Research Program at UTSW, Cancer Center Support Grant (5P30 CA 142543-03), the Gillson Longenbaugh Foundation, and a sponsored research agreement with Peregrine Pharmaceuticals Inc., Tustin, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhasan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046106; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Belhocine T, 2003, ANN NY ACAD SCI, V1010, P525, DOI 10.1196/annals.1299.097; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Belov VV, 2011, MOL PHARMACEUT, V8, P736, DOI 10.1021/mp100358f; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; Blankenberg F, 2002, CLIN CANCER RES, V8, P2757; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Capila I, 2001, STRUCTURE, V9, P57, DOI 10.1016/S0969-2126(00)00549-9; Carrasquillo JA, 2011, J NUCL MED, V52, P1173, DOI 10.2967/jnumed.110.086165; Collingridge DR, 2003, BRIT J CANCER, V89, P1327, DOI 10.1038/sj.bjc.6601262; COVELL DG, 1986, CANCER RES, V46, P3969; Czernin J, 2004, J NUCL MED, V45, p1S; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; Emonds KM, 2009, METHODS, V48, P193, DOI 10.1016/j.ymeth.2009.03.021; Gambhir SS, 2001, J NUCL MED, V42, p1S; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; He J, 2009, CLIN CANCER RES, V15, P6871, DOI 10.1158/1078-0432.CCR-09-1499; Hoebers FJP, 2008, EUR J NUCL MED MOL I, V35, P509, DOI 10.1007/s00259-007-0624-x; Huang XM, 2005, CANCER RES, V65, P4408, DOI 10.1158/0008-5472.CAN-05-0031; Jennewein M, 2008, CLIN CANCER RES, V14, P1377, DOI 10.1158/1078-0432.CCR-07-1516; Kartachova M, 2007, J CLIN ONCOL, V25, P2534, DOI 10.1200/JCO.2006.10.1337; Kemerink GJ, 2003, J NUCL MED, V44, P947; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Loose D, 2008, EUR J NUCL MED MOL I, V35, P47, DOI 10.1007/s00259-007-0577-0; Luster TA, 2006, J BIOL CHEM, V281, P29863, DOI 10.1074/jbc.M605252200; Marconescu A, 2008, BBA-BIOMEMBRANES, V1778, P2217, DOI 10.1016/j.bbamem.2008.05.006; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Ogasawara A, 2013, NUCL MED BIOL, V40, P15, DOI 10.1016/j.nucmedbio.2012.09.001; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Pentlow KS, 1996, J NUCL MED, V37, P1557; Ran S, 2002, CANCER RES, V62, P6132; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Smith BA, 2010, J AM CHEM SOC, V132, P67, DOI 10.1021/ja908467y; Stafford JH, 2011, NEOPLASIA, V13, P299, DOI 10.1593/neo.101366; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Vanderheyden JL, 2006, NUCL MED BIOL, V33, P135, DOI 10.1016/j.nucmedbio.2005.09.002; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; WAHL RL, 1983, J NUCL MED, V24, P316; Wall JS, 2006, J NUCL MED, V47, P2016; Wang F, 2008, NUCL MED BIOL, V35, P359, DOI 10.1016/j.nucmedbio.2007.12.007; Wang F, 2011, J NUCL MED, V52, P592, DOI 10.2967/jnumed.110.081588; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yagle KJ, 2005, J NUCL MED, V46, P658; Zhao DW, 2011, TRANSL ONCOL, V4, P355, DOI 10.1593/tlo.11178; ZULUETA JJ, 1995, AM J RESP CELL MOL, V12, P41, DOI 10.1165/ajrcmb.12.1.7529030	50	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84864	10.1371/journal.pone.0084864	http://dx.doi.org/10.1371/journal.pone.0084864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367699	gold, Green Submitted, Green Published			2022-12-25	WOS:000328741900070
J	Zhao, CQ; Su, EM; Yang, X; Gao, ZW; Li, L; Wu, HY; Jiang, YY; Su, X				Zhao, Caiqi; Su, Emily M.; Yang, Xi; Gao, Zhaowei; Li, Ling; Wu, Haiya; Jiang, Yiyi; Su, Xiao			Important Role of Platelets in Modulating Endotoxin-Induced Lung Inflammation in CFTR-Deficient Mice	PLOS ONE			English	Article							HIGH-DOSE IBUPROFEN; LIGAND 1 PSGL-1; CYSTIC-FIBROSIS; ACTIVATING-FACTOR; P-SELECTIN; IN-VIVO; INJURY; THROMBOSIS	Mutation of CFTR (cystic fibrosis transmembrane conductance regulator) leads to cystic fibrosis (CF). Patients with CF develop abnormalities of blood platelets and recurrent lung inflammation. However, whether CFTR-mutated platelets play a role in the development of lung inflammation is elusive. Therefore, we intratracheally challenged wildtype and F508del (a common type of CFTR mutation) mice with LPS to observe changes of F508del platelets in the peripheral blood and indexes of lung inflammation (BAL neutrophils and protein levels). Furthermore, we investigated whether or not and how F508del platelets modulate the LPS-induced acute lung inflammation by targeting anti-platelet aggregation, depletion of neutrophils, reconstitution of bone marrow or neutrophils, blockade of P-selectin glycoprotein ligand-1 (PSGL-1), platelet activating factor (PAF), and correction of mutated CFTR trafficking. We found that LPS-challenged F508del mice developed severe thrombocytopenia and had higher levels of plasma TXB2 coincided with neutrophilic lung inflammation relative to wildtype control. Inhibition of F508del platelet aggregation or depletion of F508del neutrophils diminished the LPS-induced lung inflammation in the F508del mice. Moreover, wildtype mice reconstituted with either F508del bone marrow or neutrophils developed worse thrombocytopenia. Blocking PSGL-1, platelet activating factor (PAF), or rectifying trafficking of mutated CFTR in F508del mice diminished and alveolar neutrophil transmigration in the LPS-challenged F508del mice. These findings suggest that F508del platelets and their interaction with neutrophils are requisite for the development of LPS-induced lung inflammation and injury. As such, targeting platelets might be an emerging strategy for dampening recurrent lung inflammation in cystic fibrosis patients.	[Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Li, Ling; Wu, Haiya; Jiang, Yiyi; Su, Xiao] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Su, Emily M.; Su, Xiao] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of California System; University of California San Francisco	Su, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	xsu@ips.ac.cn	Su, Xiao/CAG-9884-2022; Su, Xiao/G-4298-2010	Su, Xiao/0000-0002-8692-8365; Su, Xiao/0000-0002-8692-8365	Parker B. Francis Award; National Natural Science Foundation of China [81270139]; Key Project of Science and Technology of Shanghai [12JC1408900]; One Hundred Person Project of the Chinese Academy of Sciences [Y316P21209]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y114P11209]	Parker B. Francis Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; One Hundred Person Project of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	Parker B. Francis Award (X. S.); The National Natural Science Foundation of China (Grant No. 81270139, X. S.); The Key Project of Science and Technology of Shanghai (Grant No. 12JC1408900, X. S.); One Hundred Person Project of the Chinese Academy of Sciences (Grant No. Y316P21209, X. S.); The Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. Y114P11209, X. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIJER L, 1987, BRIT J PHARMACOL, V92, P803, DOI 10.1111/j.1476-5381.1987.tb11384.x; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Ciabattoni G, 2000, AM J RESP CRIT CARE, V162, P1195, DOI 10.1164/ajrccm.162.4.9911071; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Furie B, 2004, TRENDS MOL MED, V10, P171, DOI 10.1016/j.molmed.2004.02.008; Jacquot J, 2008, EXPERT REV MOL DIAGN, V8, P359, DOI 10.1586/14737159.8.4.359; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; KUSTER LJ, 1986, THROMB RES, V43, P425, DOI 10.1016/0049-3848(86)90087-3; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; O'Sullivan BP, 2006, AM J RESP CRIT CARE, V173, P483, DOI 10.1164/rccm.200508-1243PP; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Qian F, 2009, EMBO J, V28, P2896, DOI 10.1038/emboj.2009.234; RABINOVICI R, 1991, CIRC RES, V69, P12, DOI 10.1161/01.RES.69.1.12; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; STEAD RJ, 1987, PROSTAG LEUKOTR ESS, V26, P91, DOI 10.1016/0262-1746(87)90104-1; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Vandendries ER, 2004, THROMB HAEMOSTASIS, V92, P459, DOI 10.1160/TH04-05-0306; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	23	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82683	10.1371/journal.pone.0082683	http://dx.doi.org/10.1371/journal.pone.0082683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367540	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900010
J	Goyal, R; Van Wickle, J; Goyal, D; Matei, N; Longo, LD				Goyal, Ravi; Van Wickle, Jonathan; Goyal, Dipali; Matei, Nathanael; Longo, Lawrence D.			Antenatal Maternal Long-Term Hypoxia: Acclimatization Responses with Altered Gene Expression in Ovine Fetal Carotid Arteries	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INTRAUTERINE GROWTH RESTRICTION; TRANSCRIPTION FACTORS; MODULATES EXPRESSION; ALTITUDE; CELLS; SHEEP; PRETERM; PROTEIN; FAMILY	In humans and other species, long-term hypoxia (LTH) during pregnancy can lead to intrauterine growth restriction with reduced body/brain weight, dysregulation of cerebral blood flow (CBF), and other problems. To identify the signal transduction pathways and critical molecules, which may be involved in acclimatization to high altitude LTH, we conducted microarray with advanced bioinformatic analysis on carotid arteries (CA) from the normoxic near-term ovine fetus at sea-level and those acclimatized to high altitude for 110+ days during gestation. In response to LTH acclimatization, in fetal CA we identified mRNA from 38 genes upregulated >2 fold (P<0.05) and 9 genes downregulated >2-fold (P<0.05). The major genes with upregulated mRNA were SLC1A3, Insulin-like growth factor (IGF) binding protein 3, IGF type 2 receptor, transforming growth factor (TGF) Beta-3, and genes involved in the AKT and BCL2 signal transduction networks. Most genes with upregulated mRNA have a common motif for Pbx/Knotted homeobox in the promoter region, and Sox family binding sites in the 3' un translated region (UTR). Genes with downregulated mRNA included those involved in the P53 pathway and 5-lipoxygenase activating proteins. The promoter region of all genes with downregulated mRNA, had a common 49 bp region with a binding site for DOT6 and TOD6, components of the RPD3 histone deacetylase complex RPD3C(L). We also identified miRNA complementary to a number of the altered genes. Thus, the present study identified molecules in the ovine fetus, which may play a role in the acclimatization response to high-altitude associated LTH.	[Goyal, Ravi; Van Wickle, Jonathan; Goyal, Dipali; Matei, Nathanael; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Goyal, Ravi; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Goyal, R (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	rgoyal@llu.edu			United States Public Health Service Grant [PO1 HD031226]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD003807, P01HD031226] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by United States Public Health Service Grant PO1 HD031226 to LDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiano R, 2010, NUCLEIC ACIDS RES, V38, P5177, DOI 10.1093/nar/gkq260; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Box AH, 2010, BBA-MOL CELL RES, V1803, P951, DOI 10.1016/j.bbamcr.2010.03.011; Brown ST, 2011, BIOCHEM BIOPH RES CO, V412, P466, DOI 10.1016/j.bbrc.2011.07.122; Cabrol S, 2011, HORM RES PAEDIAT, V76, P419, DOI 10.1159/000334651; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Charboneau A., 2005, Angiogenesis, V8, P289; Dasgupta C, 2012, HYPERTENSION, V60, P697, DOI 10.1161/HYPERTENSIONAHA.112.198242; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DIECKHOFF D, 1969, PFLUG ARCH EUR J PHY, V310, P75, DOI 10.1007/BF00586876; Ducsay CA, 2007, AM J PHYSIOL-REG I, V293, pR1997, DOI 10.1152/ajpregu.00313.2007; Dukhande VV, 2011, MOL CELL BIOCHEM, V357, P189, DOI 10.1007/s11010-011-0889-z; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gentili S, 2009, BIOL REPROD, V80, P1121, DOI 10.1095/biolreprod.108.073569; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GIUDICE LC, 1995, J CLIN ENDOCR METAB, V80, P1548, DOI 10.1210/jc.80.5.1548; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Goyal R, 2012, PEDIATR RES, V72, P137, DOI 10.1038/pr.2012.57; Goyal R, 2012, AM J PHYSIOL-REG I, V302, pR433, DOI 10.1152/ajpregu.00519.2011; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Goyal R, 2010, AM J PHYSIOL-HEART C, V298, pH1797, DOI 10.1152/ajpheart.00112.2010; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; KAMITOMO M, 1992, AM J PHYSIOL, V262, pH399, DOI 10.1152/ajpheart.1992.262.2.H399; Kehrer M, 2005, PEDIATR RES, V58, P927, DOI 10.1203/01.PDR.0000182579.52820.C3; Kim MS, 2006, J INVEST DERMATOL, V126, P2697, DOI 10.1038/sj.jid.5700463; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kourembanas S, 1997, KIDNEY INT, V51, P438, DOI 10.1038/ki.1997.58; LaFramboise WA, 2009, AM J PHYSIOL-CELL PH, V297, pC556, DOI 10.1152/ajpcell.00046.2009; Lee SD, 2006, INT J CARDIOL, V108, P376, DOI 10.1016/j.ijcard.2005.05.046; Lee SJ, 2009, J PHYSIOL-LONDON, V587, P2033, DOI 10.1113/jphysiol.2009.166983; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lubec B, 2002, BIOL NEONATE, V81, P266, DOI 10.1159/000056758; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maves L, 2009, DEV BIOL, V333, P409, DOI 10.1016/j.ydbio.2009.07.004; McCullough R E, 1977, Obstet Gynecol Surv, V32, P596, DOI 10.1097/00006254-197709000-00012; METCALFE J, 1962, Q J EXP PHYSIOL CMS, V47, P305, DOI 10.1113/expphysiol.1962.sp001614; Monau TR, 2009, REPROD SCI, V16, P865, DOI 10.1177/1933719109336678; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Ninomiya M, 2010, NEUROSCI LETT, V476, P104, DOI 10.1016/j.neulet.2010.03.082; Ord JJ, 2005, BRIT J CANCER, V93, P346, DOI 10.1038/sj.bjc.6602666; Pena JP, 2007, J PHYSIOL-LONDON, V578, P359, DOI 10.1113/jphysiol.2006.119925; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reece EA, 2008, CLIN OBSTETRICS; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; UNGER C, 1988, JAMA-J AM MED ASSOC, V259, P3427, DOI 10.1001/jama.259.23.3427; van Malensteina H, 2012, CANCER LETT, V315, P178, DOI 10.1016/j.canlet.2011.09.039; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Wilson SM, 2010, FASEB J, V24; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yinon Y, 2008, AM J PATHOL, V172, P77, DOI 10.2353/ajpath.2008.070640; Zhang X, 2009, CANCER GENET CYTOGEN, V194, P23, DOI 10.1016/j.cancergencyto.2009.04.027	64	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82200	10.1371/journal.pone.0082200	http://dx.doi.org/10.1371/journal.pone.0082200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367503	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300021
J	Moelans, CB; Holst, F; Hellwinkel, O; Simon, R; van Diest, PJ				Moelans, Cathy B.; Holst, Frederik; Hellwinkel, Olaf; Simon, Ronald; van Diest, Paul J.			ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous	PLOS ONE			English	Article							GENE COPY NUMBER; CELL LUNG-CANCER; DEPENDENT PROBE AMPLIFICATION; IN-SITU HYBRIDIZATION; GEFITINIB THERAPY; SC-35 DOMAINS; GAIN; DNA; ABNORMALITIES; TRANSCRIPTION	Prevalence of ESR1 amplification in breast cancer is highly disputed and discrepancies have been related to different technical protocols and different scoring approaches. In addition, pre-mRNA artifacts have been proposed to influence outcome of ESR1 FISH analysis. We analyzed ESR1 gene copy number status combining an improved RNase FISH protocol with multiplex ligation-dependent probe amplification (MLPA) after laser microdissection. FISH showed a high prevalence of ESR1 gains and amplifications despite RNase treatment but MLPA did not confirm ESR1 copy number increases detected by FISH in more than half of cases. We suggest that the combination of the ESR1-specific intra-tumor heterogeneity and low-level copy number increase accounts for these discrepancies.	[Moelans, Cathy B.; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Holst, Frederik] Haukeland Hosp, Dept Clin Sci, Sect Gynecol & Obstet, N-5021 Bergen, Norway; [Hellwinkel, Olaf] Univ Med Ctr Hamburg Eppendorf, Dept Legal Med, Hamburg, Germany; [Holst, Frederik; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	Utrecht University; Utrecht University Medical Center; University of Bergen; Haukeland University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Moelans, CB (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	C.B.Moelans@umcutrecht.nl; Frederik.Holst@ikm.uib.no	Holst, Frederik/H-3149-2019	Holst, Frederik/0000-0002-5928-2175; Moelans, Cathy/0000-0001-9992-8703	Deutsche Forschungsgemeinschaft [DGF SI 1347/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DGF SI 1347/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Bernasconi B, 2012, BREAST CANCER RES TR, V133, P161, DOI 10.1007/s10549-011-1744-3; Braude I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-138; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Coffa J, 2008, CELL ONCOL, V30, P323, DOI 10.3233/CLO-2008-0428; Dahabreh IJ, 2011, ANN ONCOL, V22, P545, DOI 10.1093/annonc/mdq432; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; Ejlertsen B, 2012, ANN ONCOL, V23, P1138, DOI 10.1093/annonc/mdr438; EPSTEIN L, 1995, CYTOMETRY, V21, P378, DOI 10.1002/cyto.990210410; FELSENFELD G, 1963, P NATL ACAD SCI USA, V50, P644, DOI 10.1073/pnas.50.4.644; Fidler MJ, 2011, BRIT J CANCER, V105, P1920, DOI 10.1038/bjc.2011.494; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Holst F, 2012, NAT REV CANCER, V12, P149, DOI 10.1038/nrc3093-c3; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Jensen KC, 2008, BREAST CANCER RES TR, V112, P453, DOI 10.1007/s10549-007-9887-y; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Laenkholm AV, 2012, MOL ONCOL, V6, P428, DOI 10.1016/j.molonc.2012.04.003; Lin CH, 2013, J CLIN PATHOL, V66, P140, DOI [10.1136/jdinpath-2012-200929, 10.1136/jclinpath-2012-200929]; Martin V, 2009, J CLIN PATHOL, V62, P314, DOI 10.1136/jcp.2008.059592; Moelans CB, 2010, CELL ONCOL, V32, P311, DOI 10.3233/CLO-2009-0502; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Pentheroudakis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070634; REMMELE W, 1987, PATHOLOGE, V8, P138; Ribeiro FR, 2007, EUR UROL, V52, P116, DOI 10.1016/j.eururo.2006.09.018; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; SZOLLOSI J, 1995, CANCER RES, V55, P5400; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Trask BJ, 2002, NAT REV GENET, V3, P769, DOI 10.1038/nrg905; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Woelber L, 2012, J CLIN PATHOL, V65, P133, DOI 10.1136/jcp-2010-079806; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84189	10.1371/journal.pone.0084189	http://dx.doi.org/10.1371/journal.pone.0084189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367641	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300132
J	Mowat, G; Heard, DC; Schwarz, CJ				Mowat, Garth; Heard, Douglas C.; Schwarz, Carl J.			Predicting Grizzly Bear Density in Western North America	PLOS ONE			English	Article							FLATHEAD RIVER DRAINAGE; HABITAT SELECTION; BRITISH-COLUMBIA; URSUS-ARCTOS; BLACK BEAR; RELATING POPULATIONS; INTERIOR MOUNTAINS; BODY-SIZE; BROWN; ABUNDANCE	Conservation of grizzly bears (Ursus arctos) is often controversial and the disagreement often is focused on the estimates of density used to calculate allowable kill. Many recent estimates of grizzly bear density are now available but field-based estimates will never be available for more than a small portion of hunted populations. Current methods of predicting density in areas of management interest are subjective and untested. Objective methods have been proposed, but these statistical models are so dependent on results from individual study areas that the models do not generalize well. We built regression models to relate grizzly bear density to ultimate measures of ecosystem productivity and mortality for interior and coastal ecosystems in North America. We used 90 measures of grizzly bear density in interior ecosystems, of which 14 were currently known to be unoccupied by grizzly bears. In coastal areas, we used 17 measures of density including 2 unoccupied areas. Our best model for coastal areas included a negative relationship with tree cover and positive relationships with the proportion of salmon in the diet and topographic ruggedness, which was correlated with precipitation. Our best interior model included 3 variables that indexed terrestrial productivity, 1 describing vegetation cover, 2 indices of human use of the landscape and, an index of topographic ruggedness. We used our models to predict current population sizes across Canada and present these as alternatives to current population estimates. Our models predict fewer grizzly bears in British Columbia but more bears in Canada than in the latest status review. These predictions can be used to assess population status, set limits for total human-caused mortality, and for conservation planning, but because our predictions are static, they cannot be used to assess population trend.	[Mowat, Garth] Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada; [Heard, Douglas C.] Minist Forests Lands & Nat Resource Operat, Fish & Wildlife Sect, Prince George, BC, Canada; [Schwarz, Carl J.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Mowat, G (corresponding author), Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada.	garth.mowat@gov.bc.ca			BC Ministry of Environment; British Columbia Grizzly Bear Trust Fund	BC Ministry of Environment; British Columbia Grizzly Bear Trust Fund	This work was funded by BC Ministry of Environment and the British Columbia Grizzly Bear Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps C, 2009, GRIZZLY BEAR POPULAT; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Austin MA, 2004, URSUS, V15, P123, DOI 10.2192/1537-6176(2004)015<0123:GBRPIT>2.0.CO;2; Bannari A., 1995, REM SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Beck J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010416; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Boulanger J, 2004, CAN J ZOOL, V82, P1267, DOI 10.1139/Z04-100; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Boyce MS, 2003, WILDLIFE SOC B, V31, P670; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone C, 2009, INT J ECOLOGY, V2009; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Ciarniello LM, 2007, J WILDLIFE MANAGE, V71, P1446, DOI 10.2193/2006-229; Cook RD, 1982, RESIDUALS INFLUENCE; Cote SD, 2005, CONSERV BIOL, V19, P1668, DOI 10.1111/j.1523-1739.2005.00252.x; Crete M, 1999, ECOL LETT, V2, P223; Festa- Bianchet M., 2010, STATUS GRIZZLY BEAR; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Fuhr B, 1990, METHODOLOGY GRIZZLY; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gunther K, 2002, URSUS, V13, P372; Guthery FS, 2008, J WILDLIFE MANAGE, V72, P1872, DOI 10.2193/2008-179; Hamilton A, 2008, GRIZZLY BEAR POPULAT; HAMILTON AN, 2004, BRIT COLUMBIA GRIZZL; Hansen MC, 2003, EARTH INTERACT, V7; HERRERO S, 1978, CARNIVORE, V1, P7; HERRERO S., 1972, INT C BEAR RES MANAG, V2, P221; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hovey FW, 1996, CAN J ZOOL, V74, P1409, DOI 10.1139/z96-156; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Kays RW, 2008, ECOL APPL, V18, P1014, DOI 10.1890/07-0298.1; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LEWONTIN RC, 1989, AM NAT, V134, P513, DOI 10.1086/284994; Manly B., 2010, RESOURCE SELECTION A; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; Mattson DJ, 2004, URSUS, V15, P76, DOI 10.2192/1537-6176(2004)015<0076:AMAOHC>2.0.CO;2; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mattson DJ, 2002, CONSERV BIOL, V16, P1123, DOI 10.1046/j.1523-1739.2002.00414.x; Mayor SJ, 2005, OECOLOGIA, V145, P276, DOI 10.1007/s00442-005-0114-4; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; McLoughlin PD, COSEWIC STA IN PRESS; Miller S. D., 1997, WILDLIFE MONOGRAPHS, V133; Miller Sterling D., 2003, Ursus (Knoxville), V14, P130; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G, 2004, PREDICTING GRIZZLY B; Mysterud A, 1999, TRENDS ECOL EVOL, V14, P489, DOI 10.1016/S0169-5347(99)01713-9; Nagy JA, 1990, MANAGEMENT PLAN GRIZ; Nams VO, 2006, BIOL CONSERV, V128, P109, DOI 10.1016/j.biocon.2005.09.020; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Pease CM, 1999, ECOLOGY, V80, P957, DOI 10.1890/0012-9658(1999)080[0957:DOTYGB]2.0.CO;2; Popplewell C, 2003, URSUS-SERIES, V14, P27; Prather JW, 2006, J WILDLIFE MANAGE, V70, P723, DOI 10.2193/0022-541X(2006)70[723:LMTPTI]2.0.CO;2; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Proctor M., 2007, ABUNDANCE DENSITY CE; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Reynolds-Hogland MJ, 2007, J APPL ECOL, V44, P1166, DOI 10.1111/j.1365-2664.2007.01317.x; Riley SJ., 1999, INTERMOUNT J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Ritchie EG, 2008, ECOL MONOGR, V78, P105, DOI 10.1890/06-2117.1; Robbins CT, 2004, URSUS, V15, P161, DOI 10.2192/1537-6176(2004)015<0161:NEOUAR>2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rode KD, 2000, CAN J ZOOL, V78, P1640, DOI 10.1139/cjz-78-9-1640; Romain-Bondi KA, 2004, BIOL CONSERV, V117, P417, DOI 10.1016/j.biocon.2003.07.005; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001; Schwartz C. C., 2006, Wildlife Monographs; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Servheen C., 1990, MONOGRAPH SERIES, V2; Steyaert SM, 2013, J ANIM ECOL, DOI DOI 10.1111/1365-2656.12055/FULL.ACCESSED; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Taylor MK, 1994, MONOGRAPH SERIES, V3; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Wakkinen WL, 2004, URSUS, V15, P65, DOI 10.2192/1537-6176(2004)015<0065:DAPTOG>2.0.CO;2; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	94	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82757	10.1371/journal.pone.0082757	http://dx.doi.org/10.1371/journal.pone.0082757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367552	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300065
J	Islam, ZU; Bishop, SC; Savill, NJ; Rowland, RRR; Lunney, JK; Trible, B; Doeschl-Wilson, AB				Islam, Zeenath U.; Bishop, Stephen C.; Savill, Nicholas J.; Rowland, Raymond R. R.; Lunney, Joan K.; Trible, Benjamin; Doeschl-Wilson, Andrea B.			Quantitative Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Viremia Profiles from Experimental Infection: A Statistical Modelling Approach	PLOS ONE			English	Article							SYNDROME-VIRUS-INFECTION; PIGS; RESPONSES; SWINE; EVOLUTION; IMMUNITY; SUSCEPTIBILITY; REPLICATION; ARTERIVIRUS; POPULATIONS	Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically significant viral diseases facing the global swine industry. Viremia profiles of PRRS virus challenged pigs reflect the severity and progression of infection within the host and provide crucial information for subsequent control measures. In this study we analyse the largest longitudinal PRRS viremia dataset from an in-vivo experiment. The primary objective was to provide a suitable mathematical description of all viremia profiles with biologically meaningful parameters for quantitative analysis of profile characteristics. The Wood's function, a gamma-type function, and a biphasic extended Wood's function were fit to the individual profiles using Bayesian inference with a likelihood framework. Using maximum likelihood inference and numerous fit criteria, we established that the broad spectrum of viremia trends could be adequately represented by either uni-or biphasic Wood's functions. Three viremic categories emerged: cleared (uni-modal and below detection within 42 days post infection(dpi)), persistent (transient experimental persistence over 42 dpi) and rebound (biphasic within 42 dpi). The convenient biological interpretation of the model parameters estimates, allowed us not only to quantify inter-host variation, but also to establish common viremia curve characteristics and their predictability. Statistical analysis of the profile characteristics revealed that persistent profiles were distinguishable already within the first 21 dpi, whereas it is not possible to predict the onset of viremia rebound. Analysis of the neutralizing antibody(nAb) data indicated that there was a ubiquitous strong response to the homologous PRRSV challenge, but high variability in the range of cross-protection of the nAbs. Persistent pigs were found to have a significantly higher nAb cross-protectivity than pigs that either cleared viremia or experienced rebound within 42 dpi. Our study provides novel insights into the nature and degree of variation of hosts' responses to infection as well as new informative traits for subsequent genomic and modelling studies.	[Islam, Zeenath U.; Bishop, Stephen C.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Islam, Zeenath U.; Bishop, Stephen C.; Doeschl-Wilson, Andrea B.] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Savill, Nicholas J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Rowland, Raymond R. R.; Trible, Benjamin] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Lunney, Joan K.] USDA, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Kansas State University; United States Department of Agriculture (USDA)	Islam, ZU (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	zeenath.islam@roslin.ed.ac.uk		Savill, Nicholas/0000-0002-9769-6168; Wilson, Andrea/0000-0002-2658-6973; Islam, Zeenath/0000-0002-6657-9671	Wellcome Trust [091078/Z/09/Z]; NPB [12-120]; BBSRC [BBS/E/D/20211554, BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/20241864] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NPB; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The development of the model fitting code was supported by a Wellcome Trust Project grant to NJS (Grant No. 091078/Z/09/Z, http://www.wellcome.ac.uk/). The characterization of neutralizing antibody responses to PRRSV and association with host factors was supported by the NPB (Grant No. 12-120, http://www.pork.org/filelibrary/ResearchGrants/Funded2012.pdf). Funding for the project also came from "Genome Canada: Application of Genomics to Improve Swine Health and Welfare" (http://www.swineimprovement.com/) and "CSHB: Development of genetic selection tools to enhance sow health using a novel acclimation challenge model in Canadian commercial herds" (http://www.swinehealth.ca/program-research-proj-11.php). This work was supported by the Roslin Institute Strategic Grant funding from the BBSRC (ISPG 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEVER DE, 1991, LIVEST PROD SCI, V29, P115, DOI 10.1016/0301-6226(91)90061-T; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Boddicker N, 2012, J ANIMAL SCI; Brown, 2006, APPL MIXED MODELS ME; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Charpin C, 2012, I PORC, P67; Doeschl-Wilson AB, 2009, J ANIM SCI, V87, P1638, DOI 10.2527/jas.2008-1447; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; English S, 2012, OECOLOGIA, V169, P143, DOI 10.1007/s00442-011-2192-9; Fang Y, 2007, ARCH VIROL, V152, P1009, DOI 10.1007/s00705-007-0936-y; Friel N, 2008, J R STAT SOC B, V70, P589, DOI 10.1111/j.1467-9868.2007.00650.x; FRIESEN WO, 1993, ANNU REV PHYSIOL, V55, P661, DOI 10.1146/annurev.ph.55.030193.003305; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Goldberg TL, 2003, VIROLOGY, V317, P197, DOI 10.1016/j.virol.2003.07.009; Grossman M, 2003, J DAIRY SCI, V86, P988, DOI 10.3168/jds.S0022-0302(03)73682-0; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Lager KM, 1997, VET MICROBIOL, V58, P127, DOI 10.1016/S0378-1135(97)00159-4; Lawson SR, 1997, VIRUS RES, V51, P105, DOI 10.1016/S0168-1702(97)00086-5; Lewis CRG, 2007, VIRAL IMMUNOL, V20, P343, DOI 10.1089/vim.2007.0024; Lindley D.V., 1995, NEW CAMBRIDGE STAT T; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2011, PROBING GENETIC CONT, pS30; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Mengeling WL, 2003, VET MICROBIOL, V93, P25, DOI 10.1016/S0378-1135(02)00426-1; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Petry DB, 2007, J ANIM SCI, V85, P2075, DOI 10.2527/jas.2006-721; Petry DB, 2005, J ANIM SCI, V83, P1494; Prieto C, 2009, VET J, V180, P363, DOI 10.1016/j.tvjl.2008.01.005; Reiner G, 2010, J ANIM BREED GENET, V127, P100, DOI 10.1111/j.1439-0388.2009.00818.x; Reiner G, 2009, J ANIMAL BREEDING GE, V127, P100; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Rowland RRR, 2003, VET MICROBIOL, V96, P219, DOI 10.1016/j.vetmic.2003.07.006; Rowland RRR, 1999, VIROLOGY, V259, P262, DOI 10.1006/viro.1999.9789; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; Steri R, 2012, ANIMAL, V6, P1572, DOI 10.1017/S1751731112000766; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086; Trefan L, 2011, MEAT SCI, V87, P305, DOI 10.1016/j.meatsci.2010.11.002; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019	50	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83567	10.1371/journal.pone.0083567	http://dx.doi.org/10.1371/journal.pone.0083567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358295	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700061
J	Kabir, ZD; Katzman, AC; Kosofsky, BE				Kabir, Zeeba D.; Katzman, Aaron C.; Kosofsky, Barry E.			Molecular Mechanisms Mediating a Deficit in Recall of Fear Extinction in Adult Mice Exposed to Cocaine In Utero	PLOS ONE			English	Article							BDNF MESSENGER-RNA; PREFRONTAL CORTEX; NEUROTROPHIC FACTOR; NEUROBEHAVIORAL DISINHIBITION; HISTONE MODIFICATIONS; PRENATAL EXPOSURE; PRELIMBIC CORTEX; TRANSCRIPTION; RAT; PROTEIN	Prenatal cocaine exposure has been shown to alter cognitive processes of exposed individuals, presumed to be a result of long-lasting molecular alterations in the brain. In adult prenatal cocaine exposed (PCOC) mice we have identified a deficit in recall of fear extinction, a behavior that is dependent on the medial prefrontal cortex (mPFC) and the hippocampus. While we observed no change in the constitutive expression of brain derived neurotrophic factor (BDNF) protein and mRNA in the mPFC and hippocampus of adult PCOC mice, we observed blunted BDNF signaling in the mPFC of adult PCOC mice after fear extinction compared to the control animals. Specifically, during the consolidation phase of the extinction memory, we observed a decrease in BDNF protein and it's phospho-TrkB receptor expression. Interestingly, at this same time point there was a significant increase in total Bdnf mRNA levels in the mPFC of PCOC mice as compared with controls. In the Bdnf gene, we identified decreased constitutive binding of the transcription factors, MeCP2 and P-CREB at the promoters of Bdnf exons I and IV in the mPFC of PCOC mice, that unlike control mice remained unchanged when measured during the behavior. Finally, bilateral infusion of recombinant BDNF protein into the infralimbic subdivision of the mPFC during the consolidation phase of the extinction memory rescued the behavioral deficit in PCOC mice. In conclusion, these findings extend our knowledge of the neurobiologic impact of prenatal cocaine exposure on the mPFC of mice, which may lead to improved clinical recognition and treatment of exposed individuals.	[Kabir, Zeeba D.; Kosofsky, Barry E.] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY USA; [Kabir, Zeeba D.; Kosofsky, Barry E.] Weill Cornell Med Coll, Brain & Mind Inst, New York, NY USA; [Katzman, Aaron C.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA	Cornell University; Cornell University; University of Iowa	Kosofsky, BE (corresponding author), Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY USA.	bar2009@med.cornell.edu			NIH-NIDA [K02 DA00354, RO1 DA08648]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008648, K02DA000354] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH-NIDA Grants K02 DA00354 and RO1 DA08648 to BK The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen WG, 2003, J NEUROSCI, V23, P2572; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Crandall JE, 2004, CEREB CORTEX, V14, P665, DOI 10.1093/cercor/bhh027; Delaney-Black V, 2011, NEUROTOXICOL TERATOL, V33, P110, DOI 10.1016/j.ntt.2010.06.011; Eiden RD, 2007, ADDICT BEHAV, V32, P465, DOI 10.1016/j.addbeh.2006.05.013; Fisher PA, 2011, DEV PSYCHOPATHOL, V23, P777, DOI 10.1017/S0954579411000290; Frank DA, 2011, NEUROTOXICOL TERATOL, V33, P100, DOI 10.1016/j.ntt.2010.06.002; Fumagalli F, 2007, EUR J NEUROSCI, V26, P2756, DOI 10.1111/j.1460-9568.2007.05918.x; Garavan H, 2000, BEHAV NEUROSCI, V114, P725, DOI 10.1037//0735-7044.114.4.725; Giordano TP, 2006, J NEUROCHEM, V99, P1197, DOI 10.1111/j.1471-4159.2006.04186.x; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; GRESSENS P, 1992, NEUROSCI LETT, V140, P113, DOI 10.1016/0304-3940(92)90694-3; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kabir ZD, 2012, DEV NEUROSCI-BASEL, V34, P184, DOI 10.1159/000337712; Lester BM, 2012, DRUG ALCOHOL DEPEN, V126, P80, DOI 10.1016/j.drugalcdep.2012.04.014; Lester BM, 2010, J ADDICT DIS, V29, P259, DOI 10.1080/10550881003684921; Li TS, 2002, BIOPOLYMERS, V67, P10, DOI 10.1002/bip.10038; Lidow MS, 2001, J COMP NEUROL, V435, P263, DOI 10.1002/cne.1028; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Morrow BA, 2005, SYNAPSE, V56, P1, DOI 10.1002/syn.20121; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Romano AG, 1996, PHARMACOL BIOCHEM BE, V53, P617, DOI 10.1016/0091-3057(95)02061-6; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Singer LT, 2005, INFANT BEHAV DEV, V28, P431, DOI 10.1016/j.infbeh.2005.03.002; Sobreviela T, 1996, J COMP NEUROL, V375, P417; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tian F, 2010, AMINO ACIDS, V38, P1067, DOI 10.1007/s00726-009-0315-y; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Warner TD, 2006, PEDIATRICS, V118, P2014, DOI 10.1542/peds.2006-0003; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wilkins AS, 1998, NEUROTOXICOL TERATOL, V20, P215, DOI 10.1016/S0892-0362(97)00125-6; Wilkins AS, 1998, NEUROTOXICOL TERATOL, V20, P227, DOI 10.1016/S0892-0362(97)00127-X	48	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84165	10.1371/journal.pone.0084165	http://dx.doi.org/10.1371/journal.pone.0084165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358339	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700083
J	Zhao, HY; Lomash, S; Glasser, C; Mayer, ML; Schuckl, P				Zhao, Huaying; Lomash, Suvendu; Glasser, Carla; Mayer, Mark L.; Schuckl, Peter			Analysis of High Affinity Self-Association by Fluorescence Optical Sedimentation Velocity Analytical Ultracentrifugation of Labeled Proteins: Opportunities and Limitations	PLOS ONE			English	Article							N-TERMINAL DOMAIN; DETECTED SEDIMENTATION; BINDING; MACROMOLECULES; ACCURACY	Sedimentation velocity analytical ultracentrifugation (SV) is a powerful first-principle technique for the study of protein interactions, and allows a rigorous characterization of binding stoichiometry and affinities. A recently introduced commercial fluorescence optical detection system (FDS) permits analysis of high-affinity interactions by SV. However, for most proteins the attachment of an extrinsic fluorophore is an essential prerequisite for analysis by FDS-SV. Using the glutamate receptor GluA2 amino terminal domain as a model system for high-affinity homo-dimerization, we demonstrate how the experimental design and choice of fluorescent label can impact both the observed binding constants as well as the derived hydrodynamic parameter estimates for the monomer and dimer species. Specifically, FAM (5,6-carboxyfluorescein) was found to create different populations of artificially high-affinity and low-affinity dimers, as indicated by both FDS-SV and the kinetics of dimer dissociation studied using a bench-top fluorescence spectrometer and Forster Resonance Energy Transfer. By contrast, Dylight488 labeled GluA2, as well as GluA2 expressed as an EGFP fusion protein, yielded results consistent with estimates for unlabeled GluA2. Our study suggests considerations for the choice of labeling strategies, and highlights experimental designs that exploit specific opportunities of FDS-SV for improving the reliability of the binding isotherm analysis of interacting systems.	[Zhao, Huaying; Schuckl, Peter] Natl Inst Biomed Imaging & Bioengn, NIH, Lab Cellular Imaging & Macromol Biophys, Dynam Macromol Assembly Sect, Bethesda, MD USA; [Lomash, Suvendu; Glasser, Carla; Mayer, Mark L.] NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mayer, ML (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov; schuckp@mail.nih.gov	Schuck, Peter/AAA-6888-2020; Mayer, Mark/AAE-7356-2019	Schuck, Peter/0000-0002-8859-6966; Mayer, Mark/0000-0003-4378-8451	Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering and the National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisaka F, 1999, Tanpakushitsu Kakusan Koso, V44, P82; Balbo Andrea, 2009, J Vis Exp, DOI 10.3791/1530; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Ghai R, 2012, J MOL RECOGNIT, V25, P32, DOI 10.1002/jmr.1167; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Husain B, 2012, BIOCHEMISTRY-US, V51, P8764, DOI 10.1021/bi301226h; Jensen MH, 2011, J MOL BIOL, V414, P96, DOI 10.1016/j.jmb.2011.09.037; Johnson M.L., 1994, MODERN ANAL ULTRACEN, P37; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kingsbury JS, 2011, METHOD ENZYMOL, V492, P283, DOI 10.1016/B978-0-12-381268-1.00021-5; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lyons DF, 2013, ANAL BIOCHEM, V437, P133, DOI 10.1016/j.ab.2013.02.019; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Melikishvili M, 2011, DNA REPAIR, V10, P1193, DOI 10.1016/j.dnarep.2011.09.007; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; SCHMIDT B, 1992, ANAL ULTRACENTRIFUGA, P176; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Schuck Peter, 2013, Biophys Rev, V5, P159, DOI 10.1007/s12551-013-0106-2; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Zhao H., 2013, CURR PROTOC PROTEIN, V7; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077245; Zhao HY, 2013, J GEN PHYSIOL, V141, P747, DOI 10.1085/jgp.20121077004292013c; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	32	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83439	10.1371/journal.pone.0083439	http://dx.doi.org/10.1371/journal.pone.0083439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358283	Green Submitted, gold, Green Published			2022-12-25	WOS:000328737700057
J	Chi, CW; Ye, JZ; Ding, HL; He, D; Huang, WH; Zhang, GJ; Tian, J				Chi, Chongwei; Ye, Jinzuo; Ding, Haolong; He, De; Huang, Wenhe; Zhang, Guo-Jun; Tian, Jie			Use of Indocyanine Green for Detecting the Sentinel Lymph Node in Breast Cancer Patients: From Preclinical Evaluation to Clinical Validation	PLOS ONE			English	Article							FLUORESCENCE; BIOPSY; SURGERY; DYE; IDENTIFICATION; DISSECTION; TRIAL; BLUE	Assessment of the sentinel lymph node (SLN) in patients with early stage breast cancer is vital in selecting the appropriate surgical approach. However, the existing methods, including methylene blue and nuclides, possess low efficiency and effectiveness in mapping SLNs, and to a certain extent exert side effects during application. Indocyanine green (ICG), as a fluorescent dye, has been proved reliable usage in SLN detection by several other groups. In this paper, we introduce a novel surgical navigation system to detect SLN with ICG. This system contains two charge-coupled devices (CCD) to simultaneously capture real-time color and fluorescent video images through two different bands. During surgery, surgeons only need to follow the fluorescence display. In addition, the system saves data automatically during surgery enabling surgeons to find the registration point easily according to image recognition algorithms. To test our system, 5 mice and 10 rabbits were used for the preclinical setting and 22 breast cancer patients were utilized for the clinical evaluation in our experiments. The detection rate was 100% and an average of 2.7 SLNs was found in 22 patients. Our results show that the usage of our surgical navigation system with ICG to detect SLNs in breast cancer patients is technically feasible.	[Chi, Chongwei; Ye, Jinzuo; Tian, Jie] Chinese Acad Sci, Inst Automat, Intelligent Med Res Ctr, Beijing, Peoples R China; [Ding, Haolong; He, De; Huang, Wenhe; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Peoples R China.	guoj_zhang@yahoo.com; tian@ieee.org	Zhang, Guo-Jun/H-3890-2015; Tian, Jie/H-1190-2011	Zhang, Guo-Jun/0000-0001-5182-5887; Tian, Jie/0000-0003-0498-0432	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81027002]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1G0036]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	This paper is supported by the National Basic Research Program of China (973 Program) under Grant No. 2011CB707700, the National Natural Science Foundation of China under Grant No. 81027002, and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under Grant No. 2012T1G0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Crane LMA, 2011, MOL IMAGING BIOL, V13, P1043, DOI 10.1007/s11307-010-0425-7; Denninghoff Valeria C, 2004, Mol Diagn, V8, P253, DOI 10.2165/00066982-200408040-00007; Gibbs-Strauss SL, 2009, IEEE ENG MED BIO, P2001, DOI 10.1109/IEMBS.2009.5333429; Gilmore DM, 2013, ANN SURG ONCOL, V20, P2357, DOI 10.1245/s10434-013-2905-x; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Giuliano AE, 2011, ARCH SURG-CHICAGO, V146, P980; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Hutteman M, 2011, BREAST CANCER RES TR, V127, P163, DOI 10.1007/s10549-011-1419-0; Hutteman M, 2011, ANN SURG ONCOL, V18, P1006, DOI 10.1245/s10434-010-1426-0; Imai K, 2013, SURG TODAY, V43, P249, DOI 10.1007/s00595-012-0237-2; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Kootstra J, 2008, ANN SURG ONCOL, V15, P2533, DOI 10.1245/s10434-008-9996-9; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Liu Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101303; Matsui A, 2011, BRIT J SURG, V98, P1725, DOI 10.1002/bjs.7698; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Motomura K, 1999, JPN J CLIN ONCOL, V29, P604, DOI 10.1093/jjco/29.12.604; Motomura K, 2001, J SURG ONCOL, V76, P95, DOI 10.1002/1096-9098(200102)76:2<95::AID-JSO1018>3.3.CO;2-4; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Ogawa Y, 2013, SURG TODAY; Pleijhuis RG, 2011, EJSO-EUR J SURG ONC, V37, P32, DOI 10.1016/j.ejso.2010.10.006; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Schaafsma BE, 2013, BRIT J SURG, V100, P1037, DOI 10.1002/bjs.9159; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; Su ZA, 2012, J OCUL PHARMACOL TH, V28, P410, DOI 10.1089/jop.2011.0221; Sugie T, 2013, ANN SURG ONCOL, V20, P2213, DOI 10.1245/s10434-013-2890-0; Sugie Tomoharu, 2010, Cancers (Basel), V2, P713, DOI 10.3390/cancers2020713; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Valsecchi ME, 2011, J CLIN ONCOL, V29, P1479, DOI 10.1200/JCO.2010.33.1884; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Yamamoto S, 2013, BREAST, V22, P933, DOI 10.1016/j.breast.2013.05.001; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73	40	54	60	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83927	10.1371/journal.pone.0083927	http://dx.doi.org/10.1371/journal.pone.0083927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358319	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700144
J	Fujiwara, H; Takei, Y; Ishikawa, Y; Saga, Y; Machida, S; Taneichi, A; Suzuki, M				Fujiwara, Hiroyuki; Takei, Yuji; Ishikawa, Yoshiki; Saga, Yasushi; Machida, Shizuo; Taneichi, Akiyo; Suzuki, Mitsuaki			Community-Based Interventions to Improve HPV Vaccination Coverage among 13-to 15-Year-Old Females: Measures Implemented by Local Governments in Japan	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; EFFICACY; VACCINES; IMMUNITY	The purpose of this study was to examine the effect of various community-based interventions in support of HPV vaccination implemented by cities and towns within Tochigi prefecture, Japan with a view to identifying useful indicators which might guide future interventions to improve HPV vaccination coverage in the prefecture. A postal questionnaire survey of all 27 local governments in Tochigi Prefecture was conducted in December 2010. All 27 responded, and 22 provided the exact numbers of the targeted and vaccinated populations of 13- to 15-year-old girls from April to December 2010. The local governments also answered questions on the type of interventions implemented including public subsidies, school-based programs, direct mail, free tickets and recalls. Local governments that conducted a school-based vaccination program reported 96.8% coverage for the 1st dose, 96.2% for the 2nd dose, and 91.2% for the 3rd dose. Those that provided subsidies without school-based programs reported a wide range of vaccination rates: 45.7%-95.0% for the 1st dose, 41.1%-93.7% for the 2nd dose and 3.1%-90.1% for the 3rd dose. Among this group, the combination of a free ticket, direct mail and recall was most effective, with 95.0% coverage for the 1st dose, 93.7% for the 2nd dose, and 90.1% for the 3rd dose. The governments that did not offer a subsidy had the lowest vaccination coverage, with 0.8%-1.4% for the 1st dose, 0.0%-0.8% for the 2nd dose, and 0.1%-0.1% for the 3rd dose. The results of this survey indicate that school-based vaccinations and public subsidies are the most effective method to improve HPV vaccination coverage; however, the combination of a free ticket, direct mail, and recalls with public subsidies are also important measures in increasing the vaccination rate. These data may afford important indicators for the successful implementation of future HPV vaccination programs.	[Fujiwara, Hiroyuki; Takei, Yuji; Saga, Yasushi; Machida, Shizuo; Taneichi, Akiyo; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan	Jichi Medical University; University of Tokyo	Suzuki, M (corresponding author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	msuzuki@jichi.ac.jp	Takei, Yuji/ABD-2485-2020		MEXT KAKENHI [25460775]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by MEXT KAKENHI Grant Number 25460775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2010, GYNECOL OBSTET INVES, V70, P224, DOI 10.1159/000314010; Australian Government Department of Health and Ageing, 2013, INF NAT HUM PAP HPV; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; Chadenier GMC, 2011, VACCINE, V29, P4405, DOI 10.1016/j.vaccine.2011.04.007; Committee on Immunization Finance Policies and Practices Division of Health Care Services and Division of Health Promotion and Disease Prevention, 2000, CALL SHOTS IMM FIN P; Daley MF, 2009, J ADOLESCENT HEALTH, V45, P445, DOI 10.1016/j.jadohealth.2009.04.002; Fujiwara H, 2011, VACCINE, V29, P6441, DOI 10.1016/j.vaccine.2011.06.031; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2010, DRUGS, V70, P1079, DOI 10.2165/10898580-000000000-00000; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Hall AJ, 2010, VACCINE, V28, pA54, DOI 10.1016/j.vaccine.2010.02.034; Hinman AR, 2004, CLIN INFECT DIS, V38, P1445, DOI 10.1086/420748; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Lindley MC, 2008, PEDIATRICS, V121, pS46, DOI 10.1542/peds.2007-1115F; Pomfret TC, 2011, J CLIN PHARM THER, V36, P1, DOI 10.1111/j.1365-2710.2009.01150.x; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222	19	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84126	10.1371/journal.pone.0084126	http://dx.doi.org/10.1371/journal.pone.0084126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358333	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700151
J	Gonzalez, Y; Doens, D; Santamaria, R; Ramos, M; Restrepo, CM; de Arruda, LB; Lleonart, R; Gutierrez, M; Fernandez, PL				Gonzalez, Yisett; Doens, Deborah; Santamaria, Ricardo; Ramos, Marla; Restrepo, Carlos M.; de Arruda, Luciana Barros; Lleonart, Ricardo; Gutierrez, Marcelino; Fernandez, Patricia L.			A Pseudopterane Diterpene Isolated From the Octocoral Pseudopterogorgia acerosa Inhibits the Inflammatory Response Mediated by TLR-Ligands and TNF-Alpha in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; BIOLOGICAL-ACTIVITY; NATURAL-PRODUCTS; ACTIVATION; EXPRESSION; TRIPTOLIDE; (+)-TOTAROL; MODULATORS; MOLECULE	Several diterpenoids isolated from terrestrial and marine environments have been identified as important anti-inflammatory agents. Although considerable progress has been made in the area of anti-inflammatory treatment, the search for more effective and safer compounds is a very active field of research. In this study we investigated the anti-inflammatory effects of a known pseudopterane diterpene (referred here as compound 1) isolated from the octocoral Pseudopterogorgia acerosa on the tumor necrosis factor-alpha (TNF-alpha) and TLRs- induced response in macrophages. Compound 1 inhibited the expression and secretion of the inflammatory mediators TNF-alpha, interleukin (IL)-6, IL-1 beta, nitric oxide (NO), interferon gamma-induced protein 10 (IP-10), ciclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS) and monocyte chemoattractant protein-1 (MCP-1) induced by LPS in primary murine macrophages. This effect was associated with the inhibition of I.Ba degradation and subsequent activation of NF kappa B. Compound 1 also inhibited the expression of the co-stimulatory molecules CD80 and CD86, which is a hallmark of macrophage activation and consequent initiation of an adaptive immune response. The anti-inflammatory effect was not exclusive to LPS because compound 1 also inhibited the response of macrophages to TNF-alpha and TLR2 and TLR3 ligands. Taken together, these results indicate that compound 1 is an anti-inflammatory molecule, which modulates a variety of processes occurring in macrophage activation.	[Gonzalez, Yisett; Doens, Deborah; Ramos, Marla; Restrepo, Carlos M.; Lleonart, Ricardo; Fernandez, Patricia L.] Inst Invest Cient & Serv Alta Tecno, Ctr Biol Celular & Mol Enfermedades, Ciudad De Panama, Panama; [Gonzalez, Yisett; Doens, Deborah; Restrepo, Carlos M.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India; [Santamaria, Ricardo; Gutierrez, Marcelino] Inst Invest Cient & Serv Alta Tecno, Ctr Descubrimiento Drogas & Biodiversidad, Ciudad De Panama, Panama; [de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol, Lab Genet & Imunol Infeccoes Virais, Rio De Janeiro, Brazil	Acharya Nagarjuna University; Universidade Federal do Rio de Janeiro	Fernandez, PL (corresponding author), Inst Invest Cient & Serv Alta Tecno, Ctr Biol Celular & Mol Enfermedades, Ciudad De Panama, Panama.	pllanes@indicasat.org.pa	Gutiérrez, Marcelino/V-8134-2019; Lleonart, Ricardo/Q-5372-2019; Arruda, Luciana B/N-9086-2013; Arruda, Luciana/B-5806-2014	Gutiérrez, Marcelino/0000-0003-1423-3772; Lleonart, Ricardo/0000-0002-5830-6315; Gonzalez, Yisett/0000-0002-1623-9484; Llanes Fernandez, Patricia/0000-0002-0762-0566	Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama [FID11-082, COL08-064]; Fogarty International Center's International Cooperative Biodiversity Groups program [TW006634]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama; Fogarty International Center's International Cooperative Biodiversity Groups program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Secretar a Nacional de Ciencia Tecnolog a e Innovacion (SENACYT), Republic of Panama [Grants FID11-082, COL08-064]; and [in part] by the Fogarty International Center's International Cooperative Biodiversity Groups program [Grant TW006634]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo M, 2008, LIFE SCI, V82, P256, DOI 10.1016/j.lfs.2007.11.017; BANDURRAGA MM, 1982, J AM CHEM SOC, V104, P6463, DOI 10.1021/ja00387a059; Berrue F, 2009, NAT PROD REP, V26, P681, DOI 10.1039/b821918b; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Chung JY, 2002, J CELL SCI, V115, P679; Crow MK, 2006, SPRINGER SEMIN IMMUN, V27, P409, DOI 10.1007/s00281-006-0018-3; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; FENICAL W, 1987, J NAT PROD, V50, P1001, DOI 10.1021/np50054a001; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Folmer F, 2008, BIOCHEM PHARMACOL, V75, P603, DOI 10.1016/j.bcp.2007.07.044; Giron N, 2008, TOXICOL APPL PHARM, V228, P179, DOI 10.1016/j.taap.2007.12.006; Gupta SC, 2011, MOL PHARMACOL, V80, P769, DOI 10.1124/mol.111.073122; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hughes CC, 2009, ANGEW CHEM INT EDIT, V48, P725, DOI 10.1002/anie.200804890; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kondratyuk TP, 2012, MAR DRUGS, V10, P451, DOI 10.3390/md10020451; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Liu J, 2005, ACTA PHARMACOL SIN, V26, P223, DOI 10.1111/j.1745-7254.2005.00035.x; Lu L, 2011, ANTICANCER RES, V31, P1; Lucas R, 2003, LIFE SCI, V72, P2543, DOI 10.1016/S0024-3205(03)00167-X; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mateo CR, 2000, BBA-BIOMEMBRANES, V1509, P167, DOI 10.1016/S0005-2736(00)00291-1; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Micol V, 2001, BBA-BIOMEMBRANES, V1511, P281, DOI 10.1016/S0005-2736(01)00284-X; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; ODA T, 2011, INT J APP RES NAT PR, V4, P16; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Premkumar Vummidigiridhar, 2010, BMC Chemical Biology, V10, P3, DOI 10.1186/1472-6769-10-3; Roethle PA, 2008, NAT PROD REP, V25, P298, DOI 10.1039/b705660p; Singh M, 1999, PLANTA MED, V65, P2, DOI 10.1055/s-1999-13952; TINTO WF, 1991, TETRAHEDRON, V47, P8679, DOI 10.1016/S0040-4020(01)96190-3; Quang TH, 2011, BIOORGAN MED CHEM, V19, P2625, DOI 10.1016/j.bmc.2011.03.009; Urzua A, 2008, MOLECULES, V13, P882, DOI 10.3390/molecules13040822; VanGool SW, 1996, IMMUNOL REV, V153, P47; Wang W, 2010, ACTA PHARMACOL SIN, V31, P191, DOI 10.1038/aps.2009.205; Wei W, 2011, PARIS REV, P13; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84107	10.1371/journal.pone.0084107	http://dx.doi.org/10.1371/journal.pone.0084107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358331	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700150
J	Kimmerly, DS; Morris, BL; Floras, JS				Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.			Apnea-Induced Cortical BOLD-fMRI and Peripheral Sympathoneural Firing Response Patterns of Awake Healthy Humans	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SYMPATHETIC-NERVE ACTIVITY; CONGESTIVE-HEART-FAILURE; HUMAN INSULAR CORTEX; HUMAN MUSCLE NERVES; CARDIOVASCULAR FUNCTION; INTRATHORACIC PRESSURE; HEMODYNAMIC-RESPONSES; MUELLER MANEUVERS; SYSTEM ACTIVATION	End-expiratory breath-holds (BH) and Mueller manoeuvres (MM) elicit large increases in muscle sympathetic nerve activity (MSNA). In 16 healthy humans (9 female, 35 +/- 4 years) we used functional magnetic resonance imaging with blood oxygen level-dependent (BOLD) contrast to determine the cortical network associated with such sympathoexcitation. We hypothesized that increases in MSNA evoked by these simulated apneas are accompanied by BOLD contrast changes in the insular cortex, thalamus and limbic cortex. A series of 150 whole-brain images were collected during 3 randomly performed 16-second end-expiratory BHs and MMs (-30 mmHg). The identical protocol was repeated separately with MSNA recorded from the fibular nerve. The time course of the sympathoexcitatory response to both breathing tasks were correlated with whole-brain BOLD signal changes. Brain sites demonstrating both positive (activation) and negative (deactivation) correlations with the MSNA time course were identified. Sympathetic burst incidence increased (p<0.001) from 29 +/- 6 (rest) to 49 +/- 6 (BH) and 47 +/- 6 bursts/100 heartbeats (MM). Increased neural activity (Z-scores) was identified in the right posterior and anterior insular cortices (3.74, 3.64), dorsal anterior cingulate (3.42), fastigial and dentate cerebellar nuclei (3.02, 3.34). Signal intensity decreased in the left posterior insula (3.28) and ventral anterior cingulate (3.01). Apnea both activates and inhibits elements of a cortical network involved in the generation of sympathetic outflow. These findings identify a neuroanatomical substrate to guide future investigations into central mechanisms contributing to disorders characterized by elevated basal MSNA and exaggerated sympathetic responses to simulated apneas such as sleep apnea and heart failure.	[Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.] Univ Toronto, Clin Cardiovasc Physiol Lab, Univ Hlth Network, Toronto, ON, Canada; [Kimmerly, Derek S.; Morris, Beverley L.; Floras, John S.] Univ Toronto, Mt Sinai Hosp, Div Cardiol, Dept Med, Toronto, ON M5G 1X5, Canada; [Kimmerly, Derek S.] Dalhousie Univ, Fac Hlth Profess, Sch Hlth & Human Performance, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dalhousie University	Kimmerly, DS (corresponding author), Univ Toronto, Clin Cardiovasc Physiol Lab, Univ Hlth Network, Toronto, ON, Canada.	dskimmerly@dal.ca	Floras, John S./D-4042-2015; Kimmerly, Derek S/F-6536-2011	Kimmerly, Derek/0000-0002-3462-8037	Heart and Stroke Foundation of Ontario (HSFO) [NA 6407]; Canadian Institutes of Health; HSFO; Canada Research Chair in Integrative Cardiovascular Biology	Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); HSFO; Canada Research Chair in Integrative Cardiovascular Biology(Canada Research Chairs)	This work was supported by the Heart and Stroke Foundation of Ontario (HSFO, Grant #NA 6407). Derek Kimmerly was a recipient of a Canadian Institutes of Health Research Postdoctoral Fellowship. Dr. J. Floras was supported by an HSFO Career Investigator Award and Canada Research Chair in Integrative Cardiovascular Biology.	Ando S, 1997, CIRCULATION, V95, P316; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V393, P107, DOI 10.1113/jphysiol.1987.sp016813; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Bradley TD, 2003, CLIN SCI, V104, P231, DOI 10.1042/CS20020157; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; CECHETTO DF, 1990, CENTRAL REGULATION A, P208; Ciarka A, 2010, AM J RESP CRIT CARE, V181, P1269, DOI 10.1164/rccm.200912-1856OC; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Dampney RAL, 2003, ACTA PHYSIOL SCAND, V177, P209, DOI 10.1046/j.1365-201X.2003.01070.x; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P65, DOI 10.1111/j.1748-1716.1972.tb05157.x; Eckert S, 2002, BLOOD PRESS MONIT, V7, P179, DOI 10.1097/00126097-200206000-00006; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; FAGIUS J, 1989, HYPERTENSION, V14, P511, DOI 10.1161/01.HYP.14.5.511; FINDLEY LJ, 1983, J APPL PHYSIOL, V55, P1777, DOI 10.1152/jappl.1983.55.6.1777; FITZGERALD RS, 1981, AM J PHYSIOL, V240, pH721, DOI 10.1152/ajpheart.1981.240.5.H721; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; HAGBARTH KE, 1968, ACTA PHYSIOL SCAND, V74, P96, DOI 10.1111/j.1748-1716.1968.tb04218.x; Hall MJ, 1998, J APPL PHYSIOL, V85, P1476, DOI 10.1152/jappl.1998.85.4.1476; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; Kimmerly DS, 2007, AM J PHYSIOL-HEART C, V293, pH299, DOI 10.1152/ajpheart.00044.2007; Kimmerly DS, 2007, AM J PHYSIOL-REG I, V292, pR715, DOI 10.1152/ajpregu.00366.2006; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; Kimmerly DS, 2004, AUTON NEUROSCI-BASIC, V114, P61, DOI 10.1016/j.autneu.2004.06.005; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Macefield VG, 2010, HUM BRAIN MAPP, V31, P539, DOI 10.1002/hbm.20885; Macefield VG, 2006, J APPL PHYSIOL, V100, P266, DOI 10.1152/japplphysiol.00588.2005; Macefield VG, 1998, J AUTONOM NERV SYST, V68, P135, DOI 10.1016/S0165-1838(97)00129-X; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; MORGAN BJ, 1993, J APPL PHYSIOL, V74, P2969, DOI 10.1152/jappl.1993.74.6.2969; Moruzzi G, 1940, J NEUROPHYSIOL, V3, P20, DOI 10.1152/jn.1940.3.1.20; Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Peiffer C, 2008, AM J RESP CRIT CARE, V177, P440, DOI 10.1164/rccm.200612-1774OC; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; SCHOBEL HP, 1995, CLIN AUTON RES, V5, P71, DOI 10.1007/BF01827466; Shimizu T, 1997, PSYCHIAT CLIN NEUROS, V51, P397, DOI 10.1111/j.1440-1819.1997.tb02607.x; SOMERS VK, 1993, J AUTONOM NERV SYST, V44, P253, DOI 10.1016/0165-1838(93)90038-V; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Spaak J, 2005, HYPERTENSION, V46, P1327, DOI 10.1161/01.HYP.0000193497.45200.66; van de Borne P, 1998, AM J CARDIOL, V81, P432, DOI 10.1016/S0002-9149(97)00936-3; Verberne AJM, 1996, AM J PHYSIOL-REG I, V270, pR713, DOI 10.1152/ajpregu.1996.270.4.R713; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Weisz J, 2001, NEUROREPORT, V12, P3233, DOI 10.1097/00001756-200110290-00018; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; Wong SW, 2007, J APPL PHYSIOL, V103, P1402, DOI 10.1152/japplphysiol.00171.2007; Young T, 2008, SLEEP, V31, P1071	62	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82525	10.1371/journal.pone.0082525	http://dx.doi.org/10.1371/journal.pone.0082525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358198	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700077
J	Ryan, JP; Sheu, LK; Verstynen, TD; Onyewuenyi, IC; Gianaros, PJ				Ryan, John P.; Sheu, Lei K.; Verstynen, Timothy D.; Onyewuenyi, Ikechukwu C.; Gianaros, Peter J.			Cerebral Blood Flow Links Insulin Resistance and Baroreflex Sensitivity	PLOS ONE			English	Article							GLUT4 MESSENGER-RNA; FUNCTIONAL-ORGANIZATION; AUTONOMIC NEUROPATHY; HUMAN BRAIN; FOOD-INTAKE; ACTIVATION; GLUCOSE; CORTEX; MECHANISMS; PRESSURE	Insulin resistance confers risk for diabetes mellitus and associates with a reduced capacity of the arterial baroreflex to regulate blood pressure. Importantly, several brain regions that comprise the central autonomic network, which controls the baroreflex, are also sensitive to the neuromodulatory effects of insulin. However, it is unknown whether peripheral insulin resistance relates to activity within central autonomic network regions, which may in turn relate to reduced baroreflex regulation. Accordingly, we tested whether resting cerebral blood flow within central autonomic regions statistically mediated the relationship between insulin resistance and an indirect indicator of baroreflex regulation; namely, baroreflex sensitivity. Subjects were 92 community-dwelling adults free of confounding medical illnesses (48 men, 30-50 years old) who completed protocols to assess fasting insulin and glucose levels, resting baroreflex sensitivity, and resting cerebral blood flow. Baroreflex sensitivity was quantified by measuring the magnitude of spontaneous and sequential associations between beat-by-beat systolic blood pressure and heart rate changes. Individuals with greater insulin resistance, as measured by the homeostatic model assessment, exhibited reduced baroreflex sensitivity (b = -0.16, p < .05). Moreover, the relationship between insulin resistance and baroreflex sensitivity was statistically mediated by cerebral blood flow in central autonomic regions, including the insula and cingulate cortex (mediation coefficients < -0.06, p-values < .01). Activity within the central autonomic network may link insulin resistance to reduced baroreflex sensitivity. Our observations may help to characterize the neural pathways by which insulin resistance, and possibly diabetes mellitus, relates to adverse cardiovascular outcomes.	[Ryan, John P.; Gianaros, Peter J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Sheu, Lei K.; Onyewuenyi, Ikechukwu C.; Gianaros, Peter J.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Verstynen, Timothy D.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Ryan, JP (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	ryanjp@upmc.edu		Ryan, John/0000-0003-4466-4418; Verstynen, Timothy/0000-0003-4720-0336	National Institutes of Health [R01-HL089850, F32-DK-091962, K01-DK-095759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091962, K01DK095759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health R01-HL089850 (PG), F32-DK-091962, and K01-DK-095759 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2001, NEUROSCI LETT, V308, P75, DOI 10.1016/S0304-3940(01)01936-X; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Benarroch EE., 1997, CENTRAL AUTONOMIC NE; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P433, DOI 10.1017/CBO9780511546396.019; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; Clarke JA, 1999, BRAZ J MED BIOL RES, V32, P85, DOI 10.1590/S0100-879X1999000100013; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dampney RAL, 2011, J PHYSIOL-LONDON, V589, P2109, DOI 10.1113/jphysiol.2011.208579; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; DUCHEN LW, 1980, ANN INTERN MED, V92, P301, DOI 10.7326/0003-4819-92-2-301; Eckberg D, 1992, HUMAN BAROREFLEXES H; El Messari S, 2002, J CHEM NEUROANAT, V24, P225, DOI 10.1016/S0891-0618(02)00058-3; GIANAROS PJ, 2011, HUM BRAIN MAPP, P13934; Gizdulich P, 1996, J HYPERTENS, V14, P243, DOI 10.1097/00004872-199602000-00014; GOSWAMI R, 2010, NEUROIMAGE, P13934; GOSWAMI R, 2012, J NEUROPHYSIOLOGY, P13934; Gray MA, 2009, NEUROIMAGE, V47, P1105, DOI 10.1016/j.neuroimage.2009.05.033; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Henderson LA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00569; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; KULLMANN S, 2012, NEUROENDOCRINOLOGY, P13934; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; La Rovere MT, 1998, LANCET, V351, P478; Landsberg L, 2001, J HYPERTENS, V19, P523, DOI 10.1097/00004872-200103001-00001; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Meyer C, 2004, DIABETIC MED, V21, P746, DOI 10.1111/j.1464-5491.2004.01241.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MUNTZEL MS, 1994, AM J PHYSIOL-REG I, V267, pR1350, DOI 10.1152/ajpregu.1994.267.5.R1350; MUNTZEL MS, 1995, CLIN EXP HYPERTENS, V17, P39, DOI 10.3109/10641969509087053; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reims HM, 2004, J HYPERTENS, V22, P2007, DOI 10.1097/00004872-200410000-00025; Rolls ET, 2012, P NUTR SOC, V71, P488, DOI 10.1017/S0029665112000821; ROWE JW, 1981, DIABETES, V30, P219, DOI 10.2337/diab.30.3.219; RYAN JP, 2012, PSYCHOSOM MED, P13934; Saleh TM, 1998, AM J PHYSIOL-REG I, V274, pR1417, DOI 10.1152/ajpregu.1998.274.5.R1417; Sequeira H, 2000, BRAIN RES BULL, V53, P87, DOI 10.1016/S0361-9230(00)00312-9; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; SPYER KM, 1989, TRENDS NEUROSCI, V12, P506, DOI 10.1016/0166-2236(89)90111-2; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826; Westerhof BE, 2004, J HYPERTENS, V22, P1371, DOI 10.1097/01.hjh.0000125439.28861.ed; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759; Young CN, 2010, J PHYSIOL-LONDON, V588, P3593, DOI 10.1113/jphysiol.2010.191866; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018	63	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83288	10.1371/journal.pone.0083288	http://dx.doi.org/10.1371/journal.pone.0083288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358272	Green Published, gold, Green Accepted			2022-12-25	WOS:000328735700115
J	Hayashi, H; Arao, T; Togashi, Y; Kato, H; Fujita, Y; De Velasco, MA; Kimura, H; Matsumoto, K; Tanaka, K; Okamoto, I; Ito, A; Yamada, Y; Nakagawa, K; Nishio, K				Hayashi, H.; Arao, T.; Togashi, Y.; Kato, H.; Fujita, Y.; De Velasco, M. A.; Kimura, H.; Matsumoto, K.; Tanaka, K.; Okamoto, I.; Ito, A.; Yamada, Y.; Nakagawa, K.; Nishio, K.			The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer	ONCOGENE			English	Article						POU5F1B; OCT4; pseudogene; gastric cancer; gene amplification	GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; PROSTATE-CANCER; BREAST-CANCER; BLADDER-CANCER; CELLS; RISK; EXPRESSION; 8Q24; LOCUS	POU5F1B (POU domain class 5 transcription factor 1B), a processed pseudogene that is highly homologous to OCT4, was recently shown to be transcribed in cancer cells, but its clinical relevance and biological function have remained unclear. We now show that POU5F1B, which is located adjacent to MYC on human chromosome 8q24, is frequently amplified in gastric cancer (GC) cell lines. POU5F1B, but not OCT4, was also found to be expressed at a high level in GC cell lines and clinical specimens. In addition, the DNA copy number and mRNA abundance for POU5F1B showed a positive correlation in both cancer cell lines and GC specimens. Overexpression of POU5F1B in GC cells promoted colony formation in vitro as well as both tumorigenicity and tumor growth in vivo, and these effects were enhanced in the additional presence of MYC overexpression. Furthermore, knockdown of POU5F1B expression with a short hairpin RNA confirmed a role for the endogenous pseudogene in the promotion of cancer cell growth in vitro and tumor growth in vivo. POU5F1B overexpression induced upregulation of various growth factors in GC cells as well as exhibited mitogenic, angiogenic and antiapoptotic effects in GC xenografts. Finally, amplification of POU5F1B was detected in 17 (12%) of 145 cases of GC and was a significant predictor of poor prognosis in patients with stage IV disease. In conclusion, we found that the POU5F1B pseudogene is amplified and expressed at a high level in, as well as confers an aggressive phenotype on, GC, and that POU5F1B amplification is associated with a poor prognosis in GC patients.	[Hayashi, H.; Arao, T.; Togashi, Y.; Kato, H.; Fujita, Y.; De Velasco, M. A.; Kimura, H.; Matsumoto, K.; Nishio, K.] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka 5898511, Japan; [Hayashi, H.; Tanaka, K.; Okamoto, I.; Nakagawa, K.] Kinki Univ, Fac Med, Dept Med Oncol, Sayama, Osaka 5898511, Japan; [Ito, A.] Kinki Univ, Fac Med, Dept Pathol, Sayama, Osaka 5898511, Japan; [Yamada, Y.] Natl Canc Ctr, Dept Gastrointestinal Oncol, Tokyo, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); National Cancer Center - Japan	Nishio, K (corresponding author), Kinki Univ, Fac Med, Dept Genome Biol, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp	De Velasco, Marco/R-1022-2019; Yamada, Yasuhide/AAH-9124-2020	De Velasco, Marco/0000-0002-4011-6572; 	Third-Term Comprehensive 10-Year Strategy for Cancer Control; Ministry of Health, Labor and Welfare of Japan	Third-Term Comprehensive 10-Year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan. We thank Shinji Kurashimo, Yoshihiro Mine, Ayaka Kurumatani and Tomoko Kitayama for technical assistance.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Fletcher O, 2008, CANCER EPIDEM BIOMAR, V17, P702, DOI 10.1158/1055-9965.EPI-07-2564; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Furuta K, 2012, CANCER SCI, V103, P221, DOI 10.1111/j.1349-7006.2011.02132.x; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kastler S, PROSTATE, V70, P666; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Panagopoulos I, 2008, ONCOL REP, V20, P1029, DOI 10.3892/or_00000105; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda M, 2007, CLIN CANCER RES, V13, P3051, DOI 10.1158/1078-0432.CCR-06-2743; Tanaka K, 2009, INT J CANCER, V124, P1072, DOI 10.1002/ijc.24065; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wu CL, 2008, CLIN CANCER RES, V14, P1228, DOI 10.1158/1078-0432.CCR-07-1047; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu HJ, 2005, HUM MUTAT, V26, P487, DOI 10.1002/humu.20246; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827	39	93	98	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					199	208		10.1038/onc.2013.547	http://dx.doi.org/10.1038/onc.2013.547			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362523				2022-12-25	WOS:000347790500007
J	Kohler, TP; Gisch, N; Binsker, U; Schlag, M; Darm, K; Volker, U; Zahringer, U; Hammerschmidt, S				Kohler, Thomas P.; Gisch, Nicolas; Binsker, Ulrike; Schlag, Martin; Darm, Katrin; Voelker, Uwe; Zaehringer, Ulrich; Hammerschmidt, Sven			Repeating Structures of the Major Staphylococcal Autolysin Are Essential for the Interaction with Human Thrombospondin 1 and Vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Extracellular Matrix Proteins; Pathogenesis; Staphylococcus; Thrombospondin; Autolysin; Repeats; Vitronectin	ADHESIVE MATRIX MOLECULES; EXTRACELLULAR ADHERENCE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; SOLUBLE FIBRIN; AUREUS; BINDING; HOST; EPIDERMIDIS; IDENTIFICATION; COLONIZATION	Human thrombospondin 1 (hTSP-1) is a matricellular glycoprotein facilitating bacterial adherence to and invasion into eukaryotic cells. However, the bacterial adhesin(s) remain elusive. In this study, we show a dose-dependent binding of soluble hTSP-1 to Gram-positive but not Gram-negative bacteria. Diminished binding of soluble hTSP-1 to proteolytically pretreated staphylococci suggested a proteinaceous nature of potential bacterial adhesin(s) for hTSP-1. A combination of separation of staphylococcal surface proteins by two-dimensional gel electrophoresis with a ligand overlay assay with hTSP-1 and identification of the target protein by mass spectrometry revealed the major staphylococcal autolysin Atl as a bacterial binding protein for hTSP-1. Binding experiments with heterologously expressed repeats of the AtlE amidase from Staphylococcus epidermidis suggest that the repeating sequences (R1(ab)-R2(ab)) of the N-acetyl-muramoyl-l-alanine amidase of Atl are essential for binding of hTSP-1. Atl has also been identified previously as a staphylococcal vitronectin (Vn)-binding protein. Similar to the interaction with hTSP-1, the R1(ab)-R2(ab) repeats of Atl are shown here to be crucial for the interaction of Atl with the complement inhibition and matrix protein Vn. Competition assays with hTSP-1 and Vn revealed the R1(ab)-R2(ab) repeats of AtlE as the common binding domain for both host proteins. Furthermore, Vn competes with hTSP-1 for binding to Atl repeats and vice versa. In conclusion, this study identifies the Atl repeats as bacterial adhesive structures interacting with the human glycoproteins hTSP-1 and Vn. Finally, this study provides insight into the molecular interplay between hTSP-1 and Vn, respectively, and a bacterial autolysin.	[Kohler, Thomas P.; Binsker, Ulrike; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17487 Greifswald, Germany; [Darm, Katrin] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, D-17487 Greifswald, Germany; [Gisch, Nicolas; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Bioanalyt Chem, D-23845 Borstel, Germany; [Schlag, Martin] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Forschungszentrum Borstel; Eberhard Karls University of Tubingen	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269; Volker, Uwe/0000-0002-5689-3448	Deutsche Forschungsgemeinschaft [SFB TRR 34, DFG HA 3125/2-1, ZA 149/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB TRR 34, Project C10 (to S. H.), DFG HA 3125/2-1, and ZA 149/6-1.	ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; BERGER H, 1982, J BACTERIOL, V152, P1241; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bertling A, 2012, ARTERIOSCL THROM VAS, V32, P1979, DOI 10.1161/ATVBAHA.112.246249; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hirschhausen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040353; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; JAFFE EA, 1985, BLOOD, V65, P79; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Johannessen M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00056; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mack D, 1999, INFECT IMMUN, V67, P1004, DOI 10.1128/IAI.67.2.1004-1008.1999; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Masiuk H, 2010, J CLIN MICROBIOL, V48, P1527, DOI 10.1128/JCM.02094-09; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7; Niemann S, 2009, THROMB HAEMOSTASIS, V102, P735, DOI 10.1160/TH09-01-0049; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P189; RAUGI GJ, 1987, AM J PATHOL, V129, P364; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Thiele T, 2012, J PROTEOMICS, V76, P297, DOI 10.1016/j.jprot.2012.04.057; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Yanagisawa N, 2001, J MED MICROBIOL, V50, P712, DOI 10.1099/0022-1317-50-8-712; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	67	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4070	4082		10.1074/jbc.M113.521229	http://dx.doi.org/10.1074/jbc.M113.521229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371140	Green Published, hybrid			2022-12-25	WOS:000331403800021
J	Marei, HES; Althani, A; Afifi, N; Abd-Elmaksoud, A; Bernardini, C; Michetti, F; Barba, M; Pescatori, M; Maira, G; Paldino, E; Manni, L; Casalbore, P; Cenciarelli, C				Marei, Hany E. S.; Althani, Asmaa; Afifi, Nahla; Abd-Elmaksoud, Ahmed; Bernardini, Camilla; Michetti, Fabrizio; Barba, Marta; Pescatori, Mario; Maira, Giulio; Paldino, Emanuela; Manni, Luigi; Casalbore, Patrizia; Cenciarelli, Carlo			Over-Expression of hNGF in Adult Human Olfactory Bulb Neural Stem Cells Promotes Cell Growth and Oligodendrocytic Differentiation	PLOS ONE			English	Article							O2A PROGENITOR CELLS; C-FOS TRANSCRIPTION; PDGF ALPHA-RECEPTOR; NEURONAL DIFFERENTIATION; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; GENE-THERAPY; IN-VITRO; BRAIN TRANSPLANTATION	The adult human olfactory bulb neural stem/progenitor cells (OBNC/PC) are promising candidate for cell-based therapy for traumatic and neurodegenerative insults. Exogenous application of NGF was suggested as a promising therapeutic strategy for traumatic and neurodegenerative diseases, however effective delivery of NGF into the CNS parenchyma is still challenging due mainly to its limited ability to cross the blood-brain barrier, and intolerable side effects if administered into the brain ventricular system. An effective method to ensure delivery of NGF into the parenchyma of CNS is the genetic modification of NSC to overexpress NGF gene. Overexpression of NGF in adult human OBNSC is expected to alter their proliferation and differentiation nature, and thus might enhance their therapeutic potential. In this study, we genetically modified adult human OBNS/PC to overexpress human NGF (hNGF) and green fluorescent protein (GFP) genes to provide insight about the effects of hNGF and GFP genes overexpression in adult human OBNS/PC on their in vitro multipotentiality using DNA microarray, immunophenotyping, and Western blot (WB) protocols. Our analysis revealed that OBNS/PC-GFP and OBNS/PC-GFP-hNGF differentiation is a multifaceted process involving changes in major biological processes as reflected in alteration of the gene expression levels of crucial markers such as cell cycle and survival markers, stemness markers, and differentiation markers. The differentiation of both cell classes was also associated with modulations of key signaling pathways such MAPK signaling pathway, ErbB signaling pathway, and neuroactive ligand-receptor interaction pathway for OBNS/PC-GFP, and axon guidance, calcium channel, voltage-dependent, gamma subunit 7 for OBNS/PC-GFP-hNGF as revealed by GO and KEGG. Differentiated OBNS/PC-GFP-hNGF displayed extensively branched cytoplasmic processes, a significant faster growth rate and up modulated the expression of oligodendroglia precursor cells markers (PDGFR alpha, NG2 and CNPase) respect to OBNS/PC-GFP counterparts. These findings suggest an enhanced proliferation and oligodendrocytic differentiation potential for OBNS/PC-GFP-hNGF as compared to OBNS/PC-GFP.	[Marei, Hany E. S.; Abd-Elmaksoud, Ahmed] Mansoura Univ, Fac Vet Med, Dept Cytol & Histol, Mansoura, Egypt; [Althani, Asmaa] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Doha, Qatar; [Afifi, Nahla] Ain Shams Univ, Dept Anat, Fac Med, Cairo, Egypt; [Bernardini, Camilla; Michetti, Fabrizio; Barba, Marta] Univ Cattolica S Cuore, Inst Anat & Cell Biol, Rome, Italy; [Pescatori, Mario] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Maira, Giulio] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Paldino, Emanuela; Casalbore, Patrizia] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy; [Manni, Luigi; Cenciarelli, Carlo] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy	Egyptian Knowledge Bank (EKB); Mansoura University; Qatar University; Egyptian Knowledge Bank (EKB); Ain Shams University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Erasmus University Rotterdam; Erasmus MC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Marei, HES (corresponding author), Mansoura Univ, Fac Vet Med, Dept Cytol & Histol, Mansoura, Egypt.	hany800@yahoo.com	Manni, Luigi/J-5637-2018; Paldino, Emanuela/AAC-2594-2022; Marei, Hany E/AAC-7076-2019; Barba, Marta/K-5966-2016; CENCIARELLI, CARLO/AAC-1603-2019	Paldino, Emanuela/0000-0002-8483-543X; Marei, Hany E/0000-0002-0069-4212; CENCIARELLI, CARLO/0000-0001-7480-4608; Abd-Elmaksoud, Ahmed/0000-0001-5638-9578; Barba, Marta/0000-0001-6084-7666	Science and Technology Development Fund, Egypt; Associazione per le Terapie Neurochirurgiche Avanzate,Onlus	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF)); Associazione per le Terapie Neurochirurgiche Avanzate,Onlus	The authors thank (Egypt (Science and Technology Development Fund, http://www.stdf.org.eg/), Onlus (Associazione per le Terapie Neurochirurgiche Avanzate) for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H, 2001, J NEUROSCI, V21, P8505, DOI 10.1523/JNEUROSCI.21-21-08505.2001; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bishop KM, 2008, EXP NEUROL, V211, P574, DOI 10.1016/j.expneurol.2008.03.004; Bradbury J, 2005, LANCET NEUROL, V4, P335, DOI 10.1016/S1474-4422(05)70086-7; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Cenciarelli C, 2006, NEUROL RES, V28, P505, DOI 10.1179/016164106X115161; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dechant G, 2002, ADV EXP MED BIOL, V513, P303; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Fan XYS, 2013, STEM CELLS DEV, V22, P359, DOI 10.1089/scd.2012.0131; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Gage F. H., 1996, ANN NEUROL, V40, P128, DOI DOI 10.1002/ANA.410400123; Gascon E, 2005, EUR J NEUROSCI, V21, P69, DOI 10.1111/j.1460-9568.2004.03849.x; Genini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046009; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HEFTI F, 1986, J NEUROSCI, V6, P2155; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YB, 2013, CAN J NEUROL SCI, V40, P403, DOI 10.1017/S0317167100014372; Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ip NY, 1998, ANN NY ACAD SCI, V840, P97, DOI 10.1111/j.1749-6632.1998.tb09553.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kang EC, 2011, NEURON, V72, P559, DOI 10.1016/j.neuron.2011.09.032; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kawasoe T, 2000, CANCER RES, V60, P3354; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; KOLIATSOS VE, 1991, ANN NEUROL, V30, P831, DOI 10.1002/ana.410300613; KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lee HJ, 2009, GENE THER, V16, P1066, DOI 10.1038/gt.2009.51; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; LENG SL, 2009, BRAIN RES, P1170; Lin CW, 2006, J COMP NEUROL, V494, P606, DOI 10.1002/cne.20825; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Lomoio S, 2012, EUR J HISTOCHEM, V56, P170, DOI 10.4081/ejh.2012.e27; Louhivuori V, 2011, NEUROBIOL DIS, V41, P469, DOI 10.1016/j.nbd.2010.10.018; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majumder A, 2012, STEM CELLS, V30, P2387, DOI 10.1002/stem.1201; Manuel MN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-9; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nagahara AH, 2009, EXP NEUROL, V215, P153, DOI 10.1016/j.expneurol.2008.10.004; Nieto-Estevez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053594; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106; Oumesmar BN, 1997, J NEUROSCI, V17, P125, DOI 10.1523/JNEUROSCI.17-01-00125.1997; Pagani L, 2008, NEUROL RES, V30, P244, DOI 10.1179/016164107X230667; Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Redmond L, 1996, J NEUROSCI, V16, P2972; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Sanchez-Sanchez R, 2012, DEV DYNAM, V241, P953, DOI 10.1002/dvdy.23779; Schecterson LC, 2012, J NEUROSCI, V32, P14000, DOI 10.1523/JNEUROSCI.2274-12.2012; SCHUMACHER JM, 1991, NEUROSCIENCE, V45, P561, DOI 10.1016/0306-4522(91)90271-O; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SIMON R, BRB ARRAY TOOLS USER, P1012; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; Tago K, 2000, GENE DEV, V14, P1741; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tuszynski MH, 1996, GENE THER, V3, P305; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; VIGNAIS L, 1995, NEUROREPORT, V6, P1993, DOI 10.1097/00001756-199510010-00010; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	101	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82206	10.1371/journal.pone.0082206	http://dx.doi.org/10.1371/journal.pone.0082206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367504	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900007
J	Wroblewski, D; Jiang, CC; Croft, A; Farrelly, ML; Zhang, XD; Hersey, P				Wroblewski, David; Jiang, Chen Chen; Croft, Amanda; Farrelly, Margaret L.; Zhang, Xu Dong; Hersey, Peter			OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; UP-REGULATION; BCL-2 FAMILY; MCL-1; ACTIVATION; GX15-070; RESISTANCE; INHIBITOR; MECHANISMS	Anti-apoptotic Bcl-2 family proteins, in particular, Mcl-1, are known to play a critical role in resistance of human melanoma cells to induction of apoptosis by endoplasmic reticulum stress and other agents. The present study examined whether the BH3 mimetics, Obatoclax and ABT-737, which inhibit multiple anti-apoptotic Bcl-2 family proteins, would overcome resistance to apoptosis. We report that both agents induced a strong unfolded protein response (UPR) and that RNAi knockdown of UPR signalling proteins ATF6, IRE1 alpha and XBP-1 inhibited Mcl-1 upregulation and increased sensitivity to the agents. These results demonstrate that inhibition of anti-apoptotic Bcl-2 proteins by Obatoclax and ABT-737 appears to elicit a protective feedback response in melanoma cells, by upregulation of Mcl-1 via induction of the UPR. We also report that Obatoclax, but not ABT-737, strongly induces autophagy, which appears to play a role in determining melanoma sensitivity to the agents.	[Wroblewski, David; Jiang, Chen Chen; Croft, Amanda; Farrelly, Margaret L.; Zhang, Xu Dong] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Hersey, Peter] Univ Sydney, Royal N Shore Hosp, Kolling Inst, Sydney, NSW 2006, Australia	University of Newcastle; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Hersey, P (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst, Sydney, NSW 2006, Australia.	Peter.Hersey@sydney.edu.au	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Jiang, Chenchen/C-2902-2014	Zhang, Xu Dong/0000-0001-9457-8003	National Health & Medical Research Council; Hunter Melanoma Foundation	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Melanoma Foundation	This work was supported by grants from the National Health & Medical Research Council (www.nhmrc.gov.au) and the Hunter Melanoma Foundation (http://hmf.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BASIT F, 2013, CELL DEATH DIFFER, V7, P45; Bosman MCJ, 2013, EXP HEMATOL, V41, P530, DOI 10.1016/j.exphem.2013.02.002; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2009, NEOPLASIA, V11, P945, DOI 10.1593/neo.09692; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-122; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Schwartz-Roberts JL, 2013, MOL CANCER THER, V12, P448, DOI 10.1158/1535-7163.MCT-12-0617; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tang Y, 2012, MOL PHARMACOL, V81, P527, DOI 10.1124/mol.111.076851; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; Urtishak KA, 2013, BLOOD, V121, P2689, DOI 10.1182/blood-2012-04-425033; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wolter KG, 2007, CELL DEATH DIFFER, V14, P1605, DOI 10.1038/sj.cdd.4402163; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 1999, CANCER RES, V59, P2747; Zhu BK, 2008, ANTI-CANCER DRUG, V19, P189, DOI 10.1097/CAD.0b013e3282f3138a; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	42	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84073	10.1371/journal.pone.0084073	http://dx.doi.org/10.1371/journal.pone.0084073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367627	Green Submitted, gold, Green Published			2022-12-25	WOS:000328741900028
J	Cristescu, B; Stenhouse, GB; Boyce, MS				Cristescu, Bogdan; Stenhouse, Gordon B.; Boyce, Mark S.			Perception of Human-Derived Risk Influences Choice at Top of the Food Chain	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; BEAR HABITAT SELECTION; GRIZZLY BEARS; LOGISTIC-REGRESSION; WILDLIFE RESPONSES; LARGE CARNIVORES; BED-SITES; CONSERVATION; PREDATION; ROADS	On human-used landscapes, animal behavior is a trade-off between maximizing fitness and minimizing human-derived risk. Understanding risk perception in wildlife can allow mitigation of anthropogenic risk, with benefits to long-term animal fitness. Areas where animals choose to rest should minimize risk from predators, which for large carnivores typically equate to humans. We hypothesize that high human activity leads to selection for habitat security, whereas low activity enables trading security for forage. We investigated selection of resting (bedding) sites by GPS radiocollared adult grizzly bears (n = 10) in a low density population on a multiple-use landscape in Canada. We compared security and foods at resting and random locations while accounting for land use, season, and time of day. On reclaimed mines with low human access, bears selected high horizontal cover far from trails, but did not avoid open (herbaceous) areas, resting primarily at night. In protected areas bears also bedded at night, in areas with berry shrubs and Hedysarum spp., with horizontal cover selected in the summer, during high human access. On public lands with substantial human recreation, bears bedded at day, selected resting sites with high horizontal cover in the summer and habitat edges, with bedding associated with herbaceous foods. These spatial and temporal patterns of selection suggest that bears perceive human-related risk differentially in relation to human activity level, season and time of day, and employ a security-food trade-off strategy. Although grizzly bears are presently not hunted in Alberta, their perceived risks associated with humans influence resting-site selection.	[Cristescu, Bogdan; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Grizzly Bear Program, Hinton, AB, Canada	University of Alberta	Cristescu, B (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cristesc@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X; Cristescu, Bogdan/0000-0003-2964-5040	Alberta Conservation Association	Alberta Conservation Association	This study was supported financially by: 1. Alberta Conservation Association (Grant Eligible Conservation Fund): http://www. ab- conservation. com/go/ default/index. cfm/grants/grant- eligible- conservation- fund/overview/; 2. Alberta's Conservation Collaboration (Minister's Special License Program): http:// www. huntingfortomorrow. com; 3. Alberta Ingenuity Fund (Ph. D. Scholarship to primary author): http://www. albertatechfutures. ca/GSS. aspx; 4. Alberta Society of Professional Biologists (Graduate Student Scholarship to primary author): http://www. aspb. ab. ca/awards; 5. Alberta Sport, Recreation, Parks & Wildlife Foundation (Development Initiatives Program): http://www. asrpwf. ca/grant- funding- programs/development- initiatives- program. aspx; 6. American Society of Mammalogists (Grant- in- Aid of Research to primary author): http://www. mammalsociety. org/committees/grants- aid/; 7. Canadian Wildlife Federation: http://cwffcf. org/en/explore- our- work/funding- awards/; 8. Wild Sheep Foundation Alberta: http://www. wsfab. org/projects. html; 9. International Association for Bear Research and Management (Research & Conservation Grant): http://www. bearbiology. com/index. php? id = 30; 10. Mountain Equipment Co- op: http:// www. mec. ca/AST/ContentPrimary/Sustainability/CommunityContributions/ApplyForSupport. jsp 11. Safari Club International - Northern Alberta Chapter: http:// sci- northern. ab. ca/giving- back/; 12. TD Friends of the Environment Foundation: http://fef. td. com/funding/; 13. Teck Resources Limited: http://www. teck. com/ Generic. aspx? PAGE = 2008+ Sustainability+ Report+ Pages/2008+ Report& portalName = tc; 14. University of Alberta (FS Chia Ph. D. Scholarship to the primary author). All sources of funding are acknowledged and no financial benefit can result from publication. One of the funding sources for this research was a commercial source (Teck Resources Limited). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; BEERS TW, 1966, J FOREST, V64, P691; Benn B, 2002, URSUS, V13, P213; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham KP, 1998, MODEL SELECTION INFE, P514; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Ciarniello LM, 2007, J WILDLIFE MANAGE, V71, P1446, DOI 10.2193/2006-229; Comiskey EJ, 2002, ECOL SOC, V6; Conover M. R., 2007, PREDATOR PREY DYNAMI; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Cranston J., 2005, 2004 POPULATION INVE; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frid A, 2002, CONSERV ECOL, V6; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOPE KL, 1985, WILDLIFE SOC B, V13, P32; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Kortello AD, 2007, ECOSCIENCE, V14, P214, DOI 10.2980/1195-6860(2007)14[214:IBCPCA]2.0.CO;2; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Linnell JDC, 1999, WILDLIFE BIOL, V5, P225, DOI 10.2981/wlb.1999.027; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; MERRILL EH, 1991, APPL ANIM BEHAV SCI, V29, P251, DOI 10.1016/0168-1591(91)90252-S; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Mollohan CM., 1987, INT C BEAR RES MANAG, V1, P145, DOI DOI 10.2307/3872620; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; MYSTERUD A, 1995, CAN J ZOOL, V73, P924, DOI 10.1139/z95-108; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud I, 1983, INT C BEAR RES MANAG, V5, P208, DOI DOI 10.2307/3872540; Nielsen Scott E., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P149; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2003, ECOSCIENCE, V10, P1; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; PECKARSKY BL, 1988, OIKOS, V53, P185, DOI 10.2307/3566061; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Purcell KL, 2009, FOREST ECOL MANAG, V258, P2696, DOI 10.1016/j.foreco.2009.09.041; Roever CL, 2008, FOREST ECOL MANAG, V256, P1262, DOI 10.1016/j.foreco.2008.06.006; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; STIRLING I, 1990, INT C BEAR, V8, P189; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005; Zielinski WJ, 2004, J WILDLIFE MANAGE, V68, P475, DOI 10.2193/0022-541X(2004)068[0475:RHSBFI]2.0.CO;2	75	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82738	10.1371/journal.pone.0082738	http://dx.doi.org/10.1371/journal.pone.0082738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367549	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300062
J	Mattern, T; Ellenberg, U; Houston, DM; Lamare, M; Davis, LS; van Heezik, Y; Seddon, PJ				Mattern, Thomas; Ellenberg, Ursula; Houston, David M.; Lamare, Miles; Davis, Lloyd S.; van Heezik, Yolanda; Seddon, Philip J.			Straight Line Foraging in Yellow-Eyed Penguins: New Insights into Cascading Fisheries Effects and Orientation Capabilities of Marine Predators	PLOS ONE			English	Article							FOVEAUX STRAIT; GPS-TRACKING; PARAPERCIS-COLIAS; BLUE COD; NAVIGATION; DIET; RESOLUTION; BEHAVIOR; ANIMALS; SUCCESS	Free-ranging marine predators rarely search for prey along straight lines because dynamic ocean processes usually require complex search strategies. If linear movement patterns occur they are usually associated with travelling events or migratory behaviour. However, recent fine scale tracking of flying seabirds has revealed straight-line movements while birds followed fishing vessels. Unlike flying seabirds, penguins are not known to target and follow fishing vessels. Yet yellow-eyed penguins from New Zealand often exhibit directed movement patterns while searching for prey at the seafloor, a behaviour that seems to contradict common movement ecology theories. While deploying GPS dive loggers on yellow-eyed penguins from the Otago Peninsula we found that the birds frequently followed straight lines for several kilometres with little horizontal deviation. In several cases individuals swam up and down the same line, while some of the lines were followed by more than one individual. Using a remote operated vehicle (ROV) we found a highly visible furrow on the seafloor most likely caused by an otter board of a demersal fish trawl, which ran in a straight line exactly matching the trajectory of a recent line identified from penguin tracks. We noted high abundances of benthic scavengers associated with fisheries-related bottom disturbance. While our data demonstrate the acute way-finding capabilities of benthic foraging yellow-eyed penguins, they also highlight how hidden cascading effects of coastal fisheries may alter behaviour and potentially even population dynamics of marine predators, an often overlooked fact in the examination of fisheries' impacts.	[Mattern, Thomas; Ellenberg, Ursula; Davis, Lloyd S.; van Heezik, Yolanda; Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Houston, David M.] Dept Conservat Sci & Capabil, Auckland, New Zealand; [Lamare, Miles] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	University of Otago; University of Otago	Mattern, T (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	t.mattern@eudyptes.net	Ellenberg, Ursula/B-4519-2015; Seddon, Philip/G-8659-2011; Mattern, Thomas/AAJ-6325-2020; van Heezik, Yolanda/I-2744-2019; Ellenberg, Ursula/AAF-7317-2020	Ellenberg, Ursula/0000-0002-3100-6742; Seddon, Philip/0000-0001-9076-9566; Mattern, Thomas/0000-0003-0745-8180; van Heezik, Yolanda/0000-0003-0494-5311; Ellenberg, Ursula/0000-0002-3100-6742; Lamare, Miles/0000-0001-8656-7240	Leiden Conservation Foundation; Otago University	Leiden Conservation Foundation; Otago University	The Leiden Conservation Foundation provided financial support for the Polaris II cruise. All other expenses were covered by Otago University research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GOOGL EARTH VERS 7 1; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Browne T, 2011, AUSTRAL ECOL, V36, P99, DOI 10.1111/j.1442-9993.2010.02125.x; Carbines G, 2004, AQUAT CONSERV, V14, P491, DOI 10.1002/aqc.608; Cheung A, 2008, BIOL CYBERN, V99, P197, DOI 10.1007/s00422-008-0251-z; Clement & associates Ltd, 2008, NZ INSH TRAWL GEAR O; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Ellenberg U, 2012, YELLOW EYED PENGUIN; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Engel J, 1998, CONSERV BIOL, V12, P1204, DOI 10.1046/j.1523-1739.1998.0120061204.x; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Houston D. M., 2005, New Zealand Journal of Zoology, V32, P267; Humborstad OB, 2004, ICES J MAR SCI, V61, P53, DOI 10.1016/j.icesjms.2003.10.001; IUCN, 2013, IUCN RED LIST THREAT; Jiang WM, 2002, AQUAT CONSERV, V12, P257, DOI 10.1002/aqc.495; Jillett J, 2003, NATURAL HIST SO NZ U, P318; KAISER MJ, 1994, MAR ECOL PROG SER, V112, P41, DOI 10.3354/meps112041; King SD, 2012, MAR ECOL PROG SER, V467, P233, DOI 10.3354/meps09969; LEE JE, 1985, J WILDLIFE MANAGE, V49, P658, DOI 10.2307/3801690; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lokkebord S, 2005, FAO FISHERIES TECHNI; Luschi Paolo, 2013, ISRN Zoology, P1; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; Ministry for Primary Industries, 2013, NAT AQ BIOD INF SYST; Miskelly Colin M., 2008, Notornis, V55, P117; Moore P. J., 1997, Marine Ornithology, V25, P17; Moore P. J., 1999, Marine Ornithology, V27, P49; Moore PJ, 1994, WHAT IS BAD SEASON Y; Moore PJ, 1995, SCI RES SERIES; Mutch P.G., 1983, THESIS U AUCKLAND; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Papi F, 2006, MAR FRESHW BEHAV PHY, V39, P3, DOI 10.1080/10236240600563057; R Core Team, 2021, R LANG ENV STAT COMP; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Schwinghamer P, 1998, CONSERV BIOL, V12, P1251; Seddon PJ, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P91; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Tew-Kai E, 2013, J APPL ECOL, V50, P659, DOI 10.1111/1365-2664.12086; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; VANHEEZIK Y, 1990, NEW ZEAL J ZOOL, V17, P201, DOI 10.1080/03014223.1990.10422597; VANHEEZIK Y, 1990, IBIS, V132, P354; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wilson RP, 2013, ECOL LETT, V16, P1145, DOI 10.1111/ele.12149; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	51	23	23	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84381	10.1371/journal.pone.0084381	http://dx.doi.org/10.1371/journal.pone.0084381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367656	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300139
J	Qu, JX; Yu, XM; Liu, YM; Yin, YD; Gu, L; Cao, B; Wang, C				Qu, Jiuxin; Yu, Xiaomin; Liu, Yingmei; Yin, Yudong; Gu, Li; Cao, Bin; Wang, Chen			Specific Multilocus Variable-Number Tandem-Repeat Analysis Genotypes of Mycoplasma pneumoniae Are Associated with Diseases Severity and Macrolide Susceptibility	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CLINICAL STRAINS; RESISTANCE; INFECTION; CULTURE; FRANCE; ADULTS; CHINA; GENE	Clinical relevance of multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) in patients with community-acquired pneumonia (CAP) by Mycoplasma pneumoniae (M. pneumoniae) is unknown. A multi-center, prospective study was conducted from November 2010 to April 2012. Nine hundred and fifty-four CAP patients were consecutively enrolled. M. pneumoniae clinical isolates were obtained from throat swabs. MLVA typing was applied to all isolates. Comparison of pneumonia severity index (PSI) and clinical features among patients infected with different MLVA types of M. pneumoniae were conducted. One hundred and thirty-six patients were positive with M. pneumoniae culture. The clinical isolates were clustered into 18 MLVA types. One hundred and fourteen (88.3%) isolates were resistant to macrolide, covering major MLVA types. The macrolide non-resistant rate of M. pneumoniae isolates with Mpn13-14-15-16 profile of 3-5-6-2 was significantly higher than that of other types (p <= 0.001). Patients infected with types U (5-4-5-7-2) and J (3-4-5-7-2) had significantly higher PSI scores (p<0.001) and longer total duration of cough (p = 0.011). Therefore it seems that there is a correlation between certain MLVA types and clinical severity of disease and the presence of macrolide resistance.	[Qu, Jiuxin; Yu, Xiaomin; Liu, Yingmei; Yin, Yudong; Gu, Li; Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chaoyang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Wang, Chen] Beijing Hosp, China Minist Hlth, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Inst Resp Med, Beijing, Peoples R China	Capital Medical University; Beijing Hospital	Cao, B (corresponding author), Capital Med Univ, Beijing Inst Resp Med, Beijing Chaoyang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China.	caobin1999@gmail.com	Yin, Yudong/AAU-6546-2021	Yin, Yudong/0000-0001-6321-8208	New Century Excellent Talents in University [NCET-10-0006]; Chinese Respiratory Tract Infection Optimal Treatment Committee [CROTC-2009040]; Beijing Science and Technology Project [D101100049810002]; Beijing Municipal Health Bureau [2011-1004-02]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Respiratory Tract Infection Optimal Treatment Committee; Beijing Science and Technology Project; Beijing Municipal Health Bureau	This work was supported by a program for New Century Excellent Talents in University (NCET-10-0006), a grant from Chinese Respiratory Tract Infection Optimal Treatment Committee (CROTC-2009040), a grant from the Beijing Science and Technology Project (D101100049810002) and a grant from Beijing Municipal Health Bureau (2011-1004-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuch D, 2011, EMERG INFECT DIS, V17, P1079, DOI [10.3201/eid1706.101558, 10.3201/eid/1706.101558]; Bebear C, 2011, FUTURE MICROBIOL, V6, P423, DOI [10.2217/fmb.11.18, 10.2217/FMB.11.18]; Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Chalker V, 2011, EURO SURVEILL, V16; Chalker VJ, 2012, EURO SURVEILL, V17; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Eibach D, 2012, EURO SURVEILL, V17; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Liu Y, 2012, J CLIN MICROBIOL, V50, P2793, DOI 10.1128/JCM.00678-12; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; Pereyre S, 2007, J CLIN MICROBIOL, V45, P3534, DOI 10.1128/JCM.01345-07; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Pereyre S, 2012, EMERG INFECT DIS, V18, P343, DOI 10.3201/eid1802.111379; Qu JX, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-172; Sun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064607; von Baum H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-62; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2001, CUMITECH 34 LAB DIAG, P1; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12	24	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82174	10.1371/journal.pone.0082174	http://dx.doi.org/10.1371/journal.pone.0082174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367502	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300020
J	Wang, QZ; Ma, AG; Han, XX; Zhao, SL; Cai, J; Ma, YB; Zhao, J; Wang, YW; Dong, HF; Zhao, ZL; Wei, L; Yu, T; Chen, PX; Schouten, EG; Kok, FJ; Kapur, A				Wang, Qiuzhen; Ma, Aiguo; Han, Xiuxia; Zhao, Shanliang; Cai, Jing; Ma, Yunbo; Zhao, Jie; Wang, Yuwen; Dong, Huaifeng; Zhao, Zhenlei; Wei, Lai; Yu, Tao; Chen, Peixue; Schouten, Evert G.; Kok, Frans J.; Kapur, Anil			Prevalence of Type 2 Diabetes among Newly Detected Pulmonary Tuberculosis Patients in China: A Community Based Cohort Study	PLOS ONE			English	Article							DOUBLE BURDEN; MELLITUS; RISK	Background: Patients with type 2 diabetes (DM) have a higher risk of developing pulmonary tuberculosis (PTB); moreover, DM co-morbidity in PTB is associated with poor PTB treatment outcomes. Community based prevalence data on DM and prediabetes (pre-DM) among TB patients is lacking, particularly from the developing world. Therefore we conducted a prospective study to investigate the prevalence of DM and pre-DM and evaluated the risk factors for the presence of DM among newly detected PTB patients in rural areas of China. Methods and Findings: In a prospective community based study carried out from 2010 to 2012, a representative sample of 6382 newly detected PTB patients from 7 TB clinics in Linyi were tested for DM. A population of 6674 non-TB controls from the same community was similarly tested as well. The prevalence of DM in TB patients (6.3%) was higher than that in non-TB controls (4.7%, p < 0.05). PTB patients had a higher odds of DM than non-TB controls (adjusted OR 3.17, 95% CI 1.14-8.84). The prevalence of DM increased with age and was significantly higher in TB patients in the age categories above 30 years (p < 0.05). Among TB patients, those with normal weight (BMI 18.5-23.9) had the lowest prevalence of DM (5.8%). Increasing age, family history of DM, positive sputum smear, cavity on chest X-ray and higher yearly income (>= 10000 RMB yuan) were positively associated and frequent outdoor activity was negatively associated with DM in PTB patients. Conclusions: The prevalence of DM in PTB patients was higher than in non-TB controls with a 3 fold higher adjusted odds ratio of having DM. Given the increasing DM prevalence and still high burden of TB in China, this association may represent a new public health challenge concerning the prevention and treatment of both diseases.	[Wang, Qiuzhen; Ma, Aiguo; Han, Xiuxia; Cai, Jing] Qingdao Univ, Inst Nutr, Qingdao 266071, Peoples R China; [Zhao, Shanliang; Ma, Yunbo] Linyi Chest Hosp, Linyi, Peoples R China; [Zhao, Jie] Yishui TB Clin, Linyi, Peoples R China; [Wang, Yuwen] Tancheng TB Clin, Linyi, Peoples R China; [Dong, Huaifeng] Yinan TB Clin, Linyi, Peoples R China; [Zhao, Zhenlei] Lanshan TB Clin, Linyi, Peoples R China; [Wei, Lai] Feixian TB Clin, Linyi, Peoples R China; [Yu, Tao] Pingyi TB Clin, Linyi, Peoples R China; [Chen, Peixue] Cangshan TB Clin, Linyi, Peoples R China; [Schouten, Evert G.; Kok, Frans J.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Kapur, Anil] World Diabet Fdn, Gentofte, Denmark	Qingdao University; Wageningen University & Research	Ma, AG (corresponding author), Qingdao Univ, Inst Nutr, Qingdao 266071, Peoples R China.	aiguoma123@gmail.com			World Diabetes Foundation [WDF08-380]; Natural Science Foundation of China, NSFC [81172662]; Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP [20123706110004]	World Diabetes Foundation; Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the World Diabetes Foundation, WDF08-380, http://www.worlddiabetesfoundation.org/; Natural Science Foundation of China, NSFC No. 81172662 and Specialized Research Fund for the Doctoral Program of Higher Education of China, SRFDP No. 20123706110004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Cheng MH, 2010, LANCET, V375, P2207, DOI 10.1016/S0140-6736(10)61014-8; Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kapur A, 2013, DIABETES RES CLIN PR, V101, P10, DOI 10.1016/j.diabres.2012.12.001; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Lin Songbai, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P504; Ministry of Health and Chinese Centre on TB Control and Prevention (CDC), 2008, NAT TUB CONTR PROGR; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Root HF, 1934, NEW ENGL J MED, V210, P1, DOI 10.1056/NEJM193401042100101; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang QZ, 2012, DIABETES RES CLIN PR, V96, P385, DOI 10.1016/j.diabres.2011.11.012; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Q, 2009, JPN J INFECT DIS, V62, P390; Zhou B., 2002, ZHONGHUA LIU XING BI, V23, P5	28	49	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82660	10.1371/journal.pone.0082660	http://dx.doi.org/10.1371/journal.pone.0082660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367535	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300051
J	Abdullah, NR; Barber, BE; William, T; Norahmad, NA; Satsu, UR; Muniandy, PK; Ismail, Z; Grigg, MJ; Jelip, J; Piera, K; von Seidlein, L; Yeo, TW; Anstey, NM; Price, RN; Auburn, S				Abdullah, Noor Rain; Barber, Bridget E.; William, Timothy; Norahmad, Nor Azrina; Satsu, Umi Rubiah; Muniandy, Prem Kumar; Ismail, Zakiah; Grigg, Matthew J.; Jelip, Jenarun; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah			Plasmodium vivax Population Structure and Transmission Dynamics in Sabah Malaysia	PLOS ONE			English	Article							SEVERE DISEASE; MALARIA; FALCIPARUM; MARKERS; DIVERSITY; KNOWLESI	Despite significant progress in the control of malaria in Malaysia, the complex transmission dynamics of P. vivax continue to challenge national efforts to achieve elimination. To assess the impact of ongoing interventions on P. vivax transmission dynamics in Sabah, we genotyped 9 short tandem repeat markers in a total of 97 isolates (8 recurrences) from across Sabah, with a focus on two districts, Kota Marudu (KM, n = 24) and Kota Kinabalu (KK, n = 21), over a 2 year period. STRUCTURE analysis on the Sabah-wide dataset demonstrated multiple sub-populations. Significant differentiation (F-ST = 0.243) was observed between KM and KK, located just 130 Km apart. Consistent with low endemic transmission, infection complexity was modest in both KM (mean MOI = 1.38) and KK (mean MOI = 1.19). However, population diversity remained moderate (H-E = 0.583 in KM and H-E = 0.667 in KK). Temporal trends revealed clonal expansions reflecting epidemic transmission dynamics. The haplotypes of these isolates declined in frequency over time, but persisted at low frequency throughout the study duration. A diverse array of low frequency isolates were detected in both KM and KK, some likely reflecting remnants of previous expansions. In accordance with clonal expansions, high levels of Linkage Disequilibrium (I-A(S) >.0.5 [P<0.0001] in KK and KM) declined sharply when identical haplotypes were represented once (I-A(S) = 0.07 [P = 0.0076] in KM, and I-A(S) = 0.003 [P = 0.606] in KK). All 8 recurrences, likely to be relapses, were homologous to the prior infection. These recurrences may promote the persistence of parasite lineages, sustaining local diversity. In summary, Sabah's shrinking P. vivax population appears to have rendered this low endemic setting vulnerable to epidemic expansions. Migration may play an important role in the introduction of new parasite strains leading to epidemic expansions, with important implications for malaria elimination.	[Abdullah, Noor Rain; Norahmad, Nor Azrina; Satsu, Umi Rubiah; Muniandy, Prem Kumar; Ismail, Zakiah] Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur, Malaysia; [Barber, Bridget E.; William, Timothy; Grigg, Matthew J.] Queen Elizabeth Hosp, Infect Dis Unit, Kota Kinabalu, Sabah, Malaysia; [Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Barber, Bridget E.; Grigg, Matthew J.; Piera, Kim; von Seidlein, Lorenz; Yeo, Tsin W.; Anstey, Nicholas M.; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT 0909, Australia; [William, Timothy; Jelip, Jenarun] Sabah Dept Hlth, Kota Kinabalu, Sabah, Malaysia; [Anstey, Nicholas M.; Price, Ric N.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Kementerian Kesihatan Malaysia; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Oxford	Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	sarah.auburn@menzies.edu.au	Barber, Bridget/AAV-2681-2020; Yeo, Tsin Wen/F-9505-2015; Grigg, Matthew/AAB-2629-2021; Barber, Bridget/W-2965-2019; Auburn, Sarah/N-2266-2013	Barber, Bridget/0000-0003-1066-7960; Price, Richard/0000-0003-2000-2874; Auburn, Sarah/0000-0002-4638-536X; Grigg, Matthew Joseph/0000-0001-9914-8352	Asia Pacific Malaria Elimination Network; National Institute of Health, Ministry of Health Malaysia; Australian National Health and Medical Research Council; Wellcome Trust; APMEN; National Health and Medical Research Council, Australia	Asia Pacific Malaria Elimination Network; National Institute of Health, Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); APMEN; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Asia Pacific Malaria Elimination Network (APMEN research grant awarded to NRA), National Institute of Health, Ministry of Health Malaysia, Australian National Health and Medical Research Council and the Wellcome Trust. SA, LVS and RNP were funded by APMEN. BW, AP, KP, BEB, TWY, and NMA were funded by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Auburn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053160; Barber BE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-8; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Chan ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001811; Department of Statistics, 2011, POP DISTR BAS DEM CH; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Joveen-Neoh Wan Fen, 2011, J Parasitol Res, V2011, P104284, DOI 10.1155/2011/104284; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mueller I, 2013, ADV PARASIT, V81, P77, DOI 10.1016/B978-0-12-407826-0.00003-5; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rundi C, 2011, 3 ANN APMEN TECHN BU; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TRAVIS J, 1990, PHILOS T R SOC B, V330, P253, DOI 10.1098/rstb.1990.0196; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, WORLD MALARIA REPORT 2010, P1; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026	39	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82553	10.1371/journal.pone.0082553	http://dx.doi.org/10.1371/journal.pone.0082553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358203	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700021
J	Bennett, AE; Daniell, TJ; Opik, M; Davison, J; Moora, M; Zobel, M; Selosse, MA; Evans, D				Bennett, Alison Elizabeth; Daniell, Tim John; Oepik, Maarja; Davison, John; Moora, Mari; Zobel, Martin; Selosse, Marc-Andre; Evans, Darren			Arbuscular Mycorrhizal Fungal Networks Vary throughout the Growing Season and between Successional Stages	PLOS ONE			English	Article							BOREONEMORAL FOREST; PLANT; DYNAMICS; DIVERSITY; CHRONOSEQUENCE; DETERMINANTS; ARCHITECTURE; COMMUNITIES; RICHNESS; GLACIER	To date, few analyses of mutualistic networks have investigated successional or seasonal dynamics. Combining interaction data from multiple time points likely creates an inaccurate picture of the structure of networks (because these networks are aggregated across time), which may negatively influence their application in ecosystem assessments and conservation. Using a replicated bipartite mutualistic network of arbuscular mycorrhizal (AM) fungal-plant associations, detected using large sample numbers of plants and AM fungi identified through molecular techniques, we test whether the properties of the network are temporally dynamic either between different successional stages or within the growing season. These questions have never been directly tested in the AM fungal-plant mutualism or the vast majority of other mutualisms. We demonstrate the following results: First, our examination of two different successional stages (young and old forest) demonstrated that succession increases the proportion of specialists within the community and decreases the number of interactions. Second, AM fungal-plant mutualism structure changed throughout the growing season as the number of links between partners increased. Third, we observed shifts in associations between AM fungal and plant species throughout the growing season, potentially reflecting changes in biotic and abiotic conditions. Thus, this analysis opens up two entirely new areas of research: 1) identifying what influences changes in plant-AM fungal associations in these networks, and 2) what aspects of temporal variation and succession are of general importance in structuring bipartite networks and plant-AM fungal communities.	[Bennett, Alison Elizabeth; Daniell, Tim John] James Hutton Inst, Dundee, Scotland; [Oepik, Maarja; Davison, John; Moora, Mari; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Selosse, Marc-Andre] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Evans, Darren] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England	James Hutton Institute; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Museum National d'Histoire Naturelle (MNHN); University of Hull	Bennett, AE (corresponding author), James Hutton Inst, Dundee, Scotland.	alibenne@bio.indiana.edu	Öpik, Maarja/A-1765-2008; Zobel, Martin/H-1336-2015; Evans, Darren Mark/J-9782-2012; Moora, Mari/D-1961-2009; Daniell, Tim J/E-8482-2011	Öpik, Maarja/0000-0001-8025-7460; Zobel, Martin/0000-0001-7957-6704; Moora, Mari/0000-0002-4819-7506; Daniell, Tim J/0000-0003-0435-4343; Evans, Darren/0000-0003-4061-6726	Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three; Estonian Science Foundation [SF0180098s08]; Centre National de la Recherche Scientifique; European Regional Development Fund (Center of Excellence FIBIR)	Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three; Estonian Science Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Regional Development Fund (Center of Excellence FIBIR)(European Commission)	This research was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RESAS) Workpackage Themes one and three, by grants from Estonian Science Foundation (9050, 9157), targeted financing SF0180098s08), Centre National de la Recherche Scientifique and the European Regional Development Fund (Center of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2009, ANN BOT FENN, V46, P326, DOI 10.5735/085.046.0408; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Borowicz VA, 2001, ECOLOGY, V82, P3057; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chaudhary VB., 2008, MYCORRHIZA STATE ART, P529, DOI DOI 10.1007/978-3-540-78826-3_26; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Covacevich F, 2011, AFR J MICROBIOL RES, V5, P2697; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Lekberg Y, 2010, FEMS MICROBIOL ECOL, V74, P336, DOI 10.1111/j.1574-6941.2010.00956.x; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Medan D, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P245; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Moora M, 2009, OECOLOGIA, V159, P355, DOI 10.1007/s00442-008-1209-5; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2011, PEDOBIOLOGIA, V54, P321, DOI 10.1016/j.pedobi.2011.07.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2017, R PACKAGE VERSION 26; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Raymond B, 2009, ECOL MODEL, V220, P673, DOI 10.1016/j.ecolmodel.2008.12.011; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Sanders IR, 2010, ISME J, V4, P1081, DOI 10.1038/ismej.2010.109; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Uibopuu A, 2009, SOIL BIOL BIOCHEM, V41, P2141, DOI 10.1016/j.soilbio.2009.07.026; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1	59	47	50	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83241	10.1371/journal.pone.0083241	http://dx.doi.org/10.1371/journal.pone.0083241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358265	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700052
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Phenylthiophenecarboxamide Antagonists of the Olfactory Receptor Co-Receptor Subunit from a Mosquito	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; MOLECULAR-BASIS; BEHAVIOR; SYSTEM	Insects detect environmental chemicals using chemosensory receptors, such as the ORs, a family of odorant-gated ion channels. Insect ORs are multimeric complexes of unknown stoichiometry, formed by a common subunit (the odorant receptor co-receptor subunit, Orco) and one of many variable subunits that confer odorant specificity. The recent discovery of Orco directed ligands, including both agonists and antagonists, suggests Orco as a promising target for chemical control of insects. In addition to competitively inhibiting OR activation by Orco agonists, several Orco antagonists have been shown to act through a non-competitive mechanism to inhibit OR activation by odorants. We previously identified a series of Orco antagonists, including N-(4-ethylphenyl)-2-thiophenecarboxamide (OX1a, previously referred to as OLC20). Here, we explore the chemical space around the OX1a structure to identify more potent Orco antagonists. Cqui\Orco+Cqui\Or21, an OR from Culex quinquefasciatus (the Southern House Mosquito) that responds to 3-methylindole (skatole) and is thought to mediate oviposition behavior, was expressed in Xenopus oocytes and receptor function assayed by two-electrode voltage clamp electrophysiology. 22 structural analogs of OX1a were screened for antagonism of OR activation by an Orco agonist. By varying the moieties decorating the phenyl and thiophene rings, and altering the distance between the rings, we were able to identify antagonists with improved potency. Detailed examination of three of these compounds (N-mesityl-2-thiophenecarboxamide, N-(4-methylbenzyl)-2-thiophenecarboxamide and N-(2-ethylphenyl)-3-(2-thienyl)-2-propenamide)demonstrated competitive inhibition of receptor activation by an Orco agonist and non-competitive inhibition of receptor activation by an odorant. The ability to inhibit OR activation by odorants may be a general property of this class of Orco antagonist, suggesting that odorant mediated behaviors can be manipulated through Orco antagonism. The high conservation of Orco across insect species and previous demonstrations that various Orco ligands are active at ORs derived from several different insect orders suggests that Orco antagonists may have broad applicability.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA	University of Miami	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022		NIH [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by RO1 DC011091 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; Rinker DC, 2012, PHYSIOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-3032.2011.00821.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2009, ANN NY ACAD SCI, V1170, P164, DOI 10.1111/j.1749-6632.2009.04101.x; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu PX, 2013, J INSECT PHYSIOL, V59, P961, DOI 10.1016/j.jinsphys.2013.07.004	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84575	10.1371/journal.pone.0084575	http://dx.doi.org/10.1371/journal.pone.0084575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358366	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700101
J	Morken, TS; Nyman, AKG; Sandvig, I; Torp, SH; Skranes, J; Goa, PE; Brubakk, AM; Wideroe, M				Morken, Tora Sund; Nyman, Axel Karl Gotffrid; Sandvig, Ioanna; Torp, Sverre Helge; Skranes, Jon; Goa, Pal Erik; Brubakk, Ann-Mari; Wideroe, Marius			Brain Development after Neonatal Intermittent Hyperoxia-Hypoxia in the Rat Studied by Longitudinal MRI and Immunohistochemistry	PLOS ONE			English	Article							WHITE-MATTER INJURY; DIFFUSION TENSOR; POSTNATAL-DEVELOPMENT; GERMINAL MATRIX; PRETERM INFANTS; CEREBRAL-CORTEX; RETINOPATHY; PREMATURITY; GROWTH; BLOOD	Background: Neonatal intermittent hyperoxia-hypoxia (IHH) is involved in the pathogenesis of retinopathy of prematurity. Whether similar oxygen fluctuations will create pathological changes in the grey and white matter of the brain is unknown. Methods: From birth until postnatal day 14 (P14), two litters (total n = 22) were reared in IHH: hyperoxia (50% O-2) interrupted by three consecutive two-minute episodes of hypoxia (12% O-2) every sixth hour. Controls (n = 8) were reared in room-air (20.9% O-2). Longitudinal MRI (Diffusion Tensor Imaging and T2-mapping) was performed on P14 and P28 and retinal and brain tissue were examined for histopathological changes. Long-term neurodevelopment was assessed on P20 and P27. Results: Mean, radial and axial diffusivity were higher in white matter of IHH versus controls at P14 (p < 0.04), while fractional anisotropy (FA) was lower in the hippocampal fimbria and tended to be lower in corpus callosum (p = 0.08) and external capsule (p = 0.05). White matter diffusivity in IHH was similar to controls at P28. Higher cortical vessel density (p = 0.005) was observed at P14. Cortical and thalamic T-2-relaxation time and mean diffusivity were higher in the IHH group at P14 (p <= 0.03), and albumin leakage was present at P28. Rats in the IHH group ran for a longer time on a Rotarod than the control group (p <= 0.005). Pups with lower bodyweight had more severe MRI alterations and albumin leakage. Conclusion: IHH led to subtle reversible changes in brain white matter diffusivity, grey matter water content and vascular density. However, alterations in blood-brain barrier permeability may point to long-term effects. The changes seen after IHH exposure were more severe in animals with lower bodyweight and future studies should aim at exploring possible interactions between IHH and growth restriction.	[Morken, Tora Sund; Torp, Sverre Helge; Skranes, Jon; Brubakk, Ann-Mari] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Nyman, Axel Karl Gotffrid; Sandvig, Ioanna; Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skranes, Jon; Brubakk, Ann-Mari] St Olavs Univ Hosp, Cent Norway Reg Hlth Author, Dept Pediat, Trondheim, Norway; [Goa, Pal Erik] St Olavs Univ Hosp, Cent Norway Reg Hlth Author, Dept Radiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Morken, TS (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	tora.s.morken@ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852; Sandvig, Ioanna/0000-0002-2109-1357	Liaison Committee between the Central Norway Region Health Authority; Norwegian University of Science and Technology	Liaison Committee between the Central Norway Region Health Authority; Norwegian University of Science and Technology	This work was supported by a grant from the Liaison Committee between the Central Norway Region Health Authority and the Norwegian University of Science and Technology (to T.S.M.). URL: http://www.ntnu.no/dmf/rad/samorg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Brehmer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049023; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Chahboune H, 2009, CEREB CORTEX, V19, P2891, DOI 10.1093/cercor/bhp068; Chahoud I, 2009, ENVIRON RES, V109, P1021, DOI 10.1016/j.envres.2009.07.015; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Coleman RJ, 2008, PEDIATR RES, V64, P50, DOI 10.1203/PDR.0b013e31817307ac; Cunningham S, 2000, INVEST OPHTH VIS SCI, V41, P4275; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Di Fiore JM, 2012, PEDIATR RES, V72, P606, DOI 10.1038/pr.2012.132; DZIEGIELEWSKA KM, 1991, J PHYSIOL-LONDON, V439, P215, DOI 10.1113/jphysiol.1991.sp018664; El-Khoury N, 2006, PEDIATR RES, V59, P673, DOI 10.1203/01.pdr.0000214975.85311.9c; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Lepomaki V, 2013, PEDIATR RADIOL, V43, P80, DOI 10.1007/s00247-012-2509-9; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Morken TS, 2013, PEDIATR RES, V73, P171, DOI 10.1038/pr.2012.170; Msall ME, 2000, PEDIATRICS, V106, P998, DOI 10.1542/peds.106.5.998; Msall ME, 2006, PEDIATRICS, V117, P2287, DOI 10.1542/peds.2006-0385; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Palmer AK, 1997, FUND APPL TOXICOL, V38, P7, DOI 10.1006/faat.1997.2319; Paxinos G, 2008, RAT BRAIN STEREOTAXI; PENN JS, 1995, INVEST OPHTH VIS SCI, V36, P2063; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Ramani M, 2013, NEUROBIOL DIS, V50, P69, DOI 10.1016/j.nbd.2012.10.005; ROTH AM, 1977, AM J OPHTHALMOL, V84, P636, DOI 10.1016/0002-9394(77)90377-4; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schmitz T, 2012, EXP NEUROL, V235, P374, DOI 10.1016/j.expneurol.2012.03.002; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schwartz ML, 2004, SEMIN PERINATOL, V28, P379, DOI 10.1053/j.semperi.2004.10.009; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sirinyan M, 2006, STROKE, V37, P2807, DOI 10.1161/01.STR.0000245082.19294.ff; Thornton JS, 1999, MAGN RESON IMAGING, V17, P1289, DOI 10.1016/S0730-725X(99)00063-6; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Vottier G, 2011, DEV NEUROSCI-BASEL, V33, P261, DOI 10.1159/000327245; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; WIGGLESWORTH JS, 1978, EARLY HUM DEV, V2, P179, DOI 10.1016/0378-3782(78)90010-5; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025	53	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84109	10.1371/journal.pone.0084109	http://dx.doi.org/10.1371/journal.pone.0084109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358332	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700080
J	Amaral, C; Pimentel, C; Matos, RG; Arraiano, CM; Matzapetakis, M; Rodrigues-Pousada, C				Amaral, Catarina; Pimentel, Catarina; Matos, Rute G.; Arraiano, Cecilia M.; Matzapetakis, Manolis; Rodrigues-Pousada, Claudina			Two Residues in the Basic Region of the Yeast Transcription Factor Yap8 Are Crucial for Its DNA-Binding Specificity	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ACTIVATION; COMPLEX; RECOGNITION; PROTEINS; GENE; GCN4; ACR3	In Saccharomyces cerevisiae, the transcription factor Yap8 is a key determinant in arsenic stress response. Contrary to Yap1, another basic region-leucine zipper (bZIP) yeast regulator, Yap8 has a very restricted DNA-binding specificity and only orchestrates the expression of ACR2 and ACR3 genes. In the DNA-binding basic region, Yap8 has three distinct amino acids residues, Leu26, Ser29 and Asn31, at sites of highly conserved positions in the other Yap family of transcriptional regulators and Pap1 of Schizosaccharomyces pombe. To evaluate whether these residues are relevant to Yap8 specificity, we first built a homology model of the complex Yap8bZIP-DNA based on Pap1-DNA crystal structure. Several Yap8 mutants were then generated in order to confirm the contribution of the residues predicted to interact with DNA. Using bioinformatics analysis together with in vivo and in vitro approaches, we have identified several conserved residues critical for Yap8-DNA binding. Moreover, our data suggest that Leu26 is required for Yap8 binding to DNA and that this residue together with Asn31, hinder Yap1 response element recognition by Yap8, thus narrowing its DNA-binding specificity. Furthermore our results point to a role of these two amino acids in the stability of the Yap8-DNA complex.	[Amaral, Catarina; Pimentel, Catarina; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom & Stress Lab, P-2780156 Oeiras, Portugal; [Matos, Rute G.; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Control Gene Express Lab, P-2780156 Oeiras, Portugal; [Matzapetakis, Manolis] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Biomol NMR Lab, P-2780156 Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa	Rodrigues-Pousada, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom & Stress Lab, P-2780156 Oeiras, Portugal.	claudina@itqb.unl.pt	Pimentel, Catarina/G-2821-2014; Matzapetakis, Manolis/AAH-2609-2019; Matos, Rute/J-4983-2013	Matzapetakis, Manolis/0000-0001-9730-0621; Pimentel, Catarina/0000-0002-5158-6414; Matos Luis, Rute/0000-0002-9788-7562; Amaral, Catarina/0000-0002-9442-2225; Rodrigues-Pousada, Claudina/0000-0002-5075-3639; Arraiano, Cecilia/0000-0003-1934-9301	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011]; European Commission [PTDCBIA-MIC/108747/2008, FP7-KBBE-2011-1-289326]; FCT [SFRH/BPD/74294/2010, SFRH/BPD/35052/2007, SFRH/BPD/75887/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT-http://www.fct.pt) through grant PEst-OE/EQB/LA0004/2011, PTDCBIA-MIC/108747/2008 to CRP and FP7-KBBE-2011-1-289326 from European Commission to CMA. Authors are grateful for financial support of FCT: C. A. SFRH/BPD/74294/2010, C. P. SFRH/BPD/35052/2007 and R. M. SFRH/BPD/75887/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bouganim N, 2001, BIOCHEM CELL BIOL, V79, P441, DOI 10.1139/bcb-79-4-441; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Di YJ, 2007, J CELL SCI, V120, P256, DOI 10.1242/jcs.03346; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Goudot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020924; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; He XJ, 2005, MOL MICROBIOL, V58, P1454, DOI 10.1111/j.1365-2958.2005.04917.x; Ilina Y, 2008, BIOCHEM J, V415, P467, DOI 10.1042/BJ20080713; KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/jmbi.1995.0645; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Menezes RA, 2004, FEBS LETT, V566, P141, DOI 10.1016/j.febslet.2004.04.019; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Nguyen DT, 2001, J BIOL CHEM, V276, P1138, DOI 10.1074/jbc.M008377200; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83328	10.1371/journal.pone.0083328	http://dx.doi.org/10.1371/journal.pone.0083328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358276	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700119
J	Barbonetti, A; Vassallo, MRC; Cinque, B; Filipponi, S; Mastromarino, P; Cifone, MG; Francavilla, S; Francavilla, F				Barbonetti, Arcangelo; Vassallo, Maria Rosaria Caterina; Cinque, Benedetta; Filipponi, Silvia; Mastromarino, Paola; Cifone, Maria Grazia; Francavilla, Sandro; Francavilla, Felice			Soluble Products of Escherichia coli Induce Mitochondrial Dysfunction-Related Sperm Membrane Lipid Peroxidation Which Is Prevented by Lactobacilli	PLOS ONE			English	Article							HUMAN SPERMATOZOA; IN-VITRO; MOTILITY PARAMETERS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; INFERTILITY; MECHANISMS; GENERATION; APOPTOSIS; BACTERIA	Unidentified soluble factors secreted by E. coli, a frequently isolated microorganism in genitourinary infections, have been reported to inhibit mitochondrial membrane potential (Delta psi m), motility and vitality of human spermatozoa. Here we explore the mechanisms involved in the adverse impact of E. coli on sperm motility, focusing mainly on sperm mitochondrial function and possible membrane damage induced by mitochondrial-generated reactive oxygen species (ROS). Furthermore, as lactobacilli, which dominate the vaginal ecosystem of healthy women, have been shown to exert anti-oxidant protective effects on spermatozoa, we also evaluated whether soluble products from these microorganisms could protect spermatozoa against the effects of E. coli. We assessed motility (by computer-aided semen analysis), Delta psi m (with JC-1 dye by flow cytometry), mitochondrial ROS generation (with MitoSOX red dye by flow cytometry) and membrane lipid-peroxidation (with the fluorophore BODIPY C-11 by flow cytometry) of sperm suspensions exposed to E. coli in the presence and in the absence of a combination of 3 selected strains of lactobacilli (L. brevis, L. salivarius, L. plantarum). A Transwell system was used to avoid direct contact between spermatozoa and microorganisms. Soluble products of E. coli induced Delta psi m loss, mitochondrial generation of ROS and membrane lipid-peroxidation, resulting in motility loss. Soluble factors of lactobacilli prevented membrane lipid-peroxidation of E. coli-exposed spermatozoa, thus preserving their motility. In conclusion, sperm motility loss by soluble products of E. coli reflects a mitochondrial dysfunction-related membrane lipid-peroxidation. Lactobacilli could protect spermatozoa in the presence of vaginal disorders, by preventing ROS-induced membrane damage.	[Barbonetti, Arcangelo; Vassallo, Maria Rosaria Caterina; Filipponi, Silvia; Francavilla, Sandro; Francavilla, Felice] Univ Aquila, Dept Life Hlth & Environm Sci, Androl Unit, I-67100 Laquila, Italy; [Cinque, Benedetta; Cifone, Maria Grazia] Univ Aquila, Dept Life Hlth & Environm Sci, Immunopathol Lab, I-67100 Laquila, Italy; [Barbonetti, Arcangelo] San Raffaele Sulmona Inst, Sulmona, Italy; [Mastromarino, Paola] Univ Roma La Sapienza, Inst Microbiol, I-00185 Rome, Italy	University of L'Aquila; University of L'Aquila; Sapienza University Rome	Francavilla, F (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Androl Unit, I-67100 Laquila, Italy.	francavi@cc.univaq.it	Cifone, Maria Grazia/ABH-1984-2021; Cifone, Maria Grazia/I-3750-2019	Cifone, Maria Grazia/0000-0002-9923-5445; FRANCAVILLA, Sandro/0000-0003-0221-8524; FRANCAVILLA, Felice/0000-0003-1255-4062; Cinque, Benedetta/0000-0003-4510-9416; MASTROMARINO, Paola/0000-0002-8529-0216	Ministero dell'Universita e Ricerca, PRIN	Ministero dell'Universita e Ricerca, PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e Ricerca, PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2007, MOL HUM REPROD, V13, P203, DOI 10.1093/molehr/gal119; Aitken RJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102020; AITKEN RJ, 1993, MOL REPROD DEV, V35, P302, DOI 10.1002/mrd.1080350313; Amaral S, 2013, ANDROLOGY-US, V1, P707, DOI 10.1111/j.2047-2927.2013.00098.x; Barbonetti A, 2013, ANDROLOGY-US, V1, P456, DOI 10.1111/j.2047-2927.2013.00077.x; Barbonetti A, 2010, ENDOCRINOLOGY, V151, P5882, DOI 10.1210/en.2010-0484; Barbonetti A, 2011, FERTIL STERIL, V95, P2485, DOI 10.1016/j.fertnstert.2011.03.066; BURTON GW, 1989, J NUTR, V119, P109, DOI 10.1093/jn/119.1.109; Ching JCY, 2002, INFECT IMMUN, V70, P4669, DOI 10.1128/IAI.70.8.4669-4677.2002; del Porto G B, 1975, Urology, V5, P638; DELAMIRANDE E, 1993, FREE RADICAL BIO MED, V14, P157, DOI 10.1016/0891-5849(93)90006-G; Diemer T, 2000, Curr Opin Urol, V10, P39, DOI 10.1097/00042307-200001000-00010; Diemer T, 2000, INT J ANDROL, V23, P178; Diemer T, 2003, ANDROLOGIA, V35, P100, DOI 10.1046/j.1439-0272.2003.00523.x; Diemer T, 1996, INT J ANDROL, V19, P271, DOI 10.1111/j.1365-2605.1996.tb00475.x; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P657, DOI 10.1111/j.1469-0691.2007.01688.x; Fraczek M, 2012, ANDROLOGIA, V44, P315, DOI 10.1111/j.1439-0272.2012.01283.x; Fraczek M, 2007, FERTIL STERIL, V88, P1076, DOI 10.1016/j.fertnstert.2006.12.025; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Garrido-Fernandez J, 2010, INT J FOOD MICROBIOL, V140, P34, DOI 10.1016/j.ijfoodmicro.2010.02.015; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Liu JH, 2002, ASIAN J ANDROL, V4, P179; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Mikelsaar Marika, 2009, Microbial Ecology in Health and Disease, V21, P1, DOI 10.1080/08910600902815561; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MONGA M, 1994, J ANDROL, V15, P151; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Perdichizzi A, 2007, J CLIN IMMUNOL, V27, P152, DOI 10.1007/s10875-007-9071-5; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Spandorfer SD, 2001, J REPROD MED, V46, P806; TEAGUE NS, 1971, FERTIL STERIL, V22, P281; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; WOLFF H, 1993, FERTIL STERIL, V60, P154; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	41	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83136	10.1371/journal.pone.0083136	http://dx.doi.org/10.1371/journal.pone.0083136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358256	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700105
J	Bhat, PG; Kumar, AMV; Naik, B; Satyanarayana, S; Deepak, KG; Nair, SA; Suryakanth, MD; Heldal, E; Enarson, DA; Reid, AJ				Bhat, Prashant G.; Kumar, Ajay M. V.; Naik, Balaji; Satyanarayana, Srinath; Deepak, K. G.; Nair, Sreenivas A.; Suryakanth, M. D.; Heldal, Einar; Enarson, Donald A.; Reid, Anthony J.			Intensified Tuberculosis Case Finding among Malnourished Children in Nutritional Rehabilitation Centres of Karnataka, India: Missed Opportunities	PLOS ONE			English	Article							MALNUTRITION	Background: Severe acute malnutrition (SAM) is the most serious form of malnutrition affecting children under-five and is associated with many infectious diseases including Tuberculosis (TB). In India, nutritional rehabilitation centres (NRCs) have been recently established for the management of SAM including TB. The National TB Programme (NTP) in India has introduced a revised algorithm for diagnosing paediatric TB. We aimed to examine whether NRCs adhered to these guidelines in diagnosing TB among SAM children. Methods: A cross-sectional study involving review of records of all SAM children identified by health workers during 2012 in six tehsils (sub-districts) with NRCs (population: 1.8 million) of Karnataka, India. Results: Of 1927 identified SAM children, 1632 (85%) reached NRCs. Of them, 1173 (72%) were evaluated for TB and 19(2%) were diagnosed as TB. Of 1173, diagnostic algorithm was followed in 460 (37%). Among remaining 763 not evaluated as per algorithm, tuberculin skin test alone was conducted in 307 (41%), chest radiography alone in 99 (13%) and no investigations in 337 (45%). The yield of TB was higher among children evaluated as per algorithm (4%) as compared to those who were not (0.3%) (OR: 15.3 [95% CI: 3.5-66.3]). Several operational challenges including non-availability of a full-time paediatrician, non-functioning X-ray machine due to frequent power cuts, use of tuberculin with suboptimal strength and difficulties in adhering to a complex diagnostic algorithm were observed. Conclusion: This study showed that TB screening in NRCs was sub-optimal in Karnataka. Some children did not reach the NRC, while many of those who did were either not or sub-optimally evaluated for TB. This study pointed to a number of operational issues that need to be addressed if this collaborative strategy is to identify more TB cases amongst malnourished children in India.	[Bhat, Prashant G.; Naik, Balaji; Deepak, K. G.; Nair, Sreenivas A.] WHO, Country Off India, TB Control Unit, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath] Int Union TB & Lung Dis, South East Asia Reg Off, Operat Res Unit, New Delhi, India; [Suryakanth, M. D.] State TB Off, TB Control Unit, Bangalore, Karnataka, India; [Heldal, Einar; Enarson, Donald A.] Int Union TB & Lung Dis, Operat Res Unit, Paris, France; [Reid, Anthony J.] Med Sans Frontieres, Operat Res Unit LUXOR, Brussels, Luxembourg	World Health Organization; Doctors Without Borders	Bhat, PG (corresponding author), WHO, Country Off India, TB Control Unit, New Delhi, India.	bhatp74@gmail.com	Bhat, Prashant G/H-6696-2012	Bhat, Prashant G/0000-0002-2130-210X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797; Satyanarayana, Srinath/0000-0002-5420-2551	Department for International Development, UK	Department for International Development, UK	Funding for the course was from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan L, 2004, ECON HUM BIOL, V2, P139, DOI 10.1016/j.ehb.2003.09.003; Bruno Sunguya, 2006, DMSJ S1, V14; Cervantes-Rios E, 2012, MUTAT RES-FUND MOL M, V731, P68, DOI 10.1016/j.mrfmmm.2011.11.006; CTD, 2013, TB IND 2013; De Maayer T, 2011, ARCH DIS CHILD, V96, P560, DOI 10.1136/adc.2010.205039; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608; Joseph B, 2002, J HEALTH POPUL NUTR, V20, P239; Kanjilal B, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-19; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kumar A, 2013, INDIAN PEDIATR, V50, P301, DOI 10.1007/s13312-013-0085-1; LaCourse S, 2013, IUATLD NAR 17 ANN C; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Macallan Derek, 2009, MEDICINE, V37, P525, DOI DOI 10.1016/J.MPMED.2009.07.005; MoH, 2009, NFHS 3, VI; Patil NK, 2012, HINDU DAILY; UNICEF, 2009, NUTRITION; VIJAYAKUMAR M, 1990, J TROP PEDIATRICS, V36, P294, DOI 10.1093/tropej/36.6.294	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84255	10.1371/journal.pone.0084255	http://dx.doi.org/10.1371/journal.pone.0084255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358350	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700158
J	Chen, WQ; Zhou, HY; Liu, SY; Fhaner, CJ; Gross, BC; Lydic, TA; Reid, GE				Chen, Weiqin; Zhou, Hongyi; Liu, Siyang; Fhaner, Cassie J.; Gross, Bethany C.; Lydic, Todd A.; Reid, Gavin E.			Altered Lipid Metabolism in Residual White Adipose Tissues of Bscl2 Deficient Mice	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; BROWN ADIPOCYTES; IDENTIFICATION; OXIDATION; BIOLOGY; ELOVL3	Mutations in BSCL2 underlie human congenital generalized lipodystrophy type 2 disease. We previously reported that Bscl2(-/-) mice develop lipodystrophy of white adipose tissue (WAT) due to unbridled lipolysis. The residual epididymal WAT (EWAT) displays a browning phenotype with much smaller lipid droplets (LD) and higher expression of brown adipose tissue marker proteins. Here we used targeted lipidomics and gene expression profiling to analyze lipid profiles as well as genes involved in lipid metabolism in WAT of wild-type and Bscl2(-/-) mice. Analysis of total saponified fatty acids revealed that the residual EWAT of Bscl2(-/-) mice contained a much higher proportion of oleic(18:1n9) acid concomitant with a lower proportion of palmitic(16:0) acid, as well as increased n3- polyunsaturated fatty acids (PUFA) remodeling. The acyl chains in major species of triacylglyceride (TG) and diacylglyceride (DG) in the residual EWAT of Bscl2(-/-) mice were also enriched with dietary fatty acids. These changes could be reflected by upregulation of several fatty acid elongases and desaturases. Meanwhile, Bscl2(-/-) adipocytes from EWAT had increased gene expression in lipid uptake and TG synthesis but not de novo lipogenesis. Both mitochondria and peroxisomal beta-oxidation genes were also markedly increased in Bscl2(-/-) adipocytes, highlighting that these machineries were accelerated to shunt the lipolysis liberated fatty acids through uncoupling to dissipate energy. The residual subcutaneous white adipose tissue (ScWAT) was not browning but displays similar changes in lipid metabolism. Overall, our data emphasize that, other than being essential for adipocyte differentiation, Bscl2 is also important in fatty acid remodeling and energy homeostasis.	[Chen, Weiqin; Zhou, Hongyi; Liu, Siyang] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30904 USA; [Fhaner, Cassie J.; Gross, Bethany C.; Lydic, Todd A.; Reid, Gavin E.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Reid, Gavin E.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University System of Georgia; Augusta University; Michigan State University; Michigan State University	Chen, WQ (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30904 USA.	wechen@gru.edu	Chen, Weiqin/I-9782-2019; Lydic, Todd A./ADB-0177-2022	Chen, Weiqin/0000-0002-3894-5953; Reid, Gavin/0000-0002-9675-1444; Zhou, Hongyi/0000-0001-5074-5180	American Heart Association [SDG 12SDG9080000]; GRU; National Institutes of Health [GM103508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); GRU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank support from the American Heart Association SDG 12SDG9080000 and GRU start-up funds to WC, and funding from the National Institutes of Health GM103508 to GER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Aotani D, 2012, J CLIN ENDOCR METAB, V97, P3663, DOI 10.1210/jc.2012-1872; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen W, 2009, ENDOCRINOLOGY; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021603; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Fu M, 2004, J CLIN ENDOCR METAB, V89, P2916, DOI 10.1210/jc.2003-030485; Green CD, 2010, J LIPID RES, V51, P1871, DOI 10.1194/jlr.M004747; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2006, J AM SOC MASS SPECTR, V17, P264, DOI 10.1016/j.jasms.2005.11.003; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Koivusalo M, 2001, J LIPID RES, V42, P663; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Prieur X, 2013, DIABETOLOGIA; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Sim MFM, 2013, MOL METAB, V2, P38, DOI 10.1016/j.molmet.2012.11.002; Sprecher H, 1999, PROSTAG LEUKOTR ESS, V60, P317, DOI 10.1016/S0952-3278(99)80006-4; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200	42	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82526	10.1371/journal.pone.0082526	http://dx.doi.org/10.1371/journal.pone.0082526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358199	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700078
J	Ermund, A; Gustafsson, JK; Hansson, GC; Keita, AV				Ermund, Anna; Gustafsson, Jenny K.; Hansson, Gunnar C.; Keita, Asa V.			Mucus Properties and Goblet Cell Quantification in Mouse, Rat and Human Ileal Peyer's Patches	PLOS ONE			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; DENDRITIC CELLS; ANTIGEN; TRANSPORT; BACTERIA; PEPTIDOGLYCAN; EXPRESSION; INDUCTION; THICKNESS; LAYERS	Peyer's patches (PPs) are collections of lymphoid follicles in the small intestine, responsible for scanning the intestinal content for foreign antigens such as soluble molecules, particulate matter as well as intact bacteria and viruses. The immune cells of the patch are separated from the intestinal lumen by a single layer of epithelial cells, the follicle-associated epithelium (FAE). This epithelium covers the dome of the follicle and contains enterocyte-like cells and M cells, which are particularly specialized in taking up antigens from the gut. However, the presence and number of goblet cells as well as the presence of mucus on top of the FAE is controversial. When mouse ileal PPs were mounted in a horizontal Ussing-type chamber, we could observe a continuous mucus layer at mounting and new, easily removable mucus was released from the villi on the patch upon stimulation. Confocal imaging using fluorescent beads revealed a penetrable mucus layer covering the domes. Furthermore, immunostaining of FAE from mice, rats and humans with a specific antibody against the main component of intestinal mucus, the MUC2 mucin, clearly identify mucin-containing goblet cells. Transmission electron micrographs further support the identification of mucus releasing goblet cells on the domes of PPs in these species.	[Ermund, Anna; Gustafsson, Jenny K.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Keita, Asa V.] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Keita, Asa V.] Cty Council Ostergotland, Linkoping, Sweden	University of Gothenburg; Linkoping University; City Council Ostergotland	Ermund, A (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	anna.ermund@gu.se	Hansson, Gunnar C/A-1236-2009; Ermund, Anna/AAG-3160-2020; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Ermund, Anna/0000-0002-3233-043X; Keita, Asa/0000-0002-6820-0215	Swedish Research Council [7461, 21027, 342-2004-4434, K2012-55X-12618-16-3]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Riksforbundet Cystisk Fibros (RfCF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Riksforbundet Cystisk Fibros (RfCF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 21027, 342-2004-4434 to Gunnar C. Hansson and VR-m nr: K2012-55X-12618-16-3 to Asa V. Keita); The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, IngaBritt and Arne Lundberg Foundation, The Sahlgrenska University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation (to Anna Ermund, Jenny K. Gustafsson and Gunnar C. Hansson), Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, National Institute of Allergy and Infectious Diseases (U01AI095473) (The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH); and The Swedish Foundation for Strategic Research -The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program (all to Gunnar C. Hansson) and Riksforbundet Cystisk Fibros (RfCF; The National association for Cystic Fibrosis; to Anna Ermund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Beyaz F, 2010, CELL TISSUE RES, V341, P417, DOI 10.1007/s00441-010-1005-5; Castro-Sanchez P, 2013, BRIT J NUTR, V109, pS3, DOI 10.1017/S0007114512005223; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Gebert A, 1997, HISTOCHEM CELL BIOL, V108, P455, DOI 10.1007/s004180050186; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Henriksnas J, 2005, ACTA PHYSIOL SCAND, V184, P151, DOI 10.1111/j.1365-201X.2005.01434.x; Inamoto T, 2008, J VET MED SCI, V70, P235, DOI 10.1292/jvms.70.235; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Keita AV, 2006, LAB INVEST, V86, P504, DOI 10.1038/labinvest.3700397; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Khan J, 1999, JPEN-PARENTER ENTER, V23, P19, DOI 10.1177/014860719902300119; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lelouard H, 1999, INFECT IMMUN, V67, P357, DOI 10.1128/IAI.67.1.357-367.1999; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meyer T, 2012, EXP MOL PATHOL, V93, P449, DOI 10.1016/j.yexmp.2012.10.002; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Onori P, 2001, DIGEST DIS SCI, V46, P1095, DOI 10.1023/A:1010778532240; Owen RL, 1999, SEMIN IMMUNOL, V11, P157, DOI 10.1006/smim.1999.0171; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Schulz O, 2012, TRENDS IMMUNOL; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tyrer PC, 2007, VACCINE, V25, P3204, DOI 10.1016/j.vaccine.2007.01.028; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077	36	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83688	10.1371/journal.pone.0083688	http://dx.doi.org/10.1371/journal.pone.0083688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358305	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700135
J	Korkmaz, G; Tekirdag, KA; Ozturk, DG; Kosar, A; Sezerman, OU; Gozuacik, D				Korkmaz, Gozde; Tekirdag, Kumsal Ayse; Ozturk, Deniz Gulfem; Kosar, Ali; Sezerman, Osman Ugur; Gozuacik, Devrim			MIR376A Is a Regulator of Starvation-Induced Autophagy	PLOS ONE			English	Article							MICRORNA REGULATION; EXPRESSION; DIFFERENTIATION; TRANSCRIPTOME; BIOGENESIS; SIGNATURE; PROTEINS; MIR-376A; HOMOLOG; CLUSTER	Background: Autophagy is a vesicular trafficking process responsible for the degradation of long-lived, misfolded or abnormal proteins, as well as damaged or surplus organelles. Abnormalities of the autophagic activity may result in the accumulation of protein aggregates, organelle dysfunction, and autophagy disorders were associated with various diseases. Hence, mechanisms of autophagy regulation are under exploration. Methods: Over-expression of hsa-miR-376a1 (shortly MIR376A) was performed to evaluate its effects on autophagy. Autophagy-related targets of the miRNA were predicted using Microcosm Targets and MIRanda bioinformatics tools and experimentally validated. Endogenous miRNA was blocked using antagomirs and the effects on target expression and autophagy were analyzed. Luciferase tests were performed to confirm that 3' UTR sequences in target genes were functional. Differential expression of MIR376A and the related MIR376B was compared using TaqMan quantitative PCR. Results: Here, we demonstrated that, a microRNA (miRNA) from the DLK1/GTL2 gene cluster, MIR376A, played an important role in autophagy regulation. We showed that, amino acid and serum starvation-induced autophagy was blocked by MIR376A overexpression in MCF-7 and Huh7 cells. MIR376A shared the same seed sequence and had overlapping targets with MIR376B, and similarly blocked the expression of key autophagy proteins ATG4C and BECN1 (Beclin 1). Indeed, 39 UTR sequences in the mRNA of these autophagy proteins were responsive to MIR376A in luciferase assays. Antagomir tests showed that, endogenous MIR376A was participating to the control of ATG4C and BECN1 transcript and protein levels. Moreover, blockage of endogenous MIR376A accelerated starvation-induced autophagic activity. Interestingly, MIR376A and MIR376B levels were increased with different kinetics in response to starvation stress and tissue-specific level differences were also observed, pointing out to an overlapping but miRNA-specific biological role. Conclusions: Our findings underline the importance of miRNAs encoded by the DLK1/GTL2 gene cluster in stress-response control mechanisms, and introduce MIR376A as a new regulator of autophagy.	[Korkmaz, Gozde; Tekirdag, Kumsal Ayse; Ozturk, Deniz Gulfem; Kosar, Ali; Sezerman, Osman Ugur; Gozuacik, Devrim] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Gozuacik, D (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	dgozuacik@sabanciuniv.edu	Devrim, Gozuacik/C-3330-2008; SEZERMAN, OSMAN U/X-6441-2018; Korkmaz, Gozde/A-1456-2015; Öztürk, Deniz Gülfem/AAH-5404-2019; Kosar, Ali/F-5827-2014	Devrim, Gozuacik/0000-0001-7739-2346; Korkmaz, Gozde/0000-0002-3574-1015; Öztürk, Deniz Gülfem/0000-0002-2514-126X; Kosar, Ali/0000-0001-6283-6717; Tekirdag-Kosar, A.Kumsal/0000-0001-7986-0035; Sezerman, Osman Ugur/0000-0003-0905-6783	Scientific and Technological Research Council of Turkey (TUBITAK) [1001]; Sabanci University; Turkish Academy of Sciences (TUBA); EMBO Strategical Development and Installation Grant (EMBO-SDIG); TUBITAK; Yousef Jameel and TUBITAK-BIDEB PhD Scholarships	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Sabanci University(Sabanci University); Turkish Academy of Sciences (TUBA)(Turkish Academy of Sciences); EMBO Strategical Development and Installation Grant (EMBO-SDIG); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Yousef Jameel and TUBITAK-BIDEB PhD Scholarships(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant and Sabanci University. D. G. and A. K are recipients the Turkish Academy of Sciences (TUBA) GEBIP Award. D. G. is a recipient of the EMBO Strategical Development and Installation Grant (EMBO-SDIG) and A. K. is a recipient of the TUBITAK Incentive Award. G. K. and K. A. T. are recipients of Yousef Jameel and TUBITAK-BIDEB PhD Scholarships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Chan E, 2011, TRENDS MOL MED, V17, P235, DOI 10.1016/j.molmed.2011.01.008; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; le Sage C, 2006, CELL CYCLE, V5, P1415, DOI 10.4161/cc.5.13.2890; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romao S, 2013, SEMIN CANCER BIOL, V23, P391, DOI 10.1016/j.semcancer.2013.03.001; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Russo G, 2009, METHODS MOL BIOL, V563, P303, DOI 10.1007/978-1-60761-175-2_17; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Silva LM, 2013, SEMIN CANCER BIOL, V23, P323, DOI 10.1016/j.semcancer.2013.05.005; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Teferedegne B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014416; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298; Zhao BS, 2013, ASIAN PAC J CANCER P, V14, P139, DOI 10.7314/APJCP.2013.14.1.139	54	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82556	10.1371/journal.pone.0082556	http://dx.doi.org/10.1371/journal.pone.0082556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358205	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700081
J	Marshall, AG; Watson, JA; Hallengren, JJ; Walters, BJ; Dobrunz, LE; Francillon, L; Wilson, JA; Phillips, SE; Wilson, SM				Marshall, Andrea G.; Watson, Jennifer A.; Hallengren, Jada J.; Walters, Brandon J.; Dobrunz, Lynn E.; Francillon, Ludwig; Wilson, Julie A.; Phillips, Scott E.; Wilson, Scott M.			Genetic Background Alters the Severity and Onset of Neuromuscular Disease Caused by the Loss of Ubiquitin-Specific Protease 14 (Usp14)	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; ALZHEIMERS-DISEASE; ATAXIA MICE; PROTEINS; IDENTIFICATION; EXPRESSION; RELEASE; PATHWAY; UCH-L1; SYSTEM	In this study, we identified and characterized an N-ethyl-N-nitrosourea (ENU) induced mutation in Usp14 (nmf375) that leads to adult-onset neurological disease. The nmf375 mutation causes aberrant splicing of Usp14 mRNA, resulting in a 95% reduction in USP14. We previously showed that loss of USP14 in ataxia (ax(J)) mice results in reduced ubiquitin levels, motor endplate disease, Purkinje cell axonal dystrophy and decreased hippocampal paired pulse facilitation (PPF) during the first 4-6 weeks of life, and early postnatal lethality by two months of age. Although the loss of USP14 is comparable between the nmf375 and axJ mice, the nmf375 mice did not exhibit these axJ developmental abnormalities. However, by 12 weeks of age the nmf375 mutants present with ubiquitin depletion and motor endplate disease, indicating a continual role for USP14-mediated regulation of ubiquitin pools and neuromuscular junction (NMJ) structure in adult mice. The observation that motor endplate disease was only seen after ubiquitin depletion suggests that the preservation of NMJ structure requires the stable maintenance of synaptic ubiquitin pools. Differences in genetic background were shown to affect ubiquitin expression and dramatically alter the phenotypes caused by USP14 deficiency.	[Marshall, Andrea G.; Watson, Jennifer A.; Hallengren, Jada J.; Walters, Brandon J.; Dobrunz, Lynn E.; Francillon, Ludwig; Wilson, Julie A.; Phillips, Scott E.; Wilson, Scott M.] Univ Alabama Birmingham, Dept Neurobiol, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Wilson, SM (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr, Birmingham, AL 35294 USA.	Wilson@nrc.uab.edu		Dobrunz, Lynn E./0000-0002-3317-554X; Marshall, Andrea/0000-0001-9997-4478; Wilson, Scott/0000-0001-9376-9430; PHILLIPS, SCOTT/0000-0002-5451-0984; Walters, Brandon/0000-0002-8073-6573	NIH/NINDS [NS047533, NS074456]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047533, R21NS074456] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS Grants NS047533 and NS074456 to SMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljakna A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043139; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bhattacharyya BJ, 2012, AM J PHYSIOL-CELL PH, V302, pC698, DOI 10.1152/ajpcell.00326.2010; Butterfield DA, 2006, J ALZHEIMERS DIS, V10, P391; Camu W, 1999, J NEUROL SCI, V165, pS21, DOI 10.1016/S0022-510X(99)00022-2; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025176; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Crimmins S, 2009, DEV BIOL, V325, P33, DOI 10.1016/j.ydbio.2008.09.021; DAMATO CJ, 1965, ARCH PATHOL, V80, P604; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; GILLINGWATER TH, 2013, NEUROPATHOLOGY APPL, P13934; Gupta VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043794; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; JAWEED MM, 1975, J HISTOCHEM CYTOCHEM, V23, P808, DOI 10.1177/23.11.127809; JIN YN, 2012, PLOS ONE, V7, P29; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Plomp JJ, 1996, J PHYSIOL-LONDON, V493, P175, DOI 10.1113/jphysiol.1996.sp021373; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; TAI HC, 2010, PROTEINS FRONTIERS N, V3, P1; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	41	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84042	10.1371/journal.pone.0084042	http://dx.doi.org/10.1371/journal.pone.0084042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358326	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700148
J	Fry, CS; Lee, JD; Jackson, JR; Kirby, TJ; Stasko, SA; Liu, HL; Dupont-Versteegden, EE; McCarthy, JJ; Peterson, CA				Fry, Christopher S.; Lee, Jonah D.; Jackson, Janna R.; Kirby, Tyler J.; Stasko, Shawn A.; Liu, Honglu; Dupont-Versteegden, Esther E.; McCarthy, John J.; Peterson, Charlotte A.			Regulation of the muscle fiber microenvironment by activated satellite cells during hypertrophy	FASEB JOURNAL			English	Article						extracellular matrix; Tcf4; Pax7; myogenic progenitor cells; fibroblast	CONNECTIVE-TISSUE FIBROBLASTS; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; LATERAL TRANSMISSION; MYONUCLEAR ADDITION; COLLAGEN; RAT; EXPRESSION; CULTURES	Our aim in the current study was to determine the necessity of satellite cells for long-term muscle growth and maintenance. We utilized a transgenic Pax7-DTA mouse model, allowing for the conditional depletion of > 90% of satellite cells with tamoxifen treatment. Synergist ablation surgery, where removal of synergist muscles places functional overload on the plantaris, was used to stimulate robust hypertrophy. Following 8 wk of overload, satellite cell-depleted muscle demonstrated an accumulation of extracellular matrix (ECM) and fibroblast expansion that resulted in reduced specific force of the plantaris. Although the early growth response was normal, an attenuation of hypertrophy measured by both muscle wet weight and fiber cross-sectional area occurred in satellite cell-depleted muscle. Isolated primary myogenic progenitor cells (MPCs) negatively regulated fibroblast ECM mRNA expression in vitro, suggesting a novel role for activated satellite cells/MPCs in muscle adaptation. These results provide evidence that satellite cells regulate the muscle environment during growth.-Fry, C. S., Lee, J. D., Jackson, J. R., Kirby, T. J., Stasko, S. A., Liu, H., Dupont-Versteegden, E. E., McCarthy, J. J., Peterson, C. A. Regulation of the muscle fiber microenvironment by activated satellite cells during hypertrophy.	[Fry, Christopher S.; Lee, Jonah D.; Jackson, Janna R.; Liu, Honglu; Dupont-Versteegden, Esther E.; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Rehabil Sci, Lexington, KY 40536 USA; [Kirby, Tyler J.; Stasko, Shawn A.; McCarthy, John J.; Peterson, Charlotte A.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Peterson, CA (corresponding author), Univ Kentucky, 900 S Limestone,CTW 105, Lexington, KY 40536 USA.	cpete4@uky.edu	Fry, Christopher/U-2216-2019	Kirby, Tyler/0000-0002-0210-3826	Jeane B. Kempner Postdoctoral Scholar Award; Ellison Medical Foundation/American Federation of Aging Research Fellow EPD [12102]; U.S. National Institutes of Health (NIH) [AG-34453, AR-60701]; NIH [T32-HL-086341]; National Center for Advancing Translational Sciences, NIH [UL1-TR-000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K12DE023574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034453] Funding Source: NIH RePORTER	Jeane B. Kempner Postdoctoral Scholar Award; Ellison Medical Foundation/American Federation of Aging Research Fellow EPD; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge Ben Lawson and Ken Campbell (Center of Muscle Biology Single Fiber Function core services, University of Kentucky). Research was supported by the Jeane B. Kempner Postdoctoral Scholar Award (to C.S.F.); Ellison Medical Foundation/American Federation of Aging Research Fellow EPD 12102 (to J.D.L.); and U.S. National Institutes of Health (NIH) grants AG-34453 (to C.A.P.) and AR-60701 (to C.A.P. and J.J.M.). S.A.S. was supported by NIH grant T32-HL-086341. The project described was also partially supported by the National Center for Advancing Translational Sciences, NIH grant UL1-TR-000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Campbell KS, 2006, BIOPHYS J, V90, P1288, DOI 10.1529/biophysj.105.067504; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; CHEEK DB, 1965, B JOHNS HOPKINS HOSP, V116, P378; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Ferreira LF, 2012, J APPL PHYSIOL, V112, P1538, DOI 10.1152/japplphysiol.01269.2011; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Hidestrand M, 2008, J GERONTOL A-BIOL, V63, P566, DOI 10.1093/gerona/63.6.566; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x; Kay EP, 1998, CURR EYE RES, V17, P286, DOI 10.1076/ceyr.17.3.286.5212; Kirkpatrick LJ, 2010, J HISTOCHEM CYTOCHEM, V58, P317, DOI 10.1369/jhc.2009.954792; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; KUHL U, 1982, DEV BIOL, V93, P344, DOI 10.1016/0012-1606(82)90122-1; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; LIPTON BH, 1977, DEV BIOL, V61, P153, DOI 10.1016/0012-1606(77)90288-3; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; NOBLE EG, 1983, PFLUG ARCH EUR J PHY, V396, P260, DOI 10.1007/BF00587864; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; ROY RR, 1985, J APPL PHYSIOL, V59, P639, DOI 10.1152/jappl.1985.59.2.639; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SANDERSON RD, 1986, J CELL BIOL, V102, P740, DOI 10.1083/jcb.102.3.740; SASSE J, 1981, DEV BIOL, V83, P79, DOI 10.1016/S0012-1606(81)80010-3; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zanotti S, 2007, MATRIX BIOL, V26, P615, DOI 10.1016/j.matbio.2007.06.004; Zhang C, 2012, J BIOMECH, V45, P2001, DOI 10.1016/j.jbiomech.2012.04.026; Zhang Y, 2010, DEV GROWTH DIFFER, V52, P725, DOI 10.1111/j.1440-169X.2010.01209.x; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7	55	179	182	2	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1654	1665		10.1096/fj.13-239426	http://dx.doi.org/10.1096/fj.13-239426			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24376025	Green Published			2022-12-25	WOS:000335344300014
J	Tripathi, A; Dewan, PC; Siddique, SA; Varadarajan, R				Tripathi, Arti; Dewan, Pooja C.; Siddique, Shahbaz A.; Varadarajan, Raghavan			MazF-induced Growth Inhibition and Persister Generation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Death; Mutant; Protein Degradation; Protein Synthesis; Toxin-Antitoxin; Inactive; Active-site Mutant; Bacteriostasis; Antibiotic Tolerance	TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; BACTERIAL PERSISTENCE; CONTROLLED EXPRESSION; PROTEIN-SYNTHESIS; MESSENGER-RNAS; CLEAVAGE; PLASMID; LON; TRANSLATION	Background: MazEF is a chromosomally encoded bacterial toxin-antitoxin system whose cellular role is controversial. Results: Expression of chromosomal MazF inhibits cell killing by multiple antibiotics in a Lon and ClpP dependent manner. Conclusion: MazF is involved in reversible growth inhibition and bacterial drug tolerance. Significance: Inactive, active-site toxin mutants yield functional insights by selectively activating the corresponding WT toxin in vivo. Toxin-antitoxin systems are ubiquitous in nature and present on the chromosomes of both bacteria and archaea. MazEF is a type II toxin-antitoxin system present on the chromosome of Escherichia coli and other bacteria. Whether MazEF is involved in programmed cell death or reversible growth inhibition and bacterial persistence is a matter of debate. In the present work the role of MazF in bacterial physiology was studied by using an inactive, active-site mutant of MazF, E24A, to activate WT MazF expression from its own promoter. The ectopic expression of E24A MazF in a strain containing WT mazEF resulted in reversible growth arrest. Normal growth resumed on inhibiting the expression of E24A MazF. MazF-mediated growth arrest resulted in an increase in survival of bacterial cells during antibiotic stress. This was studied by activation of mazEF either by overexpression of an inactive, active-site mutant or pre-exposure to a sublethal dose of antibiotic. The MazF-mediated persistence phenotype was found to be independent of RecA and dependent on the presence of the ClpP and Lon proteases. This study confirms the role of MazEF in reversible growth inhibition and persistence.	[Tripathi, Arti; Dewan, Pooja C.; Siddique, Shahbaz A.; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560004, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Tripathi, Arti/J-6047-2019	Tripathi, Arti/0000-0002-1515-7102	Department of Biotechnology and Department of Science and Technology, Government of India	Department of Biotechnology and Department of Science and Technology, Government of India	The work was supported by grants from the Department of Biotechnology and Department of Science and Technology, Government of India (to R. V.).	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bajaj K, 2005, P NATL ACAD SCI USA, V102, P16221, DOI 10.1073/pnas.0505089102; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Brzozowska I, 2013, PLASMID, V70, P33, DOI 10.1016/j.plasmid.2013.01.007; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Frampton R, 2012, J BIOL CHEM, V287, P5340, DOI 10.1074/jbc.M111.286856; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen S., 2012, PLOS ONE, V7; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kasari V, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-45; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Tripathi A, 2012, P NATL ACAD SCI USA, V109, P12497, DOI 10.1073/pnas.1121217109; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; UZAN M, 1976, BIOCHEM BIOPH RES CO, V69, P751, DOI 10.1016/0006-291X(76)90939-6; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	65	66	72	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4191	4205		10.1074/jbc.M113.510511	http://dx.doi.org/10.1074/jbc.M113.510511			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375411	hybrid, Green Published			2022-12-25	WOS:000331403800032
J	Joseph, B; Korkhov, VM; Yulikov, M; Jeschke, G; Bordignon, E				Joseph, Benesh; Korkhov, Vladimir M.; Yulikov, Maxim; Jeschke, Gunnar; Bordignon, Enrica			Conformational Cycle of the Vitamin B-12 ABC Importer in Liposomes Detected by Double Electron-Electron Resonance (DEER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Electron Paramagnetic Resonance (EPR); Liposomes; Membrane Bilayer; Membrane Proteins; DEER; Detergent; Peldor	X-RAY-STRUCTURE; DISTANCE MEASUREMENTS; SPIN LABELS; BTUCD-F; PARAMAGNETIC-RESONANCE; ASPARTATE TRANSPORTER; EPR SPECTROSCOPY; NITROXIDE; MECHANISM; DYNAMICS	Background: Type II ABC importers transport diverse substrates into the cell. Results: EPR on BtuCD-F in liposomes shows the response of cytoplasmic gate II during nucleotide cycle in the presence of substrate. Conclusion: The cytoplasmic gate II closes with substrate and ATP as in the x-ray structure. Substrate can be released after hydrolysis. Significance: There is new insight into the mechanism of transport in membranes. Double electron-electron resonance is used here to investigate intermediates of the transport cycle of the Escherichia coli vitamin B-12 ATP-binding cassette importer BtuCD-F. Previously, we showed the ATP-induced opening of the cytoplasmic gate I in TM5 helices, later confirmed by the AMP-PNP-bound BtuCD-F crystal structure. Here, other key residues are analyzed in TM10 helices (positions 307 and 322) and in the cytoplasmic gate II, i.e. the loop between TM2 and TM3 (positions 82 and 85). Without BtuF, binding of ATP induces detectable changes at positions 307 and 85 in BtuCD in liposomes. Together with BtuF, ATP triggers the closure of the cytoplasmic gate II in liposomes (reported by both positions 82 and 85). This forms a sealed cavity in the translocation channel in agreement with the AMP-PNPBtuCD-F x-ray structure. When vitamin B-12 and AMP-PNP are simultaneously present, the extent of complex formation is reduced, but the short 82-82 interspin distance detected indicates that the substrate does not affect the closed conformation of this gate. The existence of the BtuCD-F complex under these conditions is verified with spectroscopically orthogonal nitroxide and Gd(III)-based labels. The cytoplasmic gate II remains closed also in the vanadate-trapped state, but it reopens in the ADP-bound state of the complex. Therefore, we suggest that the substrate likely trapped in ATPBtuCD-F can be released after ATP hydrolysis but before the occluded ADP-bound conformation is reached.	[Joseph, Benesh; Yulikov, Maxim; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Korkhov, Vladimir M.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	Yulikov, Maxim/AAU-3685-2020; Joseph, Benesh/AAK-9039-2020; JOSEPH, BENESH/K-4628-2016	Joseph, Benesh/0000-0003-4968-889X; JOSEPH, BENESH/0000-0003-4968-889X; Jeschke, Gunnar/0000-0001-6853-8585; Korkhov, Volodymyr/0000-0002-0962-9433; Bordignon, Enrica/0000-0003-2450-5161	Swiss Federal Institute of Technology in Zurich [ETH-21 09-1]	Swiss Federal Institute of Technology in Zurich	This work was supported by Research Grant ETH-21 09-1 from the Swiss Federal Institute of Technology in Zurich (to G. J. and E. B.).	Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dalmas O, 2012, J AM CHEM SOC, V134, P16360, DOI 10.1021/ja3069038; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denning EJ, 2013, CHEM PHYS LIPIDS, V169, P57, DOI 10.1016/j.chemphyslip.2013.02.007; Endeward B, 2009, J AM CHEM SOC, V131, P15246, DOI 10.1021/ja904808n; Garbuio L, 2013, J PHYS CHEM B, V117, P3145, DOI 10.1021/jp401806g; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kaminker I, 2012, PHYS CHEM CHEM PHYS, V14, P4355, DOI 10.1039/c2cp40219j; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lueders P, 2013, J PHYS CHEM B, V117, P2061, DOI 10.1021/jp311287t; Lueders P, 2011, J PHYS CHEM LETT, V2, P604, DOI 10.1021/jz200073h; Mittal A, 2012, J BIOL CHEM, V287, P20395, DOI 10.1074/jbc.M112.359794; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Yulikov M, 2012, PHYS CHEM CHEM PHYS, V14, P10732, DOI 10.1039/c2cp40282c; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	39	47	47	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3176	3185		10.1074/jbc.M113.512178	http://dx.doi.org/10.1074/jbc.M113.512178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362024	hybrid, Green Published			2022-12-25	WOS:000331368700007
J	Vidilaseris, K; Morriswood, B; Kontaxis, G; Dong, G				Vidilaseris, Keni; Morriswood, Brooke; Kontaxis, Georg; Dong, Gang			Structure of the TbBILBO1 Protein N-terminal Domain from Trypanosoma brucei Reveals an Essential Requirement for a Conserved Surface Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Infectious Diseases; Molecular Cell Biology; Nuclear Magnetic Resonance; Parasite; Protein Structure; Structural Biology; Trypanosoma brucei; TbBILBO1; Flagellar Pocket Collar	CELL-SURFACE; SYSTEM; CYTOSKELETON; POLARITY	Background: TbBILBO1 is the only known component of the flagellar pocket collar, a cytoskeletal structure in the parasite Trypanosoma brucei.Results: The TbBILBO1 N-terminal domain has a ubiquitin-like fold with a conserved surface patch; overexpression of constructs with a mutagenized patch is lethal. Conclusion: The conserved surface patch is essential for TbBILBO1 function. Significance: The surface patch is a potential therapeutic target. TbBILBO1 is the only known component of the flagellar pocket collar, a cytoskeletal barrier element found in trypanosomes. The N-terminal domain (NTD) of TbBILBO1 was found to be dispensable for targeting of the protein in vivo. However, overexpression of constructs lacking the NTD caused complete growth inhibition, implying an essential requirement for this domain. A high resolution structure of the NTD of TbBILBO1 showed that it forms a ubiquitin-like fold with a conserved surface patch. Mutagenesis of this patch recapitulated the phenotypic effects of deleting the entire domain and was found to cause cell death. The surface patch on the NTD of TbBILBO1 is therefore a potential drug target.	[Vidilaseris, Keni; Dong, Gang] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Morriswood, Brooke; Kontaxis, Georg] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Morriswood, B (corresponding author), Univ Vienna, Max F Perutz Labs, Waehringer Guertel 18, A-1030 Vienna, Austria.	brooke.morriswood@univie.ac.at; gang.dong@meduniwien.ac.at	Vidilaseris, Keni/Q-1243-2019; Morriswood, Brooke/AAY-9714-2020	Vidilaseris, Keni/0000-0002-6453-6600; Morriswood, Brooke/0000-0001-7031-3801; Dong, Gang/0000-0001-9745-8103	Max F. Perutz Laboratories; Austrian Science Fund [P24383-B21]; Osterreichischer Austauschdienst (OeAD) graduate scholarship; Austrian Science Fund (FWF) [P 24383] Funding Source: researchfish	Max F. Perutz Laboratories; Austrian Science Fund(Austrian Science Fund (FWF)); Osterreichischer Austauschdienst (OeAD) graduate scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by funding from the Max F. Perutz Laboratories and Grant P24383-B21 from the Austrian Science Fund (to G. D.).; Supported by an Osterreichischer Austauschdienst (OeAD) graduate scholarship during 2009-2012.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Garner TP, 2011, BIOCHEMISTRY-US, V50, P9076, DOI 10.1021/bi201137e; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Welburn SC, 2012, ADV PARASIT, V79, P299, DOI 10.1016/B978-0-12-398457-9.00004-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zucca M, 2013, CURR MED CHEM, V20, P502	27	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3724	3735		10.1074/jbc.M113.529032	http://dx.doi.org/10.1074/jbc.M113.529032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362019	hybrid, Green Published			2022-12-25	WOS:000331368700053
J	Hatch, SK; Connelly, EE; Divoll, TJ; Stenhouse, IJ; Williams, KA				Hatch, Shaylyn K.; Connelly, Emily E.; Divoll, Timothy J.; Stenhouse, Iain J.; Williams, Kathryn A.			Offshore Observations of Eastern Red Bats (Lasiurus borealis) in the Mid-Atlantic United States Using Multiple Survey Methods	PLOS ONE			English	Article							WIND; FATALITIES; MIGRATION	Little is known about the migration and movements of migratory tree-roosting bat species in North America, though anecdotal observations of migrating bats over the Atlantic Ocean have been reported since at least the 1890s. Aerial surveys and boat-based surveys of wildlife off the Atlantic Seaboard detected a possible diurnal migration event of eastern red bats (Lasiurus borealis) in September 2012. One bat was sighted approximately 44 km east of Rehoboth Beach, Delaware during a boat-based survey. Eleven additional bats were observed between 16.9 and 41.8 km east of New Jersey, Delaware, and Virginia in high definition video footage collected during digital aerial surveys. Observations were collected incidentally as part of a large baseline study of seabird, marine mammal, and sea turtle distributions and movements in the offshore environment. Digital survey methods also allowed for altitude estimation for several of these bats at >100 m above sea level. These observations provide new evidence of bat movements offshore,	[Hatch, Shaylyn K.; Connelly, Emily E.; Divoll, Timothy J.; Stenhouse, Iain J.; Williams, Kathryn A.] Biodivers Res Inst, Gorham, ME USA		Hatch, SK (corresponding author), Biodivers Res Inst, Gorham, ME USA.	shay.hatch@briloon.org	Divoll, Timothy J/L-4963-2017	Stenhouse, Iain/0000-0003-3614-9862; Divoll, Timothy/0000-0002-2586-6842	Department of Energy [DE-EE0005362]; agency of the United States Government	Department of Energy(United States Department of Energy (DOE)); agency of the United States Government	This material is based upon work supported by the Department of Energy under Award Number DE-EE0005362. This manuscript was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I, 2009, J MAMMAL, V90, P1318, DOI 10.1644/09-MAMM-S-223R.1; Allen G. M., 1923, Journal of Mammalogy, V4, P61; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arroyo-Cabrales J, 2008, IUCN 2013 IUCN RED L; Boshamer Jan P. C., 2008, Lutra, V51, P17; Breton SP, 2009, RENEW ENERG, V34, P646, DOI 10.1016/j.renene.2008.05.040; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan Paul M., 2009, P476; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Czenze Zenon, 2011, Bat Research News, V52, P28; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Grady FV, 2006, J MAMMAL, V87, P148, DOI 10.1644/05-MAMM-A-179R1.1; Griffin D. R., 1970, P233; Griffin D.R., 1940, B MUS COMP ZOOL HARV, V86, P217; Hall ER, 1946, MAMMALS NEVADA; Holland RA, 2007, BEHAV ECOL SOCIOBIOL, V61, P653, DOI 10.1007/s00265-006-0297-7; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Howell Arthur H., 1908, Proceedings of the Biological Society of Washington, V21; Krueger Thorsten, 2001, Atlantic Seabirds, V3, P203; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Mearns E.A., 1898, B AM MUS NAT HIST, V10, P303; Nichols J.T., 1920, J MAMMAL, V1, P87, DOI [10.2307/1373749, DOI 10.2307/1373749]; Norton AH, 1929, J MAMMAL, V11, P225; Pelletier SK, 2013, INFORM SYNTHESIS POT, P1; Peurach Suzanne C., 2009, Human-Wildlife Conflicts, V3, P199; Rollins KE, 2012, VET PATHOL, V49, P362, DOI 10.1177/0300985812436745; Shump K.A. Jr, 1982, Mammalian Species, P1; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Van Gelder R. G., 1961, American Museum Novitates, VNo. 2029, P1	29	14	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83803	10.1371/journal.pone.0083803	http://dx.doi.org/10.1371/journal.pone.0083803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367614	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900023
J	Reno, PL; McLean, CY; Hines, JE; Capellini, TD; Bejerano, G; Kingsley, DM				Reno, Philip L.; McLean, Cory Y.; Hines, Jasmine E.; Capellini, Terence D.; Bejerano, Gill; Kingsley, David M.			A Penile Spine/Vibrissa Enhancer Sequence Is Missing in Modern and Extinct Humans but Is Retained in Multiple Primates with Penile Spines and Sensory Vibrissae	PLOS ONE			English	Article							EVOLUTION; PAPULES; CHIMPANZEE; ALIGNMENT; GENOMICS; GLANDS	Previous studies show that humans have a large genomic deletion downstream of the Androgen Receptor gene that eliminates an ancestral mammalian regulatory enhancer that drives expression in developing penile spines and sensory vibrissae. Here we use a combination of large-scale sequence analysis and PCR amplification to demonstrate that the penile spine/vibrissa enhancer is missing in all humans surveyed and in the Neandertal and Denisovan genomes, but is present in DNA samples of chimpanzees and bonobos, as well as in multiple other great apes and primates that maintain some form of penile integumentary appendage and facial vibrissae. These results further strengthen the association between the presence of the penile spine/vibrissa enhancer and the presence of penile spines and macro-or micro-vibrissae in non-human primates as well as show that loss of the enhancer is both a distinctive and characteristic feature of the human lineage.	[Reno, Philip L.; Hines, Jasmine E.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McLean, Cory Y.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Capellini, Terence D.; Bejerano, Gill; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Kingsley, David M.] Howard Hughes Med Inst, Stanford, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Stanford University; Howard Hughes Medical Institute	Reno, PL (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	philreno@psu.edu; cmclean@stanfordalumni.org	Capellini, Terence/B-8316-2016	McLean, Cory/0000-0001-9928-8216; Reno, Philip/0000-0002-7053-0344	Center for Excellence in Genomic Sciences from the National Institutes of Health [5P50HG2568]; Microsoft Research Fellow; Howard Hughes Medical Institute; NIH NCRR [RR015087, RR014491, RR016483]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016483, U42RR015087, C06RR014491] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	Center for Excellence in Genomic Sciences from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research Fellow(Microsoft); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by a Center for Excellence in Genomic Sciences grant (5P50HG2568) from the National Institutes of Health (nih.gov). G.B. is a Packard Fellow (packard.org) and Microsoft Research Fellow (research.microsoft.com) and D. M. K. is an investigator of the Howard Hughes Medical Institute (hhmi.org). The University of Louisiana at Lafayette New Iberia Research Center is funded by NIH NCRR (RR015087, RR014491, RR016483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN AB, 1973, ARCH DERMATOL, V108, P673, DOI 10.1001/archderm.108.5.673; Agrawal SK, 2004, INT J DERMATOL, V43, P199, DOI 10.1111/j.1365-4632.2004.02057.x; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; BEACH FA, 1950, J EXP ZOOL, V114, P159, DOI 10.1002/jez.1401140108; DAHL JF, 1994, J MAMMAL, V75, P1, DOI 10.2307/1382229; Dixson A.F., 1998, PRIMATE SEXUALITY CO; DIXSON AF, 1976, FOLIA PRIMATOL, V26, P207, DOI 10.1159/000155751; GLICKSMA.JM, 1966, ARCH DERMATOL, V93, P56, DOI 10.1001/archderm.93.1.56; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Hershkovitz Philip, 1993, Fieldiana Zoology, V73, P1; HILL WCO, 1949, P ZOOL SOC LOND, V119, P363; HILL WCO, 1946, P ZOOL SOC LOND, V116, P129; HILL WCO, 1950, P ZOOL SOC LOND, V120, P311; Hiller M, 2012, CELL REP, V2, P817, DOI 10.1016/j.celrep.2012.08.032; HYMAN AB, 1969, ARCH DERMATOL, V99, P31, DOI 10.1001/archderm.99.1.31; IZOR RJ, 1981, FOLIA PRIMATOL, V35, P218, DOI 10.1159/000155973; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MATTHEWS LH, 1946, P ZOOL SOC LOND, V116, P339; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; MURAKAMI R, 1987, J ANAT, V153, P223; Oates JK, 1997, GENITOURIN MED, V73, P137; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Vowles EJ, 2006, MOL BIOL EVOL, V23, P598, DOI 10.1093/molbev/msj065	28	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84258	10.1371/journal.pone.0084258	http://dx.doi.org/10.1371/journal.pone.0084258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367647	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900040
J	Chen, J; Li, CS; Gao, XF; Li, CH; Liang, ZX; Yu, L; Li, YQ; Xiao, XY; Chen, LA				Chen, Jie; Li, Chunsun; Gao, Xiaofang; Li, Chonghui; Liang, Zhixin; Yu, Ling; Li, Yanqin; Xiao, Xiaoyi; Chen, Liangan			Keratinocyte Growth Factor Gene Delivery via Mesenchymal Stem Cells Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RESPIRATORY-DISTRESS-SYNDROME; MYOCARDIAL-INFARCTION; EPITHELIAL-CELLS; BONE; BLEOMYCIN; THERAPY; RATS; FIBROSIS; ANGIOPOIETIN-1	Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with high morbidity and mortality, and have no specific therapy. Keratinocyte growth factor (KGF) is a critical factor for pulmonary epithelial repair and acts via the stimulation of epithelial cell proliferation. Mesenchymal stem cells (MSCs) have been proved as good therapeutic vectors. Thus, we hypothesized that MSC-based KGF gene therapy would have beneficial effects on lipopolysaccharide (LPS) induced lung injury. After two hours of intratracheal LPS administration to induce lung injury, mice received saline, MSCs alone, empty vector-engineered MSCs (MSCs-vec) or KGF-engineered MSCs (MSCs-kgf) via the tail vein. The MSCs-kgf could be detected in the recipient lungs and the level of KGF expression significantly increased in the MSCs-kgf mice. The MSC-mediated administration of KGF not only improved pulmonary microvascular permeability but also mediated a down-regulation of proinflammatory responses (reducing IL-1 beta and TNF-alpha) and an up-regulation of anti-inflammatory responses (increasing cytokine IL-10). Furthermore, the total severity scores of lung injury were significantly reduced in the MSCs-kgf group compared with the other three groups. The underlying mechanism of the protective effect of KGF on ALI may be attributed to the promotion of type II lung epithelial cell proliferation and the enhancement of surfactant synthesis. These findings suggest that MSCs-based KGF gene therapy may be a promising strategy for ALI treatment.	[Chen, Jie; Li, Chunsun; Gao, Xiaofang; Li, Chonghui; Liang, Zhixin; Yu, Ling; Li, Yanqin; Xiao, Xiaoyi; Chen, Liangan] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, LA (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China.	chenliangan301@163.com		jie, Chen/0000-0002-2852-3618; Chen, Liang-an/0000-0002-1829-3134; Liang, Zhixin/0000-0001-5208-7505; Liang, Zhixin/0000-0003-3520-2297	Military Hospital of Clinic High and New Technology Fund of China [2010gxjs090]	Military Hospital of Clinic High and New Technology Fund of China	Military Hospital of Clinic High and New Technology Fund of China (2010gxjs090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; Baba Y, 2007, HUM GENE THER, V18, P130, DOI 10.1089/hum.2006.137; Bao SY, 2005, AM J PHYSIOL-LUNG C, V288, pL36, DOI 10.1152/ajplung.00309.2003; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; Devaney J, 2011, CRIT CARE, V15, DOI 10.1186/cc10216; Frutos-Vivar F, 2006, SEM RESP CRIT CARE M, V27, P327, DOI 10.1055/s-2006-948287; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Kugathasan L, 2005, CHEST, V128, p633S, DOI 10.1378/chest.128.6_suppl.633S; Lamontagne F, 2010, CRIT CARE MED, V38, P2401, DOI 10.1097/CCM.0b013e3181fa0468; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Lefort J, 1998, J IMMUNOL, V161, P474; Lesur I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011485; Lin X, 2011, CRIT CARE CLIN, V27, P705, DOI 10.1016/j.ccc.2011.04.002; Liu KD, 2008, CLIN J AM SOC NEPHRO, V3, P578, DOI 10.2215/CJN.01630407; Loebinger MR, 2010, THORAX, V65, P362, DOI 10.1136/thx.2009.128025; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sakamoto S, 2011, AM J RESP CELL MOL, V45, P489, DOI 10.1165/rcmb.2010-0092OC; Sugahara K, 1998, J PATHOL, V186, P90; Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Xie YS, 2008, COMP BIOCHEM PHYS B, V151, P225, DOI 10.1016/j.cbpb.2008.07.006; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yang ZJ, 2010, CARDIOVASC THER, V28, P380, DOI 10.1111/j.1755-5922.2009.00116.x; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yao HW, 2006, CLIN EXP PHARMACOL P, V33, P793, DOI 10.1111/j.1440-1681.2006.04440.x; Yi ES, 1996, AM J PATHOL, V149, P1963; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhu YG, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/560194	47	36	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83303	10.1371/journal.pone.0083303	http://dx.doi.org/10.1371/journal.pone.0083303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367590	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300101
J	Huiart, L; Bouhnik, AD; Rey, D; Rousseau, F; Retornaz, F; Meresse, M; Bendiane, MK; Viens, P; Giorgi, R				Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Rousseau, Frederique; Retornaz, Frederique; Meresse, Megane; Bendiane, Marc Karim; Viens, Patrice; Giorgi, Roch			Complementary or Alternative Medicine as Possible Determinant of Decreased Persistence to Aromatase Inhibitor Therapy among Older Women with Non-Metastatic Breast Cancer	PLOS ONE			English	Article							ADJUVANT HORMONAL-THERAPY; POSTMENOPAUSAL WOMEN; EARLY DISCONTINUATION; MEDICATION ADHERENCE; TAMOXIFEN THERAPY; ENDOCRINE THERAPY; CLINICAL-PRACTICE; RANDOMIZED-TRIAL; COHORT; LETROZOLE	Purpose: Aromatase inhibitor therapy (AI) significantly improves survival in breast cancer patients. Little is known about adherence and persistence to aromatase inhibitors and about the causes of treatment discontinuation among older women. Methods: We constituted a cohort of women over 65 receiving a first AI therapy for breast cancer between 2006 and 2008, and followed them until June 2011. Women were selected in the population-based French National Health Insurance databases, and data was collected on the basis of pharmacy refills, medical records and face-to-face interviews. Non-persistence to treatment was defined as the first treatment discontinuation lasting more than 3 consecutive months. Time to treatment discontinuation was studied using survival analysis techniques. Results: Overall among the 382 selected women, non-persistence to treatment went from 8.7% (95% CI: 6.2-12.1) at 1 year, to 15.6% (95% CI: 12.2-19.8) at 2 years, 20.8% (95% CI: 16.7-25.6) at 3 years, and 24.7% (95% CI: 19.5-31.0) at 4 years. In the multivariate analysis on a sub-sample of 233 women with available data, women using complementary or alternative medicine (CAM) (HR = 3.2; 95% CI: 1.5-6.9) or suffering from comorbidities (HR = 2.2; 95% CI: 1.0-4.8) were more likely to discontinue their treatment, whereas women with polypharmacy (HR = 0.4; 95% CI: 0.2-0.91) were less likely to discontinue. In addition, 13% of the women with positive hormonal receptor status did not fill any prescription for anti-hormonal therapy. Conclusion: AI therapy is discontinued prematurely in a substantial portion of older patients. Some patients may use CAM not as a complementary treatment, but as an alternative to conventional medicine. Improving patient-physician communication on the use of CAM may improve hormonal therapy adherence.	[Huiart, Laetitia] CHU La Reunion, Unite Soutien Methodol, St Denis, France; [Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Meresse, Megane; Bendiane, Marc Karim; Giorgi, Roch] INSERM, SESSTIM U912, F-13258 Marseille, France; [Huiart, Laetitia; Bouhnik, Anne-Deborah; Rey, Dominique; Meresse, Megane; Bendiane, Marc Karim; Giorgi, Roch] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Rey, Dominique; Bendiane, Marc Karim] ORS PACA, Marseille, France; [Rousseau, Frederique; Viens, Patrice] Inst J Paoli I Calmettes, Dept Med Oncol, F-13009 Marseille, France; [Retornaz, Frederique] Ctr Gerontol Dept, Marseille, France; [Viens, Patrice] Univ Aix Marseille, Ctr Rech Cancerol Marseille, INSERM U891, Marseille, France; [Giorgi, Roch] Hop Enfants La Timone, Assistance Publ Hop Marseille, Serv Biostat & Technol Informat & Commun, Marseille, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Huiart, L (corresponding author), CHU La Reunion, Unite Soutien Methodol, St Denis, France.	laetitia.huiart@mail.mcgill.ca	Bouhnik, Anne-Déborah/Q-9650-2017; Huiart, Laetitia/GQB-4064-2022; Bendiane, Marc-Karim K/F-5414-2010; Bouhnik, Anne-Deborah/M-2829-2019; Viens, Patrice/Q-8499-2018; Bendiane, Marc-Karim/M-7060-2019; GIORGI, Roch/A-6438-2009	Bouhnik, Anne-Déborah/0000-0002-5418-4592; Bendiane, Marc-Karim K/0000-0003-4329-8807; Bouhnik, Anne-Deborah/0000-0002-5418-4592; Viens, Patrice/0000-0003-1511-1048; GIORGI, Roch/0000-0001-6135-3078	French Ministry of Research; French National Institute of Cancer (INCa); cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer); National Institute for Health Research [UMR912 INSERM]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France); cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the French Ministry of Research, the French National Institute of Cancer (INCa), regional authorities (Conseil Regional Provence-Alpes Cote-d'Azur), cancer foundations (Fondation de France and Association pour la Recherche sur le Cancer), and the National Institute for Health Research (UMR912 INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Balkrishnan R, 1998, CLIN THER, V20, P764, DOI 10.1016/S0149-2918(98)80139-2; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Crivellari D, 2008, J CLIN ONCOL, V26, P1972, DOI 10.1200/JCO.2007.14.0459; Dezentje V, 2009, J CLIN ONCOL, V27; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Huiart L, 2011, BRIT J CANCER, V104, P1558, DOI 10.1038/bjc.2011.140; Huiart L, 2013, BREAST CANCER RES TR, V138, P325, DOI 10.1007/s10549-013-2422-4; Huiart L, 2012, EUR J CANCER, V48, P1939, DOI 10.1016/j.ejca.2012.03.004; Jernewall N, 2005, AIDS CARE, V17, P601, DOI 10.1080/09540120512331314295; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Knippels HMA, 2000, AIDS CARE, V12, P435, DOI 10.1080/09540120050123837; Lash TL, 2006, BREAST CANCER RES TR, V99, P215, DOI 10.1007/s10549-006-9193-0; LOVE RR, 1990, J NATL CANCER I, V82, P18, DOI 10.1093/jnci/82.1.18; Maggiore RJ, 2012, CANCER-AM CANCER SOC, V118, P4815, DOI 10.1002/cncr.27427; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; Nekhlyudov L, 2011, BREAST CANCER RES TR, V130, P681, DOI 10.1007/s10549-011-1703-z; Neugut AI, 2011, J CLIN ONCOL, V29, P2534, DOI 10.1200/JCO.2010.33.3179; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Owen-Smith A, 2007, AIDS CARE, V19, P589, DOI 10.1080/09540120701203279; Partridge AH, 2002, JNCI-J NATL CANCER I, V94, P652; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Thomas-Schoemann A, 2011, B CANCER, V98, P645, DOI 10.1684/bdc.2011.1375; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81677	10.1371/journal.pone.0081677	http://dx.doi.org/10.1371/journal.pone.0081677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367488	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300009
J	Libby, E; Rainey, PB				Libby, Eric; Rainey, Paul B.			Eco-Evolutionary Feedback and the Tuning of Proto-Developmental Life Cycles	PLOS ONE			English	Article							PHENOTYPIC DIVERSITY; NICHE CONSTRUCTION; POPULATION-GROWTH; PLASTICITY; INDIVIDUALITY; COOPERATION; CONFLICT; CONSEQUENCES; ENVIRONMENT; EXCLUSION	Multicellular organisms depend on developmental programs to coordinate growth and differentiation from single cells, but the origins of development are unclear. A possible starting point is stochastic phenotypic variation generated by molecular noise. Given appropriate environmental conditions, noise-driven differentiation could conceivably evolve so as to come under regulatory control; however, abiotic conditions are likely to be restrictive. Drawing from an experimental system, we present a model in which environmental fluctuations are coupled to population growth. We show that this coupling generates stable selection for a single optimal strategy that is largely insensitive to environmental conditions, including the number of competitors, carrying capacity of the environment, difference in growth rates among phenotypic variants, and population density. We argue that this optimal strategy establishes stabilizing conditions likely to improve the quality and reliability of information experienced by evolving organisms, thus increasing opportunity for the evolutionary emergence of developmental programs.	[Libby, Eric; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Libby, Eric] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Massey University; The Santa Fe Institute; Max Planck Society	Libby, E (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.	elibby@santafe.edu	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795	Foundational Questions in Evolutionary Biology Fund [RFP-12-20]; Marsden Research Council	Foundational Questions in Evolutionary Biology Fund; Marsden Research Council	This research was supported in part by grant RFP-12-20 from the Foundational Questions in Evolutionary Biology Fund as well as the Marsden Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BULL JJ, 1987, EVOLUTION, V41, P303, DOI 10.1111/j.1558-5646.1987.tb05799.x; Buss L., 1987, EVOLUTION INDIVIDUAL; Donaldson-Matasci MC, 2008, EVOL ECOL RES, V10, P493; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LEVINS R, 1962, AM NAT, V96, P361, DOI 10.1086/282245; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Libby E, 2011, P ROY SOC B-BIOL SCI, V278, P3574, DOI 10.1098/rspb.2011.0146; LOREAU M, 1994, THEOR POPUL BIOL, V46, P58, DOI 10.1006/tpbi.1994.1019; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Minelli A, 2010, PHILOS T R SOC B, V365, P631, DOI 10.1098/rstb.2009.0268; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Newman SA, 2000, J EXP ZOOL, V288, P304, DOI 10.1002/1097-010X(20001215)288:4&lt;304::AID-JEZ3&gt;3.0.CO;2-G; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Okasha S, 2009, EVOLUTION LEVELS SEL; Rainey PB, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S14; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Smith J. M., 1997, MAJOR TRANSITIONS EV; Snell-Rood EC, 2010, BIOESSAYS, V32, P71, DOI 10.1002/bies.200900132; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; West-Eberhard Mary Jane, 2003, pi; WOLPERT L, 1994, DEVELOPMENT, P79; WOLPERT L, 1990, BIOL J LINN SOC, V39, P109, DOI 10.1111/j.1095-8312.1990.tb00506.x; Wolpert L, 2002, NATURE, V420, P745, DOI 10.1038/420745a	39	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82274	10.1371/journal.pone.0082274	http://dx.doi.org/10.1371/journal.pone.0082274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367511	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300027
J	Querec, TD; Gurbaxani, BM; Unger, ER				Querec, Troy David; Gurbaxani, Brian Mohan; Unger, Elizabeth Robinson			Randomization Modeling to Ascertain Clustering Patterns of Human Papillomavirus Types Detected in Cervicovaginal Samples in the United States	PLOS ONE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; CERVICAL COINFECTION; HIGH-RISK; HPV TYPES; PREVALENCE; INFECTION; WOMEN; ACQUISITION; CONCURRENT; NEOPLASIA	Detection of multiple human papillomavirus (HPV) types in the genital tract is common. Associations among HPV types may impact HPV vaccination modeling and type replacement. The objectives were to determine the distribution of concurrent HPV type infections in cervicovaginal samples and examine type-specific associations. We analyzed HPV genotyping results from 32,245 cervicovaginal specimens collected from women aged 11 to 83 years in the United States from 2001 through 2011. Statistical power was enhanced by combining 6 separate studies. Expected concurrent infection frequencies from a series of permutation models, each with increasing fidelity to the real data, were compared with the observed data. Statistics were computed based on the distributional properties of the randomized data. Concurrent detection occurred more than expected with 0 or >= 3 HPV types and less than expected with 1 and 2 types. Some women bear a disproportionate burden of the HPV type prevalence. Type associations were observed that exceeded multiple hypothesis corrected significance. Multiple HPV types were detected more frequently than expected by chance and associations among particular HPV types were detected. However vaccine-targeted types were not specifically affected, supporting the expectation that current bivalent/quadrivalent HPV vaccination will not result in type replacement with other high-risk types.	[Querec, Troy David; Gurbaxani, Brian Mohan; Unger, Elizabeth Robinson] Ctr Dis Control & Prevent, Chron Viral Dis Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Querec, TD (corresponding author), Ctr Dis Control & Prevent, Chron Viral Dis Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30329 USA.	tquerec@cdc.gov	Querec, Troy/AAH-3564-2021	Querec, Troy/0000-0002-3787-6271; Unger, Elizabeth/0000-0002-2925-5635	American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610] Funding Source: NIH RePORTER	American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The stipend for Dr. Querec was provided by the American Society for Microbiology/Centers for Disease Control and Prevention Postdoctoral Research Fellowship Program. All data were previously collected for other purposes by the Centers for Disease Control and Prevention. The funders had no role in study design, aggregating previously collected data and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Carozzi F, 2011, EUR J CANC; Chaturvedi AK, 2005, J MED VIROL, V75, P105, DOI 10.1002/jmv.20244; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Elbasha EH, 2005, MATH BIOSCI, V197, P88, DOI 10.1016/j.mbs.2005.05.004; Gargiulo F, 2007, VIRUS RES, V125, P176, DOI 10.1016/j.virusres.2006.12.017; Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Oksanen J., 2016, R PACKAG; Onyekwuluje JM, 2012, CLIN LAB, V58, P61; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; R Core Team, 2011, R LANG ENV STAT COMP; Rositch AF, 2011, J INFECT DIS; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Rousseau MC, 2003, SEX TRANSM DIS, V30, P581, DOI 10.1097/00007435-200307000-00010; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Sasagawa T, 2001, CANCER EPIDEM BIOMAR, V10, P45; Schwab A, 2011, ORGAN SCI, V22, P1105, DOI 10.1287/orsc.1100.0557; Spinillo A, 2009, VIRUS RES, V142, P154, DOI 10.1016/j.virusres.2009.02.004; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Vaccarella S, 2011, J INFECT DIS, V204, P1500, DOI 10.1093/infdis/jir595; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; van der Graaf Y, 2002, AM J EPIDEMIOL, V156, P158, DOI 10.1093/aje/kwf013; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watson M, 2009, J WOMENS HEALTH, V18, P1731, DOI 10.1089/jwh.2009.1570	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82761	10.1371/journal.pone.0082761	http://dx.doi.org/10.1371/journal.pone.0082761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367553	gold, Green Submitted, Green Published			2022-12-25	WOS:000328740300066
J	Saadatian-Elahi, M; Tristan, A; Laurent, F; Rasigade, JP; Bouchiat, C; Ranc, AG; Lina, G; Dauwalder, O; Etienne, J; Bes, M; Vanderesch, F				Saadatian-Elahi, Mitra; Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Ranc, Anne-Gaelle; Lina, Gerard; Dauwalder, Olivier; Etienne, Jerome; Bes, Michele; Vanderesch, Francois			Basic Rules of Hygiene Protect Health Care and Lab Workers from Nasal Colonization by Staphylococcus aureus: An International Cross-Sectional Study	PLOS ONE			English	Article							CARRIAGE; PREVALENCE; PERSISTENT; INFECTION; CARRIERS; RISK; MICROBIOLOGY; EPIDEMIOLOGY; POPULATION; BACTEREMIA	Acquisition of nasal Staphylococcus aureus (S. aureus) colonization by contaminated hands is likely an important determinant of its nasal carriage rate in health care and lab setting. The objective of our cross-sectional study was to assess the prevalence of nasal methicillin-sensitive (MSSA) or -resistant Staphylococcus aureus (MRSA) carriage among health care professionals (HCPs) attending an international symposium and to study the association between compliance with hygiene rules, individual-related parameters, and medical conditions with nasal S. aureus carriage in this population. After obtaining consent, two nasal swabs were collected. Nasal MSSA and MRSA carriage was measured by the: i) molecular approach targeting spa, mecA and mecA-orfX junction sequences, and ii) culture on selective S. aureus media combined with mecA molecular detection of isolated strains. Information on compliance with hygiene rules, demographic variables, sector of activity and long-term medication was collected by anonymous questionnaire. The participation rate was 32.3%. In total, 176 subjects from 34 countries were included in the analysis. S. aureus was isolated from the nasal swabs of 57 (32.4%) subjects, of whom 3 (5.3%) harbored MRSA strains. Overall, 123 subjects reported working in microbiology laboratories with direct manipulation of S. aureus, and 29 acknowledged regular contacts with patients. In this exposed population, hydro-alcoholic solutions appeared to have a significant protective effect against nasal S. aureus carriage (OR = 0.36; 95% CI: 0.15-0.85). Hospital work was associated with increased risk of nasal S. aureus carriage (OR = 2.38; 95% CI: 1.07-5.29). The results of this study showed that compliance with basic rules of hygiene, such as the use of hydro-alcoholic solutions, could reduce the risk of nasal S. aureus colonization. Hydro-alcoholic solution could interrupt auto-transmission of the pathogen, consequently decreasing the overall nasal carriage rate, specifically in transient carriers.	[Saadatian-Elahi, Mitra; Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Ranc, Anne-Gaelle; Lina, Gerard; Dauwalder, Olivier; Etienne, Jerome; Bes, Michele; Vanderesch, Francois] Hosp Civils Lyon, Ctr Natl References Staphylocoques, Lyon, France; [Tristan, Anne; Laurent, Frederic; Rasigade, Jean-Philippe; Bouchiat, Coralie; Lina, Gerard; Etienne, Jerome; Bes, Michele; Vanderesch, Francois] Univ Lyon, INSERM, U1111, Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanderesch, F (corresponding author), Hosp Civils Lyon, Ctr Natl References Staphylocoques, Lyon, France.	francois.vandenesch@univ-lyon1.fr	TRISTAN, Anne/GSN-8306-2022; Lina, Gerard J/L-9352-2014; LAURENT, Frederic/AGM-0706-2022; bouchiat, coralie/AAG-3339-2020; Vandenesch, Francois/C-7209-2014; DAUWALDER, Olivier/L-9619-2014; Rasigade, Jean-Philippe/AAE-1667-2021; ETIENNE, Jerome/C-5471-2014; Rasigade, Jean-Philippe/L-9320-2014; Tristan, Anne/L-9464-2014	TRISTAN, Anne/0000-0001-9471-2655; Vandenesch, Francois/0000-0001-9412-7106; ETIENNE, Jerome/0000-0002-3348-3315; Rasigade, Jean-Philippe/0000-0002-8264-0452; DAUWALDER, Olivier/0000-0003-1722-1582; laurent, frederic/0000-0003-0609-9091; Lina, Gerard/0000-0002-9236-7998				Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Amorim ML, 2009, MICROB DRUG RESIST, V15, P19, DOI 10.1089/mdr.2009.0881; Argudin MA, 2013, MICROB PATHOGENESIS, V54, P26, DOI 10.1016/j.micpath.2012.09.001; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boisseau D, 2012, MED MALADIES INFECT, V42, P435, DOI 10.1016/j.medmal.2012.07.014; da Silva ECBF, 2008, BRAZ J INFECT DIS, V12, P504, DOI 10.1590/S1413-86702008000600012; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Elie-Turenne MC, 2010, INFECT CONT HOSP EP, V31, P574, DOI 10.1086/652525; Farzana K, 2008, PAK J PHARM SCI, V21, P290; Herwaldt LA, 1998, J HOSP INFECT, V40, pS13, DOI 10.1016/S0195-6701(98)90200-6; Herwaldt LA, 2004, INFECT CONT HOSP EP, V25, P481, DOI 10.1086/502426; Ibarra M, 2008, PEDIATR INFECT DIS J, V27, P1109, DOI 10.1097/INF.0b013e31817eeefa; Jager MM, 2010, J HOSP INFECT, V74, P292, DOI 10.1016/j.jhin.2009.11.003; Johannessen M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00056; Krebes J, 2011, J CLIN MICROBIOL, V49, P430, DOI 10.1128/JCM.02039-10; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526; Mody L, 2008, CLIN INFECT DIS, V46, P1368, DOI 10.1086/586751; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Ng LSY, 2011, J HOSP INFECT, V78, P231, DOI 10.1016/j.jhin.2011.01.025; Nulens E, 2005, EUR J CLIN MICROBIOL, V24, P145, DOI 10.1007/s10096-004-1258-6; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Padoveze MC, 2008, AM J INFECT CONTROL, V36, P187, DOI 10.1016/j.ajic.2007.05.012; Rashid Z, 2012, ACTA POL PHARM, V69, P985; Rijnders MIA, 2010, BRIT J GEN PRACT, V60, P902, DOI 10.3399/bjgp10X544078; Rodriguez-Avial C, 2013, ENFERM INFEC MICR CL, V31, P516, DOI 10.1016/j.eimc.2012.09.017; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Stiefel U, 2011, INFECT CONT HOSP EP, V32, P185, DOI 10.1086/657944; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2006, INFECT CONT HOSP EP, V27, P863, DOI 10.1086/506401; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778; Zhang M, 2011, J HOSP INFECT, V78, P113, DOI 10.1016/j.jhin.2011.02.018	41	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82851	10.1371/journal.pone.0082851	http://dx.doi.org/10.1371/journal.pone.0082851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367562	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300075
J	Sattin, G; Artese, A; Nadai, M; Costa, G; Parrotta, L; Alcaro, S; Palumbo, M; Richter, SN				Sattin, Giovanna; Artese, Anna; Nadai, Matteo; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano; Palumbo, Manlio; Richter, Sara N.			Conformation and Stability of Intramolecular Telomeric G-Quadruplexes: Sequence Effects in the Loops	PLOS ONE			English	Article							K+ SOLUTION; CIRCULAR-DICHROISM; MOLECULAR MECHANICS; DNA-SEQUENCE; FORCE-FIELD; IN-VITRO; CLEROCIDIN; CONTAIN; ADENINE; REPLICATION	Telomeres are guanine-rich sequences that protect the ends of chromosomes. These regions can fold into G-quadruplex structures and their stabilization by G-quadruplex ligands has been employed as an anticancer strategy. Genetic analysis in human telomeres revealed extensive allelic variation restricted to loop bases, indicating that the variant telomeric sequences maintain the ability to fold into G-quadruplex. To assess the effect of mutations in loop bases on G-quadruplex folding and stability, we performed a comprehensive analysis of mutant telomeric sequences by spectroscopic techniques, molecular dynamics simulations and gel electrophoresis. We found that when the first position in the loop was mutated from T to C or A the resulting structure adopted a less stable antiparallel topology; when the second position was mutated to C or A, lower thermal stability and no evident conformational change were observed; in contrast, substitution of the third position from A to C induced a more stable and original hybrid conformation, while mutation to T did not significantly affect G-quadruplex topology and stability. Our results indicate that allelic variations generate G-quadruplex telomeric structures with variable conformation and stability. This aspect needs to be taken into account when designing new potential anticancer molecules.	[Sattin, Giovanna; Nadai, Matteo; Richter, Sara N.] Univ Padua, Dept Mol Med, Padua, Italy; [Artese, Anna; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Catanzaro, Italy; [Palumbo, Manlio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua; Magna Graecia University of Catanzaro; University of Padua	Richter, SN (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	sara.richter@unipd.it	Costa, Giosuè/K-8461-2016; Richter, Sara/A-5578-2012	Costa, Giosuè/0000-0003-0947-9479; Richter, Sara/0000-0002-5446-9029; Palumbo, Manlio/0000-0002-3163-1564; ALCARO, Stefano/0000-0002-0437-358X	Italian Ministry of Education FIRB_IDEAS [RBID082ATK]; PRIN [2009MFRKZ8]	Italian Ministry of Education FIRB_IDEAS; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research work was supported by the Italian Ministry of Education FIRB_IDEAS (code RBID082ATK) and PRIN 2009 (code 2009MFRKZ8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro S, 2013, J MED CHEM, V56, P843, DOI 10.1021/jm3013486; Alcaro S, 2010, CHEMMEDCHEM, V5, P575, DOI 10.1002/cmdc.200900541; ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Gray RD, 2010, BIOCHEMISTRY-US, V49, P179, DOI 10.1021/bi901357r; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Guedin A, 2009, NUCLEIC ACIDS RES, V37, P5559, DOI 10.1093/nar/gkp563; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; He YJ, 2004, NUCLEIC ACIDS RES, V32, P5359, DOI 10.1093/nar/gkh875; Islam B, 2013, NUCLEIC ACIDS RES, V41, P2723, DOI 10.1093/nar/gks1331; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; MCDONALD DQ, 1992, TETRAHEDRON LETT, V33, P7743, DOI 10.1016/0040-4039(93)88034-G; Mendez-Bermudez A, 2009, NUCLEIC ACIDS RES, V37, P6225, DOI 10.1093/nar/gkp629; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Nadai M, 2013, BBA-GEN SUBJECTS, V1830, P4660, DOI 10.1016/j.bbagen.2013.05.039; Nadai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052994; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Randazzo A, 2012, TOP CURR CHEM; Redon S, 2003, NUCLEIC ACIDS RES, V31, P1605, DOI 10.1093/nar/gkg259; Richter S, 2003, NUCLEIC ACIDS RES, V31, P5149, DOI 10.1093/nar/gkg696; Richter SN, 2009, ORG BIOMOL CHEM, V7, P976, DOI 10.1039/b819049f; Richter SN, 2004, NUCLEIC ACIDS RES, V32, P5658, DOI 10.1093/nar/gkh898; Sagi J, 2010, BIOPOLYMERS, V93, P880, DOI 10.1002/bip.21481; Schrodinger I, 2006, DESMOND V3 1; Schrodinger I, 2001, MAESTRO 4 1; Skolakova P, 2010, BIOCHEM BIOPH RES CO, V399, P203, DOI 10.1016/j.bbrc.2010.07.055; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Tomasko M, 2009, BIOCHIMIE, V91, P171, DOI 10.1016/j.biochi.2008.07.012; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wong WC, 2010, BIOORG MED CHEM LETT, V20, P4689, DOI 10.1016/j.bmcl.2010.05.005; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	56	29	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84113	10.1371/journal.pone.0084113	http://dx.doi.org/10.1371/journal.pone.0084113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367632	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300127
J	van Eersel, MEA; Joosten, H; Gansevoort, RT; Dullaart, RPF; Slaets, JPJ; Izaks, GJ				van Eersel, Marlise E. A.; Joosten, Hanneke; Gansevoort, Ron T.; Dullaart, Robin P. F.; Slaets, Joris P. J.; Izaks, Gerbrand J.			The Interaction of Age and Type 2 Diabetes on Executive Function and Memory in Persons Aged 35 Years or Older	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; DECLINE; ATHEROSCLEROSIS; ASSOCIATION; INSULIN; MICROALBUMINURIA; ALBUMINURIA	It is generally assumed that type 2 diabetes increases the risk of cognitive dysfunction in old age. As type 2 diabetes is frequently diagnosed before the age of 50, diabetes-related cognitive dysfunction may also occur before the age of 50. Therefore, we investigated the association of type 2 diabetes with cognitive function in people aged 35-82 years. In a cross-sectional study comprising 4,135 participants of the Prevention of Renal and Vascular ENd-stage Disease study (52% men; mean age (SD), 55 (12) years) diabetes was defined according to the criteria of the American Diabetes Association. Executive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0 points; best score, 175 points), and memory was measured with the Visual Association Test (VAT; worst score, 0 points; best score, 12 points). The association of diabetes with cognitive function was investigated with multiple linear or, if appropriate, logistic regression analysis adjusting for other cardiovascular risk factors and APOE epsilon 4 carriership. Type 2 diabetes was ascertained in 264 individuals (6%). Persons with diabetes had lower RFFT scores than persons without diabetes: mean (SD), 51 (19) vs. 70 (26) points (p<0.001). The difference in RFFT score was largest at age 35-44 years (mean difference 32 points; 95% CI, 15 to 49; p<0.001) and gradually decreased with increasing age. The association of diabetes with RFFT score was not modified by APOE epsilon 4 carriership. Similar results were found for VAT score as outcome measure although these results were only borderline statistically significant (p <= 0.10). In conclusion, type 2 diabetes was associated with cognitive dysfunction, especially in young adults. This was independent of other cardiovascular risk factors and APOE epsilon 4 carriership.	[van Eersel, Marlise E. A.; Joosten, Hanneke; Slaets, Joris P. J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Joosten, Hanneke; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Slaets, Joris P. J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Alzheimer Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Eersel, MEA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.	mea.eersel@umcg.nl	Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637	Dutch Alzheimer Foundation; Dutch Kidney Foundation [E.033]	Dutch Alzheimer Foundation; Dutch Kidney Foundation	This study was supported by the Dutch Alzheimer Foundation (www.alzheimer-nederland.nl). The PREVEND study in general was supported by the Dutch Kidney Foundation (www.nierstichting.nl; grant E.033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; Baan CA, 1999, EPIDEMIOLOGY, V10, P184, DOI 10.1097/00001648-199903000-00018; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Caselli RJ, 2011, NEUROLOGY, V76, P1078, DOI 10.1212/WNL.0b013e318211c3ae; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics Division of Health Interview Statistics data from the National Health Interview Survey, 2010, DISTR AG DIAGN DIAB; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027415; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lindeboom J., 2003, VISUAL ASS TEST MANU; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; Matthews FE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-185; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Nooyens ACJ, 2010, DIABETES CARE, V33, P1964, DOI 10.2337/dc09-2038; Ott A, 2004, NEUROLOGY, V62, P920, DOI 10.1212/01.WNL.0000115110.35610.80; Pavlik VN, 2005, NEUROEPIDEMIOLOGY, V24, P42, DOI 10.1159/000081049; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruff R, 1996, RUFF FIG FLUENC TEST; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Sabayan B, 2013, STROKE, V44, P1866, DOI 10.1161/STROKEAHA.113.001460; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; Spauwen PJ, 2012, DIABETES CARE; United Nations Educational Scientific and Cultural Organization, 2006, INT STAND CLASS ED I; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; van Boxtel MPJ, 1998, J GERONTOL A-BIOL, V53, pM147; van Harten B, 2006, DIABETES CARE, V29, P2539, DOI 10.2337/dc06-1637; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	46	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82991	10.1371/journal.pone.0082991	http://dx.doi.org/10.1371/journal.pone.0082991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367577	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300088
J	Hu, YX; Xu, Q; Li, K; Zhu, H; Qi, RF; Zhang, ZG; Lu, GM				Hu, Yuxiao; Xu, Qiang; Li, Kai; Zhu, Hong; Qi, Rongfeng; Zhang, Zhigiang; Lu, Guangming			Gender Differences of Brain Glucose Metabolic Networks Revealed by FDG-PET: Evidence from a Large Cohort of 400 Young Adults	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; WHITE-MATTER MICROSTRUCTURE; VOXEL-BASED MORPHOMETRY; REGIONAL GRAY-MATTER; SEX-DIFFERENCES; CORTICAL THICKNESS; HEALTHY-INDIVIDUALS; CORPUS-CALLOSUM; DIMORPHISM; SCHIZOPHRENIA	Background: Gender differences of the human brain are an important issue in neuroscience research. In recent years, an increasing amount of evidence has been gathered from noninvasive neuroimaging studies supporting a sexual dimorphism of the human brain. However, there is a lack of imaging studies on gender differences of brain metabolic networks based on a large population sample. Materials and Methods: FDG PET data of 400 right-handed, healthy subjects, including 200 females (age: 25 similar to 45 years, mean age +/- SD: 40.9 +/- 3.9 years) and 200 age-matched males were obtained and analyzed in the present study. We first investigated the regional differences of brain glucose metabolism between genders using a voxel-based two-sample t-test analysis. Subsequently, we investigated the gender differences of the metabolic networks. Sixteen metabolic covariance networks using seed-based correlation were analyzed. Seven regions showing significant regional metabolic differences between genders, and nine regions conventionally used in the resting-state network studies were selected as regions-of-interest. Permutation tests were used for comparing within-and between-network connectivity between genders. Results: Compared with the males, females showed higher metabolism in the posterior part and lower metabolism in the anterior part of the brain. Moreover, there were widely distributed patterns of the metabolic networks in the human brain. In addition, significant gender differences within and between brain glucose metabolic networks were revealed in the present study. Conclusion: This study provides solid data that reveal gender differences in regional brain glucose metabolism and brain glucose metabolic networks. These observations might contribute to the better understanding of the gender differences in human brain functions, and suggest that gender should be included as a covariate when designing experiments and explaining results of brain glucose metabolic networks in the control and experimental individuals or patients.	[Hu, Yuxiao; Zhu, Hong] Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Nucl Med, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Qiang; Qi, Rongfeng; Zhang, Zhigiang; Lu, Guangming] Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Li, Kai] Soochow Univ, Dept Pharmacol, Suzhou, Peoples R China	Nanjing University; Nanjing University; Soochow University - China	Zhang, ZG (corresponding author), Nanjing Univ, Jinling Hosp, Coll Med, Sch Clin,Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China.	zhangzq2001@126.com; cjr.luguangming@vip.163.com		Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [81271553]; Jinling Hospital [2013018]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Jinling Hospital	This work was supported by grants from the Natural Scientific Foundation of China [Grant Nos. 81271553] and the Youth Grant supported by Jinling Hospital [Grant Nos. 2013018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2013, BRAIN IMAGING BEHAV, P1; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brun CC, 2009, NEUROREPORT, V20, P930, DOI 10.1097/WNR.0b013e32832c5e65; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Choi CH, 2010, NEUROREPORT, V21, P73, DOI 10.1097/WNR.0b013e3283345eb0; Chou KH, 2011, NEUROIMAGE, V54, P725, DOI 10.1016/j.neuroimage.2010.07.010; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Filippi M, 2012, HUMAN BRAIN MAPPING; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fujimoto T, 2008, PSYCHIAT RES-NEUROIM, V164, P58, DOI 10.1016/j.pscychresns.2006.12.014; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gur RC, 1999, J NEUROSCI, V19, P4065; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; ITO M, 1984, JPN J PHYSIOL, V34, P781, DOI 10.2170/jjphysiol.34.781; Jezzini A, 2012, P NATL ACAD SCI USA, V109, P10077, DOI 10.1073/pnas.1200143109; Junger J, 2013, NEUROIMAGE; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; Keller K, 2009, NEUROIMAGE, V47, P342, DOI 10.1016/j.neuroimage.2009.04.042; Kheradmand A, 2011, FRONTIERS NEUROLOGY, V2; Kilpatrick LA, 2006, NEUROIMAGE, V30, P452, DOI 10.1016/j.neuroimage.2005.09.065; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Leonard CM, 2008, CEREB CORTEX, V18, P2920, DOI 10.1093/cercor/bhn052; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Loven J., 2013, SOCIAL COGNITIVE AFF; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Melonakos ED, 2011, PSYCHIAT RES-NEUROIM, V193, P65, DOI 10.1016/j.pscychresns.2011.01.009; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; van Amelsvoort T, 2001, TRENDS ENDOCRIN MET, V12, P273, DOI 10.1016/S1043-2760(01)00422-2; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817	47	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83821	10.1371/journal.pone.0083821	http://dx.doi.org/10.1371/journal.pone.0083821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358312	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700072
J	Kapadia, B; Viswakarma, N; Parsa, KVL; Kain, V; Behera, S; Suraj, SK; Babu, PP; Kar, A; Panda, S; Zhu, YJ; Jia, YZ; Thimmapaya, B; Reddy, JK; Misrar, P				Kapadia, Bandish; Viswakarma, Navin; Parsa, Kishore V. L.; Kain, Vasundhara; Behera, Soma; Suraj, Sashidhara Kaimal; Babu, Phanithi Prakash; Kar, Anand; Panda, Sunanda; Zhu, Yi-Jun; Jia, Yuzhi; Thimmapaya, Bayar; Reddy, Janardan K.; Misrar, Parimal			ERK2-Mediated Phosphorylation of Transcriptional Coactivator Binding Protein PIMT/NCoA6IP at Ser(298) Augments Hepatic Gluconeogenesis	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; RECEPTOR (PPAR)-BINDING PROTEIN; THYROID-HORMONE; NONGENOMIC ACTIONS; TELOMERASE RNA; KINASE-C; EXPRESSION; NUCLEAR; METHYLTRANSFERASE; ACTIVATION	PRIP-Interacting protein with methyl transferase domain (PIMT) serves as a molecular bridge between CREB-binding protein (CBP)/ E1A binding protein p300 (Ep300) -anchored histone acetyl transferase and the Mediator complex sub-unit1 (Med1) and modulates nuclear receptor transcription. Here, we report that ERK2 phosphorylates PIMT at Ser(298) and enhances its ability to activate PEPCK promoter. We observed that PIMT is recruited to PEPCK promoter and adenoviral-mediated over-expression of PIMT in rat primary hepatocytes up-regulated expression of gluconeogenic genes including PEPCK. Reporter experiments with phosphomimetic PIMT mutant (PIMTS298D) suggested that conformational change may play an important role in PIMT-dependent PEPCK promoter activity. Overexpression of PIMT and Med1 together augmented hepatic glucose output in an additive manner. Importantly, expression of gluconeogenic genes and hepatic glucose output were suppressed in isolated liver specific PIMT knockout mouse hepatocytes. Furthermore, consistent with reporter experiments, PIMTS298D but not PIMTS298A augmented hepatic glucose output via up-regulating the expression of gluconeogenic genes. Pharmacological blockade of MAPK/ERK pathway using U0126, abolished PIMT/Med1-dependent gluconeogenic program leading to reduced hepatic glucose output. Further, systemic administration of T-4 hormone to rats activated ERK1/2 resulting in enhanced PIMT ser(298) phosphorylation. Phosphorylation of PIMT led to its increased binding to the PEPCK promoter, increased PEPCK expression and induction of gluconeogenesis in liver. Thus, ERK2-mediated phosphorylation of PIMT at Ser(298) is essential in hepatic gluconeogenesis, demonstrating an important role of PIMT in the pathogenesis of hyperglycemia.	[Kapadia, Bandish; Viswakarma, Navin; Parsa, Kishore V. L.; Kain, Vasundhara; Behera, Soma; Misrar, Parimal] Univ Hyderabad, Dr Reddys Inst Life Sci, Dept Biol, Hyderabad 500134, Andhra Pradesh, India; [Suraj, Sashidhara Kaimal; Babu, Phanithi Prakash] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Kar, Anand; Panda, Sunanda] Devi Ahilya Univ, Dept Life Sci, Indore, Madhya Pradesh, India; [Zhu, Yi-Jun; Jia, Yuzhi; Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	University of Hyderabad; University of Hyderabad; Devi Ahilya University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	jkreddy@northwestern.edu; parimalm@drils.org	Kapadia, Bandish/I-7965-2019; Kain, Vasundhara/AAL-7371-2021; Kar, Anand/AAP-9603-2021	Kapadia, Bandish/0000-0001-6021-0008; Parsa, Kishore/0000-0001-7883-2534; Panda, Sunanda/0000-0003-4679-0223	DBT (Department of Biotechnology, India) [BT/PR13527/BRB/0/765/2010]; National Institutes of Health [DK083163, DK097249, R21A1094296]; CSIR; DBT, India; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK083163, R01DK083163, R01DK097249] Funding Source: NIH RePORTER	DBT (Department of Biotechnology, India)(Department of Biotechnology (DBT) India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, India(Department of Biotechnology (DBT) India); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by DBT (Department of Biotechnology, India) funded Grant (No. BT/PR13527/BRB/0/765/2010) awarded to PM and KVLP, and the National Institutes of Health Grant DK083163 and DK097249 to J.K.R. and R21A1094296 to B. T. BK and VK are financially supported by Senior Research Fellowship from CSIR and post-doctoral fellowship from DBT, India respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati JM, 1998, J BIOL CHEM, V273, P18751, DOI 10.1074/jbc.273.30.18751; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Croniger CM, 2002, BIOCHEM MOL BIOL EDU, V30, P353, DOI 10.1002/bmb.2002.494030060151; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; Davis PJ, 2002, J ENDOCRINOL INVEST, V25, P377, DOI 10.1007/BF03344022; Delaye J, 1975, Nouv Presse Med, V4, P3239; Duplus E, 2002, J CELL BIOCHEM, V85, P651, DOI 10.1002/jcb.10175; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; JAUREGUI HO, 1981, IN VITRO CELL DEV B, V17, P1100; Jia YZ, 2012, MECH DEVELOP, V129, P193, DOI 10.1016/j.mod.2012.08.002; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kim GH, 2012, BIOCHEM J, V447, P437, DOI 10.1042/BJ20120861; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kushiyama A, 2005, J BIOL CHEM, V280, P42016, DOI 10.1074/jbc.M503065200; Lee S, 2011, BIOCHEMISTRY-US, V50, P9500, DOI 10.1021/bi201103b; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018594; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Louet JF, 2010, CELL METAB, V12, P606, DOI 10.1016/j.cmet.2010.11.009; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Misra P, 2002, J BIOL CHEM, V277, P20011, DOI 10.1074/jbc.M201739200; Monecke T, 2009, NUCLEIC ACIDS RES, V37, P3865, DOI 10.1093/nar/gkp249; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Oate SA, 1995, SCIENCE, V270, P1354, DOI DOI 10.1126/SCIENCE.270.5240.1354.PUBMED:7481822; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sikes ML, 2009, J IMMUNOL METHODS, V344, P58, DOI 10.1016/j.jim.2009.03.007; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu HY, 2005, J BIOL CHEM, V280, P36013, DOI 10.1074/jbc.M508027200; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yedavalli VSRK, 2010, P NATL ACAD SCI USA, V107, P14787, DOI 10.1073/pnas.1009490107; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	57	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83787	10.1371/journal.pone.0083787	http://dx.doi.org/10.1371/journal.pone.0083787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358311	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700071
J	Lewinska, M; Zelenko, U; Merzel, F; Grdadolnik, SG; Murray, JC; Rozman, D				Lewinska, Monika; Zelenko, Urska; Merzel, Franci; Grdadolnik, Simona Golic; Murray, Jeffrey C.; Rozman, Damjana			Polymorphisms of CYP51A1 from Cholesterol Synthesis: Associations with Birth Weight and Maternal Lipid Levels and Impact on CYP51 Protein Structure	PLOS ONE			English	Article							LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; SPONTANEOUS PRETERM BIRTH; GENES; MOUSE; PREGNANCY; DEMETHYLASE; METABOLISM; DYNAMICS; DISEASE; BINDING	We investigated the housekeeping cytochrome P450 CYP51A1 encoding lanosterol 14 alpha-demethylase from cholesterol synthesis that was so far not directly linked to human disorders. By direct sequencing of CYP51A1 in 188 women with spontaneous preterm delivery and 188 unrelated preterm infants (gestational age <37 weeks) we identified 22 variants where 10 are novel and rare. In infants there were two novel CYP51A1 variants where damaging effects of p.Tyr145Asp from the substrate recognition region, but not p. Asn193Asp, were predicted by PolyPhen2 and SIFT. This was confirmed by molecular modeling showing that Tyr145Asp substitution results in changed electrostatic potential of the CYP51 protein surface and lengthened distance to the heme which prevents hydrogen bonding. The CYP51 Tyr145Asp mutation is rare and thus very interesting for further structure/function relationship studies. From the 12 identified known variants rs6465348 was chosen for family based association studies due to its high minor allele frequency. Interestingly, this CYP51A1 common variant associates with small for gestational age weight in newborns (p = 0.028) and lower blood total cholesterol and low density lipoprotein cholesterol levels in mothers in 2nd trimester of pregnancy (p = 0.042 and p = 0.046 respectively). Our results indicate a new link between a cholesterol synthesis gene CYP51A1 and pregnancy pathologies.	[Lewinska, Monika; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Ljubljana, Slovenia; [Zelenko, Urska; Merzel, Franci; Grdadolnik, Simona Golic] Natl Inst Chem Slovenia, Lab Biomol Struct, Ljubljana, Slovenia; [Grdadolnik, Simona Golic] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Ljubljana; National Institute of Chemistry - Slovenia; University of Iowa	Rozman, D (corresponding author), Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Lewinska, Monika/N-9919-2017	Lewinska, Monika/0000-0002-5275-992X; Merzel, Franci/0000-0002-2748-4901; Golic Grdadolnik, Simona/0000-0002-0873-9593; Rozman, Damjana/0000-0002-6501-2163	FP7 FightingDrugFailure ITN Marie Curie [238132]; Slovenian Research Agency [P1-0104, P1-0010, J7-4053]; NIH [HD52953]; Bill and Melinda Gates Foundation; Slovenian Research Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	FP7 FightingDrugFailure ITN Marie Curie; Slovenian Research Agency(Slovenian Research Agency - Slovenia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Slovenian Research Agency(Slovenian Research Agency - Slovenia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the FP7 FightingDrugFailure ITN Marie Curie grant #238132 to support M. Lewinska Ph.D. thesis, and by the Slovenian Research Agency program grant P1-0104, grant P1-0010 and project J7-4053, by the NIH grant HD52953, and from the Bill and Melinda Gates Foundation to JCM. U. Zelenko was funded as young researcher by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Kristina M, 2004, Semin Fetal Neonatal Med, V9, P445, DOI 10.1016/j.siny.2004.04.001; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; Amundsen AL, 2006, ATHEROSCLEROSIS, V189, P451, DOI 10.1016/j.atherosclerosis.2006.01.002; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron IS, 2012, NEUROPSYCHOLOGY REV; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Bick D, 2012, MIDWIFERY, V28, P401, DOI 10.1016/j.midw.2012.06.010; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bream ENA, 2013, PEDIATR RES, V73, P135, DOI 10.1038/pr.2012.166; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Catov JM, 2008, OBSTET GYNECOL, V112, P1116, DOI 10.1097/AOG.0b013e31818aa5b5; Catov JM, 2007, AM J EPIDEMIOL, V166, P1312, DOI 10.1093/aje/kwm273; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Chernick MR, 2002, AM STAT, V56, P149, DOI 10.1198/000313002317572835; Costantine MM, 2013, AM J PERINAT, V30, P335, DOI 10.1055/s-0032-1324708; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; FISCHER RT, 1991, J BIOL CHEM, V266, P6124; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kelley R I, 2000, Adv Pediatr, V47, P1; Lee SM, 2013, YONSEI MED J, V54, P839, DOI 10.3349/ymj.2013.54.4.839; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lewinska M, 2013, ACTA CHIMIC IN PRESS; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mudd LM, 2012, ACTA OBSTET GYN SCAN, V91, P726, DOI 10.1111/j.1600-0412.2012.01391.x; Muscarella LA, 2010, J BIOMEDICINE BIOTEC, V2010; Nour Nawal M, 2012, Rev Obstet Gynecol, V5, P100; Peacock JL, 2013, PEDIATR RES, V73, P457, DOI 10.1038/pr.2012.201; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Rozman D, 1996, GENOMICS, V38, P371, DOI 10.1006/geno.1996.0640; Rozman D, 1996, ARCH BIOCHEM BIOPHYS, V333, P466, DOI 10.1006/abbi.1996.0416; Scheer N, 2012, MOL PHARMACOL, V81, P63, DOI 10.1124/mol.111.075192; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STAYTON PS, 1989, BIOCHEMISTRY-US, V28, P8201, DOI 10.1021/bi00446a035; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waterham HR, 2012, AM J MED GENET C, V160C, P263, DOI 10.1002/ajmg.c.31346; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Zawaira A, 2010, COMPUT BIOL CHEM, V34, P42, DOI 10.1016/j.compbiolchem.2009.10.006	57	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82554	10.1371/journal.pone.0082554	http://dx.doi.org/10.1371/journal.pone.0082554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358204	Green Submitted, gold, Green Published			2022-12-25	WOS:000328737700022
J	Peng, AP; Liu, J; Gao, YZ; Chen, ZY				Peng, Anping; Liu, Juan; Gao, Yanzheng; Chen, Zeyou			Distribution of Endophytic Bacteria in Alopecurus aequalis Sobol and Oxalis corniculata L. from Soils Contaminated by Polycyclic Aromatic Hydrocarbons	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PLANT UPTAKE; ORGANIC POLLUTANTS; DIVERSITY; PHYTOREMEDIATION; ROOTS; BIOREMEDIATION; PHENANTHRENE; PARTITION; PYRENE	The distributions of endophytic bacteria in Alopecurus aequalis Sobol and Oxalis corniculata L. grown in soils contaminated with different levels of polycyclic aromatic hydrocarbons (PAHs) were investigated with polymerase chain reaction followed by denaturing gradient gel electrophoresis technology (PCR-DGGE) and cultivation methods. Twelve types of PAHs, at concentrations varying from 0.16 to 180 mg? kg 21, were observed in the roots and shoots of the two plants. The total PAH concentrations in Alopecurus aequalis Sobol obtained from three different PAH-contaminated stations were 184, 197, and 304 mg? kg 21, and the total PAH concentrations in Oxalis corniculata L. were 251, 346, and 600 mg? kg 21, respectively. The PCR-DGGE results showed that the endophytic bacterial communities in the roots and shoots of the two plants were quite different, although most bacteria belonged to Firmicutes, Proteobacteria, Actinobacteria and Bacteroidetes. A total of 68 endophytic bacterial strains were isolated from different tissues of the two plants and classified into three phyla: Firmicutes, Proteobacteria and Bacteroidetes. In both plants, Bacillus spp. and Pseudomonas spp. were the dominant cultivable populations. With an increase in the PAH pollution level, the diversity and distribution of endophytic bacteria in the two plants changed correspondingly, and the number of cultivable endophytic bacterial strains decreased rapidly. Testing of the isolated endophytic bacteria for tolerance to each type of PAH showed that most isolates could grow well on Luria-Bertani media in the presence of different PAHs, and some isolates were able to grow rapidly on a mineral salt medium with a single PAH as the sole carbon and energy source, indicating that these strains may have the potential to degrade PAHs in plants. This research provides the first insight into the characteristics of endophytic bacterial populations under different PAH pollution levels and provides a species resource for the isolation of PAH-degrading endophytic bacteria.	[Peng, Anping; Liu, Juan; Gao, Yanzheng; Chen, Zeyou] Nanjing Agr Univ, Inst Organ Contaminant Control & Soil Remediat, Coll Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, J (corresponding author), Nanjing Agr Univ, Inst Organ Contaminant Control & Soil Remediat, Coll Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China.	liujuan@njau.edu.cn; gaoyanzheng@njau.edu.cn	Gao, Yanzheng/G-6391-2010	Gao, Yanzheng/0000-0002-3814-3555	National Science Foundation of China [41171380, 41201501, 41071212, 21077056, 41171193]; Science Foundation of Jiangsu Province [BK2012370, BE2011780]; China Postdoctoral Science Foundation [2011M501246]; Doctoral Fund of Ministry of Education of China [20120097120012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was financially supported by the National Science Foundation of China (41171380, 41201501, 41071212, 21077056, 41171193), the Science Foundation of Jiangsu Province (BK2012370, BE2011780), the China Postdoctoral Science Foundation (2011M501246) and the Doctoral Fund of Ministry of Education of China (20120097120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Brecht V, 2011, PLOS ONE, V6, DOI [10.1371/journal.Pone.0019265, DOI 10.1371/J0URNAL.P0NE.0019265]; BRIGGS GG, 1983, PESTIC SCI, V14, P492, DOI 10.1002/ps.2780140506; BROOKS DS, 1994, BIOL CONTROL, V4, P373, DOI 10.1006/bcon.1994.1047; Byers HK, 1998, FEMS MICROBIOL ECOL, V25, P391, DOI 10.1111/j.1574-6941.1998.tb00491.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen WM, 2012, AQUAT BIOL, V15, P99, DOI 10.3354/ab00422; Chiou CT, 2001, ENVIRON SCI TECHNOL, V35, P1437, DOI 10.1021/es0017561; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Dai CC, 2010, BIODEGRADATION, V21, P245, DOI 10.1007/s10532-009-9297-4; DAVISON J, 1988, BIO-TECHNOL, V6, P282, DOI 10.1038/nbt0388-282; Editorial Committee of Flora of China, 1999, FLORA CHINA, V43; Editorial Committee of Flora of China, 1987, FLORA CHINA, V9; Franzaring J, 2000, BASIC APPL ECOL, V1, P25, DOI 10.1078/1439-1791-00003; Gao YZ, 2008, CHEMOSPHERE, V72, P636, DOI 10.1016/j.chemosphere.2008.02.032; Gao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050467; Gao YZ, 2011, J ENVIRON QUAL, V40, P653, DOI 10.2134/jeq2010.0320; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Garbeva P, 2001, MICROBIAL ECOL, V41, P369, DOI 10.1007/s002480000096; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; Harish S, 2008, APPL SOIL ECOL, V39, P187, DOI 10.1016/j.apsoil.2007.12.006; Ho YN, 2009, J BIOSCI BIOENG, V108, pS94, DOI 10.1016/j.jbiosc.2009.08.276; Hung PQ., 2004, OMORNICE, V12, P92, DOI DOI 10.1177/1933719113488838; Juhasz AL, 2000, INT BIODETER BIODEGR, V45, P57, DOI 10.1016/S0964-8305(00)00052-4; Kaplan CW, 2004, APPL ENVIRON MICROB, V70, P1777, DOI 10.1128/AEM.70.3.1777-1786.2004; Kapley A, 2007, WORLD J MICROB BIOT, V23, P923, DOI 10.1007/s11274-006-9315-1; Khan Z., 2011, Current Topics in Plant Biology, Volume 12, P97; Kuklinsky-Sobral HL, 2005, PLANT SOIL, V273, P91, DOI 10.1007/s11104-004-6894-1; Ling WT, 2004, ENVIRON GEOL, V46, P553, DOI 10.1007/s00254-004-1028-x; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; McCully ME, 2001, AUST J PLANT PHYSIOL, V28, P983, DOI 10.1071/PP01101; Mckone TE, 2007, ENVIRON TOXICOL CHEM, V26, P2494, DOI 10.1897/06-269.1; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Miliute I., 2011, Biologija, V57, P98; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; MORTELMANS K, 1986, ENVIRON MOL MUTAGEN, V8, P1, DOI 10.1002/em.2860080802; Newman LA, 2005, TRENDS BIOTECHNOL, V23, P6, DOI 10.1016/j.tibtech.2004.11.010; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; PAHLMAN R, 1987, CARCINOGENESIS, V8, P773, DOI 10.1093/carcin/8.6.773; Phillips LA, 2008, SOIL BIOL BIOCHEM, V40, P3054, DOI 10.1016/j.soilbio.2008.09.006; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Robson Andreazza SP, 2010, 19 WORLD C SOIL SCI; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Sheng XF, 2008, INT BIODETER BIODEGR, V62, P88, DOI 10.1016/j.ibiod.2007.12.003; Shin DS, 2007, J MICROBIOL BIOTECHN, V17, P1361; Siciliano SD, 2001, APPL ENVIRON MICROB, V67, P2469, DOI 10.1128/AEM.67.6.2469-2475.2001; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Tang JC, 2010, SOIL TILL RES, V110, P87, DOI 10.1016/j.still.2010.06.010; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Wang YX, 2004, CURR MICROBIOL, V49, P288, DOI 10.1007/s00284-004-4348-x; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Wu Q, 2006, BIOMED ENVIRON SCI, V19, P371; Yao ZL, 2008, Improved solid double-layer flat plate method for quick high-flux sifting motion of polycyclic aromatic hydrocarbon degradation bacterium, Patent No. [CN 101245366, 101245366]; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhu LZ, 2004, ENVIRON POLLUT, V131, P505, DOI 10.1016/j.envpol.2004.02.003	63	31	33	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83054	10.1371/journal.pone.0083054	http://dx.doi.org/10.1371/journal.pone.0083054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358247	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700043
J	Wylie, KP; Tanabe, J; Martin, LF; Wongngamnit, N; Tregellas, JR				Wylie, Korey P.; Tanabe, Jody; Martin, Laura F.; Wongngamnit, Narin; Tregellas, Jason R.			Nicotine Increases Cerebellar Activity during Finger Tapping	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; SCHIZOPHRENIC-PATIENTS; NONSMOKERS; ATTENTION; BRAIN; ACTIVATION; FMRI; METAANALYSIS; MOVEMENTS; SLICES	Nicotine improves performance on several cognitive and sensorimotor tasks. The neuronal mechanisms associated with these changes in performance are, however, largely unknown. Functional magnetic resonance imaging (fMRI) was used to examine the effect of nicotine on neuronal response in nineteen healthy subjects while they performed an auditory-paced finger tapping task. Subjects performed the task, after receiving either a nicotine patch or placebo treatment, in a single blind, crossover design. Compared to placebo, nicotine treatment increased response in the cerebellar vermis. Increased vermal activity, in the absence of changes in other task-related regions suggests specificity in nicotine's effects.	[Wylie, Korey P.; Tanabe, Jody; Martin, Laura F.; Wongngamnit, Narin; Tregellas, Jason R.] Univ Colorado, Dept Psychiat, Aurora, CO 80309 USA; [Tanabe, Jody] Univ Colorado, Dept Radiol, Aurora, CO 80309 USA; [Tregellas, Jason R.] Denver Vet Affairs Med Ctr, Eastern Colorado Hlth Syst, Res Serv, Res Serv 151, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Tregellas, JR (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80309 USA.	Jason.Tregellas@UCDenver.edu	Tregellas, Jason/J-3637-2015		Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service; National Institutes of Mental Health [MH-086383]; Brain and Behavior Research Foundation; Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086383, T32MH015442] Funding Source: NIH RePORTER	Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration Biomedical Laboratory and Clinical Science Research and Development Service, the National Institutes of Mental Health grant MH-086383, the Brain and Behavior Research Foundation, and the Blowitz-Ridgeway Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Agulhon C, 1998, MOL BRAIN RES, V58, P123, DOI 10.1016/S0169-328X(98)00113-2; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Chan RCK, 2009, BRAIN RES REV, V59, P316, DOI 10.1016/j.brainresrev.2008.09.003; De Filippi G, 2001, PHARMACOL BIOCHEM BE, V70, P447, DOI 10.1016/S0091-3057(01)00653-0; Fant RV, 2000, PHARMACOL BIOCHEM BE, V67, P479, DOI 10.1016/S0091-3057(00)00399-3; Ghatan PH, 1998, PSYCHOPHARMACOLOGY, V136, P179, DOI 10.1007/s002130050554; Graham A, 2002, NEUROSCIENCE, V113, P493, DOI 10.1016/S0306-4522(02)00223-3; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; Kumari V, 2003, NEUROIMAGE, V19, P1002, DOI 10.1016/S1053-8119(03)00110-1; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Levin ED, 1998, PSYCHOPHARMACOLOGY, V140, P135, DOI 10.1007/s002130050750; OJIMA H, 1989, J COMP NEUROL, V290, P41, DOI 10.1002/cne.902900104; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Rao SM, 1997, J NEUROSCI, V17, P5528; Reno LAC, 2004, NEUROSCIENCE, V124, P647, DOI 10.1016/j.neuroscience.2003.12.023; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Rivkin MJ, 2003, PEDIATR NEUROL, V28, P89, DOI 10.1016/S0887-8994(02)00492-7; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Silver H, 2002, EUR NEUROPSYCHOPHARM, V12, P141, DOI 10.1016/S0924-977X(01)00149-3; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Tregellas JR, 2006, NEUROIMAGE, V32, P307, DOI 10.1016/j.neuroimage.2006.02.036; Turner JR, 2005, NICOTINIC CHOLINERGI; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WEST RJ, 1986, PHARMACOL BIOCHEM BE, V25, P727, DOI 10.1016/0091-3057(86)90377-1; Wignall ND, 2011, EXP CLIN PSYCHOPHARM, V19, P183, DOI 10.1037/a0023292; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025	31	6	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84581	10.1371/journal.pone.0084581	http://dx.doi.org/10.1371/journal.pone.0084581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358367	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700102
J	Enomoto, T; Ohashi, K; Shibata, R; Kambara, T; Uemura, Y; Yuasa, D; Kataoka, Y; Miyabe, M; Matsuo, K; Joki, Y; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Murohara, T; Ouchi, N				Enomoto, Takashi; Ohashi, Koji; Shibata, Rei; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Matsuo, Kazuhiro; Joki, Yusuke; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki; Ouchi, Noriyuki			Transcriptional Regulation of an Insulin-Sensitizing Adipokine Adipolin/CTRP12 in Adipocytes by Kruppel-Like Factor 15	PLOS ONE			English	Article							MACROPHAGE POLARIZATION; INFLAMMATORY DISEASE; METABOLIC SYNDROME; OBESITY; ADIPONECTIN; RESISTANCE; PROTEIN; ADIPOSE; EXPRESSION; TISSUE	Obese states characterized by chronic inflammation are closely linked to the development of metabolic dysfunction. We identified adipolin/CTRP12 as an insulin-sensitizing and anti-inflammatory adipokine. Although obese conditions down-regulate adipolin expression, its molecular mechanism is largely unknown. Here we show that the transcriptional regulator Kruppel-like factor (KLF) 15 is involved in the regulation of adipolin expression in adipocytes. White adipose tissue from diet-induced obese (DIO) mice showed decreased expression of KLF9 and KLF15 among several KLFs, which was accompanied by reduced expression of adipolin. In cultured 3T3L1 adipocytes, treatment with TNF alpha significantly reduced the mRNA levels of KLF9, KLF15 and adipolin. Adenovirus-mediated overexpression of KLF15 but not KLF9 reversed TNF alpha-induced reduction of adipolin expression in adipocytes. Conversely, gene targeting ablation of KLF15 attenuated adipolin expression in adipocytes. Expression of KLF15 but not KLF9 enhanced the promoter activity of adipolin in HEK293 cells. Pretreatment of 3T3L1 adipocytes with the JNK inhibitor SP600125, but not p38 MAPK inhibitor SB203580 blocked the inhibitory effects of TNF alpha on adipolin and KLF15 expression. These data suggest that adipose inflammation under conditions of obesity suppresses adipolin expression via JNK-dependent down-regulation of KLF15 in adipocytes.	[Enomoto, Takashi; Shibata, Rei; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Matsuo, Kazuhiro; Joki, Yusuke; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan.	nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Cardiovascular Research Fund, Tokyo, Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Cardiovascular Research Fund, Tokyo, Japan	This work was supported by Grant-in-Aid for Scientific Research, Grant-in-Aid for Challenging Exploratory Research and grants from Takeda Science Foundation, the Uehara Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, and SENSHIN Medical Research Foundation to N. Ouchi. R. Shibata was supported with the Grant-in-Aid for Young Scientists B and the Uehara Memorial Foundation. K. Ohashi was supported with the Grant-in-Aid for Scientific Research and The Cardiovascular Research Fund, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Enomoto T, 2012, BIOCHEM BIOPH RES CO, V428, P155, DOI 10.1016/j.bbrc.2012.10.031; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kawamata Y, 2007, J BIOL CHEM, V282, P28549, DOI 10.1074/jbc.M705869200; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Pereira RI, 2008, LIFE SCI, V83, P638, DOI 10.1016/j.lfs.2008.09.002; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200	43	25	32	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83183	10.1371/journal.pone.0083183	http://dx.doi.org/10.1371/journal.pone.0083183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358263	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700110
J	Gao, T; Yang, XC; Jin, YX; Ma, HL; Li, JY; Yu, HD; Yu, QY; Zheng, X; Xu, B				Gao, Tian; Yang, Xiuchun; Jin, Yunxiang; Ma, Hailong; Li, Jinya; Yu, Haida; Yu, Qiangyi; Zheng, Xiao; Xu, Bin			Spatio-Temporal Variation in Vegetation Biomass and Its Relationships with Climate Factors in the Xilingol Grasslands, Northern China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; RAIN-USE EFFICIENCY; GREEN-UP DATE; PRECIPITATION GRADIENT; CARBON STORAGE; DYNAMICS; METAANALYSIS; ECOSYSTEMS; PATTERNS; GROWTH	Knowledge about grassland biomass and its dynamics is critical for studying regional carbon cycles and for the sustainable use of grassland resources. In this study, we investigated the spatio-temporal variation of biomass in the Xilingol grasslands of northern China. Field-based biomass samples and MODIS time series data sets were used to establish two empirical models based on the relationship of the normalized difference vegetation index (NDVI) with above-ground biomass (AGB) as well as that of AGB with below-ground biomass (BGB). We further explored the climatic controls of these variations. Our results showed that the biomass averaged 99.01 Tg (1 Tg= 1012 g) over a total area of 19.6x10(4) km(2) and fluctuated with no significant trend from 2001 to 2012. The mean biomass density was 505.4 g/m(2), with 62.6 g/m(2) in AGB and 442.8 g/m(2) in BGB, which generally decreased from northeast to southwest and exhibited a large spatial heterogeneity. The year-to-year AGB pattern was generally consistent with the inter-annual variation in the growing season precipitation (GSP), showing a robust positive correlation (R-2=0.82, P<0.001), but an opposite coupled pattern was observed with the growing season temperature (GST) (R-2=0.61, P=0.003). Climatic factors also affected the spatial distribution of AGB, which increased progressively with the GSP gradient (R-2=0.76, P<0.0001) but decreased with an increasing GST (R-2=0.70, P<0.0001). An improved moisture index that combined the effects of GST and GSP explained more variation in AGB than did precipitation alone (R-2=0.81, P<0.0001). The relationship between AGB and GSP could be fit by a power function. This increasing slope of the GSP-AGB relationships along the GSP gradient may be partly explained by the GST-GSP spatial pattern in Xilingol. Our findings suggest that the relationships between climatic factors and AGB may be scale-dependent and that multi-scale studies and sufficient long-term field data are needed to examine the relationships between AGB and climatic factors.	[Gao, Tian; Zheng, Xiao] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Gao, Tian; Yang, Xiuchun; Jin, Yunxiang; Ma, Hailong; Li, Jinya; Yu, Haida; Yu, Qiangyi; Xu, Bin] Chinese Acad Agr Sci, Key Lab Agr, Minist Agr, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Xu, B (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	xubin@caas.cn	Yu, Qiangyi/AFR-0194-2022; Li, Jinya/N-2990-2014; Yu, Qiangyi/J-9360-2014	Li, Jinya/0000-0001-8596-6194; Yu, Qiangyi/0000-0002-6457-3583	National High Technology Project (863) [2006AA10Z242, 2008AA121805]; National Natural Science Foundation of China (NSFC) [40701055]	National High Technology Project (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Project (863, No. 2006AA10Z242, 2008AA121805) and the National Natural Science Foundation of China (NSFC, 40701055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Beedlow PA, 2013, AGR FOREST METEOROL, V169, P174, DOI 10.1016/j.agrformet.2012.10.010; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Department of Animal Husbandry and Veterinary General Station of Animal Husbandry and Veterinary of Ministry of Agriculture of China, 1996, RANG RES CHIN; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Fang J. Y, 1996, CARBON POOLS TERREST; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P757, DOI 10.1007/s11427-010-4029-x; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Feng XM, 2011, ECOL INDIC, V11, P175, DOI 10.1016/j.ecolind.2009.07.002; Gao T, 2012, AGR 2012 1 INT C SHA, P1; [高添 Gao Tian], 2012, [地理科学进展, Progress in Geography], V31, P1724; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Hsu JS, 2012, GLOBAL CHANGE BIOL, V18, P2246, DOI 10.1111/j.1365-2486.2012.02687.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Hu ZM, 2007, SCI CHINA SER D, V50, P754, DOI 10.1007/s11430-007-0010-3; Hu ZM, 2010, GLOBAL ECOL BIOGEOGR, V19, P842, DOI 10.1111/j.1466-8238.2010.00564.x; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; [金云翔 Jin Yunxiang], 2011, [中国科学. 生命科学, Scientia Sinica Vitae], V41, P1185; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Ni J, 2011, REG ENVIRON CHANGE, V11, pS49, DOI 10.1007/s10113-010-0170-0; Ouyang W, 2012, ECOL INDIC, V18, P163, DOI 10.1016/j.ecolind.2011.11.013; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, pB2002; Ren J, 1965, J GANSU AGR U, V2, P33; Ruppert JC, 2012, J VEG SCI, V23, P1035, DOI 10.1111/j.1654-1103.2012.01420.x; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Siefert A, 2012, J VEG SCI, V23, P942, DOI 10.1111/j.1654-1103.2012.01401.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Wu XC, 2013, GLOBAL CHANGE BIOL, V19, P870, DOI 10.1111/gcb.12086; Xu B, 2008, INT J REMOTE SENS, V29, P5313, DOI 10.1080/01431160802036276; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Zhang GL, 2011, J GEOGR SCI, V21, P634, DOI 10.1007/s11442-011-0869-y; 马文红, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P84	42	39	44	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83824	10.1371/journal.pone.0083824	http://dx.doi.org/10.1371/journal.pone.0083824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358313	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700139
J	Maestripieri, D; Klimczuk, ACE; Seneczko, M; Traficonte, DM; Wilson, MC				Maestripieri, Dario; Klimczuk, Amanda C. E.; Seneczko, Marianne; Traficonte, Daniel M.; Wilson, M. Claire			Relationship Status and Relationship Instability, but Not Dominance, Predict Individual Differences in Baseline Cortisol Levels	PLOS ONE			English	Article							ADULT ATTACHMENT; STRESS HORMONES; RESPONSES; HUMANS; POWER	We investigated variation in baseline cortisol levels in relation to relationship status (single or in a relationship), relationship characteristics (length, stability, presence or absence of clear dominance), or individual attributes (dominant or subordinate status, relative physical attractiveness, relationship worries). Study participants were 77 men and 75 women aged between 18 and 38 years. Individuals in romantic relationships had lower cortisol levels than singles. Individuals of African ethnicity, however, showed the opposite pattern. Individuals who perceived their relationship to be highly unstable had higher cortisol levels. Aside from African-Americans, married individuals reported the lowest relationship instability and the lowest cortisol levels, followed by individuals in long-term relationships, and by individuals in short-term relationships. The presence or absence of clear dominance in the relationship, dominance status, or relationship worries did not affect cortisol levels. Therefore relationship status and relationship instability were better predictors of variation in cortisol (presumably through stress-related mechanisms) than individual attributes.	[Maestripieri, Dario; Klimczuk, Amanda C. E.; Seneczko, Marianne; Traficonte, Daniel M.; Wilson, M. Claire] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA	University of Chicago	Maestripieri, D (corresponding author), Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA.	dario@uchicago.edu		Wilson, M. Claire/0000-0002-9301-246X	University of Chicago	University of Chicago(University of Chicago)	This study was funded by intramural funds from the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Adam EK, 2001, PSYCHONEUROENDOCRINO, V26, P189, DOI 10.1016/S0306-4530(00)00045-7; Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Almasi B, 2013, HORM BEHAV, V64, P161, DOI 10.1016/j.yhbeh.2013.03.001; Brooks KP, 2011, PERS RELATIONSHIP, V18, P302, DOI 10.1111/j.1475-6811.2011.01357.x; Cate RM, 2002, J SOC PERS RELAT, V19, P261, DOI 10.1177/0265407502192005; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Doane LD, 2010, PSYCHONEUROENDOCRINO, V35, P430, DOI 10.1016/j.psyneuen.2009.08.005; Ellison P. T., 2009, ENDOCRINOLOGY SOCIAL; FELMLEE DH, 1994, SEX ROLES, V31, P275, DOI 10.1007/BF01544589; Flinn MV, 2011, NEUROSCI BIOBEHAV R, V35, P1611, DOI 10.1016/j.neubiorev.2011.01.005; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P19, DOI 10.1007/s00265-012-1420-6; Hruschka DJ, 2005, PSYCHONEUROENDOCRINO, V30, P698, DOI 10.1016/j.psyneuen.2005.03.002; Kidd T, 2011, PSYCHONEUROENDOCRINO, V36, P771, DOI 10.1016/j.psyneuen.2010.10.014; Maestripieri D, 2010, STRESS, V13, P413, DOI 10.3109/10253891003681137; Masi CM, 2004, J APPL PHYSIOL, V97, P941, DOI 10.1152/japplphysiol.00256.2004; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84003	10.1371/journal.pone.0084003	http://dx.doi.org/10.1371/journal.pone.0084003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358324	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700146
J	Tillmar, AO; Dell'Amico, B; Welander, J; Holmlund, G				Tillmar, Andreas O.; Dell'Amico, Barbara; Welander, Jenny; Holmlund, Gunilla			A Universal Method for Species Identification of Mammals Utilizing Next Generation Sequencing for the Analysis of DNA Mixtures	PLOS ONE			English	Article							MITOCHONDRIAL; MARKERS	Species identification can be interesting in a wide range of areas, for example, in forensic applications, food monitoring and in archeology. The vast majority of existing DNA typing methods developed for species determination, mainly focuses on a single species source. There are, however, many instances where all species from mixed sources need to be determined, even when the species in minority constitutes less than 1 % of the sample. The introduction of next generation sequencing opens new possibilities for such challenging samples. In this study we present a universal deep sequencing method using 454 GS Junior sequencing of a target on the mitochondrial gene 16S rRNA. The method was designed through phylogenetic analyses of DNA reference sequences from more than 300 mammal species. Experiments were performed on artificial species-species mixture samples in order to verify the method's robustness and its ability to detect all species within a mixture. The method was also tested on samples from authentic forensic casework. The results showed to be promising, discriminating over 99.9 % of mammal species and the ability to detect multiple donors within a mixture and also to detect minor components as low as 1 % of a mixed sample.	[Tillmar, Andreas O.; Dell'Amico, Barbara; Holmlund, Gunilla] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Welander, Jenny; Holmlund, Gunilla] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	Swedish National Board of Forensic Medicine; Linkoping University	Tillmar, AO (corresponding author), Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden.	andreas.tillmar@rmv.se			Swedish National Board of Forensic Medicine [RMVFoU 05:25, RMVFoU 11:03]	Swedish National Board of Forensic Medicine	This work was supported by grants from the Swedish National Board of Forensic Medicine (RMVFoU 05:25 and RMVFoU 11:03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; Ali ME, 2012, GENET MOL RES, V11, P1762, DOI 10.4238/2012.June.29.9; An J, 2007, FORENSIC SCI INT, V167, P59, DOI 10.1016/j.forsciint.2005.12.031; Brenig B, 2010, FORENSIC SCI INT-GEN, V4, P228, DOI 10.1016/j.fsigen.2009.10.001; Cawthorn DM, 2012, GENE, V491, P40, DOI 10.1016/j.gene.2011.09.009; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Eurlings MCM, 2013, J FORENSIC SCI, V58, P822, DOI 10.1111/1556-4029.12072; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Gupta SK, 2006, J FORENSIC SCI, V51, P805, DOI 10.1111/j.1556-4029.2006.00154.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hancock-Hanser BL, 2013, MOL ECOL RESOUR, V13, P254, DOI 10.1111/1755-0998.12059; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Naue J, 2012, INT J LEGAL MED, V126, P483, DOI 10.1007/s00414-012-0674-x; Ortea I, 2012, ELECTROPHORESIS, V33, P2201, DOI 10.1002/elps.201100576; Sakaridis I, 2013, MEAT SCI, V94, P84, DOI 10.1016/j.meatsci.2012.12.017; Tobe SS, 2008, ELECTROPHORESIS, V29, P340, DOI 10.1002/elps.200700706; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Tobe SS, 2010, FORENSIC SCI MED PAT, V6, P195, DOI 10.1007/s12024-010-9168-7; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101	27	58	63	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83761	10.1371/journal.pone.0083761	http://dx.doi.org/10.1371/journal.pone.0083761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358309	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700137
J	Low, HZ; Reuter, S; Topperwien, M; Dankenbrink, N; Peest, D; Kabalak, G; Stripecke, R; Schmidt, RE; Matthias, T; Witte, T				Low, Hui Zhi; Reuter, Sandra; Topperwien, Michael; Dankenbrink, Nadine; Peest, Dietrich; Kabalak, Gamze; Stripecke, Renata; Schmidt, Reinhold E.; Matthias, Torsten; Witte, Torsten			Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule	PLOS ONE			English	Article							CLASS-I MOLECULES; LEUKOCYTE RECEPTOR CLUSTER; NON-HODGKIN-LYMPHOMA; INHIBITORY RECEPTOR; CYTOKINE PRODUCTION; MYELOID CELLS; IMMUNOGLOBULIN; COMPLEX; FAMILY; TRANSCRIPT-2	LILRA3 is the sole soluble member of the LILR family. Previous studies from our group had shown that a 6.7 kb genetic deletion of LILRA3 is associated with MS and Sjogrens syndrome. An impairment of the immune response leads to a predisposition for B-NHL, so we wanted to study whether the deletion of LILRA3 is also a risk factor for B-NHL, as well as the function of LILRA3. We discovered that the frequency of the homozygous LILRA3 deletion was significantly higher in B-NHL (6%) than in blood donors (3%) (P = 0.03). We detected binding of fluorochrome-conjugated recombinant LILRA3 to monocytes and B-cells. Incubation of PBMCs with recombinant LILRA3 induced proliferation of CD8(+) T-cells and NK cells, as determined by CFSE staining. Using a transwell system, we demonstrated that LILRA3-stimulated lymphocyte proliferation was mediated by monocytes and required both cell contact and soluble factors. Secretion of IL-6, IL-8, IL-1 beta and IL-10 in the cell supernatant was stimulated by LILRA3. We conclude that LILRA3 is an immunostimulatory molecule, whose deficiency is associated with higher frequency of B-NHL.	[Low, Hui Zhi; Topperwien, Michael; Dankenbrink, Nadine; Kabalak, Gamze; Schmidt, Reinhold E.; Witte, Torsten] Hannover Med Sch, Clin Immunol & Rheumatol, Hannover, Germany; [Peest, Dietrich; Stripecke, Renata] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Reuter, Sandra] AESKU KIPP Inst, Wendelsheim, Germany; [Matthias, Torsten] AESKU Diagnost, Wendelsheim, Germany	Hannover Medical School; Hannover Medical School	Low, HZ (corresponding author), Hannover Med Sch, Clin Immunol & Rheumatol, Hannover, Germany.	low.huizhi@mh-hannover.de	Witte, Torsten/B-5783-2016; Stripecke, Renata/G-3252-2013; Low, Hui Zhi/ABH-3088-2020	Low, Hui Zhi/0000-0002-3657-9371	DFG Klinische Forschergruppe [250, TP3, WI 1031/6-1]	DFG Klinische Forschergruppe(German Research Foundation (DFG))	This work was supported by the DFG Klinische Forschergruppe 250, TP3, WI 1031/6-1 to Torsten Witte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR RECOMM REP, V41, P1; Arm JP, 1997, J IMMUNOL, V159, P2342; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cho M, 2008, INT IMMUNOL, V20, P155, DOI 10.1093/intimm/dxm127; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Jones D, 2009, AGENDA, V44, P39; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Mellemkjaer L, 2008, ARTHRITIS RHEUM, V58, P657, DOI 10.1002/art.23267; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Nakajima H, 1999, J IMMUNOL, V162, P5; Pfistershammer K, 2009, BLOOD, V114, P2323, DOI 10.1182/blood-2008-10-183814; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; Saverino D, 2002, J IMMUNOL, V168, P207, DOI 10.4049/jimmunol.168.1.207; Torkar M, 1998, EUR J IMMUNOL, V28, P3959, DOI 10.1002/(SICI)1521-4141(199812)28:12<3959::AID-IMMU3959>3.0.CO;2-2; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81360	10.1371/journal.pone.0081360	http://dx.doi.org/10.1371/journal.pone.0081360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24363809	Green Published, gold, Green Submitted			2022-12-25	WOS:000328705200024
J	Haida, A; Dor, F; Guillaume, M; Quinquis, L; Marc, A; Marquet, LA; Antero-Jacquemin, J; Tourny-Chollet, C; Desgorces, F; Berthelot, G; Toussaint, JF				Haida, Amal; Dor, Frederic; Guillaume, Marion; Quinquis, Laurent; Marc, Andy; Marquet, Laurie-Anne; Antero-Jacquemin, Juliana; Tourny-Chollet, Claire; Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois			Environment and Scheduling Effects on Sprint and Middle Distance Running Performances	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; WINTER MORTALITY; HEART-DISEASE; MARATHON; PROGRESSION; RESPONSES; EXERCISE; EUROPE; CYCLE; MOOD	Purpose: Achievement of athletes' performances is related to several factors including physiological, environmental and institutional cycles where physical characteristics are involved. The objective of this study is to analyse the performance achieved in professional sprint and middle-distance running events (100 m to 1500 m) depending on the organization of the annual calendar of track events and their environmental conditions. Methods: From 2002 to 2008, all performances of the Top 50 international athletes in the 100 m to 1500 m races (men and women) are collected. The historical series of world records and the 10 best annual performances in these events, amounted to a total of 26,544 performances, are also included in the study. Results: Two periods with a higher frequency of peak performances are observed. The first peak occurs around the 27.15th +/- 0.21 week (first week of July) and the second peak around 34.75th +/- 0.14 week (fourth week of August). The second peak tends to be the time of major international competitions (Olympic Games, World Championships, and European Championships) and could be characterized as an institutional moment. The first one, however, corresponds to an environmental optimum as measured by the narrowing of the temperature range at the highest performance around 23.25 +/- 3.26 degrees C. Conclusions: This is the first study to demonstrate that there are two performance peaks at a specific time of year (27th and 34th weeks) in sprint and middle distance. Both institutional and ecophysiological aspects contribute to performance in the 100 m to 1500 m best performances and define the contours of human possibilities. Sport institutions may take this into account in order to provide ideal conditions to improve the next records.	[Haida, Amal; Dor, Frederic; Guillaume, Marion; Quinquis, Laurent; Marc, Andy; Marquet, Laurie-Anne; Antero-Jacquemin, Juliana; Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois] INSEP, IRMES Biomed Res Inst Sports Epidemiol Paris Fran, Paris, France; [Haida, Amal; Tourny-Chollet, Claire] Univ Rouen, Fac Sci Sport & Educ Phys, CETAPS, Mont St Aignan, France; [Desgorces, Francois; Berthelot, Geoffroy; Toussaint, Jean-Francois] Paris Descartes Univ, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Rouen Normandie; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Haida, A (corresponding author), INSEP, IRMES Biomed Res Inst Sports Epidemiol Paris Fran, Paris, France.	amal.haida@insep.fr		Antero, Juliana/0000-0001-6894-6693	Centre National de Developpement du sport; Ministry of Health, Youth and Sports	Centre National de Developpement du sport; Ministry of Health, Youth and Sports	The authors thank the Centre National de Developpement du sport and the Ministry of Health, Youth and Sports for financial assistance. The funders had no role in study design, data gathering, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Atkinson Greg, 2005, Clin Sports Med, V24, pe25, DOI 10.1016/j.csm.2004.11.001; Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Barnett AG, 2007, BLOOD PRESS MONIT, V12, P195, DOI 10.1097/MBP.0b013e3280b083f4; BENNETT AF, 1985, J EXP BIOL, V115, P333; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Chan CB, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-21; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; COSTILL DL, 1991, MED SCI SPORT EXER, V23, P371; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; Eccles R, 2002, ACTA OTO-LARYNGOL, V122, P183, DOI 10.1080/00016480252814207; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Ghebre MA, 2012, J THROMB HAEMOST, V10, P352, DOI 10.1111/j.1538-7836.2012.04617.x; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Josephson KR, 1984, J EXP BIOL, V108, P77; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kenefick RW, 2007, SPORTS MED, V37, P312, DOI 10.2165/00007256-200737040-00010; Koehler K, 2012, EUR J APPL PHYSIOL, V112, P513, DOI 10.1007/s00421-011-2002-4; Lincoln GA, 2005, ENDOCRINOLOGY, V146, P3782, DOI 10.1210/en.2005-0132; Magnanou E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005904; Magnusson A, 2000, ACTA PSYCHIAT SCAND, V101, P176, DOI 10.1046/j.0902-4441.2000..x; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; McCormack GR, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.092841; Montain SJ, 2007, SPORTS MED, V37, P320, DOI 10.2165/00007256-200737040-00012; Mujika I, 2010, SCAND J MED SCI SPOR, V20, P24, DOI 10.1111/j.1600-0838.2010.01189.x; Regnier-Loilier A, 2011, POPULATION SOC, P1; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Steinacker JM, 2000, J SPORT MED PHYS FIT, V40, P327; THERMINARIAS A, 1987, Science and Sports, V2, P1, DOI 10.1016/S0765-1597(87)80039-4	39	7	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79548	10.1371/journal.pone.0079548	http://dx.doi.org/10.1371/journal.pone.0079548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24363791	Green Submitted, Green Published, gold			2022-12-25	WOS:000327313100031
J	Andrechek, ER				Andrechek, E. R.			HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors	ONCOGENE			English	Article						MMTV-Neu; metastasis; E2F transcription factors; gene expression; signatures	HUMAN-BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; BINDING-SITES; NEU ONCOGENE; CYCLIN D1; PROLIFERATION; EXPRESSION; MICE; CARCINOMAS	HER2/Neu is amplified and overexpressed in a large proportion of human breast cancers, but the signaling pathways that contribute to tumor development and metastatic progression are not completely understood. Using gene expression data and pathway signatures, we predicted a role for activator E2F transcription factors in Neu-induced tumors. This was genetically tested by interbreeding Neu transgenics with knockouts of the three activator E2Fs. Loss of any E2F delayed Neu-induced tumor onset. E2F1 loss accelerated tumor growth, while E2F2 and E2F3 loss did not. Strikingly, it was observed that loss of E2F1 or E2F2 significantly reduced the metastatic capacity of the tumor and this was associated with a reduction in circulating tumor cells in the E2F2 knockout. Gene expression analysis between the tumors in the various E2F-mutant backgrounds revealed that there was extensive compensation by other E2F family members in the individual knockouts, underscoring the importance of the E2Fs in HER2/Neu-induced tumors. Extension to HER2-positive (HER2+) human breast cancer revealed a number of HER2+ subtypes based on E2F activity with differences in relapse-free survival times. Taken together, these data demonstrate that the E2F transcription factors are integral to HER2+ tumor development and progression.	Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University	Andrechek, ER (corresponding author), Michigan State Univ, Dept Physiol, 2194 Biomed Phys Sci Bldg,567 Wilson Rd, E Lansing, MI 48824 USA.	andrech1@msu.edu		Andrechek, Eran/0000-0002-8680-3423	NCI [1R01CA160514]; NATIONAL CANCER INSTITUTE [R01CA160514] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	I thank Inez Yuwanita for providing a merged human breast cancer gene expression data set and Daniel Hollern for his cell signaling predictions from his mouse breast cancer gene expression database. I thank the members of my laboratory for numerous discussions and critical reading of the manuscript and Jordan Honeysett for technical support. This work was supported by a grant from the NCI (1R01CA160514).	Andrechek ER, 2008, DEVELOPMENT, V135, P2403, DOI 10.1242/dev.019018; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; DeGregori J, 2006, CURR MOL MED, V6, P739; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eceles SA, 2001, J MAMMARY GLAND BIOL, V6, P393, DOI 10.1023/A:1014730829872; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Humbert PO, 2000, GENE DEV, V14, P690; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	36	36	38	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					217	225		10.1038/onc.2013.540	http://dx.doi.org/10.1038/onc.2013.540			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362522	Green Accepted			2022-12-25	WOS:000347790500009
J	Batlle-Lopez, A; Cortiguera, MG; Rosa-Garrido, M; Blanco, R; del Cerro, E; Torrano, V; Wagner, SD; Delgado, MD				Batlle-Lopez, A.; Cortiguera, M. G.; Rosa-Garrido, M.; Blanco, R.; del Cerro, E.; Torrano, V.; Wagner, S. D.; Delgado, M. D.			Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus	ONCOGENE			English	Article						CTCF; BCL6; lymphoma; germinal centre; epigenetics	CENTER B-CELLS; CANCER-TESTIS GENE; DNA METHYLATION; HUMAN GENOME; NEGATIVE AUTOREGULATION; EPIGENETIC REGULATION; TUMOR-SUPPRESSOR; PROTEIN CTCF; EXPRESSION; PROMOTER	BCL6 is a zinc-finger transcriptional repressor, which is highly expressed in germinal centre B-cells and is essential for germinal centre formation and T-dependent antibody responses. Constitutive BCL6 expression is sufficient to produce lymphomas in mice. Deregulated expression of BCL6 due to chromosomal rearrangements, mutations of a negative autoregulatory site in the BCL6 promoter region and aberrant post-translational modifications have been detected in a number of human lymphomas. Tight lineage and temporal regulation of BCL6 is, therefore, required for normal immunity, and abnormal regulation occurs in lymphomas. CCCTC-binding factor (CTCF) is a multi-functional chromatin regulator, which has recently been shown to bind in a methylation-sensitive manner to sites within the BCL6 first intron. We demonstrate a novel CTCF-binding site in BCL6 exon1A within a potential CpG island, which is unmethylated both in cell lines and in primary lymphoma samples. CTCF binding, which was found in BCL6-expressing cell lines, correlated with the presence of histone variant H2A. Z and active histone marks, suggesting that CTCF induces chromatin modification at a transcriptionally active BCL6 locus. CTCF binding to exon1A was required to maintain BCL6 expression in germinal centre cells by avoiding BCL6-negative autoregulation. Silencing of CTCF in BCL6-expressing cells reduced BCL6 mRNA and protein expression, which is sufficient to induce B-cell terminal differentiation toward plasma cells. Moreover, lack of CTCF binding to exon1A shifts the BCL6 local chromatin from an active to a repressive state. This work demonstrates that, in contexts in which BCL6 is expressed, CTCF binding to BCL6 exon1A associates with epigenetic modifications indicative of transcriptionally open chromatin.	[Batlle-Lopez, A.; Cortiguera, M. G.; Rosa-Garrido, M.; Blanco, R.; Torrano, V.; Delgado, M. D.] Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain; [Batlle-Lopez, A.; Cortiguera, M. G.; Rosa-Garrido, M.; Blanco, R.; Torrano, V.; Delgado, M. D.] Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol, E-39005 Santander, Spain; [Batlle-Lopez, A.; Cortiguera, M. G.; del Cerro, E.] Hosp U Marques Valdecilla, Serv Hematol, Santander, Spain; [Batlle-Lopez, A.; Cortiguera, M. G.; del Cerro, E.] IFIMAV FMV, Santander, Spain; [Wagner, S. D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Wagner, S. D.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); University of Leicester; University of Leicester	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Lancaster Rd, Leicester LE1 9HN, Leics, England.	sw227@leicester.ac.uk; delgadmd@unican.es	Torrano Moya, Veronica/D-3285-2014; Rosa-Garrido, Manuel/AAE-4188-2019; Delgado, M. Dolores/K-9056-2014	Rosa-Garrido, Manuel/0000-0002-2169-3972; Delgado, M. Dolores/0000-0003-4682-4040; Wagner, Simon/0000-0002-8914-0370; Torrano, Veronica/0000-0002-4252-1977	Instituto de Salud Carlos III grants [PI11/00397]; RETIC (Red Tematica de Investigacion Cooperativa en Cancer) [RD06/0020/0017, RD12/0036/0033]; Lopez Albo fellowship (IFIMAV, Spain); University of Cantabria; Lady Tata Memorial Trust	Instituto de Salud Carlos III grants(Instituto de Salud Carlos III); RETIC (Red Tematica de Investigacion Cooperativa en Cancer); Lopez Albo fellowship (IFIMAV, Spain); University of Cantabria; Lady Tata Memorial Trust	We thank Elena Klenova and Rainer Renkawitz for CTCF expression vectors, Miguel Angel Piris and Noemi Nagy for cell lines and Javier Leon for useful comments on the manuscript. We are grateful to the Department of Hematology of Hospital U. Marques de Valdecilla (Santander) for help with patient recruitment. Funding for this work was provided by Instituto de Salud Carlos III grants PI11/00397 (Fondo Investigaciones Sanitarias) and RETIC (Red Tematica de Investigacion Cooperativa en Cancer) RD06/0020/0017 and RD12/0036/0033. AB was supported by a Lopez Albo fellowship (IFIMAV, Spain), MRG by a PhD fellowship from the University of Cantabria and VT by the Lady Tata Memorial Trust. Part of this work is in AB's PhD dissertation (split PhD Programme between Imperial College London and the University of Cantabria).	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Batlle A, 2009, MOL IMMUNOL, V46, P1727, DOI 10.1016/j.molimm.2009.02.003; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bernardin F, 1997, ONCOGENE, V14, P849, DOI 10.1038/sj.onc.1200903; Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Fearon DT, 2002, ADV EXP MED BIOL, V512, P21; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kikuchi M, 2000, ONCOGENE, V19, P4941, DOI 10.1038/sj.onc.1203864; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon MJ, 2010, CARCINOGENESIS, V31, P974, DOI 10.1093/carcin/bgp336; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Ramachandrareddy H, 2010, P NATL ACAD SCI USA, V107, P11930, DOI 10.1073/pnas.1004962107; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rosa-Garrido M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039371; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoon B, 2005, MOL CELL BIOL, V25, P11184, DOI 10.1128/MCB.25.24.11184-11190.2005; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	59	12	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					246	256		10.1038/onc.2013.535	http://dx.doi.org/10.1038/onc.2013.535			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362533	Green Accepted, Green Submitted			2022-12-25	WOS:000347790500012
J	Ruiz, M; Ganfornina, MD; Correnti, C; Strong, RK; Sanchez, D				Ruiz, Mario; Ganfornina, Maria D.; Correnti, Colin; Strong, Roland K.; Sanchez, Diego			Ligand binding-dependent functions of the lipocalin NLaz: an in vivo study in Drosophila	FASEB JOURNAL			English	Article						lipid-binding proteins; aging; pheromonal signaling; metabolism regulation; oxidative stress	SWISS-MODEL REPOSITORY; EXTENDS LIFE-SPAN; APOLIPOPROTEIN-D; STRESS RESISTANCE; OXIDATIVE STRESS; ARACHIDONIC-ACID; HUMAN APOD; PROTEIN; LAZARILLO; GENE	Lipocalins are small extracellular proteins mostly described as lipid carriers. The Drosophila lipocalin NLaz (neural Lazarillo) modulates the IIS pathway and regulates longevity, stress resistance, and behavior. Here, we test whether a native hydrophobic pocket structure is required for NLaz to perform its functions. We use a point mutation altering the binding pocket (NLaz(L130R)) and control mutations outside NLaz binding pocket. Tryptophan fluorescence titration reveals that NLaz(L130R) loses its ability to bind ergosterol and the pheromone 7(z)-tricosene but retains retinoic acid binding. Using site-directed transgenesis in Drosophila, we test the functionality of the ligand binding-altered lipocalin at the organism level. NLaz-dependent life span reduction, oxidative stress and starvation sensitivity, aging markers accumulation, and deficient courtship are rescued by overexpression of NLaz(WT), but not of NLaz(L130R). Transcriptional responses to aging and oxidative stress show a large set of age-responsive genes dependent on the integrity of NLaz binding pocket. Inhibition of IIS activity and modulation of oxidative stress and infection-responsive genes are binding pocket-dependent processes. Control of energy metabolites on starvation appears to be, however, insensitive to the modification of the NLaz binding pocket.-Ruiz, M., Ganfornina, M. D., Correnti, C., Strong, R. K., and Sanchez, D. Ligand binding-dependent functions of the lipocalin NLaz: an in vivo study in Drosophila.	[Ruiz, Mario; Ganfornina, Maria D.; Sanchez, Diego] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Dept Bioquim & Biol Mol & Fisiol, Valladolid 47003, Spain; [Correnti, Colin; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Fred Hutchinson Cancer Center	Sanchez, D (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, C Sanz & Fores 3, Valladolid 47003, Spain.	lazarill@ibgm.uva.es	Ruiz, Mario/B-3507-2013; Sanchez, Diego/N-5990-2014; Ganfornina, Maria D/N-5743-2014	Ruiz, Mario/0000-0002-7149-6600; Sanchez, Diego/0000-0001-6296-6773; Ganfornina, Maria D/0000-0002-8567-4826	Junta de Castilla y Leon (JCyL) [VA180A11-2]; Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-01170, BFU2011-23978]; JCyL [EDU/1708/2008]	Junta de Castilla y Leon (JCyL)(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); JCyL(Junta de Castilla y Leon)	The authors thank Dr. J. M. Pereda [Centro de Investigacion del Cancer (CIC), Salamanca, Spain] for providing advice on potential residues to mutate in NLaz. Gene sequencing was performed at the CIC genomic facility. Drosophila transgenesis was carried out at BestGene Inc. (Chino Hills, CA, USA). E. Martin-Tejedor provided technical assistance throughout the project. The authors also acknowledge the critical and constructive comments of two anonymous reviewers that have certainly improved the manuscript and the accuracy of data presentation and interpretation included herein. This work was supported by grants to M. D. G. and D. S. [Junta de Castilla y Leon (JCyL) grant VA180A11-2, and Ministerio de Ciencia e Innovacion (MICINN) grants BFU2008-01170 and BFU2011-23978], and M. R. was supported by a JCyL fellowship to young researchers (EDU/1708/2008). Author contributions: M. R. designed and performed the experiments, analyzed the data, and helped in writing the manuscript; D. S. and M. D. G, designed the research project and helped with experiments and analysis of results; C. C. and R. K. S. participated in the discussion and design of experiments; M. D. G., D. S. and M. R. wrote the manuscript; all authors read and approved the final manuscript.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Akerstrom Bo, 2006, P1; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Bauer J, 2010, AGING-US, V2, P298, DOI 10.18632/aging.100146; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chiswell B, 2007, BBA-PROTEINS PROTEOM, V1774, P637, DOI 10.1016/j.bbapap.2007.03.004; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Elenewski JE, 2010, J PHYS CHEM B, V114, P11315, DOI 10.1021/jp104103f; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Ganfornina M. D., 2006, LIPOCALINS, P49; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; GANFORNINA MD, 1995, DEVELOPMENT, V121, P123; Gasymov OK, 2010, BIOCHEMISTRY-US, V49, P582, DOI 10.1021/bi901435q; Gasymov OK, 2009, BIOCHEMISTRY-US, V48, P7219, DOI 10.1021/bi9005557; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Gutierrez G, 2000, BBA-PROTEIN STRUCT M, V1482, P35, DOI 10.1016/S0167-4838(00)00151-5; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Kalikka J, 2011, EUR BIOPHYS J BIOPHY, V40, P181, DOI 10.1007/s00249-010-0638-3; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kumasaka T, 2009, J BIOL CHEM, V284, P22344, DOI 10.1074/jbc.M109.018341; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Peng Y, 2010, BBA-PROTEINS PROTEOM, V1804, P2102, DOI 10.1016/j.bbapap.2010.07.020; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ruiz M, 2013, FEBS J, V280, P3928, DOI 10.1111/febs.12394; Ruiz M, 2012, INSECT BIOCHEM MOLEC, V42, P776, DOI 10.1016/j.ibmb.2012.07.005; Ruiz M, 2011, EXP GERONTOL, V46, P579, DOI 10.1016/j.exger.2011.02.014; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sanchez D, 2000, INT J DEV BIOL, V44, P349; Sanchez D, 2008, J MOL RECOGNIT, V21, P312, DOI 10.1002/jmr.902; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sundaram M, 1998, BIOCHEM J, V334, P155, DOI 10.1042/bj3340155; Tcatchoff L, 2006, FEBS LETT, V580, P2102, DOI 10.1016/j.febslet.2006.03.017; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; Wade NM, 2012, J EXP BIOL, V215, P343, DOI 10.1242/jeb.064592; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036772; Zhou YY, 2010, FASEB J, V24, P4668, DOI 10.1096/fj.10-164863; Zsila F, 2002, BIOCHEM PHARMACOL, V64, P1651, DOI 10.1016/S0006-2952(02)01350-3	69	11	12	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1555	1567		10.1096/fj.13-240556	http://dx.doi.org/10.1096/fj.13-240556			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24361577	Green Submitted			2022-12-25	WOS:000335344300005
J	Pedragosa-Badia, X; Sliwoski, GR; Nguyen, ED; Lindner, D; Stichel, J; Kaufmann, KW; Meiler, J; Beck-Sickinger, AG				Pedragosa-Badia, Xavier; Sliwoski, Gregory R.; Elizabeth Dong Nguyen; Lindner, Diana; Stichel, Jan; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.			Pancreatic Polypeptide Is Recognized by Two Hydrophobic Domains of the Human Y-4 Receptor Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Computer Modeling; G Protein-coupled Receptors (GPCR); Molecular Modeling; Neuropeptide; Binding Pocket; Comparative Model; Pancreatic Polypeptide	NEUROPEPTIDE-Y RECEPTOR; PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; OPIOID RECEPTOR; PEPTIDE YY; STRUCTURE PREDICTION; LIGAND-BINDING; HIGH-AFFINITY; ANTAGONIST	Background: The Y4R is involved in regulation of food intake and gastrointestinal transport. Results: Mutagenesis studies revealed several residues displaying a significant loss of potency for hPP. Conclusion: Tops of TM2, TM6, and TM7 interact with the hY(4)R native agonist hPP. Significance: Characterizing the structure of the Y4R binding pocket is crucial for the development of new anti-obesity drugs. Structural characterization of the human Y-4 receptor (hY(4)R) interaction with human pancreatic polypeptide (hPP) is crucial, not only for understanding its biological function but also for testing treatment strategies for obesity that target this interaction. Here, the interaction of receptor mutants with pancreatic polypeptide analogs was studied through double-cycle mutagenesis. To guide mutagenesis and interpret results, a three-dimensional comparative model of the hY(4)R-hPP complex was constructed based on all available class A G protein-coupled receptor crystal structures and refined using experimental data. Our study reveals that residues of the hPP and the hY(4)R form a complex network consisting of ionic interactions, hydrophobic interactions, and hydrogen binding. Residues Tyr(2.64), Asp(2.68), Asn(6.55), Asn(7.32), and Phe(7.35) of Y4R are found to be important in receptor activation by hPP. Specifically, Tyr(2.64) interacts with Tyr(27) of hPP through hydrophobic contacts. Asn(7.32) is affected by modifications on position Arg(33) of hPP, suggesting a hydrogen bond between these two residues. Likewise, we find that Phe(7.35) is affected by modifications of hPP at positions 33 and 36, indicating interactions between these three amino acids. Taken together, we demonstrate that the top of transmembrane helix 2 (TM2) and the top of transmembrane helices 6 and 7 (TM6-TM7) form the core of the peptide binding pocket. These findings will contribute to the rational design of ligands that bind the receptor more effectively to produce an enhanced agonistic or antagonistic effect.	[Pedragosa-Badia, Xavier; Lindner, Diana; Stichel, Jan; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany; [Sliwoski, Gregory R.; Elizabeth Dong Nguyen; Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Struct Biol Ctr, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 5144B Biosci MRB3,465 21st Ave South, Nashville, TN 37232 USA.	jens@meilerlab.org; beck-sickinger@uni-leipzig.de	Lindner, Diana/AAL-9856-2021	Lindner, Diana/0000-0001-5477-769X; Nguyen, Elizabeth/0000-0002-2798-6581; Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [R01 GM080403, R01 MH090192, R01 DK020593, R01 GM099842, R01 DK097376]; German Research Foundation [SFB 610/3-A1, BE 1264-11]; National Science Foundation [0742762, OISE 1157751]; Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK097376, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, T32GM008320, R01GM080403, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1305874] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080403, R01 MH090192, R01 DK020593, and R01 GM099842 and Grant R01 DK097376 (to J. M. and A. B.-S.). This work was also supported by German Research Foundation Grants SFB 610/3-A1 and BE 1264-11 (to A. B.-S), National Science Foundation Grant Career 0742762 (to J. M.), a pilot and feasibility study from the Vanderbilt Diabetes Research and Training Center, and National Science Foundation Award OISE 1157751 to explore international collaboration.	Alexander N., 2011, 1 IEEE INT C COMP AD; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Eckard CP, 2001, MOLECULES, V6, P448, DOI 10.3390/60500448; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Gehlert DR, 1997, PEPTIDES, V18, P397, DOI 10.1016/S0196-9781(96)00346-4; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kanno T, 2001, PEPTIDES, V22, P405, DOI 10.1016/S0196-9781(01)00350-3; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lerch M, 2002, J MOL BIOL, V322, P1117, DOI 10.1016/S0022-2836(02)00889-6; Li JB, 2010, PEPTIDES, V31, P1706, DOI 10.1016/j.peptides.2010.06.011; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; LUNDELL I, 1995, J BIOL CHEM, V270, P29123, DOI 10.1074/jbc.270.49.29123; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Misra S, 2004, J PHARMACOL EXP THER, V311, P1154, DOI 10.1124/jpet.104.071415; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pedragosa Badia X., 2013, FRONT ENDOCRINOL, DOI 10.3389/fendo.2013.00005; Perry B, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.21; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Rathmann D, 2013, ANAL BIOCHEM, V439, P173, DOI 10.1016/j.ab.2013.04.015; Rathmann D, 2012, J BIOL CHEM, V287, P32181, DOI 10.1074/jbc.M112.349852; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sautel M, 1996, MOL PHARMACOL, V50, P285; SAUTEL M, 1995, MOL CELL ENDOCRINOL, V112, P215, DOI 10.1016/0303-7207(95)03603-5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sjodin P, 2006, BIOCHEM J, V393, P161, DOI 10.1042/BJ20050708; Sylte I, 1999, BIOORGAN MED CHEM, V7, P2737, DOI 10.1016/S0968-0896(99)00229-1; Tautermann CS, 2011, ACS MED CHEM LETT, V2, P414, DOI 10.1021/ml100247s; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tough IR, 2006, J PHARMACOL EXP THER, V319, P20, DOI 10.1124/jpet.106.106500; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Walker MW, 1997, PEPTIDES, V18, P609, DOI 10.1016/S0196-9781(97)00070-3; WALKER P, 1994, J BIOL CHEM, V269, P2863; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wraith A, 2000, GENOME RES, V10, P302, DOI 10.1101/gr.10.3.302; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	58	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5846	5859		10.1074/jbc.M113.502021	http://dx.doi.org/10.1074/jbc.M113.502021			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24375409	Green Published, hybrid			2022-12-25	WOS:000332015500043
J	Talwar, S; House, R; Sundaramurthy, S; Balasubramanian, S; Yu, H; Palanisamy, V				Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Balasubramanian, Sundaravadivel; Yu, Hong; Palanisamy, Viswanathan			Inhibition of Caspases Protects Mice from Radiation-induced Oral Mucositis and Abolishes the Cleavage of RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Enzyme Inhibitors; MRNA Decay; RNA-binding Protein; HuR; Mucositis	MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL CONTROL; MEDIATED CLEAVAGE; CANCER; EXPRESSION; APOPTOSIS; PROMOTES; HEAD; NECK	Background: In oral mucositis, cleavage product-1 of RNA-binding protein HuR regulates cell death. Results: Activation of caspases initiates HuR cleavage modification and stabilizes BAX, thereby promoting apoptosis in oral mucositis. Conclusion: Inhibition of caspases reduced the severity of oral mucositis through HuR and the expression of BAX. Significance: This is the first study implicating the RNA-binding protein HuR in oral mucositis. The oral mucosal epithelium is typically insulted during chemotherapy and ionizing radiation (IR) therapy and disposed to mucositis, which creates painful inflammation and ulceration in the oral cavity. Oral mucositis alters gene expression patterns, inhibits cellular growth, and initiates cell death in the oral epithelial compartments. Such alterations are governed by several different factors, including transcription factors, RNA-binding proteins, and microRNAs. IR-induced post-transcriptional regulation of RNA-binding proteins exists but is poorly studied in clinically relevant settings. We herein report that the RNA-binding protein human antigen R (HuR) undergoes cleavage modification by caspase-3 following IR-induced oral mucositis and subsequently promotes the expression of the pro-apoptotic factor BAX (Bcl-2-associated X protein), as well as cell death. Further analyses revealed that the HuR cleavage product-1 (HuR-CP1) directly associates and stabilizes the BAX mRNA and concurrently activates the apoptotic pathway. On the other hand, a noncleavable isoform of HuR promotes the clonogenic capacity of primary oral keratinocytes and decreases the effect of IR-induced cell death. Additionally, specific inhibition of caspase-3 by a compound, NSC321205, increases the clonogenic capacity of primary oral keratinocytes and causes increased basal layer cellularity, thickened mucosa, and elevated epithelial cell growth in the tongues of mice with oral mucositis. This protective effect of NSC321205 is mediated by a decrease in caspase-3 activity and the consequent inhibition of HuR cleavage, which reduces the expression of BAX in mice with IR-induced oral mucositis. Thus, we have identified a new molecular mechanism of HuR in the regulation of mRNA turnover and apoptosis in oral mucositis, and our data suggest that blocking the cleavage of HuR enhances cellular growth in the oral epithelial compartment.	[Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Yu, Hong; Palanisamy, Viswanathan] Med Univ S Carolina, Dept Craniofacial Biol, Coll Dent Med, Charleston, SC 29425 USA; [Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Yu, Hong; Palanisamy, Viswanathan] Med Univ S Carolina, Ctr Oral Hlth Res, Coll Dent Med, Charleston, SC 29425 USA; [Balasubramanian, Sundaravadivel] Med Univ S Carolina, Coll Med, Dept Cardiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, V (corresponding author), Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu		Palanisamy, Viswanathan/0000-0001-5128-2878	National Institutes of Health [R00DE018165, R01DE022776]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE017551, R01DE022776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DE018165 and R01DE022776 (to V. P.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chaudhuri L, 2012, ONCOGENE, V31, P1207, DOI 10.1038/onc.2011.325; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Citrin D, 2010, ONCOLOGIST, V15, P360, DOI 10.1634/theoncologist.2009-S104; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Feldman T, 2012, MOL CELL, V47, P585, DOI 10.1016/j.molcel.2012.06.007; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Han GW, 2013, NAT MED, V19, P421, DOI 10.1038/nm.3118; Henke M, 2011, J CLIN ONCOL, V29, P2815, DOI 10.1200/JCO.2010.32.4103; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kitada S, 1996, ONCOGENE, V12, P187; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, APOPTOSOME: AN UP-AND-COMING THERAPEUTICAL TOOL, P203, DOI 10.1007/978-90-481-3415-1_10; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Manakova S, 2003, TOXICOL IN VITRO, V17, P367, DOI 10.1016/S0887-2333(03)00024-9; Masuda K, 2011, EMBO J, V30, P1040, DOI 10.1038/emboj.2011.24; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T, 2007, J Support Oncol, V5, P3; Sonis ST, 2009, CORE EVID, V4, P199; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng CY, 2009, CLIN CANCER RES, V15, P4641, DOI 10.1158/1078-0432.CCR-09-0819	42	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3487	3500		10.1074/jbc.M113.504951	http://dx.doi.org/10.1074/jbc.M113.504951			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362034	hybrid, Green Published			2022-12-25	WOS:000331368700033
J	Devillers, A; Courjol, F; Fradin, C; Coste, A; Poulain, D; Pipy, B; Bernardes, ES; Jouault, T				Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Coste, Agnes; Poulain, Daniel; Pipy, Bernard; Bernardes, Emerson Soares; Jouault, Thierry			Deficient Beta-Mannosylation of Candida albicans Phospholipomannan Affects the Proinflammatory Response in Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NLRP3 INFLAMMASOME; BETA-1,2-LINKED OLIGOMANNOSIDES; BAD PHOSPHORYLATION; IN-VITRO; GALECTIN-3; FAMILY; IDENTIFICATION; RECOGNITION; ASSOCIATION	Candida albicans produces a complex glycosphingolipid called phospholipomannan (PLM), which is present on the cell-wall surface of yeast and shed upon contact with host cells. The glycan moiety of PLM is composed of beta-mannosides with degrees of polymerization up to 19 in C. albicans serotype A. PLM from serotype B strains displays a twofold decrease in the length of the glycan chains. In this study we compared the proinflammatory activities of PLMs purified from C. albicans serotype A and serotype B strains and from a bmt6 Delta mutant of C. albicans, whose PLM is composed of short truncated oligomannosidic chain. We found that PLMs activate caspase-1 in murine macrophage cell line J774 independent of the glycan chain length although IL-1 beta secretion is more intense with long glycan chain. None of the tested PLMs stimulate ROS production, indicating that caspase-1 activation may occur through a ROS-independent pathway. On the other hand, only long-chain oligomannosides present on PLM from serotype A strain (PLM-A) are able to induce TNF-alpha production in macrophages, a property that is not affect by blocking endocytosis through latrunculin A treatment. Finally, we demonstrate that soluble and not cell surface-bound galectin-3, is able to potentiate PLM-A-induced TNF-alpha production in macrophages. PLMs from C. albicans serotype B and from bmt6 Delta mutant are not able to induce TNF-alpha production and galectin-3 pretreatment does not interfere with this result. In conclusion, we show here that PLMs are able to evoke a proinflammatory state in macrophage, which is in part dependent on their glycosylation status. Long-glycan chains favor interaction with soluble galectin-3 and help amplify inflammatory response.	[Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Inserm U995, Team 2, Lille, France; [Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Univ Lille Nord France, Lille, France; [Devillers, Audrey; Courjol, Flavie; Fradin, Chantal; Poulain, Daniel; Jouault, Thierry] Univ Lille 2, Lille, France; [Coste, Agnes; Pipy, Bernard] Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Path Infl, UMR MD3, F-31062 Toulouse, France; [Coste, Agnes; Pipy, Bernard] Univ Toulouse 3, UMR 152, F-31062 Toulouse, France; [Bernardes, Emerson Soares] Canc Inst State Sao Paulo, Sao Paulo, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Jouault, T (corresponding author), Inserm U995, Team 2, Lille, France.	thierry.jouault@univ-lille2.fr	Poulain, Daniel/C-8683-2014; Fradin, Chantal/N-2382-2018; Jouault, Thierry/I-1071-2018; Agnès, Coste/AAK-9408-2020; Bernardes, Emerson Soares/D-3711-2017; Poulain, Daniel/I-6095-2018	Fradin, Chantal/0000-0002-3883-4401; Jouault, Thierry/0000-0003-1988-8647; Bernardes, Emerson Soares/0000-0002-0029-7313; Coste, Agnes/0000-0001-7781-3323; Pipy, Bernard/0000-0001-8060-7029; Poulain, Daniel/0000-0002-0729-5468	Inserm and by the European Community [HEALTH-F2-2010-260338]; ANR [09-MIEN-031-01]	Inserm and by the European Community; ANR(French National Research Agency (ANR))	This work was supported by Inserm and by the European Community's Seventh Framework Program (FP7-2007-2013) under grant agreement no. HEALTH-F2-2010-260338 'ALLFUN'. AD was supported by ANR 09-MIEN-031-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Ibata-Ombetta S, 2003, ANN NY ACAD SCI, V1010, P573, DOI 10.1196/annals.1299.107; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 1998, J INFECT DIS, V178, P792, DOI 10.1086/515361; JOUAULT T, 1994, IMMUNOLOGY, V83, P268; JOUAULT T, 1995, INFECT IMMUN, V63, P2378, DOI 10.1128/IAI.63.6.2378-2381.1995; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KOBAYASHI H, 1990, ARCH BIOCHEM BIOPHYS, V278, P195, DOI 10.1016/0003-9861(90)90248-W; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mille C, 2012, GLYCOBIOLOGY, V22, P1332, DOI 10.1093/glycob/cws097; Poulain D, 2002, INFECT IMMUN, V70, P4323, DOI 10.1128/IAI.70.8.4323-4328.2002; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Trinel PA, 2005, MOL MICROBIOL, V58, P984, DOI 10.1111/j.1365-2958.2005.04890.x; Trinel PA, 2002, J BIOL CHEM, V277, P37260, DOI 10.1074/jbc.M202295200; TRINEL PA, 1993, INFECT IMMUN, V61, P4398, DOI 10.1128/IAI.61.10.4398-4405.1993; Trinel PA, 1999, J BIOL CHEM, V274, P30520, DOI 10.1074/jbc.274.43.30520; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84771	10.1371/journal.pone.0084771	http://dx.doi.org/10.1371/journal.pone.0084771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367694	Green Published, gold			2022-12-25	WOS:000328741900065
J	Guo, W; Pleitner, JM; Saupe, KW; Greaser, ML				Guo, Wei; Pleitner, Jonathan M.; Saupe, Kurt W.; Greaser, Marion L.			Pathophysiological Defects and Transcriptional Profiling in the RBM20(-/-) Rat Model	PLOS ONE			English	Article							TITIN ISOFORM EXPRESSION; TISSUE GROWTH-FACTOR; GIANT PROTEIN TITIN; CARDIAC TITIN; DIASTOLIC DYSFUNCTION; MYOCARDIAL STIFFNESS; PASSIVE STIFFNESS; FACTOR-BETA; HUMAN HEART; GENE	Our recent study indicated that RNA binding motif 20 (Rbm20) alters splicing of titin and other genes. The current goals were to understand how the Rbm20(-/-) rat is related to physiological, structural, and molecular changes leading to heart failure. We quantitatively and qualitatively compared the expression of titin isoforms between Rbm20(-/-) and wild type rats by real time RT-PCR and SDS agarose electrophoresis. Isoform changes were linked to alterations in transcription as opposed to translation of titin messages. Reduced time to exhaustion with running in knockout rats also suggested a lower maximal cardiac output or decreased skeletal muscle performance. Electron microscopic observations of the left ventricle from knockout animals showed abnormal myofibril arrangement, Z line streaming, and lipofuscin deposits. Mutant skeletal muscle ultrastructure appeared normal. The results suggest that splicing alterations in Rbm20(-/-) rats resulted in pathogenic changes in physiology and cardiac ultrastructure. Secondary changes were observed in message levels for many genes whose splicing was not directly affected. Gene and protein expression data indicated the activation of pathophysiological and muscle stress-activated pathways. These data provide new insights on Rbm20 function and how its malfunction leads to cardiomyopathy.	[Guo, Wei; Pleitner, Jonathan M.; Greaser, Marion L.] Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA; [Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greaser, ML (corresponding author), Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA.	mgreaser@ansci.wisc.edu			National Institutes of Health [HL77196]; National Institute of Food and Agriculture; United States Department of Agriculture [WIS01556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL77196)(MLG) and the National Institute of Food and Agriculture, United States Department of Agriculture (ID number WIS01556 to MLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barta P, 2002, J HYPERTENS, V20, P1115, DOI 10.1097/00004872-200206000-00022; Bell SP, 2000, CIRC RES, V87, P235, DOI 10.1161/01.RES.87.3.235; Borg TK, 1996, TRENDS CARDIOVAS MED, V6, P65, DOI 10.1016/1050-1738(96)00005-9; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Brenner DA, 2001, CIRCULATION, V104, P221, DOI 10.1161/01.CIR.104.2.221; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; GOLDSPINK G, 1971, J CELL SCI, V9, P123; Granzier HL, 2009, CIRC RES, V105, P557, DOI 10.1161/CIRCRESAHA.109.200964; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675; Gupta A, 2010, LAB INVEST, V90, P520, DOI 10.1038/labinvest.2010.43; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hugo C, 2003, NEPHROL DIAL TRANSPL, V18, P1241, DOI 10.1093/ndt/gfg159; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; LeWinter MM, 2007, CLIN CHIM ACTA, V375, P1, DOI 10.1016/j.cca.2006.06.035; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Linke WA, 2010, PHYSIOLOGY, V25, P186, DOI 10.1152/physiol.00005.2010; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; MARON BJ, 1975, CIRCULATION, V52, P926, DOI 10.1161/01.CIR.52.5.926; MARON BJ, 1975, J MOL CELL CARDIOL, V7, P697, DOI 10.1016/0022-2828(75)90146-7; Mateja RD, 2013, BBA-MOL CELL RES, V1833, P804, DOI 10.1016/j.bbamcr.2012.08.011; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Muto M, 2001, INT J CARDIOL, V81, P189, DOI 10.1016/S0167-5273(01)00566-6; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Neagoe C, 2003, J MUSCLE RES CELL M, V24, P175, DOI 10.1023/A:1026053530766; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Patel JR, 2012, AM J PHYSIOL-HEART C, V302, pH697, DOI 10.1152/ajpheart.00800.2011; PATTERSON S, 1976, J CELL SCI, V22, P607; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLEITNER JM, 2013, THESIS U WISCONSIN M, P1012; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Raskin A, 2012, J BIOL CHEM, V287, P29273, DOI 10.1074/jbc.M112.372839; Refaat MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/j.hrthm.2011.10.016; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Wahab NA, 2005, DIABETOLOGIA, V48, P2650, DOI 10.1007/s00125-005-0006-5; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu LJ, 2006, MOL CELL BIOCHEM, V284, P65, DOI 10.1007/s11010-005-9014-5; Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017; Wu YM, 2002, J CARD FAIL, V8, pS276, DOI 10.1054/jcaf.2002.129278; Wu YM, 2002, CIRCULATION, V106, P1384, DOI 10.1161/01.CIR.0000029804.61510.02; Ye P, 2003, CLIN EXP PHARMACOL P, V30, P930, DOI 10.1111/j.1440-1681.2003.03937.x	60	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84281	10.1371/journal.pone.0084281	http://dx.doi.org/10.1371/journal.pone.0084281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367651	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900043
J	Massot, C; Bancel, D; Lauri, FL; Truffault, V; Baldet, P; Stevens, R; Gautier, H				Massot, Capucine; Bancel, Doriane; Lauri, Felicie Lopez; Truffault, Vincent; Baldet, Pierre; Stevens, Rebecca; Gautier, Helene			High Temperature Inhibits Ascorbate Recycling and Light Stimulation of the Ascorbate Pool in Tomato despite Increased Expression of Biosynthesis Genes	PLOS ONE			English	Article							L-GALACTOSE GUANYLTRANSFERASE; VITAMIN-C LEVELS; GLUTATHIONE-REDUCTASE; FRUIT-DEVELOPMENT; GROWING TEMPERATURES; RIBES-NIGRUM; ACID; PLANT; METABOLISM; PATHWAY	Understanding how the fruit microclimate affects ascorbate (AsA) biosynthesis, oxidation and recycling is a great challenge in improving fruit nutritional quality. For this purpose, tomatoes at breaker stage were harvested and placed in controlled environment conditions at different temperatures (12, 17, 23, 27 and 31 degrees C) and irradiance regimes (darkness or 150 mu mol m(-2) s(-1)). Fruit pericarp tissue was used to assay ascorbate, glutathione, enzymes related to oxidative stress and the AsA/glutathione cycle and follow the expression of genes coding for 5 enzymes of the AsA biosynthesis pathway (GME, VTC2, GPP, L-GalDH, GLDH). The AsA pool size in pericarp tissue was significantly higher under light at temperatures below 27 degrees C. In addition, light promoted glutathione accumulation at low and high temperatures. At 12 degrees C, increased AsA content was correlated with the enhanced expression of all genes of the biosynthesis pathway studied, combined with higher DHAR and MDHAR activities and increased enzymatic activities related to oxidative stress (CAT and APX). In contrast, at 31 degrees C, MDHAR and GR activities were significantly reduced under light indicating that enzymes of the AsA/glutathione cycle may limit AsA recycling and pool size in fruit pericarp, despite enhanced expression of genes coding for AsA biosynthesis enzymes. In conclusion, this study confirms the important role of fruit microclimate in the regulation of fruit pericarp AsA content, as under oxidative conditions (12 degrees C, light) total fruit pericarp AsA content increased up to 71%. Moreover, it reveals that light and temperature interact to regulate both AsA biosynthesis gene expression in tomato fruits and AsA oxidation and recycling.	[Massot, Capucine; Bancel, Doriane; Truffault, Vincent; Gautier, Helene] INRA, UR Plantes & Syst Cultures Hort 1115, Avignon, France; [Lauri, Felicie Lopez] Univ Avignon, EA4279, Avignon, France; [Baldet, Pierre] France Univ Bordeaux, INRA, UMR Biol Fruit & Pathol 1332, Bordeaux, France; [Stevens, Rebecca] INRA, UR 1052, F-84143 Montfavet, France	INRAE; Avignon Universite; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Massot, C (corresponding author), INRA, UR Plantes & Syst Cultures Hort 1115, Avignon, France.	massot.capucine@gmail.com; helene.gautier@avignon.inra.fr		Baldet, Pierre/0000-0001-7351-1803; Stevens, Rebecca/0000-0003-4401-7923	Plantinov'Ser fundings (Pays de Loire, France); PHD grant for Capucine Massot	Plantinov'Ser fundings (Pays de Loire, France); PHD grant for Capucine Massot	This work was supported by Plantinov'Ser fundings (Pays de Loire, France). INRA and Region Provence Alpes Cote d'Azur co-funded a PHD grant for Capucine Massot. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Alimohammadi M, 2012, J EXP BOT, V63, P825, DOI 10.1093/jxb/err306; Atkinson CJ, 2013, ANN BOT-LONDON, V111, P703, DOI 10.1093/aob/mct026; Badejo AA, 2012, J EXP BOT, V63, P229, DOI 10.1093/jxb/err275; Benard C, 2009, J AGR FOOD CHEM, V57, P4112, DOI 10.1021/jf8036374; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2008, J BIOL CHEM, V283, P21347, DOI 10.1074/jbc.M802601200; Conklin PL, 2001, PLANT CELL ENVIRON, V24, P383, DOI 10.1046/j.1365-3040.2001.00686.x; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Dumas Y, 2003, J SCI FOOD AGR, V83, P369, DOI 10.1002/jsfa.1370; Faria T, 1996, TREE PHYSIOL, V16, P115; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Garchery C, 2013, PLANT CELL ENVIRON, V36, P159, DOI 10.1111/j.1365-3040.2012.02564.x; Garg N, 2011, SCI HORTIC-AMSTERDAM, V131, P29, DOI 10.1016/j.scienta.2011.09.024; Gautier H, 2005, CAN J PLANT SCI, V85, P439, DOI 10.4141/P03-163; Gautier H, 2005, J SCI FOOD AGR, V85, P1009, DOI 10.1002/jsfa.2060; Gautier H, 2009, ANN BOT-LONDON, V103, P495, DOI 10.1093/aob/mcn233; Gautier H, 2008, J AGR FOOD CHEM, V56, P1241, DOI 10.1021/jf072196t; Gest N, 2013, J EXP BOT, V64, P33, DOI 10.1093/jxb/ers297; Gomez R, 1998, J FOOD QUALITY, V21, P329, DOI 10.1111/j.1745-4557.1998.tb00526.x; Green MA, 2005, NATURE, V433, P83, DOI 10.1038/nature03172; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hancock RD, 2007, FUNCT PLANT BIOL, V34, P1080, DOI 10.1071/FP07221; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Kang HM, 2002, POSTHARVEST BIOL TEC, V24, P49, DOI 10.1016/S0925-5214(01)00129-6; Koo LC, 1996, DIET LUNG CANC 20 YE, P22; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lechaudel M, 2013, J PLANT PHYSIOL, V170, P567, DOI 10.1016/j.jplph.2012.11.009; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Li MJ, 2009, PLANTA, V230, P39, DOI 10.1007/s00425-009-0925-3; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Li Y, 2007, MED HYPOTHESES, V68, P1315, DOI 10.1016/j.mehy.2006.10.035; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN BA, 1979, PLANT PHYSIOL, V63, P486, DOI 10.1104/pp.63.3.486; Massot C, 2012, PLANTA, V235, P153, DOI 10.1007/s00425-011-1493-x; Massot C, 2010, PLANT PHYSIOL BIOCH, V48, P751, DOI 10.1016/j.plaphy.2010.06.001; Melino VJ, 2011, J SCI FOOD AGR, V91, P1712, DOI 10.1002/jsfa.4376; Murshed R, 2008, ANAL BIOCHEM, V383, P320, DOI 10.1016/j.ab.2008.07.020; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ogweno JO, 2008, J PLANT GROWTH REGUL, V27, P49, DOI 10.1007/s00344-007-9030-7; Ogweno JO, 2009, SCI HORTIC-AMSTERDAM, V123, P17, DOI 10.1016/j.scienta.2009.07.011; Parsons HT, 2011, BIOCHEM J, V440, P375, DOI 10.1042/BJ20110939; Poiroux-Gonord F, 2010, J AGR FOOD CHEM, V58, P12065, DOI 10.1021/jf1037745; Richardson AC, 2004, PLANT CELL ENVIRON, V27, P423, DOI 10.1111/j.1365-3040.2003.01161.x; Rivero RM, 2004, J HORTIC SCI BIOTECH, V79, P560, DOI 10.1080/14620316.2004.11511805; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Stevens R, 2007, PLANT PHYSIOL, V143, P1943, DOI 10.1104/pp.106.091413; Stevens R, 2006, J AGR FOOD CHEM, V54, P6159, DOI 10.1021/jf061241e; Tamaoki M, 2003, PLANT SCI, V164, P1111, DOI 10.1016/S0168-9452(03)00122-5; Toor RK, 2006, J FOOD COMPOS ANAL, V19, P1, DOI 10.1016/j.jfca.2004.11.008; Torres CA, 2006, J EXP BOT, V57, P1933, DOI 10.1093/jxb/erj136; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124	63	40	45	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84474	10.1371/journal.pone.0084474	http://dx.doi.org/10.1371/journal.pone.0084474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367665	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900049
J	Viljoen, AJ; Kirsten, CJ; Baker, B; van Helden, PD; Wiid, IJF				Viljoen, Albertus J.; Kirsten, Catriona J.; Baker, Bienyameen; van Helden, Paul D.; Wiid, Ian J. F.			The Role of Glutamine Oxoglutarate Aminotransferase and Glutamate Dehydrogenase in Nitrogen Metabolism in Mycobacterium bovis BCG	PLOS ONE			English	Article							TUBERCULOSIS; GENE; GROWTH; ELECTROPORATION; SYNTHETASE; GLNE; KEGG	Recent evidence suggests that the regulation of intracellular glutamate levels could play an important role in the ability of pathogenic slow-growing mycobacteria to grow in vivo. However, little is known about the in vitro requirement for the enzymes which catalyse glutamate production and degradation in the slow-growing mycobacteria, namely; glutamine oxoglutarate aminotransferase (GOGAT) and glutamate dehydrogenase (GDH), respectively. We report that allelic replacement of the Mycobacterium bovis BCG gltBD-operon encoding for the large (gltB) and small (gltD) subunits of GOGAT with a hygromycin resistance cassette resulted in glutamate auxotrophy and that deletion of the GDH encoding-gene (gdh) led to a marked growth deficiency in the presence of L-glutamate as a sole nitrogen source as well as reduction in growth when cultured in an excess of L-asparagine.	[Viljoen, Albertus J.; Kirsten, Catriona J.; Baker, Bienyameen; van Helden, Paul D.; Wiid, Ian J. F.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University	Viljoen, AJ (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, Cape Town, South Africa.	ajvil@sun.ac.za	Baker, Bienyameen/F-9150-2015; Viljoen, Albertus/O-6794-2019	Baker, Bienyameen/0000-0002-2158-6763; Viljoen, Albertus/0000-0001-8949-7401	Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University; National Research Foundation (DAAD-NRF)	Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University; National Research Foundation (DAAD-NRF)	The study was supported financially by the Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University. AJV received a bursary from the the National Research Foundation (DAAD-NRF). The financial assistance of the National Research Foundation (DAAD-NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at, are those of the author and are not necessarily to be attributed to the DAAD-NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; BISHOP P J, 1970, Tubercle, V51, P196; Camardella L, 2002, COMP BIOCHEM PHYS A, V131, P559, DOI 10.1016/S1095-6433(01)00507-4; Carroll P, 2008, J BACTERIOL, V190, P4894, DOI 10.1128/JB.00166-08; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Cheung Y. W., 2011, Hong Kong Medical Journal, V17, P32; COHN ML, 1968, AM REV RESPIR DIS, V98, P295; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Harper C, 2008, IUBMB LIFE, V60, P643, DOI 10.1002/iub.100; Harth G, 1997, J BIOL CHEM, V272, P22728, DOI 10.1074/jbc.272.36.22728; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; JAYARAM HN, 1968, ARCH BIOCHEM BIOPHYS, V126, P165, DOI 10.1016/0003-9861(68)90570-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawakami R, 2007, J BACTERIOL, V189, P5626, DOI 10.1128/JB.00496-07; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; LYON RH, 1974, J BACTERIOL, V117, P151, DOI 10.1128/JB.117.1.151-156.1974; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pashley CA, 2006, MICROBIOL-SGM, V152, P2727, DOI 10.1099/mic.0.28942-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SORU E, 1972, CAN J BIOCHEM CELL B, V50, P1149, DOI 10.1139/o72-157; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; WEBSTER ADB, 1981, J ROY SOC MED, V74, P163, DOI 10.1177/014107688107400215	36	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84452	10.1371/journal.pone.0084452	http://dx.doi.org/10.1371/journal.pone.0084452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367660	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900047
J	Yang, L; Huang, K; Li, XR; Du, M; Kang, X; Luo, X; Gao, L; Wang, C; Zhang, YQ; Zhang, C; Tong, QS; Huang, K; Zhang, FX; Huang, D				Yang, Liu; Huang, Kun; Li, Xiangrao; Du, Meng; Kang, Xiang; Luo, Xi; Gao, Lu; Wang, Cheng; Zhang, Yanqing; Zhang, Chun; Tong, Qiangsong; Huang, Kai; Zhang, Fengxiao; Huang, Dan			Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells	PLOS ONE			English	Article							CANCER-CELLS; GENE-EXPRESSION; CARDIAC FIBROBLASTS; WAF1/CIP1 GENE; DNA-SYNTHESIS; PROTEIN; PARP-1; GROWTH; PHOSPHORYLATION; OVEREXPRESSION	The transcription factor Sp1 is implicated in the activation of G0/G1 phase genes. Modulation of Sp1 transcription activities may affect G1-S checkpoint, resulting in changes in cell proliferation. In this study, our results demonstrated that activated poly(ADP-ribose) polymerase 1 (PARP-1) promoted cell proliferation by inhibiting Sp1 signaling pathway. Cell proliferation and cell cycle assays demonstrated that PARP inhibitors or PARP-1 siRNA treatment significantly inhibited proliferation of hepatoma cells and induced G0/G1 cell cycle arrest in hepatoma cells, while overexpression of PARP-1 or PARP-1 activator treatment promoted cell cycle progression. Simultaneously, inhibition of PARP-1 enhanced the expression of Sp1-mediated checkpoint proteins, such as p21 and p27. In this study, we also showed that Sp1 was poly(ADP-ribosyl)ated by PARP-1 in hepatoma cells. Poly(ADP-ribosyl)ation suppressed Sp1 mediated transcription through preventing Sp1 binding to the Sp1 response element present in the promoters of target genes. Taken together, these data indicated that PARP-1 inhibition attenuated the poly(ADP-ribosyl)ation of Sp1 and significantly increased the expression of Sp1 target genes, resulting in G0/G1 cell cycle arrest and the decreased proliferative ability of the hepatoma cells.	[Yang, Liu; Huang, Kun; Li, Xiangrao; Du, Meng; Luo, Xi; Gao, Lu; Wang, Cheng; Zhang, Yanqing; Huang, Kai; Zhang, Fengxiao; Huang, Dan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China; [Huang, Kun; Zhang, Chun; Tong, Qiangsong; Huang, Kai; Zhang, Fengxiao; Huang, Dan] Huazhong Univ Sci & Technol, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Peoples R China; [Kang, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China.	huangkai1@mail.hust.edu.cn; xiaoyou_321@gmail.com; joy_huangdan@163.com	Kang, Xiang/H-5651-2019; Tong, Qiangsong/B-4500-2014	Kang, Xiang/0000-0002-1914-1941; Tong, Qiangsong/0000-0002-2615-6404; Zhang, Fengxiao/0000-0002-5109-4196; Yang, Liu/0000-0002-0972-8511	National Natural Science Foundation of China [81270937, 81170239, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81270937 and 81170239 to Kai Huang and 81000112 to Dan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Chen F, 2005, CELL SIGNAL, V17, P1572, DOI 10.1016/j.cellsig.2005.03.012; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Curtin Nicola J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940500904X; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Hosoi Y, 2004, INT J ONCOL, V25, P461; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kirby CA, 2012, ACTA CRYSTALLOGR F, V68, P115, DOI 10.1107/S1744309111051219; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Shimo T, 2012, BREAST CANC; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Song J, 2001, J BIOL CHEM, V276, P30429, DOI 10.1074/jbc.M103968200; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Wu JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000164; Xu W, 2003, METHOD ENZYMOL, V364, P205; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E	46	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82872	10.1371/journal.pone.0082872	http://dx.doi.org/10.1371/journal.pone.0082872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367566	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900015
J	Labudda, K; Kreisel, S; Beblo, T; Mertens, M; Kurlandchikov, O; Bien, CG; Driessen, M; Woermann, FG				Labudda, Kirsten; Kreisel, Stefan; Beblo, Thomas; Mertens, Markus; Kurlandchikov, Oleg; Bien, Christian G.; Driessen, Martin; Woermann, Friedrich G.			Mesiotemporal Volume Loss Associated with Disorder Severity: A VBM Study in Borderline Personality Disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; STRUCTURAL BRAIN ABNORMALITIES; POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD MALTREATMENT; HIPPOCAMPAL VOLUME; WOMEN; AMYGDALA; MRI; METAANALYSIS; TRAUMA	Results of MRI volumetry in Borderline Personality Disorder (BPD) are inconsistent. Some, but not all, studies reported decreased hippocampus, amygdala, and/or prefrontal volumes. In the current study, we used rater-independent voxel-based morphometry (VBM) in 33 female BPD patients and 33 healthy women. We measured gray matter (GM) volumes of the whole brain and of three volumes of interest (VOI), i.e., the hippocampus/parahippocampal gyrus, the amygdala and the anterior cingulate gyrus (ACC). Analyses were conducted using lifetime diagnoses of posttraumatic stress disorder (PTSD) and major depression (MD) as covariates. We used adversive childhood experiences and the numbers of BPD criteria (as an indicator of disorder severity) to investigate associations with GM volumes. We did not find volume differences between BPD patients and healthy subject, neither of the whole brain nor of the three VOIs, independent of presence or absence of comorbid PTSD and MD. We also did not find a relationship between childhood maltreatment and the patients' brain volumes. However, within the patient group, the number of BPD criteria fulfilled was inversely correlated with left hippocampal/parahippocampal volume (x=-32, y=-23, z=-18, k=496, t=5.08, p=.007). Consequently, mesiotemporal GM volumes do not seem to differentiate patients from healthy subjects, but might be associated with symptom severity within the BPD group.	[Labudda, Kirsten; Mertens, Markus; Bien, Christian G.; Woermann, Friedrich G.] Mara Hosp, Bethel Epilepsy Ctr, MRI Unit, Bielefeld, Germany; [Labudda, Kirsten; Kreisel, Stefan; Beblo, Thomas; Kurlandchikov, Oleg; Driessen, Martin] Evangel Krankenhaus Bielefeld, Dept Psychiat & Psychotherapy Bethel, Bielefeld, Germany	Evangelical Hospital Bethel (EvKB) - House Gilead I	Woermann, FG (corresponding author), Mara Hosp, Bethel Epilepsy Ctr, MRI Unit, Bielefeld, Germany.	friedrich.woermann@mara.de	Driessen, Martin/ABB-8229-2020	Driessen, Martin/0000-0003-3496-816X; Bien, Christian G./0000-0003-2225-8654	German Research Foundation [DR 358/5-1]	German Research Foundation(German Research Foundation (DFG))	Parts of this study were funded by the German Research Foundation (DR 358/5-1). The authors declare that the German Research Foundation only funded parts of the MRI costs, but none of the authors received financial funding for his/her work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Bernstein D.P., 1999, CHILDHOOD TRAUMA QUE; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Chanen AM, 2008, PSYCHIAT RES-NEUROIM, V163, P116, DOI 10.1016/j.pscychresns.2007.08.007; Chee MWL, 2011, J COGNITIVE NEUROSCI, V23, P1065, DOI 10.1162/jocn.2010.21513; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Fernand SC, 2012, PSYCHONEUROENDOCRINO, V37, P1659, DOI 10.1016/j.psyneuen.2012.02.012; Goodman M, 2011, J PSYCHIATR RES, V45, P803, DOI 10.1016/j.jpsychires.2010.11.011; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kreisel S, VOLUME HIPP IN PRESS; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Pagura J, 2010, J PSYCHIATR RES, V44, P1190, DOI 10.1016/j.jpsychires.2010.04.016; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vollm Birgit, 2004, Crim Behav Ment Health, V14, P39, DOI 10.1002/cbm.559; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716; Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Zetzsche T, 2007, PSYCHIAT RES-NEUROIM, V154, P157, DOI 10.1016/j.pscychresns.2006.05.010	38	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83677	10.1371/journal.pone.0083677	http://dx.doi.org/10.1371/journal.pone.0083677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367606	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300113
J	Zheng, CF; Nie, LW; Wang, J; Zhou, HX; Hou, HZ; Wang, H; Liu, JJ				Zheng, Chenfei; Nie, Liuwang; Wang, Jue; Zhou, Huaxing; Hou, Huazhen; Wang, Hao; Liu, Juanjuan			Recombination and Evolution of Duplicate Control Regions in the Mitochondrial Genome of the Asian Big-Headed Turtle, Platysternon megacephalum	PLOS ONE			English	Article							CONCERTED EVOLUTION; GENE REARRANGEMENTS; DNA-SEQUENCE; ORGANIZATION; HETEROPLASMY; TESTUDINES; PHYLOGENY; REPTILIA	Complete mitochondrial (mt) genome sequences with duplicate control regions (CRs) have been detected in various animal species. In Testudines, duplicate mtCRs have been reported in the mtDNA of the Asian big-headed turtle, Platysternon megacephalum, which has three living subspecies. However, the evolutionary pattern of these CRs remains unclear. In this study, we report the completed sequences of duplicate CRs from 20 individuals belonging to three subspecies of this turtle and discuss the micro-evolutionary analysis of the evolution of duplicate CRs. Genetic distances calculated with MEGA 4.1 using the complete duplicate CR sequences revealed that within turtle subspecies, genetic distances between orthologous copies from different individuals were 0.63% for CR1 and 1.2% for CR2app:addword:respectively, and the average distance between paralogous copies of CR1 and CR2 was 4.8%. Phylogenetic relationships were reconstructed from the CR sequences, excluding the variable number of tandem repeats (VNTRs) at the 39 end using three methods: neighbor-joining, maximum likelihood algorithm, and Bayesian inference. These data show that any two CRs within individuals were more genetically distant from orthologous genes in different individuals within the same subspecies. This suggests independent evolution of the two mtCRs within each P. megacephalum subspecies. Reconstruction of separate phylogenetic trees using different CR components (TAS, CD, CSB, and VNTRs) suggested the role of recombination in the evolution of duplicate CRs. Consequently, recombination events were detected using RDP software with break points at approximate to 290 bp and approximate to 1,080 bp. Based on these results, we hypothesize that duplicate CRs in P. megacephalum originated from heterological ancestral recombination of mtDNA. Subsequent recombination could have resulted in homogenization during independent evolutionary events, thus maintaining the functions of duplicate CRs in the mtDNA of P. megacephalum.	[Zheng, Chenfei; Nie, Liuwang; Wang, Jue; Zhou, Huaxing; Hou, Huazhen; Wang, Hao; Liu, Juanjuan] Anhui Normal Univ, Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China	Anhui Normal University	Nie, LW (corresponding author), Anhui Normal Univ, Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China.	lwnie@mail.ahnu.edu.cn		Nie, Liu-Wang/0000-0003-2660-5799; Zhou, Huaxing/0000-0002-5569-0083	National Natural Science Foundation of China (NSFC) [30770296, 30970351]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, No. 30770296 and No. 30970351)(http://www.nsfc.gov.cn/Portal0/default152.htm).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P293, DOI 10.1016/j.ympev.2010.05.012; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Ernst CH, 2002, P BIOL SOC WASH, V115, P18; ERNST CH, 1987, P BIOL SOC WASH, V100, P624; Fan SG, 2011, SCI CHINA LIFE SCI, V54, P434, DOI 10.1007/s11427-011-4168-8; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gray JE, 1870, CATALOGUE SHIELD 1 S; Gray JE, 1831, P ZOOL SOC LOND, V831, P106; Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HELL TA, 1999, NUCL ACIDS S SERIES, V41, P95; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jang KH, 2011, MITOCHONDR DNA, V22, P77, DOI 10.3109/19401736.2011.624601; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Kumazawa Y, 1998, GENETICS, V150, P313; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li XS, 2010, AMPHIBIA-REPTILIA, V31, P541, DOI 10.1163/017353710X530203; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parham JF, 2006, MOL PHYLOGENET EVOL, V38, P50, DOI 10.1016/j.ympev.2005.07.015; Peng QL, 2006, GENE, V380, P14, DOI 10.1016/j.gene.2006.04.001; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schirtzinger EE, 2012, MOL PHYLOGENET EVOL, V64, P342, DOI 10.1016/j.ympev.2012.04.009; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford DL, 2002, PAUP PHYLOGENENC ANA; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; Verkuil YI, 2010, MOL PHYLOGENET EVOL, V57, P411, DOI 10.1016/j.ympev.2010.06.010; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Xiong L, 2010, GENES GENOM, V32, P291, DOI 10.1007/s13258-010-0015-8; Zhang JF, 2009, GENE, V442, P119, DOI 10.1016/j.gene.2009.04.018; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang YY, 2009, GENES GENOM, V31, P349, DOI 10.1007/BF03191253; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026	51	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82854	10.1371/journal.pone.0082854	http://dx.doi.org/10.1371/journal.pone.0082854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367563	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300076
J	Cameron, ADS; Kroger, C; Quinn, HJ; Scally, IK; Daly, AJ; Kary, SC; Dorman, CJ				Cameron, Andrew D. S.; Kroeger, Carsten; Quinn, Heather J.; Scally, Isobel K.; Daly, Anne J.; Kary, Stefani C.; Dorman, Charles J.			Transmission of an Oxygen Availability Signal at the Salmonella enterica Serovar Typhimurium fis Promoter	PLOS ONE			English	Article							PHASE-DEPENDENT REGULATION; ESCHERICHIA-COLI; STRINGENT CONTROL; SIDD SITES; IN-VITRO; TRANSCRIPTION; EXPRESSION; GENE; IDENTIFICATION; SEQUENCE	The nucleoid-associated protein FIS is a global regulator of gene expression and chromosome structure in Escherichia coli and Salmonella enterica. Despite the importance of FIS for infection and intracellular invasion, very little is known about the regulation of S. enterica fis expression. Under standard laboratory growth conditions, fis is highly expressed during rapid growth but is then silenced as growth slows. However, if cells are cultured in non-aerated conditions, fis expression is sustained during stationary phase. This led us to test whether the redox-sensing transcription factors ArcA and FNR regulate S. enterica fis. Deletion of FNR had no detectable effect, whereas deletion of ArcA had the unexpected effect of further elevating fis expression in stationary phase. ArcA required RpoS for induction of fis expression, suggesting that ArcA indirectly affects fis expression. Other putative regulators were found to play diverse roles: FIS acted directly as an auto-repressor (as expected), whereas CRP had little direct effect on fis expression. Deleting regions of the fis promoter led to the discovery of a novel anaerobically-induced transcription start site (Pfis-2) upstream of the primary transcription start site (Pfis-1). Promoter truncation also revealed that the shortest functional fis promoter was incapable of sustained expression. Moreover, fis expression was observed to correlate directly with DNA supercoiling in non-aerated conditions. Thus, the full-length S. enterica fis promoter region may act as a topological switch that is sensitive to stress-induced duplex destabilisation and upregulates expression in non-aerated conditions.	[Cameron, Andrew D. S.; Kroeger, Carsten; Quinn, Heather J.; Scally, Isobel K.; Daly, Anne J.; Dorman, Charles J.] Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; [Cameron, Andrew D. S.; Kary, Stefani C.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	Trinity College Dublin; University of Regina	Dorman, CJ (corresponding author), Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	cjdorman@tcd.ie	Dorman, Charles J/N-9867-2015; Dorman, Charles/P-3481-2019; Kröger, Carsten/D-1863-2014	Dorman, Charles J/0000-0002-6018-9170; Dorman, Charles/0000-0002-6018-9170; Kröger, Carsten/0000-0003-0461-1530; Kary, Stefani/0000-0002-1757-7223; Cameron, Andrew/0000-0003-1560-8572	Science Foundation Ireland [07/IN1/B918]; University of Regina; Society for General Microbiology President's Fund Research Travel grant	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University of Regina; Society for General Microbiology President's Fund Research Travel grant	This work was supported by Science Foundation Ireland grant number 07/IN1/B918 (CJD), a University of Regina startup grant and a Society for General Microbiology President's Fund Research Travel grant (ADSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Beach MB, 1998, J BACTERIOL, V180, P5932, DOI 10.1128/JB.180.22.5932-5946.1998; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Bordes P, 2003, MOL MICROBIOL, V48, P561, DOI 10.1046/j.1365-2958.2003.03461.x; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Croinin TO, 2007, MOL MICROBIOL, V66, P237, DOI 10.1111/j.1365-2958.2007.05916.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorman Charles J., 2006, Science Progress, V89, P151, DOI 10.3184/003685006783238317; DORMAN CJ, 1988, J BACTERIOL, V170, P2816, DOI 10.1128/jb.170.6.2816-2826.1988; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Guadarrama-Beltran S, 2013, SUSTAINED EXPRESSION; HSIEH LS, 1991, J MOL BIOL, V219, P443, DOI 10.1016/0022-2836(91)90185-9; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Keane OM, 2003, MOL GENET GENOMICS, V270, P56, DOI 10.1007/s00438-003-0896-1; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Mallik P, 2004, J BACTERIOL, V186, P122, DOI 10.1128/JB.186.1.122-135.2004; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Nasser W, 2002, EMBO J, V21, P715, DOI 10.1093/emboj/21.4.715; Nasser W, 2001, J BIOL CHEM, V276, P17878, DOI 10.1074/jbc.M100632200; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Walker KA, 1999, J BACTERIOL, V181, P1269, DOI 10.1128/JB.181.4.1269-1280.1999; Wang HQ, 2004, GENOME RES, V14, P1575, DOI 10.1101/gr.2080004; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	39	16	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84382	10.1371/journal.pone.0084382	http://dx.doi.org/10.1371/journal.pone.0084382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358360	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700163
J	Chen, LX; Xu, QL; Tu, JG; Ge, YH; Liu, J; Liang, FT				Chen, Linxu; Xu, Qilong; Tu, Jiagang; Ge, Yihe; Liu, Jun; Liang, Fang Ting			Increasing RpoS Expression Causes Cell Death in Borrelia burgdorferi	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; LYME-DISEASE SPIROCHETE; GENE; BBK32; SEQUENCE; TICKS; INFECTIVITY; LIPOPROTEIN; ADAPTATION; VIRULENCE	RpoS, one of the two alternative sigma factors in Borrelia burgdorferi, is tightly controlled by multiple regulators and, in turn, determines expression of many critical virulence factors. Here we show that increasing RpoS expression causes cell death. The immediate effect of increasing RpoS expression was to promote bacterial division and as a consequence result in a rapid increase in cell number before causing bacterial death. No DNA fragmentation or degradation was observed during this induced cell death. Cryo-electron microscopy showed induced cells first formed blebs, which were eventually released from dying cells. Apparently blebbing initiated cell disintegration leading to cell death. These findings led us to hypothesize that increasing RpoS expression triggers intracellular programs and/or pathways that cause spirochete death. The potential biological significance of induced cell death may help B. burgdorferi regulate its population to maintain its life cycle in nature.	[Chen, Linxu; Xu, Qilong; Ge, Yihe; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Tu, Jiagang; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA	Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Health Science Center Houston	Liang, FT (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [R01 AI077733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by R01 AI077733 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; ARON L, 1994, FEMS MICROBIOL LETT, V123, P75, DOI 10.1111/j.1574-6968.1994.tb07204.x; Banik S, 2011, INFECT IMMUN, V79, P1208, DOI 10.1128/IAI.01156-10; BARBOUR AG, 1988, J CLIN MICROBIOL, V26, P475, DOI 10.1128/JCM.26.3.475-478.1988; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Bos J, 2012, P NATL ACAD SCI USA, V109, P18096, DOI 10.1073/pnas.1213332109; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Charoenwong D, 2011, APPL ENVIRON MICROB, V77, P5220, DOI 10.1128/AEM.00648-11; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gautam A, 2008, MICROBIOL-SGM, V154, P275, DOI 10.1099/mic.0.2007/011676-0; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; He M, 2007, J BACTERIOL, V189, P8377, DOI 10.1128/JB.01199-07; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Joseleau-Petit D, 1999, J BACTERIOL, V181, P9, DOI 10.1128/JB.181.1.9-14.1999; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Ouyang Z, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/J0URNAL.PPAT.1001272; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Ramamoorthy R, 1996, INFECT IMMUN, V64, P1259, DOI 10.1128/IAI.64.4.1259-1264.1996; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shi YL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003340; SIMPSON WJ, 1994, FEMS MICROBIOL LETT, V119, P381, DOI 10.1111/j.1574-6968.1994.tb06917.x; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Teng X, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.72; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Wang JH, 2013, TRENDS PLANT SCI, V18, P133, DOI 10.1016/j.tplants.2012.09.004; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Xu HJ, 2010, INFECT IMMUN, V78, P2910, DOI 10.1128/IAI.00372-10; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053212; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83276	10.1371/journal.pone.0083276	http://dx.doi.org/10.1371/journal.pone.0083276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358270	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700113
J	He, MM; Zhang, DS; Wang, F; Wang, ZQ; Luo, HY; Jin, Y; Wei, XL; Xu, RH				He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua			The Role of Non-Curative Surgery in Incurable, Asymptomatic Advanced Gastric Cancer	PLOS ONE			English	Article							TRIAL COMPARING GASTRECTOMY; QUALITY-OF-LIFE; PALLIATIVE GASTRECTOMY; STAGE-IV; INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SURGICAL-TREATMENT; CENTER EXPERIENCE; SURVIVAL BENEFIT; RESECTION	Background: Although general agreement exists on palliative surgery with intent of symptom palliation in advanced gastric cancer (AGC), the role of non-curative surgery for incurable, asymptomatic AGC is hotly debated. We aim to clarify the role of non-curative surgery in patients with incurable, asymptomatic AGC under the first-line chemotherapy. Methods: A total of 737 patients with incurable, asymptomatic advanced gastric adenocarcinoma between January 2008 and May 2012 at the Sun Yat-sen University Cancer Center were retrospectively analyzed, comprising 414 patients with non-curative surgery plus first-line chemotherapy, and 323 patients with first-line chemotherapy only. The clinicopathologic data, survival, and prognosis were evaluated, with propensity score adjustment for selection bias. Results: The median overall survival (OS) outcomes significantly favored non-curative surgery group over first-line chemotherapy only group in entire population (28.00 versus 10.37 months, P = 0.000), stage 4 patients (23.87 versus 10.37 months, P = 0.000), young patients (28.70 versus 10.37 months, P = 0.000) and elderly patients (23.07 versus 10.27 months, P = 0.031). The median OS advantages of non-curative surgery over first-line chemotherapy only were also maintained when the analyses were restricted to single organ metastasis (P = 0.001), distant lymph node metastasis (P = 0.002), peritoneal metastasis (P = 0.000), and multi-organ metastasis (P = 0.010). Significant OS advantages of non-curative surgery over chemotherapy only were confirmed solid by multivariate analyses before and after adjustment on propensity score (P = 0.000). Small subsets of patients with surgery of single metastatic lesion after previous curative gastrectomy, and with surgery of both primary and single metastatic sites showed sound median OS. Conclusions: There is a role for non-curative surgery plus first-line chemotherapy for incurable, asymptomatic AGC, in terms of survival. Randomized controlled trials are warranted to fill a gap in knowledge about the value of metastectomy and patient selection strategies.	[He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [He, Ming-ming; Zhang, Dong-sheng; Wang, Feng; Wang, Zhi-qiang; Luo, Hui-yan; Jin, Ying; Wei, Xiao-li; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	xu, rui/GRX-5734-2022; 骆, 卉妍/GWR-3383-2022; Xu, Rui-Hua/AAW-4766-2021	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534	National High Technology Research and Development Program of China (863 Program), China [2012AA02A506]; Science and Technology Department of Guangdong Province, China [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province, China [C2011019]	National High Technology Research and Development Program of China (863 Program), China(National High Technology Research and Development Program of China); Science and Technology Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This study was supported by National High Technology Research and Development Program of China (863 Program), China (No. 2012AA02A506), the Science and Technology Department of Guangdong Province, China (No. 2012B031800088), and Medical Scientific Research Foundation of Guangdong Province, China (No. C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amawi Tariq, 2011, Pol Przegl Chir, V83, P449, DOI 10.2478/v10035-011-0070-0; Amaral L, 2012, HEPATO-GASTROENTEROL, V59, P1651, DOI 10.5754/hge10201; An JY, 2009, ARCH SURG-CHICAGO, V144, P38, DOI 10.1001/archsurg.2008.502; Budisin NI, 2009, J BUON, V14, P593; Chen S, 2012, J SURG ONCOL, V106, P862, DOI 10.1002/jso.23158; Chen WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068974; Cheong JH, 2007, ANN SURG ONCOL, V14, P61, DOI 10.1245/s10434-006-9205-7; Coniglio A, 2004, J SURG ONCOL, V88, P201, DOI 10.1002/jso.20153; CROOKES PF, 1995, AM J SURG, V170, P602, DOI 10.1016/S0002-9610(99)80024-5; Dittmar Y, 2009, ZBL CHIR, V134, P77, DOI 10.1055/s-0028-1098793; Dittmar Y, 2012, LANGENBECK ARCH SURG, V397, P745, DOI 10.1007/s00423-012-0902-3; Fujitani K, 2008, JPN J CLIN ONCOL, V38, P504, DOI 10.1093/jjco/hyn058; Gastinger I, 2012, CHIRURG, V83, P472, DOI 10.1007/s00104-011-2143-3; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Hanazaki K, 2001, HEPATO-GASTROENTEROL, V48, P285; Hansson LE, 2000, EUR J SURG, V166, P787, DOI 10.1080/110241500447425; Hartgrink HH, 2002, BRIT J SURG, V89, P1438, DOI 10.1046/j.1365-2168.2002.02220.x; Heemskerk Vincent H, 2007, World J Surg Oncol, V5, P81, DOI 10.1186/1477-7819-5-81; Huang KH, 2010, WORLD J SURG, V34, P1015, DOI 10.1007/s00268-010-0467-7; Jacquet P, 1996, Cancer Treat Res, V82, P359; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karoui M, 2011, DIS COLON RECTUM, V54, P930, DOI 10.1097/DCR.0b013e31821cced0; Kerkar SP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-121; Kikuchi S, 1999, HEPATO-GASTROENTEROL, V46, P584; Kikuchi S, 2000, HEPATO-GASTROENTEROL, V47, P563; Kim DY, 2008, LANGENBECK ARCH SURG, V393, P31, DOI 10.1007/s00423-007-0206-1; Ko KJ, 2012, WORLD J SURG, V36, P1800, DOI 10.1007/s00268-012-1566-4; Kunisaki C, 2005, HEPATO-GASTROENTEROL, V52, P314; Kunisaki C, 2003, ANTICANCER RES, V23, P1853; Kunisaki C, 2008, ANTICANCER RES, V28, P1309; Li C, 2010, J GASTROINTEST SURG, V14, P282, DOI 10.1007/s11605-009-1095-0; Lin SZ, 2008, J CANCER RES CLIN, V134, P187, DOI 10.1007/s00432-007-0268-z; Liu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037284; Maetani I, 2005, J GASTROENTEROL, V40, P932, DOI 10.1007/s00535-005-1651-7; Mahar AL, 2012, GASTRIC CANCER, V15, pS125, DOI 10.1007/s10120-011-0088-3; Medina-Franco H, 2004, AM J SURG, V187, P543, DOI 10.1016/j.amjsurg.2003.12.045; Miner TJ, 2004, J AM COLL SURGEONS, V198, P1013, DOI 10.1016/j.jamcollsurg.2004.02.007; MONSON JRT, 1991, CANCER, V68, P1863, DOI 10.1002/1097-0142(19911101)68:9<1863::AID-CNCR2820680902>3.0.CO;2-1; Nazli O, 2007, HEPATO-GASTROENTEROL, V54, P298; Onate-Ocana LF, 2007, GASTRIC CANCER, V10, P215, DOI 10.1007/s10120-007-0437-4; Ouchi K, 1998, J SURG ONCOL, V69, P41, DOI 10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-K; Saidi RF, 2006, WORLD J SURG, V30, P21, DOI 10.1007/s00268-005-0129-3; Saito H, 2009, LANGENBECK ARCH SURG, V394, P99, DOI 10.1007/s00423-008-0398-z; Samarasam I, 2006, ANZ J SURG, V76, P60, DOI 10.1111/j.1445-2197.2006.03649.x; Shen JG, 2006, WORLD J GASTROENTERO, V12, P3883, DOI 10.3748/wjg.v12.i24.3883; Shim JH, 2012, J SURG ONCOL, V106, P753, DOI 10.1002/jso.23121; Shiraishi Norio, 2000, Gastric Cancer, V3, P211, DOI 10.1007/PL00011719; Sougioultzis S, 2011, EJSO-EUR J SURG ONC, V37, P312, DOI 10.1016/j.ejso.2011.01.019; Stupart D, 2009, S AFR J SURG, V44, P52; Sugarbaker Paul H, 2003, Semin Surg Oncol, V21, P233, DOI 10.1002/ssu.10042; Tamura Shigeyuki, 2010, Gan To Kagaku Ryoho, V37, P2279; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Zhang XF, 2004, WORLD J GASTROENTERO, V10, P3405	55	25	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83921	10.1371/journal.pone.0083921	http://dx.doi.org/10.1371/journal.pone.0083921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358318	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700143
J	Shahani, N; Pryor, W; Swarnkar, S; Kholodilov, N; Thinakaran, G; Burke, RE; Subramaniam, S				Shahani, Neelam; Pryor, William; Swarnkar, Supriya; Kholodilov, Nikolai; Thinakaran, Gopal; Burke, Robert E.; Subramaniam, Srinivasa			Rheb GTPase Regulates beta-Secretase Levels and Amyloid beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Amyloid; GTPase; Protein Stability; Secretases	PRECURSOR PROTEIN; MAMMALIAN TARGET; BACE1; DEGRADATION; LOCALIZATION; EXPRESSION; UBIQUITIN; MTOR; IDENTIFICATION; MYELINATION	Background: BACE1 (-secretase) is an important enzyme in Alzheimer disease pathology, but how it is regulated remains unclear. Results: Rheb GTPase binds and regulates BACE1 levels and its activity, in an mTOR independent manner. Conclusion: Rheb GTPase is a novel physiological regulator of BACE1 pathway. Significance: This study establishes a novel molecular link between Rheb and BACE1 that may have a role in age-related biology and disease. The -site amyloid precursor protein (APP)-cleaving enzyme 1 (-secretase, BACE1) initiates amyloidogenic processing of APP to generate amyloid (A), which is a hallmark of Alzheimer disease (AD) pathology. Cerebral levels of BACE1 are elevated in individuals with AD, but the molecular mechanisms are not completely understood. We demonstrate that Rheb GTPase (Ras homolog enriched in brain), which induces mammalian target of rapamycin (mTOR) activity, is a physiological regulator of BACE1 stability and activity. Rheb overexpression depletes BACE1 protein levels and reduces A generation, whereas the RNAi knockdown of endogenous Rheb promotes BACE1 accumulation, and this effect by Rheb is independent of its mTOR signaling. Moreover, GTP-bound Rheb interacts with BACE1 and degrades it through proteasomal and lysosomal pathways. Finally, we demonstrate that Rheb levels are down-regulated in the AD brain, which is consistent with an increased BACE1 expression. Altogether, our study defines Rheb as a novel physiological regulator of BACE1 levels and A generation, and the Rheb-BACE1 circuitry may have a role in brain biology and disease.	[Shahani, Neelam; Pryor, William; Swarnkar, Supriya; Subramaniam, Srinivasa] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kholodilov, Nikolai; Burke, Robert E.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Scripps Research Institute; Columbia University; University of Chicago	Subramaniam, S (corresponding author), 130 Scripps Way,3C1, Jupiter, FL 33458 USA.	ssubrama@scripps.edu	Core, Vector/CAF-4832-2022; Swarnkar, Supriya/H-8054-2016; Burke, Robert/B-7226-2011; Swarnkar, Supriya/AAU-7752-2020	Swarnkar, Supriya/0000-0001-7596-0215; Burke, Robert/0000-0002-4760-8553; Swarnkar, Supriya/0000-0001-7596-0215	Public Health Service Grant [R24 MH068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Dr. Solomon H. Snyder of Johns Hopkins University for sharing reagents during the preliminary investigation of the study and to Dr. Louis Fernandes of The Harvard Brain Tissue Resource Center, which is supported in part by Public Health Service Grant R24 MH068855, for the generous sharing of human postmortem samples and Dr. Robert Vassar for the 3D5 BACE1 antibody. We are thankful to Natalie Defraene, Nancy Norton, and Trina Miles for the administrative support. We are grateful to the people in The Scripps Research Institute, Florida, especially in the Department of Neuroscience, for their continuous support for setting up the laboratory and providing technical support whenever needed.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeppsson F, 2012, J BIOL CHEM, V287, P41245, DOI 10.1074/jbc.M112.409110; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Kim SR, 2012, MOL THER, V20, P275, DOI 10.1038/mt.2011.213; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Nawrot B, 2003, EUR J BIOCHEM, V270, P3962, DOI 10.1046/j.1432-1033.2003.03784.x; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Subramaniam S, 2012, NAT NEUROSCI, V15, P191, DOI 10.1038/nn.2994; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	55	39	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5799	5808		10.1074/jbc.M113.532713	http://dx.doi.org/10.1074/jbc.M113.532713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24368770	Green Published, hybrid			2022-12-25	WOS:000332015500039
J	Bacik, JP; Tavassoli, M; Patel, TR; McKenna, SA; Vocadlo, DJ; Khajehpour, M; Mark, BL				Bacik, John-Paul; Tavassoli, Marjan; Patel, Trushar R.; McKenna, Sean A.; Vocadlo, David J.; Khajehpour, Mazdak; Mark, Brian L.			Conformational Itinerary of Pseudomonas aeruginosa 1,6-Anhydro-N-acetylmuramic Acid Kinase during Its Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mechanisms; Fluorescence; Peptidoglycan; Pseudomonas aeruginosa; 1,6-Anhydro-N-acetylmuramic Acid; AnmK; SAXS; Sugar Kinase	SUBSTRATE-SPECIFICITY; N-ACETYLGLUCOSAMINE; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; YEAST HEXOKINASE; MECHANISM; MUREIN; GROWTH; INSIGHTS; BINDING	Anhydro-sugar kinases are unique from other sugar kinases in that they must cleave the 1,6-anhydro ring of their sugar substrate to phosphorylate it using ATP. Here we show that the peptidoglycan recycling enzyme 1,6-anhydro-N-acetylmuramic acid kinase (AnmK) from Pseudomonas aeruginosa undergoes large conformational changes during its catalytic cycle, with its two domains rotating apart by up to 32 degrees around two hinge regions to expose an active site cleft into which the substrates 1,6-anhydroMurNAc and ATP can bind. X-ray structures of the open state bound to a nonhydrolyzable ATP analog (AMPPCP) and 1,6-anhydroMurNAc provide detailed insight into a ternary complex that forms preceding an operative Michaelis complex. Structural analysis of the hinge regions demonstrates a role for nucleotide binding and possible cross-talk between the bound ligands to modulate the opening and closing of AnmK. Although AnmK was found to exhibit similar binding affinities for ATP, ADP, and AMPPCP according to fluorescence spectroscopy, small angle x-ray scattering analyses revealed that AnmK adopts an open conformation in solution in the absence of ligand and that it remains in this open state after binding AMPPCP, as we had observed for our crystal structure of this complex. In contrast, the enzyme favored a closed conformation when bound to ADP in solution, consistent with a previous crystal structure of this complex. Together, our findings show that the open conformation of AnmK facilitates binding of both the sugar and nucleotide substrates and that large structural rearrangements must occur upon closure of the enzyme to correctly align the substrates and residues of the enzyme for catalysis.	[Bacik, John-Paul; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Tavassoli, Marjan; Patel, Trushar R.; McKenna, Sean A.; Khajehpour, Mazdak] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5S 1P6, Canada	University of Manitoba; University of Manitoba; Simon Fraser University	Mark, BL (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.	brian_mark@umanitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Vocadlo, David J/E-5508-2014	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Vocadlo, David J/0000-0001-6897-5558; Bacik, John-Paul/0000-0001-9315-5332; Mark, Brian/0000-0002-7344-1355; McKenna, Sean/0000-0002-9407-7257	Canadian Institutes of Health Research [MOP97818]; Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada [314021-2012]; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; Manitoba Health Research Council (MHRC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Manitoba Health Research Council (MHRC)	This work was supported by Canadian Institutes of Health Research Grant MOP97818 and by the Cystic Fibrosis Canada and the Natural Sciences and Engineering Research Council of Canada (314021-2012). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan.; Supported by a postdoctoral fellowship from the Manitoba Health Research Council (MHRC).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen FH, 2004, CHEM SOC REV, V33, P463, DOI 10.1039/b309040j; Bacik JP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198317; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o	35	7	7	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4504	4514		10.1074/jbc.M113.521633	http://dx.doi.org/10.1074/jbc.M113.521633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362022	Green Published, hybrid			2022-12-25	WOS:000331403800058
J	Bashtrykov, P; Jankevicius, G; Jurkowska, RZ; Ragozin, S; Jeltsch, A				Bashtrykov, Pavel; Jankevicius, Gytis; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert			The UHRF1 Protein Stimulates the Activity and Specificity of the Maintenance DNA Methyltransferase DNMT1 by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Chromatin; DNA Methylation; DNA Methyltransferase; Enzyme Mechanisms	HEMI-METHYLATED DNA; HISTONE H3 TAIL; UBIQUITIN LIGASE ACTIVITY; HEMIMETHYLATED CPG SITES; RECOMBINANT HUMAN DNA; SRA DOMAIN; PHD FINGER; EPIGENETIC INHERITANCE; STRUCTURAL INSIGHT; CATALYTIC DOMAIN	The ubiquitin-like, containing PHD and RING finger domains protein 1 (UHRF1) is essential for maintenance DNA methylation by DNA methyltransferase 1 (DNMT1). UHRF1 has been shown to recruit DNMT1 to replicated DNA by the ability of its SET and RING-associated (SRA) domain to bind to hemimethylated DNA. Here, we demonstrate that UHRF1 also increases the activity of DNMT1 by almost 5-fold. This stimulation is mediated by a direct interaction of both proteins through the SRA domain of UHRF1 and the replication focus targeting sequence domain of DNMT1, and it does not require DNA binding by the SRA domain. Disruption of the interaction between DNMT1 and UHRF1 by replacement of key residues in the replication focus targeting sequence domain led to a strong reduction of DNMT1 stimulation. Additionally, the interaction with UHRF1 increased the specificity of DNMT1 for methylation of hemimethylated CpG sites. These findings show that apart from the targeting of DNMT1 to the replicated DNA UHRF1 increases the activity and specificity of DNMT1, thus exerting a multifaceted influence on the maintenance of DNA methylation.	[Bashtrykov, Pavel; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert] Univ Stuttgart, Fac Chem, Inst Biochem, D-70569 Stuttgart, Germany; [Jankevicius, Gytis] Jacobs Univ Bremen, Sch Sci & Engn, MoLife Program, D-28759 Bremen, Germany	University of Stuttgart; Jacobs University	Jeltsch, A (corresponding author), Univ Stuttgart, Fac Chem, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014; Jurkowska, Renata/AAE-2504-2020; Jankevicius, Gytis/C-7126-2015	Jeltsch, Albert/0000-0001-6113-9290; Jurkowska, Renata/0000-0002-4507-2222; Jankevicius, Gytis/0000-0002-0212-3923; Bashtrykov, Pavel/0000-0003-3838-2019	Deutsche Forschungsgemeinschaft DFG [JE 252/15-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG Grant JE 252/15-1.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bacolla A, 1999, J BIOL CHEM, V274, P33011, DOI 10.1074/jbc.274.46.33011; Bashtrykov P, 2012, FEBS LETT, V586, P1821, DOI 10.1016/j.febslet.2012.05.026; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jeltsch A, 2008, NAT STRUCT MOL BIOL, V15, P1003, DOI 10.1038/nsmb1008-1003; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	55	79	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4106	4115		10.1074/jbc.M113.528893	http://dx.doi.org/10.1074/jbc.M113.528893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368767	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000331403800024
J	Huang, CH; Chu, YR; Ye, YH; Chen, X				Huang, Chih-Hsiang; Chu, Yue-Ru; Ye, Yihong; Chen, Xin			Role of HERP and a HERP-related Protein in HRD1-dependent Protein Degradation at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; ER Quality Control; Protein Degradation; Protein Translocation; Ubiquitin Ligase	ER-ASSOCIATED DEGRADATION; UBIQUITIN-LIGASE; QUALITY-CONTROL; PATHWAY; COMPLEX; STRESS; HOMEOSTASIS; HRD1P	Misfolded proteins of the endoplasmic reticulum (ER) are retrotranslocated to the cytosol and degraded by the proteasome via a process termed ER-associated degradation (ERAD). The precise mechanism of retrotranslocation is unclear. Here, we use several lumenal ERAD substrates targeted for degradation by the ubiquitin ligase HRD1 including SHH (sonic hedgehog) and NHK (null Hong Kong 1-antitrypsin) to study the geometry, organization, and regulation of the HRD1-containing ERAD machinery. We report a new HRD1-associated membrane protein named HERP2, which is homologous to the previously identified HRD1 partner HERP1. Despite sequence homology, HERP2 is constitutively expressed in cells, whereas HERP1 is highly induced by ER stress. We find that these proteins are required for efficient degradation of both glycosylated and nonglycosylated SHH proteins as well as NHK. In cells depleted of HERPs, SHH proteins are largely trapped inside the ER with a fraction of the stabilized SHH protein bound to the HRD1-SEL1L ligase complex. Ubiquitination of SHH is significantly attenuated in the absence of HERPs, suggesting a defect in retrotranslocation. Both HERP proteins interact with HRD1 through a region located in the cytosol. However, unlike its homolog in Saccharomyces cerevisiae, HERPs do not regulate HRD1 stability or oligomerization status. Instead, they help recruit DERL2 to the HRD1-SEL1L complex. Additionally, the UBL domain of HERP1 also seems to have a function independent of DERL2 recruitment in ERAD. Our studies have revealed a critical scaffolding function for mammalian HERP proteins that is required for forming an active retrotranslocation complex containing HRD1, SEL1L, and DERL2.	[Huang, Chih-Hsiang; Chu, Yue-Ru; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan; [Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); China Medical University Taiwan	Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@niddk.nih.gov; xchen@nhri.org.tw			National Research Programs for Genomic Medicine (NRPGM), National Science Council; National Health Research Institutes, Taiwan, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008, ZIADK075044] Funding Source: NIH RePORTER	National Research Programs for Genomic Medicine (NRPGM), National Science Council; National Health Research Institutes, Taiwan, China(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Research Programs for Genomic Medicine (NRPGM), National Science Council, and National Health Research Institutes, Taiwan, China. This work was supported by the National Research Programs for Genomic Medicine (NRPGM), National Science Council and National Health Research Institutes, Taiwan, China.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bernasconi R, 2013, MOL CELL, V52, P783, DOI 10.1016/j.molcel.2013.10.016; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Huang CH, 2013, J BIOL CHEM, V288, P25330, DOI 10.1074/jbc.M113.455212; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	28	27	27	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4444	4454		10.1074/jbc.M113.519561	http://dx.doi.org/10.1074/jbc.M113.519561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366871	hybrid, Green Published			2022-12-25	WOS:000331403800054
J	Than, A; Zhang, XH; Leow, MKS; Poh, CL; Chong, SK; Chen, P				Aung Than; Zhang, Xiaohong; Leow, Melvin Khee-Shing; Poh, Chueh Loo; Chong, Seow Khoon; Chen, Peng			Apelin Attenuates Oxidative Stress in Human Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipokines; Antioxidants; Oxidative Stress; Reactive Oxygen Species (ROS)	INDUCED INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; ADIPOSE-TISSUE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; PROMOTER ACTIVITY; BIOGENESIS; OBESITY; DIFFERENTIATION; ADIPOGENESIS	Background: Antioxidant effects of apelin on adipocytes are unknown. Results: Apelin not only suppresses production and release of reactive oxygen species, but also relieves oxidative-stress induced cellular dysfunctions in adipocytes. Conclusion: Apelin-APJ signaling acts as the negative autocrine feedbacks against oxidative stress in adipocytes. Significance: Apelin signaling may serve as a potential therapeutic target for metabolic disorders. It has been recently recognized that the increased oxidative stress (ROS overproduction) in obese condition is a key contributor to the pathogenesis of obesity-associated metabolic diseases. Apelin is an adipocytokine secreted by adipocytes, and known for its anti-obesity and anti-diabetic properties. In obesity, both oxidative stress and plasma level of apelin are increased. However, the regulatory roles of apelin on oxidative stress in adipocytes remain unknown. In the present study, we provide evidence that apelin, through its interaction with apelin receptor (APJ), suppresses production and release of reactive oxygen species (ROS) in adipocytes. This is further supported by the observations that apelin promotes the expression of anti-oxidant enzymes via MAPK kinase/ERK and AMPK pathways, and suppresses the expression of pro-oxidant enzyme via AMPK pathway. We further demonstrate that apelin is able to relieve oxidative stress-induced dysregulations of the expression of anti- and pro-oxidant enzymes, mitochondrial biogenesis and function, as well as release of pro- and anti-inflammatory adipocytokines. This study, for the first time, reveals the antioxidant properties of apelin in adipocytes, and suggests its potential as a novel therapeutic target for metabolic diseases.	[Aung Than; Zhang, Xiaohong; Poh, Chueh Loo; Chong, Seow Khoon; Chen, Peng] Nanyang Technol Univ, Div Bioengn, Singapore 637457, Singapore; [Leow, Melvin Khee-Shing] Brenner Ctr Mol Med, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Singapore 308433, Singapore; [Leow, Melvin Khee-Shing] Duke NUS Grad Med Sch, Singapore 169857, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Tan Tock Seng Hospital; National University of Singapore	Chen, P (corresponding author), Nanyang Technol Univ, Div Bioengn, 70 Nanyang Dr, Singapore 637457, Singapore.	chenpeng@ntu.edu.sg	Poh, Chueh Loo/AAG-9907-2021; Leow, Melvin/H-3129-2019; Poh, Chueh Loo/G-6211-2010; Leow, Melvin/AAJ-1168-2020; Chen, Peng/G-6202-2010; Zhang, Xiaohong/A-3060-2015; Chong, Mark/D-2678-2013	Leow, Melvin/0000-0002-2837-5889; Chen, Peng/0000-0003-3730-1846; Chong, Mark/0000-0002-9586-6303; aung, than/0000-0003-1558-7310	Singapore Ministry of Health's National Medical Research Council under its EDG Grant [NMRC/EDG/1048/2011]; Singapore Ministry of Education [RGT7/13]	Singapore Ministry of Health's National Medical Research Council under its EDG Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Health's National Medical Research Council under its EDG Grant (NMRC/EDG/1048/2011) and Singapore Ministry of Education under its AcRF Tier 1 Grant (RGT7/13).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Castan-Laurell I, 2008, EUR J ENDOCRINOL, V158, P905, DOI 10.1530/EJE-08-0039; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Chu JYS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064859; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Evans J L, 2000, Diabetes Technol Ther, V2, P401, DOI 10.1089/15209150050194279; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Foussal C, 2010, FEBS LETT, V584, P2363, DOI 10.1016/j.febslet.2010.04.025; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hemmrich K, 2005, DIFFERENTIATION, V73, P28, DOI 10.1111/j.1432-0436.2005.07301003.x; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Kumar S, 2008, AM J PHYSIOL-LUNG C, V295, pL370, DOI 10.1152/ajplung.90205.2008; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Prieto-Hontoria PL, 2009, J PHYSIOL BIOCHEM, V65, P43, DOI 10.1007/BF03165968; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Sankhla M, 2012, CLIN LAB, V58, P385; Shibata M, 2010, J BIOL CHEM, V285, P20915, DOI 10.1074/jbc.M110.126482; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Tanaka T, 2003, EUR J ENDOCRINOL, V149, P61, DOI 10.1530/eje.0.1490061; Than A, 2013, J BIOL CHEM, V288, P15520, DOI 10.1074/jbc.M113.459792; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Than A, 2012, MOL CELL ENDOCRINOL, V351, P296, DOI 10.1016/j.mce.2012.01.005; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Whaley-Connell A, 2011, REV CARDIOVASC MED, V12, P21, DOI 10.3909/ricm0555; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Zhang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056346, 10.1371/journal.pone.0057885]; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhen EY, 2013, ANAL BIOCHEM, V442, P1, DOI 10.1016/j.ab.2013.07.006; Zheng XT, 2013, ACS NANO, V7, P6278, DOI 10.1021/nn4023137; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041500; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	82	69	69	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3763	3774		10.1074/jbc.M113.526210	http://dx.doi.org/10.1074/jbc.M113.526210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362107	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000331368700056
J	Barbariga, M; Curnis, F; Spitaleri, A; Andolfo, A; Zucchelli, C; Lazzaro, M; Magnani, G; Musco, G; Corti, A; Alessio, M				Barbariga, Marco; Curnis, Flavio; Spitaleri, Andrea; Andolfo, Annapaola; Zucchelli, Chiara; Lazzaro, Massimo; Magnani, Giuseppe; Musco, Giovanna; Corti, Angelo; Alessio, Massimo			Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Integrins; Oxidative Stress; Protein Deamidation; Protein Misfolding; Structural Biology; Ceruloplasmin; NGR Motif; isoNGR Motif	ALZHEIMERS-DISEASE; ISOASPARTATE FORMATION; PARKINSONS-DISEASE; CHOROID-PLEXUS; COPPER; STRESS; BRAIN; IRON; NEURODEGENERATION; ISODGR	Background: Asparagine deamidation at Asn-Gly-Arg (NGR) sites leads to the isoAsp-Gly-Arg (isoDGR) integrin-binding motif formation. Results: Ceruloplasmin (Cp), which contains two NGR sites and is oxidized in cerebrospinal fluid (CSF) in neurodegenerative diseases, can, undergo oxidation-induced structural changes fostering NGR deamidation with gain of integrin binding and signaling properties, in vitro and ex vivo in pathological CSF. Conclusion: Cp NGR motifs can deamidate acquiring integrin-binding functions. Significance: Cp structural changes favor NGR deamidation. Asparagine deamidation occurs spontaneously in proteins during aging; deamidation of Asn-Gly-Arg (NGR) sites can lead to the formation of isoAsp-Gly-Arg (isoDGR), a motif that can recognize the RGD-binding site of integrins. Ceruloplasmin (Cp), a ferroxidase present in the cerebrospinal fluid (CSF), contains two NGR sites in its sequence: one exposed on the protein surface ((568)NGR) and the other buried in the tertiary structure ((962)NGR). Considering that Cp can undergo oxidative modifications in the CSF of neurodegenerative diseases, we investigated the effect of oxidation on the deamidation of both NGR motifs and, consequently, on the acquisition of integrin binding properties. We observed that the exposed (568)NGR site can deamidate under conditions mimicking accelerated Asn aging. In contrast, the hidden (962)NGR site can deamidate exclusively when aging occurs under oxidative conditions, suggesting that oxidation-induced structural changes foster deamidation at this site. NGR deamidation in Cp was associated with gain of integrin-binding function, intracellular signaling, and cell pro-adhesive activity. Finally, Cp aging in the CSF from Alzheimer disease patients, but not in control CSF, causes Cp deamidation with gain of integrin-binding function, suggesting that this transition might also occur in pathological conditions. In conclusion, both Cp NGR sites can deamidate during aging under oxidative conditions, likely as a consequence of oxidative-induced structural changes, thereby promoting a gain of function in integrin binding, signaling, and cell adhesion.	[Barbariga, Marco; Curnis, Flavio; Lazzaro, Massimo; Corti, Angelo; Alessio, Massimo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Spitaleri, Andrea; Zucchelli, Chiara; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Spitaleri, Andrea; Zucchelli, Chiara; Musco, Giovanna] Ist Sci San Raffaele, Biomol NMR Spect, I-20132 Milan, Italy; [Andolfo, Annapaola] Ist Sci San Raffaele, Prote Serv, I-20132 Milan, Italy; [Magnani, Giuseppe] Ist Sci San Raffaele, INSPE Inst Expt Neurol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Alessio, M (corresponding author), Ist Sci San Raffaele, Via Olgettina 58, I-20132 Milan, Italy.	m.alessio@hsr.it	musco, giovanna/I-7122-2012; Curnis, Flavio/AAK-3542-2020; Alessio, Massimo/L-4518-2019; Corti, Angelo/F-7046-2012; Magnani, Giuseppe/AAN-2242-2020; Musco, Giovanna/Q-2756-2019; Zucchelli, Chiara/AAN-4832-2020; Spitaleri, Andrea/S-9368-2019; Alessio, Massimo/K-7028-2014	musco, giovanna/0000-0002-0469-2994; Curnis, Flavio/0000-0002-7231-9569; Corti, Angelo/0000-0002-0893-6191; Magnani, Giuseppe/0000-0001-8436-2903; Zucchelli, Chiara/0000-0003-2857-7170; Spitaleri, Andrea/0000-0003-3012-3557; Andolfo, Annapaola/0000-0002-0566-2391; Alessio, Massimo/0000-0002-4133-3472; Subba, Rajkrishna/0000-0003-0051-0062	Michael J. Fox Foundation for Parkinson's Research Grant [130-012/2310]; Fondazione Telethon Funding Source: Custom	Michael J. Fox Foundation for Parkinson's Research Grant; Fondazione Telethon(Fondazione Telethon)	Supported by Michael J. Fox Foundation for Parkinson's Research Grant 130-012/2310.	Arnal N, 2010, BRAIN RES, V1319, P118, DOI 10.1016/j.brainres.2009.11.085; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; Bento I, 2007, ACTA CRYSTALLOGR D, V63, P240, DOI 10.1107/S090744490604947X; Brewer GJ, 2010, AM J ALZHEIMERS DIS, V25, P490, DOI 10.1177/1533317510375083; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Curnis F, 2010, J BIOL CHEM, V285, P9114, DOI 10.1074/jbc.M109.044297; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dehart MP, 2012, J PHARM SCI-US, V101, P3096, DOI 10.1002/jps.23061; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Frank AO, 2010, ANGEW CHEM INT EDIT, V49, P9278, DOI 10.1002/anie.201004363; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; Kang JH, 2001, BBA-GEN SUBJECTS, V1568, P30, DOI 10.1016/S0304-4165(01)00198-2; Krzyzanowska A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00075; Lee KH, 2007, BRAIN RES, V1171, P1, DOI 10.1016/j.brainres.2007.07.053; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MUSCI G, 1993, J BIOL CHEM, V268, P13388; Olivieri S, 2011, J NEUROSCI, V31, P18568, DOI 10.1523/JNEUROSCI.3768-11.2011; Patel BN, 2002, J NEUROSCI, V22, P6578; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Serot JM, 2012, J ALZHEIMERS DIS, V30, P17, DOI 10.3233/JAD-2012-111964; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; Weintraub Steven J, 2007, Sci STKE, V2007, pre7, DOI 10.1126/stke.4092007re7; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	47	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3736	3748		10.1074/jbc.M113.520981	http://dx.doi.org/10.1074/jbc.M113.520981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24366863	Green Published, hybrid			2022-12-25	WOS:000331368700054
J	Martirosyan, A; Von Bargen, K; Gorvel, VA; Zhao, WD; Hanniffy, S; Bonnardel, J; Meresse, S; Gorvel, JP				Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre			In Vivo Identification and Characterization of CD4(+) Cytotoxic T Cells Induced by Virulent Brucella abortus Infection	PLOS ONE			English	Article							B-CELL; GAMMA-INTERFERON; LYMPHOCYTES; RESPONSES; IMMUNITY	CD4(+) T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4(+) T cells (CD4(+) CTL) during Brucella abortus infection. These CD4(+) CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L, CD43 molecules at their surface and produce IFN-gamma. Moreover, these cells express neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. We show here that CD4(+) CTLs are capable of cytolytic action against Brucella-infected antigen presenting cells (APC) but not against Mycobacterium-infected APC. Cytotoxic CD4(+) T cell population appears at early stages of the infection concomitantly with high levels of IFN-gamma and granzyme B expression. CD4(+) CTLs represent a so far uncharacterized immune cell sub-type triggered by early immune responses upon Brucella abortus infection.	[Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, F-13288 Marseille, France; [Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] CNRS, UMR 7280, F-13288 Marseille, France; [Martirosyan, Anna; Von Bargen, Kristine; Gorvel, Vilma Arce; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Meresse, Stephane; Gorvel, Jean-Pierre] INSERM, U631, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gorvel, JP (corresponding author), Aix Marseille Univ, CIML, F-13288 Marseille, France.	gorvel@ciml.univ-mrs.fr	Meresse, Stephane/E-2192-2012; Gorvel, Jean-Pierre/O-1332-2018	Meresse, Stephane/0000-0001-6578-5177; Gorvel, Jean-Pierre/0000-0002-2829-9804; Bonnardel, Johnny/0000-0003-2359-3438; Arce-Gorvel, Vilma/0000-0003-0090-837X	Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale, FRM, France	Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale, FRM, France	This work was supported by the Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France. AM was a recipient of the Foundation de la Recherche Medicale, FRM, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 1997, IMMUNOL TODAY, V18, P387, DOI 10.1016/S0167-5699(97)01102-X; Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Bessoles S, 2011, EUR J IMMUNOL, V41, P1619, DOI 10.1002/eji.201041230; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Cannella AP, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00001; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109; FLEISCHER B, 1984, NATURE, V308, P365, DOI 10.1038/308365a0; Glimcher LH, 2000, GENE DEV, V14, P1693; Goenka R, 2011, J INFECT DIS, V203, P1136, DOI 10.1093/infdis/jiq171; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; HUANG Z, 1992, J VIROL, V66, P2664, DOI 10.1128/JVI.66.5.2664-2669.1992; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; KRENSKY AM, 1982, J IMMUNOL, V129, P2001; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; Martirosyan A, 2013, FUTURE MICROBIOL, V8, P147, DOI [10.2217/FMB.12.140, 10.2217/fmb.12.140]; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Martorelli D, 2010, INT REV IMMUNOL, V29, P371, DOI 10.3109/08830185.2010.489658; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Omiya R, 2002, J IMMUNOL, V169, P2172, DOI 10.4049/jimmunol.169.4.2172; Porakishvili N, 2004, HAEMATOLOGICA, V89, P435; Skyberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021978; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Stuller KA, 2009, J VIROL, V83, P4700, DOI 10.1128/JVI.02240-08; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765	36	14	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82508	10.1371/journal.pone.0082508	http://dx.doi.org/10.1371/journal.pone.0082508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367519	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900009
J	Rattray, I; Smith, EJ; Crum, WR; Walker, TA; Gale, R; Bates, GP; Modo, M				Rattray, Ivan; Smith, Edward J.; Crum, William R.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.; Modo, Michel			Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC CHARACTERIZATION; PITUITARY-ADRENAL AXIS; CELLULAR PATHOLOGY; MUTANT HUNTINGTIN; GENE-EXPRESSION; FLUID REGISTRATION; STRIATAL NEURONS; TRANSGENIC MICE; PHENOTYPE; HDH(Q92)	Huntington's disease (HD) is caused by the expansion of a CAG repeat in the huntingtin (HTT) gene. The R6 mouse models of HD express a mutant version of exon 1 HTT and typically develop motor and cognitive impairments, a widespread huntingtin (HTT) aggregate pathology and brain atrophy. Unlike the more commonly used R6/2 mouse line, R6/1 mice have fewer CAG repeats and, subsequently, a less rapid pathological decline. Compared to the R6/2 line, fewer descriptions of the progressive pathologies exhibited by R6/1 mice exist. The association between the molecular and cellular neuropathology with brain atrophy, and with the development of behavioral phenotypes remains poorly understood in many models of HD. In attempt to link these factors in the R6/1 mouse line, we have performed detailed assessments of behavior and of regional brain abnormalities determined through longitudinal, in vivo magnetic resonance imaging (MRI), as well as an end-stage, ex vivo MRI study and histological assessment. We found progressive decline in both motor and non-motor related behavioral tasks in R6/1 mice, first evident at 11 weeks of age. Regional brain volumes were generally unaffected at 9 weeks, but by 17 weeks there was significant grey matter atrophy. This age-related brain volume loss was validated using a more precise, semi-automated Tensor Based morphometry assessment. As well as these clear progressive phenotypes, mutant HTT (mHTT) protein, the hallmark of HD molecular pathology, was widely distributed throughout the R6/1 brain and was accompanied by neuronal loss. Despite these seemingly concomitant, robust pathological phenotypes, there appeared to be little correlation between the three main outcome measures: behavioral performance, MRI-detected brain atrophy and histopathology. In conclusion, R6/1 mice exhibit many features of HD, but the underlying mechanisms driving these clear behavioral disturbances and the brain volume loss, still remain unclear.	[Rattray, Ivan; Smith, Edward J.; Modo, Michel] Kings Coll London, Inst Psychiat, Dept Neurosci, London, England; [Rattray, Ivan; Smith, Edward J.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London, England; [Crum, William R.] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London, England; [Modo, Michel] Univ Pittsburgh, Dept Radiol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	University of London; King's College London; University of London; King's College London; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Modo, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, London, England.	modomm@upmc.edu	Crum, William R/C-4891-2008; Bates, Gillian/E-1146-2012	Crum, William R/0000-0001-9369-2197; Modo, Michel/0000-0003-4436-735X; Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0800846]; CHDI Foundation; MRC [G0800846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (G0800846) and the CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P104, DOI 10.1016/j.brainresbull.2011.07.009; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P137, DOI 10.1016/j.brainresbull.2011.05.005; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P171, DOI 10.1016/j.brainresbull.2011.03.013; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bissonette GB, 2012, NEUROPHARMACOLOGY, V62, P1168, DOI 10.1016/j.neuropharm.2011.03.011; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bolivar VJ, 2004, BRAIN RES, V1005, P29, DOI 10.1016/j.brainres.2004.01.021; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks S, 2012, BRAIN RES BULL, V88, P148, DOI 10.1016/j.brainresbull.2010.05.003; Brooks S, 2012, BRAIN RES BULL, V88, P113, DOI 10.1016/j.brainresbull.2010.05.005; Brooks SP, 2012, BRAIN RES BULL, V88, P130, DOI 10.1016/j.brainresbull.2011.06.008; Brooks SP, 2012, BRAIN RES BULL, V88, P121, DOI 10.1016/j.brainresbull.2011.05.010; Brooks SP, 2012, BRAIN RES BULL, V88, P94, DOI 10.1016/j.brainresbull.2011.01.010; Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009; Crum WR, 2013, J NEUROSCI METH, V216, P62, DOI 10.1016/j.jneumeth.2013.03.015; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; CRUM WR, 2013, J NEUROSCIENCE METHO, P1012; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Delmaire C, 2013, HUM BRAIN MAPP, V34, P2141, DOI 10.1002/hbm.22055; Dominguez JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074131; Du X, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.58; El-Akabawy G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-97; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giles P, 2012, BRAIN RES BULL, V88, P199, DOI 10.1016/j.brainresbull.2011.10.001; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030879; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kusakabe M, 2001, J COMP NEUROL, V430, P485, DOI 10.1002/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; Macbeth AH, 2009, NAT PROTOC, V4, P1574, DOI 10.1038/nprot.2009.141; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Mouton PR, 2011, UNBIASED STEREOLOGY; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Olsson IAS, 2003, APPL ANIM BEHAV SCI, V81, P245, DOI 10.1016/S0168-1591(02)00285-X; Pardon MC, 2008, NEUROSCI BIOBEHAV R, V32, P1103, DOI 10.1016/j.neubiorev.2008.03.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rattray I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060012; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Trueman RC, 2012, BRAIN RES BULL, V88, P163, DOI 10.1016/j.brainresbull.2011.10.019; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Walker AG, 2008, J NEUROSCI, V28, P8973, DOI 10.1523/JNEUROSCI.2804-08.2008; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	76	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84726	10.1371/journal.pone.0084726	http://dx.doi.org/10.1371/journal.pone.0084726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367693	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000328741900064
J	Ryland, LK; Doshi, UA; Shanmugavelandy, SS; Fox, TE; Aliaga, C; Broeg, K; Baab, KT; Young, M; Khan, O; Haakenson, JK; Jarbadan, NR; Liao, J; Wang, HG; Feith, DJ; Loughran, TP; Liu, X; Kester, M				Ryland, Lindsay K.; Doshi, Ushma A.; Shanmugavelandy, Sriram S.; Fox, Todd E.; Aliaga, Cesar; Broeg, Kathleen; Baab, Kendall Thomas; Young, Megan; Khan, Osman; Haakenson, Jeremy K.; Jarbadan, Nancy Ruth; Liao, Jason; Wang, Hong-Gang; Feith, David J.; Loughran, Thomas P., Jr.; Liu, Xin; Kester, Mark			C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SHORT-CHAIN CERAMIDE; GENE-EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-DEATH; CANCER; PROTEIN; SURVIVAL; FLUDARABINE; GENERATION; INHIBITION	Ceramide is a sphingolipid metabolite that induces cancer cell death. When C6-ceramide is encapsulated in a nanoliposome bilayer formulation, cell death is selectively induced in tumor models. However, the mechanism underlying this selectivity is unknown. As most tumors exhibit a preferential switch to glycolysis, as described in the "Warburg effect", we hypothesize that ceramide nanoliposomes selectively target this glycolytic pathway in cancer. We utilize chronic lymphocytic leukemia (CLL) as a cancer model, which has an increased dependency on glycolysis. In CLL cells, we demonstrate that C6-ceramide nanoliposomes, but not control nanoliposomes, induce caspase 3/7-independent necrotic cell death. Nanoliposomal ceramide inhibits both the RNA and protein expression of GAPDH, an enzyme in the glycolytic pathway, which is overexpressed in CLL. To confirm that ceramide targets GAPDH, we demonstrate that downregulation of GAPDH potentiates the decrease in ATP after ceramide treatment and exogenous pyruvate treatment as well as GAPDH overexpression partially rescues ceramide-induced necrosis. Finally, an in vivo murine model of CLL shows that nanoliposomal C6-ceramide treatment elicits tumor regression, concomitant with GAPDH downregulation. We conclude that selective inhibition of the glycolytic pathway in CLL cells with nanoliposomal C6-ceramide could potentially be an effective therapy for leukemia by targeting the Warburg effect.	[Ryland, Lindsay K.; Doshi, Ushma A.; Shanmugavelandy, Sriram S.; Fox, Todd E.; Young, Megan; Haakenson, Jeremy K.; Wang, Hong-Gang; Kester, Mark] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA; [Ryland, Lindsay K.; Aliaga, Cesar; Broeg, Kathleen; Baab, Kendall Thomas; Young, Megan; Khan, Osman; Jarbadan, Nancy Ruth; Liao, Jason; Wang, Hong-Gang; Feith, David J.; Loughran, Thomas P., Jr.; Liu, Xin; Kester, Mark] Penn State Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA; [Loughran, Thomas P., Jr.; Liu, Xin] Penn State Coll Med, Dept Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kester, M (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA USA.	mkester@psu.edu	Kester, Mark/ABG-4615-2020; Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Young, Megan/0000-0003-1751-9979	National Institutes of Health [CA133525, CA098472]; Pennsylvania Tobacco Settlement Fund [R01HL76789]; NATIONAL CANCER INSTITUTE [R01CA133525, P01CA171983, R01CA098472] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant nos. CA133525 and CA098472 (to T. P. L.) and Pennsylvania Tobacco Settlement Fund, R01HL76789 (to M. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Biswal SS, 2000, TOXICOLOGY, V154, P45, DOI 10.1016/S0300-483X(00)00296-1; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; FOON KA, 1990, ANN INTERN MED, V113, P525, DOI 10.7326/0003-4819-113-7-525; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Geschwind JFH, 2002, CANCER RES, V62, P3909; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Hofheinz RD, 2005, ANTI-CANCER DRUG, V16, P691, DOI 10.1097/01.cad.0000167902.53039.5a; Huttmann A, 2006, LEUKEMIA, V20, P1774, DOI 10.1038/sj.leu.2404363; Jiang YX, 2011, CANCER BIOL THER, V12, P574, DOI 10.4161/cbt.12.7.15971; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kumagai S, 2008, BIOCHEM BIOPH RES CO, V365, P362, DOI 10.1016/j.bbrc.2007.10.199; Lavallard VJ, 2009, CANCER RES, V69, P3013, DOI 10.1158/0008-5472.CAN-08-2731; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel S, 2005, LEUKEMIA RES, V29, P1347, DOI 10.1016/j.leukres.2005.04.017; MELO JV, 1986, INT J CANCER, V38, P531, DOI 10.1002/ijc.2910380413; Mengubas K, 1999, ONCOGENE, V18, P2499, DOI 10.1038/sj.onc.1202622; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Rathmell JC, 2007, CELL, V129, P861, DOI 10.1016/j.cell.2007.05.030; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rivenzon-Segal D, 2000, AM J PHYSIOL-ENDOC M, V279, pE508, DOI 10.1152/ajpendo.2000.279.3.E508; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Shanmugam M, 2009, CURR OPIN ONCOL, V21, P531, DOI 10.1097/CCO.0b013e32832f57ec; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Song SW, 2007, NAT CELL BIOL, V9, P869, DOI 10.1038/ncb0807-869; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Veldurthy A, 2008, BLOOD, V112, P1443, DOI 10.1182/blood-2007-11-123984; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watson DG, 2013, CELL SIGNAL, V25, P1011, DOI 10.1016/j.cellsig.2013.01.002; Yang J, 2010, BLOOD, V115, P51, DOI 10.1182/blood-2009-06-223719; Yeluri S, 2009, J CANCER RES CLIN, V135, P867, DOI 10.1007/s00432-009-0590-8; Zhao XB, 2008, J PHARM SCI-US, V97, P1508, DOI 10.1002/jps.21046	48	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84648	10.1371/journal.pone.0084648	http://dx.doi.org/10.1371/journal.pone.0084648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367685	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900060
J	Wu, H; Zeng, H; Dong, AP; Li, FL; He, H; Senisterra, G; Seitova, A; Duan, S; Brown, PJ; Vedadi, M; Arrowsmith, CH; Schapira, M				Wu, Hong; Zeng, Hong; Dong, Aiping; Li, Fengling; He, Hao; Senisterra, Guillermo; Seitova, Alma; Duan, Shili; Brown, Peter J.; Vedadi, Masoud; Arrowsmith, Cheryl H.; Schapira, Matthieu			Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; LYSINE 27; FUNCTIONAL-ANALYSIS; BREAST-CANCER; H3; METHYLATION; SPECIFICITY; INHIBITION; MECHANISM; LYMPHOMA	Polycomb repressive complex 2 (PRC2) is an important regulator of cellular differentiation and cell type identity. Overexpression or activating mutations of EZH2, the catalytic component of the PRC2 complex, are linked to hyper-trimethylation of lysine 27 of histone H3 (H3K27me3) in many cancers. Potent EZH2 inhibitors that reduce levels of H3K27me3 kill mutant lymphoma cells and are efficacious in a mouse xenograft model of malignant rhabdoid tumors. Unlike most SET domain methyltransferases, EZH2 requires PRC2 components, SUZ12 and EED, for activity, but the mechanism by which catalysis is promoted in the PRC2 complex is unknown. We solved the 2.0 angstrom crystal structure of the EZH2 methyltransferase domain revealing that most of the canonical structural features of SET domain methyltransferase structures are conserved. The site of methyl transfer is in a catalytically competent state, and the structure clarifies the structural mechanism underlying oncogenic hyper-trimethylation of H3K27 in tumors harboring mutations at Y641 or A677. On the other hand, the I-SET and post-SET domains occupy atypical positions relative to the core SET domain resulting in incomplete formation of the cofactor binding site and occlusion of the substrate binding groove. A novel CXC domain N-terminal to the SET domain may contribute to the apparent inactive conformation. We propose that protein interactions within the PRC2 complex modulate the trajectory of the post-SET and I-SET domains of EZH2 in favor of a catalytically competent conformation.	[Wu, Hong; Zeng, Hong; Dong, Aiping; Li, Fengling; He, Hao; Senisterra, Guillermo; Seitova, Alma; Brown, Peter J.; Vedadi, Masoud; Arrowsmith, Cheryl H.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Vedadi, Masoud; Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Arrowsmith, CH (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	carrow@uhnresearch.ca; matthieu.schapira@utoronto.ca		Arrowsmith, Cheryl/0000-0002-4971-3250; Brown, Peter/0000-0002-8454-0367	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry Research and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research, Genome Canada through Ontario Genomics Institute; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry Research and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry Research and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campagna-Slater V, 2011, J CHEM INF MODEL, V51, P612, DOI 10.1021/ci100479z; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Copeland RA, 2013, CLIN CANCER RES, V19, P6344, DOI 10.1158/1078-0432.CCR-13-0223; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Swalm BM, 2013, BIOCHEM J, V453, P241, DOI 10.1042/BJ20130439; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061341; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yamamoto K, 2004, J BIOL CHEM, V279, P401, DOI 10.1074/jbc.M307344200; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	60	90	94	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83737	10.1371/journal.pone.0083737	http://dx.doi.org/10.1371/journal.pone.0083737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367611	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900021
J	Burghel, GJ; Lin, WY; Whitehouse, H; Brock, I; Hammond, D; Bury, J; Stephenson, Y; George, R; Cox, A				Burghel, George J.; Lin, Wei-Yu; Whitehouse, Helen; Brock, Ian; Hammond, David; Bury, Jonathan; Stephenson, Yvonne; George, Rina; Cox, Angela			Identification of Candidate Driver Genes in Common Focal Chromosomal Aberrations of Microsatellite Stable Colorectal Cancer	PLOS ONE			English	Article							INTEGRATED ANALYSIS; TUMOR-SUPPRESSOR; KCNMA1 GENE; MUTATIONS; INSTABILITY; AMPLIFICATION; PROGRESSION; ADENOMA; BREAST; CLASSIFICATION	Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. Chromosomal instability (CIN) is a major driving force of microsatellite stable (MSS) sporadic CRC. CIN tumours are characterised by a large number of somatic chromosomal copy number aberrations (SCNA) that frequently affect oncogenes and tumour suppressor genes. The main aim of this work was to identify novel candidate CRC driver genes affected by recurrent and focal SCNA. High resolution genome-wide comparative genome hybridisation (CGH) arrays were used to compare tumour and normal DNA for 53 sporadic CRC cases. Context corrected common aberration (COCA) analysis and custom algorithms identified 64 deletions and 32 gains of focal minimal common regions (FMCR) at high frequency (>10%). Comparison of these FMCR with published genomic profiles from CRC revealed common overlap (42.2% of deletions and 34.4% of copy gains). Pathway analysis showed that apoptosis and p53 signalling pathways were commonly affected by deleted FMCR, and MAPK and potassium channel pathways by gains of FMCR. Candidate tumour suppressor genes in deleted FMCR included RASSF3, IFNAR1, IFNAR2 and NFKBIA and candidate oncogenes in gained FMCR included PRDM16, TNS1, RPA3 and KCNMA1. In conclusion, this study confirms some previously identified aberrations in MSS CRC and provides in silico evidence for some novel candidate driver genes.	[Burghel, George J.; Lin, Wei-Yu; Whitehouse, Helen; Brock, Ian; George, Rina; Cox, Angela] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Inst Canc Studies, Dept Oncol, Sheffield, S Yorkshire, England; [Hammond, David] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Acad Unit Surg Oncol, Dept Oncol, Sheffield, S Yorkshire, England; [Bury, Jonathan] Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Dept Histopathol, Sheffield Teaching Hosp Fdn Trust, Sheffield, S Yorkshire, England; [Stephenson, Yvonne] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Burghel, GJ (corresponding author), Univ Sheffield, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Inst Canc Studies, Dept Oncol, Sheffield, S Yorkshire, England.	g.burghel@leeds.ac.uk	Lin, Wei-Yu/F-4505-2010	Lin, Wei-Yu/0000-0002-9267-7988; Cox, Angela/0000-0002-5138-1099	University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship; Research and Innovation award; Yorkshire Cancer Research PhD studentship [S003PHD]	University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship; Research and Innovation award; Yorkshire Cancer Research PhD studentship	This work was supported by a University of Sheffield (Faculty of Medicine Dentistry and Health) PhD scholarship, and Research and Innovation award, and a Yorkshire Cancer Research PhD studentship (S003PHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; KOZMA L, 1994, CANCER LETT, V81, P165, DOI 10.1016/0304-3835(94)90198-8; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Migliore L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/792362; Murphy KM, 2006, J MOL DIAGN, V8, P305, DOI 10.2353/jmoldx.2006.050092; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ozakyol A, 2006, HEPATO-GASTROENTEROL, V53, P192; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang KX, 2010, INT J CANCER, V127, P830, DOI 10.1002/ijc.25088; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	47	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83859	10.1371/journal.pone.0083859	http://dx.doi.org/10.1371/journal.pone.0083859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367615	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300119
J	Koch, Y; Wolf, T; Sorger, PK; Eils, R; Brors, B				Koch, Yvonne; Wolf, Thomas; Sorger, Peter K.; Eils, Roland; Brors, Benedikt			Decision-Tree Based Model Analysis for Efficient Identification of Parameter Relations Leading to Different Signaling States	PLOS ONE			English	Article							CASPASE ACTIVATION; INDUCED APOPTOSIS; CELL-DEATH; BCL-2; BISTABILITY; MECHANISM; PROTEIN; FATE; BAX	In systems biology, a mathematical description of signal transduction processes is used to gain a more detailed mechanistic understanding of cellular signaling networks. Such models typically depend on a number of parameters that have different influence on the model behavior. Local sensitivity analysis is able to identify parameters that have the largest effect on signaling strength. Bifurcation analysis shows on which parameters a qualitative model response depends. Most methods for model analysis are intrinsically univariate. They typically cannot consider combinations of parameters since the search space for such analysis would be too large. This limitation is important since activation of a signaling pathway often relies on multiple rather than on single factors. Here, we present a novel method for model analysis that overcomes this limitation. As input to a model defined by a system of ordinary differential equations, we consider parameters for initial chemical species concentrations. The model is used to simulate the system response, which is then classified into predefined classes (e.g., active or not active). This is combined with a scan of the parameter space. Parameter sets leading to a certain system response are subjected to a decision tree algorithm, which learns conditions that lead to this response. We compare our method to two alternative multivariate approaches to model analysis: analytical solution for steady states combined with a parameter scan, and direct Lyapunov exponent (DLE) analysis. We use three previously published models including a model for EGF receptor internalization and two apoptosis models to demonstrate the power of our approach. Our method reproduces critical parameter relations previously obtained by both steady-state and DLE analysis while being more generally applicable and substantially less computationally expensive. The method can be used as a general tool to predict multivariate control strategies for pathway activation and to suggest strategies for drug intervention.	[Koch, Yvonne; Wolf, Thomas; Eils, Roland; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Wolf, Thomas] Heidelberg Univ, Sch Med, Inst Gen Pathol, Heidelberg, Germany; [Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Eils, Roland] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 580, Heidelberg, Germany.	r.eils@dkfz.de	Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009	Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Sorger, Peter/0000-0002-3364-1838	Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network); German Federal Ministry of Research and Education through the National Genome Research Network [01 GS 0883]	Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network); German Federal Ministry of Research and Education through the National Genome Research Network	This study has been funded in part by a grant from the Helmholtz Society of German Research Centers through the Helmholtz Alliance on Systems Biology (SB Cancer Network), and by a grant from the German Federal Ministry of Research and Education through the National Genome Research Network (01 GS 0883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Bagci EZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002249; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; BREIMAN L., 1984, CRC PRESS; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Hautaniemi S, 2005, BIOINFORMATICS, V21, P2027, DOI 10.1093/bioinformatics/bti278; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Millat T, 2008, BIOSYSTEMS, V92, P270, DOI 10.1016/j.biosystems.2008.03.007; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmidt-Glenewinkel H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-32; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	25	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82593	10.1371/journal.pone.0082593	http://dx.doi.org/10.1371/journal.pone.0082593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367526	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300042
J	Traber, PG; Zomer, E				Traber, Peter G.; Zomer, Eliezer			Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ALTERNATIVE MACROPHAGE ACTIVATION; CARBOHYDRATE-BINDING DOMAIN; NITRIC-OXIDE SYNTHASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC-FIBROSIS; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; CELL-SURFACE; EXPRESSION	Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without effective therapy. Some data suggest that galectin-3 null mice are resistant to the development of NASH with fibrosis. We examined the ability of two complex carbohydrate drugs that bind galectin-3, GM-CT-01 and GR-MD-02, to treat NASH with fibrosis in a murine model. GR-MD-02 treatment resulted in marked improvement in liver histology with significant reduction in NASH activity and collagen deposition. Treatments seemed also to improve both glomerulopathy and interstitial fibrosis observed in kidneys. The improvement in liver histology was evident when animals were treated early in disease or after establishment of liver fibrosis. In all measures, GM-CT-01 had an intermediate effect between vehicle and GR-MD-02. Galectin-3 protein expression was increased in NASH with highest expression in macrophages surrounding lipid laden hepatocytes, and reduced following treatment with GR-MD-02, while the number of macrophages was unchanged. Treatment with GR-MD-02 also reduced the expression of pathological indicators including iNOS, an important TH1 inflammatory mediator, CD36, a scavenger receptor for lipoproteins on macrophages, and a-smooth muscle actin, a marker for activated stellate cells which are the primary collagen producing cells in liver fibrosis. We conclude that treatment with these galectin-3 targeting drugs improved histopathological findings of NASH and markedly reduced fibrosis in a murine model of NASH. While the mechanisms require further investigation, the treatment effect is associated with a reduction of galectin-3 expressed by activated macrophages which was associated with regression of NASH, including hepatocellular fat accumulation, hepatocyte ballooning, intra-portal and intra-lobular inflammatory infiltrate, and deposition of collagen. Similar effects were found with GM-CT-01, but with approximately four-fold lower potency than GR-MD-02. The results, in combination with previous experiments in toxin-induced fibrosis, suggest that these galectin-targeting drugs may have potential in human NASH with fibrosis.	[Traber, Peter G.; Zomer, Eliezer] Galectin Therapeut Inc, Norcross, GA USA; [Traber, Peter G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Emory University	Traber, PG (corresponding author), Galectin Therapeut Inc, Norcross, GA USA.	traber@galectintherapeutics.com			Galectin Therapeutics	Galectin Therapeutics	Authors PGT and EZ are or have been employed by Galectin Therapeutics INC, a public company. Additionally, Galectin Therapeutics funded this work so the same authors have an affiliation to the commercial funders. Moreover, the company funders, beyond the employees involved in the study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Bieghs V, 2013, LIVER INT, V33, P1056, DOI 10.1111/liv.12170; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dragomir AC, 2012, TOXICOL SCI, V127, P609, DOI 10.1093/toxsci/kfs117; Dragomir ACD, 2012, J IMMUNOL, V189, P5934, DOI 10.4049/jimmunol.1201851; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Garcia-Monzon C, 2000, J HEPATOL, V33, P716, DOI 10.1016/S0168-8278(00)80301-3; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P2281; Iacobini C, 2003, J AM SOC NEPHROL, V14, pS264, DOI 10.1097/01.ASN.0000077402.95720.B4; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kim H, 2007, CELL BIOL INT, V31, P655, DOI 10.1016/j.cellbi.2006.11.036; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Miller MC, 2011, GLYCOBIOLOGY, V21, P1627, DOI 10.1093/glycob/cwr083; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Nakanishi Y, 2008, HEPATOL RES, V38, P1241, DOI 10.1111/j.1872-034X.2008.00395.x; Nomoto K, 2006, J PATHOL, V210, P469, DOI 10.1002/path.2065; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Papaspyridonos M, 2008, ARTERIOSCL THROM VAS, V28, P433, DOI 10.1161/ATVBAHA.107.159160; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SATO S, 1992, J GEN MICROBIOL, V138, P1992, DOI 10.1099/00221287-138-9-1992; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yoneda M, 2009, HEPATOL RES, V39, P963, DOI 10.1111/j.1872-034X.2009.00539.x; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	118	124	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83481	10.1371/journal.pone.0083481	http://dx.doi.org/10.1371/journal.pone.0083481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367597	gold, Green Submitted, Green Published			2022-12-25	WOS:000328740300106
J	Cogo-Moreira, H; de Avila, CRB; Ploubidis, GB; Mari, JD				Cogo-Moreira, Hugo; Brandao de Avila, Clara Regina; Ploubidis, George B.; Mari, Jair de Jesus			Pathway Evidence of How Musical Perception Predicts Word-Level Reading Ability in Children with Reading Difficulties	PLOS ONE			English	Article							SPEECH; SKILLS; LANGUAGE	Objective: To investigate whether specific domains of musical perception (temporal and melodic domains) predict the word-level reading skills of eight-to ten-year-old children (n = 235) with reading difficulties, normal quotient of intelligence, and no previous exposure to music education classes. Method: A general-specific solution of the Montreal Battery of Evaluation of Amusia (MBEA), which underlies a musical perception construct and is constituted by three latent factors (the general, temporal, and the melodic domain), was regressed on word-level reading skills (rate of correct isolated words/non-words read per minute). Results: General and melodic latent domains predicted word-level reading skills.	[Cogo-Moreira, Hugo; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat & Med Psychol, Sao Paulo, Brazil; [Brandao de Avila, Clara Regina] Univ Fed Sao Paulo, Dept Hearing & Speech Pathol, Sao Paulo, Brazil; [Ploubidis, George B.] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of London; London School of Hygiene & Tropical Medicine	Cogo-Moreira, H (corresponding author), Univ Fed Sao Paulo, Dept Psychiat & Med Psychol, Sao Paulo, Brazil.	hugocogobr@gmail.com	Cogo-Moreira, Hugo/GSD-6132-2022; Cogo-Moreira, Hugo/U-6442-2019; Cogo-Moreira, Hugo/E-4602-2011; de Jesus Mari, Jair/A-7309-2008; Avila, Clara R B/J-6066-2012; Ploubidis, George B/G-9531-2011	Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; de Jesus Mari, Jair/0000-0002-5403-0112; Avila, Clara R B/0000-0002-5708-8299; Ploubidis, George B/0000-0002-8198-5790	National Council for Scientific and Technological Development (CNPq) [482321/2010-5]; ABCD Institute [a nongovernmental organisation (NGO) in Brazil]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ABCD Institute [a nongovernmental organisation (NGO) in Brazil]	We thank the National Council for Scientific and Technological Development (CNPq - grant no. 482321/2010-5) and the ABCD Institute [which is a nongovernmental organisation (NGO) that supports research on dyslexia in Brazil] for the grants that made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EDUC PSYCHOL-UK, DOI [DOI 10.1080/0144341930130103, 10.1080/0144341930130103]; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; ASPAROUHOV T, 2005, P FCMS; ASPAROUHOV T, 2006, P JOINT STAT M SEATL; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; BARROS M, 1995, JABUTI ONCA; Capovilla A. G. S., 1998, TEMAS DESENVOLVIMENT, V7, P14; CarrollPhelan B, 1996, MUSIC PERCEPT, V13, P517; Cogo-Moreira H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059984; Cogo-Moreira H, 2012, NEUROPSYCH DIS TREAT, V8, P443, DOI 10.2147/NDT.S36196; COGOMOREIRA H, 2012, COCHRANE DB SYST REV, V8; Corrigall KA, 2009, ANN NY ACAD SCI, V1169, P164, DOI 10.1111/j.1749-6632.2009.04769.x; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Dellatolas G, 2009, ARCH CLIN NEUROPSYCH, V24, P555, DOI 10.1093/arclin/acp044; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Echols CH, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P151; Figueiredo V, 2002, WISC 3 ESCALA INTELI; Fluss J, 2009, J DEV BEHAV PEDIATR, V30, P206, DOI 10.1097/DBP.0b013e3181a7ed6c; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Gough P.B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hulme C, 2012, PSYCHOL SCI, V23, P572, DOI 10.1177/0956797611435921; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kolinsky R, 2009, MUSIC PERCEPT, V26, P235, DOI 10.1525/MP.2009.26.3.235; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Lawley D.N., 1962, J R STAT SOC, V12, P209, DOI [https://doi.org/10.2307/2986915, DOI 10.2307/2986915]; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Mancilla-Martinez J, 2010, J EDUC PSYCHOL, V102, P701, DOI 10.1037/a0019135; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P2701, DOI 10.1162/jocn.2010.21585; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Noble KG, 2006, COGNITIVE DEV, V21, P349, DOI 10.1016/j.cogdev.2006.01.007; NUNESSILVA M, 2012, BRAZIL DEMENTIA NEUR, V6, P244; Pasqua L, 2002, AVALIACAO PSICOLOGIC, V1, P95; Patel AD, 2008, NATURE, V453, P726, DOI 10.1038/453726a; Patel AD, 2012, ANN NY ACAD SCI, V1252, P124, DOI 10.1111/j.1749-6632.2011.06426.x; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; PEREIRA L, 1993, PROCESSAMENTO AUDITI, V2, P7; PEREIRA L, 1981, VET MALUCO; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Rabelo Alessandra Terra Vasconcelos, 2011, J. Soc. Bras. Fonoaudiol., V23, P344, DOI 10.1590/S2179-64912011000400009; SCHBN D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI DOI 10.1111/1469-8986.00172.X.PUBMED:15102118; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Strait DL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-44; Urbina S., 2004, ESSENTIALS PSYCHOL T, V1st ed; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Ziegler JC, 2012, BRAIN LANG, V120, P265, DOI 10.1016/j.bandl.2011.12.002	57	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84375	10.1371/journal.pone.0084375	http://dx.doi.org/10.1371/journal.pone.0084375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358358	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000328737700094
J	King, R; Barker, J; Nakayiwa, S; Katuntu, D; Lubwama, G; Bagenda, D; Lane, T; Opio, A; Hladik, W				King, Rachel; Barker, Joseph; Nakayiwa, Sylvia; Katuntu, David; Lubwama, George; Bagenda, Danstan; Lane, Tim; Opio, Alex; Hladik, Wolfgang			Men at Risk; a Qualitative Study on HIV Risk, Gender Identity and Violence among Men Who Have Sex with Men Who Report High Risk Behavior in Kampala, Uganda	PLOS ONE			English	Article							BISEXUAL MEN; WORKERS; HIV/AIDS; MOMBASA; GAY	In Uganda, men who have sex with men (MSM) are at high risk for HIV. Between May 2008 and February 2009 in Kampala, Uganda, we used respondent driven sampling (RDS) to recruit 295 MSM >= 18 years who reported having had sex with another man in the preceding three months. The parent study conducted HIV and STI testing and collected demographic and HIV-related behavioral data through audio computer-assisted self-administered interviews. We conducted a nested qualitative sub-study with 16 men purposively sampled from among the survey participants based on responses to behavioral variables indicating higher risk for HIV infection. Sub-study participants were interviewed face-to-face. Domains of inquiry included sexual orientation, gender identity, condom use, stigma, discrimination, violence and health seeking behavior. Emergent themes included a description of sexual orientation/gender identity categories. All groups of men described conflicting feelings related to their sexual orientation and contextual issues that do not accept same-sex identities or behaviors and non-normative gender presentation. The emerging domains for facilitating condom use included: lack of trust in partner and fear of HIV infection. We discuss themes in the context of social and policy issues surrounding homosexuality and HIV prevention in Uganda that directly affect men's lives, risk and health-promoting behaviors.	[King, Rachel; Lane, Tim] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [King, Rachel; Barker, Joseph; Nakayiwa, Sylvia; Katuntu, David; Hladik, Wolfgang] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Entebbe, Uganda; [Lubwama, George; Bagenda, Danstan] Makerere Univ, Sch Publ Hlth MakSPH, Kampala, Uganda; [Opio, Alex; Hladik, Wolfgang] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1012 WX Amsterdam, Netherlands; Minist Hlth, Kampala, Uganda; [Barker, Joseph; Hladik, Wolfgang] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA	University of California System; University of California San Francisco; Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; Centers for Disease Control & Prevention - USA	King, R (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	rlking@psg.ucsf.edu			US President's Emergency Plan for AIDS Relief; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the US President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2011, ANSW YOUR QUEST TRAN; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Creswell J., 2017, QUAL INQ; Fay H, 2010, AIDS BEHAV; Geibel S, 2010, HIV VULNERABILITY ME; Heckathorn D, 2007, SOC PROBL, V44, P174; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Jobson GA, 2012, SAHARA J-J SOC ASP H, V9, P160, DOI 10.1080/17290376.2012.743829; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Kiyaga A, 2013, DAILY MONITOR; Knox J, 2013, AIDS BEHAV, V17, P350, DOI 10.1007/s10461-012-0337-4; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Larmarange J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013189; McIntyre J, 2013, AIDS BEHAV; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stephenson R, 2013, AIDS BEHAV, V17, pS43, DOI 10.1007/s10461-012-0293-z; Team M, 2013, DAILY MONITOR; Tucker A, 2013, AIDS CARE; van Griensven F, 2008, SEX TRANSM DIS, V35, P355, DOI 10.1097/OLQ.0b013e31816bf64c	29	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82937	10.1371/journal.pone.0082937	http://dx.doi.org/10.1371/journal.pone.0082937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358239	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700040
J	Song, M; Han, NG; Kim, YH; Ding, Y; Chambers, T				Song, Min; Han, Nam-Gi; Kim, Yong-Hwan; Ding, Ying; Chambers, Tamy			Discovering Implicit Entity Relation with the Gene-Citation-Gene Network	PLOS ONE			English	Article							PROTEIN; CTCF; PHOSPHORYLATION; CYTOKINESIS; ASSOCIATION; CENTRALITY; AXIN; NDE1	In this paper, we apply the entitymetrics model to our constructed Gene-Citation-Gene (GCG) network. Based on the premise there is a hidden, but plausible, relationship between an entity in one article and an entity in its citing article, we constructed a GCG network of gene pairs implicitly connected through citation. We compare the performance of this GCG network to a gene-gene (GG) network constructed over the same corpus but which uses gene pairs explicitly connected through traditional co-occurrence. Using 331,411 MEDLINE abstracts collected from 18,323 seed articles and their references, we identify 25 gene pairs. A comparison of these pairs with interactions found in BioGRID reveal that 96% of the gene pairs in the GCG network have known interactions. We measure network performance using degree, weighted degree, closeness, betweenness centrality and PageRank. Combining all measures, we find the GCG network has more gene pairs, but a lower matching rate than the GG network. However, combining top ranked genes in both networks produces a matching rate of 35.53%. By visualizing both the GG and GCG networks, we find that cancer is the most dominant disease associated with the genes in both networks. Overall, the study indicates that the GCG network can be useful for detecting gene interaction in an implicit manner.	[Song, Min; Han, Nam-Gi; Kim, Yong-Hwan] Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea; [Ding, Ying; Chambers, Tamy] Indiana Univ, Dept Informat & Lib Sci, Bloomington, IN USA	Yonsei University; Indiana University System; Indiana University Bloomington	Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea.	min.song@yonsei.ac.kr	Han, Namgi/AAT-6380-2020	Song, Min/0000-0003-3255-1600; Chambers, Tamy/0000-0002-2891-6665	Bio & Medical Technology Development Program [2012048758]	Bio & Medical Technology Development Program	This research was supported by the Bio & Medical Technology Development Program (2012048758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M., 2009, P 3 INT AAAI C WEBLO, V3, P361, DOI [10.13140/2.1.1341.1520, DOI 10.13140/2.1.1341.1520, 10.1609/icwsm.v3i1.13937]; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blondel V. D., 2008, ARXIV08030476; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Chang JT, 2004, PHARMACOGENETICS, V14, P577, DOI 10.1097/00008571-200409000-00002; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cooper JW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-143; Ding Y, 2013, PLOS ONE; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Esteves LID, 2006, INT J MOL MED, V17, P397; Estrada E, 2010, J THEOR BIOL, V263, P556, DOI 10.1016/j.jtbi.2010.01.014; Galvez C, 2008, C PREC INT TECHN ED; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Grbesa I, 2008, J MOL MED, V86, P1057, DOI 10.1007/s00109-008-0369-4; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Li J, 2010, J GENET GENOMICS, V37, P159, DOI 10.1016/S1673-8527(09)60034-5; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCallum Andrew, 2003, P 7 C NATURAL LANGUA, P188; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Patel M, 1997, PERSP NEURAL COMP, P199; Song M, J AM SOC INFORM SCI; Stapley B.J., 2000, P PAC S BIOC, V5, P526; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stephens M, 2001, Pac Symp Biocomput, P483; Tost J, 2006, NUCLEIC ACIDS RES, V34, P5438, DOI 10.1093/nar/gkl657; Wilkinson DM, 2004, P NATL ACAD SCI USA, V101, P5241, DOI 10.1073/pnas.0307740100; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wren JD, 2004, BIOINFORMATICS, V20, P191, DOI 10.1093/bioinformatics/btg390; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464	42	14	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84639	10.1371/journal.pone.0084639	http://dx.doi.org/10.1371/journal.pone.0084639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358368	Green Published, gold			2022-12-25	WOS:000328737700103
J	van der Leeuw, C; Marcelis, M; Peeters, SCT; Verbeek, MM; Menheere, PPCA; de Haan, L; van Os, J; van Beveren, NJM				van der Leeuw, Christine; Marcelis, Machteld; Peeters, Sanne C. T.; Verbeek, Marcel M.; Menheere, Paul P. C. A.; de Haan, Lieuwe; van Os, Jim; van Beveren, Nico J. M.		Genetic Risk Outcome Psychosis GRO	Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; FRACTIONAL ANISOTROPY; VOLUME ABNORMALITIES; INSULIN-RESISTANCE; NEGATIVE SYMPTOMS; S-100B PROTEIN; BRAIN; ANTIPSYCHOTICS; SYMPTOMATOLOGY; BIOMARKERS	Background: S100B is a potential marker of neurological and psychiatric illness. In schizophrenia, increased S100B levels, as well as associations with acute positive and persisting negative symptoms, have been reported. It remains unclear whether S100B elevation, which possibly reflects glial dysfunction, is the consequence of disease or compensatory processes, or whether it is an indicator of familial risk. Methods: Serum samples were acquired from two large independent family samples (n = 348 and n = 254) in the Netherlands comprising patients with psychotic disorder (n = 140 and n = 82), non-psychotic siblings of patients with psychotic disorder (n = 125 and n = 94) and controls (n = 83 and n = 78). S100B was analyzed with a Liaison automated chemiluminescence system. Associations between familial risk of psychotic disorder and S100B were examined. Results: Results showed that S100B levels in patients (P) and siblings (S) were not significantly different from controls (C) (dataset 1: P vs. C: B = 0.004, 95% CI 20.005 to 0.013, p = 0.351; S vs. C: B = 0.000, 95% CI 20.009 to 0.008, p = 0.926; and dataset 2: P vs. C: B = 0.008, 95% CI -0.011 to 0.028, p = 0.410; S vs. C: B = 0.002, 95% CI -0.016 to 0.021, p = 0.797). In patients, negative symptoms were positively associated with S100B (B = 0.001, 95% CI 0.000 to 0.002, p = 0.005) in one of the datasets, however with failure of replication in the other. There was no significant association between S100B and positive symptoms or present use or type of antipsychotic medication. Conclusions: S100B is neither an intermediate phenotype, nor a trait marker for psychotic illness.	[van der Leeuw, Christine; Marcelis, Machteld; Peeters, Sanne C. T.; van Os, Jim] Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Sch Mental Hlth & Neurosci,Dept Psychiat & Psycho, Maastricht, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Menheere, Paul P. C. A.] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands; [de Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Deparment Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England; [van Beveren, Nico J. M.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [van Beveren, Nico J. M.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [van Beveren, Nico J. M.] Delta Ctr Mental Hlth Care, Dept Nieuwe Kennis, Rotterdam, Netherlands	Maastricht University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Marcelis, M (corresponding author), Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Sch Mental Hlth & Neurosci,Dept Psychiat & Psycho, Maastricht, Netherlands.	m.marcelis@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; Peeters, Sanne/AAA-9523-2021; van Os, Jim/V-8884-2019; Verbeek, Marcel M/D-1971-2010; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; Verbeek, Marcel M/0000-0003-4635-7876; Marcelis, Machteld/0000-0003-0045-9244; Peeters, Sanne/0000-0002-3004-4261	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]); European Community's Seventh Framework Programme [HEALTH-F2-2009-241909]	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.])(Netherlands Organization for Scientific Research (NWO)); European Community's Seventh Framework Programme	This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; [Anonymous], 2010, CARDIOVASC PSYCHIAT; Camchong J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.035.2009; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Femandez-Egea E, 2008, SCHIZOPHR RES, V98, P302, DOI 10.1016/j.schres.2007.10.002; Fernandez-Egea E, 2008, SCHIZOPHR RES, V103, P110, DOI 10.1016/j.schres.2008.04.017; Gattaz WF, 2000, SCHIZOPHR RES, V43, P91, DOI 10.1016/S0920-9964(99)00146-2; Goldstein H., 1987, MULTILEVEL MODELS ED; Gos T, 2013, J PSYCHIAT RES; Guest PC, 2010, MOL PSYCHIATR, V15, P118, DOI 10.1038/mp.2009.81; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hao YH, 2009, SCHIZOPHR RES, V114, P128, DOI 10.1016/j.schres.2009.07.001; Hills, 1993, STAT MODELS EPIDEMIO; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Ling SH, 2007, J PSYCHIAT RES, V41, P36, DOI 10.1016/j.jpsychires.2005.11.006; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Makris N, 2010, PSYCHIAT RES-NEUROIM, V183, P21, DOI 10.1016/j.pscychresns.2010.04.016; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; MUKHERJEE S, 1989, LANCET, V1, P495; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pillai A, 2012, PSYCHIAT CLIN N AM, V35, P645, DOI 10.1016/j.psc.2012.06.006; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Rothermundt M, 2009, GEN PHYSIOL BIOPHYS, V28, pF76; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Steiner J, 2010, MOL PSYCHIATR, V15, P3, DOI 10.1038/mp.2009.87; Steiner J, 2008, J PSYCHIATR RES, V42, P868, DOI 10.1016/j.jpsychires.2007.10.001; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; van Beveren NJM, 2006, EUR NEUROPSYCHOPHARM, V16, P469, DOI 10.1016/j.euroneuro.2006.02.001; van Beveren NJM, 2011, INT REV NEUROBIOL, V101, P351, DOI 10.1016/B978-0-12-387718-5.00014-6; van Nimwegen LJM, 2008, J CLIN ENDOCR METAB, V93, P572, DOI 10.1210/jc.2007-1167; Voineskos AN, 2013, JAMA PSYCHIAT, V70, P472, DOI 10.1001/jamapsychiatry.2013.786; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Wolkin A, 2003, AM J PSYCHIAT, V160, P572, DOI 10.1176/appi.ajp.160.3.572; Yelmo-Cruz S, 2013, PSYCHIAT CLIN NEUROS, V67, P67, DOI 10.1111/pcn.12024; Zhai JG, 2012, SCHIZOPHR RES, V134, P89, DOI 10.1016/j.schres.2011.09.029; Zhang XY, 2010, J PSYCHIATR RES, V44, P1236, DOI 10.1016/j.jpsychires.2010.04.023	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82535	10.1371/journal.pone.0082535	http://dx.doi.org/10.1371/journal.pone.0082535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358202	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700020
J	Treydte, AC; Baumgartner, S; Heitkonig, IMA; Grant, CC; Getz, WM				Treydte, Anna Christina; Baumgartner, Sabine; Heitkoenig, Ignas M. A.; Grant, Catharina C.; Getz, Wayne M.			Herbaceous Forage and Selection Patterns by Ungulates across Varying Herbivore Assemblages in a South African Savanna	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; SPATIAL HETEROGENEITY; SEMIARID SAVANNA; DIET SELECTION; DRY SEASON; CATTLE; VEGETATION; LANDSCAPE; LIVESTOCK; FIRE	Herbivores generally have strong structural and compositional effects on vegetation, which in turn determines the plant forage species available. We investigated how selected large mammalian herbivore assemblages use and alter herbaceous vegetation structure and composition in a southern African savanna in and adjacent to the Kruger National Park, South Africa. We compared mixed and mono-specific herbivore assemblages of varying density and investigated similarities in vegetation patterns under wildlife and livestock herbivory. Grass species composition differed significantly, standing biomass and grass height were almost twice as high at sites of low density compared to high density mixed wildlife species. Selection of various grass species by herbivores was positively correlated with greenness, nutrient content and palatability. Nutrient-rich Urochloa mosambicensis Hack. and Panicum maximum Jacq. grasses were preferred forage species, which significantly differed in abundance across sites of varying grazing pressure. Green grasses growing beneath trees were grazed more frequently than dry grasses growing in the open. Our results indicate that grazing herbivores appear to base their grass species preferences on nutrient content cues and that a characteristic grass species abundance and herb layer structure can be matched with mammalian herbivory types.	[Treydte, Anna Christina; Baumgartner, Sabine] Univ Hohenheim, Stuttgart, Germany; [Heitkoenig, Ignas M. A.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Grant, Catharina C.] Sci Serv Kruger Natl Pk, Syst Ecol, Skukuza, South Africa; [Getz, Wayne M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University Hohenheim; Wageningen University & Research; University of California System; University of California Berkeley; University of Kwazulu Natal	Treydte, AC (corresponding author), Univ Hohenheim, Stuttgart, Germany.	anna.treydte@uni-hohenheim.de	; Getz, Wayne/I-4521-2013	Heitkonig, Ignas/0000-0001-7771-3111; Treydte, Anna/0000-0003-0605-3069; Getz, Wayne/0000-0001-8784-9354	Humboldt foundation; NIH [GM083863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	Humboldt foundation(Alexander von Humboldt Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Part of this study was funded by the "Feodor-Lynen-Stipendium fur Erfahrene Wissenschaftler'' of the Humboldt foundation to ACT (http://www.humboldt-foundation.de/web/feodor-lynen-fellowship-postdoc.html). WMG was supported by Grant NIH GM083863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2000, APPL VEG SCI, V3, P213, DOI 10.2307/1479000; Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Anderson TM, 2007, AM NAT, V170, P343, DOI 10.1086/520120; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Bailey Derek W., 2008, V23, P7; Baumgartner SA, BASIC APPL IN PRESS; BELOVSKY GE, 1984, AM NAT, V124, P97, DOI 10.1086/284254; BENSHAHAR R, 1991, AFR J ECOL, V29, P302, DOI 10.1111/j.1365-2028.1991.tb00468.x; Botha MS, 2005, S AFR J SCI, V101, P371; Burns CE, 2009, BIODIVERS CONSERV, V18, P2327, DOI 10.1007/s10531-009-9590-x; Carlassare M, 2002, AGRON J, V94, P840; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Druce DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003979; DYKSTERHUIS E. J., 1949, JOUR RANGE MANAGEMENT, V2, P104, DOI 10.2307/3893680; EAST RM, 1993, AGROFOREST SYST, V22, P91, DOI 10.1007/BF00705139; Frank DA, 2005, OECOLOGIA, V143, P629, DOI 10.1007/s00442-005-0019-2; Fynn RWS, 2012, RANGELAND ECOL MANAG, V65, P319, DOI 10.2111/REM-D-11-00141.1; Fynn RWS, 2000, J APPL ECOL, V37, P491, DOI 10.1046/j.1365-2664.2000.00513.x; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Grant CC, 2003, AFRICAN J RANGE FORA, V20, P1; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Hayes GF, 2003, CONSERV BIOL, V17, P1694, DOI 10.1111/j.1523-1739.2003.00281.x; Hurlbert SH, 2004, OIKOS, V104, P591, DOI 10.1111/j.0030-1299.2004.12752.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Iason GR, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P337; Jacobs SM, 2008, J ARID ENVIRON, V72, P891, DOI 10.1016/j.jaridenv.2007.11.015; JARRELL WM, 1981, ADV AGRON, V34, P197, DOI 10.1016/S0065-2113(08)60887-1; Jones WM, 2011, BIOL CONSERV, V144, P511, DOI 10.1016/j.biocon.2010.10.005; Kent M., 1994, VEGETATION DESCRIPTI; Lessard JP, 2012, BASIC APPL ECOL, V13, P59, DOI 10.1016/j.baae.2011.11.001; Letnic M, 2004, RANGELAND J, V26, P34, DOI 10.1071/RJ04003; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; Murray M G, 2001, INFLUENCE LARGE ANIM; Musiega DE, 2006, ECOL RES, V21, P530, DOI 10.1007/s11284-006-0175-9; OCONNOR TG, 1994, J APPL ECOL, V31, P155, DOI 10.2307/2404608; Odadi WO, 2010, THESIS EGERTON U NJO; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; OWENSMITH N, 1989, J ZOOL, V219, P29, DOI 10.1111/j.1469-7998.1989.tb02563.x; PEEL MJS, 1999, AFRICAN J RANGE FORA, V15, P117, DOI DOI 10.1080/10220119.1998.9647953; Radloff FGT, 2007, J VEG SCI, V18, P719, DOI 10.1111/j.1654-1103.2007.tb02586.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Stock WD, 2010, PLANT ECOL, V206, P15, DOI 10.1007/s11258-009-9621-4; TAYLOR RD, 1978, J APPL ECOL, V15, P565, DOI 10.2307/2402611; THRASH I, 1995, J ARID ENVIRON, V29, P213, DOI 10.1016/S0140-1963(05)80091-6; Treydte AC, 2009, BIODIVERS CONSERV, V18, P3989, DOI 10.1007/s10531-009-9694-3; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; Van Oudtshoorn F.P., 2004, GUIDE GRASSES SO AFR; Van Rooyen J, 2011, THESIS U PRETORIA; van Wilgen BW, 2007, INT J WILDLAND FIRE, V16, P519, DOI 10.1071/WF06115; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Veblen KE, 2010, J ECOL, V98, P993, DOI 10.1111/j.1365-2745.2010.01705.x; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Verweij RJT, 2006, OIKOS, V114, P108, DOI 10.1111/j.2006.0030-1299.14209.x; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; WONG CC, 1980, AUST J AGR RES, V31, P269, DOI 10.1071/AR9800269; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	65	31	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82831	10.1371/journal.pone.0082831	http://dx.doi.org/10.1371/journal.pone.0082831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358228	gold, Green Published			2022-12-25	WOS:000328735700094
J	Zhang, XX; Fang, JZ; Xu, B; Zhang, SL; Su, SF; Song, Z; Deng, YF; Wang, HN; Zhao, D; Niu, XB; Wang, ZJ				Zhang, Xiangxiang; Fang, Jianzheng; Xu, Bin; Zhang, Shengli; Su, Shifeng; Song, Zhen; Deng, Yunfei; Wang, Hainan; Zhao, Dan; Niu, Xiaobing; Wang, Zengjun			Correlation of Epididymal Protease Inhibitor and Fibronectin in Human Semen	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; ARG-GLY-ASP; SEMENOGELIN-I; HUMAN SPERM; HUMAN SPERMATOZOA; EPPIN; PROTEINS; MOTILITY; CAPACITATION; LIQUEFACTION	Objective: Epididymal protease inhibitor (Eppin) was located on the surface of spermatozoa and modulates the liquefaction of human semen. Here, we identify the correlative protein partner of Eppin to explore the molecular mechanism of liquefaction of human semen. Methods: (1) Human seminal vesicle proteins were transferred on the membrane by Western blotting and separated by 2-D electrophoresis and incubated in recombinant Eppin. The correlative protein was identified by Mass Spectrometry (MS) (2). Western blotting was used to determine the relation of rEppin and rFibronectin(Fn); (3) Co-localization in spermatozoa were detected using immunofluorescence; (4) Correalation of Eppin and Fn was proved by co-immunoprecipitation. Results: Fn was identified as the binding partner of recombinant Eppin by MS. Recombinant of Eppin was made and demonstrated that the Eppin fragment binds the fn 607-1265 fragment. The Eppin-Fn complex presents on the sperm tail and particularly in the midpiece region of human ejaculated spermatozoa. Immunoprecipitation indicated that Eppin in the spermatozoa lysates was complexed with Fn. Conclusions: Our study demonstrates that Eppin and Fn bind to each other in human semen and on human ejaculated spermatozoa. Eppin-Fn complex may involve in semen coagulation, liquefaction and the survival and preparation of spermatozoa for fertility in the female reproductive tract.	[Zhang, Xiangxiang; Fang, Jianzheng; Zhang, Shengli; Su, Shifeng; Song, Zhen; Deng, Yunfei; Wang, Hainan; Zhao, Dan; Niu, Xiaobing; Wang, Zengjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Bin] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiangxiang] Jiangsu Provice Official Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Wang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zengjunwang@njmu.edu.cn		Xu, Bin/0000-0001-5511-8055	National Natural Science Foundation of China [81270685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (NO.81270685) (http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Attia AM, 2011, ANDROLOGIA, V43, P387, DOI 10.1111/j.1439-0272.2010.01056.x; Bronson RA, 1996, MOL HUM REPROD, V2, P153, DOI 10.1093/molehr/2.3.153; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; De Lamirande E, 2001, J ANDROL, V22, P672; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; Fung KYC, 2004, PROSTATE, V61, P171, DOI 10.1002/pros.20089; FUSI FM, 1993, MOL REPROD DEV, V36, P212, DOI 10.1002/mrd.1080360212; FUSI FM, 1992, J ANDROL, V13, P28; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Malm J, 1996, EUR J BIOCHEM, V238, P48, DOI 10.1111/j.1432-1033.1996.0048q.x; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; MIRANDA PV, 1992, MOL REPROD DEV, V33, P443, DOI 10.1002/mrd.1080330411; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Wang ZJ, 2008, ASIAN J ANDROL, V10, P770, DOI 10.1111/j.1745-7262.2008.00393.x; Wang ZJ, 2007, BIOL REPROD, V77, P476, DOI 10.1095/biolreprod.107.060194; Wang ZJ, 2005, BIOL REPROD, V72, P1064, DOI 10.1095/biolreprod.104.036483; Wennemuth G, 1997, INT J ANDROL, V20, P10, DOI 10.1046/j.1365-2605.1997.00005.x; Wennemuth G, 2001, ANDROLOGIA, V33, P43, DOI 10.1046/j.1439-0272.2001.00370.x	29	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82600	10.1371/journal.pone.0082600	http://dx.doi.org/10.1371/journal.pone.0082600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358212	gold, Green Published			2022-12-25	WOS:000328735700085
J	Faleri, A; Santini, L; Brier, S; Pansegrau, W; Lo Surdo, P; Scarselli, M; Buricchi, F; Volpini, G; Genovese, A; van der Veen, S; Lea, S; Tang, CM; Savino, S; Pizza, M; Finco, O; Norais, N; Masignani, V				Faleri, Agnese; Santini, Laura; Brier, Sebastien; Pansegrau, Werner; Lo Surdo, Paola; Scarselli, Maria; Buricchi, Francesca; Volpini, Gianfranco; Genovese, Alessia; van der Veen, Stijn; Lea, Susan; Tang, Christoph M.; Savino, Silvana; Pizza, Mariagrazia; Finco, Oretta; Norais, Nathalie; Masignani, Vega			Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties	FASEB JOURNAL			English	Article						mAb synergy; MenB vaccine; meningococcal antigen; hydrogen/deuterium exchange mass spectrometry	BACTERICIDAL ACTIVITY; SEROGROUP-B; PROTECTIVE ANTIGEN; VIRULENCE FACTOR; VACCINE; COMPLEMENT; RESPONSES; SURVIVAL; SEQUENCE; GNA1870	Factor H binding protein (fHbp) is one of the main antigens of the 4-component meningococcus B (4CMenB) multicomponent vaccine against disease caused by serogroup B Neisseria meningitidis (MenB). fHbp binds the complement down-regulating protein human factor H (hfH), thus resulting in immune evasion. fHbp exists in 3 variant groups with limited cross-protective responses. Previous studies have described the generation of monoclonal antibodies (mAbs) targeting variant-specific regions of fHbp. Here we report for the first time the functional characterization of two mAbs that recognize a wide panel of fHbp variants and subvariants on the MenB surface and that are able to inhibit fHbp binding to hfH. The antigenic regions targeted by the two mAbs were accurately mapped by hydrogen-deuterium exchange mass spectrometry (HDX-MS), revealing partially overlapping epitopes on the N terminus of fHbp. Furthermore, while none of the mAbs had bactericidal activity on its own, a synergistic effect was observed for each of them when tested by the human complement serum bactericidal activity (hSBA) assay in combination with a second nonbactericidal mAb. The bases underlying fHbp variant cross-reactivity, as well as inhibition of hfH binding and cooperativity effect observed for the two mAbs, are discussed in light of the mapped epitopes.-Faleri, A., Santini, L., Brier, S., Pansegrau, W., Lo Surdo, P., Scarselli, M., Buricchi, F., Volpini, G., Genovese, A., van der Veen, S., Lea, S., Tang, C. M., Savino, S., Pizza, M., Finco, O., Norais, N., Masignani, V. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.	[Faleri, Agnese; Santini, Laura; Brier, Sebastien; Pansegrau, Werner; Lo Surdo, Paola; Scarselli, Maria; Buricchi, Francesca; Volpini, Gianfranco; Genovese, Alessia; Savino, Silvana; Pizza, Mariagrazia; Finco, Oretta; Norais, Nathalie; Masignani, Vega] Novartis Vaccines & Diagnost Srl, Res Ctr, I-53100 Siena, Italy; [van der Veen, Stijn; Lea, Susan; Tang, Christoph M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Novartis; University of Oxford	Masignani, V (corresponding author), Novartis Vaccines & Diagnost Srl, Res Ctr, Via Fiorentina 1, I-53100 Siena, Italy.	vega.masignani@novartis.com	Brier, Sebastien/L-7787-2019; Lea, Susan M/B-7678-2009; Brier, Sébastien/E-8558-2019	Brier, Sebastien/0000-0003-1758-8237; Lea, Susan M/0000-0001-9287-8053; van der Veen, Stijn/0000-0002-8176-391X	Medical Research Council [G0900888] Funding Source: Medline; Wellcome Trust [102908] Funding Source: Medline; MRC [G0900888] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baerga-Ortiz A, 2002, PROTEIN SCI, V11, P1300, DOI 10.1110/ps.4670102; Bai XL, 2010, EXPERT REV VACCINES, V9, P1203, DOI 10.1586/ERV.10.116; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Brier S, 2012, BIOCHEMISTRY-US, V51, P6738, DOI 10.1021/bi300656w; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034272; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Konar M, 2013, J INFECT DIS, V208, P627, DOI 10.1093/infdis/jit239; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P1002, DOI 10.1128/CVI.00055-11; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Marshall HS, 2012, PEDIATR INFECT DIS J, V31, P1061, DOI 10.1097/INF.0b013e31826327e4; Mascioni A, 2010, BBA-BIOMEMBRANES, V1798, P87, DOI 10.1016/j.bbamem.2009.09.021; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2009, VACCINE, V27, P3417, DOI 10.1016/j.vaccine.2009.01.075; Nissen MD, 2013, PEDIATR INFECT DIS J, V32, P364, DOI 10.1097/INF.0b013e31827b0d24; Richmond PC, 2012, VACCINE, V30, P6163, DOI 10.1016/j.vaccine.2012.07.065; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sheldon EA, 2012, HUM VACC IMMUNOTHER, V8, P888, DOI 10.4161/hv.19983; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Zimmer SM, 2004, EXPERT OPIN PHARMACO, V5, P855, DOI 10.1517/14656566.5.4.855	42	32	32	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1644	1653		10.1096/fj.13-239012	http://dx.doi.org/10.1096/fj.13-239012			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371123				2022-12-25	WOS:000335344300013
J	Jeong, SM; Lee, A; Lee, J; Haigis, MC				Jeong, Seung Min; Lee, Annie; Lee, Jaewon; Haigis, Marcia C.			SIRT4 Protein Suppresses Tumor Formation in Genetic Models of Myc-induced B Cell Lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glutamine; Mitochondria; Mitochondrial metabolism; Sirtuins	GLUTAMINE-METABOLISM; CALORIE RESTRICTION; CANCER-THERAPY; PROLIFERATION; INHIBITION; PHYSIOLOGY; ADDICTION; SIRTUINS; SURVIVAL	Background: Glutamine metabolism is essential for Myc-induced tumors. Results: SIRT4 regulates mitochondrial glutamine metabolism and the growth and survival of Burkitt lymphoma cells independent of Myc. Conclusion: SIRT4 has a tumor-suppressive role in Myc-induced B cell lymphoma. Significance: SIRT4 may be a potential target against Myc-driven and glutamine-dependent tumors. Glutamine metabolism plays an essential role for growth and proliferation of many cancer cells by providing metabolites for the maintenance of mitochondrial functions and macromolecular synthesis. Aberrant activation of the transcription factor c-Myc, e.g. caused by t(8;14) chromosomal translocation commonly found in Burkitt lymphoma, is a key driver of cellular glutamine metabolism in many tumors, highlighting the need to identify molecular mechanisms that can suppress glutamine usage in these cancers. Recently, the mitochondrial sirtuin SIRT4 has been reported to function as a tumor suppressor by regulating glutamine metabolism, suggesting that it might have therapeutic potential for treating glutamine-dependent cancers. Here, we report that SIRT4 represses Myc-induced B cell lymphomagenesis via inhibition of mitochondrial glutamine metabolism. We found that SIRT4 overexpression can dampen glutamine utilization even in Myc-driven human Burkitt lymphoma cells and inhibit glutamine-dependent proliferation of these cells. Importantly, SIRT4 overexpression sensitizes Burkitt lymphoma cells to glucose depletion and synergizes with pharmacological glycolysis inhibitors to induce cell death. Moreover, SIRT4 loss in a genetic mouse model of Myc-induced Burkitt lymphoma, E-Myc transgenic mouse, greatly accelerates lymphomagenesis and mortality. Indeed, E-Myc-induced B cell lymphoma cells from SIRT4 null mice exhibit increased glutamine uptake and glutamate dehydrogenase activity. Furthermore, we establish that SIRT4 regulates glutamine metabolism independent of Myc. Together, these results highlight the tumor-suppressive role of SIRT4 in Myc-induced B cell lymphoma and suggest that SIRT4 may be a potential target against Myc-induced and/or glutamine-dependent cancers.	[Jeong, Seung Min; Lee, Annie; Lee, Jaewon; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, SGM 329C,240 Longwood Ave, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu		Lee, Jaewon/0000-0002-5677-2398	National Institutes of Health [R01 AG032375]; American Cancer Society; Ellison Medical Foundation; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG032375 (to M. C. H.).; Supported by the American Cancer Society New Scholar Award, Ellison Medical Foundation New Scholar Award, and the Glenn Foundation for Medical Research. To whom correspondence should be addressed: Dept. of Cell Biology, Harvard Medical School, SGM 329C, 240 Longwood Ave., Boston, MA 02115. Tel.: 617-432-6865; Fax: 617-432-6225; E-mail: marcia_haigis@hms.harvard.edu.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Papaldo P, 2003, J CLIN ONCOL, V21, P3462, DOI 10.1200/JCO.2003.03.034; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	27	86	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4135	4144		10.1074/jbc.M113.525949	http://dx.doi.org/10.1074/jbc.M113.525949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368766	Green Published, hybrid			2022-12-25	WOS:000331403800027
J	Loibl, M; Klein, I; Prattes, M; Schmidt, C; Kappel, L; Zisser, G; Gungl, A; Krieger, E; Pertschy, B; Bergler, H				Loibl, Mathias; Klein, Isabella; Prattes, Michael; Schmidt, Claudia; Kappel, Lisa; Zisser, Gertrude; Gungl, Anna; Krieger, Elmar; Pertschy, Brigitte; Bergler, Helmut			The Drug Diazaborine Blocks Ribosome Biogenesis by Inhibiting the AAA-ATPase Drg1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Drug Action; Enzyme Inhibitors; Protein-Drug Interactions; Ribosome Assembly; AAA-ATPases; Diazaborine; Small Molecule Inhibitor	SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; PROTEIN; YEAST; COMPLEX; MATURATION; REDUCTASE; SYSTEM; GENE	The drug diazaborine is the only known inhibitor of ribosome biogenesis and specifically blocks large subunit formation in eukaryotic cells. However, the target of this drug and the mechanism of inhibition were unknown. Here we identify the AAA-ATPase Drg1 as a target of diazaborine. Inhibitor binding into the second AAA domain of Drg1 requires ATP loading and results in inhibition of ATP hydrolysis in this site. As a consequence the physiological activity of Drg1, i.e. the release of Rlp24 from pre-60S particles, is blocked, and further progression of cytoplasmic preribosome maturation is prevented. Our results identify the first target of an inhibitor of ribosome biogenesis and provide the mechanism of inhibition of a key step in large ribosomal subunit formation.	[Loibl, Mathias; Klein, Isabella; Prattes, Michael; Schmidt, Claudia; Zisser, Gertrude; Gungl, Anna; Pertschy, Brigitte; Bergler, Helmut] Karl Franzens Univ Graz, Inst Mol Biowissensch, A-8010 Graz, Austria; [Krieger, Elmar] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat 260, NL-6500 HB Nijmegen, Netherlands	University of Graz; Radboud University Nijmegen	Bergler, H (corresponding author), Karl Franzens Univ Graz, Inst Mol Biowissensch, Humboldtstr 50-EG, A-8010 Graz, Austria.	helmut.bergler@uni-graz.at	Birnhuber, Anna/AAX-3065-2021	Birnhuber, Anna/0000-0002-8358-8377; Pertschy, Brigitte/0000-0003-3558-0191; Bergler, Helmut/0000-0002-7724-309X; Prattes, Michael/0000-0002-2526-9896; Kappel, Lisa/0000-0001-9633-9030; Klein, Isabella/0000-0001-5879-3777	European Union [289350]; Austrian Science Fund (FWF) [P21991, P26136]; Austrian Science Fund (FWF) [P 26136, P 21991] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 289350 (to E. K.) and Austrian Science Fund (FWF) Grants P21991 and P26136 (to H. B.).	Baldock C, 1996, ACTA CRYSTALLOGR D, V52, P1181, DOI 10.1107/S0907444996005458; Bassler J, 2012, MOL CELL BIOL, V32, P4898, DOI 10.1128/MCB.00910-12; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bursavich MG, 2010, BIOORG MED CHEM LETT, V20, P1677, DOI 10.1016/j.bmcl.2010.01.058; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; GRASSBERGER MA, 1984, J MED CHEM, V27, P947, DOI 10.1021/jm00374a003; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; KATER MM, 1994, PLANT MOL BIOL, V25, P771, DOI 10.1007/BF00028873; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Levy CW, 2001, J MOL BIOL, V309, P171, DOI 10.1006/jmbi.2001.4643; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Muckstein U, 2002, BIOINFORMATICS, V18, pS153, DOI 10.1093/bioinformatics/18.suppl_2.S153; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2004, MOL CELL BIOL, V24, P6476, DOI 10.1128/MCB.24.14.6476-6487.2004; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; SIKORSKI RS, 1989, GENETICS, V122, P19; THORSNESS PE, 1993, YEAST, V9, P1267, DOI 10.1002/yea.320091114; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wendler F, 1997, J BIOL CHEM, V272, P27091, DOI 10.1074/jbc.272.43.27091; Zakalskiy A, 2002, J BIOL CHEM, V277, P26788, DOI 10.1074/jbc.M201515200	32	39	39	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3913	3922		10.1074/jbc.M113.536110	http://dx.doi.org/10.1074/jbc.M113.536110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371142	Green Published, hybrid			2022-12-25	WOS:000331403800008
J	Quinn, SR; Mangan, NE; Caffrey, BE; Gantier, MP; Williams, BRG; Hertzog, PJ; McCoy, CE; O'Neill, LAJ				Quinn, Susan R.; Mangan, Niamh E.; Caffrey, Brian E.; Gantier, Michael P.; Williams, Bryan R. G.; Hertzog, Paul J.; McCoy, Claire E.; O'Neill, Luke A. J.			The Role of Ets2 Transcription Factor in the Induction of MicroRNA-155 (miR-155) by Lipopolysaccharide and Its Targeting by Interleukin-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ets Family Transcription Factor; Interleukin; Lipopolysaccharide (LPS); MicroRNA; Toll-like Receptors (TLR); Ets2; Interleukin 10; SHIP1; TLR4; miR-155	MACROPHAGES; LPS; CELLS; INFLAMMATION; STIMULATION; ACTIVATION; EXPRESSION; IMMUNITY; SHOCK; MICE	Background: miR-155 is strongly induced by LPS, a response inhibited by IL-10. Results: The Ets2 transcription factor is required for induction of miR-155 by LPS. IL-10 can subsequently decrease miR-155 via suppression of Ets2. Conclusion: Ets2 is an important transcription factor for regulation of miR-155. Significance: This study reports a detailed mechanism of induction of miR-155 and provides a new means of inhibition for IL-10 via suppression of Ets2. MicroRNA-155 (miR-155) is highly expressed in many cancers such as B cell lymphomas and myeloid leukemia and inflammatory disorders such as rheumatoid arthritis, atopic dermatitis, and multiple sclerosis. The role of miR-155 as both a promoter of inflammation and an oncogenic agent provides a clear need for miR-155 itself to be stringently regulated. We therefore investigated the transcriptional regulation of miR-155 in response to the respective pro- and anti-inflammatory mediators LPS and IL-10. Bioinformatic analysis revealed Ets binding sites on the miR-155 promoter, and we found that Ets2 is critical for miR-155 induction by LPS. Truncation and mutational analysis of the miR-155 promoter confirmed the role of the Ets2 binding site proximal to the transcription start site for LPS responsiveness. We observed increased binding of Ets2 to the miR-155 promoter and Ets2 deficient mice displayed decreased induction of miR-155 in response to LPS. IL-10 inhibited the induction of Ets2 mRNA and protein by LPS, thereby decreasing Ets2 function on the pri-155 promoter. We have thus identified Ets2 as a key novel regulator in both the positive and negative control of miR-155 in the inflammatory response.	[Quinn, Susan R.; McCoy, Claire E.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Mangan, Niamh E.; Gantier, Michael P.; Williams, Bryan R. G.; Hertzog, Paul J.; McCoy, Claire E.] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Caffrey, Brian E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland	Trinity College Dublin; Monash University; Trinity College Dublin	Quinn, SR (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	quinns1@tcd.ie	Gantier, Michael/B-7512-2011; Williams, Bryan R. G./A-5021-2009; Hertzog, Paul J/I-7053-2013; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Williams, Bryan R. G./0000-0002-4969-1151; Hertzog, Paul J/0000-0002-1373-8472; Gantier, Michael/0000-0003-3740-698X; O'Neill, Luke/0000-0002-4333-2748; Mangan, Niamh/0000-0003-3844-0709; McCoy, Claire/0000-0001-8710-896X	Science Foundation Ireland; Health Research Board/Marie Curie CoFund; European Research Council; Australian National Health and Medical Research Council; Australian Research Council; Victorian government	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board/Marie Curie CoFund; European Research Council(European Research Council (ERC)European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian government	This work was supported by the Science Foundation Ireland, Health Research Board/Marie Curie CoFund, and the European Research Council. The Monash Institute of Medical Research was supported by the Australian National Health and Medical Research Council, Australian Research Council, Health Research Board/Marie Curie CoFund, and the Victorian government's operational infrastructure support program.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BOULUKOS KE, 1990, GENE DEV, V4, P401, DOI 10.1101/gad.4.3.401; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Escobar T, 2013, INVEST OPHTH VIS SCI, V54, P4017, DOI 10.1167/iovs.13-11937; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Sweet MJ, 1998, J INFLAMM, V48, P67; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	35	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4316	4325		10.1074/jbc.M113.522730	http://dx.doi.org/10.1074/jbc.M113.522730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362029	Green Published, hybrid			2022-12-25	WOS:000331403800042
J	Sturrock, A; Mir-Kasimov, M; Baker, J; Rowley, J; Paine, R				Sturrock, Anne; Mir-Kasimov, Mustafa; Baker, Jessica; Rowley, Jesse; Paine, Robert			Key Role of MicroRNA in the Regulation of Granulocyte Macrophage Colony-stimulating Factor Expression in Murine Alveolar Epithelial Cells during Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Growth Factors; Lung Injury; Microarray; MicroRNA; Oxidative Stress; Array	INDUCED PULMONARY-FIBROSIS; INNATE IMMUNE-RESPONSE; GROWTH-FACTOR RECEPTOR; CSF-DEFICIENT MICE; ACUTE LUNG INJURY; GM-CSF; HYPEROXIC STRESS; TRANSGENIC MICE; GENE-REGULATION; INFLAMMATION	GM-CSF is an endogenous pulmonary cytokine produced by normal alveolar epithelial cells (AEC) that is a key defender of the alveolar space. AEC GM-CSF expression is suppressed by oxidative stress through alternations in mRNA turnover, an effect that is reversed by treatment with recombinant GM-CSF. We hypothesized that specific microRNA (miRNA) would play a key role in AEC GM-CSF regulation. A genome-wide miRNA microarray identified 19 candidate miRNA altered in primary AEC during oxidative stress with reversal by treatment with GM-CSF. Three of these miRNA (miR 133a, miR 133a*, and miR 133b) are also predicted to bind the GM-CSF 3-untranslated region (UTR). PCR for the mature miRNA confirmed induction during oxidative stress that was reversed by treatment with GM-CSF. Experiments using a GM-CSF 3-UTR reporter construct demonstrated that miR133a and miR133b effects on GM-CSF expression are through interactions with the GM-CSF 3-UTR. Using lentiviral transduction of specific mimics and inhibitors in primary murine AEC, we determined that miR133a and miR133b suppress GM-CSF expression and that their inhibition both reverses oxidant-induced suppression of GM-CSF expression and increases basal expression of GM-CSF in cells in normoxia. In contrast, these miRNAs are not active in regulation of GM-CSF expression in murine EL4 T cells. Thus, members of the miR133 family play key roles in regulation of GM-CSF expression through effects on mRNA turnover in AEC during oxidative stress. Increased understanding of GM-CSF gene regulation may provide novel miRNA-based interventions to augment pulmonary innate immune defense in lung injury.	[Sturrock, Anne; Mir-Kasimov, Mustafa; Paine, Robert] Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Sturrock, Anne; Mir-Kasimov, Mustafa; Baker, Jessica; Rowley, Jesse; Paine, Robert] Univ Utah, Sch Med, Div Resp Crit Care & Occupat Pulm Med, Dept Med, Salt Lake City, UT 84132 USA; [Rowley, Jesse] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84132 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Paine, R (corresponding author), Univ Utah, Sch Med, Div Resp Crit Care & Occupat Pulm Med, 26 North 1900 East,Rm 701, Salt Lake City, UT 84132 USA.	robert.paine@hsc.utah.edu			Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM103806] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001777] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Research Grant from the Department of Veterans Affairs (to R. P.).	Baleeiro CEO, 2006, AM J PHYSIOL-LUNG C, V291, pL1246, DOI 10.1152/ajplung.00016.2006; Baleeiro CEO, 2003, J IMMUNOL, V171, P955, DOI 10.4049/jimmunol.171.2.955; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Charbeneau RP, 2003, AM J PHYSIOL-LUNG C, V284, pL1103, DOI 10.1152/ajplung.00350.2002; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Christensen PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL487, DOI 10.1152/ajplung.2000.279.3.L487; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Ikegami M, 1997, AM J PHYSIOL-LUNG C, V273, pL709, DOI 10.1152/ajplung.1997.273.4.L709; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Mendez MP, 2006, AM J PHYSIOL-LUNG C, V290, pL962, DOI 10.1152/ajplung.00352.2005; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; OREILLY MA, 1989, AM J PHYSIOL, V257, pL385, DOI 10.1152/ajplung.1989.257.6.L385; OSBORNE CS, 1995, J IMMUNOL, V155, P226; Paine R, 2003, AM J PATHOL, V163, P2397, DOI 10.1016/S0002-9440(10)63594-8; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; PIGUET PF, 1993, EXP LUNG RES, V19, P579, DOI 10.3109/01902149309031729; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reed JA, 1998, P ASSOC AM PHYSICIAN, V110, P321; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sotillo E, 2011, PHARMACOL THERAPEUT, V131, P18, DOI 10.1016/j.pharmthera.2011.04.006; Sturrock A, 2010, AM J PHYSIOL-LUNG C, V298, pL446, DOI 10.1152/ajplung.00161.2009; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Villar AV, 2011, HEART, V97, P1132, DOI 10.1136/hrt.2010.220418; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478	51	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4095	4105		10.1074/jbc.M113.535922	http://dx.doi.org/10.1074/jbc.M113.535922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371146	Green Published, hybrid			2022-12-25	WOS:000331403800023
J	Syeda, R; Santos, JS; Montal, M				Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio			Lipid Bilayer Modules as Determinants of K+ Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gating; Lipid Structure; Membrane Bilayer; Phospholipid; Potassium Channels; Asymmetric Lipid Bilayers; Gating Modifiers; Phosphoglycerides; Voltage-gated Channels	PHOSPHOLIPID SURFACE-CHARGE; VOLTAGE-SENSOR DOMAIN; MOLECULAR TEMPLATE; CRYSTAL-STRUCTURE; MEMBRANE-LIPIDS; FORCE-FIELD; PORE MODULE; INACTIVATION; BINDING; PIP2	Background: Lipid bilayer composition and asymmetry modulate K+ channel function by unknown mechanisms. Results: Lipid headgroups with exposed hydroxyls on the extracellular facing monolayer stabilize the channel open conformation irrespective of charge. Conclusion: Stabilization is mediated through a change of interfacial water structure. Significance: Lipid bilayer asymmetry and its individual monolayers emerge as crucial determinants of K+ channel gating. The crystal structure of the sensorless pore module of a voltage-gated K+ (Kv) channel showed that lipids occupy a crevice between subunits. We asked if individual lipid monolayers of the bilayer embody independent modules linked to channel gating modulation. Functional studies using single channel current recordings of the sensorless pore module reconstituted in symmetric and asymmetric lipid bilayers allowed us to establish the deterministic role of lipid headgroup on gating. We discovered that individual monolayers with headgroups that coat the bilayer-aqueous interface with hydroxyls stabilize the channel open conformation. The hydroxyl need not be at a terminal position and the effect is not dependent on the presence of phosphate or net charge on the lipid headgroup. Asymmetric lipid bilayers allowed us to determine that phosphoglycerides with glycerol or inositol on the extracellular facing monolayer stabilize the open conformation of the channel. This indirect effect is attributed to a change in water structure at the membrane interface. By contrast, inclusion of the positively charged lysyl-dioleoyl-phosphatidylglycerol exclusively on the cytoplasmic facing monolayer of the bilayer increases drastically the probability of finding the channel open. Such modulation is mediated by a -cation interaction between Phe-19 of the pore module and the lysyl moiety anchored to the phosphatidylglycerol headgroup. The new findings imply that the specific chemistry of the lipid headgroup and its selective location in either monolayer of the bilayer dictate the stability of the open conformation of a Kv pore module in the absence of voltage-sensing modules.	[Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Montal, M (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health [GM-49711]; University of California, San Diego [RK-174C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-49711 and University of California, San Diego, Grant RK-174C (to M. M.). The results presented were reported at the 2010 Biophysical Society Meeting of the Membrane Biophysics Subgroup Symposia (San Francisco, CA, February 20-24, 2010).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Alvis SJ, 2003, BIOPHYS J, V85, P3828, DOI 10.1016/S0006-3495(03)74797-3; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; FORTE M, 1981, P NATL ACAD SCI-BIOL, V78, P7195, DOI 10.1073/pnas.78.11.7195; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Iwamoto M, 2013, P NATL ACAD SCI USA, V110, P749, DOI 10.1073/pnas.1217323110; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundby A, 2006, J GEN PHYSIOL, V128, P293, DOI 10.1085/jgp.200609573; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; MONTAL M, 1976, ANNU REV BIOPHYS BIO, V5, P119, DOI 10.1146/annurev.bb.05.060176.001003; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; MONTAL M, 1973, BIOCHIM BIOPHYS ACTA, V298, P750, DOI 10.1016/0005-2736(73)90092-8; Murzyn K, 2006, BIOINTERPHASES, V1, P98, DOI 10.1116/1.2354573; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; ROTHMAN JE, 1977, J MOL BIOL, V110, P603, DOI 10.1016/S0022-2836(77)80114-9; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Santos JS, 2013, J BIOL CHEM, V288, P16619, DOI 10.1074/jbc.M113.468728; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Tirosh O, 1998, BIOPHYS J, V74, P1371, DOI 10.1016/S0006-3495(98)77849-X; Towey JJ, 2012, J PHYS CHEM B, V116, P13898, DOI 10.1021/jp3093034; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2004, BBA-MOL CELL RES, V1694, P97, DOI 10.1016/j.bbamcr.2004.03.007; van der Cruijsen EAW, 2013, P NATL ACAD SCI USA, V110, P13008, DOI 10.1073/pnas.1305563110; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	63	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4233	4243		10.1074/jbc.M113.530055	http://dx.doi.org/10.1074/jbc.M113.530055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362039	Green Published, hybrid			2022-12-25	WOS:000331403800035
J	Wong, W; Webb, AI; Olshina, MA; Infusini, G; Tan, YH; Hanssen, E; Catimel, B; Suarez, C; Condron, M; Angrisano, F; NebI, T; Kovar, DR; Baum, J				Wong, Wilson; Webb, Andrew I.; Olshina, Maya A.; Infusini, Giuseppe; Tan, Yan Hong; Hanssen, Eric; Catimel, Bruno; Suarez, Cristian; Condron, Melanie; Angrisano, Fiona; Neb, Thomas, I; Kovar, David R.; Baum, Jake			A Mechanism for Actin Filament Severing by Malaria Parasite Actin Depolymerizing Factor 1 via a Low Affinity Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cofilin; Cytoskeleton; Electron Microscopy (EM); Malaria; Mass Spectrometry (MS); Plasmodium; Protein Cross-linking	CHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; TOXOPLASMA-GONDII; LINKED PEPTIDES; MICROFILAMENT DYNAMICS; CRYSTAL-STRUCTURES; CYTOCHALASIN D; COFILIN; ADF/COFILIN; IDENTIFICATION	Actin depolymerizing factor (ADF)/cofilins are essential regulators of actin turnover in eukaryotic cells. These multifunctional proteins facilitate both stabilization and severing of filamentous (F)-actin in a concentration-dependent manner. At high concentrations ADF/cofilins bind stably to F-actin longitudinally between two adjacent actin protomers forming what is called a decorative interaction. Low densities of ADF/cofilins, in contrast, result in the optimal severing of the filament. To date, how these two contrasting modalities are achieved by the same protein remains uncertain. Here, we define the proximate amino acids between the actin filament and the malaria parasite ADF/cofilin, PfADF1 from Plasmodium falciparum. PfADF1 is unique among ADF/cofilins in being able to sever F-actin but do so without stable filament binding. Using chemical cross-linking and mass spectrometry (XL-MS) combined with structure reconstruction we describe a previously overlooked binding interface on the actin filament targeted by PfADF1. This site is distinct from the known binding site that defines decoration. Furthermore, total internal reflection fluorescence (TIRF) microscopy imaging of single actin filaments confirms that this novel low affinity site is required for F-actin severing. Exploring beyond malaria parasites, selective blocking of the decoration site with human cofilin (HsCOF1) using cytochalasin D increases its severing rate. HsCOF1 may therefore also use a decoration-independent site for filament severing. Thus our data suggest that a second, low affinity actin-binding site may be universally used by ADF/cofilins for actin filament severing.	[Wong, Wilson; Olshina, Maya A.; Tan, Yan Hong; Condron, Melanie; Angrisano, Fiona; Baum, Jake] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia; [Webb, Andrew I.; Infusini, Giuseppe; Neb, Thomas, I] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Wong, Wilson; Webb, Andrew I.; Olshina, Maya A.; Infusini, Giuseppe; Tan, Yan Hong; Condron, Melanie; Angrisano, Fiona; Neb, Thomas, I; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Hanssen, Eric] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Electron Microscopy Unit, Parkville, Vic 3010, Australia; [Suarez, Cristian; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Catimel, Bruno] Austin Hosp, Olivia Newton John Canc & Wellness Ctr, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Chicago; University of Chicago; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Ludwig Institute for Cancer Research	Baum, J (corresponding author), Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England.	jake.baum@imperial.ac.uk	Nebl, Thomas/N-1620-2017; Hanssen, Eric/A-7217-2013	Nebl, Thomas/0000-0003-4003-9340; Hanssen, Eric/0000-0002-4064-1844; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X; CATIMEL, Bruno/0000-0002-4350-6875; Wong, Wilson/0000-0003-1335-8047	National Health and Medical Research Council of Australia (NHMRC) [APP1024678]; Human Frontier Science Program (HFSP) Young Investigator Program [RGY0071/2011]; Australian Research Council (ARC) Discovery Project Grant [DP1094497]; Victorian State Government; Australian Government NHMRC IRIISS; NHMRC [APP1053801]; NHMRC Dora Lush Scholarship [APP1018002]; Oversea Research Experience Scholarship; University of Melbourne; Australian Society of Parasitology; Australian Research Council (ARC) [FT100100112]; Wellcome Trust [100993/Z/13/Z]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program (HFSP) Young Investigator Program; Australian Research Council (ARC) Discovery Project Grant(Australian Research Council); Victorian State Government; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Oversea Research Experience Scholarship; University of Melbourne(University of Melbourne); Australian Society of Parasitology; Australian Research Council (ARC)(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported in part by National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1024678 (to J. B.), Human Frontier Science Program (HFSP) Young Investigator Program Grant RGY0071/2011 (to J. B. and D. R. K.), and Australian Research Council (ARC) Discovery Project Grant DP1094497 (to B. C.), Victorian State Government Operational Infrastructure Support, and Australian Government NHMRC IRIISS.; Supported through Early Career Fellowship APP1053801 from the NHMRC.; Supported through NHMRC Dora Lush Scholarship APP1018002 and an Oversea Research Experience Scholarship and travel award provided by the University of Melbourne and the Australian Society of Parasitology, respectively.; Supported by Future Fellowship FT100100112 from the Australian Research Council (ARC) and currently supported by a New Investigator Award from the Wellcome Trust 100993/Z/13/Z. To whom correspondence should be addressed: Dept. of Life Sciences, Imperial College of Science, Technology and Medicine, London SW7 2AZ, United Kingdom. E-mail: jake.baum@imperial.ac.uk.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Chen Q, 2011, J CELL BIOL, V195, P485, DOI 10.1083/jcb.201103067; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mehta S, 2011, MOL BIOL CELL, V22, P1290, DOI 10.1091/mbc.E10-12-0939; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neuhauser N, 2012, MOL CELL PROTEOMICS, V11, P1500, DOI 10.1074/mcp.M112.020271; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	45	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4043	4054		10.1074/jbc.M113.523365	http://dx.doi.org/10.1074/jbc.M113.523365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371134	hybrid, Green Published			2022-12-25	WOS:000331403800019
J	Workman, E; Veith, A; Battle, DJ				Workman, Eileen; Veith, Alex; Battle, Daniel J.			U1A Regulates 3 ' Processing of the Survival Motor Neuron mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Neurodegenerative Diseases; Polyadenylation; RNA Processing; RNA-binding Proteins; SMA; SMN; Spinal Muscular Atrophy; Survival Motor Neuron; U1A	SPINAL MUSCULAR-ATROPHY; POLYADENYLATION FACTOR CPSF-73; BINDING PROTEIN; SMN COMPLEX; SPECIFICITY FACTOR; SINGLE NUCLEOTIDE; A-PROTEIN; IDENTIFICATION; CLEAVAGE; SITE	Background: Insufficient expression of survival motor neuron (SMN), a protein involved in small nuclear ribonucleoprotein (snRNP) biogenesis, causes spinal muscular atrophy (SMA). Results: The U1A protein binds to and inhibits polyadenylation and cleavage of the SMN pre-mRNA. Conclusion: The U1A protein is a critical regulator of SMN expression. Significance: Understanding of the regulation of SMN expression is fundamental for developing treatments for SMA. Insufficient expression of the survival motor neuron (SMN) protein causes spinal muscular atrophy, a neurodegenerative disease characterized by loss of motor neurons. Despite the importance of maintaining adequate SMN levels, little is known about factors that control SMN expression, particularly 3 end processing of the SMN pre-mRNA. In this study, we identify the U1A protein as a key regulator of SMN expression. U1A, a component of the U1 snRNP, is known to inhibit polyadenylation upon direct binding to mRNA. We show that U1A binds directly and with high affinity and specificity to the SMN 3-UTR adjacent to the polyadenylation site, independent of the U1 snRNP (U1 small nuclear ribonucleoprotein). Binding of U1A inhibits polyadenylation of the SMN pre-mRNA by specifically inhibiting 3 cleavage by the cleavage and polyadenylation specificity factor. Expression of U1A in excess of U1 snRNA causes inhibition of SMN polyadenylation and decreases SMN protein levels. This work reveals a new mechanism for regulating SMN levels and provides new insight into the roles of U1A in 3 processing of mRNAs.	[Workman, Eileen; Veith, Alex; Battle, Daniel J.] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA; [Battle, Daniel J.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Battle, DJ (corresponding author), Dept Mol & Cellular Biochem, 383 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	battle.59@osu.edu			National Institutes of Health [R01NS077010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS077010 (to D. B.).	Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fischer U, 2011, WIRES RNA, V2, P718, DOI 10.1002/wrna.87; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Guan F, 2003, MOL CELL BIOL, V23, P3163, DOI 10.1128/MCB.23.9.3163-3172.2003; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3; Gunnewiek JMTK, 2000, MOL CELL BIOL, V20, P2209, DOI 10.1128/MCB.20.6.2209-2217.2000; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liang SC, 2006, RNA, V12, P111, DOI 10.1261/rna.2213506; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; LUTZREYERMUTH C, 1989, MOL CELL BIOL, V9, P2975, DOI 10.1128/MCB.9.7.2975; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Milcarek C, 2003, MOL IMMUNOL, V39, P809, DOI 10.1016/S0161-5890(02)00263-8; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Parsons DW, 1998, AM J HUM GENET, V63, P1712, DOI 10.1086/302160; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Phillips C, 2003, J BIOL CHEM, V278, P22102, DOI 10.1074/jbc.M301349200; Phillips C, 2001, EMBO J, V20, P6443, DOI 10.1093/emboj/20.22.6443; Phillips C, 2004, MOL CELL BIOL, V24, P6162, DOI 10.1128/MCB.24.14.6162-6171.2004; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; VANGELDER CWG, 1993, EMBO J, V12, P5191, DOI 10.1002/j.1460-2075.1993.tb06214.x; Varani L, 2000, NAT STRUCT BIOL, V7, P329; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle M., 1994, RNA PROCESSING PRACT, P1; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; ZERRES K, 1995, LANCET, V346, P1162, DOI 10.1016/S0140-6736(95)91835-3; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; ZHOU Z, 2003, CURR PROTOC MOL BIOL, pCH27	70	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3703	3712		10.1074/jbc.M113.538264	http://dx.doi.org/10.1074/jbc.M113.538264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362020	hybrid, Green Published			2022-12-25	WOS:000331368700051
J	Millier, A; Cohen, J; Toumi, M				Millier, Aurelie; Cohen, Joshua; Toumi, Mondher			Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE UTILIZATION; MEDICATION OVERUSE; COST-EFFECTIVENESS; CHRONIC MIGRAINE; PREVALENCE; MANAGEMENT; DISABILITY; GUIDELINES; DIAGNOSIS	Introduction: Triptans have been safely and effectively used in the management of migraine for more than fifteen years, and it seems reasonable to wonder what would be the economic impact of moving a specific triptan to OTC availability. The objective of this study was then to examine the economic impact of payer policies of a triptan Rx-toOTC switch in six EU countries (France, UK, Spain, Italy, Germany and Poland). Methods: A decision model was used to model the budgetary impact of a triptan Rx-to-OTC switch from the thirdparty payer (TPP) and the societal perspectives, using a one-year timeframe. Results: From the TPP perspective, it is estimated that the current overall direct spending on the management of migraine attacks across the 6 EU Member States is (sic)582 million annually, and that the savings would reach (sic)75 million (13% of the overall direct economic burden of migraine). From the societal perspective, 86 million annually would be added. Conclusions: Given evidence of effectiveness and safety, and given the potential savings, a triptan Rx-to-OTC switch is a reasonable public policy decision.	[Millier, Aurelie] Creativ Ceut, Hlth Econ & Outcomes Res Dept, Paris, France; [Cohen, Joshua] Tufts Univ, Tufts Ctr, Study Drug Dev, Boston, MA 02111 USA; [Toumi, Mondher] Univ Lyon 1, Unite Format & Rech Odontol, F-69365 Lyon, France	Tufts University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Millier, A (corresponding author), Creativ Ceut, Hlth Econ & Outcomes Res Dept, Paris, France.	ami@creativ-ceutical.com						Abel H, 2009, OPTOMETRY, V80, P138, DOI 10.1016/j.optm.2008.06.008; [Anonymous], 2011, BMC NEUROLOGY; [Anonymous], 2005, SOIK HEALTHC COSTS D; [Anonymous], EC PUBL HLTH VAL SEL; [Anonymous], 2010, ANN SURVEY HOURS EAR; [Anonymous], 2010, WART STAW KAP POR RY; Baggott M, 2000, JAMA-J AM MED ASSOC, V284, P2190, DOI 10.1001/jama.284.17.2190; Banque mondiale, 2011, BANQUE MONDIALE INDI; Bewertungsmalistab Einheitlicher, 2011, EBM; British. Association for the Study of Headache, 2007, GUID HEALTHC PROF DI; Brown JS, 2006, CEPHALALGIA, V26, P1473, DOI 10.1111/j.1468-2982.2006.01240.x; Christian Lucas, 2011, CEPH CHRON QUOT AB M; Cohen J, 2013, J Med Econ, V16, P835, DOI 10.3111/13696998.2013.793693; Creac'h C, 2009, HEADACHE, V49, P519, DOI 10.1111/j.1526-4610.2009.01365.x; D'Amico D, 2005, HEADACHE, V45, P553, DOI 10.1111/j.1526-4610.2005.05109.x; D'Amico D, 2003, NEUROL SCI, V24, pS97; Demarin V, 2005, ACTA MED CROATICA, V62, P99; Falagas ME, 2007, INT J CLIN PRACT, V61, P1569, DOI 10.1111/j.1742-1241.2007.01423.x; Food and Drug Administration, 2005, T0523 FAO; Gallai V, 2001, J HEADACHE PAIN, V2, P125; Geraud G, 2004, CLIN THER, V26, P1305; Gerth WC, 2001, PHARMACOECONOMICS, V19, P197, DOI 10.2165/00019053-200119020-00006; Gomez-Gerique Juan Antonio, 2004, Eur J Health Econ, V5, P278, DOI 10.1007/s10198-003-0222-1; Guidotti M, 2009, CLIN DRUG INVEST, V29, P693, DOI 10.2165/11315330-000000000-00000; Haag G, 2011, J HEADACHE PAIN, V12, P201, DOI 10.1007/s10194-010-0266-4; Ilioudi Stamatia, 2010, Int J Electron Healthc, V5, P327, DOI 10.1504/IJEH.2010.036205; Jamieson DG, 2002, AM J MED, V112, P135, DOI 10.1016/S0002-9343(01)01064-6; Jensen K, 1998, CEPHALALGIA, V18, P9, DOI 10.1046/j.1468-2982.1998.1801009.x; Johnston MM, 2010, DRUGS, V70, P1505, DOI 10.2165/11537990-000000000-00000; Kalra Arun A, 2007, Ther Clin Risk Manag, V3, P449; KOFOED LL, 1985, GERIATRICS, V40, P55; Lainez JM, 2007, REV CLIN ESP, V207, P190, DOI [10.1157/13101849, DOI 10.1157/13101849.PUBMED:17475183]; Lainez MJA, 2005, HEADACHE, V45, P883, DOI 10.1111/j.1526-4610.2005.05156.x; Landy SH, 2012, HEADACHE, V52, P363, DOI 10.1111/j.1526-4610.2011.02029.x; Lanteri-Minet M, 2011, CEPHALALGIA, V31, P837, DOI 10.1177/0333102411398400; Lipton RB, 2003, NEUROLOGY, V60, P441, DOI 10.1212/WNL.60.3.441; Lordick F, 2007, EUR J CANCER, V43, P299, DOI 10.1016/j.ejca.2006.09.019; MacGregor EA, 2004, CURR MED RES OPIN, V20, P1777, DOI 10.1185/030079904X10142; MacGregor EA, 1998, DRUG TODAY, V34, P1027, DOI 10.1358/dot.1998.34.12.487488; Matias-Guiu J, 2011, CEPHALALGIA, V31, P463, DOI 10.1177/0333102410382794; National Institute on Drug Abuse, 2001, NIH PUBLICATION; Navarro A, 2011, BMC NEUROLOGY BMC NE, V20, P11; Perearnau P, 2006, REV NEUROL-FRANCE, V162, P347, DOI 10.1016/S0035-3787(06)75021-4; Radtke A, 2009, HEADACHE, V49, P79, DOI 10.1111/j.1526-4610.2008.01263.x; Raybaud H, 2011, MIGRAINES CEPHALEES; Roncolato M, 2000, EUR NEUROL, V43, P102, DOI 10.1159/000008143; Scottish Intercollegiate Guidelines Network, 2008, DIAGN MAN HEAD AD GU; Societe Suisse pour l'etude des cephalees, 2008, CEPH ALG FAC REC THE; Stefanache F, 2006, HEADACHE CRANIAL NEU, P140; Steiner T, 2008, EC COST MIGRANINE HA; Steiner TJ, 2003, CEPHALALGIA, V23, P519, DOI 10.1046/j.1468-2982.2003.00568.x; Stepien A, 2003, BOL, P3; Stovner LJ, 2009, J HEADACHE PAIN, V10, P395, DOI 10.1007/s10194-009-0156-9; Tfelt-Hansen P, 2007, CNS DRUGS, V21, P877, DOI 10.2165/00023210-200721110-00001; Villalon Carlos M., 2003, Current Vascular Pharmacology, V1, P71, DOI 10.2174/1570161033386826; Williams AE, 2006, EUR RESPIR REV, V15, P4, DOI 10.1183/09059180.06.00009801; Winner P, 2005, CLIN THER, V27, P1785, DOI 10.1016/j.clinthera.2005.11.009; Yu J, 2009, J PAIN PALLIATIVE CA, V23, P693	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84088	10.1371/journal.pone.0084088	http://dx.doi.org/10.1371/journal.pone.0084088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367628	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900029
J	Bell, AV; Hinde, K; Newson, L				Bell, Adrian Viliami; Hinde, Katie; Newson, Lesley			Who Was Helping? The Scope for Female Cooperative Breeding in Early Homo	PLOS ONE			English	Article							MALE CHIMPANZEES; HUMAN ORIGINS; EVOLUTION; MORTALITY; SELECTION; HUNTER; MILK; COMPETITION; KINSHIP; CHOICE	Derived aspects of our human life history, such as short interbirth intervals and altricial newborns, have been attributed to male provisioning of nutrient-rich meat within monogamous relationships. However, many primatologists and anthropologists have questioned the relative importance of pair-bonding and biparental care, pointing to evidence that cooperative breeding better characterizes human reproductive and child-care relationships. We present a mathematical model with empirically-informed parameter ranges showing that natural selection favors cooperation among mothers over a wide range of conditions. In contrast, our analysis provides a far more narrow range of support for selection favoring male coalition-based monogamy over more promiscuous independent males, suggesting that provisioning within monogamous relationships may fall short of explaining the evolution of Homo life history. Rather, broader cooperative networks within and between the sexes provide the primary basis for our unique life history.	[Bell, Adrian Viliami] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hinde, Katie] Univ Calif Davis, Brain Mind & Behav Unit, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Newson, Lesley] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Newson, Lesley] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Utah System of Higher Education; University of Utah; Harvard University; University of California System; University of California Davis; University of California System; University of California Davis; University of Exeter	Bell, AV (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	adrian.bell@anthro.utah.edu		Hinde, Katie/0000-0002-0528-866X				Apostolou M, 2007, EVOL HUM BEHAV, V28, P403, DOI 10.1016/j.evolhumbehav.2007.05.007; Apostolou M, 2010, EVOL HUM BEHAV, V31, P39, DOI 10.1016/j.evolhumbehav.2009.06.010; Baldovino MC, 2008, FOLIA PRIMATOL, V79, P79, DOI 10.1159/000108780; Bell MBV, 2012, P ROY SOC B-BIOL SCI, V279, P619, DOI 10.1098/rspb.2011.1093; Bobe R, 2009, 1 HUMANS ORIGINS EAR; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Eberle M, 2006, BEHAV ECOL SOCIOBIOL, V60, P582, DOI 10.1007/s00265-006-0203-3; Gangestad SW, 2011, NAT S FAM ISS BIOS F; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Gettler LT, 2012, AM ANTHROPOL, V112, P7; Gurven M, 2009, CURR ANTHROPOL, V50, P51, DOI 10.1086/595620; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1995, EVOL ECOL, V9, P662, DOI 10.1007/BF01237661; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Henrich J, 2012, PHILOS T R SOC B, V367, P657, DOI 10.1098/rstb.2011.0290; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hill K, 2007, J HUM EVOL, V52, P443, DOI 10.1016/j.jhevol.2006.11.003; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hodge SJ, 2011, BIOL LETTERS, V7, P54, DOI 10.1098/rsbl.2010.0555; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Hrdy SB., 1976, ADV STUD BEHAV, P101, DOI [DOI 10.1016/S0065-3454(08)60083-2, DOI 10.1002/AJP.22456]; Hrdy SB, 2010, ESTIMATING PREVALENC; Huck M., 2013, BUILDING BABIES PRIM, P361; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Jaeggi AV, 2011, BEHAV ECOL SOCIOBIOL, V65, P2125, DOI 10.1007/s00265-011-1221-3; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kramer KL, 2010, EVOL ANTHROPOL, V19, P136, DOI 10.1002/evan.20265; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Mace R., 2005, GRANDMOTHERHOOD EVOL, P143; Marlowe FW, 2001, CURR ANTHROPOL, V42, P755, DOI 10.1086/323820; MENDOZA SP, 1986, ANIM BEHAV, V34, P1336, DOI 10.1016/S0003-3472(86)80205-6; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Parkes P, 2005, SOC ANTHROPOL, V13, P307, DOI 10.1017/S0964028205001564; Perry S, 1996, AM J PRIMATOL, V40, P167, DOI 10.1002/(SICI)1098-2345(1996)40:2<167::AID-AJP4>3.0.CO;2-W; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Reichard Ulrich H., 2003, P3; Robson S, 2006, EVOLUTION HUMAN LIFE; Rusu AS, 2004, ACTA ETHOL, V6, P53; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shaw R, 2007, WOMEN STUD INT FORUM, V30, P439, DOI 10.1016/j.wsif.2007.07.001; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Weidt A, 2008, ANIM BEHAV, V75, P801, DOI 10.1016/j.anbehav.2007.06.017; Winking J, 2011, EVOL HUM BEHAV, V32, P79, DOI 10.1016/j.evolhumbehav.2010.08.002	55	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83667	10.1371/journal.pone.0083667	http://dx.doi.org/10.1371/journal.pone.0083667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367605	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300112
J	Junghans, AF; Evers, C; De Ridder, DTD				Junghans, Astrid F.; Evers, Catharine; De Ridder, Denise T. D.			Eat Me If You Can: Cognitive Mechanisms Underlying the Distance Effect	PLOS ONE			English	Article							OBJECTS; LANGUAGE; CUES; FMRI	Proximal objects provide affordances that activate the motor information involved in interacting with the objects. This effect has previously been shown for artifacts but not for natural objects, such as food. This study examined whether the sight of proximal food, compared to distant food activates eating-related information. In two experiments reaction times to verbal labels following the sight of proximal and distant objects (food and toys) were measured. Verbal labels included function words that were compatible with one object category (eating and playing) and observation words compatible with both object categories. The sight of food was expected to activate eating-related information when presented at proximity but not at distance, as reflected by faster reaction times to proximal than distant compatible eating words and no difference between reaction times to proximal and distant food for observation words (Experiment 1). Experiment 2 additionally compared the reaction times to wrapped and unwrapped food. The distance effect was expected to occur only for unwrapped food because only unwrapped food is readily edible. As expected, Experiment 1 and 2 revealed faster responses to compatible eating words at proximity than at distance. In Experiment 2 this distance effect occurred only for readily edible, unwrapped food but not for wrapped food. For observation words no difference in response times between the distances was found. These findings suggest that the sight of proximal food activates eating-related information, which could explain people's differential behavioral responses to reachable versus distant food. The activation of eating-related information upon sight of accessible food could provide a cognition-based explanation for mindless eating.	[Junghans, Astrid F.; Evers, Catharine; De Ridder, Denise T. D.] Univ Utrecht, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands	Utrecht University	Junghans, AF (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands.	a.f.junghans@uu.nl			European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT)	European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT)	This research was funded by the European Commission's Framework Programme 7, People Action, through the Marie Curie Initial Training Network CONsumer COmpetence Research Training (CONCORT) (www.concort-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSINI E, 2011, EUROPEAN PERSPECTIVE; Ambrosini E, 2013, EXP BRAIN RES, V229, P197, DOI 10.1007/s00221-013-3607-0; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; De Stefani E, 2012, EXP BRAIN RES, V218, P539, DOI 10.1007/s00221-012-3047-2; Fedoroff IC, 1997, APPETITE, V28, P33, DOI 10.1006/appe.1996.0057; Ferri F, 2011, NEUROPSYCHOLOGIA, V49, P3519, DOI 10.1016/j.neuropsychologia.2011.09.001; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Geyskens K, 2008, J CONSUM RES, V35, P600, DOI 10.1086/591106; Gibson JJ, 1979, ECOLOGICAL APPROACH; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; HERMAN CP, 1975, J ABNORM PSYCHOL, V84, P666, DOI 10.1037/0021-843X.84.6.666; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Maas J, 2012, PSYCHOL HEALTH, V27, P59, DOI 10.1080/08870446.2011.565341; MICHAELS CF, 1988, J EXP PSYCHOL HUMAN, V14, P231, DOI 10.1037/0096-1523.14.2.231; Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Ranganathan R, 2011, HUM MOVEMENT SCI, V30, P1102, DOI 10.1016/j.humov.2010.11.012; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Wansink B, 2006, INT J OBESITY, V30, P871, DOI 10.1038/sj.ijo.0803217; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Waugh C, 2008, MOTIV EMOTION, V32, P323, DOI 10.1007/s11031-008-9104-2; WILF M, 2013, FRONT PSYCHOL, V4, P1; WMO, 2012, CENTR COMM RES INV H	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84643	10.1371/journal.pone.0084643	http://dx.doi.org/10.1371/journal.pone.0084643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367684	Green Published, gold			2022-12-25	WOS:000328740300152
J	Sivakumar, PM; Moritsugu, N; Obuse, S; Isoshima, T; Tashiro, H; Ito, Y				Sivakumar, Ponnurengam Malliappan; Moritsugu, Nozomi; Obuse, Sei; Isoshima, Takashi; Tashiro, Hideo; Ito, Yoshihiro			Novel Microarrays for Simultaneous Serodiagnosis of Multiple Antiviral Antibodies	PLOS ONE			English	Article							ANTIGEN MICROARRAYS; PHOTOIMMOBILIZED MICROARRAY; INFECTIOUS-DISEASES; ASSAY SYSTEM; REAGENTS; PHOTOPHORES; POLYMER; AZIDES; CELLS; ARRAY	We developed an automated diagnostic system for the detection of virus-specific immunoglobulin Gs (IgGs) that was based on a microarray platform. We compared efficacies of our automated system with conventional enzyme immunoassays (EIAs). Viruses were immobilized to microarrays using a radical cross-linking reaction that was induced by photo-irradiation. A new photoreactive polymer containing perfluorophenyl azide (PFPA) and poly(ethylene glycol) methacrylate was prepared and coated on plates. Inactivated measles, rubella, mumps, Varicella-Zoster and recombinant Epstein-Barr viruse antigen were added to coated plates, and irradiated with ultraviolet light to facilitate immobilization. Virus-specific IgGs in healthy human sera were assayed using these prepared microarrays and the results obtained compared with those from conventional EIAs. We observed high correlation (0.79-0.96) in the results between the automated microarray technique and EIAs. The microarray-based assay was more rapid, involved less reagents and sample, and was easier to conduct compared with conventional EIA techniques. The automated microarray system was further improved by introducing reagent storage reservoirs inside the chamber, thereby conserving the use of expensive reagents and antibodies. We considered the microarray format to be suitable for rapid and multiple serological diagnoses of viral diseases that could be developed further for clinical applications.	[Sivakumar, Ponnurengam Malliappan; Moritsugu, Nozomi; Obuse, Sei; Isoshima, Takashi; Tashiro, Hideo; Ito, Yoshihiro] RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan; [Tashiro, Hideo; Ito, Yoshihiro] Consonal Biotechnol Co Ltd, Funabashi, Chiba, Japan; [Ito, Yoshihiro] RIKEN, Ctr Emergent Matter Sci, Emergent Bioengn Mat Res Team, Wako, Saitama, Japan	RIKEN; RIKEN	Ito, Y (corresponding author), RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan.	y-ito@riken.jp	Isoshima, Takashi/S-5421-2017; Ito, Yoshihiro/F-4370-2012; Ito, Yoshihiro/T-1095-2019	Isoshima, Takashi/0000-0002-3421-036X; Ito, Yoshihiro/0000-0002-1154-253X; Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596	Japan Society for the Promotion of Science [22220009]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was sopported by Japan Society for the Promotion of Science KAKENHI Grant Number 22220009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacarese-Hamilton T, 2004, J APPL MICROBIOL, V96, P10, DOI 10.1046/j.1365-2672.2003.02111.x; BAYLEY H, 1978, BIOCHEMISTRY-US, V17, P2414, DOI 10.1021/bi00605a025; Blencowe A, 2005, SOFT MATTER, V1, P178, DOI 10.1039/b501989c; Caelen I, 2002, LANGMUIR, V18, P2463, DOI 10.1021/la0113217; Cismas C, 2008, TETRAHEDRON LETT, V49, P1336, DOI 10.1016/j.tetlet.2007.12.083; Desmet C, 2011, ANALYST, V136, P2918, DOI 10.1039/c1an15121e; Di Cristina M, 2010, NAT PROTOC, V5, P1932, DOI 10.1038/nprot.2010.161; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; Hashimoto M, 2008, EUR J ORG CHEM, V2008, P2513, DOI 10.1002/ejoc.200701069; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Ito Y, 2006, BIOMATERIALS, V27, P2502, DOI 10.1016/j.biomaterials.2005.11.030; Ito Y, 2005, BIOMATERIALS, V26, P211, DOI 10.1016/j.biomaterials.2004.02.019; Ito Y, 2003, BIOMATERIALS, V24, P3021, DOI 10.1016/S0142-9612(03)00134-0; Ito Y, 2012, J BIOTECHNOL, V161, P414, DOI 10.1016/j.jbiotec.2012.07.196; Jaaskelainen AJ, 2009, J VIROL METHODS, V160, P167, DOI 10.1016/j.jviromet.2009.05.013; Kanoh N, 2006, CHEM-ASIAN J, V1, P789, DOI 10.1002/asia.200600208; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; Liang M, 2010, ACS NANO, V4, P403, DOI 10.1021/nn9011237; Matsudaira T, 2008, BIOTECHNOL PROGR, V24, P1384, DOI 10.1002/btpr.63; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Nakashima H, 2006, J AM CHEM SOC, V128, P15092, DOI 10.1021/ja066479y; Ohyama K., 2005, ALLERGOL INT, V54, P627, DOI [DOI 10.2332/ALLERGOLINT.54.627, 10.2332/allergolint.54.627]; Papp K, 2012, METHODS MOL BIOL, V815, P175, DOI 10.1007/978-1-61779-424-7_14; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; SCHNAPP KA, 1993, BIOCONJUGATE CHEM, V4, P172, DOI 10.1021/bc00020a010; Sharma S, 2005, J NANOSCI NANOTECHNO, V5, P235, DOI 10.1166/jnn.2005.030; To Y, 2007, ACTA BIOMATER, V3, P1024, DOI 10.1016/j.actbio.2007.05.010; Tsuzuki S, 2009, BIOTECHNOL BIOENG, V102, P700, DOI 10.1002/bit.22102; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Wadia PP, 2011, METHODS MOL BIOL, V723, P81, DOI 10.1007/978-1-61779-043-0_7; Yang P, 2013, CHEM REV, V113, P5547, DOI 10.1021/cr300246p; Zhao Y, 2012, LANGMUIR, V28, P6328, DOI 10.1021/la300281q	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81726	10.1371/journal.pone.0081726	http://dx.doi.org/10.1371/journal.pone.0081726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367491	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300011
J	Zheng, YH; Li, FD; Tian, C; Ren, HL; Du, J; Li, HH				Zheng, Yue-Hong; Li, Fang-Da; Tian, Cui; Ren, Hua-Liang; Du, Jie; Li, Hui-Hua			Notch gamma-Secretase Inhibitor Dibenzazepine Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in ApoE Knockout Mice by Multiple Mechanisms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CARDIAC FIBROSIS; T-LYMPHOCYTES; EXPRESSION; INFLAMMATION; RECEPTORS; CYTOKINES; RESPONSES; MEMBRANE; DISEASE	Abdominal aortic aneurysm (AAA) is a life-threatening aortic disease in the elderly. Activation of Notch1 pathway plays a critical role in the development of AAA, but the underlying mechanisms remain poorly understood. In the present study, we explored the mechanisms by which Notch1 activation regulates angiotensin II (Ang II)-induced AAA formation and evaluated the therapeutic potential of a new Notch.-secretase inhibitor, dibenzazepine (DBZ), for the treatment of AAA. Apolipoprotein E knockout (Apo E-/-) mice infused for 4 weeks with Ang II (1000 ng/kg/min, IP) using osmotic mini-pumps were received an intraperitoneal injection of either vehicle or 1 mg/kg/d DBZ. Notch1 signaling was activated in AAA tissue from both Ang II-infused Apo E-/- mice and human undergoing AAA repair in vivo, with increased expression of Notch intracellular domain (NICD) and its target gene Hes1, and this effect was effectively blocked by DBZ. Moreover, infusion of Ang II markedly increased the incidence and severity of AAA in Apo E-/- mice. In contrast, inhibition of Notch activation by DBZ prevented AAA formation in vivo. Furthermore, DBZ markedly prevented Ang II-stimulated accumulation of macrophages and CD4(+) T cells, and ERK-mediated angiogenesis, simultaneously reversed Th2 response, in vivo. In conclusion, these findings provide new insight into the multiple mechanisms of Notch signaling involved in AAA formation and suggest that.-secretase inhibitor DBZ might be a novel therapeutic drug for treating AAAS.	[Zheng, Yue-Hong; Li, Fang-Da; Ren, Hua-Liang] Peking Union Med Hosp, Dept Vasc Surg, Beijing, Peoples R China; [Tian, Cui; Du, Jie; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci,Beijing AnZhen Hosp, Beijing Key Lab Cardiovasc Dis Related Metab, Key Lab Remodeling Related Cardiovasc Dis,Dept Ph, Beijing, Peoples R China; [Tian, Cui; Du, Jie; Li, Hui-Hua] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Zheng, YH (corresponding author), Peking Union Med Hosp, Dept Vasc Surg, Beijing, Peoples R China.	yuehongzheng@yahoo.com; hhli1995@yahoo.com			Natural Science Foundation of China [81270390, 81025001]; 973 program [2012CB517802]; Chang Jiang Scholar Program; Beijing High-level Talents Program (HL) [PH20110507]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Chang Jiang Scholar Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing High-level Talents Program (HL)	This work was supported by grants from the Natural Science Foundation of China (81270390 and 81025001), 973 program (2012CB517802), Chang Jiang Scholar Program and the Beijing High-level Talents Program (HL, PH20110507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bennett J Claude, 2008, Arthritis Rheum, V58, pS53, DOI 10.1002/art.23045; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Cheng CY, 2012, STEM CELL RES, V9, P9, DOI 10.1016/j.scr.2012.02.005; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; de La Coste A, 2005, J IMMUNOL, V174, P2730, DOI 10.4049/jimmunol.174.5.2730; Dees C, 2011, ARTHRITIS RHEUM-US, V63, P1396, DOI 10.1002/art.30254; Dong X, 2011, PLOS ONE, V4, P18481, DOI DOI 10.1371/J0URNAL.P0NE.0018481.PUBMED:21526177; Fischer S, 2001, EUR J PHARMACOL, V411, P231, DOI 10.1016/S0014-2999(00)00915-8; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hans CP, 2012, ARTERIOSCL THROM VAS, V32, P3012, DOI 10.1161/ATVBAHA.112.254219; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; HERRON GS, 1991, ARTERIOSCLER THROMB, V11, P1667, DOI 10.1161/01.ATV.11.6.1667; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Klein LW, 2009, JACC-CARDIOVASC INTE, V2, P136, DOI 10.1016/j.jcin.2008.09.012; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Ocana E, 2003, ATHEROSCLEROSIS, V170, P39, DOI 10.1016/S0021-9150(03)00282-X; Ozasa Y, 2013, HYPERTENS RES, V36, P859, DOI 10.1038/hr.2013.52; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Piggott K, 2011, CIRCULATION, V123, P309, DOI 10.1161/CIRCULATIONAHA.110.936203; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Yang K, 2012, AM J HYPERTENS, V25, P994, DOI 10.1038/ajh.2012.74; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Zhang JD, 2012, CIRC RES, V110, P1604, DOI 10.1161/CIRCRESAHA.111.261768; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	36	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83310	10.1371/journal.pone.0083310	http://dx.doi.org/10.1371/journal.pone.0083310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358274	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700117
J	Rodrigue-Way, A; Caron, V; Bilodeau, S; Keil, S; Hassan, M; Levy, E; Mitchell, GA; Tremblay, A				Rodrigue-Way, Amelie; Caron, Veronique; Bilodeau, Stephanie; Keil, Sarah; Hassan, Meryl; Levy, Emile; Mitchell, Grant A.; Tremblay, Andre			Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPAR gamma/PGC-1 alpha pathway and Insig1/2 expression in hepatocytes	FASEB JOURNAL			English	Article						HMG-CoA reductase; hexarelin; Insig-1/2; SREBP-2	HMG-COA REDUCTASE; ELEMENT-BINDING PROTEIN; HORMONE-RELEASING PEPTIDE; PPAR-GAMMA; DIRECT PHOSPHORYLATION; GHRELIN RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; DEGRADATION; METABOLISM	The scavenger receptor CD36 plays a central role in lipid metabolism by promoting macrophage cholesterol efflux with the potential to reduce atherosclerotic lesions. However, the effect of CD36 on de novo cholesterol synthesis is not known. Here, we describe the cellular mechanism by which CD36 activation induces cholesterol depletion in HepG2 cells. Using the CD36 ligand hexarelin, we found a rapid phosphorylation of HMG-CoA reductase Ser-872 in treated cells, resulting in inactivation of the rate-limiting enzyme in sterol synthesis. Degradation of HMG-CoA reductase by the ubiquitin-proteasome pathway was also enhanced by hexarelin, through an increased recruitment of the anchor proteins insulin-induced gene (Insig)-1 and Insig-2. Genes encoding key enzymes involved in cholesterol synthesis and under the control of transcription factor sterol regulatory element-binding protein (SREBP)-2 remained unresponsive to sterol depletion, due to retention of the SREBP-2 escort protein Scap by Insig-1/2. Insig1 and Insig2 gene expression was also increased through activation of nuclear receptor peroxisome-proliferator activating receptor gamma (PPAR gamma) by CD36, which lifted the inhibitory effect of PPAR gamma 1 Ser-84 phosphorylation. Recruitment of coactivator peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC1 alpha) to activated AMPK alpha was also promoted, resulting in PGC-1 alpha transcriptional activation through Sirt1-mediated deacetylation, increased recruitment of PPAR gamma, and up-regulation of Insig-1/2, revealing a regulatory role of CD36 on PGC-1 alpha signaling. Our data identify CD36 as a novel regulator of HMG-CoA reductase function and Insig-1/2 expression, 2 critical steps regulating cholesterol synthesis in hepatocytes.-Rodrigue-Way, A., Caron, V., Bilodeau, S., Keil, S., Hassan, M., Levy, E., Mitchell, G. A., Tremblay, A. Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPAR gamma/PGC-1 alpha pathway and Insig1/2 expression in hepatocytes.	[Rodrigue-Way, Amelie; Caron, Veronique; Bilodeau, Stephanie; Keil, Sarah; Hassan, Meryl; Levy, Emile; Mitchell, Grant A.; Tremblay, Andre] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Rodrigue-Way, Amelie; Bilodeau, Stephanie; Keil, Sarah; Mitchell, Grant A.; Tremblay, Andre] Univ Montreal, Fac Med, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada; [Mitchell, Grant A.] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Tremblay, Andre] Univ Montreal, Fac Med, Dept Obstet & Gynecol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal	Tremblay, A (corresponding author), Ste Justine Hosp, Res Ctr, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	andre.tremblay.1@umontreal.ca			Canadian Institutes of Health Research [MOP102645]; Canadian Diabetes Association [OG3-12-3827]; Natural Sciences and Engineering Research Council of Canada; Fondation de l'Hopital Ste-Justine	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fondation de l'Hopital Ste-Justine	The authors thank Pere Puigserver (Harvard Medical School, Boston, MA, USA) for the generous gift of GCN-5 plasmid. This research was supported by the Canadian Institutes of Health Research (grant MOP102645 to A. T.) and by the Canadian Diabetes Association (grant OG3-12-3827 to A. T.). A.R.-W. was supported by a doctoral award from the Natural Sciences and Engineering Research Council of Canada, S. B. by a doctoral award from the Fondation de l'Hopital Ste-Justine, and S. K. by the Faculte des Etudes Superieures de l'Universite de Montreal. The authors declare no conflicts of interest.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Demers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007728; Demers A, 2008, PPAR RES, V2008, DOI 10.1155/2008/364784; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Habets DDJ, 2009, BBA-MOL CELL BIOL L, V1791, P212, DOI 10.1016/j.bbalip.2008.12.009; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kast-Woelbern HR, 2004, J BIOL CHEM, V279, P23908, DOI 10.1074/jbc.M403145200; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; LEVY E, 1990, J LIPID RES, V31, P2009; Loirdighi N, 1997, AM J PHYSIOL-GASTR L, V273, pG62, DOI 10.1152/ajpgi.1997.273.1.G62; Luangrath V, 2008, ARTERIOSCL THROM VAS, V28, P1290, DOI 10.1161/ATVBAHA.107.161653; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Marleau Sylvie, 2005, FASEB J, V19, P1869; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Namgaladze D, 2013, CARDIOVASC RES, V98, P479, DOI 10.1093/cvr/cvt073; Rodrigue-Way A, 2007, ENDOCRINOLOGY, V148, P1009, DOI 10.1210/en.2006-0975; Sanchez M, 2013, ONCOGENE, V32, P117, DOI 10.1038/onc.2012.19; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Thielemans L, 2007, J RECEPT SIG TRANSD, V27, P309, DOI 10.1080/10799890701519587; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	46	24	27	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1910	1923		10.1096/fj.13-240168	http://dx.doi.org/10.1096/fj.13-240168			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371122				2022-12-25	WOS:000335344300035
J	Williams, CR; Gooch, JL				Williams, Clintoria R.; Gooch, Jennifer L.			Calcineurin A beta Regulates NADPH Oxidase ( Nox) Expression and Activity via Nuclear Factor of Activated T Cells ( NFAT) in Response to High Glucose*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Kidney; NADPH Oxidase; NFAT Transcription Factor; Oxidative Stress; Reactive Oxygen Species (ROS); High Glucose; Renal Hypertrophy	GROWTH-FACTOR-BETA; NAD(P)H OXIDASE; DIABETIC KIDNEY; RENAL INJURY; HYPERTROPHY; ALPHA; STREPTOZOTOCIN; NEPHROTOXICITY; ACCUMULATION; FIBRONECTIN	Background: Similar to its role in other organs, calcineurin is involved in kidney hypertrophy. However, downstream targets are not known. Results: The isoform of calcineurin (CnA) is required for hypertrophy and regulates Nox2 and Nox4 expression and function through NFAT. Conclusion: CnA and not CnA mediates hypertrophy in renal cells and is required for chronic ROS generation. Significance: Interaction of calcineurin and Nox signaling is essential for renal hypertrophy. Hypertrophy is an adaptive response that enables organs to appropriately meet increased functional demands. Previously, we reported that calcineurin (Cn) is required for glomerular and whole kidney hypertrophy in diabetic rodents (Gooch, J. L., Barnes, J. L., Garcia, S., and Abboud, H. E. (2003). Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am. J. Physiol. Renal Physiol. 284, F144-F154; Reddy, R. N., Knotts, T. L., Roberts, B. R., Molkentin, J. D., Price, S. R., and Gooch, J. L. (2011). Calcineurin A is required for hypertrophy but not matrix expansion in the diabetic kidney. J. Cell Mol. Med. 15, 414-422). Because studies have also implicated the reactive oxygen species-generating enzymes NADPH oxidases (Nox) in diabetic kidney responses, we tested the hypothesis that Nox and Cn cooperate in a common signaling pathway. First, we examined the role of the two main isoforms of Cn in hypertrophic signaling. Using primary kidney cells lacking a catalytic subunit of Cn (CnA(-/-) or CnA(-/-)), we found that high glucose selectively activates CnA, whereas CnA is constitutively active. Furthermore, CnA but not CnA mediates hypertrophy. Next, we found that chronic reactive oxygen species generation in response to high glucose is attenuated in CnA(-/-) cells, suggesting that Cn is upstream of Nox. Consistent with this, loss of CnA reduces basal expression and blocks high glucose induction of Nox2 and Nox4. Inhibition of nuclear factor of activated T cells (NFAT), a CnA-regulated transcription factor, decreases Nox2 and Nox4 expression, whereas NFAT overexpression increases Nox2 and Nox4, indicating that the CnA/NFAT pathway modulates Nox. These data reveal that the CnA/NFAT pathway regulates Nox and plays an important role in high glucose-mediated hypertrophic responses in the kidney.	[Williams, Clintoria R.; Gooch, Jennifer L.] Atlanta Vet Adm Med Ctr, Atlanta, GA 30033 USA; [Williams, Clintoria R.; Gooch, Jennifer L.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA 30322 USA	Emory University	Williams, CR (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,WMB 338, Atlanta, GA 30322 USA.	clricha@emory.edu			National Institutes of Health, NIDDK [T32 DK00756]; Department of Veterans Affairs MERIT award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007656] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs MERIT award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant T32 DK00756 (to C. R. W.). This work was also supported by a Department of Veterans Affairs MERIT award (to J. L. G.).	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Cheng HF, 2002, KIDNEY INT, V62, P929, DOI 10.1046/j.1523-1755.2002.00520.x; Cobbs SL, 2007, BIOCHEM BIOPH RES CO, V362, P288, DOI 10.1016/j.bbrc.2007.07.186; Djamali A, 2012, AM J TRANSPLANT, V12, P1997, DOI 10.1111/j.1600-6143.2012.04081.x; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; Gooch JL, 2004, AM J PATHOL, V165, P1755, DOI 10.1016/S0002-9440(10)63430-X; Gooch JL, 2006, AM J PHYSIOL-RENAL, V290, pF769, DOI 10.1152/ajprenal.00281.2005; Gooch JL, 2004, J AM SOC NEPHROL, V15, P1421, DOI 10.1097/01.ASN.0000128076.91545.BB; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Gooch JL, 2003, AM J PHYSIOL-RENAL, V284, pF144, DOI 10.1152/ajprenal.00158.2002; Gooch JL, 2001, J BIOL CHEM, V276, P42492, DOI 10.1074/jbc.M102994200; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011; Qi XM, 2011, INT IMMUNOPHARMACOL, V11, P1613, DOI 10.1016/j.intimp.2011.05.023; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reddy RN, 2011, J CELL MOL MED, V15, P414, DOI 10.1111/j.1582-4934.2009.00910.x; Roberts B, 2008, CELL CALCIUM, V43, P515, DOI 10.1016/j.ceca.2007.08.004; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; SEYERHANSEN K, 1983, KIDNEY INT, V23, P643, DOI 10.1038/ki.1983.71; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Williams CR, 2012, AM J PHYSIOL-CELL PH, V303, pC213, DOI 10.1152/ajpcell.00227.2011; Zhang R, 2009, HYPERTENSION, V53, P556, DOI 10.1161/HYPERTENSIONAHA.108.124594	33	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4896	4905		10.1074/jbc.M113.514869	http://dx.doi.org/10.1074/jbc.M113.514869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371139	Green Published, hybrid			2022-12-25	WOS:000331607900036
J	Balan, M; Pal, S				Balan, Murugabaskar; Pal, Soumitro			A Novel CXCR3-B Chemokine Receptor-induced Growth-inhibitory Signal in Cancer Cells Is Mediated through the Regulation of Bach-1 Protein and Nrf2 Protein Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chemokines; Heme Oxygenase; Nrf2; Nuclear Transport; Signal Transduction; Signaling	HEME OXYGENASE-1 GENE; HUMAN BREAST-CANCER; SPLICE VARIANT; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; CXC CHEMOKINES; MURINE MODEL; I-TAC; EXPRESSION; APOPTOSIS	Background: The chemokine receptor CXCR3-B initiates inhibitory signals. Results: CXCR3-B-mediated signal induced apoptosis and inhibited autophagy of breast cancer cells. It is associated with nuclear translocation of Bach-1, nuclear export of Nrf2, and down-regulation of HO-1. Conclusion: A CXCR3-B-mediated signal promotes apoptosis of breast cancer cells. Significance: Induction of CXCR3-B-mediated signaling can serve as a novel therapeutic approach for the treatment of breast cancer. Chemokines and their receptors play diverse roles in regulating cancer growth and progression. The receptor CXCR3 can have two splice variants with opposite functions. CXCR3-A promotes cell growth, whereas CXCR3-B mediates growth-inhibitory signals. However, the negative signals through CXCR3-B in cancer cells are not well characterized. In this study, we found that CXCR3-B-mediated signaling in MCF-7 and T47D breast cancer cells induced apoptotic cell death. Signals through CXCR3-B decreased the levels of the antiapoptotic proteins Bcl-2 and Bcl-xL and increased the expression of apoptotic cleaved poly(ADP-ribose) polymerase. Along with up-regulation in apoptosis, CXCR3-B signals were associated with a decrease in cellular autophagy with reduced levels of the autophagic markers Beclin-1 and LC3B. Notably, CXCR3-B down-regulated the expression of the cytoprotective and antiapoptotic molecule heme oxygenase-1 (HO-1) at the transcriptional level. There was an increased nuclear localization of Bach-1 and nuclear export of Nrf2, which are important negative and positive transcription factors, respectively, for HO-1 expression. We also observed that CXCR3-B promoted the activation of p38 MAPK and the inhibition of ERK-1/2. CXCR3-B could not induce cancer cell apoptosis at the optimal level when we either inhibited p38 activity or knocked down Bach-1. Further, CXCR3-B-induced apoptosis was down-regulated when we overexpressed HO-1. Together, our data suggest that CXCR3-B mediates a growth-inhibitory signal in breast cancer cells through the modulations of nuclear translocation of Bach-1 and Nrf2 and down-regulation of HO-1. We suggest that the induction of CXCR3-B-mediated signaling can serve as a novel therapeutic approach where the goal is to promote tumor cell apoptosis.	[Balan, Murugabaskar; Pal, Soumitro] Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Balan, Murugabaskar; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145, R21 CA172946]; NATIONAL CANCER INSTITUTE [R01CA131145, R21CA172946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA131145 and R21 CA172946 (to S. P.).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Alam J, 2000, J BIOL CHEM, V275, P27694; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banerjee P, 2012, J BIOL CHEM, V287, P32113, DOI 10.1074/jbc.M112.393140; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Datta D, 2008, J AM SOC NEPHROL, V19, P2437, DOI 10.1681/ASN.2008040394; Deng YT, 2010, MOL CARCINOGEN, V49, P141, DOI 10.1002/mc.20583; Gacci M, 2009, J UROLOGY, V181, P843, DOI 10.1016/j.juro.2008.10.063; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Jain K, 2013, AM J CANCER RES, V3, P251; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kelsen SG, 2004, AM J PHYSIOL-LUNG C, V287, pL584, DOI 10.1152/ajplung.00453.2003; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wu Q, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-3; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	39	39	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3126	3137		10.1074/jbc.M113.508044	http://dx.doi.org/10.1074/jbc.M113.508044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24366869	Green Published, hybrid			2022-12-25	WOS:000331368700003
J	Chen, XF; Radany, EH; Wong, P; Ma, SL; Wu, K; Wang, B; Wong, JYC				Chen, Xufeng; Radany, Eric H.; Wong, Patty; Ma, Shenglin; Wu, Kan; Wang, Bing; Wong, Jeffrey Y. C.			Suberoylanilide Hydroxamic Acid Induces Hypersensitivity to Radiation Therapy in Acute Myelogenous Leukemia Cells Expressing Constitutively Active FLT3 Mutants	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TOTAL-BODY IRRADIATION; DOUBLE-STRAND BREAKS; TOTAL-MARROW IRRADIATION; HISTONE DEACETYLASE INHIBITORS; INTERNAL TANDEM DUPLICATIONS; TYROSINE KINASE; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; CONDITIONING REGIMEN	Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) can increase radiosensitivity of acute myeloid leukemia (AML) cells through posttranslational modification of Rad51 protein responses and selective inhibition of the homology-directed repair (HDR) pathway. Our data also showed that AML cells with mutant, constitutively active FMS-like tyrosine kinase-3 (FLT3) were more radiation sensitive, caused by compromised non-homologous end joining (NHEJ) repair. Furthermore, SAHA-induced radiosensitization were enhanced in AML cells with expression of these FLT3 mutants. The results of this study suggest that SAHA, a recently approved HDI in clinical trials, may act as a candidate component for novel conditioning regimens to improve efficacy for AML patients undergoing radiotherapy and chemotherapy.	[Chen, Xufeng; Radany, Eric H.; Wong, Patty; Wong, Jeffrey Y. C.] City Hope Natl Med Ctr, Ctr Canc, Dept Radiat Oncol, Duarte, CA USA; [Ma, Shenglin; Wu, Kan; Wang, Bing] First People s Hosp, Hangzhou Med Grp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China	City of Hope; Hangzhou Medical College	Wong, JYC (corresponding author), City Hope Natl Med Ctr, Ctr Canc, Dept Radiat Oncol, Duarte, CA USA.	jwong@coh.org						Advani AS, 2005, CURR PHARM DESIGN, V11, P3449, DOI 10.2174/138161205774370807; Appelbaum FR, 2009, BEST PRACT RES CL HA, V22, P543, DOI 10.1016/j.beha.2009.10.004; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Blaise D, 2001, BLOOD, V97, P3669, DOI 10.1182/blood.V97.11.3669; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Brunet S, 2012, J CLIN ONCOL; Chen XF, 2012, MOL CANCER RES, V10, P1052, DOI 10.1158/1541-7786.MCR-11-0587; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; CLIFT RA, 1991, BLOOD, V77, P1660; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Dikomey E, 2000, INT J RADIAT ONCOL, V46, P481, DOI 10.1016/S0360-3016(99)00335-1; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; DUSENBERY KE, 1995, INT J RADIAT ONCOL, V31, P119, DOI 10.1016/0360-3016(94)00335-I; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Govedarovic N, 2011, J BUON, V16, P108; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; HAROUSSEAU JL, 1989, J CLIN ONCOL, V7, P45, DOI 10.1200/JCO.1989.7.1.45; Hine CM, 2012, MOL THER, V20, P347, DOI 10.1038/mt.2011.215; Kadia TM, 2010, BRIT J HAEMATOL, V150, P72, DOI 10.1111/j.1365-2141.2010.08211.x; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kuroda S, 2012, ACTA MED OKAYAMA, V66, P83; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Li L, 2011, BLOOD, V117, P3131, DOI 10.1182/blood-2010-05-286070; Li YZ, 2002, BIOCHEM BIOPH RES CO, V299, P697, DOI 10.1016/S0006-291X(02)02692-X; Majhail NS, 2008, BIOL BLOOD MARROW TR, V14, P282, DOI 10.1016/j.bbmt.2007.12.488; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Mukherjee B, 2010, SEMIN RADIAT ONCOL, V20, P250, DOI 10.1016/j.semradonc.2010.05.002; Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Raderschall E, 2002, CANCER RES, V62, P219; Romanski A, 2012, CELL CYCLE, V11, P3219, DOI 10.4161/cc.21565; Sak A, 2005, BRIT J CANCER, V92, P1089, DOI 10.1038/sj.bjc.6602457; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Sheikhha Mohammad Hasan, 2003, Hematol J, V4, P41, DOI 10.1038/sj.thj.6200224; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Shulman LN, 1998, INT J RADIAT ONCOL, V42, P1113, DOI 10.1016/S0360-3016(98)00344-7; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Wong JYC, 2013, INT J RADIAT ONCOL, V85, P148, DOI 10.1016/j.ijrobp.2012.03.033; Wong JYC, 2009, INT J RADIAT ONCOL, V73, P273, DOI 10.1016/j.ijrobp.2008.04.071; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84515	10.1371/journal.pone.0084515	http://dx.doi.org/10.1371/journal.pone.0084515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367670	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900051
J	Gronli, O; Kvamme, JM; Friborg, O; Wynn, R				Gronli, Ole; Kvamme, Jan Magnus; Friborg, Oddgeir; Wynn, Rolf			Zinc Deficiency Is Common in Several Psychiatric Disorders	PLOS ONE			English	Article							LOWER SERUM ZINC; MAJOR DEPRESSION; HUMAN HEALTH; SUPPLEMENTATION; HYPERPARATHYROIDISM; SYMPTOMS; BEHAVIOR; CALCIUM; METALS; COPPER	Background: Mounting evidence suggests a link between low zinc levels and depression. There is, however, little knowledge about zinc levels in older persons with other psychiatric diagnoses. Therefore, we explore the zinc status of elderly patients suffering from a wide range of psychiatric disorders. Methods: Clinical data and blood samples for zinc analyzes were collected from 100 psychogeriatric patients over 64 of age. Psychiatric and cognitive symptoms were assessed using the Montgomery and Aasberg Depression Rating Scale, the Cornell Scale for Depression in Dementia, the Mini-Mental State Examination, the Clockdrawing Test, clinical interviews and a review of medical records. In addition, a diagnostic interview was conducted using the Mini International Neuropsychiatric Interview instrument. The prevalence of zinc deficiency in patients with depression was compared with the prevalence in patients without depression, and the prevalence in a control group of 882 older persons sampled from a population study. Results: There was a significant difference in zinc deficiency prevalence between the control group (14.4%) and the patient group (41.0%) (chi(2) = 44.81, df = 1, p<0.001). In a logistic model with relevant predictors, zinc deficiency was positively associated with gender and with serum albumin level. The prevalence of zinc deficiency in the patient group was significantly higher in patients without depression (i.e. with other diagnoses) than in patients with depression as a main diagnosis or comorbid depression (chi(2) = 4.36, df = 1, p = 0.037). Conclusions: Zinc deficiency is quite common among psychogeriatric patients and appears to be even more prominent in patients suffering from other psychiatric disorders than depression. Limitations: This study does not provide a clear answer as to whether the observed differences represent a causal relationship between zinc deficiency and psychiatric symptoms. The blood sample collection time points varied in both the control group and the patient group. No data regarding zinc supplementation were collected.	[Gronli, Ole; Kvamme, Jan Magnus; Wynn, Rolf] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Gronli, Ole; Friborg, Oddgeir; Wynn, Rolf] Univ Hosp North Norway, Div Addict & Specialized Psychiat Serv, Tromso, Norway; [Friborg, Oddgeir] Univ Tromso, Fac Hlth Sci, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Gronli, O (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.	ole.gronli@unn.no	Wynn, Rolf/ABE-8410-2020; Kvamme, Jan-Magnus/AAH-6578-2020	Wynn, Rolf/0000-0002-2254-3343; Kvamme, Jan-Magnus/0000-0002-5029-1606; Friborg, Oddgeir/0000-0001-6629-0782	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	The study was funded with grand from Northern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Barnett JB, 2010, NUTR REV, V68, P30, DOI 10.1111/j.1753-4887.2009.00253.x; Baune BT, 2011, WORLD J BIOL PSYCHIA, V12, P28, DOI 10.3109/15622975.2011.603223; CHAN AK, 1995, ANN SURG, V222, P402, DOI 10.1097/00000658-199509000-00017; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Cichy A, 2009, PHARMACOL REP, V61, P1184, DOI 10.1016/S1734-1140(09)70182-3; Cieslik K, 2007, PHARMACOL REP, V59, P46; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Debnath M, 2011, TRANSL NEUROSCI, V2, P121, DOI 10.2478/s13380-011-0019-0; Dong J, 2008, J ALZHEIMERS DIS, V15, P443; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gronli O, 2013, PSYCHOSOMATICS, V54, P493, DOI 10.1016/j.psym.2012.10.008; HAINES A, 1991, CLIN CHIM ACTA, V198, P261, DOI 10.1016/0009-8981(91)90360-O; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Irmisch G, 2010, NEUROCHEM RES, V35, P1376, DOI 10.1007/s11064-010-0194-3; Jacka FN, 2012, J AFFECT DISORDERS, V141, P79, DOI 10.1016/j.jad.2012.02.018; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai J, 2012, J AFFECT DISORDERS, V136, pE31, DOI 10.1016/j.jad.2011.06.022; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Maes M, 1999, J AFFECT DISORDERS, V56, P189, DOI 10.1016/S0165-0327(99)00011-7; Maes M, 1997, BIOL PSYCHIAT, V42, P349, DOI 10.1016/S0006-3223(96)00365-4; Marcellini F, 2006, BIOGERONTOLOGY, V7, P339, DOI 10.1007/s10522-006-9048-4; Maserejian NN, 2012, J AFFECT DISORDERS, V136, P781, DOI 10.1016/j.jad.2011.09.039; Mlyniec K, 2012, PHARMACOL REP, V64, P567; Mlyniec K, 2012, PHARMACOL REP, V64, P249; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NARANG R L, 1991, Indian Journal of Physiology and Pharmacology, V35, P272; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Pedersen Reidar, 2007, Tidsskr Nor Laegeforen, V127, P1644; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad; Rahman MA, 2009, BIOL TRACE ELEM RES, V127, P102, DOI 10.1007/s12011-008-8230-8; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Rosa AO, 2003, BEHAV BRAIN RES, V144, P87, DOI 10.1016/S0166-4328(03)00069-X; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shcherbatykh I, 2007, J ALZHEIMERS DIS, V11, P191; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHORE D, 1984, J AM GERIATR SOC, V32, P892, DOI 10.1111/j.1532-5415.1984.tb00889.x; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Siwek M, 2010, J AFFECT DISORDERS, V126, P447, DOI 10.1016/j.jad.2010.04.024; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Stern RA, 1996, J NEUROPSYCH CLIN N, V8, P181; Szewczyk B, 2002, POL J PHARMACOL, V54, P681; Szewczyk B, 2011, PROG NEURO-PSYCHOPH, V35, P693, DOI 10.1016/j.pnpbp.2010.02.010; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Wang CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015349; Whittle N, 2009, AMINO ACIDS, V36, P147, DOI 10.1007/s00726-008-0195-6; Yanik M, 2004, BIOL TRACE ELEM RES, V98, P109, DOI 10.1385/BTER:98:2:109; Yary T, 2012, BIOL TRACE ELEM RES, V145, P286, DOI 10.1007/s12011-011-9202-y	57	44	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82793	10.1371/journal.pone.0082793	http://dx.doi.org/10.1371/journal.pone.0082793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367556	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900013
J	Vincent-Bugnas, S; Vitale, S; Mouline, CC; Khaali, W; Charbit, Y; Mahler, P; Precheur, I; Hofman, P; Maryanski, JL; Doglio, A				Vincent-Bugnas, Severine; Vitale, Sebastien; Mouline, Caroline C.; Khaali, Wafa; Charbit, Yves; Mahler, Patrick; Precheur, Isabelle; Hofman, Paul; Maryanski, Janet L.; Doglio, Alain			EBV Infection Is Common in Gingival Epithelial Cells of the Periodontium and Worsens during Chronic Periodontitis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYTOMEGALOVIRUS; NASOPHARYNGEAL CARCINOMA; JUNCTIONAL EPITHELIUM; IN-VITRO; REPLICATION; EXPRESSION; VIVO; DISEASES; TISSUES	An amplifying role for oral epithelial cells (ECs) in Epstein-Barr Virus (EBV) infection has been postulated to explain oral viral shedding. However, while lytic or latent EBV infections of oro/nasopharyngeal ECs are commonly detected under pathological conditions, detection of EBV-infected ECs in healthy conditions is very rare. In this study, a simple non-surgical tissue sampling procedure was used to investigate EBV infection in the periodontal epithelium that surrounds and attaches teeth to the gingiva. Surprisingly, we observed that the gingival ECs of the periodontium (pECs) are commonly infected with EBV and may serve as an important oral reservoir of latently EBV-infected cells. We also found that the basal level of epithelial EBV-infection is significantly increased in chronic periodontitis, a common inflammatory disease that undermines the integrity of tooth-supporting tissues. Moreover, the level of EBV infection was found to correlate with disease severity. In inflamed tissues, EBV-infected pECs appear to be prone to apoptosis and to produce larger amounts of CCL20, a pivotal inflammatory chemokine that controls tissue infiltration by immune cells. Our discovery that the periodontal epithelium is a major site of latent EBV infection sheds a new light on EBV persistence in healthy carriers and on the role of this ubiquitous virus in periodontitis. Moreover, the identification of this easily accessible site of latent infection may encourage new approaches to investigate and monitor other EBV-associated disorders.	[Vincent-Bugnas, Severine; Khaali, Wafa; Maryanski, Janet L.; Doglio, Alain] Univ Nice Sophia Antipolis, UFR Med, ImCelVir, URE004, F-06189 Nice, France; [Vincent-Bugnas, Severine; Charbit, Yves; Precheur, Isabelle] Univ Nice Sophia Antipolis, UFR Odontol, LSBV, URE001, F-06189 Nice, France; [Vincent-Bugnas, Severine; Charbit, Yves; Mahler, Patrick; Precheur, Isabelle] Ctr Hosp Univ Nice, Hop St Roch, Nice, France; [Vincent-Bugnas, Severine; Mouline, Caroline C.; Khaali, Wafa; Maryanski, Janet L.; Doglio, Alain] Ctr Hosp Univ Nice, Unite Therapie Cellulaire & Gen, Nice, France; [Vitale, Sebastien; Hofman, Paul] Ctr Hosp Univ Nice, INSERM, Cancerpole PACA, Biobanque IRCAN,Lab Pathol Clin & Expt, Nice, France; [Maryanski, Janet L.] INSERM, UMR 576, F-06202 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Doglio, A (corresponding author), Univ Nice Sophia Antipolis, UFR Med, ImCelVir, URE004, F-06189 Nice, France.	doglio@unice.fr	Hofman, Paul/P-7654-2018; DOGLIO, Alain/ABF-2581-2020; Precheur, Isabelle/Q-2047-2019	Hofman, Paul/0000-0003-0431-9353; Precheur, Isabelle/0000-0001-8134-0127; VINCENT-BUGNAS, Severine/0000-0001-7782-0558; DOGLIO, Alain/0000-0002-5456-5598	Centre Hospitalier de Nice [AOI] [2010-A01119-30]; Agence Nationale de Recherche contre le SIDA [ANRS] [10338]; Sidaction; Agence Nationale de Recherche [ANR-2010-RFCS-007-02]	Centre Hospitalier de Nice [AOI]; Agence Nationale de Recherche contre le SIDA [ANRS](ANRSFrench National Research Agency (ANR)); Sidaction; Agence Nationale de Recherche(French National Research Agency (ANR))	This work was supported in part by the Centre Hospitalier de Nice [AOI No2010-A01119-30 to SVB] and the Agence Nationale de Recherche contre le SIDA [ANRS No 10338 to AD]. SV was the recipient of a fellowship from Sidaction, and CCM was the recipient of a fellowship from the Agence Nationale de Recherche [ANR-2010-RFCS-007-02 to AD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Baumforth KRN, 2008, AM J PATHOL, V173, P195, DOI 10.2353/ajpath.2008.070845; Bollard CM, 2011, CYTOTHERAPY, V13, P518, DOI 10.3109/14653249.2011.561983; Borza CM, 2004, J VIROL, V78, P5007, DOI 10.1128/JVI.78.10.5007-5014.2004; Caton J, 2011, PHARMACOL RES, V63, P114, DOI 10.1016/j.phrs.2010.12.003; Chalabi M, 2010, MOL ORAL MICROBIOL, V25, P236, DOI 10.1111/j.2041-1014.2010.00571.x; Chang KP, 2008, CLIN CANCER RES, V14, P6979, DOI 10.1158/1078-0432.CCR-08-0090; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Contreras A, 1996, ORAL MICROBIOL IMMUN, V11, P381, DOI 10.1111/j.1399-302X.1996.tb00199.x; Das Sushma, 2012, J Oral Maxillofac Pathol, V16, P203, DOI 10.4103/0973-029X.98502; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hosokawa Y, 2002, CLIN EXP IMMUNOL, V128, P548, DOI 10.1046/j.1365-2249.2002.01865.x; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Jacobsen J, 1999, EUR J ORAL SCI, V107, P138, DOI 10.1046/j.0909-8836.1999.eos107210.x; Jarnbring F, 2002, J CLIN PERIODONTOL, V29, P1065, DOI 10.1034/j.1600-051X.2002.291203.x; Kato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071990; Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Lmbronito AV, 2008, J PERIODONTOL, V79, P2313, DOI [10.1902/jop.2008.070388, 10.1902/jop.2008.070388 ]; MADINIER I, 1992, BRIT J ORAL MAX SURG, V30, P237, DOI 10.1016/0266-4356(92)90266-L; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pollanen MT, 2003, PERIODONTOL 2000, V31, P12, DOI 10.1034/j.1600-0757.2003.03102.x; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; RAABTRAUB N, 1983, J VIROL, V48, P580, DOI 10.1128/JVI.48.3.580-590.1983; Rotola A, 2008, J CLIN PERIODONTOL, V35, P831, DOI 10.1111/j.1600-051X.2008.01301.x; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; SIXBEY JW, 1983, NATURE, V306, P480, DOI 10.1038/306480a0; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Teughels W, 2007, J DENT RES, V86, P1078, DOI 10.1177/154405910708601111; Tomaszewski-Flick MJ, 2007, VIRUS GENES, V35, P225, DOI 10.1007/s11262-007-0118-8; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tugizov S, 2007, J VIROL, V81, P5484, DOI 10.1128/JVI.00171-07; Tugizov SM, 2013, J VIROL, V87, P8179, DOI 10.1128/JVI.00443-13; Vitkov L, 2005, ULTRASTRUCT PATHOL, V29, P121, DOI 10.1080/01913120590916832; Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992; Wu YM, 2007, J CLIN MICROBIOL, V45, P3665, DOI 10.1128/JCM.00374-07; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zetterberg H, 1999, J GEN VIROL, V80, P457, DOI 10.1099/0022-1317-80-2-457	51	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e80336	10.1371/journal.pone.0080336	http://dx.doi.org/10.1371/journal.pone.0080336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367478	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900002
J	McLeod, EM; Guay, PJ; Taysom, AJ; Robinson, RW; Weston, MA				McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.; Weston, Michael A.			Buses, Cars, Bicycles and Walkers The Influence of the Type of Human Transport on the Flight Responses of Waterbirds	PLOS ONE			English	Article							BUFFER-ZONE DISTANCES; DOVES ZENAIDA-AURITA; RISK-TAKING BEHAVIOR; PERDIX-PERDIX L.; HUMAN DISTURBANCE; INITIATION DISTANCE; BALD EAGLES; INTERSPECIFIC VARIATION; THINORNIS-RUBRICOLLIS; ANTIPREDATOR BEHAVIOR	One way to manage disturbance to waterbirds in natural areas where humans require access is to promote the occurrence of stimuli for which birds tolerate closer approaches, and so cause fewer responses. We conducted 730 experimental approaches to 39 species of waterbird, using five stimulus types (single walker, three walkers, bicycle, car and bus) selected to mimic different human management options available for a controlled access, Ramsar-listed wetland. Across species, where differences existed (56% of 25 cases), motor vehicles always evoked shorter flight-initiation distances (FID) than humans on foot. The influence of stimulus type on FID varied across four species for which enough data were available for complete cross-stimulus analysis. All four varied FID in relation to stimuli, differing in 4 to 7 of 10 possible comparisons. Where differences occurred, the effect size was generally modest, suggesting that managing stimulus type (e. g. by requiring people to use vehicles) may have species-specific, modest benefits, at least for the waterbirds we studied. However, different stimulus types have different capacities to reduce the frequency of disturbance (i.e. by carrying more people) and vary in their capacity to travel around important habitat.	[McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Appl Ecol Res Grp, Melbourne, Vic 8001, Australia; [McLeod, Emily M.; Guay, Patrick-Jean; Taysom, Alice J.; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia; [Guay, Patrick-Jean] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Weston, Michael A.] Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Australia	Victoria University; Victoria University; Victoria University	Weston, MA (corresponding author), Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Australia.	mweston@deakin.edu.au		Robinson, Randall/0000-0001-8425-0709; McLeod, Emily/0000-0002-1811-6584	Melbourne Water; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme	Melbourne Water; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme	This research was funded by Melbourne Water, a Victoria University Fellowship and a Faculty of Health Engineering and Science Collaborative Research Grant Scheme to P. J. Guay (no URLs are available for these funding sources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2004, WILSON BULL, V116, P146, DOI 10.1676/03-110; Adams JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P742, DOI 10.1007/s00265-006-0218-9; Albrecht T, 2004, ETHOLOGY, V110, P603, DOI 10.1111/j.1439-0310.2004.00992.x; ANDERSEN DE, 1989, CONDOR, V91, P296, DOI 10.2307/1368307; Antos MJ, 2007, LANDSCAPE URBAN PLAN, V80, P173, DOI 10.1016/j.landurbplan.2006.07.005; Atwell JW, 2012, BEHAV ECOL, V23, P960, DOI 10.1093/beheco/ars059; Baines D, 2007, IBIS, V149, P56, DOI 10.1111/j.1474-919X.2007.00638.x; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Baudains TP, 2007, ANIM CONSERV, V10, P400, DOI 10.1111/j.1469-1795.2007.00126.x; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Boyer JS, 2006, AUST J ZOOL, V54, P363, DOI 10.1071/ZO05080; Bregnballe Thomas, 2009, Wildfowl, P115; BUEHLER DA, 1991, J WILDLIFE MANAGE, V55, P282, DOI 10.2307/3809151; BUICK AM, 1989, EMU, V89, P159, DOI 10.1071/MU9890159; Burger J, 1998, CONDOR, V100, P528, DOI 10.2307/1369719; BURGER J, 1988, AGGRESSIVE BEHAV, V14, P169, DOI 10.1002/1098-2337(1988)14:3<169::AID-AB2480140303>3.0.CO;2-D; Burger J, 2010, J WILDLIFE MANAGE, V74, P102, DOI 10.2193/2008-576; BURGER J, 1989, BEHAVIOUR, V111, P129, DOI 10.1163/156853989X00628; BURGER J, 1991, ENVIRON CONSERV, V18, P158, DOI 10.1017/S0376892900021743; Burhans DE, 2001, AUK, V118, P237, DOI 10.1642/0004-8038(2001)118[0237:ROSNCT]2.0.CO;2; Cardenas YL, 2005, ANIM BEHAV, V70, P1395, DOI 10.1016/j.anbehav.2005.03.022; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Christidis L, 2008, SYSTEMATICS TAXONOMY; Clucas B, 2012, AUK, V129, P8, DOI 10.1525/auk.2011.11121; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Eason P, 2010, ZOOL MIDDLE EAST, V51, P9, DOI 10.1080/09397140.2010.10638435; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fernandez-Juricic E, 2004, BIOL CONSERV, V117, P407, DOI 10.1016/j.biocon.2003.02.001; Fernandez-Juricic E, 2003, APPL ANIM BEHAV SCI, V84, P219, DOI 10.1016/j.applanim.2003.08.004; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2006, EVOL ECOL RES, V8, P731; Fernandez-Juricic E, 2009, AVIAN CONSERV ECOL, V4; Fox AD, 1997, J APPL ECOL, V34, P1, DOI 10.2307/2404842; FRASER JD, 1985, J WILDLIFE MANAGE, V49, P585, DOI 10.2307/3801676; Ge C, 2011, TRANSPORT RES D-TR E, V16, P604, DOI 10.1016/j.trd.2011.08.003; Geist C., 2005, Animal Biodiversity and Conservation, V28, P69; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Gould ML, 2004, EMU, V104, P267, DOI 10.1071/MU03033; Greeney HF, 2008, ORNITOL NEOTROP, V19, P213; Guay PJ, 2013, AUSTRAL ECOL, V38, P516, DOI 10.1111/j.1442-9993.2012.02441.x; Gulbransen D, 2006, ETHOLOGY, V112, P1056, DOI 10.1111/j.1439-0310.2006.01265.x; Heil L, 2007, BIODIVERS CONSERV, V16, P1009, DOI 10.1007/s10531-006-9040-y; Hess MF, 2005, J WILDLIFE MANAGE, V69, P650, DOI 10.2193/0022-541X(2005)069[0650:DIFCOP]2.0.CO;2; Holmes N, 2005, BIOL CONSERV, V126, P339, DOI 10.1016/j.biocon.2005.06.009; HOLMES TL, 1993, WILDLIFE SOC B, V21, P461; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Javurkova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032522; Karp DS, 2009, BIODIVERS CONSERV, V18, P3733, DOI 10.1007/s10531-009-9675-6; Kerbiriou C, 2009, J APPL ECOL, V46, P657, DOI 10.1111/j.1365-2664.2009.01646.x; Keyel AC, 2012, CONDOR, V114, P212, DOI 10.1525/cond.2012.110095; Kirby JS, 1993, DISTURBANCE WATERFOW, P53; Kitchen Kim, 2010, Australian Field Ornithology, V27, P1; KUSHLAN JA, 1979, J WILDLIFE MANAGE, V43, P756, DOI 10.2307/3808757; Lee Jeong-Eun, 2012, [Korean Journal of Ornithology, 한국조류학회지], V19, P93; Levey DJ, 2009, P NATL ACAD SCI USA, V106, P8959, DOI 10.1073/pnas.0811422106; Lin T, 2012, ECOL INDIC, V15, P30, DOI 10.1016/j.ecolind.2011.09.018; Lord A, 2001, BIOL CONSERV, V98, P233, DOI 10.1016/S0006-3207(00)00158-0; Loyn R. H., 2002, USE SEWAGE TREATMENT; Madsen J, 2009, POLAR RES, V28, P376, DOI 10.1111/j.1751-8369.2009.00120.x; Magige FJ, 2009, BIODIVERS CONSERV, V18, P1361, DOI 10.1007/s10531-008-9481-6; Martin CA, 2010, ANIM CONSERV, V13, P383, DOI 10.1111/j.1469-1795.2010.00349.x; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; Martin J, 2004, POLAR BIOL, V27, P775, DOI 10.1007/s00300-004-0653-x; Martinez-Abrain A, 2008, ENVIRON CONSERV, V35, P104, DOI 10.1017/S0376892908004748; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2010, J EVOLUTION BIOL, V23, P1689, DOI 10.1111/j.1420-9101.2010.02034.x; Moller AP, 2009, J EVOLUTION BIOL, V22, P2420, DOI 10.1111/j.1420-9101.2009.01850.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2013, BEHAV ECOL, V24, P267, DOI 10.1093/beheco/ars163; Moller AP, 2012, BEHAV ECOL, V23, P1030, DOI 10.1093/beheco/ars067; Moller AP, 2012, BEHAV ECOL, V23, P843, DOI 10.1093/beheco/ars040; Moller Anders Pape, 2011, Zoological Research, V32, P115, DOI 10.3724/SP.J.1141.2011.02115; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Mori Y, 2001, J ETHOL, V19, P115, DOI 10.1007/s101640170007; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Navedo JG, 2012, J COAST CONSERV, V16, P373, DOI 10.1007/s11852-012-0208-1; Osiejuk TS, 2007, WILDLIFE BIOL, V13, P11, DOI 10.2981/0909-6396(2007)13[11:FAFDII]2.0.CO;2; Ramsar Convention Bureau, 1984, P 2 C PART GRON NETH; Randler C, 2008, J ETHOL, V26, P309, DOI 10.1007/s10164-007-0062-z; Randler C, 2006, EUR J WILDLIFE RES, V52, P265, DOI 10.1007/s10344-006-0049-z; RODGERS JA, 1995, CONSERV BIOL, V9, P89, DOI 10.1046/j.1523-1739.1995.09010089.x; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Rodgers JA, 2003, WATERBIRDS, V26, P437, DOI 10.1675/1524-4695(2003)026[0437:BZDTPF]2.0.CO;2; Rodgers JA, 1997, WILDLIFE SOC B, V25, P139; Rodriguez-Prieto I, 2008, BEHAVIOUR, V145, P1125, DOI 10.1163/156853908784474489; Rodriguez-Prieto I, 2009, BEHAV ECOL, V20, P371, DOI 10.1093/beheco/arn151; Rollinson Daniel J., 2006, Australian Field Ornithology, V23, P29; Scales J, 2011, ETHOLOGY, V117, P887, DOI 10.1111/j.1439-0310.2011.01943.x; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Seltmann MW, 2012, ANIM BEHAV, V84, P889, DOI 10.1016/j.anbehav.2012.07.012; Smith PA, 2007, AUK, V124, P276, DOI 10.1642/0004-8038(2007)124[276:AVITBO]2.0.CO;2; Smith-Castro JR, 2010, J FIELD ORNITHOL, V81, P130, DOI 10.1111/j.1557-9263.2010.00270.x; St Clair JJH, 2010, BEHAV ECOL, V21, P1285, DOI 10.1093/beheco/arq144; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Steidl RJ, 1996, ECOL APPL, V6, P482, DOI 10.2307/2269385; Thiel D, 2007, J WILDLIFE MANAGE, V71, P1784, DOI 10.2193/2006-268; Tillmann JE, 2009, BEHAVIOUR, V146, P999, DOI 10.1163/156853908X398924; Tillmann JE, 2009, J ETHOL, V27, P117, DOI 10.1007/s10164-008-0094-z; Valcarcel A, 2009, BEHAV ECOL SOCIOBIOL, V63, P673, DOI 10.1007/s00265-008-0701-6; Wang Yan-Ping, 2004, Zoological Research, V25, P214; WATSON JW, 1993, WILDLIFE SOC B, V21, P171; Webb NV, 2005, CONDOR, V107, P178, DOI 10.1650/7607; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Weston MA, 2005, BIRD CONSERV INT, V15, P193; Weston MA, 2007, J COASTAL RES, V23, P569, DOI 10.2112/04-0151.1; Weston MA, 2011, J WILDLIFE MANAGE, V75, P252, DOI 10.1002/jwmg.7; Wood PB, 1999, J RAPTOR RES, V33, P97; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zuberogoitia I, 2010, ORNIS FENNICA, V87, P52	122	65	72	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82008	10.1371/journal.pone.0082008	http://dx.doi.org/10.1371/journal.pone.0082008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367498	Green Published, gold			2022-12-25	WOS:000328740300017
J	Wang, K; Bhandari, V; Chepustanova, S; Huber, G; O'Hara, S; O'Hern, CS; Shattuck, MD; Kirby, M				Wang, Kun; Bhandari, Vineet; Chepustanova, Sofya; Huber, Greg; O'Hara, Stephen; O'Hern, Corey S.; Shattuck, Mark D.; Kirby, Michael			Which Biomarkers Reveal Neonatal Sepsis?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SENSITIVE DIAGNOSTIC MARKER; NEUTROPHIL CD64 EXPRESSION; LATE-ONSET SEPSIS; PROCALCITONIN; INFECTION; COUNT; TESTS; SCORE	We address the identification of optimal biomarkers for the rapid diagnosis of neonatal sepsis. We employ both canonical correlation analysis (CCA) and sparse support vector machine (SSVM) classifiers to select the best subset of biomarkers from a large hematological data set collected from infants with suspected sepsis from Yale-New Haven Hospital's Neonatal Intensive Care Unit (NICU). CCA is used to select sets of biomarkers of increasing size that are most highly correlated with infection. The effectiveness of these biomarkers is then validated by constructing a sparse support vector machine diagnostic classifier. We find that the following set of five biomarkers capture the essential diagnostic information (in order of importance): Bands, Platelets, neutrophil CD64, White Blood Cells, and Segs. Further, the diagnostic performance of the optimal set of biomarkers is significantly higher than that of isolated individual biomarkers. These results suggest an enhanced sepsis scoring system for neonatal sepsis that includes these five biomarkers. We demonstrate the robustness of our analysis by comparing CCA with the Forward Selection method and SSVM with LASSO Logistic Regression.	[Wang, Kun; Chepustanova, Sofya; O'Hara, Stephen] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; O'Hern, Corey S.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, Div Perinatal Med, New Haven, CT 06510 USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT USA; [O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT USA; [Shattuck, Mark D.] CUNY City Coll, Benjamin Levich Inst, New York, NY 10031 USA; [Shattuck, Mark D.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Colorado State University; Yale University; Yale University; University of California System; University of California Santa Barbara; Yale University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)		kirby@math.colostate.edu	Shattuck, Mark D/F-5680-2015; Bhandari, Vineet/AAS-3365-2020; O'Hern, Corey S/I-3459-2014	Shattuck, Mark D/0000-0001-8473-2505; O'Hern, Corey S/0000-0002-8272-5640	DARPA (Space and Naval Warfare Systems Center Pacic) [N66001-11-1-4184]; Infectious Disease Supercluster, Colorado State University	DARPA (Space and Naval Warfare Systems Center Pacic); Infectious Disease Supercluster, Colorado State University	This material is based on work partially supported by DARPA (Space and Naval Warfare Systems Center Pacic) under Award No. N66001-11-1-4184 http://www.darpa.mil/. Additional support for this work was provided by Infectious Disease Supercluster, Colorado State University, 2012 seed grant http://infectiousdisease.colostate.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; BJORCK A, 1973, MATH COMPUT, V27, P579, DOI 10.2307/2005662; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cetinkaya M, 2009, J PERINATOL, V29, P225, DOI 10.1038/jp.2008.207; Chepustanova S, 2013, BAND SELECTION UNPUB; Choo Young Kwang, 2012, Korean J Pediatr, V55, P11, DOI 10.3345/kjp.2012.55.1.11; DASILVA O, 1995, PEDIATR INFECT DIS J, V14, P362; Davis Bruce H, 2005, Lab Hematol, V11, P137, DOI 10.1532/LH96.04077; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dilli D, 2010, J CLIN LAB ANAL, V24, P363, DOI 10.1002/jcla.20370; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Fendler WM, 2008, J PAEDIATR CHILD H, V44, P114, DOI 10.1111/j.1440-1754.2007.01230.x; Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004; Garcia-Prats JA, 2000, PEDIATRICS, V105, P523, DOI 10.1542/peds.105.3.523; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gonzalez BE, 2003, J PERINAT MED, V31, P60, DOI 10.1515/JPM.2003.009; Groselj-Grenc M, 2008, MEDIATORS INFLAMMATI; Groselj-Grenc M, 2009, INTENS CARE MED, V35, P1950, DOI 10.1007/s00134-009-1637-7; Hatherill M, 1999, ARCH DIS CHILD, V81, P417, DOI 10.1136/adc.81.5.417; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Klinger G, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.006; Kudawla M, 2008, J TROP PEDIATRICS, V54, P66, DOI 10.1093/tropej/fmm065; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Lopez Sastre Jose B, 2006, BMC Pediatr, V6, P16; Malik A, 2003, ARCH PEDIAT ADOL MED, V157, P511, DOI 10.1001/archpedi.157.6.511; Mangasarian OL, 1999, OPER RES LETT, V24, P15, DOI 10.1016/S0167-6377(98)00049-2; Mannan M A, 2010, Mymensingh Med J, V19, P259; Manucha V, 2002, J PAEDIATR CHILD H, V38, P459, DOI 10.1046/j.1440-1754.2002.00018.x; Mardia K.V, 1980, MULTIVARIATE ANAL; Milbrandt EB, 2006, CRIT CARE, V10, DOI 10.1186/cc4847; Monneret G, 1997, ACTA PAEDIATR, V86, P209, DOI 10.1111/j.1651-2227.1997.tb08870.x; Morik K, 1999, MACHINE LEARNING, PROCEEDINGS, P268; Morsy Amal A, 2008, Egypt J Immunol, V15, P53; Mussap M., 2012, J MATERN-FETAL NEO M, V25, P24; Naher B S, 2011, Bangladesh Med Res Counc Bull, V37, P40; Narasimha A, 2011, INDIAN J HEMATOL BLO, V27, P14, DOI 10.1007/s12288-010-0050-2; Ng A. Y., 2004, P 21 INT C MACH LEAR, P78, DOI DOI 10.1145/1015330.1015435; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Selimovic A, 2010, TURKISH J PEDIATR, V52, P139; Singh SA, 2003, J TROP PEDIATRICS, V49, P235, DOI 10.1093/tropej/49.4.235; Sjostrand K, 2012, J STAT SOFT IN PRESS; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Streimish I, 2013, AM J PERINATOLOGY; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tofallis C, 1999, J ROY STAT SOC D-STA, V48, P371, DOI 10.1111/1467-9884.00195; Vouloumanou EK, 2011, INTENS CARE MED, V37, P747, DOI 10.1007/s00134-011-2174-8; Waliullah S M, 2010, Mymensingh Med J, V19, P41; Zeitoun AAH, 2010, SCAND J INFECT DIS, V42, P299, DOI 10.3109/00365540903449832	58	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82700	10.1371/journal.pone.0082700	http://dx.doi.org/10.1371/journal.pone.0082700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367543	Green Published, gold			2022-12-25	WOS:000328740300058
J	Bao, B; Chen, YG; Zhang, L; Xu, YLN; Wang, X; Liu, J; Qu, W				Bao, Bin; Chen, Yan-Guang; Zhang, Lei; Xu, Yan Lin Na; Wang, Xin; Liu, Jian; Qu, Wei			Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues	PLOS ONE			English	Article							WILD VARIANT; RISK-FACTORS; INSULIN; ACCUMULATION; ACTIVATION; RATS; STABILIZATION; CONSTITUENTS; ADIPOCYTES; MICE	Obesity is a world-wide epidemic disease that correlates closely with type 2 diabetes and cardiovascular diseases. Obesity-induced chronic adipose tissue inflammation is now considered as a critical contributor to the above complications. Momordica charantia (bitter melon, BM) is a traditional Chinese food and well known for its function of reducing body weight gain and insulin resistance. However, it is unclear whether BM could alleviate adipose tissue inflammation caused by obesity. In this study, C57BL/6 mice were fed high fat diet (HFD) with or without BM for 12 weeks. BM-contained diets ameliorated HFD-induced obesity and insulin resistance. Histological and real-time PCR analysis demonstrated BM not only reduced macrophage infiltration into epididymal adipose tissues (EAT) and brown adipose tissues (BAT). Flow cytometry show that BM could modify the M1/M2 phenotype ratio of macrophages in EAT. Further study showed that BM lowered mast cell recruitments in EAT, and depressed pro-inflammatory cytokine monocyte chemotactic protein-1 (MCP-1) expression in EAT and BAT as well as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) expression in EAT. Finally, ELISA analysis showed BM-contained diets also normalized serum levels of the cytokines. In summary, in concert with ameliorated insulin resistance and fat deposition, BM reduced adipose tissue inflammation in diet-induced obese (DIO) mice.	[Bao, Bin; Chen, Yan-Guang; Zhang, Lei; Xu, Yan Lin Na; Wang, Xin; Liu, Jian; Qu, Wei] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China	Hefei University of Technology	Liu, J (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	liujian509@hfut.edu.cn; quweiok@gmail.com		Bao, Bin/0000-0001-7610-3426	National Natural Science Foundation of China [31171315]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100111110009, 20110111120025]; Anhui Provincial Natural Science Foundation of China [11040606M92]; Fundamental Research Funds for the Central Universities, China [2012HGCX0003, 2011HGB21280, 2012HGQC0019]; China Postdoctoral Science Foundation [2013M541817]; Foundation of Anhui Educational Committee [KJ2011A214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation of China(Natural Science Foundation of Anhui Province); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Anhui Educational Committee	This work was supported by a project from National Natural Science Foundation of China (Grant No. 31171315) (J.L.); Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100111110009 and 20110111120025 to J.L. and W. Q.); Anhui Provincial Natural Science Foundation of China (Grant No. 11040606M92 to J.L.); The Fundamental Research Funds for the Central Universities, China (Grant No. 2012HGCX0003 and 2011HGB21280, 2012HGQC0019 to J.L. and B. B.); China Postdoctoral Science Foundation (Grant No. 2013M541817 to B. B.); and Foundation of Anhui Educational Committee (Grant No.KJ2011A214 to W. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas MM, 2011, J LIPID RES, V52, P480, DOI 10.1194/jlr.M011338; Anila L, 2000, PHYTOTHER RES, V14, P592, DOI 10.1002/1099-1573(200012)14:8&lt;592::AID-PTR772&gt;3.0.CO;2-#; Chan LLY, 2005, J NUTR, V135, P2517, DOI 10.1093/jn/135.11.2517; Chang CI, 2011, FOOD CHEM, V125, P521, DOI 10.1016/j.foodchem.2010.09.043; Chao CY, 2011, J ETHNOPHARMACOL, V135, P156, DOI 10.1016/j.jep.2011.03.001; Chatzigeorgiou A, 2012, DIABETOLOGIA, V55, P2583, DOI 10.1007/s00125-012-2607-0; Chen PH, 2012, J NUTR, V142, P1197, DOI 10.3945/jn.112.159939; Chen QX, 2003, J NUTR, V133, P1088, DOI 10.1093/jn/133.4.1088; Chen QX, 2005, BRIT J NUTR, V93, P747, DOI 10.1079/BJN20051388; Cheng HL, 2012, EUR J PHARMACOL, V689, P241, DOI 10.1016/j.ejphar.2012.05.033; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Fang EF, 2011, CURR MOL MED, V11, P417; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gadang V, 2011, J MED FOOD, V14, P86, DOI 10.1089/jmf.2010.0010; Grover JK, 2004, J ETHNOPHARMACOL, V93, P123, DOI 10.1016/j.jep.2004.03.035; Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Harinantenaina L, 2006, CHEM PHARM BULL, V54, P1017, DOI 10.1248/cpb.54.1017; Huang HL, 2008, BRIT J NUTR, V99, P230, DOI 10.1017/S0007114507793947; Iseli TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062309; Keller AC, 2011, PHYTOMEDICINE, V19, P32, DOI 10.1016/j.phymed.2011.06.019; Klomann SD, 2010, BRIT J NUTR, V104, P1613, DOI 10.1017/S0007114510002680; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nerurkar PV, 2008, BRIT J NUTR, V100, P751, DOI 10.1017/S0007114508937430; Nerurkar PV, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-64; Nerurkar PV, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-34; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Overman A, 2011, INT J OBESITY, V35, P1165, DOI 10.1038/ijo.2010.272; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shih CC, 2008, DIABETES RES CLIN PR, V81, P134, DOI 10.1016/j.diabres.2008.04.023; Singh Jaipaul, 2011, Open Med Chem J, V5, P70, DOI 10.2174/1874104501105010070; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Sridhar MG, 2008, BRIT J NUTR, V99, P806, DOI 10.1017/S000711450783176X; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Wang J, 2011, DIABETES-METAB RES, V27, P919, DOI 10.1002/dmrr.1272; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P1064, DOI 10.1016/j.jnutbio.2010.09.004; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yu WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013973	45	52	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84075	10.1371/journal.pone.0084075	http://dx.doi.org/10.1371/journal.pone.0084075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358329	gold, Green Submitted, Green Published			2022-12-25	WOS:000328737700078
J	Chen, YJ; Thang, MWC; Chan, YT; Huang, YF; Ma, NAH; Yu, AL; Wu, CY; Hu, ML; Chiu, KP				Chen, Yen-Ju; Thang, Mike W. C.; Chan, Yu-Tzu; Huang, Yu-Feng; Ma, Nianhan; Yu, Alice L.; Wu, Chung-Yi; Hu, Miao-Lin; Chiu, Kuo Ping			Global Assessment of Antrodia cinnamomea-Induced MicroRNA Alterations in Hepatocarcinoma Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; FRUITING BODIES; DOWN-REGULATION; APOPTOSIS; INHIBITION; PI3K/AKT; SURVIVAL; PROTEIN; POLYSACCHARIDES; EXPRESSION	Recent studies have demonstrated a potent anticancer potential of medicinal fungus Antrodia cinnamomea, especially against hepatocarcinoma. These studies, however, were performed with prolonged treatments, and the early anticancer events remain missing. To probe the early anticancer mechanisms of A. cinnamomea, we treated SK-Hep-1 liver cancer cell with A. cinnamomea fruiting body extract for 2 and 4 hours, sequenced RNA samples with next-generation sequencing approach, and profiled the genome-wide miRNA and mRNA transcriptomes. Results unmistakably associated the early anticancer effect of A. cinnamomea fruiting body extract with a global downregulation of miRNAs which occurred solely in the A. cinnamomea fruiting body extract-treated SK-Hep-1 cells. Moreover, the inhibitory effect of A. cinnamomea fruiting body extract upon cancer miRNAs imposed no discrimination against any particular miRNA species, with oncomirs miR-21, miR-191 and major oncogenic clusters miR-17-92 and miR-106b-25 among the most severely downregulated. Western blotting further indicated a decrease in Drosha and Dicer proteins which play a key role in miRNA biogenesis, together with an increase of XRN2 known to participate in miRNA degradation pathway. Transcriptome profiling followed by GO and pathway analyses indicated that A. cinnamomea induced apoptosis, which was tightly associated with a downregulation of PI3K/AKT and MAPK pathways. Phosphorylation assay further suggested that JNK and c-Jun were closely involved in the apoptotic process. Taken together, our data indicated that the anticancer effect of A. cinnamomea can take place within a few hours by targeting multiple proteins and the miRNA system. A. cinnamomea indiscriminately induced a global downregulation of miRNAs by simultaneously inhibiting the key enzymes involved in miRNA maturation and activating XRN2 protein involved in miRNA degradation. Collapsing of the miRNA system together with downregulation of cell growth and survival pathways and activation of JNK signaling unleash the extrinsic and intrinsic apoptosis pathways, leading to the cancer cell death.	[Chen, Yen-Ju; Thang, Mike W. C.; Chan, Yu-Tzu; Huang, Yu-Feng; Wu, Chung-Yi; Chiu, Kuo Ping] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Yen-Ju] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Chan, Yu-Tzu; Yu, Alice L.] Chang Gung Mem Hosp, Ctr Stem Cell & Translat Canc Res, Tao Yuan, Taiwan; [Ma, Nianhan] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Yu, Alice L.] Chang Gung Univ, Tao Yuan, Taiwan; [Hu, Miao-Lin] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiu, Kuo Ping] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Chang Gung Memorial Hospital; National Central University; Chang Gung University; National Chung Hsing University; National Taiwan University	Chiu, KP (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chiukp@gate.sinica.edu.tw	Ma, Nianhan/AAB-9869-2020; Wu, Chung-Yi/K-8334-2018; Chiu, Kuo-Ping/AAG-8855-2020; Huang, Yu-Feng/Y-5818-2019; Thang, Wai Cheng/D-6097-2017	Ma, Nianhan/0000-0003-1800-2306; Chiu, Kuo-Ping/0000-0001-9144-0674; Huang, Yu-Feng/0000-0001-5822-3635; Thang, Wai Cheng/0000-0002-1480-3563; yu, alice/0000-0003-2444-0505	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This study is supported by research grant from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chiang LC, 2006, CANCER LETT, V237, P207, DOI 10.1016/j.canlet.2005.06.002; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Hsu YL, 2007, FOOD CHEM TOXICOL, V45, P1249, DOI 10.1016/j.fct.2007.01.005; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; Huang Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-48; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Li QH, 2013, INT J HEMATOL, V97, P617, DOI 10.1007/s12185-013-1317-9; Li W, 2012, MOL CELL BIOCHEM, V363, P135, DOI 10.1007/s11010-011-1166-x; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Liu CL, 2009, CHEM-BIOL INTERACT, V182, P165, DOI 10.1016/j.cbi.2009.08.017; Liu JJ, 2004, TOXICOL APPL PHARM, V201, P186, DOI 10.1016/j.taap.2004.05.016; Liu YM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/569737; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murata M, 2005, EXP CELL RES, V310, P140, DOI 10.1016/j.yexcr.2005.07.017; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Shan RJ, 1999, BLOOD, V94, P4067, DOI 10.1182/blood.V94.12.4067.424k12_4067_4076; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yang CM, 2009, J ETHNOPHARMACOL, V123, P407, DOI 10.1016/j.jep.2009.03.034	38	9	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82751	10.1371/journal.pone.0082751	http://dx.doi.org/10.1371/journal.pone.0082751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358224	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700030
J	Kersulyte, D; Rossi, M; Berg, DE				Kersulyte, Dangeruta; Rossi, Mirko; Berg, Douglas E.			Sequence Divergence and Conservation in Genomes of Helicobacter cetorum Strains from a Dolphin and a Whale	PLOS ONE			English	Article							INSERTION SPECIFICITY; GASTRIC PATHOGEN; FUNCTIONAL-ORGANIZATION; BACTERIAL COMMUNITIES; TRANSPOSABLE ELEMENT; IV SECRETION; PYLORI VACA; DISEASE; EVOLUTION; UREASE	Background and Objectives: Strains of Helicobacter cetorum have been cultured from several marine mammals and have been found to be closely related in 16 S rDNA sequence to the human gastric pathogen H. pylori, but their genomes were not characterized further. Methods: The genomes of H. cetorum strains from a dolphin and a whale were sequenced completely using 454 technology and PCR and capillary sequencing. Results: These genomes are 1.8 and 1.95 mb in size, some 7-26% larger than H. pylori genomes, and differ markedly from one another in gene content, and sequences and arrangements of shared genes. However, each strain is more related overall to H. pylori and its descendant H. acinonychis than to other known species. These H. cetorum strains lack cag pathogenicity islands, but contain novel alleles of the virulence-associated vacuolating cytotoxin (vacA) gene. Of particular note are (i) an extra triplet of vacA genes with <= 50% protein-level identity to each other in the 59 two-thirds of the gene needed for host factor interaction; (ii) divergent sets of outer membrane protein genes; (iii) several metabolic genes distinct from those of H. pylori; (iv) genes for an iron-cofactored urease related to those of Helicobacter species from terrestrial carnivores, in addition to genes for a nickel co-factored urease; and (v) members of the slr multigene family, some of which modulate host responses to infection and improve Helicobacter growth with mammalian cells. Conclusions: Our genome sequence data provide a glimpse into the novelty and great genetic diversity of marine helicobacters. These data should aid further analyses of microbial genome diversity and evolution and infection and disease mechanisms in vast and often fragile ocean ecosystems.	[Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Rossi, Mirko] Univ Helsinki, Fac Vet Med, Helsinki, Finland	Washington University (WUSTL); University of Helsinki	Berg, DE (corresponding author), Univ Calif, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.	berg@borcim.wustl.edu	Rossi, Mirko/D-1509-2012	Rossi, Mirko/0000-0002-1585-6384	US National Institutes of Health [R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R21AI088337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the US National Institutes of Health R21 AI078237 and R21 AI088337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Beinart RA, 2012, P NATL ACAD SCI USA, V109, pE3241, DOI 10.1073/pnas.1202690109; Blanchard Thomas G, 2012, Curr Protoc Microbiol, VChapter 8, DOI [10.1002/9780471729259.mc08b01s00, 10.1002/9780471729259.mc08b01s24]; Carter EL, 2011, P NATL ACAD SCI USA, V108, P13095, DOI 10.1073/pnas.1106915108; Chambers MG, 2013, J MOL BIOL, V425, P524, DOI 10.1016/j.jmb.2012.11.020; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Dailidiene D, 2004, J BACTERIOL, V186, P356, DOI 10.1128/JB.186.2.356-365.2004; Doolittle WF, 2012, CURR BIOL, V22, pR451, DOI 10.1016/j.cub.2012.04.034; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Dwivedi GR, 2013, NUCLEIC ACIDS RES, V41, P3274, DOI 10.1093/nar/gkt024; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Garcia-Amado MA, 2007, HELICOBACTER, V12, P553, DOI 10.1111/j.1523-5378.2007.00526.x; Goldman CG, 2009, RES VET SCI, V86, P18, DOI 10.1016/j.rvsc.2008.04.001; Goldman CG, 2009, VET MICROBIOL, V133, P287, DOI 10.1016/j.vetmic.2008.06.023; Goldman CG, 2011, VET MICROBIOL, V152, P138, DOI 10.1016/j.vetmic.2011.04.023; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harper CG, 2003, DIS AQUAT ORGAN, V57, P1, DOI 10.3354/dao057001; Harper CG, 2002, J CLIN MICROBIOL, V40, P4536, DOI 10.1128/JCM.40.12.4536-4543.2002; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kim IJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00037; LEE A, 1993, GASTROENTEROL CLIN N, V22, P21; Lehmann JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002468; Lehours P, 2011, MBIO, V2, DOI 10.1128/mBio.00239-11; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luo CH, 2012, J VIROL, V86, P8781, DOI 10.1128/JVI.00446-12; McLaughlin RW, 2011, DIS AQUAT ORGAN, V95, P241, DOI 10.3354/dao02364; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Putty K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059560; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; Roschitzki B, 2011, CURR MICROBIOL, V63, P239, DOI 10.1007/s00284-011-9969-2; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Sause WE, 2012, INFECT IMMUN, V80, P2286, DOI 10.1128/IAI.00312-12; Schott T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-534; SOLNICK JV, 2001, HELICOBACTER PYLORI, P39; Stoof J, 2008, ENVIRON MICROBIOL, V10, P2586, DOI 10.1111/j.1462-2920.2008.01681.x; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Uchiyama J, 2012, J VIROL, V86, P11400, DOI 10.1128/JVI.01767-12; Webster NS, 2008, ENVIRON MICROBIOL, V10, P3366, DOI 10.1111/j.1462-2920.2008.01734.x; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	62	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83177	10.1371/journal.pone.0083177	http://dx.doi.org/10.1371/journal.pone.0083177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358262	Green Published, gold			2022-12-25	WOS:000328737700051
J	Mesquita, RC; D'Souza, A; Bilfinger, TV; Galler, RM; Emanuel, A; Schenkel, SS; Yodh, AG; Floyd, TF				Mesquita, Rickson C.; D'Souza, Angela; Bilfinger, Thomas V.; Galler, Robert M.; Emanuel, Asher; Schenkel, Steven S.; Yodh, Arjun G.; Floyd, Thomas F.			Optical Monitoring and Detection of Spinal Cord Ischemia	PLOS ONE			English	Article							MOTOR-EVOKED-POTENTIALS; BLOOD-FLOW; INJURY; OUTCOMES; SURGERY; COMPLICATIONS; CATHETER; EPIDEMIOLOGY; PREVALENCE; WORLDWIDE	Spinal cord ischemia can lead to paralysis or paraparesis, but if detected early it may be amenable to treatment. Current methods use evoked potentials for detection of spinal cord ischemia, a decades old technology whose warning signs are indirect and significantly delayed from the onset of ischemia. Here we introduce and demonstrate a prototype fiber optic device that directly measures spinal cord blood flow and oxygenation. This technical advance in neurological monitoring promises a new standard of care for detection of spinal cord ischemia and the opportunity for early intervention. We demonstrate the probe in an adult Dorset sheep model. Both open and percutaneous approaches were evaluated during pharmacologic, physiological, and mechanical interventions designed to induce variations in spinal cord blood flow and oxygenation. The induced variations were rapidly and reproducibly detected, demonstrating direct measurement of spinal cord ischemia in real-time. In the future, this form of hemodynamic spinal cord diagnosis could significantly improve monitoring and management in a broad range of patients, including those undergoing thoracic and abdominal aortic revascularization, spine stabilization procedures for scoliosis and trauma, spinal cord tumor resection, and those requiring management of spinal cord injury in intensive care settings.	[Mesquita, Rickson C.; Schenkel, Steven S.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Mesquita, Rickson C.] Univ Estadual Campinas, Inst Phys, Campinas, SP, Brazil; [D'Souza, Angela; Emanuel, Asher; Floyd, Thomas F.] SUNY Stony Brook, Med Ctr, Dept Anesthesiol, Stony Brook, NY 11794 USA; [D'Souza, Angela; Floyd, Thomas F.] SUNY Stony Brook, Med Ctr, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Bilfinger, Thomas V.] SUNY Stony Brook, Med Ctr, Dept Surg, Stony Brook, NY 11794 USA; [Galler, Robert M.] SUNY Stony Brook, Med Ctr, Dept Neurosurg, Stony Brook, NY 11794 USA	University of Pennsylvania; Universidade Estadual de Campinas; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Floyd, TF (corresponding author), SUNY Stony Brook, Med Ctr, Dept Anesthesiol, Stony Brook, NY 11794 USA.	thomas.floyd@sbumed.org	Bilfinger, Thomas V./J-6392-2019; Mesquita, Rickson C/N-9119-2013; Floyd, Thomas/AAD-7818-2019	Mesquita, Rickson C/0000-0003-1945-6713; 	Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research; Stony Brook Medicine's School of Medicine; Stony Brook University Hospital; National Institutes of Health [R01-NS060653, P41-EB015893]; Sao Paulo Research Foundation [2012/02500-8]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060653] Funding Source: NIH RePORTER	Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research; Stony Brook Medicine's School of Medicine; Stony Brook University Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was partially supported by Stony Brook University's Department of Anesthesiology, Office of the Vice President for Research, and by Stony Brook Medicine's School of Medicine and Stony Brook University Hospital. This work was also supported by the National Institutes of Health (http://www.nih.gov) through R01-NS060653 (AGY) and P41-EB015893 (AGY), and the Sao Paulo Research Foundation (http://www.fapesp.br) through 2012/02500-8 (RCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Bockler D, 2007, EUR J VASC ENDOVASC, V34, P461, DOI 10.1016/j.ejvs.2007.04.030; Cermik TF, 2006, BRAIN RES, V1109, P54, DOI 10.1016/j.brainres.2006.06.044; Coffey RJ, 2010, STEREOT FUNCT NEUROS, V88, P337, DOI 10.1159/000319034; Costa P, 2007, SPINAL CORD, V45, P86, DOI 10.1038/sj.sc.3101934; De Visscher G, 2003, ADV EXP MED BIOL, V540, P37; Deiner S, 2010, SEMIN CARDIOTHORAC V, V14, P51, DOI 10.1177/1089253210362792; Deletis V, 2008, CLIN NEUROPHYSIOL, V119, P248, DOI 10.1016/j.clinph.2007.09.135; Dimar JR, 2010, J TRAUMA, V69, P1497, DOI 10.1097/TA.0b013e3181cc853b; Drazin D, 2011, J NEUROIMAGING; Duhamel G, 2009, MAGN RESON MED, V62, P430, DOI 10.1002/mrm.22015; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Etz CD, 2008, EUR J CARDIO-THORAC, V33, P1030, DOI 10.1016/j.ejcts.2008.01.069; Eucker SA, 2010, BRAIN RES, V1326, P128, DOI 10.1016/j.brainres.2010.02.059; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gradert TL, 2003, ANESTHESIOLOGY, V99, P188, DOI 10.1097/00000542-200307000-00029; Grady RE, 1999, ANESTH ANALG, V88, P388; Grono L R, 1966, Aust Vet J, V42, P58, DOI 10.1111/j.1751-0813.1966.tb04660.x; Gupta R, 2010, J AM ACAD ORTHOP SUR, V18, P210, DOI 10.5435/00124635-201004000-00004; Hong JY, 2010, SPINE, V35, pE912, DOI 10.1097/BRS.0b013e3181d8fabb; Hull EL, 1998, PHYS MED BIOL, V43, P3381, DOI 10.1088/0031-9155/43/11/014; Jia X, 2013, INJURY J INTENSIVE C, V28, P12, DOI [10.1177/0885066611403270, DOI 10.1177/0885066611403270]; Kakinohana M, 2008, J ANESTH, V22, P304, DOI 10.1007/s00540-008-0633-3; KAPLAN BJ, 1987, NEUROSURGERY, V21, P668, DOI 10.1227/00006123-198711000-00012; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; LESSER RP, 1986, ANN NEUROL, V19, P22, DOI 10.1002/ana.410190105; Luchtel DL, 1998, BIOTECH HISTOCHEM, V73, P291, DOI 10.3109/10520299809141123; Mahmoud M, 2010, ANESTHESIOLOGY, V112, P1364, DOI 10.1097/ALN.0b013e3181d74f55; Mesquita R. C., 2011, PHIL T R SOC A, V369, P4358, DOI DOI 10.1098/RSTA.2011.0302.PUBMED:22006897; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P1173, DOI 10.1364/BOE.1.001173; Messe SR, 2008, NEUROCRIT CARE, V9, P344, DOI 10.1007/s12028-008-9104-9; Modi Hitesh N, 2009, Spine (Phila Pa 1976), V34, pE896, DOI 10.1097/BRS.0b013e3181b40d4f; Moomiaie RMA, 2007, J CARDIOVASC SURG, V48, P103; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pastorelli F, 2011, EUR SPINE J, V20, P105, DOI 10.1007/s00586-011-1756-z; Patil CG, 2008, SPINAL CORD, V46, P375, DOI 10.1038/sj.sc.3102155; Ratajczak-Enselme M, 2009, EUR J PHARM BIOPHARM, V72, P54, DOI 10.1016/j.ejpb.2008.11.003; Reames DL, 2011, SPINE, V36, P1484, DOI 10.1097/BRS.0b013e3181f3a326; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Simonovich M, 2008, SPINE, V33, P2495, DOI 10.1097/BRS.0b013e3181859a92; ter Wolbeek C, 2010, THORAC CARDIOV SURG, V58, P260, DOI 10.1055/s-0030-1249904; Ture H, 2010, ANAESTHESIA, V65, P473, DOI 10.1111/j.1365-2044.2010.06309.x; Utzinger U, 2003, J BIOMED OPT, V8, P121, DOI 10.1117/1.1528207; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; VANOOSTERHOUT NFM, 1995, AM J PHYSIOL-HEART C, V269, pH725, DOI 10.1152/ajpheart.1995.269.2.H725; Wang AC, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09145; Wang HW, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2743082; Wheatley RG, 2001, BRIT J ANAESTH, V87, P47, DOI 10.1093/bja/87.1.47; Wilson B. C., 1990, FUTURE DIRECTIONS AP, P219; Wilson JR, 2011, NEUROTHERAPEUTICS, V8, P187, DOI 10.1007/s13311-011-0027-3; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	53	27	27	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83370	10.1371/journal.pone.0083370	http://dx.doi.org/10.1371/journal.pone.0083370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358279	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700122
J	Prunskaite-Hyyrylainen, R; Shan, JD; Railo, A; Heinonen, KM; Miinalainen, I; Yan, WY; Shen, BR; Perreault, C; Vainio, SJ				Prunskaite-Hyyrylainen, Renata; Shan, Jingdong; Railo, Antti; Heinonen, Krista M.; Miinalainen, Ilkka; Yan, Wenying; Shen, Bairong; Perreault, Claude; Vainio, Seppo J.			Wnt4, a pleiotropic signal for controlling cell polarity, basement membrane integrity, and antimullerian hormone expression during oocyte maturation in the female follicle	FASEB JOURNAL			English	Article						premature ovarian failure; sex determination; cell polarity; ovarian development	ANTI-MULLERIAN HORMONE; OVARIAN FAILURE; DUCT REGRESSION; NEST BREAKDOWN; PATHWAYS; MUTATION; PROLIFERATION; DEFICIENCY; GENES; FOXL2	Wnt4 is a key signal that channels the developmental fate of the indifferent mammalian gonad toward the ovary, but whether Wnt4 has later roles during ovary development remains unknown. To investigate this, we inactivated the Wnt4 gene by crossing Amhr2Cre and doxycycline-inducible Rosa(rtTA)-knock-in Cre mice with mice carrying a floxed Wnt4 allele and used a novel Wnt4(mCherry)-knock-in mouse. In these models, ovarian folliculogenesis was compromised, and female fertility was severely reduced, and Wnt4 deficiency eventually led to premature ovarian failure. These anomalies were associated with cell polarity defects in the follicle. Within the follicle, laminin and type IV collagen assembled ectopic basement membrane-like structures, the cell adherens junction components N-cadherin and beta-catenin lost their polarized expression pattern, and expression of the gap junction protein connexin 43 was reduced by similar to 30% when compared with that of the controls. Besides these changes, expression of antimullerian hormone (Amh) was inhibited in the absence of Wnt4 signaling in vivo. Consistent with this, Wnt4 signaling up-regulated Amh gene expression in KK1 cells in vitro. Thus, Wnt4 signaling is necessary during maturation of the ovarian follicles, where it coordinates expression of Amh, cell survival, and polarized organization of the follicular cells.-Prunskaite-Hyyrylainen, R., Shan, J., Railo, A., Heinonen, K. M., Miinalainen, I., Yan, W., Shen, B., Perreault, C., Vainio, S. J. Wnt4, a pleiotropic signal for controlling cell polarity, basement membrane integrity, and antimullerian hormone expression during oocyte maturation in the female follicle.	[Prunskaite-Hyyrylainen, Renata; Shan, Jingdong; Railo, Antti; Miinalainen, Ilkka; Yan, Wenying; Vainio, Seppo J.] Univ Oulu, Dept Med Biochem & Mol Biol, Inst Biomed, Oulu Ctr Cell Matrix Res, FIN-90220 Oulu, Finland; [Prunskaite-Hyyrylainen, Renata; Shan, Jingdong; Railo, Antti; Miinalainen, Ilkka; Yan, Wenying; Vainio, Seppo J.] Univ Oulu, Dev Biol Lab, Bioctr Oulu, FIN-90220 Oulu, Finland; [Heinonen, Krista M.; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Heinonen, Krista M.; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Heinonen, Krista M.] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Yan, Wenying; Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China	University of Oulu; University of Oulu; Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); Soochow University - China	Vainio, SJ (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, Dev Biol Lab, Aapistie 5,POB 5000, FIN-90220 Oulu, Finland.	seppo.vainio@oulu.fi	Yan, Wenying/G-9951-2017; Shen, Bairong/W-1254-2019; Yan, Wenying/N-7542-2014; Heinonen, Krista M/G-9769-2016; Shen, Bairong/E-6431-2012; Perreault, Claude/A-7220-2008	Yan, Wenying/0000-0001-5016-575X; Shen, Bairong/0000-0003-2899-1531; Yan, Wenying/0000-0001-5016-575X; Heinonen, Krista M/0000-0002-2410-4432; Shen, Bairong/0000-0003-2899-1531; Perreault, Claude/0000-0001-9453-7383; Miinalainen, Ilkka/0000-0002-3922-3442; Prunskaite-Hyyrylainen, Renata/0000-0001-5453-2983; Vainio, Seppo/0000-0001-9319-3566	Academy of Finland [206038, 121647, 250900, 260056]; Centre of Excellence grant of the Academy of Finland [251314]; Sigrid Juselius; Novonordisk; Finnish Cancer Research Foundations; European Community [FP7-HEALTH-F5-2012-INNOVATION-1 EURenOmics 305608]; Ministry of Education, China; Orion-Farmos Research Foundation; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Fonden [NNF11OC1014597] Funding Source: researchfish	Academy of Finland(Academy of Finland); Centre of Excellence grant of the Academy of Finland; Sigrid Juselius(Sigrid Juselius Foundation); Novonordisk(Novo Nordisk); Finnish Cancer Research Foundations; European Community(European Commission); Ministry of Education, China(Ministry of Education, China); Orion-Farmos Research Foundation; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Dr. Richard R. Behringer (University of Texas M. D. Anderson Cancer Center, Houston, TX, USA) for his gift of the Amhr2-Cer-knock-in transgenic mice; H. Harkman, J. Kekolahti-Liias, J. Kujala, R. Vuento, T. Leinonen, and A. Viklund for excellent technical assistance; T. Jokela for taking part in the sampling of the Wnt4<SUP>W4mCh</SUP> specimens; H.-M. Lee and S. Murugan for analyzing the Amh biding sites; and Dr. H. Peltoketo, Dr. T. Pikkarainen, and I. Pietila for discussions and critical comments. This work was supported by the Academy of Finland (grants 206038, 121647, 250900 and 260056); Centre of Excellence grant 2012-2017 of the Academy of Finland (grant 251314), the Sigrid Juselius, Novonordisk, and Finnish Cancer Research Foundations; and the European Community's Seventh Framework Programme (FP7/2007-2013; grant FP7-HEALTH-F5-2012-INNOVATION-1 EURenOmics 305608). The work of W.Y. was supported by a grant from the Ministry of Education, China. The work of R.P.-H. was supported by the Orion-Farmos Research Foundation and the Jalmari and Rauha Ahokas Foundation.	Arora P, 2011, OBSTET GYNAECOL, V13, P67, DOI 10.1576/toag.13.2.67.27648; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Caligioni C. S., 2009, CURR PROTOCOLS NEURO; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; Crisosto N, 2009, ENDOCRINE, V36, P339, DOI 10.1007/s12020-009-9227-6; Da Silva-Buttkus P, 2008, J CELL SCI, V121, P3890, DOI 10.1242/jcs.036400; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Heinonen KM, 2011, BLOOD, V118, P5163, DOI 10.1182/blood-2011-04-350553; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; IGUCHI T, 1990, BIOL REPROD, V43, P478, DOI 10.1095/biolreprod43.3.478; Irving-Rodgers HF, 2004, MATRIX BIOL, V23, P207, DOI 10.1016/j.matbio.2004.05.008; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kaku U, 2008, ENDOCR J, V55, P1043, DOI 10.1507/endocrj.K08E-102; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kuo FT, 2011, ENDOCRINOLOGY, V152, P3917, DOI 10.1210/en.2010-0989; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; Mora JM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096156; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Peltoketo H, 2010, ENDOCRINOLOGY, V151, P1872, DOI 10.1210/en.2009-0966; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Philibert P, 2011, FERTIL STERIL, V95, P2683, DOI 10.1016/j.fertnstert.2011.01.152; Piltonen T, 2005, HUM REPROD, V20, P1820, DOI 10.1093/humrep/deh850; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; Railo A, 2009, EXP CELL RES, V315, P2690, DOI 10.1016/j.yexcr.2009.06.021; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schulte DM, 2007, GENE EXPR PATTERNS, V7, P72, DOI 10.1016/j.modgep.2006.05.009; Shan JD, 2010, DIFFERENTIATION, V79, P57, DOI 10.1016/j.diff.2009.08.006; Shan J, 2009, GENESIS, V47, P782, DOI 10.1002/dvg.20566; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Veiga-Lopez A, 2012, FERTIL STERIL, V97, P748, DOI 10.1016/j.fertnstert.2011.12.028; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Wang C, 2010, ENDOCRINOLOGY, V151, P2319, DOI 10.1210/en.2009-1489; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094	51	39	42	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1568	1581		10.1096/fj.13-233247	http://dx.doi.org/10.1096/fj.13-233247			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371124				2022-12-25	WOS:000335344300006
J	Das, A; Durrant, D; Koka, S; Salloum, FN; Xi, L; Kukreja, RC				Das, Anindita; Durrant, David; Koka, Saisudha; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.			Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice POTENTIAL ROLE OF ATTENUATED OXIDATIVE STRESS AND ALTERED CONTRACTILE PROTEIN EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Cardiovascular Disease; Diabetes; mTOR; Oxidative Stress; Proteomics	CARBONIC-ANHYDRASE-II; ISCHEMIA-REPERFUSION INJURY; INDUCED INSULIN-RESISTANCE; SIROLIMUS-ELUTING STENTS; RENAL TUBULAR-ACIDOSIS; COENZYME-A SYNTHESIS; CARDIOMYOCYTE HYPERTROPHY; DILATED CARDIOMYOPATHY; MYOCARDIAL-ISCHEMIA; NEBULETTE MUTATIONS	Background: Elevated mammalian target of rapamycin (mTOR) signaling contributes to diabetic complications. Results: mTOR inhibitor, rapamycin, improves metabolic status and cardiac function, attenuates oxidative stress, and alters antioxidant and contractile protein expression in type 2 diabetic mice. Conclusion: Rapamycin may provide metabolic and cardiac benefits in diabetic mice. Significance: mTOR inhibition may be an attractive novel therapeutic strategy for diabetes-related complications. Elevated mammalian target of rapamycin (mTOR) signaling contributes to the pathogenesis of diabetes, with increased morbidity and mortality, mainly because of cardiovascular complications. Because mTOR inhibition with rapamycin protects against ischemia/reperfusion injury, we hypothesized that rapamycin would prevent cardiac dysfunction associated with type 2 diabetes (T2D). We also investigated the possible mechanisms and novel protein targets involved in rapamycin-induced preservation of cardiac function in T2D mice. Adult male leptin receptor null, homozygous db/db, or wild type mice were treated daily for 28 days with vehicle (5% DMSO) or rapamycin (0.25 mg/kg, intraperitoneally). Cardiac function was monitored by echocardiography, and protein targets were identified by proteomics analysis. Rapamycin treatment significantly reduced body weight, heart weight, plasma glucose, triglyceride, and insulin levels in db/db mice. Fractional shortening was improved by rapamycin treatment in db/db mice. Oxidative stress as measured by glutathione levels and lipid peroxidation was significantly reduced in rapamycin-treated db/db hearts. Rapamycin blocked the enhanced phosphorylation of mTOR and S6, but not AKT in db/db hearts. Proteomic (by two-dimensional gel and mass spectrometry) and Western blot analyses identified significant changes in several cytoskeletal/contractile proteins (myosin light chain MLY2, myosin heavy chain 6, myosin-binding protein C), glucose metabolism proteins (pyruvate dehydrogenase E1, PYGB, Pgm2), and antioxidant proteins (peroxiredoxin 5, ferritin heavy chain 1) following rapamycin treatment in db/db heart. These results show that chronic rapamycin treatment prevents cardiac dysfunction in T2D mice, possibly through attenuation of oxidative stress and alteration of antioxidants and contractile as well as glucose metabolic protein expression.	[Das, Anindita; Durrant, David; Koka, Saisudha; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University	Das, A (corresponding author), Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, 1101 East Marshall St,Sangar Hall,Rm 7020B, Richmond, VA 23298 USA.	adas2@vcu.edu	Das, Anindita/K-8003-2013; Salloum, Fadi N/C-2391-2008; Xi, Lei/A-3078-2008	Das, Anindita/0000-0003-4422-7277; Salloum, Fadi N/0000-0002-8947-9315; Xi, Lei/0000-0002-7569-3329	National Institutes of Health [RO1 HL51045, HL79424, HL93685, HL118808]; American Heart Association [10SDG3770011]; Virginia Commonwealth University [UL1RR031990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118808, R01HL051045, R01HL093685, R01HL079424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Virginia Commonwealth University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL51045, HL79424, HL93685, and HL118808 (to R. C. K.). This work was also supported by American Heart Association National Scientist Development Grant 10SDG3770011 (to F. N. S.) and A. D. Williams' Fund of Virginia Commonwealth University Grant UL1RR031990 (to A. D.).	Adameova A, 2014, HEART FAIL REV, V19, P25, DOI 10.1007/s10741-013-9378-7; Alvarez BV, 2007, J PHYSIOL-LONDON, V579, P127, DOI 10.1113/jphysiol.2006.123638; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Baumgart D, 2007, J AM COLL CARDIOL, V50, P1627, DOI 10.1016/j.jacc.2007.07.035; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brickson S, 2007, AM J PHYSIOL-HEART C, V292, pH1747, DOI 10.1152/ajpheart.01037.2006; Brown BF, 2012, CAN J PHYSIOL PHARM, V90, P1599, DOI 10.1139/y2012-142; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Chong ZZ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-45; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; de Waha A, 2011, CLIN RES CARDIOL, V100, P561, DOI 10.1007/s00392-010-0278-8; Deepa Sathyaseelan S, 2013, J Biochem Pharmacol Res, V1, P114; Dillmann W H, 1986, Adv Exp Med Biol, V194, P469; DILLMANN WH, 1980, DIABETES, V29, P579, DOI 10.2337/diab.29.7.579; Drake JC, 2010, AM J PHYSIOL-REG I, V299, pR1546, DOI 10.1152/ajpregu.00337.2010; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Ernande L, 2012, ARCH CARDIOVASC DIS, V105, P218, DOI 10.1016/j.acvd.2011.11.007; Essop MF, 2011, CARDIOVASC J AFR, V22, P175, DOI 10.5830/CVJA-2010-058; French CJ, 2011, CORONARY ARTERY DIS, V22, P479, DOI 10.1097/MCA.0b013e32834a3a71; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gao G, 2011, AM J PHYSIOL-HEART C, V300, pH1583, DOI 10.1152/ajpheart.01084.2010; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Howarth FC, 2011, EXP PHYSIOL, V96, P325, DOI 10.1113/expphysiol.2010.055574; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jiang JH, 2013, INT J MOL MED, V31, P825, DOI 10.3892/ijmm.2013.1280; Jweied EE, 2005, AM J PHYSIOL-HEART C, V289, pH2478, DOI 10.1152/ajpheart.00638.2005; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Koka S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0249-5; KUKREJA RC, 1992, CARDIOVASC RES, V26, P641, DOI 10.1093/cvr/26.7.641; Lai LW, 1998, J CLIN INVEST, V101, P1320, DOI 10.1172/JCI1694; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Matsushima S, 2006, AM J PHYSIOL-HEART C, V291, pH2237, DOI 10.1152/ajpheart.00427.2006; Mellor KM, 2013, CLIN EXP PHARMACOL P, V40, P56, DOI 10.1111/j.1440-1681.2012.05738.x; Mellor KM, 2011, AUTOPHAGY, V7, P1263, DOI 10.4161/auto.7.10.17148; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136; Omiya S, 2009, J MOL CELL CARDIOL, V46, P59, DOI 10.1016/j.yjmcc.2008.09.714; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Rajapakse AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019237; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroeder MA, 2013, P NATL ACAD SCI USA, V110, pE958, DOI 10.1073/pnas.1213471110; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Shin YJ, 2011, CURR EYE RES, V36, P1116, DOI 10.3109/02713683.2011.614372; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stohr A, 2013, J MOL CELL CARDIOL, V63, P189, DOI 10.1016/j.yjmcc.2013.07.011; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Xi L, 2011, J CELL MOL MED, V15, P2512, DOI 10.1111/j.1582-4934.2011.01257.x; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250	74	112	117	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4145	4160		10.1074/jbc.M113.521062	http://dx.doi.org/10.1074/jbc.M113.521062			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371138	hybrid, Green Published			2022-12-25	WOS:000331403800028
J	Choi, JS; Baek, HM; Kim, S; Kim, MJ; Youk, JH; Moon, HJ; Kim, EK; Nam, YK				Choi, Ji Soo; Baek, Hyeon-Man; Kim, Suhkmann; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung; Nam, Youn Ki			Magnetic Resonance Metabolic Profiling of Breast Cancer Tissue Obtained with Core Needle Biopsy for Predicting Pathologic Response to Neoadjuvant Chemotherapy	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; GENE-EXPRESSION; CHOLINE METABOLISM; DIAGNOSIS; SIGNATURES; SURVIVAL; MARKERS; WOMEN; PROGNOSIS	The purpose of this study was to determine whether metabolic profiling of core needle biopsy (CNB) samples using high-resolution magic angle spinning (HR-MAS) magnetic resonance spectroscopy (MRS) could be used for predicting pathologic response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer. After institutional review board approval and informed consent were obtained, CNB tissue samples were collected from 37 malignant lesions in 37 patients before NAC treatment. The metabolic profiling of CNB samples were performed by HR-MAS MRS. Metabolic profiles were compared according to pathologic response to NAC using the Mann-Whitney test. Multivariate analysis was performed with orthogonal projections to latent structure-discriminant analysis (OPLS-DA). Various metabolites including choline-containing compounds were identified and quantified by HR-MAS MRS in all 37 breast cancer tissue samples obtained by CNB. In univariate analysis, the metabolite concentrations and metabolic ratios of CNB samples obtained with HR-MAS MRS were not significantly different between different pathologic response groups. However, there was a trend of lower levels of phosphocholine/creatine ratio and choline-containing metabolite concentrations in the pathologic complete response group compared to the non-pathologic complete response group. In multivariate analysis, the OPLS-DA models built with HR-MAS MR metabolic profiles showed visible discrimination between the pathologic response groups. This study showed OPLS-DA multivariate analysis using metabolic profiles of pretreatment CNB samples assessed by HR-MAS MRS may be used to predict pathologic response before NAC, although we did not identify the metabolite showing statistical significance in univariate analysis. Therefore, our preliminary results raise the necessity of further study on HR-MAS MR metabolic profiling of CNB samples for a large number of cancers.	[Choi, Ji Soo; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Choi, Ji Soo] Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Div Magnet Resonance, Chungbuk, South Korea; [Baek, Hyeon-Man] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Dept Chem, Busan, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Chem Inst Funct Mat, Busan, South Korea; [Nam, Youn Ki] Agilent Technol Korea, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Basic Science Institute (KBSI); Pusan National University; Pusan National University	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885	Basic Science Research Program of the National Research Foundation of Korea; Ministry of Science, ICT&Future Planning, Republic of Korea [2013R1A1A3013165]	Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT&Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT&Future Planning, Republic of Korea (preparation of the manuscript. grant 2013R1A1A3013165). The funders had no role in study design, data collection and analysis, decision to publish, or or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Alvarado-Cabrero I, 2009, ANN DIAGN PATHOL, V13, P151, DOI 10.1016/j.anndiagpath.2009.02.003; Amat S, 2005, BREAST CANCER RES TR, V94, P255, DOI 10.1007/s10549-005-9008-8; Baek HM, 2008, MAGN RESON IMAGING, V26, P523, DOI 10.1016/j.mri.2007.10.002; Baek HM, 2009, RADIOLOGY, V251, P653, DOI 10.1148/radiol.2512080553; Bassett LW, 2007, RADIOL CLIN N AM, V45, P881, DOI 10.1016/j.rcl.2007.06.010; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Begley JKP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3132; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Cao MD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-39; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chang J, 1999, J CLIN ONCOL, V17, P3058, DOI 10.1200/JCO.1999.17.10.3058; Chen JH, 2011, NMR BIOMED, V24, P316, DOI 10.1002/nbm.1595; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051712; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellis P, 1998, J CLIN ONCOL, V16, P107, DOI 10.1200/JCO.1998.16.1.107; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jones RL, 2006, BRIT J CANCER, V94, P358, DOI 10.1038/sj.bjc.6602950; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; Katz-Brull R, 2002, CANCER RES, V62, P1966; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; MacKinnon N, 2012, METABOLOMICS, V8, P1026, DOI 10.1007/s11306-012-0398-4; Makris A, 1998, ANN ONCOL, V9, P1179, DOI 10.1023/A:1008400706949; Moestue SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-433; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prevos R, 2012, EUR RADIOL, V22, P2607, DOI 10.1007/s00330-012-2653-5; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Shin HJ, 2012, NMR BIOMED, V25, P1349, DOI 10.1002/nbm.2807; SINGER S, 1995, CANCER RES, V55, P5140; Sinha S, 2009, NMR BIOMED, V22, P3, DOI 10.1002/nbm.1270; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tripathi P, 2013, J PROTEOME RES, V12, P3519, DOI 10.1021/pr4004135; Tripathi P, 2012, INT J BIOCHEM CELL B, V44, P1852, DOI 10.1016/j.biocel.2012.06.025; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	56	37	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83866	10.1371/journal.pone.0083866	http://dx.doi.org/10.1371/journal.pone.0083866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367616	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900024
J	Lebrato, M; Molinero, JC; Cartes, JE; Lloris, D; Melin, F; Beni-Casadella, L				Lebrato, Mario; Molinero, Juan-Carlos; Cartes, Joan E.; Lloris, Domingo; Melin, Frederic; Beni-Casadella, Laia			Sinking Jelly-Carbon Unveils Potential Environmental Variability along a Continental Margin	PLOS ONE			English	Article							MASS DEPOSITION; DEEP-WATER; SEA; PYROSOMA; PHYTOPLANKTON; MEGAFAUNA; MORTALITY; RANGE; FLOOR; COLOR	Particulate matter export fuels benthic ecosystems in continental margins and the deep sea, removing carbon from the upper ocean. Gelatinous zooplankton biomass provides a fast carbon vector that has been poorly studied. Observational data of a large-scale benthic trawling survey from 1994 to 2005 provided a unique opportunity to quantify jelly-carbon along an entire continental margin in the Mediterranean Sea and to assess potential links with biological and physical variables. Biomass depositions were sampled in shelves, slopes and canyons with peaks above 1000 carcasses per trawl, translating to standing stock values between 0.3 and 1.4 mg C m(2) after trawling and integrating between 30,000 and 175,000 m(2) of seabed. The benthopelagic jelly-carbon spatial distribution from the shelf to the canyons may be explained by atmospheric forcing related with NAO events and dense shelf water cascading, which are both known from the open Mediterranean. Over the decadal scale, we show that the jelly-carbon depositions temporal variability paralleled hydroclimate modifications, and that the enhanced jelly-carbon deposits are connected to a temperature-driven system where chlorophyll plays a minor role. Our results highlight the importance of gelatinous groups as indicators of large-scale ecosystem change, where jelly-carbon depositions play an important role in carbon and energy transport to benthic systems.	[Lebrato, Mario; Molinero, Juan-Carlos] Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Biogeochem & Ecol, Kiel, Germany; [Lebrato, Mario] Scripps Inst Oceanog, Dept Geosci, San Diego, CA USA; [Cartes, Joan E.; Lloris, Domingo; Beni-Casadella, Laia] CSIC, Inst Ciencies Mar Barcelona, Barcelona, Spain; [Melin, Frederic] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of California System; University of California San Diego; Scripps Institution of Oceanography; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); European Commission Joint Research Centre; EC JRC ISPRA Site	Lebrato, M (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Biogeochem & Ecol, Kiel, Germany.	mlebrato13@gmail.com		MELIN, FREDERIC/0000-0003-4381-682X	European Project on Ocean Acidification (EPOCA); European Community [211384]; Kiel Cluster of Excellence "The Future Ocean" [D1067/87]	European Project on Ocean Acidification (EPOCA); European Community(European Commission); Kiel Cluster of Excellence "The Future Ocean"	This study was supported by the European Project on Ocean Acidification (EPOCA) funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. This work was also funded by the Kiel Cluster of Excellence "The Future Ocean" (D1067/87). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELLO P, 2002, SCI MAR, V66, P1, DOI DOI 10.3989/SCIMAR.2002.66S2; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; Billett DSM, 2006, LIMNOL OCEANOGR, V51, P2077, DOI 10.4319/lo.2006.51.5.2077; BOUCHER J, 1987, J MAR RES, V45, P133, DOI 10.1357/002224087788400891; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Canals M, 2013, PROG OCEANO IN PRESS; Carrasson M, 2002, MAR ECOL PROG SER, V241, P41, DOI 10.3354/meps241041; Cartes JE, 2009, PROG OCEANOGR, V82, P32, DOI 10.1016/j.pocean.2009.03.003; Cartes JE, 1998, MAR ECOL PROG SER, V171, P233, DOI 10.3354/meps171233; Cartes JE, 2004, DEEP-SEA RES PT I, V51, P263, DOI 10.1016/j.dsr.2003.10.001; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Condon R.H., 2011, ECOLOGY, V92, P1704, DOI [10.1890/11-0302.1, DOI 10.1890/11-0302.1]; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; COWPER TR, 1960, NATURE, V187, P878, DOI 10.1038/187878b0; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2833, DOI 10.1109/TGRS.2003.818020; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2861, DOI 10.1109/TGRS.2003.817682; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DELGADO M, 1990, Scientia Marina, V54, P169; Estrada M, 1999, J PLANKTON RES, V21, P1, DOI 10.1093/plankt/21.1.1; Fanelli E, 2011, DEEP-SEA RES PT I, V58, P98, DOI 10.1016/j.dsr.2010.12.005; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; FONT J, 1987, DEEP-SEA RES, V34, P1745, DOI 10.1016/0198-0149(87)90022-7; FRANQUEVILLE C, 1971, Tethys, V3, P11; Frost JR, 2012, HYDROBIOLOGIA, V690, P247, DOI 10.1007/s10750-012-1042-z; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; GRIFFIN DJG, 1970, NATURE, V226, P464, DOI 10.1038/226464a0; Harris PT, 2011, MAR GEOL, V285, P69, DOI 10.1016/j.margeo.2011.05.008; Henschke N, 2013, MAR ECOL PROG SER, V491, P165, DOI 10.3354/meps10450; Hofmann M, 2009, P NATL ACAD SCI USA, V106, P3017, DOI 10.1073/pnas.0813384106; HURLEY DE, 1959, NATURE, V183, P554, DOI 10.1038/183554a0; Lebrato M, 2009, LIMNOL OCEANOGR, V54, P1197, DOI 10.4319/lo.2009.54.4.1197; Lebrato M, 2013, LIMNOL OCEANOGR, V58, P1113, DOI 10.4319/lo.2013.58.3.1113; Lebrato M, 2012, HYDROBIOLOGIA, V690, P227, DOI 10.1007/s10750-012-1046-8; Lebrato M, 2011, LIMNOL OCEANOGR, V56, P1917, DOI 10.4319/lo.2011.56.5.1917; Lopez-Jurado JL, 2008, J MARINE SYST, V71, P303, DOI 10.1016/j.jmarsys.2007.03.007; Melin F, 2011, PROG OCEANOGR, V91, P229, DOI 10.1016/j.pocean.2010.12.001; Millot C, 1981, AM GEOPHYS UNION, V514; MILLS CE, 1993, B MAR SCI, V53, P194; MONNIOT C, 1966, CR ACAD SCI D NAT, V263, P368; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; PLOBERGER W, 1992, ECONOMETRICA, V60, P271, DOI 10.2307/2951597; Purcell J.E., 2001, DEV HYDROBIOL, P1; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Riaux-Gobin C, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68n17; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; ROE HSJ, 1990, PROG OCEANOGR, V24, P127, DOI 10.1016/0079-6611(90)90025-W; Tinta T, 2010, HYDROBIOLOGIA, V645, P179, DOI 10.1007/s10750-010-0223-x; Vargas-Yanez M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015306; Vazquez-Cuervo J, 2010, J CLIMATE, V23, P1047, DOI 10.1175/2009JCLI2839.1; Volpe G, 2007, REMOTE SENS ENVIRON, V107, P625, DOI 10.1016/j.rse.2006.10.017; West EJ, 2009, HYDROBIOLOGIA, V616, P151, DOI 10.1007/s10750-008-9586-7	55	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82070	10.1371/journal.pone.0082070	http://dx.doi.org/10.1371/journal.pone.0082070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367499	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000328740300018
J	Lindsey, PA; Barnes, J; Nyirenda, V; Pumfrett, B; Tambling, CJ; Taylor, WA; Rolfes, MT				Lindsey, Peter A.; Barnes, Jonathan; Nyirenda, Vincent; Pumfrett, Belinda; Tambling, Craig J.; Taylor, W. Andrew; Rolfes, Michael t'Sas			The Zambian Wildlife Ranching Industry: Scale, Associated Benefits, and Limitations Affecting Its Development	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; BUSHMEAT TRADE; CONSERVATION; IMPACTS; AFRICA; RAINFALL; ANTELOPE; DECLINE	The number and area of wildlife ranches in Zambia increased from 30 and 1,420 km 2 in 1997 to 177 and similar to 6,000 km(2) by 2012. Wild ungulate populations on wildlife ranches increased from 21,000 individuals in 1997 to similar to 91,000 in 2012, while those in state protected areas declined steeply. Wildlife ranching and crocodile farming have a turnover of similar to USD15.7 million per annum, compared to USD16 million from the public game management areas which encompass an area 29 times larger. The wildlife ranching industry employs 1,200 people (excluding jobs created in support industries), with a further similar to 1,000 individuals employed through crocodile farming. Wildlife ranches generate significant quantities of meat (295,000 kg/annum), of which 30,000 kg of meat accrues to local communities and 36,000 kg to staff. Projected economic returns from wildlife ranching ventures are high, with an estimated 20-year economic rate of return of 28%, indicating a strong case for government support for the sector. There is enormous scope for wildlife ranching in Zambia due to the availability of land, high diversity of wildlife and low potential for commercial livestock production. However, the Zambian wildlife ranching industry is small and following completion of field work for this study, there was evidence of a significant proportion of ranchers dropping out. The industry is performing poorly, due to inter alia: rampant commercial bushmeat poaching; failure of government to allocate outright ownership of wildlife to landowners; bureaucratic hurdles; perceived historical lack of support from the Zambia Wildlife Authority and government; a lack of a clear policy on wildlife ranching; and a ban on hunting on unfenced lands including game ranches. For the wildlife ranching industry to develop, these limitations need to be addressed decisively. These findings are likely to apply to other savanna countries with large areas of marginal land potentially suited to wildlife ranching.	[Lindsey, Peter A.] Panthera, Lion Program, New York, NY USA; [Lindsey, Peter A.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Barnes, Jonathan] Design & Dev Serv, Windhoek, Khomas Region, Namibia; [Nyirenda, Vincent] Zambia Wildlife Author, Chilanga, Lusaka Province, Zambia; [Pumfrett, Belinda] Kafue Trust, Lusaka, Lusaka Province, Zambia; [Tambling, Craig J.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, Eastern Cape, South Africa; [Taylor, W. Andrew] Univ Pretoria, Fac Vet Sci, Ctr Vet Wildlife Studies, ZA-0002 Pretoria, Gauteng, South Africa	University of Pretoria; Nelson Mandela University; University of Pretoria	Lindsey, PA (corresponding author), Panthera, Lion Program, New York, NY USA.	plindsey@panthera.org	Tambling, Craig/H-3554-2019; Sas-Rolfes, Michael t/ABC-7132-2020; Lindsey, Peter A/J-8368-2012	Tambling, Craig/0000-0001-9830-5985; Sas-Rolfes, Michael t/0000-0002-2220-6072; Lindsey, Peter A/0000-0002-9197-2897; Nyirenda, Vincent Raphael/0000-0002-3506-3912	Wildlife Producers Association of Zambia	Wildlife Producers Association of Zambia	Research was funded by the Wildlife Producers Association of Zambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVOLUTION INNOVATION; Barnat Jiri, 2009, Proceedings of the 2009 IEEE 15th International Conference on Parallel and Distributed Systems (ICPADS 2009), P34, DOI 10.1109/ICPADS.2009.50; Barnes J, 1998, THESIS U COLL LONDON; Barnes J, 1994, SUGGESTED CRITERIA S, P7; Barnes J, 2010, EC VALUATION IMPACT, P37; Barnes J, 2003, EPHEMERAL CITY CITE, P73; Barnett R, 2006, SPORT HUNTING SO AFR, P128; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; BOND I, 2004, PARKS TRANSITION BIO, P29; Carruthers Jane, 2008, Transactions of the Royal Society of South Africa, V63, P160; Child B., 2008, EVOLUTION INNOVATION, P103; Child Brian, 2009, P3; Child Brian, 2000, Conservation Biology Series (Dordrecht), V12, P335; Child BA, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-18; Child GFT, 1987, ZAMBEZIA, V14, P11; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Cousins JA, 2008, ECOL SOC, V13; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cumming DHM., 2004, PARKS TRANSITION BIO, P105; Davies R, 1997, STATUS PROSPECTS SUS; DNPWS, 1998, POL NAT PARKS WILDL; du P Bothma J., 2010, GAME RANCH MANAGEMEN, P979; du Toit R, 2004, REV WILDLIFE ISSUES, P67; Dunham KM, 2004, BIOL CONSERV, V117, P83, DOI 10.1016/S0006-3207(03)00267-2; Falkena H, 2003, GAME RANCH PROFITABI, P92; Frederick H, 2011, AERIAL SURVEY KAFUE, P71; Frederick H, 2013, AERIAL SURVEY REPORT, P30; Hamilton K, 2007, REAL EC IMPACT NATUR, P28; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Humavindu M, 2008, ESSAYS NAMIBIAN EC, P156; Jansen D, 1998, CATTLE WILDLIFE BOTH, P45; Kampamba G, 2005, MANAGEMENT GUIDELINE; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey P., 2013, REASONS WHY ZAMBIAN; Lindsey P, 2012, ILLEGAL HUNTING BUSH, P84; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, ORYX, V47, P41, DOI 10.1017/S0030605311001049; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P215, DOI 10.1007/978-1-4614-0902-1_12; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052458; MacKenzie John, 1988, EMPIRE NATURE HUNTIN; Manning I, 2011, THESIS U PRETORIA S, P209; Manning I., 2012, NAT RESOUR J, V52, P61; Martin R, 2007, POTENTIAL TOUR UNPUB, P58; MEISSNER HH, 1982, S AFR J WILDL RES, V12, P41; Mozambique Ministry of Tourism, 2004, STRAT PLAN DEV TOUR, V1; Murombedzi J.C., 2003, PRECOLONIAL COLONIAL; National Institute of Nutrition Hyderabad, 2006, ROL NUTR ENV TOX, P62; Price Waterhouse, 1994, LOWVELD CONSERVANCIE, P39; SAS Institute, 2000, JMPIN; Siamudaala V, 1997, REPORT GAME RANCHING; Simasiku P, 2008, IMPACT WILDLIFE MANA; Simukonda C, 2011, WET SEASON SURVEY AF; Simwanza H, 2004, AERIAL SURVEY LARGE; Simwanza H, 2004, AERIAL SURVEY ESTABL; Simwanza H, 2005, AERIAL SURVEY LARGE; Sinclair AR, 2009, WILDLIFE ECOLOGY CON, P334; Smith N, 2002, CHANGING LAND USE TR, P29; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; TAYLOR RD, 1987, ENVIRON MANAGE, V11, P327, DOI 10.1007/BF01867160; Thomas S, 2012, FINANCIAL MAIL  0406, P28; Thomson G, 2008, SHORT OVERVIEW REGIO, P24; Vinya R., 2011, PRLIMINARY STUDY DRI PRLIMINARY STUDY DRI; Watson FGR, HUMAN ENCRO IN PRESS; Wels H, 2003, PRIVATE WILDLIFE CON, P259; World Health Organization. Department of Reprodutive Health and Research, 2012, WHO REC PREV TREATM, P41; WTTC, 2021, TRAV TOUR EC IMP 202; WWF, 1987, QUOT SETT MAN, P43; Zambia Ministry of Finance, 2012, ANN EC REP 2011, P24; ZAWA, 2013, LIUW PLAIN NAT PARK	71	17	18	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81761	10.1371/journal.pone.0081761	http://dx.doi.org/10.1371/journal.pone.0081761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367493	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300012
J	Sanchez-Fernandez, G; Cabezudo, S; Garcia-Hoz, C; Tobin, AB; Mayor, F; Ribas, C				Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Tobin, Andrew B.; Mayor, Federico, Jr.; Ribas, Catalina			ERK5 Activation by Gq-Coupled Muscarinic Receptors Is Independent of Receptor Internalization and beta-Arrestin Recruitment	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN; TRAFFICKING; ENDOCYTOSIS; G-ALPHA(Q); PATHWAY; BETA-ARRESTIN-2; CELLS; GPCR	G-protein-coupled receptors (GPCRs) are known to activate both G protein- and beta-arrestin-dependent signalling cascades. The initiation of mitogen-activated protein kinase (MAPK) pathways is a key downstream event in the control of cellular functions including proliferation, differentiation, migration and apoptosis. Both G proteins and beta-arrestins have been reported to mediate context-specific activation of ERK1/2, p38 and JNK MAPKs. Recently, the activation of ERK5 MAPK by Gq-coupled receptors has been described to involve a direct interaction between Gaq and two novel effectors, PKC zeta and MEK5. However, the possible contribution of beta-arrestin towards this pathway has not yet been addressed. In the present work we sought to investigate the role of receptor internalization processes and beta-arrestin recruitment in the activation of ERK5 by Gq-coupled GPCRs. Our results show that ERK5 activation is independent of M1 or M3 muscarinic receptor internalization. Furthermore, we demonstrate that phosphorylation-deficient muscarinic M1 and M3 receptors are still able to fully activate the ERK5 pathway, despite their reported inability to recruit beta-arrestins. Indeed, the overexpression of Gaq, but not that of beta-arrestin1 or beta-arrestin2, was found to potently enhance ERK5 activation by GPCRs, whereas silencing of beta-arrestin2 expression did not affect the activation of this pathway. Finally, we show that a beta-arrestin-biased mutant form of angiotensin II (SII; Sar1-Ile4-Ile8 AngII) failed to promote ERK5 phosphorylation in primary cardiac fibroblasts, as compared to the natural ligand. Overall, this study shows that the activation of ERK5 MAPK by model Gq-coupled GPCRs does not depend on receptor internalization, beta-arrestin recruitment or receptor phosphorylation but rather is dependent on Gaq-signalling.	[Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, UAM CSIC, Dept Biol Mol, Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, UAM CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid, Spain; [Tobin, Andrew B.] Univ Leicester, Med Res Council Toxicol Unit, Leicester, Leics, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester	Mayor, F (corresponding author), Univ Autonoma Madrid, UAM CSIC, Dept Biol Mol, Madrid, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Cabezudo, Sofia/AAA-6434-2020; Mayor, Federico/N-7644-2016	Garcia-Hoz, Carlota/0000-0001-8268-4159; Cabezudo, Sofia/0000-0001-5675-458X; Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Educacion y Ciencia [SAF2011-23800]; Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III [RD12/0042/0012]; Comunidad de Madrid [S-2011/BMD-2332]; Instituto de Salud Carlos III [PI11/00126]; Wood-Whelan Research Felowship (IUMBM)	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Wood-Whelan Research Felowship (IUMBM)	The study was funded by grants from Ministerio de Educacion y Ciencia (SAF2011-23800), Fundacion Ramon Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332) and Instituto de Salud Carlos III (PI11/00126). Collaboration with Dr. Andrew Tobin was possible thanks to a Wood-Whelan Research Felowship (IUMBM) awarded to GSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Budd DC, 1999, J BIOL CHEM, V274, P12355, DOI 10.1074/jbc.274.18.12355; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Shmuel M, 2007, MOL BIOL CELL, V18, P1570, DOI 10.1091/mbc.E06-07-0618; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84174	10.1371/journal.pone.0084174	http://dx.doi.org/10.1371/journal.pone.0084174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358341	Green Published, gold			2022-12-25	WOS:000328737700084
J	Shah, D; Jonckers, E; Praet, J; Vanhoutte, G; Palacios, RDY; Bigot, C; D'Souza, DV; Verhoye, M; Van der Linden, A				Shah, Disha; Jonckers, Elisabeth; Praet, Jelle; Vanhoutte, Greetje; Delgado y Palacios, Rafael; Bigot, Christian; D'Souza, Dany V.; Verhoye, Marleen; Van der Linden, Annemie			Resting State fMRI Reveals Diminished Functional Connectivity in a Mouse Model of Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HIPPOCAMPUS; DEPOSITION; NETWORKS	Introduction: Functional connectivity (FC) studies have gained immense popularity in the evaluation of several neurological disorders, such as Alzheimer's disease (AD). AD is a complex disorder, characterised by several pathological features. The problem with FC studies in patients is that it is not straightforward to focus on a specific aspect of pathology. In the current study, resting state functional magnetic resonance imaging (rsfMRI) is applied in a mouse model of amyloidosis to assess the effects of amyloid pathology on FC in the mouse brain. Methods: Nine APP/PS1 transgenic and nine wild-type mice (average age 18.9 months) were imaged on a 7T MRI system. The mice were anesthetized with medetomidine and rsfMRI data were acquired using a gradient echo EPI sequence. The data were analysed using a whole brain seed correlation analysis and interhemispheric FC was evaluated using a pairwise seed analysis. Qualitative histological analyses were performed to assess amyloid pathology, inflammation and synaptic deficits. Results: The whole brain seed analysis revealed an overall decrease in FC in the brains of transgenic mice compared to wild-type mice. The results showed that interhemispheric FC was relatively preserved in the motor cortex of the transgenic mice, but decreased in the somatosensory cortex and the hippocampus when compared to the wild-type mice. The pairwise seed analysis confirmed these results. Histological analyses confirmed the presence of amyloid pathology, inflammation and synaptic deficits in the transgenic mice. Conclusions: In the current study, rsfMRI demonstrated decreased FC in APP/PS1 transgenic mice compared to wild-type mice in several brain regions. The APP/PS1 transgenic mice had advanced amyloid pathology across the brain, as well as inflammation and synaptic deficits surrounding the amyloid plaques. Future studies should longitudinally evaluate APP/PS1 transgenic mice and correlate the rsfMRI findings to specific stages of amyloid pathology.	[Shah, Disha; Jonckers, Elisabeth; Praet, Jelle; Vanhoutte, Greetje; Delgado y Palacios, Rafael; Bigot, Christian; D'Souza, Dany V.; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium; [D'Souza, Dany V.] F Hoffmann La Roche Pharmaceut Ltd, Neurosci Discovery, Basel, Switzerland	University of Antwerp; Roche Holding	Shah, D (corresponding author), Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium.	Disha.Shah@ua.ac.be	Vanhoutte, Greetje/GZG-7992-2022; Praet, Jelle/I-9181-2014; Van der Linden, Annemie/L-7855-2017	Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611; Praet, Jelle/0000-0002-9484-4532; Shah, Disha/0000-0001-7946-8594	European Union [278850]; UA doctoral grant (BOF DOCPRO VERHOYE M); EC [CP-IP 212043-2]	European Union(European Commission); UA doctoral grant (BOF DOCPRO VERHOYE M); EC(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278850 (INMiND), the UA doctoral grant (BOF DOCPRO 2013 VERHOYE M) and partial funding by the EC-FP7 project NAD, CP-IP 212043-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAANSE SM, 2012, HUM BRAIN MAPP, P38869; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Filippi Massimo, 2012, Expert Opin Med Diagn, V6, P109, DOI 10.1517/17530059.2012.657624; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Little DM, 2012, J ALZHEIMERS DIS, V32, P101, DOI 10.3233/JAD-2012-111508; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reitz Christiane, 2012, Int J Alzheimers Dis, V2012, P369808, DOI 10.1155/2012/369808; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; SFORAZZINI F, 2013, NEUROIMAGE, P80504; SHELINE YI, 2013, J ALZHEIMERS DIS BIO; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	36	39	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84241	10.1371/journal.pone.0084241	http://dx.doi.org/10.1371/journal.pone.0084241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358348	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700089
J	Zhang, ZY; Convertini, P; Shen, ML; Xu, X; Lemoine, F; de la Grange, P; Andres, DA; Stamm, S				Zhang, Zhaiyi; Convertini, Paolo; Shen, Manli; Xu, Xiu; Lemoine, Frederic; de la Grange, Pierre; Andres, Douglas A.; Stamm, Stefan			Valproic Acid Causes Proteasomal Degradation of DICER and Influences miRNA Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; MOOD STABILIZER; DOWN-REGULATION; SODIUM VALPROATE; CELLS; INHIBITOR; DRUG; DIVALPROEX; MICRORNAS	Valproic acid (VPA) is a commonly used drug to treat epilepsy and bipolar disorders. Known properties of VPA are inhibitions of histone deacetylases and activation of extracellular signal regulated kinases (ERK), which cannot fully explain VPA's clinical features. We found that VPA induces the proteasomal degradation of DICER, a key protein in the generation of micro RNAs. Unexpectedly, the concentration of several micro RNAs increases after VPA treatment, which is caused by the upregulation of their hosting genes prior to DICER degradation. The data suggest that a loss of DICER protein and changes in micro RNA concentration contributes to the clinical properties of VPA. VPA can be used experimentally to down regulate DICER protein levels, which likely reflects a natural regulation of DICER.	[Zhang, Zhaiyi; Convertini, Paolo; Shen, Manli; Xu, Xiu; Andres, Douglas A.; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Lemoine, Frederic; de la Grange, Pierre] Hop St Louis, GenoSplice Technol, Paris, France	University of Kentucky; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Stamm, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	stefan@stamms-lab.net		Convertini, Paolo/0000-0001-7250-0678	NIH [RO1 GM083187, 5P20RR020171-08]; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the NIH [RO1 GM083187 and 5P20RR020171-08]; and a grant from the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Bosetti F, 2005, BRAIN RES BULL, V65, P331, DOI 10.1016/j.brainresbull.2005.01.004; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chetcuti A, 2006, INT J NEUROPSYCHOPH, V9, P267, DOI 10.1017/S1461145705005717; Chodurek E, 2012, CELL MOL BIOL LETT, V17, P616, DOI 10.2478/s11658-012-0033-4; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Falaleeva M, 2013, CLIN MED CA IN PRESS; Frazee LA, 2008, ANN PHARMACOTHER, V42, P403, DOI 10.1345/aph.1K531; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kapur K, 2008, BIOINFORMATICS, V24, P2887, DOI 10.1093/bioinformatics/btn571; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kissel JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021296; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michaelis M, 2007, CURR PHARM DESIGN, V13, P3378, DOI 10.2174/138161207782360519; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Petak I, 2000, CLIN CANCER RES, V6, P4119; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reed RC, 2006, EPILEPSY BEHAV, V8, P391, DOI 10.1016/j.yebeh.2005.12.004; Reed RC, 2006, THER DRUG MONIT, V28, P413, DOI 10.1097/01.ftd.0000211814.12311.3f; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Stephen LJ, 2003, DRUG AGING, V20, P141, DOI 10.2165/00002512-200320020-00005; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200	48	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82895	10.1371/journal.pone.0082895	http://dx.doi.org/10.1371/journal.pone.0082895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358235	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700038
J	Atallah, J; Plachetzki, DC; Jasper, WC; Johnson, BR				Atallah, Joel; Plachetzki, David C.; Jasper, W. Cameron; Johnson, Brian R.			The Utility of Shallow RNA-Seq for Documenting Differential Gene Expression in Genes with High and Low Levels of Expression	PLOS ONE			English	Article							APIS-MELLIFERA; TRANSCRIPTION FACTORS; HONEY-BEE; CHIP-SEQ; GENERATION; GENOMICS; HYMENOPTERA; ANNOTATION; INSIGHTS; TOOL	The sequencing depth necessary for documenting differential gene expression using RNA-Seq has been little explored outside of model systems. In particular, the depth required to analyze large-scale patterns of differential transcription factor expression is not known. The goal of the present study is to explore the effectiveness of shallow (relatively low read depth) RNA-Seq. We focus on two tissues in the honey bee: the sting gland and the digestive tract. The sting gland is an experimentally well-understood tissue that we use to benchmark the utility of this approach. We use the digestive tract to test the results obtained with the sting gland, and to conduct RNA-Seq between tissue types. Using a list of experimentally verified genes conferring tissue-specific functions in the sting gland, we show that relatively little read depth is necessary to identify them. We argue that this result should be broadly applicable, since genes important for tissue-specific functions often have robust expression patterns, and because we obtained similar results in our analysis of the digestive tract. Furthermore, we demonstrate that the differential expression of transcription factors, which are transcribed at low levels compared to other genes, can nevertheless often be determined using shallow RNA-Seq. Overall, we find over 150 differentially expressed transcription factors in our tissues at a read depth of only 12 million. This work shows the utility of low-depth sequencing for identifying genes important for tissue-specific functions. It also verifies the often-held belief that transcription factors show low levels of expression, while demonstrating that, in spite of this, they are frequently amenable to shallow RNA-Seq. Our findings should be of benefit to researchers using RNA-Seq in many different biological systems.	[Atallah, Joel; Jasper, W. Cameron; Johnson, Brian R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Plachetzki, David C.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Johnson, BR (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	brnjohnson@ucdavis.edu			UC Davis	UC Davis	Lab startup funds from UC Davis funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kliebenstein DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00213; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin M., 2011, EMBNET J N AM    MAY; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; OWEN MD, 1995, TOXICON, V33, P1181, DOI 10.1016/0041-0101(95)00054-P; OWEN MD, 1976, TOXICON, V14, P1, DOI 10.1016/0041-0101(76)90113-6; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Perkins TT, 2009, PLOS GENET, P5; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roat TC, 2004, SOCIOBIOLOGY, V43, P193; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shpigler H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-120; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wegener J, 2009, INSECT SOC, V56, P85, DOI 10.1007/s00040-008-1042-1; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711	46	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84160	10.1371/journal.pone.0084160	http://dx.doi.org/10.1371/journal.pone.0084160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358338	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700154
J	Cao, HD; Wen, P; Ye, H; Sun, ZP; Shen, X; Wu, XC; Dai, CS; Yang, JW				Cao, Hongdi; Wen, Ping; Ye, Hong; Sun, Zhiping; Shen, Xia; Wu, Xiaochun; Dai, Chunsun; Yang, Junwei			A Study of the Immunoloregulation of Double Filtration Plasmapheresis in Maintenance Hemodialysis Patients with Chronic Hepatitis C	PLOS ONE			English	Article							REGULATORY T-CELLS; VIRUS-INFECTION; INTERFERON THERAPY; RENAL-DISEASE; RISK-FACTORS; METAANALYSIS; COMBINATION; PREVALENCE; INFLAMMATION; DYSFUNCTION	Although a large number of drugs have been used to treat chronic hepatitis C (CHC), there still remains a great challenge to treat maintenance hemodialysis (MHD) patients with chronic hepatitis C. To clarify the immunnoloregulation of double filtration plasmapheresis (DFPP) in MHD patients with CHC, DFPP was performed in 20 MHD patients with CHC (HCV-antibody positive, serum HCV RNA >500 IU/ml more than 6 months and HCV genotype 1b). The clinical data was collected and peripheral blood mononuclear cells (PBMCs) were analyzed by flow cytometry at the time of hour 0, hour 3, day 3, day 7 and day 28 after the DFPP, respectively. Serum HCV particles could be removed partially by the DFPP. The titer of serum HCV RNA could remain in a lower level even 28 days after the treatment. Compared to MHD patients without HCV infection, the frequencies of innate immune cells were similar in MHD patients with CHC, while Th1/Th2 was elevated and the frequencies of regulatory T (Treg) cells were higher in those MHD patients with CHC. The frequencies of monocytes and natural killer (NK) cells remained after the DFPP in MHD patients with CHC. There were no significant changes of Th1, Th2 and Th1/Th2 in PBMC after DFPP. DFPP could reduce the frequencies of Th17 cells and Treg cells in PBMC from 7 days after DFPP in MHD patients with CHC. DFPP could partially remove the serum HCV particles mechanically. The titer of HCV RNA could remain in a lower level at least for 28 days probably due to the redistribution of the immunocytes in circulation.	[Cao, Hongdi; Wen, Ping; Ye, Hong; Sun, Zhiping; Shen, Xia; Wu, Xiaochun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			Ministry of Science and Technology, China [2011CB504000]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by "973'' Science Program of the Ministry of Science and Technology, China (2011CB504000) to Junwei Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Cohen G, 2012, TOXINS, V4, P962, DOI 10.3390/toxins4110962; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Fabrizi F, 2008, J VIRAL HEPATITIS, V15, P79, DOI [10.1111/j.1365-2893.2007.00907.x, 10.1111/j.1365-2893.2008.01039.x]; Fabrizi F, 2004, ALIMENT PHARM THER, V20, P1271, DOI 10.1111/j.1365-2036.2004.02290.x; Fabrizi F, 2007, SEMIN DIALYSIS, V20, P416, DOI 10.1111/j.1525-139X.2007.00311.x; Fissell RB, 2004, KIDNEY INT, V65, P2335, DOI 10.1111/j.1523-1755.2004.00649.x; Fujiwara K, 2007, HEPATOL RES, V37, P701, DOI 10.1111/j.1872-034X.2007.00117.x; Furusyo N, 2000, DIGEST DIS SCI, V45, P2221, DOI 10.1023/A:1026696721059; Gordon CE, 2008, AM J KIDNEY DIS, V52, P811, DOI 10.1053/j.ajkd.2008.08.005; Gordon CE, 2008, AM J KIDNEY DIS, V51, P263, DOI 10.1053/j.ajkd.2007.11.003; HURAIB S, 1995, NEPHROL DIAL TRANSPL, V10, P470, DOI 10.1093/ndt/10.4.470; Kalantar-Zadeh K, 2007, J AM SOC NEPHROL, V18, P1584, DOI 10.1681/ASN.2006070736; Kaneko S, 2010, HEPATOL RES, V40, P1072, DOI 10.1111/j.1872-034X.2010.00708.x; Knoll GA, 1997, AM J KIDNEY DIS, V29, P608, DOI 10.1016/S0272-6386(97)90345-0; Kondo Y, 2012, THER APHER DIAL, V16, P478, DOI 10.1111/j.1744-9987.2012.01113.x; Kondo Y, 2011, HEPATOL RES, V41, P1153, DOI 10.1111/j.1872-034X.2011.00878.x; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Levent F, 2011, HEPATOL RES, V41, P197, DOI 10.1111/j.1872-034X.2010.00759.x; Libetta C, 2010, NEPHROL DIAL TRANSPL, V25, P1723, DOI 10.1093/ndt/gfq055; Lim WH, 2007, KIDNEY INT, V72, P1138, DOI 10.1038/sj.ki.5002425; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Okuda K, 2004, WORLD J GASTROENTERO, V10, P2209; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Perrella A, 2006, GUT, V55, P1370, DOI 10.1136/gut.2006.099887; Pol S, 2002, SEMIN NEPHROL, V22, P331, DOI 10.1053/snep.2002.33674; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Saison J, 2013, CYTOM PART B-CLIN CY, V84B, P50, DOI 10.1002/cyto.b.21047; Su YY, 2013, J MED VIROL, V85, P425, DOI 10.1002/jmv.23486; Takada Y, 2008, LIVER TRANSPLANT, V14, P1044, DOI 10.1002/lt.21441; Tang Sydney, 2005, Hemodial Int, V9, P169, DOI 10.1111/j.1492-7535.2005.01129.x; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vacher-Coponat H, 2008, NEPHROL DIAL TRANSPL, V23, P1406, DOI 10.1093/ndt/gfm596	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82524	10.1371/journal.pone.0082524	http://dx.doi.org/10.1371/journal.pone.0082524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358197	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700076
J	El Meouche, I; Peltier, J; Monot, M; Soutourina, O; Pestel-Caron, M; Dupuy, B; Pons, JL				El Meouche, Imane; Peltier, Johann; Monot, Marc; Soutourina, Olga; Pestel-Caron, Martine; Dupuy, Bruno; Pons, Jean-Louis			Characterization of the SigD Regulon of C. difficile and Its Positive Control of Toxin Production through the Regulation of tcdR	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; BACILLUS-SUBTILIS; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; FLAGELLAR REGULON; RNA-POLYMERASE; MOTILITY; TRANSCRIPTION; OPERON; SPORULATION	Clostridium difficile intestinal disease is mediated largely by the actions of toxins A (TcdA) and B (TcdB), whose production occurs after the initial steps of colonization involving different surface or flagellar proteins. In B. subtilis, the sigma factor SigD controls flagellar synthesis, motility, and vegetative autolysins. A homolog of SigD encoding gene is present in the C. difficile 630 genome. We constructed a sigD mutant in C. difficile 630.erm to analyze the regulon of SigD using a global transcriptomic approach. A total of 103 genes were differentially expressed between the wild- type and the sigD mutant, including genes involved in motility, metabolism and regulation. In addition, the sigD mutant displayed decreased expression of genes involved in flagellar biosynthesis, and also of genes encoding TcdA and TcdB as well as TcdR, the positive regulator of the toxins. Genomic analysis and RACE- PCR experiments allowed us to characterize promoter sequences of direct target genes of SigD including tcdR and to identify the SigD consensus. We then established that SigD positively regulates toxin expression via direct control of tcdR transcription. Interestingly, the overexpression of FlgM, a putative anti- SigD factor, inhibited the positive regulation of motility and toxin synthesis by SigD. Thus, SigD appears to be the first positive regulator of the toxin synthesis in C. difficile.	[El Meouche, Imane; Peltier, Johann; Pestel-Caron, Martine; Pons, Jean-Louis] Univ Rouen, Lab GRM EA IFR IHURBM 2656 23, Rouen, France; [Monot, Marc; Soutourina, Olga; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Soutourina, Olga] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Pons, Jean-Louis] Univ Paris 05, Lab Ecosyst Intestinal, Antibiot EA 4065, IFR IMTCE, Paris, France	Universite de Rouen Normandie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Peltier, J (corresponding author), Univ Rouen, Lab GRM EA IFR IHURBM 2656 23, Rouen, France.	j.peltier@imperial.ac.uk	Monot, Marc/F-3058-2015; Soutourina, Olga/F-2042-2015; Peltier, Johann/Q-2001-2017	Monot, Marc/0000-0003-0738-7335; Peltier, Johann/0000-0003-3207-9465; Soutourina, Olga/0000-0001-6439-7228; El Meouche, Imane/0000-0002-0886-6752	University of Rouen	University of Rouen	Funding was provided by the University of Rouen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmansberger R, 1997, J BACTERIOL, V179, P6531, DOI 10.1128/jb.179.20.6531-6535.1997; Andre G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-234; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Bakker D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043247; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Caramori T, 1996, J BACTERIOL, V178, P3113, DOI 10.1128/jb.178.11.3113-3118.1996; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; CHEN YF, 1992, P NATL ACAD SCI USA, V89, P5123, DOI 10.1073/pnas.89.11.5123; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Cozy LM, 2010, MOL MICROBIOL, V76, P273, DOI 10.1111/j.1365-2958.2010.07112.x; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Estacio W, 1998, J BACTERIOL, V180, P3548, DOI 10.1128/JB.180.14.3548-3555.1998; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; GAUR NK, 1986, J BACTERIOL, V168, P860, DOI 10.1128/jb.168.2.860-869.1986; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; HELMANN JD, 1988, J BACTERIOL, V170, P1568, DOI 10.1128/jb.170.4.1568-1574.1988; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Iyoda S, 1995, MOL GEN GENET, V249, P417; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KURODA A, 1993, J BACTERIOL, V175, P795, DOI 10.1128/JB.175.3.795-801.1993; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; MARQUEZ LM, 1990, J BACTERIOL, V172, P3435, DOI 10.1128/jb.172.6.3435-3443.1990; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; MCKEE RW, 2013, J BACTERIOL, P13934; MIREL DB, 1989, J BACTERIOL, V171, P3095, DOI 10.1128/jb.171.6.3095-3101.1989; MIREL DB, 1992, J BACTERIOL, V174, P4197, DOI 10.1128/JB.174.13.4197-4204.1992; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; OHNISHI K, 1990, MOL GEN GENET, V221, P139, DOI 10.1007/BF00261713; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Olling A, 2012, MICROB PATHOGENESIS, V52, P92, DOI 10.1016/j.micpath.2011.10.009; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosenbusch KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048608; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sebaihia M, 2006, NAT REV MICROBIOL, V4, P882, DOI 10.1038/nrmicro1571; Serizawa M, 2004, GENE, V329, P125, DOI 10.1016/j.gene.2003.12.024; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; TRIEUCUOT P, 1987, MICROBIOL SCI, V4, P263; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Walters Julian R F, 2010, Therap Adv Gastroenterol, V3, P349, DOI 10.1177/1756283X10377126; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000	67	70	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83748	10.1371/journal.pone.0083748	http://dx.doi.org/10.1371/journal.pone.0083748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358307	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700136
J	Sallee, M; Fontes, M; Louis, L; Cerini, C; Brunet, P; Burtey, S				Sallee, Marion; Fontes, Michel; Louis, Laurence; Cerini, Claire; Brunet, Philippe; Burtey, Stephane			Alternative Splicing Events Is Not a Key Event for Gene Expression Regulation in Uremia	PLOS ONE			English	Article							MESSENGER-RNA; DISEASE; PROFILE; CELLS; ASSOCIATION; FIBROBLASTS; MICROARRAY; CANCER; RISK	Background: The control of gene expression in the course of chronic kidney disease (CKD) is not well addressed. Alternative splicing is a common way to increase complexity of proteins. More than 90% of human transcripts are alternatively spliced. We hypothesised that CKD can induce modification of the alternative splicing machinery. Methods: During mutation screening in autosomal dominant polycystic kidney disease, we identified in mononuclear cells (PBMC), an alternative splicing event on the exon 30 of PKD1 gene, the gene implicated in this disease. This alternative splice variant was not correlated with the cystic disease but with CKD. To confirm the association between this variant and CKD, a monocentric clinical study was performed with 3 different groups according to their kidney function (CKD5D, CKD3-5 and normal kidney function). An exon microarray approach was used to highlight splicing events in whole human genome in a normal cell model (fibroblasts) incubated with uremic serum. Alternative splicing variants identified were confirmed by RTPCR. Results: The splicing variant of the exon 30 of PKD1 was more frequent in PBMCs from patients with CKD compared to control. With the microarray approach, despite the analysis of more than 230 000 probes, we identified 36 genes with an abnormal splicing index evocating splicing event in fibroblasts exposed to uremic serum. Only one abnormal splicing event in one gene, ADH1B, was confirmed by RT-PCR. Conclusion: We observed two alternative spliced genes in two different cell types associated with CKD. Alternative splicing could play a role in the control of gene expression during CKD but it does not seem to be a major mechanism.	[Sallee, Marion; Cerini, Claire; Brunet, Philippe; Burtey, Stephane] Aix Marseille Univ, INSERM, UMR S 1076, UFR Pharm, Marseille, France; [Sallee, Marion; Brunet, Philippe; Burtey, Stephane] Hop Conception, Assistance Publ Hop Marseille, Ctr Nephrol & Transplantat Renale, Marseille, France; [Fontes, Michel] Aix Marseille Univ, INSERM, UMR S 1062, UFR Med, Marseille, France; [Louis, Laurence] Aix Marseille Univ, UMR S 910, UFR Med, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Burtey, S (corresponding author), Aix Marseille Univ, INSERM, UMR S 1076, UFR Pharm, Marseille, France.	Stephane.burtey@univ-amu.fr	Burtey, Stéphane/S-2433-2019	Burtey, Stéphane/0000-0003-1813-7884	Aix-Marseille Universite; Fondation du Rein	Aix-Marseille Universite; Fondation du Rein	MS is supported by a PhD grant from Aix-Marseille Universite. This work was supported by Fondation du Rein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUEHLER R, 1982, AM J PATHOL, V108, P89; Burtey S, 2002, J MED GENET, V39, P422, DOI 10.1136/jmg.39.6.422; Freedman BI, 2006, HYPERTENSION, V48, P8, DOI 10.1161/01.HYP.0000227047.26988.3e; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Hori Y, 2007, J PATHOL, V212, P218, DOI 10.1002/path.2176; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Ishikawa I, 2003, CLIN NEPHROL, V59, P153; Jia CQ, 2007, THROMB RES, V120, P679, DOI 10.1016/j.thromres.2006.12.023; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Konishi T, 2004, ALCOHOL CLIN EXP RES, V28, P1145, DOI 10.1097/01.ALC.0000134231.48395.42; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Petersen B J, 1980, Adv Exp Med Biol, V132, P533; Rittie L, 2005, METH MOLEC MED, V117, P83; Sciarretta S, 2010, J HYPERTENS, V28, P251, DOI 10.1097/HJH.0b013e3283326718; Shah VO, 2006, AM J KIDNEY DIS, V48, P616, DOI 10.1053/j.ajkd.2006.05.032; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Skjorringe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018599; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZN, 2003, CANCER RES, V63, P655; Yalcindag C, 1999, J AM SOC NEPHROL, V10, P2562; Zhang XZ, 2012, ONCOL REP, V27, P1258, DOI 10.3892/or.2011.1601; Zhou WY, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-63	30	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82702	10.1371/journal.pone.0082702	http://dx.doi.org/10.1371/journal.pone.0082702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358217	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700090
J	Noel, SD; Abreu, AP; Xu, SY; Muyide, T; Gianetti, E; Tusset, C; Carroll, J; Latronico, AC; Seminara, SB; Carroll, RS; Kaiser, UB				Noel, Sekoni D.; Abreu, Ana Paula; Xu, Shuyun; Muyide, Titilayo; Gianetti, Elena; Tusset, Cintia; Carroll, Jessica; Latronico, Ana Claudia; Seminara, Stephanie B.; Carroll, Rona S.; Kaiser, Ursula B.			TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients	FASEB JOURNAL			English	Article						tachykinins; GPCR; hypogonadotropic hypogonadism; neurokinin B	CALCIUM-SENSING RECEPTOR; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; ACTIVITY-MODIFYING PROTEINS; 3RD INTRACELLULAR LOOP; 1ST EXTRACELLULAR LOOP; NEUROKININ B RECEPTOR; HUMAN SUBSTANCE-P; ARCUATE NUCLEUS; HORMONE SECRETION; QUALITY-CONTROL	Neurokinin B (NKB) and its G-protein-coupled receptor, NK3R, have been implicated in the neuroendocrine control of GnRH release; however, little is known about the structure-function relationship of this ligand-receptor pair. Moreover, loss-of-function NK3R mutations cause GnRH deficiency in humans. Using missense mutations in NK3R we previously identified in patients with GnRH deficiency, we demonstrate that Y256H and Y315C NK3R mutations in the fifth and sixth transmembrane domains (TM5 and TM6), resulted in reduced whole-cell (79.3 +/- 7.2%) or plasma membrane (67.3 +/- 7.3%) levels, respectively, compared with wild-type (WT) NK3R, with near complete loss of inositol phosphate (IP) signaling, implicating these domains in receptor trafficking, processing, and/or stability. We further demonstrate in a FRET-based assay that R295S NK3R, in the third intracellular loop (IL3), bound NKB but impaired dissociation of G(q)-protein subunits from the receptor compared with WT NK3R, which showed a 10.0 +/- 1.3% reduction in FRET ratios following ligand binding, indicating activation of G(q)-protein signaling. Interestingly, R295S NK3R, identified in the heterozygous state in a GnRH-deficient patient, also interfered with dissociation of G proteins and IP signaling from wild-type NK3R, indicative of dominant-negative effects. Collectively, our data illustrate roles for TM5 and TM6 in NK3R trafficking and ligand binding and for IL3 in NK3R signaling.-Noel, S. D., Abreu, A. P., Xu, S., Muyide, T., Gianetti, E., Tusset, C., Carroll, J., Latronico, A. C., Seminara, S. B., Carroll, R. S., Kaiser, U. B. TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients.	[Noel, Sekoni D.; Abreu, Ana Paula; Xu, Shuyun; Muyide, Titilayo; Carroll, Jessica; Carroll, Rona S.; Kaiser, Ursula B.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Noel, Sekoni D.; Abreu, Ana Paula; Xu, Shuyun; Muyide, Titilayo; Carroll, Jessica; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Univ, Sch Med, Boston, MA USA; [Abreu, Ana Paula; Tusset, Cintia; Latronico, Ana Claudia] Univ Sao Paulo, Sch Med, Teaching Hosp, Dev Endocrinol Unit,Lab Hormones & Mol Genet, Sao Paulo, Brazil; [Gianetti, Elena; Seminara, Stephanie B.] Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital	Kaiser, UB (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	ukaiser@partners.org	Latronico, Ana Claudia/E-1198-2012; Latronico, Ana Claudia/AAC-5112-2019	Latronico, Ana Claudia/0000-0001-6782-693X; Latronico, Ana Claudia/0000-0001-6782-693X; /0000-0002-5505-0852	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54 HD028138]; Ruth L. Kirschstein National Research Service Postdoctoral Award [T32 DK007529-25]; NIH Fellowship [F05 HD072773-01];  [R01 HD019938];  [R01 HD019938-21S]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD067388, P30HD018655, P50HD028138, F05HD072773, U54HD028138, R01HD019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth L. Kirschstein National Research Service Postdoctoral Award; NIH Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. John Gill and Dr. Ann-Marie Zavacki for helpful discussions. The authors also thank Drs. Bertil Hille (University of Washington School of Medicine, Seattle, WA, USA), Narasimhan Gautam (Washington University School of Medicine in St. Louis, St. Louis, MO, USA), Stephen Ikeda [National Institute on Alcohol Abuse and Alcoholism, Division of Clinical and Biological Research, U. S. National Institutes of Health (NIH), Bethesda, MD, USA] and Moritz Buneman (Philipps-Universtitaet Marburg, Marburg, Germany) for providing DNA constructs. This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, through cooperative agreement U54 HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to U. B. K. and S. B. S.), by R01 HD019938 (to U. B. K.), by a T32 DK007529-25 Ruth L. Kirschstein National Research Service Postdoctoral Award (to S.D.N.), by a F05 HD072773-01 NIH Fellowship (to A. P. A.), and by R01 HD019938-21S1 (to J.C.). Author contributions: S.D.N., R. S. C., and U. B. K. designed the study; S.D.N, A. P. A, S. X, T. M., E. G., and J.C. performed experiments; S.D.N. collected and analyzed data; E. G., C. T., A. C. L., S. B. S., R. S. C., and U. B. K. provided materials and reagents; S.D.N. and U. B. K. wrote the manuscript; A. C. L., S. B. S., R. S. C., and U. B. K. gave technical support and conceptual advice. The authors declare no conflicts of interest.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Al-Salameh A, 2011, EUR J ENDOCRINOL, V165, P359, DOI 10.1530/EJE-11-0141; Amstalden M, 2010, J NEUROENDOCRINOL, V22, P1, DOI 10.1111/j.1365-2826.2009.01930.x; Bai M, 1999, P NATL ACAD SCI USA, V96, P2834, DOI 10.1073/pnas.96.6.2834; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bedecarrats GY, 2003, MOL CELL ENDOCRINOL, V205, P51, DOI 10.1016/S0303-7207(03)00201-6; Billings HJ, 2010, ENDOCRINOLOGY, V151, P3836, DOI 10.1210/en.2010-0174; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; Chen SH, 2000, EMBO J, V19, P4265, DOI 10.1093/emboj/19.16.4265; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Conn PM, 2009, MOL CELL ENDOCRINOL, V299, P137, DOI 10.1016/j.mce.2008.10.051; Corander MP, 2010, J NEUROENDOCRINOL, V22, P181, DOI 10.1111/j.1365-2826.2009.01951.x; Dawson LA, 2010, CURR PHARM DESIGN, V16, P344, DOI 10.2174/138161210790170067; DORLEANSJUSTE P, 1986, EUR J PHARMACOL, V125, P37, DOI 10.1016/0014-2999(86)90081-6; Eghlidi DH, 2010, ENDOCRINOLOGY, V151, P3783, DOI 10.1210/en.2010-0198; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Ganjiwale AD, 2011, J CHEM INF MODEL, V51, P2932, DOI 10.1021/ci2000264; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gaskins GT, 2013, ENDOCRINOLOGY, V154, P3984, DOI 10.1210/en.2013-1479; GERARD NP, 1990, J BIOL CHEM, V265, P20455; GETHER U, 1993, J BIOL CHEM, V268, P7893; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Glidewell-Kenney CA, 2013, MOL ENDOCRINOL, V27, P437, DOI 10.1210/me.2012-1271; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Janovick JA, 2009, MOL ENDOCRINOL, V23, P157, DOI 10.1210/me.2008-0384; Kallo I, 2012, J NEUROENDOCRINOL, V24, P464, DOI 10.1111/j.1365-2826.2011.02262.x; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; Kinsey-Jones JS, 2012, ENDOCRINOLOGY, V153, P307, DOI 10.1210/en.2011-1641; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; Kung TT, 2004, PHARMACOL RES, V50, P611, DOI 10.1016/j.phrs.2004.07.002; Maya-Nunez Guadalupe, 2012, Subcell Biochem, V63, P263, DOI 10.1007/978-94-007-4765-4_14; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; NAWA H, 1984, LIFE SCI, V34, P1153, DOI 10.1016/0024-3205(84)90087-0; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nordquist RE, 2008, PSYCHOPHARMACOLOGY, V198, P211, DOI 10.1007/s00213-008-1119-6; OSAKADA F, 1986, EUR J PHARMACOL, V120, P201, DOI 10.1016/0014-2999(86)90541-8; Page NM, 2000, NATURE, V405, P797, DOI 10.1038/35015579; Peeters MC, 2011, FASEB J, V25, P632, DOI 10.1096/fj.10-164319; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Pidasheva S, 2004, HUM MUTAT, V24, P107, DOI 10.1002/humu.20067; Punn A, 2012, J BIOL CHEM, V287, P8974, DOI 10.1074/jbc.M111.272161; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; Rance NE, 2009, PEPTIDES, V30, P111, DOI 10.1016/j.peptides.2008.05.016; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sandoval-Guzman T, 2004, BRAIN RES, V1026, P307, DOI 10.1016/j.brainres.2004.08.026; Schliefenbaum J., 2008, BIOPHYS J, V94, P665; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Siffroi-Fernandez S, 2002, EUR J BIOCHEM, V269, P4930, DOI 10.1046/j.1432-1033.2002.03192.x; Simonsen KB, 2010, CURR OPIN DRUG DISC, V13, P379; Siuciak JA, 2007, PSYCHOPHARMACOLOGY, V194, P185, DOI 10.1007/s00213-007-0828-6; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TAKAHASHI K, 1992, EUR J BIOCHEM, V204, P1025, DOI 10.1111/j.1432-1033.1992.tb16724.x; TAKEDA Y, 1991, BIOCHEM BIOPH RES CO, V179, P1232, DOI 10.1016/0006-291X(91)91704-G; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Todman MG, 2005, NEUROSCIENCE, V132, P703, DOI 10.1016/j.neuroscience.2005.01.035; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Ward BK, 2006, CLIN ENDOCRINOL, V64, P580, DOI 10.1111/j.1365-2265.2006.02512.x; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Yang JJ, 2012, ENDOCRINOLOGY, V153, P1498, DOI 10.1210/en.2011-1949; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	87	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1924	1937		10.1096/fj.13-240630	http://dx.doi.org/10.1096/fj.13-240630			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24376026	Green Published			2022-12-25	WOS:000335344300036
J	Toko, H; Hariharan, N; Konstandin, MH; Ormachea, L; McGregor, M; Gude, NA; Sundararaman, B; Joyo, E; Joyo, AY; Collins, B; Din, S; Mohsin, S; Uchida, T; Sussman, MA				Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Uchida, Takafumi; Sussman, Mark A.			Differential Regulation of Cellular Senescence and Differentiation by Prolyl Isomerase Pin1 in Cardiac Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Cellular Senescence; Differentiation; Molecular Cell Biology; Stem Cells; Pin1	STEM-CELLS; STABILITY; PROTEIN; P53; PHOSPHORYLATION; ACTIVATION; CHECKPOINTS; EXPRESSION; SUBSTRATE; DYNAMICS	Background: Pin1 is a prolyl isomerase that modulates the structure of phosphoproteins. Results: Loss of Pin1 causes cell cycle arrest and senescence, whereas Pin1 overexpression increases differentiation and inhibits senescence of cardiac progenitor cells (CPCs). Conclusion: Pin1 has pleiotropic roles in CPCs. Significance: Pin1 may be a molecular target to enhance repair, survival, and differentiation and antagonize senescence of CPCs. Autologous c-kit(+) cardiac progenitor cells (CPCs) are currently used in the clinic to treat heart disease. CPC-based regeneration may be further augmented by better understanding molecular mechanisms of endogenous cardiac repair and enhancement of pro-survival signaling pathways that antagonize senescence while also increasing differentiation. The prolyl isomerase Pin1 regulates multiple signaling cascades by modulating protein folding and thereby activity and stability of phosphoproteins. In this study, we examine the heretofore unexplored role of Pin1 in CPCs. Pin1 is expressed in CPCs in vitro and in vivo and is associated with increased proliferation. Pin1 is required for cell cycle progression and loss of Pin1 causes cell cycle arrest in the G(1) phase in CPCs, concomitantly associated with decreased expression of Cyclins D and B and increased expression of cell cycle inhibitors p53 and retinoblastoma (Rb). Pin1 deletion increases cellular senescence but not differentiation or cell death of CPCs. Pin1 is required for endogenous CPC response as Pin1 knock-out mice have a reduced number of proliferating CPCs after ischemic challenge. Pin1 overexpression also impairs proliferation and causes G(2)/M phase cell cycle arrest with concurrent down-regulation of Cyclin B, p53, and Rb. Additionally, Pin1 overexpression inhibits replicative senescence, increases differentiation, and inhibits cell death of CPCs, indicating that cell cycle arrest caused by Pin1 overexpression is a consequence of differentiation and not senescence or cell death. In conclusion, Pin1 has pleiotropic roles in CPCs and may be a molecular target to promote survival, enhance repair, improve differentiation, and antagonize senescence.	[Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Sussman, Mark A.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Sussman, Mark A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan	California State University System; San Diego State University; California State University System; San Diego State University; Tohoku University	Sussman, MA (corresponding author), San Diego State Univ, Dept Biol, North Life Sci Rm 426,5500 Campanile Dr, San Diego, CA 92182 USA.	heartman4ever@icloud.com	Sundararaman, Balaji/GWQ-5695-2022; Sussman, Mark/H-2284-2014	Sundararaman, Balaji/0000-0001-8559-1660; Sussman, Mark/0000-0002-0104-4799; Uchida, Takafumi/0000-0003-3665-4906	National Institutes of Health [1R37HL091102, 1R01HL105759, 5R01HL067245, 1R01HL113656, 1R01HL117163, 1R01HL113647]; American Heart Association [11POST7610164, 12POST12060191, 12PRE12060248]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Deutsche Forschungsgemeinschaft [DFG 3900/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL091102, P01HL085577, R01HL067245, R01HL105759, R01HL122525, R01HL113656, R01HL117163, R01HL113647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R37HL091102, 1R01HL105759, 5R01HL067245, 1R01HL113656, 1R01HL117163, and 1R01HL113647 (to M. A. S.), American Heart Association Grants 11POST7610164 (to H. T.), 12POST12060191 (to N. H.), and 12PRE12060248 (to S. D.), grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research and The Uehara Memorial Foundation (to H. T.), and Deutsche Forschungsgemeinschaft Grant DFG 3900/1-1 (to M. H. K.).	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bicknell K, 2005, BIOCHEM BIOPH RES CO, V332, P817, DOI 10.1016/j.bbrc.2005.05.022; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005; Chu KL, 2013, CELL CYCLE, V12, P944, DOI 10.4161/cc.23916; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; De Nicola F, 2007, J BIOL CHEM, V282, P19685, DOI 10.1074/jbc.M610282200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Gallo G, 2005, J CELL PHYSIOL, V205, P176, DOI 10.1002/jcp.20451; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Jentsch S, 2009, CELL CYCLE, V8, P3800, DOI 10.4161/cc.8.23.9971; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Mantovani F, 2004, CELL CYCLE, V3, P905; Marques L, 2013, DIFFERENTIATION, V86, P48, DOI 10.1016/j.diff.2013.07.001; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874; Nishi M, 2011, J BIOL CHEM, V286, P11593, DOI 10.1074/jbc.M110.187989; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Sundararaman B, 2012, CIRC RES, V110, P1169, DOI 10.1161/CIRCRESAHA.112.267716; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Toko H, 2013, CIRC RES, V112, P1244, DOI 10.1161/CIRCRESAHA.113.301084; Uchida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031823; Wheaton K, 2010, AGING CELL, V9, P747, DOI 10.1111/j.1474-9726.2010.00601.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	50	26	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5348	5356		10.1074/jbc.M113.526442	http://dx.doi.org/10.1074/jbc.M113.526442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24375406	hybrid, Green Published			2022-12-25	WOS:000332015500001
J	Byerly, MS; Petersen, PS; Ramamurthy, S; Seldin, MM; Lei, X; Provost, E; Wei, ZK; Ronnett, GV; Wong, GW				Byerly, Mardi S.; Petersen, Pia S.; Ramamurthy, Santosh; Seldin, Marcus M.; Lei, Xia; Provost, Elayne; Wei, Zhikui; Ronnett, Gabriele V.; Wong, G. William			C1q/TNF-related Protein 4 (CTRP4) Is a Unique Secreted Protein with Two Tandem C1q Domains That Functions in the Hypothalamus to Modulate Food Intake and Body Weight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Hormones; Hypothalamus; Metabolism; Neuropeptide; Obesity	SHORT-CHAIN COLLAGEN; NEUROTROPHIC FACTOR; CRYSTAL-STRUCTURE; NEUROPEPTIDE-Y; ENERGY-BALANCE; REGIONAL-DISTRIBUTION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; FAMILY; BRAIN	CTRP4 is a unique member of the C1q family, possessing two tandem globular C1q domains. Its physiological function is poorly defined. Here, we show that CTRP4 is an evolutionarily conserved, approximate to 34-kDa secretory protein expressed in the brain. In human, mouse, and zebrafish brain, CTRP4 expression begins early in development and is widespread in the central nervous system. Neurons, but not astrocytes, express and secrete CTRP4, and secreted proteins form higher-order oligomeric complexes. CTRP4 is also produced by peripheral tissues and circulates in blood. Its serum levels are increased in leptin-deficient obese (ob/ob) mice. Functional studies suggest that CTRP4 acts centrally to modulate energy metabolism. Refeeding following an overnight fast induced the expression of CTRP4 in the hypothalamus. Central administration of recombinant protein suppressed food intake and altered the whole-body energy balance in both chow-fed and high-fat diet-fed mice. Suppression of food intake by CTRP4 is correlated with a decreased expression of orexigenic neuropeptide (Npy and Agrp) genes in the hypothalamus. These results establish CTRP4 as a novel nutrient-responsive central regulator of food intake and energy balance.	[Byerly, Mardi S.; Petersen, Pia S.; Seldin, Marcus M.; Lei, Xia; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Ramamurthy, Santosh; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Provost, Elayne] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Byerly, Mardi S.; Petersen, Pia S.; Ramamurthy, Santosh; Seldin, Marcus M.; Lei, Xia; Wei, Zhikui; Ronnett, Gabriele V.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171]; American Heart Association [SDG2260721]; NIDDK/National Institutes of Health [T32DK007751]; Carlsberg Foundation of Denmark; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, T32DK007751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carlsberg Foundation of Denmark; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported by American Heart Association Grant SDG2260721 (to G. W. W.).; Supported by NIDDK/National Institutes of Health Training Grant T32DK007751 in cellular and molecular endocrinology.; Supported by a fellowship from the Carlsberg Foundation of Denmark.	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Byerly M. S., 2013, PLOS ONE, V8; Byerly MS, 2013, AM J PHYSIOL-REG I, V304, pR1085, DOI 10.1152/ajpregu.00368.2012; Byerly MS, 2013, EUR J NEUROSCI, V37, P1033, DOI 10.1111/ejn.12122; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; de Jonghe BC, 2009, PHYSIOL BEHAV, V97, P87, DOI 10.1016/j.physbeh.2009.02.009; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Decressac M, 2012, EXP NEUROL, V238, P265, DOI 10.1016/j.expneurol.2012.09.004; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Grill HJ, 2009, INT J OBESITY, V33, pS11, DOI 10.1038/ijo.2009.10; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; Jeimy SB, 2008, PLATELETS, V19, P83, DOI 10.1080/09537100701832157; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Liu J, 2012, P NATL ACAD SCI USA, V109, P12248, DOI 10.1073/pnas.1202835109; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Lusk G, 1928, ELEMENTS SCI NUTR; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; Tu XY, 2012, J STRUCT BIOL, V180, P439, DOI 10.1016/j.jsb.2012.07.011; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	73	41	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4055	4069		10.1074/jbc.M113.506956	http://dx.doi.org/10.1074/jbc.M113.506956			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366864	hybrid, Green Published			2022-12-25	WOS:000331403800020
J	Jean-Alphonse, F; Bowersox, S; Chen, S; Beard, G; Puthenveedu, MA; Hanyaloglu, AC				Jean-Alphonse, Frederic; Bowersox, Shanna; Chen, Stanford; Beard, Gemma; Puthenveedu, Manojkumar A.; Hanyaloglu, Aylin C.			Spatially Restricted G Protein-coupled Receptor Activity via Divergent Endocytic Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endosomes; G Protein-coupled Receptor (GPCR); Receptor Recycling; Signaling; Sorting; GAIP-interacting Protein C Terminus (GIPC)	HUMAN LUTROPIN RECEPTOR; C-TERMINAL TAIL; HORMONE-RECEPTOR; EARLY ENDOSOME; PDZ-DOMAIN; BETA-2-ADRENERGIC RECEPTORS; BETA(1)-ADRENERGIC RECEPTOR; BINDING MOTIF; LH RECEPTOR; TRAFFICKING	Postendocytic sorting of G protein-coupled receptors (GPCRs) is driven by their interactions between highly diverse receptor sequence motifs with their interacting proteins, such as postsynaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), zonula occludens-1 protein (zo-1) (PDZ) domain proteins. However, whether these diverse interactions provide an underlying functional specificity, in addition to driving sorting, is unknown. Here we identify GPCRs that recycle via distinct PDZ ligand/PDZ protein pairs that exploit their recycling machinery primarily for targeted endosomal localization and signaling specificity. The luteinizing hormone receptor (LHR) and 2-adrenergic receptor (B2AR), two GPCRs sorted to the regulated recycling pathway, underwent divergent trafficking to distinct endosomal compartments. Unlike B2AR, which traffics to early endosomes (EE), LHR internalizes to distinct pre-early endosomes (pre-EEs) for its recycling. Pre-EE localization required interactions of the LHR C-terminal tail with the PDZ protein GAIP-interacting protein C terminus, inhibiting its traffic to EEs. Rerouting the LHR to EEs, or EE-localized GPCRs to pre-EEs, spatially reprograms MAPK signaling. Furthermore, LHR-mediated activation of MAPK signaling requires internalization and is maintained upon loss of the EE compartment. We propose that combinatorial specificity between GPCR sorting sequences and interacting proteins dictates an unprecedented spatiotemporal control in GPCR signal activity.	[Jean-Alphonse, Frederic; Chen, Stanford; Beard, Gemma; Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England; [Bowersox, Shanna; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Imperial College London; Carnegie Mellon University	Hanyaloglu, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England.	a.hanyaloglu@imperial.ac.uk	; Puthenveedu, Manojkumar/A-3795-2016	JEAN-ALPHONSE, Frederic/0000-0002-7380-5825; /0000-0003-4206-737X; Puthenveedu, Manojkumar/0000-0002-3177-4231	Wellcome Trust Grant [WT085099MA]; Genesis Research Trust Grant; National Institutes of Health [R00 DA024698]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024698, R21DA036086] Funding Source: NIH RePORTER	Wellcome Trust Grant(Wellcome Trust); Genesis Research Trust Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Wellcome Trust Grant WT085099MA and a Genesis Research Trust Grant (to A. C. H.). This work was also supported in part by National Institutes of Health Grant R00 DA024698 (to M. A. P.).	Alvarez CA, 1999, ENDOCRINOLOGY, V140, P1775, DOI 10.1210/en.140.4.1775; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cullen Peter J, 2012, Subcell Biochem, V59, P65, DOI 10.1007/978-94-007-3015-1_3; Danson C, 2013, J CELL SCI, V126, P4885, DOI 10.1242/jcs.125732; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Galet C, 2004, MOL ENDOCRINOL, V18, P434, DOI 10.1210/me.2003-0293; Galet C, 2003, MOL ENDOCRINOL, V17, P411, DOI 10.1210/me.2002-0161; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; GHINEA N, 1992, J CELL BIOL, V118, P1347, DOI 10.1083/jcb.118.6.1347; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Gulappa T, 2011, CELL MOL LIFE SCI, V68, P2785, DOI 10.1007/s00018-010-0594-1; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jeanneteau F, 2004, MOL BIOL CELL, V15, P4926, DOI 10.1091/mbc.E04-04-0285; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kishi M, 2001, MOL ENDOCRINOL, V15, P1624, DOI 10.1210/me.15.9.1624; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; MOORE RH, 1995, J CELL SCI, V108, P2983; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Vistein R, 2013, P NATL ACAD SCI USA, V110, P15289, DOI 10.1073/pnas.1306340110; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	68	67	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3960	3977		10.1074/jbc.M113.526350	http://dx.doi.org/10.1074/jbc.M113.526350			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375413	Green Published, hybrid			2022-12-25	WOS:000331403800012
J	Chan, KYK; Jiang, HS; Padilla, DK				Chan, Kit Yu Karen; Jiang, Houshuo; Padilla, Dianna K.			Swimming Speed of Larval Snail Does Not Correlate with Size and Ciliary Beat Frequency	PLOS ONE			English	Article							GASTROPOD CREPIDULA-FORNICATA; MARINE INVERTEBRATE LARVAE; METAMORPHIC COMPETENCE; DENDRASTER-EXCENTRICUS; FOOD LIMITATION; VELIGER LARVAE; FLOW-FIELDS; LOCOMOTION; EFFICIENCY; GROWTH	Many marine invertebrates have planktonic larvae with cilia used for both propulsion and capturing of food particles. Hence, changes in ciliary activity have implications for larval nutrition and ability to navigate the water column, which in turn affect survival and dispersal. Using high-speed high-resolution microvideography, we examined the relationship between swimming speed, velar arrangements, and ciliary beat frequency of freely swimming veliger larvae of the gastropod Crepidula fornicata over the course of larval development. Average swimming speed was greatest 6 days post hatching, suggesting a reduction in swimming speed towards settlement. At a given age, veliger larvae have highly variable speeds (0.8-4 body lengths s(-1)) that are independent of shell size. Contrary to the hypothesis that an increase in ciliary beat frequency increases work done, and therefore speed, there was no significant correlation between swimming speed and ciliary beat frequency. Instead, there are significant correlations between swimming speed and visible area of the velar lobe, and distance between centroids of velum and larval shell. These observations suggest an alternative hypothesis that, instead of modifying ciliary beat frequency, larval C. fornicata modify swimming through adjustment of velum extension or orientation. The ability to adjust velum position could influence particle capture efficiency and fluid disturbance and help promote survival in the plankton.	[Chan, Kit Yu Karen] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jiang, Houshuo] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Padilla, Dianna K.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chan, KYK (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	kchan@whoi.edu	Jiang, Houshuo/I-1894-2013	Jiang, Houshuo/0000-0002-8175-3500	Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI); Coastal Ocean Institute; Croucher Foundation; Royal Swedish Academy of Sciences; National Science Foundation [OCE-1129496]; WHOI's Ocean Life Institute; NSF [IOS-0920032]; Directorate For Geosciences [1129496] Funding Source: National Science Foundation	Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI); Coastal Ocean Institute; Croucher Foundation; Royal Swedish Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); WHOI's Ocean Life Institute; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	K.Y.K. Chan was supported by the Postdoctoral Scholar 1 Program at the Woods Hole Oceanographic Institution (WHOI), with funding provided by the Coastal Ocean Institute, the Croucher Foundation, and the Royal Swedish Academy of Sciences. H. Jiang was supported by National Science Foundation grant NSF OCE-1129496 and an award from WHOI's Ocean Life Institute, and D. K. Padilla was supported by NSF IOS-0920032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKETT SA, 1987, BIOL BULL, V173, P513, DOI 10.2307/1541697; BARILE PJ, 1994, J EXP MAR BIOL ECOL, V183, P147; BAYNE BL, 1964, OIKOS, V15, P162, DOI 10.2307/3564753; Braubach OR, 2006, J EXP BIOL, V209, P4676, DOI 10.1242/jeb.02556; Chan KYK, 2012, INTEGR COMP BIOL, V52, P458, DOI 10.1093/icb/ics092; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; CRAGG SM, 1980, J MAR BIOL ASSOC UK, V60, P551, DOI 10.1017/S002531540004025X; Dickinson AJG, 1999, ZOOMORPHOLOGY, V119, P49, DOI 10.1007/s004350050080; Dimova S, 2005, J PHARM PHARMACOL, V57, P521, DOI 10.1211/0022357055777; EMLET RB, 1990, MAR ECOL PROG SER, V63, P211, DOI 10.3354/meps063211; EMLET RB, 1994, AM ZOOL, V34, P570; Fenchel T, 2002, OPHELIA, V56, P171, DOI 10.1080/00785236.2002.10409497; GALLAGER SM, 1993, J PLANKTON RES, V15, P1277, DOI 10.1093/plankt/15.11.1277; Grunbaum D, 2003, J MAR RES, V61, P659, DOI 10.1357/002224003771815990; Henry JJ, 2010, BIOL BULL-US, V218, P211, DOI 10.1086/BBLv218n3p211; Hilbish TJ, 1999, J EXP MAR BIOL ECOL, V239, P183, DOI 10.1016/S0022-0981(99)00009-X; Jiang HS, 2011, J R SOC INTERFACE, V8, P1090, DOI 10.1098/rsif.2010.0481; Jiang HS, 2011, J EXP BIOL, V214, P476, DOI 10.1242/jeb.049288; Jiang HS, 1999, J PLANKTON RES, V21, P1391, DOI 10.1093/plankt/21.8.1391; Katsu-Kimura Y, 2009, J EXP BIOL, V212, P1819, DOI 10.1242/jeb.028894; Kiorboe T, 2013, INTEGR COMP BIOL; Kuang SH, 2001, J NEUROBIOL, V47, P1, DOI 10.1002/neu.1011; LIMA GM, 1982, AM ZOOL, V22, P861; MACKIE GO, 1976, BIOL BULL-US, V151, P182, DOI 10.2307/1540713; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; MILLER SE, 1986, J EXP MAR BIOL ECOL, V97, P95, DOI 10.1016/0022-0981(86)90070-5; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; Osterman N, 2011, P NATL ACAD SCI USA, V108, P15727, DOI 10.1073/pnas.1107889108; PECHENIK JA, 1985, AM ZOOL, V25, pA128; PECHENIK JA, 1993, J EXP MAR BIOL ECOL, V167, P59, DOI 10.1016/0022-0981(93)90184-P; Pechenik JA, 1996, MAR BIOL, V127, P267, DOI 10.1007/BF00942112; PODOLSKY RD, 1993, J EXP BIOL, V176, P207; Purcell EM, 1997, P NATL ACAD SCI USA, V94, P11307, DOI 10.1073/pnas.94.21.11307; Romero MR, 2010, BIOL BULL-US, V218, P145, DOI 10.1086/BBLv218n2p145; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Strathmann RR, 2006, INTEGR COMP BIOL, V46, P312, DOI 10.1093/icb/icj031; STRATHMANN RR, 1979, BIOL BULL, V157, P524, DOI 10.2307/1541035; Vogel S., 1994, LIFE MOVING FLUIDS P; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690	42	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82764	10.1371/journal.pone.0082764	http://dx.doi.org/10.1371/journal.pone.0082764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367554	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300067
J	Imamura, M; Kato, N; Okada, H; Yoshioka, M; Iwamaru, Y; Shimizu, Y; Mohri, S; Yokoyama, T; Murayama, Y				Imamura, Morikazu; Kato, Nobuko; Okada, Hiroyuki; Yoshioka, Miyako; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi; Murayama, Yuichi			Insect Cell-Derived Cofactors Become Fully Functional after Proteinase K and Heat Treatment for High-Fidelity Amplification of Glycosylphosphatidylinositol-Anchored Recombinant Scrapie and BSE Prion Proteins	PLOS ONE			English	Article							IN-VITRO; PRESYMPTOMATIC DETECTION; CYCLIC AMPLIFICATION; SURFACE RETENTION; INFECTIOUS PRIONS; PRPSC; AGGREGATION; REPLICATION; PROPAGATION; ABSENCE	The central event in prion infection is the conformational conversion of host-encoded cellular prion protein (PrPC) into the pathogenic isoform (PrPSc). Diverse mammalian species possess the cofactors required for in vitro replication of PrPSc by protein-misfolding cyclic amplification (PMCA), but lower organisms, such as bacteria, yeasts, and insects, reportedly lack the essential cofactors. Various cellular components, such as RNA, lipids, and other identified cofactor molecules, are commonly distributed in both eukaryotes and prokaryotes, but the reasons for the absence of cofactor activity in lower organisms remain to be elucidated. Previously, we reported that brain-derived factors were necessary for the in vitro replication of glycosylphosphatidylinositol-anchored baculovirus-derived recombinant PrP (Bac-PrP). Here, we demonstrate that following protease digestion and heat treatment, insect cell lysates had the functional cofactor activity required for Bac-PrP replication by PMCA. Mammalian PrPSc seeds and Bac-PrPSc generated by PMCA using Bac-PrP and insect cell-derived cofactors showed similar pathogenicity and produced very similar lesions in the brains of inoculated mice. These results suggested that the essential cofactors required for the high-fidelity replication of mammalian PrPSc were present in the insect cells but that the cofactor activity was masked or inhibited in the native state. We suggest that not only RNA, but also DNA, are the key components of PMCA, although other cellular factors were necessary for the expression of the cofactor activity of nucleic acids. PMCA using only insect cell-derived substances (iPMCA) was highly useful for the ultrasensitive detection of PrPSc of some prion strains.	[Imamura, Morikazu; Kato, Nobuko; Okada, Hiroyuki; Yoshioka, Miyako; Iwamaru, Yoshifumi; Shimizu, Yoshihisa; Mohri, Shirou; Yokoyama, Takashi; Murayama, Yuichi] Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Res Area Pathol & Pathophysiol, Tsukuba, Ibaraki 305, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan; JSPS KAKENHI [25460575]; Grants-in-Aid for Scientific Research [25460575] Funding Source: KAKEN	BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from the BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan and in part by JSPS KAKENHI Grant Number 25460575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Imamura M, 2011, J VIROL, V85, P2582, DOI 10.1128/JVI.02098-10; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Lawson VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012351; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Shi S, 2009, FEBS J, V276, P1536, DOI 10.1111/j.1742-4658.2009.06871.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072; Yoshioka M, 2011, MICROBIOL IMMUNOL, V55, P331, DOI 10.1111/j.1348-0421.2011.00328.x	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82538	10.1371/journal.pone.0082538	http://dx.doi.org/10.1371/journal.pone.0082538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367521	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300037
J	Kawano, F; Aono, Y; Suzuki, H; Sato, M				Kawano, Fuun; Aono, Yuki; Suzuki, Hideyuki; Sato, Moritoshi			Fluorescence Imaging-Based High-Throughput Screening of Fast- and Slow-Cycling LOV Proteins	PLOS ONE			English	Article							LIGHT PHOTORECEPTOR PHOTOTROPIN; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; SIGNALING STATE; BINDING DOMAINS; CELL BIOLOGY; OPTOGENETICS; ARABIDOPSIS; PHOTOCYCLE; RECEPTOR	Light-oxygen-voltage (LOV) domains function as blue light-inducible molecular switches. The photosensory LOV domains derived from plants and fungi have provided an indispensable tool for optogenetics. Here we develop a high-throughput screening system to efficiently improve switch-off kinetics of LOV domains. The present system is based on fluorescence imaging of thermal reversion of a flavin cofactor bound to LOV domains. We conducted multi site-directed random mutagenesis of seven amino acid residues surrounding the flavin cofactor of the second LOV domain derived from Avena sativa phototropin 1 (AsLOV2). The gene library was introduced into Escherichia coli cells. Then thermal reversion of AsLOV2 variants, respectively expressed in different bacterial colonies on agar plate, was imaged with a stereoscopic fluorescence microscope. Based on the mutagenesis and imaging-based screening, we isolated 12 different variants showing substantially faster thermal reversion kinetics than wild-type AsLOV2. Among them, AsLOV2-V416T exhibited thermal reversion with a time constant of 2.6 s, 21-fold faster than wild-type AsLOV2. With a slight modification of the present approach, we also have efficiently isolated 8 different decelerated variants, represented by AsLOV2-V416L that exhibited thermal reversion with a time constant of 4.3x10(3) s (78-fold slower than wild-type AsLOV2). The present approach based on fluorescence imaging of the thermal reversion of the flavin cofactor is generally applicable to a variety of blue light-inducible molecular switches and may provide a new opportunity for the development of molecular tools for emerging optogenetics.	[Kawano, Fuun; Aono, Yuki; Suzuki, Hideyuki; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Sato, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp	Sato, Moritoshi/O-2735-2018; Kawano, Fuun/U-5777-2019	Sato, Moritoshi/0000-0002-3095-5831; 	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants to M. S. from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), and Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	26	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82693	10.1371/journal.pone.0082693	http://dx.doi.org/10.1371/journal.pone.0082693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367542	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300057
J	McCracken, KG; Wilson, RE; Martin, AR				McCracken, Kevin G.; Wilson, Robert E.; Martin, Anthony R.			Gene Flow and Hybridization between Numerically Imbalanced Populations of Two Duck Species on the Subantarctic Island of South Georgia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANAS; INTROGRESSION; SPECIATION; EVOLUTION; CONSEQUENCES; DEGLACIATION; EXTINCTION; DIVERGENCE; COALESCENT	Hybridization is common between species of animals, particularly in waterfowl (Anatidae). One factor shown to promote hybridization is restricted mate choice, which can occur when 2 species occur in sympatry but one is rare. According to the Hubbs principle, or "desperation hypothesis," the rarer species is more likely to mate with heterospecifics. We report the second of 2 independent examples of hybridization between 2 species of ducks inhabiting island ecosystems in the Subantarctic and South Atlantic Ocean. Yellow-billed pintails (Anas georgica) and speckled teal (Anas flavirostris) are abundant in continental South America, where they are sympatric and coexist in mixed flocks. But on South Georgia, an isolated island in the Subantarctic, the pintail population of approximately 6000 pairs outnumbers a small breeding population of speckled teal 300:1. Using 6 genetic loci (mtDNA and 5 nuclear introns) and Bayesian assignment tests coupled with coalescent analyses, we identified hybrid-origin speckled teal alleles in 2 pintails on South Georgia. While it is unclear whether introgression has also occurred into the speckled teal population, our data suggest that this hybridization was not a recent event, but occurred some time ago. We also failed to identify unequivocal evidence of introgression in a much larger sample of pintails and speckled teal from Argentina using a 3-population "Isolation-with-Migration" coalescent analysis. Combined with parallel findings of hybridization between these same 2 duck species in the Falkland Islands, where population ratios are reversed and pintails are outnumbered by speckled teal 1: 10, our results provide further support for the desperation hypothesis, which predicts that scarcity in one population and abundance of another will often lead to hybridization. While the South Georgia pintail population appears to be thriving, it's possible that low density of conspecific mates and inverse density dependence (Allee effect) may be one factor limiting the reproductive output of the speckled teal population, and this situation may persist unless speckled teal increase in abundance on South Georgia.	[McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Inst Arctic Biol, Univ Alaska Museum, Fairbanks, AK 99775 USA; [McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Martin, Anthony R.] Univ Dundee, Ctr Remote Environm, Dundee, Scotland	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Dundee	McCracken, KG (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Univ Alaska Museum, Fairbanks, AK 99775 USA.	kmccrack@iab.alaska.edu			Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] [EPS-0092040, EPS-0346770]; Delta Waterfowl Foundation; Frank M. Chapman Fund at the American Museum of Natural History; NSF [DEB-0444748, IOS-0949439]	Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF](National Science Foundation (NSF)); Delta Waterfowl Foundation; Frank M. Chapman Fund at the American Museum of Natural History; NSF(National Science Foundation (NSF))	Funding was provided by the Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] EPS-0092040 and EPS-0346770), grants from the Delta Waterfowl Foundation and Frank M. Chapman Fund at the American Museum of Natural History to R. E. W., and NSF grants DEB-0444748 and IOS-0949439 to KGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bentley MJ, 2007, QUATERNARY SCI REV, V26, P644, DOI 10.1016/j.quascirev.2006.11.019; Bos DH, 2007, HEREDITAS, V144, P228, DOI 10.1111/j.2007.0018-0661.01994.x; BOTTEMA CDK, 1993, METHOD ENZYMOL, V218, P388; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; CAWKELL E. M., 1961, IBIS, V103a, P1, DOI 10.1111/j.1474-919X.1961.tb02417.x; Clapperton C. M., 1978, ANTARCTIC GLACIAL HI, P95; Clapperton C.M., 1971, 70 BRIT ANT SURV, V70; Clarke Andrew, 2012, British Birds, V105, P118; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edwards SV, 2000, EVOLUTION, V54, P1839; Fowler AC, 2009, CONSERV GENET, V10, P1747, DOI 10.1007/s10592-008-9778-8; Fretwell PT, 2009, ANTARCT SCI, V21, P171, DOI 10.1017/S0954102008001703; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Graham AGC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001993; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant V., 1981, PLANT SPECIATION, Vsecond; Gray A.P., 1958, TECHNICAL COMMUNICAT; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Headland R.K., 1984, ISLAND S GEORGIA; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUDSON RR, 1985, GENETICS, V111, P147; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kulikova IV, 2010, RUSS J GENET+, V46, P976, DOI 10.1134/S1022795410080090; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Martin AR, 2005, BIRD FAMILIES WORLD, P590; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; McCracken KG, 2013, J BIOGEOGR, V40, P2348, DOI 10.1111/jbi.12162; McCracken KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023173; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Munoz-Fuentes V, 2007, MOL ECOL, V16, P629, DOI 10.1111/j.1365-294X.2006.03170.x; Munoz-Fuentes V, 2010, CONSERV GENET, V11, P547, DOI 10.1007/s10592-009-9974-1; Newman L., 2009, PAGES (Past Global Changes) News, V17, P22; Panov, 1989, NATURAL HYBRIDIZATIO; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031972; Prince P. A., 1996, Bulletin of the British Ornithologists' Club, V116, P81; Prince P. A., 1996, S GEORGIA ECOLOGICAL; Pritchard JK, 2000, GENETICS, V155, P945; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Randler C, 2008, WATERBIRDS, V31, P143, DOI 10.1675/1524-4695(2008)31[143:HWICEA]2.0.CO;2; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 2001, MOL ECOL, V10, P737, DOI 10.1046/j.1365-294x.2001.01208.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; SUGDEN DE, 1977, QUATERNARY RES, V7, P268, DOI 10.1016/0033-5894(77)90041-2; TEGELSTROM H, 1990, EVOLUTION, V44, P2012, DOI 10.1111/j.1558-5646.1990.tb04307.x; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; TURELLI M, 1995, GENETICS, V140, P389; Van der Putten N, 2005, ANTARCT SCI, V17, P29, DOI 10.1017/S0954102005002397; Van der Putten N, 2009, QUATERNARY SCI REV, V28, P65, DOI 10.1016/j.quascirev.2008.09.023; Van der Putten N, 2010, J BIOGEOGR, V37, P582, DOI 10.1111/j.1365-2699.2009.02217.x; Wakeley J, 1996, THEOR POPUL BIOL, V49, P39, DOI 10.1006/tpbi.1996.0002; WELLER M W, 1972, Wildfowl, V23, P25; Weller M.W., 1972, Bulletin Br Antarct Surv, VNo. 30, P65; Weller M.W., 1980, ISLAND WATERFOWL; Wetlands International, 2019, WATERBIRD POPULATION; Williams CL, 2005, CONSERV GENET, V6, P445, DOI 10.1007/s10592-005-4978-y; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Woods RW, 1997, ATLAS BREEDING BIRDS; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	81	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82664	10.1371/journal.pone.0082664	http://dx.doi.org/10.1371/journal.pone.0082664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367536	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300052
J	Nattier, R; Grandcolas, P; Pellens, R; Jourdan, H; Couloux, A; Poulain, S; Robillard, T				Nattier, Romain; Grandcolas, Philippe; Pellens, Roseli; Jourdan, Herve; Couloux, Arnaud; Poulain, Simon; Robillard, Tony			Climate and Soil Type Together Explain the Distribution of Microendemic Species in a Biodiversity Hotspot	PLOS ONE			English	Article							CALEDONIA SOUTHWEST PACIFIC; MOLECULAR PHYLOGENY; ORTHOPTERA; EVOLUTION; ACRIDIDAE; RADIATION; DIVERSIFICATION; TETTIGONIIDAE; CONSERVATION; DIVERGENCE	The grasshopper genus Caledonula, endemic to New Caledonia, was studied to understand the evolution of species distributions in relation to climate and soil types. Based on a comprehensive sampling of 80 locations throughout the island, the genus was represented by five species, four of which are new to science, of which three are described here. All the species have limited distributions in New Caledonia. Bioclimatic niche modelling shows that all the species were found in association with a wet climate and reduced seasonality, explaining their restriction to the southern half of the island. The results suggest that the genus was ancestrally constrained by seasonality. A molecular phylogeny was reconstructed using two mitochondrial and two nuclear markers. The partially resolved tree showed monophyly of the species found on metalliferous soils, and molecular dating indicated a rather recent origin for the genus. Adaptation to metalliferous soils is suggested by both morphological changes and radiation on these soils. The genus Caledonula is therefore a good model to understand the origin of microendemism in the context of recent and mixed influences of climate and soil type.	[Nattier, Romain; Grandcolas, Philippe; Pellens, Roseli; Poulain, Simon; Robillard, Tony] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Nattier, Romain] UPR 9034 CNRS, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Nattier, Romain] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Jourdan, Herve] Aix Marseille Univ, UMR IRD 237, Inst Mediterrane Biodivers & Ecol Terr & Marine, CNRS IRD UAPV,Ctr IRD Noumea, Noumea, New Caledonia; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Nattier, R (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France.	romain.nattier@legs.cnrs-gif.fr	Robillard, Tony/H-3523-2011; Nattier, Romain/C-7005-2016; Jourdan, Herve/D-1452-2011	Robillard, Tony/0000-0002-2177-9549; Jourdan, Herve/0000-0002-3756-4008; Couloux, Arnaud/0000-0003-2356-0062; Grandcolas, Philippe/0000-0003-1374-1222	Consortium National de Recherche en Genomique; UMS 2700 CNRS; Genoscope [2005/67]; MNHN	Consortium National de Recherche en Genomique; UMS 2700 CNRS; Genoscope; MNHN	The authors are grateful to the following institutions or programs that made their work possible: the Directions de l'Environnement of New Caledonia's Province Nord and Province Sud for permits to work in natural parks and forest reserves; the Direction des Infrastructures, de la Topographie et des Transports Terrestres of the Gouvernement de la Nouvelle-Caledonie for kindly providing the GIS layers and electronic maps of New Caledonia (agreement number CS11-3170-865) and the IRD authorities for local support and hosting. The study was also made possible by the grant "ANR Bioneocal" to PG and by a PhD grant of the Gouvernement de Nouvelle-Caledonie and from the Prevost Fund of the Ecole Doctorale of the Museum national d'Histoire naturelle, Paristo RN. The molecular work was supported by the Consortium National de Recherche en Genomique and the UMS 2700 CNRS, and was carried out under agreement no. 2005/67 between Genoscope and the MNHN for the project 'Macrophylogeny of life' of Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JC, 1995, GEOLOGY, V23, P161, DOI 10.1130/0091-7613(1995)023<0161:EACCIN>2.3.CO;2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albrecht FO, 1953, ANATOMY MIGRATORY LO; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Boyd Robert S., 2006, Insect Science, V13, P271, DOI 10.1111/j.1744-7917.2006.00094.x; Bradford J, 2004, BIODIVERS CONSERV, V13, P2253, DOI 10.1023/B:BIOC.0000047901.33761.3c; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Chapco W, 1999, ANN ENTOMOL SOC AM, V92, P617, DOI 10.1093/aesa/92.5.617; Chapco William, 2002, Journal of Orthoptera Research, V11, P1, DOI 10.1665/1082-6467(2002)011[0001:AMPAOT]2.0.CO;2; Chazeau J., 1993, Biodiversity Letters, V1, P123, DOI 10.2307/2999756; Chevillotte V, 2006, GEOMORPHOLOGY, V81, P361, DOI 10.1016/j.geomorph.2006.04.020; Cluzel D, 2001, TECTONOPHYSICS, V340, P23, DOI 10.1016/S0040-1951(01)00148-2; Cluzell D, 2012, EPISODES, V35, P72, DOI 10.18814/epiiugs/2012/v35i1/007; Colombo P, 2005, CLADISTICS, V21, P375, DOI 10.1111/j.1096-0031.2005.00068.x; Crawford A., 2003, GEOLOGICAL SOC AUSTR, V22, P377; de Kok Rogier, 2002, Adansonia (Paris), V24, P229; De Laubenfels David J., 1996, P261; Desutter-Grandcolas L, 2006, SYST ENTOMOL, V31, P65, DOI 10.1111/j.1365-3113.2005.00299.x; Dirsh V. M., 1956, Transactions of the Royal Entomological Society of London, V108, P223; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edelman WC, 2010, INSECT SYST EVOL, V41, P303, DOI 10.1163/187631210X519709; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasc A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065311; GELLISSEN G, 1983, NATURE, V301, P631, DOI 10.1038/301631a0; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Grandcolas P, 2001, P ACAD NAT SCI PHILA, V151, P61, DOI 10.1635/0097-3157(2001)151[0061:WDCKNS]2.0.CO;2; Grandcolas P, 2002, MEMOIRES MUSEUM NATL, P117; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas Philippe, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P91; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hochkirch A, 2008, ZOOL STUD, V47, P495; Hochkirch A, 2009, SYST ENTOMOL, V34, P188, DOI 10.1111/j.1365-3113.2008.00449.x; Jaffre T., 1992, P101; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; KALTENBACH A, 1976, Annalen des Naturhistorischen Museums in Wien, V80, P657; KALTENBACH A, 1968, Annalen des Naturhistorischen Museums in Wien, V72, P539; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; Morat P., 1986, ADANSONIA, V4, P133; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Murienne J, 2008, ZOOLOGIA NEOCALEDONI, P261; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Nattier R, 2011, J BIOGEOGR, V38, P2195, DOI 10.1111/j.1365-2699.2011.02563.x; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Oneal E, 2010, J BIOGEOGR, V37, P530, DOI 10.1111/j.1365-2699.2009.02231.x; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paris J.-P., 1981, Memoire du B.R.G.M., P1; Paris J.P., 1981, ATLAS NOUVELLE CALED; Pellens R, 2009, BIODIVERSITY HOTSPOT; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pfeiler E, 2007, HEREDITAS, V144, P63, DOI 10.1111/j.2007.0018-0661.01997.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pillon Y, 2012, BOT J LINN SOC, V170, P288, DOI 10.1111/j.1095-8339.2012.01274.x; Pillon Y, 2010, J ECOL, V98, P1108, DOI 10.1111/j.1365-2745.2010.01689.x; Pintaud JC, 2001, CR ACAD SCI III-VIE, V324, P453, DOI 10.1016/S0764-4469(01)01312-9; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; RAVEN PH, 1972, SCIENCE, V176, P1379, DOI 10.1126/science.176.4042.1379; Ren ZM, 2004, MOL PHYLOGENET EVOL, V33, P516, DOI 10.1016/j.ympev.2004.06.003; Reusch DN, 2011, GEOLOGY, V39, P807, DOI 10.1130/G31981.1; Robillard Tony, 2010, Zootaxa, V2559, P17; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultz O, 2007, SYST ENTOMOL, V32, P712, DOI 10.1111/j.1365-3113.2007.00395.x; Snyder RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007203; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Ullrich B, 2010, J ZOOL SYST EVOL RES, V48, P219, DOI 10.1111/j.1439-0469.2009.00553.x; Uvarov, 1939, ANN MAGAZINE NATURAL, V11, P459; Willemse C, 1923, NOVA CALEDONIA A, P99	86	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e80811	10.1371/journal.pone.0080811	http://dx.doi.org/10.1371/journal.pone.0080811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367480	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300002
J	Bull, JK; Sands, CJ; Garrick, RC; Gardner, MG; Tait, NN; Briscoe, DA; Rowell, DM; Sunnucks, P				Bull, James K.; Sands, Chester J.; Garrick, Ryan C.; Gardner, Michael G.; Tait, Noel N.; Briscoe, David A.; Rowell, David M.; Sunnucks, Paul			Environmental Complexity and Biodiversity: The Multi-Layered Evolutionary History of a Log-Dwelling Velvet Worm in Montane Temperate Australia	PLOS ONE			English	Article							EUPERIPATOIDES-ROWELLI ONYCHOPHORA; CLIMATIC OSCILLATIONS; POPULATION-STRUCTURE; GENETIC-STRUCTURE; GIANT SPRINGTAIL; PHYLOGEOGRAPHY; PERIPATOPSIDAE; SOFTWARE; ZONE; PLANIPAPILLUS	Phylogeographic studies provide a framework for understanding the importance of intrinsic versus extrinsic factors in shaping patterns of biodiversity through identifying past and present microevolutionary processes that contributed to lineage divergence. Here we investigate population structure and diversity of the Onychophoran (velvet worm) Euperipatoides rowelli in southeastern Australian montane forests that were not subject to Pleistocene glaciations, and thus likely retained more forest cover than systems under glaciation. Over a similar to 100 km transect of structurally-connected forest, we found marked nuclear and mitochondrial (mt) DNA genetic structuring, with spatially-localised groups. Patterns from mtDNA and nuclear data broadly corresponded with previously defined geographic regions, consistent with repeated isolation in refuges during Pleistocene climatic cycling. Nevertheless, some E. rowelli genetic contact zones were displaced relative to hypothesized influential landscape structures, implying more recent processes overlying impacts of past environmental history. Major impacts at different timescales were seen in the phylogenetic relationships among mtDNA sequences, which matched geographic relationships and nuclear data only at recent timescales, indicating historical gene flow and/or incomplete lineage sorting. Five major E. rowelli phylogeographic groups were identified, showing substantial but incomplete reproductive isolation despite continuous habitat. Regional distinctiveness, in the face of lineages abutting within forest habitat, could indicate pre- and/or postzygotic gene flow limitation. A potentially functional phenotypic character, colour pattern variation, reflected the geographic patterns in the molecular data. Spatial-genetic patterns broadly match those in previously-studied, co-occurring low-mobility organisms, despite a variety of life histories. We suggest that for E. rowelli, the complex topography and history of the region has led to interplay among limited dispersal ability, historical responses to environmental change, local adaptation, and some resistance to free admixture at geographic secondary contact, leading to strong genetic structuring at fine spatial scale.	[Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Sands, Chester J.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Garrick, Ryan C.] Univ Mississippi, Dept Biol, Oxford, MS USA; [Gardner, Michael G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Gardner, Michael G.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Tait, Noel N.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Briscoe, David A.; Rowell, David M.] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Monash University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Mississippi; Flinders University South Australia; Macquarie University; Australian National University	Bull, JK (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	james.bull.au@gmail.com	Rowell, David/C-9751-2009; Gardner, Michael G/A-8280-2011	Rowell, David/0000-0002-2077-9774; Gardner, Michael G/0000-0002-8629-354X; Sunnucks, Paul/0000-0002-8139-7059; Sands, Chester/0000-0003-1028-0328; Bull, James/0000-0002-0274-4359; Garrick, Ryan/0000-0002-4057-7061	School of Biological Sciences, Monash; Australian Research Council [DP0211156]; Holsworth Wildlife Endowment awards; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	School of Biological Sciences, Monash; Australian Research Council(Australian Research Council); Holsworth Wildlife Endowment awards; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded in part by a small grant from the School of Biological Sciences, Monash, and drew on some materials from an Australian Research Council (www.arc.gov.au/) grant DP0211156 partially-funded in 2002-2004 awarded to PS and DMR. CJS and RCG were supported by Holsworth Wildlife Endowment awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Allendorf F., 2007, CONSERVATION GENETIC; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise John C., 1994, pi; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barclay S, 2000, J ZOOL, V250, P425, DOI 10.1111/j.1469-7998.2000.tb00786.x; Barclay SD, 2000, J ZOOL, V250, P437; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beavis AS, 2011, BIOL J LINN SOC, V104, P805, DOI 10.1111/j.1095-8312.2011.01753.x; Blaxter M, 2011, CURR BIOL, V21, pR238, DOI 10.1016/j.cub.2011.02.017; BRISCOE DA, 1995, ZOOL J LINN SOC-LOND, V114, P91, DOI 10.1006/zjls.1995.0018; BULL JK, BIOL J LINNEAN SOC; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Curach N, 1999, MOL ECOL, V8, P1375, DOI 10.1046/j.1365-294x.1999.00698.x; Daniels SR, 2010, J ZOOL, V282, P171, DOI 10.1111/j.1469-7998.2010.00722.x; Daniels SR, 2009, BIOL J LINN SOC, V97, P200, DOI 10.1111/j.1095-8312.2009.01205.x; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; EAKIN RM, 1965, Z ZELLFORSCH MIK ANA, V68, P278, DOI 10.1007/BF00342434; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fortin MJ, 2000, LANDSCAPE ECOL, V15, P453, DOI 10.1023/A:1008194205292; Fu YX, 1997, GENETICS, V147, P915; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrick RC, 2007, MOL ECOL, V16, P1865, DOI 10.1111/j.1365-294X.2006.03165.x; Garrick RC, 2004, MOL ECOL, V13, P3329, DOI 10.1111/j.1365-294X.2004.02340.x; Garrick RC, 2008, EVOLUTION, V62, P1103, DOI 10.1111/j.1558-5646.2008.00349.x; Garrick Ryan C., 2012, Insects, V3, P270, DOI 10.3390/insects3010270; Garrick RC, 2011, J INSECT CONSERV, V15, P469, DOI 10.1007/s10841-010-9349-4; GILL AM, 1994, AUSTR VEGETATION; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; Gleeson DM, 1998, MOL PHYLOGENET EVOL, V10, P237, DOI 10.1006/mpev.1998.0512; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hodges KM, 2007, J ZOOL, V272, P64, DOI 10.1111/j.1469-7998.2006.00244.x; Hope G. S., 1994, HIST AUSTR VEGETATIO, P368; JACQUEZ GM, 1995, STAT MED, V14, P2343, DOI 10.1002/sim.4780142107; JACQUEZ GM, 2000, J GEOGRAPHICAL SYSTE, V2, P211; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mayer G, 2009, ZOOL J LINN SOC-LOND, V157, P17, DOI 10.1111/j.1096-3642.2009.00523.x; McDonald DE, 2012, J EVOLUTION BIOL, V25, P824, DOI 10.1111/j.1420-9101.2012.02482.x; MEGLECZ E, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0040861.PUBMED:22815847; Monge-Najera Julian, 1994, Biogeographica (Paris), V70, P111; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; ODEN NL, 1993, GEOGR ANAL, V25, P315; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Oliveira IS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019973; PATTERSON C, 1988, MOL BIOL EVOL, V5, P603; Pritchard JK, 2000, GENETICS, V155, P945; Quinn GP, 2002, EXPT DESIGN DATA ANA, DOI DOI 10.1017/CBO9780511806384; R Core Team, 2021, R LANG ENV STAT COMP; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; REID AL, 1995, ZOOL J LINN SOC-LOND, V114, P115, DOI 10.1006/zjls.1995.0020; Reinhard J, 2005, J ZOOL, V267, P1, DOI 10.1017/S0952836905007090; Rockman MV, 2002, EVOLUTION, V56, P58; Rockman MV, 2001, MOL PHYLOGENET EVOL, V21, P103, DOI 10.1006/mpev.2001.0990; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowell DM, 2002, J ZOOL, V257, P171, DOI 10.1017/S0952836902000778; ROWELL DM, 1995, ZONING, P139; Rozen S, 2000, Methods Mol Biol, V132, P365; Sands CJ, 2009, CONSERV GENET RESOUR, V1, P17, DOI 10.1007/s12686-009-9004-0; SCOTT IAW, 1991, AUST J ZOOL, V39, P499, DOI 10.1071/ZO9910499; Servedio MR, 2004, EVOLUTION, V58, P913, DOI 10.1111/j.0014-3820.2004.tb00425.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Siwek M, 2011, ANIM GENET, V42, P93, DOI 10.1111/j.1365-2052.2010.02080.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Sunnucks P, 1999, MOL ECOL, V8, P899; Sunnucks P, 2000, J ZOOL, V250, P447, DOI 10.1111/j.1469-7998.2000.tb00788.x; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; SUNNUCKS P, 2001, TALES UNEXPECTED; Sunnucks P, 2006, MOL ECOL, V15, P4513, DOI 10.1111/j.1365-294X.2006.03107.x; Tait Noel N., 1995, Memoir of the Association of Australasian Palaeontologists, V18, P21; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trewick SA, 1998, BIOL J LINN SOC, V63, P307, DOI 10.1006/bijl.1997.0197; Weigand AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037089; Woodman JD, 2007, COMP BIOCHEM PHYS A, V147, P514, DOI 10.1016/j.cbpa.2007.01.024; Woodman JD, 2006, J ZOOL, V268, P325, DOI 10.1111/j.1469-7998.2005.00012.x	92	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84559	10.1371/journal.pone.0084559	http://dx.doi.org/10.1371/journal.pone.0084559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358365	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000328737700100
J	Jiang, GH; Wen, X; Qiu, YW; Zhang, RB; Wang, JJ; Li, M; Ma, XF; Tian, JZ; Huang, RW				Jiang, Guihua; Wen, Xue; Qiu, Yingwei; Zhang, Ruibin; Wang, Junjing; Li, Meng; Ma, Xiaofen; Tian, Junzhang; Huang, Ruiwang			Disrupted Topological Organization in Whole-Brain Functional Networks of Heroin-Dependent Individuals: A Resting-State fMRI Study	PLOS ONE			English	Article							SMALL-WORLD; DRUG-ADDICTION; DECISION-MAKING; CORTICAL NETWORKS; OPIOID RECEPTORS; COCAINE USERS; CONNECTIVITY; MEMORY; ABNORMALITIES; NEUROBIOLOGY	Neuroimaging studies have shown that heroin addiction is related to abnormalities in widespread local regions and in the functional connectivity of the brain. However, little is known about whether heroin addiction changes the topological organization of whole-brain functional networks. Seventeen heroin-dependent individuals (HDIs) and 15 age-, gender-matched normal controls (NCs) were enrolled, and the resting-state functional magnetic resonance images (RS-fMRI) were acquired from these subjects. We constructed the brain functional networks of HDIs and NCs, and compared the between-group differences in network topological properties using graph theory method. We found that the HDIs showed decreases in the normalized clustering coefficient and in small-worldness compared to the NCs. Furthermore, the HDIs exhibited significantly decreased nodal centralities primarily in regions of cognitive control network, including the bilateral middle cingulate gyrus, left middle frontal gyrus, and right precuneus, but significantly increased nodal centralities primarily in the left hippocampus. The between-group differences in nodal centralities were not corrected by multiple comparisons suggesting these should be considered as an exploratory analysis. Moreover, nodal centralities in the left hippocampus were positively correlated with the duration of heroin addiction. Overall, our results indicated that disruptions occur in the whole-brain functional networks of HDIs, findings which may be helpful in further understanding the mechanisms underlying heroin addiction.	[Jiang, Guihua; Qiu, Yingwei; Ma, Xiaofen; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wen, Xue; Zhang, Ruibin; Wang, Junjing; Li, Meng; Huang, Ruiwang] S China Normal Univ, Sch Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University	Tian, JZ (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jz.tian@163.com; ruiwang.huang@gmail.com	meng, li/GVT-2063-2022	Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	Guangdong No. 2 Provincial People's Hospital; National Natural Science Foundation of China [81071149, 81271548, 81371535]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2010B031600116]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Guangdong No. 2 Provincial People's Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was partially supported by the Guangdong No. 2 Provincial People's Hospital, the funding of National Natural Science Foundation of China (Grant numbers: 81071149, 81271548, and 81371535), the Science and Technology Planning Project of Guangdong Province, China (Grant numbers: 2011B031800044 and 2010B031600116), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (RH), State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ersche KD, 2006, PSYCHOPHARMACOLOGY, V188, P364, DOI 10.1007/s00213-006-0515-z; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gorelick DA, 2005, BIOL PSYCHIAT, V57, P1573, DOI 10.1016/j.biopsych.2005.02.026; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Henriksen G, 2008, BRAIN, V131, P1171, DOI 10.1093/brain/awm255; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Khalili-Mahani N, 2012, HUM BRAIN MAPP, V33, P1003, DOI 10.1002/hbm.21265; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Li XY, 2013, DRUG ALCOHOL DEPEN, V130, P61, DOI 10.1016/j.drugalcdep.2012.10.012; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; Prosser J, 2009, DRUG ALCOHOL DEPEN, V104, P228, DOI 10.1016/j.drugalcdep.2009.04.022; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riedel G, 2001, PROG NEURO-PSYCHOPH, V25, P835, DOI 10.1016/S0278-5846(01)00153-1; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Scott DJ, 2007, NEUROPSYCHOPHARMACOL, V32, P450, DOI 10.1038/sj.npp.1301238; Spreng RN, 2012, CEREB CORTEX, V22, P2610, DOI 10.1093/cercor/bhr339; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang Y, 2011, BRAIN RES, V1402, P46, DOI 10.1016/j.brainres.2011.05.054; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	66	96	100	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82715	10.1371/journal.pone.0082715	http://dx.doi.org/10.1371/journal.pone.0082715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358220	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700028
J	Latifi, K; Feygelman, V; Moros, EG; Dilling, TJ; Stevens, CW; Zhang, GG				Latifi, Kujtim; Feygelman, Vladimir; Moros, Eduardo G.; Dilling, Thomas J.; Stevens, Craig W.; Zhang, Geoffrey G.			Normalization of Ventilation Data from 4D-CT to Facilitate Comparison between Datasets Acquired at Different Times	PLOS ONE			English	Article							DEFORMABLE IMAGE REGISTRATION; COMPUTED-TOMOGRAPHY DENSITY; NONRIGID REGISTRATION; REGIONAL VENTILATION; LUNG-FUNCTION; CT; VALIDATION; SPECT	Purpose: The 4D-CT data used for comparing a patient's ventilation distributions before and after lung radiotherapy are acquired at different times. As a result, an additional variable - the tidal volume (TV) - can alter the results. Therefore, in this paper we propose to normalize the ventilation to the same TV to eliminate that uncertainty. Methods: Absolute ventilation (AV) data were generated for 6 stereotactic body radiation therapy (SBRT) cases before and after treatment, using the direct geometric algorithm and diffeomorphic morphons deformable image registration (DIR). Each pair of AV distributions was converted to TV-normalized, percentile ventilation (PV) and low-dose well-ventilated-normalized ventilation (LDWV) distributions. The ventilation change was calculated in various dose regions based on the treatment plans using the DIR-registered before and after treatment data sets. The ventilation change based on TV-normalized ventilation was compared with the AV as well as the data normalized by PV and LDWV. Results: AV change may be misleading when the TV differs before and after treatment, which was found to be up to 6.7%. All three normalization methods produced a similar trend in ventilation change: the higher the dose to a region of lung, the greater the degradation in ventilation. In low dose regions (<5 Gy), ventilation appears relatively improved after treatment due to the relative nature of the normalized ventilation. However, the LDWV may not be reliable when the ventilation in the low-dose regions varies. PV exhibited a similar ventilation change trend compared to the TV-normalized in all cases. However, by definition, the ventilation distribution in the PV is significantly different from the original distribution. Conclusion: Normalizing ventilation distributions by the TV is a simple and reliable method for evaluation of ventilation changes.	[Latifi, Kujtim; Feygelman, Vladimir; Moros, Eduardo G.; Dilling, Thomas J.; Stevens, Craig W.; Zhang, Geoffrey G.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute	Zhang, GG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA.	Geoffrey.Zhang@Moffitt.org	Moros, Eduardo G./AAY-2771-2020	Moros, Eduardo G./0000-0003-1964-2460	Varian Medical Systems, Inc., Palo Alto, California	Varian Medical Systems, Inc., Palo Alto, California	This work was partially supported by a research grant from Varian Medical Systems, Inc., Palo Alto, California. decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis,	Castillo R, 2010, PHYS MED BIOL, V55, P4661, DOI 10.1088/0031-9155/55/16/004; Chon D, 2005, RESP PHYSIOL NEUROBI, V148, P65, DOI 10.1016/j.resp.2005.06.003; Ding K, 2012, MED PHYS, V39, P5084, DOI 10.1118/1.4736808; Ding K, 2010, MED PHYS, V37, P1261, DOI 10.1118/1.3312210; Du KF, 2012, MED PHYS, V39, P1595, DOI 10.1118/1.3685589; Guerrero T, 2005, INT J RADIAT ONCOL, V62, P630, DOI 10.1016/j.ijrobp.2005.03.023; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Janssens G, 2009, MED PHYS, V36, P4268, DOI 10.1118/1.3194750; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Latifi K, 2013, J APPL CLIN MED PHYS, V14, P19, DOI 10.1120/jacmp.v14i1.3834; Petersson J, 2004, J APPL PHYSIOL, V96, P1127, DOI 10.1152/japplphysiol.00092.2003; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Simon BA, 2000, J CLIN MONITOR COMP, V16, P433, DOI 10.1023/A:1011444826908; Suga K, 2002, ANN NUCL MED, V16, P303, DOI 10.1007/BF02988614; Vinogradskiy YY, 2012, MED PHYS, V39, P289, DOI 10.1118/1.3668056; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064665; Wrangsjo A, 2005, LECT NOTES COMPUT SC, V3540, P501; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526; Zhang G. G., 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P1834, DOI 10.1007/978-3-642-03882-2_487; Zhang G, 2008, J APPL CLIN MED PHYS, V9, P59, DOI 10.1120/jacmp.v9i1.2738; Zhang G, 2011, PHYS MED BIOL, V56, P3445, DOI 10.1088/0031-9155/56/11/N03; Zhang GG, 2008, COMPUT METH PROG BIO, V90, P25, DOI 10.1016/j.cmpb.2007.11.015	23	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84083	10.1371/journal.pone.0084083	http://dx.doi.org/10.1371/journal.pone.0084083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358330	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700079
J	Mantella, NM; Kent, PF; Youngentob, SL				Mantella, Nicole M.; Kent, Paul F.; Youngentob, Steven L.			Fetal Nicotine Exposure Increases Preference for Nicotine Odor in Early Postnatal and Adolescent, but Not Adult, Rats	PLOS ONE			English	Article							GESTATIONAL ETHANOL EXPOSURE; NEUROPHYSIOLOGIC OLFACTORY RESPONSE; PRENATAL ALCOHOL EXPOSURE; MUCOSAL ACTIVITY PATTERNS; MATERNAL SMOKING; RECEPTOR SENSITIVITY; CIGARETTE-SMOKING; INFANT RATS; PREGNANCY; BULB	Human studies demonstrate a four-fold increased possibility of smoking in the children of mothers who smoked during pregnancy. Nicotine is the active addictive component in tobacco-related products, crossing the placenta and contaminating the amniotic fluid. It is known that chemosensory experience in the womb can influence postnatal odor-guided preference behaviors for an exposure stimulus. By means of behavioral and neurophysiologic approaches, we examined whether fetal nicotine exposure, using mini-osmotic pumps, altered the response to nicotine odor in early postnatal (P17), adolescent (P35) and adult (P90) progeny. Compared with controls, fetal exposed rats displayed an altered innate response to nicotine odor that was evident at P17, declined in magnitude by P35 and was absent at P90 - these effects were specific to nicotine odor. The behavioral effect in P17 rats occurred in conjunction with a tuned olfactory mucosal response to nicotine odor along with an untoward consequence on the epithelial response to other stimuli - these P17 neural effects were absent in P35 and P90 animals. The absence of an altered neural effect at P35 suggests that central mechanisms, such as nicotine-induced modifications of the olfactory bulb, bring about the altered behavioral response to nicotine odor. Together, these findings provide insights into how fetal nicotine exposure influences the behavioral preference and responsiveness to the drug later in life. Moreover, they add to a growing literature demonstrating chemosensory mechanisms by which patterns of maternal drug use can be conveyed to offspring, thereby enhancing postnatal vulnerability for subsequent use and abuse.	[Mantella, Nicole M.; Youngentob, Steven L.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Kent, Paul F.] SUNY Upstate Med Univ, Dept Neurol, Syracuse, NY 13210 USA; [Youngentob, Steven L.] SUNY Dev Exposure Alcohol Res Ctr, Syracuse, NY USA; [Youngentob, Steven L.] SUNY Dev Exposure Alcohol Res Ctr, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) System	Youngentob, SL (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.	youngens@upstate.edu			NIH-NIDA [1R21DA027740-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027740] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH-NIDA Grant # 1R21DA027740-01 to SL Youngentob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate P, 2001, ALCOHOL CLIN EXP RES, V25, P989, DOI 10.1111/j.1530-0277.2001.tb02307.x; Abate P, 2000, ALCOHOL CLIN EXP RES, V24, P39, DOI 10.1111/j.1530-0277.2000.tb04551.x; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Baer JS, 1998, J STUD ALCOHOL, V59, P533, DOI 10.15288/jsa.1998.59.533; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; BUTLER NR, 1973, BRIT MED J, V4, P573, DOI 10.1136/bmj.4.5892.573; CARR LA, 1989, NEUROCHEM RES, V14, P511, DOI 10.1007/BF00964911; Chotro MG, 2007, NEUROSCI BIOBEHAV R, V31, P181, DOI 10.1016/j.neubiorev.2006.06.021; Chotro MG, 1996, ALCOHOL, V13, P377, DOI 10.1016/0741-8329(96)00027-4; COOPERSMITH R, 1986, DEV BRAIN RES, V27, P191, DOI 10.1016/0165-3806(86)90245-2; Cornelius M D, 2000, Nicotine Tob Res, V2, P45; DENSON R, 1975, CAN PSYCHIAT ASSOC J, V20, P183, DOI 10.1177/070674377502000302; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Eade AM, 2010, ALCOHOL CLIN EXP RES, V34, P206, DOI 10.1111/j.1530-0277.2009.01083.x; Eade AM, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-3; EDWARDS DA, 1987, EXPERIENTIA, V43, P868, DOI 10.1007/BF01951644; Elliott BM, 2006, PRENATAL NICOTINE EX, P329; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; ESKENAZI B, 1995, AM J EPIDEMIOL, V142, pS19, DOI 10.1093/aje/142.Supplement_9.S19; Faas AE, 2000, ALCOHOL, V22, P7, DOI 10.1016/S0741-8329(00)00103-8; Fielding JE, 1998, TOBACCO HLTH EFFECTS, P817; GERVAIS R, 1988, CHEM SENSES, V13, P3, DOI 10.1093/chemse/13.1.3; GESTELAND RC, 1982, NEUROSCIENCE, V7, P3127, DOI 10.1016/0306-4522(82)90235-4; Getchell TV., 1991, SMELL TASTE HLTH DIS, P19; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hannigan JH, 1999, ALCOHOL ALCOHOLISM E; Hudson R, 1998, ANN NY ACAD SCI, V855, P109, DOI 10.1111/j.1749-6632.1998.tb10552.x; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Hussein J, 2007, TOXICOL APPL PHARM, V218, P1, DOI 10.1016/j.taap.2006.10.019; KANDEL DB, 1994, AM J PUBLIC HEALTH, V84, P1407, DOI 10.2105/AJPH.84.9.1407; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KENT PF, 1995, J NEUROPHYSIOL, V74, P1777, DOI 10.1152/jn.1995.74.4.1777; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; KRISTJANSSON EA, 1989, DRUG ALCOHOL DEPEN, V24, P11, DOI 10.1016/0376-8716(89)90003-3; LAING DG, 1980, PHYSIOL BEHAV, V25, P555, DOI 10.1016/0031-9384(80)90121-3; LAING DG, 1978, J COMP PHYSIOL, V124, P259, DOI 10.1007/BF00657057; LICHTENSTEIGER W, 1988, PROG BRAIN RES, V73, P137; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; Matta SG, 2007, PSYCHOPHARMACOLOGY, V193, P199, DOI 10.1007/s00213-007-0767-2; McLean JH, 2004, NEUROREPORT, V15, P1691, DOI 10.1097/01.wnr.0000134988.51310.c3; McLean JH, 1999, LEARN MEMORY, V6, P608, DOI 10.1101/lm.6.6.608; McMurray MS, 2008, NEUROTOXICOL TERATOL, V30, P475, DOI 10.1016/j.ntt.2008.07.001; Middleton FA, 2009, BRAIN RES, V1252, P105, DOI 10.1016/j.brainres.2008.11.023; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; NAEYE RL, 1992, J DEV BEHAV PEDIATR, V13, P425; Niaura R, 2001, AM J ADDICTION, V10, P16, DOI 10.1080/105504901750160420; Pritchard WS, 1996, PSYCHOPHARMACOLOGY, V127, P55, DOI 10.1007/BF02805975; ROSE JE, 1985, PHARMACOL BIOCHEM BE, V23, P289, DOI 10.1016/0091-3057(85)90572-6; Roth TL, 2003, PHYSIOL BEHAV, V78, P135, DOI 10.1016/S0031-9384(02)00961-7; Roth TL, 2001, DEV PSYCHOBIOL, V39, P188, DOI 10.1002/dev.1044; Salcedo E, 2005, CHEM SENSES, V30, P615, DOI 10.1093/chemse/bji055; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Smotherman W. P., 1987, PERINATAL DEV PSYCHO, P39; SMOTHERMAN WP, 1982, PHYSIOL BEHAV, V29, P769, DOI 10.1016/0031-9384(82)90322-5; SMOTHERMAN WP, 1988, BEHAV NEUROSCI, V102, P24, DOI 10.1037/0735-7044.102.1.24; SMOTHERMAN WP, 1985, BEHAV NEUROSCI, V99, P521, DOI 10.1037/0735-7044.99.3.521; SMOTHERMAN WP, 1990, PHYSIOL BEHAV, V47, P863, DOI 10.1016/0031-9384(90)90010-2; SMOTHERMAN WP, 1987, DEV PSYCHOBIOL, V20, P415, DOI 10.1002/dev.420200406; SMOTHERMAN WP, 1982, BEHAV NEURAL BIOL, V36, P61, DOI 10.1016/S0163-1047(82)90245-X; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spear NE, 2005, ALCOHOL CLIN EXP RES, V29, P909, DOI 10.1097/01.ALC.0000171046.78556.66; STICKROD G, 1982, PHYSIOL BEHAV, V28, P5, DOI 10.1016/0031-9384(82)90093-2; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Trauth JA, 2000, BRAIN RES, V867, P29, DOI 10.1016/S0006-8993(00)02208-3; Ulrich YM, 1997, NEUROPHARMACOLOGY, V36, P1119, DOI 10.1016/S0028-3908(97)00107-X; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Voznessenskaya VV, 1995, ADV BIOSCI, V93, P399; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Williams SK, 2009, NEUROTOXICOL TERATOL, V31, P291, DOI 10.1016/j.ntt.2009.06.001; WILSON DA, 1988, DEV BRAIN RES, V42, P69, DOI 10.1016/0165-3806(88)90202-7; WILSON DA, 1990, DEV BRAIN RES, V53, P215, DOI 10.1016/0165-3806(90)90009-N; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Yates WR, 1998, ALCOHOL ALCOHOLISM, V33, P488, DOI 10.1093/alcalc/33.5.488; Youngentob SL, 2005, CHEM SENSES, V30, P219, DOI 10.1093/chemse/bji017; YOUNGENTOB SL, 1995, J NEUROPHYSIOL, V73, P387, DOI 10.1152/jn.1995.73.1.387; YOUNGENTOB SL, 1995, BRAIN RES, V670, P82, DOI 10.1016/0006-8993(94)01275-M; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1293, DOI 10.1037/0735-7044.121.6.1293; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1306, DOI 10.1037/0735-7044.121.6.1306; Youngentob SL, 2012, EXP BIOL MED, V237, P1197, DOI 10.1258/ebm.2012.012132; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1346, DOI 10.1037/0735-7044.120.6.1346; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106	94	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84989	10.1371/journal.pone.0084989	http://dx.doi.org/10.1371/journal.pone.0084989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358374	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700108
J	Boukary, AR; Saegerman, C; Abatih, E; Fretin, D; Bada, RA; De Deken, R; Harouna, HA; Yenikoye, A; Thys, E				Boukary, Abdou Razac; Saegerman, Claude; Abatih, Emmanuel; Fretin, David; Bada, Rianatou Alambedji; De Deken, Reginald; Harouna, Halimatou Adamou; Yenikoye, Alhassane; Thys, Eric			Seroprevalence and Potential Risk Factors for Brucella Spp. Infection in Traditional Cattle, Sheep and Goats Reared in Urban, Periurban and Rural Areas of Niger	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; DIAGNOSIS; IDENTIFICATION; SEROPOSITIVITY; EPIDEMIOLOGY; PREVALENCE; LIVESTOCK; AFRICA; ZONE	Introduction: In Niamey, Niger, interactions within the interface between animals, humans and the environment induce a potential risk of brucellosis transmission between animals and from animals to humans. Currently, little is known about the transmission of Brucella in this context. Results: 5,192 animals from 681 herds were included in the study. Serum samples and hygroma fluids were collected. A household survey enabled to identify the risk factors for transmission of brucellosis. The true adjusted herd-level prevalence of brucellosis ranged between 11.2% and 17.2% and the true adjusted animal-population level prevalence was 1.3% (95% CI: 0.9-1.8%) based on indirect ELISA test for Brucella antibodies. Animals aged of 1-4 years were found to be more susceptible than animals less than 1 year old (Odds ratio [OR] of 2.7; 95% CI: 1.43-5.28). For cattle, the odds of brucellosis seropositivity were higher in rural compared to the periurban areas (OR of 2.8; 95% CI: 1.48-5.17) whereas for small ruminants the risk of seropositivity appeared to be higher in urban compared to periurban areas (OR of 5.5; 95% CI: 1.48-20.38). At herd level, the risk of transmission was increased by transhumance (OR of 5.4; 95% CI: 2.84-10.41), the occurrence of abortions (OR of 3.0; 95% CI: 1.40-6.41), and for herds having more than 50 animals (OR of 11.0; 95% CI: 3.75-32.46). Brucella abortus biovar 3 was isolated from the hygromas. Conclusion: brucellosis in Niger is a serious problem among cattle especially in the rural areas around Niamey and among sheep in the urban areas of Niamey. The seroprevalence varies across strata and animal species with important risk factors including herd size, abortion and transhumance at herd level and age at animal population level. For effective control of brucellosis, an integrated approach seems appropriate involving all stakeholders working in public and animal health.	[Boukary, Abdou Razac] ONG Karkara, Dept Livestock Promot & Management Nat Resources, Niamey, Niger; [Boukary, Abdou Razac; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Dept Infect & Parasit Dis, Liege, Belgium; [Boukary, Abdou Razac; Abatih, Emmanuel; De Deken, Reginald; Thys, Eric] Inst Trop Med, Unit Biostat & Epidemiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fretin, David] Vet & Agrochem Res Ctr, Dept Bacteriol & Immunol, Uccle, Belgium; [Bada, Rianatou Alambedji] Interstate Sch Vet Sci & Med, Serv Microbiol Immunol Infect Pathol, Dakar, Senegal; [Harouna, Halimatou Adamou] Direct Anim Hlth, Minist Livestock, Maradi, Niger; [Boukary, Abdou Razac; Yenikoye, Alhassane] Univ Niamey, Fac Agron, Niamey, Niger	University of Liege; Institute of Tropical Medicine (ITM)	Thys, E (corresponding author), Inst Trop Med, Unit Biostat & Epidemiol, Dept Biomed Sci, B-2000 Antwerp, Belgium.	ethys@itg.be		Saegerman, Claude/0000-0001-9087-7436	Belgian Directorate for Development (DGD)	Belgian Directorate for Development (DGD)	The authors wish to thank the Belgian Directorate for Development (DGD) for funding this study and VAR-Belgium for the contribution in the laboratory tests. DGD had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VAR had a role in the analysis and preparation of the manuscript.	ACHA P., 2005, ZOONOSES MALADIES TR; Akakpo A J, 1987, Rev Sci Tech, V6, P981, DOI 10.20506/rst.6.4.313; Akakpo A J, 1986, Rev Elev Med Vet Pays Trop, V39, P175; Alton GG, 1988, TECHNIQUES BRUCELLOS, p[29, 82]; Bankole AA, 2010, VET REC, V166, P753, DOI 10.1136/vr.b4862; Benkirane A., 2001, ORIENT REV SCI TECH, V20, P757; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Bloch N, 1991, Rev Elev Med Vet Pays Trop, V44, P117; Boukary A. R., 2010, Globalization of tropical animal diseases and public health concerns. Proceedings of the 13th Association of Institutions for Tropical Veterinary Medicine (AITVM) Conference, Bangkok, Thailand, 23-26 August 2010, P22; Boukary AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024629; Boukary AR., 2007, REV ELEV MED VET PAY, V60, P113; Cadmus S.I.B., 2006, AFR J BIOMED RES, V9, P163, DOI DOI 10.4314/ajbr.v9i3.48900; Chimana HM, 2010, TROP ANIM HEALTH PRO, V42, P1541, DOI 10.1007/s11250-010-9604-4; Corbel M., 1988, BRUCELLOSIS FERTILIT, V4th, P190; Corbel MJ, 1984, BERGEYS MANUAL SYSTE, P377; DOMENECH J, 1983, REV ELEV MED VET PAY, V36, P19; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gidel R., 1974, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V27, P403; Halling SM, 1994, FOODBORNE DIS HDB DI, P63; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Ibrahim N, 2010, TROP ANIM HEALTH PRO, V42, P35, DOI 10.1007/s11250-009-9382-z; Kangethe EK, 2007, E AFR MED J, V84, P96; Kore H., 2005, REPOL; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; LIMET JN, 1988, ANN MED VET, V132, P565; LY C., 2007, AGR ELEVAGE PAUVRETE, P71; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; Mangen MJ, 2002, BOVINE BRUCELLOSIS S; Matope G, 2010, PREV VET MED, V94, P213, DOI 10.1016/j.prevetmed.2010.01.003; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Megersa B, 2011, TROP ANIM HEALTH PRO, V43, P651, DOI 10.1007/s11250-010-9748-2; Mekonnen H, 2010, PREV VET MED, V94, P28, DOI 10.1016/j.prevetmed.2009.12.001; MERLE F., 1953, BULL SOC PATH EXOT, V46, P211; Muendo EN, 2012, TROP ANIM HEALTH PRO, V44, P17, DOI 10.1007/s11250-011-9899-9; Muma JB, 2007, REV SCI TECH OIE, V26, P721, DOI 10.20506/rst.26.3.1782; Musa M. T., 2001, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V54, P11; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Saegerman C, 2004, VET MICROBIOL, V100, P91, DOI 10.1016/j.vetmic.2004.02.003; Saegerman C., 2010, INFECT PARASITIC DIS, P971; Sanogo M., 2008, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V61, P147; Sanogo M, 2012, PREV VET MED, V107, P51, DOI 10.1016/j.prevetmed.2012.05.010; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Solorio-Rivera JL, 2007, PREV VET MED, V82, P282, DOI 10.1016/j.prevetmed.2007.05.024; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Thys E., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P205; Thys E, 2006, OUTLOOK AGR, V35, P7, DOI 10.5367/000000006776207654; TURKSON PK, 1992, ACTA TROP, V52, P39, DOI 10.1016/0001-706X(92)90005-I; Twisk JWR, 2003, APPL LONGITUDINAL DA; VERGER JM, 1979, REV ELEV MED VET PAY, V32, P25, DOI 10.19182/remvt.8185; Wagner B, 2004, PREV VET MED, V66, P1, DOI 10.1016/j.prevetmed.2004.07.008	55	50	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83175	10.1371/journal.pone.0083175	http://dx.doi.org/10.1371/journal.pone.0083175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358261	gold, Green Published			2022-12-25	WOS:000328735700109
J	Najafpanah, MJ; Sadeghi, M; Bakhtiarizadeh, MR				Najafpanah, Mohammad Javad; Sadeghi, Mostafa; Bakhtiarizadeh, Mohammad Reza			Reference Genes Selection for Quantitative Real-Time PCR Using RankAggreg Method in Different Tissues of Capra hircus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN ADIPOSE-TISSUE; RT-PCR; MESSENGER-RNA; CHROMIUM SUPPLEMENTATION; RELATIVE QUANTIFICATION; HOUSEKEEPING GENES; EXPRESSION; NORMALIZATION; VALIDATION	Identification of reference genes with stable levels of gene expression is an important prerequisite for obtaining reliable results in analysis of gene expression data using quantitative real time PCR (RT-qPCR). Since the underlying assumption of reference genes is that expressed at the exact same level in all sample types, in this study, we evaluated the expression stability of nine most commonly used endogenous controls (GAPDH, ACTB, 18S rRNA, RPS18, HSP-90, ALAS, HMBS, ACAC, and B2M) in four different tissues of the domestic goat, Capra hircus, including liver, visceral, subcutaneous fat and longissimus muscles, across different experimental treatments (a standard diet prepared using the NRC computer software as control and the same diet plus one mg chromium/day). We used six different software programs for ranking of reference genes and found that individual rankings of the genes differed among them. Additionally, there was a significant difference in ranking patterns of the studied genes among different tissues. A rank aggregation method was applied to combine the ranking lists of the six programs to a consensus ranking. Our results revealed that HSP-90 was nearly always among the two most stable genes in all studied tissues. Therefore, it is recommended for accurate normalization of RT-qPCR data in goats, while GAPDH, ACTB, and RPS18 showed the most varied expressions and should be avoided as reference genes.	[Najafpanah, Mohammad Javad; Sadeghi, Mostafa] Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran; [Bakhtiarizadeh, Mohammad Reza] Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran	University of Tehran; University of Tehran	Najafpanah, MJ (corresponding author), Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran.	mjnajafpanah@alumni.ut.ac.ir; sadeghimos@ut.ac.ir						Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson R.A., 1994, STRESS EFFECTS CHROM, P267; Becker C, 2011, ANALYST, V136, P1204, DOI 10.1039/c0an00703j; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; El-Monem U. M. A., 2008, Egyptian Journal of Sheep and Goat Sciences, V3, P95; Emami A., 2012, Online Journal of Animal and Feed Research (OJAFR), V2, P127; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fulton L. K., 1994, ILAR News, V36, P21; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Haldar S, 2009, ANIMAL, V3, P209, DOI 10.1017/S1751731108003418; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Lallemant B, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-78; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Maples NL, 2004, ENVIRON TOXICOL CHEM, V23, P626, DOI 10.1897/03-130; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Neville MJ, 2011, OBESITY, V19, P888, DOI 10.1038/oby.2010.257; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Pechova A, 2002, ACTA VET BRNO, V71, P9, DOI 10.2754/avb200271010009; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sadeghi M, 2013, BIOL TRACE ELEMENT R, P1; Seol Dongrim, 2011, BMC Res Notes, V4, P162, DOI 10.1186/1756-0500-4-162; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	54	29	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83041	10.1371/journal.pone.0083041	http://dx.doi.org/10.1371/journal.pone.0083041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358246	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700102
J	Weenen, TC; Ramezanpour, B; Pronker, ES; Commandeur, H; Claassen, E				Weenen, Tamar C.; Ramezanpour, Bahar; Pronker, Esther S.; Commandeur, Harry; Claassen, Eric			Food-Pharma Convergence in Medical Nutrition - Best of Both Worlds?	PLOS ONE			English	Article							CROSS IMPACT ANALYSIS; FUNCTIONAL FOODS; PATENT CITATIONS; TECHNOLOGY; INNOVATION; INDUSTRY; NUTRACEUTICALS; ACCEPTANCE; DIFFUSION; PRODUCTS	At present, industries within the health and life science sector are moving towards one another resulting in new industries such as the medical nutrition industry. Medical nutrition products are specific nutritional compositions for intervention in disease progression and symptom alleviation. Industry convergence, described as the blurring of boundaries between industries, plays a crucial role in the shaping of new markets and industries. Assuming that the medical nutrition industry has emerged from the convergence between the food and pharma industries, it is crucial to research how and which distinct industry domains have contributed to establish this relatively new industry. The first two stages of industry convergence (knowledge diffusion and consolidation) are measured by means of patent analysis. First, the extent of knowledge diffusion within the medical nutrition industry is graphed in a patent citation interrelations network. Subsequently the consolidation based on technological convergence is determined by means of patent co-classification. Furthermore, the medical nutrition core domain and technology interrelations are measured by means of a cross impact analysis. This study proves that the medical nutrition industry is a result of food and pharma convergence. It is therefore crucial for medical nutrition companies to effectively monitor technological developments within as well as across industry boundaries. This study further reveals that although the medical nutrition industry's core technology domain is food, technological development is mainly driven by pharmaceutical/pharmacological technologies Additionally, the results indicate that the industry has surpassed the knowledge diffusion stage of convergence, and is currently in the consolidation phase of industry convergence. Nevertheless, while the medical nutrition can be classified as an industry in an advanced phase of convergence, one cannot predict that the pharma and food industry segments will completely converge or whether the medical industry will become an individual successful industry.	[Weenen, Tamar C.; Commandeur, Harry] Erasmus Univ, Fac Econ, Rotterdam, Netherlands; [Weenen, Tamar C.; Claassen, Eric] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Ramezanpour, Bahar; Claassen, Eric] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Pronker, Esther S.] Viroclin, Rotterdam, Netherlands; [Commandeur, Harry] Nyenrode Business Univ, Breukelen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Nyenrode Business University	Weenen, TC (corresponding author), Erasmus Univ, Fac Econ, Rotterdam, Netherlands.	tamarchekaweenen@gmail.com	Han, KyungJu/J-5563-2014	Han, KyungJu/0000-0002-5006-1886				[Anonymous], 2001, 8498 NBER; Bagchi D, 2008, FOOD SCI TECHNOL-INT, P1; Blackman M, 1995, WORLD PATENT INFORM, V17, P115, DOI DOI 10.1016/0172-2190(95)00012-O; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; Bossink BAG, 2004, J CONSTR ENG M, V130, P337, DOI 10.1061/(ASCE)0733-9364(2004)130:3(337); Breschi S, 2003, RES POLICY, V32, P69, DOI 10.1016/S0048-7333(02)00004-5; Broring S, 2006, R&D MANAGE, V36, P487, DOI 10.1111/j.1467-9310.2006.00449.x; Broring S., 2007, CREAT INNOV MANAG, V16, P165, DOI DOI 10.1111/J.1467-8691.2007.00425.X; Chang SB, 2009, TECHNOL FORECAST SOC, V76, P107, DOI 10.1016/j.techfore.2008.03.014; Choi C, 2007, TECHNOL FORECAST SOC, V74, P1296, DOI 10.1016/j.techfore.2006.10.008; Csardi G, 2007, PHYSICA A, V374, P783, DOI 10.1016/j.physa.2006.08.022; Curran CS, 2011, TECHNOL FORECAST SOC, V78, P256, DOI 10.1016/j.techfore.2010.06.021; Curran CS, 2010, TECHNOL FORECAST SOC, V77, P385, DOI 10.1016/j.techfore.2009.10.002; Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009; Dernis H, 2002, NEW SCI TECHNOLOGY I, V27, P129; Duysters G., 1998, INT J ECON BUS, V5, P355, DOI DOI 10.1080/13571519884431; El-Sohaimy S. A., 2012, World Applied Sciences Journal, V20, P691; ENZER S, 1972, FUTURES, V4, P30, DOI 10.1016/0016-3287(72)90023-7; Ernst H, 1997, SMALL BUS ECON, V9, P361, DOI 10.1023/A:1007921808138; Eussen SRBM, 2011, EUR J PHARMACOL, V668, pS2, DOI 10.1016/j.ejphar.2011.07.008; Furst P, 2000, NUTRITION, V16, P603, DOI 10.1016/S0899-9007(00)00321-X; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Geum Y, 2012, ETRI J, V34, P439, DOI 10.4218/etrij.12.1711.0010; Gilbert L., 1997, Journal of Nutraceuticals, Functional and Medical Foods, V1, P5; Greenstein S, 1997, COMPETING IN THE AGE OF DIGITAL CONVERGENCE, P201; Grunert KG, 2000, INT DAIRY J, V10, P575, DOI 10.1016/S0958-6946(00)00085-6; Hacklin F, 2008, CONTRIB MANAG SCI, P1, DOI 10.1007/978-3-7908-1990-8; Henry CJ, 2010, EUR J CLIN NUTR, V64, P657, DOI 10.1038/ejcn.2010.101; Howlett J, 2008, ILSI EUR CONCISE MON, P1; Hu AGZ, 2003, INT J IND ORGAN, V21, P849, DOI 10.1016/S0167-7187(03)00035-3; Jaffe A. B., 1999, EC INNOVATION NEW TE, V8, P105, DOI DOI 10.1080/10438599900000006; Jeong GH, 1997, TECHNOL FORECAST SOC, V55, P203, DOI 10.1016/S0040-1625(96)00209-0; Johnstone N, 2010, ENVIRON RESOUR ECON, V45, P133, DOI 10.1007/s10640-009-9309-1; Karvonen M, 2012, TECHNOLOGICAL FORECA; KATZ L., 1996, IND CORP CHANG, V5, P1079, DOI DOI 10.1093/ICC/5.4.1079; Kim C, 2011, EXPERT SYST APPL, V38, P12559, DOI 10.1016/j.eswa.2011.04.042; Lee H, 2009, EXPERT SYST APPL, V36, P894, DOI 10.1016/j.eswa.2007.10.026; Lukach R., 2002, 754 CESIFO; Medical Nutrition International Industry (MNI), 2012, OR NUTR SUPPL TACKL; Nemet GF, 2012, RES POLICY, V41, P190, DOI 10.1016/j.respol.2011.08.009; OECD, 1994, US PAT DAT SCI TECHN; Pennings J. M., 2000, MARKET CONVERGENCE F; Phyllis Balch A, 2010, PRESCRIPTION NUTR HE; Prahalad CK, 1998, RES TECHNOL MANAGE, V41, P14, DOI 10.1080/08956308.1998.11671205; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; SCHULER A, 1991, IEEE T ENG MANAGE, V38, P224, DOI 10.1109/17.83755; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006547; Siro I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060; Suzuki J, 2004, RES POLICY, V33, P531, DOI 10.1016/j.respol.2003.10.005; Teratanavat R, 2006, J FOOD SCI, V71, pS533, DOI 10.1111/j.1750-3841.2006.00120.x; Thorleuchter D, 2010, TECHNOL FORECAST SOC, V77, P1037, DOI 10.1016/j.techfore.2010.03.002; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Tseng FM, 2011, TECHNOL FORECAST SOC, V78, P332, DOI 10.1016/j.techfore.2010.10.010; van Kreijl CF, 2006, OUR FOOD OUR HLTH HL, P189; Verhagen H, 2010, ARCH BIOCHEM BIOPHYS, V501, P6, DOI 10.1016/j.abb.2010.04.012; von Delft S, 2013, LETT EDITOR, V10, P67; Weaver B, 2007, RES PROPOSAL IND CON; Weenen T, 2013, PHARMANUTRITION; Weenen TC, 2013, BRIDGING PH IN PRESS; Weststrate JA, 2002, BRIT J NUTR, V88, pS233, DOI 10.1079/BJN2002688; Williams J, 2009, HLTH LIFESCIENCES IR; Yoon B., 2004, J HIGH TECHNOLOGY MA, V15, P37, DOI [DOI 10.1016/J.IPM.2006.11.011, 10.1016/j.hitech.2003.09.003, DOI 10.1016/J.HITECH.2003.09.003]	62	15	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82609	10.1371/journal.pone.0082609	http://dx.doi.org/10.1371/journal.pone.0082609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358214	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700087
J	Barbetti, V; Morandi, A; Tusa, I; Digiacomo, G; Riverso, M; Marzi, I; Cipolleschi, MG; Bessi, S; Giannini, A; Di Leo, A; Dello Sbarba, P; Rovida, E				Barbetti, V.; Morandi, A.; Tusa, I.; Digiacomo, G.; Riverso, M.; Marzi, I.; Cipolleschi, M. G.; Bessi, S.; Giannini, A.; Di Leo, A.; Dello Sbarba, P.; Rovida, E.			Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells	ONCOGENE			English	Article						CSF-1; nuclear proteins; breast cancer; Fms; nuclear receptor tyrosine kinase	COLONY-STIMULATING FACTOR; FIBROBLAST-GROWTH-FACTOR; FACTOR-I; NUCLEAR TRANSLOCATION; FACTOR-RECEPTOR; C-FMS; MACROPHAGE PRODUCTION; SIGNAL-TRANSDUCTION; TYROSINE KINASE; CERVICAL-CANCER	The colony-stimulating factor-1 (CSF-1) and its receptor CSF-1R physiologically regulate the monocyte/macrophage system, trophoblast implantation and breast development. An abnormal CSF-1R expression has been documented in several human epithelial tumors, including breast carcinomas. We recently demonstrated that CSF-1/CSF-1R signaling drives proliferation of breast cancer cells via 'classical' receptor tyrosine kinase signaling, including activation of the extracellular signal-regulated kinase 1/2. In this paper, we show that CSF-1R can also localize within the nucleus of breast cancer cells, either cell lines or tissue specimens, irrespectively of their intrinsic molecular subtype. We found that the majority of nuclear CSF-1R is located in the chromatin-bound subcellular compartment. Chromatin immunoprecipitation revealed that CSF-1R, once in the nucleus, binds to the promoters of the proliferation-related genes CCND1, c-JUN and c-MYC. CSF-1R also binds the promoter of its ligand CSF-1 and positively regulates CSF-1 expression. The existence of such a receptor/ligand regulatory loop is a novel aspect of CSF-1R signaling. Moreover, our results provided the first evidence of a novel localization site of CSF-1R in breast cancer cells, suggesting that CSF-1R could act as a transcriptional regulator on proliferation-related genes.	[Barbetti, V.; Morandi, A.; Tusa, I.; Digiacomo, G.; Riverso, M.; Marzi, I.; Cipolleschi, M. G.; Dello Sbarba, P.; Rovida, E.] Univ Florence, Sez Patol, Dipartimento Sci Biomed Sperimentali & Clin, Ist Toscano Tumori, I-50134 Florence, Italy; [Bessi, S.; Giannini, A.] Osped Prato, Prato, Italy; [Di Leo, A.] Hosp Prato, Ist Toscano Tumori, Dept Oncol, Sandro Pitigliani Med Oncol Unit, Prato, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence; Prato Hospital; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Prato Hospital	Rovida, E (corresponding author), Univ Florence, Sez Patol, Dipartimento Sci Biomed Sperimentali & Clin, Viale GB Morgagni 50, I-50134 Florence, Italy.	erovida@unifi.it	Dello Sbarba, Persio/AAX-9887-2020; Rovida, Elisabetta/F-3565-2015; Morandi, Andrea/AAC-1901-2022	Rovida, Elisabetta/0000-0002-5949-3239; Morandi, Andrea/0000-0002-9222-5332; Tusa, Ignazia/0000-0002-9198-2630	Istituto Toscano Tumori, Associazione Italiana per la Ricerca sul Cancro, Ministero della Salute (Ricerca Finalizzata) [RF-TOS-2008-1163728]; Regione Toscana (Programma per la Ricerca in Materia di Salute); Associazione Italiana per la Lotta contro le Leucemie e i Linfomi (sezione di Prato); Fondazione Cassa di Risparmio di Volterra; Fondazione Oretta Bartolomei-Corsi	Istituto Toscano Tumori, Associazione Italiana per la Ricerca sul Cancro, Ministero della Salute (Ricerca Finalizzata)(Fondazione AIRC per la ricerca sul cancro); Regione Toscana (Programma per la Ricerca in Materia di Salute)(Regione Toscana); Associazione Italiana per la Lotta contro le Leucemie e i Linfomi (sezione di Prato)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Volterra; Fondazione Oretta Bartolomei-Corsi(Fondazione CarifeFondazione Caritro)	This work was supported by Istituto Toscano Tumori, Associazione Italiana per la Ricerca sul Cancro, Ministero della Salute (Ricerca Finalizzata, Grant number RF-TOS-2008-1163728), Regione Toscana (Programma per la Ricerca in Materia di Salute), Associazione Italiana per la Lotta contro le Leucemie e i Linfomi (sezione di Prato), Fondazione Cassa di Risparmio di Volterra, Fondazione Oretta Bartolomei-Corsi. We thank Professor Clare M Isacke (Breakthrough Breast Cancer Research Centre, London, UK) for revising the manuscript.	Barbetti V, 2008, ONCOGENE, V27, P1767, DOI 10.1038/sj.onc.1210820; Barbetti V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.49; Barbetti V, 2013, EPIGENETICS-US, V8, P210, DOI 10.4161/epi.23538; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Dittmann K, 2010, STRAHLENTHER ONKOL, V186, P1, DOI 10.1007/s00066-009-2026-4; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; GUILBERT LJ, 1986, J BIOL CHEM, V261, P4024; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hammes LS, 2008, GYNECOL ONCOL, V110, P445, DOI 10.1016/j.ygyno.2008.04.038; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Johnston CL, 1995, J BIOL CHEM, V270, P30643, DOI 10.1074/jbc.270.51.30643; KACINSKI BM, 1991, ONCOGENE, V6, P941; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Mancini A, 2004, ONCOGENE, V23, P6581, DOI 10.1038/sj.onc.1207841; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Morandi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027450; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; ROUSSEL MF, 1989, P NATL ACAD SCI USA, V86, P7924, DOI 10.1073/pnas.86.20.7924; ROUSSEL MF, 1994, J CELL SCI, P105; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Rovida E, 2002, ONCOGENE, V21, P3670, DOI 10.1038/sj.onc.1205409; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Seol KC, 2003, BIOCHEM BIOPH RES CO, V306, P898, DOI 10.1016/S0006-291X(03)01046-5; SHADLE PJ, 1989, J CELL BIOCHEM, V40, P91, DOI 10.1002/jcb.240400110; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Stachowiak MK, 1996, MOL BRAIN RES, V38, P161, DOI 10.1016/0169-328X(96)00010-1; STANLEY ER, 1978, NATURE, V274, P168, DOI 10.1038/274168a0; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Toy EP, 2009, NEOPLASIA, V11, P136, DOI 10.1593/neo.81150; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Yee LD, 2000, ANTICANCER RES, V20, P4379; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; Zwaenepoel O, 2012, FASEB J, V26, P691, DOI 10.1096/fj.11-189753	51	21	24	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4359	4364		10.1038/onc.2013.542	http://dx.doi.org/10.1038/onc.2013.542			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24362524	Green Published, hybrid			2022-12-25	WOS:000341156900009
J	Hsu, WY; Chen, CJ; Huang, YC; Tsai, FJ; Jeng, LB; Lai, CC				Hsu, Wei-Yi; Chen, Chao-Jung; Huang, Yu-Chuen; Tsai, Fuu-Jen; Jeng, Long-Bin; Lai, Chien-Chen			Urinary Nucleosides as Biomarkers of Breast, Colon, Lung, and Gastric Cancer in Taiwanese	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; POTENTIAL TUMOR-MARKERS; LIQUID-CHROMATOGRAPHY; CLINICAL-DIAGNOSIS; TRANSFER-RNA; SEPARATION; SERUM	Urinary nucleosides are associated with many types of cancer. In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. Urine samples were purified using solid-phase extraction (SPE) and then analyzed using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The Mann-Whitney U test and Principal Component Analysis (PCA) were used to compare differences in urinary nucleosides between patients with one of four types of cancer and healthy controls. The diagnostic sensitivity of single nucleosides for different types of cancer ranged from 14% to 69%. In contrast, the diagnostic sensitivity of a set of six nucleosides ranged from 37% to 69%. The false-positive identification rate associated with the set of six nucleosides in urine was less than 2% compared with that of less than 5% for a single nucleoside. Furthermore, combining the set of six urinary nucleosides with carcinoembryonic antigen improved the diagnostic sensitivity for colon cancer. In summary, the study show that a set of six targeted nucleosides is a good diagnostic marker for breast and colon cancers but not for lung and gastric cancers.	[Hsu, Wei-Yi; Chen, Chao-Jung; Huang, Yu-Chuen; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsu, Wei-Yi] China Med Univ, Taichung, Taiwan; [Chen, Chao-Jung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Huang, Yu-Chuen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Lai, Chien-Chen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Lai, Chien-Chen] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan	Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Taichung, Taiwan.	longbin@mail.cmuh.org.tw; lailai@dragon.nchu.edu.tw	Tsai, Fuu-Jen/J-4140-2015; Chen, Chao-Jung/E-5481-2011; /AGZ-4617-2022	Chen, Chao-Jung/0000-0003-3834-9243; /0000-0002-7133-8266	China Medical University; National Science Council of the Republic of China	China Medical University(China Medical University); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The study was funded by a grant from China Medical University and the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS H, 1972, CLIN CHIM ACTA, V37, P193, DOI 10.1016/0009-8981(72)90432-9; BOREK E, 1971, CANCER RES, V31, P596; BOREK E, 1977, CANCER RES, V37, P3362; Cho SH, 2009, CLIN BIOCHEM, V42, P540, DOI 10.1016/j.clinbiochem.2008.12.026; DAVIS GE, 1977, CLIN CHEM, V23, P1427; GEHRKE CW, 1978, J CHROMATOGR, V150, P455, DOI 10.1016/S0021-9673(00)88205-9; Hsu WY, 2011, CLIN CHIM ACTA, V412, P1861, DOI 10.1016/j.cca.2011.06.027; Hsu WY, 2009, CLIN CHIM ACTA, V402, P31, DOI 10.1016/j.cca.2008.12.009; Li HY, 2009, J MASS SPECTROM, V44, P641, DOI 10.1002/jms.1539; Markuszewski MJ, 2010, ELECTROPHORESIS, V31, P2300, DOI 10.1002/elps.200900785; MCENTIRE JE, 1989, CANCER RES, V49, P1057; Rodriguez-Gonzalo E, 2011, J CHROMATOGR A, V1218, P9055, DOI 10.1016/j.chroma.2011.10.016; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Struck W, 2013, J CHROMATOGR A, V1283, P122, DOI 10.1016/j.chroma.2013.01.111; Struck W, 2011, ANAL BIOANAL CHEM, V401, P2039, DOI 10.1007/s00216-011-4789-6; Szymanska E, 2010, J PHARMACEUT BIOMED, V53, P1305, DOI 10.1016/j.jpba.2010.07.031; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014	18	40	41	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e81701	10.1371/journal.pone.0081701	http://dx.doi.org/10.1371/journal.pone.0081701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367489	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900004
J	Kline, C; Ndjomou, J; Franks, T; Kiser, R; Coalter, V; Smedley, J; Piatak, M; Mellors, JW; Lifson, JD; Ambrose, Z				Kline, Christopher; Ndjomou, Jean; Franks, Tamera; Kiser, Rebecca; Coalter, Vicky; Smedley, Jeremy; Piatak, Michael, Jr.; Mellors, John W.; Lifson, Jeffrey D.; Ambrose, Zandrea			Persistence of Viral Reservoirs in Multiple Tissues after Antiretroviral Therapy Suppression in a Macaque RT-SHIV Model	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-POSITIVE PATIENTS; CD4(+) T-LYMPHOCYTES; RALTEGRAVIR INTENSIFICATION; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; GENITAL-TRACT; REPLICATION; EVOLUTION; VIREMIA	Although antiretroviral therapy (ART) can suppress HIV-1 replication sufficiently to eliminate measurable plasma viremia, infected cells remain and ensure viral recrudescence after discontinuation of ART. We used a macaque model of HIV-1/AIDS to evaluate the location of infected cells during ART. Twelve macaques were infected with RT-SHIVmne, a SIV containing HIV-1 reverse transcriptase, conferring sensitivity to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Ten to fourteen weeks post-infection, 6 animals were treated with 3 or 4 antiretroviral drugs for 17-20 weeks; 6 control animals remained untreated. Viral DNA (vDNA) and RNA (vRNA) were measured in peripheral blood mononuclear cells (PBMC) and at necropsy in multiple tissues by quantitative PCR and RT-PCR. The majority of virally infected cells were located in lymphoid tissues with variable levels in the gastrointestinal tract of both treated and untreated animals. Tissue viral DNA levels correlated with week 1 plasma viremia, suggesting that tissues that harbor proviral DNA are established within the first week of infection. PBMC vDNA levels did not correlate with plasma viremia or tissue levels of vDNA. vRNA levels were high in lymphoid and gastrointestinal tissues of the untreated animals; animals on ART had little vRNA expressed in tissues and virus could not be cultured from lymph node resting CD4+ cells after 17-20 weeks on ART, indicating little or no ongoing viral replication. Strategies for eradication of HIV-1 will need to target residual virus in ART suppressed individuals, which may not be accurately reflected by frequencies of infected cells in blood.	[Kline, Christopher; Ndjomou, Jean; Franks, Tamera; Mellors, John W.; Ambrose, Zandrea] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA; [Kiser, Rebecca; Coalter, Vicky; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Smedley, Jeremy] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambrose, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	zaa4@pitt.edu	; Kline, Christopher/B-1477-2012	Ambrose, Zandrea/0000-0002-8610-2766; Smedley, Jeremy/0000-0003-3369-4662; Kline, Christopher/0000-0003-1025-9430	American Foundation for AIDS Research (amfAR) [107149-44-RGRL]; Merck Co., Inc. [33665]; National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]	American Foundation for AIDS Research (amfAR); Merck Co., Inc.(Merck & Company); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants 107149-44-RGRL from the American Foundation for AIDS Research (amfAR) and 33665 from Merck & Co., Inc. (Z.A.) and with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E (J.D.L.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BALZARINI J, 1995, BIOCHEM BIOPH RES CO, V211, P850, DOI 10.1006/bbrc.1995.1890; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2011, CURR OPIN HIV AIDS, V6, P37, DOI 10.1097/COH.0b013e3283412413; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Hogan C, 2011, CLIN MED, V11, P571, DOI 10.7861/clinmedicine.11-6-571; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Persaud D, 2007, AIDS RES HUM RETROV, V23, P381, DOI 10.1089/aid.2006.0175; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Siliciano JD, 2005, ENHANCED CULTURE ASS; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Telenti A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007203; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	62	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84275	10.1371/journal.pone.0084275	http://dx.doi.org/10.1371/journal.pone.0084275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367650	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000328740300135
J	Place, TL; Nauseef, JT; Peterson, MK; Henry, MD; Mezhir, JJ; Domann, FE				Place, Trenton L.; Nauseef, Jones T.; Peterson, Maina K.; Henry, Michael D.; Mezhir, James J.; Domann, Frederick E.			Prolyl-4-Hydroxylase 3 (PHD3) Expression Is Downregulated during Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL-HYDROXYLASE PHD3; CELL-MIGRATION; PANCREATIC-CANCER; E-CADHERIN; APOPTOSIS; PROMOTES; GROWTH; DEATH; GENE	Prolyl-4-hydroxylation by the intracellular prolyl-4-hydroxylase enzymes (PHD1-3) serves as a master regulator of environmental oxygen sensing. The activity of these enzymes is tightly tied to tumorigenesis, as they regulate cell metabolism and angiogenesis through their control of hypoxia-inducible factor (HIF) stability. PHD3 specifically, is gaining attention for its broad function and rapidly accumulating array of non-HIF target proteins. Data from several recent studies suggest a role for PHD3 in the regulation of cell morphology and cell migration. In this study, we aimed to investigate this role by closely examining the relationship between PHD3 expression and epithelial-to-mesenchymal transition (EMT); a transcriptional program that plays a major role in controlling cell morphology and migratory capacity. Using human pancreatic ductal adenocarcinoma (PDA) cell lines and Madin-Darby Canine Kidney (MDCK) cells, we examined the correlation between several markers of EMT and PHD3 expression. We demonstrated that loss of PHD3 expression in PDA cell lines is highly correlated with a mesenchymal-like morphology and an increase in cell migratory capacity. We also found that induction of EMT in MDCK cells resulted in the specific downregulation of PHD3, whereas the expression of the other HIF-PHD enzymes was not affected. The results of this study clearly support a model by which the basal expression and hypoxic induction of PHD3 is suppressed by the EMT transcriptional program. This may be a novel mechanism by which migratory or metastasizing cells alter signaling through specific pathways that are sensitive to regulation by O-2. The identification of downstream pathways that are affected by the suppression of PHD3 expression during EMT may provide important insight into the crosstalk between O-2 and the migratory and metastatic potential of tumor cells.	[Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA; [Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Peterson, Maina K.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Mezhir, James J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Domann, FE (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	frederick-domann@uiowa.edu		Domann, Frederick/0000-0002-0489-2179; Maina, Peterson/0000-0002-5909-190X; Henry, Michael/0000-0002-7871-245X	National Institutes of Health (NIH) [CA115438, NIH CA130916, TL1RR024981]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of Health; American Medical Association Foundation Seed Grant; NATIONAL CANCER INSTITUTE [R01CA115438, R01CA130916, P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Medical Association Foundation Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) CA115438 (FED); NIH CA130916 (MDH); TLP received salary support from NIH TL1RR024981 from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences, National Institutes of Health; the work was also partially supported by an American Medical Association Foundation Seed Grant (TLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen SF, 2011, MOL CELL BIOCHEM, V358, P257, DOI 10.1007/s11010-011-0976-1; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Liu Y, 2010, BIOCHEM BIOPH RES CO, V401, P231, DOI 10.1016/j.bbrc.2010.09.037; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nishioka R, 2010, EXP MOL PATHOL, V89, P149, DOI 10.1016/j.yexmp.2010.05.008; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Place T, J HYPOXIA; Place TL, 2013, HP, P13, DOI [10.2147/HP.S50091, DOI 10.2147/HP.S50091]; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; STERNFELD J, 1981, J CELL SCI, V50, P9; Straub JA, 2003, J NEUROCHEM, V85, P318, DOI 10.1046/j.1471-4159.2003.01688.x; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tennant DA, 2010, J MOL MED, V88, P839, DOI 10.1007/s00109-010-0627-0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; WAX SD, 1994, J BIOL CHEM, V269, P13041; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324	43	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83021	10.1371/journal.pone.0083021	http://dx.doi.org/10.1371/journal.pone.0083021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367580	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300091
J	Cheng, RB; Zheng, XD; Ma, YY; Li, Q				Cheng, Rubin; Zheng, Xiaodong; Ma, Yuanyuan; Li, Qi			The Complete Mitochondrial Genomes of Two Octopods Cistopus chinensis and Cistopus taiwanicus: Revealing the Phylogenetic Position of the Genus Cistopus within the Order Octopoda	PLOS ONE			English	Article							WATER OCTOPUSES CEPHALOPODA; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; GENES; SELECTION; ALIGNMENT; MOLLUSCA; PROGRAM	In the present study, we determined the complete mitochondrial DNA (mtDNA) sequences of two species of Cistopus, namely C. chinensis and C. taiwanicus, and conducted a comparative mt genome analysis across the class Cephalopoda. The mtDNA length of C. chinensis and C. taiwanicus are 15706 and 15793 nucleotides with an AT content of 76.21% and 76.5%, respectively. The sequence identity of mtDNA between C. chinensis and C. taiwanicus was 88%, suggesting a close relationship. Compared with C. taiwanicus and other octopods, C. chinensis encoded two additional tRNA genes, showing a novel gene arrangement. In addition, an unusual 23 poly (A) signal structure is found in the ATP8 coding region of C. chinensis. The entire genome and each protein coding gene of the two Cistopus species displayed notable levels of AT and GC skews. Based on sliding window analysis among Octopodiformes, ND1 and DN5 were considered to be more reliable molecular beacons. Phylogenetic analyses based on the 13 protein-coding genes revealed that C. chinensis and C. taiwanicus form a monophyletic group with high statistical support, consistent with previous studies based on morphological characteristics. Our results also indicated that the phylogenetic position of the genus Cistopus is closer to Octopus than to Amphioctopus and Callistoctopus. The complete mtDNA sequence of C. chinensis and C. taiwanicus represent the first whole mt genomes in the genus Cistopus. These novel mtDNA data will be important in refining the phylogenetic relationships within Octopodiformes and enriching the resource of markers for systematic, population genetic and evolutionary biological studies of Cephalopoda.	[Cheng, Rubin; Zheng, Xiaodong; Ma, Yuanyuan; Li, Qi] Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China; [Cheng, Rubin] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Zheng, Xiaodong] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China	Ocean University of China; Zhejiang Chinese Medical University; Ocean University of China	Zheng, XD (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China.	xdzheng@mail.ouc.edu.cn			National Natural Science Foundation of China [31172058]; Fundamental Research Funds for the Central Universities [201362022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grant from the National Natural Science Foundation of China (31172058) and the Fundamental Research Funds for the Central Universities (201362022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng RB, 2012, MOL BIOL REP, V39, P3461, DOI 10.1007/s11033-011-1118-2; Dai LN, 2012, MOL ECOL RESOUR, V12, P437, DOI 10.1111/j.1755-0998.2012.03118.x; Danic-Tchaleu Gwenaelle, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-400; DONOVAN DT, 1964, BIOL REV, V39, P259, DOI 10.1111/j.1469-185X.1964.tb01160.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Goloboff P, 2008, CLADISTICS, V24, P91; Guerra A, 2010, ICES J MAR SCI, V67, P1401, DOI 10.1093/icesjms/fsq040; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LIAO JX, 2009, J MOLLUS STUD, V75, P1; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Nateewathana Anuwat, 1997, Phuket Marine Biological Center Special Publication, V17, P407; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Norman MD, 2000, RAFFLES B ZOOL, P539; Norman MD, 1997, INVERTEBR TAXON, V11, P89, DOI 10.1071/IT95026; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Strugnell J, 2007, J MOLLUS STUD, V73, P399, DOI 10.1093/mollus/eym038; Strugnell JM, 2014, HYDROBIOLOGIA, V725, P215, DOI 10.1007/s10750-013-1517-6; Sun Y, 2012, MOL ECOL RESOUR, V12, P209, DOI 10.1111/j.1755-0998.2011.03085.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xie Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027066; Yamazaki N, 1997, GENETICS, V145, P749; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Yokobori S, 2004, MOL BIOL EVOL, V21, P2034, DOI 10.1093/molbev/msh227; Yokobori SI, 2007, MOL PHYLOGENET EVOL, V44, P898, DOI 10.1016/j.ympev.2007.05.009; ZHENG X, 2005, PHUKET MAR BIO CENT, P195; Zheng XD, 2004, J SHELLFISH RES, V23, P881; Zheng XD, 2012, J NAT HIST, V46, P355, DOI 10.1080/00222933.2011.639964; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	39	30	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84216	10.1371/journal.pone.0084216	http://dx.doi.org/10.1371/journal.pone.0084216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358345	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700087
J	Gomez-Mestre, I; Kulkarni, S; Buchholz, DR				Gomez-Mestre, Ivan; Kulkarni, Saurabh; Buchholz, Daniel R.			Mechanisms and Consequences of Developmental Acceleration in Tadpoles Responding to Pond Drying	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; THYROID-HORMONE RECEPTOR; CORTICOTROPIN-RELEASING HORMONE; SCAPHIOPUS-COUCHII TADPOLES; OXIDATIVE STRESS; AMPHIBIAN METAMORPHOSIS; LARVAL DEVELOPMENT; SPADEFOOT TOADS; ECOLOGICAL CONSEQUENCES; COMPENSATORY GROWTH	Many amphibian species exploit temporary or even ephemeral aquatic habitats for reproduction by maximising larval growth under benign conditions but accelerating development to rapidly undergo metamorphosis when at risk of desiccation from pond drying. Here we determine mechanisms enabling developmental acceleration in response to decreased water levels in western spadefoot toad tadpoles (Pelobates cultripes), a species with long larval periods and large size at metamorphosis but with a high degree of developmental plasticity. We found that P. cultripes tadpoles can shorten their larval period by an average of 30% in response to reduced water levels. We show that such developmental acceleration was achieved via increased endogenous levels of corticosterone and thyroid hormone, which act synergistically to achieve metamorphosis, and also by increased expression of the thyroid hormone receptor TR., which increases tissue sensitivity and responsivity to thyroid hormone. However, developmental acceleration had morphological and physiological consequences. In addition to resulting in smaller juveniles with proportionately shorter limbs, tadpoles exposed to decreased water levels incurred oxidative stress, indicated by increased activity of the antioxidant enzymes catalase, superoxide dismutase, and gluthatione peroxidase. Such increases were apparently sufficient to neutralise the oxidative damage caused by presumed increased metabolic activity. Thus, developmental acceleration allows spadefoot toad tadpoles to evade drying ponds, but it comes at the expense of reduced size at metamorphosis and increased oxidative stress.	[Gomez-Mestre, Ivan] CSIC, Ecol Evolut & Dev Grp, Donana Biol Stn, E-41080 Seville, Spain; [Kulkarni, Saurabh; Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kulkarni, Saurabh] Yale Univ, Dept Pediat, Yale Sch Med, New Haven, CT 06520 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University System of Ohio; University of Cincinnati; Yale University	Gomez-Mestre, I (corresponding author), CSIC, Ecol Evolut & Dev Grp, Donana Biol Stn, E-41080 Seville, Spain.	igmestre@ebd.csic.es	Gomez-Mestre, Ivan/F-8226-2014	Gomez-Mestre, Ivan/0000-0003-0094-8195; Kulkarni, Saurabh/0000-0002-0882-6478	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11123]; NSF IOS [0950538]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NSF IOS(National Science Foundation (NSF))	This research was supported by grant CGL2009-11123 from the Spanish Ministerio de Ciencia e Innovacion to IGM and by NSF IOS 0950538 to DRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, TADPOLES, P240; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bonett RM, 2010, GEN COMP ENDOCR, V168, P209, DOI 10.1016/j.ygcen.2010.03.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001; Buchholz DR, 2005, EVOL DEV, V7, P458, DOI 10.1111/j.1525-142X.2005.05049.x; Buchholz DR, 2002, COPEIA, P180, DOI 10.1643/0045-8511(2002)002[0180:EPODIS]2.0.CO;2; Buege J A, 1978, Methods Enzymol, V52, P302; COHEN G, 1969, J BACTERIOL, V98, P543, DOI 10.1128/JB.98.2.543-546.1969; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; CRUMP ML, 1989, COPEIA, P794, DOI 10.2307/1445521; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.1890/0012-9658(1998)079[1859:APIAMR]2.0.CO;2; Denver RJ, 1997, AM ZOOL, V37, P172; Denver RJ, 1998, GEN COMP ENDOCR, V110, P326, DOI 10.1006/gcen.1998.7082; DENVER RJ, 1988, J EXP ZOOL, V246, P293, DOI 10.1002/jez.1402460309; DENVER RJ, 1993, GEN COMP ENDOCR, V91, P38, DOI 10.1006/gcen.1993.1102; DENVER RJ, 1996, METAMORPHOSIS POSTEM, P433, DOI DOI 10.1016/B978-012283245-1/50014-2; Denver RJ, 2013, CURR TOP DEV BIOL, V103, P195, DOI 10.1016/B978-0-12-385979-2.00007-1; Enriquez-Urzelai U, 2013, OECOLOGIA, V173, P117, DOI 10.1007/s00442-013-2596-9; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Galvan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013369; Garcia-Paris M, 2004, AMPHIBIA; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Gomez-Mestre I, 2003, EVOLUTION, V57, P1889; Gomez-Mestre I, 2010, J EVOLUTION BIOL, V23, P1364, DOI 10.1111/j.1420-9101.2010.02016.x; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hollar AR, 2011, GEN COMP ENDOCR, V173, P190, DOI 10.1016/j.ygcen.2011.05.013; Hurd T.R., 2009, REDOX SIGNALING REGU, P13, DOI DOI 10.1002/9783527627585.CH2; JOHANSSON F, 2013, EVOL BIOL, P1; Kappus H., 1985, OXIDATIVE STRESS, V40, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/B978-0-12-642760-8.50016-8]; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Kulkarni SS, 2011, J EVOLUTION BIOL, V24, P2445, DOI 10.1111/j.1420-9101.2011.02370.x; Kulkarni SS, 2012, ENDOCRINOLOGY, V153, P5309, DOI 10.1210/en.2012-1432; Laurila A, 2002, EVOLUTION, V56, P617; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morey S, 2000, ECOLOGY, V81, P1736, DOI 10.2307/177320; Morey SR, 2004, OIKOS, V104, P172, DOI 10.1111/j.0030-1299.2004.12623.x; Nakajima K, 2012, GENES CELLS, V17, P645, DOI 10.1111/j.1365-2443.2012.01614.x; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1989, ECOLOGY, V70, P1775, DOI 10.2307/1938111; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pigliucci M., 2001, SYN ECO EVO; Richter-Boix A, 2006, EVOL ECOL RES, V8, P309; Richter-Boix A, 2006, EVOL ECOL RES, V8, P1139; Richter-Boix A, 2011, ECOL EVOL, V1, P15, DOI 10.1002/ece3.2; Rizzo AM, 2007, COMP BIOCHEM PHYS B, V146, P94, DOI 10.1016/j.cbpb.2006.09.009; Rosa CE, 2008, COMP BIOCHEM PHYS B, V149, P209, DOI 10.1016/j.cbpb.2007.09.010; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; West-Eberhard Mary Jane, 2003, pi; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917	69	81	86	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84266	10.1371/journal.pone.0084266	http://dx.doi.org/10.1371/journal.pone.0084266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358352	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700160
J	Uthicke, S; Pecorino, D; Albright, R; Negri, AP; Cantin, N; Liddy, M; Dworjanyn, S; Kamya, P; Byrne, M; Lamare, M				Uthicke, Sven; Pecorino, Danilo; Albright, Rebecca; Negri, Andrew Peter; Cantin, Neal; Liddy, Michelle; Dworjanyn, Symon; Kamya, Pamela; Byrne, Maria; Lamare, Miles			Impacts of Ocean Acidification on Early Life-History Stages and Settlement of the Coral-Eating Sea Star Acanthaster planci	PLOS ONE			English	Article							LARVAL DEVELOPMENT; CLIMATE-CHANGE; URCHIN LARVAE; RECRUITMENT; FERTILIZATION; INDUCTION; CO2; PH; CALCIFICATION; METAMORPHOSIS	Coral reefs are marine biodiversity hotspots, but their existence is threatened by global change and local pressures such as land-runoff and overfishing. Population explosions of coral-eating crown of thorns sea stars (COTS) are a major contributor to recent decline in coral cover on the Great Barrier Reef. Here, we investigate how projected near-future ocean acidification (OA) conditions can affect early life history stages of COTS, by investigating important milestones including sperm motility, fertilisation rates, and larval development and settlement. OA (increased pCO(2) to 900-1200 mu atm pCO(2)) significantly reduced sperm motility and, to a lesser extent, velocity, which strongly reduced fertilization rates at environmentally relevant sperm concentrations. Normal development of 10 d old larvae was significantly lower under elevated pCO(2) but larval size was not significantly different between treatments. Settlement of COTS larvae was significantly reduced on crustose coralline algae (known settlement inducers of COTS) that had been exposed to OA conditions for 85 d prior to settlement assays. Effect size analyses illustrated that reduced settlement may be the largest bottleneck for overall juvenile production. Results indicate that reductions in fertilisation and settlement success alone would reduce COTS population replenishment by over 50%. However, it is unlikely that this effect is sufficient to provide respite for corals from other negative anthropogenic impacts and direct stress from OA and warming on corals.	[Uthicke, Sven; Albright, Rebecca; Negri, Andrew Peter; Cantin, Neal; Liddy, Michelle] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Pecorino, Danilo; Lamare, Miles] Univ Otago, Dept Marine Biol, Dunedin, New Zealand; [Dworjanyn, Symon; Kamya, Pamela] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Australian Institute of Marine Science; University of Otago; Southern Cross University; University of Sydney; University of Sydney	Uthicke, S (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	S.Uthicke@aims.gov.au	Uthicke, Sven/F-1810-2010; Byrne, Maria/K-6355-2016; Dworjanyn, Symon A/O-5633-2017; Negri, Andrew/G-9909-2017	Uthicke, Sven/0000-0002-3476-6595; Byrne, Maria/0000-0002-8902-9808; Dworjanyn, Symon A/0000-0002-6690-8033; Lamare, Miles/0000-0001-8656-7240; Negri, Andrew/0000-0003-1388-7395; Albright, Rebecca/0000-0003-3409-8766	Australian Institute of Marine Science	Australian Institute of Marine Science	The study was funded from appropriation funding of the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Byrne M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0439; Byrne M, 2013, MAR ECOL PROG SER, V473, P235, DOI 10.3354/meps10058; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Challener Roberta C., 2013, Journal of Applied Aquaculture, V25, P154, DOI 10.1080/10454438.2013.791911; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Fabricius K, P ROYAL S B IN PRESS; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Gonzalez-Bernat MJ, 2013, POLAR BIOL, V36, P235, DOI 10.1007/s00300-012-1255-7; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hintze J., 2001, NCSS PASS NUMBER CRU; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; KANATANI H, 1969, EXP CELL RES, V57, P333, DOI 10.1016/0014-4827(69)90158-X; Kelly MW, 2013, GLOBAL CHANGE BIOL; Koch M, 2012, GLOBAL CHANGE BIOL; KROEKER KJ, 2013, GLOBAL CHANGE BIOL; MORSE ANC, 1984, J EXP MAR BIOL ECOL, V75, P191, DOI 10.1016/0022-0981(84)90166-7; Mortensen T., 1921, STUDIES DEV LARVAL F, DOI [10.5962/bhl.title.11376, DOI 10.5962/BHL.TITLE.11376]; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakajima A, 2005, J EXP BIOL, V208, P4411, DOI 10.1242/jeb.01906; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Russell BD, 2013, MARINE POLLUTION B; Schlegel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053118; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Team RC, 2012, R LANG ENV STAT COMP; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2013, MAR BIOL, V160, P1913, DOI 10.1007/s00227-012-2023-5; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; ZANN L, 1987, B MAR SCI, V41, P561	51	64	65	1	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82938	10.1371/journal.pone.0082938	http://dx.doi.org/10.1371/journal.pone.0082938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358240	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700098
J	Horsley, H; Malone-Lee, J; Holland, D; Tuz, M; Hibbert, A; Kelsey, M; Kupelian, A; Rohn, JL				Horsley, Harry; Malone-Lee, James; Holland, David; Tuz, Madeleine; Hibbert, Andrew; Kelsey, Michael; Kupelian, Anthony; Rohn, Jennifer L.			Enterococcus faecalis Subverts and Invades the Host Urothelium in Patients with Chronic Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; INTRACELLULAR BACTERIAL COMMUNITIES; KLEBSIELLA-PNEUMONIAE; OVERACTIVE BLADDER; BIOFILM FORMATION; SYMPTOMS; EPIDEMIOLOGY; DIAGNOSIS; DIFFERENTIATION; PATHOGENESIS	Bacterial urinary tract infections (UTI) are a major growing concern worldwide. Uropathogenic Escherichia coli has been shown to invade the urothelium during acute UTI in mice and humans, forming intracellular reservoirs that can evade antibiotics and the immune response, allowing recurrence at a later date. Other bacterial species, such as Staphylococcus saprophyticus, Klebsiella pneumonia and Salmonella enterica have also been shown to be invasive in acute UTI. However, the role of intracellular infection in chronic UTI causing more subtle lower urinary tract symptoms (LUTS), a particular problem in the elderly population, is poorly understood. Moreover, the species of bacteria involved remains largely unknown. A previous study of a large cohort of non-acute LUTS patients found that Enterococcus faecalis was frequently found in urine specimens. E. faecalis accounts for a significant proportion of chronic bladder infections worldwide, although the invasive lifestyle of this uropathogen has yet to be reported. Here, we wanted to explore this question in more detail. We harvested urothelial cells shed in response to inflammation and, using advanced imaging techniques, inspected them for signs of bacterial pathology and invasion. We found strong evidence of intracellular E. faecalis harboured within urothelial cells shed from the bladder of LUTS patients. Furthermore, using a culture model system, these patient-isolated strains of E. faecalis were able to invade a transitional carcinoma cell line. In contrast, we found no evidence of cellular invasion by E. coli in the patient cells or the culture model system. Our data show that E. faecalis is highly competent to invade in this context; therefore, these results have implications for both the diagnosis and treatment of chronic LUTS.	[Horsley, Harry; Malone-Lee, James; Holland, David; Tuz, Madeleine; Kupelian, Anthony; Rohn, Jennifer L.] UCL, Ctr Clin Sci & Technol, Res Dept Clin Physiol, Div Med, London, England; [Hibbert, Andrew] Univ London Royal Vet Coll, London, England; [Kelsey, Michael] Whittington Hosp NHS Trust, Dept Microbiol, London, England	University of London; University College London; University of London; University of London Royal Veterinary College	Rohn, JL (corresponding author), UCL, Ctr Clin Sci & Technol, Res Dept Clin Physiol, Div Med, London, England.	j.rohn@ucl.ac.uk		Rohn, Jennifer/0000-0001-8766-6056	Research into Ageing [315]	Research into Ageing	This work was partially funded by Research into Ageing (grant number: 315; http://www.ageuk.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2004, MICROBES INFECT, V6, P1094, DOI 10.1016/j.micinf.2004.05.023; Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; BRAUNER A, 1992, CLIN NEPHROL, V38, P318; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CASS AS, 1985, UROLOGY, V25, P492, DOI 10.1016/0090-4295(85)90458-3; Chai Wen L, 2007, J Oral Sci, V49, P161, DOI 10.2334/josnusd.49.161; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Colgan R, 2011, AM FAM PHYSICIAN, V84, P771; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; DALAL E, 1994, INFECT IMMUN, V62, P5505, DOI 10.1128/IAI.62.12.5505-5510.1994; Dukes C, 1928, Proc R Soc Med, V21, P1179; Edwards AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2693; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; FELMINGHAM D, 1992, CLIN INFECT DIS, V15, P295, DOI 10.1093/clinids/15.2.295; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Gill K, 2011, INT UROGYNECOL J, V22, P1769, DOI [10.1007/s00192-011-1521-1, DOI 10.1007/S00192-011-1521-1]; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Guiton PS, 2013, INFECT IMMUN, V81, P329, DOI 10.1128/IAI.00856-12; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Khasriya R, 2010, J UROLOGY, V183, P1843, DOI 10.1016/j.juro.2010.01.008; Kupelian AS, 2013, BJU INT, V112, P231, DOI 10.1111/j.1464-410X.2012.11694.x; Lutters M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001535.pub2; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nakipoglu GF, 2009, J CLIN NEUROSCI, V16, P1321, DOI 10.1016/j.jocn.2008.12.012; National Institute for Health and Clinical Excellence, 2006, URIN INC MAN UR INC; Nichol KA, 2006, INT J ANTIMICROB AG, V27, P392, DOI 10.1016/j.ijantimicag.2005.12.006; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; Poulsen LL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-320; Pouwels KB, 2013, J ANTIMICROB CHEMOTH, V68, P708, DOI 10.1093/jac/dks419; Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031; Rosen DA, 2008, INFECT IMMUN, V76, P3337, DOI 10.1128/IAI.00090-08; Rosen DA, 2008, INFECT IMMUN, V76, P3346, DOI 10.1128/IAI.00340-08; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; RUSSO TA, 1995, J INFECT DIS, V172, P440, DOI 10.1093/infdis/172.2.440; Sartingen S, 2000, INFECT IMMUN, V68, P6044, DOI 10.1128/IAI.68.10.6044-6047.2000; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001; SIZEMORE RK, 1990, APPL ENVIRON MICROB, V56, P2245, DOI 10.1128/AEM.56.7.2245-2247.1990; Smith YC, 2008, INFECT IMMUN, V76, P2978, DOI 10.1128/IAI.00075-08; Snyder JA, 2006, INFECT IMMUN, V74, P1387, DOI 10.1128/IAI.74.2.1387-1393.2006; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Swaminathan Subramanian, 2010, Curr Infect Dis Rep, V12, P455, DOI 10.1007/s11908-010-0138-8; Szabados F, 2008, FEMS MICROBIOL LETT, V285, P163, DOI 10.1111/j.1574-6968.2008.01218.x; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170	63	57	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83637	10.1371/journal.pone.0083637	http://dx.doi.org/10.1371/journal.pone.0083637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24363814	Green Published, Green Submitted, gold			2022-12-25	WOS:000328707400137
J	Zhou, AX; El Hed, A; Mercer, F; Kozhaya, L; Unutmaz, D				Zhou, Angela X.; El Hed, Aimee; Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya			The Metalloprotease ADAM12 Regulates the Effector Function of Human Th17 Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-CELLS; CYTOKINE SIGNALS; MELTRIN ALPHA; T(H)17 CELLS; EX-VIVO; EXPRESSION; RECEPTOR; DIFFERENTIATION; INDUCTION	A key modulator of immune homeostasis, TGF beta has an important role in the differentiation of regulatory T cells (Tregs) and IL-17-secreting T cells (Th17). How TGF beta regulates these functionally opposing T cell subsets is not well understood. We determined that an ADAM family metalloprotease called ADAM12 is specifically and highly expressed in both Tregs and CCR6+ Th17 cells. ADAM12 is induced in vitro upon differentiation of naive T cells to Th17 cells or IL-17-secreting Tregs. Remarkably, silencing ADAM12 expression in CCR6+ memory T cells enhances the production of Th17 cytokines, similar to suppressing TGF beta signaling. Further, ADAM12 knockdown in naive human T cells polarized towards Th17/Treg cells, or ectopically expressing RORC, greatly enhances IL-17-secreting cell differentiation, more potently then inhibiting TGF beta signals. Together, our findings reveal a novel regulatory role for ADAM12 in Th17 cell differentiation or function and may have implications in regulating their aberrant responses during immune pathologies.	[Zhou, Angela X.; El Hed, Aimee; Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com			National Institutes of Health (NIH) [R01AI065303]; NIH [R21AI087973, 5T32AI007647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, T32AI007180, R21AI087973, T32AI007647] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from National Institutes of Health (NIH) grant R01AI065303 and NIH R21AI087973 to DU and NIH training grant 5T32AI007647 to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gruel Jeremy, 2009, BMC Res Notes, V2, P193, DOI 10.1186/1756-0500-2-193; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	37	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81146	10.1371/journal.pone.0081146	http://dx.doi.org/10.1371/journal.pone.0081146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24363794	Green Published, gold, Green Submitted			2022-12-25	WOS:000327539800106
J	Shore, DM; Baillie, GL; Hurst, DH; Navas, F; Seltzman, HH; Marcu, JP; Abood, ME; Ross, RA; Reggio, PH				Shore, Derek M.; Baillie, Gemma L.; Hurst, Dow H.; Navas, Frank, III; Seltzman, Herbert H.; Marcu, Jahan P.; Abood, Mary E.; Ross, Ruth A.; Reggio, Patricia H.			Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cannabinoid Receptors; Cannabinoids; G Protein-coupled Receptors (GPCR); Signaling	MUSCARINIC ACETYLCHOLINE-RECEPTORS; CB1 RECEPTOR; EXTRACELLULAR LOOP; STRUCTURAL BASIS; DRUG DISCOVERY; ACTIVATION; AGONISTS; INTERNALIZATION; CONSTRUCTION; RECOGNITION	Background: Cannabinoid-1 (CB1) receptor allosteric modulator ORG27569 increases CP55,940 binding, yet antagonizes G protein signaling. Results: ORG27569 binding sterically blocks movement in CB1 extracellular loops and transmembrane helix 6 (TMH6). Conclusion: ORG27569 increases CP55,940 binding by promoting an intermediate receptor conformation where changes important for signaling are blocked. Significance: This information may lead to the rational design of new allosteric modulators. The cannabinoid 1 (CB1) allosteric modulator, 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide) (ORG27569), has the paradoxical effect of increasing the equilibrium binding of [H-3](-)-3-[2-hydroxyl-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxylpropyl]cyclohexan-1-ol (CP55,940, an orthosteric agonist) while at the same time decreasing its efficacy (in G protein-mediated signaling). ORG27569 also decreases basal signaling, acting as an inverse agonist for the G protein-mediated signaling pathway. In ligand displacement assays, ORG27569 can displace the CB1 antagonist/inverse agonist, N-(piperidiny-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide(SR141716A). The goal of this work was to identify the binding site of ORG27569 at CB1. To this end, we used computation, synthesis, mutation, and functional studies to identify the ORG27569-binding site in the CB1 TMH3-6-7 region. This site is consistent with the results of K3.28(192)A, F3.36(200)A, W5.43(279)A, W6.48(356)A, and F3.25(189)A mutation studies, which revealed the ORG27569-binding site overlaps with our previously determined binding site of SR141716A but extends extracellularly. Additionally, we identified a key electrostatic interaction between the ORG27569 piperidine ring nitrogen and K3.28(192) that is important for ORG27569 to act as an inverse agonist. At this allosteric site, ORG27569 promotes an intermediate conformation of the CB1 receptor, explaining ORG27569's ability to increase equilibrium binding of CP55,940. This site also explains ORG27569's ability to antagonize the efficacy of CP55,940 in three complementary ways. 1) ORG27569 sterically blocks movements of the second extracellular loop that have been linked to receptor activation. 2) ORG27569 sterically blocks a key electrostatic interaction between the third extracellular loop residue Lys-373 and D2.63(176). 3) ORG27569 packs against TMH6, sterically hindering movements of this helix that have been shown to be important for receptor activation.	[Shore, Derek M.; Hurst, Dow H.; Reggio, Patricia H.] Univ N Carolina, Ctr Drug Discovery, Greensboro, NC 27402 USA; [Baillie, Gemma L.; Ross, Ruth A.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Baillie, Gemma L.; Ross, Ruth A.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Navas, Frank, III; Seltzman, Herbert H.] Res Triangle Inst, Res Triangle Pk, NC 27709 USA; [Marcu, Jahan P.; Abood, Mary E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Marcu, Jahan P.; Abood, Mary E.] Temple Univ, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA	University of North Carolina; University of North Carolina Greensboro; University of Aberdeen; University of Toronto; Research Triangle Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Reggio, PH (corresponding author), Univ N Carolina, Ctr Drug Discovery, Dept Chem & Biochem, Patricia A Sullivan Sci Bldg,POB 26170, Greensboro, NC 27402 USA.	phreggio@uncg.edu	Ross, R./AAG-7468-2019	Abood, Mary/0000-0002-1744-2820	National Institutes of Health [RO1 DA003934, KO5 DA021358]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003934, K05DA021358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA003934 and KO5 DA021358 (to P. H. R.).	Ahn KH, 2013, J BIOL CHEM, V288, P9790, DOI 10.1074/jbc.M112.438804; Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahn KH, 2009, BIOPOLYMERS, V91, P565, DOI 10.1002/bip.21179; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Al-awar R. S., 2003, [No title captured], Patent No. [2003/0229026 A1, 20030229026, US 2003/0229026]; Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Bertalovitz AC, 2010, DRUG DEVELOP RES, V71, P404, DOI 10.1002/ddr.20388; Birdsall NJM, 1996, PROG BRAIN RES, V109, P147; BRAMBLETT RD, 1995, LIFE SCI, V56, P1971, DOI 10.1016/0024-3205(95)00178-9; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; Fay JF, 2012, J BIOL CHEM, V287, P33873, DOI 10.1074/jbc.M112.352328; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Huang XP, 2007, MOL PHARMACOL, V71, P759, DOI 10.1124/mol.106.028944; Hurst D, 2006, J MED CHEM, V49, P5969, DOI 10.1021/jm060446b; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Kapur A, 2007, MOL PHARMACOL, V71, P1512, DOI 10.1124/mol.107.034645; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Marcu J, 2013, J PHARMACOL EXP THER, V345, P189, DOI 10.1124/jpet.112.201046; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; Okazaki K, 2003, Patent, Patent No. [EP1331221A1, 1331221]; Peeters MC, 2012, BIOCHEM PHARMACOL, V84, P76, DOI 10.1016/j.bcp.2012.03.008; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pelcman B, 2006, U. S. Patent Application, Patent No. [20120029016 A1, 20120029016]; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Piscitelli F, 2012, J MED CHEM, V55, P5627, DOI 10.1021/jm201485c; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Ripka A, 2010, U. S. Patent, Patent No. [WO2010/006130, 2010006130]; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Song ZH, 1996, MOL PHARMACOL, V49, P891; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Wang CIA, 2013, BIOCHEM PHARMACOL, V85, P153, DOI 10.1016/j.bcp.2012.09.001; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D	56	60	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5828	5845		10.1074/jbc.M113.478495	http://dx.doi.org/10.1074/jbc.M113.478495			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24366865	Green Published, hybrid			2022-12-25	WOS:000332015500042
J	Lundius, EG; Vukojevic, V; Hertz, E; Stroth, N; Cederlund, A; Hiraiwa, M; Terenius, L; Svenningsson, P				Lundius, Ebba Gregorsson; Vukojevic, Vladana; Hertz, Ellen; Stroth, Nikolas; Cederlund, Andreas; Hiraiwa, Masao; Terenius, Lars; Svenningsson, Per			GPR37 Protein Trafficking to the Plasma Membrane Regulated by Prosaposin and GM1 Gangliosides Promotes Cell Viability*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Correlation Spectroscopy; G Protein-coupled Receptors (GPCR); Ganglioside; Lipid Raft; Parkinson Disease; Pael-R	FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; ENDOPLASMIC-RETICULUM STRESS; POLYMERASE-CHAIN-REACTION; DELTA-OPIOID RECEPTORS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; LIPID RAFTS; PAEL-R; NEUROTROPHIC FACTOR	Background: Intracellular GPR37 accumulation is neurotoxic and associated with parkinsonism, whereas plasma membrane association is protective. Results: The endogenous GPR37 ligand prosaposin promotes GPR37 surface density and association with GM1-enriched lipid rafts. Conclusion: GPR37, prosaposin, and GM1 constitute a pathway that improves cell viability through GPR37 trafficking to the plasma membrane. Significance: Targeting this pathway could reduce toxic intracellular GPR37 accumulation observed in parkinsonism. The subcellular distribution of the G protein-coupled receptor GPR37 affects cell viability and is implicated in the pathogenesis of parkinsonism. Intracellular accumulation and aggregation of GPR37 cause cell death, whereas GPR37 located in the plasma membrane provides cell protection. We define here a pathway through which the recently identified natural ligand, prosaposin, promotes plasma membrane association of GPR37. Immunoabsorption of extracellular prosaposin reduced GPR37(tGFP) surface density and decreased cell viability in catecholaminergic N2a cells. We found that GPR37(tGFP) partitioned in GM1 ganglioside-containing lipid rafts in the plasma membrane of live cells. This partitioning required extracellular prosaposin and was disrupted by lipid raft perturbation using methyl--cyclodextrin or cholesterol oxidase. Moreover, complex formation between GPR37(tGFP) and the GM1 marker cholera toxin was observed in the plasma membrane. These data show functional association between GPR37, prosaposin, and GM1 in the plasma membrane. These results thus tie together the three previously defined components of the cellular response to insult. Our findings identify a mechanism through which the receptor's natural ligand and GM1 may protect against toxic intracellular GPR37 aggregates observed in parkinsonism.	[Lundius, Ebba Gregorsson; Hertz, Ellen; Stroth, Nikolas; Cederlund, Andreas; Svenningsson, Per] Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Translat Neuropharmacol, S-17176 Stockholm, Sweden; [Vukojevic, Vladana; Terenius, Lars] Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Expt Alcohol & Drug Addict Res, S-17176 Stockholm, Sweden; [Hiraiwa, Masao] Vet Therapeut, San Diego, CA 92121 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Svenningsson, P (corresponding author), Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Translat Neuropharmacol, S-17176 Stockholm, Sweden.	per.svenningsson@ki.se	Lundius, Ebba/J-6844-2014; Svenningsson, Per JL/K-5210-2014; Vukojevic, Vladana B/AAY-3144-2021	Lundius, Ebba/0000-0002-3616-9997; Vukojevic, Vladana/0000-0003-0873-5653	Swedish Research Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council and Karolinska Institutet.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Bjork K, 2011, ANNU REV PHARMACOL, V51, P211, DOI 10.1146/annurev-pharmtox-010510-100520; Bleicken S, 2011, CURR PROTEIN PEPT SC, V12, P691, DOI 10.2174/138920311798841744; Cahill CM, 2001, J COMP NEUROL, V440, P65, DOI 10.1002/cne.1370; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Campana WM, 2000, J PERIPHER NERV SYST, V5, P126, DOI 10.1046/j.1529-8027.2000.00019.x; Castro BM, 2013, METHOD CELL BIOL, V117, P105, DOI 10.1016/B978-0-12-408143-7.00006-2; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Dusonchet J, 2009, NEUROBIOL DIS, V35, P32, DOI 10.1016/j.nbd.2009.03.013; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Elson EL, 2013, METHOD ENZYMOL, V518, P11, DOI 10.1016/B978-0-12-388422-0.00002-9; Foldes-Papp Z, 2001, BIOL CHEM, V382, P473, DOI 10.1515/BC.2001.057; Foldes-Papp Z, 2001, J BIOTECHNOL, V86, P237, DOI 10.1016/S0168-1656(00)00416-8; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hiraiwa M, 1997, BIOCHEM BIOPH RES CO, V240, P415, DOI 10.1006/bbrc.1997.7673; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Leng N, 1999, MOL BRAIN RES, V69, P73, DOI 10.1016/S0169-328X(99)00092-3; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lundius EG, 2013, J NEUROCHEM, V124, P410, DOI 10.1111/jnc.12081; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Misasi R, 1998, J NEUROCHEM, V71, P2313; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Navarro A, 1999, BRAIN RES, V816, P47, DOI 10.1016/S0006-8993(98)01062-2; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; Pfeiffer R, 1998, EXP CELL RES, V244, P327, DOI 10.1006/excr.1998.4159; PICH EM, 1992, STROKE, V23, P234, DOI 10.1161/01.STR.23.2.234; Qi XY, 1999, BIOCHEMISTRY-US, V38, P6284, DOI 10.1021/bi990079o; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; Sjogren B, 2006, EUR J PHARMACOL, V552, P1, DOI 10.1016/j.ejphar.2006.08.069; Sorice M, 2008, FEBS J, V275, P4903, DOI 10.1111/j.1742-4658.2008.06630.x; Ulrich M, 2006, BIOINFORMATICS, V22, P2709, DOI 10.1093/bioinformatics/btl456; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107; Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Weise K, 2010, BBA-BIOMEMBRANES, V1798, P1409, DOI 10.1016/j.bbamem.2009.12.006; Weisshart K, 2004, CURR PHARM BIOTECHNO, V5, P135, DOI 10.2174/1389201043376913; Yan LZ, 2000, NEUROSCI LETT, V278, P120, DOI 10.1016/S0304-3940(99)00902-7; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V233, P559, DOI 10.1006/bbrc.1997.6408	58	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4660	4673		10.1074/jbc.M113.510883	http://dx.doi.org/10.1074/jbc.M113.510883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371137	Green Published, hybrid			2022-12-25	WOS:000331607900014
J	Cam, M; Bid, HK; Xiao, LL; Zambetti, GP; Houghton, PJ; Cam, H				Cam, Maren; Bid, Hemant K.; Xiao, Linlin; Zambetti, Gerard P.; Houghton, Peter J.; Cam, Hakan			p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; DNA Damage Response; mTOR; mTOR Complex (mTORC); p53; p63; 4EBP1; REDD1; S6K1; Sestrin	PROTEIN-KINASE; S6 KINASE; IN-VIVO; P53; PHOSPHORYLATION; ACTIVATION; GROWTH; TSC2; STRESS; HYPOXIA	Under conditions of DNA damage, the mammalian target of rapamycin complex 1 (mTORC1) is inhibited, preventing cell cycle progression and conserving cellular energy by suppressing translation. We show that suppression of mTORC1 signaling to 4E-BP1 requires the coordinated activity of two tumor suppressors, p53 and p63. In contrast, suppression of S6K1 and ribosomal protein S6 phosphorylation by DNA damage is Akt-dependent. We find that loss of either p53, required for the induction of Sestrin 1/2, or p63, required for the induction of REDD1 and activation of the tuberous sclerosis complex, prevents the DNA damage-induced suppression of mTORC1 signaling. These data indicate that the negative regulation of cap-dependent translation by mTORC1 inhibition subsequent to DNA damage is abrogated in most human cancers.	[Cam, Maren; Bid, Hemant K.; Xiao, Linlin; Houghton, Peter J.; Cam, Hakan] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Houghton, Peter J.; Cam, Hakan] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; St Jude Children's Research Hospital; University System of Ohio; Ohio State University	Cam, H (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA.	hakan.cam@nationwidechildrens.org	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007	National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS) [CA77776]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA077776] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS) grant CA77776.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Dotsch V., 2010, COLD SPRING HARB PER, V2; Edwards E, 2002, CANCER RES, V62, P4671; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Smith MA, 2012, PEDIATR BLOOD CANCER, V59, P329, DOI 10.1002/pbc.23319; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	45	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4083	4094		10.1074/jbc.M113.530303	http://dx.doi.org/10.1074/jbc.M113.530303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366874	hybrid, Green Published			2022-12-25	WOS:000331403800022
J	Capdevila, JH; Pidkovka, N; Mei, SJ; Gong, Y; Falck, JR; Imig, JD; Harris, RC; Wang, WH				Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Falck, John R.; Imig, John D.; Harris, Raymond C.; Wang, Wenhui			The Cyp2c44 Epoxygenase Regulates Epithelial Sodium Channel Activity and the Blood Pressure Responses to Increased Dietary Salt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ENaC; Epoxygenase Pathway; ERK; Hypertension; Sodium Transport; EETs; Natriuresis	EPIDERMAL-GROWTH-FACTOR; COLLECTING DUCT CELLS; ARACHIDONIC-ACID; NA+ CHANNEL; RAT-KIDNEY; POTASSIUM INTAKE; LIDDLE-SYNDROME; ENAC; HYPERTENSION; PHOSPHORYLATION	Background: Epoxyeicosatrienoic acids (EETs) regulate sodium excretion in the distal nephron. Results: Lack of a Cyp2c44 epoxygenase blunts the ERK1/2-mediated inhibition of ENaC and causes salt-sensitive hypertension. Conclusion: Cyp2c44 is the epoxygenase responsible for the synthesis of natriuretic EETs during increased salt intake. Significance: Roles for the human CYP2C8 and CYP2C9 epoxygenases as antihypertensive therapeutic targets are proposed. Hypertension is a major risk factor for cerebral, cardiovascular, and renal disease, and its prevalence and devastating consequences raises a need for new strategies for its early diagnosis and treatment. We show here that lack of a Cyp2c44 epoxygenase causes dietary salt-sensitive hypertension, a common form of the human disease. Cyp2c44(-/-) mice on normal salt diets are normotensive but become hypertensive when fed high salt. Hypertensive Cyp2c44(-/-) mice show a hyperactive kidney epithelial sodium channel (ENaC) and reductions in ERK1/2 and ENaC subunit phosphorylation. The demonstration that amiloride, an ENaC inhibitor, lowers the blood pressure of hypertensive Cyp2c44(-/-) mice identifies a role for the channel in the hypertensive phenotype of the animals. These studies: (a) identify an antihypertensive role for the kidney Cyp2c44 epoxygenase and for its epoxyeicosatrienoic acid (EET) metabolites in the in vivo control of ENaC activity and the activation of mitogenic kinase pathways; (b) provide evidence for a Cyp2c44 epoxygenase, EET-mediated mechanism of ENaC regulation involving an ERK1/2-catalyzed threonine phosphorylation of the channel subunit: and (c) characterize a common scientific platform that could explain the seemingly unrelated biological activities attributed to the epoxygenase metabolites in cell proliferation, angiogenesis, channel activity, and blood pressure control. It is expected that these results will serve as a basis for the development of novel strategies for the early diagnosis and treatment of hypertension and of pathophysiologies associated with dysfunctional mitogenic signaling.	[Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Harris, Raymond C.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Imig, John D.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; [Wang, Wenhui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; New York Medical College	Capdevila, JH (corresponding author), Vanderbilt Univ, Med Ctr North S3223, Sch Med, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu		Imig, John/0000-0002-9668-2899	National Institutes of Health from the U.S. Public Health Service [DK038226, HL34300]; Robert A. Welch Foundation [GL625910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER	National Institutes of Health from the U.S. Public Health Service; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK038226 and HL34300 (to W.-H. W.) from the U.S. Public Health Service. This work was also supported by Robert A. Welch Foundation Grant GL625910 (to J. R. F.).	Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; ELLIOTT P, 1988, BRIT MED J, V297, P319; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; HOLTHOFER H, 1987, CELL TISSUE RES, V249, P481; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Imig JD, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00157; JACOBSON HR, 1984, PROSTAGLANDINS MEMBR, P311; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; MOLLER B, 1995, ACTA PHYSIOL SCAND, V155, P165, DOI 10.1111/j.1748-1716.1995.tb09961.x; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; ROMAN RJ, 1987, AM J PHYSIOL, V252, pR833, DOI 10.1152/ajpregu.1987.252.5.R833; Rossier BC, 2008, HYPERTENSION, V52, P595, DOI 10.1161/HYPERTENSIONAHA.107.097147; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Schild L, 1996, NEPHROLOGIE, V17, P395; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sun P, 2012, HYPERTENSION, V59, P339, DOI 10.1161/HYPERTENSIONAHA.111.178475; Sun P, 2010, J AM SOC NEPHROL, V21, P1667, DOI 10.1681/ASN.2009111110; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; Tsao CC, 2001, J PHARMACOL EXP THER, V299, P39; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Zhang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC141, DOI 10.1152/ajpcell.00343.2004	51	44	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4377	4386		10.1074/jbc.M113.508416	http://dx.doi.org/10.1074/jbc.M113.508416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368771	hybrid, Green Published			2022-12-25	WOS:000331403800048
J	Feng, XH; Huang, Y; Lu, YG; Xiong, J; Wong, CO; Yang, P; Xia, JT; Chen, D; Du, GW; Venkatachalam, K; Xia, XF; Zhu, MX				Feng, Xinghua; Huang, Yu; Lu, Yungang; Xiong, Jian; Wong, Ching-On; Yang, Pu; Xia, Jintang; Chen, De; Du, Guangwei; Venkatachalam, Kartik; Xia, Xuefeng; Zhu, Michael X.			Drosophila TRPML Forms PI(3,5)P-2-activated Cation Channels in Both Endolysosomes and Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosomes; Lysosomal Storage Disease; Lysosomes; Phosphoinositides; TRP Channels; Mucolipidosis; Mucolipin	MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER PHENOTYPE; RECEPTOR POTENTIAL CHANNEL; CONSTITUTIVE ACTIVITY; CELL DEGENERATION; PROTEIN; MUTATION; GENE; TRAFFICKING; DEAFNESS	Background:Drosophila trpml mutants reproduced many defects associated with mucolipidosis type IV, but the fly TRPML channel remains uncharacterized. Results:Drosophila TRPML is a phosphoinositide-regulated cation channel on endolysosome and plasma membranes. Conclusion: Fly TRPML largely resembles mammalian TRPML1, but exhibits differences in subcellular localization and pH dependence. Significance: The data support using Drosophila for assessing TRPML1 function. Transient Receptor Potential mucolipin (TRPML) channels are implicated in endolysosomal trafficking, lysosomal Ca2+ and Fe2+ release, lysosomal biogenesis, and autophagy. Mutations in human TRPML1 cause the lysosome storage disease, mucolipidosis type IV (MLIV). Unlike vertebrates, which express three TRPML genes, TRPML1-3, the Drosophila genome encodes a single trpml gene. Although the trpml-deficient flies exhibit cellular defects similar to those in mammalian TRPML1 mutants, the biophysical properties of Drosophila TRPML channel remained uncharacterized. Here, we show that transgenic expression of human TRPML1 in the neurons of Drosophila trpml mutants partially suppressed the pupal lethality phenotype. When expressed in HEK293 cells, Drosophila TRPML was localized in both endolysosomes and plasma membrane and was activated by phosphatidylinositol 3,5-bisphosphate (PI(3,5)P-2) applied to the cytoplasmic side in whole lysosomes and inside-out patches excised from plasma membrane. The PI(3,5)P-2-evoked currents were blocked by phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), but not other phosphoinositides. Using TRPML A487P, which mimics the varitint-waddler (Va) mutant of mouse TRPML3 with constitutive whole-cell currents, we show that TRPML is biphasically regulated by extracytosolic pH, with an optimal pH about 0.6 pH unit higher than that of human TRPML1. In addition to monovalent cations, TRPML exhibits high permeability to Ca2+, Mn2+, and Fe2+, but not Fe3+. The TRPML currents were inhibited by trivalent cations Fe3+, La3+, and Gd3+. These features resemble more closely to mammalian TRPML1 than TRPML2 and TRPML3, but with some obvious differences. Together, our data support the use of Drosophila for assessing functional significance of TRPML1 in cell physiology.	[Feng, Xinghua; Lu, Yungang; Xia, Jintang; Chen, De; Xia, Xuefeng] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Feng, Xinghua; Huang, Yu; Lu, Yungang; Xiong, Jian; Wong, Ching-On; Yang, Pu; Du, Guangwei; Venkatachalam, Kartik; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Huang, Yu; Xiong, Jian; Du, Guangwei; Venkatachalam, Kartik; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Grad Program Cell & Regulatory Biol, Houston, TX 77030 USA; [Venkatachalam, Kartik] Univ Texas Hlth Sci Ctr Houston, Grad Program Neurosci, Houston, TX 77030 USA; [Xia, Xuefeng] Houston Methodist Res Inst, Ctr Genom Med, Houston, TX 77030 USA	Guangzhou Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Xia, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China.	xuefengx@gmail.com; michael.x.zhu@uth.tmc.edu	Lu, yungang/N-1955-2015; Xiong, Jian/AAC-1836-2021; HUANG, YU/U-2835-2019	Lu, yungang/0000-0001-8949-661X; Xiong, Jian/0000-0001-9008-3134; Du, Guangwei/0000-0003-4193-6975; HUANG, YU/0000-0002-6982-8485	National Institutes of Health [R01 GM081658, GM092759]; Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China [81270868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759, R01GM081658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants R01 GM081658 and GM092759 from the National Institutes of Health (to M. X. Z.), postdoctoral fellowships from the Third Affiliated Hospital of Guangzhou Medical University (to X. F. and Y. L.), and the National Natural Science Foundation of China (No. 81270868, to X. X.).	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2009, J BIOL CHEM, V284, P32040, DOI 10.1074/jbc.M109.037184; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2012, J BIOL CHEM, V287, P22701, DOI 10.1074/jbc.M112.368876; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Sun T, 2011, AUTOPHAGY, V7, P1308, DOI 10.4161/auto.7.11.17759; Swetha MG, 2011, TRAFFIC, V12, P1037, DOI 10.1111/j.1600-0854.2011.01214.x; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wong CO, 2012, CURR BIOL, V22, P1616, DOI 10.1016/j.cub.2012.06.055; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	40	48	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4262	4272		10.1074/jbc.M113.506501	http://dx.doi.org/10.1074/jbc.M113.506501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375408	Green Published, hybrid			2022-12-25	WOS:000331403800037
J	Tian, WH; Wang, Y; Xu, Y; Guo, XP; Wang, B; Sun, L; Liu, LQ; Cui, FG; Zhuang, Q; Bao, XC; Schley, G; Chung, TL; Laslett, AL; Willam, C; Qin, BM; Maxwell, PH; Esteban, MA				Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Schley, Gunnar; Chung, Tung-Liang; Laslett, Andrew L.; Willam, Carsten; Qin, Baoming; Maxwell, Patrick H.; Esteban, Miguel A.			The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; DNA Damage; Hypoxia-inducible Factor (HIF); Oxidative Stress; Vitamin C; Warburg Effect; Renal Cancer	ASCORBIC-ACID THERAPY; DEHYDROASCORBIC ACID; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE; SURVIVAL TIMES; VHL; TRANSPORTERS; CARCINOMA; EXPRESSION	Background: There is renewed interest in the possibility of using Vc as an anticancer agent. Results: Activation of HIF triggers a Warburg effect that renders cancer cells more sensitive to Vc-induced toxicity. Conclusion: These results provide a link between the metabolic state and the susceptibility to Vc. Significance: Our work helps to understand the preferential toxicity of Vc toward cancer cells. Megadose vitamin C (Vc) is one of the most enduring alternative treatments for diverse human diseases and is deeply engrafted in popular culture. Preliminary studies in the 1970s described potent effects of Vc on prolonging the survival of patients with terminal cancer, but these claims were later criticized. An improved knowledge of the pharmacokinetics of Vc and recent reports using cancer cell lines have renewed the interest in this subject. Despite these findings, using Vc as an adjuvant for anticancer therapy remains questionable, among other things because there is no proper mechanistic understanding. Here, we show that a Warburg effect triggered by activation of the hypoxia-inducible factor (HIF) pathway greatly enhances Vc-induced toxicity in multiple cancer cell lines, including von Hippel-Lindau (VHL)-defective renal cancer cells. HIF increases the intracellular uptake of oxidized Vc through its transcriptional target glucose transporter 1 (GLUT1), synergizing with the uptake of its reduced form through sodium-dependent Vc transporters. The resulting high levels of intracellular Vc induce oxidative stress and massive DNA damage, which then causes metabolic exhaustion by depleting cellular ATP reserves. HIF-positive cells are particularly sensitive to Vc-induced ATP reduction because they mostly rely on the rather inefficient glycolytic pathway for energy production. Thus, our experiments link Vc-induced toxicity and cancer metabolism, providing a new explanation for the preferential effect of Vc on cancer cells.	[Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Qin, Baoming; Esteban, Miguel A.] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Qin, Baoming; Esteban, Miguel A.] Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Tian, Weihua] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Schley, Gunnar; Willam, Carsten] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Chung, Tung-Liang; Laslett, Andrew L.] CSIRO, Mat Sci & Engn Div, Clayton, Vic 3168, Australia; [Chung, Tung-Liang; Laslett, Andrew L.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Maxwell, Patrick H.] Cambridge Inst Med Res, Cambridge CB20XY, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Erlangen Nuremberg; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Regenerative Medicine Institute; Monash University	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org	Tian, Weihua/AAC-8919-2022; Maxwell, Patrick H/C-5557-2008; Laslett, Andrew L/A-9760-2011	Maxwell, Patrick H/0000-0002-0338-2679; Laslett, Andrew L/0000-0003-4729-8193; Xu, Yan/0000-0001-5653-291X; Schley, Gunnar/0000-0001-9929-5854; Tian, Weihua/0000-0003-2357-3947	National Natural Science Foundation of China [31071309, 81202010]; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by National Natural Science Foundation of China Grants 31071309 and 81202010.	Abdel-Latif MMM, 2005, J CHEMOTHERAPY, V17, P539, DOI 10.1179/joc.2005.17.5.539; Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; Alexander B, 2013, INTEGR CANCER THER, V12, P442, DOI 10.1177/1534735412473643; Bevan RJ, 2010, BRIT J NUTR, V103, P686, DOI 10.1017/S0007114509992285; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMERON E, 1979, CANCER RES, V39, P663; Carosio R, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-55; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cheng F, 2011, J BIOL CHEM, V286, P27559, DOI 10.1074/jbc.M111.243345; Corpe CP, 2013, J BIOL CHEM, V288, P9092, DOI 10.1074/jbc.M112.436790; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2012, NAT GENET, V44, P366, DOI 10.1038/ng.2222; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Graumlich JF, 1997, PHARMACEUT RES, V14, P1133, DOI 10.1023/A:1012186203165; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hong SW, 2013, ONCOGENE, V32, P1508, DOI 10.1038/onc.2012.176; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim J, 2012, FREE RADICAL BIO MED, V53, P1607, DOI 10.1016/j.freeradbiomed.2012.07.079; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowles HJ, 2003, CANCER RES, V63, P1764; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; May JM, 2011, BRIT J PHARMACOL, V164, P1793, DOI 10.1111/j.1476-5381.2011.01350.x; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michels AJ, 2013, ANNU REV NUTR, V33, P45, DOI 10.1146/annurev-nutr-071812-161246; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Ohno S, 2009, ANTICANCER RES, V29, P809; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Parrow NL, 2013, ANTIOXID REDOX SIGN, V19, P2141, DOI 10.1089/ars.2013.5372; Pokorski M, 2003, J BIOMED SCI, V10, P193, DOI 10.1159/000068707; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimizu S, 1996, CANCER RES, V56, P2161; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu J, 2012, ONCOGENE, V31, P1065, DOI 10.1038/onc.2011.305; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	68	36	36	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3339	3351		10.1074/jbc.M113.538157	http://dx.doi.org/10.1074/jbc.M113.538157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24371136	hybrid, Green Published			2022-12-25	WOS:000331368700021
J	Flowerdew, SE; Wick, D; Himmelein, S; Horn, AKE; Sinicina, I; Strupp, M; Brandt, T; Theil, D; Hufner, K				Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Horn, Anja K. E.; Sinicina, Inga; Strupp, Michael; Brandt, Thomas; Theil, Diethilde; Huefner, Katharina			Characterization of Neuronal Populations in the Human Trigeminal Ganglion and Their Association with Latent Herpes Simplex Virus-1 Infection	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; POLYMERASE CHAIN-REACTION; PRIMARY AFFERENT NEURONS; DORSAL-ROOT GANGLION; VARICELLA-ZOSTER; TRANSCRIPT GENE; TYPE-1 LATENCY; IMMUNOHISTOCHEMICAL ANALYSIS; CEREBROSPINAL-FLUID	Following primary infection Herpes simplex virus-1 (HSV-1) establishes lifelong latency in the neurons of human sensory ganglia. Upon reactivation HSV-1 can cause neurological diseases such as facial palsy, vestibular neuritis or encephalitis. Certain populations of sensory neurons have been shown to be more susceptible to latent infection in the animal model, but this has not been addressed in human tissue. In the present study, trigeminal ganglion (TG) neurons expressing six neuronal marker proteins were characterized, based on staining with antibodies against the GDNF family ligand receptor Ret, the high-affinity nerve growth factor receptor TrkA, neuronal nitric oxide synthase (nNOS), the antibody RT97 against 200kDa neurofilament, calcitonin gene-related peptide and peripherin. The frequencies of marker-positive neurons and their average neuronal sizes were assessed, with TrkA-positive (61.82%) neurons being the most abundant, and Ret-positive (26.93%) the least prevalent. Neurons positive with the antibody RT97 (1253 mm 2) were the largest, and those stained against peripherin (884 mu m(2)) were the smallest. Dual immunofluorescence revealed at least a 4.5% overlap for every tested marker combination, with overlap for the combinations TrkA/Ret, TrkA/RT97 and Ret/nNOS lower, and the overlap between Ret/CGRP being higher than would be expected by chance. With respect to latent HSV-1 infection, latency associated transcripts (LAT) were detected using in situ hybridization (ISH) in neurons expressing each of the marker proteins. In contrast to the mouse model, co-localization with neuronal markers Ret or CGRP mirrored the magnitude of these neuron populations, whereas for the other four neuronal markers fewer marker-positive cells were also LAT-ISH+. Ret and CGRP are both known to label neurons related to pain signaling.	[Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Strupp, Michael; Theil, Diethilde; Huefner, Katharina] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Flowerdew, Sarah E.; Wick, Desiree; Himmelein, Susanne; Horn, Anja K. E.; Strupp, Michael; Brandt, Thomas; Huefner, Katharina] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Horn, Anja K. E.] Univ Munich, Inst Anat, Dept 1, Munich, Germany; [Sinicina, Inga] Univ Munich, Dept Legal Med, Munich, Germany; [Brandt, Thomas] Univ Munich, Klinikum Grosshadern, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Himmelein, S (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.	susanne.himmelein@med.uni-muenchen.de		Hufner, Katharina/0000-0002-5453-8792; Horn, Anja/0000-0001-7797-1516	German Ministry for Education and Research [IFB 01EO0901]; Hertie Foundation	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This study was funded by the German Ministry for Education and Research (IFB 01EO0901) and the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ FJ, 1991, J NEUROCYTOL, V20, P716, DOI 10.1007/BF01187846; Arbusow V, 2010, J MED VIROL, V82, P1917, DOI 10.1002/jmv.21904; AURELIUS E, 1993, J MED VIROL, V39, P179, DOI 10.1002/jmv.1890390302; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; Bergman E, 1999, BRAIN RES, V832, P63, DOI 10.1016/S0006-8993(99)01469-9; Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Borsani E, 2010, ACTA HISTOCHEM, V112, P444, DOI 10.1016/j.acthis.2009.04.006; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; FELIPE CD, 1999, EUR J PAIN, V3, P31; Flores CM, 1996, J NEUROSCI, V16, P7892; Gaspersic R, 2007, NEUROSCI LETT, V418, P253, DOI 10.1016/j.neulet.2007.03.060; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; HARBOUR DA, 1983, J GEN VIROL, V64, P1491, DOI 10.1099/0022-1317-64-7-1491; Held K, 2011, J NEUROVIROL, V17, P518, DOI 10.1007/s13365-011-0063-0; Held K, 2011, J VIROL, V85, P9680, DOI 10.1128/JVI.00874-11; HILL JM, 1990, VIROLOGY, V174, P117, DOI 10.1016/0042-6822(90)90060-5; Hilliges M, 1996, ANAT RECORD, V245, P621, DOI 10.1002/(SICI)1097-0185(199608)245:4<621::AID-AR2>3.0.CO;2-R; Hufner K, 2009, J VIROL, V83, P3696, DOI 10.1128/JVI.02464-08; KAIKAI MA, 1989, COMP BIOCHEM PHYS A, V93, P183, DOI 10.1016/0300-9629(89)90206-5; Lariviere RC, 2002, J NEUROCHEM, V81, P525, DOI 10.1046/j.1471-4159.2002.00853.x; Lazarov NE, 2002, PROG NEUROBIOL, V66, P19, DOI 10.1016/S0301-0082(01)00021-1; Margolis TP, 2007, J VIROL, V81, P1872, DOI 10.1128/JVI.02110-06; MARGOLIS TP, 1992, INVEST OPHTH VIS SCI, V33, P259; Mark KE, 2010, JAIDS-J ACQ IMM DEF, V54, P482, DOI 10.1097/QAI.0b013e3181d91322; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Perng GC, 1999, J VIROL, V73, P9669, DOI 10.1128/JVI.73.11.9669-9672.1999; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; PRICE J, 1985, J NEUROSCI, V5, P2051; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Quartu M, 2006, BRAIN RES BULL, V69, P393, DOI 10.1016/j.brainresbull.2006.02.003; QUARTU M, 1992, J CHEM NEUROANAT, V5, P143, DOI 10.1016/0891-0618(92)90040-W; Quartu M, 1996, NEUROREPORT, V7, P1013, DOI 10.1097/00001756-199604100-00012; Quartu M, 1997, NEUROREPORT, V8, P3611, DOI 10.1097/00001756-199711100-00038; Rusu MC, 2011, ANN ANAT, V193, P403, DOI 10.1016/j.aanat.2011.06.005; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; Sniderhan LF, 2009, EXP HEMATOL, V37, P1295, DOI 10.1016/j.exphem.2009.08.005; SOMMER EW, 1985, BRAIN RES, V346, P310, DOI 10.1016/0006-8993(85)90865-0; STEINER I, 1995, J NEUROVIROL, V1, P19, DOI 10.3109/13550289509111007; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Vang Hue, 2012, Exp Neurobiol, V21, P68, DOI 10.5607/en.2012.21.2.68; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; Wauters O, 2012, J AM ACAD DERMATOL, V66, pE217, DOI 10.1016/j.jaad.2010.07.011; Wilson AC, 2012, TRENDS MICROBIOL, V20, P604, DOI 10.1016/j.tim.2012.08.005; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yang L, 2000, J VIROL, V74, P209, DOI 10.1128/JVI.74.1.209-217.2000; Zerboni L, 2012, J VIROL, V86, P578, DOI 10.1128/JVI.05950-11; Zylka MJ, 2005, NEURON, V47, P771, DOI 10.1016/j.neuron.2005.09.003	57	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83603	10.1371/journal.pone.0083603	http://dx.doi.org/10.1371/journal.pone.0083603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367603	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900019
J	Lum, M; Attridge, SR; Morona, R				Lum, Mabel; Attridge, Stephen R.; Morona, Renato			Impact of Dynasore an Inhibitor of Dynamin II on Shigella flexneri Infection	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN-BINDING PROTEIN; ANTIGEN CHAIN-LENGTH; TO-CELL SPREAD; O-ANTIGEN; UNIPOLAR LOCALIZATION; INTERCELLULAR SPREAD; MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS	Shigella flexneri remains a significant human pathogen due to high morbidity among children < 5 years in developing countries. One of the key features of Shigella infection is the ability of the bacterium to initiate actin tail polymerisation to disseminate into neighbouring cells. Dynamin II is associated with the old pole of the bacteria that is associated with F-actin tail formation. Dynamin II inhibition with dynasore as well as siRNA knockdown significantly reduced Shigella cell to cell spreading in vitro. The ocular mouse Sereny model was used to determine if dynasore could delay the progression of Shigella infection in vivo. While dynasore did not reduce ocular inflammation, it did provide significant protection against weight loss. Therefore dynasore's effects in vivo are unlikely to be related to the inhibition of cell spreading observed in vitro. We found that dynasore decreased S. flexneri-induced HeLa cell death in vitro which may explain the protective effect observed in vivo. These results suggest the administration of dynasore or a similar compound during Shigella infection could be a potential intervention strategy to alleviate disease symptoms.	[Lum, Mabel; Attridge, Stephen R.; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Morona, Renato/B-7746-2013	Morona, Renato/0000-0001-7009-7440; Lum, Mabel/0000-0002-4712-0603	National Health and Medical Research Council (NHMRC) of Australia [565526]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by a Program Grant (565526) from the National Health and Medical Research Council (NHMRC) of Australia. ML was the recipient of the Australian Postgraduate Award from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Ambrosi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049625; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Barman S, 2011, FEMS IMMUNOL MED MIC, V62, P304, DOI 10.1111/j.1574-695X.2011.00810.x; Barry EM, 2013, NAT REV GASTRO HEPAT, V10, P245, DOI 10.1038/nrgastro.2013.12; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bishai EA, 2013, CELL MICROBIOL, V15, P353, DOI 10.1111/cmi.12051; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Francis MS, 1996, J MED MICROBIOL, V45, P323, DOI 10.1099/00222615-45-5-323; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Gao DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060967; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; KADURUGAMUWA JL, 1991, INFECT IMMUN, V59, P3463, DOI 10.1128/IAI.59.10.3463-3471.1991; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kotloff KL, 1996, INFECT IMMUN, V64, P4542, DOI 10.1128/IAI.64.11.4542-4548.1996; Lagendijk EL, 2010, FEMS MICROBIOL LETT, V305, P81, DOI 10.1111/j.1574-6968.2010.01916.x; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; OKAMURA N, 1983, INFECT IMMUN, V39, P505, DOI 10.1128/IAI.39.2.505-513.1983; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; RABBANI GH, 1995, INFECT IMMUN, V63, P4350, DOI 10.1128/IAI.63.11.4350-4357.1995; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; Sandlin RC, 1996, MOL MICROBIOL, V22, P63, DOI 10.1111/j.1365-2958.1996.tb02656.x; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; SANSONETTI PJ, 1994, CELL, V76, P829, DOI 10.1016/0092-8674(94)90358-1; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schuch R, 1999, MOL MICROBIOL, V34, P675, DOI 10.1046/j.1365-2958.1999.01627.x; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Suzuki T, 2006, J IMMUNOL, V177, P4709, DOI 10.4049/jimmunol.177.7.4709; Terada N, 2009, CELL TISSUE RES, V337, P91, DOI 10.1007/s00441-009-0804-z; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; YANG JY, 2013, J INFECT DIS; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	70	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84975	10.1371/journal.pone.0084975	http://dx.doi.org/10.1371/journal.pone.0084975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367704	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900073
J	Steel, JJ; Franz, AWE; Sanchez-Vargas, I; Olson, KE; Geiss, BJ				Steel, J. Jordan; Franz, Alexander W. E.; Sanchez-Vargas, Irma; Olson, Ken E.; Geiss, Brian J.			Subgenomic Reporter RNA System for Detection of Alphavirus Infection in Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; VIRUS TRANSDUCING SYSTEM; SINDBIS-VIRUS; AEDES-AEGYPTI; GENE-EXPRESSION; MINUS-STRAND; GENOME; REPLICATION; RESISTANCE; PROMOTERS	Current methods for detecting real-time alphavirus (Family Togaviridae) infection in mosquitoes require the use of recombinant viruses engineered to express a visibly detectable reporter protein. These altered viruses expressing fluorescent proteins, usually from a duplicated viral subgenomic reporter, are effective at marking infection but tend to be attenuated due to the modification of the genome. Additionally, field strains of viruses cannot be visualized using this approach unless infectious clones can be developed to insert a reporter protein. To circumvent these issues, we have developed an insect cell-based system for detecting wild-type sindbis virus infection that uses a virus inducible promoter to express a fluorescent reporter gene only upon active virus infection. We have developed an insect expression system that produces sindbis virus minigenomes containing a subgenomic promoter sequence, which produces a translatable RNA species only when infectious virus is present and providing viral replication proteins. This subgenomic reporter RNA system is able to detect wild-type Sindbis infection in cultured mosquito cells. The detection system is relatively species specific and only detects closely related viruses, but can detect low levels of alphavirus specific replication early during infection. A chikungunya virus detection system was also developed that specifically detects chikungunya virus infection. Transgenic Aedes aegypti mosquito families were established that constitutively express the sindbis virus reporter RNA and were found to only express fluorescent proteins during virus infection. This virus inducible reporter system demonstrates a novel approach for detecting non-recombinant virus infection in mosquito cell culture and in live transgenic mosquitoes.	[Steel, J. Jordan; Sanchez-Vargas, Irma; Olson, Ken E.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Colorado State University; Colorado State University; University of Missouri System; University of Missouri Columbia	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Steel, James Jordan/0000-0002-1256-2639	National Institutes of Health [AI046435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant #AI046435 to KEO and BJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2004, TRANSGENIC RES, V13, P411, DOI 10.1007/s11248-004-6067-2; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; Atkinson PW, 2001, ANNU REV ENTOMOL, V46, P317, DOI 10.1146/annurev.ento.46.1.317; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Carpenetti TLG, 2012, INSECT MOL BIOL, V21, P97, DOI 10.1111/j.1365-2583.2011.01116.x; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Coates CJ, 2000, INSECT BIOCHEM MOLEC, V30, P1003, DOI 10.1016/S0965-1748(00)00110-7; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Fabbrini MS, 1997, BIOCHEM J, V322, P719, DOI 10.1042/bj3220719; Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x; Foy BD, 2008, ADV EXP MED BIOL, V627, P19, DOI 10.1007/978-0-387-78225-6_2; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Franz AWE, 2009, INSECT MOL BIOL, V18, P661, DOI 10.1111/j.1365-2583.2009.00908.x; FRANZ AW, 2006, ENG RNA INTERFERENCE, P37508; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Frolov I, 2001, RNA, V7, P1638, DOI 10.1017/S135583820101010X; Geiss BJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-112; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; JARVIS DL, 1990, BIO-TECHNOL, V8, P950, DOI 10.1038/nbt1090-950; JASINSKIENE N, 2007, MICROINJECTION A AEG, P1012; Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130; KIM JY, 2013, NEUROBIOLOGY DIS, P1012; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Li JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033007; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604; Mossel EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060427; Myles KM, 2004, J MED ENTOMOL, V41, P95, DOI 10.1603/0022-2585-41.1.95; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; OLIVO PD, 1994, VIROLOGY, V198, P381, DOI 10.1006/viro.1994.1046; Olivo PD, 1996, CLIN MICROBIOL REV, V9, P321, DOI 10.1128/CMR.9.3.321; Patel RK, 2013, VIROLOGY, V441, P171, DOI 10.1016/j.virol.2013.03.022; PHILLIPS A, 2010, JOVE-J VIS EXP, pR1, DOI DOI 10.3791/2363.PUBMED:21178952; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Pierro DJ, 2003, INSECT MOL BIOL, V12, P107, DOI 10.1046/j.1365-2583.2003.00392.x; Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515; Seabaugh RC, 1998, VIROLOGY, V243, P99, DOI 10.1006/viro.1998.9034; Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12; Steel JJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-356; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; WEAVER SC, 1993, VIROLOGY, V197, P375, DOI 10.1006/viro.1993.1599; Wiley MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013924	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84930	10.1371/journal.pone.0084930	http://dx.doi.org/10.1371/journal.pone.0084930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367703	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900072
J	Chen, HX; Jin, ZL; Zhang, LM; Xue, R; Xu, XD; Zhao, N; Qiu, ZK; Wang, XW; Zhang, YZ; Yang, RF; Li, YF				Chen, Hong-xia; Jin, Zeng-liang; Zhang, Li-ming; Xue, Rui; Xu, Xiao-dan; Zhao, Nan; Qiu, Zhi-kun; Wang, Xian-wang; Zhang, You-zhi; Yang, Ri-fang; Li, Yun-feng			Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist	PLOS ONE			English	Article							MILD STRESS; AFFECTIVE-DISORDERS; BEHAVIORAL DESPAIR; RAT-BRAIN; VILAZODONE; PINDOLOL; 5-HYDROXYTRYPTAMINE; RECOMBINANT; TRANSPORTER; ANTAGONIST	It has been suggested that drugs combining activities of selective serotonin reuptake inhibitor and 5-HT1A receptor agonist may form a novel strategy for higher therapeutic efficacy of antidepressant. The present study aimed to examine the pharmacology of YL-0919, a novel synthetic compound with combined high affinity and selectivity for serotonin transporter and 5-HT1A receptors. We performed in vitro binding and function assays and in vivo behavioral tests to assess the pharmacological properties and antidepressant-like efficacy of YL-0919. YL-0919 displayed high affinity in vitro to both 5-HT1A receptor and 5-HT transporter prepared from rat cortical tissue. It exerted an inhibitory effect on forskolin-stimulated cAMP formation and potently inhibited 5-HT uptake in both rat cortical synaptosomes and recombinant cells. After acute p.o. administration, very low doses of YL-0919 reduced the immobility time in tail suspension test and forced swimming test in mice and rats, with no significant effect on locomotor activity in open field test. Furthermore, WAY-100635 (a selective 5HT(1A) receptor antagonist, 0.3 mg/kg) significantly blocked the effect of YL-0919 in tail suspension test and forced swimming test. In addition, chronic YL-0919 treatment significantly reversed the depressive-like behaviors in chronically stressed rats. These findings suggest that YL-0919, a novel structure compound, exerts dual effect on the serotonergic system, as both 5HT(1A) receptor agonist and 5-HT uptake blocker, showing remarkable antidepressant effects in animal models. Therefore, YL-0919 may be used as a new option for the treatment of major depressive disorder.	[Chen, Hong-xia; Jin, Zeng-liang; Zhang, Li-ming; Xue, Rui; Xu, Xiao-dan; Zhao, Nan; Qiu, Zhi-kun; Wang, Xian-wang; Zhang, You-zhi; Li, Yun-feng] Beijing Inst Pharmacol & Toxicol, Dept New Drug Evaluat, Beijing, Peoples R China; [Jin, Zeng-liang] Capital Med Univ, Sch Basic Med Scieneces, Dept Pharmacol, Beijing, Peoples R China; [Wang, Xian-wang] Chinese PLA 309 Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Yang, Ri-fang] Beijing Inst Pharmacol & Toxicol, Dept Med Chem, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Capital Medical University; Academy of Military Medical Sciences - China	Yang, RF (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Med Chem, Beijing, Peoples R China.	yangrf@yahoo.com; lyf619@aliyun.com		Yang, Rifang/0000-0001-8087-9614	National Natural Science Foundation of China [81102423, 81001653, 81173036]; National Key New Drug Creation Program [2012ZX09301003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Program	This work was supported by the National Natural Science Foundation of China (No: 81102423, 81001653, and 81173036), and the National Key New Drug Creation Program (No: 2012ZX09301003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, PHARMACOL BIOCHEM BE, V89, P572, DOI 10.1016/j.pbb.2008.02.014; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Beasley C M Jr, 1993, Ann Clin Psychiatry, V5, P199, DOI 10.3109/10401239309148983; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BLIER P, 1990, Journal of Clinical Psychopharmacology, V10, p13S; BLIER P, 1995, J CLIN PSYCHOPHARM, V15, P217, DOI 10.1097/00004714-199506000-00011; Bodnoff SR, 1998, PSYCHOPHARMACOLOGY B, V95, P298; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; BORSINI F, 1995, NEUROSCI BIOBEHAV R, V19, P377, DOI 10.1016/0149-7634(94)00050-B; [陈红霞 Chen Hongxia], 2011, [军事医学, Military Medical Sciences], V35, P676; CHENG CHK, 1993, EUR J PHARMACOL, V239, P211, DOI 10.1016/0014-2999(93)90996-U; Citrome L, 2012, INT J CLIN PRACT, V66, P356, DOI 10.1111/j.1742-1241.2011.02885.x; COOKSON J, 1993, BRIT J PSYCHIAT, V163, P20, DOI 10.1192/S0007125000292325; Crema L, 2010, NEUROCHEM RES, V35, P1787, DOI 10.1007/s11064-010-0245-9; Cruz Martin Paspe, 2012, P T, V37, P28; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; DAVIDSON C, 1995, BRIT J PHARMACOL, V114, P1107, DOI 10.1111/j.1476-5381.1995.tb13321.x; Dutta AK, 2008, EUR J PHARMACOL, V589, P73, DOI 10.1016/j.ejphar.2008.05.008; Engleman EA, 1996, J NEUROCHEM, V66, P599; Fava M, 2000, J CLIN PSYCHIAT, V61, P26; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Guay David R P, 2012, Consult Pharm, V27, P857, DOI 10.4140/TCP.n.2012.857; Harvey K V, 1995, Ann Clin Psychiatry, V7, P143, DOI 10.3109/10401239509149042; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; JANOWSKY A, 1986, J NEUROCHEM, V46, P1272, DOI 10.1111/j.1471-4159.1986.tb00649.x; [金艳燕 Jin Yanyan], 2010, [基础医学与临床, Basic & Clinical Medicine], V30, P487; Khan A, 2009, EXPERT OPIN INV DRUG, V18, P1753, DOI 10.1517/13543780903286396; Kwon S, 2009, BIOL PSYCHIAT, V34, P265; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Millan MJ, 2012, J PHARMACOL EXP THER, V340, P750, DOI 10.1124/jpet.111.187468; Nemeroff CB, 1998, BIOL PSYCHIAT, V44, P517; Newman-Tancredi A, 1998, NEUROPSYCHOPHARMACOL, V18, P395; Page ME, 2002, J PHARMACOL EXP THER, V302, P1220, DOI 10.1124/jpet.102.034280; Papp M, 1996, EUR J PHARMACOL, V296, P129, DOI 10.1016/0014-2999(95)00697-4; PINDER RM, 1993, MED RES REV, V13, P259, DOI 10.1002/med.2610130304; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Portella MJ, 2009, EUR NEUROPSYCHOPHARM, V19, P516, DOI 10.1016/j.euroneuro.2009.04.004; Rabiner EA, 2004, NEUROPSYCHOPHARMACOL, V29, P1688, DOI 10.1038/sj.npp.1300472; Reed CR, 2012, CURR MED RES OPIN, V28, P27, DOI 10.1185/03007995.2011.628303; Romero L, 2003, NEUROPSYCHOPHARMACOL, V28, P445, DOI 10.1038/sj.npp.1300062; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schoeffter P, 1997, NEUROPHARMACOLOGY, V36, P429, DOI 10.1016/S0028-3908(97)00043-9; Serrats J, 2004, INT J NEUROPSYCHOPH, V7, P27, DOI 10.1017/S1461145703003924; Sim-Selley LJ, 2000, EUR J PHARMACOL, V389, P147, DOI 10.1016/S0014-2999(99)00875-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tordera RM, 2002, EUR J PHARMACOL, V442, P63, DOI 10.1016/S0014-2999(02)01504-2; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van Borren MMGJ, 2010, BASIC RES CARDIOL, V105, P73, DOI 10.1007/s00395-009-0048-9; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Xue R, 2013, EUR NEUROPSYCHOPHARM, V23, P728, DOI 10.1016/j.euroneuro.2012.06.001; Zomkowski ADE, 2004, BRAIN RES, V1023, P253, DOI 10.1016/j.brainres.2004.07.041	57	21	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83271	10.1371/journal.pone.0083271	http://dx.doi.org/10.1371/journal.pone.0083271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367588	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300099
J	Li, GB; Petiwala, SM; Pierce, DR; Nonn, L; Johnson, JJ				Li, Gongbo; Petiwala, Sakina M.; Pierce, Dana R.; Nonn, Larisa; Johnson, Jeremy J.			Selective Modulation of Endoplasmic Reticulum Stress Markers in Prostate Cancer Cells by a Standardized Mangosteen Fruit Extract	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ALPHA-MANGOSTIN; DIETARY DITERPENE; INDUCED APOPTOSIS; CYCLE ARREST; XANTHONES; CARNOSOL; PATHWAY; DEATH	The increased proliferation of cancer cells is directly dependent on the increased activity of the endoplasmic reticulum (ER) machinery which is responsible for protein folding, assembly, and transport. In fact, it is so critical that perturbations in the endoplasmic reticulum can lead to apoptosis. This carefully regulated organelle represents a unique target of cancer cells while sparing healthy cells. In this study, a standardized mangosteen fruit extract (MFE) was evaluated for modulating ER stress proteins in prostate cancer. Two human prostate cancer cell lines, 22Rv1 and LNCaP, and prostate epithelial cells (PrECs) procured from two patients undergoing radical prostatectomy were treated with MFE. Flow cytometry, MTT, BrdU and Western blot were used to evaluate cell apoptosis, viability, proliferation and ER stress. Next, we evaluated MFE for microsomal stability and anti-cancer activity in nude mice. MFE induced apoptosis, decreased viability and proliferation in prostate cancer cells. MFE increased the expression of ER stress proteins. Interestingly, MFE selectively promotes ER stress in prostate cancer cells while sparing PrECs. MFE suppressed tumor growth in a xenograft tumor model without obvious toxicity. Mangosteen fruit extract selectively promotes endoplasmic reticulum stress in cancer cells while sparing non-tumorigenic prostate epithelial cells. Furthermore, in an in vivo setting mangosteen fruit extract significantly reduces xenograft tumor formation.	[Li, Gongbo; Petiwala, Sakina M.; Pierce, Dana R.; Johnson, Jeremy J.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA; [Nonn, Larisa] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Nonn, Larisa; Johnson, Jeremy J.] Univ Illinois, Coll Med, Ctr Canc, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, JJ (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	jjjohn@uic.edu	li, gongbo/C-6778-2008		National Institutes of Health/National Cancer Institute [1R03CA138953]; NATIONAL CANCER INSTITUTE [R03CA138953] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute 1R03CA138953 (J. Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAU Z, 1990, NEUROTOXICOL TERATOL, V12, P547, DOI 10.1016/0892-0362(90)90021-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Chen JJ, 2014, LEUKEMIA LYMPHOMA, V55, P628, DOI 10.3109/10428194.2013.802312; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; Johnson JJ, 2010, CANCER PREV RES, V3, P1112, DOI 10.1158/1940-6207.CAPR-10-0168; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Liu KC, 2014, ENVIRON TOXICOL, V29, P428, DOI 10.1002/tox.21769; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Nabandith Viengvansay, 2004, Asian Pac J Cancer Prev, V5, P433; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Obolskiy D, 2009, PHYTOTHER RES, V23, P1047, DOI 10.1002/ptr.2730; Pae HO, 2007, BIOCHEM BIOPH RES CO, V353, P1040, DOI 10.1016/j.bbrc.2006.12.133; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sato A, 2004, J PHARMACOL SCI, V95, P33, DOI 10.1254/jphs.95.33; Suksamrarn S, 2006, CHEM PHARM BULL, V54, P301, DOI 10.1248/cpb.54.301; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, CANC LETT, V332, P249; Walker EB, 2007, J SEP SCI, V30, P1229, DOI 10.1002/jssc.200700024; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	29	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81572	10.1371/journal.pone.0081572	http://dx.doi.org/10.1371/journal.pone.0081572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367485	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300006
J	Liu, F; Archer, SR; Gelwick, F; Bai, E; Boutton, TW; Wu, XYB				Liu, Feng; Archer, Steven R.; Gelwick, Frances; Bai, Edith; Boutton, Thomas W.; Wu, Xinyuan Ben			Woody Plant Encroachment into Grasslands: Spatial Patterns of Functional Group Distribution and Community Development	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; SUBTROPICAL SAVANNA; SOIL INTERACTIONS; SHRUB ENCROACHMENT; ECOSYSTEM CARBON; WATER-USE; PARKLAND; VEGETATION; INVASION; SUCCESSION	Woody plant encroachment into grasslands has been globally widespread. The woody species invading grasslands represent a variety of contrasting plant functional groups and growth forms. Are some woody plant functional types (PFTs) better suited to invade grasslands than others? To what extent do local patterns of distribution and abundance of woody PFTs invading grasslands reflect intrinsic topoedaphic properties versus plant-induced changes in soil properties? We addressed these questions in the Southern Great Plains, United States at a subtropical grassland known to have been encroached upon by woody species over the past 50-100 years. A total of 20 woody species (9 tree-statured; 11 shrub-statured) were encountered along a transect extending from an upland into a playa basin. About half of the encroaching woody plants were potential N-2-fixers (55% of species), but they contributed only 7% to 16 % of the total basal area. Most species and the PFTs they represent were ubiquitously distributed along the topoedaphic gradient, but with varying abundances. Overstory-understory comparisons suggest that while future species composition of these woody communities is likely to change, PFT composition is not. Canonical correspondence analysis (CCA) ordination and variance partitioning (Partial CCA) indicated that woody species and PFT composition in developing woody communities was primarily influenced by intrinsic landscape location variables (e. g., soil texture) and secondarily by plant-induced changes in soil organic carbon and total nitrogen content. The ubiquitous distribution of species and PFTs suggests that woody plants are generally well-suited to a broad range of grassland topoedaphic settings. However, here we only examined categorical and non-quantitative functional traits. Although intrinsic soil properties exerted more control over the floristics of grassland-to-woodland succession did plant modifications of soil carbon and nitrogen concentrations, the latter are likely to influence productivity and nutrient cycling and may, over longer time-frames, feed back to influence PFT distributions.	[Liu, Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Liu, Feng; Boutton, Thomas W.; Wu, Xinyuan Ben] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA; [Archer, Steven R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Gelwick, Frances] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Bai, Edith] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Texas A&M University System; Texas A&M University College Station; University of Arizona; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Liu, F (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	liufeng@wbgcas.cn	Liu, Feng/A-1410-2014; Wu, X. Ben/E-3772-2010; Noojipady, Praveen/B-2511-2010; Boutton, Thomas W./C-5821-2016	Liu, Feng/0000-0003-3383-7598; Wu, X. Ben/0000-0001-5947-3118; Boutton, Thomas W./0000-0002-7522-5728	National Science Foundation Ecosystem Studies Program [DEB-9981723]; CAS Hundred Talends Program	National Science Foundation Ecosystem Studies Program; CAS Hundred Talends Program	Funding for this research was provided by National Science Foundation Ecosystem Studies Program (Grant DEB-9981723) and partly by the CAS Hundred Talends Program to Feng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TREES SHRUBS CACTI S; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; ARCHER S, 1988, ECOL MONOGR, V58, P111, DOI 10.2307/1942463; Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; Archer S.R., 2010, WILD RANGELANDS CONS, P53, DOI DOI 10.1002/9781444317091.CH4; Asner G.P., 2009, LIVESTOCK CHANGING L, P69; Bai E, 2008, OECOLOGIA, V156, P479, DOI 10.1007/s00442-008-1003-4; Bai E, 2012, ORG GEOCHEM, V42, P1512, DOI 10.1016/j.orggeochem.2010.11.004; Barger NN, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001506; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; Barnes PW, 1996, OECOLOGIA, V105, P493, DOI 10.1007/BF00330012; Biederman LA, 2009, SOIL BIOL BIOCHEM, V41, P1943, DOI 10.1016/j.soilbio.2009.06.019; BLAIR WF, 1950, J SCI, V2, P93; Boo R. M., 1991, B SOCIEDAD ARGENTINA, V27, P135; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boutton T.W., 2009, SOIL CARBON SEQUESTR, P181; Boutton TW, 1999, RAPID COMMUN MASS SP, V13, P1263, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1263::AID-RCM653>3.0.CO;2-J; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; BOUTTON TW, 2010, BIOGEOSCIENCES, V115, P3019; BROWN JR, 1990, OIKOS, V57, P366, DOI 10.2307/3565966; BROWN JR, 1988, VEGETATIO, V73, P73, DOI 10.1007/BF00031854; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Burke IC, 1998, BIOGEOCHEMISTRY, V42, P121, DOI 10.1023/A:1005987807596; COFFEY CR, 1986, FLORISTIC STUDY LA C; Dickie IA, 2011, J APPL ECOL, V48, P926, DOI 10.1111/j.1365-2664.2011.01980.x; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Garcia C, 2005, GEODERMA, V124, P193, DOI 10.1016/j.geoderma.2004.04.013; Hibbard KA, 2003, ECOL APPL, V13, P911, DOI 10.1890/1051-0761(2003)13[911:GTWTIC]2.0.CO;2; Hibbard KA, 2001, ECOLOGY, V82, P1999, DOI 10.1890/0012-9658(2001)082[1999:BCAWPE]2.0.CO;2; Higgins SI, 2012, J ECOL, V100, P1400, DOI 10.1111/j.1365-2745.2012.02026.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Laungani R, 2009, P NATL ACAD SCI USA, V106, P12400, DOI 10.1073/pnas.0900921106; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; McCune B., 2011, PC ORD MULTIVARIATE; MCLENDON T, 1991, TEX J SCI, V43, P13; Midgley JJ, 2001, J TROP ECOL, V17, P871, DOI 10.1017/S026646740100164X; Midwood AJ, 1998, PLANT SOIL, V205, P13, DOI 10.1023/A:1004355423241; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Nelson JA, 2002, PLANT ECOL, V160, P193, DOI 10.1023/A:1015828604444; O'Grady AP, 2009, OECOLOGIA, V160, P643, DOI 10.1007/s00442-009-1332-y; Okland RH, 2003, J VEG SCI, V14, P693, DOI 10.1111/j.1654-1103.2003.tb02201.x; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; PARKER AL, 2010, J ARID ENVIRON, P1487; Qian H, 2003, J VEG SCI, V14, P173, DOI 10.1658/1100-9233(2003)014[0173:UVIBPM]2.0.CO;2; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; REID N, 1990, J VEG SCI, V1, P529, DOI 10.2307/3235787; Rossi BE, 2003, J VEG SCI, V14, P543, DOI 10.1658/1100-9233(2003)014[0543:EOPFOS]2.0.CO;2; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Schlesinger WH, 1998, BIOGEOCHEMISTRY, V42, P169, DOI 10.1023/A:1005939924434; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SCIFRES CJ, 1975, J RANGE MANAGE, V28, P279, DOI 10.2307/3897776; Soil Survey Staff, 2004, 42 SOIL SURV STAFF; Stokes CJ, 2010, ECOLOGY, V91, P1152, DOI 10.1890/08-1105.1; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Breemen N, 1998, BIOGEOCHEMISTRY, V42, P1, DOI 10.1023/A:1005962124317; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758; Wakeling JL, 2011, OIKOS, V120, P1448, DOI 10.1111/j.1600-0706.2011.19957.x; WATTS SE, 1993, ROOTING PATTERNS COO; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Zitzer SF, 1996, J APPL ECOL, V33, P1125, DOI 10.2307/2404692; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	70	19	20	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84364	10.1371/journal.pone.0084364	http://dx.doi.org/10.1371/journal.pone.0084364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367655	Green Published, gold			2022-12-25	WOS:000328740300138
J	Ruan, GP; Xu, F; Li, ZA; Zhu, GX; Pang, RQ; Wang, JX; Cai, XM; He, J; Yao, X; Ruan, GH; Xu, XM; Pan, XH				Ruan, Guang-Ping; Xu, Fan; Li, Zi-An; Zhu, Guang-Xu; Pang, Rong-Qing; Wang, Jin-Xiang; Cai, Xue-Min; He, Jie; Yao, Xiang; Ruan, Guang-Hong; Xu, Xin-Ming; Pan, Xing-Hua			Induced Autologous Stem Cell Transplantation for Treatment of Rabbit Renal Interstitial Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SOMATIC-CELLS; MOUSE MODEL; CONTRIBUTE; REPAIR; PLURIPOTENCY; REGENERATION; INHIBITION; KIDNEY; INJURY	Introduction: Renal interstitial fibrosis (RIF) is a significant cause of end-stage renal failure. The goal of this study was to characterize the distribution of transplanted induced autologous stem cells in a rabbit model of renal interstitial fibrosis and evaluate its therapeutic efficacy for treatment of renal interstitial fibrosis. Methods: A rabbit model of renal interstitial fibrosis was established. Autologous fibroblasts were cultured, induced and labeled with green fluorescent protein (GFP). These labeled stem cells were transplanted into the renal artery of model animals at 8 weeks. Results: Eight weeks following transplantation of induced autologous stem cells, significant reductions (P < 0.05) were observed in serum creatinine (SCr) (14.8 +/- 1.9 mmol/L to 10.1 +/- 2.1 mmol/L) and blood urea nitrogen (BUN) (119 +/- 22 mu mol/L to 97 +/- 13 mu mol/L), indicating improvement in renal function. Conclusions: We successfully established a rabbit model of renal interstitial fibrosis and demonstrated that transplantation of induced autologous stem cells can repair kidney damage within 8 weeks. The repair occurred by both inhibition of further development of renal interstitial fibrosis and partial reversal of pre-existing renal interstitial fibrosis. These beneficial effects lead to the development of normal tissue structure and improved renal function.	[Ruan, Guang-Ping; Xu, Fan; Li, Zi-An; Zhu, Guang-Xu; Pang, Rong-Qing; Wang, Jin-Xiang; Cai, Xue-Min; He, Jie; Yao, Xiang; Ruan, Guang-Hong; Xu, Xin-Ming; Pan, Xing-Hua] Chengdu Mil Command, Kunming Gen Hosp, Stem Cell Engn Lab Yunnan Prov, Kunming, Peoples R China	Kunming General Hospital	Pan, XH (corresponding author), Chengdu Mil Command, Kunming Gen Hosp, Stem Cell Engn Lab Yunnan Prov, Kunming, Peoples R China.	ynkmry@163.com			National Natural Science Foundation of China [31172170]; 973 Projects [2012CB518106]; Special Project of High-new Technology Industrial Development in Yunnan Province [201204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Projects(National Basic Research Program of China); Special Project of High-new Technology Industrial Development in Yunnan Province	This work was supported by the National Natural Science Foundation of China (31172170), 973 Projects (2012CB518106) and Special Project of High-new Technology Industrial Development in Yunnan Province (201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrion FA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt64; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Misseri R, 2004, J SURG RES, V119, P149, DOI 10.1016/j.jss.2004.02.016; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uchimura H, 2005, J AM SOC NEPHROL, V16, P997, DOI 10.1681/ASN.2004050367; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Zhu XQ, 2010, BIOMATERIALS, V31, P2779, DOI 10.1016/j.biomaterials.2009.12.027	24	7	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83507	10.1371/journal.pone.0083507	http://dx.doi.org/10.1371/journal.pone.0083507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367598	Green Submitted, gold, Green Published			2022-12-25	WOS:000328740300107
J	Samji, H; Cescon, A; Hogg, RS; Modur, SP; Althoff, KN; Buchacz, K; Burchell, AN; Cohen, M; Gebo, KA; Gill, MJ; Justice, A; Kirk, G; Klein, MB; Korthuis, PT; Martin, J; Napravnik, S; Rourke, SB; Sterling, TR; Silverberg, MJ; Deeks, S; Jacobson, LP; Bosch, RJ; Kitahata, MM; Goedert, JJ; Moore, R; Gange, SJ				Samji, Hasina; Cescon, Angela; Hogg, Robert S.; Modur, Sharada P.; Althoff, Keri N.; Buchacz, Kate; Burchell, Ann N.; Cohen, Mardge; Gebo, Kelly A.; Gill, M. John; Justice, Amy; Kirk, Gregory; Klein, Marina B.; Korthuis, P. Todd; Martin, Jeff; Napravnik, Sonia; Rourke, Sean B.; Sterling, Timothy R.; Silverberg, Michael J.; Deeks, Stephen; Jacobson, Lisa P.; Bosch, Ronald J.; Kitahata, Mari M.; Goedert, James J.; Moore, Richard; Gange, Stephen J.		North Amer AIDS Cohort	Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTING DRUG-USERS; INFECTED PERSONS; INCOME COUNTRIES; COHORT; INEQUALITIES; MORTALITY; SURVIVAL; TIME	Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U. S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U. S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >= 20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm(3). Conclusions: A 20-year-old HIV-positive adult on ART in the U. S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.	[Samji, Hasina; Cescon, Angela; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Modur, Sharada P.; Althoff, Keri N.; Gebo, Kelly A.; Kirk, Gregory; Jacobson, Lisa P.; Moore, Richard; Gange, Stephen J.] Johns Hopkins Univ, Baltimore, MD USA; [Buchacz, Kate] Ctr Dis Control & Prevent, Atlanta, GA USA; [Burchell, Ann N.; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Cohen, Mardge] Bur Hlth Serv Cook Cty, Core Ctr, Chicago, IL USA; [Gill, M. John] Univ Calgary, Calgary, AB, Canada; [Justice, Amy] Vet Adm Connecticut Healthcare Syst, West Haven, CT USA; [Justice, Amy] Yale Univ, West Haven, CT USA; [Klein, Marina B.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Martin, Jeff] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Napravnik, Sonia] Univ N Carolina, Chapel Hill, NC USA; [Sterling, Timothy R.] Vanderbilt Univ, Nashville, TN 37235 USA; [Silverberg, Michael J.] Kaiser Permanente No Calif, Oakland, CA USA; [Deeks, Stephen] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; [Bosch, Ronald J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Kitahata, Mari M.] Univ Washington, Seattle, WA 98195 USA; [Goedert, James J.] NCI, Rockville, MD USA	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of Calgary; Yale University; McGill University; Oregon Health & Science University; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Kaiser Permanente; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hogg, RS (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	rhogg@sfu.ca	Dodsley, Maria/G-7083-2016; Gange, Stephen/AGY-5004-2022; Althoff, Keri N/HGC-5595-2022; Gebo, Kelly/AHA-7533-2022; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gange, Stephen/0000-0001-7842-512X; Gebo, Kelly/0000-0003-4010-398X; Korthuis, Philip/0000-0001-5556-3597; Klein, Marina/0000-0002-3063-8430; Hogg, Robert/0000-0003-3463-5488; Jacobson, Lisa P./0000-0003-1722-6826; Althoff, Keri/0000-0002-5068-6595; Samji, Hasina/0000-0002-4555-7609; Gill, Michael John/0000-0002-8546-8790	National Institutes of Health [U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K24 AI65298, K01-AI093197]; Agency for Healthcare Research and Quality [290-01-0012]; CDC [CDC200-2006-18797]; Canadian Institutes of Health Research [TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, 169621]; Canadian HIV Trials Network [24]; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010214, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000052, UL1RR024131, M01RR000083, UL1RR025747, M01RR000722, M01RR000071] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY008052, U10EY008057, U10EY008067, K23EY013707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432, U01AI035039, U01AI035042, U01AI037613, U01AI035040, P30AI054999, U01AI031834, U01AI068636, P30AI027757, U01AI035004, U01AI034993, K01AI071725, U01AI069432, U01AI037984, U01AI038855, P30AI027767, U01AI034989, P30AI050410, P30AI027763, U01AI035043, U01AI069918, K01AI093197, K24AI065298, U01AI068634, U01AI038858, U01AI042590, UM1AI069434, U01AI034994, U01AI035041, U01AI069434, R24AI067039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893, U01AA020790, U10AA013566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, K24DA000432, U01DA036935, R01DA004334, R01DA012568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K24 AI65298 and K01-AI093197 from the National Institutes of Health; contract 290-01-0012 from the Agency for Healthcare Research and Quality; contract CDC200-2006-18797 from the CDC; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, and 169621 from the Canadian Institutes of Health Research; the Canadian HIV Trials Network, project 24; and the government of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d; Chiang, 1968, INTRO STOCHASTIC PRO, P189; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Minino A.M., 2011, NATL VITAL STAT REPO, V59; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Palella FJ, 2011, AIDS, V25, P1865, DOI 10.1097/QAD.0b013e32834b3537; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2013, LIF EXP; World Health Organization, 2012, LIF TABL WHO MEMBR S	31	908	927	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81355	10.1371/journal.pone.0081355	http://dx.doi.org/10.1371/journal.pone.0081355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367482	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300004
J	Wan, L; Ma, JS; Wang, NL; Wang, DH; Xu, GY				Wan, Lu; Ma, Jisi; Wang, Nianlu; Wang, Daihua; Xu, Gangyi			Molecular Cloning and Characterization of Different Expression of MYOZ2 and MYOZ3 in Tianfu Goat	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; SKELETAL-MUSCLE; MEAT QUALITY; HYPERTROPHIC CARDIOMYOPATHY; GENE-EXPRESSION; FILAMIN-BINDING; ACTININ-BINDING; Z-DISC; CALSARCIN-1; PROTEIN	The myozenin family of proteins binds calcineurin, which is involved in myocyte differentiation of skeletal muscle. Moreover, gene expression of myozenin is closely related to meat quality. To further understand the functions and effects of myozenin2 (MYOZ2) and myozenin3 (MYOZ3) genes in goat, we cloned them from Tianfu goat longissimus dorsi muscle. Sequence analyses revealed that full-length coding sequence of MYOZ2 consisted of 795 bp and encoded 264 amino acids, and full-length coding sequence of MYOZ3 consisted of 735 bp and encoded 244 amino acids. RT-qPCR analyses revealed that mRNA expressions of MYOZ2 and MYOZ3 were detected in heart, liver, spleen, lung, kidney, leg muscle, abdominal muscle, and longissimus dorsi muscle. Particularly high expression levels of MYOZ2 were seen in abdominal muscle and heart (P<0.01), low expression levels were seen in leg muscle (P<0.01), longissimus dorsi muscle (P>0.05) and very little expression were detected in liver, spleen, lung and kidney (P>0.05). In addition, high expression levels of MYOZ3 were seen in abdominal muscle, leg muscle, lungs and kidney (P<0.01), low expression levels were found in longissimus dorsi muscle and spleen (P<0.01) and very little expression were detected in heart and liver (P>0.05). Temporal mRNA expression results showed that MYOZ2 and MYOZ3 gene expression varied across four muscle tissues with different ages of the goats. Western blotting further revealed that MYOZ2 and MYOZ3 proteins were only expressed in goat muscle, with notable temporal expression differences in specialized muscle tissues from five development age stages. This work provides the first evidence that MYOZ2 and MYOZ3 genes are expressed abundantly in Tianfu goat muscle tissues from different development age stages, and lay a foundation for understanding the functions of MYOZ2 and MYOZ3 genes in muscle fiber differentiation.	[Wan, Lu; Ma, Jisi; Wang, Nianlu; Xu, Gangyi] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China; [Wang, Daihua] Mianyang Agr Bur, Mianyang, Sichuan, Peoples R China	Sichuan Agricultural University	Xu, GY (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China.	goatsxgy@263.net			China Agricultural Research System [CARS-39]; Selecting Projects of New Breeds in Sichuan Province [01NG002-04]	China Agricultural Research System; Selecting Projects of New Breeds in Sichuan Province	This work was financially supported by the China Agricultural Research System (CARS-39) and the Selecting Projects of New Breeds in Sichuan Province (01NG002-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2000, GENOMICS, V70, P347, DOI 10.1006/geno.2000.6399; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; EROBONBORMIOLI SP, 1981, J HISTOCHEM CYTOCHEM, V29, P1179, DOI 10.1177/29.10.7028858; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; Fiedler I, 1999, MEAT SCI, V53, P9, DOI 10.1016/S0309-1740(99)00030-3; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gentry JG, 2002, J ANIM SCI, V80, P2833; Karlsson AH, 1999, LIVEST PROD SCI, V60, P255, DOI 10.1016/S0301-6226(99)00098-6; Klont RE, 1998, MEAT SCI, V49, pS219; LIND A, 1991, J HISTOCHEM CYTOCHEM, V39, P589, DOI 10.1177/39.5.1826695; Liu YW, 2005, J MUSCLE RES CELL M, V26, P13, DOI 10.1007/s10974-005-9002-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monin G., 1991, DEV MEAT SCI, V5, P157; Nii M, 2005, J ANIM SCI, V83, P308; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Ruggiero A, 2013, CARDIOVASC RES, V97, P44, DOI 10.1093/cvr/cvs294; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Schiaffino S, 2002, TRENDS PHARMACOL SCI, V23, P569, DOI 10.1016/S0165-6147(02)02111-9; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Swoap SJ, 2000, AM J PHYSIOL-CELL PH, V279, pC915, DOI 10.1152/ajpcell.2000.279.4.C915; SYROVY I, 1977, PFLUG ARCH EUR J PHY, V369, P85, DOI 10.1007/BF00580815; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; TAUVERON I, 1994, AM J PHYSIOL-ENDOC M, V267, pE877, DOI 10.1152/ajpendo.1994.267.6.E877; Wang DH, 2011, SMALL RUMINANT RES, V95, P88, DOI 10.1016/j.smallrumres.2010.10.010; Wang H, 2006, GENE, V374, P104, DOI 10.1016/j.gene.2006.01.035; Xu HG, 2013, GENE, V515, P71, DOI 10.1016/j.gene.2012.11.025; Yan Z, 1998, J APPL PHYSIOL, V85, P973, DOI 10.1152/jappl.1998.85.3.973	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82550	10.1371/journal.pone.0082550	http://dx.doi.org/10.1371/journal.pone.0082550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367523	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300039
J	Kawano, T; Prananingrum, W; Ishida, Y; Goto, T; Naito, Y; Watanabe, M; Tomotake, Y; Ichikawa, T				Kawano, Takanori; Prananingrum, Widyasri; Ishida, Yuichi; Goto, Takaharu; Naito, Yoshihito; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo			Blue-Violet Laser Modification of Titania Treated Titanium: Antibacterial and Osteo-Inductive Effects	PLOS ONE			English	Article							UVA RADIATION; IN-VITRO; BONE; SURFACES; WATER; TIO2; BACTERIA; LESIONS	Background: Many studies on surface modifications of titanium have been performed in an attempt to accelerate osseointegration. Recently, anatase titanium dioxide has been found to act as a photocatalyst that expresses antibiotic properties and exhibits hydrophilicity after ultraviolet exposure. A blue-violet semiconductor laser (BV-LD) has been developed as near-ultraviolet light. The purpose of this study was to investigate the effects of exposure to this BV-LD on surface modifications of titanium with the goal of enhancing osteoconductive and antibacterial properties. Methods: The surfaces of pure commercial titanium were polished with #800 waterproof polishing papers and were treated with anatase titania solution. Specimens were exposed using BV-LD (lambda = 405 nm) or an ultraviolet light-emitting diode (UV-LED, lambda = 365 nm) at 6 mW/cm(2) for 3 h. The surface modification was evaluated physically and biologically using the following parameters or tests: surface roughness, surface temperature during exposure, X-ray diffraction (XRD) analysis, contact angle, methylene blue degradation tests, adherence of Porphyromonas gingivalis, osteoblast and fibroblast proliferation, and histological examination after implantation in rats. Results: No significant changes were found in the surface roughness or XRD profiles after exposure. BV-LD exposure did not raise the surface temperature of titanium. The contact angle was significantly decreased, and methylene blue was significantly degraded. The number of attached P. gingivalis organisms was significantly reduced after BV-LD exposure compared to that in the no exposure group. New bone was observed around exposed specimens in the histological evaluation, and both the bone-to-specimen contact ratio and the new bone area increased significantly in exposed groups. Conclusions: This study suggested that exposure of titanium to BV-LD can enhance the osteoconductivity of the titanium surface and induce antibacterial properties, similar to the properties observed following exposure to UV-LED.	[Kawano, Takanori; Prananingrum, Widyasri; Ishida, Yuichi; Goto, Takaharu; Naito, Yoshihito; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Hlth, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan	Tokushima University	Goto, T (corresponding author), Univ Tokushima, Inst Hlth, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan.	tak510@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304				Ahn SJ, 2011, INT J ORAL MAX IMPL, V26, P39; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031212; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Fujishima A, 2006, CR CHIM, V9, P750, DOI 10.1016/j.crci.2005.02.055; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Hamamoto A, 2007, J APPL MICROBIOL, V103, P2291, DOI 10.1111/j.1365-2672.2007.03464.x; Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005; Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hirakawa Y, 2013, CLIN ORAL IMPLAN RES, V24, P139, DOI 10.1111/j.1600-0501.2011.02401.x; Lin HX, 2008, J BIOMED MATER RES B, V87B, P425, DOI 10.1002/jbm.b.31120; Liou JW, 2012, ARCH IMMUNOL THER EX, V60, P267, DOI 10.1007/s00005-012-0178-x; Mori M, 2007, MED BIOL ENG COMPUT, V45, P1237, DOI 10.1007/s11517-007-0263-1; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Takeshita F, 1997, J BIOMED MATER RES, V37, P235, DOI 10.1002/(SICI)1097-4636(199711)37:2<235::AID-JBM13>3.0.CO;2-D; Tsai TM, 2010, J CHEM TECHNOL BIOT, V85, P1642, DOI 10.1002/jctb.2476; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E	23	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84327	10.1371/journal.pone.0084327	http://dx.doi.org/10.1371/journal.pone.0084327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358355	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700091
J	Walker, CR; Hautefort, I; Dalton, JE; Overweg, K; Egan, CE; Bongaerts, RJ; Newton, DJ; Cruickshank, SM; Andrew, EM; Carding, SR				Walker, Catherine R.; Hautefort, Isabelle; Dalton, Jane E.; Overweg, Karin; Egan, Charlotte E.; Bongaerts, Roy J.; Newton, Darren J.; Cruickshank, Sheena M.; Andrew, Elizabeth M.; Carding, Simon R.			Intestinal Intraepithelial Lymphocyte-Enterocyte Crosstalk Regulates Production of Bactericidal Angiogenin 4 by Paneth Cells upon Microbial Challenge	PLOS ONE			English	Article							DELTA T-CELLS; ENTERICA SEROTYPE TYPHIMURIUM; GAMMA-DELTA; GENE-EXPRESSION; IL-17 PRODUCTION; IN-VITRO; SALMONELLA; IL-23; INFECTION; INNATE	Antimicrobial proteins influence intestinal microbial ecology and limit proliferation of pathogens, yet the regulation of their expression has only been partially elucidated. Here, we have identified a putative pathway involving epithelial cells and intestinal intraepithelial lymphocytes (iIELs) that leads to antimicrobial protein (AMP) production by Paneth cells. Mice lacking gamma delta iIELs (TCR delta(-/-)) express significantly reduced levels of the AMP angiogenin 4 (Ang4). These mice were also unable to up-regulate Ang4 production following oral challenge by Salmonella, leading to higher levels of mucosal invasion compared to their wild type counterparts during the first 2 hours post-challenge. The transfer of gamma delta iIELs from wild type (WT) mice to TCR delta(-/-) mice restored Ang4 production and Salmonella invasion levels were reduced to those obtained in WT mice. The ability to restore Ang4 production in TCR delta(-/-) mice was shown to be restricted to gamma delta iIELs expressing V gamma 7-encoded TCRs. Using a novel intestinal crypt co-culture system we identified a putative pathway of Ang4 production initiated by exposure to Salmonella, intestinal commensals or microbial antigens that induced intestinal epithelial cells to produce cytokines including IL-23 in a TLR-mediated manner. Exposure of TCR-V gamma 7(+) gamma delta iIELs to IL-23 promoted IL-22 production, which triggered Paneth cells to secrete Ang4. These findings identify a novel role for gamma delta iIELs in mucosal defence through sensing immediate epithelial cell cytokine responses and influencing AMP production. This in turn can contribute to the maintenance of intestinal microbial homeostasis and epithelial barrier function, and limit pathogen invasion.	[Walker, Catherine R.; Hautefort, Isabelle; Overweg, Karin; Bongaerts, Roy J.; Carding, Simon R.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Walker, Catherine R.; Dalton, Jane E.; Egan, Charlotte E.; Newton, Darren J.; Cruickshank, Sheena M.; Andrew, Elizabeth M.; Carding, Simon R.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Dalton, Jane E.] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Egan, Charlotte E.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Newton, Darren J.] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Walker, Catherine R.; Cruickshank, Sheena M.; Andrew, Elizabeth M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Carding, Simon R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Leeds; University of York - UK; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint James's University Hospital; University of Manchester; University of East Anglia	Carding, SR (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	simon.carding@ifr.ac.uk	Newton, Darren/CAA-0475-2022	Carding, Simon/0000-0002-2383-9701; Dalton, Jane/0000-0001-9115-8855; Cruickshank, Sheena/0000-0002-3047-5475	Biotechnology of Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC-DTA studentship; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044446] Funding Source: researchfish; BBSRC [BBS/E/F/00044446] Funding Source: UKRI	Biotechnology of Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC-DTA studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants awarded by the Biotechnology of Biological Sciences Research Council (BBSRC) and the Wellcome Trust (SRC). Catherine Walker was supported by a BBSRC-DTA studentship awarded to the University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; Andrew EM, 2005, MICROBES INFECT, V7, P529, DOI 10.1016/j.micinf.2004.12.010; Arques JL, 2009, GASTROENTEROLOGY, V137, P579, DOI 10.1053/j.gastro.2009.04.010; Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baumgart DC, 1998, CELL IMMUNOL, V187, P52, DOI 10.1006/cimm.1998.1307; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; BUCY RP, 1988, J IMMUNOL, V141, P2200; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P2431, DOI 10.1021/bi062158n; D'Elia R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-492; Dalton JE, 2006, GASTROENTEROLOGY, V131, P818, DOI 10.1053/j.gastro.2006.06.003; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; GuyGrand D, 1996, EUR J IMMUNOL, V26, P2248, DOI 10.1002/eji.1830260942; HAVRAN WL, 2005, AM J PHYSIOL, V289, P627; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Jabri B, 2007, IMMUNOL REV, V215, P202, DOI 10.1111/j.1600-065X.2006.00481.x; KawaguchiMiyashita M, 1996, IMMUNOLOGY, V89, P268, DOI 10.1046/j.1365-2567.1996.d01-740.x; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; KYES S, 1989, P NATL ACAD SCI USA, V86, P5527, DOI 10.1073/pnas.86.14.5527; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rowley G, 2005, INFECT IMMUN, V73, P459, DOI 10.1128/IAI.73.1.459-463.2005; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schechter LM, 1999, MOL MICROBIOL, V32, P629, DOI 10.1046/j.1365-2958.1999.01381.x; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Singh JCI, 2005, AM J PHYSIOL-GASTR L, V288, pG514, DOI 10.1152/ajpgi.00377.2004; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; TREJDOSIEWICZ LK, 1989, IMMUNOLOGY, V68, P7; Umemura M, 2004, INT IMMUNOL, V16, P1099, DOI 10.1093/intimm/dxh111; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	81	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84553	10.1371/journal.pone.0084553	http://dx.doi.org/10.1371/journal.pone.0084553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358364	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000328737700099
J	Sackett, O; Petrou, K; Reedy, B; De Grazia, A; Hill, R; Doblin, M; Beardall, J; Ralph, P; Heraud, P				Sackett, Olivia; Petrou, Katherina; Reedy, Brian; De Grazia, Adrian; Hill, Ross; Doblin, Martina; Beardall, John; Ralph, Peter; Heraud, Philip			Phenotypic Plasticity of Southern Ocean Diatoms: Key to Success in the Sea Ice Habitat?	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; PHOTOSYNTHETIC ENERGY-CONVERSION; BIOCHEMICAL-COMPOSITION; MARINE-PHYTOPLANKTON; EXTREME CONDITIONS; FTIR SPECTROSCOPY; PROTEIN-SYNTHESIS; LIMITED GROWTH; ALGAE; ANTARCTICA	Diatoms are the primary source of nutrition and energy for the Southern Ocean ecosystem. Microalgae, including diatoms, synthesise biological macromolecules such as lipids, proteins and carbohydrates for growth, reproduction and acclimation to prevailing environmental conditions. Here we show that three key species of Southern Ocean diatom (Fragilariopsis cylindrus, Chaetoceros simplex and Pseudo-nitzschia subcurvata) exhibited phenotypic plasticity in response to salinity and temperature regimes experienced during the seasonal formation and decay of sea ice. The degree of phenotypic plasticity, in terms of changes in macromolecular composition, was highly species-specific and consistent with each species' known distribution and abundance throughout sea ice, meltwater and pelagic habitats, suggesting that phenotypic plasticity may have been selected for by the extreme variability of the polar marine environment. We argue that changes in diatom macromolecular composition and shifts in species dominance in response to a changing climate have the potential to alter nutrient and energy fluxes throughout the Southern Ocean ecosystem.	[Sackett, Olivia; Petrou, Katherina; Doblin, Martina; Ralph, Peter] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Sackett, Olivia; Petrou, Katherina; Doblin, Martina; Ralph, Peter] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Sackett, Olivia; Heraud, Philip] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Reedy, Brian; De Grazia, Adrian] Univ Technol Sydney, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney Inst Marine Sci, Sydney, NSW 2052, Australia; [Heraud, Philip] Monash Univ, Ctr Biospect, Clayton, Vic 3800, Australia	University of Technology Sydney; University of Technology Sydney; Monash University; University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney; Monash University	Heraud, P (corresponding author), Monash Univ, Ctr Biospect, Clayton, Vic 3800, Australia.	phil.heraud@monash.edu	Doblin, Martina A/E-8719-2013; Hill, Ross/E-6075-2013; Ralph, Peter J/C-5029-2009; Beardall, John/L-5262-2019; Doblin, Martina/L-1804-2019; Ralph, Peter/L-1527-2019	Doblin, Martina A/0000-0001-8750-3433; Hill, Ross/0000-0002-4623-1563; Ralph, Peter J/0000-0002-3103-7346; Beardall, John/0000-0001-7684-446X; Doblin, Martina/0000-0001-8750-3433; Ralph, Peter/0000-0002-3103-7346; Heraud, Philip/0000-0003-4377-9184; Petrou, Katherina/0000-0002-2703-0694				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Almandoz GO, 2008, POLAR BIOL, V31, P429, DOI 10.1007/s00300-007-0369-9; Armand LK, 2005, PALAEOGEOGR PALAEOCL, V223, P93, DOI 10.1016/j.palaeo.2005.02.015; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Devos N, 1998, J PHYCOL, V34, P655, DOI 10.1046/j.1529-8817.1998.340655.x; Diekmann ABS, 2009, J PLANKTON RES, V31, P1391, DOI 10.1093/plankt/fbp073; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; FAHL K, 1993, POLAR BIOL, V13, P405, DOI 10.1007/BF01681982; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Heraud P, 2005, FEMS MICROBIOL LETT, V249, P219, DOI 10.1016/j.femsle.2005.06.021; Heraud P, 2007, ACS SYM SER, V963, P85; Heraud P, 2008, J PHYCOL, V44, P1335, DOI 10.1111/j.1529-8817.2008.00564.x; HORNER R, 1992, POLAR BIOL, V12, P417; Jakob T, 2007, J EXP BOT, V58, P2101, DOI 10.1093/jxb/erm084; Jungandreas A, 2012, PLANT CELL PHYSIOL, V53, P2153, DOI 10.1093/pcp/pcs144; Krell A, 2008, EUR J PHYCOL, V43, P423, DOI 10.1080/09670260802348615; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee SH, 2008, J EXP MAR BIOL ECOL, V367, P204, DOI 10.1016/j.jembe.2008.09.018; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; LOHRENZ SE, 1987, MAR ECOL PROG SER, V35, P277, DOI 10.3354/meps035277; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mock T, 2004, J PHYCOL, V40, P732, DOI 10.1111/j.1529-8817.2004.03224.x; Mock T, 2002, PHYTOCHEMISTRY, V61, P41, DOI 10.1016/S0031-9422(02)00216-9; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Mock Thomas, 2007, V11; Murdock JN, 2009, APPL SPECTROSC REV, V44, P335, DOI 10.1080/05704920902907440; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; NICHOLS PD, 1989, ANTARCT SCI, V1, P133, DOI 10.1017/S0954102089000209; Petrou K, 2011, MAR ECOL PROG SER, V437, P27, DOI 10.3354/meps09291; Petrou K, 2011, MAR BIOL, V158, P1029, DOI 10.1007/s00227-011-1628-4; Pocock T, 2011, J EXP BOT, V62, P1169, DOI 10.1093/jxb/erq347; Ralph PJ, 2007, J PHYCOL, V43, P948, DOI 10.1111/j.1529-8817.2007.00382.x; Raymond JA, 2000, POLAR BIOL, V23, P721, DOI 10.1007/s003000000147; RIVKIN RB, 1987, LIMNOL OCEANOGR, V32, P249, DOI 10.4319/lo.1987.32.1.0249; RIVKIN RB, 1985, MAR BIOL, V89, P135, DOI 10.1007/BF00392884; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Suarez I, 2003, J SEA RES, V50, P285, DOI 10.1016/j.seares.2003.04.002; Tang KW, 2009, P ROY SOC B-BIOL SCI, V276, P81, DOI 10.1098/rspb.2008.0598; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Wagner H, 2010, J BIOPHOTONICS, V3, P557, DOI 10.1002/jbio.201000019; WHYTE JNC, 1987, AQUACULTURE, V60, P231, DOI 10.1016/0044-8486(87)90290-0; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Xie YP, 2012, J FOOD SAFETY, V32, P176, DOI 10.1111/j.1745-4565.2012.00365.x	62	42	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81185	10.1371/journal.pone.0081185	http://dx.doi.org/10.1371/journal.pone.0081185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24363795	gold, Green Published			2022-12-25	WOS:000327539800110
J	Xiang, T; Long, H; He, L; Han, X; Lin, K; Liang, Z; Zhuo, W; Xie, R; Zhu, B				Xiang, T.; Long, H.; He, L.; Han, X.; Lin, K.; Liang, Z.; Zhuo, W.; Xie, R.; Zhu, B.			Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133(+) cancer stem-like cells in ovarian cancer	ONCOGENE			English	Article						cancer stem cells; IL-17; self-renewal; ovarian cancer	BREAST-CANCER; INITIATING CELLS; IL-17 PROMOTES; MESSENGER-RNA; LUNG-CANCER; EXPRESSION; GROWTH; POPULATION; BETA; DIFFERENTIATION	Inflammatory cytokines, components of cancer stem cells (CSCs) niche, could affect the characteristics of CSCs such as self-renewal and metastasis. Interleukin-17 (IL-17) is a new pro-inflammatory cytokine mainly produced by T-helper (Th17) cells and macrophages. The effects of IL-17 on the characteristics of CSCs remain to be explored. Here we first demonstrated a role of IL-17 in promoting the self-renewal of ovarian CD133(+) cancer stem-like cells (CSLCs). We detected IL-17-producing cells (CD4(+) cells and CD68(+) macrophages) in the niche of CD133(+) CSLCs. Meanwhile, there was IL-17 receptor expression on CD133(+)CSLCs derived from A2780 cell line and primary ovarian cancer tissues. By recombinant human IL-17 stimulation and IL-17 transfection, the growth and sphere formation capacities of ovarian CD133(+)CSLCs were significantly enhanced in a dose-dependent manner. Moreover, ovarian CD133(+)CSLCs transfected with IL-17 showed greater tumorigenesis capacity in nude mice. These data suggest that IL-17 promoted the self-renewal of ovarian CD133(+)CSLCs. Further investigation through gene profiling revealed that the stimulation function of IL-17 on self-renewal of ovarian CD133(+)CSLCs might be mediated by the nuclear factor (NF)-kappa B and p38 mitogen-activated protein kinases (MAPK) signaling pathway. NF-kappa B and p38 MAPK were activated by IL-17. More importantly, IL-17 promoted self-renewal was inhibited by specific inhibitors of NF-kappa B and p38 MAPK. Taken together, our data indicate that IL-17 contributed to ovarian cancer malignancy through promoting the self-renewal of CD133(+)CSLCs and that IL-17 and its signaling pathway might serve as therapeutic targets for the treatment of ovarian cancer.	[Xiang, T.; Long, H.; He, L.; Han, X.; Lin, K.; Zhuo, W.; Xie, R.; Zhu, B.] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing 400037, Peoples R China; [Liang, Z.] Third Mil Med Univ, Southwest Hosp, Dept Obstet & Gynecol, Chongqing 400037, Peoples R China; [Xie, R.] Third Mil Med Univ, Xinqiao Hosp, Dept Obstet & Gynecol, Chongqing 400037, Peoples R China; [Zhu, B.] Third Mil Med Univ, Biomed Anal Ctr, Chongqing 400037, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Xie, R (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Obstet & Gynecol, Chongqing 400037, Peoples R China.	xrkai@163.com; b.davis.zhu@gmail.com			National Nature Science Foundation of China [81070018, 81071772, 81222031]; outstanding Youth Scientist Foundation of Chongqing [CSTC 2008BA5035]; National Key Basic Research Program of China (973 program) [2010CB529404, 2012CB526603]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); outstanding Youth Scientist Foundation of Chongqing; National Key Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by National Nature Science Foundation of China (grant nos. 81070018, 81071772 and 81222031), by the outstanding Youth Scientist Foundation of Chongqing (no. CSTC, 2008BA5035) and by National Key Basic Research Program of China (973 program, grant nos. 2010CB529404 and 2012CB526603).	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen X, 2010, CANCER SCI, V101, P2384, DOI 10.1111/j.1349-7006.2010.01684.x; Ciucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060145; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Du JW, 2012, MOL MED REP, V6, P1099, DOI 10.3892/mmr.2012.1036; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; HAMILTON TC, 1983, P AM ASSOC CANC RES, V24, P313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Kusumbe AP, 2009, STEM CELLS, V27, P498, DOI 10.1634/stemcells.2008-0868; Lai DM, 2012, CANCER IMMUNOL IMMUN, V61, P979, DOI 10.1007/s00262-011-1166-4; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lan CY, 2013, CELL TISSUE RES, V352, P351, DOI 10.1007/s00441-013-1567-0; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Numasaki M, 2004, IMMUNOL LETT, V93, P39, DOI 10.1016/j.imlet.2004.01.014; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pasquier J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/630782; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; Subramaniam SV, 1999, BIOCHEM BIOPH RES CO, V259, P172, DOI 10.1006/bbrc.1999.0746; Subramaniam SV, 1999, BIOCHEM BIOPH RES CO, V262, P14, DOI 10.1006/bbrc.1999.1156; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yi LA, 2011, J NEUROIMMUNOL, V232, P75, DOI 10.1016/j.jneuroim.2010.10.011; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	50	99	104	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					165	176		10.1038/onc.2013.537	http://dx.doi.org/10.1038/onc.2013.537			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362529				2022-12-25	WOS:000347790500004
J	Chislock, EM; Pendergast, AM				Chislock, Elizabeth M.; Pendergast, Ann Marie			Abl Family Kinases Regulate Endothelial Barrier Function In Vitro and in Mice	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; GROWTH-FACTOR RECEPTORS; TYROSINE KINASE; VE-CADHERIN; VASCULAR-PERMEABILITY; CELL PERMEABILITY; MICROVASCULAR PERMEABILITY; DIFFERENTIAL REGULATION; ADHERENS JUNCTIONS; INDUCED INCREASE	The maintenance of endothelial barrier function is essential for normal physiology, and increased vascular permeability is a feature of a wide variety of pathological conditions, leading to complications including edema and tissue damage. Use of the pharmacological inhibitor imatinib, which targets the Abl family of non-receptor tyrosine kinases (Abl and Arg), as well as other tyrosine kinases including the platelet-derived growth factor receptor (PDGFR), Kit, colony stimulating factor 1 receptor (CSF1R), and discoidin domain receptors, has shown protective effects in animal models of inflammation, sepsis, and other pathologies characterized by enhanced vascular permeability. However, the imatinib targets involved in modulation of vascular permeability have not been well-characterized, as imatinib inhibits multiple tyrosine kinases not only in endothelial cells and pericytes but also immune cells important for disorders associated with pathological inflammation and abnormal vascular permeability. In this work we employ endothelial Abl knockout mice to show for the first time a direct role for Abl in the regulation of vascular permeability in vivo. Using both Abl/Arg-specific pharmacological inhibition and endothelial Abl knockout mice, we demonstrate a requirement for Abl kinase activity in the induction of endothelial permeability by vascular endothelial growth factor both in vitro and in vivo. Notably, Abl kinase inhibition also impaired endothelial permeability in response to the inflammatory mediators thrombin and histamine. Mechanistically, we show that loss of Abl kinase activity was accompanied by activation of the barrier-stabilizing GTPases Rac1 and Rap1, as well as inhibition of agonist-induced Ca2+ mobilization and generation of acto-myosin contractility. In all, these findings suggest that pharmacological targeting of the Abl kinases may be capable of inhibiting endothelial permeability induced by a broad range of agonists and that use of Abl kinase inhibitors may have potential for the treatment of disorders involving pathological vascular leakage.	[Chislock, Elizabeth M.; Pendergast, Ann Marie] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	ann.pendergast@duke.edu		Chislock, Elizabeth/0000-0002-9776-4271; Pendergast, Ann Marie/0000-0002-1250-6880	Pharmaceutical Research and Manufacturers of America Foundation; American Heart Association; National Institutes of Health [CA155160, CA070940, HL084102, AI056266]; NATIONAL CANCER INSTITUTE [R01CA155160, R01CA070940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056266] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pharmaceutical Research and Manufacturers of America Foundation (www.phrmafoundation.org) Predoctoral Fellowship in Pharmacology/Toxicology (to EMC), an American Heart Association (www.heart.org) Predoctoral Fellowship (to EMC), and National Institutes of Health (www.nih.gov) Grants CA155160, CA070940, HL084102, and AI056266 (to AMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Anselmi F, 2012, ANGIOGENESIS, V15, P187, DOI 10.1007/s10456-012-9252-6; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chislock EM, 2013, P NATL ACAD SCI USA, V110, P12432, DOI 10.1073/pnas.1304188110; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Di Lorenzo A, 2013, J CELL SCI; Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100; Esser S, 1998, J CELL SCI, V111, P1853; Fujii E, 1997, N-S ARCH PHARMACOL, V356, P475, DOI 10.1007/PL00005079; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2; Gu JJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002632; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kim IK, 2013, CRIT CARE, V17, DOI 10.1186/cc12786; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kurimoto N, 2004, AM J PHYSIOL-HEART C, V287, pH100, DOI 10.1152/ajpheart.00922.2003; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Le Q, 1998, J IMMUNOL, V160, P3330; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pietras K, 2001, CANCER RES, V61, P2929; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vlahovic G, 2007, BRIT J CANCER, V97, P735, DOI 10.1038/sj.bjc.6603941; Vlahovic G, 2006, BRIT J CANCER, V95, P1013, DOI 10.1038/sj.bjc.6603366; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	71	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e85231	10.1371/journal.pone.0085231	http://dx.doi.org/10.1371/journal.pone.0085231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367707	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900075
J	Tanninen, SE; Morrissey, MD; Takehara-Nishiuchi, K				Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori			Unilateral Lateral Entorhinal Inactivation Impairs Memory Expression in Trace Eyeblink Conditioning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; VENTRAL HIPPOCAMPUS; DORSAL HIPPOCAMPUS; ACQUISITION; CONSOLIDATION; RETRIEVAL; AMYGDALA; LESIONS; MICROINJECTION; PROJECTIONS	Memory in trace eyeblink conditioning is mediated by an inter-connected network that involves the hippocampus (HPC), several neocortical regions, and the cerebellum. This network reorganizes after learning as the center of the network shifts from the HPC to the medial prefrontal cortex (mPFC). Despite the network reorganization, the lateral entorhinal cortex (LEC) plays a stable role in expressing recently acquired HPC-dependent memory as well as remotely acquired mPFC-dependent memory. Entorhinal involvement in recent memory expression may be attributed to its previously proposed interactions with the HPC. In contrast, it remains unknown how the LEC participates in memory expression after the network disengages from the HPC. The present study tested the possibility that the LEC and mPFC functionally interact during remote memory expression by examining the impact of pharmacological inactivation of the LEC in one hemisphere and the mPFC in the contralateral hemisphere on memory expression in rats. Memory expression one day and one month after learning was significantly impaired after LEC-mPFC inactivation; however, the degree of impairment was comparable to that after unilateral LEC inactivation. Unilateral mPFC inactivation had no effect on recent or remote memory expression. These results suggest that the integrity of the LEC in both hemispheres is necessary for memory expression. Functional interactions between the LEC and mPFC should therefore be tested with an alternative design.	[Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Tanninen, Stephanie E.; Morrissey, Mark D.; Takehara-Nishiuchi, Kaori] Univ Toronto, Program Neurosci, Toronto, ON, Canada; [Takehara-Nishiuchi, Kaori] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Takehara-Nishiuchi, K (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	takehara@psych.utoronto.ca	Takehara-Nishiuchi, Kaori/Q-9053-2019; Takehara, Kaori/ABD-2977-2020	Takehara-Nishiuchi, Kaori/0000-0002-7282-7838; Takehara, Kaori/0000-0002-7282-7838; Morrissey, Mark/0000-0002-3300-162X	National Sciences and Engineering Research Council of Canada (NSERC) [386683]; Canadian Foundation for Innovation Leaders [25026]; NSERC	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Leaders; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding sources: National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 386683 (K.T.-N); Canadian Foundation for Innovation Leaders Opportunity Grant 25026 (K.T.-N.); NSERC Canadian Graduate Scholarship D (M. D. M.); NSERC Canadian Graduate Scholarship M (S. E. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2009, HIPPOCAMPUS, V19, P1159, DOI 10.1002/hipo.20578; Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Cimadevilla JM, 2005, COGNITIVE BRAIN RES, V25, P741, DOI 10.1016/j.cogbrainres.2005.09.001; ColemanMesches K, 1996, BEHAV BRAIN RES, V77, P175, DOI 10.1016/0166-4328(95)00231-6; ColemanMesches K, 1997, BEHAV BRAIN RES, V86, P17, DOI 10.1016/S0166-4328(96)02211-5; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; MARKOWITSCH HJ, 1983, BRAIN RES BULL, V10, P805, DOI 10.1016/0361-9230(83)90212-5; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Morrissey MD, 2012, J NEUROSCI, V32, P5356, DOI 10.1523/JNEUROSCI.5227-11.2012; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Oswald BB, 2008, BEHAV NEUROSCI, V122, P841, DOI 10.1037/0735-7044.122.4.841; Oswald BB, 2010, NEUROBIOL LEARN MEM, V93, P37, DOI 10.1016/j.nlm.2009.08.001; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Ryou JW, 2001, NEUROBIOL LEARN MEM, V75, P121, DOI 10.1006/nlme.2000.3966; Simon B, 2005, J NEUROSCI, V25, P10740, DOI 10.1523/JNEUROSCI.3003-05.2005; Suter EE, 2013, LEARN MEMORY, V20, P80, DOI 10.1101/lm.028894.112; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Takehara-Nishiuchi K, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00090; Thompson LT, 1997, J PHARMACOL EXP THER, V281, P928; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Weible AP, 2006, NEUROSCIENCE, V141, P1123, DOI 10.1016/j.neuroscience.2006.04.065; Weiss C, 1999, BEHAV BRAIN RES, V99, P123, DOI 10.1016/S0166-4328(98)00096-5; Wilson DI, 2013, HIPPOCAMPUS, V23, P352, DOI 10.1002/hipo.22095; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84543	10.1371/journal.pone.0084543	http://dx.doi.org/10.1371/journal.pone.0084543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367674	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900054
J	Chiefari, E; Arcidiacono, B; Possidente, K; Iiritano, S; Ventura, V; Pandolfo, R; Brunetti, FS; Greco, M; Foti, D; Brunetti, A				Chiefari, Eusebio; Arcidiacono, Biagio; Possidente, Katiuscia; Iiritano, Stefania; Ventura, Valeria; Pandolfo, Rosantony; Brunetti, Francesco Saverio; Greco, Manfredi; Foti, Daniela; Brunetti, Antonio			Transcriptional Regulation of the HMGA1 Gene by Octamer-Binding Proteins Oct-1 and Oct-2	PLOS ONE			English	Article							INSULIN-RECEPTOR GENE; IFN-BETA-GENE; ACTIVATION DOMAINS; VIRUS INDUCTION; EXPRESSION; PROMOTER; CANCER; ORGANIZATION; HMG-I(Y); MOTIF	The High-Mobility Group AT-Hook 1 (HMGA1) protein is an architectural transcription factor that binds to AT-rich sequences in the promoter region of DNA and functions as a specific cofactor for gene activation. Previously, we demonstrated that HMGA1 is a key regulator of the insulin receptor (INSR) gene and an important downstream target of the INSR signaling cascade. Moreover, from a pathogenic point of view, overexpression of HMGA1 has been associated with human cancer, whereas functional variants of the HMGA1 gene have been recently linked to type 2 diabetes mellitus and metabolic syndrome. However, despite of this biological and pathological relevance, the mechanisms that control HMGA1 gene expression remain unknown. In this study, to define the molecular mechanism(s) that regulate HMGA1 gene expression, the HMGA1 gene promoter was investigated by transient transfection of different cell lines, either before or after DNA and siRNA cotransfections. An octamer motif was identified as an important element of transcriptional regulation of this gene, the interaction of which with the octamer transcription factors Oct-1 and Oct-2 is crucial in modulating HMGA1 gene and protein expression. Additionally, we demonstrate that HMGA1 binds its own promoter and contributes to its transactivation by Oct-2 (but not Oct-1), supporting its role in an auto-regulatory circuit. Overall, our results provide insight into the transcriptional regulation of the HMGA1 gene, revealing a differential control exerted by both Oct-1 and Oct-2. Furthermore, they consistently support the hypothesis that a putative defect in Oct-1 and/or Oct-2, by affecting HMGA1 expression, may cause INSR dysfunction, leading to defects of the INSR signaling pathway.	[Chiefari, Eusebio; Arcidiacono, Biagio; Possidente, Katiuscia; Iiritano, Stefania; Ventura, Valeria; Pandolfo, Rosantony; Foti, Daniela; Brunetti, Antonio] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Brunetti, Francesco Saverio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Greco, Manfredi] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Brunetti, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa Loc Germaneto, Catanzaro, Italy.	brunetti@unicz.it	Foti, Daniela P/K-8038-2016; Arcidiacono, Biagio/I-6040-2019; Brunetti, Antonio/K-7756-2016; Chiefari, Eusebio/Y-2558-2019	Arcidiacono, Biagio/0000-0003-4343-678X; Chiefari, Eusebio/0000-0001-5329-3124; Foti, Daniela/0000-0002-9536-5736; Brunetti, Antonio/0000-0003-1533-8779; VENTURA, Valeria/0000-0001-6378-9916	MIUR Italy [2004062059-002]; Cultural Association "Compagnia dei Sognattori'' of Soverato	MIUR Italy(Ministry of Education, Universities and Research (MIUR)); Cultural Association "Compagnia dei Sognattori'' of Soverato	This work was supported by MIUR Italy (protocol 2004062059-002). Also, the authors acknowledge financial support received by the Cultural Association "Compagnia dei Sognattori'' of Soverato, led by the director Antonio Pittelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 1998, J LEUKOCYTE BIOL, V64, P681, DOI 10.1002/jlb.64.5.681; ASMAN DC, 1993, J BIOL CHEM, V268, P12530; Bianconcini A, 2009, INT J BIOCHEM CELL B, V41, P2189, DOI 10.1016/j.biocel.2009.04.011; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; BRUNETTI A, 1993, J CLIN INVEST, V92, P1288, DOI 10.1172/JCI116702; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chiefari E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01491; Chiefari E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00251; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Chiefari E, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-24; CLEARY MA, 1993, GENE DEV, V7, P72, DOI 10.1101/gad.7.1.72; Cleynen I, 2008, INT J ONCOL, V32, P289; Cleynen I, 2007, CANCER RES, V67, P4620, DOI 10.1158/0008-5472.CAN-06-4325; Costa V, 2008, ENDOCR-RELAT CANCER, V15, P325, DOI 10.1677/ERC-07-0226; Darville MI, 2004, ENDOCRINOLOGY, V145, P1130, DOI 10.1210/en.2003-1200; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Iiritano S, 2012, MOL ENDOCRINOL, V26, P1578, DOI 10.1210/me.2011-1379; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Liu L, 2012, DIABETOLOGIA, V55, P1685, DOI 10.1007/s00125-012-2518-0; Ng MCY, 2010, DIABETIC MED, V27, P1443, DOI 10.1111/j.1464-5491.2010.03124.x; OGRAM SA, 1995, J BIOL CHEM, V270, P14235, DOI 10.1074/jbc.270.23.14235; Paonessa F, 2006, CANCER RES, V66, P5085, DOI 10.1158/0008-5472.CAN-05-3678; Pullinger CR, 2013, METAB SYNDR RELAT DI; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2002, BIOCHIM BIOPHYS ACTA, V1519, P13; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Wang PX, 2010, ISLETS, V2, P46, DOI 10.4161/isl.2.1.10017; Wang PX, 2009, J BIOL CHEM, V284, P26456, DOI 10.1074/jbc.M109.030668; Zhao FQ, 2013, FRONT BIOSCI-LANDMRK, V18, P1051, DOI 10.2741/4162	41	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83969	10.1371/journal.pone.0083969	http://dx.doi.org/10.1371/journal.pone.0083969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367622	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300123
J	Li, CY; Zhang, SY; Lu, Y; Zhang, Y; Wang, EH; Cui, ZS				Li, Chunyan; Zhang, Siyang; Lu, Yao; Zhang, Ying; Wang, Enhua; Cui, Zeshi			The Roles of Notch3 on the Cell Proliferation and Apoptosis Induced by CHIR99021 in NSCLC Cell Lines: A Functional Link between Wnt and Notch Signaling Pathways	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PANCREATIC-CANCER CELLS; HUMAN LUNG CANCERS; CARCINOMA-CELLS; PROTEIN-KINASE; BETA-CATENIN; INHIBITION; GROWTH; ACTIVATION; CYCLE	Wnt and Notch signaling pathways both play essential roles and interact closely in development and carcinogenesis, but their interaction in non-small-cell lung cancer (NSCLC) is poorly unknown. Here we investigated the effects of CHIR99021, a Wnt signaling agonist, or Notch3-shRNA, or the combined application of CHIR99021 and Notch3-shRNA on cell proliferation and apoptosis, as well as the expressions of Notch3, its downstream genes, cyclinA and caspase-3. Our results showed that CHIR99021 up-regulated the expression of Notch3 protein and HES1 and HEYL mRNA. CHIR99021 promoted cell proliferation and the expression of cyclinA, which were inhibited by Notch3-shRNA in these three cell lines. Moreover, Notch3-shRNA significantly attenuated the positive effects of CHIR99021 on cell proliferation and cyclinA in H460 and H157. As for apoptosis, Notch3-shRNA induced cell apoptosis and increased the expression of caspase-3, whereas CHIR99021 showed the different effects in these three cell lines. The inhibitory effect of CHIR99021 on apoptosis was significantly weakened by Notch3-shRNA only in H460. Overall, although the effects of CHIR99021 and the combined application of CHIR99021 and Notch3-shRNA on the cell proliferation and apoptosis aren't completely similar in the three cell lines, our findings still indicate that Notch3 signaling can be activated by canonical Wnt signaling and a functional link between Wnt and Notch signaling pathways exists in NSCLC, at least, which partially is associated with their regulations on the expressions of cyclinA and caspase-3.	[Li, Chunyan; Zhang, Siyang; Lu, Yao; Zhang, Ying; Cui, Zeshi] China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China; [Wang, Enhua] China Med Univ, Dept Pathol, Shenyang, Peoples R China	China Medical University; China Medical University	Li, CY (corresponding author), China Med Univ, Ctr Lab Technol & Expt Med, Shenyang, Peoples R China.	chyli@mail.cmu.edu.cn			Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20091001]; Liaoning Nature Science Project [201102258]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Liaoning Nature Science Project	The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (to Chunyan Li, No. 20091001), Liaoning Nature Science Project (to Chunyan Li, No. 201102258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gaujoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055743; Grottkau BE, 2009, INT J ORAL SCI, V1, P81, DOI 10.4248/ijos.08025; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Katoh M, 2006, INT J MOL MED, V18, P517; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036520; Li CY, 2011, J CANCER RES CLIN, V137, P771, DOI 10.1007/s00432-010-0934-4; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu YL, 2011, CURR CANCER DRUG TAR, V11, P1098, DOI 10.2174/156800911798073041; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Mizugaki H, 2012, BRIT J CANCER, V106, P1953, DOI 10.1038/bjc.2012.178; Mori M, 2012, HUM CELL, V25, P9, DOI 10.1007/s13577-011-0038-8; Peng XR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-196; Shapiro M, 2013, ANN SURG, V257, P548, DOI 10.1097/SLA.0b013e31826d81fd; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Subramaniam D, 2011, MOL CANCER THER, V10, P2146, DOI 10.1158/1535-7163.MCT-11-0399; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Yang LL, 2012, CARCINOGENESIS, V33, P1863, DOI 10.1093/carcin/bgs226; Zhou M, 2013, ONCOL LETT, V5, P499, DOI 10.3892/ol.2012.1033	30	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84659	10.1371/journal.pone.0084659	http://dx.doi.org/10.1371/journal.pone.0084659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367688	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300154
J	Ross, RL; Burns, JE; Taylor, CF; Mellor, P; Anderson, DH; Knowles, MA				Ross, Rebecca L.; Burns, Julie E.; Taylor, Claire F.; Mellor, Paul; Anderson, Deborah H.; Knowles, Margaret A.			Identification of Mutations in Distinct Regions of p85 Alpha in Urothelial Cancer	PLOS ONE			English	Article							INVASIVE BLADDER-CANCER; REGULATORY SUBUNIT P85-ALPHA; INTEGRATED GENOMIC ANALYSIS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOMETRIAL CANCER; CATALYTIC SUBUNIT; HIGH-FREQUENCY; CARCINOMA; PTEN	Bladder cancers commonly show genetic aberrations in the phosphatidylinositol 3-kinase signaling pathway. Here we have screened for mutations in PIK3R1, which encodes p85 alpha, one of the regulatory subunits of PI3K. Two hundred and sixty-four bladder tumours and 41 bladder tumour cell lines were screened and 18 mutations were detected. Thirteen mutations were in C-terminal domains and are predicted to interfere with the interaction between p85 alpha and p110 alpha. Five mutations were in the BH domain of PIK3R1. This region has been implicated in p110 alpha-independent roles of p85 alpha, such as binding to and altering the activities of PTEN, Rab4 and Rab5. Expression of these mutant BH-p85 alpha forms in mouse embryonic fibroblasts with p85 alpha knockout indicated that all forms, except the truncation mutants, could bind and stabilize p110 alpha but did not increase AKT phosphorylation, suggesting that BH mutations function independently of p110 alpha. In a panel of 44 bladder tumour cell lines, 80% had reduced PIK3R1 mRNA expression relative to normal urothelial cells. This, along with mutation of PIK3R1, may alter BH domain functioning. Our findings suggest that mutant forms of p85 alpha may play an oncogenic role in bladder cancer, not only via loss of ability to regulate p110 alpha but also via altered function of the BH domain.	[Ross, Rebecca L.; Burns, Julie E.; Knowles, Margaret A.] St James Univ Hosp, Leeds Inst Canc & Pathol, Sect Expt Oncol, Leeds, W Yorkshire, England; [Taylor, Claire F.] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds Canc Res United Kingdom Ctr Genom Facil, Leeds, W Yorkshire, England; [Mellor, Paul; Anderson, Deborah H.] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada; [Mellor, Paul; Anderson, Deborah H.] Univ Saskatchewan, Saskatoon, SK, Canada	Saint James's University Hospital; Saint James's University Hospital; University of Saskatchewan; University of Saskatchewan	Knowles, MA (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Sect Expt Oncol, Leeds, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Burns, Julie/0000-0003-1238-8826; Knowles, Margaret/0000-0002-9363-8657	Yorkshire Cancer Research; University of Leeds MRC studentship; Canadian Institutes of Health Research [MOP84277]; Saskatchewan Health Research Foundation Fellowship	Yorkshire Cancer Research; University of Leeds MRC studentship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation Fellowship	Financial support provided by Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk/) (L362) and University of Leeds MRC studentship (MK, RR), Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (MOP84277)(DA), and Saskatchewan Health Research Foundation Fellowship (http://shrf.ca/)(PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chapman EJ, 2009, GENE CHROMOSOME CANC, V48, P694, DOI 10.1002/gcc.20672; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jucker M, 2002, LEUKEMIA, V16, P894, DOI 10.1038/sj.leu.2402484; Knowles MA, 2003, CANCER RES, V63, P7652; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Philp AJ, 2001, CANCER RES, V61, P7426; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Ross RL, 2013, ONCOGENE, V32, P768, DOI 10.1038/onc.2012.87; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Simon R, 2000, INT J ONCOL, V17, P1025; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; *UICC, 1978, TNM CLASS MAL TUM BL, P113; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Wang DS, 2000, INT J CANCER, V88, P620, DOI 10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z; WHO, 1973, HIST TYP UR BLADD TU; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zieger K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-149	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84411	10.1371/journal.pone.0084411	http://dx.doi.org/10.1371/journal.pone.0084411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367658	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300140
J	Warszycki, D; Mordalski, S; Kristiansen, K; Kafel, R; Sylte, I; Chilmonczyk, Z; Bojarski, AJ				Warszycki, Dawid; Mordalski, Stefan; Kristiansen, Kurt; Kafel, Rafal; Sylte, Ingebrigt; Chilmonczyk, Zdzislaw; Bojarski, Andrzej J.			A Linear Combination of Pharmacophore Hypotheses as a New Tool in Search of New Active Compounds - An Application for 5-HT1A Receptor Ligands	PLOS ONE			English	Article							HIGH-AFFINITY; DERIVATIVES; INHIBITORS; DISCOVERY; MODEL; AGENTS; CONFORMATION; TRANSPORTER; ANALOGS; BINDING	This study explores a new approach to pharmacophore screening involving the use of an optimized linear combination of models instead of a single hypothesis. The implementation and evaluation of the developed methodology are performed for a complete known chemical space of 5-HT1AR ligands (3616 active compounds with K-i < 100 nM) acquired from the ChEMBL database. Clusters generated from three different methods were the basis for the individual pharmacophore hypotheses, which were assembled into optimal combinations to maximize the different coefficients, namely, MCC, accuracy and recall, to measure the screening performance. Various factors that influence filtering efficiency, including clustering methods, the composition of test sets (random, the most diverse and cluster population-dependent) and hit mode (the compound must fit at least one or two models from a final combination) were investigated. This method outmatched both single hypothesis and random linear combination approaches.	[Warszycki, Dawid; Mordalski, Stefan; Kafel, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland; [Kristiansen, Kurt; Sylte, Ingebrigt] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Chilmonczyk, Zdzislaw] Natl Med Inst, Dept Cell Biol, Warsaw, Poland	Polish Academy of Sciences; UiT The Arctic University of Tromso; National Medicines Institute Lekow (NIL)	Bojarski, AJ (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland.	bojarski@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022; Warszycki, Dawid/T-9712-2017	Bojarski, Andrzej/0000-0003-1417-6333; Mordalski, Stefan/0000-0003-4089-6369; Sylte, Ingebrigt/0000-0002-3290-3736; Warszycki, Dawid/0000-0002-2393-4709; Chilmonczyk, Zdzislaw/0000-0002-5871-4458	European Union from the European Fund of Regional Development (EFRD); Norway Grants within the Polish-Norwegian Research Programme [Pol-Nor/198887/73/2013];  [UDA-POIG. 01.03.01-12-063/09-00 Prokog]	European Union from the European Fund of Regional Development (EFRD); Norway Grants within the Polish-Norwegian Research Programme; 	This study was supported by the project UDA-POIG. 01.03.01-12-063/09-00 Prokog, which is co-financed by the European Union from the European Fund of Regional Development (EFRD) and by Norway Grants within the Polish-Norwegian Research Programme, grant no. Pol-Nor/198887/73/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 1993, J MED CHEM, V36, P4006, DOI 10.1021/jm00077a003; [Anonymous], 2011, PHAS VERS 3 3; [Anonymous], 2011, CANV VERS 1 4; Bojarski AJ, 2005, BIOORGAN MED CHEM, V13, P2293, DOI 10.1016/j.bmc.2004.12.041; Bojarski AJ, 2006, CURR TOP MED CHEM, V6, P2005, DOI 10.2174/156802606778522186; Caliendo G, 2005, CURR MED CHEM, V12, P1721, DOI 10.2174/0929867054367220; CHIDESTER CG, 1993, J MED CHEM, V36, P1301, DOI 10.1021/jm00062a001; Chilmonczyk Z, 1997, ARCH PHARM, V330, P146, DOI 10.1002/ardp.19973300507; Chiu TL, 2012, J CHEM INF MODEL, V52, P1886, DOI 10.1021/ci300121p; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Franchini S, 2010, BIOORG MED CHEM LETT, V20, P2017, DOI 10.1016/j.bmcl.2010.01.030; Guner Osman F., 2002, Current Topics in Medicinal Chemistry, V2, P1321, DOI 10.2174/1568026023392940; HIBERT MF, 1988, J MED CHEM, V31, P1087, DOI 10.1021/jm00401a007; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KELLY JL, 1956, IRE T INFORM THEOR, V2, P185, DOI 10.1109/TIT.1956.1056803; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; LANGLOIS M, 1993, EUR J PHARM-MOLEC PH, V244, P77, DOI 10.1016/0922-4106(93)90061-D; Lepailleur A, 2005, J CHEM INF MODEL, V45, P1075, DOI 10.1021/ci050045p; Lopez-Rodriguez ML, 2002, CURR MED CHEM, V9, P443, DOI 10.2174/0929867023371030; Manepalli S, 2011, J CHEM INF MODEL, V51, P2417, DOI 10.1021/ci200280m; MELLIN C, 1991, J MED CHEM, V34, P497, DOI 10.1021/jm00106a004; MOKROSZ MJ, 1995, BIOORGAN MED CHEM, V3, P533, DOI 10.1016/0968-0896(95)00039-J; Ngo T, 2013, J COMPUT AID MOL DES, V27, P305, DOI 10.1007/s10822-013-9647-5; Nowak M, 2006, J MED CHEM, V49, P205, DOI 10.1021/jm050826h; Oh SJ, 2001, CURR MED CHEM, V8, P999, DOI 10.2174/0929867013372599; Olivier B, 1999, Prog Drug Res, V52, P103; Orus L, 2002, J MED CHEM, V45, P4128, DOI 10.1021/jm0111200; Paluchowska MH, 1999, J MED CHEM, V42, P4952, DOI 10.1021/jm991045h; Paluchowska MH, 2002, EUR J MED CHEM, V37, P273, DOI 10.1016/S0223-5234(01)01312-5; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Sanders MPA, 2012, J CHEM INF MODEL, V52, P1607, DOI 10.1021/ci2005274; Sanders MPA, 2011, J CHEM INF MODEL, V51, P2277, DOI 10.1021/ci200088d; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; SLEIGHT AJ, 1991, N-S ARCH PHARMACOL, V343, P109, DOI 10.1007/BF00168596; Svegelj MB, 2011, J CHEM INF MODEL, V51, P1716, DOI 10.1021/ci2001499; Svensson F, 2012, J CHEM INF MODEL, V52, P225, DOI 10.1021/ci2004835; van Drie JH, 2003, CURR PHARM DESIGN, V9, P1649, DOI 10.2174/1381612033454568; VANSTEEN BJ, 1994, J MED CHEM, V37, P2761, DOI 10.1021/jm00043a015; Weber KC, 2010, EUR J MED CHEM, V45, P1508, DOI 10.1016/j.ejmech.2009.12.059; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043	43	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84510	10.1371/journal.pone.0084510	http://dx.doi.org/10.1371/journal.pone.0084510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367669	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300146
J	Xi, M; Liu, SL; Zhao, L; Shen, JX; Zhang, L; Zhang, P; Liu, MZ				Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong			Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PRIMARY CANCERS; INDUCED SARCOMA; PRIMARY TUMORS; PRIMARY HEAD; NECK; RISK; RECURRENT	Purpose: To analyze the clinicopathological characteristics, treatment modalities, and potential prognostic factors of radiation-related second malignant neoplasms (SMNs) in a large group of nasopharyngeal carcinoma (NPC) cases. Methods and Materials: Institutional electronic medical records of 39,118 patients with NPC treated by definitive radiotherapy between February 1964 and December 2003 were reviewed. A total of 247 patients with confirmed SMN attributable to radiotherapy were included. Results: Median latency between radiotherapy for NPC and the diagnosis of SMN was 9.5 years (range, 3.1-36.8 years). Squamous cell carcinoma was the most common histologic type, followed by fibrosarcoma and adenocarcinoma. Median progression-free survival and overall survival (OS) of the 235 patients who underwent treatment were 17.3 months and 28.5 months, respectively. The 5-year OS rates were 42.9%, 23.7%, and 0% for the surgery, radiotherapy, and chemotherapy groups, respectively. The independent prognostic factors associated with survival were sex, histologic type, and treatment modality in both the early stage subgroup and the advanced stage subgroup of SMN. Conclusions: Sex, histologic type, and treatment modality were the significant prognostic factors for SMN. Complete resection offers the best chance for long-term survival. In select patients with locally advanced and unresectable SMN, reirradiation should be strongly considered as a curative option.	[Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xi, Mian; Liu, Shi-Liang; Zhao, Lei; Shen, Jing-Xian; Zhang, Li; Zhang, Peng; Liu, Meng-Zhong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Shen, Jing-Xian] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Liu, MZ (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.	liumengzhong@126.com			National Natural Science Foundation of China [NSFC 81201748]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81201748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrigo JM, 2009, EUR RADIOL, V19, P1197, DOI 10.1007/s00330-008-1265-6; Amemiya K, 2005, BRIT J RADIOL, V78, P1028, DOI 10.1259/bjr/86352309; ARLEN M, 1971, CANCER-AM CANCER SOC, V28, P1087, DOI 10.1002/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F; Boussen H, 2004, Ann Otolaryngol Chir Cervicofac, V121, P282; BRADY MS, 1992, ARCH SURG-CHICAGO, V127, P1379; Cahan WG, 1998, CANCER-AM CANCER SOC, V82, P8, DOI 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W; Cha C, 2004, ANN SURG, V239, P903, DOI 10.1097/01.sla.0000128686.51815.8b; Chen AM, 2011, INT J RADIAT ONCOL, V80, P669, DOI 10.1016/j.ijrobp.2010.02.023; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; de Gonzalez AB, 2011, LANCET ONCOL, V12, P353, DOI 10.1016/S1470-2045(11)70061-4; Gao X, 2003, INT J RADIAT ONCOL, V56, P427, DOI 10.1016/S0360-3016(02)04613-8; Goggins WB, 2010, CANCER CAUSE CONTROL, V21, P1461, DOI 10.1007/s10552-010-9574-x; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; King AD, 2000, CLIN RADIOL, V55, P684, DOI 10.1053/crad.2000.0503; Kong L, 2006, CANCER-AM CANCER SOC, V107, P1287, DOI 10.1002/cncr.22119; Kuttesch JF, 1996, J CLIN ONCOL, V14, P2818, DOI 10.1200/JCO.1996.14.10.2818; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Liu WW, 2005, LARYNGOSCOPE, V115, P1574, DOI 10.1097/01.mlg.0000173166.48440.e4; Lo WC, 2008, LARYNGOSCOPE, V118, P2151, DOI 10.1097/MLG.0b013e3181839b8c; Malone JP, 2002, SKULL BASE-INTERD AP, V12, P87, DOI 10.1055/s-2002-31576-1; MARK RJ, 1993, CANCER, V72, P887, DOI 10.1002/1097-0142(19930801)72:3<887::AID-CNCR2820720338>3.0.CO;2-5; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Palazzi M, 2009, INT J RADIAT ONCOL, V74, P774, DOI 10.1016/j.ijrobp.2008.08.068; Scelo G, 2007, CANCER CAUSE CONTROL, V18, P269, DOI 10.1007/s10552-006-0101-z; Sher DJ, 2010, CANCER-AM CANCER SOC, V116, P4761, DOI 10.1002/cncr.25305; Teo PML, 1999, EUR J CANCER, V35, P219, DOI 10.1016/S0959-8049(98)00386-4; TESHIMA T, 1992, Strahlentherapie und Onkologie, V168, P213; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Tubiana M, 2009, RADIOTHER ONCOL, V91, P4, DOI 10.1016/j.radonc.2008.12.016; Wang CC, 2000, INT J CANCER, V87, P228, DOI 10.1002/1097-0215(20000715)87:2&lt;228::AID-IJC12&gt;3.0.CO;2-T; Wong SJ, 2012, SEMIN RADIAT ONCOL, V22, P214, DOI 10.1016/j.semradonc.2012.03.006; Xi MA, 2010, CANCER-AM CANCER SOC, V116, P5479, DOI 10.1002/cncr.25329; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01	34	6	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84586	10.1371/journal.pone.0084586	http://dx.doi.org/10.1371/journal.pone.0084586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367679	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300150
J	Zheng, RN; Rebolledo-Jaramillo, B; Zong, YW; Wang, LQ; Russo, P; Hancock, W; Stanger, BZ; Hardison, RC; Blobel, GA				Zheng, Rena; Rebolledo-Jaramillo, Boris; Zong, Yiwei; Wang, Liqing; Russo, Pierre; Hancock, Wayne; Stanger, Ben Z.; Hardison, Ross C.; Blobel, Gerd A.			Function of GATA Factors in the Adult Mouse Liver	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; STEROL TRANSPORTERS ABCG5; ZINC-FINGER PROTEINS; HEART TUBE FORMATION; GENE-EXPRESSION; VENTRAL MORPHOGENESIS; RAT HEPATOCYTES; FACTOR NETWORK; FOG COFACTORS; DIFFERENTIATION	GATA transcription factors and their Friend of Gata (FOG) cofactors control the development of diverse tissues. GATA4 and GATA6 are essential for the expansion of the embryonic liver bud, but their expression patterns and functions in the adult liver are unclear. We characterized the expression of GATA and FOG factors in whole mouse liver and purified hepatocytes. GATA4, GATA6, and FOG1 are the most prominently expressed family members in whole liver and hepatocytes. GATA4 chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) identified 4409 occupied sites, associated with genes enriched in ontologies related to liver function, including lipid and glucose metabolism. However, hepatocyte-specific excision of Gata4 had little impact on gross liver architecture and function, even under conditions of regenerative stress, and, despite the large number of GATA4 occupied genes, resulted in relatively few changes in gene expression. To address possible redundancy between GATA4 and GATA6, both factors were conditionally excised. Surprisingly, combined Gata4,6 loss did not exacerbate the phenotype resulting from Gata4 loss alone. This points to the presence of an unusually robust transcriptional network in adult hepatocytes that ensures the maintenance of liver function.	[Zheng, Rena; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zheng, Rena; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Rebolledo-Jaramillo, Boris] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Zong, Yiwei; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wang, Liqing; Hancock, Wayne] Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Liqing; Hancock, Wayne] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA; [Russo, Pierre] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Dept Med,Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blobel, GA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	Hardison, Ross C/G-1142-2010; Rebolledo-Jaramillo, Boris/L-8144-2019	Hardison, Ross C/0000-0003-4084-7516; Rebolledo-Jaramillo, Boris/0000-0001-8059-3202	National Institutes of Health (NIH) [5R37DK058044, DK083355]; NIH training grant [T32 H107971]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK083355, R56DK065806, R01DK065806] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants 5R37DK058044 (to G.A.B.), DK083355 (to B.Z.S.), and NIH training grant T32 H107971 (to R.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SS, 2013, BMB REP, V46, P322, DOI 10.5483/BMBRep.2013.46.6.246; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Bossard P, 1998, DEVELOPMENT, V125, P4909; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chlon TM, 2012, DEVELOPMENT, V139, P3905, DOI 10.1242/dev.080440; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; DALET C, 1982, ANAL BIOCHEM, V122, P119, DOI 10.1016/0003-2697(82)90259-7; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Divine JK, 2004, AM J PHYSIOL-GASTR L, V287, pG1086, DOI 10.1152/ajpgi.00421.2003; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Haworth KE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-74; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hung HL, 2001, BLOOD, V97, P946, DOI 10.1182/blood.V97.4.946; Island ML, 2011, BIOCHEM J, V437, P477, DOI 10.1042/BJ20110225; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kitade M, 2013, GENE DEV, V27, P1706, DOI 10.1101/gad.214601.113; Krier M, 2009, CLIN LIVER DIS, V13, P167, DOI 10.1016/j.cld.2009.02.001; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; MATSUDA K, 1994, FEBS LETT, V353, P269, DOI 10.1016/0014-5793(94)01062-5; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Mwinyi J, 2010, DRUG METAB DISPOS, V38, P415, DOI 10.1124/dmd.109.029405; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; PERTOFT H, 1977, EXP CELL RES, V110, P449, DOI 10.1016/0014-4827(77)90311-1; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2007, MOL CELL BIOL, V27, P5286, DOI 10.1128/MCB.00176-07; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005	79	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83723	10.1371/journal.pone.0083723	http://dx.doi.org/10.1371/journal.pone.0083723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367609	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300116
J	Schubert, G; Vigilant, L; Boesch, C; Klenke, R; Langergraber, K; Mundry, R; Surbeck, M; Hohmann, G				Schubert, Grit; Vigilant, Linda; Boesch, Christophe; Klenke, Reinhard; Langergraber, Kevin; Mundry, Roger; Surbeck, Martin; Hohmann, Gottfried			Co-Residence between Males and Their Mothers and Grandmothers Is More Frequent in Bonobos Than Chimpanzees	PLOS ONE			English	Article							WILD CHIMPANZEES; PAN-PANISCUS; NATIONAL-PARK; KIN; PATERNITY; SUCCESS; DNA; TROGLODYTES; COMPETITION; EVOLUTION	In long-lived social mammals such as primates, individuals can benefit from social bonds with close kin, including their mothers. In the patrilocal chimpanzee (Pan troglodytes spp.) and bonobo (Pan paniscus), sexually mature males reside and reproduce in their natal groups and can retain post-dependency bonds with their mothers, while immatures of both sexes might also have their paternal grandmothers available. However, quantitative information on the proportion of males and immatures that co-reside with both types of these close female relatives is limited for both species. Combining genetic parentage determination and group composition data from five communities of wild chimpanzees and three communities of wild bonobos, we estimated the frequency of co-residence between (1) mature males and their mothers, and (2) immature males and females and their paternal grandmothers. We found that adult males resided twice as frequently with their mothers in bonobos than in chimpanzees, and that immature bonobos were three times more likely to possess a living paternal grandmother than were immature chimpanzees. Patterns of female and male survivorship from studbook records of captive individuals of both species suggest that mature bonobo females survive longer than their chimpanzee counterparts, possibly contributing to the differences observed in mother-son and grandmother-immature co-residency levels. Taking into account reports of bonobo mothers supporting their sons' mating efforts and females sharing food with immatures other than their own offspring, our findings suggest that life history traits may facilitate maternal and grandmaternal support more in bonobos than in chimpanzees.	[Schubert, Grit; Vigilant, Linda; Boesch, Christophe; Langergraber, Kevin; Mundry, Roger; Surbeck, Martin; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Schubert, Grit] Robert Koch Inst, Berlin, Germany; [Klenke, Reinhard] UFZ, Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA	Max Planck Society; Robert Koch Institute; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Boston University	Schubert, G (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	schubertg@rki.de	Klenke, Reinhard/J-4686-2013	Klenke, Reinhard/0000-0002-6860-8085	Max Planck Society; LSB Leakey Foundation [2540]	Max Planck Society(Max Planck SocietyFoundation CELLEX); LSB Leakey Foundation	This work was funded by the Max Planck Society and a grant from the LSB Leakey Foundation to GS (grant number 2540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann Stuart A., 1979, PRIMATE ECOLOGY HUMA; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Borries C, 1988, HUM EVOL, V3, P239, DOI DOI 10.1007/BF02435856; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Carlsen F, 2007, EUROPEAN STUDBOOK CH; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; Clay Z, 2013, P NATL ACAD SCI USA, V110, P18121, DOI 10.1073/pnas.1316449110; Clutton-Brock T. H., 1988, REPROD SUCCESS; COX DR, 1972, J R STAT SOC B, V34, P187; De Lathouwers M, 2005, INT J PRIMATOL, V26, P55, DOI 10.1007/s10764-005-0723-0; DYKE B, 1995, AM J PRIMATOL, V37, P25, DOI 10.1002/ajp.1350370104; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; FAIRBANKS LA, 1986, ANIM BEHAV, V34, P1710, DOI 10.1016/S0003-3472(86)80258-5; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; FURUICHI T, 1994, BEHAVIOUR, V130, P211, DOI 10.1163/156853994X00532; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Gibson MA, 2005, EVOL HUM BEHAV, V26, P469, DOI 10.1016/j.evolhumbehav.2005.03.004; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hashimoto C, 1996, PRIMATES, V37, P305, DOI 10.1007/BF02381862; Hashimoto C, 2008, DEV PRIMATOL-PROG PR, P107, DOI 10.1007/978-0-387-74787-3_6; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; Hohmann G, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-9699-0_1; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kuroda S., 1989, P184; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, P1; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mitani JC, 2002, ANIM BEHAV, V64, P727, DOI 10.1006/anbe.2002.4014; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Mulder MB, 2007, EVOL HUM BEHAV, V28, P299, DOI 10.1016/j.evolhumbehav.2007.05.009; Murdock G. P., 1981, ATLAS WORLD CULTURES; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Pavelka MSM, 2002, ANIM BEHAV, V64, P407, DOI 10.1006/anbe.2002.3085; Perebom ZJJM, 2008, INT STUDBOOK BONOBO; Pusey A., 1979, Perspectives on Human Evolution, V5, P465; R Development Core Team, 2012, R LANG ENV STAT COMP; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, PHILOS T R SOC B, V364, P3243, DOI 10.1098/rstb.2009.0118; Stearns S.C., 1992, pi; Strassmann BI, 2011, HUM NATURE-INT BIOS, V22, P201, DOI 10.1007/s12110-011-9114-8; Strier KB, 2008, ANNU REV ANTHROPOL, V37, P21, DOI 10.1146/annurev.anthro.37.081407.085218; Strier KB, 2011, P NATL ACAD SCI USA, V108, P18915, DOI 10.1073/pnas.1116737108; Stumpf R, 2007, PRIMATES PERSPECTIVE, P321; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, P1; Surbeck M, 2012, HORM BEHAV, V62, P27, DOI 10.1016/j.yhbeh.2012.04.013; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Susman RL, 1984, PYGMY CHIMPANZEE EVO; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Therneau T, 2009, PACKAGE COXME MIXED; Therneau T, 2009, PACKAGE SURVIVAL SUR; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; VAN LAWICK-GOODALL JANE, 1967, P287; van Schaik C.P., 1989, Special Publication of the British Ecological Society, P195; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Voland E., 2005, GRANDMOTHERHOOD EVOL, P1; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wittiger L, 2013, BEHAV ECOL SOCIOBIOL, V67, P1097, DOI 10.1007/s00265-013-1534-5; Wobber Victoria, 2010, Communicative & Integrative Biology, V3, P337; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014	92	17	19	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83870	10.1371/journal.pone.0083870	http://dx.doi.org/10.1371/journal.pone.0083870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358316	Green Published, gold			2022-12-25	WOS:000328737700073
J	Zhang, QL; Ding, YX; Yao, YQ; Yu, Y; Yang, LJ; Cui, H				Zhang, Qiaoli; Ding, Yingxue; Yao, Yanqing; Yu, Yang; Yang, Lijun; Cui, Hong			Creating Rat Model for Hypoxic Brain Damage in Neonates by Oxygen Deprivation	PLOS ONE			English	Article							ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; HYPOTHERMIA; INJURY	Current study explores the feasibility of using a non-surgical method of oxygen deprivation to create Hypoxic brain damage in neonatal rats for medical studies. 7-day-old Sprague Dowley (SD) rats were kept in a container with low oxygen level (8%) for 1.5h. A second group had bilateral cephalic artery ligation before the 1.5h-low oxygen treatment, a method similar to the popular Rice method, to expose the brain to both hypoxic and ischemic situations. Short term neural functions and brain water weights were evaluated 1 day after the hypoxic treatment. Brain pathology and histology were also examined at 1 day and 3 days after the hypoxic treatment. Both groups showed impaired neural functions and increased brain water weight compared to the controls. Histology studies also revealed injuries in the subcortex, hippocampus and lateral ventricle in the brains from both groups. There is no significant difference in the degree of brain damages observed in the two groups. Our work demonstrated that oxygen deprivation alone is sufficient to cause brain damages similar to those seen in Hypoxic-ischemic brain disease (HIBD). Because this method avoids the invasive surgical procedure and therefore reduces the stress and mortality of laboratory animals during the experiment, we recommend it to be the favorable method for creating rat models for HIBD studies.	[Zhang, Qiaoli; Ding, Yingxue; Yao, Yanqing; Yu, Yang; Yang, Lijun; Cui, Hong] Capital Med Univ, Beijing Friendship Hosp, Dept Pediat, Beijing, Peoples R China	Capital Medical University	Yang, LJ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Pediat, Beijing, Peoples R China.	ljy20082008@126.com; cuihong6699@163.com	姚, 艳青/HHC-4907-2022		Natural Science Foundation of China [81241022, 81200407]; Natural Science Foundation of Beijing [7122045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	The study was supported by Natural Science Foundation of China (81241022, 81200407); Natural Science Foundation of Beijing (7122045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlKharfy TM, 2013, NEUROSCIENCES, V18, P18; Douglas-Escobar Martha, 2012, Front Neurol, V3, P144, DOI 10.3389/fneur.2012.00144; Guo, 2005, TECHNIQUES NEURAL PA, P216; Jin RL, 2006, NEUROSCI RES, V55, P65, DOI 10.1016/j.neures.2006.01.006; Kim JJ, 2013, MED DEVICES-EVID RES, V6, P1, DOI 10.2147/MDER.S39254; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Pan R, 2012, PEDIATR RES, V72, P479, DOI 10.1038/pr.2012.107; Peliowski-Davidovich A, 2012, PAED CHILD HEALT-CAN, V17, P41, DOI 10.1093/pch/17.1.41; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Shian W J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P154; Triulzi F, 2006, PEDIATR RADIOL, V36, P608, DOI 10.1007/s00247-006-0203-5; Triulzi F, 2001, Magn Reson Imaging Clin N Am, V9, P57; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; Wallin A, 2012, J NEUROL SCI, V322, P192, DOI 10.1016/j.jns.2012.07.068; Xinling Hou CZ, 2009, J PEKING U MED, P42; YJ W, 2005, DEV MODERN NEURAL PA, P35; Zhang L, 2012, NEUROTOX RES, V22, P280, DOI 10.1007/s12640-012-9312-0	18	9	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83589	10.1371/journal.pone.0083589	http://dx.doi.org/10.1371/journal.pone.0083589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358300	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700064
J	Zhang, ZH; Yao, YF; Wu, WL; Feng, RL; Wu, ZX; Cun, W; Dong, SZ				Zhang, Zhihui; Yao, Yufeng; Wu, Wenlong; Feng, Ruilin; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong			Hepatitis C Virus Genotype Diversity among Intravenous Drug Users in Yunnan Province, Southwestern China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; INFECTION; HIV	Background: Recently, high proportions (15.6%-98.7%) of intravenous drug users (IDUs) in China were found to be positive for hepatitis C virus (HCV). Yunnan Province is located in southwestern China and borders one of the world's most important opium-producing regions, thus it is an important drug trafficking route to other regions of China. Methodology/Principal Findings: Here, we assessed 100 HCV-positive plasma samples from IDUs who were enrolled through the Kunming Center for Disease Control and Prevention in 2012. HCV C/E1 fragments were PCR-amplified and sequenced. We identified eight HCV subtypes (1a, 1b, 3a, 3b, 6a, 6n, 6u and 6v), of which genotype 6 was most predominant (frequency, 47%) followed by genotypes 3 (41%) and 1 (12%). HCV subtypes 6n (30%) and 3b (29%) were most common and were identified in 59% of the IDUs. We compared HCV genotypes among IDUs in Yunnan Province with those from other regions and found that the distribution patterns of HCV genotypes in Yunnan Province were similar to those in southern China, but different from those in eastern China. However, the distribution patterns of HCV subtypes varied among Yunnan Province and southern China, despite the shared similar genotypes. A comparison of the current data with those previously reported showed that the frequency of HCV genotype 6 increased from 25% to 47% within 5 years, especially subtypes 6a (5% to 15%) and 6n (11.2% to 30%). In contrast, the frequencies of subtypes 3b and 1b decreased by almost 50% within 5 years. Conclusion/Significance: Our results provided further information to support the assertion that drug trafficking routes influence HCV transmission patterns among IDUs in Yunnan Province. The frequency of HCV genotypes and subtypes changed rapidly among IDUs in Yunnan Province and subtypes 6a and 6n may have originated in Vietnam and Myanmar, respectively.	[Zhang, Zhihui; Yao, Yufeng; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong] Chinese Acad Med Sci, Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Zhang, Zhihui; Yao, Yufeng; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Wu, Wenlong; Feng, Ruilin] Kunming Ctr Dis Control & Prevent, HIV Confirmatory Lab, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cun, W (corresponding author), Chinese Acad Med Sci, Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Inst Med Biol, Kunming, Yunnan, Peoples R China.	cunwei@gmail.com; shaozhongdong@gmail.com	zhang, zh/GWV-4677-2022		Fundamental Research Funds for the Central Universities [2012Y08]; Natural Science Foundation of Yunnan Province [2013FZ138, 2013FA053]; Fundamental Research Funds for the Institute of Pathogen Biology [2013IPB201]; State Project for Essential Drug Research and Development [2012ZX09105302]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Fundamental Research Funds for the Institute of Pathogen Biology; State Project for Essential Drug Research and Development	This work was supported by the Fundamental Research Funds for the Central Universities (2012Y08), Natural Science Foundation of Yunnan Province (2013FZ138, 2013FA053), Fundamental Research Funds for the Institute of Pathogen Biology (2013IPB201), and State Project for Essential Drug Research and Development (2012ZX09105302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Du H, 2012, J CLIN VIROL, V54, P207, DOI 10.1016/j.jcv.2012.04.017; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041266; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Ye Y, 2013, ARCH VIROL, V158, P611, DOI 10.1007/s00705-012-1513-6; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	20	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82598	10.1371/journal.pone.0082598	http://dx.doi.org/10.1371/journal.pone.0082598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358211	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700025
J	Zhu, LQ; Zhen, YF; Zhang, Y; Guo, ZX; Dai, J; Wang, XD				Zhu, Lun-qing; Zhen, Yun-fang; Zhang, Ya; Guo, Zhi-xiong; Dai, Jin; Wang, Xiao-dong			Salinomycin Activates AMP-Activated Protein Kinase-Dependent Autophagy in Cultured Osteoblastoma Cells: A Negative Regulator against Cell Apoptosis	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; GROWTH; DEATH; MTOR; PHOSPHORYLATION; OSTEOSARCOMA; DEGRADATION; INHIBITION; SURVIVAL	Background: The malignant osteoblastoma has poor prognosis, thus the search for novel and more efficient chemo-agents against this disease is urgent. Salinomycin induces broad anti-cancer effects both in vivo and in vitro, however, its role in osteoblastoma is still not clear. Key Findings: Salinomycin induced both apoptosis and autophagy in cultured U2OS and MG-63 osteoblastoma cells. Inhibition of autophagy by 3-methyladenine (3-MA), or by RNA interference (RNAi) of light chain 3B (LC3B), enhanced salinomycin-induced cytotoxicity and apoptosis. Salinomycin induced a profound AMP-activated protein kinase (AMPK) activation, which was required for autophagy induction. AMPK inhibition by compound C, or by AMPK alpha RNAi prevented salinomycin-induced autophagy activation, while facilitating cancer cell death and apoptosis. On the other hand, the AMPK agonist AICAR promoted autophagy activation in U2OS cells. Salinomycin-induced AMPK activation was dependent on reactive oxygen species (ROS) production in osteoblastoma cells. Antioxidant n-acetyl cysteine (NAC) significantly inhibited salinomycin-induced AMPK activation and autophagy induction. Conclusions: Salinomycin activates AMPK-dependent autophagy in osteoblastoma cells, which serves as a negative regulator against cell apoptosis. AMPK-autophagy inhibition might be a novel strategy to sensitize salinomycin's effect in cancer cells.	[Zhu, Lun-qing; Zhen, Yun-fang; Zhang, Ya; Guo, Zhi-xiong; Dai, Jin; Wang, Xiao-dong] Soochow Univ, Childrens Hosp, Ctr Diag & Treatment Childrens Bone Dis, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Zhen, YF (corresponding author), Soochow Univ, Childrens Hosp, Ctr Diag & Treatment Childrens Bone Dis, Suzhou, Jiangsu, Peoples R China.	orthowxd@hotmail.com; xiaodongwangsz@163.com			Suzhou Science and Technology Bureau, China [874531]	Suzhou Science and Technology Bureau, China	This study is supported by fund from Suzhou Science and Technology Bureau (874531), China (http://kjxm.szkj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Ham SJ, 1998, EUR J SURG ONCOL, V24, P584, DOI 10.1016/S0748-7983(98)93896-3; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jangamreddy JR, 2013, BBA-MOL CELL RES, V1833, P2057, DOI 10.1016/j.bbamcr.2013.04.011; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li TL, 2013, AUTOPHAGY, V9, P1057, DOI 10.4161/auto.24632; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaelson MD, 2005, J CLIN ONCOL, V23, P8219, DOI 10.1200/JCO.2005.02.9579; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Yao C, 2013, CELL BIOCHEM BIOPHYS, V65, P217, DOI 10.1007/s12013-012-9423-5; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093	52	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84175	10.1371/journal.pone.0084175	http://dx.doi.org/10.1371/journal.pone.0084175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358342	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700085
J	Sun, XQ; Pang, H; Li, MM; Peng, B; Guo, HS; Yan, QQ; Hang, YY				Sun, Xiaoqin; Pang, Hui; Li, Mimi; Peng, Bin; Guo, Haisong; Yan, Qinqin; Hang, Yueyu			Evolutionary Pattern of the FAE1 Gene in Brassicaceae and Its Correlation with the Erucic Acid Trait	PLOS ONE			English	Article							KETOACYL-COA SYNTHASE; FUNCTIONAL-CHARACTERIZATION; PHYLOGENY; BIOCHEMISTRY; COMPLEMENTS; MUTATION; CLONING; PLANTS; LOCUS; OIL	The fatty acid elongase 1 (FAE1) gene catalyzes the initial condensation step in the elongation pathway of VLCFA (very long chain fatty acid) biosynthesis and is thus a key gene in erucic acid biosynthesis. Based on a worldwide collection of 62 accessions representing 14 tribes, 31 genera, 51 species, 4 subspecies and 7 varieties, we conducted a phylogenetic reconstruction and correlation analysis between genetic variations in the FAE1 gene and the erucic acid trait, attempting to gain insight into the evolutionary patterns and the correlations between genetic variations in FAE1 and trait variations. The five clear, deeply diverged clades detected in the phylogenetic reconstruction are largely congruent with a previous multiple gene-derived phylogeny. The Ka/Ks ratio (< 1) and overall low level of nucleotide diversity in the FAE1 gene suggest that purifying selection is the major evolutionary force acting on this gene. Sequence variations in FAE1 show a strong correlation with the content of erucic acid in seeds, suggesting a causal link between the two. Furthermore, we detected 16 mutations that were fixed between the low and high phenotypes of the FAE1 gene, which constitute candidate active sites in this gene for altering the content of erucic acid in seeds. Our findings begin to shed light on the evolutionary pattern of this important gene and represent the first step in elucidating how the sequence variations impact the production of erucic acid in plants.	Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences		hangyueyu@gmail.com			Jiangsu Provincial Natural Science Foundation of China [BK2010476]; Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation [QIAN201202]	Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation	This work was supported by Jiangsu Provincial Natural Science Foundation of China (Grant No. BK2010476) and Funds of Jiangsu Province Key Laboratory for Plant Ex Situ Conservation (Grant No. QIAN201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barret P, 1998, THEOR APPL GENET, V96, P177, DOI 10.1007/s001220050725; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Carmona-Antonanzas G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-85; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ding J, 2007, GENETICA, V129, P235, DOI 10.1007/s10709-006-0002-9; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Franzke A, 2009, TAXON, V58, P425, DOI 10.1002/tax.582009; Ghanevati M, 2002, EUR J BIOCHEM, V269, P3531, DOI 10.1046/j.1432-1033.2002.03039.x; Ghanevati M, 2001, BBA-MOL CELL BIOL L, V1530, P77, DOI 10.1016/S1388-1981(00)00168-2; Han JX, 2001, PLANT MOL BIOL, V46, P229, DOI 10.1023/A:1010665121980; HUDSON RR, 1992, GENETICS, V132, P583; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Katavic V, 2002, EUR J BIOCHEM, V269, P5625, DOI 10.1046/j.1432-1033.2002.03270.x; Koch MA, 2007, MOL BIOL EVOL, V24, P63, DOI 10.1093/molbev/msl130; KUMAR PR, 1978, J AM OIL CHEM SOC, V55, P320, DOI 10.1007/BF02669920; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; LYNCH DV, 1993, PLANT PHYSIOL, V103, P1421, DOI 10.1104/pp.103.4.1421; Mandal S, 2002, GENET RESOUR CROP EV, V49, P551, DOI 10.1023/A:1021210800414; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mietkiewska E, 2007, PLANT SCI, V173, P198, DOI 10.1016/j.plantsci.2007.05.001; Mietkiewska E, 2007, PLANT BIOTECHNOL J, V5, P636, DOI 10.1111/j.1467-7652.2007.00268.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Pang Hui, 2013, Journal of Plant Resources and Environment, V22, P8; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roscoe TJ, 2001, FEBS LETT, V492, P107, DOI 10.1016/S0014-5793(01)02243-8; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schulz O.E., 1936, NATURLICHEN PFLANZEN, V17B, P227; Sun XiaoQin, 2011, Chemistry and Industry of Forest Products, V31, P46; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Velasco L, 1998, GENET RESOUR CROP EV, V45, P371, DOI 10.1023/A:1008628624867; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI., 1997, OPERA BOT, V132, P159; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Wu YuHua, 2009, Scientia Agricultura Sinica, V42, P3819; [No title captured]	47	10	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83535	10.1371/journal.pone.0083535	http://dx.doi.org/10.1371/journal.pone.0083535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358289	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700128
J	Tatsumi, K; Sugimoto, M; Lillicrap, D; Shima, M; Ohashi, K; Okano, T; Matsui, H				Tatsumi, Kohei; Sugimoto, Mitsuhiko; Lillicrap, David; Shima, Midori; Ohashi, Kazuo; Okano, Teruo; Matsui, Hideto			A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A	PLOS ONE			English	Article							AAV-FACTOR-IX; GENE-THERAPY; TISSUES; RECONSTRUCTION; PROLIFERATION; EXPRESSION; TOXICITY; VECTORS; MUSCLE; LIVER	Gene- or cell-based therapies aimed at creating delivery systems for coagulation factor VIII (FVIII) protein have emerged as promising options for hemophilia A treatment. However, several issues remain to be addressed regarding the efficacies and adverse events of these new classes of therapies. To improve an existing cell-based therapy involving the subcutaneous transplantation of FVIII-transduced blood outgrowth endothelial cells (BOECs), we employed a novel cell-sheet technology that allows individual dispersed cells to form a thin and contiguous monolayer without traditional bioabsorbable scaffold matrices. Compared to the traditional methodology, our cell-sheet approach resulted in longer-term and 3-5-fold higher expression of FVIII (up to 11% of normal) in recipient hemophilia A mice that lacked a FVIII humoral immune response due to transient immunosuppression with cyclophosphamide. Histological studies revealed that the transplanted BOEC sheets were structured as flat clusters, supporting the long-term expression of therapeutic FVIII in plasma from an ectopic subcutaneous space. Our novel tissue-engineering approach using genetically modified BOEC sheets could aid in development of cell-based therapy that will allow safe and effective in vivo delivery of functional FVIII protein in patients with hemophilia A.	[Tatsumi, Kohei; Ohashi, Kazuo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Sugimoto, Mitsuhiko; Matsui, Hideto] Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan; [Lillicrap, David] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan	Tokyo Women's Medical University; Nara Medical University; McMaster University; Queens University - Canada; Nara Medical University	Sugimoto, M (corresponding author), Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan.	sugi-ped@naramed-u.ac.jp; hide-ped@naramed-u.ac.jp		Okano, Teruo/0000-0002-4470-9842	Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)''; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Bayer Hemophilia Awards Program	Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)''; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bayer Hemophilia Awards Program	This work was supported by the Program for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas in the Project for Developing Innovation Systems "Cell-Sheet Tissue-Engineering Center (CSTEC)'' (K.O. and T.O.); a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (H. M.); and the Bayer Hemophilia Awards Program (H. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2007, J NANOSCI NANOTECHNO, V7, P796, DOI 10.1166/jnn.2007.509; Arruda VR, 2010, BLOOD, V115, P4678, DOI 10.1182/blood-2009-12-261156; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Chuah MKL, 2004, SEMIN THROMB HEMOST, V30, P249, DOI 10.1055/s-2004-825638; Chuah MKL, 2003, BLOOD, V101, P1734, DOI 10.1182/blood-2002-03-0823; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haurigot V, 2010, MOL THER, V18, P1318, DOI 10.1038/mt.2010.73; Iwata T, 2010, J CLIN PERIODONTOL, V37, P1088, DOI 10.1111/j.1600-051X.2010.01597.x; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Sabatino DE, 2011, MOL THER, V19, P442, DOI 10.1038/mt.2010.240; Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Thakur A, 2010, J BIOMED MATER RES B, V94B, P296, DOI 10.1002/jbm.b.31648; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yokoyama T, 2006, AM J TRANSPLANT, V6, P50, DOI 10.1111/j.1600-6143.2005.01155.x	28	21	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83280	10.1371/journal.pone.0083280	http://dx.doi.org/10.1371/journal.pone.0083280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358271	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700114
J	Yi, ZL; Su, XY; Revindran, V; Mackie, RI; Cann, I				Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac			Molecular and Biochemical Analyses of CbCel9A/Cel48A, a Highly Secreted Multi-Modular Cellulase by Caldicellulosiruptor bescii during Growth on Crystalline Cellulose	PLOS ONE			English	Article							PROCESSIVE ENDOCELLULASE CELF; FREE QUANTITATIVE PROTEOMICS; CLOSTRIDIUM-CELLULOLYTICUM; GLYCOSIDE HYDROLASE; ANAEROCELLUM-THERMOPHILUM; PLANT BIOMASS; FAMILY 48; ENDOGLUCANASE; THERMOCELLUM; GENE	During growth on crystalline cellulose, the thermophilic bacterium Caldicellulosiruptor bescii secretes several cellulose-degrading enzymes. Among these enzymes is CelA (CbCel9A/Cel48A), which is reported as the most highly secreted cellulolytic enzyme in this bacterium. CbCel9A/Cel48A is a large multi-modular polypeptide, composed of an N-terminal catalytic glycoside hydrolase family 9 (GH9) module and a C-terminal GH48 catalytic module that are separated by a family 3c carbohydrate-binding module (CBM3c) and two identical CBM3bs. The wild-type CbCel9A/Cel48A and its truncational mutants were expressed in Bacillus megaterium and Escherichia coli, respectively. The wild-type polypeptide released twice the amount of glucose equivalents from Avicel than its truncational mutant that lacks the GH48 catalytic module. The truncational mutant harboring the GH9 module and the CBM3c was more thermostable than the wild-type protein, likely due to its compact structure. The main hydrolytic activity was present in the GH9 catalytic module, while the truncational mutant containing the GH48 module and the three CBMs was ineffective in degradation of either crystalline or amorphous cellulose. Interestingly, the GH9 and/or GH48 catalytic modules containing the CBM3bs form low-density particles during hydrolysis of crystalline cellulose. Moreover, TM3 (GH9/CBM3c) and TM2 (GH48 with three CBM3 modules) synergistically hydrolyze crystalline cellulose. Deletion of the CBM3bs or mutations that compromised their binding activity suggested that these CBMs are important during hydrolysis of crystalline cellulose. In agreement with this observation, seven of nine genes in a C. bescii gene cluster predicted to encode cellulose-degrading enzymes harbor CBM3bs. Based on our results, we hypothesize that C. bescii uses the GH48 module and the CBM3bs in CbCel9A/Cel48A to destabilize certain regions of crystalline cellulose for attack by the highly active GH9 module and other endoglucanases produced by this hyperthermophilic bacterium.	[Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Energy Biosci Inst, Urbana, IL USA; [Yi, Zhuolin; Su, Xiaoyun; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, I (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL USA.	icann@illinois.edu			Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes	Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes	This work was funded by the Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes to Improve Biocatalysis and Conversion of Plant Cell Wall Polysaccharides to Biofuels Program at the University of Illinois, Urbana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BRONNENMEIER K, 1991, EUR J BIOCHEM, V200, P379, DOI 10.1111/j.1432-1033.1991.tb16195.x; Bronnenmeier K, 1997, MICROBIOL-SGM, V143, P891, DOI 10.1099/00221287-143-3-891; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Chiriac AI, 2010, APPL MICROBIOL BIOT, V86, P1125, DOI 10.1007/s00253-009-2350-8; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gal L, 1997, J BACTERIOL, V179, P6595, DOI 10.1128/jb.179.21.6595-6601.1997; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Iakiviak M, 2011, APPL ENVIRON MICROB, V77, P7541, DOI 10.1128/AEM.06088-11; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Kakiuchi M, 1998, J BACTERIOL, V180, P4303, DOI 10.1128/JB.180.16.4303-4308.1998; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; KRUUS K, 1995, J BACTERIOL, V177, P1641, DOI 10.1128/jb.177.6.1641-1644.1995; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu CC, 1998, GENE, V211, P39, DOI 10.1016/S0378-1119(98)00081-X; Lochner A, 2011, J PROTEOME RES, V10, P5302, DOI 10.1021/pr200536j; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Park S, 2009, CELLULOSE, V16, P641, DOI 10.1007/s10570-009-9321-1; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Petkun S, 2010, ACTA CRYSTALLOGR D, V66, P33, DOI 10.1107/S0907444909043030; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Riedel K, 1998, MOL MICROBIOL, V28, P767, DOI 10.1046/j.1365-2958.1998.00834.x; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Siddiqui MA, 1998, FEBS LETT, V434, P372, DOI 10.1016/S0014-5793(98)00998-3; Spiridonov NA, 1998, J BACTERIOL, V180, P3529, DOI 10.1128/JB.180.14.3529-3532.1998; Su XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043828; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Wilson DB, 2010, P NATL ACAD SCI USA, V107, P17855, DOI 10.1073/pnas.1012746107; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Yaniv O, 2012, ACTA CRYSTALLOGR F, V68, P8, DOI 10.1107/S174430911104807X; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Zhang XZ, 2010, APPL MICROBIOL BIOT, V86, P525, DOI 10.1007/s00253-009-2231-1; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	52	55	58	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84172	10.1371/journal.pone.0084172	http://dx.doi.org/10.1371/journal.pone.0084172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358340	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700155
J	Gouspillou, G; Sgarioto, N; Kapchinsky, S; Purves-Smith, F; Norris, B; Pion, CH; Barbat-Artigas, S; Lemieux, F; Taivassalo, T; Morais, JA; Aubertin-Leheudre, M; Hepple, RT				Gouspillou, Gilles; Sgarioto, Nicolas; Kapchinsky, Sophia; Purves-Smith, Fennigje; Norris, Brandon; Pion, Charlotte H.; Barbat-Artigas, Sebastien; Lemieux, Francois; Taivassalo, Tanja; Morais, Jose A.; Aubertin-Leheudre, Mylene; Hepple, Russell T.			Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans	FASEB JOURNAL			English	Article						reactive oxygen species; sarcopenia; aging; mitophagy	HUMAN SKELETAL-MUSCLE; LYSOSOMAL AXIS THEORY; OXIDATIVE CAPACITY; DEGENERATIVE DISEASES; DNA MUTATIONS; IN-VIVO; AGE; APOPTOSIS; PORE; ACCUMULATION	Mitochondrial dysfunction is implicated in skeletal muscle atrophy and dysfunction with aging, with strong support for an increased mitochondrial-mediated apoptosis in sedentary rodent models. Whether this applies to aged human muscle is unknown, nor is it clear whether these changes are caused by sedentary behavior. Thus, we examined mitochondrial function [respiration, reactive oxygen species (ROS) emission, and calcium retention capacity (CRC)] in permeabilized myofibers obtained from vastus lateralis muscle biopsies of healthy physically active young (23.7 +/- 2.7 yr; mean +/- sd) and older (71.2 +/- 4.9 yr) men. Although mitochondrial ROS and maximal respiratory capacity were unaffected, the acceptor control ratio was reduced by 18% with aging, suggesting mild uncoupling of oxidative phosphorylation. CRC was reduced by 50% with aging, indicating sensitization of the mitochondrial permeability transition pore (mPTP) to apoptosis. Consistent with the mPTP sensitization, older muscles showed a 3-fold greater fraction of endonuclease G (a mitochondrial proapoptotic factor)-positive myonuclei. Aged muscles also had lower mitophagic potential, based on a 43% reduction in Parkin to the voltage-dependent anion channel (VDAC) protein ratio. Collectively, these results show that mitochondrial-mediated apoptotic signaling is increased in older human muscle and suggest that accumulation of dysfunctional mitochondria with exaggerated apoptotic sensitivity is due to impaired mitophagy.-Gouspillou, G., Sgarioto, N., Kapchinsky, S., Purves-Smith, F., Norris, B., Pion, C. H., Barbat-Artigas, S., Lemieux, F., Taivassalo, T., Morais, J. A., Aubertin-Leheudre, M., Hepple, R. T. Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans.	[Gouspillou, Gilles; Sgarioto, Nicolas; Norris, Brandon; Morais, Jose A.; Hepple, Russell T.] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Kapchinsky, Sophia; Purves-Smith, Fennigje; Taivassalo, Tanja; Hepple, Russell T.] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada; [Hepple, Russell T.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Gouspillou, Gilles; Pion, Charlotte H.; Barbat-Artigas, Sebastien; Lemieux, Francois; Aubertin-Leheudre, Mylene] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada	McGill University; McGill University; McGill University; University of Quebec; University of Quebec Montreal	Hepple, RT (corresponding author), Royal Victoria Hosp, Dept Crit Care Med, 687 Pine Ave W, Montreal, PQ H3A 1A, Canada.	russell.hepple@mcgill.ca		Gouspillou, Gilles/0000-0002-8543-3619; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes of Health Research [MOP125986, MOP119583]; Quebec Network for Research on Aging; Canadian Foundation for Innovation; Fonds de Recherche du Quebec-Sante; McGill University Health Center	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Network for Research on Aging; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); McGill University Health Center	Operating funds were provided for this project from the Canadian Institutes of Health Research (MOP125986 and MOP119583 to R.T.H.) and a pilot grant from the Quebec Network for Research on Aging (to M.A.-L. and R.T.H.). R.T.H. was also supported by a Leaders Opportunity Fund from the Canadian Foundation for Innovation and a Chercheurs Boursiers Senior Award from the Fonds de Recherche du Quebec-Sante. G.G. was supported by a postdoctoral fellowship from the McGill University Health Center.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001; Hepple RT, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P135, DOI 10.1007/978-90-481-9713-2_7; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hutter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x; Hunter SK, 1999, J APPL PHYSIOL, V86, P1858, DOI 10.1152/jappl.1999.86.6.1858; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591; Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Narayanan N, 1996, AM J PHYSIOL-CELL PH, V271, pC1032, DOI 10.1152/ajpcell.1996.271.4.C1032; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nauratil M, 2008, EXP CELL RES, V314, P164, DOI 10.1016/j.yexcr.2007.09.013; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502; Purves-Smith FM, 2012, EXP GERONTOL, V47, P913, DOI 10.1016/j.exger.2012.07.013; Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005; Russ DW, 2004, SPORTS MED, V34, P221, DOI 10.2165/00007256-200434040-00002; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Selman C, 2003, BIOGERONTOLOGY, V4, P141, DOI 10.1023/A:1024149923693; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282; Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	66	126	128	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1621	1633		10.1096/fj.13-242750	http://dx.doi.org/10.1096/fj.13-242750			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371120				2022-12-25	WOS:000335344300011
J	Cheng, W; Wang, L; Yang, BY; Zhang, R; Yao, C; He, LQ; Liu, ZX; Du, P; Hammache, K; Wen, J; Li, H; Xu, Q; Hua, ZC				Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun			Self-renewal and Differentiation of Muscle Satellite Cells Are Regulated by the Fas-associated Death Domain*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Differentiation; Muscle; Notch Pathway; Stem Cells	TEMPLATE DNA STRANDS; STEM-CELLS; ASYMMETRIC DIVISION; CONTAINING PROTEIN; FADD; CYCLE; PHOSPHORYLATION; ACTIVATION; NOTCH; MECHANISMS	Background: The balance between self-renewal and differentiation in muscle stem cells is critical for tissue homeostasis. Results: Fas-associated death domain (FADD) phosphorylation mutation regulates muscle satellite cell cycle progression, inhibits muscle stem cell differentiation, and promotes muscle stem cell self-renewal. Conclusion: FADD regulates muscle stem cell fate decisions. Significance: The characterization of proteins involved in fate decisions in muscle stem cells is crucial for muscle stem cell biology. Making the decision between self-renewal and differentiation of adult stem cells is critical for tissue repair and homeostasis. Here we show that the apoptotic adaptor Fas-associated death domain (FADD) regulates the fate decisions of muscle satellite cells (SCs). FADD phosphorylation was specifically induced in cycling SCs, which was high in metaphase and declined in later anaphase. Furthermore, phosphorylated FADD at Ser-191 accumulated in the uncommitted cycling SCs and was asymmetrically localized in the self-renewing daughter SCs. SCs containing a phosphoryl-mimicking mutation at Ser-191 of FADD (FADD-D) expressed higher levels of stem-like markers and reduced commitment-associated markers. Moreover, a phosphoryl-mimicking mutation at Ser-191 of FADD suppressed SC activation and differentiation, which promoted the cycling SCs into a reversible quiescent state. Therefore, these data indicate that FADD regulates the fate determination of cycling SCs.	[Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun] Nanjing Univ, Affiliated Stomatol Hosp, State Key Lab Pharmaceut Biotechnol, Coll Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun] Nanjing Univ, Sch Stomatol, Affiliated Stomatol Hosp, Nanjing 210093, Jiangsu, Peoples R China; [Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China; [Hua, Zichun] Jiangsu TargetPharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Hua, ZC (corresponding author), Nanjing Univ, Dept Biochem, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	zchua@nju.edu.cn		Wen, Juan/0000-0001-9832-2056	National Key Basic Research Program from Ministry of Science and Technology Grants [2012CB967004, 2014CB744501, 2011CB933502]; National Natural Science Foundation of China Grants [81121062, 30425009, 30330530, 30270291]; Jiangsu Provincial Nature Science Foundation Grants [BE2013630, BZ2012050, BK2011573]; Bureau of Science and Technology of Changzhou Grants [CM20122003, CZ20120004, CZ20130011, CE20135013, WF201207]	National Key Basic Research Program from Ministry of Science and Technology Grants; National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation Grants; Bureau of Science and Technology of Changzhou Grants	This work was supported by National Key Basic Research Program from Ministry of Science and Technology Grants 2012CB967004, 2014CB744501, and 2011CB933502; by National Natural Science Foundation of China Grants 81121062, 30425009, 30330530, and 30270291 by Jiangsu Provincial Nature Science Foundation Grants BE2013630, BZ2012050, and BK2011573; and by Bureau of Science and Technology of Changzhou Grants CM20122003, CZ20120004, CZ20130011, CE20135013, and WF201207.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shimada K, 2005, J PATHOL, V206, P423, DOI 10.1002/path.1791; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Steinhart R, 2007, GLIA, V55, P224, DOI 10.1002/glia.20454; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Ueno H, 2008, DEVELOPMENT, V135, P2023, DOI 10.1242/dev.019893; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida N, 1998, J CELL SCI, V111, P769; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	54	6	6	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5040	5050		10.1074/jbc.M113.533448	http://dx.doi.org/10.1074/jbc.M113.533448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375410	hybrid, Green Published			2022-12-25	WOS:000331607900048
J	Cao, Y; Lupo, PJ; Swartz, MD; Nousome, D; Scheurer, ME				Cao, Ying; Lupo, Philip J.; Swartz, Michael D.; Nousome, Darryl; Scheurer, Michael E.			Using a Bayesian Hierarchical Model for Identifying Single Nucleotide Polymorphisms Associated with Childhood Acute Lymphoblastic Leukemia Risk in Case-Parent Triads	PLOS ONE			English	Article							VARIABLE SELECTION; STOCHASTIC SEARCH; GENE; HOMOCYSTEINE; METAANALYSIS; PATHWAY; DISEASE	Childhood acute lymphoblastic leukemia (ALL) is a condition that arises from complex etiologies. The absence of consistent environmental risk factors and the presence of modest familial associations suggest ALL is a complex trait with an underlying genetic component. The identification of genetic factors associated with disease is complicated by complex genetic covariance structures and multiple testing issues. Both issues can be resolved with appropriate Bayesian variable selection methods. The present study was undertaken to extend our hierarchical Bayesian model for case-parent triads to incorporate single nucleotide polymorphisms (SNPs) and incorporate the biological grouping of SNPs within genes. Based on previous evidence that genetic variation in the folate metabolic pathway influences ALL risk, we evaluated 128 tagging SNPs in 16 folate metabolic genes among 118 ALL case-parent triads recruited from the Texas Children's Cancer Center (Houston, TX) between 2003 and 2010. We used stochastic search gene suggestion (SSGS) in hierarchical Bayesian models to evaluate the association between folate metabolic SNPs and ALL. Using Bayes factors among these variants in childhood ALL case-parent triads, two SNPs were identified with a Bayes factor greater than 1. There was evidence that the minor alleles of NOS3 rs3918186 (OR = 2.16; 95% CI: 1.51-3.15) and SLC19A1 rs1051266 (OR = 2.07; 95% CI: 1.25-3.46) were positively associated with childhood ALL. Our findings are suggestive of the role of inherited genetic variation in the folate metabolic pathway on childhood ALL risk, and they also suggest the utility of Bayesian variable selection methods in the context of case-parent triads for evaluating the role of SNPs on disease risk.	[Cao, Ying; Swartz, Michael D.] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Lupo, Philip J.; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Nousome, Darryl] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Scheurer, ME (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	scheurer@bcm.edu	Swartz, Michael/AEX-2820-2022; Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; Scheurer, Michael/0000-0002-8379-6088; Swartz, Michael/0000-0003-3953-8775; Nousome, Darryl/0000-0002-5259-8599	Dan L. Duncan Cancer Center at Baylor College of Medicine [P30CA125123]; NCI [K07CA131505]; Kurt Groten Family Research Scholars Award; NATIONAL CANCER INSTITUTE [K07CA131505, P30CA125123] Funding Source: NIH RePORTER	Dan L. Duncan Cancer Center at Baylor College of Medicine; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kurt Groten Family Research Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The genotyping for this work was supported by an Inter-Institutional Pilot Project (to M. E. S. and P.J.L.) from the Dan L. Duncan Cancer Center at Baylor College of Medicine, P30CA125123 (PI: Osborne). M. E. S. was also supported in part by an NCI Career Development Award, K07CA131505 and in part by Kurt Groten Family Research Scholars Award (P.J.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialecka M, 2012, PHARMACOGENET GENOM, V22, P716, DOI 10.1097/FPC.0b013e32835693f7; Brown KS, 2003, ARTERIOSCL THROM VAS, V23, P1014, DOI 10.1161/01.ATV.0000071348.70527.F4; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chipman H., 2001, PRACTICAL IMPLEMENTA; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Dervieux T, 2004, ARTHRITIS RHEUM-US, V50, P2766, DOI 10.1002/art.20460; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2006, COMPUTER PROGRAM POW; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Genome Variation Server, 2010, GVS GEN VAR SERV VER; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Infante-Rivard C, 2007, AM J EPIDEMIOL, V165, P1248, DOI 10.1093/aje/kwm022; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koppen IJN, 2010, BRIT J HAEMATOL, V148, P3, DOI 10.1111/j.1365-2141.2009.07898.x; Levine AJ, 2011, CANCER CAUSE CONTROL, V22, P541, DOI 10.1007/s10552-011-9726-7; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Lupo PJ, 2012, PEDIATR HEMAT ONCOL, V29, P679, DOI 10.3109/08880018.2012.722747; Lupo PJ, 2012, CANCER CAUSE CONTROL, V23, P1797, DOI 10.1007/s10552-012-0058-z; Margolin JF, 2011, PRINCIPLES PRACTICE, P518; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; National Heart L, 2010, GVS GEN VAR SERV VER; Nousome D, 2013, LEUKEMIA RES, V37, P531, DOI 10.1016/j.leukres.2013.01.020; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Sherborne AL, 2011, HAEMATOL-HEMATOL J, V96, P1049, DOI 10.3324/haematol.2011.040121; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Smith BJ, 2008, BAYESIAN OUTPUT ANAL; Sobel E, 1996, AM J HUM GENET, V58, P1323; Spector LG, 2013, PEDIATR BLOOD CANCER, V60, P1059, DOI 10.1002/pbc.24434; Swartz MD, 2006, BIOMETRICS, V62, P495, DOI 10.1111/j.1541-0420.2005.00451.x; Swartz Michael D, 2007, BMC Proc, V1 Suppl 1, pS113; Swartz MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053475; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84658	10.1371/journal.pone.0084658	http://dx.doi.org/10.1371/journal.pone.0084658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367687	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900062
J	Maketa, V; Vuna, M; Baloji, S; Lubanza, S; Hendrickx, D; Inocencio da Luz, RA; Boelaert, M; Lutumba, P				Maketa, Vivi; Vuna, Mimy; Baloji, Sylvain; Lubanza, Symphorien; Hendrickx, David; Inocencio da Luz, Raquel Andrea; Boelaert, Marleen; Lutumba, Pascal			Perceptions of Health, Health Care and Community-Oriented Health Interventions in Poor Urban Communities of Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							PUBLIC-HEALTH; INITIATIVES; PROGRAM; IMPACT	In Democratic Republic of Congo access to health care is limited because of many geographical and financial barriers, while quality of care is often low. Global health donors assist the country with a number of community-oriented interventions such as free distribution of bednets, antihelminthic drugs, vitamin A supplementation and vaccination campaigns, but uptake of these interventions is not always optimal. The aim of this study was to explore the perceptions of poor urban communities of the capital Kinshasa with regard to health issues in general as well as their experiences and expectations concerning facility-based health services and community-oriented health interventions. Applying an approach rooted in the grounded theory framework, focus group discussions were conducted in eight neighborhoods of poor urban areas in the city of Kinshasa in July 2011. Study participants were easily able to evoke the city's major health problems, with the notable exceptions of malnutrition and HIV/AIDS. They perceive the high out-of-pocket cost of health services as the major obstacle when seeking access to quality care. Knowledge of ongoing community-oriented health interventions seems good. Still, while the study participants agree that those interventions are beneficial; their acceptability seems to be problematic. This is chiefly put down to a lack of information and government communication about the programs and their interventions. Furthermore, the study participants referred to rumors and the deterring effect of stories about alleged harmful consequences of those interventions. Along with improving the provision and quality of general health care, the government and international actors must improve their efforts in informing the communities about disease control programs, their rationale and benefit/risk ratio. Directly engaging community members in a dialogue might be beneficial in terms of improving acceptability and overall access to health services and interventions. Novel ways of reducing the high out-of-pocket expenditure should also be explored.	[Maketa, Vivi; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Vuna, Mimy; Lutumba, Pascal] Inst Natl Rech Biomed, Epidemiol Unit, Kinshasa, DEM REP CONGO; [Baloji, Sylvain] Inst Super Tech Med, Epidemiol Unit, Kinshasa, DEM REP CONGO; [Lubanza, Symphorien] Univ Kinshasa, Dept Social Sci, Kinshasa, DEM REP CONGO; [Hendrickx, David; Boelaert, Marleen; Lutumba, Pascal] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Hendrickx, David] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, Australia; [Inocencio da Luz, Raquel Andrea] Univ Antwerp, Fac Med, Int Hlth Unit, B-2020 Antwerp, Belgium	Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; Institute of Tropical Medicine (ITM); Telethon Kids Institute; University of Western Australia; University of Antwerp	Maketa, V (corresponding author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	vmaketa@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; da Luz, Raquel A Inocencio/L-9676-2016; Boelaert, Marleen/E-2698-2012	Inocencio da Luz, Raquel/0000-0002-2870-0311; da Luz, Raquel A Inocencio/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	World Health Organization/TDR [A90072]	World Health Organization/TDR(World Health Organization)	This study has been done with the financial support of World Health Organization/TDR through the grant A90072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MC, 2007, INT J HEALTH PLAN M, V22, P337, DOI 10.1002/hpm.900; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; Faltermaier T, 1997, EUR J PUBLIC HEALTH, V7, P357, DOI 10.1093/eurpub/7.4.357; Fatungase KO, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-11; Gilson Lucy, 2006, J Health Organ Manag, V20, P359, DOI 10.1108/14777260610701768; Glaser B., 1992, BASICS GROUNDED THEO; Husserl Edmund, 1989, IDEAS PERTAINING PUR; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Olsen OE, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-14; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5; Republique Democratique du Congo Ministere de la Sante Publique, 2010, STRATEGIE RENFORCEME; Republique Democratique du Congo Ministere du Plan, 2010, DOCUMNET STRATEGIQUE; Republique Democratique du Congo Ministere du Plan en collaboration avec le Ministere de la Sante Publique, 2008, ENQUETE DEMOGRAPHIQU; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schulz AJ, 2011, HEALTH PROMOT PRACT, V12, P900, DOI 10.1177/1524839909359156; Wagstaff A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P181	20	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84314	10.1371/journal.pone.0084314	http://dx.doi.org/10.1371/journal.pone.0084314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HY	24367653	Green Submitted, gold, Green Published			2022-12-25	WOS:000328741900044
J	Colombo, GL; Agabiti-Rosei, E; Margonato, A; Mencacci, C; Montecucco, CM; Trevisan, R				Colombo, Giorgio L.; Agabiti-Rosei, Enrico; Margonato, Alberto; Mencacci, Claudio; Montecucco, Carlo Maurizio; Trevisan, Roberto			Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy	PLOS ONE			English	Article							ADHERENCE; THERAPY; STATIN; PRICE; DISCONTINUATION; SUBSTITUTION; COMPETITION; IMPACT; RATES; COST	The scientific documentation supporting the potential clinical and economic benefits of a growing use of off-patent generic drugs in clinical practice seems to be limited in Italy as yet. Methods: We compared differences in outcomes between off-patent generic drugs and off-patent brand drugs in real clinical practice. The outcomes were: persistence and compliance with therapy, mortality, and other health resources consumption (hospitalizations, specialist examinations, other drugs) and total costs. Retrospective analysis was carried out by using the administrative databases of five Local Healthcare Units (ASLs - Aziende Sanitarie Locali) in the Lombardy Region of Italy. Data from the five ASLs were aggregated through a meta-analysis, which produced an estimate indicator of the mean or percentage difference between the two groups (branded vs. generic) and their respective significance tests. The therapeutic areas and studied drugs were: diabetes: metformin - A10BA02; hypertension: amlodipine - C08CA01; dyslipidemia: simvastatin - C10AA01; psychiatry: sertraline - N06AB06; cardiology: propafenone - C01BC03; osteoporosis: alendronate - M05BA04. Results: The 5 Local Healthcare Units (ASL) represent a population of 3,847,004 inhabitants. The selected sample included 347,073 patients, or 9.02% of the total ASL population; 67% of the patients were treated with off-patent brand drugs. The average age was 68 years, with no difference between the two groups. After 34 months of observation, compliance and persistence were in favor to generic drugs in all therapeutic areas and statistically significant in the metformin, amlodipine, simvastatin, and sertraline groups. The clinical outcomes (hospitalizations, mortality, and other health costs) show no statistically significant differences between off-patent generic vs. off-patent brand medicines. Conclusions: Off-patent generic drugs appear to be a therapy option of choice in Italy as well, based on clinical outcomes and economic consequences, both for the National Health Service and patients, considering that the price difference between brand and generic drugs is completely charged on patients.	[Colombo, Giorgio L.] Univ Pavia, Dept Drug Sci, I-27100 Pavia, Italy; [Colombo, Giorgio L.] SAVE Anal Valutaz Econ, Milan, Italy; [Agabiti-Rosei, Enrico] Spedali Civil Brescia, Div Med & Surg, I-25125 Brescia, Italy; [Margonato, Alberto] San Raffaele Univ Hosp, Div Cardiol, Milan, Italy; [Mencacci, Claudio] AO Fatebenefratelli & Oftalm, Dept Neurosci, Milan, Italy; [Montecucco, Carlo Maurizio] Univ Pavia, Div Rheumatol, IRCCS Policlin S Matteo, I-27100 Pavia, Italy; [Trevisan, Roberto] Osped Riuniti Bergamo, Unit Diabetol, I-24100 Bergamo, Italy	University of Pavia; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Fondazione San Matteo; University of Pavia; Ospedali Riuniti di Bergamo	Colombo, GL (corresponding author), Univ Pavia, Dept Drug Sci, Via Palestro 3, I-27100 Pavia, Italy.	giorgio.colombo@unipv.it	MARGONATO, ALBERTO/B-4185-2015; TREVISAN, ROBERTO/Q-8706-2016; MONTECUCCO, CARLOMAURIZIO/K-5236-2018	TREVISAN, ROBERTO/0000-0003-0420-4468; MONTECUCCO, CARLOMAURIZIO/0000-0001-8263-3925	DOC Generici, Milan (Italy)	DOC Generici, Milan (Italy)	This work was supported by a DOC Generici, Milan (Italy), non-discretionary educational grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2007, PHARMACOEPIDEM DR S, V16, P1298, DOI 10.1002/pds.1494; AIFA Italian Medicines Agency - Gruppo di lavoro OSMED L'uso dei farmaci in Italia, 2012, RAPP OSMED GENN SETT; Aronica A, 2011, CLINICOECONOMICS ITA, V6, P15; Atar D, 2009, ANN MED, V41, P242, DOI 10.1080/07853890902729786; Borenstein M., 2009, INTRO METAANALYSIS; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Catapano AL, 2010, CARE, V6, P33; Cerra C, 2004, PHARMACOECONOMICS IT, V6, P141, DOI DOI 10.1007/BF03320632; Colombo GL, 2012, PATIENT PREFER ADHER, V6, P653, DOI 10.2147/PPA.S33968; CRAMER JA, 1995, AM J HEALTH-SYST PH, V52, pS27, DOI 10.1093/ajhp/52.14_Suppl_3.S27; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Dylst P, 2011, PHARMACOECONOMICS, V29, P875, DOI 10.2165/11585970-000000000-00000; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Lexchin J, 2004, HEALTH POLICY, V68, P47, DOI 10.1016/j.healthpol.2003.07.007; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peters JR, 2009, DERMATOL THER, V22, P229, DOI 10.1111/j.1529-8019.2009.01236.x; Puig-Junoy J, 2010, PHARMACOECONOMICS, V28, P649, DOI 10.2165/11535360-000000000-00000; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Ruggeri I, 2012, CLINICOECONOMIC OUTC, V4, P375, DOI 10.2147/CEOR.S36499; Sabate E., 2003, ADHERENCE LONG TERM; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Simoens S, 2007, CURR MED RES OPIN, V23, P2647, DOI 10.1185/030079907X233395; Simoens Steven, 2008, J Med Econ, V11, P171, DOI 10.3111/13696990801939716; Van Wijk BLG, 2006, ANN PHARMACOTHER, V40, P15, DOI 10.1345/aph.1G163; Vlahiotis A, 2011, J MANAGE CARE PHARM, V17, P123; WHO, WORLD HLTH REP HLTH	31	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82990	10.1371/journal.pone.0082990	http://dx.doi.org/10.1371/journal.pone.0082990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367576	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300087
J	Simpson, EA; Paukner, A; Sclafani, V; Suomi, SJ; Ferrari, PF				Simpson, Elizabeth A.; Paukner, Annika; Sclafani, Valentina; Suomi, Stephen J.; Ferrari, Pier F.			Lipsmacking Imitation Skill in Newborn Macaques Is Predictive of Social Partner Discrimination	PLOS ONE			English	Article							NEONATAL IMITATION; MEMORY	Newborn rhesus macaques imitate facial gestures even after a delay, revealing the flexible nature of their early communicative exchanges. In the present study we examined whether newborn macaques are also sensitive to the identities of the social partners with whom they are interacting. We measured infant monkeys' (n = 90) lipsmacking and tongue protrusion gestures in a face-to-face interaction task with a human experimenter in the first week of life. After a one-minute delay, the same person who previously presented gestures or a different person returned and presented a still face to infants. We had two primary predictions: (1) infants would demonstrate higher rates of overall gesturing, and especially lipsmacking-an affiliative gesture-to a familiar person, compared to a novel person, and (2) infants' imitative skills would positively correlate with gestures to familiar, but not unfamiliar, social partners, as both abilities may reflect a strong general social interest. We found that overall infants did not produce more gestures or more lipsmacking when approached by a familiar person compared to a novel person; however, we did find individual differences in infants' social responsiveness: lipsmacking imitation was positively correlated with lipsmacking during the return period when the person was the same (p =.025), but not when the person was novel (p =.44). These findings are consistent with the notion that imitative skill is reflective of infants' more general interest in social interactions.	[Simpson, Elizabeth A.; Paukner, Annika; Suomi, Stephen J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Poolesville, MD USA; [Simpson, Elizabeth A.; Sclafani, Valentina; Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Parma	Simpson, EA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, Poolesville, MD USA.	simpsonea@mail.nih.gov	Simpson, Elizabeth A./H-5479-2019; Paukner, Annika/ABA-3275-2020; Ferrari, Pier Francesco/G-5547-2017	Simpson, Elizabeth A./0000-0003-2715-2533; Paukner, Annika/0000-0002-3421-1864; 	Division of Intramural Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107, P01HD064653] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development. EAS, VS, and PFF were supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development P01 HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORKLUND DF, 1987, DEV REV, V7, P86, DOI 10.1016/0273-2297(87)90006-2; Braten S., 1998, INTERSUBJECTIVE COMM, P15; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Ferrari PF, 2012, J COGNITIVE NEUROSCI, V24, P1165, DOI 10.1162/jocn_a_00198; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; LEGERSTEE M, 1991, J EXP CHILD PSYCHOL, V51, P423, DOI 10.1016/0022-0965(91)90086-8; MAESTRIPIERI D, 1994, BEHAVIOUR, V131, P75, DOI 10.1163/156853994X00226; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; MELTZOFF AN, 1994, INFANT BEHAV DEV, V17, P83, DOI 10.1016/0163-6383(94)90024-8; MELTZOFF AN, 1992, INFANT BEHAV DEV, V15, P479, DOI 10.1016/0163-6383(92)80015-M; PAUKNER A, 2013, NAVIGATING SOCIAL WO, P133; Paukner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028848; Schwartz BL, 2001, AM J PRIMATOL, V55, P71, DOI 10.1002/ajp.1041; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Simpson EA, 2014, DEV PSYCHOBIOL, V56, P864, DOI 10.1002/dev.21146; UZGIRIS IC, 1981, INT J BEHAV DEV, V4, P1, DOI 10.1177/016502548100400101	16	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82921	10.1371/journal.pone.0082921	http://dx.doi.org/10.1371/journal.pone.0082921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367569	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000328740300080
J	Ud-Din, AMS; Wahid, SUH; Latif, HA; Shahnaij, M; Akter, M; Azmi, IJ; Hasan, TN; Ahmed, D; Hossain, MA; Faruque, AG; Faruque, SM; Talukder, KA				Ud-Din, Abu I. M. S.; Wahid, Syeda U. H.; Latif, Hasan A.; Shahnaij, Mohammad; Akter, Mahmuda; Azmi, Ishrat J.; Hasan, Trisheeta N.; Ahmed, Dilruba; Hossain, Mohammad A.; Faruque, Abu S. G.; Faruque, Shah M.; Talukder, Kaisar A.			Changing Trends in the Prevalence of Shigella Species: Emergence of Multi-Drug Resistant Shigella sonnei Biotype g in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CARRYING CLASS-2 INTEGRONS; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; PATTERNS; STRAINS	Shigellosis, caused by Shigella species, is a major public health problem in Bangladesh. To determine the prevalence and distribution of different Shigella species, we analyzed 10,827 Shigella isolates from patients between 2001 and 2011. S. flexneri was the predominant species isolated throughout the period. However, the prevalence of S. flexneri decreased from 65.7% in 2001 to 47% in 2011, whereas the prevalence of S. sonnei increased from 7.2% in 2001 to 25% in 2011. S. boydii and S. dysenteriae accounted for 17.3% and 7.7% of the isolates respectively throughout the period. Of 200 randomly selected S. sonnei isolates for extensive characterization, biotype g strains were predominant (95%) followed by biotype a (5%). Resistance to commonly used antibiotics including trimethoprim-sulfamethoxazole, nalidixic acid, ciprofloxacin, mecillinam and ampicillin was 89.5%, 86.5%, 17%, 10.5%, and 9.5%, respectively. All isolates were susceptible to ceftriaxone, cefotaxime, ceftazidime and imipenem. Ninety-eight percent of the strains had integrons belonging to class 1, 2 or both. The class 1 integron contained only dfrA5 gene, whereas among class 2 integron, 16% contained dhfrAI-sat1-aadA1-orfX gene cassettes and 84% harbored dhfrA1-sat2 gene cassettes. Plasmids of similar to 5, similar to 1.8 and similar to 1.4 MDa in size were found in 92% of the strains, whereas only 33% of the strains carried the 120 MDa plasmid. PFGE analysis showed that strains having different integron patterns belonged to different clusters. These results show a changing trend in the prevalence of Shigella species with the emergence of multidrug resistant S. sonnei. Although S. flexneri continues to be the predominant species albeit with reduced prevalence, S. sonnei has emerged as the second most prevalent species replacing the earlier dominance by S. boydii and S. dysenteriae in Bangladesh.	[Ud-Din, Abu I. M. S.; Wahid, Syeda U. H.; Latif, Hasan A.; Shahnaij, Mohammad; Akter, Mahmuda; Azmi, Ishrat J.; Hasan, Trisheeta N.; Ahmed, Dilruba; Hossain, Mohammad A.; Faruque, Abu S. G.; Faruque, Shah M.; Talukder, Kaisar A.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Talukder, KA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, GPO Box 128, Dhaka 1000, Bangladesh.	kaisar@icddrb.org	Shahnaij, Mohammad/GMX-3978-2022	Mohammad, Shahnaij/0000-0002-3693-7239; Faruque, Shah/0000-0002-7006-622X; Ahmed, Dilruba/0000-0001-8961-2406	icddr,b; Government of the People's Republic of Bangladesh; Australian Agency for International Development (AusAID); Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Government of the People's Republic of Bangladesh; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This study was funded by icddr,b and its donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh, Australian Agency for International Development (AusAID), Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr,b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; BENNISH ML, 1990, J INFECT DIS, V162, P711, DOI 10.1093/infdis/162.3.711; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Chiou CS, 2009, J CLIN MICROBIOL, V47, P1149, DOI 10.1128/JCM.01607-08; Church DL, 2004, CLIN LAB MED, V24, P559, DOI 10.1016/j.cll.2004.05.008; Clinical and Laboratory Standard Institute (CLSI), 2010, M100S20U CLSI; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; DeLappe N, 2003, J CLIN MICROBIOL, V41, P1919, DOI 10.1128/JCM.41.5.1919-1924.2003; Faruque ASG, 2008, J HEALTH POPUL NUTR, V26, P325; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Goh K, 2011, ARCH MICROBIOL, V193, P179, DOI 10.1007/s00203-010-0656-7; HAIDER K, 1989, EPIDEMIOL INFECT, V102, P421, DOI 10.1017/S0950268800030132; Hoe CH, 2005, J APPL MICROBIOL, V99, P133, DOI 10.1111/j.1365-2672.2005.02581.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; Izumiya H, 2009, J MED MICROBIOL, V58, P1486, DOI 10.1099/jmm.0.011809-0; Jin YH, 2010, J MICROBIOL, V48, P236, DOI 10.1007/s12275-010-9220-z; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Khatun F, 2011, EPIDEMIOL INFECT, V139, P446, DOI 10.1017/S0950268810001093; Koh XP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-122; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LIU PYF, 1995, J CLIN MICROBIOL, V33, P1779, DOI 10.1128/JCM.33.7.1779-1783.1995; Madiyarov RS, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-18; Mammina C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-117; McIver CJ, 2002, J CLIN MICROBIOL, V40, P1538, DOI 10.1128/JCM.40.4.1538-1540.2002; NASTASI A, 1993, EPIDEMIOL INFECT, V110, P23, DOI 10.1017/S0950268800050640; Niyogi SK, 2005, J MICROBIOL, V43, P133; Oh JY, 2003, J CLIN MICROBIOL, V41, P421, DOI 10.1128/JCM.41.1.421-423.2003; Putnam SD, 2004, CLIN MICROBIOL INFEC, V10, P804, DOI 10.1111/j.1469-0691.2004.00927.x; Ranjbar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-62; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rowe-Magnus DA, 2002, INT J MED MICROBIOL, V292, P115, DOI 10.1078/1438-4221-00197; Sabat A.J., 2013, EURO SURVEILL, V18; SAYEED S, 1992, J MED MICROBIOL, V37, P382, DOI 10.1099/00222615-37-6-382; Seol SY, 2006, J MED MICROBIOL, V55, P871, DOI 10.1099/jmm.0.46441-0; Shiferaw B, 2012, CLIN INFECT DIS, V54, pS458, DOI 10.1093/cid/cis230; Talukder KA, 2006, EPIDEMIOL INFECT, V134, P1249, DOI 10.1017/S0950268806006029; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2006, J MED MICROBIOL, V55, P1257, DOI 10.1099/jmm.0.46641-0; Talukder KA, 2012, FOODBORNE AND WATERBORNE BACTERIAL PATHOGENS: EPIDEMIOLOGY, EVOLUTION AND MOLECULAR BIOLOGY, P63; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08; WEISSMAN JB, 1975, LANCET, V1, P88; Wen X., 2012, AFR J MICROBIOL RES, V6, P6987; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; World Health Organization, 1987, MAN LAB INV AC ENT I, P9; Zafar A, 2009, INT J INFECT DIS, V13, P668, DOI 10.1016/j.ijid.2008.10.005	54	52	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82601	10.1371/journal.pone.0082601	http://dx.doi.org/10.1371/journal.pone.0082601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367527	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300043
J	Tecilazich, F; Dinh, T; Pradhan-Nabzdyk, L; Leal, E; Tellechea, A; Kafanas, A; Gnardellis, C; Magargee, ML; Dejam, A; Toxavidis, V; Tigges, JC; Carvalho, E; Lyons, TE; Veves, A				Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Gnardellis, Charalambos; Magargee, Mary L.; Dejam, Andre; Toxavidis, Vasilis; Tigges, John C.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis			Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers	PLOS ONE			English	Article							BONE-MARROW; MOBILIZATION; ISCHEMIA; EXPRESSION; MARKER; NUMBER; BLOOD	Background: To evaluate changes in endothelial progenitor cells (EPCs) and cytokines in patients with diabetic foot ulceration (DFU) in association with wound healing. Methods: We studied healthy subjects, diabetic patients not at risk of DFU, at risk of DFU and with active DFU. We prospectively followed the DFU patients over a 12-week period. We also investigated similar changes in diabetic rabbit and mouse models of wound healing. Results: All EPC phenotypes except the kinase insert domain receptor (KDR)(+)CD133(+) were reduced in the at risk and the DFU groups compared to the controls. There were no major EPC differences between the control and not at risk group, and between the at risk and DFU groups. Serum stromal-cell derived factor-1 (SDF-1) and stem cell factor (SCF) were increased in DFU patients. DFU patients who healed their ulcers had lower CD34(+)KDR(+) count at visits 3 and 4, serum c-reactive protein (CRP) and granulocyte-macrophage colony-stimulating factor (GM-CSF) at visit 1, interleukin-1 (IL-1) at visits 1 and 4. EPCs tended to be higher in both diabetic animal models when compared to their non-diabetic counterparts both before and ten days after wounding. Conclusions: Uncomplicated diabetes does not affect EPCs. EPCs are reduced in patients at risk or with DFU while complete wound healing is associated with CD34(+)KDR(+) reduction, suggesting possible increased homing. Low baseline CRP, IL-1 alpha and GM-CSF serum levels were associated with complete wound healing and may potentially serve as prognostic markers of DFU healing. No animal model alone is representative of the human condition, indicating the need for multiple experimental models.	[Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Magargee, Mary L.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Microcirculat Lab, Boston, MA 02215 USA; [Tecilazich, Francesco; Thanh Dinh; Pradhan-Nabzdyk, Leena; Leal, Ermelindo; Tellechea, Ana; Kafanas, Antonios; Magargee, Mary L.; Carvalho, Eugenia; Lyons, Thomas E.; Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Joslin Beth Israel Deaconess Foot Ctr, Boston, MA 02215 USA; [Tellechea, Ana] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gnardellis, Charalambos] Technol Educ Inst Messolonghi, Mesolongion, Greece; [Dejam, Andre] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, Boston, MA 02215 USA; [Toxavidis, Vasilis; Tigges, John C.] Beth Israel Deaconess Med Ctr, Flow Cytometry Core Facil, Boston, MA 02215 USA; [Toxavidis, Vasilis; Tigges, John C.] Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Joslin Diabetes Center, Inc.; Universidade de Coimbra; Western Greece University of Applied Sciences (TEI of Western Greece); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Veves, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Microcirculat Lab, Boston, MA 02215 USA.	aveves@bidmc.harvard.edu	Carvalho, Eugenia/AAV-6868-2021; Tellechea, Ana/O-8325-2019; Leal, Ermelindo/G-3051-2010	Carvalho, Eugenia/0000-0001-6264-3632; Tellechea, Ana/0000-0001-9387-7706; Leal, Ermelindo/0000-0003-1748-9861; GNARDELLIS, CHARALAMPOS/0000-0001-8862-7868	National Institutes of Health [R01-DK076937, R21-DK082987, R01 NS066205]; FCT [SFRH/BPD/46341/2008, SFRH/BD/48624/2008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082987, R01DK076937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-DK076937, R21-DK082987 and R01 NS066205 to AV, as well as FCT fellowships SFRH/BPD/46341/2008 (EL) and SFRH/BD/48624/2008 (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero M, 2011, DIABETOLOGIA, V54, P945, DOI 10.1007/s00125-010-2007-2; Association A.D., 1999, DIABETES CARE, V22, P1354, DOI DOI 10.2337/DIACARE.22.8.1354; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; Bermudez DM, 2011, J VASC SURG, V53, P774, DOI 10.1016/j.jvs.2010.10.056; Bertolini F, 2009, BBA-REV CANCER, V1796, P27, DOI 10.1016/j.bbcan.2009.04.003; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Flammer AJ, 2012, J CLIN ENDOCR METAB, V97, P4761, DOI 10.1210/jc.2012-2642; GAHRING LC, 1985, J CLIN INVEST, V76, P1585, DOI 10.1172/JCI112141; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Greenman RL, 2005, LANCET, V366, P1711, DOI 10.1016/S0140-6736(05)67696-9; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang PP, 2005, DIABETES CARE, V28, P2155, DOI 10.2337/diacare.28.9.2155; Khaodhiar L, 2007, DIABETES CARE, V30, P903, DOI 10.2337/dc06-2209; Liao YF, 2010, VASC MED, V15, P279, DOI 10.1177/1358863X10367537; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pradhan L, 2011, J SURG RES, V167, P336, DOI 10.1016/j.jss.2009.09.012; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Saito H, 2012, AM J PHYSIOL-CELL PH, V302, pC892, DOI 10.1152/ajpcell.00380.2011; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Dinh T, 2012, DIABETES, V61, P2937, DOI 10.2337/db12-0227; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; van Ark J, 2012, DIABETOLOGIA, V55, P2501, DOI 10.1007/s00125-012-2590-5; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zerbini G, 2012, DIABETES, V61, P908, DOI 10.2337/db11-1197	37	49	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83314	10.1371/journal.pone.0083314	http://dx.doi.org/10.1371/journal.pone.0083314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358275	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700118
J	Pang, SS; Nguyen, STS; Perry, AJ; Day, CJ; Panjikar, S; Tiralongo, J; Whisstock, JC; Kwok, T				Pang, Siew Siew; Stanley Thai Son Nguyen; Perry, Andrew J.; Day, Christopher J.; Panjikar, Santosh; Tiralongo, Joe; Whisstock, James C.; Kwok, Terry			The Three-dimensional Structure of the Extracellular Adhesion Domain of the Sialic Acid-binding Adhesin SabA from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Carbohydrate Binding Protein; Helicobacter pylori; Membrane Proteins; X-ray Crystallography; Outer Membrane Protein	DIFFRACTION DATA; REPLACEMENT; INSIGHTS	Background:Helicobacter pylori SabA outer membrane protein is crucial for the bacteria to adhere to host stomach surface during chronic infection. Results: The structure of the extracellular SabA adhesion region is determined by x-ray crystallography. Conclusion: SabA adhesion structure may provide insight into binding sites important for ligand receptor interactions. Significance: SabA is the first reported extracellular domain structure of the H. pylori outer membrane protein family. The gastric pathogen Helicobacter pylori is a major cause of acute chronic gastritis and the development of stomach and duodenal ulcers. Chronic infection furthermore predisposes to the development of gastric cancer. Crucial to H. pylori survival within the hostile environment of the digestive system are the adhesins SabA and BabA; these molecules belong to the same protein family and permit the bacteria to bind tightly to sugar moieties Lewis(B) and sialyl-Lewis(X), respectively, on the surface of epithelial cells lining the stomach and duodenum. To date, no representative SabA/BabA structure has been determined, hampering the development of strategies to eliminate persistent H. pylori infections that fail to respond to conventional therapy. Here, using x-ray crystallography, we show that the soluble extracellular adhesin domain of SabA shares distant similarity to the tetratricopeptide repeat fold family. The molecule broadly resembles a golf putter in shape, with the head region featuring a large cavity surrounded by loops that vary in sequence between different H. pylori strains. The N-terminal and C-terminal helices protrude at right angles from the head domain and together form a shaft that connects to a predicted outer membrane protein-like -barrel trans-membrane domain. Using surface plasmon resonance, we were able to detect binding of the SabA adhesin domain to sialyl-Lewis(X) and Lewis(X) but not to Lewis(A), Lewis(B), or Lewis(Y). Substitution of the highly conserved glutamine residue 159 in the predicted ligand-binding pocket abrogates the binding of the SabA adhesin domain to sialyl-Lewis(X) and Lewis(X). Taken together, these data suggest that the adhesin domain of SabA is sufficient in isolation for specific ligand binding.	[Pang, Siew Siew; Stanley Thai Son Nguyen; Perry, Andrew J.; Panjikar, Santosh; Whisstock, James C.; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Stanley Thai Son Nguyen; Whisstock, James C.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Melbourne, Vic 3800, Australia; [Kwok, Terry] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Day, Christopher J.; Tiralongo, Joe] Griffith Univ, Inst Glyc, Brisbane, Qld 4222, Australia; [Panjikar, Santosh] Australian Synchrotron, Melbourne, Vic 3168, Australia	Monash University; Monash University; Monash University; Griffith University	Whisstock, JC (corresponding author), Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia.	james.whisstock@monash.edu; terry.kwok@monash.edu	Perry, Andrew/E-5607-2010; Panjikar, Santosh/D-2709-2012	Perry, Andrew/0000-0001-9256-6068; Panjikar, Santosh/0000-0001-7429-3879; Whisstock, James/0000-0003-4200-5611; Tiralongo, Joe/0000-0002-3529-6310; Day, Christopher/0000-0001-7953-4408; Kwok, Terry/0000-0002-5905-3233				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Aspholm M, 2006, METHOD ENZYMOL, V417, P293, DOI 10.1016/S0076-6879(06)17020-2; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Huergo LF, 2013, J BACTERIOL, V195, P1970, DOI 10.1128/JB.00059-13; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kuipers EJ, 2005, HELICOBACTER, V10, P66, DOI 10.1111/j.1523-5378.2005.00336.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheu BS, 2003, GUT, V52, P927, DOI 10.1136/gut.52.7.927; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Unemo M, 2005, J BIOL CHEM, V280, P15390, DOI 10.1074/jbc.M412725200; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599	30	36	38	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6332	6340		10.1074/jbc.M113.513135	http://dx.doi.org/10.1074/jbc.M113.513135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24375407	Green Published, hybrid			2022-12-25	WOS:000332389400002
J	Kabeya, Y; Goto, A; Kato, M; Takahashi, Y; Matsushita, Y; Inoue, M; Mizoue, T; Tsugane, S; Kadowaki, T; Noda, M				Kabeya, Yusuke; Goto, Atsushi; Kato, Masayuki; Takahashi, Yoshihiko; Matsushita, Yumi; Inoue, Manami; Mizoue, Tetsuya; Tsugane, Shoichiro; Kadowaki, Takashi; Noda, Mitsuhiko			History of Having a Macrosomic Infant and the Risk of Diabetes: The Japan Public Health Center-Based Prospective Diabetes Study	PLOS ONE			English	Article							PREGNANCY OUTCOMES; WOMEN; HYPERGLYCEMIA; ALCOHOL; IMPACT	Objective: The aim of the present study was to test a hypothesis that a history of having a macrosomic infant (>= 4000g) is associated with the risk of diabetes. Methods: Data on the Japan Public Health Center-based Prospective diabetes cohort were analyzed, which is a population-based cohort study on diabetes. The survey of diabetes was performed at baseline and at the 5-year follow-up. A history of having a macrosomic infant was assessed using a self-administered questionnaire. A cross-sectional analysis was performed among 12,153 women who participated in the 5-year survey of the cohort. Logistic regression was used to examine the relationship between a history of having a macrosomic infant and the presence of diabetes. A longitudinal analysis was also conducted among 7,300 women without diabetes who participated in the baseline survey. Logistic regression was used to investigate the relationship between a history of having a macrosomic infant and the incidence of diabetes between the baseline survey and the 5-year survey. Results: In the cross-sectional analysis, parous women with a positive history were more likely to have diabetes in relation to parous women without (OR = 1.44, 95% CI = 1.13-1.83). The longitudinal analysis showed a modest but non-significant increased risk of developing diabetes among women with a positive history (OR = 1.24, 95% CI = 0.80-1.94). Conclusions: An increased risk of diabetes was implied among women with a history of having a macrosomic infant although the longitudinal analysis showed a non-significant increased risk.	[Kabeya, Yusuke; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Kabeya, Yusuke] Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Kato, Masayuki; Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res Coordinat, Tokyo, Japan; [Takahashi, Yoshihiko] Iwate Med Univ, Sch Med, Div Diabet & Metab, Morioka, Iwate 020, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Tokyo Saiseikai Central Hospital; National Center for Global Health & Medicine - Japan; Iwate Medical University; National Cancer Center - Japan; University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015	Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; Goto, Atsushi/0000-0003-0669-654X	Health Sciences Research Grants [H10-074]; Medical Frontier Strategy Research [H13-008]; Clinical Research for Evidence-based Medicine [H14-008, H15-006]; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H16-019, H17-019, H18-028, H19-016, H25-016]; Ministry of Health, Labour and Welfare of Japan	Health Sciences Research Grants; Medical Frontier Strategy Research; Clinical Research for Evidence-based Medicine; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Health Sciences Research Grants (Research on Health Services H10-074, Medical Frontier Strategy Research H13-008, Clinical Research for Evidence-based Medicine H14-008 and H15-006, and Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H16-019, H17-019, H18-028, H19-016, and H25-016) and a grant-in-aid for Cancer Research and a grant-in-aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; Jensen DM, 2001, AM J OBSTET GYNECOL, V185, P413, DOI 10.1067/mob.2001.115864; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Makino S, 1985, Nihon Eiseigaku Zasshi, V40, P756; Mariscal M, 2006, ANN EPIDEMIOL, V16, P432, DOI 10.1016/j.annepidem.2005.07.058; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Ministry of Internal Affairs and Communications, 2006, KOR SHAK HAK; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Vambergue A, 2000, DIABETIC MED, V17, P203, DOI 10.1046/j.1464-5491.2000.00237.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Yang XL, 2002, DIABETES CARE, V25, P1619, DOI 10.2337/diacare.25.9.1619	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84542	10.1371/journal.pone.0084542	http://dx.doi.org/10.1371/journal.pone.0084542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367673	gold, Green Submitted, Green Published			2022-12-25	WOS:000328741900053
J	Li, G; Qiu, YZ; Su, ZW; Ren, SL; Liu, C; Tian, YQ; Liu, Y				Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong			Genome-Wide Analyses of Radioresistance-Associated miRNA Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing	PLOS ONE			English	Article							BREAST-CANCER CELLS; RADIATION-THERAPY; MICRORNA GENES; LUNG-CANCER; INVASION; MIGRATION; IDENTIFICATION; APOPTOSIS; MIR-375; PREDICTION	Background: Rapidly growing evidence suggests that microRNAs (miRNAs) are involved in a wide range of cancer malignant behaviours including radioresistance. Therefore, the present study was designed to investigate miRNA expression patterns associated with radioresistance in NPC. Methods: The differential expression profiles of miRNAs and mRNAs associated with NPC radioresistance were constructed. The predicted target mRNAs of miRNAs and their enriched signaling pathways were analyzed via biological informatical algorithms. Finally, partial miRNAs and pathways-correlated target mRNAs were validated in two NPC radioreisitant cell models. Results: 50 known and 9 novel miRNAs with significant difference were identified, and their target mRNAs were narrowed down to 53 nasopharyngeal-/NPC-specific mRNAs. Subsequent KEGG analyses demonstrated that the 53 mRNAs were enriched in 37 signaling pathways. Further qRT-PCR assays confirmed 3 down-regulated miRNAs (miR-324-3p, miR-93-3p and miR-4501), 3 up-regulated miRNAs (miR-371a-5p, miR-34c-5p and miR-1323) and 2 novel miRNAs. Additionally, corresponding alterations of pathways-correlated target mRNAs were observed including 5 up-regulated mRNAs (ICAM1, WNT2B, MYC, HLA-F and TGF-beta 1) and 3 down-regulated mRNAs (CDH1, PTENP1 and HSP90AA1). Conclusions: Our study provides an overview of miRNA expression profile and the interactions between miRNA and their target mRNAs, which will deepen our understanding of the important roles of miRNAs in NPC radioresistance.	[Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Li, Guo; Qiu, Yuanzheng; Su, Zhongwu; Ren, Shuling; Liu, Chao; Tian, Yongquan; Liu, Yong] Otolaryngol Major Dis Res Key Lab Hunan Prov, Changsha, Hunan, Peoples R China	Central South University	Liu, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	braver19840112@hotmail.com		Liu, Chao/0000-0003-2184-9102	National Natural Science Foundation of China [81202128, 81272974]; Research Fund for the Doctoral Program of Higher Education of China [20120162120049]; Freedom Explore Program of Central South University [2012QNZT099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Freedom Explore Program of Central South University	Grants were provided by the National Natural Science Foundation of China (No. 81202128 and No. 81272974), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120162120049), and the Freedom Explore Program of Central South University (No. 2012QNZT099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Cai KM, 2010, INT J MOL MED, V25, P565, DOI 10.3892/ijmm_00000378; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; CHATANI M, 1986, CANCER, V57, P2267, DOI 10.1002/1097-0142(19860615)57:12<2267::AID-CNCR2820571205>3.0.CO;2-C; Cheng Jin-Jian, 2006, Ai Zheng, V25, P45; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2012, INT J ONCOL, V40, P85, DOI 10.3892/ijo.2011.1172; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Henness S, 2002, INT J RADIAT ONCOL, V54, P895, DOI 10.1016/S0360-3016(02)03037-7; Ho CM, 2011, HEPATOLOGY, V54, P1105, DOI 10.1002/hep.24521; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee HC, 2004, INT J MOL MED, V13, P883; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Guo, 2013, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V48, P662; Li G, 2013, EUR J CANCER, V49, P2596, DOI 10.1016/j.ejca.2013.03.001; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Liang ZX, 2013, PHARM RES-DORDR, V30, P1008, DOI 10.1007/s11095-012-0936-9; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Luo Zhaohui, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P604, DOI 10.3969/j.issn.1672-7347.2011.07.004; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Ng EKO, 2009, J ONCOL, V2009, DOI 10.1155/2009/305420; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roses RE, 2008, ONCOGENE, V27, P200, DOI 10.1038/sj.onc.1210909; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Virsik-Kopp P, 2005, RADIAT RES, V164, P148, DOI 10.1667/RR3396.1; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang H, 2012, ONCOGENE, DOI [10.1038/onc.2012.574, DOI 10.1038/0NC.2012.574.PUBMED:23222716]; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	57	59	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84486	10.1371/journal.pone.0084486	http://dx.doi.org/10.1371/journal.pone.0084486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367666	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900050
J	Brainard, RE; Watson, LJ; DeMartino, AM; Brittian, KR; Readnower, RD; Boakye, AA; Zhang, DQ; Hoetker, JD; Bhatnagar, A; Baba, SP; Jones, SP				Brainard, Robert E.; Watson, Lewis J.; DeMartino, Angelica M.; Brittian, Kenneth R.; Readnower, Ryan D.; Boakye, Adjoa Agyemang; Zhang, Deqing; Hoetker, Joseph David; Bhatnagar, Aruni; Baba, Shahid Pervez; Jones, Steven P.			High Fat Feeding in Mice Is Insufficient to Induce Cardiac Dysfunction and Does Not Exacerbate Heart Failure	PLOS ONE			English	Article							MYOCARDIAL REPERFUSION INJURY; GENE; DIET; CARBOHYDRATE; HYPERTROPHY; INHIBITION; EXPRESSION; MORTALITY	Preclinical studies of animals with risk factors, and how those risk factors contribute to the development of cardiovascular disease and cardiac dysfunction, are clearly needed. One such approach is to feed mice a diet rich in fat (i.e. 60%). Here, we determined whether a high fat diet was sufficient to induce cardiac dysfunction in mice. We subjected mice to two different high fat diets (lard or milk as fat source) and followed them for over six months and found no significant decrement in cardiac function (via echocardiography), despite robust adiposity and impaired glucose disposal. We next determined whether antecedent and concomitant exposure to high fat diet (lard) altered the murine heart's response to infarct-induced heart failure; high fat feeding during, or before and during, heart failure did not significantly exacerbate cardiac dysfunction. Given the lack of a robust effect on cardiac dysfunction with high fat feeding, we then examined a commonly used mouse model of overt diabetes, hyperglycemia, and obesity (db/db mice). db/db mice (or STZ treated wild-type mice) subjected to pressure overload exhibited no significant exacerbation of cardiac dysfunction; however, ischemia-reperfusion injury significantly depressed cardiac function in db/db mice compared to their non-diabetic littermates. Thus, we were able to document a negative influence of a risk factor in a relevant cardiovascular disease model; however, this did not involve exposure to a high fat diet. High fat diet, obesity, or hyperglycemia does not necessarily induce cardiac dysfunction in mice. Although many investigators use such diabetes/obesity models to understand cardiac defects related to risk factors, this study, along with those from several other groups, serves as a cautionary note regarding the use of murine models of diabetes and obesity in the context of heart failure.	[Brainard, Robert E.; Watson, Lewis J.; DeMartino, Angelica M.; Brittian, Kenneth R.; Readnower, Ryan D.; Boakye, Adjoa Agyemang; Zhang, Deqing; Hoetker, Joseph David; Bhatnagar, Aruni; Baba, Shahid Pervez; Jones, Steven P.] Univ Louisville, Dept Med, Dept Physiol & Biophys, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	Jones, SP (corresponding author), Univ Louisville, Dept Med, Dept Physiol & Biophys, Inst Mol Cardiol, Louisville, KY 40292 USA.	Steven.P.Jones@Louisville.edu	Watson, Lewis J/F-3688-2011; Jones, Steven P./D-5092-2009	Watson, Lewis J/0000-0002-8273-7676; Jones, Steven P./0000-0001-5376-8089	NIH [R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094419, R01HL055477, P01HL078825, R01HL083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825). REB was an American Heart Association Predoctoral Fellow, Great Rivers Affiliate. LJW was an American Heart Association Predoctoral Fellow, Great Rivers Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Chess DJ, 2008, J CARD FAIL, V14, P82, DOI 10.1016/j.cardfail.2007.09.004; Chess DJ, 2007, AM J PHYSIOL-HEART C, V293, pH1853, DOI 10.1152/ajpheart.00544.2007; Chess DJ, 2009, AM J PHYSIOL-HEART C, V297, pH1585, DOI 10.1152/ajpheart.00599.2009; Christopher BA, 2010, AM J PHYSIOL-HEART C, V299, pH1917, DOI 10.1152/ajpheart.00687.2010; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Greer JJM, 2006, AM J PHYSIOL-HEART C, V291, pH2743, DOI 10.1152/ajpheart.00347.2006; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Jones S., 1999, AM J PHYSIOL, V46, P763; Jones SP, 2000, CORONARY ARTERY DIS, V11, P593, DOI 10.1097/00019501-200012000-00004; Jones SP, 2001, ACTA PHYSIOL SCAND, V173, P139, DOI 10.1046/j.1365-201X.2001.00899.x; Jones SP, 2005, AM J PHYSIOL-HEART C, V288, pH365, DOI 10.1152/ajpheart.00245.2004; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Jones SP, 2003, AM J PHYSIOL-HEART C, V284, pH277, DOI 10.1152/ajpheart.00236.2002; Jones SP, 2001, CORONARY ARTERY DIS, V12, P37, DOI 10.1097/00019501-200102000-00006; Jones SP, 2000, NEWS PHYSIOL SCI, V15, P303; Jones SP, 2000, AM J PHYSIOL-HEART C, V279, pH2196; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Khairallah RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034402; Krentz AJ, 1996, DIABETIC MED, V13, P30, DOI 10.1002/(SICI)1096-9136(199601)13:1<30::AID-DIA5>3.0.CO;2-I; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lopaschuk GD, 2008, CARDIOVASC RES, V79, P205, DOI 10.1093/cvr/cvn134; Morgan EE, 2006, EUR J HEART FAIL, V8, P687, DOI 10.1016/j.ejheart.2006.01.005; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Ogden CL, 2009, PREVALENCE OBESITY U; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Rennison JH, 2009, J MOL CELL CARDIOL, V46, P883, DOI 10.1016/j.yjmcc.2009.02.019; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sharma N, 2008, J HYPERTENS, V26, P1402, DOI 10.1097/HJH.0b013e3283007dda; Sharma N, 2007, AM J HYPERTENS, V20, P403, DOI 10.1016/j.amjhyper.2006.09.022; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; Wang XY, 2009, AM J PHYSIOL-CELL PH, V297, pC1490, DOI 10.1152/ajpcell.00049.2009; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107	38	62	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83174	10.1371/journal.pone.0083174	http://dx.doi.org/10.1371/journal.pone.0083174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367585	Green Published, gold			2022-12-25	WOS:000328740300096
J	Ghosal, R; Ganswindt, A; Seshagiri, PB; Sukumar, R				Ghosal, Ratna; Ganswindt, Andre; Seshagiri, Polani B.; Sukumar, Raman			Endocrine Correlates of Musth in Free-Ranging Asian Elephants (Elephas maximus) Determined by Non-Invasive Faecal Steroid Hormone Metabolite Measurements	PLOS ONE			English	Article							MALE AFRICAN ELEPHANTS; LOXODONTA-AFRICANA; CORTISOL METABOLITES; TESTOSTERONE; BEHAVIOR; SIGNALS; STATE; CYCLE	The occurrence of musth, a period of elevated levels of androgens and heightened sexual activity, has been well documented for the male Asian elephant (Elephas maximus). However, the relationship between androgen-dependent musth and adrenocortical function in this species is unclear. The current study is the first assessment of testicular and adrenocortical function in free-ranging male Asian elephants by measuring levels of testosterone (androgen) and cortisol (glucocorticoid - a physiological indicator of stress) metabolites in faeces. During musth, males expectedly showed significant elevation in faecal testosterone metabolite levels. Interestingly, glucocorticoid metabolite concentrations remained unchanged between musth and non-musth periods. This observation is contrary to that observed with wild and captive African elephant bulls and captive Asian bull elephants. Our results show that musth may not necessarily represent a stressful condition in free-ranging male Asian elephants.	[Ghosal, Ratna; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Ganswindt, Andre] Univ Pretoria, Fac Vet Sci, Endocrine Res Lab, Dept Anat & Physiol, ZA-0110 Onderstepoort, South Africa; [Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Seshagiri, Polani B.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; University of Pretoria; University of Pretoria; Indian Institute of Science (IISC) - Bangalore	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	GHOSAL, RATNA/AAB-9470-2020; Raman, Sukumar/C-9809-2013; Ganswindt, Andre/G-9856-2014	Ganswindt, Andre/0000-0002-1474-7602; Ghosal, RATNA/0000-0002-2295-453X	The Rufford Small Grants Foundation, London, U.K. [8350-1]	The Rufford Small Grants Foundation, London, U.K.	The Rufford Small Grants Foundation, London, U.K. Grant # 8350-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Chelliah K, 2013, ANIM BEHAV, V86, P1207, DOI 10.1016/j.anbehav.2013.09.022; Fanson KV, 2013, EUR J WILDLIFE RES, V59, P655, DOI 10.1007/s10344-013-0718-7; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Fowler M, 2006, BIOL MED SURG ELEPHA; Ganswindt A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P505, DOI 10.1086/430237; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Ghosal R, 2010, THERIOGENOLOGY, V73, P1051, DOI 10.1016/j.theriogenology.2010.01.004; GHOSH R, 2005, GODS CHAINS; HALLMARTIN AJ, 1987, S AFR J SCI, V83, P616; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; JAINUDEEN M R, 1972, Mammalia, V36, P247, DOI 10.1515/mamm.1972.36.2.247; JAINUDEEN MR, 1972, J REPROD FERTIL, V29, P99, DOI 10.1530/jrf.0.0290099; Kenagy GJ, 1999, GEN COMP ENDOCR, V115, P236, DOI 10.1006/gcen.1999.7307; Kushwaha S.P.S., 2008, MAPPING KAZIRANGA CO; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; MULLER A, 2008, THESIS HUMBOLDT U BE; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Patton ML, 1999, ZOO BIOL, V18, P111, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;111::AID-ZOO3&gt;3.0.CO;2-0; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Rasmussen HB, 2008, HORM BEHAV, V54, P539, DOI 10.1016/j.yhbeh.2008.05.008; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; Rasmussen LEL, 1996, J MAMMAL, V77, P422, DOI 10.2307/1382819; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Schwarzenberger F, 1998, ANIM REPROD SCI, V53, P173, DOI 10.1016/S0378-4320(98)00112-2; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sukumar R., 2011, STORY ASIAS ELEPHANT; Viljoen Jozua J., 2008, Koedoe, V50, P18; Yon L, 2008, GEN COMP ENDOCR, V155, P109, DOI 10.1016/j.ygcen.2007.03.006	37	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84787	10.1371/journal.pone.0084787	http://dx.doi.org/10.1371/journal.pone.0084787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358371	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000328737700105
J	Pasini, AF; Stranieri, C; Pasini, A; Vallerio, P; Mozzini, C; Solani, E; Cominacini, M; Cominacini, L; Garbin, U				Pasini, Anna Fratta; Stranieri, Chiara; Pasini, Andrea; Vallerio, Paola; Mozzini, Chiara; Solani, Erika; Cominacini, Mattia; Cominacini, Luciano; Garbin, Ulisse			Lysophosphatidylcholine and Carotid Intima-Media Thickness in Young Smokers: A Role for Oxidized LDL-Induced Expression of PBMC Lipoprotein-Associated Phospholipase A2?	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; RISK-FACTOR; ATHEROSCLEROSIS; A(2); PROTEOGLYCANS; CORONARY; PATHOPHYSIOLOGY; EPIDEMIOLOGY	Background: Although cigarette smoking has been associated with carotid intima-media thickness (CIMT) the mechanisms are yet not completely known. Lysophosphatidylcholine (lysoPC), a main product of lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, appears to be a major determinant of the pro-atherogenic properties of oxidized LDL (oxLDL) and to induce proteoglycan synthesis, a main player in intimal thickening. In this study we assessed whether cigarette smoking-induced oxidative stress may influence plasma Lp-PLA2 and lysoPC and Lp-PLA2 expression in peripheral blood mononuclear cells (PBMC), as well as the relationship between lysoPC and CIMT. Methods/Results: 45 healthy smokers and 45 age and sex-matched subjects participated in this study. Smokers, compared to non-smokers, showed increased plasma concentrations of oxLDL, Lp-PLA2 and lysoPC together with up-regulation of Lp-PLA2 (mRNA and protein) expression in PBMC (P<0.001). Plasma Lp-PLA2 positively correlated with both lysoPC (r=0.639, P<0.001) and PBMC mRNA Lp-PLA2 (r=0.484, P<0.001) in all subjects. Moreover CIMT that was higher in smokers (P<0.001), positively correlated with lysoPC (r=0.55, P<0.001). Then in in vitro study we demonstrated that both oxLDL (at concentrations similar to those found in smoker's serum) and oxidized phospholipids contained in oxLDL, were able to up-regulate mRNA Lp-PLA2 in PBMC. This effect was likely due, at least in part, to the enrichment in oxidized phospholipids found in PBMC after exposure to oxLDL. Our results also showed that in human aortic smooth muscle cells lysoPC, at concentrations similar to those found in smokers, increased the expression of biglycan and versican, two main proteoglycans. Conclusions: In smokers a further effect of raised oxidative stress is the up-regulation of Lp-PLA2 expression in PBMC with subsequent increase of plasma Lp-PLA2 and lysoPC. Moreover the correlation between lysoPC and CIMT together with the finding that lysoPC up-regulates proteoglycan synthesis suggests that lysoPC may be a link between smoking and intimal thickening.	[Pasini, Anna Fratta; Stranieri, Chiara; Pasini, Andrea; Vallerio, Paola; Mozzini, Chiara; Solani, Erika; Cominacini, Mattia; Cominacini, Luciano; Garbin, Ulisse] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy	University of Verona	Pasini, AF (corresponding author), Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy.	anna.frattapasini@univr.it	Vallerio, Paola/AAC-4874-2022; mozzini, chiara/AAW-3028-2021; Stranieri, Chiara/GWV-1749-2022; cominacini, luciano/B-2775-2011		Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Fondazione Cariverona, Verona, Italy; by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Bianchini E, 2010, J ULTRAS MED, V29, P1169, DOI 10.7863/jum.2010.29.8.1169; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Chang MY, 2003, ARTERIOSCL THROM VAS, V23, P809, DOI 10.1161/01.ATV.0000069208.20268.D0; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Epps KC, 2011, J INTERN MED, V269, P94, DOI 10.1111/j.1365-2796.2010.02297.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fratta Pasini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030291; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Johnson Heather M, 2010, Prev Cardiol, V13, P166, DOI 10.1111/j.1751-7141.2010.00068.x; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kiortsis DN, 2005, ANGIOLOGY, V56, P451, DOI 10.1177/000331970505600413; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Nakashima Y, 2002, VIRCHOWS ARCH, V441, P279, DOI 10.1007/s00428-002-0605-1; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Paik JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029675; Persson M, 2007, ATHEROSCLEROSIS, V190, P388, DOI 10.1016/j.atherosclerosis.2006.02.016; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Tao Z, 1997, ATHEROSCLEROSIS, V135, P171, DOI 10.1016/S0021-9150(97)00158-5; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Tselepis AD, 2009, ATHEROSCLEROSIS, V206, P303, DOI 10.1016/j.atherosclerosis.2009.02.016; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WIGHT TN, 1996, ATHEROSCLEROSIS CORO, P421; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83092	10.1371/journal.pone.0083092	http://dx.doi.org/10.1371/journal.pone.0083092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358251	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700047
J	Xie, Y; Niu, LL; Zhao, B; Wang, Q; Nong, X; Chen, L; Zhou, X; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Xie, Yue; Niu, Lili; Zhao, Bo; Wang, Qiang; Nong, Xiang; Chen, Lin; Zhou, Xuan; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Complete Mitochondrial Genomes of Chimpanzee- and Gibbon-Derived Ascaris Isolated from a Zoological Garden in Southwest China	PLOS ONE			English	Article							COMPLETE SEQUENCE; CAENORHABDITIS-ELEGANS; PHYLOGENETIC ANALYSIS; INTESTINAL PARASITES; POPULATION-GENETICS; ANIMAL HEALTH; CODON USAGE; NEMATODES; DNA; EVOLUTION	Roundworms (Ascaridida: Nematoda), one of the most common soil-transmitted helminths (STHs), can cause ascariasis in various hosts worldwide, ranging from wild to domestic animals and humans. Despite the veterinary and health importance of the Ascaridida species, little or no attention has been paid to roundworms infecting wild animals including non-human primates due to the current taxon sampling and survey bias in this order. Importantly, there has been considerable controversy over the years as to whether Ascaris species infecting non-human primates are the same as or distinct from Ascaris lumbricoides infecting humans. Herein, we first characterized the complete mitochondrial genomes of two representative Ascaris isolates derived from two non-human primates, namely, chimpanzees (Pan troglodytes) and gibbons (Hylobates hoolock), in a zoological garden of southwest China and compared them with those of A. lumbricoides and the congeneric Ascaris suum as well as other related species in the same order, and then used comparative mitogenomics, genome-wide nucleotide sequence identity analysis, and phylogeny to determine whether the parasites from chimpanzees and gibbons represent a single species and share genetic similarity with A. lumbricoides. Taken together, our results yielded strong statistical support for the hypothesis that the chimpanzee-and gibbon-derived Ascaris represent a single species that is genetically similar to A. lumbricoides, consistent with the results of previous morphological and molecular studies. Our finding should enhance public alertness to roundworms originating from chimpanzees and gibbons and the mtDNA data presented here also serves to enrich the resource of markers that can be used in molecular diagnostic, systematic, population genetic, and evolutionary biological studies of parasitic nematodes from either wild or domestic hosts.	[Xie, Yue; Nong, Xiang; Chen, Lin; Zhou, Xuan; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Sichuan, Peoples R China; [Niu, Lili; Zhao, Bo; Wang, Qiang] Vet Hosp, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Sichuan, Peoples R China.	guangyou1963@aliyun.com	zhou, xuan/GZA-8157-2022		Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0848]; Research Fund for the Chengdu Research of Giant Panda Breeding [CPF2012-13]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Research Fund for the Chengdu Research of Giant Panda Breeding	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (Grant no. IRT0848) and the Research Fund for the Chengdu Research of Giant Panda Breeding (Project no. CPF2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2003, ZOONOSES COMMUNICABL, P285; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chowdhury N., 2001, HELMINTHS WILDLIFE; Dangoudoubiyam S, 2009, J PARASITOL, V95, P571, DOI 10.1645/GE-1905.1; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gasser RB, 2000, INT J PARASITOL, V30, P509, DOI 10.1016/S0020-7519(00)00021-7; Gasser RB, 2012, INFECT GENET EVOL, V12, P1884, DOI 10.1016/j.meegid.2012.07.022; Gatcombe RR, 2010, PARASITOL RES, V106, P499, DOI 10.1007/s00436-009-1692-6; Ghikas DV, 2006, ARCH MICROBIOL, V185, P393, DOI 10.1007/s00203-006-0104-x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hartwich G., 1974, CIH Keys Nematode Parasites Vert, VNo. 2,1974, P1; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Hu M, 2004, ADV PARASIT, V56, P133, DOI 10.1016/S0065-308X(03)56003-1; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jeon HK, 2005, PARASITOLOGY, V130, P717, DOI 10.1017/S0031182004007164; Jex AR, 2010, BIOTECHNOL ADV, V28, P151, DOI 10.1016/j.biotechadv.2009.11.002; Jex AR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000273; Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79; Jia WanZhong, 2011, Scientia Agricultura Sinica, V44, P1255; Kalema-Zikusoka G, 2005, PRIMATES, V46, P59, DOI 10.1007/s10329-004-0103-y; Kim KH, 2006, INT J PARASITOL, V36, P319, DOI 10.1016/j.ijpara.2005.10.004; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Li Y, 2012, PARASITOLOGY, V139, P1329, DOI 10.1017/S003118201200056X; Lin RQ, 2012, EXP PARASITOL, V130, P135, DOI 10.1016/j.exppara.2011.11.003; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nejsum P, 2006, VET PARASITOL, V139, P203, DOI 10.1016/j.vetpar.2006.02.025; Nejsum P, 2010, VET PARASITOL, V171, P273, DOI 10.1016/j.vetpar.2010.03.030; [牛李丽 Niu Lili], 2012, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V43, P1645; Ocaido M, 2003, AFR J ECOL, V41, P356, DOI 10.1111/j.1365-2028.2003.00483.x; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1992, GENETICS, V130, P471; Okulewicz A., 2002, Polish Journal of Veterinary Sciences, V5, P277; Park JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-392; Park YC, 2011, MITOCHONDR DNA, V22, P91, DOI 10.3109/19401736.2011.624608; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saccone C, 2000, GENE, V261, P153, DOI 10.1016/S0378-1119(00)00484-4; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; SPRENT JFA, 1968, PARASITOLOGY, V58, P185, DOI 10.1017/S0031182000073534; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wickramasinghe S, 2009, MOL BIOCHEM PARASIT, V166, P89, DOI 10.1016/j.molbiopara.2009.02.012; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xie Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027066; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Yang G.Y., 2013, PARASITIC DIS WILDLI; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yatawara L, 2010, MOL BIOCHEM PARASIT, V173, P32, DOI 10.1016/j.molbiopara.2010.05.004	65	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82795	10.1371/journal.pone.0082795	http://dx.doi.org/10.1371/journal.pone.0082795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358225	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700031
J	Gorini, G; Roberts, AJ; Mayfield, RD				Gorini, Giorgio; Roberts, Amanda J.; Mayfield, R. Dayne			Neurobiological Signatures of Alcohol Dependence Revealed by Protein Profiling	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; GENE-EXPRESSION; HUMAN BRAIN; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SYNAPTIC PROTEOME; ETHANOL EXPOSURE; NETWORK ANALYSIS; C57BL/6J MICE; DRINKING	Alcohol abuse causes dramatic neuroadaptations in the brain, which contribute to tolerance, dependence, and behavioral modifications. Previous proteomic studies in human alcoholics and animal models have identified candidate alcoholism-related proteins. However, recent evidences suggest that alcohol dependence is caused by changes in co-regulation that are invisible to single protein-based analysis. Here, we analyze global proteomics data to integrate differential expression, co-expression networks, and gene annotations to unveil key neurobiological rearrangements associated with the transition to alcohol dependence modeled by a Chronic Intermittent Ethanol (CIE), two-bottle choice (2BC) paradigm. We analyzed cerebral cortices (CTX) and midbrains (MB) from male C57BL/6J mice subjected to a CIE, 2BC paradigm, which induces heavy drinking and represents one of the best available animal models for alcohol dependence and relapse drinking. CIE induced significant changes in protein levels in dependent mice compared with their non-dependent controls. Multiple protein isoforms showed region-specific differential regulation as a result of post-translational modifications. Our integrative analysis identified modules of co-expressed proteins that were highly correlated with CIE treatment. We found that modules most related to the effects of CIE treatment coordinate molecular imbalances in endocytic- and energy-related pathways, with specific proteins involved, such as dynamin-1. The qRT-PCR experiments validated both differential and co-expression analyses, and the correspondence among our data and previous genomic and proteomic studies in humans and rodents substantiates our findings. The changes identified above may play a key role in the escalation of ethanol consumption associated with dependence. Our approach to alcohol addiction will advance knowledge of brain remodeling mechanisms and adaptive changes in response to drug abuse, contribute to understanding of organizational principles of CTX and MB proteomes, and define potential new molecular targets for treating alcohol addiction. The integrative analysis employed here highlight the advantages of systems approaches in studying the neurobiology of alcohol addiction.	[Gorini, Giorgio; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Roberts, Amanda J.] Scripps Res Inst, Mol & Cellular Neurosci Dept, La Jolla, CA 92037 USA	University of Texas System; University of Texas Austin; Scripps Research Institute	Gorini, G (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	gorini@utexas.edu	Gorini, Giorgio/D-7053-2014	Gorini, Giorgio/0000-0002-0893-5922	NIAAA [AA016648, AA0107838, AA019382, AA020683]; Integrative Neuroscience Initiative on Alcoholism (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016648, RC2AA019382, R01AA012404, U01AA020926, U01AA020893, P01AA020683] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Integrative Neuroscience Initiative on Alcoholism (INIA)(Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grants AA016648, AA0107838, AA019382, AA020683, and Integrative Neuroscience Initiative on Alcoholism (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Kaufman K, 2007, PROTEOM CLIN APPL, V1, P62, DOI 10.1002/prca.200600417; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bell RL, 2009, PHARMACOL BIOCHEM BE, V94, P131, DOI 10.1016/j.pbb.2009.07.019; Calabrese V, 2000, BIOCHEM BIOPH RES CO, V269, P397, DOI 10.1006/bbrc.2000.2311; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dood PR, 1998, ANN NY ACAD SCI, V844, P50, DOI 10.1111/j.1749-6632.1998.tb08221.x; Etheridge N, 2011, CURR NEUROPHARMACOL, V9, P122, DOI 10.2174/157015911795017164; Etheridge N, 2009, PROTEOM CLIN APPL, V3, P730, DOI 10.1002/prca.200800202; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Fodor IK, 2005, BIOINFORMATICS, V21, P3733, DOI 10.1093/bioinformatics/bti612; Gorini G, 2011, PROG MOL BIOL TRANSL, V98, P293, DOI 10.1016/B978-0-12-385506-0.00007-7; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kimpel MW, 2007, ALCOHOL, V41, P95, DOI 10.1016/j.alcohol.2007.03.003; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewohl JM, 2004, ANN NY ACAD SCI, V1025, P14, DOI 10.1196/annals.1316.002; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li MD, 2007, PROTEOM CLIN APPL, V1, P1406, DOI 10.1002/prca.200700321; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; McBride WJ, 2009, PHARMACOL BIOCHEM BE, V92, P304, DOI 10.1016/j.pbb.2008.12.019; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Phillips TJ, 2002, GENES BRAIN BEHAV, V1, P14, DOI 10.1046/j.1601-1848.2001.00011.x; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pignataro L, 2007, J NEUROSCI, V27, P12957, DOI 10.1523/JNEUROSCI.4142-07.2007; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sullivan EV, 2002, NEUROPSYCHOLOGY, V16, P74, DOI 10.1037//0894-4105.16.1.74; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Volkow ND, 2008, PSYCHIAT RES-NEUROIM, V162, P205, DOI 10.1016/j.pscychresns.2007.04.010; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82656	10.1371/journal.pone.0082656	http://dx.doi.org/10.1371/journal.pone.0082656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358215	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700088
J	Nomachi, A; Yoshinaga, M; Liu, J; Kanchanawong, P; Tohyama, K; Thumkeo, D; Watanabe, T; Narumiya, S; Hirata, T				Nomachi, Akira; Yoshinaga, Masanori; Liu, Jaron; Kanchanawong, Pakorn; Tohyama, Kiyoshi; Thumkeo, Dean; Watanabe, Takeshi; Narumiya, Shuh; Hirata, Takako			Moesin Controls Clathrin-Mediated S1PR1 Internalization in T Cells	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; LYMPHOCYTE EGRESS; STRUCTURED ILLUMINATION; EZRIN; ENDOCYTOSIS; TRAFFICKING; SPHINGOSINE-1-PHOSPHATE; CYTOSKELETON; AGONISTS; RADIXIN	The lipid mediator sphingosine 1-phosphate (S1P) regulates a wide range of cellular activities, including vascular maturation, angiogenesis, and immune-cell trafficking. Among the five known receptors for S1P (S1PR1-S1PR5), S1PR1 is a critical regulator of lymphocyte trafficking: its signaling is required for lymphocyte egress from lymphoid organs, while its down-modulation by agonist-induced internalization is a prerequisite for lymphocyte entry into lymphoid organs from the bloodstream. Despite the importance of S1PR1 down-regulation in determining lymphocyte behavior, the molecular mechanism of its internalization in lymphocytes has not been defined. Here we show that agonist-induced S1PR1 internalization in T cells occurs via clathrin-mediated endocytosis and is regulated by moesin, an ezrin-radixin-moesin (ERM) family member. In S1P-stimulated T cells, S1PR1 relocalized within clathrin-coated vesicles (CCVs) and early endosomes, and S1PR1 internalization was blocked when clathrin was pharmacologically inhibited. Stimulating moesin-deficient T cells with S1P failed to induce S1PR1 internalization and CCV formation. Furthermore, treating moesin-deficient mice with FTY720, an S1P receptor agonist known to internalize S1PR1, caused delayed lymphopenia, and lymphocytes isolated from FTY720-treated moesin-deficient mice still responded to S1P ex vivo in chemotaxis assays. These results reveal a novel role for moesin in regulating clathrin-dependent S1PR1 internalization through CCV formation.	[Nomachi, Akira; Watanabe, Takeshi; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Yoshinaga, Masanori; Tohyama, Kiyoshi; Thumkeo, Dean; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Liu, Jaron; Kanchanawong, Pakorn] Mechanobiol Inst, Singapore, Singapore; [Kanchanawong, Pakorn] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Hirata, Takako] Shiga Univ Med Sci, Dept Fundamental Biosci, Otsu, Shiga 52021, Japan	Kyoto University; Kyoto University; National University of Singapore; Shiga University of Medical Science	Hirata, T (corresponding author), Shiga Univ Med Sci, Dept Fundamental Biosci, Otsu, Shiga 52021, Japan.	tahirata@belle.shiga-med.ac.jp	Kanchanawong, Pakorn/M-1315-2017	Kanchanawong, Pakorn/0000-0001-8765-3861; Yoshinaga, Masanori/0000-0001-5642-9752; Hirata, Takako/0000-0002-1740-6168	Ministry of Education, Culture, Sports, Science and Technology, Japan [22590433, 33021022]; Japanese Government; Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program; Grants-in-Aid for Scientific Research [24111009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22590433 and 33021022), and by Special Coordination Funds for Promoting Science and Technology of the Japanese Government and Astellas Pharma Inc. in the Formation of the Innovation Center for Fusion and Advanced Technologies Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Barroso-Gonzalez J, 2009, J BIOL CHEM, V284, P2419, DOI 10.1074/jbc.M805311200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hirata T, 2012, INT IMMUNOL, V24, P705, DOI 10.1093/intimm/dxs077; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kanchanawong P, 2012, CURR OPIN CELL BIOL, V24, P125, DOI 10.1016/j.ceb.2011.11.010; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Shigeta A, 2008, BLOOD, V112, P4915, DOI 10.1182/blood-2008-04-153866; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Van der Lee MMC, 2008, J BIOMOL SCREEN, V13, P986, DOI 10.1177/1087057108326144; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	41	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82590	10.1371/journal.pone.0082590	http://dx.doi.org/10.1371/journal.pone.0082590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358210	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700084
J	Xue, M; Shi, XM; Zhao, Y; Cui, HY; Hu, SL; Cui, XL; Wang, YF				Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Cui, Xianlan; Wang, Yunfeng			Effects of Reticuloendotheliosis Virus Infection on Cytokine Production in SPF Chickens	PLOS ONE			English	Article							TYPE-1 INFECTION; IMMUNE-RESPONSE; GENE-EXPRESSION; GROWTH-FACTOR; TNF-ALPHA; INTERLEUKIN-10; TRANSFORMATION; CHEMOKINES; RECEPTORS; GENOME	Infection with reticuloendotheliosis virus (REV), a gammaretrovirus in the Retroviridae family, can result in immunosuppression and subsequent increased susceptibility to secondary infections. The effects of REV infection on expression of mRNA for cytokine genes in chickens have not been completely elucidated. In this study, using multiplex branched DNA (bDNA) technology, we identified molecular mediators that participated in the regulation of the immune response during REV infection in chickens. Cytokine and chemokine mRNA expression levels were evaluated in the peripheral blood mononuclear cells (PBMCs). Expression levels of interleukin (IL)-4, IL-10, IL-13 and tumor necrosis factor (TNF)-alpha were significantly up-regulated while interferon (IFN)-alpha, IFN-beta, IFN-gamma, IL-1 beta square IL-2, IL-3, IL-15, IL-17F, IL-18 and colony-stimulating factor (CSF)-1 were markedly decreased in PBMCs at all stages of infection. Compared with controls, REV infected chickens showed greater expression levels of IL-8 in PBMCs 21 and 28 days post infection. In addition, REV regulates host immunity as a suppressor of T cell proliferative responses. The results in this study will help us to understand the host immune response to virus pathogens.	[Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Xue, Mei; Shi, Xingming; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Wang, Yunfeng] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China; [Cui, Xianlan] Dept Primary Ind Pk Water & Environm, Hlth Anim Lab, Hobart, Tas, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China [SKLVBP201317]	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China	The study was supported by a grant from the National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (SKLVBP201317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Avery S, 2004, J INTERF CYTOK RES, V24, P600, DOI 10.1089/1079990042280865; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Becker Y, 2004, VIRUS GENES, V29, P147, DOI 10.1023/B:VIRU.0000032797.43537.d3; Becker Y, 2004, VIRUS GENES, V28, P5, DOI 10.1023/B:VIRU.0000012260.32578.72; BEEMON KL, 1976, J VIROL, V17, P525, DOI 10.1128/JVI.17.2.525-537.1976; BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Bohls RL, 2006, VIRUS RES, V119, P187, DOI 10.1016/j.virusres.2006.01.011; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; CHEN PY, 1987, ARCH VIROL, V93, P233, DOI 10.1007/BF01310977; Coffin JM, 1996, NATURE, V382, P762, DOI 10.1038/382762a0; Conrad CT, 1999, J EXP CLIN CANC RES, V18, P225; COOK MK, 1969, J NATL CANCER I, V43, P203; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Davidson I, 2008, J GEN VIROL, V89, P2456, DOI 10.1099/vir.0.2008/001313-0; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Ebnet K, 1999, HISTOCHEM CELL BIOL, V112, P1, DOI 10.1007/s004180050387; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; HAMILTON JA, 1993, LANCET, V342, P536, DOI 10.1016/0140-6736(93)91653-4; HOELZER JD, 1979, VIROLOGY, V93, P20, DOI 10.1016/0042-6822(79)90272-1; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jarosinski KW, 2005, VIRAL IMMUNOL, V18, P148, DOI 10.1089/vim.2005.18.148; KAWAMURA H, 1976, NATL I ANIM HEALTH Q, V16, P135; Khatri M, 2006, VIRUS RES, V118, P70, DOI 10.1016/j.virusres.2005.11.015; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Lillehoj HS, 2001, VET IMMUNOL IMMUNOP, V82, P229, DOI 10.1016/S0165-2427(01)00360-9; LUDFORD CG, 1972, EXP PARASITOL, V31, P29, DOI 10.1016/0014-4894(72)90044-6; LUSCHER U, 1994, INT J CANCER, V57, P612, DOI 10.1002/ijc.2910570428; MALEFYT RD, 1991, J EXP MED, V174, P915; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Markowski-Grimsrud CJ, 2003, IMMUNOLOGY, V109, P283, DOI 10.1046/j.1365-2567.2003.01643.x; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murtaugh MP, 1996, VET IMMUNOL IMMUNOP, V54, P45, DOI 10.1016/S0165-2427(96)05698-X; Ortegel JW, 2002, LUNG CANCER, V36, P17, DOI 10.1016/S0169-5002(01)00472-X; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Peterson KE, 2001, J VIROL, V75, P2848, DOI 10.1128/JVI.75.6.2848-2856.2001; Sun AJ, 2010, VIROLOGY, V397, P270, DOI 10.1016/j.virol.2009.11.017; Sundick RS, 1997, J IMMUNOL, V159, P720; TRAGER W, 1959, P SOC EXP BIOL MED, V101, P578, DOI 10.3181/00379727-101-25023; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; WITTER RL, 1981, AVIAN DIS, V25, P374, DOI 10.2307/1589930; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yue FY, 1997, INT J CANCER, V71, P630, DOI 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.3.CO;2-H; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	53	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83918	10.1371/journal.pone.0083918	http://dx.doi.org/10.1371/journal.pone.0083918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358317	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700142
J	Barupal, DK; Lee, SJ; Karoly, ED; Adhya, S				Barupal, Dinesh Kumar; Lee, Sang Jun; Karoly, Edward D.; Adhya, Sankar			Inactivation of Metabolic Genes Causes Short- and Long-Range dys-Regulation in Escherichia coli Metabolic Network	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; EVOLUTION; GLUCOSE; STRESS; FLUX; EXPRESSION; MODULARITY; CONVERSION; PATHWAYS; BACTERIA	The metabolic network in E. coli can be severely affected by the inactivation of metabolic genes that are required to catabolize a nutrient (D-galactose). We hypothesized that the resulting accumulation of small molecules can yield local as well as systemic effects on the metabolic network. Analysis of metabolomics data in wild-type and D-galactose non-utilizing mutants, galT, galU and galE, reveal the large metabolic differences between the wild-type and the mutants when the strains were grown in D-galactose. Network mapping suggested that the enzymatic defects affected the metabolic modules located both at short-and long-ranges from the D-galactose metabolic module. These modules suggested alterations in glutathione, energy, nucleotide and lipid metabolism and disturbed carbon to nitrogen ratio in mutant strains. The altered modules are required for normal cell growth for the wild-type strain, explaining why the cell growth is inhibited in the mutants in the presence of D-galactose. Identification of these distance-based dys-regulations would enhance the systems level understanding of metabolic networks of microorganisms having importance in biomedical and biotechnological research.	[Barupal, Dinesh Kumar] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Lee, Sang Jun] KRIBB, Infect & Immun Res Ctr, Taejon, South Korea; [Lee, Sang Jun] Univ Sci & Technol, Taejon, South Korea; [Lee, Sang Jun; Adhya, Sankar] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Karoly, Edward D.] Metabolon Inc, Durham, NC USA	University of California System; University of California Davis; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Metabolon	Adhya, S (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	sadhya@helix.nih.gov	Barupal, Dinesh K/A-9341-2010	barupal, dinesh/0000-0002-9954-8628; Lee, Sang Jun/0000-0002-2803-753X	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008751] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA SL, 1969, GENETICS, V62, P231; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; BOHRINGER J, 1995, J BACTERIOL, V177, P413; BROUQUISSE R, 1992, PLANTA, V188, P384, DOI 10.1007/BF00192806; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; DECKER K, 1993, J BACTERIOL, V175, P5655, DOI 10.1128/JB.175.17.5655-5665.1993; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; ROSENBERG H, 1984, J BACTERIOL, V158, P69, DOI 10.1128/JB.158.1.69-72.1984; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e78360	10.1371/journal.pone.0078360	http://dx.doi.org/10.1371/journal.pone.0078360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24363806	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566100003
J	Saligrama, N; Case, LK; Krementsov, DN; Teuscher, C				Saligrama, Naresha; Case, Laure K.; Krementsov, Dimitry N.; Teuscher, Cory			Histamine H-2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis	FASEB JOURNAL			English	Article						pertussis toxin; multiple sclerosis; effector T-cell response; CD4 T cells	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PERTUSSIS TOXIN; T-CELLS; PHARMACOLOGICAL CHARACTERIZATION; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; CYCLIC-AMP; CLONAL EXPANSION; IMMUNE-RESPONSE	Histamine and its receptors are important in both multiple sclerosis and experimental allergic encephalomyelitis (EAE). C57BL/6J (B6) mice deficient for the histamine H-2 receptor (H2RKO) are less susceptible to EAE and exhibit blunted Th1 responses. However, whether decreased antigen-specific T-cell effector responses in H2RKO mice were due to a lack of H2R signaling in CD4(+) T cells or antigen-presenting cells has remained unclear. We generated transgenic mice expressing H2R specifically in T cells on the H2RKO background, and, using wild-type B6 and H2RKO mice as controls, induced EAE either in the presence or absence of the ancillary adjuvant pertussis toxin (PTX), which models the effects of infectious inflammatory stimuli on autoimmune disease. We monitored the mice for clinical signs of EAE and neuropathology, as well as effector T-cell responses using flow cytometry. EAE severity and neuropathology in H2RKO mice expressing H2R exclusively in T cells become equal to those in wild-type B6 mice only when PTX is used to elicit disease. EAE complementation was associated with frequencies of CD4(+)IFN-gamma(+) and CD4(+)IL-17(+) cells that are equal to or greater than those in wild-type B6, respectively. Thus, the regulation of encephalitogenic T-cell responses and EAE susceptibility by H2R signaling in CD4(+) T cells is dependent on gene x environment interactions.-Saligrama, N., Case, L. K., Krementsov, D. N., Teuscher, C. Histamine H-2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis.	[Saligrama, Naresha; Case, Laure K.; Krementsov, Dimitry N.; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Immunobiol Program, C331 Given Med Bldg, Burlington, VT 05405 USA.	c.teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466; Saligrama, Naresha/0000-0003-2526-7150	U.S. National Institute of Health [NS061014, AI041747, NS060901, NS036526, NS069628]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061014, R01NS036526, R01NS060901, R01NS069628] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the University of Vermont transgenic/knockout facility, Dr. Mercedes R. Rincon, and Dr. John Dodge for their help in generating the H2RKO-dlck<SUP>Hrh2</SUP>Tg mice; Drs. Rachael M. Hannah and Adrian D. Bonev, (Department of Pharmacology, University of Vermont) for technical assistance with Ca<SUP>2+</SUP> imaging; and Suzanne Newberry and Dr. Alan K. Howe (Department of Pharmacology, University of Vermont) for their design and completion of the in vitro PKA activity assay. This work was supported by the U.S. National Institute of Health (grants NS061014, AI041747, NS060901, NS036526, and NS069628 to C.T.). The authors declare no conflicts of interest.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Akdis CA, 2006, EUR J PHARMACOL, V533, P69, DOI 10.1016/j.ejphar.2005.12.044; ALGADI M, 1985, BRIT J PHARMACOL, V85, P877, DOI 10.1111/j.1476-5381.1985.tb11087.x; Banu Y, 1999, J EXP MED, V189, P673, DOI 10.1084/jem.189.4.673; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BATZRI S, 1978, BIOCHIM BIOPHYS ACTA, V541, P181, DOI 10.1016/0304-4165(78)90391-4; BenNun A, 1997, P ASSOC AM PHYSICIAN, V109, P120; Biswas S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-57; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Burnette W N, 1997, Behring Inst Mitt, P434; Caldwell GB, 2012, J CELL BIOCHEM, V113, P39, DOI 10.1002/jcb.23325; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; CHEW CS, 1986, BIOCHIM BIOPHYS ACTA, V888, P116, DOI 10.1016/0167-4889(86)90077-7; CHEW CS, 1980, AM J PHYSIOL, V238, pG312, DOI 10.1152/ajpgi.1980.238.4.G312; CORUZZI G, 1993, N-S ARCH PHARMACOL, V348, P77, DOI 10.1007/BF00168540; Denkinger CM, 2007, CELL IMMUNOL, V246, P46, DOI 10.1016/j.cellimm.2007.05.004; Dy M, 2004, CYTOKINE GROWTH F R, V15, P393, DOI 10.1016/j.cytogfr.2004.06.003; Elliott KA, 2001, INT IMMUNOPHARMACOL, V1, P1923, DOI 10.1016/S1567-5769(01)00117-5; Emerson MR, 2002, NEUROREPORT, V13, P1407, DOI 10.1097/00001756-200208070-00012; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553, DOI 10.1042/bj3100553; Fumagalli F, 2004, ALLERGY, V59, P74, DOI 10.1111/j.1398-9995.2004.00573.x; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P5937, DOI 10.1073/pnas.88.13.5937a; GRAY LS, 1989, J IMMUNOL, V142, P1631; GRUND VR, 1975, J PHARMACOL EXP THER, V195, P176; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Hart PH, 1997, IMMUNOLOGY, V91, P601, DOI 10.1046/j.1365-2567.1997.00284.x; Higuchi M, 2000, NEUROSCIENCE, V99, P721, DOI 10.1016/S0306-4522(00)00230-X; Hill SJ, 1997, PHARMACOL REV, V49, P253; HILL SJ, 1990, PHARMACOL REV, V42, P45; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Idzko M, 2002, J ALLERGY CLIN IMMUN, V109, P839, DOI 10.1067/mai.2002.124044; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2001, INT ARCH ALLERGY IMM, V124, P190, DOI 10.1159/000053707; Krementsov DN, 2013, MULT SCLER J, V19, P1684, DOI 10.1177/1352458513506954; Kunzmann S, 2003, FASEB J, V17, P1089, DOI 10.1096/fj.02-1008com; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; LEURS R, 1994, BRIT J PHARMACOL, V112, P847, DOI 10.1111/j.1476-5381.1994.tb13157.x; LICHTENSTEIN LM, 1975, J IMMUNOL, V114, P1692; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; MacGlashan Donald Jr., 2003, Journal of Allergy and Clinical Immunology, V112, pS53, DOI 10.1016/S0091-6749(03)01877-3; Mazzoni A, 2001, J CLIN INVEST, V108, P1865, DOI 10.1172/JCI13930; McGlade JP, 2007, J IMMUNOL, V178, P2794, DOI 10.4049/jimmunol.178.5.2794; MERRILL JE, 1987, INT ARCH ALLER A IMM, V82, P195, DOI 10.1159/000234186; MITSUHASHI M, 1989, J BIOL CHEM, V264, P18356; Munoz JJ, 1985, PERTUSSIS TOXIN, P1; Murphey C, 2011, CELL IMMUNOL, V267, P50, DOI 10.1016/j.cellimm.2010.11.003; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Ohman L, 2002, GUT, V51, P392, DOI 10.1136/gut.51.3.392; Ohman L, 2000, SCAND J IMMUNOL, V52, P80; Omata N, 2002, J IMMUNOL, V169, P4861, DOI 10.4049/jimmunol.169.9.4861; Osna N, 2001, INT IMMUNOPHARMACOL, V1, P85, DOI 10.1016/S0162-3109(00)00268-X; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Pedotti R, 2003, P NATL ACAD SCI USA, V100, P1867, DOI 10.1073/pnas.252777399; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Ryan M, 1998, INT IMMUNOL, V10, P651, DOI 10.1093/intimm/10.5.651; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Shayo C, 1997, MOL PHARMACOL, V51, P983, DOI 10.1124/mol.51.6.983; Shive CL, 2000, EUR J IMMUNOL, V30, P2422, DOI 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H; Spach KM, 2009, J IMMUNOL, V182, P7776, DOI 10.4049/jimmunol.0900142; Teuscher C, 2004, AM J PATHOL, V165, P1593, DOI 10.1016/S0002-9440(10)63416-5; Teuscher C, 2004, AM J PATHOL, V164, P883, DOI 10.1016/S0002-9440(10)63176-8; TOLONE G, 1982, EXPERIENTIA, V38, P966, DOI 10.1007/BF01953681; TRAIFFORT E, 1992, J NEUROCHEM, V59, P290, DOI 10.1111/j.1471-4159.1992.tb08903.x; TUOMISTO L, 1983, AGENTS ACTIONS, V13, P255, DOI 10.1007/BF01967346; Wakatsuki A, 2003, EUR J IMMUNOL, V33, P1859, DOI 10.1002/eji.200323675; Wang LD, 1997, AM J PHYSIOL-CELL PH, V273, pC2037, DOI 10.1152/ajpcell.1997.273.6.C2037; Yokoyama H, 2001, BRAIN DEV-JPN, V23, P542, DOI 10.1016/S0387-7604(01)00261-3; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	80	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1898	1909		10.1096/fj.13-239939	http://dx.doi.org/10.1096/fj.13-239939			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371118	Green Published			2022-12-25	WOS:000335344300034
J	Iwai, K; Shibukawa, Y; Yamazaki, N; Wada, Y				Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao			Transglutaminase 2-dependent Deamidation of Glyceraldehyde-3-phosphate Dehydrogenase Promotes Trophoblastic Cell Fusion*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cytoskeleton; Protein Deamidation; Transglutaminases; Trophoblast; Cell Fusion; Glyceraldehyde-3-phosphate Dehydrogenase	TISSUE TRANSGLUTAMINASE; MULTIFUNCTIONAL PROTEIN; CELIAC-DISEASE; HUMAN PLACENTA; SYNCYTIN; EXPRESSION; ACTIN; GCMA; SYNCYTIOTROPHOBLAST; IDENTIFICATION	Background: This work explores proteins participating in trophoblastic cell fusion. Results: Gln-deamidated GAPDH accumulates at the plasma membrane and promotes cell fusion. Conclusion: Transglutaminase-2 regulates trophoblastic cell fusion through GAPDH deamidation. Significance: GAPDH and transglutaminase-2 have a novel function in cell fusion. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional protein as well as a classic glycolytic enzyme, and its pleiotropic functions are achieved by various post-translational modifications and the resulting translocations to intracellular compartments. In the present study, GAPDH in the plasma membrane of BeWo choriocarcinoma cells displayed a striking acidic shift in two-dimensional electrophoresis after cell-cell fusion induction by forskolin. This post-translational modification was deamidation of multiple glutaminyl residues, as determined by molecular mass measurement and tandem mass spectrometry of acidic GAPDH isoforms. Transglutaminase (TG) inhibitors prevented this acidic shift and reduced cell fusion. Knockdown of the TG2 gene by short hairpin RNA reproduced these effects of TG inhibitors. Various GAPDH mutants with replacement of different numbers (one to seven) of Gln by Glu were expressed in BeWo cells. These deamidated mutants reversed the suppressive effect of wild-type GAPDH overexpression on cell fusion. Interestingly, the mutants accumulated in the plasma membrane, and this accumulation was increased according to the number of Gln/Glu substitutions. Considering that GAPDH binds F-actin via an electrostatic interaction and that the cytoskeleton is rearranged in trophoblastic cell fusion, TG2-dependent GAPDH deamidation was suggested to participate in actin cytoskeletal remodeling.	[Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan; [Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Iwai, Kaori; Wada, Yoshinao] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Wada, Y (corresponding author), Osaka Med Ctr, Dept Mol Med, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	waday@mch.pref.osaka.jp			Japan Society for the Promotion of Science [23390081, 24591618, 22-3627]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research B (23390081) and C (24591618) and for JSPS Fellows (22-3627) from the Japan Society for the Promotion of Science.	Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Anjum N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-16; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; Boros S, 2008, EXP EYE RES, V86, P383, DOI 10.1016/j.exer.2007.11.011; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Del Bello A, 2012, TRANSPLANTATION, V93, P936, DOI 10.1097/TP.0b013e31824b3720; Di Simone N, 2010, AM J GASTROENTEROL, V105, P2254, DOI 10.1038/ajg.2010.233; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Forlemu NY, 2011, PROTEINS, V79, P2813, DOI 10.1002/prot.23107; Fornelli L, 2011, CHEM-EUR J, V17, P486, DOI 10.1002/chem.201002483; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hager H, 1997, J PATHOL, V181, P106, DOI 10.1002/(SICI)1096-9896(199701)181:1<106::AID-PATH725>3.0.CO;2-K; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiefte-de Jong JC, 2013, GASTROENTEROLOGY, V144, P726, DOI 10.1053/j.gastro.2013.01.003; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Robinson NJ, 2007, BIOL REPROD, V77, P648, DOI 10.1095/biolreprod.107.061747; Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110; Schmid AW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176149; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	39	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4989	4999		10.1074/jbc.M113.525568	http://dx.doi.org/10.1074/jbc.M113.525568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375405	hybrid, Green Published			2022-12-25	WOS:000331607900044
J	Yao, ST; Miao, C; Tian, H; Sang, H; Yang, NN; Jiao, P; Han, JJ; Zong, CL; Qin, SC				Yao, Shutong; Miao, Cheng; Tian, Hua; Sang, Hui; Yang, Nana; Jiao, Peng; Han, Jiju; Zong, Chuanlong; Qin, Shucun			Endoplasmic Reticulum Stress Promotes Macrophage-derived Foam Cell Formation by Up-regulating Cluster of Differentiation 36 (CD36) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endoplasmic Reticulum Stress; Low Density Lipoprotein (LDL); Macrophages; Unfolded Protein Response; CD36; Foam Cell; Oxidized Low-density Lipoprotein	ATHEROSCLEROTIC LESION DEVELOPMENT; LOW-DENSITY LIPOPROTEINS; B SCAVENGER RECEPTOR; APOPTOSIS; LDL; ACTIVATION; PROTEIN; ACCUMULATION; MICE	Oxidized low-density lipoprotein (ox-LDL) up-regulates CD36, a scavenger receptor responsible for macrophage uptake of ox-LDL without limitation. However, the precise underlying mechanism is not completely understood. Our previous study has demonstrated that ox-LDL induces endoplasmic reticulum (ER) stress in macrophages. The goal of this study was to explore the exact relationship between ER stress and macrophage-derived foam cell formation and whether ER stress would be involved in ox-LDL-induced CD36 up-regulation. Our results showed that ox-LDL-induced lipid accumulation in macrophages was promoted synergistically by ER stress inducer tunicamycin (TM), while attenuated by ER stress inhibitor 4-phenylbutyric acid (PBA). Ox-LDL caused CD36 up-regulation with concomitant activation of ER stress as assessed by phosphorylation of inositol-requiring kinase/endonuclease-1 (IRE-1) and protein kinase-like ER kinase (PERK), up-regulation of X-box-binding protein 1 (XBP1) and glucose-regulated protein 78 (GRP 78), and nuclear translocation of activating transcription factor 6 (ATF6). TM not only up-regulated CD36 alone but also synergized with ox-LDL to increase CD36 expression. Alleviation of ER stress with PBA and siRNA against ATF6, IRE1, and GRP78 mitigated ox-LDL-induced CD36 protein up-regulation. Moreover, administration of apoE(-/-) mice with PBA suppressed the up-regulation of CD36, phospho-IRE1, and GRP78 in macrophage-dense atherosclerotic lesions and in peritoneal macrophages. Additionally, CD36 silencing attenuated ox-LDL-induced nuclear translocation of ATF6, phosphorylation of IRE1 and up-regulation of XBP1 and GRP78. These data indicate that CD36-mediated ox-LDL uptake in macrophages triggers ER stress response, which, in turn, plays a critical role in CD36 up-regulation, enhancing the foam cell formation by uptaking more ox-LDL.	[Yao, Shutong; Miao, Cheng; Tian, Hua; Sang, Hui; Yang, Nana; Jiao, Peng; Han, Jiju; Zong, Chuanlong; Qin, Shucun] Taishan Med Univ, Inst Atherosclerosis, Key Lab Atherosclerosis Univ Shandong, Tai An 271000, Shandong, Peoples R China; [Yao, Shutong; Sang, Hui] Taishan Med Univ, Coll Basic Med Sci, Tai An 271000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Qin, SC (corresponding author), Taishan Med Univ, Inst Atherosclerosis, Tai An 271000, Shandong, Peoples R China.	shucunqin@hotmail.com			Taishan Scholars Foundation of the Shandong Province [zd056, zd057]; National Natural Science Foundation of China [81202949, 81370381, 81070247]	Taishan Scholars Foundation of the Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Taishan Scholars Foundation of the Shandong Province (zd056, zd057) and National Natural Science Foundation of China (81202949, 81370381, 81070247).	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gora S, 2010, FASEB J, V24, P3284, DOI 10.1096/fj.09-146852; Goyal T, 2012, CURR ATHEROSCLER REP, V14, P150, DOI 10.1007/s11883-012-0228-1; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hua YA, 2010, J CARDIOVASC PHARM, V55, P49, DOI 10.1097/FJC.0b013e3181c37d86; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tiwari RL, 2008, MED RES REV, V28, P483, DOI 10.1002/med.20118; Yao Shu-Tong, 2010, Shengli Xuebao, V62, P433; Yao ST, 2013, J ATHEROSCLER THROMB, V20, P94, DOI 10.5551/jat.13425; Yao ST, 2012, BBA-MOL CELL BIOL L, V1821, P954, DOI 10.1016/j.bbalip.2012.03.003; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou MS, 2013, AM J PHYSIOL-HEART C, V305, pH563, DOI 10.1152/ajpheart.00042.2013	37	71	78	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4032	4042		10.1074/jbc.M113.524512	http://dx.doi.org/10.1074/jbc.M113.524512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366867	hybrid, Green Published			2022-12-25	WOS:000331403800018
J	Spruiell, K; Richardson, RM; Cullen, JM; Awumey, EM; Gonzalez, FJ; Gyamfi, MA				Spruiell, Krisstonia; Richardson, Ricardo M.; Cullen, John M.; Awumey, Emmanuel M.; Gonzalez, Frank J.; Gyamfi, Maxwell A.			Role of Pregnane X Receptor in Obesity and Glucose Homeostasis in Male Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Metabolic Syndrome; Nuclear Receptors; Obesity; Peroxisome Proliferator-activated Receptor (PPAR)	ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; CONSTITUTIVE ANDROSTANE RECEPTOR; LOW PLASMA LEPTIN; NUCLEAR RECEPTOR; CROSS-TALK; INSULIN-RESISTANCE; INDUCED THERMOGENESIS; TARGETED DISRUPTION; HEPATIC STEATOSIS	Background: PXR is a xenobiotic nuclear receptor that defends against toxic agents. Results: In male mice fed a HFD, the mouse PXR gene promoted obesity, whereas mice lacking the PXR or possessing the human transgene were hyperglycemic. Conclusion: The impact of PXR on HFD-induced obesity and hyperglycemia is species-dependent. Significance: The current data provide in vivo significance of PXR in metabolic syndrome. Clinical obesity is a complex metabolic disorder affecting one in three adults. Recent reports suggest that pregnane X receptor (PXR), a xenobiotic nuclear receptor important for defense against toxic agents and for eliminating drugs and other xenobiotics, may be involved in obesity. Noting differences in ligand specificities between human and mouse PXRs, the role of PXR in high fat diet (HFD)-induced obesity was examined using male PXR-humanized (hPXR) transgenic and PXR-knock-out (PXR-KO) mice in comparison to wild-type (WT) mice. After 16 weeks on either a control diet or HFD, WT mice showed greater weight gain, whereas PXR-KO mice gained less weight due to their resistance to HFD-induced decreases in adipose tissue peroxisome proliferator-activated receptor and induction of hepatic carnitine palmitoyltransferase 1, suggesting increased energy metabolism. Interestingly, control-fed PXR-KO mice exhibited hepatomegaly, hyperinsulinemia, and hyperleptinemia but hypoadiponectinemia and lower adiponectin receptor R2 mRNA levels relative to WT mice. Evaluation of these biologic indicators in hPXR mice fed a control diet or HFD revealed further differences between the mouse and human receptors. Importantly, although HFD-fed hPXR mice were resistant to HFD-induced obesity, both PXR-KO and hPXR mice exhibited impaired induction of glucokinase involved in glucose utilization and displayed elevated fasting glucose levels and severely impaired glucose tolerance. Moreover, the basal hepatic levels of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase 1 were increased in hPXR mice compared with WT mice. Altogether, although the mouse PXR promotes HFD-induced obesity, the hPXR mouse carries a genetic predisposition for type 2 diabetes and thus provides a model for exploring the role of human PXR in the metabolic syndrome.	[Spruiell, Krisstonia; Richardson, Ricardo M.; Awumey, Emmanuel M.; Gyamfi, Maxwell A.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Cullen, John M.] N Carolina State Univ, North Carolina Coll Vet Med, Raleigh, NC 27607 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gyamfi, MA (corresponding author), N Carolina Cent Univ, JLC Biomed Biotechnol Res Inst, Cardiovasc & Metab Dis Res Program, 700 George St, Durham, NC 27707 USA.	mgyamfi@nccu.edu	Cullen, John M/I-2051-2019		National Institutes of Health [U54 AA019765, SC1 HL099139, U54 CA156735, RO1 HL064761, R25HL059868, P20 MD000175]; National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005562, ZIABC005708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 AA019765, SC1 HL099139, U54 CA156735, RO1 HL064761, R25HL059868, and P20 MD000175, and the National Cancer Institute Intramural Research Program.	[Anonymous], [No title captured]; ASTRUP A, 1994, AM J CLIN NUTR, V59, P350, DOI 10.1093/ajcn/59.2.350; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246; BUTLER PC, 1990, DIABETES, V39, P217, DOI 10.2337/diabetes.39.2.217; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng J, 2012, TOXICOL SCI, V129, P456, DOI 10.1093/toxsci/kfs211; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Costa Angels, 2002, Treat Endocrinol, V1, P205; Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1; Gao J, 2010, DRUG METAB DISPOS, V38, P2091, DOI 10.1124/dmd.110.035568; George J, 2008, MOL PHARMACEUT, V5, P49, DOI 10.1021/mp700110z; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2006, J PHARMACOL EXP THER, V319, P360, DOI 10.1124/jpet.106.108175; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; Korach-Andre M, 2011, AM J PHYSIOL-ENDOC M, V301, pE210, DOI 10.1152/ajpendo.00541.2010; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Oleszczuk A, 2007, EXP TOXICOL PATHOL, V59, P205, DOI 10.1016/j.etp.2007.05.009; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Shemesh T, 2006, CLIN CHIM ACTA, V367, P69, DOI 10.1016/j.cca.2005.11.014; Sonoda J, 2005, P NATL ACAD SCI USA, V102, P2198, DOI 10.1073/pnas.0409481102; Sookoian S, 2010, PHARMACOGENET GENOM, V20, P1, DOI 10.1097/FPC.0b013e328333a1dd; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Surwit RS, 1997, DIABETES, V46, P1516, DOI 10.2337/diabetes.46.9.1516; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Valls C, 2006, EUR RADIOL, V16, P2292, DOI 10.1007/s00330-006-0146-0; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zhang H, 1999, ARCH BIOCHEM BIOPHYS, V368, P14, DOI 10.1006/abbi.1999.1307; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	71	59	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3244	3261		10.1074/jbc.M113.494575	http://dx.doi.org/10.1074/jbc.M113.494575			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362030	Green Published, hybrid			2022-12-25	WOS:000331368700013
J	Jansma, JM; van Raalten, TR; Boessen, R; Neggers, SFW; Jacobs, RHAH; Kahn, RS; Ramsey, NF				Jansma, Johan Martijn; van Raalten, Tamar R.; Boessen, Ruud; Neggers, Sebastiaan F. W.; Jacobs, Richard H. A. H.; Kahn, Rene S.; Ramsey, Nick F.			fMRI Guided rTMS Evidence for Reduced Left Prefrontal Involvement after Task Practice	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VERBAL WORKING-MEMORY; FUNCTIONAL-ANATOMY; AUTOMATICITY; ACTIVATION; SEARCH; CORTEX; NETWORK	Introduction: Cognitive tasks that do not change the required response for a stimulus over time ('consistent mapping') show dramatically improved performance after relative short periods of practice. This improvement is associated with reduced brain activity in a large network of brain regions, including left prefrontal and parietal cortex. The present study used fMRI-guided repetitive transcranial magnetic stimulation (rTMS), which has been shown to reduce processing efficacy, to examine if the reduced activity in these regions also reflects reduced involvement, or possibly increased efficiency. Methods: First, subjects performed runs of a Sternberg task in the scanner with novel or practiced target-sets. This data was used to identify individual sites for left prefrontal and parietal peak brain activity, as well as to examine the change in activity related to practice. Outside of the scanner, real and sham rTMS was applied at left prefrontal and parietal cortex to examine their involvement novel and practiced conditions. Results: Prefrontal as well as parietal rTMS significantly reduced target accuracy for novel targets. Prefrontal, but not parietal, rTMS interference was significantly lower for practiced than novel target-sets. rTMS did not affect nontarget accuracy, or reaction time in any condition. Discussion: These results show that task practice in a consistent environment reduces involvement of the prefrontal cortex. Our findings suggest that prefrontal cortex is predominantly involved in target maintenance and comparison, as rTMS interference was only detectable for targets. Findings support process switching hypotheses that propose that practice creates the possibility to select a response without the need to compare with target items. Our results also support the notion that practice allows for redistribution of limited maintenance resources.	[Jansma, Johan Martijn; van Raalten, Tamar R.; Boessen, Ruud; Jacobs, Richard H. A. H.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands; [van Raalten, Tamar R.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Utrecht, Netherlands; [Neggers, Sebastiaan F. W.; Kahn, Rene S.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Jansma, JM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands.	jjansma2@umcutrecht.nl		ramsey, nick/0000-0002-7136-259X	Netherlands Organization for Scientific Research (NWO); Utrecht University [016.036.401]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University	This work was supported by Netherlands Organization for Scientific Research (NWO) and Utrecht University, Grant 016.036.401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; BURROWS D, 1969, J EXP PSYCHOL, V82, P7; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Cousineau D, 2004, PSYCHOL RES-PSYCH FO, V69, P77, DOI 10.1007/s00426-003-0170-5; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Hamidi M, 2009, NEUROPSYCHOLOGIA, V47, P295, DOI 10.1016/j.neuropsychologia.2008.08.026; Jansma JM, 2001, NEUROIMAGE, V13, pS421; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Lee J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00026; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P478; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mottaghy FM, 2000, NUKLEARMED-NUCL MED, V39, P196; Mottaghy FM, 2002, EUR J NEUROSCI, V16, P1627, DOI 10.1046/j.1460-9568.2002.02209.x; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1994, NEUROREPORT, V5, P2517, DOI 10.1097/00001756-199412000-00028; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ramsey NF, 2004, BRAIN, V127, P517, DOI 10.1093/brain/awh060; RYAN C, 1983, PSYCHOL REV, V90, P171, DOI 10.1037/0033-295X.90.2.171; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schutter DJLG, 2006, J ECT, V22, P176, DOI 10.1097/01.yct.0000235924.60364.27; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Raalten TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003270; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	38	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e80256	10.1371/journal.pone.0080256	http://dx.doi.org/10.1371/journal.pone.0080256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376494	Green Published, gold, Green Submitted			2022-12-25	WOS:000328745100001
J	Lam, PY; Harvie, EA; Huttenlocher, A				Lam, Pui-ying; Harvie, Elizabeth A.; Huttenlocher, Anna			Heat Shock Modulates Neutrophil Motility in Zebrafish	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; FEVER-LIKE TEMPERATURES; GENE-EXPRESSION; ACTIN POLYMERIZATION; LEUKOCYTE MIGRATION; STREPTOCOCCUS-INIAE; IMMUNE-RESPONSE; ER STRESS; HSP27; PROTEINS	Heat shock is a routine method used for inducible gene expression in animal models including zebrafish. Environmental temperature plays an important role in the immune system and infection progression of ectotherms. In this study, we analyzed the impact of short-term heat shock on neutrophil function using zebrafish (Danio rerio) as an animal model. Short-term heat shock decreased neutrophil recruitment to localized Streptococcus iniae infection and tail fin wounding. Heat shock also increased random neutrophil motility transiently and increased the number of circulating neutrophils. With the use of the translating ribosome affinity purification (TRAP) method for RNA isolation from specific cell types such as neutrophils, macrophages and epithelial cells, we found that heat shock induced the immediate expression of heat shock protein 70 (hsp70) and a prolonged expression of heat shock protein 27 (hsp27). Heat shock also induced cell stress as detected by the splicing of X-box binding protein 1 (xbp1) mRNA, a marker for endoplasmic reticulum (ER) stress. Exogenous expression of Hsp70, Hsp27 and spliced Xbp1 in neutrophils or epithelial cells did not reproduce the heat shock induced effects on neutrophil recruitment. The effect of heat shock on neutrophils is likely due to a combination of complex changes, including, but not limited to changes in gene expression. Our results indicate that routine heat shock can alter neutrophil function in zebrafish. The findings suggest that caution should be taken when employing a heat shock-dependent inducible system to study the innate immune response.	[Lam, Pui-ying] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Lam, Pui-ying; Harvie, Elizabeth A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Harvie, Elizabeth A.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Lam, Pui-Ying/0000-0002-6319-5752	National Institutes of Health [GM074827]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health [grant numbers GM074827 to A. H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bacaj T, 2007, GENETICS, V176, P2651, DOI 10.1534/genetics.107.074369; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Colaco CA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461230; Costa CZF, 2011, SCAND J IMMUNOL, V73, P436, DOI 10.1111/j.1365-3083.2010.02504.x; COVERT JB, 1977, NATURE, V267, P43, DOI 10.1038/267043a0; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Deng Q, 2012, J CELL SCI, V125, P3949, DOI 10.1242/jcs.093633; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Faucherre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016587; Grans A, 2012, J FISH BIOL, V81, P1111, DOI 10.1111/j.1095-8649.2012.03333.x; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kettritz R, 2006, J AM SOC NEPHROL, V17, P1345, DOI 10.1681/ASN.2005090948; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kudo K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq024; Lam PY, 2013, CURR OPIN CELL BIOL, V25, P650, DOI 10.1016/j.ceb.2013.05.007; Lam PY, 2012, J CELL SCI, V125, P4973, DOI 10.1242/jcs.106625; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Mao L, 2005, EXP CELL RES, V306, P230, DOI 10.1016/j.yexcr.2005.02.007; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; NAHAS GG, 1971, P SOC EXP BIOL MED, V138, P350; Ndong D, 2007, FISH SHELLFISH IMMUN, V22, P686, DOI 10.1016/j.fsi.2006.08.015; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; REYNOLDS WW, 1976, NATURE, V259, P41, DOI 10.1038/259041a0; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Salanova B, 2005, FASEB J, V19, P816, DOI 10.1096/fj.04-2983fje; Schneider GB, 1998, J CELL PHYSIOL, V177, P575, DOI 10.1002/(SICI)1097-4652(199812)177:4<575::AID-JCP8>3.0.CO;2-1; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stocki P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/617213; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Todryk SM, 2003, IMMUNOLOGY, V110, P1, DOI 10.1046/j.1365-2567.2003.01725.x; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tucker NR, 2009, EXP CELL RES, V315, P3176, DOI 10.1016/j.yexcr.2009.06.030; Tucker NR, 2009, CELL STRESS CHAPERON, V14, P521, DOI 10.1007/s12192-009-0105-1; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Vinokurov M, 2012, CELL STRESS CHAPERON, V17, P89, DOI 10.1007/s12192-011-0288-0; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.3.CO;2-V; Wu TC, 2006, CELL STRESS CHAPERON, V11, P1, DOI 10.1379/CSC-155R.1; Wu YL, 2008, GENE, V408, P85, DOI 10.1016/j.gene.2007.10.027; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	67	20	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84436	10.1371/journal.pone.0084436	http://dx.doi.org/10.1371/journal.pone.0084436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367659	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900046
J	Barelli, C; Mundry, R; Heistermann, M; Hammerschmidt, K				Barelli, Claudia; Mundry, Roger; Heistermann, Michael; Hammerschmidt, Kurt			Cues to Androgens and Quality in Male Gibbon Songs	PLOS ONE			English	Article							WHITE-HANDED GIBBONS; FORMANT FREQUENCIES INFLUENCE; SEX-RELATED VARIATIONS; REFLECT BODY-SIZE; BABOON LOUD CALLS; ACOUSTIC FEATURES; VOCAL FOLD; VOICE PITCH; FUNDAMENTAL-FREQUENCY; TESTOSTERONE LEVELS	Animal vocal signals may provide information about senders and mediate important social interactions like sexual competition, territory maintenance and mate selection. Hence, it is important to understand whether vocal signals provide accurate information about animal attributes or status. Gibbons are non-human primates that produce loud, distinctive and melodious vocalizations resembling more those of birds than of other non-human primates. Wild gibbons are characterized by flexibility in social organization (i.e., pairs and multimale units) as well as in mating system (i.e., monogamy and polyandry). Such features make them a suitable model to investigate whether the physiology (hormonal status) and socio-demographic features find their correspondence in the structure of their songs. By combining male solo song recordings, endocrine outputs using non-invasive fecal androgen measures and behavioral observations, we studied 14 groups (10 pair-living, 4 multimale) of wild white-handed gibbons (Hylobates lar) residing at Khao Yai National Park, Thailand. We collected a total of 322 fecal samples and recorded 48 songs from 18 adult animals. Our results confirmed inter-individuality in male gibbon songs, and showed a clear correlation between androgen levels and song structures. Gibbons with higher androgen levels produced calls having higher pitch, and similarly adult individuals produced longer calls than senior males. Thus, it is plausible that gibbon vocalizations provide receivers with information about singers' attributes.	[Barelli, Claudia] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Heistermann, Michael] German Primate Ctr, Endocrinol Lab, Gottingen, Germany; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Max Planck Society; Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)		claudia.barelli@muse.it; KHammerschmidt@dpz.eu			Alexander von Humboldt Foundation; German Research Foundation [HE2699/6-1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG))	This research was supported by grants from Alexander von Humboldt Foundation (post-doctoral fellowship to CB) and the German Research Foundation (grant HE2699/6-1 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, LANGUAGER DATA SETS; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Barelli C, 2008, ANIM BEHAV, V75, P991, DOI 10.1016/j.anbehav.2007.08.012; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; Barelli C, 2013, AM J PRIMATOL, V75, P1185, DOI 10.1002/ajp.22180; Barelli C, 2012, INT J PRIMATOL, V33, P784, DOI 10.1007/s10764-012-9606-3; Barelli C, 2011, ANIM BEHAV, V82, P801, DOI 10.1016/j.anbehav.2011.07.012; Bass AH, 2008, HORM BEHAV, V53, P659, DOI 10.1016/j.yhbeh.2007.12.010; Bates D., 2013, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Ey E, 2007, INT J PRIMATOL, V28, P947, DOI 10.1007/s10764-007-9139-3; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fichtel C, 2003, J ACOUST SOC AM, V113, P2927, DOI 10.1121/1.1548158; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Geissmann T, 1999, BEHAVIOUR, V136, P1005, DOI 10.1163/156853999501694; Geissmann T, 2000, ORIGINS OF MUSIC, P103; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Harries M, 1998, J LARYNGOL OTOL, V112, P451, DOI 10.1017/S0022215100140757; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Jenkins JS, 1998, LANCET, V351, P1877, DOI 10.1016/S0140-6736(97)10198-2; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; King A, 2001, J VOICE, V15, P553, DOI 10.1016/S0892-1997(01)00055-8; Kitchen DM, 2009, AM J PHYS ANTHROPOL, P166; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Lappan S., 2009, GIBBONS NEW PERSPECT; Lynam A.J., 2006, STATUS BIRDS LARGE M; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McCowan B, 2002, J ACOUST SOC AM, V111, P1157, DOI 10.1121/1.1446048; McGregor PK., 1992, PLAYBACK STUDIES ANI; MITANI JC, 1987, BEHAV ECOL SOCIOBIOL, V20, P265, DOI 10.1007/BF00292179; MITANI JC, 1985, INT J PRIMATOL, V6, P193; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Moore FL, 2005, HORM BEHAV, V48, P373, DOI 10.1016/j.yhbeh.2005.05.011; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Notman H, 2005, ANIM BEHAV, V70, P177, DOI 10.1016/j.anbehav.2004.08.024; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Oyakawa C, 2007, AM J PRIMATOL, V69, P777, DOI 10.1002/ajp.20390; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Pirovino M, 2011, INT J PRIMATOL, V32, P1161, DOI 10.1007/s10764-011-9532-9; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; R Core Team, 2012, R LANG ENV STAT COMP; RAEMAEKERS JJ, 1985, ANIM BEHAV, V33, P481, DOI 10.1016/S0003-3472(85)80071-3; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Reichard Ulrich H., 2009, P347, DOI 10.1007/978-0-387-88604-6_17; Riede T., 2013, NOVA ACTA LEOPOLDINA, V111, P1, DOI DOI 10.1007/3-540-32504-2_10; Riede T, 2008, J EXP BIOL, V211, P2144, DOI 10.1242/jeb.017004; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schneider C, 2008, INT J PRIMATOL, V29, P601, DOI 10.1007/s10764-007-9181-1; Semple S, 2001, ANIM BEHAV, V61, P1023, DOI 10.1006/anbe.2001.1692; Smith JM, 1995, J THEOR BIOL, V177, P305; Sun GZ, 2011, AM J PRIMATOL, V73, P431, DOI 10.1002/ajp.20917; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Thinh VN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-36; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Voelter C, 2008, EUR ARCH OTO-RHINO-L, V265, P1239, DOI 10.1007/s00405-008-0632-x; Voigt C, 2013, HORM BEHAV, V63, P122, DOI 10.1016/j.yhbeh.2012.10.006; Weingrill T, 2011, GEN COMP ENDOCR, V172, P446, DOI 10.1016/j.ygcen.2011.04.008; Wich SA, 2003, INT J PRIMATOL, V24, P1251, DOI 10.1023/B:IJOP.0000005991.97232.2a; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; [No title captured]; [No title captured]	105	38	38	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82748	10.1371/journal.pone.0082748	http://dx.doi.org/10.1371/journal.pone.0082748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367551	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300064
J	Coburn, LA; Horst, SN; Chaturvedi, R; Brown, CT; Allaman, MM; Scull, BP; Singh, K; Piazuelo, MB; Chitnavis, MV; Hodges, ME; Rosen, MJ; Williams, CS; Slaughter, JC; Beaulieu, DB; Schwartz, DA; Wilson, KT				Coburn, Lori A.; Horst, Sara N.; Chaturvedi, Rupesh; Brown, Caroline T.; Allaman, Margaret M.; Scull, Brooks P.; Singh, Kshipra; Piazuelo, M. Blanca; Chitnavis, Maithili V.; Hodges, Mallary E.; Rosen, Michael J.; Williams, Christopher S.; Slaughter, James C.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.			High-Throughput Multi-Analyte Luminex Profiling Implicates Eotaxin-1 in Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELICOBACTER-PYLORI; MACROPHAGE APOPTOSIS; MOUSE MODEL; ARGINASE; ACTIVATION; CELLS	Accurate and high-throughput technologies are needed for identification of new therapeutic targets and for optimizing therapy in inflammatory bowel disease. Our aim was to assess multi-analyte protein-based assays of cytokines/chemokines using Luminex technology. We have reported that Luminex-based profiling was useful in assessing response to L-arginine therapy in the mouse model of dextran sulfate sodium colitis. Therefore, we studied prospectively collected samples from ulcerative colitis (UC) patients and control subjects. Serum, colon biopsies, and clinical information were obtained from subjects undergoing colonoscopy for evaluation of UC or for non-UC indications. In total, 38 normal controls and 137 UC cases completed the study. Histologic disease severity and the Mayo Disease Activity Index (DAI) were assessed. Serum and colonic tissue cytokine/chemokine profiles were measured by Luminex-based multiplex testing of 42 analytes. Only eotaxin-1 and G-CSF were increased in serum of patients with histologically active UC vs. controls. While 13 cytokines/chemokines were increased in active UC vs. controls in tissues, only eotaxin-1 was increased in all levels of active disease in both serum and tissue. In tissues, eotaxin-1 correlated with the DAI and with eosinophil counts. Increased eotaxin-1 levels were confirmed by real-time PCR. Tissue eotaxin-1 levels were also increased in experimental murine colitis induced by dextran sulfate sodium, oxazolone, or Citrobacter rodentium, but not in murine Helicobacter pylori infection. Our data implicate eotaxin-1 as an etiologic factor and therapeutic target in UC, and indicate that Luminex-based assays may be useful to assess IBD pathogenesis and to select patients for anti-cytokine/chemokine therapies.	[Coburn, Lori A.; Horst, Sara N.; Chaturvedi, Rupesh; Brown, Caroline T.; Allaman, Margaret M.; Scull, Brooks P.; Singh, Kshipra; Piazuelo, M. Blanca; Chitnavis, Maithili V.; Hodges, Mallary E.; Williams, Christopher S.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Williams, Christopher S.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Coburn, Lori A.; Horst, Sara N.; Allaman, Margaret M.; Williams, Christopher S.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Rosen, Michael J.] Vanderbilt Univ, Med Ctr, Dept Pediat Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Slaughter, James C.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA.	keith.wilson@vanderbilt.edu	Allaman, Margaret/GNO-9854-2022; Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Coburn, Lori/0000-0003-3249-9806; Wilson, Keith/0000-0003-4421-1830; Rosen, Michael/0000-0002-5149-718X; Schwartz, David/0000-0002-7026-7099; Slaughter, James/0000-0002-8770-980X; Allaman, Margaret M./0000-0002-2803-1365	National Institutes of Health (NIH) [R01AT004821, 3R01AT004821-02S1, 5T32DK007673, K23DK094832, K01AT007324, P30DK058404, UL1TR000445]; Vanderbilt Physician Scientist Development Award; Thomas F. Frist, Sr. Endowment; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK094832, P30DK058404, T32DK007673, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Award; Thomas F. Frist, Sr. Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) grants R01AT004821 and 3R01AT004821-02S1 to KTW. LAC was supported by NIH training grant 5T32DK007673 as well as a Vanderbilt Physician Scientist Development Award. Additional support was provided by NIH grant K23DK094832 to MJR, K01AT007324 to RC, NIH Grant P30DK058404 (Vanderbilt Digestive Disease Research Center), NIH grant UL1TR000445 (Vanderbilt CTSA), and the Thomas F. Frist, Sr. Endowment to KTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Barrie A, 2013, DIGEST DIS SCI, V58, P222, DOI 10.1007/s10620-012-2329-7; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chen W, 2001, SCAND J GASTROENTERO, V36, P515, DOI 10.1080/003655201750153377; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Christophi GP, 2012, INFLAMM BOWEL DIS, V18, P2342, DOI 10.1002/ibd.22957; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kumawat AK, 2013, MOL IMMUNOL, V55, P355, DOI 10.1016/j.molimm.2013.03.007; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Ohman L, 2013, INFLAMM BOWEL DIS, V19, P2433, DOI 10.1097/MIB.0b013e3182a563cb; Rosen MJ, 2013, J IMMUNOL, V190, P1849, DOI 10.4049/jimmunol.1201373; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh K, 2013, AM J PHYSIOL-GASTR L, V305, pG225, DOI 10.1152/ajpgi.00091.2013; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Williams CS, 2013, GUT, V62, P1446, DOI 10.1136/gutjnl-2011-301439	33	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82300	10.1371/journal.pone.0082300	http://dx.doi.org/10.1371/journal.pone.0082300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367513	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300029
J	Jeffries, DL; Chapman, J; Roy, HE; Humphries, S; Harrington, R; Brown, PMJ; Handley, LJL				Jeffries, Daniel L.; Chapman, Jason; Roy, Helen E.; Humphries, Stuart; Harrington, Richard; Brown, Peter M. J.; Handley, Lori-J. Lawson			Characteristics and Drivers of High-Altitude Ladybird Flight: Insights from Vertical-Looking Entomological Radar	PLOS ONE			English	Article							COCCINELLA-SEPTEMPUNCTATA COLEOPTERA; HARMONIA-AXYRIDIS COLEOPTERA; BEETLES COCCINELLIDAE; MIGRATION; DISPERSAL; PREY; PREDATION; APHIDS; AGGREGATION; MOVEMENT	Understanding the characteristics and drivers of dispersal is crucial for predicting population dynamics, particularly in range-shifting species. Studying long-distance dispersal in insects is challenging, but recent advances in entomological radar offer unique insights. We analysed 10 years of radar data collected at Rothamsted Research, U.K., to investigate characteristics (altitude, speed, seasonal and annual trends) and drivers (aphid abundance, air temperature, wind speed and rainfall) of high-altitude flight of the two most abundant U.K. ladybird species (native Coccinella septempunctata and invasive Harmonia axyridis). These species cannot be distinguished in the radar data since their reflectivity signals overlap, and they were therefore analysed together. However, their signals do not overlap with other, abundant insects so we are confident they constitute the overwhelming majority of the analysed data. The target species were detected up to similar to 1100 m above ground level, where displacement speeds of up to similar to 60 km/h were recorded, however most ladybirds were found between similar to 150 and 500 m, and had a mean displacement of 30 km/h. Average flight time was estimated, using tethered flight experiments, to be 36.5 minutes, but flights of up to two hours were observed. Ladybirds are therefore potentially able to travel 18 km in a "typical'' high-altitude flight, but up to 120 km if flying at higher altitudes, indicating a high capacity for long-distance dispersal. There were strong seasonal trends in ladybird abundance, with peaks corresponding to the highest temperatures of mid-summer, and warm air temperature was the key driver of ladybird flight. Climatic warming may therefore increase the potential for long-distance dispersal in these species. Low aphid abundance was a second significant factor, highlighting the important role of aphid population dynamics in ladybird dispersal. This research illustrates the utility of radar for studying high-altitude insect flight and has important implications for predicting long-distance dispersal.	[Jeffries, Daniel L.; Humphries, Stuart; Handley, Lori-J. Lawson] Univ Hull, Dept Biol Sci, Kingston Upon Hull, Humberside, England; [Chapman, Jason; Harrington, Richard] Rothamsted Res, Harpenden, Herts, England; [Chapman, Jason] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Roy, Helen E.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Brown, Peter M. J.] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England	University of Hull; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter; UK Centre for Ecology & Hydrology (UKCEH); Anglia Ruskin University	Handley, LJL (corresponding author), Univ Hull, Dept Biol Sci, Kingston Upon Hull, Humberside, England.	l.lawson-handley@hull.ac.uk	Roy, Helen/A-1488-2010; Humphries, Stuart/A-5664-2008	Humphries, Stuart/0000-0001-9766-6404; Chapman, Jason/0000-0002-7475-4441; Brown, Peter Michael James/0000-0002-6163-4504; Lawson Handley, Lori/0000-0002-8153-5511	Department of Biological Sciences, University of Hull; UK Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council; Joint Nature Conservation Committee; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00005191, BBS/E/C/00005195] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish; BBSRC [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: UKRI	Department of Biological Sciences, University of Hull(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Joint Nature Conservation Committee; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was primarily funded by the Department of Biological Sciences, University of Hull. In addition, Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). HER is funded by the Natural Environment Research Council and also receives funding from the Joint Nature Conservation Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054202; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; Brown PMJ, 2011, ECOL ENTOMOL, V36, P231, DOI 10.1111/j.1365-2311.2011.01264.x; Cardinale BJ, 2006, J ANIM ECOL, V75, P497, DOI 10.1111/j.1365-2656.2006.01070.x; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2006, ECOL ENTOMOL, V31, P378, DOI 10.1111/j.1365-2311.2006.00797.x; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, COMPUT ELECTRON AGR, V35, P95, DOI 10.1016/S0168-1699(02)00013-3; Crawley MJ, 2007, TIME SERIES ANAL R B; DAVIDSON W. M., 1924, Transactions Amer. ent. Soc., V50, P163; Dingle Hugh, 1996, P1; DRAKE VA, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P427, DOI 10.1017/CBO9780511470875.022; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; Elliott NC, 2000, BIOL CONTROL, V17, P218, DOI 10.1006/bcon.1999.0797; Evans EW, 2007, POPUL ECOL, V49, P29, DOI 10.1007/s10144-006-0022-4; Evans EW, 2011, BIOCONTROL, V56, P597, DOI 10.1007/s10526-011-9374-6; EVANS EW, 1991, OECOLOGIA, V87, P401, DOI 10.1007/BF00634598; Evans EW, 2003, EUR J ENTOMOL, V100, P1, DOI 10.14411/eje.2003.001; EVANS EW, 1986, J ANIM ECOL, V55, P1027, DOI 10.2307/4431; Evans WE, 1992, UTAH ALFALFA FIELDS, V65, P30; Fabre F, 2010, ECOL MODEL, V221, P1770, DOI 10.1016/j.ecolmodel.2010.04.006; Frazer B.D., 1988, P231; FRAZER BD, 1981, CAN ENTOMOL, V113, P1025, DOI 10.4039/Ent1131025-11; Grez AA, 2005, EUR J ENTOMOL, V102, P209, DOI 10.14411/eje.2005.033; HAGEN KS, 1962, ANNU REV ENTOMOL, V7, P289, DOI 10.1146/annurev.en.07.010162.001445; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; HEMPTINNE JL, 1992, OECOLOGIA, V90, P238, DOI 10.1007/BF00317181; HODEK I, 1993, EUR J ENTOMOL, V90, P403; Hodek I, 1996, ECOLOGY COCCINELLIDA; Huelsman MF., 2002, P 4 INT C URB PESTS, P243; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; IVES PM, 1981, CAN ENTOMOL, V113, P981, DOI 10.4039/Ent113981-11; Johnson C.G., 1969, MIGRATION DISPERSAL; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; KIECKHEF.RW, 1974, J ECON ENTOMOL, V67, P52, DOI 10.1093/jee/67.1.52; Krivan V, 2008, EUR J ENTOMOL, V105, P405, DOI 10.14411/eje.2008.051; MACAULAY EDM, 1988, B ENTOMOL RES, V78, P121, DOI 10.1017/S0007485300016126; NAKAMUTA K, 1987, PHYSIOL ENTOMOL, V12, P91, DOI 10.1111/j.1365-3032.1987.tb00727.x; Okuda T, 1986, ECOLOGY APHIDOPHAGA, P217; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; R Core Development Team, 2008, R LANG ENV STAT COMP; RANKIN MA, 1980, BIOL BULL, V158, P356, DOI 10.2307/1540862; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; RILEY JR, 1985, P IEEE, V73, P228, DOI 10.1109/PROC.1985.13135; Roy H., 2011, LADYBIRDS COCCINELLI; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; SAROSPATAKI M, 1995, EUR J ENTOMOL, V92, P415; Smith AD, 1996, COMPUT ELECTRON AGR, V15, P267, DOI 10.1016/0168-1699(96)00021-X; Smith AD, 2000, B ENTOMOL RES, V90, P265, DOI 10.1017/S0007485300000389; SMITH AD, 1993, PHILOS T R SOC B, V340, P393, DOI 10.1098/rstb.1993.0081; SOLBRECK C, 1974, OECOLOGIA, V17, P265, DOI 10.1007/BF00344926; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Stals R, 2009, IOBC WPRS B, V58, P125; Sullivan MJP, 2012, METHODS ECOL EVOL, V3, P870, DOI 10.1111/j.2041-210X.2012.00219.x; TAYLOR LR, 1974, J ANIM ECOL, V43, P225, DOI 10.2307/3169; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; Van der Werf W, 2000, EUR J ENTOMOL, V97, P487; WOIWOD IP, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P321; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	67	32	42	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82278	10.1371/journal.pone.0082278	http://dx.doi.org/10.1371/journal.pone.0082278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367512	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300028
J	Kotaki, T; Khairunisa, SQ; Sukartiningrum, SD; Arfijanto, MV; Utsumi, T; Normalina, I; Handajani, R; Widiyanti, P; Rusli, M; Rahayu, RP; Lusida, MI; Hayashi, Y; Nasronudin; Kameoka, M				Kotaki, Tomohiro; Khairunisa, Siti Qamariyah; Sukartiningrum, Septhia Dwi; Arfijanto, M. Vitanata; Utsumi, Takako; Normalina, Irine; Handajani, Retno; Widiyanti, Prihartini; Rusli, Musofa; Rahayu, Retno Pudji; Lusida, Maria Inge; Hayashi, Yoshitake; Nasronudin; Kameoka, Masanori			High Prevalence of HIV-1 CRF01_AE Viruses among Female Commercial Sex Workers Residing in Surabaya, Indonesia	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; C VIRUS; EPIDEMIOLOGY; IDENTIFICATION; PREVENTION; THAILAND; BANGKOK	Background: Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) cause serious health problems and have an impact on the Indonesian economy. In addition, the rapid epidemic growth of HIV is continuing in Indonesia. Commercial sex plays a significant role in the spread of HIV; therefore, in order to reveal the current HIV prevalence rate among commercial sex workers (CSWs), we conducted an epidemiological study on HIV infection among CSWs residing in Surabaya, the capital of East Java province of Indonesia with large communities of CSWs. Methodology/Principal Findings: The prevalence of HIV infection among 200 CSWs was studied. In addition, the subtype of HIV type 1 (HIV-1) and the prevalence of other blood-borne viruses, hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus C (GBV-C), were studied. The prevalence rates of HIV, hepatitis B core antibody, hepatitis B surface antigen, anti-HCV antibodies and anti-GBV-C antibodies were 11%, 64%, 4%, 0.5% and 0% among CSWs involved in this study, respectively. HIV-1 CRF01_AE viral gene fragments were detected in most HIV-positive samples. In addition, most CSWs showed low awareness of sexually transmitted diseases and had unprotected sex with their clients. Conclusions/Significance: The HIV prevalence rate among CSWs was significantly higher than that among the general population in Indonesia (0.2-0.4%). In addition, CSWs were at a high risk of exposure to HBV, although chronic HBV infection was less frequently established. Our results suggest the necessity of efficient prevention programs for HIV and other blood-borne viral infections among CSWs in Surabaya, Indonesia.	[Kotaki, Tomohiro; Khairunisa, Siti Qamariyah; Sukartiningrum, Septhia Dwi; Arfijanto, M. Vitanata; Utsumi, Takako; Normalina, Irine; Handajani, Retno; Widiyanti, Prihartini; Rusli, Musofa; Rahayu, Retno Pudji; Lusida, Maria Inge; Nasronudin] Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia; [Kotaki, Tomohiro; Utsumi, Takako; Hayashi, Yoshitake; Kameoka, Masanori] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan; [Arfijanto, M. Vitanata; Handajani, Retno; Rusli, Musofa; Lusida, Maria Inge; Nasronudin] Airlangga Univ, Fac Med, Surabaya, Indonesia; [Kameoka, Masanori] Kobe Univ, Dept Int Hlth, Grad Sch Hlth Sci, Kobe, Hyogo, Japan	Airlangga University; Kobe University; Airlangga University; Kobe University	Kameoka, M (corresponding author), Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan.	mkameoka@port.kobe-u.ac.jp	Khairunisa, Siti Qamariyah/AAM-6019-2021; Khairunisa, Siti Qamariyah/AAK-8975-2021; Rusli, Musofa/ABC-3885-2020; Widiyanti, Prihartini/G-7385-2017; Handajani, Retno/AAQ-3664-2021	Khairunisa, Siti Qamariyah/0000-0002-0006-4229; Rusli, Musofa/0000-0002-4834-2259; Widiyanti, Prihartini/0000-0002-5636-5100; nasronudin, nasronudin/0000-0001-7882-9992; effendi, wiwin is/0000-0003-3716-2452; Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology of Japan; Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriandi Irvan, 2009, Acta Med Indones, V41 Suppl 1, P75; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Anggorowati N, 2013, MICROBIOL IMMUNOL, V57, P298, DOI 10.1111/1348-0421.12033; Anggorowati N, 2012, J MED VIROL, V84, P857, DOI 10.1002/jmv.23293; Couture MC, 2011, SEX TRANSM DIS, V38, P33, DOI 10.1097/OLQ.0b013e3182000e47; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Guy R, 2011, INT J STD AIDS, V22, P505, DOI 10.1258/ijsa.2009.009445; Gyarmathy VA, 2002, J ACQ IMMUN DEF SYND, V30, P448, DOI [10.1097/00042560-200208010-00011, 10.1097/01.QAI.0000018880.78058.98]; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Hasan Irsan, 2005, Acta Med Indones, V37, P231; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ibrahim K, 2010, INT J NURS PRACT, V16, P87, DOI 10.1111/j.1440-172X.2010.01816.x; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau KA, 2007, AIDS REV, V9, P218; Magnani R, 2010, SEX TRANSM INFECT, V86, P393, DOI 10.1136/sti.2009.038059; Manopaiboon C, 2013, INT J STD AIDS, V24, P34, DOI 10.1177/0956462412472300; MIURA T, 1990, AIDS, V4, P1257, DOI 10.1097/00002030-199012000-00012; Morineau G, 2011, SE ASIAN J TROP MED, V42, P634; Nasronudin, 2008, FOLIA MED INDONESIA, V44, P93; Nhurod P, 2010, SE ASIAN J TROP MED, V41, P153; Panigrahi R, 2012, ANN HEPATOL, V11, P870, DOI 10.1016/S1665-2681(19)31412-7; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Sahbandar IN, 2009, AIDS RES HUM RETROV, V25, P637, DOI 10.1089/aid.2008.0266; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soetjipto, 1996, J CLIN MICROBIOL, V34, P2875, DOI 10.1128/JCM.34.12.2875-2880.1996; Takehisa J, 1998, VIROLOGY, V245, P1, DOI 10.1006/viro.1998.9141; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thedja MD, 2010, HEPATOL INT, V4, P608, DOI 10.1007/s12072-010-9203-5; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Utsumi T, 2013, HEPATOL RES, V43, P1032, DOI 10.1111/hepr.12053; Yan YX, 2011, EPIDEMIOL INFECT, V139, P354, DOI 10.1017/S0950268810001597	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82645	10.1371/journal.pone.0082645	http://dx.doi.org/10.1371/journal.pone.0082645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367533	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000328740300049
J	Smith, SDA; Markic, A				Smith, Stephen D. A.; Markic, Ana			Estimates of Marine Debris Accumulation on Beaches Are Strongly Affected by the Temporal Scale of Sampling	PLOS ONE			English	Article							LITTER POLLUTION; PLASTIC LITTER; ISLAND; SEA; ARCHIPELAGO; ENVIRONMENT; ABUNDANCE; DYNAMICS; IMPACTS; SHORES	Marine debris is a global issue with impacts on marine organisms, ecological processes, aesthetics and economies. Consequently, there is increasing interest in quantifying the scale of the problem. Accumulation rates of debris on beaches have been advocated as a useful proxy for at-sea debris loads. However, here we show that past studies may have vastly underestimated the quantity of available debris because sampling was too infrequent. Our study of debris on a small beach in eastern Australia indicates that estimated daily accumulation rates decrease rapidly with increasing intervals between surveys, and the quantity of available debris is underestimated by 50% after only 3 days and by an order of magnitude after 1 month. As few past studies report sampling frequencies of less than a month, estimates of the scale of the marine debris problem need to be critically re-examined and scaled-up accordingly. These results reinforce similar, recent work advocating daily sampling as a standard approach for accurate quantification of available debris in coastal habitats. We outline an alternative approach whereby site-specific accumulation models are generated to correct bias when daily sampling is impractical.	[Smith, Stephen D. A.; Markic, Ana] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	Southern Cross University	Smith, SDA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steve.smith@scu.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441				Ariza E, 2008, WASTE MANAGE, V28, P2604, DOI 10.1016/j.wasman.2007.11.012; Ballance A, 2000, S AFR J SCI, V96, P210; Bowman D, 1998, J COASTAL RES, V14, P418; Bravo M, 2009, MAR POLLUT BULL, V58, P1718, DOI 10.1016/j.marpolbul.2009.06.017; Cheshire A. C., 2009, UNEP REGIONAL SEAS R, V83; Cheshire A.C., 2009, UNEP REGIONAL SEAS R, V186; Convey P, 2002, POLAR BIOL, V25, P612, DOI 10.1007/s00300-002-0391-x; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Debrot AO, 2013, MAR POLLUT BULL, V72, P1, DOI 10.1016/j.marpolbul.2013.03.023; Eastman LB, 2013, OCEAN COAST MANAGE, V78, P18, DOI 10.1016/j.ocecoaman.2013.02.014; Eriksson C, 2013, MAR POLLUT BULL, V66, P199, DOI 10.1016/j.marpolbul.2012.08.026; Frost A, 1997, MAR POLLUT BULL, V34, P348, DOI 10.1016/S0025-326X(96)00149-X; GARRITY SD, 1993, MAR POLLUT BULL, V26, P317, DOI 10.1016/0025-326X(93)90574-4; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hammer J, 2012, REV ENVIRON CONTAM T, V220, P1, DOI 10.1007/978-1-4614-3414-6_1; Hinojosa IA, 2009, MAR POLLUT BULL, V58, P341, DOI 10.1016/j.marpolbul.2008.10.020; Hong S, 2013, MAR POLLUT BULL, V66, P117, DOI 10.1016/j.marpolbul.2012.10.022; Kusui T, 2003, MAR POLLUT BULL, V47, P175, DOI 10.1016/S0025-326X(02)00478-2; Madzena A, 1997, MAR POLLUT BULL, V34, P900, DOI 10.1016/S0025-326X(97)00052-0; Martin JM, 2013, MAR POLLUT BULL, V74, P165, DOI 10.1016/j.marpolbul.2013.07.009; Martinez E, 2009, MAR POLLUT BULL, V58, P1347, DOI 10.1016/j.marpolbul.2009.04.022; Martinez-Ribes L, 2007, SCI MAR, V71, P305, DOI 10.3989/scimar.2007.71n2305; MERRELL TR, 1980, MAR ENVIRON RES, V3, P171, DOI 10.1016/0141-1136(80)90025-2; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moore E, 2009, MAR POLLUT BULL, V58, P1045, DOI 10.1016/j.marpolbul.2009.02.006; Moore SL, 2001, MAR POLLUT BULL, V42, P241, DOI 10.1016/S0025-326X(00)00148-X; Morishige C, 2007, MAR POLLUT BULL, V54, P1162, DOI 10.1016/j.marpolbul.2007.04.014; Pichel WG, 2007, MAR POLLUT BULL, V54, P1207, DOI 10.1016/j.marpolbul.2007.04.010; Ribic C. A., 1992, MARINE DEBRIS SURVEY; Ribic CA, 2012, MAR POLLUT BULL, V64, P1726, DOI 10.1016/j.marpolbul.2012.04.001; Rollason V., 2009, COFFS HARBOUR COASTA; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos IR, 2005, OCEAN COAST MANAGE, V48, P742, DOI 10.1016/j.ocecoaman.2005.08.006; Santos IR, 2009, ENVIRON MONIT ASSESS, V148, P455, DOI 10.1007/s10661-008-0175-z; Short AD, 2003, J COASTAL RES, P7; Silva-Cavalcanti JS, 2009, WASTE MANAGE RES, V27, P93, DOI 10.1177/0734242X08088705; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Smith SDA, 2012, MAR POLLUT BULL, V64, P1880, DOI 10.1016/j.marpolbul.2012.06.013; Smith V. K., 1997, Environmental and Resource Economics, V10, P223, DOI 10.1023/A:1026465413899; Somerville SE, 2003, MAR POLLUT BULL, V46, P1184, DOI 10.1016/S0025-326X(03)00126-7; Thiel M, 2013, MAR POLLUT BULL, V71, P307, DOI 10.1016/j.marpolbul.2013.01.005; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Thornton L, 1998, MAR POLLUT BULL, V36, P705, DOI 10.1016/S0025-326X(98)00041-1; Uneputty PA, 1997, MAR POLLUT BULL, V34, P652, DOI 10.1016/S0025-326X(97)00006-4; VAUK GJM, 1987, MAR POLLUT BULL, V18, P316, DOI 10.1016/S0025-326X(87)80018-8; Williams AT, 2001, J COASTAL RES, V17, P137; WILLOUGHBY NG, 1986, MAR POLLUT BULL, V17, P224, DOI 10.1016/0025-326X(86)90605-3	47	39	39	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83694	10.1371/journal.pone.0083694	http://dx.doi.org/10.1371/journal.pone.0083694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367607	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300114
J	Tian, Y; Ding, WC; Wang, YY; Ji, T; Sun, SJ; Mo, QQ; Chen, PB; Fang, Y; Liu, J; Wang, BB; Zhou, JF; Ma, D; Wu, P				Tian, Yuan; Ding, Wencheng; Wang, Yingying; Ji, Teng; Sun, Shujuan; Mo, Qingqing; Chen, Pingbo; Fang, Yong; Liu, Jia; Wang, Beibei; Zhou, Jianfeng; Ma, Ding; Wu, Peng			Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MOLECULAR-MECHANISMS; POLYUBIQUITIN; IRRADIATION; TUMORS; GENES	Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degradation associated with an elevated metabolic turnover rate. Ubiquitin, which is a small, highly conserved protein expressed in all eukaryotic cells, can be covalently linked to certain target proteins to mark them for degradation by the ubiquitin-proteasome system. Previous studies highlight the essential role of Ubiquitin B (UbB) and UbB-dependent proteasomal protein degradation in histone deacetylase inhibitor (HDACi) -induced tumor selectivity. We hypothesized that UbB plays a critical role in the function of cervical cancer stem cells. We measured endogenous UbB levels in mammospheres in vitro by real-time PCR and Western blotting. The function of UbB in cancer stem-like cells was assessed after knockdown of UbB expression in prolonged Trichostatin A-selected HeLa cells (HeLa/TSA) by measuring in vitro cell proliferation, cell apoptosis, invasion, and chemotherapy resistance as well as by measuring in vivo growth in an orthotopic model of cervical cancer. We also assessed the cancer stem cell frequency, tumorsphere formation, and in vivo growth of human cervical cancer xenografts after UbB silencing. We found that HeLa/TSA were resistant to chemotherapy, highly expressed the UbB gene and the stem cell markers Sox2, Oct4 and Nanog. These cells also displayed induced differentiation abilities, including enhanced migration/invasion/malignancy capabilities in vitro and in vivo. Furthermore, an elevated expression of UbB was shown in the tumor samples of chemotherapy patients. Silencing of UbB inhibited tumorsphere formation, lowered the expression of stem cell markers and decreased cervical xenograft growth. Our results demonstrate that UbB was significantly increased in prolonged Trichostatin A-selected HeLa cells and it played a key role in the maintenance of cervical cancer stem-like cells.	[Tian, Yuan; Ding, Wencheng; Ji, Teng; Sun, Shujuan; Mo, Qingqing; Chen, Pingbo; Fang, Yong; Liu, Jia; Wang, Beibei; Zhou, Jianfeng; Ma, Ding; Wu, Peng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Wang, Yingying] Zhengzhou Univ, Affiliated Hosp 3, Dept Gynecol, Zhengzhou 450052, Henan, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University	Wu, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	pengwu8626@126.com	wu, peng/M-1812-2019; wang, yingying/GRS-3058-2022	wu, peng/0000-0002-4016-6641; 	National Science Foundation of China [81372806, 81101962, 81101965, 81202060]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China (No. 81372806; 81101962; 81101965; 81202060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bosch FX, 2012, VACCINE, V30, pF1, DOI 10.1016/j.vaccine.2012.05.090; Cadron I, 2007, GYNECOL ONCOL, V107, pS113, DOI 10.1016/j.ygyno.2007.07.004; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; DELIC J, 1993, MOL CELL BIOL, V13, P4875, DOI 10.1128/MCB.13.8.4875; FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269; Hemmings C, 2010, PATHOLOGY, V42, P105, DOI 10.3109/00313020903488773; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim HJ, 2011, AM J TRANSL RES, V3, P166; NENOI M, 1992, INT J RADIAT BIOL, V61, P205, DOI 10.1080/09553009214550831; Peralta-Zaragoza O, 2012, ONCOTARGETS THER, V5, P315, DOI 10.2147/OTT.S25123; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Todaro M, 2010, CELL CYCLE, V9, P1238; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	18	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84457	10.1371/journal.pone.0084457	http://dx.doi.org/10.1371/journal.pone.0084457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367661	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300141
J	Khanna, N; Godbold, JA; Austin, WEN; Paterson, DM				Khanna, Nikki; Godbold, Jasmin A.; Austin, William E. N.; Paterson, David M.			The Impact of Ocean Acidification on the Functional Morphology of Foraminifera	PLOS ONE			English	Article							BENTHIC FORAMINIFERA; CLIMATE-CHANGE	Culturing experiments were performed on sediment samples from the Ythan Estuary, N. E. Scotland, to assess the impacts of ocean acidification on test surface ornamentation in the benthic foraminifer Haynesina germanica. Specimens were cultured for 36 weeks at either 380, 750 or 1000 ppm atmospheric CO2. Analysis of the test surface using SEM imaging reveals sensitivity of functionally important ornamentation associated with feeding to changing seawater CO2 levels. Specimens incubated at high CO2 levels displayed evidence of shell dissolution, a significant reduction and deformation of ornamentation. It is clear that these calcifying organisms are likely to be vulnerable to ocean acidification. A reduction in functionally important ornamentation could lead to a reduction in feeding efficiency with consequent impacts on this organism's survival and fitness.	[Khanna, Nikki; Paterson, David M.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Godbold, Jasmin A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Khanna, Nikki; Austin, William E. N.] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Austin, William E. N.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Khanna, Nikki] Ichron Ltd, Northwich, England	University of St Andrews; NERC National Oceanography Centre; University of Southampton; University of St Andrews; UHI Millennium Institute	Khanna, N (corresponding author), Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland.	nk274@st-andrews.ac.uk	Godbold, Jasmin/AAB-2522-2022; Godbold, Jasmin A/F-1577-2012; Paterson, David/D-5202-2013	Godbold, Jasmin/0000-0001-5558-8188; Godbold, Jasmin A/0000-0001-5558-8188; Paterson, David/0000-0003-1174-6476	NERC UK Ocean Acidification Research Programme [NE/H017445/1]; NERC [NE/G018502/1]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [NE/E006795/1, NE/H017135/1, NE/H017445/2, NE/G018502/1] Funding Source: researchfish; NERC [NE/H017445/2, NE/H017135/1, NE/E006795/1] Funding Source: UKRI	NERC UK Ocean Acidification Research Programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the NERC UK Ocean Acidification Research Programme grant NE/H017445/1. WENA acknowledges NERC support (NE/G018502/1). DMP received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland). MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin HA, 2005, MAR MICROPALEONTOL, V57, P68, DOI 10.1016/j.marmicro.2005.07.002; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dissard D, 2010, BIOGEOSCIENCES, V7, P81, DOI 10.5194/bg-7-81-2010; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0186; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Hallock P., 1991, P41; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hansen HJ, 1999, MODERN FORAMINIFERA, P57; Haynert K, 2011, MAR ECOL PROG SER, V432, P53, DOI 10.3354/meps09138; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Cadre V, 2003, J FORAMIN RES, V33, P1, DOI 10.2113/0330001; Lee J.J., 1980, BIOCH PHYSL PROTOZOA, V3, P43; Loeblich Jr A.R., 2015, FORAMINIFERAL GENERA; Marszalek D. S, 1969, Transactions Gulf Coast Ass Geol Socs, V19, P341; Moodley L, 2000, MAR ECOL PROG SER, V202, P289, DOI 10.3354/meps202289; Murray J. W., 1991, ECOLOGY PALAEOECOLOG; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; R Development Core Team, 2012, R LANG ENV STAT COMP	24	22	25	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83118	10.1371/journal.pone.0083118	http://dx.doi.org/10.1371/journal.pone.0083118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358253	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000328737700048
J	Arai, M; Tokunaga, Y; Takagi, A; Tobita, Y; Hirata, Y; Ishida, Y; Tateno, C; Kohara, M				Arai, Masaaki; Tokunaga, Yuko; Takagi, Asako; Tobita, Yoshimi; Hirata, Yuichi; Ishida, Yuji; Tateno, Chise; Kohara, Michinori			Isolation and Characterization of Highly Replicable Hepatitis C Virus Genotype 1a Strain HCV-RMT	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; B TYPE-I; EFFICIENT REPLICATION; RNA REPLICATION; LIPID DROPLET; CORE PROTEIN; HUMAN LIVER; CDNA-CLONE; INFECTION; CULTURE	Multiple genotype 1a clones have been reported, including the very first hepatitis C virus (HCV) clone called H77. The replication ability of some of these clones has been confirmed in vitro and in vivo, although this ability is somehow compromised. We now report a newly isolated genotype 1a clone, designated HCV-RMT, which has the ability to replicate efficiently in patients, chimeric mice with humanized liver, and cultured cells. An authentic subgenomic replicon cell line was established from the HCV-RMT sequence with spontaneous introduction of three adaptive mutations, which were later confirmed to be responsible for efficient replication in HuH-7 cells as both subgenomic replicon RNA and viral genome RNA. Following transfection, the HCV-RMT RNA genome with three adaptive mutations was maintained for more than 2 months in HuH-7 cells. One clone selected from the transfected cells had a high copy number, and its supernatant could infect naive HuH-7 cells. Direct injection of wild-type HCV-RMT RNA into the liver of chimeric mice with humanized liver resulted in vigorous replication, similar to inoculation with the parental patient's serum. A study of virus replication using HCV-RMT derivatives with various combinations of adaptive mutations revealed a clear inversely proportional relationship between in vitro and in vivo replication abilities. Thus, we suggest that HCV-RMT and its derivatives are important tools for HCV genotype 1a research and for determining the mechanism of HCV replication in vitro and in vivo.	[Arai, Masaaki; Tokunaga, Yuko; Takagi, Asako; Tobita, Yoshimi; Hirata, Yuichi; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Ishida, Yuji; Tateno, Chise] PhoenixBio Co Ltd, Hiroshima, Japan	Tokyo Metropolitan Institute of Medical Science; PHOENIXBIO CO. LTD.	Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan.	kohara-mc@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Arai M, 2011, ARCH VIROL, V156, P295, DOI 10.1007/s00705-010-0859-x; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hiraga N, 2007, FEBS LETT, V581, P1983, DOI 10.1016/j.febslet.2007.04.021; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Kamiya N, 2010, J GEN VIROL, V91, P1668, DOI 10.1099/vir.0.019315-0; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Li YP, 2012, P NATL ACAD SCI USA, V109, P19757, DOI 10.1073/pnas.1218260109; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SHIMIZU YK, 1990, P NATL ACAD SCI USA, V87, P6441, DOI 10.1073/pnas.87.16.6441; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82527	10.1371/journal.pone.0082527	http://dx.doi.org/10.1371/journal.pone.0082527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358200	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700079
J	Zhou, X; Xie, WH; Li, Q; Zhang, YF; Zhang, J; Zhao, XP; Liu, JJ; Huang, G				Zhou, Xiang; Xie, Wenhui; Li, Qian; Zhang, Yifan; Zhang, Jie; Zhao, Xiaoping; Liu, Jianjun; Huang, Gang			TIGAR Is Correlated with Maximal Standardized Uptake Value on FDG-PET and Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE-TRANSPORTER; METABOLISM; EXPRESSION; APOPTOSIS	Objective: Evaluation of F-18-FDG uptake value via PET is central to current methods of diagnosis and staging of non-small cell lung cancer (NSCLC) due to its ability to evaluate expression levels of key regulators associated with glucose metabolism in tumor cells. Tp53-induced glycolysis and apoptosis regulator (TIGAR) is an important P53-induced protein that can inhibit glycolysis; however, there have been few clinical studies on its mechanism. Here we have investigated the relationship between TIGAR expression and F-18-FDG PET in tumors, along with its relationship with the clinical characteristics of NSCLC. Methods: We analyzed SUVmax in 79 patients with NSCLC through immunohistochemical staining of TIGAR and five other biological markers associated with tumor cell glycolysis, in order to evaluate the correlation between their expression and SUVmax. We also plotted Kaplan-Meier survival curves to assess TIGAR expression with the prognosis and survival of patients with NSCLC. Results: The key findings were as follows: SUVmax was negatively correlated with the expression of TIGAR (r = 20.31, p<0.01); TIGAR expression was correlated with tumor size (p = 0.01), histological type (p<0.01), differentiation degree (p<0.01) and lymph node metastasis(p<0.01) in patients with NSCLC; and the survival time of patients whose TIGAR was negatively expressed was significantly shorter than for those whose TIGAR was positively expressed (P = 0.023). Conclusions: The expression of TIGAR in primary tumors is significantly correlated with SUVmax, and low expression of TIGAR may predict a worse clinical outcome in patients with NSCLC.	[Zhou, Xiang; Li, Qian; Zhao, Xiaoping; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Xie, Wenhui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhang, Yifan] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhang, Jie] Shanghai Jiao Tong Univ, Dept Pathol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	ljjsh@133sh.com; huang2802@163.com	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232	National Natural Science Foundation of China [30830038, 30970842, 81071180]; Major State Basic Research Development Program of China (973 Program) [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); New Drug Discovery Project	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30830038, 30970842, and 81071180), the Major State Basic Research Development Program of China (973 Program) (No. 2012CB932604), and the New Drug Discovery Project (No. 2012ZX09506-001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Bille A, 2009, EUR J CARDIO-THORAC, V36, P440, DOI 10.1016/j.ejcts.2009.04.003; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Corcoran CA, 2006, CANCER BIOL THER, V5, P1610, DOI 10.4161/cbt.5.12.3617; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa H, 2009, LEUKEMIA, V23, P2090, DOI 10.1038/leu.2009.171; Herling A, 2011, FEBS J, V278, P2436, DOI 10.1111/j.1742-4658.2011.08174.x; Kobayashi M, 2012, CLIN NUCL MED, V37, P447, DOI 10.1097/RLU.0b013e31823924bb; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Li L, 2013, LUNG CANCER, V81, P213, DOI 10.1016/j.lungcan.2013.04.012; Li MH, 2009, LUNG CANCER, V63, P383, DOI 10.1016/j.lungcan.2008.06.004; Lopez-Guerra M, 2008, HAEMATOL-HEMATOL J, V93, P1843, DOI 10.3324/haematol.13186; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Nguyen XC, 2008, EUR J CANCER, V44, P692, DOI 10.1016/j.ejca.2008.02.009; Shimizu K, 2012, ANN THORAC SURG, V93, P398, DOI 10.1016/j.athoracsur.2011.10.033; Tateishi U, 2006, EUR J NUCL MED MOL I, V33, P683, DOI 10.1007/s00259-005-0044-8; Taylor MD, 2009, J THORAC CARDIOV SUR, V137, P43, DOI 10.1016/j.jtcvs.2008.10.014; Tohma T, 2005, HEPATO-GASTROENTEROL, V52, P486; Vesselle H, 2007, CLIN CANCER RES, V13, P3105; Watanabe Yoh, 2003, Ann Thorac Cardiovasc Surg, V9, P343; Wu CD, 2004, ENDOCRINOLOGY, V145, P650, DOI 10.1210/en.2003-1290; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	24	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80576	10.1371/journal.pone.0080576	http://dx.doi.org/10.1371/journal.pone.0080576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24363807	Green Published, Green Submitted, gold			2022-12-25	WOS:000328707400004
J	de Wilde, JA; van Dommelen, P; Middelkoop, BJC				de Wilde, Jeroen A.; van Dommelen, Paula; Middelkoop, Barend J. C.			Appropriate Body Mass Index Cut-Offs to Determine Thinness, Overweight and Obesity in South Asian Children in The Netherlands	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; CHILDHOOD OVERWEIGHT; ETHNIC-DIFFERENCES; DIABETES-MELLITUS; ABDOMINAL OBESITY; GROWTH REFERENCE; PREVALENCE; RISK; RECOMMENDATIONS; ANTHROPOMETRY	Background: Asian populations have an increased risk of developing cardiometabolic disorders at a lower body mass index (BMI) than other ethnic groups. Therefore, lower adult BMI cut-offs to determine overweight and obesity are recommended to assess the associated health risks for Asian (23 and 27.5 kg/m(2) respectively) and Asian Indian (23, 25 kg/m(2)) populations. The objective of this study was to develop BMI cut-offs for thinness, overweight, and obesity for South Asian children in the Netherlands, and to compare the BMI cut-offs and distribution with an Asian Indian reference, the WHO Child Growth Reference, and universal BMI cut-offs. Methods: A reference cohort of 546 Surinamese South Asian boys and 521 girls, born between 1974-1976 (during the pre-obesity era) with 3408 and 3267 BMI measurements respectively, was retrospectively analysed. BMI-for-age charts were created with the LMS method. BMI centile curves passing through the cut-off points of 15 (thinness), 23 (overweight), 25 and 27.5 kg/m(2) (obesity) at 18y were drawn as cut-off levels. Results: The BMI of Surinamese South Asian children had a similar distribution to the Asian Indian reference, apart from a lower mean and less variation. The BMI distribution differed considerably from the WHO reference and universal BMI criteria. The calculated BMI cut-offs corresponding to a BMI of 15, 23, 25, and 27.5 kg/m(2) at 18y were at the 7.1, 81.1, 89.8, and 95.5 percentile respectively in boys, and at the 2.7, 79.5, 89.2, and 95.2 percentile in girls. Conclusions: This is the first study proposing BMI cut-offs for South Asian children based on measurements from a prosperous population unaffected by the obesity epidemic. We recommend the use of these cut-offs in South Asian children in the Netherlands as these better reflect the health risks associated with thinness, overweight and obesity, and therefore may prevent the development of cardiometabolic disorders.	[de Wilde, Jeroen A.] Municipal Hlth Serv The Hague GGD Den Haag, Dept Youth Hlth Care, The Hague, Netherlands; [de Wilde, Jeroen A.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Middelkoop, Barend J. C.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Middelkoop, Barend J. C.] Municipal Hlth Serv The Hague GGD Den Haag, Dept Epidemiol, The Hague, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Wilde, JA (corresponding author), Municipal Hlth Serv The Hague GGD Den Haag, Dept Youth Hlth Care, The Hague, Netherlands.	Jeroen.deWilde@denhaag.nl						Agyemang C, 2011, EPIDEMIOLOGY, V22, P563, DOI 10.1097/EDE.0b013e31821d1096; Agyemang C, 2010, AM J HYPERTENS, V23, P639, DOI 10.1038/ajh.2010.39; Balchin I, 2007, EARLY HUM DEV, V83, P749, DOI 10.1016/j.earlhumdev.2007.09.003; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Central Committee on Research Involving Human Subjects, 2012, STEP BY STEP PLAN RC; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; De Klerk C. J M., 1953, IMMIGRATIE HINDOSTAN; de Onis M, 2004, INT J OBESITY, V28, pS81, DOI 10.1038/sj.ijo.0802810; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2009, INDIAN PEDIATR, V46, P463; de Wilde JA, 2013, ARCH DIS CHILD, V98, P280, DOI 10.1136/archdischild-2012-303045; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Duncan JS, 2010, NEW ZEAL MED J, V123, P22; Duncan JS, 2009, ASIA PAC J CLIN NUTR, V18, P404; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ganzeboom HBG, 2012, SOCIALE MOBILITEIT S; Garduno-Diaz SD, 2012, DIABETES-METAB RES, V28, P6, DOI 10.1002/dmrr.1219; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Khadilkar VV, 2012, INDIAN PEDIATR, V49, P29, DOI 10.1007/s13312-012-0011-y; Khadilkar VV, 2009, INDIAN PEDIATR, V46, P477; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Middelkoop BJC, 1999, INT J EPIDEMIOL, V28, P1119, DOI 10.1093/ije/28.6.1119; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2011, ANN NUTR METAB, V58, P203, DOI 10.1159/000329431; Mungra G., 1990, HINDOESTAANSE GEZINN; Nube M, 2009, PUBLIC HEALTH NUTR, V12, P507, DOI 10.1017/S1368980008002826; Pandey RM, 2009, METAB SYNDR RELAT D, V7, P133, DOI 10.1089/met.2008.0053; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Schweitz R, 1996, Ned Tijdschr Geneeskd, V140, P717; Tambyraja R L, 1991, Indian J Pediatr, V58, P415, DOI 10.1007/BF02750921; UN Inter-agency Group for Child Mortality Estimation, 2010, LEV TRENDS CHILD MOR; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wickramasinghe VP, 2013, ANN HUM BIOL, V40, P168, DOI 10.3109/03014460.2012.753109; Wickramasinghe VP, 2011, ANN HUM BIOL, V38, P537, DOI 10.3109/03014460.2011.573505; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434	49	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82822	10.1371/journal.pone.0082822	http://dx.doi.org/10.1371/journal.pone.0082822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367559	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900014
J	Ventura, E; Riondato, M; Sambuceti, G; Salis, A; Damonte, G; Cordazzo, C; Besir, H; Pistoia, V; Zardi, L				Ventura, Elisa; Riondato, Mattia; Sambuceti, Gianmario; Salis, Annalisa; Damonte, Gianluca; Cordazzo, Cinzia; Besir, Hueseyin; Pistoia, Vito; Zardi, Luciano			Use of the Uteroglobin Platform for the Expression of a Bivalent Antibody against Oncofetal Fibronectin in Escherichia coli	PLOS ONE			English	Article							SELECTIVE TARGETED DELIVERY; ED-B DOMAIN; MESSENGER-RNA; TNF-ALPHA; ANGIOGENESIS; ISOFORM; MARKER; PHAGE; RADIOIMMUNOTHERAPY; VASCULATURE	Escherichia coli is a robust, economic and rapid expression system for the production of recombinant therapeutic proteins. However, the expression in bacterial systems of complex molecules such as antibodies and fusion proteins is still affected by several drawbacks. We have previously described a procedure based on uteroglobin (UG) for the engineering of very soluble and stable polyvalent and polyspecific fusion proteins in mammalian cells (Ventura et al. 2009. J. Biol. Chem. 284:26646-26654.) Here, we applied the UG platform to achieve the expression in E. coli of a bivalent human recombinant antibody (L19) toward the oncofetal fibronectin (B-FN), a pan-tumor target. Purified bacterial L19-UG was highly soluble, stable, and, in all molecules, the L19 moiety maintained its immunoreactivity. About 50-70% of the molecules were covalent homodimer, however after refolding with the redox couple reduced-glutathione/oxidized-glutathione (GSH/GSSG), 100% of molecules were covalent dimers. Mass spectrometry studies showed that the proteins produced by E. coli and mammalian cells have an identical molecular mass and that both proteins are not glycosylated. L19-UG from bacteria can be freeze-dried without any loss of protein and immunoreactivity. In vivo, in tumor-bearing mice, radio-iodinated L19-UG selectively accumulated in neoplastic tissues showing the same performance of L19-UG from mammalian cells. The UG-platform may represent a general procedure for production of various biological therapeutics in E. coli.	[Ventura, Elisa; Pistoia, Vito] G Gaslini Inst Children, Lab Oncol, Genoa, Italy; [Riondato, Mattia; Sambuceti, Gianmario] Univ Genoa, IRCCS AOU San Martino, IST, Dept Hlth Sci Nucl Med, Genoa, Italy; [Salis, Annalisa] Ctr Excellence Biomed Res, Dept Hearth Environm & Life Sci, Genoa, Italy; [Damonte, Gianluca] Dept Expt Med, Genoa, Italy; [Damonte, Gianluca] Ctr Excellence Biomed Res, Genoa, Italy; [Cordazzo, Cinzia; Zardi, Luciano] Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy; [Besir, Hueseyin] EMBL Heidelberg, Prot Express & Purificat Core Facil, Heidelberg, Germany	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; European Molecular Biology Laboratory (EMBL)	Zardi, L (corresponding author), Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy.	luciano.zardi@sirius-biotech.com	Sambuceti, Gianmario/H-7767-2018; Salis, Annalisa/R-9241-2018	Sambuceti, Gianmario/0000-0003-2979-6500; RIONDATO, MATTIA/0000-0001-9046-7170; Ventura, Elisa/0000-0002-5999-7613; Salis, Annalisa/0000-0002-3082-2908; Besir, Huseyin/0000-0002-7249-4762	"Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health; "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro); EMBO Short Term Fellowship; Regione Liguria-Italy [PO CRO FSE 2007/13]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	"Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health; "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Regione Liguria-Italy; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was partially supported by "Cinque per mille e Ricerca Corrente, Ministero della Salute" from the Italian Ministry of Health. EV was supported by the "8 fellowship - Lenino Fontana e Maria Lionello" from FIRC (Fondazione Italiana per la Ricerca sul Cancro) and by an "EMBO Short Term Fellowship." CC and MR were supported by post-doctoral fellowships from Regione Liguria-Italy (PO CRO FSE 2007/13). Sirius-biotech S. R. L. financed the article-processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALZA E, 1988, FEBS LETT, V228, P42, DOI 10.1016/0014-5793(88)80580-5; Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; BORSI L, 1994, CELL ADHES COMMUN, V1, P307, DOI 10.3109/15419069409097262; BORSI L, 1995, J BIOL CHEM, V270, P6243, DOI 10.1074/jbc.270.11.6243; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Erba PA, 2012, J NUCL MED, V53, P922, DOI 10.2967/jnumed.111.101006; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Hynes RO, 1990, FIBRONECTINS; Johannsen M, 2010, EUR J CANCER, V46, P2926, DOI 10.1016/j.ejca.2010.07.033; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Miura K, 2012, CARCINOGENESIS, V33, P2311, DOI 10.1093/carcin/bgs347; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Neri D, 1998, ADV DRUG DELIVER REV, V31, P43, DOI 10.1016/S0169-409X(97)00093-8; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Papadia F, 2013, J SURG ONCOL, V107, P173, DOI 10.1002/jso.23168; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Ventura E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-104; Ventura E, 2009, J BIOL CHEM, V284, P26646, DOI 10.1074/jbc.M109.025924; ZARDI L, 1982, EMBO J, V1, P929, DOI 10.1002/j.1460-2075.1982.tb01273.x; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	34	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82878	10.1371/journal.pone.0082878	http://dx.doi.org/10.1371/journal.pone.0082878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367567	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900016
J	Chowdhury, UR; Holman, BH; Fautsch, MP				Chowdhury, Uttio Roy; Holman, Bradley H.; Fautsch, Michael P.			A Novel Rat Model to Study the Role of Intracranial Pressure Modulation on Optic Neuropathies	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; LAMINA-CRIBROSA; SPACE; PEOPLE; NUMBER	Reduced intracranial pressure is considered a risk factor for glaucomatous optic neuropathies. All current data supporting intracranial pressure as a glaucoma risk factor comes from retrospective and prospective studies. Unfortunately, there are no relevant animal models for investigating this link experimentally. Here we report a novel rat model that can be used to study the role of intracranial pressure modulation on optic neuropathies. Stainless steel cannulae were inserted into the cisterna magna or the lateral ventricle of Sprague-Dawley and Brown Norway rats. The cannula was attached to a pressure transducer connected to a computer that recorded intracranial pressure in real-time. Intracranial pressure was modulated manually by adjusting the height of a column filled with artificial cerebrospinal fluid in relation to the animal's head. After data collection the morphological appearance of the brain tissue was analyzed. Based on ease of surgery and ability to retain the cannula, Brown Norway rats with the cannula implanted in the lateral ventricle were selected for further studies. Baseline intracranial pressure for rats was 5.5 +/- 1.5 cm water (n=5). Lowering of the artificial cerebrospinal fluid column by 2 cm and 4 cm below head level reduced ICP to 3.7 +/- 1.0 cm water (n=5) and 1.5 +/- 0.6 cm water (n=4), a reduction of 33.0% and 72.7% below baseline. Raising the cerebrospinal fluid column by 4 cm increased ICP to 7.5 +/- 1.4 cm water (n=2) corresponding to a 38.3% increase in intracranial pressure. Histological studies confirmed correct cannula placement and indicated minimal invasive damage to brain tissues. Our data suggests that the intraventricular cannula model is a unique and viable model that can be used to study the effect of altered intracranial pressure on glaucomatous optic neuropathies.	[Chowdhury, Uttio Roy; Holman, Bradley H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA	Mayo Clinic	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN USA.	fautsch.michael@mayo.edu			Bright Focus Foundation [G2010019]; NIH [EY21727]; Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY021727] Funding Source: NIH RePORTER	Bright Focus Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Rochester, MN; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by Bright Focus Foundation grant G2010019; NIH research grant EY21727; Mayo Foundation, Rochester, MN; and Research to Prevent Blindness, New York, NY (MPF is a recipient of a Lew R. Wasserman Merit Award and the Department of Ophthalmology, Mayo Clinic is the recipient of an unrestricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler CK, 2012, AM J OPHTHALMOL, V153, P1206, DOI 10.1016/j.ajo.2011.12.017; Basati S, 2012, J NEUROSURG-PEDIATR, V10, P347, DOI 10.3171/2012.6.PEDS11457; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, MED HYPOTHESES, V79, P719, DOI 10.1016/j.mehy.2012.08.009; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2010, CURR OPIN OPHTHALMOL, V21, P106, DOI 10.1097/ICU.0b013e32833651d8; Berdahl JP, 2009, AM J OPHTHALMOL, V148, P623, DOI 10.1016/j.ajo.2009.06.002; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; BERDAHL JP, 2009, A VONGRAEFES ARCH KL, V247, P1284; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6435, DOI 10.1167/iovs.11-7523; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Goetz C.G., 2003, TXB CLIN NEUROLOGY, V2nd ed., P511; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Hoffmann J, 2013, CURR OPIN NEUROL, V26, P240, DOI 10.1097/WCO.0b013e328360eccc; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas Jost B, 2013, J Glaucoma, V22 Suppl 5, pS13, DOI 10.1097/IJG.0b013e31829349bf; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Li Z, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-66; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Morgan WH, 2003, CLIN EXP OPHTHALMOL, V31, P167, DOI 10.1046/j.1442-9071.2003.00629.x; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; MORROW BA, 1990, AM J PHYSIOL, V258, pR1170; Park YS, 2011, CHILD NERV SYST, V27, P903, DOI 10.1007/s00381-011-1398-9; Parrish RK, 2009, AM J OPHTHALMOL, V147, P717, DOI 10.1016/j.ajo.2008.10.007; Pollay M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-9; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Richling B, 1982, Neurosurg Rev, V5, P41, DOI 10.1007/BF01793630; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Szymanski JW., 1925, KLIN OCZ, V3, P145; VOGEL R, 1990, BRIT J OPHTHALMOL, V74, P3, DOI 10.1136/bjo.74.1.3; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wostyn P, 2011, MED HYPOTHESES, V77, P598, DOI 10.1016/j.mehy.2011.06.043; WOZNIAK M, 1975, J NEUROSURG, V43, P535, DOI 10.3171/jns.1975.43.5.0535; Xu H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-148; YAMADA S, 1975, CHILD BRAIN, V1, P187; Yang Y, 2010, MED HYPOTHESES, V74, P31, DOI 10.1016/j.mehy.2009.08.024	47	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82151	10.1371/journal.pone.0082151	http://dx.doi.org/10.1371/journal.pone.0082151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367501	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300019
J	Rotman, N; Guex, N; Gouranton, E; Wahli, W				Rotman, Nicolas; Guex, Nicolas; Gouranton, Erwan; Wahli, Walter			PPAR beta Interprets a Chromatin Signature of Pluripotency to Promote Embryonic Differentiation at Gastrulation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-BETA/DELTA; STEM-CELLS; TARGET GENES; PCR DATA; METHYLATION; REPRESSION; REGULATORS; PRC2; FATE; EZH2	Epigenetic post-transcriptional modifications of histone tails are thought to help in coordinating gene expression during development. An epigenetic signature is set in pluripotent cells and interpreted later at the onset of differentiation. In pluripotent cells, epigenetic marks normally associated with active genes (H3K4me3) and with silent genes (H3K27me3) atypically co-occupy chromatin regions surrounding the promoters of important developmental genes. However, it is unclear how these epigenetic marks are recognized when cell differentiation starts and what precise role they play. Here, we report the essential role of the nuclear receptor peroxisome proliferator-activated receptor beta (PPAR beta, NR1C2) in Xenopus laevis early development. By combining loss-of-function approaches, large throughput transcript expression analysis by the mean of RNA-seq and intensive chromatin immunoprecipitation experiments, we unveil an important cooperation between epigenetic marks and PPAR beta. During Xenopus laevis gastrulation PPAR beta recognizes H3K27me3 marks that have been deposited earlier at the pluripotent stage to activate early differentiation genes. Thus, PPAR beta is the first identified transcription factor that interprets an epigenetic signature of pluripotency, in vivo, during embryonic development. This work paves the way for a better mechanistic understanding of how the activation of hundreds of genes is coordinated during early development.	[Rotman, Nicolas; Gouranton, Erwan; Wahli, Walter] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, Lausanne, Switzerland; [Guex, Nicolas] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Wahli, Walter] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	University of Lausanne; Swiss Institute of Bioinformatics; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wahli, W (corresponding author), Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, Lausanne, Switzerland.	walter.wahli@unil.ch	Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009	Wahli, Walter/0000-0002-5966-9089; GUEX, Nicolas/0000-0001-6023-0519	Swiss National Science Foundation [NRP50]; Bonizzi-Theler-Stiftung; Etat de Vaud	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler-Stiftung; Etat de Vaud	This work was supported by grants from the Swiss National Science Foundation (NRP50, NCCR Frontiers in Genetics, individual grants to WW), the Bonizzi-Theler-Stiftung (WW), and the Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizu N, 2010, DEVELOPMENT, V137, P2915, DOI 10.1242/dev.049395; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rotman N, 2006, ADV DEV BIOL; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032	33	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83300	10.1371/journal.pone.0083300	http://dx.doi.org/10.1371/journal.pone.0083300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367589	Green Published, gold			2022-12-25	WOS:000328740300100
J	Yamanaka, O; Yuan, Y; Coulson-Thomas, VJ; Gesteira, TF; Call, MK; Zhang, YJ; Zhang, JH; Chang, SH; Xie, CC; Liu, CY; Saika, S; Jester, JV; Kao, WWY				Yamanaka, Osamu; Yuan, Yong; Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Call, Mindy K.; Zhang, Yujin; Zhang, Jianhua; Chang, Shao-Hsuan; Xie, Changchun; Liu, Chia-Yang; Saika, Shizuya; Jester, James V.; Kao, Winston W-Y			Lumican Binds ALK5 to Promote Epithelium Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-DYNAMICS SIMULATIONS; KERATAN SULFATE PROTEOGLYCAN; P38 MAP KINASE; TGF-BETA; CORNEAL EPITHELIUM; FACTOR RECEPTOR; CELL-MIGRATION; DEFICIENT MICE; UP-REGULATION	Lumican (Lum), a small leucine-rich proteoglycan (SLRP) family member, has multiple matricellular functions both as an extracellular matrix component and as a matrikine regulating cell proliferation, gene expression and wound healing. To date, no cell surface receptor has been identified to mediate the matrikine functions of Lum. This study aimed to identify a perspective receptor that mediates Lum effects on promoting wound healing. Transforming growth factor-beta receptor 1 (ALK5) was identified as a potential Lum-interacting protein through in silico molecular docking and molecular dynamics. This finding was verified by biochemical pull-down assays. Moreover, the Lum function on wound healing was abrogated by an ALK5-specific chemical inhibitor as well as by ALK5 shRNAi. Finally, we demonstrated that eukaryote-specific post-translational modifications are not required for the wound healing activity of Lum, as recombinant GST-Lum fusion proteins purified from E. coli and a chemically synthesized LumC(13) peptide (the last C-terminal 13 amino acids of Lum) have similar effects on wound healing in vitro and in vivo.	[Yamanaka, Osamu; Yuan, Yong; Coulson-Thomas, Vivien Jane; Call, Mindy K.; Zhang, Yujin; Zhang, Jianhua; Chang, Shao-Hsuan; Liu, Chia-Yang; Kao, Winston W-Y] Univ Cincinnati, Deparment Ophthalmol, Cincinnati, OH 45221 USA; [Gesteira, Tarsis Ferreira] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Xie, Changchun] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Saika, Shizuya] Wakayama Med Coll, Dept Ophthalmol, Wakayama 640, Japan; [Jester, James V.] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Wakayama Medical University; University of California System; University of California Irvine	Kao, WWY (corresponding author), Univ Cincinnati, Deparment Ophthalmol, Cincinnati, OH 45221 USA.	Winston.Kao@UC.Edu		Jester, James/0000-0002-9246-0981; Liu, Chia-yang/0000-0002-8398-5516	NEI/NIH [011845, 013755]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; Grants-in-Aid for Scientific Research [25462759] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY013755, R01EY011845] Funding Source: NIH RePORTER	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The studies were in part supported by NEI/NIH grants EY#011845, EY#013755, Research to Prevent Blindness, and Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; BERENDSEN HJC, 1987, COMPUT PHYS COMMUN, V44, P233, DOI 10.1016/0010-4655(87)90078-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2013, AM J PATHOL, V183, P247, DOI 10.1016/j.ajpath.2013.04.001; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Coulson-Thomas VJ, 2013, EXP CELL RES, V319, P967, DOI 10.1016/j.yexcr.2013.01.023; Csordas G, 2000, J BIOL CHEM; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; FONT B, 1993, J BIOL CHEM, V268, P25015; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; Fraternali F, 1996, J MOL BIOL, V256, P939, DOI 10.1006/jmbi.1996.0139; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gesteira TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070880; Gesteira TF, 2011, BBA-PROTEINS PROTEOM, V1814, P1862, DOI 10.1016/j.bbapap.2011.07.024; GRESSNER AM, 1994, PATHOL RES PRACT, V190, P864; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Hayashi Y, 2005, DEV BIOL, V277, P222, DOI 10.1016/j.ydbio.2004.09.022; Hayashi Y, 2010, INVEST OPHTH VIS SCI, V51, P4562, DOI 10.1167/iovs.10-5331; Hayashi Y, 2010, J CELL SCI, V123, P2987, DOI 10.1242/jcs.068221; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Lohr K, 2012, INFLAMM BOWEL DIS, V18, P143, DOI 10.1002/ibd.21713; London NaS-FO, 2012, PROTEIN PROTEN COMPL, P209; Meij JTA, 2007, MOL VIS, V13, P2012; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Peng JW, 1996, J BIOMOL NMR, V8, P453, DOI 10.1007/BF00228147; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Radwanska A, 2012, EXP CELL RES, V318, P2312, DOI 10.1016/j.yexcr.2012.07.005; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roth GJ, 2010, J MED CHEM, V53, P7287, DOI 10.1021/jm100812a; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Saika S, 2001, EXP EYE RES, V72, P679, DOI 10.1006/exer.2001.1002; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Seomun Y, 2008, BIOCHEM BIOPH RES CO, V372, P221, DOI 10.1016/j.bbrc.2008.05.014; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sulochana KN, 2005, J BIOL CHEM; Terai K, 2011, INVEST OPHTH VIS SCI, V11-8017, DOI DOI 10.1167/I0VS.11-8017; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Tuli SS, 2006, CURR EYE RES, V31, P709, DOI 10.1080/02713680600837390; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Yeh LK, 2005, INVEST OPHTH VIS SCI, V46, P479, DOI 10.1167/iovs.04-1014; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zelenka PS, 2008, SEMIN CELL DEV BIOL, V19, P113, DOI 10.1016/j.semcdb.2007.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YJ, 2011, J CELL SCI, V124, P2561, DOI 10.1242/jcs.085001; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	89	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82730	10.1371/journal.pone.0082730	http://dx.doi.org/10.1371/journal.pone.0082730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367547	Green Published, gold			2022-12-25	WOS:000328740300060
J	Depner, CM; Traber, MG; Bobe, G; Kensicki, E; Bohren, KM; Milne, G; Jump, DB				Depner, Christopher M.; Traber, Maret G.; Bobe, Gerd; Kensicki, Elizabeth; Bohren, Kurt M.; Milne, Ginger; Jump, Donald B.			A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR-/- Mice	PLOS ONE			English	Article							LIVER-DISEASE; VITAMIN-E; MOUSE MODEL; INFLAMMATION; ENDOTOXEMIA; PATHOGENESIS; PROGRESSION; MANAGEMENT; STEATOSIS; DECREASES	Background: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6, n-3) was more effective than eicosapentaenoic acid (EPA, 20:5, n-3) at reversing western diet (WD) induced NASH in LDLR-/- mice. Methods: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to quantify diet-induced changes in hepatic metabolism. Results: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3 polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoylsphingomyelin, cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids (12-HETE) and depleted of C20-22 n-3 PUFA-containing phosphoglycerolipids, C20-22 n-3 PUFA-derived oxidized lipids (18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C20-22 PUFA content. Hepatic C20-22 n-3 PUFA content was inversely associated with hepatic a-tocopherol and ascorbate content and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress. Conclusion: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and S-lactoylglutathione may explain the protective effects of DHA against WD-induced NASH in LDLR-/- mice.	[Depner, Christopher M.; Traber, Maret G.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Depner, Christopher M.; Traber, Maret G.; Bobe, Gerd; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kensicki, Elizabeth] Metabolon Inc, Durham, NC USA; [Bohren, Kurt M.] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX USA; [Milne, Ginger] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Eicosanoid Core Lab, Nashville, TN USA	Oregon State University; Oregon State University; Oregon State University; Metabolon; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); Vanderbilt University	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Milne, Ginger/D-7648-2014	Traber, Maret G./0000-0002-2892-4024; Milne, Ginger/0000-0003-3890-151X; Bohren, Kurt/0000-0002-3183-4118	United States Department of Agriculture National Institute of Food and Agriculture [2009-65200-05846]; National Institutes of Health [DK043220, DK094600]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094600] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the United States Department of Agriculture National Institute of Food and Agriculture (2009-65200-05846) and the National Institutes of Health Grants to DBJ (DK043220; DK094600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Bikman BT, 2011, ADV EXP MED BIOL, V721, P87, DOI 10.1007/978-1-4614-0650-1_6; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; GARCIAHEREDIA A, 2013, APPROACH J IN PRESS; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Ikeda R, 2011, INFLAMM RES, V60, P597, DOI 10.1007/s00011-011-0309-6; Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kalish BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059653; KIM HY, 1990, J LIPID RES, V31, P2285; Lam BP, 2009, ANN HEPATOL, V8, pS51, DOI 10.1016/S1665-2681(19)31827-7; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Traber MG, 2007, ANNU REV NUTR, V27, P347, DOI 10.1146/annurev.nutr.27.061406.093819; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Walenbergh SMA, 2013, J HEPATOL, V58, P801, DOI 10.1016/j.jhep.2012.11.014; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wei YR, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-32; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005	46	40	41	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83756	10.1371/journal.pone.0083756	http://dx.doi.org/10.1371/journal.pone.0083756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358308	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700070
J	Forthmann, B; van Bergeijk, J; Lee, YW; Lubben, V; Schill, Y; Brinkmann, H; Ratzka, A; Stachowiak, MK; Hebert, M; Grothe, C; Claus, P				Foerthmann, Benjamin; van Bergeijk, Jeroen; Lee, Yu-Wei; Luebben, Verena; Schill, Yvonne; Brinkmann, Hella; Ratzka, Andreas; Stachowiak, Michal K.; Hebert, Michael; Grothe, Claudia; Claus, Peter			Regulation of Neuronal Differentiation by Proteins Associated with Nuclear Bodies	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; TYROSINE-HYDROXYLASE GENE; GROWTH FACTOR-2 ISOFORMS; FGFR1 SIGNALING INFS; CAJAL BODY NUMBER; MOTONEURON PROTEIN; SMN PROTEIN; ZEBRAFISH EMBRYOGENESIS; NEURITE OUTGROWTH; FACTOR RECEPTOR	Nuclear bodies are large sub-nuclear structures composed of RNA and protein molecules. The Survival of Motor Neuron (SMN) protein localizes to Cajal bodies (CBs) and nuclear gems. Diminished cellular concentration of SMN is associated with the neurodegenerative disease Spinal Muscular Atrophy (SMA). How nuclear body architecture and its structural components influence neuronal differentiation remains elusive. In this study, we analyzed the effects of SMN and two of its interaction partners in cellular models of neuronal differentiation. The nuclear 23 kDa isoform of Fibroblast Growth Factor 2 (FGF-2(23)) is one of these interacting proteins - and was previously observed to influence nuclear bodies by destabilizing nuclear gems and mobilizing SMN from Cajal bodies (CBs). Here we demonstrate that FGF-2(23) blocks SMN-promoted neurite outgrowth, and also show that SMN disrupts FGF-2(23) - dependent transcription. Our results indicate that FGF-2(23) and SMN form an inactive complex that interferes with neuronal differentiation by mutually antagonizing nuclear functions. Coilin is another nuclear SMN binding partner and a marker protein for Cajal bodies (CBs). In addition, coilin is essential for CB function in maturation of small nuclear ribonucleoprotein particles (snRNPs). The role of coilin outside of Cajal bodies and its putative impacts in tissue differentiation are poorly defined. The present study shows that protein levels of nucleoplasmic coilin outside of CBs decrease during neuronal differentiation. Overexpression of coilin has an inhibitory effect on neurite outgrowth. Furthermore, we find that nucleoplasmic coilin inhibits neurite outgrowth independent of SMN binding revealing a new function for coilin in neuronal differentiation.	[Foerthmann, Benjamin; van Bergeijk, Jeroen; Luebben, Verena; Schill, Yvonne; Brinkmann, Hella; Ratzka, Andreas; Grothe, Claudia; Claus, Peter] Hannover Med Sch, Inst Neuroanat, Hannover, Germany; [Foerthmann, Benjamin; Grothe, Claudia; Claus, Peter] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany; [Lee, Yu-Wei; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Hebert, Michael] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Mississippi; University of Mississippi Medical Center	Claus, P (corresponding author), Hannover Med Sch, Inst Neuroanat, Hannover, Germany.	claus.peter@mh-hannover.de	Claus, Peter/A-7978-2008; Ratzka, Andreas/H-7917-2012	Claus, Peter/0000-0003-3824-9445; 	German National Academic Foundation	German National Academic Foundation	The work was partially financed by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Bruns AF, 2009, P NATL ACAD SCI USA, V106, P12747, DOI 10.1073/pnas.0900122106; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Claus P, 2004, BIOCHEM J, V384, P559, DOI 10.1042/BJ20040801; Clelland AK, 2009, TRAFFIC, V10, P1585, DOI 10.1111/j.1600-0854.2009.00972.x; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Forthmann B, 2013, CELL MOL LIFE SCI, V70, P2555, DOI 10.1007/s00018-012-1242-8; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grothe C, 1998, MOL BRAIN RES, V57, P97, DOI 10.1016/S0169-328X(98)00076-X; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Janevski J, 1997, J HISTOCHEM CYTOCHEM, V45, P1523, DOI 10.1177/002215549704501109; Jungnickel J, 2004, MOL CELL NEUROSCI, V25, P444, DOI 10.1016/j.mcn.2003.11.007; Jungnickel J, 2010, EXP NEUROL, V223, P166, DOI 10.1016/j.expneurol.2009.06.003; Kim EL, 1996, J NEUROCHEM, V67, P26; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Maira M, 1999, MOL CELL BIOL, V19, P7549; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Meisinger C, 1997, J NEUROCHEM, V68, P1150; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Muller-Ostermeyer F, 2001, GROWTH FACTORS, V19, P175; Navascues J, 2004, CHROMOSOMA, V112, P398, DOI 10.1007/s00412-004-0285-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Ramon y Cajal S., 1903, TRAD LAB INVEST BIOL, V2, P129; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Santama N, 1996, EUR J NEUROSCI, V8, P892, DOI 10.1111/j.1460-9568.1996.tb01576.x; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sleeman JE, 2001, J CELL SCI, V114, P4407; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Takata H, 2012, J CELL SCI, V125, P166, DOI 10.1242/jcs.090837; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Tapia O, 2010, CHROMOSOMA, V119, P527, DOI 10.1007/s00412-010-0276-7; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Yoon JH, 2010, NAT STRUCT MOL BIOL, V17, P391, DOI 10.1038/nsmb0410-391; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	67	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82871	10.1371/journal.pone.0082871	http://dx.doi.org/10.1371/journal.pone.0082871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358231	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700035
J	Rojas, M; Zhang, WB; Xu, ZM; Lemtalsi, T; Chandler, P; Toque, HA; Caldwell, RW; Caldwell, RB				Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Chandler, Phillip; Toque, Haroldo A.; Caldwell, Robert W.; Caldwell, Ruth B.			Requirement of NOX2 Expression in Both Retina and Bone Marrow for Diabetes-Induced Retinal Vascular Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; NADPH OXIDASE; TYROSINE NITRATION; OXIDATIVE STRESS; RETINOPATHY; PEROXYNITRITE; INCREASES; CELLS; DYSFUNCTION	Objective: Diabetic retinopathy, a major cause of blindness, is characterized by increased expression of vascular endothelial growth factor (VEGF), leukocyte attachment to the vessel walls and increased vascular permeability. Previous work has shown that reactive oxygen species (ROS) produced by the superoxide generating enzyme NOX2/NADPH oxidase play a crucial role in the vascular pathology. The aim of this work was to identify the cellular sources of the damaging NOX2 activity by studies using bone marrow chimera mice. Methods: Bone marrow cells were collected from the femurs and tibias of wild type and NOX2 deficient (NOX2(-/-)) donor mice and injected intravenously into lethally irradiated NOX2(-/-) and wild type recipients. Following recovery from radiation, mice were rendered diabetic by streptozotocin injections. The following groups of bone marrow chimeras were studied: non-diabetic WT -> WT, diabetic WT -> WT, diabetic WT -> NOX2(-/-), diabetic NOX2(-/-)-> WT. After 4 weeks of diabetes, early signs of retinopathy were examined by measuring ROS, expression of VEGF and ICAM-1, leukocyte attachment to the vessel wall and vascular permeability. Results: The retinas of the diabetic WT -> WT chimeras showed significant increases in ROS as compared with the non-diabetic chimeras. These diabetes-induced alterations were correlated with increases in expression of VEGF and ICAM-1, leukocyte adhesion and vascular permeability. Each of these diabetes-induced alterations were significantly attenuated in the diabetic WT -> NOX2(-/-) and NOX2(-/-)-> WT chimera groups (p<0.05). Conclusion: NOX2-generated ROS produced by both bone marrow-derived cells and resident retinal cells contribute importantly to retinal vascular injury in the diabetic retina. Targeting NOX2 in bone marrow and/or retinal cells may represent a novel therapeutic strategy for the treatment/prevention of vascular injury in the diabetic retina.	[Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Caldwell, Ruth B.] VA Med Ctr, Augusta, GA USA; [Rojas, Modesto; Zhang, Wenbo; Xu, Zhimin; Lemtalsi, Tahira; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Chandler, Phillip] Georgia Reagents Univ, Immunotherapy Ctr, Augusta, GA USA; [Toque, Haroldo A.; Caldwell, Robert W.] Georgia Reagents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Caldwell, RB (corresponding author), VA Med Ctr, Augusta, GA USA.	rcaldwel@gru.edu		Rojas, Modesto/0000-0002-9441-3302; Caldwell, Ruth/0000-0003-0168-0354	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH) [R01-EY11766, R01-EY04618, R01-HL70215]; American Heart Association [11SDG4960005]; Culver Vision Discovery Institute at Georgia Regents University; NIH [EY022694]; International Retinal Research Foundation; Juvenile Diabetes Research Foundation JDRF [10-2009-575]; NATIONAL EYE INSTITUTE [R01EY004618, R01EY022694, R01EY011766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070215] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH)(US Department of Veterans Affairs); American Heart Association(American Heart Association); Culver Vision Discovery Institute at Georgia Regents University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; Juvenile Diabetes Research Foundation JDRF(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, National Institute of Health (NIH grants R01-EY11766, R01-EY04618, R01-HL70215), American Heart Association and the Culver Vision Discovery Institute at Georgia Regents University. Wenbo Zhang is supported by the American Heart Association 11SDG4960005, NIH grant EY022694, the International Retinal Research Foundation, and Juvenile Diabetes Research Foundation JDRF 10-2009-575. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Babior BM, 2002, ISRAEL MED ASSOC J, V4, P1023; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2002, NITRIC OXIDE-BIOL CH, V6, P295, DOI 10.1006/niox.2001.0419; Flaquer M, 2009, TRANSPL P, V41, P2282, DOI 10.1016/j.transproceed.2009.06.034; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hazra S, 2013, DIABETOLOGIA, V56, P644, DOI 10.1007/s00125-012-2781-0; Huang XQ, 2011, DIABETES RES CLIN PR, V91, P371, DOI 10.1016/j.diabres.2010.12.026; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Nicoletti VG, 2003, EXP CLIN ENDOCR DIAB, V111, P209, DOI 10.1055/s-2003-40465; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Santos JM, 2011, CURR PHARM BIOTECHNO, V12, P352; Schafer A, 2004, ARTERIOSCL THROM VAS, V24, P1720, DOI 10.1161/01.ATV.0000138072.76902.dd; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Vinores SA, 1999, DOC OPHTHALMOL, V97, P217, DOI 10.1023/A:1002136712070; WARD JM, 2010, VET PATHOL; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Zhang CX, 2004, DIABETES, V53, P2950, DOI 10.2337/diabetes.53.11.2950; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]	41	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84357	10.1371/journal.pone.0084357	http://dx.doi.org/10.1371/journal.pone.0084357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358357	gold, Green Submitted, Green Published			2022-12-25	WOS:000328737700093
J	Gorini, G; Nunez, YO; Mayfield, RD				Gorini, Giorgio; Nunez, Yury O.; Mayfield, R. Dayne			Integration of miRNA and Protein Profiling Reveals Coordinated Neuroadaptations in the Alcohol-Dependent Mouse Brain	PLOS ONE			English	Article							INTERMITTENT ETHANOL EXPOSURE; GENE-EXPRESSION; MESSENGER-RNA; FRONTAL-CORTEX; MICRORNAS; PROTEOMICS; NETWORK; IDENTIFICATION; DYSREGULATION; INTERACTOME	The molecular mechanisms underlying alcohol dependence involve different neurochemical systems and are brain region-dependent. Chronic Intermittent Ethanol (CIE) procedure, combined with a Two-Bottle Choice voluntary drinking paradigm, represents one of the best available animal models for alcohol dependence and relapse drinking. MicroRNAs, master regulators of the cellular transcriptome and proteome, can regulate their targets in a cooperative, combinatorial fashion, ensuring fine tuning and control over a large number of cellular functions. We analyzed cortex and midbrain microRNA expression levels using an integrative approach to combine and relate data to previous protein profiling from the same CIE-subjected samples, and examined the significance of the data in terms of relative contribution to alcohol consumption and dependence. MicroRNA levels were significantly altered in CIE-exposed dependent mice compared with their non-dependent controls. More importantly, our integrative analysis identified modules of coexpressed microRNAs that were highly correlated with CIE effects and predicted target genes encoding differentially expressed proteins. Coexpressed CIE-relevant proteins, in turn, were often negatively correlated with specific microRNA modules. Our results provide evidence that microRNA-orchestrated translational imbalances are driving the behavioral transition from alcohol consumption to dependence. This study represents the first attempt to combine ex vivo microRNA and protein expression on a global scale from the same mammalian brain samples. The integrative systems approach used here will improve our understanding of brain adaptive changes in response to drug abuse and suggests the potential therapeutic use of microRNAs as tools to prevent or compensate multiple neuroadaptations underlying addictive behavior.	[Gorini, Giorgio; Nunez, Yury O.; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Gorini, G (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	gorini@utexas.edu	Lopez, Yury O. Nunez/B-9382-2019; Gorini, Giorgio/D-7053-2014	Lopez, Yury O. Nunez/0000-0003-0382-9124; Gorini, Giorgio/0000-0002-0893-5922	NIAAA [AA016648, AA0107838, AA019382, AA020683]; Integrative Neuroscience Initiative on Alcoholism (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016648, R01AA012404, RC2AA019382, U01AA020926, P01AA020683] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Integrative Neuroscience Initiative on Alcoholism (INIA)(Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA grants AA016648, AA0107838, AA019382, AA020683, and Integrative Neuroscience Initiative on Alcoholism (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Ballard IC, 2011, J NEUROSCI, V31, P10340, DOI 10.1523/JNEUROSCI.0895-11.2011; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chin CS, 2003, BIOINFORMATICS, V19, P2413, DOI 10.1093/bioinformatics/btg339; Clarke C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-656; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dood PR, 1998, ANN NY ACAD SCI, V844, P50, DOI 10.1111/j.1749-6632.1998.tb08221.x; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Fodor IK, 2005, BIOINFORMATICS, V21, P3733, DOI 10.1093/bioinformatics/bti612; Gorini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082656; Gorini G, 2011, PROG MOL BIOL TRANSL, V98, P293, DOI 10.1016/B978-0-12-385506-0.00007-7; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Grosshans H, 2008, CELL, V134, P560, DOI 10.1016/j.cell.2008.08.008; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Huang TC, 2013, PROTEOMICS, V13, P558, DOI 10.1002/pmic.201200339; Huang WH, 2009, INT J NEUROPSYCHOPH, V12, P537, DOI 10.1017/S1461145708009528; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li CY, 2012, EXPERT REV PROTEOMIC, V9, P549, DOI [10.1586/EPR.12.49, 10.1586/epr.12.49]; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nunez Yury O., 2012, Frontiers in Genetics, V3, P43, DOI 10.3389/fgene.2012.00043; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Xu SJ, 2012, INT J MOL SCI, V13, P16945, DOI 10.3390/ijms131216945; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yuan XY, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-65; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	72	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82565	10.1371/journal.pone.0082565	http://dx.doi.org/10.1371/journal.pone.0082565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358208	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700083
J	Yasuda, K; Ohyama, K; Onga, K; Kakizuka, A; Mori, N				Yasuda, Kunihiko; Ohyama, Kyoji; Onga, Kazuko; Kakizuka, Akira; Mori, Nozomu			Mdm20 Stimulates PolyQ Aggregation via Inhibiting Autophagy Through Akt-Ser473 Phosphorylation	PLOS ONE			English	Article							N-TERMINAL ACETYLTRANSFERASES; PROTEIN-KINASE-B; MOLECULAR CHAPERONES; YEAST; ACETYLATION; COMPLEX; HDAC6; IDENTIFICATION; HIF-1-ALPHA; ACTIVATION	Mdm20 is an auxiliary subunit of the NatB complex, which includes Nat5, the catalytic subunit for protein N-terminal acetylation. The NatB complex catalyzes N-acetylation during de novo protein synthesis initiation; however, recent evidence from yeast suggests that NatB also affects post-translational modification of tropomyosin, which is involved in intracellular sorting of aggregated proteins. We hypothesized that an acetylation complex such as NatB may contribute to protein clearance and/or proteostasis in mammalian cells. Using a poly glutamine (polyQ) aggregation system, we examined whether the NatB complex or its components affect protein aggregation in rat primary cultured hippocampal neurons and HEK293 cells. The number of polyQ aggregates increased in Mdm20 over-expressing (OE) cells, but not in Nat5-OE cells. Conversely, in Mdm20 knockdown (KD) cells, but not in Nat5-KD cells, polyQ aggregation was significantly reduced. Although Mdm20 directly associates with Nat5, the overall cellular localization of the two proteins was slightly distinct, and Mdm20 apparently co-localized with the polyQ aggregates. Furthermore, in Mdm20-KD cells, a punctate appearance of LC3 was evident, suggesting the induction of autophagy. Consistent with this notion, phosphorylation of Akt, most notably at Ser473, was greatly reduced in Mdm20-KD cells. These results demonstrate that Mdm20, the so-called auxiliary subunit of the translation-coupled protein N-acetylation complex, contributes to protein clearance and/or aggregate formation by affecting the phosphorylation level of Akt indepenently from the function of Nat5.	[Yasuda, Kunihiko; Ohyama, Kyoji; Onga, Kazuko; Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan; [Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto, Japan	Nagasaki University; Kyoto University	Mori, N (corresponding author), Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan.	morinosm@nagasaki-u.ac.jp			MEXT Japan (Kiban B); Smoking Research Foundation; Asian CORE program of JSPS	MEXT Japan (Kiban B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Asian CORE program of JSPS	This work was supported by Grants-in-Aid for Scientific Research from MEXT Japan (Kiban B) and also, in part, by a fund from Smoking Research Foundation (http://www.srf.or.jp/) and the Asian CORE program of JSPS (to N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Asaumi M, 2005, J BIOCHEM, V137, P147, DOI 10.1093/jb/mvi014; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Harting K, 2010, EUR J CELL BIOL, V89, P262, DOI 10.1016/j.ejcb.2009.11.006; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Matsuzaki H, 2004, BIOCHEMISTRY-US, V43, P4284, DOI 10.1021/bi0498712; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Murray-Rust TA, 2006, FEBS LETT, V580, P1911, DOI 10.1016/j.febslet.2006.02.012; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohyama K, 2012, GENE EXPR PATTERNS, V12, P36, DOI 10.1016/j.gep.2011.11.001; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Singer JM, 2000, GENETICS, V156, P523; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Tanaka K, 1998, MOL CELLS, V8, P503; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028950	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82523	10.1371/journal.pone.0082523	http://dx.doi.org/10.1371/journal.pone.0082523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358196	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700075
J	Kwon, Y; Smith, BD; Zhou, Y; Kaufman, MD; Godwin, AK				Kwon, Y.; Smith, B. D.; Zhou, Y.; Kaufman, M. D.; Godwin, A. K.			Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment	ONCOGENE			English	Article						ovarian cancer; human ovarian fibroblast; c-MET; hepatocyte growth factor; DCC-2701	TUMOR-ASSOCIATED FIBROBLASTS; HEPARAN-SULFATE; KINASE; MATRIX; OLIGOSACCHARIDES; TRANSFORMATION; STROMAGENESIS; RESISTANCE	The signaling mediated by c-MET and its ligand, hepatocyte growth factor (HGF), has been implicated in malignant progression of cancer involving stimulation of proliferation, invasion and metastasis. We studied the c-MET/HGF axis as a mediator of tumor-stromal interaction in ovarian cancer and the value of targeting c-MET for the treatment of ovarian cancer. To assess c-MET signaling, we established in vitro models of the microenvironment using primary and immortalized human fibroblasts from normal ovary and tumor samples and epithelial ovarian cancer cell lines. We found that fibroblast from normal ovaries secreted high levels of HGF (1500-3800 pg/ml) as compared with tumor-derived fibroblasts (undetectable level) and could elicit cellular biological responses on c-MET-expressing ovarian cancer cells including increase of cell proliferation and migration (2- to 140-fold increase). HGF secreted by fibroblasts was also found sequestered within extracellular matrices (ECMs) and when degraded this ECM-derived HGF stimulated cancer cell migration (1.5- to 24-fold). In cells containing constitutive c-MET phosphorylation, recombinant HGF and fibroblast-derived HGF negligibly affect c-MET phosphorylation on Tyr(1234) and Tyr(1003). However, both sources of HGF increased the phosphorylation of c-MET on Tyr(1349), the multi-substrate docking site, by more than sixfold and led to activation of downstream signaling transducers. DCC-2701 (Deciphera Pharmaceuticals, LLC), a novel c-MET/TIE-2/VEGFR inhibitor was able to effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. Importantly, DCC-2701's anti-proliferative activity was dependent on c-MET activation induced by stromal human fibroblasts and to a lesser extent exogenous HGF. Our data suggest for the first time that DCC-2701 may be superior to HGF antagonists that are in clinical trials and that pTyr(134)(levels might be a good indicator of c-MET activation and likely response to targeted therapy as a result of signals from the microenvironment.	[Kwon, Y.; Godwin, A. K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Kwon, Y.] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea; [Smith, B. D.; Kaufman, M. D.] Deciphera Pharmaceut LLC, Lawrence, KS USA; [Zhou, Y.] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA; [Godwin, A. K.] Univ Kansas, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; Ewha Womans University; Fox Chase Cancer Center; University of Kansas	Godwin, AK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Mail Stop 3040,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	AGodwin@kumc.edu		Kwon, Youngjoo/0000-0003-3582-4192	Ovarian Cancer Research Fund; NCI [R01 CA140323]; University of Kansas Cancer Center's CCSG [P30 CA168524]; Kansas Bioscience Authority Eminent Scholar Program; NATIONAL CANCER INSTITUTE [R01CA140323, P30CA168524] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Kansas Cancer Center's CCSG; Kansas Bioscience Authority Eminent Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Ziyan Pessetto for her expertise in the cell viability assays and Dr Daniel Flynn for his helpful comments and guidance in regards the biology and activity of DCC-2701. The study was supported in part by a program project grant from Ovarian Cancer Research Fund (http://www.ocrf.org) and a grant from the NCI (R01 CA140323) to AKG. We would also like to acknowledge support from the University of Kansas Cancer Center's CCSG (P30 CA168524), the Kansas Bioscience Authority Eminent Scholar Program. AKG is the Chancellors Distinguished Chair in Biomedical Sciences endowed Professor.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Ayhan A, 2005, INT J GYNECOL CANCER, V15, P618, DOI 10.1111/j.1525-1438.2005.00117.x; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corps AN, 1997, INT J CANCER, V73, P151, DOI 10.1002/(SICI)1097-0215(19970926)73:1<151::AID-IJC23>3.0.CO;2-I; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Flynn DL, 2013, ACS NAT M NEW ORL 8; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Gordon MS, 2010, CLIN CANCER RES, V16, P699, DOI 10.1158/1078-0432.CCR-09-1365; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; LANGDON SP, 1988, CANCER RES, V48, P6166; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; LYON M, 1994, J BIOL CHEM, V269, P11216; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Marchand-Adam S, 2003, AM J RESP CRIT CARE, V168, P1156, DOI 10.1164/rccm.200212-1514OC; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Matsuoka H, 2006, AM J RESP CELL MOL, V35, P705, DOI 10.1165/rcmb.2006-0006OC; Michieli P, 1999, ONCOGENE, V18, P5221, DOI 10.1038/sj.onc.1202899; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Nayeri F, 2008, GROWTH FACTORS, V26, P163, DOI 10.1080/08977190802128083; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zillhardt M, 2011, CLIN CANCER RES, V17, P4042, DOI 10.1158/1078-0432.CCR-10-3387; Zillhardt M, 2010, NEOPLASIA, V12, P1, DOI 10.1593/neo.09948; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	41	45	46	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					144	153		10.1038/onc.2013.539	http://dx.doi.org/10.1038/onc.2013.539			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362531	Green Accepted			2022-12-25	WOS:000347790500002
J	Shen, RR; Zhou, AY; Kim, E; O'Connell, JT; Hagerstrand, D; Beroukhim, R; Hahn, WC				Shen, R. R.; Zhou, A. Y.; Kim, E.; O'Connell, J. T.; Hagerstrand, D.; Beroukhim, R.; Hahn, W. C.			TRAF2 is an NF-kappa B-activating oncogene in epithelial cancers	ONCOGENE			English	Article						TRAF2; NF-kappa B; cancer; 9q34 amplification	TUMOR-SUPPRESSOR CYLD; K63-LINKED POLYUBIQUITINATION; MULTIPLE-MYELOMA; CELL LYMPHOMA; MOUSE MODEL; IKK; PHOSPHORYLATION; TUMORIGENESIS; MUTATIONS; PATHWAY	Aberrant nuclear factor (NF)-kappa B activation is frequently observed in human cancers. Genome characterization efforts have identified genetic alterations in multiple components of the NF-kappa B pathway, some of which have been shown to be essential for cancer initiation and tumor maintenance. Here, using patient tumors and cancer cell lines, we identify the NF-kappa B regulator, TRAF2 (tumor necrosis factor (TNF) receptor-associated factor 2), as an oncogene that is recurrently amplified and rearranged in 15% of human epithelial cancers. Suppression of TRAF2 in cancer cells harboring TRAF2 copy number gain inhibits proliferation, NF-kappa B activation, anchorage-independent growth and tumorigenesis. Cancer cells that are dependent on TRAF2 also require NF-kappa B for survival. The phosphorylation of TRAF2 at serine 11 is essential for the survival of cancer cells harboring TRAF2 amplification. Together, these observations identify TRAF2 as a frequently amplified oncogene.	[Shen, R. R.; Zhou, A. Y.; Kim, E.; O'Connell, J. T.; Hagerstrand, D.; Beroukhim, R.; Hahn, W. C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shen, R. R.; Zhou, A. Y.; Kim, E.; O'Connell, J. T.; Hagerstrand, D.; Beroukhim, R.; Hahn, W. C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Shen, R. R.; Zhou, A. Y.; Kim, E.; O'Connell, J. T.; Hagerstrand, D.; Beroukhim, R.; Hahn, W. C.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hahn, WC (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Dana 1538, Boston, MA 02215 USA.	William_Hahn@dfci.harvard.edu	Hägerstrand, Daniel/AAH-3009-2019; Hägerstrand, Daniel C/D-1584-2014	Hägerstrand, Daniel/0000-0001-7270-0776; Hägerstrand, Daniel C/0000-0001-7270-0776; Zhou, Alicia/0000-0003-0388-8909	Ruth L. Kirschstein National Research Service Award [F32 CA128265]; Aid for Cancer Research;  [R01 CA130988]; NATIONAL CANCER INSTITUTE [P30CA006516, F32CA128265, P01CA154303, R01CA130988] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aid for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hahn lab and the Cichowski lab for thoughtful discussion, reagents and technical assistance. We also thank Hasem Habelhah for providing the pTRAF2 (Ser11) antibody. We further thank Shumei Wang, Anita Hawkins, Chengzeng Zhang and Cynthia Morton at the DFCI Cytogenetics Core for TRAF2 FISH analysis and discussion. This work was supported in part by R01 CA130988 (to WCH), a Ruth L. Kirschstein National Research Service Award F32 CA128265 (to RRS) and The Aid for Cancer Research (to RRS).	Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Blackwell K, 2009, MOL CELL BIOL, V29, P303, DOI 10.1128/MCB.00699-08; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas GS, 2009, CANCER RES, V69, P3665, DOI 10.1158/0008-5472.CAN-08-4867; Wood KC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002612; Zhou AY, 2013, CELL REP, V3, P724, DOI 10.1016/j.celrep.2013.01.031	43	42	44	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					209	216		10.1038/onc.2013.543	http://dx.doi.org/10.1038/onc.2013.543			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24362534	Green Accepted, Green Submitted			2022-12-25	WOS:000347790500008
J	Hornburger, MC; Mayer, BA; Leonhardt, S; Willer, EA; Zahler, S; Beyerle, A; Rajalingam, K; Vollmar, AM; Furst, R				Hornburger, Michael C.; Mayer, Bettina A.; Leonhardt, Stefanie; Willer, Elisabeth A.; Zahler, Stefan; Beyerle, Andrea; Rajalingam, Krishnaraj; Vollmar, Angelika M.; Fuerst, Robert			A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation	FASEB JOURNAL			English	Article						inflammation; permeability; small RhoA GTPases	NF-KAPPA-B; ACUTE LUNG INJURY; CASPASE INHIBITION; CELL-MIGRATION; INFLAMMATION; CANCER; XIAP; MECHANISMS; THROMBIN; HYPERPERMEABILITY	Inhibitor of apoptosis (IAP) proteins, such as XIAP or cIAP1/2, are important regulators of apoptosis in cancer cells, and IAP antagonists are currently evaluated as antitumor agents. Beyond their function in cancer cells, this study demonstrates a novel role of IAPs as regulators of vascular endothelial permeability. Two structurally different IAP antagonists, ABT and Smac085, as well as silencing of IAPs, reduced the thrombin receptor-activating peptide (TRAP)-induced barrier dysfunction in human endothelial cells as assessed by measuring macromolecular permeability or transendothelial electrical resistance. ABT diminished thrombin-evoked stress fiber formation, activation of myosin light chain 2, and disassembly of adherens junctions independent of calcium signaling, protein kinase C, and mitogen-activated protein kinases. Interestingly, ABT and silencing of IAPs, in particular XIAP, reduced the TRAP-evoked RhoA activation, whereas Rac1 was not affected. XIAP and, to a lesser extent, cIAP1 were found to directly interact with RhoA independently of the RhoA activation status. Under cell-free conditions, XIAP did not induce an ubiquitination of RhoA. In summary, our work discloses IAPs as crucial regulators of endothelial permeability and suggests IAP inhibition as interesting approach for the prevention of endothelial barrier dysfunction.-Hornburger, M. C., Mayer, B. A., Leonhardt, S., Willer, E. A., Zahler, S., Beyerle, A., Rajalingam, K., Vollmar, A. M., Furst, R. A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation.	[Hornburger, Michael C.; Beyerle, Andrea; Fuerst, Robert] Goethe Univ Frankfurt, Inst Pharmaceut Biol, Bioctr, D-60438 Frankfurt, Germany; [Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60438 Frankfurt, Germany; [Hornburger, Michael C.; Mayer, Bettina A.; Leonhardt, Stefanie; Willer, Elisabeth A.; Zahler, Stefan; Vollmar, Angelika M.] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Munich	Furst, R (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Biol, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	fuerst@em.uni-frankfurt.de		Furst, Robert/0000-0002-9926-7578; Zahler, Stefan/0000-0002-5140-7287				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bubik MF, 2012, J MOL CELL CARDIOL, V52, P196, DOI 10.1016/j.yjmcc.2011.10.020; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Foley JF, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003938; Furst R, 2008, MOL PHARMACOL, V74, P1, DOI 10.1124/mol.108.045773; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Kearney CJ, 2013, J BIOL CHEM, V288, P4878, DOI 10.1074/jbc.M112.422410; Kim KM, 2012, J CELL PHYSIOL, V227, P1701, DOI 10.1002/jcp.22894; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Mayer BA, 2011, ARTERIOSCL THROM VAS, V31, P2240, DOI 10.1161/ATVBAHA.111.234294; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Oberoi-Khanuja Tripat Kaur, 2012, Small GTPases, V3, P131, DOI 10.4161/sgtp.19988; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Vandenabeele P, 2012, NAT REV IMMUNOL, V12, P833, DOI 10.1038/nri3325; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17; Willer EA, 2012, J MOL CELL CARDIOL, V53, P567, DOI 10.1016/j.yjmcc.2012.07.002	33	17	17	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1938	1946		10.1096/fj.13-235754	http://dx.doi.org/10.1096/fj.13-235754			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24371121				2022-12-25	WOS:000335344300037
J	Grin, I; Hartmann, MD; Sauer, G; Hernandez Alvarez, B; Schutz, M; Wagner, S; Madlung, J; Macek, B; Felipe-Lopez, A; Hensel, M; Lupas, A; Linke, D				Grin, Iwan; Hartmann, Marcus D.; Sauer, Guido; Hernandez Alvarez, Birte; Schuetz, Monika; Wagner, Samuel; Madlung, Johannes; Macek, Boris; Felipe-Lopez, Alfonso; Hensel, Michael; Lupas, Andrei; Linke, Dirk			A Trimeric Lipoprotein Assists in Trimeric Autotransporter Biogenesis in Enterobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Crystal Structure; Lipoprotein; Membrane Trafficking; Enterobacteria; Gram-negative Bacteria; Membrane Insertion; Autotransport	ENTERICA SEROVAR TYPHIMURIUM; GRAM-NEGATIVE BACTERIA; COILED-COIL; PROTEIN; ADHESINS; IDENTIFICATION; EXPRESSION; PREDICTION; SYSTEM; SERVER	Background: Autotransporter adhesins reach the bacterial cell surface by a complex mechanism. Results: In the case of the autotransporter SadA from Salmonella, a lipoprotein assists in surface display. Conclusion: The similarity to eukaryotic MATH domains suggests that the lipoprotein assists in trimerization of SadA. Significance: Understanding the similarities between autotransport systems might lead to new ways of inhibiting bacterial adhesion. Trimeric autotransporter adhesins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. TAAs form fibrous, adhesive structures on the bacterial cell surface. Their N-terminal extracellular domains are exported through a C-terminal membrane pore; the insertion of the pore domain into the bacterial outer membrane follows the rules of -barrel transmembrane protein biogenesis and is dependent on the essential Bam complex. We have recently described the full fiber structure of SadA, a TAA of unknown function in Salmonella and other enterobacteria. In this work, we describe the structure and function of SadB, a small inner membrane lipoprotein. The sadB gene is located in an operon with sadA; orthologous operons are only found in enterobacteria, whereas other TAAs are not typically associated with lipoproteins. Strikingly, SadB is also a trimer, and its co-expression with SadA has a direct influence on SadA structural integrity. This is the first report of a specific export factor of a TAA, suggesting that at least in some cases TAA autotransport is assisted by additional periplasmic proteins.	[Grin, Iwan; Hartmann, Marcus D.; Sauer, Guido; Hernandez Alvarez, Birte; Lupas, Andrei; Linke, Dirk] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Grin, Iwan; Schuetz, Monika; Wagner, Samuel] Univ Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany; [Madlung, Johannes; Macek, Boris] Univ Tubingen, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Felipe-Lopez, Alfonso; Hensel, Michael] Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49076 Osnabruck, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University Osnabruck	Linke, D (corresponding author), Univ Oslo, Dept Biosci, N-0316 Oslo, Norway.	dirk.linke@ibv.uio.no	Linke, Dirk/F-9147-2010; Hartmann, Marcus/L-8759-2019; Macek, Boris/N-1442-2015	Linke, Dirk/0000-0003-3150-6752; Hartmann, Marcus/0000-0001-6937-5677; Macek, Boris/0000-0002-1206-2458; Hensel, Michael/0000-0001-6604-6253; Hernandez Alvarez, Birte/0000-0003-0635-8698	Collaborative Research Center Grant (German Science Foundation) [SFB766]; Max Planck Society; Collaborative Research Center Grant from the German Science Foundation [SFB944]; Alexander von Humboldt Foundation; Deutscher Akademischer Austauschdienst fellowship	Collaborative Research Center Grant (German Science Foundation); Max Planck Society(Max Planck Society); Collaborative Research Center Grant from the German Science Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutscher Akademischer Austauschdienst fellowship(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Collaborative Research Center Grant SFB766 (German Science Foundation) (to D. L.) and by institutional funds from the Max Planck Society.; Supported by Collaborative Research Center Grant SFB944 from the German Science Foundation.; Supported by the Alexander von Humboldt Foundation through a Sofja Kovalevskaja Award.; Supported by a Deutscher Akademischer Austauschdienst fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Eckert DM, 1998, J MOL BIOL, V284, P859, DOI 10.1006/jmbi.1998.2214; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerlach RG, 2007, APPL ENVIRON MICROB, V73, P4234, DOI 10.1128/AEM.00509-07; Grin I, 2011, NUCLEIC ACIDS RES, V39, pW353, DOI 10.1093/nar/gkr364; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hiss JA, 2009, BRIEF BIOINFORM, V10, P569, DOI 10.1093/bib/bbp030; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paramasivam N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00218; Raghunathan D, 2011, INFECT IMMUN, V79, P4342, DOI 10.1128/IAI.05592-11; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Schulz GE, 2003, ADV PROTEIN CHEM, V63, P47; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438	40	19	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7388	7398		10.1074/jbc.M113.513275	http://dx.doi.org/10.1074/jbc.M113.513275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24369174	Green Published, hybrid			2022-12-25	WOS:000332761500011
J	Zamiri, B; Reddy, K; Macgregor, RB; Pearson, CE				Zamiri, Bita; Reddy, Kaalak; Macgregor, Robert B., Jr.; Pearson, Christopher E.			TMPyP4 Porphyrin Distorts RNA G- quadruplex Structures of the Disease- associated r( GGGGCC) n Repeat of the C9orf72 Gene and Blocks Interaction of RNAbinding Proteins*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig Disease); RNA; RNA-binding Protein; RNA Structure; RNA-Protein Interaction; ASF; SF2; C9orf72; G-quadruplex; TMPyP4; hnRNPA1	MENTAL-RETARDATION PROTEIN; FRAGILE-X; HEXANUCLEOTIDE REPEAT; MESSENGER-RNA; ANTISENSE TRANSCRIPTS; TRANSLATION; FOCI; FORM; DNA; EXPANSION	Background: Amyotrophic lateral sclerosis and frontotemporal dementia are caused by expansion of the C9orf72 (GGGGCC)n repeat, whose RNA can form G-quadruplexes. Results: r(GGGGCC)n G-quadruplex distortion by TMPyP4 ablates interaction of the hnRNPA1 and ASF/SF2 proteins. Conclusion: G-quadruplexes can be modulated by TMPyP4, which can ablate protein interactions. Significance: Disruption of secondary structures in the C9orf72 RNA repeats may be a potential therapeutic avenue. Certain DNA and RNA sequences can form G-quadruplexes, which can affect genetic instability, promoter activity, RNA splicing, RNA stability, and neurite mRNA localization. Amyotrophic lateral sclerosis and frontotemporal dementia can be caused by expansion of a (GGGGCC)n repeat in the C9orf72 gene. Mutant r(GGGGCC)n- and r(GGCCCC)n-containing transcripts aggregate in nuclear foci, possibly sequestering repeat-binding proteins such as ASF/SF2 and hnRNPA1, suggesting a toxic RNA pathogenesis, as occurs in myotonic dystrophy. Furthermore, the C9orf72 repeat RNA was recently demonstrated to undergo the noncanonical repeat-associated non-AUG translation (RAN translation) into pathologic dipeptide repeats in patient brains, a process that is thought to depend upon RNA structure. We previously demonstrated that the r(GGGGCC)n RNA forms repeat tract length-dependent G-quadruplex structures that bind the ASF/SF2 protein. Here we show that the cationic porphyrin (5,10,15,20-tetra(N-methyl-4-pyridyl) porphyrin (TMPyP4)), which can bind some G-quadruplex-forming sequences, can bind and distort the G-quadruplex formed by r(GGGGCC)8, and this ablates the interaction of either hnRNPA1 or ASF/SF2 with the repeat. These findings provide proof of concept that nucleic acid binding small molecules, such as TMPyP4, can distort the secondary structure of the C9orf72 repeat, which may beneficially disrupt protein interactions, which may ablate either protein sequestration and/or RAN translation into potentially toxic dipeptides. Disruption of secondary structure formation of the C9orf72 RNA repeats may be a viable therapeutic avenue, as well as a means to test the role of RNA structure upon RAN translation.	[Zamiri, Bita; Macgregor, Robert B., Jr.] Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Reddy, Kaalak; Pearson, Christopher E.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Reddy, Kaalak; Pearson, Christopher E.] Univ Toronto, Program Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 101 Coll St East Tower,15-312 TMDT, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR); Natural Science and Engineering Research Council of Canada	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Amyotrophic Lateral Sclerosis Association of America (to C. E. P.), the Canadian Institutes of Health Research (CIHR) (to C. E. P.), and the Natural Science and Engineering Research Council of Canada (to R. B. M.).	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Darnell JC, 2004, MENT RETARD DEV D R, V10, P49, DOI 10.1002/mrdd.20008; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duchler M, 2012, J DRUG TARGET, V20, P389, DOI 10.3109/1061186X.2012.669384; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Keating LR, 2004, BIOCHEMISTRY-US, V43, P15891, DOI 10.1021/bi0483209; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; MIURA T, 1995, J MOL BIOL, V248, P233, DOI 10.1006/jmbi.1995.0217; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Morris MJ, 2012, NUCLEIC ACIDS RES, V40, P4137, DOI 10.1093/nar/gkr1308; Nakagama H, 2006, MUTAT RES-FUND MOL M, V598, P120, DOI 10.1016/j.mrfmmm.2006.01.014; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Reddy K, 2013, NEURON, V78, P405, DOI 10.1016/j.neuron.2013.04.034; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Weisman-Shomer P, 2003, NUCLEIC ACIDS RES, V31, P3963, DOI 10.1093/nar/gkg453; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Xu Y, 2013, CHEMBIOCHEM, V14, P927, DOI 10.1002/cbic.201300157; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	51	145	148	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4653	4659		10.1074/jbc.C113.502336	http://dx.doi.org/10.1074/jbc.C113.502336			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371143	Green Published, hybrid			2022-12-25	WOS:000331607900013
J	Fujiwara, T; Saburi, W; Matsui, H; Mori, H; Yao, M				Fujiwara, Takaaki; Saburi, Wataru; Matsui, Hirokazu; Mori, Haruhide; Yao, Min			Structural Insights into the Epimerization of beta-1,4-Linked Oligosaccharides Catalyzed by Cellobiose 2-Epimerase, the Sole Enzyme Epimerizing Non-anomeric Hydroxyl Groups of Unmodified Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Carbohydrate-binding Protein; Crystal Structure; Enzyme Mechanisms; Glycobiology; AGE Superfamily; Cellobiitol; Cellobiose 2-Epimerase; Epimerization	CRYSTAL-STRUCTURE; RUMINOCOCCUS-ALBUS; X-RAY; MECHANISM; COMPLEX; THERMOSTABILITY; ABSORPTION; EPILACTOSE; BACTERIUM; ISOMERASE	Background: The details of the catalytic mechanism of cellobiose 2-epimerase (CE) remains unclear. Results: The crystal structures of Rhodothermus marinus CE in the apo form and complexes with its substrates/products 4-O--d-glucopyranosyl-d-mannnose, epilactose, or cellobiitol (reaction intermediate analog) were elucidated. Conclusion: Epimerization catalyzed by CE proceeds through ring opening, deprotonation/reprotonation, carbon-carbon bond rotation, and ring closure. Significance: This study yielded structural insights into epimerization catalyzed by CE. Cellobiose 2-epimerase (CE) reversibly converts d-glucose residues into d-mannose residues at the reducing end of unmodified 1,4-linked oligosaccharides, including -1,4-mannobiose, cellobiose, and lactose. CE is responsible for conversion of 1,4-mannobiose to 4-O--d-mannosyl-d-glucose in mannan metabolism. However, the detailed catalytic mechanism of CE is unclear due to the lack of structural data in complex with ligands. We determined the crystal structures of halothermophile Rhodothermus marinus CE (RmCE) in complex with substrates/products or intermediate analogs, and its apo form. The structures in complex with the substrates/products indicated that the residues in the 5-6 loop as well as those in the inner six helices form the catalytic site. Trp-322 and Trp-385 interact with reducing and non-reducing end parts of these ligands, respectively, by stacking interactions. The architecture of the catalytic site also provided insights into the mechanism of reversible epimerization. His-259 abstracts the H2 proton of the d-mannose residue at the reducing end, and consistently forms the cis-enediol intermediate by facilitated depolarization of the 2-OH group mediated by hydrogen bonding interaction with His-200. His-390 subsequently donates the proton to the C2 atom of the intermediate to form a d-glucose residue. The reverse reaction is mediated by these three histidines with the inverse roles of acid/base catalysts. The conformation of cellobiitol demonstrated that the deprotonation/reprotonation step is coupled with rotation of the C2-C3 bond of the open form of the ligand. Moreover, it is postulated that His-390 is closely related to ring opening/closure by transferring a proton between the O5 and O1 atoms of the ligand.	[Fujiwara, Takaaki; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Saburi, Wataru; Matsui, Hirokazu; Mori, Haruhide] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Yao, M (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	Saburi, Wataru/A-4271-2012; Mori, Haruhide/AAV-6374-2021; yao, min/F-5287-2011	Saburi, Wataru/0000-0002-2015-7086; Mori, Haruhide/0000-0001-7346-9131; yao, min/0000-0003-1687-5904	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26660081] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMEIN M, 1969, BIOCHEM BIOPH RES CO, V36, P223, DOI 10.1016/0006-291X(69)90318-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara T, 2013, FEBS LETT, V587, P840, DOI 10.1016/j.febslet.2013.02.007; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Ito S, 2009, BIOTECHNOL LETT, V31, P1065, DOI 10.1007/s10529-009-9979-3; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh T, 2008, J MOL BIOL, V377, P1443, DOI 10.1016/j.jmb.2008.01.090; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Kovalevsky AY, 2010, STRUCTURE, V18, P688, DOI 10.1016/j.str.2010.03.011; Lee YC, 2007, J MOL BIOL, V367, P895, DOI 10.1016/j.jmb.2006.11.001; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343; Nishimukai M, 2008, J AGR FOOD CHEM, V56, P10340, DOI 10.1021/jf801556m; Ojima T, 2013, BIOSCI BIOTECH BIOCH, V77, P189, DOI 10.1271/bbb.120742; Ojima T, 2011, BIOSCI BIOTECH BIOCH, V75, P2162, DOI 10.1271/bbb.110456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Solomons JTG, 2004, J MOL BIOL, V342, P847, DOI 10.1016/j.jmb.2004.07.085; Suzuki T, 2010, J AGR FOOD CHEM, V58, P1927, DOI 10.1021/jf9035063; Takano K, 2009, J BIOCHEM, V145, P79, DOI 10.1093/jb/mvn144; Thoden JB, 2003, PROTEIN SCI, V12, P1051, DOI 10.1110/ps.0243203; TYLER TR, 1967, ARCH BIOCHEM BIOPHYS, V119, P363, DOI 10.1016/0003-9861(67)90466-3; Watanabe J, 2008, J DAIRY SCI, V91, P4518, DOI 10.3168/jds.2008-1367; Yamane J, 2010, J APPL CRYSTALLOGR, V43, P1329, DOI 10.1107/S0021889810037222; Yoshida H, 2013, FEBS OPEN BIO, V3, P35, DOI 10.1016/j.fob.2012.11.008	31	34	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3405	3415		10.1074/jbc.M113.531251	http://dx.doi.org/10.1074/jbc.M113.531251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362032	Green Published, hybrid			2022-12-25	WOS:000331368700026
J	Frisvad, JC; Yilmaz, N; Thrane, U; Rasmussen, KB; Houbraken, J; Samson, RA				Frisvad, Jens C.; Yilmaz, Neriman; Thrane, Ulf; Rasmussen, Kasper Bowig; Houbraken, Jos; Samson, Robert A.			Talaromyces atroroseus, a New Species Efficiently Producing Industrially Relevant Red Pigments	PLOS ONE			English	Article							PENICILLIUM-PURPUROGENUM; PP-V; SUBMERGED CULTURE; INDOLE ALKALOIDS; B HYDROCHLORIDE; ACYL-COA; COLORANTS; ACID; RUGULOVASINE; ASSIMILATION	Some species of Talaromyces secrete large amounts of red pigments. Literature has linked this character to species such as Talaromyces purpurogenus, T. albobiverticillius, T. marneffei, and T. minioluteus often under earlier Penicillium names. Isolates identified as T. purpurogenus have been reported to be interesting industrially and they can produce extracellular enzymes and red pigments, but they can also produce mycotoxins such as rubratoxin A and B and luteoskyrin. Production of mycotoxins limits the use of isolates of a particular species in biotechnology. Talaromyces atroroseus sp. nov., described in this study, produces the azaphilone biosynthetic families mitorubrins and Monascus pigments without any production of mycotoxins. Within the red pigment producing clade, T. atroroseus resolved in a distinct clade separate from all the other species in multigene phylogenies ( ITS, beta-tubulin and RPB1), which confirm its unique nature. Talaromyces atroroseus resembles T. purpurogenus and T. albobiverticillius in producing red diffusible pigments, but differs from the latter two species by the production of glauconic acid, purpuride and ZG-1494 alpha and by the dull to dark green, thick walled ellipsoidal conidia produced. The type strain of Talaromyces atroroseus is CBS 133442	[Frisvad, Jens C.; Thrane, Ulf; Rasmussen, Kasper Bowig] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Yilmaz, Neriman; Houbraken, Jos; Samson, Robert A.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Yilmaz, Neriman] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University	Frisvad, JC (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jcf@bio.dtu.dk	Frisvad, Jens C/K-2818-2017; Houbraken, Jos/AAE-7955-2019; Yilmaz, Neriman/AAF-6814-2021; Samson, Robert/ABE-6704-2020; Thrane, Ulf/G-2978-2016	Frisvad, Jens C/0000-0002-0573-4340; Houbraken, Jos/0000-0003-4893-4438; Yilmaz, Neriman/0000-0002-4396-4630; Thrane, Ulf/0000-0002-6040-4141; Samson, Robert A./0000-0002-2979-3097	Danish Research Agency for Technology and Production [09-064967]; Agilent Technologies	Danish Research Agency for Technology and Production; Agilent Technologies	Part of this work was supported by the Danish Research Agency for Technology and Production Grant 09-064967 and an equipment grant from Agilent Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-19; Arai T, 2012, BIOSCI BIOTECH BIOCH, V76, P120, DOI 10.1271/bbb.110589; BALDWIN J E, 1962, Experientia, V18, P345, DOI 10.1007/BF02172243; BARTON DHR, 1965, J CHEM SOC, P1779, DOI 10.1039/jr9650001779; BARTON DHR, 1965, J CHEM SOC, P1772, DOI 10.1039/jr9650001772; BARTON DHR, 1965, J CHEM SOC, P1769, DOI 10.1039/jr9650001769; Bollinger P, 1972, US Pat., Patent No. [3,655,880, 3655880]; BUCHI G, 1965, J AM CHEM SOC, V87, P3484, DOI 10.1021/ja01093a036; de Silva ED, 2011, ORG LETT, V13, P1174, DOI 10.1021/ol200031t; Espinoza-Hernandez T. C., 2013, African Journal of Biotechnology, V12, P3405; Feng YL, 2012, APPL MICROBIOL BIOT, V96, P1421, DOI 10.1007/s00253-012-4504-3; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Fujimoto H., 1988, Proceedings of the Japanese Association of Mycotoxicology, P15; Gao JM, 2013, CHEM REV, V113, P4755, DOI 10.1021/cr300402y; Gunasekaran S, 2008, AFR J BIOTECHNOL, V7, P1894; Herrick HT, 1928, J BIOL CHEM, V77, P185; Houbraken J, 2007, STUD MYCOL, P107, DOI 10.3114/sim.2007.59.12; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Houbraken J, 2011, INT J SYST EVOL MICR, V61, P1462, DOI 10.1099/ijs.0.025098-0; Hsieh HM, 2010, FUNG SCI, V25, P25; HUFF RK, 1972, J CHEM SOC PERK T 1, P2584, DOI 10.1039/p19720002584; Huff RK, 1968, J CHEM SOC CHEM COMM, V1968, P1192; Jiang Y., 2005, J AGR TECHNOL, V1, P113; KING TJ, 1970, J CHEM SOC CHEM COMM, P1499; KING TJ, 1973, J CHEM SOC PERK T 1, P78, DOI 10.1039/p19730000078; Kondo H, 1993, New substance BE-25327 which is an estradiol agonist - useful for treating oestrogen-deficient gynaecological diseases, osteoporous, prostatic cancer and prostatomegaly. Jpn. Kokai Tokkyo Koho, Patent No. [JP05032579 A2, 05032579]; Lin YL, 2008, APPL MICROBIOL BIOT, V77, P965, DOI 10.1007/s00253-007-1256-6; Liu BH, 2005, J AGR FOOD CHEM, V53, P170, DOI 10.1021/jf048878n; Mapari SAS, 2008, J AGR FOOD CHEM, V56, P9981, DOI 10.1021/jf801817q; Mapari SAS, 2010, TRENDS BIOTECHNOL, V28, P300, DOI 10.1016/j.tibtech.2010.03.004; Mapari SAS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-24; Mapari SAS, 2005, CURR OPIN BIOTECH, V16, P231, DOI 10.1016/j.copbio.2005.03.004; Marsini MA, 2006, ORG LETT, V8, P3481, DOI 10.1021/ol0610993; Mendez A, 2011, J ZHEJIANG UNIV-SC B, V12, P961, DOI 10.1631/jzus.B1100039; Mendez-Zavala A, 2007, REV MEX ING QUIM, V6, P267; NAGAOKA A, 1972, ARZNEI-FORSCHUNG, V22, P137; NAGAOKA A, 1972, ARZNEI-FORSCHUNG, V22, P143; NATSUME M, 1985, AGR BIOL CHEM TOKYO, V49, P2517, DOI 10.1080/00021369.1985.10867121; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; NISHIDA H, 1991, J ANTIBIOT, V44, P144, DOI 10.7164/antibiotics.44.144; Ogihara J, 2002, J BIOSCI BIOENG, V93, P54, DOI 10.1263/jbb.93.54; Ogihara J, 2001, J BIOSCI BIOENG, V91, P44, DOI 10.1263/jbb.91.44; Ogihara J, 2000, J BIOSCI BIOENG, V90, P549, DOI 10.1263/jbb.90.549; Osmanova N, 2010, PHYTOCHEM REV, V9, P315, DOI 10.1007/s11101-010-9171-3; Patakova P, 2013, J IND MICROBIOL BIOT, V40, P169, DOI 10.1007/s10295-012-1216-8; Pharm Amano, 1974, Jap. Pat. JP, Patent No. [49093587-A, 49093587]; Pitt J. I., 1980, GENUS PENICILLIUM IT; Qiu M, 2010, WORLD J MICROB BIOT, V26, P993, DOI 10.1007/s11274-009-0261-6; Raper KB, 1949, MANUAL PENICILLIA; ROBERTS JC, 1971, J CHEM SOC C, P3493, DOI 10.1039/j39710003493; ROBERTS JC, 1971, J CHEM SOC C, P3488, DOI 10.1039/j39710003488; ROBERTS JC, 1955, J CHEM SOC, P2992, DOI 10.1039/jr9550002992; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; SAMSON RA, 1989, STUD MYCOL, P133; Samson RA, 2010, FOOD INDOOR FUNGI; Santos-Ebinuma VC, 2013, J MICROBIOL BIOTECHN, V23, P802, DOI 10.4014/jmb.1211.11057; Santos-Ebinuma VC, 2013, BIOTECHNOL PROGR, V29, P778, DOI 10.1002/btpr.1720; Steglich W, 1974, PHYTOCHEMISTRY; Stoll O, 1903, THESIS WURZBERG; Suzuki S, 1999, J NAT PROD, V62, P1328, DOI 10.1021/np990146f; Takashima M, 1955, J AGRIC CHEM SOC, V29, P25; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMODA H, 1991, J ANTIBIOT, V44, P136, DOI 10.7164/antibiotics.44.136; VANREENENHOEKSTRA ES, 1990, NATO ADV SCI I A-LIF, V185, P173; Velmurugan P, 2010, J BIOSCI BIOENG, V109, P346, DOI 10.1016/j.jbiosc.2009.10.003; Velmurugan P, 2010, CARBOHYD POLYM, V79, P262, DOI 10.1016/j.carbpol.2009.07.058; Wang H, 2011, J NAT PROD, V74, P2014, DOI 10.1021/np2004769; West RR, 1996, J ANTIBIOT, V49, P967, DOI 10.7164/antibiotics.49.967; Wijkman N, 1931, LIEBIGS ANN CHEM, V485, P61; Yilmaz N, 2012, PERSOONIA, V29, P39, DOI 10.3767/003158512X659500; Yuill JL, 1934, BIOCHEM J, V28, P222, DOI 10.1042/bj0280222	73	86	95	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84102	10.1371/journal.pone.0084102	http://dx.doi.org/10.1371/journal.pone.0084102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367630	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900031
J	Teschler, S; Bartkuhn, M; Kunzel, N; Schmidt, C; Kiehl, S; Dammann, G; Dammann, R				Teschler, Stefanie; Bartkuhn, Marek; Kuenzel, Natascha; Schmidt, Christian; Kiehl, Steffen; Dammann, Gerhard; Dammann, Reinhard			Aberrant Methylation of Gene Associated CpG Sites Occurs in Borderline Personality Disorder	PLOS ONE			English	Article							DNA METHYLATION; SEXUAL ABUSE; PROMOTER; DIAGNOSIS; PROTEIN; STRESS; EPIGENOMICS; SEVERITY; SYMPTOMS; CHILDREN	Borderline personality disorder (BPD) is a complex psychiatric disease with an increased impact in the last years. While the diagnosis and therapy are well established, little is known on the pathogenesis of borderline personality disorder. Previously, a significant increase in DNA methylation of relevant neuropsychiatric genes in BPD patients has been reported. In our study we performed genome wide methylation analysis and revealed specific CpG sites that exhibited increased methylation in 24 female BPD patients compared to 11 female healthy controls. Bead chip technology and quantitative bisulfite pyrosequencing showed a significantly increased methylation at CpG sites of APBA2 (1.1 fold) and APBA3 (1.1 fold), KCNQ1 (1.5 fold), MCF2 (1.1 fold) and NINJ2 (1.2 fold) in BPD patients. For the CpG sites of GATA4 and HLCS an increase in DNA methylation was observed, but was only significant in the bead chip assay. Moreover genome wide methylation levels of blood samples of BPD patients and control samples are similar. In summary, our results show a significant 1.26 fold average increase in methylation at the analyzed gene associated CpG sites in the blood of BPD patients compared to controls samples (p<0.001). This data may provide new insights into epigenetic mechanisms underlying the pathogenesis of BPD.	[Teschler, Stefanie; Bartkuhn, Marek; Kuenzel, Natascha; Schmidt, Christian; Kiehl, Steffen; Dammann, Reinhard] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Dammann, Gerhard] Spital Thurgau AG, Hosp Psychiat, Munsterlingen, Switzerland; [Dammann, Gerhard] Univ Basel, Sch Med, Dept Psychiat, Basel, Switzerland	Justus Liebig University Giessen; University of Basel	Dammann, R (corresponding author), Univ Giessen, Inst Genet, D-35390 Giessen, Germany.	reinhard.dammann@gen.bio.uni-giessen.de		Kunzel, Natascha Andrea/0000-0001-8885-5123; Bartkuhn, Marek/0000-0001-6872-9082	Land Hessen (LOEWE); Deutsche Forschungsgemeinschaft [TRR81]	Land Hessen (LOEWE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research in Reinhard Dammann's laboratory is funded by Land Hessen (LOEWE) and Deutsche Forschungsgemeinschaft (TRR81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; APA, 1994, DIAGN STAT MAN MENT; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Dammann G, 2003, PSYCHIAT PRAX, V30, P304; Dammann G, 2011, EPIGENETICS-US, V6, P1454, DOI 10.4161/epi.6.12.18363; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FAMULARO R, 1991, J NERV MENT DIS, V179, P428, DOI 10.1097/00005053-199107000-00007; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gabbard GO, 2001, AM J PSYCHIAT, V158, P1, DOI 10.1176/appi.ajp.158.1.1; GOLDMAN SJ, 1992, AM J PSYCHIAT, V149, P1723; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Hao Y, 2012, NEUROREPORT, V23, P146, DOI 10.1097/WNR.0b013e32834f1934; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Hirsch E, 2002, AM POETRY REV, V31, P22; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Johansson L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003142; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; KARPYAK VM, 2012, ADDICT BIOL, P62823; Kraus A, 2009, BIOL PSYCHIAT, V65, P819, DOI 10.1016/j.biopsych.2008.10.028; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020573; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Murphy BC, 2005, AM J MED GENET B, V133B, P37, DOI 10.1002/ajmg.b.30134; PARIS J, 1994, J NERV MENT DIS, V182, P375, DOI 10.1097/00005053-199407000-00002; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Rashid A, 2001, AM J PATHOL, V159, P1129, DOI 10.1016/S0002-9440(10)61789-0; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Siever LJ, 2002, BIOL PSYCHIAT, V51, P964, DOI 10.1016/S0006-3223(02)01326-4; SILK KR, 1995, AM J PSYCHIAT, V152, P1059; Skodol AE, 2002, AM J PSYCHIAT, V159, P276, DOI 10.1176/appi.ajp.159.2.276; Skodol AE, 2002, BIOL PSYCHIAT, V51, P951, DOI 10.1016/S0006-3223(02)01325-2; Soloff PH, 2002, J PERS DISORD, V16, P201, DOI 10.1521/pedi.16.3.201.22542; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Steiger H, 2013, INT J EAT DISORDER, V46, P246, DOI 10.1002/eat.22113; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tanaka K, 2001, ONCOLOGY-BASEL, V60, P268, DOI 10.1159/000055328; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; WALLER G, 1994, CHILD ABUSE NEGLECT, V18, P97, DOI 10.1016/0145-2134(94)90099-X; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Walter M, 2009, PSYCHOPATHOLOGY, V42, P399, DOI 10.1159/000241196; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WIDIGER TA, 1991, HOSP COMMUNITY PSYCH, V42, P1015; Yuferov V, 2011, PHARMACOGENET GENOM, V21, P185, DOI 10.1097/FPC.0b013e32833eecbc; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225	66	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84180	10.1371/journal.pone.0084180	http://dx.doi.org/10.1371/journal.pone.0084180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367640	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900036
J	Wei, HF; Zhao, LK; Li, W; Fan, KX; Qian, WZ; Hou, S; Wang, H; Dai, M; Hellstrom, I; Hellstrom, KE; Guo, YJ				Wei, Huafeng; Zhao, Likun; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Dai, Min; Hellstrom, Ingegerd; Hellstrom, Karl Erik; Guo, Yajun			Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PERIPHERAL-BLOOD LYMPHOCYTES; EPITHELIAL OVARIAN-CANCER; ANTITUMOR IMMUNITY; T-CELLS; MONOCLONAL-ANTIBODY; ANTI-PD-1 ANTIBODY; DENDRITIC CELLS; IMMUNOTHERAPY; INFLAMMATION	There is an urgent need for improved therapy for advanced ovarian carcinoma, which may be met by administering immune-modulatory monoclonal antibodies (mAbs) to generate a tumor-destructive immune response. Using the ID8 mouse ovarian cancer model, we investigated the therapeutic efficacy of various mAb combinations in mice with intraperitoneal (i.p.) tumor established by transplanting 3 x 10(6) ID8 cells 10 days previously. While most of the tested mAbs were ineffective when given individually or together, the data confirm our previous finding that 2 i.p. injections of a combination of anti-CD137 with anti-PD-1 mAbs doubles overall survival. Mice treated with this mAb combination have a significantly increased frequency and total number of CD8(+) T cells both in the peritoneal lavage and spleens, and these cells are functional as demonstrated by antigen-specific cytolytic activity and IFN-gamma production. While administration of anti-CD137 mAb as a single agent similarly increases CD8(+) T cells, these have no functional activity, which may be attributed to up-regulation of co-inhibitory PD-1 and TIM-3 molecules induced by CD137. Addition of the anti-cancer drug cisplatin to the 2 mAb combination increased overall survival >90 days (and was probably curative) by a mechanism which included a systemic CD8(+) T cell response with tumor specificity and immunological memory. Strikingly, combined treatment of cisplatin and CD137/PD-1 mAb also gave rise to the long-term survival of mice with established TC1 lung tumors. A similar combination of the 2 mAbs and cisplatin should be considered for clinical 'translation'.	[Wei, Huafeng; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Zhao, Likun; Guo, Yajun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Wei, Huafeng; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Liaocheng Univ, Sch Pharm, Liaocheng, Peoples R China; [Dai, Min; Hellstrom, Ingegerd; Hellstrom, Karl Erik] Univ Washington, Harborview Med Ctr, Dept Pathol, Seattle, WA 98104 USA	Naval Medical University; South China University of Technology; Liaocheng University; Harborview Medical Center; University of Washington; University of Washington Seattle	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China.	yguo_smmu@163.com	DAI, M/GPS-8291-2022		National Natural Science Foundation of China [81372528]; Ministry of Science & Technology of China "973" [2012CB917104]; Ministry of Education of China; Shanghai Commission of Education for excellent research team in Oncology; U.S. National Institutes of Health [RO1CA134487]; NATIONAL CANCER INSTITUTE [R01CA134487] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China "973"; Ministry of Education of China(Ministry of Education, China); Shanghai Commission of Education for excellent research team in Oncology; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (No. 81372528), Ministry of Science & Technology of China "973" (No. 2012CB917104), special grants from Ministry of Education of China and Shanghai Commission of Education for excellent research team in Oncology and Shanghai Key Project in Oncology as well as by RO1CA134487 from U.S. National Institutes of Health. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AY, 2012, ANN NY ACAD SCI, V1271, P58, DOI 10.1111/j.1749-6632.2012.06734.x; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dai M, 2013, J IMMUNOTHER, V36, P248, DOI 10.1097/CJI.0b013e3182943549; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Feng QH, 2012, GYNECOL ONCOL, V127, P412, DOI 10.1016/j.ygyno.2012.07.098; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Graziani G, 2012, PHARMACOL RES, V65, P9, DOI 10.1016/j.phrs.2011.09.002; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kim YH, 2008, CANCER RES, V68, P7264, DOI 10.1158/0008-5472.CAN-08-1365; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Leary A, 2012, B CANCER, V99, P1161, DOI 10.1684/bdc.2012.1667; Li QS, 2004, CANCER RES, V64, P1130, DOI 10.1158/0008-5472.CAN-03-1715; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Mantia-Smaldone GM, 2012, HUM VACC IMMUNOTHER, V8, P1179, DOI 10.4161/hv.20738; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ramakrishna V, 2003, INT IMMUNOL, V15, P751, DOI 10.1093/intimm/dxg074; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; Schondorf T, 1998, J SOC GYNECOL INVEST, V5, P102, DOI 10.1016/S1071-5576(97)00112-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Vermeij R, 2012, CURR PHARM DESIGN, V18, P3804, DOI 10.2174/138161212802002805; Wei HF, 2008, CANCER RES, V68, P3854, DOI 10.1158/0008-5472.CAN-07-6051; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; Wei HF, 2012, J IMMUNOTHER, V35, P267, DOI 10.1097/CJI.0b013e31824d72ee; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yang Y, 2007, CANCER RES, V67, P2339, DOI 10.1158/0008-5472.CAN-06-3593; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Zhang HT, 2006, MOL CANCER THER, V5, P149, DOI 10.1158/1535-7163.MCT-05-0206; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	44	66	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84927	10.1371/journal.pone.0084927	http://dx.doi.org/10.1371/journal.pone.0084927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367702	Green Published, gold			2022-12-25	WOS:000328741900071
J	Ahn, SY; Ryu, J; Baek, SH; Kim, S; Na, KY; Kim, KW; Chae, DW; Chin, HJ				Ahn, Shin Young; Ryu, Jiwon; Baek, Seon Ha; Kim, Sejoong; Na, Ki Young; Kim, Ki Woong; Chae, Dong-Wan; Chin, Ho Jun			Incident Chronic Kidney Disease and Newly Developed Complications Related to Renal Dysfunction in an Elderly Population during 5 Years: A Community-Based Elderly Population Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; FAILURE; ADULTS; ONSET	Background: Few studies have evaluated the association between incident chronic kidney disease (CKD) and related complications, especially in elderly population. We attempted to verify the association between GFR and concurrent CKD complications and elucidate the temporal relationship between incident CKD and new CKD complications in a community-based prospective elderly cohort. Method: We analyzed the available data from 984 participants in the Korean Longitudinal Study on Health and Aging. Participants were categorized into 6 groups according to eGFR at baseline examination (>= 90, 75-89, 60-74, 45-59, 30-44, and <30 ml/min/1.73 m(2)). Result: The mean age of study population was 76 +/- 9.1 years and mean eGFR was 72.3 +/- 17.0 ml/min/1.73 m(2). Compared to eGFR group 1, the odds ratio (OR) for hypertension was 2.363 (95% CI, 1.299-4.298) in group 4, 5.191 (2.074-12.995) in group 5, and 13.675 (1.611-115.806) in group 6; for anemia, 7.842 (2.265-27.153) in group 5 and 13.019 (2.920-58.047) in group 6; for acidosis, 69.580 (6.770-715.147) in group 6; and for hyperkalemia, 19.177 (1.798-204.474) in group 6. Over a 5-year observational period, CKD developed in 34 (9.6%) among 354 participants with GFR >= 60 ml/min/1.73 m(2) at basal examination. The estimated mean number of new complications according to analysis of co-variance was 0.52 (95% CI, 0.35-0.68) in subjects with incident CKD and 0.24 (0.19-0.29) in subjects without CKD (p = 0.002). Subjects with incident CKD had a 2.792-fold higher risk of developing new CKD complications. A GFR level of 52.4 ml/min/1.73 m(2) (p = 0.032) predicted the development of a new CKD complication with a 90% sensitivity. Conclusion: In an elderly prospective cohort, CKD diagnosed by current criteria is related to an increase in the number of concurrent CKD complications and the development of new CKD complications.	[Ahn, Shin Young; Ryu, Jiwon; Baek, Seon Ha; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ Bundang Hopsital, Dept Internal Med, Seong Nam, South Korea; [Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ Coll Med, Dept Internal Mecidine, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ Bundang Hopsital, Dept Neuropsychiat, Seong Nam, South Korea; [Chin, Ho Jun] Seoul Natl Univ Coll Med, Clin Res Ctr, Renal Inst, Seoul, South Korea	Seoul National University (SNU); Samsung; Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ Bundang Hopsital, Dept Internal Med, Seong Nam, South Korea.	mednep@snubh.org	Kim, Ki Woong/D-5801-2012; Kim, Sejoong/J-5356-2015	Kim, Ki Woong/0000-0002-1103-3858; Kim, Sejoong/0000-0002-7238-9962	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant number. 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant number. 800-20050211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Cirillo M, 2006, KIDNEY INT, V70, P800, DOI 10.1038/sj.ki.5001641; Drawz PE, 2012, J AM GERIATR SOC, V60, P310, DOI 10.1111/j.1532-5415.2011.03818.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Hollowell Joseph G, 2005, Vital Health Stat 11, P1; Kim YC, 2012, TOHOKU J EXP MED, V227, P149, DOI 10.1620/tjem.227.149; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Oh SW, 2012, NEPHROL DIAL TRANSPL, V27, P267, DOI 10.1093/ndt/gfr296; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; RADTKE HW, 1979, BLOOD, V54, P877; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Vaziri ND, 2004, KIDNEY INT, V66, P262, DOI 10.1111/j.1523-1755.2004.00724.x; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang XW, 2012, CARDIORENAL MED, V2, P57, DOI 10.1159/000335509; 1968, WHO TECH REP SER, P5	23	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84467	10.1371/journal.pone.0084467	http://dx.doi.org/10.1371/journal.pone.0084467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367663	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300142
J	Bergerot, B; Hugueny, B; Belliard, J				Bergerot, Benjamin; Hugueny, Bernard; Belliard, Jerome			When Local Extinction and Colonization of River Fishes Can Be Predicted by Regional Occupancy: the Role of Spatial Scales	PLOS ONE			English	Article							HABITAT MODEL OUTPUTS; RISK; ASSEMBLAGES; RARITY; FRAGMENTATION; VARIABILITY; POPULATIONS; FRAMEWORK; RICHNESS; DYNAMICS	Background: Predicting which species are likely to go extinct is perhaps one of the most fundamental yet challenging tasks for conservation biologists. This is particularly relevant for freshwater ecosystems which tend to have the highest proportion of species threatened with extinction. According to metapopulation theories, local extinction and colonization rates of freshwater subpopulations can depend on the degree of regional occupancy, notably due to rescue effects. However, relationships between extinction, colonization, regional occupancy and the spatial scales at which they operate are currently poorly known. Methods: And Findings: We used a large dataset of freshwater fish annual censuses in 325 stream reaches to analyse how annual extinction/colonization rates of subpopulations depend on the regional occupancy of species. For this purpose, we modelled the regional occupancy of 34 fish species over the whole French river network and we tested how extinction/colonization rates could be predicted by regional occupancy described at five nested spatial scales. Results show that extinction and colonization rates depend on regional occupancy, revealing existence a rescue effect. We also find that these effects are scale dependent and their absolute contribution to colonization and extinction tends to decrease from river section to larger basin scales. Conclusions: In terms of management, we show that regional occupancy quantification allows the evaluation of local species extinction/colonization dynamics and reduction of local extinction risks for freshwater fish species implies the preservation of suitable habitats at both local and drainage basin scales.	[Bergerot, Benjamin; Belliard, Jerome] Inst Natl Rech Sci & Technol Environm & Agr, Dept Hydrosyst & Bioproc Res Unit, Antony, France; [Bergerot, Benjamin] Univ Appl Sci Western Switzerland, Hepia Geneva, Dept Technol Architecture & Landscape, Jussey, Switzerland; [Hugueny, Bernard] Museum Natl Hist Nat, Dept Biol Organismes & Ecosyst Aquat, F-75231 Paris, France	INRAE; University of Applied Sciences & Arts Western Switzerland; Museum National d'Histoire Naturelle (MNHN)	Bergerot, B (corresponding author), Inst Natl Rech Sci & Technol Environm & Agr, Dept Hydrosyst & Bioproc Res Unit, Antony, France.	benjamin.bergerot@hesge.ch	bergerot, benjamin/AAD-4591-2021	Jerome, Belliard/0000-0001-8757-125X; bergerot, benjamin/0000-0003-4313-4925	Agence Nationale de la Recherche [ANR-09-PEXT-008]; Office National de l'Eau et des Milieux Aquatiques	Agence Nationale de la Recherche(French National Research Agency (ANR)); Office National de l'Eau et des Milieux Aquatiques	Financial support was provided by the Agence Nationale de la Recherche under the project named "6th Extinction 2009"(ANR-09-PEXT-008). BB was also supported by a research grant of the Office National de l'Eau et des Milieux Aquatiques ("Fish-Hydro" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1981, CC ENG TECHNOL APPL, V51, P22; Albanese B, 2009, FRESHWATER BIOL, V54, P1444, DOI 10.1111/j.1365-2427.2009.02194.x; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Driscoll DA, 2010, J ANIM ECOL, V79, P294, DOI 10.1111/j.1365-2656.2009.01609.x; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Fagan WE, 2005, ECOLOGY, V86, P34, DOI 10.1890/04-0491; Fagan WF, 2002, ECOLOGY, V83, P3250, DOI 10.1890/0012-9658(2002)083[3250:RFAERI]2.0.CO;2; Falke JA, 2010, AM FISH S S, V73, P207; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; GOTELLI NJ, 1993, OIKOS, V68, P36, DOI 10.2307/3545306; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I, 1999, METAPOPULATION ECOLO; Hitt NP, 2008, J N AM BENTHOL SOC, V27, P304, DOI 10.1899/07-096.1; Hitt NP, 2012, OIKOS, V121, P127, DOI 10.1111/j.1600-0706.2011.19482.x; Ibarra AA, 2005, ECOL FRESHW FISH, V14, P233, DOI 10.1111/j.1600-0633.2005.00096.x; Lamouroux N, 2002, FRESHWATER BIOL, V47, P1531, DOI 10.1046/j.1365-2427.2002.00880.x; Lamouroux N, 2002, FRESHWATER BIOL, V47, P1543, DOI 10.1046/j.1365-2427.2002.00879.x; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Levins R., 1970, SOME MATH PROBLEMS B, P77; MINNS CK, 1995, CAN J FISH AQUAT SCI, V52, P1499, DOI 10.1139/f95-144; Minto C, 2008, NATURE, V452, P344, DOI 10.1038/nature06605; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Oberdorff T, 2002, B FR PECHE PISCIC, P405, DOI 10.1051/kmae:2002043; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Olden JD, 2008, ECOLOGY, V89, P847, DOI 10.1890/06-1864.1; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Pella H, 2012, GEOMORPHOLOGIE, P317; Pfister CA, 1998, OECOLOGIA, V114, P118, DOI 10.1007/s004420050427; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Pretty JL, 2003, J APPL ECOL, V40, P251, DOI 10.1046/j.1365-2664.2003.00808.x; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Sauquet E, 2006, J HYDROL, V331, P300, DOI 10.1016/j.jhydrol.2006.05.018; Scheurer JA, 2003, T AM FISH SOC, V132, P840, DOI 10.1577/T02-037; STOTT B, 1967, J ANIM ECOL, V36, P407, DOI 10.2307/2922; Taylor CM, 1997, OECOLOGIA, V110, P560, DOI 10.1007/s004420050196; Taylor CM, 2001, ECOLOGY, V82, P2320, DOI 10.2307/2680234	41	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84138	10.1371/journal.pone.0084138	http://dx.doi.org/10.1371/journal.pone.0084138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367636	gold, Green Published, Green Submitted			2022-12-25	WOS:000328740300130
J	Gese, EM; Dowd, JLB; Aubry, LM				Gese, Eric M.; Dowd, Jennifer L. B.; Aubry, Lise M.			The Influence of Snowmobile Trails on Coyote Movements during Winter in High-Elevation Landscapes	PLOS ONE			English	Article							SEASONAL-VARIATION; NATIONAL-PARK; LYNX; BEHAVIOR; SNOW; DEER	Competition between sympatric carnivores has long been of interest to ecologists. Increased understanding of these interactions can be useful for conservation planning. Increased snowmobile traffic on public lands and in habitats used by Canada lynx (Lynx canadensis) remains controversial due to the concern of coyote (Canis latrans) use of snowmobile trails and potential competition with lynx. Determining the variables influencing coyote use of snowmobile trails has been a priority for managers attempting to conserve lynx and their critical habitat. During 2 winters in northwest Wyoming, we backtracked coyotes for 265 km to determine how varying snow characteristics influenced coyote movements; 278 km of random backtracking was conducted simultaneously for comparison. Despite deep snow (>1 m deep), radio-collared coyotes persisted at high elevations (2,500 m) year-round. All coyotes used snowmobile trails for some portion of their travel. Coyotes used snowmobile trails for 35% of their travel distance (random: 13%) for a mean distance of 149 m (random: 59 m). Coyote use of snowmobile trails increased as snow depth and penetrability off trails increased. Essentially, snow characteristics were most influential on how much time coyotes spent on snowmobile trails. In the early months of winter, snow depth was low, yet the snow column remained dry and the coyotes traveled off trails. As winter progressed and snow depth increased and snow penetrability increased, coyotes spent more travel distance on snowmobile trails. As spring approached, the snow depth remained high but penetrability decreased, hence coyotes traveled less on snowmobile trails because the snow column off trail was more supportive. Additionally, coyotes traveled closer to snowmobile trails than randomly expected and selected shallower snow when traveling off trails. Coyotes also preferred using snowmobile trails to access ungulate kills. Snow compaction from winter recreation influenced coyote movements within an area containing lynx and designated lynx habitat.	[Gese, Eric M.] Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA; [Dowd, Jennifer L. B.; Aubry, Lise M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011	Aubry, Lise/0000-0003-3318-7329	United States Department of Agriculture, Wildlife Services; National Wildlife Research Center; United States Forest Service; Bridger-Teton National Forest; Endeavor Wildlife Research Foundation	United States Department of Agriculture, Wildlife Services; National Wildlife Research Center(United States Department of Agriculture (USDA)); United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Bridger-Teton National Forest; Endeavor Wildlife Research Foundation	The research was supported by funding from the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center; the United States Forest Service, Bridger-Teton National Forest; and Endeavor Wildlife Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood TC, 2008, ANIM BEHAV, V75, P753, DOI 10.1016/j.anbehav.2007.08.024; Aubry Keith B., 2000, P373; Berry KJ, 2001, SPRINGER SERIES STAT; Bunnell KD, 2006, WILDLIFE SOC B, V34, P828, DOI 10.2193/0091-7648(2006)34[828:PIOCAS]2.0.CO;2; Burnham KP, 2002, MODELING SELECTION M; Buskirk Steven W., 2000, P83; Crete M, 2003, CAN J ZOOL, V81, P1808, DOI 10.1139/Z03-182; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Dowd JLB, 2012, NORTHWEST SCI, V86, P289, DOI 10.3955/046.086.0405; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; GESE EM, 1995, AM MIDL NAT, V133, P36, DOI 10.2307/2426345; GESE EM, 1987, WILDLIFE SOC B, V15, P444; KOEHLER GM, 1991, J MAMMAL, V72, P391, DOI 10.2307/1382112; Kolbe JA, 2007, J WILDLIFE MANAGE, V71, P1409, DOI 10.2193/2005-682; Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85; McKelvey Kevin S., 2000, P307; MURRAY DL, 1995, ANIM BEHAV, V50, P1203, DOI 10.1016/0003-3472(95)80037-9; MURRAY DL, 1991, OECOLOGIA, V88, P463, DOI 10.1007/BF00317707; Natural Resources Conservation Service, 2008, SNOTEL DAT NETW; Neter J., 1996, APPL LINEAR STAT MOD; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; R Core Team, 2022, R LANG ENV STAT COMP; RUEDIGER B, 2000, CANADA LYNX CONSERVA; RUGGIERO LF, 2000, ECOLOGY CONSERVATION; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevens MHH, 2009, MULTIRESPONSE PERMUT; *US DEP INT FISH W, 2000, FED REGISTER, V65, P16052; US Department of Agriculture, 2007, NO ROCK LYNX MAN DIR; Wyoming Department of State Parks and Cultural Services, 2008, WYOM STAT GOV ANN RE	29	9	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82862	10.1371/journal.pone.0082862	http://dx.doi.org/10.1371/journal.pone.0082862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367565	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300078
J	Nam, YD; Kim, HJ; Seo, JG; Kang, SW; Bae, JW				Nam, Young-Do; Kim, Hak Jae; Seo, Jae-Gu; Kang, Seung Wan; Bae, Jin-Woo			Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing	PLOS ONE			English	Article							COLORECTAL-CANCER; RADIATION; PREDISPOSE; DIVERSITY; RESPONSES; STRESS; HEALTH; INJURY; RISK	Although pelvic irradiation is effective for the treatment of various cancer types, many patients who receive radiotherapy experience serious complications. Gut microbial dysbiosis was hypothesized to be related to the occurrence of radiation-induced complications in cancer patients. Given the lack of clinical or experimental data on the impact of radiation on gut microbiota, a prospective observational study of gut microbiota was performed in gynecological cancer patients receiving pelvic radiotherapy. In the current study, the overall composition and alteration of gut microbiota in cancer patients receiving radiation were investigated by 454 pyrosequencing. Gut microbial composition showed significant differences (P < 0.001) between cancer patients and healthy individuals. The numbers of species-level taxa were severely reduced after radiotherapy (P < 0.045), and the abundance of each community largely changed. In particular, the phyla Firmicutes and Fusobacterium were significantly decreased by 10% and increased by 3% after radiation therapy, respectively. In addition, overall gut microbial composition was gradually remolded after the full treatment course of pelvic radiotherapy. In this set of cancer patients, dysbiosis of the gut microbiota was linked to health status, and the gut microbiota was influenced by pelvic radiotherapy. Although further studies are needed to elucidate the relationship between dysbiosis and complications induced by pelvic radiotherapy, the current study may offer insights into the treatment of cancer patients suffering from complications after radiation therapy.	[Nam, Young-Do; Bae, Jin-Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Nam, Young-Do; Bae, Jin-Woo] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Nam, Young-Do] Korea Food Res Inst, Fermentat & Funct Res Grp, Sungnam, South Korea; [Kim, Hak Jae] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul 110744, South Korea; [Seo, Jae-Gu] Cell Biotech Co Ltd, Seoul, South Korea; [Kang, Seung Wan] Seoul Natl Univ, Coll Nursing, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Korea Food Research Institute (KFRI); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kang, SW (corresponding author), Seoul Natl Univ, Coll Nursing, Seoul, South Korea.	drdemian@snu.ac.kr; baejw@khu.ac.kr	Bae, Jin-Woo/S-1955-2017	Bae, Jin-Woo/0000-0001-6433-5270; Nam, Young-Do/0000-0002-2660-3569	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF) [2011-0028854]; Ministry of Education, Science, and Technology (MEST); SNUH CRI grant [0620122120]	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); SNUH CRI grant	This work was supported by a grant from the Mid-Career Researcher Program (2011-0028854 to J.-W.B.) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST); SNUH CRI grant (0620122120), and nonprofit research donation for integrative medicine from SK Holdings and the late Chairman Jong-Hyun Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasakoor F, 2006, COLORECTAL DIS, V8, P2, DOI 10.1111/j.1463-1318.2005.00851.x; Alonso C, 2008, GASTROENTEROLOGY, V135, P163, DOI 10.1053/j.gastro.2008.03.036; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Beg AA, 2004, NAT IMMUNOL, V5, P14, DOI 10.1038/ni0104-14; Bismar Mike M, 2002, Curr Gastroenterol Rep, V4, P361, DOI 10.1007/s11894-002-0005-3; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Giralt J, 2008, INT J RADIAT ONCOL, V71, P1213, DOI 10.1016/j.ijrobp.2007.11.009; Gotelli NJ, 2002, NATURE, V419, P575, DOI 10.1038/419575a; Guschin DY, 1997, APPL ENVIRON MICROB, V63, P2397, DOI 10.1128/AEM.63.6.2397-2402.1997; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Homann N, 2000, INT J CANCER, V86, P169, DOI 10.1002/(SICI)1097-0215(20000415)86:2&lt;169::AID-IJC4&gt;3.0.CO;2-3; HUSEBYE E, 1995, GASTROENTEROLOGY, V109, P1078, DOI 10.1016/0016-5085(95)90565-0; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Johnson Louis Banka, 2004, BMC Surg, V4, P10, DOI 10.1186/1471-2482-4-10; Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; PACE NR, 1985, ASM NEWS, V51, P4; Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHIN NR, 2013, GUT, P4561; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Tong JL, 2008, YONSEI MED J, V49, P792, DOI 10.3349/ymj.2008.49.5.792; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	44	113	121	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82659	10.1371/journal.pone.0082659	http://dx.doi.org/10.1371/journal.pone.0082659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367534	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300050
J	Zhang, RZ; Zhang, BT; Xu, Y; Li, YH; Li, M; Liang, HB; Xiao, R				Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo; Xiao, Rong			Efficicent (R)-Phenylethanol Production with Enantioselectivity-Alerted (S)-Carbonyl Reductase II and NADPH Regeneration	PLOS ONE			English	Article							GLUCOSE-DEHYDROGENASE; CARBONYL REDUCTASE; ESCHERICHIA-COLI; TRANSLATION INITIATION; COFACTOR REGENERATION; CANDIDA-PARAPSILOSIS; EXPRESSION; KETONES; CELLS; (S)-1-PHENYL-1,2-ETHANEDIOL	The NADPH-dependent (S)-carbonyl reductaseII from Candida parapsilosis catalyzes acetophenone to chiral phenylethanol in a very low yield of 3.2%. Site-directed mutagenesis was used to design two mutants Ala220Asp and Glu228Ser, inside or adjacent to the substrate-binding pocket. Both mutations caused a significant enantioselectivity shift toward (R)-phenylethanol in the reduction of acetophenone. The variant E228S produced (R)-phenylethanol with an optical purity above 99%, in 80.2% yield. The E228S mutation resulted in a 4.6-fold decrease in the K-M value, but nearly 5-fold and 21-fold increases in the k(cat) and k(cat)/K-M values with respect to the wild type. For NADPH regeneration, Bacillus sp. YX-1 glucose dehydrogenase was introduced into the (R)-phenylethanol pathway. A coexpression system containing E228S and glucose dehydrogenase was constructed. The system was optimized by altering the coding gene order on the plasmid and using the Shine-Dalgarno sequence and the aligned spacing sequence as a linker between them. The presence of glucose dehydrogenase increased the NADPH concentration slightly and decreased NADP(+) pool 2- to 4-fold; the NADPH/NADP(+) ratio was improved 2- to 5-fold. The recombinant Escherichia coli/pET-MS-SD-AS-G, with E228S located upstream and glucose dehydrogenase downstream, showed excellent performance, giving (R)-phenylethanol of an optical purity of 99.5 % in 92.2% yield in 12 h in the absence of an external cofactor. When 0.06 mM NADP(+) was added at the beginning of the reaction, the reaction duration was reduced to 1 h. Optimization of the coexpression system stimulated an over 30-fold increase in the yield of (R)phenylethanol, and simultaneously reduced the reaction time 48-fold compared with the wild-type enzyme. This report describes possible mechanisms for alteration of the enantiopreferences of carbonyl reductases by site mutation, and cofactor rebalancing pathways for efficient chiral alcohols production.	[Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zhang, Rongzhen; Zhang, Botao; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Zhang, Rongzhen; Xu, Yan; Li, Yaohui; Li, Ming; Liang, Hongbo] Jiangnan Univ, Natl Key Lab Food Sci, Wuxi, Peoples R China; [Zhang, Botao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Xiao, Rong] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Jiangnan University; Jiangnan University; Jiangnan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Rutgers State University New Brunswick	Xu, Y (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	yxu@jiangnan.edu.cn			National Key Basic Research and Development Program of China (973 Program) [2011CB710800]; National Science Foundation of China [31070059, 31370100]; Programme of Introducing Talents of Discipline to Universities [111-2-06]; Jiangsu Province Basic Research Program (Natural Science Foundation) [BK20131101]	National Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Jiangsu Province Basic Research Program (Natural Science Foundation)	This project was supported by the National Key Basic Research and Development Program of China (973 Program 2011CB710800), the National Science Foundation of China (31070059 and 31370100), the Programme of Introducing Talents of Discipline to Universities (No. 111-2-06), and Jiangsu Province Basic Research Program (Natural Science Foundation BK20131101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bergmeyer H, 1985, METHOD ENZYMAT AN, V5, P15; Blaser H.-U., 2010, ASYMMETRIC CATALYSIS, Vsecond; Blazyk JL, 2004, J BIOL CHEM, V279, P5630, DOI 10.1074/jbc.M308940200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cedrone F, 2000, CURR OPIN STRUC BIOL, V10, P405, DOI 10.1016/S0959-440X(00)00106-8; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chen XJ, 2011, AFR J MICROBIOL RES, V5, P5882, DOI 10.5897/AJMR11.831; de Felipe FL, 1998, J BACTERIOL, V180, P3804; Endo T, 2001, ADV SYNTH CATAL, V343, P521, DOI 10.1002/1615-4169(200108)343:6/7<521::AID-ADSC521>3.0.CO;2-5; Faber K., 2018, BIOTRANSFORMATIONS O; Faber K., 2002, ANGEW CHEM, V114, P1056, DOI [10.1002/1521-3757(20020315)114:6, DOI 10.1002/1521-3757(20020315)114:6]; Flanagan JU, 2004, BIOCHEM J, V380, P353, DOI 10.1042/BJ20040062; Groger H, 2004, TETRAHEDRON, V60, P633, DOI 10.1016/j.tet.2003.11.066; Groger H, 2006, ANGEW CHEM INT EDIT, V45, P5677, DOI 10.1002/anie.200503394; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUMMEL W, 1989, EUR J BIOCHEM, V184, P1, DOI 10.1111/j.1432-1033.1989.tb14983.x; Itoh N, 2004, APPL MICROBIOL BIOT, V66, P53, DOI 10.1007/s00253-004-1702-7; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kataoka M, 1999, APPL MICROBIOL BIOT, V51, P486, DOI 10.1007/s002530051421; Kizaki N, 2001, APPL MICROBIOL BIOT, V55, P590, DOI 10.1007/s002530100599; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Kosjek B, 2008, ORG PROCESS RES DEV, V12, P584, DOI 10.1021/op700255b; Kroutil W, 2004, CURR OPIN CHEM BIOL, V8, P120, DOI 10.1016/j.cbpa.2004.02.005; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Nie Y, 2007, APPL ENVIRON MICROB, V73, P3759, DOI 10.1128/AEM.02185-06; Nissen TL, 2001, YEAST, V18, P19, DOI 10.1002/1097-0061(200101)18:1<19::AID-YEA650>3.3.CO;2-X; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pfrunder H, 2004, ANGEW CHEM, V116, P4629, DOI [DOI 10.1002/ANGE.200460241, 10.1002/ange.200460241]; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schroer K, 2009, BIOTECHNOL BIOENG, V104, P251, DOI 10.1002/bit.22390; Tishkov VI, 1999, BIOTECHNOL BIOENG, V64, P187, DOI 10.1002/(SICI)1097-0290(19990720)64:2<187::AID-BIT7>3.0.CO;2-0; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Wandrey C, 2004, CHEM REC, V4, P254, DOI 10.1002/tcr.20016; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Ye Q, 2010, BIORESOURCE TECHNOL, V101, P6761, DOI 10.1016/j.biortech.2010.03.099; Zhang RZ, 2008, PROTEIN SCI, V17, P1412, DOI 10.1110/ps.035089.108; Zhang RZ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-167; Zhang RZ, 2011, BIORESOURCE TECHNOL, V102, P483, DOI 10.1016/j.biortech.2010.08.060; Zhang Rongzhen, 2009, Weishengwu Xuebao, V49, P204; Zhang YP, 2009, METAB ENG, V11, P101, DOI 10.1016/j.ymben.2008.11.001	47	14	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83586	10.1371/journal.pone.0083586	http://dx.doi.org/10.1371/journal.pone.0083586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358299	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700063
J	Dasgupta, SK; Le, A; Haudek, SB; Entman, ML; Rumbaut, RE; Thiagarajan, P				Dasgupta, Swapan K.; Anhquyen Le; Haudek, Sandra B.; Entman, Mark L.; Rumbaut, Rolando E.; Thiagarajan, Perumal			Rho Associated Coiled-Coil Kinase-1 Regulates Collagen-Induced Phosphatidylserine Exposure in Platelets	PLOS ONE			English	Article							BCL-X(L)-INHIBITORY BH3 MIMETICS; ACTIN STRESS FIBERS; PROTEIN-KINASE; SHAPE CHANGE; PROCOAGULANT RESPONSE; SIGNALING PATHWAYS; ROCK-II; PHOSPHORYLATION; BINDING; CYTOSKELETON	Background: The transbilayer movement of phosphatidylserine mediates the platelet procoagulant activity during collagen stimulation. The Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 inhibits senescence induced but not activation induced phosphatidylserine exposure. To investigate further the specific mechanisms, we now utilized mice with genetic deletion of the ROCK1 isoform. Methods and Results: ROCK1-deficient mouse platelets expose significantly more phosphatidylserine and generate more thrombin upon activation with collagen compared to wild-type platelets. There were no significant defects in platelet shape change, aggregation, or calcium response compared to wild-type platelets. Collagen-stimulated ROCK1-deficient platelets also displayed decreased phosphorylation levels of Lim Kinase-1 and cofilin-1. However, there was no reduction in phosphorylation levels of myosin phosphatase subunit-1 (MYPT1) or myosin light chain (MLC). In an in vivo light/dye-induced endothelial injury/thrombosis model, ROCK1-deficient mice presented a shorter occlusion time in cremasteric venules when compared to wild-type littermates (3.16 +/- 1.33 min versus 6.6 +/- 2.6 min; p = 0.01). Conclusions: These studies define ROCK1 as a new regulator for collagen-induced phosphatidylserine exposure in platelets with functional consequences on thrombosis. This effect was downstream of calcium signaling and was mediated by Lim Kinase-1 / cofilin-1-induced cytoskeletal changes.	[Dasgupta, Swapan K.; Anhquyen Le; Rumbaut, Rolando E.; Thiagarajan, Perumal] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Dasgupta, Swapan K.; Anhquyen Le; Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Haudek, Sandra B.; Entman, Mark L.; Rumbaut, Rolando E.; Thiagarajan, Perumal] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dasgupta, SK (corresponding author), Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA.	swapand@bcm.edu		Rumbaut, Rolando/0000-0002-8486-1013; Thiagarajan, Perumal/0000-0003-2186-7036	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institutes of Health [HL116524, HL089792]; National Blood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524, R01HL089792] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550, I01BX000502] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Blood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (to PT and RR), grants from National Institutes of Health (HL116524 to RR and PT; HL089792 to MLE and SBH) and by a grant from the National Blood Foundation (to SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bender M, 2010, BLOOD, V116, P1767, DOI 10.1182/blood-2010-03-274340; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Dasgupta SK, 2006, TRANSL RES, V148, P19, DOI 10.1016/j.lab.2006.03.006; Dasgupta SK, 2010, TRANSFUSION, V50, P2167, DOI 10.1111/j.1537-2995.2010.02676.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Freikman I, 2012, J MEMBRANE BIOL, V245, P779, DOI 10.1007/s00232-012-9478-7; Garg S, 2009, J STRUCT BIOL, V168, P11, DOI 10.1016/j.jsb.2009.04.001; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Rennebaum S, 2012, PROTEINS, V80, P1998, DOI 10.1002/prot.24088; Schoenwaelder SM, 2012, BLOOD, V119, P1320, DOI 10.1182/blood-2011-10-387399; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; STOUT AL, 1994, BIOPHYS J, V67, P1324, DOI 10.1016/S0006-3495(94)80604-6; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki Y, 1999, BLOOD, V93, P3408, DOI 10.1182/blood.V93.10.3408.410k37_3408_3417; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; WEISS HJ, 1994, SEMIN HEMATOL, V31, P312; Wilde JI, 2000, PLATELETS, V11, P286; WILLIAMSON P, 1985, J CELL PHYSIOL, V123, P209, DOI 10.1002/jcp.1041230209; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84649	10.1371/journal.pone.0084649	http://dx.doi.org/10.1371/journal.pone.0084649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358370	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700164
J	Flatten, I; Skarstad, K				Flatten, Ingvild; Skarstad, Kirsten			The Fis Protein Has a Stimulating Role in Initiation of Replication in Escherichia coli In Vivo	PLOS ONE			English	Article							DNA-REPLICATION; CHROMOSOME-REPLICATION; DIVISION CYCLE; FLOW-CYTOMETRY; ORIGIN; BINDING; MECHANISM; EXPRESSION; COMPLEXES; INVERSION	The Fis protein is a nucleoid associated protein that has previously been reported to act negatively in initiation of replication in Escherichia coli. In this work we have examined the influence of this protein on the initiation of replication under different growth conditions using flow cytometry. The Fis protein was found to be increasingly important with increasing growth rate. During multi-fork replication severe under-initiation occurred in cells lacking the Fis protein; the cells initiated at an elevated mass, had fewer origins per cell and the origins were not initiated in synchrony. These results suggest a positive role for the Fis protein in the initiation of replication.	[Flatten, Ingvild; Skarstad, Kirsten] Oslo Univ Hosp, Dept Cell Biol, Inst Canc Res, Norwegian Radiumhosp, Oslo, Norway	University of Oslo	Skarstad, K (corresponding author), Oslo Univ Hosp, Dept Cell Biol, Inst Canc Res, Norwegian Radiumhosp, Oslo, Norway.	Kirsten.Skarstad@rr-research.no		Flatten, Ingvild/0000-0002-4213-1135	Norwegian Research Council FUGE program; CAMST platform; FRIBIO program	Norwegian Research Council FUGE program(Research Council of Norway); CAMST platform; FRIBIO program	This work was supported by The Norwegian Research Council FUGE program and CAMST platform and the FRIBIO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAI T, 1992, MOL GEN GENET, V231, P169, DOI 10.1007/BF00279788; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; BATES DB, 1995, NUCLEIC ACIDS RES, V23, P3119, DOI 10.1093/nar/23.16.3119; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; Boye E, 1996, P NATL ACAD SCI USA, V93, P12206, DOI 10.1073/pnas.93.22.12206; Boye E, 1992, DNA REPLICATION CELL, P15; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Bremer H, 1996, ESCHERICHIA COLI SAL; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Flatten I, 2009, MOL MICROBIOL, V71, P1018, DOI 10.1111/j.1365-2958.2008.06585.x; Froelich JM, 1996, J BACTERIOL, V178, P6006, DOI 10.1128/jb.178.20.6006-6012.1996; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; GILLE H, 1991, NUCLEIC ACIDS RES, V19, P4167, DOI 10.1093/nar/19.15.4167; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; HIASA H, 1994, J BIOL CHEM, V269, P24999; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KOCH C, 1988, P NATL ACAD SCI USA, V85, P4237, DOI 10.1073/pnas.85.12.4237; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Margulies C, 1998, NUCLEIC ACIDS RES, V26, P5170, DOI 10.1093/nar/26.22.5170; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; ROTH A, 1994, BIOCHIMIE, V76, P917, DOI 10.1016/0300-9084(94)90016-7; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; SKARSTAD K, 1990, EMBO J, V9, P2341, DOI 10.1002/j.1460-2075.1990.tb07406.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stokke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030981; Torheim NK, 2000, MOL MICROBIOL, V37, P629, DOI 10.1046/j.1365-2958.2000.02031.x; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; Wold S, 1996, NUCLEIC ACIDS RES, V24, P3527, DOI 10.1093/nar/24.18.3527	46	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83562	10.1371/journal.pone.0083562	http://dx.doi.org/10.1371/journal.pone.0083562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358293	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700131
J	Kedem, A; Haas, J; Geva, LL; Yerushalmi, G; Gilboa, Y; Kanety, H; Hanochi, M; Maman, E; Hourvitz, A				Kedem, Alon; Haas, Jigal; Geva, Liat Lerner; Yerushalmi, Gil; Gilboa, Yinon; Kanety, Hanna; Hanochi, Mirit; Maman, Ettie; Hourvitz, Ariel			Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; ANTRAL FOLLICLE COUNT; ANTIMULLERIAN HORMONE; OVARIAN RESPONSE; LIVE-BIRTH; ASSISTED REPRODUCTION; MENSTRUAL-CYCLE; PREDICTION; IVF	Background: The ideal test for ovarian reserve should permit the identification of women who have no real chance of pregnancy with IVF treatments consequent upon an extremely reduced ovarian reserve. The aim of the current study was to evaluate pregnancy rates in patients with low AMH levels (0.2-1 ng/ml) and extremely low AMH levels (< 0.2 ng/ml) and to determine the cumulative pregnancy rates following consecutive IVF treatments. Methods: We conducted an historical cohort analysis at a tertiary medical center. Serum AMH levels were measured at initial clinic visit and prior to all following treatment cycles in 181 women (769 cycles) with an initial AMH level <= 1 ng/ml, undergoing IVF-ICSI. Main outcome measures were laboratory outcomes and pregnancy rates. Results: Seventy patients undergoing 249 cycles had extremely low AMH levels (<= 0.2 ng/ml), whereas 111 patients undergoing 520 cycles had low AMH levels (0.21-1.0 ng/ml). Number of oocytes retrieved per cycle, fertilized oocytes and number of transferred embryos were significantly lower in the extremely low AMH levels group compared to the low AMH levels (P < 0.003). Crude ongoing pregnancy rates were 4.4% for both groups of patients. Among 48 cycles of women aged >= 42 with AMH levels of <= 0.2 ng/ml no pregnancies were observed. But, in patients with AMH levels of 0.2-1.0 ng/ml, 3 ongoing pregnancies out of 192 cycles (1.6%) were observed. However, in a multivariate regression analysis adjusted for age and cycle characteristics, no significant differences in ongoing pregnancy rates per cycle between the two groups were evident. Cumulative pregnancy rates of 20% were observed following five cycles, for both groups of patients. Conclusions: Patients with extremely low AMH measurements have reasonable and similar pregnancy rates as patients with low AMH. Therefore, AMH should not be used as the criterion to exclude couples from performing additional IVF treatments.	[Kedem, Alon; Haas, Jigal; Yerushalmi, Gil; Gilboa, Yinon; Maman, Ettie; Hourvitz, Ariel] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, IL-52621 Tel Hashomer, Israel; [Kedem, Alon; Haas, Jigal; Geva, Liat Lerner; Yerushalmi, Gil; Gilboa, Yinon; Kanety, Hanna; Hanochi, Mirit; Maman, Ettie; Hourvitz, Ariel] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Geva, Liat Lerner] Gertner Inst Epidemiol & Hlth Policy Res Ltd, Women & Childrens Hlth Res Unit, Tel Hashomer, Israel; [Kanety, Hanna; Hanochi, Mirit] Chaim Sheba Med Ctr, Inst Endocrinol, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Kedem, A (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, IL-52621 Tel Hashomer, Israel.	kedem2001@gmail.com						Arce JC, 2013, FERTIL STERIL, V99, P1644, DOI 10.1016/j.fertnstert.2012.12.048; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; Bhide P, 2013, REPROD BIOMED ONLINE, V26, P247, DOI 10.1016/j.rbmo.2012.11.018; Brodin T, 2013, J CLIN ENDOCR METAB, V98, P1107, DOI 10.1210/jc.2012-3676; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Kedem A, 2013, J ASSIST REPROD GENE; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; Lande Y, 2011, FERTIL STERIL, V95, P568, DOI 10.1016/j.fertnstert.2010.06.005; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Nakhuda GS, 2006, FERTIL STERIL, V85, P1541, DOI 10.1016/j.fertnstert.2005.10.052; Nardo LG, 2007, GYNECOL ENDOCRINOL, V23, P486, DOI 10.1080/09513590701532815; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P411, DOI 10.1016/j.rbmo.2011.06.011; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Patrelli TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044571; Singer T, 2009, FERTIL STERIL, V91, P2616, DOI 10.1016/j.fertnstert.2008.03.034; Smeenk JMJ, 2007, FERTIL STERIL, V87, P223, DOI 10.1016/j.fertnstert.2006.06.019; Streuli I, 2008, FERTIL STERIL, V90, P395, DOI 10.1016/j.fertnstert.2007.06.023; Tokura Y, 2013, J ASSIST REPROD GENE; Wang JG, 2010, REPROD BIOMED ONLINE, V21, P757, DOI 10.1016/j.rbmo.2010.06.041; Weghofer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034290; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134	25	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81629	10.1371/journal.pone.0081629	http://dx.doi.org/10.1371/journal.pone.0081629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24363812	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700015
J	Piepenbrink, KH; Maldarelli, GA; de la Pena, CFM; Mulvey, GL; Snyder, GA; De Masi, L; von Rosenvinge, EC; Gunther, S; Armstrong, GD; Donnenberg, MS; Sundberg, EJ				Piepenbrink, Kurt H.; Maldarelli, Grace A.; de la Pena, Claudia F. Martinez; Mulvey, George L.; Snyder, Greg A.; De Masi, Leon; von Rosenvinge, Erik C.; Guenther, Sebastian; Armstrong, Glen D.; Donnenberg, Michael S.; Sundberg, Eric J.			Structure of Clostridium difficile PilJ Exhibits Unprecedented Divergence from Known Type IV Pilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Microbiology; Microfilaments; Protein Assembly; Protein Structure	ENTEROTOXIGENIC ESCHERICHIA-COLI; TOXIN-COREGULATED PILUS; X-RAY; PATHOGENESIS; COMPUTATION; BIOGENESIS; SCATTERING; SOFTWARE; PROTEINS; MOTILITY	Background: Type IV pili are non-covalently assembled appendages, characterized now in both Gram-negative and Gram-positive bacteria. Results:Clostridium difficile produces Type IV pili containing PilJ, a pilin with a novel dual-pilin fold. Conclusion: Models suggest that the C-terminal pilin domain is exposed in pili, providing a unique interaction surface. Significance: The novel fold of PilJ suggests a new mode for Type IV pilus function. Type IV pili are produced by many pathogenic Gram-negative bacteria and are important for processes as diverse as twitching motility, cellular adhesion, and colonization. Recently, there has been an increased appreciation of the ability of Gram-positive species, including Clostridium difficile, to produce Type IV pili. Here we report the first three-dimensional structure of a Gram-positive Type IV pilin, PilJ, demonstrate its incorporation into Type IV pili, and offer insights into how the Type IV pili of C. difficile may assemble and function. PilJ has several unique structural features, including a dual-pilin fold and the incorporation of a structural zinc ion. We show that PilJ is incorporated into Type IV pili in C. difficile and present a model in which the incorporation of PilJ into pili exposes the C-terminal domain of PilJ to create a novel interaction surface.	[Piepenbrink, Kurt H.; Snyder, Greg A.; Guenther, Sebastian; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Maldarelli, Grace A.; Snyder, Greg A.; De Masi, Leon; von Rosenvinge, Erik C.; Donnenberg, Michael S.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Donnenberg, Michael S.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de la Pena, Claudia F. Martinez; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [de la Pena, Claudia F. Martinez; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Alberta Glycom Ctr, Calgary, AB T2N 1N4, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Calgary; University of Calgary	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu	Guenther, Sebastian/GON-7207-2022	Guenther, Sebastian/0000-0002-7329-6653; Donnenberg, Michael/0000-0002-8818-3184; von Rosenvinge, Erik C./0000-0002-1862-7288; Martinez de la Pena, Claudia Fabiola/0000-0003-4516-3404; Piepenbrink, Kurt/0000-0002-2527-0301; Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [T32 AI095190, R21 AI105881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI110045, T32AI095190, R21AI105881, R01AI114902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI095190 and R21 AI105881.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhuptani P, 2012, CRIT CARE MED, V40, pU105; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BORRIELLO SP, 1988, FEMS MICROBIOL LETT, V49, P65, DOI 10.1111/j.1574-6968.1988.tb02683.x; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Lammie D, 2007, ACTA CRYSTALLOGR D, V63, P1022, DOI 10.1107/S0907444907032933; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; LEE KK, 1994, MOL MICROBIOL, V11, P705, DOI 10.1111/j.1365-2958.1994.tb00348.x; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Liu HG, 2012, ACTA CRYSTALLOGR A, V68, P278, DOI 10.1107/S010876731104788X; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Ramboarina S, 1999, BIOCHEMISTRY-US, V38, P9600, DOI 10.1021/bi9905258; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	52	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4334	4345		10.1074/jbc.M113.534404	http://dx.doi.org/10.1074/jbc.M113.534404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362261	Green Published, hybrid			2022-12-25	WOS:000331403800044
J	de Quiros, YB; Seewald, JS; Sylva, SP; Greer, B; Niemeyer, M; Bogomolni, AL; Moore, MJ				de Quiros, Yara Bernaldo; Seewald, Jeffrey S.; Sylva, Sean P.; Greer, Bill; Niemeyer, Misty; Bogomolni, Andrea L.; Moore, Michael J.			Compositional Discrimination of Decompression and Decomposition Gas Bubbles in Bycaught Seals and Dolphins	PLOS ONE			English	Article							CETACEANS; EMBOLISM; LESIONS	Gas bubbles in marine mammals entangled and drowned in gillnets have been previously described by computed tomography, gross examination and histopathology. The absence of bacteria or autolytic changes in the tissues of those animals suggested that the gas was produced peri- or post-mortem by a fast decompression, probably by quickly hauling animals entangled in the net at depth to the surface. Gas composition analysis and gas scoring are two new diagnostic tools available to distinguish gas embolisms from putrefaction gases. With this goal, these methods have been successfully applied to pathological studies of marine mammals. In this study, we characterized the flux and composition of the gas bubbles from bycaught marine mammals in anchored sink gillnets and bottom otter trawls. We compared these data with marine mammals stranded on Cape Cod, MA, USA. Fresh animals or with moderate decomposition (decomposition scores of 2 and 3) were prioritized. Results showed that bycaught animals presented with significantly higher gas scores than stranded animals. Gas composition analyses indicate that gas was formed by decompression, confirming the decompression hypothesis.	[de Quiros, Yara Bernaldo; Bogomolni, Andrea L.; Moore, Michael J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Seewald, Jeffrey S.; Sylva, Sean P.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Greer, Bill] Integrated Stat, Woods Hole, MA USA; [Greer, Bill] NOAA NMFS Northeast Fisheries, Woods Hole, MA USA; [Niemeyer, Misty] Int Fund Anim Welf, Yarmouth Port, MA USA; [Bogomolni, Andrea L.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Connecticut	de Quiros, YB (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ybernaldodequiros@whoi.edu	Sylva, Sean/D-4400-2014; Moore, Michael/E-1707-2015; de Quirós, Yara Bernaldo/A-3628-2015	Sylva, Sean/0000-0002-4727-440X; Moore, Michael/0000-0003-3074-6631; de Quirós, Yara Bernaldo/0000-0002-2611-0406	Woods Hole Oceanographic Institution Marine Mammal Center; Wick and Sloan Simmons	Woods Hole Oceanographic Institution Marine Mammal Center; Wick and Sloan Simmons	This study was funded by the Woods Hole Oceanographic Institution Marine Mammal Center, and Wick and Sloan Simmons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong HG, 1939, ANAL GAS EMBOLI ENG; Bernaldo de Quiros Y, 2011, THESIS U PALMAS GRAN; de Quiros YB, 2013, INT J LEGAL MED, V127, P437, DOI 10.1007/s00414-012-0783-6; de Quiros YB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00177; Bernaldo de QuiruEs, 2012, PROTOCOL EXCHANGE, DOI 10.1038/protex.2012.002; Bert P., 1878, PRESSION BAROMETRIQU; BROWN CD, 1978, J FORENSIC SCI, V23, P511; Cole AJ, 2006, J CLIN PATHOL, V59, P489, DOI 10.1136/jcp.2005.031708; Cowan D, 1979, DIS FACTORS STENELLA; de Quiros YB, 2011, SCI REP-UK, V1, DOI 10.1038/srep00193; Dennison S, 2012, P ROY SOC B-BIOL SCI, V279, P1396, DOI 10.1098/rspb.2011.1754; EGGLETON P, 1945, J PHYSIOL-LONDON, V104, P129, DOI 10.1113/jphysiol.1945.sp004111; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Fernandez A, 2012, J MARINE SCI RES DEV, V2; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; HARRIS M, 1945, J GEN PHYSIOL, V28, P225, DOI 10.1085/jgp.28.3.225; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Hutter CDD, 2000, MED HYPOTHESES, V54, P585, DOI 10.1054/mehy.1999.0901; ISHIYAMA A, 1983, Bulletin of Tokyo Medical and Dental University, V30, P25; Ishiyama A, 1981, 6 M PAN DIV PHYS TEC, P201; Jackowski C, 2005, FORENSIC SCI INT, V149, P11, DOI 10.1016/j.forsciint.2004.05.019; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, VET PATHOL, V42, P291, DOI 10.1354/vp.42-3-291; King J. M., 1989, NECROPSY BOOK; Knight B., 1996, FORENSIC PATHOLOGY, V2nd ed.; Kuiken T, 1991, NEWSLETTER; Lawrence C., 1997, SPUMS J, V27, P228; LEVER MJ, 1966, J PHYSIOL-LONDON, V184, P964, DOI 10.1113/jphysiol.1966.sp007960; LILLO RS, 1992, UNDERSEA BIOMED RES, V19, P375; Lorber B, 2000, PRINCIPLES PRACTICE; Moore MJ, 2009, VET PATHOL, V46, P536, DOI 10.1354/vp.08-VP-0065-M-FL; Moore MJ, 2004, SCIENCE, V306, P2215, DOI 10.1126/science.1105452; Pierucci G, 1968, Zacchia, V4, P347; ROMMEL SA, 1994, J COMP PHYSIOL B, V164, P130, DOI 10.1007/BF00301654; SHIM SS, 1967, CAN MED ASSOC J, V97, P1263	35	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83994	10.1371/journal.pone.0083994	http://dx.doi.org/10.1371/journal.pone.0083994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367623	gold, Green Submitted, Green Published			2022-12-25	WOS:000328741900027
J	Dickson, BG; Roemer, GW; McRae, BH; Rundall, JM				Dickson, Brett G.; Roemer, Gary W.; McRae, Brad H.; Rundall, Jill M.			Models of Regional Habitat Quality and Connectivity for Pumas (Puma concolor) in the Southwestern United States	PLOS ONE			English	Article							SOUTHERN CALIFORNIA; GENETIC-STRUCTURE; COUGAR; CONSERVATION; POPULATIONS; VEGETATION; MOVEMENT; RANGE; CARNIVORES; DISPERSAL	The impact of landscape changes on the quality and connectivity of habitats for multiple wildlife species is of global conservation concern. In the southwestern United States, pumas (Puma concolor) are a well distributed and wide-ranging large carnivore that are sensitive to loss of habitat and to the disruption of pathways that connect their populations. We used an expert-based approach to define and derive variables hypothesized to influence the quality, location, and permeability of habitat for pumas within an area encompassing the entire states of Arizona and New Mexico. Survey results indicated that the presence of woodland and forest cover types, rugged terrain, and canyon bottom and ridgeline topography were expected to be important predictors of both high quality habitat and heightened permeability. As road density, distance to water, or human population density increased, the quality and permeability of habitats were predicted to decline. Using these results, we identified 67 high quality patches across the study area, and applied concepts from electronic circuit theory to estimate regional patterns of connectivity among these patches. Maps of current flow among individual pairs of patches highlighted possible pinch points along two major interstate highways. Current flow summed across all pairs of patches highlighted areas important for keeping the entire network connected, regardless of patch size. Cumulative current flow was highest in Arizona north of the Colorado River and around Grand Canyon National Park, and in the Sky Islands region owing to the many small habitat patches present. Our outputs present a first approximation of habitat quality and connectivity for dispersing pumas in the southwestern United States. Map results can be used to help target finer-scaled analyses in support of planning efforts concerned with the maintenance of puma metapopulation structure, as well as the protection of landscape features that facilitate the dispersal process.	[Dickson, Brett G.] Conservat Sci Partners Inc, Truckee, CA USA; [Dickson, Brett G.; Rundall, Jill M.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA; [Roemer, Gary W.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [McRae, Brad H.] Nature Conservancy, Seattle, WA USA	Northern Arizona University; New Mexico State University; Nature Conservancy	Dickson, BG (corresponding author), Conservat Sci Partners Inc, Truckee, CA USA.	brett@csp-inc.org			Wilburforce Foundation; Grand Canyon Trust; New Mexico State University Agricultural Experiment Station	Wilburforce Foundation; Grand Canyon Trust; New Mexico State University Agricultural Experiment Station	Funding for this work was provided by the Wilburforce Foundation, the Grand Canyon Trust, and the New Mexico State University Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Beier Paul, 2010, P141; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carroll C, 2012, CONSERV BIOL, V26, P78, DOI 10.1111/j.1523-1739.2011.01753.x; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dickson BG, 2007, J ZOOL, V271, P270, DOI 10.1111/j.1469-7998.2006.00215.x; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Flesch AD, 2010, CONSERV BIOL, V24, P171, DOI 10.1111/j.1523-1739.2009.01277.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson CJ, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P153, DOI 10.1007/978-1-4614-1034-8_8; Kalies EL, 2010, FOREST ECOL MANAG, V259, P333, DOI 10.1016/j.foreco.2009.10.024; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Kunkel KE, 2013, ANIM CONSERV, V16, P32, DOI 10.1111/j.1469-1795.2012.00568.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Malczewski J., 2000, T GIS, V4, P5, DOI [10.1111/1467-9671.00035, DOI 10.1111/1467-9671.00035]; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McKinney T, 2009, SOUTHWEST NAT, V54, P151, DOI 10.1894/CLG-14.1; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Nicholson KL, 2009, THESIS U ARIZONA TUC; Noon Barry R., 2008, P51; Pearce JL, 2001, J APPL ECOL, V38, P412, DOI 10.1046/j.1365-2664.2001.00608.x; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878	45	58	61	1	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81898	10.1371/journal.pone.0081898	http://dx.doi.org/10.1371/journal.pone.0081898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367495	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300014
J	Peng, H; Yang, M; Chen, ZY; Chen, P; Guan, CX; Xiang, XD; Cai, S; Chen, Y; Fang, X				Peng, Hong; Yang, Min; Chen, Zhi-yong; Chen, Ping; Guan, Cha-xiang; Xiang, Xu-dong; Cai, Shan; Chen, Yan; Fang, Xiang			Expression and Methylation of Mitochondrial Transcription Factor A in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer	PLOS ONE			English	Article							SEPTAL CELL APOPTOSIS; DNA METHYLATION; CIGARETTE-SMOKE; PROMOTER METHYLATION; N-ACETYLCYSTEINE; FACTOR-I; GENE; EPIGENETICS; DEATH; HYPERMETHYLATION	Background: Apoptosis plays a central role in the pathogenesis of chronic obstructive pulmonary disease (COPD), and this process can be regulated by mitochondrial transcription factor A (mtTFA). Epigenetics is involved in the regulation and modification of the genes involved in lung cancer and COPD. In this study, we determined the expression of mtTFA and its methylation levels in the COPD patients with lung cancer. Methods: Twenty-one squamous cell lung cancer patients, 11 with COPD and 10 without COPD, undergoing pneumonectomy were enrolled. The apoptotic index (AI) of pulmonary vascular endothelial cells was analyzed by transferase-mediated deoxyuridine triphosphate-biotin nick end labeling assay. The expression of mtTFA mRNA and protein was measured using PCR, immunohistochemistry and Western-blot. Methylation of the mtTFA promoter was detected using bisulfite sequencing PCR. Results: Compared to the non-COPD group, the AI was higher, and expression of mtTFA mRNA and protein was lower in the COPD group (P < 0.001). Expression of the mtTFA protein was positively correlated with FEV1/Pre (r = 0.892, P < 0.001), and negatively correlated with AI (r = -20.749, P < 0.001) and smoke index (r = 20.763, P < 0.001). Percentage of mtTFA promoter methylation in the COPD patients was significantly higher compared to the non-COPD patients (P < 0.05). Conclusion: These results suggest that the expression of mtTFA mRNA and protein is down-regulated in the lung tissue from the COPD patients with squamous cell lung cancer, and the level of mtTFA protein is related to apoptosis of pulmonary vascular endothelial cells. Aberrant mtTFA methylation may also play an important role in the pathogenesis of COPD.	[Peng, Hong; Yang, Min; Chen, Ping; Xiang, Xu-dong; Cai, Shan; Chen, Yan] Cent S Univ, Dept Resp Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Yang, Min] Cent S Univ, Human Key Lab Med Epigen, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Chen, Zhi-yong] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Guan, Cha-xiang] Cent S Univ, Physiol Res Ctr, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Fang, Xiang] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA	Central South University; Central South University; Central South University; Central South University; University of Texas System; University of Texas Medical Branch Galveston	Chen, P (corresponding author), Cent S Univ, Dept Resp Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	pingchen0731@sina.com		Guan, Cha-Xiang/0000-0002-8505-8724; Peng, Hong/0000-0003-3235-3348; Chen, Ping/0000-0001-6707-8636	National Natural Science Foundation of China [30800503, 30770931, 81070039]; National Natural Science Foundation of Hunan Province [09JJ3036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The study was supported by the National Natural Science Foundation of China (No. 30800503, No. 30770931 and No. 81070039) and the National Natural Science Foundation of Hunan Province (No. 09JJ3036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Baryshnikova E, 2008, CLIN CANCER RES, V14, P1913, DOI 10.1158/1078-0432.CCR-07-1741; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Bowman RV, 2006, RESPIROLOGY, V11, P355, DOI 10.1111/j.1440-1843.2006.00859.x; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Cai S, 2009, RESPIROLOGY, V14, P354, DOI 10.1111/j.1440-1843.2009.01511.x; CAPLIN M, 1975, BRIT MED J, V3, P678, DOI 10.1136/bmj.3.5985.678; Chen Y, 2009, AM J PHYSIOL-LUNG C, V296, pL648, DOI 10.1152/ajplung.90270.2008; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Kagan Jacob, 2007, Cancer Res, V67, P4545, DOI 10.1158/0008-5472.CAN-06-2888; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kikuchi S, 2006, CANCER-AM CANCER SOC, V106, P1751, DOI 10.1002/cncr.21800; Lange NE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001231; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pulling LC, 2004, CANCER RES, V64, P3844, DOI 10.1158/0008-5472.CAN-03-2119; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shivapurkar N, 2007, CANCER LETT, V247, P56, DOI 10.1016/j.canlet.2006.03.020; Soria JC, 2002, CANCER RES, V62, P351; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Xu L, 2004, CHINESE MED J-PEKING, V117, P1611; Zhang C, 2008, CHINESE MED J-PEKING, V121, P597, DOI 10.1097/00029330-200804010-00005	45	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82739	10.1371/journal.pone.0082739	http://dx.doi.org/10.1371/journal.pone.0082739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367550	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300063
J	Utsumi, F; Kajiyama, H; Nakamura, K; Tanaka, H; Mizuno, M; Ishikawa, K; Kondo, H; Kano, H; Hori, M; Kikkawa, F				Utsumi, Fumi; Kajiyama, Hiroaki; Nakamura, Kae; Tanaka, Hiromasa; Mizuno, Masaaki; Ishikawa, Kenji; Kondo, Hiroki; Kano, Hiroyuki; Hori, Masaru; Kikkawa, Fumitaka			Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; EPITHELIAL OVARIAN; ENHANCED CHEMOSENSITIVITY; HYDROGEN-PEROXIDE; NONTHERMAL PLASMA; PACLITAXEL; APOPTOSIS	Purpose: Nonequilibrium atmospheric pressure plasma (NEAPP) therapy has recently been focused on as a novel medical practice. Using cells with acquired paclitaxel/cisplatin resistance, we elucidated effects of indirect NEAPP-activated medium (NEAPP-AM) exposure on cell viability and tumor growth in vitro and in vivo. Methods: Using chronic paclitaxel/cisplatin-resistant ovarian cancer cells, we applied indirect NEAPP-exposed medium to cells and xenografted tumors in a mouse model. Furthermore, we examined the role of reactive oxygen species (ROS) or their scavengers in the above-mentioned EOC cells. Results: We assessed the viability of NOS2 and NOS3 cells exposed to NEAPP-AM, which was prepared beforehand by irradiation with NEAPP for the indicated time. In NOS2 cells, viability decreased by approximately 30% after NEAPP-AM 120-sec treatment (P<0.01). The growth-inhibitory effects of NEAPP-AM were completely inhibited by N-acetyl cysteine treatment, while L-buthionine-[S, R]-sulfoximine, an inhibitor of the ROS scavenger used with NEAPP-AM, decreased cell viability by 85% after NEAPP-AM 60-sec treatment(P<0.05) and by 52% after 120 sec, compared to the control (P<0.01). In the murine subcutaneous tumor-formation model, NEAPP-AM injection resulted in an average inhibition of the NOS2 cell-inoculated tumor by 66% (P<0.05) and NOS2TR cell-inoculated tumor by 52% (P<0.05), as compared with the control. Conclusion: We demonstrated that plasma-activated medium also had an anti-tumor effect on chemo-resistant cells in vitro and in vivo. Indirect plasma therapy is a promising treatment option for EOC and may contribute to a better patient prognosis in the future.	[Utsumi, Fumi; Kajiyama, Hiroaki; Nakamura, Kae; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Tanaka, Hiromasa; Ishikawa, Kenji; Kondo, Hiroki; Hori, Masaru] Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mizuno, Masaaki] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Showa Ku, Nagoya, Aichi 4648601, Japan; [Kano, Hiroyuki] NU Ecoengn Co Ltd, Miyoshi, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Kajiyama, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4648601, Japan.	kajiyama@med.nagoya-u.ac.jp	Ishikawa, Kenji/I-6758-2014; Tanaka, Hiromasa/AAE-3764-2019; KIKKAWA, Fumitaka/I-7341-2014; Kondo, Hiroki/I-6759-2014; UTSUMI, Fumi/I-6388-2015	Ishikawa, Kenji/0000-0002-8288-6620; Kondo, Hiroki/0000-0002-8336-3995; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [24108008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas, Grant No. 24108008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjunan KP, 2011, PLASMA PROCESS POLYM, V8, P1154, DOI 10.1002/ppap.201100078; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Cotgreave I, 1997, ADV PHARMACOL, V38, P206; FRIDMAN A, 2008, PLASMA CHEM; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Iwasaki M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885084; Jia FD, 2011, APPL PHYS EXPRESS, V4; Kajiyama H, 2002, CANCER RES, V62, P2753; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kajiyama H, 2010, CANCER SCI, V101, P347, DOI 10.1111/j.1349-7006.2009.01378.x; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Lee J, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF01; Maeda O, 2012, INT J CANCER, V130, P113, DOI 10.1002/ijc.25983; Miyahara T, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/45001; Morfill GE, 2009, NEW J PHYS, V11; Naitali M, 2010, APPL ENVIRON MICROB, V76, P7662, DOI 10.1128/AEM.01615-10; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tanaka H, 2011, PLASMA MED, V1, P265, DOI DOI 10.1615/PLASMAMED.2012006275; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; Usha L, 2011, GYNECOL ONCOL, V121, P455, DOI 10.1016/j.ygyno.2011.02.013; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Wang QO, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-159; Yamashita M, 2007, INT J CANCER, V120, P2243, DOI 10.1002/ijc.22528; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Yousfi M, 2013, FUNDAMENTAL CLIN PHA	39	274	278	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e81576	10.1371/journal.pone.0081576	http://dx.doi.org/10.1371/journal.pone.0081576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367486	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300007
J	de Goeij, M; van Eijk, LT; Vanelderen, P; Wilder-Smith, OH; Vissers, KC; van der Hoeven, JG; Kox, M; Scheffer, GJ; Pickkers, P				de Goeij, Moniek; van Eijk, Lucas T.; Vanelderen, Pascal; Wilder-Smith, Oliver H.; Vissers, Kris C.; van der Hoeven, Johannes G.; Kox, Matthijs; Scheffer, Gert Jan; Pickkers, Peter			Systemic Inflammation Decreases Pain Threshold in Humans In Vivo	PLOS ONE			English	Article							TO-BRAIN COMMUNICATION; MELANOCYTE-STIMULATING HORMONE; TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; MECHANICAL ALLODYNIA; INDUCED HYPERALGESIA; HUMAN ENDOTOXEMIA; CYTOKINE; INTERLEUKIN-10; BEHAVIOR	Background: Hyperalgesia is a well recognized hallmark of disease. Pro-inflammatory cytokines have been suggested to be mainly responsible, but human data are scarce. Changes in pain threshold during systemic inflammation evoked by human endotoxemia, were evaluated with three quantitative sensory testing methods. Methods and Results: Pressure pain thresholds, electrical pain thresholds and tolerance to the cold pressor test were measured before and 2 hours after the intravenous administration of 2 ng/kg purified E. coli endotoxin in 27 healthy volunteers. Another 20 subjects not exposed to endotoxemia served as controls. Endotoxemia led to a rise in body temperature and inflammatory symptom scores and a rise in plasma TNF-alpha, IL-6, IL-10 and IL-1RA. During endotoxemia, pressure pain thresholds and electrical pain thresholds were reduced with 20 +/- 4 % and 13 +/- 3 %, respectively. In controls only a minor decrease in pressure pain thresholds (7 +/- 3 %) and no change in electrical pain thresholds occurred. Endotoxin-treated subjects experienced more pain during the cold pressor test, and fewer subjects were able to complete the cold pressor test measurement, while in controls the cold pressor test results were not altered. Peak levels and area under curves of each individual cytokine did not correlate to a change in pain threshold measured by one of the applied quantitative sensory testing techniques. Conclusions and Significance: In conclusion, this study shows that systemic inflammation elicited by the administration of endotoxin to humans, results in lowering of the pain threshold measured by 3 quantitative sensory testing techniques. The current work provides additional evidence that systemic inflammation is accompanied by changes in pain perception.	[de Goeij, Moniek; Vanelderen, Pascal; Wilder-Smith, Oliver H.; Vissers, Kris C.; Kox, Matthijs; Scheffer, Gert Jan] RUNMC, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [van Eijk, Lucas T.; van der Hoeven, Johannes G.; Kox, Matthijs; Pickkers, Peter] RUNMC, Dept Intens Care Med, Nijmegen, Netherlands; [van Eijk, Lucas T.; van der Hoeven, Johannes G.; Kox, Matthijs; Pickkers, Peter] Nijmegen Inst Infect Inflammat & Immun RUNMC, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Pickkers, P (corresponding author), RUNMC, Dept Intens Care Med, Nijmegen, Netherlands.	p.pickkers@ic.umcn.nl	Wilder-Smith, Oliver H.G./E-7541-2012; Pickkers, P./H-8080-2014; Vissers, Kris/H-8110-2014; Kox, Matthijs/L-4454-2015; van der Hoeven, J.G./H-8048-2014; van Eijk, Lucas T/H-4036-2016; Vissers, Kris C.P./D-3569-2009; Scheffer, G.J./H-8086-2014	Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Pickkers, P./0000-0002-1104-4303; Vissers, Kris/0000-0002-2919-6356; Vissers, Kris C.P./0000-0002-2919-6356; 	Organisation for Health Research and Development (ZonMw), The Hague, Netherlands	Organisation for Health Research and Development (ZonMw), The Hague, Netherlands	LvE is a recipient of a grant from the Organisation for Health Research and Development (ZonMw), The Hague, Netherlands(http://www.zonmw.nl/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Bahador M, 2007, J ENDOTOXIN RES, V13, P251, DOI 10.1177/0968051907085986; Benson S, 2012, PAIN, V153, P794, DOI 10.1016/j.pain.2011.12.001; Chacur M, 2004, PAIN, V108, P180, DOI 10.1016/j.pain.2003.12.023; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Diogenes A, 2011, DENT RES, V90, P759, DOI [10.1177/0022034511400225, DOI 10.1177/0022034511400225.PUBMED:21393555]; Dorresteijn MJ, 2005, J ENDOTOXIN RES, V11, P287, DOI 10.1179/096805105X58715; FOLLENFANT RL, 1989, BRIT J PHARMACOL, V98, P41, DOI 10.1111/j.1476-5381.1989.tb16860.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Laughlin TM, 2000, PAIN, V84, P159, DOI 10.1016/S0304-3959(99)00195-5; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Ozaktay AC, 2006, EUR SPINE J, V15, P1529, DOI 10.1007/s00586-005-0058-8; Oka T, 1996, BRAIN RES, V736, P237, DOI 10.1016/S0006-8993(96)00705-6; POOLE S, 1992, BRIT J PHARMACOL, V106, P489, DOI 10.1111/j.1476-5381.1992.tb14361.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; van Eijk LTGJ, 2005, CRIT CARE, V9, pR157, DOI 10.1186/cc3050; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Wieseler-Frank J, 2005, BRAIN BEHAV IMMUN, V19, P104, DOI 10.1016/j.bbi.2004.08.004; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148	27	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84159	10.1371/journal.pone.0084159	http://dx.doi.org/10.1371/journal.pone.0084159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358337	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700082
J	Hammar, L; Andersson, S; Eggertsen, L; Haglund, J; Gullstrom, M; Ehnberg, J; Molander, S				Hammar, Linus; Andersson, Sandra; Eggertsen, Linda; Haglund, Johan; Gullstrom, Martin; Ehnberg, Jimmy; Molander, Sverker			Hydrokinetic Turbine Effects on Fish Swimming Behaviour	PLOS ONE			English	Article							RENEWABLE ENERGY; GENERATING ELECTRICITY; REEF FISHES; CONNECTIVITY; ECOLOGY; PREDATORS; PROSPECTS; TURBIDITY; TESTS; VIDEO	Hydrokinetic turbines, targeting the kinetic energy of fast-flowing currents, are under development with some turbines already deployed at ocean sites around the world. It remains virtually unknown as to how these technologies affect fish, and rotor collisions have been postulated as a major concern. In this study the effects of a vertical axis hydrokinetic rotor with rotational speeds up to 70 rpm were tested on the swimming patterns of naturally occurring fish in a subtropical tidal channel. Fish movements were recorded with and without the rotor in place. Results showed that no fish collided with the rotor and only a few specimens passed through rotor blades. Overall, fish reduced their movements through the area when the rotor was present. This deterrent effect on fish increased with current speed. Fish that passed the rotor avoided the near-field, about 0.3 m from the rotor for benthic reef fish. Large predatory fish were particularly cautious of the rotor and never moved closer than 1.7 m in current speeds above 0.6 ms(-1). The effects of the rotor differed among taxa and feeding guilds and it is suggested that fish boldness and body shape influenced responses. In conclusion, the tested hydrokinetic turbine rotor proved non-hazardous to fish during the investigated conditions. However, the results indicate that arrays comprising multiple turbines may restrict fish movements, particularly for large species, with possible effects on habitat connectivity if migration routes are exploited. Arrays of the investigated turbine type and comparable systems should therefore be designed with gaps of several metres width to allow large fish to pass through. In combination with further research the insights from this study can be used for guiding the design of hydrokinetic turbine arrays where needed, so preventing ecological impacts.	[Hammar, Linus; Ehnberg, Jimmy; Molander, Sverker] Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden; [Andersson, Sandra] Marine Monitoring AB, Lysekil, Sweden; [Eggertsen, Linda; Haglund, Johan; Gullstrom, Martin] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Chalmers University of Technology; Stockholm University	Hammar, L (corresponding author), Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden.	linus.hammar@chalmers.se	Molander, Sverker/E-1462-2012	Molander, Sverker/0000-0002-9081-8847	Chalmersska Research Foundation [Dnr CS2010/53]; Aforsk foundation; Swedish International Development Cooperation Agency (Sida) [SWE-2010-194]	Chalmersska Research Foundation; Aforsk foundation; Swedish International Development Cooperation Agency (Sida)	The study recieved financial support from the Chalmersska Research Foundation (Dnr CS2010/53), the Aforsk foundation (http://www.aforsk.se/in-english.php), and Swedish International Development Cooperation Agency (Sida) (SWE-2010-194, http://www.sida.se/English/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2005, ESTUAR COAST SHELF S, V64, P5, DOI 10.1016/j.ecss.2005.02.002; Bahaj AS, 2011, RENEW SUST ENERG REV, V15, P3399, DOI 10.1016/j.rser.2011.04.032; Battey, 2013, ENV EFFECTS MARINE E; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkstrom C, 2012, ESTUAR COAST SHELF S, V107, P1, DOI 10.1016/j.ecss.2012.03.020; Boehlert GW, 2010, OCEANOGRAPHY, V23, P68, DOI 10.5670/oceanog.2010.46; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Broadhurst M, 2011, 9 EUR WAV TID EN C S; Bshary R, 2002, BEHAV ECOL SOCIOBIOL, V52, P365, DOI 10.1007/s00265-002-0527-6; Cada G.F., 1997, DEV BIOL CRITERIA DE; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dirnwoeber M, 2012, REMOTE SENS-BASEL, V4, P3346, DOI 10.3390/rs4113346; Domenici P, 2002, MAR FRESHW BEHAV PHY, V35, P87, DOI 10.1080/10236240290025635; Douglas R.H., 1990, P373; EPRI, 2011, EV FISH INJ MORT ASS; Esteban M, 2012, APPL ENERG, V90, P128, DOI 10.1016/j.apenergy.2011.06.011; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Froese R, 2013, FISHBASE; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Gorlov A, 2001, TIDAL ENERGY; Grabbe M, 2009, RENEW SUST ENERG REV, V13, P1898, DOI 10.1016/j.rser.2009.01.026; Hammar L, 2012, 1 ASIAN WAVE TIDAL C, P8; Hammar L, 2012, RENEW ENERG, V44, P414, DOI 10.1016/j.renene.2012.02.010; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Jeffrey H, TECHNOL FOR IN PRESS; Kennish M.J., 1992, ECOLOGY ESTUARIES AN; Khan MJ, 2008, RENEW SUST ENERG REV, V12, P2177, DOI 10.1016/j.rser.2007.04.016; Khan MJ, 2009, APPL ENERG, V86, P1823, DOI 10.1016/j.apenergy.2009.02.017; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Laroche J, 1997, J FISH BIOL, V51, P3, DOI 10.1111/j.1095-8649.1997.tb02509.x; Lewis A., 2011, IPCC SPECIAL REPORT; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lindsey CC, 1978, FISH PHYSIOL, VVII, DOI DOI 10.1016/S1546-5098(08)60163-6; Mavume AF, 2000, THROUGHFLOW PONTA TE; Meager JJ, 2006, J EXP BIOL, V209, P4174, DOI 10.1242/jeb.02489; Miner JG, 1996, T AM FISH SOC, V125, P97, DOI 10.1577/1548-8659(1996)125<0097:DOPAHC>2.3.CO;2; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Mumby PJ, 2002, MAR POLLUT BULL, V44, P85, DOI 10.1016/S0025-326X(01)00097-2; Muntz W.R.A., 1990, P491; Normandeau Associates, 2009, EST SURV INJ FISH PA; Pelc R, 2002, MAR POLICY, V26, P471, DOI 10.1016/S0308-597X(02)00045-3; Quinn G, 2002, EXPT DES DATA ANAL B, P339; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Robinson CJ, 2007, J FISH BIOL, V71, P200, DOI 10.1111/j.1095-8649.2007.01484.x; Rourke FO, 2010, APPL ENERG, V87, P398, DOI 10.1016/j.apenergy.2009.08.014; Schilt CR, 2007, APPL ANIM BEHAV SCI, V104, P295, DOI 10.1016/j.applanim.2006.09.004; Schweizer PE, 2011, ESTIMATION RISKS COL; SMITH J. L. B., 1938, TRANS ROY SOC S AFRICA, V26, P225; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; Verdant Power, 2010, FIN KIN HYDR PIL LIC; Viehman HA, 2012, FISH TIDALLY DYNAMIC; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wilson B., 2007, REPORT SCOTTISH EXEC	63	37	37	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84141	10.1371/journal.pone.0084141	http://dx.doi.org/10.1371/journal.pone.0084141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358334	gold, Green Published			2022-12-25	WOS:000328737700081
J	Jenks, KR; Lucas, MM; Duffy, BA; Robbins, AA; Gimi, B; Barry, JM; Scott, RC				Jenks, Kyle R.; Lucas, Marcella M.; Duffy, Ben A.; Robbins, Ashlee A.; Gimi, Barjor; Barry, Jeremy M.; Scott, Rod C.			Enrichment and Training Improve Cognition in Rats with Cortical Malformations	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; METHYLAZOXYMETHANOL ACETATE; EPILEPSY; CHILDHOOD; CHILDREN; SEIZURE; DISRUPTION; BEHAVIOR; NEURONS; MODEL	Children with malformations of cortical development (MCD) frequently have associated cognitive impairments which reduce quality of life. We hypothesized that cognitive deficits associated with MCD can be improved with environmental manipulation or additional training. The E17 methylazoxymethanol acetate (MAM) exposure model bears many anatomical hallmarks seen in human MCDs as well as similar behavioral and cognitive deficits. We divided control and MAM exposed Sprague-Dawley rats into enriched and non-enriched groups and tested performance in the Morris water maze. Another group similarly divided underwent sociability testing and also underwent Magnetic Resonance Imaging (MRI) scans pre and post enrichment. A third group of control and MAM rats without enrichment were trained until they reached criterion on the place avoidance task. MAM rats had impaired performance on spatial tasks and enrichment improved performance of both control and MAM animals. Although MAM rats did not have a deficit in sociability they showed similar improvement with enrichment as controls. MRI revealed a whole brain volume decrease with MAM exposure, and an increase in both MAM and control enriched volumes in comparison to non-enriched animals. In the place avoidance task, MAM rats required approximately 3 times as long to reach criterion as control animals, but with additional training were able to reach control performance. Environmental manipulation and additional training can improve cognition in a rodent MCD model. We therefore suggest that patients with MCD may benefit from appropriate alterations in educational strategies, social interaction and environment. These factors should be considered in therapeutic strategies.	[Jenks, Kyle R.; Lucas, Marcella M.; Robbins, Ashlee A.; Barry, Jeremy M.; Scott, Rod C.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Duffy, Ben A.] UCL, Div Med, Ctr Adv Biomed Imaging, London, England; [Gimi, Barjor] Geisel Sch Med Dartmouth, Dept Radiol, Lebanon, NH USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	Dartmouth College; University of London; University College London; Dartmouth College; University of London; University College London	Scott, RC (corresponding author), Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA.	Rodney.Scott@med.uvm.edu		Scott, Rod/0000-0002-8944-928X	National Institute of Health (NIH) [R01NS075249, 1S10RR25048]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute of Health (NIH) grants R01NS075249 and 1S10RR25048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Chevassus-au-Louis N, 1998, BRAIN RES, V812, P252, DOI 10.1016/S0006-8993(98)00932-9; Espie CA, 2003, J NEUROL NEUROSUR PS, V74, P1485, DOI 10.1136/jnnp.74.11.1485; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Fausto D, 2006, NEUROTOXICOL TERATOL, V29, P273; Featherstone RE, 2007, NEUROPSYCHOPHARMACOL, V32, P483, DOI 10.1038/sj.npp.1301223; Flagstad P, 2005, NEUROPSYCHOPHARMACOL, V30, P250, DOI 10.1038/sj.npp.1300625; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P746; Jennekens-Schinkel A, 2005, EPILEPSIA, V46, P599, DOI 10.1111/j.0013-9580.2005.64204_1.x; KUZNIECKY R, 1994, J CHILD NEUROL, V9, P420, DOI 10.1177/088307389400900418; Kuzniecky RI, 2001, BRAIN DEV-JPN, V23, P2, DOI 10.1016/S0387-7604(00)00195-9; Kwong KL, 2000, ACTA PAEDIATR, V89, P593, DOI 10.1080/080352500750027916; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; Lucas MM, 2011, BRAIN, V134, P1684, DOI 10.1093/brain/awr087; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Moy SS, 2013, NEUROTOXICOL TERATOL, V36, P36, DOI 10.1016/j.ntt.2012.07.007; Oostrom KJ, 2005, BRAIN, V128, P1546, DOI 10.1093/brain/awh494; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Pang T, 2008, NEUROLOGIST, V14, P181, DOI 10.1097/NRL.0b013e31816606b9; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; PIVEN J, 1990, AM J PSYCHIAT, V147, P734; Popp SS, 2011, NEUROSCIENCE, V192, P537, DOI 10.1016/j.neuroscience.2011.06.086; Ryan BL, 2003, SEIZURE-EUR J EPILEP, V12, P359, DOI 10.1016/S1059-1311(02)00325-4; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Woo CC, 2013, BEHAV NEUROSCI, V127, P487, DOI 10.1037/a0033010; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	33	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84492	10.1371/journal.pone.0084492	http://dx.doi.org/10.1371/journal.pone.0084492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358362	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700097
J	Bowser, AK; Diamond, AW; Addison, JA				Bowser, A. Kirsten; Diamond, Antony W.; Addison, Jason A.			From Puffins to Plankton: A DNA-Based Analysis of a Seabird Food Chain in the Northern Gulf of Maine	PLOS ONE			English	Article							PREY DNA; DIET; CONSUMPTION; ECOSYSTEM; SAMPLES; FISH; FISHERIES; SELECTION; PREDATOR; PRIMERS	The predator-prey interactions within food chains are used to both characterize and understand ecosystems. Conventional methods of constructing food chains from visual identification of prey in predator diet can suffer from poor taxonomic resolution, misidentification, and bias against small or completely digestible prey. Next-generation sequencing (NGS) technology has become a powerful tool for diet reconstruction through barcoding of DNA in stomach content or fecal samples. Here we use multi-locus (16S and CO1) next-generation sequencing of DNA barcodes on the feces of Atlantic puffin (Fratercula arctica) chicks (n=65) and adults (n=64) and the stomach contents of their main prey, Atlantic herring (Clupea harengus, n=44) to investigate a previously studied food chain. We compared conventional and molecular-derived chick diet, tested the similarity between the diets of puffin adults and chicks, and determined whether herring prey can be detected in puffin diet samples. There was high variability in the coverage of prey groups between 16S and CO1 markers. We identified more unique prey with our 16S compared to CO1 barcoding markers (51 and 39 taxa respectively) with only 12 taxa identified by both genes. We found no significant difference between the 16S-identified diets of puffin adults (n=17) and chicks (n=41). Our molecular method is more taxonomically resolved and detected chick prey at higher frequencies than conventional field observations. Many likely planktonic prey of herring were detected in feces from puffin adults and chicks, highlighting the impact secondary consumption may have on the interpretation of molecular dietary analysis. This study represents the first simultaneous molecular investigation into the diet of multiple components of a food chain and highlights the utility of a multi-locus approach to diet reconstruction that is broadly applicable to food web analysis.	[Bowser, A. Kirsten; Diamond, Antony W.; Addison, Jason A.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; [Bowser, A. Kirsten; Diamond, Antony W.] Univ New Brunswick, Atlantic Lab Avian Res, Fredericton, NB, Canada	University of New Brunswick; University of New Brunswick	Bowser, AK (corresponding author), Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada.	akbowser@gmail.com			NSERC; Environment Canada; Canadian Wildlife Service (Atlantic Region); University of New Brunswick; New Brunswick Innovation Foundation; Canada Foundation for Innovation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Canadian Wildlife Service (Atlantic Region); University of New Brunswick; New Brunswick Innovation Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by NSERC, Environment Canada, Canadian Wildlife Service (Atlantic Region), University of New Brunswick, New Brunswick Innovation Foundation, and Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2012, MAR BIOL, V159, P1197, DOI 10.1007/s00227-012-1900-2; BAIRD PH, 1991, CONDOR, V93, P503, DOI 10.2307/1368182; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Battle H. I., 1936, Journal of the Biological Board of Canada, V2, P401; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOND AL, 2007, THESIS U NEW BRUNSWI; Bowman R.E., 2000, NMFSNE155 NOAA, pNMFS; Braley M, 2010, MOL ECOL RESOUR, V10, P466, DOI 10.1111/j.1755-0998.2009.02767.x; Brown DS, 2012, MOL ECOL RESOUR, V12, P259, DOI 10.1111/j.1755-0998.2011.03098.x; Bugge J, 2011, J ORNITHOL, V152, P253, DOI 10.1007/s10336-010-0578-9; Casper RM, 2007, MAR BIOL, V152, P815, DOI 10.1007/s00227-007-0732-y; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Diamond AW, 2013, SEABIRD RES MONITORI; Drolet D, 2012, MAR ECOL PROG SER, V449, P197, DOI 10.3354/meps09495; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; GRAHAME J, 1977, MAR BIOL, V40, P217, DOI 10.1007/BF00390877; Grosberg RK, 1996, CHARACTERIZATION GEN, P67; Hibert F, 2013, PLOS ONE, V8, P11; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; Jones M, 2011, UNITS PLOS ONE, V6, DOI [10.1371/journal.pone.0019259, DOI 10.1371/J0URNAL.P0NE.0019259]; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; KULKA DW, 1982, CAN J FISH AQUAT SCI, V39, P326, DOI 10.1139/f82-045; LEE WY, 1979, ESTUARIES, V2, P228, DOI 10.2307/1351569; LEGARE JEH, 1960, J FISH RES BOARD CAN, V17, P409, DOI 10.1139/f60-030; Lowther P, 2002, ATLANTIC PUFFIN FRAT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pollupuu M, 2010, J PLANKTON RES; Puritz JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034241; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2011, ECOL EVOL, V1, P15, DOI [10.1002/ece3.2, DOI 10.1002/ECE3.2.PUBMED:22393479]; Read AJ, 2003, CONSERV ECOL, V7; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; SHERMAN K, 1971, T AM FISH SOC, V100, P121, DOI 10.1577/1548-8659(1971)100<121:SVITFO>2.0.CO;2; SHERMAN K, 1971, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V160, P121; Stuglik MT, 2011, MOL ECOL RESOUR, V11, P739, DOI 10.1111/j.1755-0998.2011.02997.x; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Wilson LJ, 2004, ARDEA, V92, P197; Ydenberg RC, 1994, ECOSCIENCE, V1, P1	59	60	63	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83152	10.1371/journal.pone.0083152	http://dx.doi.org/10.1371/journal.pone.0083152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358258	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700107
J	Zauberman, A; Flashner, Y; Levy, Y; Vagima, Y; Tidhar, A; Cohen, O; Bar-Haim, E; Gur, D; Aftalion, M; Halperin, G; Shafferman, A; Mamroud, E				Zauberman, Ayelet; Flashner, Yehuda; Levy, Yinon; Vagima, Yaron; Tidhar, Avital; Cohen, Ofer; Bar-Haim, Erez; Gur, David; Aftalion, Moshe; Halperin, Gideon; Shafferman, Avigdor; Mamroud, Emanuelle			Yopp-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SMALL-MOLECULE INHIBITORS; PNEUMONIC PLAGUE; GAMMA-INTERFERON; ENTEROCOLITICA INFECTION; III SECRETION; MACROPHAGES; RESISTANCE; VACCINE; FRANCISELLA	Plague, initiated by Yersinia pestis infection, is a rapidly progressing disease with a high mortality rate if not quickly treated. The existence of antibiotic- resistant Y. pestis strains emphasizes the need for the development of novel countermeasures against plague. We previously reported the generation of a recombinant Y. pestis strain (Kim53 Delta J+ P) that over-expresses Y. enterocolitica YopP. When this strain was administered subcutaneously to mice, it elicited a fast and effective protective immune response in models of bubonic, pneumonic and septicemic plague. In the present study, we further characterized the immune response induced by the Kim53 Delta J+ P recombinant strain. Using a panel of mouse strains defective in specific immune functions, we observed the induction of a prompt protective innate immune response that was interferon- c dependent. Moreover, inoculation of mice with Y. pestis Kim53 Delta J+ P elicited a rapid protective response against secondary infection by other bacterial pathogens, including the enteropathogen Y. enterocolitica and the respiratory pathogen Francisella tularensis. Thus, the development of new therapies to enhance the innate immune response may provide an initial critical delay in disease progression following the exposure to highly virulent bacterial pathogens, extending the time window for successful treatment.	[Zauberman, Ayelet; Flashner, Yehuda; Levy, Yinon; Vagima, Yaron; Tidhar, Avital; Cohen, Ofer; Bar-Haim, Erez; Gur, David; Aftalion, Moshe; Halperin, Gideon; Shafferman, Avigdor; Mamroud, Emanuelle] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Mamroud, E (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	emmym@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	Israel Institute for Biological Research funds [SB/5112-50]	Israel Institute for Biological Research funds	This work was supported by the Israel Institute for Biological Research funds, grand number SB/5112-50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; AUTENRIETH IB, 1992, MED MICROBIOL IMMUN, V181, P333; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Ber R, 2003, APPL ENVIRON MICROB, V69, P5787, DOI 10.1128/AEM.69.10.5787-5792.2003; BHARDWAJ N, 1986, J IMMUNOL, V137, P2662; BOHN E, 1994, INFECT IMMUN, V62, P3027, DOI 10.1128/IAI.62.7.3027-3032.1994; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Butler T, 1983, PLAGUE OTHER YERSIAN; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dentovskaya SV, 2013, MOL GENET MICROBIOL+, V28, P87, DOI 10.3103/S089141681303004X; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Elkins KL, 1998, INFECT IMMUN, V66, P3467, DOI 10.1128/IAI.66.7.3467-3469.1998; Elkins KL, 1999, J IMMUNOL, V162, P2291; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Elvin SJ, 2004, MICROB PATHOGENESIS, V37, P177, DOI 10.1016/j.micpath.2004.06.009; Eriksson J, 2012, ADV EXP MED BIOL, V954, P357, DOI 10.1007/978-1-4614-3561-7_43; Feodorova VA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.34; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; HENDERSON D. W., 1964, SYMP SOC GEN MICROBIOL, V14, P241; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; KILLAR LM, 1985, INFECT IMMUN, V47, P605, DOI 10.1128/IAI.47.3.605-612.1985; Kool JL, 2005, CLIN INFECT DIS, V40, P1166, DOI 10.1086/428617; Kummer LW, 2008, VACCINE, V26, P6901, DOI 10.1016/j.vaccine.2008.09.063; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; Lin JS, 2010, VACCINE, V29, P357, DOI 10.1016/j.vaccine.2010.08.099; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Mamroud E, 2003, ADV EXP MED BIOL, V529, P425; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Pan N, 2007, ADV EXP MED BIOL, V603, P367; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rosenzweig JA, 2011, APPL MICROBIOL BIOT, V91, P265, DOI 10.1007/s00253-011-3380-6; Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; Wang XY, 2013, EXPERT REV VACCINES, V12, P677, DOI [10.1586/erv.13.42, 10.1586/ERV.13.42]; Williamson ED, 2013, CLIN EXP IMMUNOL, V172, P1, DOI 10.1111/cei.12044; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2010, INFECT IMMUN, V78, P2329, DOI 10.1128/IAI.00094-10	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83560	10.1371/journal.pone.0083560	http://dx.doi.org/10.1371/journal.pone.0083560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358292	gold, Green Submitted, Green Published			2022-12-25	WOS:000328735700130
J	Ren, T; Takahashi, Y; Liu, X; Loughran, TP; Sun, SC; Wang, HG; Cheng, H				Ren, T.; Takahashi, Y.; Liu, X.; Loughran, T. P.; Sun, S-C; Wang, H-G; Cheng, H.			HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains	ONCOGENE			English	Article						HTLV-1 Tax; IKK; autophagy; lipid rafts; Beclin1; Bif-1	NF-KAPPA-B; STARVATION-INDUCED AUTOPHAGY; CELL LEUKEMIA-CELLS; IKK-BETA; PERSISTENT ACTIVATION; TRANSFORMING PROTEIN; METABOLIC STRESS; KINASE SUBUNITS; BECLIN 1; T-CELLS	The retroviral oncoprotein Tax from human T-cell leukemia virus type 1 (HTLV-1), an etiological factor that causes adult T-cell leukemia and lymphoma, has a crucial role in initiating T-lymphocyte transformation by inducing oncogenic signaling activation. We here report that Tax is a determining factor for dysregulation of autophagy in HTLV-1-transformed T cells and Tax-immortalized CD4 memory T cells. Tax facilitated autophagic process by activating inhibitor of kappa B (I kappa B) kinase (IKK) complex, which subsequently recruited an autophagy molecular complex containing Beclin1 and Bif-1 to the lipid raft microdomains. Tax engaged a crosstalk between IKK complex and autophagic molecule complex by directly interacting with both complexes, promoting assembly of LC3 + autophagosomes. Moreover, expression of lipid raft-targeted Bif-1 or Beclin1 was sufficient to induce formation of LC3+ autophagosomes, suggesting that Tax recruitment of autophagic molecules to lipid rafts is a dominant strategy to deregulate autophagy in the context of HTLV-1 transformation of T cells. Furthermore, depletion of autophagy molecules such as Beclin1 and PI3 kinase class III resulted in impaired growth of HTLV-1-transformed T cells, indicating a critical role of Tax-deregulated autophagy in promoting survival and transformation of virally infected T cells.	[Ren, T.; Liu, X.; Loughran, T. P.] Penn State Univ, Penn State Hershey Canc Inst, Coll Med, Hershey, PA USA; [Ren, T.] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA; [Takahashi, Y.; Wang, H-G] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA; [Sun, S-C] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Cheng, H.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; UTMD Anderson Cancer Center; University System of Maryland; University of Maryland Baltimore	Cheng, H (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St,S219, Baltimore, MD 21201 USA.	hcheng@ihv.umaryland.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R01AI090113];  [CA129682]; NATIONAL CANCER INSTITUTE [R01CA129682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090113] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Atsushi Koito and Takeo Ohsugi for MT-1 cell line, and Wen Dong, Li Chen, Dan Liu, Di Xiang and Huan Zhang for technical assistance. Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award number R01AI090113 to H Cheng and was partly supported by the award CA129682 to HG Wang.	ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Baudhuin P, 1966, Brux Med, V46, P1059; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Carter RS, 2001, J BIOL CHEM, V276, P24445, DOI 10.1074/jbc.C000777200; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hatanaka M, 1992, Uirusu, V42, P13; Horiuchi S, 2006, INT J CANCER, V119, P823, DOI 10.1002/ijc.21918; Huang JN, 2009, J BIOL CHEM, V284, P6208, DOI 10.1074/jbc.M806390200; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Y, 2001, ONCOGENE, V20, P2514, DOI 10.1038/sj.onc.1204364; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mathew R, 2009, METHOD ENZYMOL, V453, P53, DOI 10.1016/S0076-6879(08)04004-4; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; MORI N, 1995, CANCER RES, V55, P3592; Nakamura N, 1999, ONCOGENE, V18, P2667, DOI 10.1038/sj.onc.1202608; Niso-Santano M, 2012, AUTOPHAGY, V8, P268, DOI 10.4161/auto.8.2.18845; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Omodei Zorini A, 1965, Lotta Tuberc, V35, P946; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren T, 2012, J BIOL CHEM, V287, P34683, DOI 10.1074/jbc.M112.377143; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Tang SW, 2013, J VIROL, V87, P1699, DOI 10.1128/JVI.02147-12; Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; TSUDO M, 1983, BLOOD, V61, P1014; Valentin-Acevedo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025467; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161; VONWILLEBRAND M, 1994, EUR J IMMUNOL, V24, P234, DOI 10.1002/eji.1830240137; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; WEISS RA, 1990, CANCER CELL-MON REV, V2, P281; Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10; Yan PR, 2007, AUTOPHAGY, V3, P600, DOI 10.4161/auto.4761; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	66	35	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					373	384		10.1038/onc.2013.552	http://dx.doi.org/10.1038/onc.2013.552			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24362528	Green Accepted			2022-12-25	WOS:000348145500011
J	Kirwan, JP; Hodges, RS				Kirwan, J. Paul; Hodges, Robert S.			Transmission of Stability Information through the N-domain of Tropomyosin Is Interrupted by a Stabilizing Mutation (A109L) in the Hydrophobic Core of the Stability Control Region (Residues 97-118)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circular Dichroism (CD); Contractile Protein; Protein Stability; Recombinant Protein Expression; Tropomyosin; Stability Control Region; Tropomyosin N-domain 1-131; Differential Scanning Calorimetry (DSC); Stability Signal Transmission; Two-stranded Coiled-coils	HELICAL COILED-COILS; GCN4 LEUCINE-ZIPPER; DE-NOVO DESIGN; PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID SUBSTITUTIONS; AMPHIPATHIC ALPHA-HELIX; OLIGOMERIZATION-STATE; PROTEIN STABILITY; MUSCLE REGULATION; CRYSTAL-STRUCTURE	Background: A stability control region (SCR) (residues 97-118) is conserved in vertebrate tropomyosins and controls overall stability. Results: An A109L mutation interrupts the transmission of stability information along the coiled-coil, inducing two domains. Conclusion: The optimum stability provided by the SCR is critical for transmission of the stability signal. Significance: Learning how stability information is transmitted along tropomyosin is crucial to understanding function and signaling. Tropomyosin (Tm) is an actin-binding, thin filament, two-stranded -helical coiled-coil critical for muscle contraction and cytoskeletal function. We made the first identification of a stability control region (SCR), residues 97-118, in the Tm sequence that controls overall protein stability but is not required for folding. We also showed that the individual -helical strands of the coiled-coil are stabilized by Leu-110, whereas the hydrophobic core is destabilized in the SCR by Ala residues at three consecutive d positions. Our hypothesis is that the stabilization of the individual -helices provides an optimum stability and allows functionally beneficial dynamic motion between the -helices that is critical for the transmission of stabilizing information along the coiled-coil from the SCR. We prepared three recombinant (rat) Tm(1-131) proteins, including the wild type sequence, a destabilizing mutation L110A, and a stabilizing mutation A109L. These proteins were evaluated by circular dichroism (CD) and differential scanning calorimetry. The single mutation L110A destabilizes the entire Tm(1-131) molecule, showing that the effect of this mutation is transmitted 165 along the coiled-coil in the N-terminal direction. The single mutation A109L prevents the SCR from transmitting stabilizing information and separates the coiled-coil into two domains, one that is approximate to 9 degrees C more stable than wild type and one that is approximate to 16 degrees C less stable. We know of no other example of the substitution of a stabilizing Leu residue in a coiled-coil hydrophobic core position d that causes this dramatic effect. We demonstrate the importance of the SCR in controlling and transmitting the stability signal along this rodlike molecule.	[Kirwan, J. Paul; Hodges, Robert S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Program Struct Biol & Biophys, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hodges, RS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, L18-9118,MS 8101,12801 E 17th Ave, Aurora, CO 80045 USA.	Robert.Hodges@ucdenver.edu	Kirwan, John P/G-6942-2012					Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; BAILEY K, 1948, BIOCHEM J, V43, P271, DOI 10.1042/bj0430271; BAILEY K, 1946, NATURE, V157, P368, DOI 10.1038/157368b0; Brown JH, 2013, PROTEINS, V81, P635, DOI 10.1002/prot.24218; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Freire E, 2001, Methods Mol Biol, V168, P37; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gunning P. W., 2008, TROPOMYOSIN; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; HITCHCOCK SE, 1973, J MOL BIOL, V80, P825, DOI 10.1016/0022-2836(73)90212-X; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; HODGES R S, 1992, Current Biology, V2, P122, DOI 10.1016/0960-9822(92)90241-2; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; Karibe A, 2001, CIRCULATION, V103, P65; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kawai M., 2009, J BIOPHYS, V2009; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; Kirwan JP, 2010, J STRUCT BIOL, V170, P294, DOI 10.1016/j.jsb.2010.01.020; Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; Kovacs JM, 2006, BIOPOLYMERS, V84, P283, DOI 10.1002/bip.20417; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Landis CA, 1997, J BIOL CHEM, V272, P14051, DOI 10.1074/jbc.272.22.14051; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lee DL, 2003, PROTEIN SCI, V12, P1395, DOI 10.1110/ps.0241403; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Li XC, 2010, J STRUCT BIOL, V170, P307, DOI 10.1016/j.jsb.2009.12.017; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lin JJC, 2008, ADV EXP MED BIOL, V644, P201; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mathur MC, 2011, BIOCHEM BIOPH RES CO, V406, P74, DOI 10.1016/j.bbrc.2011.01.112; Matousek WM, 2007, J MOL BIOL, V374, P206, DOI 10.1016/j.jmb.2007.09.007; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Mills JB, 2006, J CHROMATOGR A, V1133, P248, DOI 10.1016/j.chroma.2006.08.042; Monera OD, 1996, PROTEIN ENG, V9, P353, DOI 10.1093/protein/9.4.353; MONERA OD, 1993, J BIOL CHEM, V268, P19218; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; OBrien R, 1996, BIOPHYS J, V70, P2403, DOI 10.1016/S0006-3495(96)79808-9; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PATO MD, 1981, J BIOL CHEM, V256, P593; Paulucci AA, 2002, J BIOL CHEM, V277, P39574, DOI 10.1074/jbc.M204749200; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; SCHOLTZ JM, 1993, BIOCHEMISTRY-US, V32, P9668, DOI 10.1021/bi00088a019; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; Siththanandan VB, 2009, PFLUG ARCH EUR J PHY, V458, P761, DOI 10.1007/s00424-009-0653-3; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; SUEKI M, 1984, MACROMOLECULES, V17, P148, DOI 10.1021/ma00132a006; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; THOMPSON KS, 1993, BIOCHEMISTRY-US, V32, P5491, DOI 10.1021/bi00072a001; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; Woods E. F., 1977, AUST J BIOL SCI, V6, P527; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; WRABL J, 1994, BIOPOLYMERS, V34, P1659, DOI 10.1002/bip.360341210; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365; ZHOU NE, 1994, PROTEIN PEPTIDE LETT, V1, P114; Zoetewey DL, 2003, J MOL BIOL, V334, P1063, DOI 10.1016/j.jmb.2003.10.020	120	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4356	4366		10.1074/jbc.M113.507236	http://dx.doi.org/10.1074/jbc.M113.507236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362038	hybrid, Green Published			2022-12-25	WOS:000331403800046
J	Koehler, S; Ovadia-Caro, S; van der Meer, E; Villringer, A; Heinz, A; Romanczuk-Seiferth, N; Margulies, DS				Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Romanczuk-Seiferth, Nina; Margulies, Daniel S.			Increased Functional Connectivity between Prefrontal Cortex and Reward System in Pathological Gambling	PLOS ONE			English	Article							TOURETTE-SYNDROME; PROBLEM GAMBLERS; DECISION-MAKING; BRAIN ACTIVITY; ACTIVATION; DYSFUNCTION; TASK; HYPERSENSITIVITY; ABNORMALITIES; METAANALYSIS	Pathological gambling (PG) shares clinical characteristics with substance-use disorders and is thus discussed as a behavioral addiction. Recent neuroimaging studies on PG report functional changes in prefrontal structures and the mesolimbic reward system. While an imbalance between these structures has been related to addictive behavior, whether their dysfunction in PG is reflected in the interaction between them remains unclear. We addressed this question using functional connectivity resting-state fMRI in male subjects with PG and controls. Seed-based functional connectivity was computed using two regions-of-interest, based on the results of a previous voxel-based morphometry study, located in the prefrontal cortex and the mesolimbic reward system (right middle frontal gyrus and right ventral striatum). PG patients demonstrated increased connectivity from the right middle frontal gyrus to the right striatum as compared to controls, which was also positively correlated with nonplanning aspect of impulsiveness, smoking and craving scores in the PG group. Moreover, PG patients demonstrated decreased connectivity from the right middle frontal gyrus to other prefrontal areas as compared to controls. The right ventral striatum demonstrated increased connectivity to the right superior and middle frontal gyrus and left cerebellum in PG patients as compared to controls. The increased connectivity to the cerebellum was positively correlated with smoking in the PG group. Our results provide further evidence for alterations in functional connectivity in PG with increased connectivity between prefrontal regions and the reward system, similar to connectivity changes reported in substance use disorder.	[Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Margulies, Daniel S.] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke; Villringer, Arno; Heinz, Andreas; Margulies, Daniel S.] Humboldt Univ, Mind Brain Inst, D-10099 Berlin, Germany; [Koehler, Saskia; Heinz, Andreas; Romanczuk-Seiferth, Nina] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; van der Meer, Elke] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Koehler, Saskia; Ovadia-Caro, Smadar; Villringer, Arno; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society	Koehler, S (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany.	saskia.koehler@psychologie.hu-berlin.de	Heinz, Andreas/ABB-7736-2020; Romanczuk-Seiferth, Nina/AFN-7029-2022; Romanczuk-Seiferth, Nina/AFN-0829-2022; Margulies, Daniel/L-4719-2016	Heinz, Andreas/0000-0001-5405-9065; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Villringer, Arno/0000-0003-2604-2404; Margulies, Daniel/0000-0002-8880-9204	Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin; Deutsche Forschungsgemeinschaft (DFG); graduate school 86 "Berlin School of Mind and Brain"; Minerva Stiftung; German Research Foundation (Deutsche Forschungsgemeinschaft) [HE 2597/4-3, 7-3, 13-1, 14-1, 15-1, 1430/2-1]; German Federal Ministry of Education and Research [01GQ0411, 01QG87164, NGFN Plus 01 GS 08152, 01 GS 08 159]	Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); graduate school 86 "Berlin School of Mind and Brain"; Minerva Stiftung; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by "Senatsverwaltung fur Gesundheit, Umwelt und Verbraucherschutz, Berlin", Deutsche Forschungsgemeinschaft (DFG), graduate school 86 "Berlin School of Mind and Brain" (Koehler and Ovadia-Caro), and Minerva Stiftung (Ovadia-Caro). Andreas Heinz has received research funding from the German Research Foundation (Deutsche Forschungsgemeinschaft; HE 2597/4-3; 7-3; 13-1; 14-1; 15-1; Excellence Cluster Exc 257 & STE 1430/2-1) and the German Federal Ministry of Education and Research (01GQ0411; 01QG87164; NGFN Plus 01 GS 08152 and 01 GS 08 159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; CHANRAUD S, 2011, CEREB CORTEX, V21, P1; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI [10.1093/acprof:oso/9780195391381.003.0008, DOI 10.1093/ACPROF:OSO/9780195391381.003.0008]; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Diekhof EK, 2010, J NEUROSCI, V30, P1488, DOI 10.1523/JNEUROSCI.4690-09.2010; Diekhof EK, 2012, HUM BRAIN MAPP, V33, P2768, DOI 10.1002/hbm.21398; First M. B., 2014, SCID 5 105 STRUCTURE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Jia ZR, 2011, BIOL PSYCHIAT, V70, P553, DOI 10.1016/j.biopsych.2011.05.008; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; KOEHLER S, 2013, BRAIN STRUCT FUNCT; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Lutz R, 2005, MMW Fortschr Med, V147, P41; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Marazziti Donatella, 2008, Clin Pract Epidemiol Ment Health, V4, P7, DOI 10.1186/1745-0179-4-7; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oberg SAK, 2011, NEUROPSYCHOLOGIA, V49, P3768, DOI 10.1016/j.neuropsychologia.2011.09.037; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; PETRY J, 1996, KFG KURZFRAGEBOGEN Z, P300; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Rogers BP, 2012, ALCOHOL CLIN EXP RES, V36, P294, DOI 10.1111/j.1530-0277.2011.01614.x; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tomasi Dardo, 2010, PLoS One, V5, pe10815, DOI 10.1371/journal.pone.0010815; Tschernegg M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00625; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; van Holst RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030909; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030; von Aster M., 2006, WECHSLER INTELLIGENZ, V2; Wang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058098; Wilcox CE, 2011, DRUG ALCOHOL DEPEN, V115, P137, DOI 10.1016/j.drugalcdep.2011.01.009; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005	70	38	38	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84565	10.1371/journal.pone.0084565	http://dx.doi.org/10.1371/journal.pone.0084565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367675	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900055
J	Sundblad, BM; Jansson, SA; Nystrom, L; Arvidsson, P; Lundback, B; Larsson, K				Sundblad, Britt-Marie; Jansson, Sven-Arne; Nystrom, Lennarth; Arvidsson, Peter; Lundback, Bo; Larsson, Kjell			Chronic Obstructive Pulmonary Disease (COPD) During the Two Last Years of Life - A Retrospective Study of Decedents	PLOS ONE			English	Article							SEX-DIFFERENCES; LUNG-DISEASE; GENDER-DIFFERENCE; SMOKING-HABITS; GLOBAL BURDEN; MORTALITY; SURVIVAL; HOSPITALIZATION; WOMEN; RISK	Background: Little is known about the management of patients suffering from chronic obstructive pulmonary disease (COPD) during the last years of life. The aim of the study was to describe how management of COPD is performed in Sweden during the last two years of life. Methods: From the nationwide Cause of Death register all individuals with COPD as the underlying cause of death during two years were identified in one sparsely and one densely populated area of Sweden. Data were collected from medical records using a pre-defined protocol, especially developed for this purpose. Results: Of 822 individuals with COPD as underlying cause of death, medical records from 729 were available. The COPD diagnosis was based on lung function measurements in approximately half of the patients and median age at COPD diagnosis was 74 years (range 34-95). Women died at younger age, median 78 years (range 52-96) than did men (80 years (51-99)). The median survival time from diagnosis to death was 6 years in men and women in both areas. Among women and men 8.3% and 4.3% were never smokers, respectively. The structure of COPD management differed between the two areas, with utilization of physiotherapists, dieticians and working therapists being more used in the northern area, likely because of differences in accessibility to care institutions. Conclusions: In Sweden COPD is mostly diagnosed late in life and often not verified by lung function measurements. Opposite to the general population, women with COPD die at a lower age than men.	[Sundblad, Britt-Marie; Jansson, Sven-Arne; Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Lundback, Bo] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Krefting Res Ctr, Gothenburg, Sweden; [Nystrom, Lennarth] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Arvidsson, Peter] GlaxoSmithKline Sweden, Astma COPD, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Umea University; GlaxoSmithKline	Sundblad, BM (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	britt-marie.sundblad@ki.se		Sundblad, Britt-Marie/0000-0002-9939-418X	GlaxoSmithKline, Sweden	GlaxoSmithKline, Sweden(GlaxoSmithKline)	The study was supported from GlaxoSmithKline, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Cleland JGF, 2000, EUR J HEART FAIL, V2, P123, DOI 10.1016/S1388-9842(00)00081-7; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Ekstrom M, 2010, CHEST, V137, P31, DOI 10.1378/chest.09-0636; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Gonzalez AV, 2011, THORAX, V66, P38, DOI 10.1136/thx.2010.141978; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lindberg A, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-1; Linstrom M, 2002, INT J TUBERC LUNG D, V6, P76; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Machado MCL, 2006, AM J RESP CRIT CARE, V174, P524, DOI 10.1164/rccm.200507-1057OC; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Prescott E, 1997, EUR RESPIR J, V10, P822; Prescott E, 1998, J EPIDEMIOL COMMUN H, V52, P131, DOI 10.1136/jech.52.2.131; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sundblad BM, 2008, CLIN RESPIR J, V2, P11, DOI 10.1111/j.1752-699X.2007.00020.x; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; XU X, 1994, EUR RESPIR J, V7, P1056	25	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84110	10.1371/journal.pone.0084110	http://dx.doi.org/10.1371/journal.pone.0084110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367631	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900032
J	Xu, WJ; Shi, LL; Chan, O; Li, J; Casper, P; Zou, XM				Xu, Wenjing; Shi, Lingling; Chan, Onchim; Li, Jiao; Casper, Peter; Zou, Xiaoming			Assessing the Effect of Litter Species on the Dynamic of Bacterial and Fungal Communities during Leaf Decomposition in Microcosm by Molecular Techniques	PLOS ONE			English	Article							NUTRIENT DYNAMICS; HEADWATER STREAM; DECAYING LEAVES; FOREST STREAM; DIVERSITY; QUALITY; ECOSYSTEMS; COLONIZATION; TANNINS; BEECH	Although bacteria and fungi are well-known to be decomposers of leaf litter, few studies have examined their compositions and diversities during the decomposition process in tropical stream water. Xishuangbanna is a tropical region preserving one of the highest floristic diversity areas in China. In this study, leaf litter of four dominant plant species in Xishuangbanna was incubated in stream water for 42 days during which samples were taken regularly. Following DNA extraction, PCR-DGGE (denaturing gradient gel electrophoresis) and clone-sequencing analyses were performed using bacterial and fungal specific primers. Leaf species have slightly influences on bacterial community rather than fungal community. The richness and diversity of bacteria was higher than that of fungi, which increased towards the end of the 42-day-incubation. The bacterial community was initially more specific upon the type of leaves and gradually became similar at the later stage of decomposition with alpha-proteobacteria as major component. Sequences affiliated to methanotrophs were obtained that indicates potentially occurrence of methane oxidation and methanogenesis. For the fungal community, sequences affiliated to Aspergillus were predominant at the beginning and then shifted to Pleosporales. Our results suggest that the microorganisms colonizing leaf biofilm in tropical stream water were mostly generalists that could exploit the resources of leaves of various species equally well.	[Xu, Wenjing; Shi, Lingling; Chan, Onchim; Li, Jiao] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China; [Xu, Wenjing; Shi, Lingling] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Wenjing] Anhui Acad Agr Sci, Inst Agr Engn, Hefei, Anhui, Peoples R China; [Li, Jiao] Yunnan Univ, Fac Life Sci, Dept Biol, Kunming, Yunnan, Peoples R China; [Casper, Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Germany; [Zou, Xiaoming] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Zou, Xiaoming] Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui Academy of Agricultural Sciences; Yunnan University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Nanjing Forestry University; University of Puerto Rico; University of Puerto Rico Rio Piedras	Shi, LL (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	shill@xtbg.ac.cn	Casper, Peter/B-7384-2011; Zou, Xiaoming/GWV-5608-2022	Casper, Peter/0000-0002-5956-4674; Zou, Xiaoming/0000-0001-9023-3067	National Science Foundation of China [30670308]; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank National Science Foundation of China (Grant no. 30670308) and Program of Studying Abroad, Chinese Academy of Sciences, for the financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3; Buesing N, 2006, APPL ENVIRON MICROB, V72, P596, DOI 10.1128/AEM.72.1.596-605.2006; CHAMIER AC, 1984, OECOLOGIA, V64, P92, DOI 10.1007/BF00377550; Chan OC, 2008, FEMS MICROBIOL ECOL, V64, P449, DOI 10.1111/j.1574-6941.2008.00488.x; Cortez J, 1996, SOIL BIOL BIOCHEM, V28, P443, DOI 10.1016/0038-0717(96)00005-3; COVICH AP, 1988, J N AM BENTHOL SOC, V7, P361, DOI 10.2307/1467297; Cox P., 1997, Mycologist, V11, P55, DOI 10.1016/S0269-915X(97)80034-1; Das M, 2008, MYCOL PROG, V7, P267, DOI 10.1007/s11557-008-0569-x; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Enya J, 2007, J PHYTOPATHOL, V155, P446, DOI 10.1111/j.1439-0434.2007.01256.x; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gulis V, 2003, AQUAT MICROB ECOL, V30, P149, DOI 10.3354/ame030149; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Mathuriau C, 2002, J N AM BENTHOL SOC, V21, P384, DOI 10.2307/1468477; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mfilinge PL, 2002, TREES-STRUCT FUNCT, V16, P172, DOI 10.1007/s00468-001-0156-0; Mille-Lindblom C, 2006, FRESHWATER BIOL, V51, P730, DOI 10.1111/j.1365-2427.2006.01532.x; Moller J, 1999, SOIL BIOL BIOCHEM, V31, P367, DOI 10.1016/S0038-0717(98)00138-2; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Nikolcheva Liliya G., 2005, P169, DOI 10.1007/1-4020-3466-0_22; Pearson RG, 2000, FRESHWATER BIOL, V43, P31, DOI 10.1046/j.1365-2427.2000.00504.x; Sridhar KR, 2000, APPL ENVIRON MICROB, V66, P1114, DOI 10.1128/AEM.66.3.1114-1119.2000; SRINIVASAN MC, 1991, WORLD J MICROB BIOT, V7, P171, DOI 10.1007/BF00328987; STOUT RJ, 1989, CAN J FISH AQUAT SCI, V46, P1097, DOI 10.1139/f89-142; TEUBEN A, 1990, BIOL FERT SOILS, V9, P145, DOI 10.1007/BF00335798; Tuchman NC, 2003, HYDROBIOLOGIA, V495, P203, DOI 10.1023/A:1025493018012; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Webster JR, 1997, J N AM BENTHOL SOC, V16, P3, DOI 10.2307/1468223; Weidner S, 2000, MICROBIAL ECOL, V39, P22, DOI 10.1007/s002489900194; White, 1990, PCR PROTOCOLS GUIDE, P315; Wohl DL, 1998, FEMS MICROBIOL ECOL, V26, P135, DOI 10.1111/j.1574-6941.1998.tb00499.x; Wright MS, 2005, MICROB ECOL, V49, P536, DOI 10.1007/s00248-004-0052-4	40	14	14	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84613	10.1371/journal.pone.0084613	http://dx.doi.org/10.1371/journal.pone.0084613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367682	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900058
J	Lee, Y				Lee, Youngseok			Contribution of Drosophila TRPA1-Expressing Neurons to Circadian Locomotor Activity Patterns	PLOS ONE			English	Article							TEMPERATURE SYNCHRONIZATION; FRUIT-FLY; CLOCK; LIGHT; BEHAVIOR; CHANNEL; GENE; RHYTHM; CRYPTOCHROME; NEUROPEPTIDE	In both vertebrates and invertebrates, Transient Receptor Potential (TRP) channels are expressed in sensory neurons and mediate environmental stimuli such as light, sound, temperature, and taste. Some of these channels, however, are expressed only in the brain and their functions remain incompletely understood. Using the GAL4/UAS binary system with a line in which the GAL4 had been knocked into the trpA1 locus in Drosophila, we recently reported new insights into TRPA1 localization and function, including its expression in approximately 15% of all circadian neurons. TRPA1 is expressed in lateral posterior neurons (LPNs), which are known to be highly sensitive to entrainment by temperature cycles. Here, I used the bacterial sodium channel, NaChBac, to examine the effects of altering the electrical properties of trpA1 neurons on circadian rhythms. My results indicate that circadian activity of the flies in the morning, daytime, and evening was affected in a temperature-dependent manner following TRPA1 neuronal activation. Remarkably, TRPA1 neuron activation in flies kept at 18 degrees C impacted the morning peak of circadian activity even though TRPA1 is not expressed in morning cells. Taken together, these results suggest that the activation of TRPA1-expressing neurons may differentially coordinate light/dark circadian entrainment, depending on the temperature.	Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea	Kookmin University	Lee, Y (corresponding author), Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea.	ylee@kookmin.ac.kr		Lee, Youngseok/0000-0003-0459-1138	National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [2012M3A9B2052525]; Basic Science Research Program of the NRF of Korea; Ministry of Education [2012R1A1A2003727]; Kookmin University in Korea [J2013-0027]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program of the NRF of Korea(National Research Foundation of Korea); Ministry of Education; Kookmin University in Korea	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B2052525), the Basic Science Research Program of the NRF of Korea funded by the Ministry of Education (2012R1A1A2003727) and the new faculty research program (J2013-0027) of Kookmin University in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Gentile C, 2013, CURR BIOL, V23, P185, DOI 10.1016/j.cub.2012.12.023; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	36	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e85189	10.1371/journal.pone.0085189	http://dx.doi.org/10.1371/journal.pone.0085189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367706	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300160
J	Nakielski, J; Lipowczan, M				Nakielski, Jerzy; Lipowczan, Marcin			Spatial and Directional Variation of Growth Rates in Arabidopsis Root Apex: A Modelling Study	PLOS ONE			English	Article							TENSOR-BASED MODEL; CELL DIVISIONS; THALIANA; ANISOTROPY; MERISTEM; MOTION; APICES	Growth and cellular organization of the Arabidopsis root apex are investigated in various aspects, but still little is known about spatial and directional variation of growth rates in very apical part of the apex, especially in 3D. The present paper aims to fill this gap with the aid of a computer modelling based on the growth tensor method. The root apex with a typical shape and cellular pattern is considered. Previously, on the basis of two types of empirical data: the published velocity profile along the root axis and dimensions of cell packets formed in the lateral part of the root cap, the displacement velocity field for the root apex was determined. Here this field is adopted to calculate the linear growth rate in different points and directions. The results are interpreted taking principal growth directions into account. The root apex manifests a significant anisotropy of the linear growth rate. The directional preferences depend on a position within the root apex. In the root proper the rate in the periclinal direction predominates everywhere, while in the root cap the predominating direction varies with distance from the quiescent centre. The rhizodermis is distinguished from the neighbouring tissues (cortex, root cap) by relatively high contribution of the growth rate in the anticlinal direction. The degree of growth anisotropy calculated for planes defined by principal growth directions and exemplary cell walls may be as high as 25. The changes in the growth rate variation are modelled.	[Nakielski, Jerzy; Lipowczan, Marcin] Univ Silesia, Dept Biophys & Morphogenesis Plants, Katowice, Poland	University of Silesia in Katowice	Nakielski, J (corresponding author), Univ Silesia, Dept Biophys & Morphogenesis Plants, Katowice, Poland.	jerzy.nakielski@us.edu.pl	Lipowczan, Marcin/ABF-6842-2020	Lipowczan, Marcin/0000-0002-2508-3354				Barlow Peter W., 1997, P29, DOI 10.1016/B978-012563455-7/50003-9; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Baskin TI, 1999, PLANT PHYSIOL, V119, P681, DOI 10.1104/pp.119.2.681; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; CLOWES FAL, 1956, J EXP BOT, V7, P307, DOI 10.1093/jxb/7.3.307; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; ERICKSON RO, 1986, PLANT PHYSIOL, V82, P1153, DOI 10.1104/pp.82.4.1153; ERICKSON RO, 1966, J EXP BOT, V17, P390, DOI 10.1093/jxb/17.2.390; GANDAR PW, 1983, BOT GAZ, V144, P1, DOI 10.1086/337337; HEJNOWICZ Z, 1984, ACTA SOC BOT POL, V53, P29; HEJNOWICZ Z, 1988, ACTA SOC BOT POL, V57, P31, DOI 10.5586/asbp.1988.004; HEJNOWICZ Z, 1989, ENVIRON EXP BOT, V29, P85, DOI 10.1016/0098-8472(89)90041-5; HEJNOWICZ Z, 1984, J THEOR BIOL, V110, P93, DOI 10.1016/S0022-5193(84)80017-X; HEJNOWICZ Z, 1986, J THEOR BIOL, V121, P59, DOI 10.1016/S0022-5193(86)80028-5; HEJNOWICZ Z, 1993, AM J BOT, V80, P309, DOI 10.2307/2445354; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kwiatkowska D, 2004, AM J BOT, V91, P1277, DOI 10.3732/ajb.91.9.1277; NAKIELSKI J, 1987, ACTA SOC BOT POL, V56, P625, DOI 10.5586/asbp.1987.055; Nakielski J, 2003, NATO SCI SER II-MATH, V121, P119; Nakielski J, 2008, PLANTA, V228, P179, DOI 10.1007/s00425-008-0728-y; Nakielski Jerzy, 1991, Acta Societatis Botanicorum Poloniae, V60, P77, DOI 10.5586/asbp.1991.005; Nakielski J, 2012, PLANTA, V236, P1547, DOI 10.1007/s00425-012-1707-x; Priestley J., 1930, NEW PHYTOL, V29, P96, DOI [10.1111/j.1469-8137.1930.tb06983.x, DOI 10.1111/J.1469-8137.1930.TB06983.X]; Richards OW, 1943, AM NAT, V77, P385, DOI 10.1086/281140; Romberger JA, 2004, PLANT STRUCTURE FUNC, V1st; Sachs J., 1887, LECT PLANT PHYSL, P431; SILK WK, 1979, J THEOR BIOL, V76, P481, DOI 10.1016/0022-5193(79)90014-6; Silk WK, 2006, J PLANT RES, V119, P23, DOI 10.1007/s10265-005-0248-9; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Spiegel M.R., 1959, THEORY PROBLEMS VECT; Szymanowska-Pulka J, 2010, PLANTA, V232, P1207, DOI 10.1007/s00425-010-1239-1; van den Berg C, 1998, PLANTA, V205, P483, DOI 10.1007/s004250050347; van der Weele CM, 2003, PLANT PHYSIOL, V132, P1138, DOI 10.1104/pp.103.021345; Waishel, 1996, PLANT ROOTS HIDDEN H, P51; Wasteneys GO, 2006, J PLANT RES, V119, P5, DOI 10.1007/s10265-005-0233-3; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Wuyts N, 2011, PLANTA, V234, P769, DOI 10.1007/s00425-011-1435-7	40	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84337	10.1371/journal.pone.0084337	http://dx.doi.org/10.1371/journal.pone.0084337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367654	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300137
J	van't Hoog, AH; Cobelens, F; Vassall, A; van Kampen, S; Dorman, SE; Alland, D; Ellner, J				van't Hoog, Anna H.; Cobelens, Frank; Vassall, Anna; van Kampen, Sanne; Dorman, Susan E.; Alland, David; Ellner, Jerrold			Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MALARIA CONTROL; RESISTANCE; DURATION; COUGH	Background: High costs are a limitation to scaling up the Xpert MTB/RIF assay (Xpert) for the diagnosis of tuberculosis in resource-constrained settings. A triaging strategy in which a sensitive but not necessarily highly specific rapid test is used to select patients for Xpert may result in a more affordable diagnostic algorithm. To inform the selection and development of particular diagnostics as a triage test we explored combinations of sensitivity, specificity and cost at which a hypothetical triage test will improve affordability of the Xpert assay. Methods: In a decision analytical model parameterized for Uganda, India and South Africa, we compared a diagnostic algorithm in which a cohort of patients with presumptive TB received Xpert to a triage algorithm whereby only those with a positive triage test were tested by Xpert. Findings: A triage test with sensitivity equal to Xpert, 75% specificity, and costs of US$5 per patient tested reduced total diagnostic costs by 42% in the Uganda setting, and by 34% and 39% respectively in the India and South Africa settings. When exploring triage algorithms with lower sensitivity, the use of an example triage test with 95% sensitivity relative to Xpert, 75% specificity and test costs $5 resulted in similar cost reduction, and was cost-effective by the WHO willingness-to-pay threshold compared to Xpert for all in Uganda, but not in India and South Africa. The gain in affordability of the examined triage algorithms increased with decreasing prevalence of tuberculosis among the cohort. Conclusions: A triage test strategy could potentially improve the affordability of Xpert for TB diagnosis, particularly in low-income countries and with enhanced case-finding. Tests and markers with lower accuracy than desired of a diagnostic test may fall within the ranges of sensitivity, specificity and cost required for triage tests and be developed as such.	[van't Hoog, Anna H.; Cobelens, Frank] AIGHD, Amsterdam, Netherlands; [van't Hoog, Anna H.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Vassall, Anna] London Sch Hyg & Trop Med, Social & Math Epidemiol Grp SAME, Dept Global Hlth & Dev, London WC1, England; [van Kampen, Sanne] KNCV TB Fdn, The Hague, Netherlands; [Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Ellner, Jerrold] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ellner, Jerrold] Boston Med Ctr, Boston, MA 02118 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; KNCV Tuberculosis Foundation; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; Boston Medical Center	van't Hoog, AH (corresponding author), AIGHD, Amsterdam, Netherlands.	a.h.vanthoog@aighd.org		Vassall, Anna/0000-0002-2911-1375; van Kampen, Sanne/0000-0002-1519-5248; Cobelens, Frank/0000-0002-4367-1133	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900050C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900050C., "The Tuberculosis Clinical Diagnostics Research Consortium''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mabaera B, 2007, INT J TUBERC LUNG D, V11, P959; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; Otero L, 2010, TROP MED INT HEALTH, V15, P1475, DOI 10.1111/j.1365-3156.2010.02645.x; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Stop TB Department, 2012, BUY DOWN AGR RED COS; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012; The World Bank, 2012, DAT GDP PER CAP CURR; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Weyer K, 2013, EUR RESP J, V42; Weyer K, 2011, J INFECT DIS, V204, pS1196, DOI 10.1093/infdis/jir452; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, 2013, WHO MON XPERT MTB RI; World Health Organization, 2012, CHOOSING INT AR COST	31	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82786	10.1371/journal.pone.0082786	http://dx.doi.org/10.1371/journal.pone.0082786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367555	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000328740300069
J	Vazquez-de-Aldana, BR; Garcia-Ciudad, A; Garcia-Criado, B; Vicente-Tavera, S; Zabalgogeazcoa, I				Vazquez-de-Aldana, Beatriz R.; Garcia-Ciudad, Antonia; Garcia-Criado, Balbino; Vicente-Tavera, Santiago; Zabalgogeazcoa, Inigo			Fungal Endophyte (Epichloe festucae) Alters the Nutrient Content of Festuca rubra Regardless of Water Availability	PLOS ONE			English	Article							INFECTED TALL FESCUE; LOLIUM-PERENNE; ACREMONIUM-COENOPHIALUM; DEFENSIVE MUTUALISM; STRESS TOLERANCE; ALKALOID CONTENT; GROWTH; DROUGHT; GRASSES; RESISTANCE	Festuca rubra plants maintain associations with the vertically transmitted fungal endophyte Epichloe festucae. A high prevalence of infected host plants in semiarid grasslands suggests that this association could be mutualistic. We investigated if the Epichloe-endophyte affects the growth and nutrient content of F. rubra plants subjected to drought. Endophyte-infected (E+) and non-infected (E-) plants of two half-sib lines (PEN and RAB) were subjected to three water availability treatments. Shoot and root biomass, nutrient content, proline, phenolic compounds and fungal alkaloids were measured after the treatments. The effect of the endophyte on shoot and root biomass and dead leaves depended on the plant line. In the PEN line, E+ plants had a greater S: R ratio than E-, but the opposite occurred in RAB. In both plant lines and all water treatments, endophyte-infected plants had greater concentrations of N, P and Zn in shoots and Ca, Mg and Zn in roots than E- plants. On average, E+ plants contained in their shoots more P (62%), Zn (58%) and N (19%) than E- plants. While the proline in shoots increased in response to water stress, the endophyte did not affect this response. A multivariate analysis showed that endophyte status and plant line impose stronger differences in the performance of the plants than the water stress treatments. Furthermore, differences between PEN and RAB lines seemed to be greater in E- than in E+ plants, suggesting that E+ plants of both lines are more similar than those of their non-infected version. This is probably due to the endophyte producing a similar effect in both plant lines, such as the increase in N, P and Zn in shoots. The remarkable effect of the endophyte in the nutrient balance of the plants could help to explain the high prevalence of infected plants in natural grasslands.	[Vazquez-de-Aldana, Beatriz R.; Garcia-Ciudad, Antonia; Garcia-Criado, Balbino; Zabalgogeazcoa, Inigo] CSIC, Inst Recursos Nat & Agrobiol Salamanca IRNASA, Dept Abiot Stress, Salamanca, Spain; [Vicente-Tavera, Santiago] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); University of Salamanca	Vazquez-de-Aldana, BR (corresponding author), CSIC, Inst Recursos Nat & Agrobiol Salamanca IRNASA, Dept Abiot Stress, Salamanca, Spain.	beatriz.dealdana@irnasa.csic.es	Vazquez de Aldana, Beatriz R/A-7760-2008; Vicente-Tavera, Santiago/L-5605-2014; Zabalgogeazcoa, Iñigo/F-9523-2016; Vázquez-de-Aldana, Beatriz R./AGN-2436-2022	Vazquez de Aldana, Beatriz R/0000-0001-6549-3545; Vicente-Tavera, Santiago/0000-0001-5929-6844; Zabalgogeazcoa, Iñigo/0000-0002-9524-7799; Vázquez-de-Aldana, Beatriz R./0000-0001-6549-3545	Spanish Ministry of Economy and Competitiveness [AGL2008-01159, AGL2011-22783]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was funded by projects AGL2008-01159 and AGL2011-22783 from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; [Anonymous], 2004, WILD SOWN GRASSES PR; AOAC, 2002, OFFICIAL METHODS ANA, V15th, DOI DOI 10.1007/978-3-642-31241-0; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Assuero SG, 2000, NEW ZEAL J AGR RES, V43, P49, DOI 10.1080/00288233.2000.9513408; Bacon C.W., 1994, BIOTECHNOLOGY ENDOPH, P47; BACON CW, 1995, J ANIM SCI, V73, P861; Barker DJ., 1993, P 2 INT S ACR GRASS, P67; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Bazely DR, 1997, J APPL ECOL, V34, P847, DOI 10.2307/2405276; BELESKY DP, 1989, ANN BOT-LONDON, V64, P343, DOI 10.1093/oxfordjournals.aob.a087850; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cheplick GP, 2004, AM J BOT, V91, P1960, DOI 10.3732/ajb.91.12.1960; Cheplick GP, 2000, FUNCT ECOL, V14, P657, DOI 10.1046/j.1365-2435.2000.00466.x; Christensen MJ, 1997, MYCOL RES, V101, P493, DOI 10.1017/S0953756296002833; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Duque Macias F, 1970, AN EDAFOL AGROBIOL, V30, P207; Elbersen HW, 1996, GRASS FORAGE SCI, V51, P333, DOI 10.1111/j.1365-2494.1996.tb02068.x; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; Galindo P., 1986, PUBLICACIONES BIOEST, V17, P45; Galindo Villardon M.P., 1986, QUESTIIO, V10, P13; Gange AC, 1999, NEW PHYTOL, V142, P123, DOI 10.1046/j.1469-8137.1999.00371.x; Garcia RA, 2002, MOL ECOL, V11, P355, DOI 10.1046/j.0962-1083.2001.01456.x; Garcia-Talegon J, 1999, CHEM GEOL, V153, P37, DOI 10.1016/S0009-2541(98)00151-X; GARNER GB, 1993, AGR ECOSYST ENVIRON, V44, P65, DOI 10.1016/0167-8809(93)90039-R; Gibert A, 2012, NEW PHYTOL, V194, P561, DOI 10.1111/j.1469-8137.2012.04073.x; Granath G, 2007, ECOGRAPHY, V30, P422, DOI [10.1111/j.2007.0906-7590.05027.x, 10.1111/j.0906-7590.2007.05027.x]; Gundel PE, 2011, CROP PASTURE SCI, V62, P1010, DOI 10.1071/CP11300; Hahn H, 2008, ENVIRON EXP BOT, V63, P183, DOI 10.1016/j.envexpbot.2007.10.021; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Hesse U, 2005, EUR J AGRON, V22, P45, DOI 10.1016/j.eja.2003.12.002; HILL NS, 1993, CROP SCI, V33, P331, DOI 10.2135/cropsci1993.0011183X003300020024x; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; LEUCHTMANN A, 1994, MYCOLOGIA, V86, P802, DOI 10.2307/3760595; LEWIS GC, 1992, GRASS FORAGE SCI, V47, P302, DOI 10.1111/j.1365-2494.1992.tb02274.x; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048010; LYONS PC, 1990, PLANT PHYSIOL, V92, P726, DOI 10.1104/pp.92.3.726; Malinowski DP, 1998, PLANT SOIL, V205, P1, DOI 10.1023/A:1004331932018; Malinowski DP, 2000, PLANT SOIL, V227, P115, DOI 10.1023/A:1026518828237; Malinowski DP, 1998, PLANT SOIL, V198, P53, DOI 10.1023/A:1004279401196; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Monnet F, 2005, FUNCT PLANT BIOL, V32, P131, DOI 10.1071/FP04129; Ponce MA, 2009, BIOCHEM SYST ECOL, V37, P245, DOI 10.1016/j.bse.2009.03.010; READ JC, 1986, AGRON J, V78, P848, DOI 10.2134/agronj1986.00021962007800050021x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Ren AZ, 2011, PLANT SOIL, V346, P363, DOI 10.1007/s11104-011-0824-9; Richardson MD, 1999, J PLANT NUTR, V22, P67, DOI 10.1080/01904169909365607; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saint Yves A, 1930, CANDOLLEA, V4, P146; Marquez SS, 2012, FUNGAL ECOL, V5, P289, DOI 10.1016/j.funeco.2010.12.001; Schardl CL, 2007, PHYTOCHEMISTRY, V68, P980, DOI 10.1016/j.phytochem.2007.01.010; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Torres MS, 2012, FUNGAL ECOL, V5, P322, DOI 10.1016/j.funeco.2011.05.006; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; de Aldana BRV, 2014, GRASS FORAGE SCI, V69, P462, DOI 10.1111/gfs.12049; Vazquez-de-Aldana BR, 2008, AUST J AGR RES, V59, P769, DOI 10.1071/AR07359; Vazquez-de-Aldana BR, 2011, ANN APPL BIOL, V159, P281, DOI 10.1111/j.1744-7348.2011.00495.x; Vazquez-de-Aldana BR, 2013, PLANT SOIL, V362, P201, DOI 10.1007/s11104-012-1283-7; Vicente-Tavera S, 1992, THESIS U SALAMANCA S; Vicente-Villardon J.L., 2012, MULTBIPLOT MULTIVARI; Volaire F, 1998, NEW PHYTOL, V140, P439, DOI [10.1046/j.1469-8137.1998.00288.x, 10.1111/j.1469-8137.1998.00288.x]; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WEST CP, 1993, AGRON J, V85, P264, DOI 10.2134/agronj1993.00021962008500020019x; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; White Philip J., 2008, V7, P51; Yue Q, 2000, J CHEM ECOL, V26, P279, DOI 10.1023/A:1005410115940; Zabalgogeazcoa I, 2008, PLANT PATHOL, V57, P467, DOI 10.1111/j.1365-3059.2007.01784.x; Zabalgogeazcoa I, 2006, EUR J AGRON, V24, P374, DOI 10.1016/j.eja.2006.01.003; Zabalgogeazcoa I, 2006, GRASS FORAGE SCI, V61, P71, DOI 10.1111/j.1365-2494.2006.00509.x; Zabalgogeazcoa I, 1999, GRASS FORAGE SCI, V54, P91, DOI 10.1046/j.1365-2494.1999.00155.x	81	49	50	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84539	10.1371/journal.pone.0084539	http://dx.doi.org/10.1371/journal.pone.0084539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367672	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300147
J	Frerichs, LM; Araz, OM; Huang, TTK				Frerichs, Leah M.; Araz, Ozgur M.; Huang, Terry T. -K.			Modeling Social Transmission Dynamics of Unhealthy Behaviors for Evaluating Prevention and Treatment Interventions on Childhood Obesity	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC-HEALTH; US CHILDREN; SYSTEM DYNAMICS; WEIGHT; ADOLESCENTS; PREVALENCE; TRENDS; OVERWEIGHT; ADULTS	Research evidence indicates that obesity has spread through social networks, but lever points for interventions based on overlapping networks are not well studied. The objective of our research was to construct and parameterize a system dynamics model of the social transmission of behaviors through adult and youth influence in order to explore hypotheses and identify plausible lever points for future childhood obesity intervention research. Our objectives were: (1) to assess the sensitivity of childhood overweight and obesity prevalence to peer and adult social transmission rates, and (2) to test the effect of combinations of prevention and treatment interventions on the prevalence of childhood overweight and obesity. To address the first objective, we conducted two-way sensitivity analyses of adult-to-child and child-to-child social transmission in relation to childhood overweight and obesity prevalence. For the second objective, alternative combinations of prevention and treatment interventions were tested by varying model parameters of social transmission and weight loss behavior rates. Our results indicated child overweight and obesity prevalence might be slightly more sensitive to the same relative change in the adult-to-child compared to the child-to-child social transmission rate. In our simulations, alternatives with treatment alone, compared to prevention alone, reduced the prevalence of childhood overweight and obesity more after 10 years (1.2-1.8% and 0.2-1.0% greater reduction when targeted at children and adults respectively). Also, as the impact of adult interventions on children was increased, the rank of six alternatives that included adults became better (i.e., resulting in lower 10 year childhood overweight and obesity prevalence) than alternatives that only involved children. The findings imply that social transmission dynamics should be considered when designing both prevention and treatment intervention approaches. Finally, targeting adults may be more efficient, and research should strengthen and expand adult-focused interventions that have a high residual impact on children.	[Frerichs, Leah M.; Araz, Ozgur M.; Huang, Terry T. -K.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Frerichs, LM (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA.	leah.frerichs@unmc.edu	Araz, Ozgur/AAC-5266-2020	Huang, Terry/0000-0001-5544-5187				Abdel-Hamid TK, 2002, SYST DYNAM REV, V18, P431, DOI 10.1002/sdr.240; Ali MM, 2012, APPL ECON, V44, P2969, DOI 10.1080/00036846.2011.568408; Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021179; [Anonymous], 1998, OBES RES, V6, p51S; [Anonymous], P 29 INT C SYST DYN; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; BARLAS Y, 1989, EUR J OPER RES, V42, P59, DOI 10.1016/0377-2217(89)90059-3; Birch LL, 2009, INT J OBESITY, V33, pS74, DOI 10.1038/ijo.2009.22; Boutelle KN, 2011, OBESITY, V19, P574, DOI 10.1038/oby.2010.238; Brownell KD, 2010, HEALTH AFFAIR, V29, P379, DOI 10.1377/hlthaff.2009.0739; *CDCP NCHS, 2009, NAT HLTH NUTR EX SUR; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Davison KK, 2012, HEALTH PROMOT PRACT, V13, P454, DOI 10.1177/1524839910377966; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Division of Nutrition Physical Activity and Obesity National Center for Chronic Disease Prevention and Health Promotion, 2011, LOS WEIGHT; Evangelista A.M., 2004, US FAST FOOD NATION; Feunekes GIJ, 1998, PREV MED, V27, P645, DOI 10.1006/pmed.1998.0341; Flatt JP, 2004, OBES RES, V12, P2013, DOI 10.1038/oby.2004.252; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FORRESTER JW, 1994, SYST DYNAM REV, V10, P245, DOI 10.1002/sdr.4260100211; Fortin B, 2011, CIRANO SCI PUBLICATI; Franzini L, 2009, AM J PUBLIC HEALTH, V99, P271, DOI 10.2105/AJPH.2007.128702; Gable S, 2000, FAM RELAT, V49, P293, DOI 10.1111/j.1741-3729.2000.00293.x; Goetzel RZ, 2009, HEALTH AFFAIR, V28, P37, DOI 10.1377/hlthaff.28.1.37; Golan M, 1998, AM J CLIN NUTR, V67, P1130, DOI 10.1093/ajcn/67.6.1130; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Goldbeter A, 2006, J BIOSCIENCES, V31, P129, DOI 10.1007/BF02705242; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Gonzalez-Parra G, 2010, MATH POPUL STUD, V17, P1, DOI 10.1080/07481180903467218; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hammond RA, 2010, CURR OPIN ENDOCRINOL, V17, P467, DOI 10.1097/MED.0b013e32833d4687; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Homer J, 2006, P 24 INT SYST DYN C; Huang TT, 2009, PREV CHRONIC DIS, V6; IOM, 2012, ACC PROGR OB PREV SO; Jodar L, 2008, COMPUT MATH APPL, V56, P679, DOI 10.1016/j.camwa.2008.01.011; Kapka, 2011, 1105159EF1 AG HEALTH; Karanfil O, 2011, MULTISCALE PARADIGM; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Koehly LM, 2009, PREV CHRONIC DIS, V6; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; McDermott R, 2008, PUBLIC HLTH B SA, V6, P14; Ogden C., 2010, PREVALENCE OBESITY C, P201; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rappange DR, 2010, J PUBLIC HEALTH-UK, V32, P440, DOI 10.1093/pubmed/fdp079; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rein AS, 2012, J PUBLIC HEALTH MAN, V18, P299, DOI 10.1097/PHH.0b013e31825d25dd; Renna F, 2008, ECON HUM BIOL, V6, P377, DOI 10.1016/j.ehb.2008.06.005; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Santonja FJ, 2012, EVAL PROGRAM PLANN, V35, P34, DOI 10.1016/j.evalprogplan.2011.06.004; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Vasan RS, 2005, ANN INTERN MED, V143, P473, DOI 10.7326/0003-4819-143-7-200510040-00005; Wagner A, 2004, DIABETES METAB, V30, P359, DOI 10.1016/S1262-3636(07)70129-5; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Waters E, 2009, B WORLD HEALTH ORGAN, V87, P164, DOI 10.2471/BLT.09.064022; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955; Williamson DA, 2010, OBESITY, V19, P667; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; Wrotniak BH, 2004, ARCH PEDIAT ADOL MED, V158, P342, DOI 10.1001/archpedi.158.4.342	64	23	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82887	10.1371/journal.pone.0082887	http://dx.doi.org/10.1371/journal.pone.0082887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	24358234	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700037
J	Hausmann, A; Godfray, HCJ; Huemer, P; Mutanen, M; Rougerie, R; van Nieukerken, EJ; Ratnasingham, S; Hebert, PDN				Hausmann, Axel; Godfray, H. Charles J.; Huemer, Peter; Mutanen, Marko; Rougerie, Rodolphe; van Nieukerken, Erik J.; Ratnasingham, Sujeevan; Hebert, Paul D. N.			Genetic Patterns in European Geometrid Moths Revealed by the Barcode Index Number (BIN) System	PLOS ONE			English	Article							DNA TAXONOMY; SPECIES DELIMITATION; PHYLOGENY; SCALE	Background: The geometrid moths of Europe are one of the best investigated insect groups in traditional taxonomy making them an ideal model group to test the accuracy of the Barcode Index Number (BIN) system of BOLD (Barcode of Life Datasystems), a method that supports automated, rapid species delineation and identification. Methodology/Principal Findings: This study provides a DNA barcode library for 219 of the 249 European geometrid moth species (88%) in five selected subfamilies. The data set includes COI sequences for 2130 specimens. Most species (93%) were found to possess diagnostic barcode sequences at the European level while only three species pairs (3%) were genetically indistinguishable in areas of sympatry. As a consequence, 97% of the European species we examined were unequivocally discriminated by barcodes within their natural areas of distribution. We found a 1: 1 correspondence between BINs and traditionally recognized species for 67% of these species. Another 17% of the species (15 pairs, three triads) shared BINs, while specimens from the remaining species (18%) were divided among two or more BINs. Five of these species are mixtures, both sharing and splitting BINs. For 82% of the species with two or more BINs, the genetic splits involved allopatric populations, many of which have previously been hypothesized to represent distinct species or subspecies. Conclusions/Significance: This study confirms the effectiveness of DNA barcoding as a tool for species identification and illustrates the potential of the BIN system to characterize formal genetic units independently of an existing classification. This suggests the system can be used to efficiently assess the biodiversity of large, poorly known assemblages of organisms. For the moths examined in this study, cases of discordance between traditionally recognized species and BINs arose from several causes including overlooked species, synonymy, and cases where DNA barcodes revealed regional variation of uncertain taxonomic significance.	[Hausmann, Axel] Bavarian State Collect Zool, Dept Entomol, Munich, Germany; [Hausmann, Axel] Bavarian Nat Hist Collect, Munich, Germany; [Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Huemer, Peter] Tiroler Landesmuseen Betriebsgesell, Nat Wissensch Sammlungen, Innsbruck, Austria; [Mutanen, Marko] Univ Oulu, Zool Museum, Dept Biol, Oulu, Finland; [Rougerie, Rodolphe] Univ Rouen, Ecol Lab, Mont St Aignan, France; [Rougerie, Rodolphe] Unite Rech Zool Forestiere, Orleans, France; [van Nieukerken, Erik J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Ratnasingham, Sujeevan; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Oxford; University of Oulu; Universite de Rouen Normandie; Naturalis Biodiversity Center; University of Guelph	Hausmann, A (corresponding author), Bavarian State Collect Zool, Dept Entomol, Munich, Germany.	axel.hausmann@zsm.mwn.de	van Nieukerken, Erik/B-4512-2012; Hebert, Paul DN/C-4161-2013; CHARLES, Hubert/B-9392-2011; Ratnasingham, Sujeevan/G-9103-2014; Rougerie, Rodolphe/D-2930-2009	van Nieukerken, Erik/0000-0002-5721-1840; Hebert, Paul DN/0000-0002-3081-6700; CHARLES, Hubert/0000-0002-0809-4705; Rougerie, Rodolphe/0000-0003-0937-2815	components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany); "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01 LI 1101 B]; project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation; Kone Foundation	components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany); "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation; Kone Foundation	This study represents a contribution to WG1.9 of the International Barcode of Life Project. Sequence analysis was supported by Genome Canada through the Ontario Genomics Institute, while informatics support was provided through a grant from the Ontario Ministry of Research and Innovation. The collection and processing of specimens were funded as components of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany), the "German Barcode of Life" project by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung; 01 LI 1101 B), the project on Barcoding Lepidoptera of Finland by the Finnish Cultural Foundation, Kone Foundation and the project on Barcoding Lepidoptera of northern France by the Conseil Regional de Haute-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grill A, 2007, J EVOLUTION BIOL, V20, P1255, DOI 10.1111/j.1420-9101.2007.01358.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hausmann Axel, 2011, Mitteilungen Muenchener Entomologischen Gesellschaft, V101, P73; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hausmann Axel, 2004, V2, P7; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2012, BARCODE B, V3, P4; Huemer P, 2012, ZOOTAXA, P1; Hundsdoerfer AK, 2009, MOL PHYLOGENET EVOL, V52, P852, DOI 10.1016/j.ympev.2009.05.023; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karsholt O, 2012, FAUNA EUROPAEA LEPID; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Nyst R.H., 1993, Entomologica Gallica, V4, P159; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118.PUBMED:20919633; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S., 2013, BOLD BARCODE LIFE DA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Scoble M. J., 1999, GEOMETRID MOTHS WORL, V1; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; Usami T, 2006, BIOL J LINN SOC, V87, P145, DOI 10.1111/j.1095-8312.2006.00562.x; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Whittaker RJ, 1998, ECOLOGY EVOLUTION CO; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zerche Lothar, 1996, Beitraege zur Entomologie, V46, P277	44	118	123	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84518	10.1371/journal.pone.0084518	http://dx.doi.org/10.1371/journal.pone.0084518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358363	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700098
J	Martinez-Cabrera, HI; Peres-Neto, PR				Martinez-Cabrera, Hugo I.; Peres-Neto, Pedro R.			Shifts in Climate Foster Exceptional Opportunities for Species Radiation: The Case of South African Geraniums	PLOS ONE			English	Article							DIVERSITY PATTERNS; PHYLOGENETIC RELATEDNESS; DIVERSIFICATION RATES; NICHE CONSERVATISM; EVOLUTION; DIVERGENCE; RICHNESS; EXPLAIN; MODELS; CLADES	Climate change is often assumed to be a major driver of biodiversity loss. However, it can also set the stage for novel diversification in lineages with the evolutionary ability to colonize new environments. Here we tested if the extraordinary evolutionary success of the genus Pelargonium was related to the ability of its species to capitalize on the climate niche variation produced by the historical changes in southern Africa. We evaluated the relationship between rates of climate niche evolution and diversification rates in the main Pelargonium lineages and disentangled the roles of deep and recent historical events in the modification of species niches. Pelargonium clades exhibiting higher ecological differentiation along summer precipitation (SPP) gradients also experienced higher diversification rates. Faster rates of niche differentiation in spatially structured variables, along with lower levels of niche overlap among closely related species, suggest recent modification in species niches (e.g. dispersal or range shift) and niche lability. We suggest that highly structured SPP gradients established during the aridification process within southern Africa, in concert with niche lability and low niche overlap, contributed to species divergence. These factors are likely to be responsible for the extensive diversification of other lineages in this diversity hot spot.	[Martinez-Cabrera, Hugo I.; Peres-Neto, Pedro R.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Peres-Neto, Pedro R.] Univ Quebec, Canada Res Chair Spatial Modelling & Biodivers, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Martinez-Cabrera, HI (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	huismaca@yahoo.com.mx		Peres Neto, Pedro/0000-0002-5629-8067	CONACYT; FQRNT; NSERC; CRC; "Plan Vert'' of the Government of Quebec [554010-107]; NSF-IRE [OISE-0623341]; NSF Dimensions of Biodiversity [1046328]; Division Of Environmental Biology [1046328] Funding Source: National Science Foundation	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FQRNT(FQRNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); "Plan Vert'' of the Government of Quebec; NSF-IRE; NSF Dimensions of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CONACYT and FQRNT provided postdoctoral support to HIM-C. PRP-N was supported by NSERC and CRC grants. Funding was partially provided by the "Plan Vert'' of the Government of Quebec via a grant by the Ouranos consortium (project 554010-107). Species field locations were determined during research that was funded by NSF-IRE (OISE-0623341) and NSF Dimensions of Biodiversity (1046328) to C. Schlichting, C. Jones, K. Holsinger and J. Silander (University of Connecticut). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Bakker FT, 2005, REGNUM VEG, V143, P75; Bakker FT, 2004, TAXON, V53, P17, DOI 10.2307/4135485; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; COETZEE J A, 1983, Bothalia, V14, P345; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Cowling R. M., 1997, P99; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Jones C. S., 1996, Aliso, V14, P281; Jones CS, 2013, AM J BOT, V100, P1306, DOI 10.3732/ajb.1200526; Jones CS, 2009, EVOLUTION, V63, P479, DOI 10.1111/j.1558-5646.2008.00552.x; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; LINDER HP, 1991, J BIOGEOGR, V18, P509, DOI 10.2307/2845687; Losos JB, 2002, AM NAT, V160, P147, DOI 10.1086/341557; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Martinez-Cabrera HI, 2010, INFLUENCE CLIMATE FU; Martinez-Cabrera HI, 2012, AM J BOT, V99, P954, DOI 10.3732/ajb.1100600; Morris JW, 1978, PRECIS NATL HERBARIU; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peres-Neto PR, 2012, ECOLOGY, V93, pS14, DOI 10.1890/11-0494.1; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Roncal J, 2011, BIOTROPICA, V43, P324, DOI 10.1111/j.1744-7429.2010.00696.x; Rutherford MC, 2003, S AFR J BOT, V69, P99, DOI 10.1016/S0254-6299(15)30364-1; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHULZE RE, 2007, S AFRICAN ATLAS CLIM; SIESSER WG, 1980, SCIENCE, V208, P283, DOI 10.1126/science.208.4441.283; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	50	9	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83087	10.1371/journal.pone.0083087	http://dx.doi.org/10.1371/journal.pone.0083087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358250	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700046
J	McCarroll, MN; Nechiporuk, AV				McCarroll, Matthew N.; Nechiporuk, Alex V.			Fgf3 and Fgf10a Work in Concert to Promote Maturation of the Epibranchial Placodes in Zebrafish	PLOS ONE			English	Article							NEURAL CREST CELLS; INNER-EAR; OTIC PLACODE; INDUCTION; SPECIFICATION; FOXI1; FATE; GENE; DOWNSTREAM; ECTODERM	Essential cellular components of the paired sensory organs of the vertebrate head are derived from transient thickenings of embryonic ectoderm known as cranial placodes. The epibranchial (EB) placodes give rise to sensory neurons of the EB ganglia that are responsible for relaying visceral sensations form the periphery to the central nervous system. Development of EB placodes and subsequent formation of EB ganglia is a multistep process regulated by various extrinsic factors, including fibroblast growth factors (Fgfs). We discovered that two Fgf ligands, Fgf3 and Fgf10a, cooperate to promote EB placode development. Whereas EB placodes are induced in the absence of Fgf3 and Fgf10a, they fail to express placode specific markers Pax2a and Sox3. Expression analysis and mosaic rescue experiments demonstrate that Fgf3 signal is derived from the endoderm, whereas Fgf10a is emitted from the lateral line system and the otic placode. Further analyses revealed that Fgf3 and Fgf10a activities are not required for cell proliferation or survival, but are required for placodal cells to undergo neurogenesis. Based on these data, we conclude that a combined loss of these Fgf factors results in a failure of the EB placode precursors to initiate a transcriptional program needed for maturation and subsequent neurogenesis. These findings highlight the importance and complexity of reiterated Fgf signaling during cranial placode formation and subsequent sensory organ development.	[McCarroll, Matthew N.; Nechiporuk, Alex V.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Nechiporuk, AV (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA.	nechipor@ohsu.edu			NICHD [HD055303]; OHSU Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OHSU Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NICHD HD055303 to AVN; OHSU Brain Institute Predoctoral Fellowship to MNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; BANCROFT M, 1977, ANAT EMBRYOL, V151, P97, DOI 10.1007/BF00315302; Begbie J, 1999, DEVELOPMENT, V126, P895; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; Culbertson MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024443; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Grandel H, 2000, DEVELOPMENT, V127, P4169; Hammond KL, 2011, DEVELOPMENT, V138, P3977, DOI 10.1242/dev.066639; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hans S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-5; Hans S, 2013, DEVELOPMENT, V140, P1936, DOI 10.1242/dev.087718; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Lee SA, 2003, DEVELOPMENT, V130, P2669, DOI 10.1242/dev.00502; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Maroon H, 2002, DEVELOPMENT, V129, P2099; MCCARROLL MN, 2012, GRADED LEVELS PAX2A, DOI DOI 10.1242/DEV.076075; Nechiporuk A, 2005, DEVELOPMENT, V132, P3717, DOI 10.1242/dev.01876; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Nikaido M, 2007, DEV DYNAM, V236, P564, DOI 10.1002/dvdy.21050; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Picker A, 2002, DEVELOPMENT, V129, P3227; Sahly I, 1999, DEV GENES EVOL, V209, P399, DOI 10.1007/s004270050270; Sakaguchi T, 2001, MECH DEVELOP, V107, P25, DOI 10.1016/S0925-4773(01)00453-1; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Sun SK, 2007, DEV BIOL, V303, P675, DOI 10.1016/j.ydbio.2006.12.008; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Zelarayan LC, 2007, DEV BIOL, V308, P379, DOI 10.1016/j.ydbio.2007.05.033	49	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85087	10.1371/journal.pone.0085087	http://dx.doi.org/10.1371/journal.pone.0085087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358375	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700109
J	Zhu, ZX; Liu, YX; Zhang, CQ; Yuan, ZS; Zhang, Q; Tang, F; Lin, HY; Zhang, YY; Liu, LJ; Xue, FZ				Zhu, Zhenxin; Liu, Yanxun; Zhang, Chengqi; Yuan, Zhongshang; Zhang, Qian; Tang, Fang; Lin, Haiyan; Zhang, Yongyuan; Liu, Longjian; Xue, Fuzhong			Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study	PLOS ONE			English	Article							BLOOD-CELL COUNT; INSULIN-RESISTANCE SYNDROME; GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER-DISEASE; SERUM URIC-ACID; FOLLOW-UP; 10-YEAR RISK; STROKE; ASSOCIATION; MORTALITY	Background: Metabolic syndrome (MetS) is proposed as a predictor for cardiovascular disease (CVD). It involves the mechanisms of insulin resistance, obesity, inflammation process of atherosclerosis, and their complex relationship in the metabolic network. Therefore, more cardiovascular risk-related biomarkers within this network should be considered as components of MetS in order to improve the prediction of CVD. Methods: Factor analysis was performed in 5311 (4574 males and 737 females) Han Chinese subjects with MetS to extract CVD-related factors with specific clinical significance from 16 biomarkers tested in routine health check-up. Logistic regression model, based on an extreme case-control design with 445 coronary heart disease (CHD) patients and 890 controls, was performed to evaluate the extracted factors used to identify CHD. Then, Cox model, based on a cohort design with 1923 subjects followed up for 5 years, was conducted to validate their predictive effects. Finally, a synthetic predictor (SP) was created by weighting each factor with their risks for CHD to develop a risk matrix to predicting CHD. Results: Eight factors were obtained from both males and females with a similar pattern. The AUC to classify CHD under the extreme case-control suggested that SP might serve as a useful tool in identifying CHD with 0.994 (95% CI 0.984-0.998) for males and 0.998 (95% CI 0.982-1.000) for females respectively. In the cohort study, the AUC to predict CHD was 0.871 (95% CI 0.851-0.889) for males and 0.899 (95% CI 0.873-0.921) for females, highlighting that SP was a powerful predictor for CHD. The SP-based 5-year CHD risk matrix provided as convenient tool for CHD risk appraisal. Conclusions: Eight factors were extracted from sixteen biomarkers in subjects with MetS and the SP adds to new insights into studies of prediction of CHD risk using data from routine health check-up.	[Zhu, Zhenxin; Liu, Yanxun; Yuan, Zhongshang; Zhang, Qian; Zhang, Yongyuan; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China; [Zhang, Chengqi; Tang, Fang] Shandong Prov QianFoShan Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Lin, Haiyan] Shandong Univ, Prov Hosp, Ctr Hlth Management, Jinan 250100, Shandong, Peoples R China; [Liu, Longjian] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Drexel University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China.	xuefzh@sdu.edu.cn	Yuan, Zhongshang/GVT-8351-2022; Xue, Fuzhong/AAG-4808-2020; zhang, chi/GRX-3610-2022; Liu, Longjian/Q-4774-2018	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81273177]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grant 81273177 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Borges RL, 2010, CURR HYPERTENS REP, V12, P113, DOI 10.1007/s11906-010-0098-2; CDS (Chinese Diabetes Society), 2004, CHIN J DIABETES, P156, DOI DOI 10.1002/IJG0.12802; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; Cheung BMY, 2011, CLIN CHIM ACTA, V412, P1326, DOI 10.1016/j.cca.2011.03.030; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; Cui RZ, 2012, ATHEROSCLEROSIS, V221, P565, DOI 10.1016/j.atherosclerosis.2012.01.013; Deedwania PC, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000110642.73995.BF; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P1508, DOI 10.3748/wjg.v18.i13.1508; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Jimba S, 2009, METAB SYNDR RELAT D, V7, P411, DOI 10.1089/met.2008.0082; Kwon CH, 2011, METABOLISM, V60, P1136, DOI 10.1016/j.metabol.2010.12.007; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lao XQ, 2008, ATHEROSCLEROSIS, V201, P418, DOI 10.1016/j.atherosclerosis.2007.12.053; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Lehto S, 2000, DIABETOLOGIA, V43, P148, DOI 10.1007/s001250050023; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lin YC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-747; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Meng WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049875; Nebeck K, 2012, DIABETES METAB SYND, V6, P22, DOI 10.1016/j.dsx.2012.05.009; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Onat A, 2013, J INVEST MED, V61, P27, DOI 10.2310/JIM.0b013e318276de59; Onat A, 2012, OBESITY, V20, P842, DOI 10.1038/oby.2011.136; Povel CM, 2013, DIABETES CARE, V36, P362, DOI 10.2337/dc11-2546; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Nguyen QM, 2011, DIABETES CARE, V34, P2603, DOI 10.2337/dc11-0919; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Scott R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-102; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Steuenson JE, 2012, METABOLISM, V61, P1582, DOI 10.1016/j.metabol.2012.04.010; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Hong TK, 2012, PREV MED, V55, P409, DOI 10.1016/j.ypmed.2012.09.002; Treeprasertsuk S, 2012, LIVER INT, V32, P945, DOI 10.1111/j.1478-3231.2011.02753.x; Treeprasertsuk S, 2011, DIGEST DIS SCI, V56, P35, DOI 10.1007/s10620-010-1241-2; Tsai CH, 2011, ENDOCRINE, V40, P256, DOI 10.1007/s12020-011-9466-1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Xu Y, 2011, J DIABETES, V3, P38, DOI 10.1111/j.1753-0407.2010.00111.x; Zhang Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-419	55	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84204	10.1371/journal.pone.0084204	http://dx.doi.org/10.1371/journal.pone.0084204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358344	Green Submitted, gold, Green Published			2022-12-25	WOS:000328737700086
J	Kelkka, T; Pizzolla, A; Laurila, JP; Friman, T; Gustafsson, R; Kallberg, E; Olsson, O; Leanderson, T; Rubin, K; Salmi, M; Jalkanen, S; Holmdahl, R				Kelkka, Tiina; Pizzolla, Angela; Laurila, Juha Petteri; Friman, Tomas; Gustafsson, Renata; Kallberg, Eva; Olsson, Olof; Leanderson, Tomas; Rubin, Kristofer; Salmi, Marko; Jalkanen, Sirpa; Holmdahl, Rikard			Mice Lacking NCF1 Exhibit Reduced Growth of Implanted Melanoma and Carcinoma Tumors	PLOS ONE			English	Article							OXIDATIVE STRESS; CELLS; ARTHRITIS; GENE; MACROPHAGES; EXPRESSION; CANCER; INHIBITION; BURST; ROS	The NADPH oxidase 2 (NOX2) complex is a professional producer of reactive oxygen species (ROS) and is mainly expressed in phagocytes. While the activity of the NOX2 complex is essential for immunity against pathogens and protection against autoimmunity, its role in the development of malignant tumors remains unclear. We compared wild type and Ncf1(m1J) mutated mice, which lack functional NOX2 complex, in four different tumor models. Ncf1(m1J) mutated mice developed significantly smaller tumors in two melanoma models in which B16 melanoma cells expressing a hematopoietic growth factor FLT3L or luciferase reporter were used. Ncf1(m1J) mutated mice developed significantly fewer Lewis Lung Carcinoma (LLC) tumors, but the tumors that did develop, grew at a pace that was similar to the wild type mice. In the spontaneously arising prostate carcinoma model (TRAMP), tumor growth was not affected. The lack of ROS-mediated protection against tumor growth was associated with increased production of immunity-associated cytokines. A significant increase in Th2 associated cytokines was observed in the LLC model. Our present data show that ROS regulate rejection of the antigenic B16-luc and LLC tumors, whereas the data do not support a role for ROS in growth of intrinsically generated tumors.	[Kelkka, Tiina; Laurila, Juha Petteri; Salmi, Marko; Jalkanen, Sirpa; Holmdahl, Rikard] Medicity Res Lab, Turku, Finland; [Kelkka, Tiina] Turku Doctoral Programme Biomed Sci, Turku, Finland; [Pizzolla, Angela; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Friman, Tomas; Gustafsson, Renata; Olsson, Olof; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Leanderson, Tomas] Lund Univ, Immunol Grp, Biomed Ctr, Lund, Sweden	University of Turku; Karolinska Institutet; Uppsala University; Lund University	Holmdahl, R (corresponding author), Medicity Res Lab, Turku, Finland.	rikard.holmdahl@ki.se	Rubin, Kristofer/AAC-1810-2020; Holmdahl, Rikard/AAI-7682-2020; Kelkka, Tiina/ABI-2952-2022; Pizzolla, Angela/AAN-1566-2021	Rubin, Kristofer/0000-0003-2789-6276; Kelkka, Tiina/0000-0003-1085-6382; Pizzolla, Angela/0000-0003-2024-4144; Olsson, P. Olof/0000-0002-1048-0832	Swedish Strategic Science Foundation; Knut and Alice Wallenberg foundation; Swedish Research Council; Swedish Rheumatism Association; Swedish Cancer Society; The Alfred stelunds Stiftelse (Sweden); Juselius Foundation; Finnish Academy; Finnish Cancer Foundation; Svenska Kulturfonden in Finland; EU Masterswitch [HEALTH-F2-2008-223404]; Neurinox; BeTheCure	Swedish Strategic Science Foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Cancer Society(Swedish Cancer Society); The Alfred stelunds Stiftelse (Sweden); Juselius Foundation; Finnish Academy(Academy of Finland); Finnish Cancer Foundation; Svenska Kulturfonden in Finland; EU Masterswitch; Neurinox; BeTheCure	This study was supported by grants from the Swedish Strategic Science Foundation, Knut and Alice Wallenberg foundation, Swedish Research Council, Swedish Rheumatism Association, Swedish Cancer Society, The Alfred stelunds Stiftelse (Sweden), Juselius Foundation, Finnish Academy, the Finnish Cancer Foundation, Svenska Kulturfonden in Finland, EU Masterswitch (Grant No. HEALTH-F2-2008-223404), Neurinox and BeTheCure grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Antony S, 2013, FREE RADICAL BIO MED, V65, P497, DOI 10.1016/j.freeradbiomed.2013.07.005; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; Hellstrand K, 2000, MED ONCOL, V17, P258, DOI 10.1007/BF02782190; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Holmdahl R, 2013, ANTIOXID REDOX SIGN, V18, P1463, DOI 10.1089/ars.2012.4734; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Mach N, 2000, CANCER RES, V60, P3239; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Meitzler JL, 2013, ANTIOX REDOX SIGNAL; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Olsson LM, 2012, ANTIOXID REDOX SIGN, V16, P71, DOI 10.1089/ars.2011.4013; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	29	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84148	10.1371/journal.pone.0084148	http://dx.doi.org/10.1371/journal.pone.0084148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358335	Green Published, gold			2022-12-25	WOS:000328735700152
J	Tocco, C; Probo, M; Lonati, M; Lombardi, G; Negro, M; Nervo, B; Rolando, A; Palestrini, C				Tocco, Claudia; Probo, Massimiliano; Lonati, Michele; Lombardi, Giampiero; Negro, Matteo; Nervo, Beatrice; Rolando, Antonio; Palestrini, Claudia			Pastoral Practices to Reverse Shrub Encroachment of Sub-Alpine Grasslands: Dung Beetles (Coleoptera, Scarabaeoidea) Respond More Quickly Than Vegetation	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; CATTLE; BIODIVERSITY; RESTORATION; CONSEQUENCES; CONSERVATION; ASSEMBLAGES; ABANDONMENT; HEATHLAND; DYNAMICS	In recent decades, pastoral abandonment has produced profound ecological changes in the Alps. In particular, the reduction in grazing has led to extensive shrub encroachment of semi-natural grasslands, which may represent a threat to open habitat biodiversity. To reverse shrub encroachment, we assessed short-term effects of two different pastoral practices on vegetation and dung beetles (Coleoptera, Scarabaeoidea). Strategic placement of mineral mix supplements (MMS) and arrangement of temporary night camp areas (TNCA) for cattle were carried out during summer 2011 in the Val Troncea Natural Park, north-western Italian Alps. In 2012, one year after treatment, a reduction in shrub cover and an increase in bare ground cover around MMS sites was detected. A more intense effect was detected within TNCA through increases in forage pastoral value, and in the cover and height of the herbaceous layer. Immediately after treatment, changes in dung beetle diversity (total abundance, species richness, Shannon diversity, taxonomic and functional diversity) showed a limited disturbance effect caused by high cattle density. In contrast, dung beetle diversity significantly increased one year later both at MMS and TNCA sites, with a stronger effect within TNCA. Multivariate Regression Trees and associated Indicator Value analyses showed that some ecologically relevant dung beetle species preferred areas deprived of shrub vegetation. Our main conclusions are: i) TNCA are more effective than MMS in terms of changes to vegetation and dung beetles, ii) dung beetles respond more quickly than vegetation to pastoral practices, and iii) the main driver of the rapid response by dung beetles is the removal of shrubs. The resulting increase in dung beetle abundance and diversity, which are largely responsible for grassland ecosystem functioning, may have a positive effect on meso-eutrophic grassland restoration. Shrub encroachment in the Alps may therefore be reversed, and restoration of grassland enhanced, by using appropriate pastoral practices.	[Tocco, Claudia; Negro, Matteo; Nervo, Beatrice; Rolando, Antonio; Palestrini, Claudia] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy; [Probo, Massimiliano; Lonati, Michele; Lombardi, Giampiero] Univ Turin, Dept Agr Forest & Food Sci, Turin, Italy	University of Turin; University of Turin	Tocco, C (corresponding author), Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy.	claudia.tocco@unito.it	Lombardi, Giampiero/G-3714-2012	Lombardi, Giampiero/0000-0003-3787-2374; Probo, Massimiliano/0000-0002-0017-7557; ROLANDO, Antonio/0000-0002-3432-1780				Ascoli D, 2009, INT J WILDLAND FIRE, V18, P727, DOI 10.1071/WF07114; Bailey DW, 2007, RANGELAND ECOL MANAG, V60, P54, DOI 10.2111/05-138R1.1; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; Barbaro L, 2001, BIODIVERS CONSERV, V10, P119, DOI 10.1023/A:1016629507196; Barragan F, 2011, PLOS ONE, V6; Beynon SA, 2012, J APPL ECOL, V49, P1365, DOI 10.1111/j.1365-2664.2012.02210.x; Bokdam J, 2000, J APPL ECOL, V37, P415, DOI 10.1046/j.1365-2664.2000.00507.x; Borghesio L, 1999, PEDOBIOLOGIA, V43, P97; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Cavallero A., 2007, TIPI PASTORALI ALPI; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dellacasa G., 2006, FAUNA ITALIA; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dzwonko Z, 2007, J VEG SCI, V18, P203, DOI 10.1111/j.1654-1103.2007.tb02531.x; Elzein TM, 2011, ALPINE BOT, V121, P129, DOI 10.1007/s00035-011-0095-3; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Finn JA, 2003, ECOL ENTOMOL, V28, P1, DOI 10.1046/j.1365-2311.2002.00487.x; Gallet S, 2001, BIOL CONSERV, V97, P189, DOI 10.1016/S0006-3207(00)00111-7; Gusewell S, 2005, PLANT SOIL, V268, P135, DOI 10.1007/s11104-004-0304-6; Jay-Robert P, 2008, ANN ENTOMOL SOC AM, V101, P58, DOI 10.1603/0013-8746(2008)101[58:SATVOM]2.0.CO;2; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; LANDOLT E., 1977, OKOLOGISCHE ZEIGERWE; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lyet A, 2009, ANIM CONSERV, V12, P238, DOI 10.1111/j.1469-1795.2009.00245.x; Macagno ALM, 2009, BIODIVERS CONSERV, V18, P3309, DOI 10.1007/s10531-009-9643-1; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Mitlacher K, 2002, APPL VEG SCI, V5, P63, DOI 10.1111/j.1654-109X.2002.tb00536.x; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Negro M, 2011, ENVIRON ENTOMOL, V40, P1081, DOI 10.1603/EN11105; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Numa C, 2012, INSECT CONSERV DIVER, V5, P106, DOI 10.1111/j.1752-4598.2011.00137.x; Obrist MK, 2011, FOREST ECOL MANAG, V261, P789, DOI 10.1016/j.foreco.2010.12.010; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Probo M, 2013, RANGELAND J, V35, P85, DOI 10.1071/RJ12108; R Development Core Team, 2005, R LANG ENV STAT COMP; Rolando A, 2013, INSECT CONSERV DIVER, V6, P212, DOI 10.1111/j.1752-4598.2012.00204.x; Rosenlew H, 2008, OIKOS, V117, P1659, DOI 10.1111/j.1600-0706.2008.16904.x; Scrucca L., 2004, R NEWS, V4, P11; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tocco C, 2013, J INSECT CONSERV, V17, P207, DOI 10.1007/s10841-012-9498-8; Torok P, 2011, BIODIVERS CONSERV, V20, P2311, DOI 10.1007/s10531-011-9992-4; Zuur Alain F., 2009, P1	51	38	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83344	10.1371/journal.pone.0083344	http://dx.doi.org/10.1371/journal.pone.0083344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358277	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700120
J	Myatt, SS; Kongsema, M; Man, CWY; Kelly, DJ; Gomes, AR; Khongkow, P; Karunarathna, U; Zona, S; Langer, JK; Dunsby, CW; Coombes, RC; French, PM; Brosens, JJ; Lam, EWF				Myatt, S. S.; Kongsema, M.; Man, C. W-Y; Kelly, D. J.; Gomes, A. R.; Khongkow, P.; Karunarathna, U.; Zona, S.; Langer, J. K.; Dunsby, C. W.; Coombes, R. C.; French, P. M.; Brosens, J. J.; Lam, E. W-F			SUMOylation inhibits FOXM1 activity and delays mitotic transition	ONCOGENE			English	Article						FOXM1; SUMO; chemotherapy; drug resistance; breast cancer; cell cycle	BREAST-CANCER; TRANSCRIPTION FACTOR; POSTTRANSLATIONAL MODIFICATION; UBIQUITIN LIGASE; SUMO; CELLS; RNF4; EXPRESSION; RESISTANCE; PATHWAY	The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation is enhanced in MCF-7 breast cancer cells in response to treatment with epirubicin and mitotic inhibitors. Mutation of five consensus conjugation motifs yielded a SUMOylation-deficient mutant FOXM1. Conversely, fusion of the E2 ligase Ubc9 to FOXM1 generated an auto-SUMOylating mutant (FOXM1-Ubc9). Analysis of wild-type FOXM1 and mutants revealed that SUMOylation inhibits FOXM1 activity, promotes translocation to the cytoplasm and enhances APC/Cdh1-mediated ubiquitination and degradation. Further, expression of the SUMOylation-deficient mutant enhanced cell proliferation compared with wild-type FOXM1, whereas the FOXM1-Ubc9 fusion protein resulted in persistent cyclin B1 expression and slowed the time from mitotic entry to exit. In summary, our findings suggest that SUMOylation attenuates FOXM1 activity and causes mitotic delay in cytotoxic drug response.	[Myatt, S. S.; Kongsema, M.; Kelly, D. J.; Gomes, A. R.; Khongkow, P.; Karunarathna, U.; Zona, S.; Langer, J. K.; Coombes, R. C.; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, London W12 0NN, England; [Man, C. W-Y] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Kelly, D. J.; Dunsby, C. W.; French, P. M.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Photon Grp, London W12 0NN, England; [Brosens, J. J.] Univ Hosp, Warwick Med Sch, Div Reprod Hlth, Clin Sci Res Labs, Coventry, W Midlands, England	Imperial College London; Hong Kong Polytechnic University; Imperial College London; University of Warwick	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, Room 134,1st Floor,Du Cane Rd, London W12 0NN, England.	eric.lam@imperial.ac.uk	French, Paul/E-8649-2011; Kongsema, Mesayamas/H-3063-2017; Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Khongkow, Pasarat/0000-0003-3068-2412; Brosens, Jan/0000-0003-0116-9329; Coombes, Raoul Charles/0000-0002-4811-1100; French, Paul/0000-0002-0478-6755; Kongsema, Mesayamas/0000-0001-7146-9349	Breast Cancer Campaign; Cancer Research UK; Royal Thai Government; BBSRC; EPSRC; Biomedical Research Unit in Reproductive Health, University Hospital Coventry and Warwickshire, UK; Biotechnology and Biological Sciences Research Council [1243234] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Breast Cancer Campaign [2012MayPR070, 2012NovPhD016] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Royal Thai Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biomedical Research Unit in Reproductive Health, University Hospital Coventry and Warwickshire, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	This work was funded by grants from Breast Cancer Campaign and from Cancer Research UK. MK and PK are recipients of studentships from the Royal Thai Government, and UK is supported by BBSRC. ARG is a post-doctoral fellow supported by Cancer Research UK, and SZ is a post-doc funded by Breast Cancer Campaign. DJK is supported by a studentship from EPSRC. JJ.B was supported by the Biomedical Research Unit in Reproductive Health, University Hospital Coventry and Warwickshire, UK.	Alibhai D, 2013, J BIOPHOTONICS, V6, P398, DOI 10.1002/jbio.201200185; Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Burrage PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2564; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Chien AJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2008.02.010; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; de Olano N, 2012, MOL CANCER RES, V10, P1189, DOI 10.1158/1541-7786.MCR-11-0559; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Leisner C, 2008, CURR BIOL, V18, P1249, DOI 10.1016/j.cub.2008.07.091; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wadosky KM, 2012, AM J PHYSIOL-HEART C, V302, pH515, DOI 10.1152/ajpheart.00703.2011; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	54	71	72	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4316	4329		10.1038/onc.2013.546	http://dx.doi.org/10.1038/onc.2013.546			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24362530	Green Accepted, Green Published			2022-12-25	WOS:000341156900005
J	Matsumura, N; Takami, M; Okochi, M; Wada-Kakuda, S; Fujiwara, H; Tagami, S; Funamoto, S; Ihara, Y; Morishima-Kawashima, M				Matsumura, Nobutaka; Takami, Mako; Okochi, Masayasu; Wada-Kakuda, Satoko; Fujiwara, Hitomi; Tagami, Shinji; Funamoto, Satoru; Ihara, Yasuo; Morishima-Kawashima, Maho			gamma Secretase Associated with Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein; Lipid Raft; Membrane; Secretases; Amyloid -Protein; -Secretase	AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMER-DISEASE; CARBOXYL-TERMINAL FRAGMENT; INTRAMEMBRANE CLEAVAGE; BETA-PROTEIN; PRESENILIN ENDOPROTEOLYSIS; TRANSMEMBRANE DOMAIN; MECHANISM; A-BETA-42; BETA-PROTEIN-42	Background: Intramembranous cleavages of -carboxyl-terminal fragment (CTF) by -secretase generate amyloid -protein (A). Results: Three- to six-residue peptides are released successively along with A generation by lipid raft-associated -secretase. Conclusion: -Secretase cleaves CTF through multiple interactive pathways for stepwise successive processing to generate A. Significance: This cleavage model provides insights into the precise molecular mechanism of A generation. -Secretase generates amyloid -protein (A), a pathogenic molecule in Alzheimer disease, through the intramembrane cleavage of the -carboxyl-terminal fragment (CTF) of -amyloid precursor protein. We previously showed the framework of the -secretase cleavage, i.e. the stepwise successive processing of CTF at every three (or four) amino acids. However, the membrane integrity of -secretase was not taken into consideration because of the use of the 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid-solubilized reconstituted -secretase system. Here, we sought to address how the membrane-integrated -secretase cleaves CTF by using -secretase associated with lipid rafts. Quantitative analyses using liquid chromatography-tandem mass spectrometry of the CTF transmembrane domain-derived peptides released along with A generation revealed that the raft-associated -secretase cleaves CTF in a stepwise sequential manner, but novel penta- and hexapeptides as well as tri- and tetrapeptides are released. The cropping of these peptides links the two major tripeptide-cleaving pathways generating A40 and A42 at several points, implying that there are multiple interactive pathways for the stepwise cleavages of CTF. It should be noted that A38 and A43 are generated through three routes, and -secretase modulator 1 enhances all the three routes generating A38, which results in decreases in A42 and A43 and an increase in A38. These observations indicate that multiple interactive pathways for stepwise successive processing by -secretase define the species and quantity of A produced.	[Matsumura, Nobutaka; Morishima-Kawashima, Maho] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600812, Japan; [Takami, Mako; Wada-Kakuda, Satoko; Fujiwara, Hitomi; Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kizugawa 6190225, Japan; [Okochi, Masayasu; Tagami, Shinji] Osaka Univ, Grad Sch Med, Dept Integrated Med, Osaka 5650871, Japan; [Funamoto, Satoru; Ihara, Yasuo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Hokkaido University; Doshisha University; Osaka University; Japan Science & Technology Agency (JST)	Morishima-Kawashima, M (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maho@pharm.hokudai.ac.jp		Okochi, Masayasu/0000-0002-2318-7651	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science (to M. M.-K.) and by a Ministry of Education, Culture, Sports, Science and Technology-supported program for the Strategic Research Foundation at Private Universities, 2012-2017 (to Y. I.).	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B., 2012, COLD SPRING HARBOR P, V2; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200	36	67	70	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5109	5121		10.1074/jbc.M113.510131	http://dx.doi.org/10.1074/jbc.M113.510131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375443	Green Published, hybrid			2022-12-25	WOS:000331607900054
J	Niegowski, D; Kleinschmidt, T; Olsson, U; Ahmad, S; Rinaldo-Matthis, A; Haeggstrom, JZ				Niegowski, Damian; Kleinschmidt, Thea; Olsson, Ulrika; Ahmad, Shabbir; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.			Crystal Structures of Leukotriene C-4 Synthase in Complex with Product Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Asthma; Glutathion; Leukotriene; Lipid-binding Protein; Membrane Proteins; LTA4; LTC4; LTC4 Synthase	MEMBRANE-ASSOCIATED PROTEINS; MAPEG; TRANSFERASES; SUPERFAMILY; ASTHMA; MODEL	Background: Leukotriene (LT) C-4 synthase (LTC4S) is a membrane protein catalyzing the formation of pathogenic mediators of asthma. Results: Crystal structures of complexes of WT and mutated LTC4S with three product analogs. Conclusion: Evidence for the binding mode of LTA(4) and LTC4 at the active site of LTC4S and a mechanistic model. Significance: New insights into the molecular mechanism of LTC4S. Leukotriene (LT) C-4 synthase (LTC4S) catalyzes the conjugation of the fatty acid LTA(4) with the tripeptide GSH to produce LTC4, the parent compound of the cysteinyl leukotrienes, important mediators of asthma. Here we mutated Trp-116 in human LTC4S, a residue proposed to play a key role in substrate binding, into an Ala or Phe. Biochemical and structural characterization of these mutants along with crystal structures of the wild type and mutated enzymes in complex with three product analogs, viz. S-hexyl-, 4-phenyl-butyl-, and 2-hydroxy-4-phenyl-butyl-glutathione, provide new insights to binding of substrates and product, identify a new conformation of the GSH moiety at the active site, and suggest a route for product release, aided by Trp-116.	[Niegowski, Damian; Kleinschmidt, Thea; Olsson, Ulrika; Ahmad, Shabbir; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, S-10777 Stockholm, Sweden	Karolinska Institutet	Rinaldo-Matthis, A (corresponding author), Karolinska Insitutet, Dept Med Biochem & Biophys, Div Chem 2, S-10777 Stockholm, Sweden.	agnes.rinaldo-matthis@ki.se; jesper.haeggstrom@ki.se		Ahmad, Shabbir/0000-0003-2374-1197	Swedish Research Council [621-2011-5003, 10350, 20854]; Vinnova Foundation; Stockholm County Council; FP7 [201668]; Karolinska Institutet; CERIC Linneus grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova Foundation(Vinnova); Stockholm County Council(Stockholm County Council); FP7; Karolinska Institutet(Karolinska Institutet); CERIC Linneus grant	This work was supported by The Swedish Research Council Grants 621-2011-5003, 10350, 20854, and CERIC Linneus grant), the Vinnova Foundation (CIDaT project), Dr. Hans Kroner Graduiertenkolleg, the Stockholm County Council (Cardiovascular Program, Thematic Center of Inflammation), and FP7 (201668).; Recipient of a Distinguished Professor Award from Karolinska Institutet. To whom correspondence may be addressed: Div. of Chemistry II, Dept. of Medical Biochemistry and Biophysics, Karolinska Insitutet, S-107 77 Stockholm, Sweden. Tel.: 46-8-524-87612 or 46-8-524-87648; Fax: 46-8-736-0439; E-mail: jesper.haeggstrom@ki.se.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lundstrom K, 2004, COMB CHEM HIGH T SCR, V7, P431, DOI 10.2174/1386207043328634; Lynch KR, 1999, NATURE, V399, P789; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Muller G, 2000, CURR MED CHEM, V7, P861, DOI 10.2174/0929867003374534; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rinaldo-Matthis A, 2010, J BIOL CHEM, V285, P40771, DOI 10.1074/jbc.M110.105940; Saino H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.150177; Salinas AE, 1999, CURR MED CHEM, V6, P279; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145	29	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5199	5207		10.1074/jbc.M113.534628	http://dx.doi.org/10.1074/jbc.M113.534628			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24366866	hybrid, Green Published			2022-12-25	WOS:000331607900061
J	Eitas, TK; Chou, WC; Wen, HT; Gris, D; Robbins, GR; Brickey, J; Oyama, Y; Ting, JPY				Eitas, Timothy K.; Chou, Wei-Chun; Wen, Haitao; Gris, Denis; Robbins, Gregory R.; Brickey, June; Oyama, Yoshitaka; Ting, Jenny P. -Y.			The Nucleotide-binding Leucine-rich Repeat (NLR) Family Member NLRX1 Mediates Protection against Experimental Autoimmune Encephalomyelitis and Represses Macrophage/Microglia-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Immunology; Innate immunity; Interleukin; Neuroimmunology	ALZHEIMERS-DISEASE; CNS; DEATH; MICROGLIA; RESPONSES; TH1	Background: The nucleotide-binding leucine-rich repeat (NLR) family of innate immune genes are important regulators of inflammatory responses in mammals. Results: The NLR gene, Nlrx1, suppresses neuroinflammation in vivo and inhibits microglial (Mg) activation. Conclusion: NLRX1 immunosuppressive function in Mg correlates with suppression of neuroinflammation during mouse models of Multiple Sclerosis (MS). Significance: NLR genes can have protective roles during neuroinflammation. The nucleotide binding domain and leucine-rich repeat-containing (NLR) family of proteins is known to activate innate immunity, and the inflammasome-associated NLRs are prime examples. In contrast, the concept that NLRs can inhibit innate immunity is still debated, and the impact of such inhibitory NLRs in diseases shaped by adaptive immune responses is entirely unexplored. This study demonstrates that, in contrast to other NLRs that activate immunity, NLRX1 plays a protective role in experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis. When compared with wild-type controls, Nlrx1(-/-) mice have significantly worsened clinical scores and heightened CNS tissue damage during EAE. NLRX1 does not alter the production of encephalitogenic T cells in the peripheral lymphatic tissue, but Nlrx1(-/-) mice are more susceptible to adoptively transferred myelin-reactive T cells. Analysis of the macrophage and microglial populations indicates that NLRX1 reduces activation during both active and passive EAE models. This work represents the first case of an NLR that attenuates microglia inflammatory activities and protects against a neurodegenerative disease model caused by autoreactive T cells.	[Eitas, Timothy K.; Chou, Wei-Chun; Wen, Haitao; Robbins, Gregory R.; Brickey, June; Oyama, Yoshitaka; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Canc Res Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Canc Res Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Gris, Denis] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1H 5N4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Sherbrooke	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Dept Microbiol & Immunol, Curriculum Genet & Mol Biol, Campus Box 7295, Chapel Hill, NC 27599 USA.	jpyting@gmail.com	Gris, Denis/ABE-5229-2021; Gris, Denis/AGA-1192-2022; Wen, Haitao/AAJ-7621-2020; Chou, Wei-Chun/AAO-6532-2020	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Chou, Wei-Chun/0000-0003-3355-6921	National Multiple Sclerosis Society (NMSS) [CA-10530A-8, RG-1785G9/2]; Cancer Research Institute; NMSS; Canadian Institutes of Health and Research; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Cancer Research Institute; NMSS(National Multiple Sclerosis Society); Canadian Institutes of Health and Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Multiple Sclerosis Society (NMSS) Grants CA-10530A-8 and RG-1785G9/2 (to J. P. Y. T.).; Supported by the Irvington Fellowship Program of the Cancer Research Institute.; Supported by a postdoctoral fellowship from NMSS.; Supported by a fellowship from the Canadian Institutes of Health and Research.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Dienz O., 2006, CLIN IMMUNOL, V30, P27; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296	33	38	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4173	4179		10.1074/jbc.M113.533034	http://dx.doi.org/10.1074/jbc.M113.533034			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366868	Green Published, hybrid			2022-12-25	WOS:000331403800030
J	Dong, YS; Zhang, LJ; Bai, YP; Zhou, HM; Campbell, AM; Chen, HY; Yong, WD; Zhang, WJ; Zeng, Q; Shou, WN; Zhang, ZY				Dong, Yuanshu; Zhang, Lujuan; Bai, Yunpeng; Zhou, Hong-Ming; Campbell, Amanda M.; Chen, Hanying; Yong, Weidong; Zhang, Wenjun; Zeng, Qi; Shou, Weinian; Zhang, Zhong-Yin			Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Phosphatase; Pten; Signal Transduction; Spermatogenesis; Testis	RECEPTOR TYROSINE KINASE; HUMAN COLORECTAL-CANCER; GENE-EXPRESSION; C-KIT; GERM-CELLS; IN-VITRO; PROTEIN; METASTASIS; INVASION; MOUSE	Background: The PRLs are oncogenic when overexpressed but their physiological function is not well defined. Results: PRL2-deficient mice exhibit testis hypotrophy, decreased sperm production, and impaired reproductive potential. Conclusion: PRL2 promotes Kit signaling and germ cell survival by down-regulating PTEN. Significance: The study reveals the biological importance of PRL2 in spermatogenesis and identifies PRL2 as a novel target for cancer and male contraception. The Phosphatase of Regenerating Liver (PRL) proteins promote cell signaling and are oncogenic when overexpressed. However, our understanding of PRL function came primarily from studies with cultured cell lines aberrantly or ectopically expressing PRLs. To define the physiological roles of the PRLs, we generated PRL2 knock-out mice to study the effects of PRL deletion in a genetically controlled, organismal model. PRL2-deficient male mice exhibit testicular hypotrophy and impaired spermatogenesis, leading to decreased reproductive capacity. Mechanistically, PRL2 deficiency results in elevated PTEN level in the testis, which attenuates the Kit-PI3K-Akt pathway, resulting in increased germ cell apoptosis. Conversely, increased PRL2 expression in GC-1 cells reduces PTEN level and promotes Akt activation. Our analyses of PRL2-deficient animals suggest that PRL2 is required for spermatogenesis during testis development. The study also reveals that PRL2 promotes Kit-mediated PI3K/Akt signaling by reducing the level of PTEN that normally antagonizes the pathway. Given the strong cancer susceptibility to subtle variations in PTEN level, the ability of PRL2 to repress PTEN expression qualifies it as an oncogene and a novel target for developing anti-cancer agents.	[Dong, Yuanshu; Zhang, Lujuan; Bai, Yunpeng; Zhou, Hong-Ming; Campbell, Amanda M.; Shou, Weinian; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Hanying; Yong, Weidong; Zhang, Wenjun; Shou, Weinian] Indiana Univ Sch Med, Dept Pediat, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Zeng, Qi] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iu.edu	Bai, Yunpeng/M-8396-2014		National Institutes of Health [CA69202, HL85098, HD42024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants CA69202, HL85098, and HD42024.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Anai S, 2006, HUM GENE THER, V17, P975, DOI 10.1089/hum.2006.17.975; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Ciraolo E, 2010, MOL BIOL CELL, V21, P704, DOI 10.1091/mbc.E09-08-0744; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Guerif F, 2002, BIOL REPROD, V67, P70, DOI 10.1095/biolreprod67.1.70; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kim ST, 2012, REPROD SCI, V19, P31, DOI 10.1177/1933719111424449; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Li ZR, 2006, BIOCHEM BIOPH RES CO, V348, P229, DOI 10.1016/j.bbrc.2006.07.043; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu ZB, 2012, INT J NANOMED, V7, P5039, DOI 10.2147/IJN.S34022; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rasoulpour T, 2006, ENDOCRINOLOGY, V147, P4213, DOI 10.1210/en.2006-0174; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Saito Y, 2003, GENE THER, V10, P1961, DOI 10.1038/sj.gt.3302100; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Vincent S, 1998, DEVELOPMENT, V125, P4585; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhang Lei, 2011, Spermatogenesis, V1, P186; Zhao ZY, 1996, GENOMICS, V35, P172, DOI 10.1006/geno.1996.0336; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	64	23	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3799	3810		10.1074/jbc.M113.512079	http://dx.doi.org/10.1074/jbc.M113.512079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24371141	Green Published, hybrid			2022-12-25	WOS:000331368700059
J	Chiang, WC; Lai, CF; Su, CT; Peng, WH; Wu, CF; Chang, FC; Chen, YT; Lin, SL; Chen, YM; Wu, KD; Lu, KS; Tsai, TJ				Chiang, Wen Chih; Lai, Chun Fu; Su, Chi Ting; Peng, Wei Hao; Wu, Ching Fang; Chang, Fan Chi; Chen, Yi Ting; Lin, Shuei Liong; Chen, Yung Ming; Wu, Kwan Dun; Lu, Kuo Shyan; Tsai, Tun Jun			Angiopoietins Modulate Endothelial Adaptation, Glomerular and Podocyte Hypertrophy after Uninephrectomy	PLOS ONE			English	Article							BASEMENT-MEMBRANE COMPONENTS; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; IN-VIVO; CELL SURVIVAL; TIE2 RECEPTOR; VEGF; ANGIOGENESIS; MODEL; EXPRESSION	Glomerular capillary remodeling is an essential process in the development of glomerular hypertrophy. Angiopoietins, which are important regulators in angiogenesis, plays a role in the development of glomerulus during embryogenesis. Here, we evaluated the influence of angiopoietin on glomerular components and hypertrophy after uninephrectomy in adult male BALB/c mice. The actions of angiopoietin 1 or 2 were systemically antagonized by the subcutaneous administration of antagonists. We observed that the angiopoietin system was activated after uninephrectomy, and that the blockade of angiopoietin 1 or 2 decreased the activation of the angiopoietin receptor-tyrosine kinase with Ig and EGF homology domains-2-and attenuated the development of glomerular and podocyte hypertrophy. The increase in endothelial density staining (anti-CD31) following uninephrectomy was also reversed by angiopoietin 1 or 2 blockades. Glomerular basement thickness and foot process width were observed to decrease in the angiopoietin blockade groups. These changes were associated with the down regulation of the expression of genes for the glomerular matrix and basement membrane, including collagen type IV alpha 1, collagen type IV alpha 2, collagen type IV alpha 5, and laminin alpha 5. Thus, angiopoietin 1 or 2 may play an important role in the development of glomerular hypertrophy after uninephrectomy. A blockade of the angiopoietin system not only influenced the endothelium but also the podocyte, leading to diminished gene expression and morphological changes after uninephrectomy.	[Chiang, Wen Chih; Lai, Chun Fu; Wu, Ching Fang; Lin, Shuei Liong; Chen, Yung Ming; Wu, Kwan Dun; Tsai, Tun Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Su, Chi Ting] Natl Taiwan Univ Hosp Yunlin Branch, Dept Internal Med, Taipei, Yunlin Branch, Taiwan; [Peng, Wei Hao; Lu, Kuo Shyan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Chang, Fan Chi] Natl Taiwan Univ Hosp Zhudong Branch, Dept Internal Med, Zhudong, Hsinchu County, Taiwan; [Chen, Yi Ting] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Shuei Liong] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; National Taiwan University	Tsai, TJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	tjtsai@ntuh.gov.tw	Lin, Shuei-Liong/AGR-2002-2022; Chang, Fan-Chi/GOK-2657-2022	Lin, Shuei-Liong/0000-0002-1041-5571; CHEN, YUNG-MING/0000-0002-9241-1258; WU, KWAN-DUN/0000-0002-3339-1509; Su, Chi-Ting/0000-0002-2926-3950; peng, wei hao/0000-0002-7524-1218; LAI, CHUN-FU/0000-0003-2109-1522; TSAI, TUN-JUN/0000-0002-1666-8940; Chiang, Wen Chih/0000-0002-8844-0988	National Health Research Institute Taiwan [PS9505, NHRI-EX101-10125SC]; National Taiwan University Hospital [100N01]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation	National Health Research Institute Taiwan(National Health Research Institutes - Taiwan); National Taiwan University Hospital(National Taiwan University); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation	This study was supported by grant from the National Health Research Institute Taiwan (PS9505, NHRI-EX101-10125SC), grant from National Taiwan University Hospital (100N01), Ta-Tung Kidney Foundation, Mrs. Hsiu-Chin Lee Kidney Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; [Anonymous], 1979, STEREOLOGICAL METHOD; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Campean V, 2008, AM J PHYSIOL-RENAL, V294, pF1174, DOI 10.1152/ajprenal.00320.2007; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Flyvbjerg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE362, DOI 10.1152/ajpendo.00007.2002; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Henao DE, 2010, HYPERTENS PREGNANCY, V29, P10, DOI 10.3109/10641950802631036; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim KE, 2007, ARTERIOSCL THROM VAS, V27, P564, DOI 10.1161/01.ATV.0000256458.82320.be; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARCUSSEN N, 1994, LAB INVEST, V70, P868; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NYENGAARD JR, 1993, KIDNEY INT, V43, P1049, DOI 10.1038/ki.1993.147; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Schrijvers BF, 2006, NEPHROL DIAL TRANSPL, V21, P324, DOI 10.1093/ndt/gfi217; Schrijvers BF, 2005, NEPHRON EXP NEPHROL, V101, pE9, DOI 10.1159/000086034; Schrijvers BF, 2002, KIDNEY INT, V61, P1600, DOI 10.1046/j.1523-1755.2002.00310.x; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Yuan HT, 1999, J AM SOC NEPHROL, V10, P1722	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82592	10.1371/journal.pone.0082592	http://dx.doi.org/10.1371/journal.pone.0082592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367525	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300041
J	Molero-Luis, M; Fernandez-Urena, S; Jordan, I; Serrano, M; Ormazabal, A; Garcia-Cazorla, A; Artuch, R				Molero-Luis, Marta; Fernandez-Urena, Sergio; Jordan, Iolanda; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael		Neopterin Working Grp	Cerebrospinal Fluid Neopterin Analysis in Neuropediatric Patients: Establishment of a New Cut Off-Value for the Identification of Inflammatory-Immune Mediated Processes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NEUROLOGICAL DISORDERS; INTERFERON-GAMMA; PTERINS; CHILDREN; ACTIVATION; BIOPTERIN; INFECTIONS; SEROTONIN	Objective: A high level of cerebrospinal fluid (CSF) neopterin is a marker of central nervous system inflammatory-immune mediated processes. We aimed to assess data from 606 neuropediatric patients, describing the clinical and biochemical features of those neurological disorders presenting CSF neopterin values above a new cut-off value that was defined in our laboratory. Methods: To establish the new CSF neopterin cut-off value, we studied two groups of patients: Group 1 comprised 68 patients with meningoencephalitis, and Group 2 comprised 52 children with a confirmed peripheral infection and no central nervous system involvement. We studied 606 CSF samples from neuropediatric patients who were classified into 3 groups: genetic diagnosis (A), acquired/unknown etiologic neurologic diseases (B) and inflammatory-immune mediated processes (C). Results: The CSF neopterin cut-off value was 61 nmol/L. Out of 606 cases, 56 presented a CSF neopterin level above this value. Group C had significantly higher CSF neopterin, protein and leukocyte values than the other groups. Sixteen of twenty-three patients in this group had a CSF neopterin level above the cut-off, whereas three and seven patients presented increased leukocyte and protein values, respectively. A significant association was found among CSF neopterin, proteins and leukocytes in the 606 patients. White matter disturbances were associated with high CSF neopterin concentrations. Conclusions: Although children with inflammatory-immune mediated processes presented higher CSF neopterin values, patients with other neurological disorders also showed increased CSF neopterin concentrations. These results stress the importance of CSF neopterin analysis for the identification of inflammatory-immune mediated processes.	[Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Dept Clin Biochem, Univ Hosp St Joan de Deu, Barcelona, Spain; [Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Neuropediatrc Dept, Univ Hosp St Joan de Deu, Barcelona, Spain; [Molero-Luis, Marta; Serrano, Mercedes; Ormazabal, Aida; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain; [Fernandez-Urena, Sergio; Jordan, Iolanda] Univ Hosp St Joan de Deu, Intens Pediat Care Unit Serv, Barcelona, Spain; [Neopterin Working Grp] Univ Hosp St Joan de Deu, Dept Mol Microbiol, Microbiol Serv, Barcelona, Spain	Instituto de Salud Carlos III; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Molero-Luis, M (corresponding author), Inst Salud Carlos III, Dept Clin Biochem, Univ Hosp St Joan de Deu, Barcelona, Spain.	mmolerol@hsjdbcn.org	Muñoz-Almagro, Carmen/N-7248-2015; Munoz-Almagro, Carmen/B-4308-2015	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Munoz-Almagro, Carmen/0000-0001-5586-404X; Serrano, Mercedes/0000-0002-2056-2428; Artuch, Rafael/0000-0002-3422-9685; Molero, Marta/0000-0002-6839-1963	Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII); CIBER-ER; ISCIII; program Rio Hortega (ISCIII); Jose Luis Castano Foundation	Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII); CIBER-ER; ISCIII(Instituto de Salud Carlos III); program Rio Hortega (ISCIII); Jose Luis Castano Foundation	This research was supported by Centre for Biomedical Research on Rare Diseases (CIBER-ER, ISCIII). Dr. Mercedes Serrano and Mercedes Casado were supported by a CIBER-ER contract. Dr. Rafael Artuch is supported by the "programa de intensificacion de la actividad investigadora'' from ISCIII. Marta Molero was supported by program Rio Hortega (ISCIII) and Jose Luis Castano Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Azumagawa K, 2003, BRAIN DEV-JPN, V25, P200, DOI 10.1016/S0387-7604(02)00217-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; Blau N., 2003, PHYS GUIDE LAB DIAGN, P89; Dale RC, 2009, DEV MED CHILD NEUROL, V51, P317, DOI 10.1111/j.1469-8749.2008.03225.x; De Grandis E, 2010, J INHERIT METAB DIS, V33, P803, DOI 10.1007/s10545-010-9200-9; Duarte S, 2008, BRAIN DEV-JPN, V30, P106, DOI 10.1016/j.braindev.2007.06.009; FREDRIKSON S, 1987, CLIN EXP IMMUNOL, V67, P76; FURUKAWA Y, 1992, J NEUROL SCI, V111, P65, DOI 10.1016/0022-510X(92)90113-Y; Ghanem E, 2008, J ARTHROPLASTY, V23, P182, DOI 10.1016/j.arth.2007.08.016; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HYLAND K, 1993, PEDIATR RES, V34, P10, DOI 10.1203/00006450-199307000-00003; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kawakami Yasuhiko, 1996, No To Hattatsu, V28, P23; Millner MM, 1998, CLIN CHEM, V44, P161; Molero-Luis M, 2013, DEV MED CHILD NEUROL, V55, P559, DOI 10.1111/dmcn.12116; Ormazabal A, 2005, J NEUROSCI METH, V142, P153, DOI 10.1016/j.jneumeth.2004.08.007; Pranzatelli MR, 2004, J CHILD NEUROL, V19, P919, DOI 10.1177/08830738040190120201; Sawada Y, 1999, BRAIN DEV-JPN, V21, P264, DOI 10.1016/S0387-7604(99)00021-2; SCHOEDON G, 1986, J INTERFERON RES, V6, P697, DOI 10.1089/jir.1986.6.697; Serrano M, 2009, PEDIATR NEUROL, V41, P448, DOI 10.1016/j.pediatrneurol.2009.06.008; Speth C, 2000, IMMUNOBIOLOGY, V202, P460, DOI 10.1016/S0171-2985(00)80104-7; WACHTER H, 1989, ADV CLIN CHEM, V27, P81, DOI 10.1016/S0065-2423(08)60182-1	27	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83237	10.1371/journal.pone.0083237	http://dx.doi.org/10.1371/journal.pone.0083237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367586	Green Published, gold			2022-12-25	WOS:000328740300097
J	Noreen, AME; Webb, EL				Noreen, Annika M. E.; Webb, Edward L.			High Genetic Diversity in a Potentially Vulnerable Tropical Tree Species Despite Extreme Habitat Loss	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; KOOMPASSIA-MALACCENSIS; MICROSATELLITE MARKERS; FLOW; EXTINCTION; FRAGMENTATION; FOREST; SINGAPORE; SUSCEPTIBILITY; CONSERVATION	Over the last 150 years, Singapore's primary forest has been reduced to less than 0.2% of its previous area, resulting in extinctions of native flora and fauna. Remaining species may be threatened by genetic erosion and inbreeding. We surveyed >95% of the remaining primary forest in Singapore and used eight highly polymorphic microsatellite loci to assess genetic diversity indices of 179 adults (>30 cm stem diameter), 193 saplings (>1 yr), and 1,822 seedlings (<1 yr) of the canopy tree Koompassia malaccensis (Fabaceae). We tested hypotheses relevant to the genetic consequences of habitat loss: (1) that the K. malaccensis population in Singapore experienced a genetic bottleneck and a reduction in effective population size, and (2) K. malaccensis recruits would exhibit genetic erosion and inbreeding compared to adults. Contrary to expectations, we detected neither a population bottleneck nor a reduction in effective population size, and high genetic diversity in all age classes. Genetic diversity indices among age classes were not significantly different: we detected overall high expected heterozygosity (H-e = 0.843-0.854), high allelic richness (R = 16.7-19.5), low inbreeding co-efficients (F-IS = 0.013-0.076), and a large proportion (30.1%) of rare alleles (i.e. frequency <1%). However, spatial genetic structure (SGS) analyses showed significant differences between the adults and the recruits. We detected significantly greater SGS intensity, as well as higher relatedness in the 0-10 m distance class, for seedlings and saplings compared to the adults. Demographic factors for this population (i.e. <200 adult trees) are a cause for concern, as rare alleles could be lost due to stochastic factors. The high outcrossing rate (t(m) = 0.961), calculated from seedlings, may be instrumental in maintaining genetic diversity and suggests that pollination by highly mobile bee species in the genus Apis may provide resilience to acute habitat loss.	[Noreen, Annika M. E.; Webb, Edward L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Webb, EL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	ted.webb@nus.edu.sg	Webb, Edward L/E-8343-2011	Webb, Edward L/0000-0001-5554-9955; Noreen, Annika/0000-0002-7695-5095	Singapore Ministry of Education [R154-000-400-133]; Lee Hiok Kwee Endowment [R-154-000-480-720]	Singapore Ministry of Education(Ministry of Education, Singapore); Lee Hiok Kwee Endowment	The study was supported by the Singapore Ministry of Education (grant R154-000-400-133) and the Lee Hiok Kwee Endowment to the Department of Biological Sciences, NUS (grant R-154-000-480-720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2009, CHECKLIST TOTAL VASC; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Corlett RT, 2011, HONEYBEES OF ASIA, P215, DOI 10.1007/978-3-642-16422-4_10; Corlett Richard T., 1997, Gardens' Bulletin (Singapore), V49, P147; CORLETT RT, 1990, J TROP ECOL, V6, P55, DOI 10.1017/S0266467400004028; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Cornuet JM, 1996, GENETICS, V144, P2001; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dutta A, 2001, BIODIVERSITY ECOSYST, P173; Fenster CB, 2003, EVOLUTION, V57, P995, DOI 10.1111/j.0014-3820.2003.tb00311.x; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Fiumera AC, 2000, CONSERV BIOL, V14, P886, DOI 10.1046/j.1523-1739.2000.97337.x; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goudet J, 2001, FSTAT VERS 2 9 3 PRO; Hamrick JL, 2012, HEREDITY, V109, P330, DOI 10.1038/hdy.2012.47; Harata T, 2012, BIOTROPICA, V44, P586, DOI 10.1111/j.1744-7429.2011.00836.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; IUCN (International Union for Conservation of Nature), 2012, RED LIST THREAT SPEC; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kim Su Lee, 2007, Sains Malaysiana, V36, P233; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lasso E, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.40; Lee CT, 2006, MOL ECOL NOTES, V6, P1198, DOI 10.1111/j.1471-8286.2006.01490.x; Lee CT, 2011, J TROP FOR SCI, V23, P410; Lee C. T., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P127; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; McGreevy TJ, 2011, ZOO BIOL, V30, P636, DOI 10.1002/zoo.20362; Menges ES, 2000, TRENDS ECOL EVOL, V15, P51, DOI 10.1016/S0169-5347(99)01763-2; Michalski SG, 2007, MOL ECOL, V16, P4715, DOI 10.1111/j.1365-294X.2007.03547.x; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; Nuismer SL, 2012, J EVOLUTION BIOL, V25, P2665, DOI 10.1111/jeb.12002; OOSTERMEIJER JGB, 1994, OECOLOGIA, V97, P289, DOI 10.1007/BF00317317; Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x; Pastor T, 2004, J HERED, V95, P291, DOI 10.1093/jhered/esh055; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; R Core Team, 2012, R LANG ENV STAT COMP; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rosas F, 2011, BIOL CONSERV, V144, P3082, DOI 10.1016/j.biocon.2011.10.003; Sebbenn AM, 2011, HEREDITY, V106, P134, DOI 10.1038/hdy.2010.33; Shono K, 2007, J TROP FOR SCI, V19, P25; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; TURNER IM, 1994, CONSERV BIOL, V8, P705, DOI 10.1046/j.1523-1739.1994.08030705.x; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Treuren R., 1991, HEREDITY, V48, P996; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vieira FD, 2012, TREE GENET GENOMES, V8, P1191, DOI 10.1007/s11295-012-0506-7; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; Willi Y, 2009, J EVOLUTION BIOL, V22, P124, DOI 10.1111/j.1420-9101.2008.01631.x; Yee A. T. K., 2011, Gardens' Bulletin (Singapore), V63, P205	68	16	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82632	10.1371/journal.pone.0082632	http://dx.doi.org/10.1371/journal.pone.0082632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367531	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300047
J	Luu, AN; Anez-Bustillos, L; Aran, S; Arroyo, FJA; Entezari, V; Rosso, C; Snyder, BD; Nazarian, A				Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara			Microstructural, Densitometric and Metabolic Variations in Bones from Rats with Normal or Altered Skeletal States	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; VITAMIN-D DEFICIENCY; MINERAL DENSITY; OVARIECTOMIZED RATS; CANCELLOUS BONE; FEMORAL-NECK; IN-VIVO; VERTEBRAL FRACTURES; TEMPORAL CHANGES	Background: High resolution mu CT, and combined mu PET/CT have emerged as non-invasive techniques to enhance or even replace dual energy X-ray absorptiometry (DXA) as the current preferred approach for fragility fracture risk assessment. The aim of this study was to assess the ability of mu PET/CT imaging to differentiate changes in rat bone tissue density and microstructure induced by metabolic bone diseases more accurately than current available methods. Methods: Thirty three rats were divided into three groups of control, ovariectomy and vitamin-D deficiency. At the conclusion of the study, animals were subjected to glucose ((18)FDG) and sodium fluoride ((NaF)-F-18) PET/CT scanning. Then, specimens were subjected to mu CT imaging and tensile mechanical testing. Results: Compared to control, those allocated to ovariectomy and vitamin D deficiency groups showed 4% and 22% (significant) increase in (18)FDG uptake values, respectively. DXA-based bone mineral density was higher in the vitamin D deficiency group when compared to the other groups (cortical bone), yet mu CT-based apparent and mineral density results were not different between groups. DXA-based bone mineral density was lower in the ovariectomy group when compared to the other groups (cancellous bone); yet mu CT-based mineral density results were not different between groups, and the mu CT-based apparent density results were lower in the ovariectomy group compared to the other groups. Conclusion: PET and micro-CT provide an accurate three-dimensional measurement of the changes in bone tissue mineral density, as well as microstructure for cortical and cancellous bone and metabolic activity. As osteomalacia is characterized by impaired bone mineralization, the use of densitometric analyses may lead to misinterpretation of the condition as osteoporosis. In contrast, mu CT alone and in combination with the PET component certainly provides an accurate three-dimensional measurement of the changes in both bone tissue mineral density, as well as microstructure for cortical and cancellous bone and metabolic activity.	[Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Luu, Andrew N.; Anez-Bustillos, Lorenzo; Aran, Shima; Arroyo, Francisco J. Araiza; Entezari, Vahid; Rosso, Claudio; Snyder, Brian D.; Nazarian, Ara] Harvard Univ, Sch Med, Boston, MA USA; [Snyder, Brian D.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Luu, Andrew N.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Rosso, Claudio] Univ Basel Hosp, Dept Orthopaed Surg, CH-4031 Basel, Switzerland; [Rosso, Claudio] Univ Basel, Basel, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Tufts University; University of Basel; University of Basel	Nazarian, A (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	anazaria@bidmc.harvard.edu	entezari, vahid/B-5459-2013		NIH LRP [L30 AR056606]; Boston Children's Hospital Orthopedic Surgery Foundation	NIH LRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Orthopedic Surgery Foundation	The authors would like to acknowledge the NIH LRP program for providing financial support to AN (L30 AR056606) for the duration of this study. The authors would also like to acknowledge the Boston Children's Hospital Orthopedic Surgery Foundation for providing support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082; Akhter MP, 2007, BONE, V41, P111, DOI 10.1016/j.bone.2007.03.019; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Bhambri R, 2006, J CLIN DENSITOM, V9, P120, DOI 10.1016/j.jocd.2005.11.001; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; BLAU M, 1962, J NUCL MED, V3, P332; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Consensus development conference, 1993, AM J MED, V94, P646, DOI DOI 10.1016/0002-9343(93)90218-E.PUBMED:8506892; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; DEMPSTER DW, 1995, BONE, V16, P157, DOI 10.1016/S8756-3282(94)00024-7; Dougherty G, 1996, MED ENG PHYS, V18, P557, DOI 10.1016/1350-4533(96)00011-2; FRASER DR, 1995, LANCET, V345, P104, DOI 10.1016/S0140-6736(95)90067-5; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; Genant HK, 1996, J BONE MINER RES, V11, P707; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; GURKAN L, 1986, ACTA ORTHOP SCAND, V57, P67; Hashefi M, 2011, ANN NY ACAD SCI, V1228, P167, DOI 10.1111/j.1749-6632.2011.06082.x; Haugeberg G, 2008, BEST PRACT RES CL RH, V22, P1127, DOI 10.1016/j.berh.2008.09.016; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; HILDEBRAND T, 1997, METHODS, V1, P15; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; HORDON LD, 1990, BONE MINER, V11, P247, DOI 10.1016/0169-6009(90)90063-L; Kaastad TS, 2001, CALCIFIED TISSUE INT, V69, P102, DOI 10.1007/s00223-001-0009-2; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kato K, 2003, ANN NUCL MED, V17, P41, DOI 10.1007/BF02988257; Kim CH, 2007, J BIOMECH ENG-T ASME, V129, P481, DOI 10.1115/1.2746368; Krupski W, 2007, B VET I PULAWY, V51, P621; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li JL, 2005, BONE, V37, P819, DOI 10.1016/j.bone.2005.06.022; Li M, 1997, BONE, V20, P55, DOI 10.1016/S8756-3282(96)00317-1; Li Y, 2012, BONE, V50, P128, DOI 10.1016/j.bone.2011.09.053; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; Lim R, 2007, J PEDIATR ORTHOPED, V27, P277, DOI 10.1097/BPO.0b013e31803409ba; Lochmuller EM, 2002, BONE, V31, P77, DOI 10.1016/S8756-3282(02)00792-5; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Melhus G, 2007, ACTA ORTHOP, V78, P393, DOI 10.1080/17453670710013988; Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16; MOSEKILDE L, 1995, BONE, V17, pS343, DOI 10.1016/8756-3282(95)00312-2; Nazarian A, 2009, OSTEOPOROSIS INT, V20, P123, DOI 10.1007/s00198-008-0632-0; Nazarian A, 2011, J BIOMECH, V44, P2482, DOI 10.1016/j.jbiomech.2011.06.016; OOMS ME, 1995, J BONE MINER RES, V10, P1177; Perez-Casanova JC, 2008, FISH SHELLFISH IMMUN, V24, P600, DOI 10.1016/j.fsi.2008.01.012; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Schmitz A, 2002, OSTEOPOROSIS INT, V13, P755, DOI 10.1007/s001980200103; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sekhon K, 2009, BONE, V45, P473, DOI 10.1016/j.bone.2009.05.023; SHEN V, 1993, J CLIN INVEST, V91, P2479, DOI 10.1172/JCI116483; Silva MJ, 2006, BONE, V39, P229, DOI 10.1016/j.bone.2006.01.149; SOKOLOFF L, 1978, AM J SURG PATHOL, V2, P21, DOI 10.1097/00000478-197803000-00003; Tatara MR, 2006, MED WETER, V62, P266; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; Uchida K, 2009, J NUCL MED, V50, P1808, DOI 10.2967/jnumed.109.062570; Wang P, 2008, NAN FANG YI KE DA XU, V28, P76; Weatherall M, 2000, NEW ZEAL MED J, V113, P137; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007	59	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82709	10.1371/journal.pone.0082709	http://dx.doi.org/10.1371/journal.pone.0082709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358219	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700027
J	Sheng, L; Liu, Y; Jiang, L; Chen, Z; Zhou, YJ; Cho, KW; Rui, LY				Sheng, Liang; Liu, Yan; Jiang, Lin; Chen, Zheng; Zhou, Yingjiang; Cho, Kae Won; Rui, Liangyou			Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADAPTER PROTEIN; INSULIN-RECEPTOR; NEURONAL SH2B1; BODY-WEIGHT; SH2-B; KINASE; IDENTIFICATION; SENSITIVITY; ACTIVATION	SH2B1 is an SH2 and PH domain-containing adaptor protein. Genetic deletion of SH2B1 results in obesity, type 2 diabetes, and fatty liver diseases in mice. Mutations in SH2B1 are linked to obesity in humans. SH2B1 in the brain controls energy balance and body weight at least in part by enhancing leptin sensitivity in the hypothalamus. SH2B1 in peripheral tissues also regulates glucose and lipid metabolism, presumably by enhancing insulin sensitivity in peripheral metabolically-active tissues. However, the function of SH2B1 in individual peripheral tissues is unknown. Here we generated and metabolically characterized hepatocyte-specific SH2B1 knockout (HKO) mice. Blood glucose and plasma insulin levels, glucose tolerance, and insulin tolerance were similar between HKO, albumin-Cre, and SH2B1(f/f) mice fed either a normal chow diet or a high fat diet (HFD). Adult-onset deletion of SH2B1 in the liver either alone or in combination with whole body SH2B2 knockout also did not exacerbate HFD-induced insulin resistance and glucose intolerance. Adult-onset, but not embryonic, deletion of SH2B1 in the liver attenuated HFD-induced hepatic steatosis. In agreement, adult-onset deletion of hepatic SH2B1 decreased the expression of diacylglycerol acyltransferase-2 (DGAT2) and increased the expression of adipose triglyceride lipase (ATGL). Furthermore, deletion of liver SH2B1 in SH2B2 null mice attenuated very low-density lipoprotein (VLDL) secretion. These data indicate that hepatic SH2B1 is not required for the maintenance of normal insulin sensitivity and glucose metabolism; however, it regulates liver triacylglycerol synthesis, lipolysis, and VLDL secretion.	[Sheng, Liang; Liu, Yan; Jiang, Lin; Chen, Zheng; Zhou, Yingjiang; Cho, Kae Won; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	chen, zheng/J-4600-2014; Liu, Yan/J-7597-2019	chen, zheng/0000-0003-2161-6106; Liu, Yan/0000-0002-3961-9172	National Institutes of Health (NIH) [DK 065122, DK091591, DK094014]; Michigan Diabetes Research and Training Center; NIH [5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK094014, P30DK034933, P60DK020572, R01DK091591, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) grants DK 065122, DK091591, and DK094014. This work utilized cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2003, BIOCHEM J, V371, P405, DOI 10.1042/BJ20021589; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Chen Z, 2013, DIABETES; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Herrington J, 2000, J BIOL CHEM, V275, P13126, DOI 10.1074/jbc.275.17.13126; Javadi M, 2012, J BIOL CHEM, V287, P26223, DOI 10.1074/jbc.M112.382721; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Liu MX, 2012, BBA-MOL CELL BIOL L, V1821, P770, DOI 10.1016/j.bbalip.2011.09.020; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Mendez-Sanchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x; Minami A, 2003, DIABETES, V52, P2657, DOI 10.2337/diabetes.52.11.2657; Morris DL, 2010, ENDOCRINOLOGY, V151, P3643, DOI 10.1210/en.2010-0254; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rider L, 2011, MOL ENDOCRINOL, V25, P1231, DOI 10.1210/me.2011-0056; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sheng L, 2013, AM J PHYSIOL-ENDOC M, V305, pE1115, DOI 10.1152/ajpendo.00401.2013; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Zhang MC, 2008, J CELL BIOCHEM, V103, P162, DOI 10.1002/jcb.21397	42	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83269	10.1371/journal.pone.0083269	http://dx.doi.org/10.1371/journal.pone.0083269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358267	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700054
J	Tangen, SE; Tsinajinnie, D; Nunez, M; Shaibi, GQ; Mandarino, LJ; Coletta, DK				Tangen, Samantha E.; Tsinajinnie, Darwin; Nunez, Martha; Shaibi, Gabriel Q.; Mandarino, Lawrence J.; Coletta, Dawn K.			Whole Blood Gene Expression Profiles in Insulin Resistant Latinos with the Metabolic Syndrome	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; GLYCOGEN-SYNTHASE; MESSENGER-RNA; HEXOKINASE-II; US POPULATION; BETA-CELL; PROTEIN; PREVALENCE; DISEASE	Although insulin resistance in skeletal muscle is well-characterized, the role of circulating whole blood in the metabolic syndrome phenotype is not well understood. We set out to test the hypothesis that genes involved in inflammation, insulin signaling and mitochondrial function would be altered in expression in the whole blood of individuals with metabolic syndrome. We further wanted to examine whether similar relationships that we have found previously in skeletal muscle exist in peripheral whole blood cells. All subjects (n=184) were Latino descent from the Arizona Insulin Resistance registry. Subjects were classified based on the metabolic syndrome phenotype according to the National Cholesterol Education Program's Adult Treatment Panel III. Of the 184 Latino subjects in the study, 74 were classified with the metabolic syndrome and 110 were without. Whole blood gene expression profiling was performed using the Agilent 4x44K Whole Human Genome Microarray. Whole blood microarray analysis identified 1,432 probes that were altered in expression >= 1.2 fold and P<0.05 after Benjamini-Hochberg in the metabolic syndrome subjects. KEGG pathway analysis revealed significant enrichment for pathways including ribosome, oxidative phosphorylation and MAPK signaling (all Benjamini-Hochberg P<0.05). Whole blood mRNA expression changes observed in the microarray data were confirmed by quantitative RT-PCR. Transcription factor binding motif enrichment analysis revealed E2F1, ELK1, NF-kappaB, STAT1 and STAT3 significantly enriched after Bonferroni correction (all P<0.05). The results of the present study demonstrate that whole blood is a useful tissue for studying the metabolic syndrome and its underlying insulin resistance although the relationship between blood and skeletal muscle differs.	[Tangen, Samantha E.; Tsinajinnie, Darwin; Nunez, Martha; Mandarino, Lawrence J.; Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Shaibi, Gabriel Q.] Arizona State Univ, Coll Nursing & Hlth Innovat, Tempe, AZ USA; [Shaibi, Gabriel Q.; Mandarino, Lawrence J.; Coletta, Dawn K.] Mayo Clin Arizona, Scottsdale, AZ USA; [Coletta, Dawn K.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; University of Arizona	Coletta, DK (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	dawn.coletta@asu.edu	Coletta, Dawn/G-6382-2016; Day, Samantha/K-4569-2019	Shaibi, Gabriel/0000-0002-6890-2903; Coletta, Dawn/0000-0001-5819-5152; Day, Samantha/0000-0002-9818-0972	NIDDK NIH HHS [R01 DK094013] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accardi G, 2012, REJUV RES, V15, P217, DOI 10.1089/rej.2011.1289; Adlerova L, 2008, VET MED-CZECH, V53, P457, DOI 10.17221/1978-VETMED; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bonadonna RC, 1996, DIABETES, V45, P915, DOI 10.2337/diabetes.45.7.915; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Christian P, 2013, BBA-MOL CELL BIOL L, V1831, P819, DOI 10.1016/j.bbalip.2012.12.009; Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Feitosa MF, 2013, ATHEROSCLEROSIS, V227, P420, DOI 10.1016/j.atherosclerosis.2013.01.013; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Kashyap Sangeeta R, 2007, Diab Vasc Dis Res, V4, P13, DOI 10.3132/dvdr.2007.001; KELLEY DE, 1990, J CLIN INVEST, V86, P1999, DOI 10.1172/JCI114935; Kim JY, 2012, DIABETES CARE, V35, P1925, DOI 10.2337/dc11-2476; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magkos F, 2010, NUTRITION, V26, P686, DOI 10.1016/j.nut.2009.10.013; MANDARINO LJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE701; Manoel-Caetano FS, 2012, GENE, V511, P151, DOI 10.1016/j.gene.2012.09.090; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; Perl Andras, 2012, Methods Mol Biol, V900, P61, DOI 10.1007/978-1-60761-720-4_4; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; VESTERGAARD H, 1993, J CLIN INVEST, V91, P2342, DOI 10.1172/JCI116466; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84002	10.1371/journal.pone.0084002	http://dx.doi.org/10.1371/journal.pone.0084002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358323	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700076
J	Tng, DYP; Jordan, GJ; Bowman, DMJS				Tng, David Y. P.; Jordan, Greg J.; Bowman, David M. J. S.			Plant Traits Demonstrate That Temperate and Tropical Giant Eucalypt Forests Are Ecologically Convergent with Rainforest Not Savanna	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; CARBON-ISOTOPE DISCRIMINATION; DOMINATED WOODLAND SAVANNA; NORTH-EASTERN AUSTRALIA; FUNCTIONAL TRAITS; LEAF SIZE; ECONOMICS SPECTRUM; REGIME SHIFTS; IRON RANGE; DRY FOREST	Ecological theory differentiates rainforest and open vegetation in many regions as functionally divergent alternative stable states with transitional (ecotonal) vegetation between the two forming transient unstable states. This transitional vegetation is of considerable significance, not only as a test case for theories of vegetation dynamics, but also because this type of vegetation is of major economic importance, and is home to a suite of species of conservation significance, including the world's tallest flowering plants. We therefore created predictions of patterns in plant functional traits that would test the alternative stable states model of these systems. We measured functional traits of 128 trees and shrubs across tropical and temperate rainforest - open vegetation transitions in Australia, with giant eucalypt forests situated between these vegetation types. We analysed a set of functional traits: leaf carbon isotopes, leaf area, leaf mass per area, leaf slenderness, wood density, maximum height and bark thickness, using univariate and multivariate methods. For most traits, giant eucalypt forest was similar to rainforest, while rainforest, particularly tropical rainforest, was significantly different from the open vegetation. In multivariate analyses, tropical and temperate rainforest diverged functionally, and both segregated from open vegetation. Furthermore, the giant eucalypt forests overlapped in function with their respective rainforests. The two types of giant eucalypt forests also exhibited greater overall functional similarity to each other than to any of the open vegetation types. We conclude that tropical and temperate giant eucalypt forests are ecologically and functionally convergent. The lack of clear functional differentiation from rainforest suggests that giant eucalypt forests are unstable states within the basin of attraction of rainforest. Our results have important implications for giant eucalypt forest management.	[Tng, David Y. P.; Jordan, Greg J.; Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Tasmania	Tng, DYP (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	david.tng@utas.edu.au	Jordan, Gregory/B-3932-2013; Tng, David/J-3156-2015; Bowman, David/A-2930-2011	Jordan, Gregory/0000-0002-6033-2766; Tng, David/0000-0001-5135-0922; Bowman, David/0000-0001-8075-124X	Wet Tropics Management Authority [B002055]; ARC [DP0878177]	Wet Tropics Management Authority; ARC(Australian Research Council)	Part of this research was also carried out under a student grant B002055 from the Wet Tropics Management Authority (http://www.wettropics.gov.au/) awarded to DYPT and an ARC (http://www.arc.gov.au/ncgp/) Discovery Grant (DP0878177) given to DMJSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1992, AUSTR RAINFORESTS; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Beckage B, 2008, COMPLEX SYST, V18, P159; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Boland DJ, 2006, FOREST TREES AUSTR; Bonal D, 2007, ANN FOREST SCI, V64, P169, DOI 10.1051/forest:2006101; Bowman, 2000, AUSTR GEOGRAPHICAL S, V38, P327, DOI DOI 10.1111/1467-8470.00120; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Bowman DMJS, 2013, FRONT ECOL ENVIRON, V11, P66, DOI 10.1890/13.WB.005; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Campbell N. A., 1984, AUSTR J STAT, V26, P86, DOI DOI 10.1111/J.1467-842X.1984.TB01271.X; Carpenter R. J., 1994, AUSTR VEGETATION HIS, P276; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cremer K. W., 1960, Australian Forestry, V24, P120; Crowley BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044538; Curtis W., 1975, STUDENTS FLORA TASMA, V1; CURTIS WM, 1967, STUDENTS FLORA TAS 3; CURTIS WM, 1963, STUDENTS FLORA TAS 2; Dantas VD, 2013, ECOLOGY, V94, P2454, DOI 10.1890/12-1629.1; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Diaz-Sierra R, 2010, THEOR POPUL BIOL, V77, P131, DOI 10.1016/j.tpb.2009.12.001; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FRANCIS WD, 1951, AUSTR RAIN FOREST TR; Fukami T, 2006, OIKOS, V113, P353, DOI 10.1111/j.2006.0030-1299.14563.x; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Goosem S., 1999, CONSERVATION STATUS; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Harrington Graham N., 2000, Proceedings of the Royal Society of Queensland, V109, P59; Harris S., 2005, FOREST FJAELDMARK DE; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HUC R, 1994, OECOLOGIA, V99, P297, DOI 10.1007/BF00627742; Hutyra LR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024981; Ibanez T, 2013, AUST J BOT, V61, P128, DOI 10.1071/BT12255; Jarman SJ, 1991, 3 NRCP FOR COMM; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kirkpatrick JB, 1988, WET EUCALYPT FORESTS, P156; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; LEWONTIN RC, 1969, BROOKHAVEN SYM BIOL, P13; Lusk CH, 2013, ANN BOT-LONDON, V111, P479, DOI 10.1093/aob/mcs289; Mayer AL, 2011, SCIENCE, V334, P188, DOI 10.1126/science.1213908; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Musselwhite G, 2005, FOREST POLICY ECON, V7, P579, DOI 10.1016/j.forpol.2003.11.001; Nicholas AMM, 2011, J ARID ENVIRON, V75, P1090, DOI 10.1016/j.jaridenv.2011.06.016; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Orchard KA, 2010, FUNCT PLANT BIOL, V37, P1050, DOI 10.1071/FP09306; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Pinard MA, 1997, J TROP ECOL, V13, P727, DOI 10.1017/S0266467400010890; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Russell-Smith J, 2004, J BIOGEOGR, V31, P1305, DOI 10.1111/j.1365-2699.2004.01070.x; Russell-Smith J, 2004, J BIOGEOGR, V31, P1293, DOI 10.1111/j.1365-2699.2004.01069.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; SMITH JMB, 1983, AUST J ECOL, V8, P55, DOI 10.1111/j.1442-9993.1983.tb01518.x; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Sniderman JMK, 2011, J BIOGEOGR, V38, P1445, DOI 10.1111/j.1365-2699.2011.02519.x; Specht R.L., 1981, VEGETATION CLASSIFIC, P10; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Tng DYP, 2012, ECOL EVOL, V2, P34, DOI 10.1002/ece3.70; Tracey JG, 1982, VEGETATION HUMID TRO; UNWIN GL, 1989, AUST J BOT, V37, P413, DOI 10.1071/BT9890413; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Warman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060789; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wood SW, 2012, LANDSCAPE ECOL, V27, P13, DOI 10.1007/s10980-011-9677-0; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Xiang S, 2013, FUNCT ECOL, V27, P522, DOI 10.1111/1365-2435.12047	91	24	27	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84378	10.1371/journal.pone.0084378	http://dx.doi.org/10.1371/journal.pone.0084378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358359	gold, Green Published			2022-12-25	WOS:000328737700095
J	Alessi-Severini, S; Le Dorze, JA; Nguyen, D; Honcharik, P; Eleff, M				Alessi-Severini, Silvia; Le Dorze, Josee-Anne; Nguyen, David; Honcharik, Patricia; Eleff, Michael			Clozapine Prescribing in a Canadian Outpatient Population	PLOS ONE			English	Article							SCHIZOPHRENIA; DISCONTINUATION; ANTIPSYCHOTICS	Objective: Description of demographics of an outpatient population of clozapine users. Methods: Retrospective chart review study of an urban population diagnosed with schizophrenia. Assessment of therapeutic histories in relation to clinical practice guidelines. Results: Seventy-seven of the 467 patients were on clozapine therapy. Average patients' age was 39.4 +/- 11.8 years) and 68% were males. The majority of patients (68%) had tried 3 or more antipsychotics before switching to clozapine, 21% had tried two and 11% had tried one. Median length of therapy prior to clozapine initiation was 8.9 years in males and 7.7 years in females. Conclusion: Until 2010, the use of clozapine was often delayed and more than 2 antipsychotic medications were tried for relatively long periods of time before patients were switched to this effective agent.	[Alessi-Severini, Silvia; Le Dorze, Josee-Anne; Nguyen, David; Honcharik, Patricia] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada; [Honcharik, Patricia] Hlth Sci Ctr, Dept Pharmaceut Serv, Winnipeg, MB, Canada; [Eleff, Michael] Univ Manitoba, Fac Med, Dept Psychiat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Alessi-Severini, S (corresponding author), Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada.	Silvia.Alessi-Severini@ad.umanitoba.ca		Alessi-Severini, Silvia/0000-0002-6543-7719	Faculty of Pharmacy, University of Manitoba	Faculty of Pharmacy, University of Manitoba	JAL and DN were supported by institutional summer studentship awards from the Faculty of Pharmacy, University of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asenjo Lobos C, 2010, COCHRANE DB SYST REV, V12, P1; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Canadian Psychiatric Association, 2005, CAN J PSYCHIAT S1, V50, p7S; Ciudad A, 2008, EUR PSYCHIAT, V23, P1, DOI 10.1016/j.eurpsy.2007.09.008; Essali A, 2009, COCHRANE DB SYST REV, V1, P1; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P94, DOI 10.1093/schbul/sbp130; Mcilwain ME, 2011, NEUROPSYCH DIS TREAT, V7, P135, DOI 10.2147/NDT.S12769; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Mortimer Ann M, 2010, Clin Schizophr Relat Psychoses, V4, P49, DOI 10.3371/CSRP.4.1.4; National Institute of Health and Clinical Excellence, 2009, COR INT TREATM MAN S; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; Taylor DM, 2003, J CLIN PSYCHIAT, V64, P30, DOI 10.4088/JCP.v64n0107; Taylor M, 2008, J CLIN PSYCHIAT, V69, P240, DOI 10.4088/JCP.v69n0210; Werneck AP, 2011, PSYCHIAT RES, V188, P315, DOI 10.1016/j.psychres.2011.04.004; Wheeler AJ, 2008, ANN PHARMACOTHER, V42, P852, DOI 10.1345/aph.1K662	15	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83539	10.1371/journal.pone.0083539	http://dx.doi.org/10.1371/journal.pone.0083539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358290	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700129
J	Roth-Johnson, EA; Vizcarra, CL; Bois, JS; Quinlan, ME				Roth-Johnson, Elizabeth A.; Vizcarra, Christina L.; Bois, Justin S.; Quinlan, Margot E.			Interaction between Microtubules and the Drosophila Formin Cappuccino and Its Effect on Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Polarity; Cytoskeleton; Formin; Microtubules; Oocyte; Capu; TIRF	HOMOLOGY-2 DOMAIN; MOUSE OOCYTES; SPIRE; NUCLEATORS; MDIA1; COORDINATION; ASSOCIATION; ALIGNMENT; FILAMENTS; PROFILIN	Background: Cappuccino is a formin actin nucleator that regulates cytoskeletal organization during Drosophila oogenesis. Results: Cappuccino binds microtubules through two domains and cannot nucleate actin filaments when bound to microtubules. Conclusion: Actin filament assembly and microtubule binding are mutually exclusive activities of Cappuccino. Significance: We provide mechanistic insight into the role of formins as coordinators of the actin and microtubule cytoskeletons. Formin family actin nucleators are potential coordinators of the actin and microtubule cytoskeletons, as they can both nucleate actin filaments and bind microtubules in vitro. To gain a more detailed mechanistic understanding of formin-microtubule interactions and formin-mediated actin-microtubule cross-talk, we studied microtubule binding by Cappuccino (Capu), a formin involved in regulating actin and microtubule organization during Drosophila oogenesis. We found that two distinct domains within Capu, FH2 and tail, work together to promote high-affinity microtubule binding. The tail domain appears to bind microtubules through nonspecific charge-based interactions. In contrast, distinct residues within the FH2 domain are important for microtubule binding. We also report the first visualization of a formin polymerizing actin filaments in the presence of microtubules. Interestingly, microtubules are potent inhibitors of the actin nucleation activity of Capu but appear to have little effect on Capu once it is bound to the barbed end of an elongating filament. Because Capu does not simultaneously bind microtubules and assemble actin filaments in vitro, its actin assembly and microtubule binding activities likely require spatial and/or temporal regulation within the Drosophila oocyte.	[Roth-Johnson, Elizabeth A.] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Vizcarra, Christina L.; Bois, Justin S.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr East, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu		Bois, Justin/0000-0001-7137-8746	National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM007185]; National Institutes of Health-National Research Service Award Fellowship [F32GM087857]; National Institutes of Health, NIGMS [R01 GM096133]; Burroughs Welcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [5-FY10-81]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, F32GM087857, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Welcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM007185 (to E. A. R.-J.), National Institutes of Health-National Research Service Award Fellowship F32GM087857 (to C. L. V.), National Institutes of Health, NIGMS Grant R01 GM096133, a Burroughs Welcome Fund Career Award in the Biomedical Sciences, and March of Dimes Foundation Grant 5-FY10-81 (to M. E. Q.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dehmelt L, 2005, GENOME BIOL, V6; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; SINGLETON K, 1994, DEV BIOL, V161, P154, DOI 10.1006/dbio.1994.1017; Tanaka T, 2011, DEVELOPMENT, V138, P2523, DOI 10.1242/dev.062208; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wen YD, 2004, KENYON REV, V26, P1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185	43	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4395	4404		10.1074/jbc.M113.499921	http://dx.doi.org/10.1074/jbc.M113.499921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362037	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000331403800050
J	Antonysamy, S; Condon, B; Druzina, Z; Bonanno, JB; Gheyi, T; Zhang, F; MacEwan, I; Zhang, A; Ashok, S; Rodgers, L; Russell, M; Luz, JG				Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Bonanno, Jeffrey B.; Gheyi, Tarun; Zhang, Feiyu; MacEwan, Iain; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately			Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; CAUSE WEAVER SYNDROME; STEM-LIKE CELLS; SOMATIC MUTATIONS; MYELODYSPLASTIC SYNDROMES; CANCER CELLS; GENE EZH2; LYMPHOMA; COMPLEX	The enhancer-of-zeste homolog 2 (EZH2) gene product is an 87 kDa polycomb group (PcG) protein containing a Cterminal methyltransferase SET domain. EZH2, along with binding partners, i. e., EED and SUZ12, upon which it is dependent for activity forms the core of the polycomb repressive complex 2 (PRC2). PRC2 regulates gene silencing by catalyzing the methylation of histone H3 at lysine 27. Both overexpression and mutation of EZH2 are associated with the incidence and aggressiveness of various cancers. The novel crystal structure of the SET domain was determined in order to understand disease-associated EZH2 mutations and derive an explanation for its inactivity independent of complex formation. The 2.00 angstrom crystal structure reveals that, in its uncomplexed form, the EZH2 Cterminus folds back into the active site blocking engagement with substrate. Furthermore, the S-adenosyl-Lmethionine (SAM) binding pocket observed in the crystal structure of homologous SET domains is notably absent. This suggests that a conformational change in the EZH2 SET domain, dependent upon complex formation, must take place for cofactor and substrate binding activities to be recapitulated. In addition, the data provide a structural context for clinically significant mutations found in the EZH2 SET domain.	[Antonysamy, Stephen; Condon, Bradley; Druzina, Zhanna; Gheyi, Tarun; Zhang, Feiyu; Zhang, Aiping; Ashok, Sheela; Rodgers, Logan; Russell, Marijane; Luz, John Gately] Lilly Biotechnol Ctr San Diego, San Diego, CA USA; [Bonanno, Jeffrey B.] Albert Einstein Coll Med Univ, Dept Biochem, Bronx, NY USA; [MacEwan, Iain] Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA	Loma Linda University	Luz, JG (corresponding author), Lilly Biotechnol Ctr San Diego, San Diego, CA USA.	luz_john@lilly.com			Eli Lily and Company; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Eli Lily and Company; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The funders of this study were Eli Lily and Company and the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Eli Lilly and Company is a pharmaceutical company focused on discovering medicines to treat human disease. The LRL-CAT synchrotron beamline at the Advanced Photon Source in Chicago is in part funded by the aforementioned grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Brecqueville M, 2013, HAEMATOLOGICA; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst T, 2012, LEUKEMIA, V26, P1701, DOI 10.1038/leu.2012.16; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Grossmann V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/leu.2011.10; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolaev SI, 2013, BLOOD, V122, P554, DOI 10.1182/blood-2013-03-491936; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Wang JY, 2013, LEUKEMIA RES, V37, P305, DOI 10.1016/j.leukres.2012.10.004; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061341; WEDEEN C, 1986, CELL, V44, P739, DOI 10.1016/0092-8674(86)90840-8; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	57	63	66	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84147	10.1371/journal.pone.0084147	http://dx.doi.org/10.1371/journal.pone.0084147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367637	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900034
J	Dickie, DA; Job, DE; Gonzalez, DR; Shenkin, SD; Ahearn, TS; Murray, AD; Wardlaw, JM				Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Ahearn, Trevor S.; Murray, Alison D.; Wardlaw, Joanna M.			Variance in Brain Volume with Advancing Age: Implications for Defining the Limits of Normality	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; WHITE-MATTER; OLDER-ADULTS; MR-IMAGES; REGISTRATION; ATROPHY	Background: Statistical models of normal ageing brain tissue volumes may support earlier diagnosis of increasingly common, yet still fatal, neurodegenerative diseases. For example, the statistically defined distribution of normal ageing brain tissue volumes may be used as a reference to assess patient volumes. To date, such models were often derived from mean values which were assumed to represent the distributions and boundaries, i. e. percentile ranks, of brain tissue volume. Since it was previously unknown, the objective of the present study was to determine if this assumption was robust, i. e. whether regression models derived from mean values accurately represented the distributions and boundaries of brain tissue volume at older ages. Materials and Methods: We acquired T1-w magnetic resonance (MR) brain images of 227 normal and 219 Alzheimer's disease (AD) subjects (aged 55-89 years) from publicly available databanks. Using nonlinear regression within both samples, we compared mean and percentile rank estimates of whole brain tissue volume by age. Results: In both the normal and AD sample, mean regression estimates of brain tissue volume often did not accurately represent percentile rank estimates (errors=-74% to 75%). In the normal sample, mean estimates generally underestimated differences in brain volume at percentile ranks below the mean. Conversely, in the AD sample, mean estimates generally underestimated differences in brain volume at percentile ranks above the mean. Differences between ages at the 5th percentile rank of normal subjects were similar to 39% greater than mean differences in the AD subjects. Conclusions: While more data are required to make true population inferences, our results indicate that mean regression estimates may not accurately represent the distributions of ageing brain tissue volumes. This suggests that percentile rank estimates will be required to robustly define the limits of brain tissue volume in normal ageing and neurodegenerative disease.	[Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Wardlaw, Joanna M.] Univ Edinburgh, Western Gen Hosp, BRIC, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.] Univ Edinburgh, Royal Infirm Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Ahearn, Trevor S.; Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Ahearn, Trevor S.; Murray, Alison D.; Wardlaw, Joanna M.] Platform Sci Excellence SINAPSE Collaborat, Scottish Imaging Network, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Job, DE (corresponding author), Univ Edinburgh, Western Gen Hosp, BRIC, Edinburgh, Midlothian, Scotland.	Dominic.Job@ed.ac.uk	Rodriguez Gonzalez, David/AAA-1966-2019; Hernandez, María/GYU-3543-2022; Shenkin, Susan/GWZ-3174-2022; Wardlaw, Joanna M/Y-3456-2019; Murray, Alison/H-6250-2017	Rodriguez Gonzalez, David/0000-0002-9160-5106; Wardlaw, Joanna M/0000-0002-9812-6642; Murray, Alison/0000-0003-4915-4847; Dickie, David Alexander/0000-0002-9443-8403; Shenkin, Susan/0000-0001-7375-4776; Job, Dominic/0000-0002-7829-7217	Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health (NIH) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Open Access Series of Imaging Studies (OASIS) [P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382]; MRC [G1001245, G0701120] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0701120, G1001245] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, K01AG030514, P30AG010129, P50AG005681, U01AG024904, R01AG021910] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Series of Imaging Studies (OASIS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI - PI Michael W. Weiner, MD); data were acquired through the National Institutes of Health (NIH) Grant U01 AG024904, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Abbott, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Amorfix Life Sciences Ltd., AstraZeneca, Bayer HealthCare, BioClinica, Inc., Biogen Idec Inc., Bristol- Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals Inc., Eli Lilly and Company, F. Hoffmann- La Roche Ltd., and its affiliated company Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., Novartis Pharmaceuticals Corporation, Pfizer Inc., Servier, Synarc Inc., Takeda Pharmaceutical Company, Canadian Institutes of Health Research, Foundation for the National Institutes of Health (www.fnih.org), Northern California Institute for Research and Education, Alzheimer's Disease Cooperative Study at the University of California, San Diego, Laboratory for Neuro Imaging at the University of California, Los Angeles, and NIH grants P30 AG010129 and K01 AG030514. The Open Access Series of Imaging Studies (OASIS) data were acquired through grants: P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Aribisala BS, 2012, EUR RADIOL, DOI [10.1007/s00330-00012-02677-x, DOI 10.1007/S00330-00012-02677-X]; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dickie DA, 2012, EUR RADIOL, V22, P1385, DOI 10.1007/s00330-012-2392-7; Ellis KA, 2010, ALZHEIMERS DEMENT, V6, P291, DOI 10.1016/j.jalz.2010.03.009; ELVEBACK LR, 1970, J AMER MED ASSOC, V211, P69, DOI 10.1001/jama.211.1.69; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kruggel F, 2006, NEUROIMAGE, V30, P1, DOI 10.1016/j.neuroimage.2005.09.063; Malone IB, 2013, NEUROIMAGE, V70, P33, DOI 10.1016/j.neuroimage.2012.12.044; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 2013, ANN NEUROL IN PRESS, P1012; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	36	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84093	10.1371/journal.pone.0084093	http://dx.doi.org/10.1371/journal.pone.0084093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367629	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000328741900030
J	Frade, AF; Teixeira, PC; Ianni, BM; Pissetti, CW; Saba, B; Wang, LHT; Kuramoto, A; Nogueira, LG; Buck, P; Dias, F; Giniaux, H; Llored, A; Alves, S; Schmidt, A; Donadi, E; Marin-Neto, JA; Hirata, M; Sampaio, M; Fragata, A; Bocchi, EA; Stolf, AN; Fiorelli, AI; Santos, RHB; Rodrigues, V; Pereira, AC; Kalil, J; Cunha-Neto, E; Chevillard, C				Frade, Amanda Farage; Teixeira, Priscila Camilo; Ianni, Barbara Maria; Pissetti, Cristina Wide; Saba, Bruno; Tzu Wang, Lin Hui; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Buck, Paula; Dias, Fabricio; Giniaux, Helene; Llored, Agnes; Alves, Sthefanny; Schmidt, Andre; Donadi, Eduardo; Marin-Neto, Jose Antonio; Hirata, Mario; Sampaio, Marcelo; Fragata, Abilio; Bocchi, Edimar Alcides; Stolf, Antonio Noedir; Fiorelli, Alfredo Inacio; Barros Santos, Ronaldo Honorato; Rodrigues, Virmondes; Pereira, Alexandre Costa; Kalil, Jorge; Cunha-Neto, Edecio; Chevillard, Christophe			Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy	PLOS ONE			English	Article							CHRONIC CHAGAS-DISEASE; NECROSIS-FACTOR-ALPHA; MYOSIN HEAVY-CHAIN; HEART-FAILURE; DILATED CARDIOMYOPATHY; EXPRESSION; MYOCARDITIS; CHEMOKINES; INFECTION; CYTOKINES	Aims: Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in Latin America, and may lead to a life-threatening inflammatory dilated, chronic Chagas cardiomyopathy (CCC). One third of T. cruzi-infected individuals progress to CCC while the others remain asymptomatic (ASY). A possible genetic component to disease progression was suggested by familial aggregation of cases and the association of markers of innate and adaptive immunity genes with CCC development. Since mutations in multiple sarcomeric genes, including alpha-cardiac actin (ACTC1) have been involved in hereditary dilated cardiomyopathy, we investigated the involvement of the ACTC1 gene in CCC pathogenesis. Methods and Results: We conducted a proteomic and genetic study on a Brazilian study population. The genetic study was done on a main cohort including 118 seropositive asymptomatic subjects and 315 cases and the replication was done on 36 asymptomatic and 102 CCC cases. ACTC1 protein and mRNA levels were lower in myocardial tissue from patients with end-stage CCC than those found in hearts from organ donors. Genotyping a case-control cohort of CCC and ASY subjects for all informative single nucleotide polymorphism (SNP) in the ACTC1 gene identified rs640249 SNP, located at the 5' region, as associated to CCC. Associations are borderline after correction for multiple testing. Correlation and haplotype analysis led to the identification of a susceptibility haplotype. Functional assays have shown that the rs640249A/C polymorphism affects the binding of transcriptional factors in the promoter regions of the ACTC1 gene. Confirmation of the detected association on a larger independent replication cohort will be useful. Conclusions: Genetic variations at the ACTC1 gene may contribute to progression to chronic Chagas Cardiomyopathy among T. cruzi-infected patients, possibly by modulating transcription factor binding to ACTC1 promoter regions.	[Frade, Amanda Farage; Teixeira, Priscila Camilo; Ianni, Barbara Maria; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Buck, Paula; Alves, Sthefanny; Fiorelli, Alfredo Inacio; Barros Santos, Ronaldo Honorato; Pereira, Alexandre Costa; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Frade, Amanda Farage; Teixeira, Priscila Camilo; Kuramoto, Andreia; Nogueira, Luciana Gabriel; Kalil, Jorge; Cunha-Neto, Edecio] Inst Nacl Ciencias & Tecnol, Inst Invest Immunol 3, Sao Paulo, Brazil; [Pissetti, Cristina Wide] Univ Fed Triangulo Mineiro, Immunol Lab, Uberaba, MG, Brazil; [Saba, Bruno; Tzu Wang, Lin Hui; Hirata, Mario; Sampaio, Marcelo; Fragata, Abilio] Inst Cardiol Dante Pazzanese, Sao Paulo, Brazil; [Dias, Fabricio; Schmidt, Andre; Donadi, Eduardo; Marin-Neto, Jose Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Frade, Amanda Farage; Giniaux, Helene; Llored, Agnes; Chevillard, Christophe] Aix Marseille Univ, Marseille, France; [Bocchi, Edimar Alcides; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; UDICE-French Research Universities; Aix-Marseille Universite; Universidade de Sao Paulo	Chevillard, C (corresponding author), Aix Marseille Univ, Marseille, France.	christophe.chevillard@univ-amu.fr	Buck, Paula C/F-8781-2012; Hirata, Mario Hiroyuki/C-9718-2013; Barbosa, Luciana Gabriel Nogueira/AAH-3061-2021; Cunha-Neto, Edecio/B-4157-2009; donadi, eduardo A/H-7080-2013; Frade Barros, Amanda Farage/O-3322-2017; KALIL, JORGE/C-8029-2012; Ianni, Barbara Maria/C-7689-2012; Pereira, Alexandre/HHN-1038-2022; Chevillard, Christophe/A-7087-2015; Schmidt, André/G-1569-2011; Marin-Neto, Jose Antonio/F-6099-2012	Buck, Paula C/0000-0002-1411-4485; Hirata, Mario Hiroyuki/0000-0002-9521-7979; Barbosa, Luciana Gabriel Nogueira/0000-0003-1396-2949; Cunha-Neto, Edecio/0000-0002-3699-3345; donadi, eduardo A/0000-0002-9457-9601; Frade Barros, Amanda Farage/0000-0002-9004-8811; KALIL, JORGE/0000-0001-8415-4274; Ianni, Barbara Maria/0000-0002-1588-5492; Chevillard, Christophe/0000-0002-5269-8813; Schmidt, André/0000-0002-1090-8165; Camillo Teixeira, Priscila/0000-0002-9698-4563; Lin-Wang, Hui Tzu/0000-0002-7027-7748; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Rodrigues Jr, Virmondes/0000-0001-8706-4223	Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales); USP-COFECUB program; ARCUS II PACA Brasil program; CNPq (the Brazilian National Research Council); FAPESP (Sao Paulo State Research Funding Agency-Brazil); French ANR agency; Brazilian FAPESP agency	Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales); USP-COFECUB program; ARCUS II PACA Brasil program; CNPq (the Brazilian National Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Sao Paulo State Research Funding Agency-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); French ANR agency(French National Research Agency (ANR)); Brazilian FAPESP agency(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), Aix-Marseille University (Direction des Relations Internationales), the USP-COFECUB program, the ARCUS II PACA Brasil program, CNPq (the Brazilian National Research Council), and FAPESP (Sao Paulo State Research Funding Agency-Brazil). ECN and CC received support from an international program funded by the French ANR agency and the Brazilian FAPESP agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; BARRETTO ACP, 1986, AM HEART J, V111, P307, DOI 10.1016/0002-8703(86)90144-4; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1; Bilate AMB, 2003, MICROBES INFECT, V5, P1116, DOI 10.1016/j.micinf.2003.07.001; Bilate AM, 2008, J INFECT DIS, V198, P614, DOI 10.1086/590347; Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018; Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Gregorio CC, 1997, CELL STRUCT FUNCT, V22, P191, DOI 10.1247/csf.22.191; HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; Januzzi JL, 2013, J AM COLL CARDIOL, V61, P1507, DOI 10.1016/j.jacc.2013.01.039; Jiang HK, 2010, CIRC J, V74, P2410, DOI 10.1253/circj.CJ-10-0234; Jorge MT, 2003, ANN TROP MED PARASIT, V97, P139, DOI 10.1179/000349803235001561; Kirchhoff LV, 2004, FRONT BIOSCI-LANDMRK, V9, P706, DOI 10.2741/1255; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kubota T, 2000, CIRCULATION, V101, P2518, DOI 10.1161/01.CIR.101.21.2518; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; LU MH, 1992, J CELL BIOL, V117, P1007, DOI 10.1083/jcb.117.5.1007; MADY C, 1994, CIRCULATION, V90, P3098, DOI 10.1161/01.CIR.90.6.3098; MARTIN UO, 1987, MEDICINA-BUENOS AIRE, V47, P159; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Nyholt DR, 2005, HUM HERED, V60, P61, DOI 10.1159/000087919; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pulkki KJ, 1997, ANN MED, V29, P339, DOI 10.3109/07853899708999358; Ramasawmy R, 2006, CLIN INFECT DIS, V43, P305, DOI 10.1086/505395; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; Teixeira PC, 2012, WORLD J CLIN INFECT, V2, P39, DOI DOI 10.5495/WJCID.V2.I3.39; Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205; Tostes S, 2005, INT J CARDIOL, V99, P233, DOI 10.1016/j.ijcard.2004.01.026; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; ZICKER F, 1990, AM J TROP MED HYG, V43, P498, DOI 10.4269/ajtmh.1990.43.498	52	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83446	10.1371/journal.pone.0083446	http://dx.doi.org/10.1371/journal.pone.0083446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367596	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900018
J	Que, YA; Hazan, R; Strobel, B; Maura, D; He, JX; Kesarwani, M; Panopoulos, P; Tsurumi, A; Giddey, M; Wilhelmy, J; Mindrinos, MN; Rahme, LG				Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Giddey, Marlyse; Wilhelmy, Julie; Mindrinos, Michael N.; Rahme, Laurence G.			A Quorum Sensing Small Volatile Molecule Promotes Antibiotic Tolerance in Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PERSISTER CELLS; MULTIDRUG TOLERANCE; GENE; MECHANISM; MVFR; 2-AMINOACETOPHENONE; IDENTIFICATION; LEISHMANIASIS; INFECTIONS	Bacteria can be refractory to antibiotics due to a sub-population of dormant cells, called persisters that are highly tolerant to antibiotic exposure. The low frequency and transience of the antibiotic tolerant "persister" trait has complicated elucidation of the mechanism that controls antibiotic tolerance. In this study, we show that 2' Aminoacetophenone (2-AA), a poorly studied but diagnostically important small, volatile molecule produced by the recalcitrant gram-negative human pathogen Pseudomonas aeruginosa, promotes antibiotic tolerance in response to quorum-sensing (QS) signaling. Our results show that 2-AA mediated persister cell accumulation occurs via alteration of the expression of genes involved in the translational capacity of the cell, including almost all ribosomal protein genes and other translation-related factors. That 2-AA promotes persisters formation also in other emerging multi-drug resistant pathogens, including the non 2-AA producer Acinetobacter baumannii implies that 2-AA may play an important role in the ability of gram-negative bacteria to tolerate antibiotic treatments in polymicrobial infections. Given that the synthesis, excretion and uptake of QS small molecules is a common hallmark of prokaryotes, together with the fact that the translational machinery is highly conserved, we posit that modulation of the translational capacity of the cell via QS molecules, may be a general, widely distributed mechanism that promotes antibiotic tolerance among prokaryotes.	[Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Que, Yok-Ai; Hazan, Ronen; Strobel, Benjamin; Maura, Damien; He, Jianxin; Kesarwani, Meenu; Panopoulos, Panagiotis; Tsurumi, Amy; Rahme, Laurence G.] Shriners Hosp Children, Boston, MA USA; [Wilhelmy, Julie; Mindrinos, Michael N.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hazan, Ronen] Hebrew Univ Jerusalem, Inst Dent Sci, Jerusalem, Israel; [Hazan, Ronen] Hebrew Univ Jerusalem, Sch Dent Med, Jerusalem, Israel; [Giddey, Marlyse] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Lausanne	Rahme, LG (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	rahme@molbio.mgh.harvard.edu	Tsurumi, Amy/AAJ-7857-2020; Hazan, Ronen/ABI-1067-2020; Que, Yok Ai/AAE-5474-2020; Hazan, Ronen/R-8384-2016	Tsurumi, Amy/0000-0001-7678-169X; Hazan, Ronen/0000-0001-9967-730X; Que, Yok Ai/0000-0001-9443-6101; Hazan, Ronen/0000-0001-9967-730X; Strobel, Benjamin/0000-0002-8687-3499	NIH [AI105902, R56AI063433]; Swiss National Science Foundation/Swiss Medical Association (FMH) [PASMP3-123226]; SICPA Foundation; Shriners' Hospitals Research Fellowship [8494];  [8770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105902, R56AI063433, R33AI105902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation/Swiss Medical Association (FMH)(Swiss National Science Foundation (SNSF)); SICPA Foundation; Shriners' Hospitals Research Fellowship; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Shriners' research grant #8770, and NIH grants AI105902 and R56AI063433 to LGR. YAQ was supported by a Swiss National Science Foundation/Swiss Medical Association (FMH) grant #PASMP3-123226 and a grant from the SICPA Foundation. RH was supported by Shriners' Hospitals Research Fellowship #8494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Bigger JW, 1944, LANCET, V2, P497; Bolstad B, 2005, BIOINFORMATICS COMPU; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hazan R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-259; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Kayama S, 2009, FEMS MICROBIOL LETT, V298, P184, DOI 10.1111/j.1574-6968.2009.01717.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lewis Kim, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-28951-4_8; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; MANN S, 1966, ARCH MIKROBIOL, V54, P184, DOI 10.1007/BF00408715; Miller JH, 1972, DETERMINATION VIABLE, P31; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Que YA, 1998, J INFECT DIS, V177, P146, DOI 10.1086/513805; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rezaei E, 2011, BURNS, V37, P805, DOI 10.1016/j.burns.2011.01.019; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SAHM DF, 1991, MANUAL CLIN MICROBIO, P1109; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Tozawa Y, 2011, PLANT BIOLOGY, V13, P699, DOI 10.1111/j.1438-8677.2011.00484.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Tzika AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074528; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wada A, 1998, GENES CELLS, V3, P203, DOI 10.1046/j.1365-2443.1998.00187.x; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; Yoshida H, 2004, GENES CELLS, V9, P271, DOI 10.1111/j.1356-9597.2004.00723.x	55	93	97	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e80140	10.1371/journal.pone.0080140	http://dx.doi.org/10.1371/journal.pone.0080140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367477	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900001
J	McKay, BS; Congrove, NR; Johnson, AA; Dismuke, WM; Bowen, TJ; Stamer, WD				McKay, Brian S.; Congrove, Nicole R.; Johnson, Adiv A.; Dismuke, W. Michael; Bowen, Trent J.; Stamer, W. Daniel			A Role for Myocilin in Receptor-Mediated Endocytosis	PLOS ONE			English	Article							MULTIVESICULAR BODY; CHEMICAL CHAPERONE; RETICULUM STRESS; EXOSOME RELEASE; MOUSE MODEL; GLAUCOMA; PROTEIN; MUTATIONS; BETA; GENE	Myocilin is a broadly expressed protein that when mutated uniquely causes glaucoma. While no function has been ascribed to explain focal disease, some properties of myocilin are known. Myocilin is a cytoplasmic protein that also localizes to vesicles specifically as part of a large membrane-associated complex with properties similar to the SNARE machinery that function in vesicle fusion. Its role in vesicle dynamics has not been detailed, however myocilin intersects with the endocytic compartment at the level of the multivesicular body. Since internalized GPCRs are sorted in the multivesicular body, we investigated whether myocilin functions in ligand-dependent GPR143 endocytosis. Using recombinant systems we found that the kinetics of myocilin recruitment to biotinylated membrane proteins was similar to that of arrestin-3. We also co-localized myocilin with GPR143 and Arrestin-2 by confocal microscopy. However, wild-type myocilin differed significantly in its association kinetics and co-localization with internalized proteins from mutant myocilin (P370L or T377M). Moreover, we found that myocilin bound to the cytoplasmic tail of GPR143, an interaction mediated by its amino terminal helix-turn-helix domain. Hydrodynamic analyses show that the myocilin-GPR143 protein complex is >158 kD and stable in 500 mM KCl, but not 0.1% SDS. Collectively, data indicate that myocilin is recruited to the membrane compartment, interacting with GPCR proteins during ligand-mediated endocytosis and that GPCR signaling underlies pathology in myocilin glaucoma.	[McKay, Brian S.; Congrove, Nicole R.; Johnson, Adiv A.; Bowen, Trent J.] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA; [McKay, Brian S.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Dismuke, W. Michael; Stamer, W. Daniel] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Stamer, W. Daniel] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	University of Arizona; University of Arizona; Duke University; Duke University	McKay, BS (corresponding author), Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA.	bsmckay@eyes.arizona.edu		McKay, Brian/0000-0002-2893-3959	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was funded by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Blanc L, 2005, BLOOD CELL MOL DIS, V35, P21, DOI 10.1016/j.bcmd.2005.04.008; Cartier A, 2011, J CELL SCI, V124, P3292, DOI 10.1242/jcs.085795; Cattaneo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017206; Cullis DN, 2002, J BIOL CHEM, V277, P49158, DOI 10.1074/jbc.M206316200; Da Q, 2011, J IMMUNOL, V186, P3023, DOI 10.4049/jimmunol.1000262; Denzer K, 2000, J CELL SCI, V113, P3365; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; He Y, 2009, MOL VIS, V15, P815; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kennan AM, 1998, J MED GENET, V35, P957, DOI 10.1136/jmg.35.11.957; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kubota R, 1998, BIOCHEM BIOPH RES CO, V242, P396, DOI 10.1006/bbrc.1997.7972; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mertts M, 1999, LAB INVEST, V79, P1237; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Noda S, 2000, BIOCHEM BIOPH RES CO, V276, P1129, DOI 10.1006/bbrc.2000.3591; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Resch ZT, 2010, EXP EYE RES, V91, P901, DOI 10.1016/j.exer.2010.09.017; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schilders G, 2008, METHOD ENZYMOL, V448, P211, DOI 10.1016/S0076-6879(08)02611-6; Seo S, 2013, CURR EYE RES, V38, P310, DOI 10.3109/02713683.2012.754047; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Stamer WD, 2006, EXP EYE RES, V83, P1386, DOI 10.1016/j.exer.2006.07.018; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Taniguchi F, 1999, JPN J OPHTHALMOL, V43, P80, DOI 10.1016/S0021-5155(98)00074-4; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; Wang L, 2007, MOL VIS, V13, P618; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2004, J CELL PHYSIOL, V200, P45, DOI 10.1002/jcp.10478; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	67	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82301	10.1371/journal.pone.0082301	http://dx.doi.org/10.1371/journal.pone.0082301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367514	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300030
J	Niederkrotenthaler, T; Parker, EM; Ovalle, F; Noe, RE; Bell, J; Xu, LK; Morrison, MA; Mertzlufft, CE; Sugerman, DE				Niederkrotenthaler, Thomas; Parker, Erin M.; Ovalle, Fernando; Noe, Rebecca E.; Bell, Jeneita; Xu, Likang; Morrison, Melissa A.; Mertzlufft, Caitlin E.; Sugerman, David E.			Injuries and Post-Traumatic Stress following Historic Tornados: Alabama, April 2011	PLOS ONE			English	Article							RISK-FACTORS; DISASTER PREPAREDNESS; NATURAL DISASTER; DISORDER; OKLAHOMA; DEATH; BANGLADESH; ILLINOIS; GEORGIA; SYSTEM	Objectives: We analyzed tornado-related injuries seen at hospitals and risk factors for tornado injury, and screened for post-traumatic stress following a statewide tornado-emergency in Alabama in April 2011. Methods: We conducted a chart abstraction of 1,398 patients at 39 hospitals, mapped injured cases, and conducted a case-control telephone survey of 98 injured cases along with 200 uninjured controls. Results: Most (n = 1,111, 79.5%) injuries treated were non-life threatening (Injury Severity Score <= 15). Severe injuries often affected head (72.9%) and chest regions (86.4%). Mobile home residents showed the highest odds of injury (OR, 6.98; 95% CI: 2.10-23.20). No severe injuries occurred in tornado shelters. Within permanent homes, the odds of injury were decreased for basements (OR, 0.13; 95% CI: 0.04-0.40), bathrooms (OR, 0.22; 95% CI: 0.06-0.78), hallways (OR, 0.31; 95% CI: 0.11-0.90) and closets (OR, 0.25; 95% CI: 0.07-0.80). Exposure to warnings via the Internet (aOR, 0.20; 95% CI: 0.09-0.49), television (aOR, 0.45; 95% CI: 0.24-0.83), and sirens (aOR, 0.50; 95% CI: 0.30-0.85) decreased the odds of injury, and residents frequently exposed to tornado sirens had lower odds of injury. The prevalence of PTSD in respondents was 22.1% and screening positive for PTSD symptoms was associated with tornado-related loss events. Conclusions: Primary prevention, particularly improved shelter access, and media warnings, seem essential to prevent severe tornado-injury. Small rooms such as bathrooms may provide some protection within permanent homes when no underground shelter is available.	[Niederkrotenthaler, Thomas; Parker, Erin M.; Ovalle, Fernando; Bell, Jeneita; Sugerman, David E.] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA; [Niederkrotenthaler, Thomas; Parker, Erin M.] Ctr Dis Control & Prevent CDC, Sci Educ & Profess Dev Program Off, Div Appl Sci, Epidem Intelligence Serv, Atlanta, GA USA; [Noe, Rebecca E.] Ctr Dis Control & Prevent CDC, Natl Ctr Environm Hlth, Div Environm Hazards & Hlth Effects, Atlanta, GA USA; [Xu, Likang] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Anal Res & Practice Integrat, Atlanta, GA USA; [Morrison, Melissa A.] Ctr Dis Control & Prevent CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA USA; [Morrison, Melissa A.] Alabama Dept Publ Hlth, Montgomery, AL 36102 USA; [Mertzlufft, Caitlin E.] ATSDR, Div Toxicol & Human Hlth Sci, Geospatial Res Anal & Serv Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Niederkrotenthaler, T (corresponding author), Med Univ Vienna, Dept Gen Practice & Family Med, Ctr Publ Hlth, Vienna, Austria.	thomas.niederkrotenthaler@meduniwien.ac.at	Ovalle, Fernando/Q-6647-2019	Ovalle, Fernando/0000-0002-6711-071X; Niederkrotenthaler, Thomas/0000-0001-9550-628X				[Anonymous], 2009, STAND DEF FIN DISP C; Balluz L, 2000, DISASTERS, V24, P71, DOI 10.1111/1467-7717.00132; Bisson J, 2009, PSYCHOL TREATMENT PO; Bohonos JJ, 1999, J EMERG MED, V17, P67, DOI 10.1016/S0736-4679(98)00125-5; BRENNER SA, 1995, INT J EPIDEMIOL, V24, P144, DOI 10.1093/ije/24.1.144; BRENNER SA, 1992, AM J PUBLIC HEALTH, V82, P1296, DOI 10.2105/AJPH.82.9.1296-a; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Caldera T, 2001, SOC PSYCH PSYCH EPID, V36, P108, DOI 10.1007/s001270050298; CARTER AO, 1989, AM J EPIDEMIOL, V130, P1209, DOI 10.1093/oxfordjournals.aje.a115449; Casey-Lockyer Mary, 2012, Morbidity and Mortality Weekly Report, V61, P529; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P412; Chaudhuri A, 2005, TELECOMMUN POLICY, V29, P731, DOI 10.1016/j.telpol.2005.07.001; Chern JJ, 2011, J NEUROSURG-PEDIATR, V8, P588, DOI 10.3171/2011.9.PEDS11207; Choudhury WA, 2006, INT REV PSYCHIATR, V18, P529, DOI 10.1080/09540260601037896; Comstock RD, 2005, DISASTERS, V29, P277, DOI 10.1111/j.0361-3666.2005.00291.x; Cook L.J., 2009, MOTORCYCLE HELMET US; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; DUCLOS PJ, 1989, INT J EPIDEMIOL, V18, P213, DOI 10.1093/ije/18.1.213; EIDSON M, 1990, INT J EPIDEMIOL, V19, P1051, DOI 10.1093/ije/19.4.1051; Federal Emergency Management Agency, 2012, P908 FEMA; Friedman M. J., 2007, HDB PTSD SCI PRACTIC, V3rd; GLASS RI, 1980, SCIENCE, V207, P734, DOI 10.1126/science.207.4432.734; Gregg Michael, 2008, FIELD EPIDEMIOLOGY; Hammer B, 2002, WEATHER FORECAST, V17, P577, DOI 10.1175/1520-0434(2002)017<0577:RTWDTM>2.0.CO;2; Hartmann EH, 2012, AM SURGEON, V78, P770; Liu S, 1996, AM J PUBLIC HEALTH, V86, P87, DOI 10.2105/AJPH.86.1.87; MacKenzie E, 1997, ICDMAP 90 USERS GUID; MADAKASIRA S, 1987, J NERV MENT DIS, V175, P286, DOI 10.1097/00005053-198705000-00008; MANDELBAUM I, 1966, J TRAUM, V6, P353, DOI 10.1097/00005373-196605000-00005; May AK, 2000, J TRAUMA, V48, P666, DOI 10.1097/00005373-200004000-00014; May Beth M., 2002, Journal of the American Osteopathic Association, V102, P225; Middleton KL, 2002, INT J STRESS MANAGE, V9, P229, DOI 10.1023/A:1015571816227; Millie M, 2000, AM SURGEON, V66, P223; National Oceanic and Atmospheric Administration, 2009, SERV ASS MOTH DAY WE; National Oceanic and Atmospheric Administration, 2011, SERV ASS HIST TORN A; Peitzmann A.B., 2008, TRAUMA MANUAL TRAUMA; Penick E C, 1976, J Community Psychol, V4, P64, DOI 10.1002/1520-6629(197601)4:1<64::AID-JCOP2290040103>3.0.CO;2-0; Polusny MA, 2008, J TRAUMA STRESS, V21, P75, DOI 10.1002/jts.20281; PTSD, COCHRANE DATABASE SY; SCHMIDLIN TW, 1995, DISASTERS, V19, P170, DOI 10.1111/j.1467-7717.1995.tb00367.x; Sorensen JH, 2006, HDB DISASTER RES; Sugimoto JD, 2011, DISASTERS, V35, P329, DOI 10.1111/j.1467-7717.2010.01214.x; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Wind Science and Engineering Center, REC ENH FUJ SCAL EF	44	17	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e83038	10.1371/journal.pone.0083038	http://dx.doi.org/10.1371/journal.pone.0083038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276HL	24367581	gold, Green Published			2022-12-25	WOS:000328740300092
J	Huang, XC; Rong, J; Liu, Y; Zhang, MH; Wan, Y; Ouyang, S; Zhou, CH; Wu, XP				Huang, Xiao-Chen; Rong, Jun; Liu, Yong; Zhang, Ming-Hua; Wan, Yuan; Ouyang, Shan; Zhou, Chun-Hua; Wu, Xiao-Ping			The Complete Maternally and Paternally Inherited Mitochondrial Genomes of the Endangered Freshwater Mussel Solenaia carinatus (Bivalvia: Unionidae) and Implications for Unionidae Taxonomy	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; MOLECULAR PHYLOGENETIC ANALYSIS; SUBUNIT-II PROTEIN; MYTILUS-GALLOPROVINCIALIS; FUNCTIONAL-ROLE; DNA; EVOLUTION; GENE; UNIONOIDA; MOLLUSCA	Doubly uniparental inheritance (DUI) is an exception to the typical maternal inheritance of mitochondrial (mt) DNA in Metazoa, and found only in some bivalves. In species with DUI, there are two highly divergent gender-associated mt genomes: maternal (F) and paternal (M), which transmit independently and show different tissue localization. Solenaia carinatus is an endangered freshwater mussel species exclusive to Poyang Lake basin, China. Anthropogenic events in the watershed greatly threaten the survival of this species. Nevertheless, the taxonomy of S. carinatus based on shell morphology is confusing, and the subfamilial placement of the genus Solenaia remains unclear. In order to clarify the taxonomic status and discuss the phylogenetic implications of family Unionidae, the entire F and M mt genomes of S. carinatus were sequenced and compared with the mt genomes of diverse freshwater mussel species. The complete F and M mt genomes of S. carinatus are 16716 bp and 17102 bp in size, respectively. The F and M mt genomes of S. carinatus diverge by about 40% in nucleotide sequence and 48% in amino acid sequence. Compared to F counterparts, the M genome shows a more compact structure. Different gene arrangements are found in these two gender-associated mt genomes. Among these, the F genome cox2-rrnS gene order is considered to be a genome-level synapomorphy for female lineage of the subfamily Gonideinae. From maternal and paternal mtDNA perspectives, the phylogenetic analyses of Unionoida indicate that S. carinatus belongs to Gonideinae. The F and M clades in freshwater mussels are reciprocal monophyly. The phylogenetic trees advocate the classification of sampled Unionidae species into four subfamilies: Gonideinae, Ambleminae, Anodontinae, and Unioninae, which is supported by the morphological characteristics of glochidia.	[Huang, Xiao-Chen; Rong, Jun; Wan, Yuan; Zhou, Chun-Hua; Wu, Xiao-Ping] Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Peoples R China; [Huang, Xiao-Chen; Liu, Yong; Zhang, Ming-Hua; Wan, Yuan; Ouyang, Shan; Zhou, Chun-Hua; Wu, Xiao-Ping] Nanchang Univ, Sch Life Sci & Food Engn, Nanchang, Peoples R China	Nanchang University; Nanchang University	Zhou, CH (corresponding author), Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Peoples R China.	zhouchunhuajx@hotmail.com; xpwu@ncu.edu.cn	Rong, Jun/B-6037-2008	Rong, Jun/0000-0003-1408-2898; Huang, Xiao-Chen/0000-0002-0242-3571	National Natural Science Foundation of China [31260515]; Leading talent training plan of the GanPo Outstanding Talents 555 Project [18000041]; Youth Science Foundation of Jiangxi province education department [GJJ13025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading talent training plan of the GanPo Outstanding Talents 555 Project; Youth Science Foundation of Jiangxi province education department	This work is supported by grants from the National Natural Science Foundation of China (No. 31260515), Leading talent training plan of the GanPo Outstanding Talents 555 Project (18000041), and the Youth Science Foundation of Jiangxi province education department (GJJ13025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; BERNT M, 2012, MITOS IMPROVED NOVO, P42937; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bouchet P, 2010, MALACOLOGIA, V52, P4; Breton S, 2006, GENETICS, V172, P1107, DOI 10.1534/genetics.105.047159; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019365; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Brown WM, 1985, MOL EVOLUTIONARY GEN, DOI DOI 10.1007/978-1-4684-4988-4_2; Campbell DC, 2005, INVERTEBR BIOL, V124, P131, DOI 10.1111/j.1744-7410.2005.00015.x; Chakrabarti R, 2007, FEBS LETT, V581, P5213, DOI 10.1016/j.febslet.2007.10.006; Chapman EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-165; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; [陈玲 Chen Ling], 2012, [生态学报, Acta Ecologica Sinica], V32, P2420; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Deein Gridsada, 2008, Natural History Journal of Chulalongkorn University, V8, P61; Doucet-Beaupre H, 2012, MOL PHYLOGENET EVOL, V63, P430, DOI 10.1016/j.ympev.2012.01.017; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garrido-Ramos MA, 1998, GENOME, V41, P818, DOI 10.1139/gen-41-6-818; Geist J, 2010, HYDROBIOLOGIA, V644, P69, DOI 10.1007/s10750-010-0190-2; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Graf DL, 2002, J MOLLUS STUD, V68, P65, DOI 10.1093/mollus/68.1.65; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAS F, 1969, SUPERFAMILIA UNIONAC, V88, P1; Heude R. P., 1875, CONCHYLIOLOGIE FLUVI; Howard JK, 2006, FRESHWATER BIOL, V51, P460, DOI 10.1111/j.1365-2427.2005.01507.x; Huang YY, 2002, J MOLLUS STUD, V68, P359, DOI 10.1093/mollus/68.4.359; Jiang Wen-Ping, 2010, Yichuan, V32, P153, DOI 10.3724/SP.J.1005.2010.00153; KAT PW, 1984, BIOL REV, V59, P189, DOI 10.1111/j.1469-185X.1984.tb00407.x; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Krebs RA, 2013, BIOL J LINN SOC, V109, P229, DOI 10.1111/bij.12025; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Lefevre G, 1910, J EXP ZOOL, V9, P79, DOI 10.1002/jez.1400090105; LIU Y-Y, 1991, Acta Zootaxonomica Sinica, V16, P122; Liu YY, 1979, EC FAUNA CHINA FRESH, P116; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Maddison WP, 2009, MESQUITE MODULAR SYS; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nylander J, 2004, MR MODELTEST V2 PROG; Obata M, 2006, DEV GROWTH DIFFER, V48, P253, DOI [10.1111/j.1440-169x.2006.00863.x, 10.1111/j.1440-169X.2006.00863.x]; Obata M, 2007, DEV GROWTH DIFFER, V49, P335, DOI [10.1111/j.1440-169X.2007.00930.x, 10.1111/j.1440-169x.2007.00930.x]; Ouyang JX, 2011, J CONCHOL, V40, P543; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Prozorova L.A., 2005, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V9, P46; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAVAZZI E, 1992, LETHAIA, V25, P195, DOI 10.1111/j.1502-3931.1992.tb01384.x; Serb JM, 2003, MOL PHYLOGENET EVOL, V28, P1, DOI 10.1016/S1055-7903(03)00026-5; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shu Feng-Yue, 2009, Acta Hydrobiologica Sinica, V33, P1051, DOI 10.3724/SP.J.0000.2009.61051; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simpson C. T., 1914, DESCRIPTIVE CATALOGU; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; Soroka M, 2010, J APPL GENET, V51, P469, DOI 10.1007/BF03208876; Soroka Marianna, 2010, Folia Malacologica, V18, P189, DOI 10.2478/v10125-010-0016-x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart DT, 1996, GENETICS, V143, P1349; STOGER I, 2012, MOL PHYLOGE IN PRESS, P42937; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchang S, 1965, ACTA ZOOL SINICA, V17, P309; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Walker JM, 2007, MOL ECOL NOTES, V7, P489, DOI 10.1111/j.1471-8286.2006.01630.x; Whelan NV, 2011, MOL PHYLOGENET EVOL, V61, P504, DOI 10.1016/j.ympev.2011.07.016; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu Xiaoping, 2000, Hupo Kexue, V12, P111; Wu Xiaoping, 1999, Acta Hydrobiologica Sinica, V23, P139; Xiong LF, 2012, CHIN J OCEANOL LIMN, V30, P124, DOI 10.1007/s00343-012-1070-6; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YEAGER MM, 1994, J N AM BENTHOL SOC, V13, P217, DOI 10.2307/1467240; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0	90	50	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84352	10.1371/journal.pone.0084352	http://dx.doi.org/10.1371/journal.pone.0084352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358356	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700092
J	Liao, YC; Lin, HH; Lin, CH; Chung, WB				Liao, Yu-Chieh; Lin, Hsin-Hung; Lin, Chieh-Hua; Chung, Wen-Bin			Identification of Cytotoxic T Lymphocyte Epitopes on Swine Viruses: Multi-Epitope Design for Universal T Cell Vaccine	PLOS ONE			English	Article							BINDING PREDICTION; PROTEIN; CD8(+); IMMUNOGENICITY; COMPLEX; GENOTYPE; UTILITY	Classical swine fever (CSF), foot-and-mouth disease (FMD) and porcine reproductive and respiratory syndrome (PRRS) are the primary diseases affecting the pig industry globally. Vaccine induced CD8(+) T cell-mediated immune response might be long-lived and cross-serotype and thus deserve further attention. Although large panels of synthetic overlapping peptides spanning the entire length of the polyproteins of a virus facilitate the detection of cytotoxic T lymphocyte (CTL) epitopes, it is an exceedingly costly and cumbersome approach. Alternatively, computational predictions have been proven to be of satisfactory accuracy and are easily performed. Such a method enables the systematic identification of genome-wide CTL epitopes by incorporating epitope prediction tools in analyzing large numbers of viral sequences. In this study, we have implemented an integrated bioinformatics pipeline for the identification of CTL epitopes of swine viruses including the CSF virus (CSFV), FMD virus (FMDV) and PRRS virus (PRRSV) and assembled these epitopes on a web resource to facilitate vaccine design. Identification of epitopes for cross protections to different subtypes of virus are also reported in this study and may be useful for the development of a universal vaccine against such viral infections among the swine population. The CTL epitopes identified in this study have been evaluated in silico and possibly provide more and wider protection in compared to traditional single-reference vaccine design. The web resource is free and open to all users through http://sb.nhri.org.tw/ICES.	[Liao, Yu-Chieh; Lin, Hsin-Hung; Lin, Chieh-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Lin, Chieh-Hua] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chung, Wen-Bin] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Pingtung University Science & Technology	Liao, YC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.	jade@nhri.org.tw	Liao, Yu-Chieh/L-5113-2019; Liao, Yu-Chieh/E-5031-2011	Liao, Yu-Chieh/0000-0002-4360-7932; 	National Health Research Institutes, Taiwan [PH-101-PP-45]; National Science Council, Taiwan [NSC101-2319-B-400-001, NSC101-2313-B-020-017-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural funding from the National Health Research Institutes, Taiwan (PH-101-PP-45 to YCLiao). The computational facilities for this work were partly supported by the National Science Council, Taiwan (NSC101-2319-B-400-001 to YC Liao and NSC101-2313-B-020-017-MY3 to WB Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol E, 2002, J GEN VIROL, V83, P551, DOI 10.1099/0022-1317-83-3-551; Barfoed AM, 2006, ANTIVIR RES, V72, P178, DOI 10.1016/j.antiviral.2006.07.002; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Ceppi M, 2005, J GEN VIROL, V86, P2525, DOI 10.1099/vir.0.80907-0; Chaves FA, 2012, J IMMUNOL, V188, P4235, DOI 10.4049/jimmunol.1103640; Chen WH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-199; Diaz I, 2009, VACCINE, V27, P5603, DOI 10.1016/j.vaccine.2009.07.029; Gao FS, 2006, VET IMMUNOL IMMUNOP, V113, P328, DOI 10.1016/j.vetimm.2006.06.002; Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Guo KK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-236; Guzman E, 2010, J VIROL, V84, P12375, DOI 10.1128/JVI.01545-10; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Martin W, 2003, METHODS, V29, P289, DOI 10.1016/S1046-2023(02)00351-1; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Pan XC, 2011, ACTA CRYSTALLOGR F, V67, P568, DOI 10.1107/S174430911100741X; Patch JR, 2011, CLIN VACCINE IMMUNOL, V18, P280, DOI 10.1128/CVI.00417-10; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; Pedersen LE, 2011, IMMUNOGENETICS, V63, P821, DOI 10.1007/s00251-011-0555-3; Pedersen LE, 2012, ANIM GENET; Powell TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062778; Rock MT, 2011, J IMMUNOL METHODS, V374, P13, DOI 10.1016/j.jim.2011.08.004; Sanchez-Burgos G, 2010, VIRUS RES, V153, P113, DOI 10.1016/j.virusres.2010.07.014; Somvanshi P, 2009, INDIAN J BIOTECHNOL, V8, P193; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Vanhee M, 2011, VACCINE, V29, P4794, DOI 10.1016/j.vaccine.2011.04.071; Vashisht K, 2008, VACCINE, V26, P4747, DOI 10.1016/j.vaccine.2008.06.047; Xu YG, 2011, CLIN VACCINE IMMUNOL, V18, P1979, DOI 10.1128/CVI.05204-11; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84443	10.1371/journal.pone.0084443	http://dx.doi.org/10.1371/journal.pone.0084443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358361	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700096
J	Suemizu, H; Kawai, K; Higuchi, Y; Hashimoto, H; Ogura, T; Itoh, T; Sasaki, E; Nakamura, M				Suemizu, Hiroshi; Kawai, Kenji; Higuchi, Yuichiro; Hashimoto, Haruo; Ogura, Tomoyuki; Itoh, Toshio; Sasaki, Erika; Nakamura, Masato			A Versatile Technique for the In Vivo Imaging of Human Tumor Xenografts Using Near-Infrared Fluorochrome-Conjugated Macromolecule Probes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NOG MICE; ORTHOTOPIC MODELS; LIVER METASTASIS; CANCER; PROTEINS; THERAPEUTICS; ENGRAFTMENT; EXPRESSION; ADVANTAGES	Here, we present a versatile method for detecting human tumor xenografts in vivo, based on the enhanced permeability and retention (EPR) effect, using near-infrared (NIR) fluorochrome-conjugated macromolecule probes. Bovine serum albumin (BSA) and two immunoglobulins-an anti-human leukocyte antigen (HLA) monoclonal antibody and isotype control IgG(2a)-were labeled with XenoLight CF770 fluorochrome and used as NIR-conjugated macromolecule probes to study whole-body imaging in a variety of xenotransplantation mouse models. NIR fluorescent signals were observed in subcutaneously transplanted BxPC-3 (human pancreatic cancer) cells and HCT 116 (colorectal cancer) cells within 24 h of NIR-macromolecule probe injection, but the signal from the fluorochrome itself or from the NIR-conjugated small molecule (glycine) injection was not observed. The accuracy of tumor targeting was confirmed by the localization of the NIR-conjugated immunoglobulin within the T-HCT 116 xenograft (in which the orange-red fluorescent protein tdTomato was stably expressed by HCT 116 cells) in the subcutaneous transplantation model. However, there was no significant difference in the NIR signal intensity of the region of interest between the anti-HLA antibody group and the isotype control group in the subcutaneous transplantation model. Therefore, the antibody accumulation within the tumor in vivo is based on the EPR effect. The liver metastasis generated by an intrasplenic injection of T-HCT 116 cells was clearly visualized by the NIR-conjugated anti-HLA probe but not by the orange-red fluorescent signal derived from the tdTomato reporter. This result demonstrated the superiority of the NIR probes over the tdTomato reporter protein at enhancing tissue penetration. In another xenograft model, patient-derived xenografts (PDX) of LC11-JCK (human non-small cell lung cancer) were successfully visualized using the NIR-conjugated macromolecule probe without any genetic modification. These results suggested that NIR-conjugated macromolecule, preferably, anti-HLA antibody probe is a valuable tool for the detection of human tumors in experimental metastasis models using whole-body imaging.	[Suemizu, Hiroshi; Higuchi, Yuichiro; Hashimoto, Haruo] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan; [Kawai, Kenji; Nakamura, Masato] Cent Inst Expt Anim, Dept Pathol Res, Kawasaki, Kanagawa, Japan; [Ogura, Tomoyuki] Cent Inst Expt Anim, Anim Resource Dept, Kawasaki, Kanagawa, Japan; [Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan; [Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki, Kanagawa, Japan; [Nakamura, Masato] Tokai Univ, Sch Med, Dept Pathol & Regenerat Med, Isehara, Kanagawa 25911, Japan	Tokai University	Suemizu, H (corresponding author), Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan.	suemizu@ciea.or.jp		Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [21240042]; MEXT of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A part of this work was supported by a Grant-in-Aid for Scientific Research (21240042) to HS from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan: the Project for the Realization of Regenerative Medicine from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOUSE NEWS LETT; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Chang CJ, 2004, J IMMUNOL, V173, P6025, DOI 10.4049/jimmunol.173.10.6025; Concha A, 1991, Semin Cancer Biol, V2, P47; Deliolanis NC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967184; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; GIAVAZZI R, 1986, CANCER RES, V46, P1928; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Greish K, 2003, CLIN PHARMACOKINET, V42, P1089, DOI 10.2165/00003088-200342130-00002; Hamada K, 2008, INT J ONCOL, V32, P153; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Keereweer S, 2012, J SURG ONCOL, V105, P714, DOI 10.1002/jso.22102; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mizukami Y, 2008, BRIT J CANCER, V99, P1462, DOI 10.1038/sj.bjc.6604715; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Oshika Y, 1998, EUR J CANCER, V34, P1958, DOI 10.1016/S0959-8049(98)00236-6; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Suemizu H, 2007, INT J ONCOL, V31, P741; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Vora AR, 1997, BRIT J CANCER, V76, P836, DOI 10.1038/bjc.1997.472; Zhang Xuan, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1227s60	29	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82708	10.1371/journal.pone.0082708	http://dx.doi.org/10.1371/journal.pone.0082708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358218	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700026
J	Chung, SJ; Kwon, H; Lee, DK; Hong, JY; Sunwoo, MK; Sohn, YH; Lee, JM; Lee, PH				Chung, Seok Jong; Kwon, Hunki; Lee, Dong-Kyun; Hong, Jin Yong; Sunwoo, Mun-Kyung; Sohn, Young H.; Lee, Jong-Min; Lee, Phil Hyu			Neuroanatomical Heterogeneity of Essential Tremor According to Propranolol Response	PLOS ONE			English	Article							BETA-ADRENORECEPTOR MECHANISMS; AUTOMATED 3-D EXTRACTION; VOXEL-BASED MORPHOMETRY; LOCUS-COERULEUS; CEREBELLAR DYSFUNCTION; SPATIAL STATISTICS; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; CEREBRAL-CORTEX; DOUBLE-BLIND	Background: Recent studies have suggested that essential tremor (ET) is a more complex and heterogeneous clinical entity than initially thought. In the present study, we assessed the pattern of cortical thickness and diffusion tensor white matter (WM) changes in patients with ET according to the response to propranolol to explore the pathogenesis underlying the clinical heterogeneity of ET. Methods: A total of 32 patients with drug naive ET were recruited prospectively from the Movement Disorders outpatient clinic. The patients were divided into a propranolol-responder group (n = 18) and a non-responder group (n = 14). We analyzed the pattern of cortical thickness and diffusion tensor WM changes between these two groups and performed correlation analysis between imaging and clinical parameters. Results: There were no significant differences in demographic characteristics, general cognition, or results of detailed neuropsychological tests between the groups. The non-responder group showed more severe cortical atrophy in the left orbitofrontal cortex and right temporal cortex relative to responders. However, the responders exhibited significantly lower fractional anisotropy values in the bilateral frontal, corpus callosal, and right parietotemporal WM compared with the non-responder group. There were no significant clusters where the cortical thickness or WM alterations were significantly correlated with initial tremor severity or disease duration. Conclusions: The present data suggest that patients with ET have heterogeneous cortical thinning and WM alteration with respect to responsiveness to propranolol, suggesting that propranolol responsiveness may be a predictive factor to determine ET subtypes in terms of neuroanatomical heterogeneity.	[Chung, Seok Jong; Sunwoo, Mun-Kyung; Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kwon, Hunki; Lee, Dong-Kyun; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Hong, Jin Yong] Yonsei Univ, Wonju Coll Med, Dept Neurol, Wonju, South Korea	Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.net		Sohn, Young H./0000-0001-6533-2610; Hong, Jin Yong/0000-0002-2476-3737; Chung, Seok Jong/0000-0001-6086-3199; Lee, Phil Hyu/0000-0001-9931-8462	Korea Healthcare technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091159]	Korea Healthcare technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8; Baker MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049088; Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2009, J NEUROL SCI, V287, P138, DOI 10.1016/j.jns.2009.08.037; CALZETTI S, 1981, J NEUROL NEUROSUR PS, V44, P814, DOI 10.1136/jnnp.44.9.814; Cerasa A, 2009, AM J NEURORADIOL, V30, P1240, DOI 10.3174/ajnr.A1544; CLEEVES L, 1984, J NEUROL NEUROSUR PS, V47, P976, DOI 10.1136/jnnp.47.9.976; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; DAVIS CH, 1951, ARCH INTERN MED, V87, P808, DOI 10.1001/archinte.1951.03810060035004; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Elble RJ, 2002, MOVEMENT DISORD, V17, P633, DOI 10.1002/mds.10222; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Helmchen C, 2003, BRAIN, V126, P1319, DOI 10.1093/brain/awg132; HOFFER BJ, 1973, J PHARMACOL EXP THER, V184, P553; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; JEFFERSON D, 1979, J NEUROL NEUROSUR PS, V42, P904, DOI 10.1136/jnnp.42.10.904; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Kang YW, 1997, J KOREAN NEUROL ASS, V15, P300; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Kolasiewicz W, 2011, CEREBELLUM, V10, P267, DOI 10.1007/s12311-011-0250-9; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; KOLLER WC, 1986, ARCH NEUROL-CHICAGO, V43, P42, DOI 10.1001/archneur.1986.00520010038018; Koster B, 2002, J NEUROL NEUROSUR PS, V73, P400, DOI 10.1136/jnnp.73.4.400; Lee JE, 2010, J NEUROL NEUROSUR PS, V81, P320, DOI 10.1136/jnnp.2009.184747; Lee KS, 2003, PARKINSONISM RELAT D, V9, P341, DOI 10.1016/S1353-8020(03)00029-4; LEIGH PN, 1983, J NEUROL NEUROSUR PS, V46, P710, DOI 10.1136/jnnp.46.8.710; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu J, 2011, J NEUROIMAGING, V21, P370, DOI 10.1111/j.1552-6569.2010.00535.x; Louis ED, 2002, NEUROLOGY, V59, P1631, DOI 10.1212/01.WNL.0000033798.85208.F2; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Morita S, 2005, PARKINSONISM RELAT D, V11, P101, DOI 10.1016/j.parkreldis.2004.09.004; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Nicoletti G, 2010, NEUROLOGY, V74, P988, DOI 10.1212/WNL.0b013e3181d5a460; Quattrone A, 2008, AM J NEURORADIOL, V29, P1692, DOI 10.3174/ajnr.A1190; Saini J, 2012, PARKINSONISM RELAT D, V18, P477, DOI 10.1016/j.parkreldis.2012.01.006; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Shill HA, 2008, NEUROLOGY, V70, P1452, DOI 10.1212/01.wnl.0000310425.76205.02; Shin DH, 2008, AM J NEURORADIOL, V29, P151, DOI 10.3174/ajnr.A0744; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Suemaru K, 1997, N-S ARCH PHARMACOL, V355, P571, DOI 10.1007/PL00004985; Troster AI, 2002, EUR J NEUROL, V9, P143; Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; YAMAZAKI M, 1979, PHARMACOL BIOCHEM BE, V10, P421, DOI 10.1016/0091-3057(79)90207-7; YOUNG RR, 1975, NEW ENGL J MED, V293, P950, DOI 10.1056/NEJM197511062931902; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	60	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84054	10.1371/journal.pone.0084054	http://dx.doi.org/10.1371/journal.pone.0084054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358327	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700149
J	Diez-del-Molino, D; Carmona-Catot, G; Araguas, RM; Vidal, O; Sanz, N; Garcia-Berthou, E; Garcia-Marin, JL				Diez-del-Molino, David; Carmona-Catot, Gerard; Araguas, Rosa-Maria; Vidal, Oriol; Sanz, Nuria; Garcia-Berthou, Emili; Garcia-Marin, Jose-Luis			Gene Flow and Maintenance of Genetic Diversity in Invasive Mosquitofish (Gambusia holbrooki)	PLOS ONE			English	Article							INTRODUCED EASTERN MOSQUITOFISH; GUPPIES POECILIA-RETICULATA; LIFE-HISTORY TRAITS; FRESH-WATER FISH; COMPUTER-PROGRAM; POPULATIONS; SUCCESS; BIOLOGY; SOFTWARE; DIFFERENTIATION	Genetic analyses contribute to studies of biological invasions by mapping the origin and dispersal patterns of invasive species occupying new territories. Using microsatellite loci, we assessed the genetic diversity and spatial population structure of mosquitofish (Gambusia holbrooki) that had invaded Spanish watersheds, along with the American locations close to the suspected potential source populations. Mosquitofish populations from the Spanish streams that were studied had similar levels of genetic diversity to the American samples; therefore, these populations did not appear to have undergone substantial losses of genetic diversity during the invasion process. Population structure analyses indicated that the Spanish populations fell into four main clusters, which were primarily associated with hydrography. Dispersal patterns indicated that local populations were highly connected upstream and downstream through active dispersal, with an average of 21.5% fish from other locations in each population. After initially introducing fish to one location in a given basin, such dispersal potential might contribute to the spread and colonization of suitable habitats throughout the entire river basin. The two-dimension isolation-by-distance pattern here obtained, indicated that the human-mediated translocation of mosquitofish among the three study basins is a regular occurrence. Overall, both phenomena, high natural dispersal and human translocation, favor gene flow among river basins and the retention of high genetic diversity, which might help retain the invasive potential of mosquitofish populations.	[Diez-del-Molino, David; Araguas, Rosa-Maria; Vidal, Oriol; Sanz, Nuria; Garcia-Marin, Jose-Luis] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Carmona-Catot, Gerard; Garcia-Berthou, Emili] Univ Girona, Dept Biol, Inst Ecol Aquat, Girona, Spain	Universitat de Girona; Universitat de Girona	Diez-del-Molino, D (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain.	david.diez@udg.edu	Diez-del-Molino, David/ABC-3313-2020; Sanz, Nuria/L-3074-2014; Araguas, Rosa M./L-3073-2014; Vidal, Oriol/C-8973-2009; García-Berthou, Emili/A-5392-2008; Garcia-Marin, Jose-Luis/B-9597-2009	Diez-del-Molino, David/0000-0002-9701-5940; Sanz, Nuria/0000-0001-5274-1917; Araguas, Rosa M./0000-0001-6306-2282; Vidal, Oriol/0000-0002-8197-1567; García-Berthou, Emili/0000-0001-8412-741X; Garcia-Marin, Jose-Luis/0000-0001-9976-5211	Spanish Ministry of Economy and Competitiveness (MINECO); University of Girona (UdG)	Spanish Ministry of Economy and Competitiveness (MINECO); University of Girona (UdG)	Financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) and the University of Girona (UdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Alemadi SD, 2008, BIOL INVASIONS, V10, P59, DOI 10.1007/s10530-007-9109-x; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Araguas RM, 2007, ECOL FRESHW FISH, V16, P257, DOI 10.1111/j.1600-0633.2006.00217.x; Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Ayres RM, 2010, BIOL INVASIONS, V12, P3727, DOI 10.1007/s10530-010-9766-z; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Boix D, 2008, HYDROBIOLOGIA, V597, P53, DOI 10.1007/s10750-007-9221-z; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; Carmona-Catot G, 2011, DIVERS DISTRIB, V17, P214, DOI 10.1111/j.1472-4642.2011.00743.x; Chapman P, 2006, ECOL FRESHW FISH, V15, P357, DOI 10.1111/j.1600-0633.2006.00145.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clavero M, 2009, ECOL FRESHW FISH, V18, P550, DOI 10.1111/j.1600-0633.2009.00369.x; CONGDON BC, 1995, COPEIA, P162, DOI 10.2307/1446811; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Courtenay W.R. Jr, 1989, P319; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Echelle A, 1989, ECOLOGY EVOLUTION LI, V1991, P217; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Astasio B, 2002, THESIS U COMPLUTENSE; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Garcia-Berthou E, 2000, ARCH HYDROBIOL, V149, P271; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; GARCIAMARIN JL, 1991, AQUACULTURE, V95, P235, DOI 10.1016/0044-8486(91)90090-T; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Grapputo A, 2006, ITAL J ZOOL, V73, P67, DOI 10.1080/11250000500502111; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hardie DC, 2010, ENVIRON REV, V18, P1, DOI 10.1139/A09-014; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HERNANDEZMARTICH JD, 1990, COPEIA, P619; HernandezMartich JD, 1997, HEREDITY, V79, P295, DOI 10.1038/hdy.1997.157; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; KENNEDY PK, 1986, COPEIA, P937, DOI 10.2307/1445290; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Levine JM, 2008, CURR BIOL, V18, pR57, DOI 10.1016/j.cub.2007.11.030; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Lintermans M, 2004, NEW ZEAL J MAR FRESH, V38, P481, DOI 10.1080/00288330.2004.9517255; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lowe S., 2000, ENCY BIOL INVASIONS; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MCCLENAGHAN LR, 1985, EVOLUTION, V39, P451, DOI [10.1111/j.1558-5646.1985.tb05681.x, 10.2307/2408377]; McElroy TC, 2011, J HERED, V102, P678, DOI 10.1093/jhered/esr088; Najera L, 1944, B REAL SOC ESP HIST, V42, P51; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ribeiro F, 2008, BIOL INVASIONS, V10, P89, DOI 10.1007/s10530-007-9112-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 1997, GENETICS, V145, P1219; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; SCRIBNER KT, 1993, MOL ECOL, V2, P139, DOI 10.1111/j.1365-294X.1993.tb00103.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith M.H., 1989, P235; SMITH MW, 1983, COPEIA, P182; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidal O, 2012, ECOL FRESHW FISH, V21, P100, DOI 10.1111/j.1600-0633.2011.00527.x; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Wilson GA, 2003, GENETICS, V163, P1177; Zane L, 1999, J EVOLUTION BIOL, V12, P61, DOI 10.1046/j.1420-9101.1999.00006.x	78	26	27	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82501	10.1371/journal.pone.0082501	http://dx.doi.org/10.1371/journal.pone.0082501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358194	Green Published, gold, Green Submitted			2022-12-25	WOS:000328735700073
J	Li, Y; Liu, H; Sato, Y				Li, Ying; Liu, Hua; Sato, Yasuto			The Association between the Serum C-Peptide Level and Bone Mineral Density	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; INSULIN-SECRETION; BODY-COMPOSITION; OSTEOPOROTIC FRACTURES; FAT MASS; WOMEN; CLEARANCE; TURNOVER; CELLS; AGE	Objective: Although serum C-peptide was previously considered biologically inactive, a growing number of recent studies have shown that it is an active peptide with important physiologic functions. The present study aimed to investigate the association of serum C-peptide level with bone mineral density (BMD) in residents of the United States. Methods: The study included 6,625 participants aged 12-85 years. Total and regional BMD were measured using dual-energy X-ray absorptiometry. Stratified multiple linear regression analysis was performed to determine the association of the serum C-peptide level with BMD. Three regression models were produced for each stratum. All models were adjusted for ethnicity, height, weight, education level, physical activity, smoking status, alcohol use, triglycerides and creatinine level, and models 2 and 3 were further adjusted for the fasting plasma glucose (FPG) and alkaline phosphatase (ALP) levels, respectively. Results: Sex-specific results showed a significant association between the serum C-peptide level and total BMD in both sexes. Stratified analyses based on age and body mass index showed that serum C-peptide levels were significantly negatively associated with most regional BMD, and most of these associations remained significant after stratification based on the serum insulin level. Conclusion: The serum C-peptide level was significantly negatively associated with the total and most regional BMD. These findings suggest that serum C-peptide may have biological activity associated with bone metabolism and therefore serum C-peptide control is advisable in order to reduce the risk of low bone mineral density.	[Li, Ying] Zhejiang Univ, Dept Social Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Liu, Hua] Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Sato, Yasuto] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 2, Tokyo, Japan	Zhejiang University; Zhejiang University; Tokyo Women's Medical University	Li, Y (corresponding author), Zhejiang Univ, Dept Social Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China.	ying_li@zju.edu.cn		Liu, Hua/0000-0001-7729-1246				Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Centers for Disease Control and Prevention, NHANES AN REP GUID N; Centers for Disease Control and Prevention, LAB PROC MAN C PEPT; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P535, DOI 10.2307/2288115; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275; Fukunaga Y, 1997, ARCH INTERN MED, V157, P2668; GALLACHER SJ, 1993, DIABETIC MED, V10, P129, DOI 10.1111/j.1464-5491.1993.tb00029.x; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549; HAKEDA Y, 1991, Acta Anatomica Nipponica, V66, P215; HOOGWERF BJ, 1983, J CLIN ENDOCR METAB, V56, P60, DOI 10.1210/jcem-56-1-60; Hsu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055625; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; KAO CH, 1993, NUCL MED COMMUN, V14, P373, DOI 10.1097/00006231-199305000-00005; Kelsey J L, 1989, Public Health Rep, V104 Suppl, P14; LINDSAY R, 1992, J BONE MINER RES, V7, P55; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Marx N, 2013, DIABETES CARE, V36, P708, DOI 10.2337/dc12-1211; National Center for Health Statistics. Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR; Okazaki R, 1997, J CLIN ENDOCR METAB, V82, P2915, DOI 10.1210/jc.82.9.2915; PACINI G, 1990, J AM GERIATR SOC, V38, P1283, DOI 10.1111/j.1532-5415.1990.tb03449.x; Petrone A, 2005, DIABETES-METAB RES, V21, P271, DOI 10.1002/dmrr.549; Pinkney J., 2001, BR J DIABETES VASC D, V1, P103; RAPOPORT RM, 1985, EUR J PHARMACOL, V110, P203, DOI 10.1016/0014-2999(85)90212-2; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shafqat J, 2002, CELL MOL LIFE SCI, V59, P1185, DOI 10.1007/s00018-002-8496-5; Terada M, 1998, BONE, V22, P17, DOI 10.1016/S8756-3282(97)00220-2; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; VANDAELE PLA, 1995, ANN INTERN MED, V122, P409, DOI 10.7326/0003-4819-122-6-199503150-00002; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; Yoon HJ, 2012, DIABETES METAB J, V36, P379, DOI 10.4093/dmj.2012.36.5.379; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhou YJ, 2010, DIABETES RES CLIN PR, V90, P261, DOI 10.1016/j.diabres.2010.09.013	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83107	10.1371/journal.pone.0083107	http://dx.doi.org/10.1371/journal.pone.0083107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358252	Green Submitted, gold, Green Published			2022-12-25	WOS:000328735700103
J	Papke, RL; Horenstein, NA; Kulkarni, AR; Stokes, C; Corrie, LW; Maeng, CY; Thakur, GA				Papke, Roger L.; Horenstein, Nicole A.; Kulkarni, Abhijit R.; Stokes, Clare; Corrie, Lu W.; Maeng, Cheol-Young; Thakur, Ganesh A.			The Activity of GAT107, an Allosteric Activator and Positive Modulator of alpha 7 Nicotinic Acetylcholine Receptors (nAChR), Is Regulated by Aromatic Amino Acids That Span the Subunit Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Electrophysiology; Mutagenesis Site-specific; Nicotinic Acetylcholine Receptors; Structural Biology; Voltage Clamp	LIGAND-BINDING DOMAIN; AGONIST BINDING; PNU-120596; SITE; SELECTIVITY; DIVERSITY; AUGMENTS; RELEASE; RAT	GAT107, the (+)-enantiomer of racemic 4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, is a strong positive allosteric modulator (PAM) of 7 nicotinic acetylcholine receptor (nAChR) activation by orthosteric agonists with intrinsic allosteric agonist activities. The direct activation produced by GAT107 in electrophysiological studies is observed only as long as GAT107 is freely diffusible in solution, although the potentiating activity primed by GAT107 can persist for over 30 min after drug washout. Direct activation is sensitive to 7 nAChR antagonist methyllycaconitine, although the primed potentiation is not. The data are consistent with GAT107 activity arising from two different sites. We show that the coupling between PAMs and the binding of orthosteric ligands requires tryptophan 55 (Trp-55), which is located at the subunit interface on the complementary surface of the orthosteric binding site. Mutations of Trp-55 increase the direct activation produced by GAT107 and reduce or prevent the synergy between allosteric and orthosteric binding sites, so that these mutants can also be directly activated by other PAMs such as PNU-120596 and TQS, which do not activate wild-type 7 in the absence of orthosteric agonists. We identify Tyr-93 as an essential element for orthosteric activation, because Y93C mutants are insensitive to orthosteric agonists but respond to GAT107. Our data show that both orthosteric and allosteric activation of 7 nAChR require cooperative activity at the interface between the subunits in the extracellular domain. These cooperative effects rely on key aromatic residues, and although mutations of Trp-55 reduce the restraints placed on the requirement for orthosteric agonists, Tyr-93 can conduct both orthosteric activation and desensitization among the subunits.	[Papke, Roger L.; Stokes, Clare; Corrie, Lu W.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Kulkarni, Abhijit R.; Thakur, Ganesh A.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Kulkarni, Abhijit R.; Thakur, Ganesh A.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Maeng, Cheol-Young] SK Biopharmaceut, Taejon 305712, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northeastern University; Northeastern University; SK Group	Papke, RL (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Acad Res Bldg,Rm R5-234,POB 100267,1200 Newell Dr, Gainesville, FL 32610 USA.	rlpapke@ufl.edu; g.thakur@neu.edu			National Institutes of Health [GM57481, DA027113]; NATIONAL EYE INSTITUTE [R01EY024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM57481 (to R. L. P.) and DA027113 (to G. A. T.).	Akk G, 2001, J PHYSIOL-LONDON, V535, P729, DOI 10.1111/j.1469-7793.2001.00729.x; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Brejc K, 2002, NOVART FDN SYMP, V245, P22; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; Corringer PJ, 1998, J NEUROSCI, V18, P648; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hajos M, 2010, CURR PHARM DESIGN, V16, P538, DOI 10.2174/138161210790361434; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kulkarni AR, 2013, TETRAHEDRON LETT, V54, P6592, DOI 10.1016/j.tetlet.2013.09.107; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Peng C, 2013, MOL PHARMACOL, V84, P459, DOI 10.1124/mol.113.086462; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Stewart DS, 2006, BIOCHEMISTRY-US, V45, P10641, DOI 10.1021/bi060686t; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thakur GA, 2013, J MED CHEM, V56, P8943, DOI 10.1021/jm401267t; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Thomsen MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027014; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	39	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4515	4531		10.1074/jbc.M113.524603	http://dx.doi.org/10.1074/jbc.M113.524603			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362025	Green Published, hybrid			2022-12-25	WOS:000331403800059
J	Tracy, CM; Gray, AJ; Cuellar, J; Shaw, TS; Howlett, AC; Taylor, RM; Prince, JT; Ahn, NG; Valpuesta, JM; Willardson, BM				Tracy, Christopher M.; Gray, Amy J.; Cuellar, Jorge; Shaw, Tanner S.; Howlett, Alyson C.; Taylor, Ryan M.; Prince, John T.; Ahn, Natalie G.; Valpuesta, Jose M.; Willardson, Barry M.			Programmed Cell Death Protein 5 Interacts with the Cytosolic Chaperonin Containing Tailless Complex Polypeptide 1 (CCT) to Regulate beta-Tubulin Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chaperone Chaperonin; Electron Microscopy (EM); Protein Folding; Tubulin; Programmed Cell Death Protein 5	PHOSDUCIN-LIKE PROTEIN; GROUP-II CHAPERONIN; GAMMA-DIMER; LID CLOSURE; MOLECULAR CHAPERONES; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; MECHANISM	Programmed cell death protein 5 (PDCD5) has been proposed to act as a pro-apoptotic factor and tumor suppressor. However, the mechanisms underlying its apoptotic function are largely unknown. A proteomics search for binding partners of phosducin-like protein, a co-chaperone for the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT), revealed a robust interaction between PDCD5 and CCT. PDCD5 formed a complex with CCT and -tubulin, a key CCT-folding substrate, and specifically inhibited -tubulin folding. Cryo-electron microscopy studies of the PDCD5CCT complex suggested a possible mechanism of inhibition of -tubulin folding. PDCD5 bound the apical domain of the CCT subunit, projecting above the folding cavity without entering it. Like PDCD5, -tubulin also interacts with the CCT apical domain, but a second site is found at the sensor loop deep within the folding cavity. These orientations of PDCD5 and -tubulin suggest that PDCD5 sterically interferes with -tubulin binding to the CCT apical domain and inhibits -tubulin folding. Given the importance of tubulins in cell division and proliferation, PDCD5 might exert its apoptotic function at least in part through inhibition of -tubulin folding.	[Tracy, Christopher M.; Gray, Amy J.; Shaw, Tanner S.; Howlett, Alyson C.; Taylor, Ryan M.; Prince, John T.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Cuellar, Jorge; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Ahn, Natalie G.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Brigham Young University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Colorado System; University of Colorado Boulder	Willardson, BM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	bmwillardson@chem.byu.edu	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Cuéllar, Jorge/GOH-3100-2022; Cuéllar, Jorge/S-4269-2017	Valpuesta, José M/0000-0001-7468-8053; Cuéllar, Jorge/0000-0002-7789-807X; Cuéllar, Jorge/0000-0002-7789-807X; Willardson, Barry/0000-0002-8503-2268	National Institutes of Health [GM078550]; MINECO Grant [BFU2010-15703]; Madrid Regional Government Grant [S2009MAT-1507]; NATIONAL EYE INSTITUTE [R01EY012287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO Grant(Spanish Government); Madrid Regional Government Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078550 (to B. M. W.). This work was also supported by MINECO Grant BFU2010-15703 (to J. M. V.) and Madrid Regional Government Grant S2009MAT-1507 (to J. M. V.).	Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Han XR, 2012, CELL SIGNAL, V24, P1713, DOI 10.1016/j.cellsig.2012.04.011; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; Lai CWJ, 2013, J NEUROSCI, V33, P7941, DOI 10.1523/JNEUROSCI.5001-12.2013; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li HY, 2008, ONCOL REP, V20, P573, DOI 10.3892/or_00000044; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prince JT, 2008, BIOINFORMATICS, V24, P2796, DOI 10.1093/bioinformatics/btn513; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007; Shen PS, 2012, J VIROL, V86, P7907, DOI 10.1128/JVI.00407-12; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Spinola M, 2006, J CLIN ONCOL, V24, P1672, DOI 10.1200/JCO.2005.04.4339; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Xu LJ, 2012, APOPTOSIS, V17, P1235, DOI 10.1007/s10495-012-0754-x; Xu LJ, 2009, NEOPLASIA, V11, P345, DOI 10.1593/neo.81524; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yao HW, 2009, ARCH BIOCHEM BIOPHYS, V486, P141, DOI 10.1016/j.abb.2009.03.018; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Zhang JJ, 2011, STRUCTURE, V19, P633, DOI 10.1016/j.str.2011.03.005; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	52	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4490	4502		10.1074/jbc.M113.542159	http://dx.doi.org/10.1074/jbc.M113.542159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375412	hybrid, Green Published			2022-12-25	WOS:000331403800057
J	Painter, JA; Graviss, EA; Hai, HH; Nhung, DTC; Nga, TTT; Ha, NP; Wall, K; Loan, LTH; Parker, M; Manangan, L; O'Brien, R; Maloney, SA; Hoekstra, RM; Reves, R				Painter, John A.; Graviss, Edward A.; Hoang Hoa Hai; Duong Thi Cam Nhung; Tran Thi Thanh Nga; Ha, Ngan P.; Wall, Kirsten; Le Thien Huong Loan; Parker, Matt; Manangan, Lilia; O'Brien, Rick; Maloney, Susan A.; Hoekstra, R. M.; Reves, Randall			Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON (R)-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; FOREIGN-BORN PERSONS; UNITED-STATES; DIAGNOSIS; INFECTION	Rationale: Each year 1 million persons acquire permanent U. S. residency visas after tuberculosis (TB) screening. Most applicants undergo a 2-stage screening with tuberculin skin test (TST) followed by CXR only if TST-positive at > 5 mm. Due to cross reaction with bacillus Calmette-Guerin (BCG), TST may yield false positive results in BCG-vaccinated persons. Interferon gamma release assays exclude antigens found in BCG. In Vietnam, like most high TB-prevalence countries, there is universal BCG vaccination at birth. Objectives: 1. Compare the sensitivity of QuantiFERON (R)-TB Gold In-Tube Assay (QFT) and TST for culture-positive pulmonary TB. 2. Compare the age-specific and overall prevalence of positive TST and QFT among applicants with normal and abnormal CXR. Methods: We obtained TST and QFT results on 996 applicants with abnormal CXR, of whom 132 had TB, and 479 with normal CXR. Results: The sensitivity for tuberculosis was 86.4% for QFT; 89.4%, 81.1%, and 52.3% for TST at 5, 10, and 15 mm. The estimated prevalence of positive results at age 15-19 years was 22% and 42% for QFT and TST at 10 mm, respectively. The prevalence increased thereafter by 0.7% year of age for TST and 2.1% for QFT, the latter being more consistent with the increase in TB among applicants. Conclusions: During 2-stage screening, QFT is as sensitive as TST in detecting TB with fewer requiring CXR and being diagnosed with LTBI. These data support the use of QFT over TST in this population.	[Painter, John A.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Graviss, Edward A.; Ha, Ngan P.] Methodist Hosp Res Inst, Houston, TX USA; [Hoang Hoa Hai; Duong Thi Cam Nhung; Tran Thi Thanh Nga; Le Thien Huong Loan] Cho Ray Hosp, Visa Med Unit, Ho Chi Minh City, Vietnam; [Wall, Kirsten; Parker, Matt; Reves, Randall] Denver Hlth & Hosp Author, Denver, CO USA; [Manangan, Lilia] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [O'Brien, Rick] Fdn Innovat New Diagnost, Geneva, Switzerland; [Maloney, Susan A.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Hoekstra, R. M.] Ctr Dis Control & Prevent, Biostat & Informat Management Off, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Denver Health Medical Center; Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Painter, JA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	jpainter@cdc.gov	Hải, Hoàng/GXA-2392-2022	Hoekstra, Robert Michael/0000-0002-0340-8015	Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention	Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention	Funding for the study was achieved through the Tuberculosis Epidemiologic Studies Consortium (TBESC) of the United States Centers for the Disease Control and Prevention. QuantiFERON (R)-TB Gold In-Tube Assay kits were provided by the Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CDCP, 2008, TECHN INSTR MED EX A; *CDCP, 2009, TECHN INSTR MED EX A; *CDCP, 2007, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P333; Czajkowski M, 2008, STAT MED, V27, P1508, DOI 10.1002/sim.3017; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Jacobs S, 2011, PEDIATR INFECT DIS J, V30, P754, DOI 10.1097/INF.0b013e31821b8f54; Kent PT, 1985, GUIDE LEVEL 3 LAB; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MONGER RY, 2012, ANN FLOW REPORT; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; REISNER BS, 1994, J CLIN MICROBIOL, V32, P2995, DOI 10.1128/JCM.32.12.2995-2998.1994; Reves RR, 2012, AM J RESP CRIT CARE, V186, pI, DOI 10.1164/rccm.201206-1039ED; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; Team R. D. C, 2011, R LANG ENV STAT COMP; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; *WHO, 2010, GLOB TUB CONTR 2011; Wickaham H., 2009, GGPLOT2 ELEGANT GRAP; Winje BA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-140; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012; 2011, J AM COLL HLTH, V59, P670	37	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e82727	10.1371/journal.pone.0082727	http://dx.doi.org/10.1371/journal.pone.0082727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367546	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900012
J	Shen, B; He, PJ; Shao, CL				Shen, Bo; He, Pei-Jie; Shao, Chun-Lin			Norcantharidin Induced DU145 Cell Apoptosis through ROS-Mediated Mitochondrial Dysfunction and Energy Depletion	PLOS ONE			English	Article							ORAL-CANCER CELLS; CASPASE; GROWTH; PROLIFERATION; INHIBITION; ACTIVATION; AMPK	Norcantharidin (NCTD), a demethylated analog of cantharidin derived from blister beetles, has attracted considerable attentions in recent years due to their definitely toxic properties and the noteworthy advantages in stimulating bone marrow and increasing the peripheral leukocytes. Hence, it is worth studying the anti-tumor effect of NCTD on human prostate cancer cells DU145. It was found that after the treatment of NCTD with different concentrations (25-100 mu M), the cell proliferation was significantly inhibited, which led to the appearance of micronucleus (MN). Moreover, the cells could be killed in a dose-/ time-dependent manner along with the reduction of PCNA (proliferating cell nuclear antigen) expression, destruction of mitochondrial membrane potential (MMP), down-regulation of MnSOD, induction of ROS, depletion of ATP, and activation of AMPK (Adenosine 5'-monophosphate -activated protein kinase). In addition, a remarkable release of cytochrome c was found in the cells exposed to 100 mu M NCTD and exogenous SOD-PEG could eliminate the generation of NCTD-induced MN. In conclusion, our studies indicated that NCTD could induce the collapse of MMP and mitochondria dysfunction. Accumulation of intercellular ROS could eventually switch on the apoptotic pathway by causing DNA damage and depleting ATP.	[Shen, Bo; Shao, Chun-Lin] Fudan Univ, Inst Radiat Med, Shanghai 200433, Peoples R China; [He, Pei-Jie] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shen, B (corresponding author), Fudan Univ, Inst Radiat Med, Shanghai 200433, Peoples R China.	shenbo@fudan.edu.cn; clshao@shmu.edu.cn		Shao, Chunlin/0000-0001-9336-9912	National Natural Science Foundation of China [11105031]; Youth Foundation of Fudan University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Fudan University of China	This study was supported the by the National Natural Science Foundation of China (No. 11105031) (http://www.nsfc.gov.cn/Portal0/default152.html) and the Youth Foundation of Fudan University of China (http://dst.fudan.edu.cn/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, J KOREAN MED SCI, V19, P560, DOI 10.3346/jkms.2004.19.4.560; An WW, 2004, ACTA PHARMACOL SIN, V25, P1502; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-145; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Chen YC, 2009, LIFE SCI, V84, P218, DOI 10.1016/j.lfs.2008.11.020; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Fan YZ, 2010, HEPATOB PANCREAT DIS, V9, P414; Fan Yue-Zu, 2004, Hepatobiliary Pancreat Dis Int, V3, P603; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gast RE, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-28; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Hong CY, 2000, BIOCHEM BIOPH RES CO, V276, P278, DOI 10.1006/bbrc.2000.3341; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Kok SH, 2003, ORAL ONCOL, V39, P19, DOI 10.1016/S1368-8375(01)00129-4; Kuo JH, 2010, INT J ONCOL, V37, P1243, DOI 10.3892/ijo_00000775; Liao HF, 2007, FOOD CHEM TOXICOL, V45, P1678, DOI 10.1016/j.fct.2007.03.003; Liao HF, 2011, TOXICOL IN VITRO, V25, P206, DOI 10.1016/j.tiv.2010.11.001; LIU XH, 1995, EUR J CANCER, V31A, P953, DOI 10.1016/0959-8049(95)00050-X; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Meador JA, 2008, ONCOGENE, V27, P5662, DOI 10.1038/onc.2008.187; Miyaguchi Chosei, 2004, Physiological Chemistry and Physics and Medical NMR, V36, P21; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Takeuchi I, 2012, PROSTATE, V72, P1124, DOI 10.1002/pros.22460; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; VERMA A, 1982, PHOTOCHEM PHOTOBIOL, V36, P627, DOI 10.1111/j.1751-1097.1982.tb09482.x; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074; Yang PQ, 2010, CHINESE J MED, V45, P11; Yang Yan, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P594; YI SN, 1991, LEUKEMIA RES, V15, P883, DOI 10.1016/0145-2126(91)90163-N; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; Zou J, 2012, GLIA, V60, P661, DOI 10.1002/glia.22302	44	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84610	10.1371/journal.pone.0084610	http://dx.doi.org/10.1371/journal.pone.0084610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367681	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900057
J	Stewart, ZP; Oxborough, RM; Tungu, PK; Kirby, MJ; Rowland, MW; Irish, SR				Stewart, Zachary P.; Oxborough, Richard M.; Tungu, Patrick K.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.			Indoor Application of Attractive Toxic Sugar Bait (ATSB) in Combination with Mosquito Nets for Control of Pyrethroid-Resistant Mosquitoes	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; ALTERNATIVE INSECTICIDES; MALARIA VECTORS; POPULATIONS; CHLORFENAPYR; ARABIENSIS; EFFICACY; DIPTERA	Background: Attractive toxic sugar bait (ATSB) sprayed onto vegetation has been successful in controlling Anopheles mosquitoes outdoors. Indoor application of ATSB has yet to be explored. The purpose of this study was to determine whether ATSB stations positioned indoors have the potential to kill host-seeking mosquitoes and constitute a new approach to control of mosquito-borne diseases. Methods: Insecticides were mixed with dyed sugar solution and tested as toxic baits against Anopheles arabiensis, An. Gambiae s. s. and Culex quinquefasciatus in feeding bioassay tests to identify suitable attractant-insecticide combinations. The most promising ATSB candidates were then trialed in experimental huts in Moshi, Tanzania. ATSB stations were hung in huts next to untreated mosquito nets occupied by human volunteers. The proportions of mosquitoes killed in huts with ATSB treatments relative to huts with non-insecticide control treatments huts were recorded, noting evidence of dye in mosquito abdomens. Results: In feeding bioassays, chlorfenapyr 0.5% v/v, boric acid 2% w/v, and tolfenpyrad 1% v/v, mixed in a guava juice-based bait, each killed more than 90% of pyrethroid-susceptible An. Gambiae s. s. and pyrethroid-resistant An. arabiensis and Cx. quinquefasciatus. In the hut trial, mortality rates of the three ATSB treatments ranged from 41-48% against An. arabiensis and 36-43% against Cx. quinquefasciatus and all were significantly greater than the control mortalities: 18% for An. arabiensis, 7% for Cx. quinquefasciatus (p< 0.05). Mortality rates with ATSB were comparable to those with long lasting insecticidal nets previously tested against the same species in this area. Conclusions: Indoor ATSB shows promise as a supplement to mosquito nets for controlling mosquitoes. Indoor ATSB constitute a novel application method for insecticide classes that act as stomach poisons and have not hitherto been exploited for mosquito control. Combined with LLIN, indoor use of ATSB has the potential to serve as a strategy for managing insecticide resistance.	[Stewart, Zachary P.; Oxborough, Richard M.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.] Univ London London Sch Hyg & Trop Med, Fac Infect Trop Dis, London WC1E 7HT, England; [Stewart, Zachary P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Oxborough, Richard M.; Tungu, Patrick K.; Kirby, Matthew J.; Rowland, Mark W.; Irish, Seth R.] Pan African Malaria Vector Res Consortium PAMVERC, Moshi, Tanzania; [Oxborough, Richard M.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll KCMUCo, Dept Parasitol & Entomol, Moshi, Tanzania; [Tungu, Patrick K.] Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania; [Kirby, Matthew J.] Malaria Consortium, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Nebraska System; University of Nebraska Lincoln; National Institute of Medical Research	Irish, SR (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect Trop Dis, Keppel St, London WC1E 7HT, England.	seth.irish@lshtm.ac.uk		Stewart, Zachary/0000-0003-4058-8526	London School of Hygiene; Tropical Medicine; Helena Vrbova; Gordon Smith Scholarships	London School of Hygiene; Tropical Medicine; Helena Vrbova; Gordon Smith Scholarships	This work was supported by the London School of Hygiene and Tropical Medicine and Helena Vrbova and Gordon Smith Scholarships. The funders played no role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PESTICIDES THEIR APP; [Anonymous], 2011, TECHN BAS ACT INS RE; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Curtis CF, 1998, PHILOS T ROY SOC B, V353, P1769, DOI 10.1098/rstb.1998.0329; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; EBELING W, 1966, J ECON ENTOMOL, V59, P1374, DOI 10.1093/jee/59.6.1374; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; Mosha FW, 2008, ANN TROP MED PARASIT, V102, P367, DOI 10.1179/136485908X278829; Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ngufor C, 2011, MALARIA J, V16, P10; Raghavendra K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-16; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rowland M, 2012, OUTLOOK PEST MANAG, V23, P150, DOI [DOI 10.1564/23AUG01, 10.1564/23aug01]; Rowland M, 2009, ACS SYM SER, V1014, P13, DOI 10.1021/bk-2009-1014.ch002; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Stone CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-3; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2012, WHO GLOB MAL PROGR G; Xue RD, 2003, J ECON ENTOMOL, V96, P1559, DOI 10.1603/0022-0493-96.5.1559; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	31	55	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84168	10.1371/journal.pone.0084168	http://dx.doi.org/10.1371/journal.pone.0084168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367638	Green Accepted, Green Published, gold			2022-12-25	WOS:000328741900035
J	Brassey, CA; Holdaway, RN; Packham, AG; Anne, J; Manning, PL; Sellers, WI				Brassey, Charlotte A.; Holdaway, Richard N.; Packham, Abigail G.; Anne, Jennifer; Manning, Philip L.; Sellers, William I.			More than One Way of Being a Moa: Differences in Leg Bone Robustness Map Divergent Evolutionary Trajectories in Dinornithidae and Emeidae (Dinornithiformes)	PLOS ONE			English	Article							NEW-ZEALAND; AVES DINORNITHIFORMES; MECHANICAL-PROPERTIES; LIMB POSTURE; GROWTH; REVEAL; MASS; ALLOMETRY; STRUTHIO; KINETICS	The extinct moa of New Zealand included three families (Megalapterygidae; Dinornithidae; Emeidae) of flightless palaeognath bird, ranging in mass from < 15 kg to > 200 kg. They are perceived to have evolved extremely robust leg bones, yet current estimates of body mass have very wide confidence intervals. Without reliable estimators of mass, the extent to which dinornithid and emeid hindlimbs were more robust than modern species remains unclear. Using the convex hull volumetric-based method on CT-scanned skeletons, we estimate the mass of a female Dinornis robustus (Dinornithidae) at 196 kg (range 155-245 kg) and of a female Pachyornis australis (Emeidae) as 50 kg (range 33-68 kg). Finite element analysis of CT-scanned femora and tibiotarsi of two moa and six species of modern palaeognath showed that P. australis experienced the lowest values for stress under all loading conditions, confirming it to be highly robust. In contrast, stress values in the femur of D. robustus were similar to those of modern flightless birds, whereas the tibiotarsus experienced the highest level of stress of any palaeognath. We consider that these two families of Dinornithiformes diverged in their biomechanical responses to selection for robustness and mobility, and exaggerated hindlimb strength was not the only successful evolutionary pathway.	[Brassey, Charlotte A.; Packham, Abigail G.; Sellers, William I.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Anne, Jennifer; Manning, Philip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Manchester; University of Canterbury; University of Manchester	Brassey, CA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	charlotte.brassey-2@postgrad.manchester.ac.uk	Sellers, William Irvin/Q-3843-2019; Brassey, Charlotte A/R-2029-2017; Manning, Phillip/F-9966-2011	Sellers, William Irvin/0000-0002-2913-5406; Brassey, Charlotte A/0000-0002-6552-541X; Manning, Phillip/0000-0002-7161-6246	Natural Environment Research Council Doctoral Training Grant [NE/1528134/1]; Engineering and Physical Sciences Research Council [EP/F007906, EP/I02249X]	Natural Environment Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a Natural Environment Research Council Doctoral Training Grant (NE/1528134/1). The Henry Moseley X-Ray Imaging Facility (University of Manchester) is supported by the Engineering and Physical Sciences Research Council under nos. EP/F007906 and EP/I02249X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1983, J ZOOL, V201, P363; ALEXANDER RM, 1983, J ZOOL, V200, P215; ALEXANDER RM, 1985, ACTA BIOTHEOR, V34, P165, DOI 10.1007/BF00046782; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Bourdon E, 2009, BIOL LETTERS, V5, P639, DOI 10.1098/rsbl.2009.0310; Brassey CA, 2013, ANAT REC, V296, P395, DOI 10.1002/ar.22658; Brassey CA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0823; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BURROWS C J, 1981, Records of the Canterbury Museum, V9, P309; CRACRAFT J, 1976, Paleobiology, V2, P166; Cubo J, 1997, NETH J ZOOL, V47, P209, DOI 10.1163/156854297X00175; Cubo J, 2000, EUR J MORPHOL, V38, P112, DOI 10.1076/0924-3860(200004)38:2;1-F;FT112; Currey J.D., 2006, BONES STRUCTURE MECH; Currey JD, 1999, J EXP BIOL, V202, P2495; CURREY JD, 1985, J ZOOL, V206, P453; Currey JD, 2007, J R SOC INTERFACE, V4, P127, DOI 10.1098/rsif.2006.0166; Dickison M, 2009, THESIS DUKE U; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Goonewardene LA, 2003, J APPL POULTRY RES, V12, P27, DOI 10.1093/japr/12.1.27; HAZLEHURST GA, 1992, PALEOBIOLOGY, V18, P447, DOI 10.1017/S009483730001099X; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; NOBLE JC, 1991, REV CHIL HIST NAT, V64, P85; Panagiotopoulou O, 2012, J R SOC INTERFACE, V9, P351, DOI 10.1098/rsif.2011.0323; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Picasso MBJ, 2012, J ZOOL, V286, P303, DOI 10.1111/j.1469-7998.2011.00880.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; R Core Team, 2021, R LANG ENV STAT COMP; Ramos A, 2006, MED ENG PHYS, V28, P916, DOI 10.1016/j.medengphy.2005.12.006; Rawlence NJ, 2012, QUATERNARY SCI REV, V50, P141, DOI 10.1016/j.quascirev.2012.07.004; Reid B., 1987, International Zoo Yearbook, V26, P189; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Smith NC, 2010, J EXP BIOL, V213, P1347, DOI 10.1242/jeb.020271; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Tennyson AJD, 2010, REC AUST MUS, V62, P105, DOI 10.3853/j.0067-1975.62.2010.1546; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Welty J.C., 1988, LIFE BIRDS, V4th edn; Wood JR, 2013, P NATL ACAD SCI USA, V110, P16910, DOI 10.1073/pnas.1307700110; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy T. H., 2002, LOST WORLD MOA PREHI; WORTHY TH, 1991, J ROY SOC NEW ZEAL, V21, P101; Worthy TH, 2013, P 8 M SOC AV PAL EV	53	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82668	10.1371/journal.pone.0082668	http://dx.doi.org/10.1371/journal.pone.0082668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367537	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000328740300053
J	Gonzalez-Cabrera, J; Davies, TGE; Field, LM; Kennedy, PJ; Williamson, MS				Gonzalez-Cabrera, Joel; Davies, T. G. Emyr; Field, Linda M.; Kennedy, Peter J.; Williamson, Martin S.			An Amino Acid Substitution (L925V) Associated with Resistance to Pyrethroids in Varroa destructor	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; FLUVALINATE-RESISTANCE; MITE; MUTATIONS; JACOBSONI; IDENTIFICATION; SENSITIVITY	The Varroa mite, Varroa destructor, is an important pest of honeybees and has played a prominent role in the decline in bee colony numbers over recent years. Although pyrethroids such as tau-fluvalinate and flumethrin can be highly effective in removing the mites from hives, their intensive use has led to many reports of resistance. To investigate the mechanism of resistance in UK Varroa samples, the transmembrane domain regions of the V. destructor voltage-gated sodium channel (the main target site for pyrethroids) were PCR amplified and sequenced from pyrethroid treated/untreated mites collected at several locations in Central/Southern England. A novel amino acid substitution, L925V, was identified that maps to a known hot spot for resistance within the domain IIS5 helix of the channel protein; a region that has also been proposed to form part of the pyrethroid binding site. Using a high throughput diagnostic assay capable of detecting the mutation in individual mites, the L925V substitution was found to correlate well with resistance, being present in all mites that had survived tau-fluvalinate treatment but in only 8 % of control, untreated samples. The potential for using this assay to detect and manage resistance in Varroa-infected hives is discussed.	[Gonzalez-Cabrera, Joel; Davies, T. G. Emyr; Field, Linda M.; Kennedy, Peter J.; Williamson, Martin S.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Gonzalez-Cabrera, J (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England.	joel.gonzalez@rothamsted.ac.uk	Davies, Thomas G. Emyr/C-2795-2017; Gonzalez-Cabrera, Joel/B-2279-2013	Davies, Thomas G. Emyr/0000-0002-9452-2947; Gonzalez-Cabrera, Joel/0000-0002-8338-370X; Field, Linda/0000-0002-3328-2513	Marie Curie Intra European Fellowship; Biotechnology and Biological Sciences Research Council of the United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193] Funding Source: UKRI	Marie Curie Intra European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Joel Gonzalez-Cabrera-Cabrera was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework. http://ec.europa.eu/research/mariecurieactions/index_en.htm. Rothamsted Research is supported by the Biotechnology and Biological Sciences Research Council of the United Kingdom. http://bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Bak B, 2012, MED WETER, V68, P603; Baxter JR, 2000, AM BEE J, V140, P898; Bell J., 1999, AM BEE J, V139, P308; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dietemann V, 2013, COLOSS BEEBOOK, V2; Elzen PJ, 1998, AM BEE J, V138, P674; Gracia-Salinas MJ, 2006, J APICULT RES, V45, P101, DOI 10.1080/00218839.2006.11101326; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Gregorc A, 2012, J APIC SCI, V56, P61, DOI 10.2478/v10289-012-0024-8; Karatolos N, 2012, PEST MANAG SCI, V68, P834, DOI 10.1002/ps.2334; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Liu ZQ, 2006, INSECT BIOCHEM MOLEC, V36, P885, DOI 10.1016/j.ibmb.2006.08.006; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Martin S, 1998, APIDOLOGIE, V29, P369, DOI 10.1051/apido:19980407; MILANI N, 1995, APIDOLOGIE, V26, P415, DOI 10.1051/apido:19950507; Morgan JAT, 2009, INT J PARASITOL, V39, P775, DOI 10.1016/j.ijpara.2008.12.006; Mozes-Koch R, 2000, EXP APPL ACAROL, V24, P35, DOI 10.1023/A:1006379114942; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Soderlund DM, 2001, NEUROTOXICOLOGY, V22, P755, DOI 10.1016/S0161-813X(01)00065-1; Stanton JM, 1998, AUSTRALAS PLANT PATH, V27, P112, DOI 10.1071/AP98014; Thompson HM, 2002, APIDOLOGIE, V33, P357, DOI 10.1051/apido:2002027; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7; Wang RW, 2002, J APICULT RES, V41, P17, DOI 10.1080/00218839.2002.11101064; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; 김원태, 2009, Journal of Apiculture, V24, P159	34	55	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82941	10.1371/journal.pone.0082941	http://dx.doi.org/10.1371/journal.pone.0082941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367572	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300083
J	Gyorffy, B; Surowiak, P; Budczies, J; Lanczky, A				Gyorffy, Balazs; Surowiak, Pawel; Budczies, Jan; Lanczky, Andras			Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; SQUAMOUS-CELL; STAGE-I; MARKER; ADENOCARCINOMA; METAANALYSIS; PREDICTION; RECEPTOR; OSTEOPONTIN	In the last decade, optimized treatment for non-small cell lung cancer had lead to improved prognosis, but the overall survival is still very short. To further understand the molecular basis of the disease we have to identify biomarkers related to survival. Here we present the development of an online tool suitable for the real-time meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival. We searched the caBIG, GEO and TCGA repositories to identify samples with published gene expression data and survival information. Univariate and multivariate Cox regression analysis, Kaplan-Meier survival plot with hazard ratio and logrank P value are calculated and plotted in R. The complete analysis tool can be accessed online at: www.kmplot.com/lung. All together 1,715 samples of ten independent datasets were integrated into the system. As a demonstration, we used the tool to validate 21 previously published survival associated biomarkers. Of these, survival was best predicted by CDK1 (p<1E-16), CD24 (p<1E-16) and CADM1 (p = 7E-12) in adenocarcinomas and by CCNE1 (p = 2.3E-09) and VEGF (p = 3.3E-10) in all NSCLC patients. Additional genes significantly correlated to survival include RAD51, CDKN2A, OPN, EZH2, ANXA3, ADAM28 and ERCC1. In summary, we established an integrated database and an online tool capable of uni- and multivariate analysis for in silico validation of new biomarker candidates in non-small cell lung cancer.	[Gyorffy, Balazs; Lanczky, Andras] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary; [Surowiak, Pawel] Wroclaw Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Budczies, Jan] Charite, Inst Pathol, D-13353 Berlin, Germany	Hungarian Academy of Sciences; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gyorffy, B (corresponding author), Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary.	zsalab2@yahoo.com	Gyorffy, Balazs/AAA-9135-2021; Budczies, Jan/AAG-8122-2020	Gyorffy, Balazs/0000-0002-5772-3766; Surowiak, Pawel/0000-0002-4241-5197	OTKA [PD 83154]; EU Health [259303, 2010.2.4.1.-8]; KTIA [U_BONUS_12-1-2013-0003]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU Health; KTIA	The authors work was supported by the OTKA PD 83154 grant, by the Predict project (grant no. 259303 of the EU Health. 2010.2.4.1.-8 call) and by the KTIA U_BONUS_12-1-2013-0003 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, CANCER RES, V56, P1751; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BOTLING J, 2012, CLIN CANC RES; Boyle P, 1996, INT J CANCER, V67, P63, DOI 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-D; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Chambers AF, 1996, LUNG CANCER-J IASLC, V15, P311, DOI 10.1016/0169-5002(95)00595-1; Chen YB, 2011, CHINESE MED J-PEKING, V124, P3238, DOI 10.3760/cma.j.issn.0366-6999.2011.20.006; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; FORD CHJ, 1981, BRIT J CANCER, V44, P145, DOI 10.1038/bjc.1981.164; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang LN, 2012, CLIN CHIM ACTA, V413, P663, DOI 10.1016/j.cca.2011.12.020; Huqun, 2012, CANCER-AM CANCER SOC, V118, P1599, DOI 10.1002/cncr.26441; Jin ML, 2001, LUNG CANCER-J IASLC, V34, P207, DOI 10.1016/S0169-5002(01)00225-2; Kuroda H, 2010, INT J CANCER, V127, P1844, DOI 10.1002/ijc.25212; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee HJ, 2010, J THORAC ONCOL, V5, P649, DOI 10.1097/JTO.0b013e3181d5e554; Liu YF, 2009, J PATHOL, V217, P54, DOI 10.1002/path.2429; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Schneider S, 2004, CLIN CANCER RES, V10, P1588, DOI 10.1158/1078-0432.CCR-0565-3; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tanaka S, 2012, PATHOBIOLOGY, V79, P24, DOI 10.1159/000331230; Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0; Tsuna M, 2009, ANTICANCER RES, V29, P2547; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Xi LQ, 2005, CLIN CANCER RES, V11, P4128, DOI 10.1158/1078-0432.CCR-04-2525; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Zhan P, 2009, J THORAC ONCOL, V4, P1094, DOI 10.1097/JTO.0b013e3181a97e31; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; Zhang LQ, 2012, CLIN LUNG CANCER, V13, P188, DOI 10.1016/j.cllc.2011.10.003; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	48	1220	1241	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82241	10.1371/journal.pone.0082241	http://dx.doi.org/10.1371/journal.pone.0082241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367507	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000328740300023
J	Hasan, MR; Sharma, R; Saraya, A; Chattopadhyay, TK; DattaGupta, S; Walfish, PG; Chauhan, SS; Ralhan, R				Hasan, Md Raghibul; Sharma, Rinu; Saraya, Anoop; Chattopadhyay, Tushar K.; DattaGupta, Siddartha; Walfish, Paul G.; Chauhan, Shyam S.; Ralhan, Ranju			Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TRANSCRIPTION FACTORS; LUNG ADENOCARCINOMA; BREAST-CANCER; EXPRESSION; MARKERS; EPIDEMIOLOGY; SNAIL; PROGRESSION	Background: Slug, a regulator of epithelial mesenchymal transition, was identified to be differentially expressed in esophageal squamous cell carcinoma (ESCC) using cDNA microarrays by our laboratory. This study aimed to determine the clinical significance of Slug overexpression in ESCC and determine its correlation with clinicopathological parameters and disease prognosis for ESCC patients. Methods: Immunohistochemical analysis of Slug expression was carried out in archived tissue sections from 91 ESCCs, 61 dysplastic and 47 histologically normal esophageal tissues. Slug immunopositivity in epithelial cells was correlated with clinicopathological parameters and disease prognosis over up to 7.5 years for ESCC patients. Results: Increased expression of Slug was observed in esophageal dysplasia [cytoplasmic, 24/61 (39.3%) cases, p = 0.001, odd's ratio (OR) = 4.7; nuclear, 11/61 (18%) cases, p < 0.001, OR = 1.36] in comparison with normal esophageal tissues. The Slug expression was further increased in ESCCs [cytoplasmic, 64/91 (70.3%) p < 0.001, OR = 10.0; nuclear, 27/91 (29.7%) p < 0.001, OR = 1.42]. Kaplan Meier survival analysis showed significant association of nuclear Slug accumulation with reduced disease free survival of ESCC patients (median disease free survival (DFS) = 6 months, as compared to those that did not show overexpression, DFS = 18 months; p = 0.006). In multivariate Cox regression analysis nuclear Slug expression [p=0.005, Hazard's ratio (HR) = 2.269, 95% CI = 1.289 -3.996] emerged as the most significant independent predictor of poor prognosis for ESCC patients. Conclusions: Alterations in Slug expression occur in early stages of development of ESCC and are sustained during disease progression. Slug may serve as a diagnostic biomarker and as a predictor of poor disease prognosis to identify ESCC patients that are likely to show recurrence of the disease.	[Hasan, Md Raghibul; Chauhan, Shyam S.; Ralhan, Ranju] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Sharma, Rinu] Guru Gobind Singh Indraprastha Univ, Sch Biotechnol, Delhi, India; [Saraya, Anoop] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Chattopadhyay, Tushar K.] All India Inst Med Sci, Dept Gastrointestinal Surg, New Delhi, India; [DattaGupta, Siddartha] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Univ Toronto, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; GGS Indraprastha University; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Chauhan, SS (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	s_s_chauhan@hotmail.com; rralhan@mtsinai.on.ca			Senior Research Fellowship from Department of Biotechnology, India; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics	Senior Research Fellowship from Department of Biotechnology, India; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR))	MRH is the recipient of Senior Research Fellowship from Department of Biotechnology, India. The financial support of this work from the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Behnsawy HM, 2013, BJU INT, V111, P30, DOI 10.1111/j.1464-410X.2012.11551.x; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giarnieri E, 2013, J CELL PHYSIOL, V228, P1720, DOI 10.1002/jcp.24300; Hajra KM, 2002, CANCER RES, V62, P1613; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jethwa P, 2008, WORLD J GASTROENTERO, V14, P1044, DOI 10.3748/wjg.14.1044; Kausar T, 2011, CANCER INVEST, V29, P42, DOI 10.3109/07357907.2010.512597; Kumar A, 2007, INT J CANCER, V120, P230, DOI 10.1002/ijc.22246; Lee JM, 2011, ANN SURG, V253, P918, DOI 10.1097/SLA.0b013e318216f374; Lee JM, 2011, ANN SURG ONCOL, V18, P2066, DOI 10.1245/s10434-011-1559-9; Liu MN, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-142; Markiewicz A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-226; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prasad CP, 2008, LIFE SCI, V83, P318, DOI 10.1016/j.lfs.2008.06.019; Ryan AM, 2011, CANCER EPIDEMIOL, V35, P309, DOI 10.1016/j.canep.2011.03.001; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Tang P, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-60; Tomizawa Y, 2012, ONCOL LETT, V3, P1059, DOI 10.3892/ol.2012.632; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Worni M, 2012, J AM COLL SURGEONS, V215, P643, DOI 10.1016/j.jamcollsurg.2012.07.006; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Zhang KJ, 2012, LAB INVEST, V92, P1801, DOI 10.1038/labinvest.2012.138	33	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82846	10.1371/journal.pone.0082846	http://dx.doi.org/10.1371/journal.pone.0082846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367561	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300074
J	Li, XX; Shen, YD; Huang, QQ; Fan, ZW; Huang, DD				Li, Xiaoxia; Shen, Yide; Huang, Qiaoqiao; Fan, Zhiwei; Huang, Dongdong			Regeneration Capacity of Small Clonal Fragments of the Invasive Mikania micrantha HBK: Effects of Burial Depth and Stolon Internode Length	PLOS ONE			English	Article							RHIZOME FRAGMENTS; SAND BURIAL; VEGETATIVE REGENERATION; REPENS L; GROWTH; SOIL; SURVIVAL; INTEGRATION; ALLOCATION; RESOURCES	The perennial stoloniferous herbaceous vine Mikania micrantha H. B. K. is among the most noxious exotic invaders in China and the world. Disturbance can fragment stolons of M. micrantha and disperse these fragments over long distances or bury them in soils at different depths. To test their regeneration capacity, single-node stolon fragments with stolon internode lengths of 0, 3, 6 and 12 cm were buried in soil at 0, 2, 5 and 8 cm depths, respectively. The fragments were growing for nine weeks, and their emergence status, growth and morphological traits were measured. The results indicated that increasing burial depth significantly decreased survival rate and increased the emergence time of the M. micrantha plants. At an 8-cm burial depth, very few fragments (2.19%) emerged and survived. Burial did not affect the total biomass and root to shoot ratio of the surviving M. micrantha plants that emerged from the 0- and 2-cm burial depths. Increasing internode length significantly increased survival rate and growth measures, but there was no interaction effect with burial depth for any traits measured. These results suggest that M. micrantha can regenerate from buried stolon fragments, and thus, disturbance may contribute to the spread of this exotic invader. Any human activities producing stolon fragments or facilitating dispersal should be avoided.	[Li, Xiaoxia; Shen, Yide; Huang, Qiaoqiao; Fan, Zhiwei; Huang, Dongdong] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Huang, QQ (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China.	Cosplete@126.com; Fanweed@163.com			Provincial Natural Science Found of Hainan [313084]; International Cooperative Project of the Ministry of Science and Technology [2011DFB30040]; Fundamental Research Funds for Environment and Plant Protection Institute, CATAS [2012hzs1J007-1]; Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds [201303031]; Key Science and Technology Project of Hainan Province [080149]	Provincial Natural Science Found of Hainan; International Cooperative Project of the Ministry of Science and Technology; Fundamental Research Funds for Environment and Plant Protection Institute, CATAS; Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds; Key Science and Technology Project of Hainan Province	This research is supported by the Provincial Natural Science Found of Hainan (313084), the International Cooperative Project of the Ministry of Science and Technology (2011DFB30040), the Fundamental Research Funds for Environment and Plant Protection Institute, CATAS (2012hzs1J007-1), the Project of Research on and Demonstrations of the Techniques in Monitoring and Managing Herbicide-Resistant Weeds (201303031), and the Key Science and Technology Project of Hainan Province (080149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine H, 2007, WEED BIOL MANAG, V7, P188, DOI 10.1111/j.1445-6664.2007.00255.x; BALDWIN KA, 1983, CAN J BOT, V61, P241, DOI 10.1139/b83-028; Balestri E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072598; BAURHOCH B, 1990, J EXP BOT, V41, P573, DOI 10.1093/jxb/41.5.573; Bimova K, 2003, PLANT ECOL, V166, P1, DOI 10.1023/A:1023299101998; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Chen BM, 2009, BIOL INVASIONS, V11, P1291, DOI 10.1007/s10530-008-9336-9; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; Cordazzo CV, 1999, J COASTAL RES, V15, P520; D'Hertefeldt T, 1998, OIKOS, V81, P229, DOI 10.2307/3547044; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dietz H, 2002, PLANT ECOL, V158, P171, DOI 10.1023/A:1015567316004; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; [范志伟 Fan Zhiwei], 2010, [热带作物学报, Chinese Journal of Tropical Crops], V31, P1596; Feng Hui-ling, 2002, Journal of Tropical and Subtropical Botany, V10, P263; Frosini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047561; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; Henry GM, 2007, WEED SCI, V55, P486, DOI 10.1614/WS-07-030.1; Hou YP, 2011, BIOL INVASIONS, V13, P381, DOI 10.1007/s10530-010-9830-8; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; KLIMES L, 1993, VEGETATIO, V109, P153, DOI 10.1007/BF00044747; Klingeman WE, 2004, HORTSCIENCE, V39, P746; LEAKEY RRB, 1978, ANN BOT-LONDON, V42, P205, DOI 10.1093/oxfordjournals.aob.a085441; Li SL, 2010, TREES-STRUCT FUNCT, V24, P515, DOI 10.1007/s00468-010-0422-0; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Pan Y, 2009, J AQUAT PLANT MANAGE, V47, P96; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ren MX, 2005, WEED RES, V45, P236, DOI 10.1111/j.1365-3180.2005.00445.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; Song YB, 2013, BIOL INVASIONS, V15, P1367, DOI 10.1007/s10530-012-0374-y; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; SYKES MT, 1990, ACTA BOT NEERL, V39, P171, DOI 10.1111/j.1438-8677.1990.tb01485.x; Wang T, 2008, J HERED, V99, P22, DOI 10.1093/jhered/esm080; Weber E, 2011, BIOL INVASIONS, V13, P2947, DOI 10.1007/s10530-011-9977-y; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu H, 2009, BIOL INVASIONS, V11, P835, DOI 10.1007/s10530-008-9297-z; YUAN T, 1993, FUNCT ECOL, V7, P676, DOI 10.2307/2390188; ZHANG JH, 1990, CAN J BOT, V68, P304, DOI 10.1139/b90-041; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	48	23	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84657	10.1371/journal.pone.0084657	http://dx.doi.org/10.1371/journal.pone.0084657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367686	Green Submitted, gold, Green Published			2022-12-25	WOS:000328740300153
J	Pandey, RN; Wang, TS; Tadjuidje, E; McDonald, MG; Rettie, AE; Hegde, RS				Pandey, Ram Naresh; Wang, Tim Sen; Tadjuidje, Emmanuel; McDonald, Matthew G.; Rettie, Allan E.; Hegde, Rashmi S.			Structure-Activity Relationships of Benzbromarone Metabolites and Derivatives as EYA Inhibitory Anti-Angiogenic Agents	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES ABSENT; DRUG-INTERACTIONS; CANCER; DEPHOSPHORYLATION; PROLIFERATION; SURVIVAL; MARKET; MODEL; 1B	The tyrosine phosphatase activity of the phosphatase-transactivator protein Eyes Absent (EYA) is angiogenic through its roles in endothelial cell migration and tube formation. Benzbromarone, a known anti-gout agent, was previously identified as an inhibitor of EYA with anti-angiogenic properties. Here we show that the major metabolite of BBR, 6-hydroxy benzbromarone, is a significantly more potent inhibitor of cell migration, tubulogenesis and angiogenic sprouting. In contrast, other postulated metabolites of BBR such as 5-hydroxy benzbromaorne and 1'-hydroxy benzbromarone are less potent inhibitors of EYA tyrosine phosphatase activity as well as being less effective in cellular assays for endothelial cell migration and angiogenesis. Longer substituents at the 2 position of the benzofuran ring promoted EYA3 binding and inhibition, but were less effective in cellular assays, likely reflecting nonspecific protein binding and a resulting reduction in free, bio-available inhibitor. The observed potency of 6-hydroxy benzbromarone is relevant in the context of the potential re-purposing of benzbromarone and its derivatives as anti-angiogenic agents. 6-hydroxy benzbromarone represents a metabolite with a longer half-life and greater pharmacological potency than the parent compound, suggesting that biotransformation of benzbromarone could contribute to its therapeutic activity.	[Pandey, Ram Naresh; Wang, Tim Sen; Tadjuidje, Emmanuel; Hegde, Rashmi S.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [McDonald, Matthew G.; Rettie, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Cincinnati Children's Hospital Medical Center; University of Washington; University of Washington Seattle	Hegde, RS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	rashmi.hegde@cchmc.org		Wang, Tim/0000-0001-5518-508X	National Institutes of Health, National Eye Institute [R01 EY014648]; NATIONAL EYE INSTITUTE [R01EY022917, R01EY014648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032165] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Eye Institute [Grant R01 EY014648]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; DEVRIES JX, 1993, CLIN INVESTIGATOR, V71, P947; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Jansen TLTA, 2004, CLIN EXP RHEUMATOL, V22, P651; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Locuson CW, 2003, DRUG METAB DISPOS, V31, P967, DOI 10.1124/dmd.31.7.967; Malamas MS, 2000, J MED CHEM, V43, P1293, DOI 10.1021/jm990560c; McDonald MG, 2012, CLIN PHARMACOL THER, V91, P709, DOI 10.1038/clpt.2011.283; McDonald MG, 2007, CHEM RES TOXICOL, V20, P1833, DOI 10.1021/tx7001228; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reed MJ, 2007, MICROVASC RES, V73, P248, DOI 10.1016/j.mvr.2007.02.002; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tadjuidje E, 2013, CELL MOL LIFE SCI, V70, P1897, DOI 10.1007/s00018-012-1144-9; Tadjuidje E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034806; Takahashi H, 1999, CLIN PHARMACOL THER, V66, P569, DOI 10.1016/S0009-9236(99)90064-4; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Trujillo TC, 2000, DRUG SAFETY, V23, P509, DOI 10.2165/00002018-200023060-00003; Uchida S, 2010, DRUG METAB PHARMACOK, V25, P605, DOI 10.2133/dmpk.DMPK-10-NT-040; WALTERSACK I, 1990, EUR J CLIN PHARMACOL, V39, P577, DOI 10.1007/BF00316099; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wrobel J, 1999, J MED CHEM, V42, P3199, DOI 10.1021/jm990260v; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Zhang L, 2005, CANCER RES, V65, P925	34	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e84582	10.1371/journal.pone.0084582	http://dx.doi.org/10.1371/journal.pone.0084582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367676	Green Published, gold, Green Submitted			2022-12-25	WOS:000328740300148
J	Rivera-Ordaz, A; Bracher, S; Sarrach, S; Li, Z; Shi, L; Quick, M; Hilger, D; Haas, R; Jung, H				Rivera-Ordaz, Araceli; Bracher, Susanne; Sarrach, Sannia; Li, Zheng; Shi, Lei; Quick, Matthias; Hilger, Daniel; Haas, Rainer; Jung, Heinrich			The Sodium/Proline Transporter PutP of Helicobacter pylori	PLOS ONE			English	Article							ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; SYMPORTER FAMILY; GASTRIC-CANCER; PROLINE UPTAKE; NA+; BINDING; PROTEIN	Helicobacter pylori is cause of chronic gastritis, duodenal ulcer and gastric carcinoma in humans. L-proline is a preferred energy source of the microaerophilic bacterium. Previous analyses revealed that HpputP and HpputA, the genes that are predicted to play a central role in proline metabolism as they encode for the proline transporter and proline dehydrogenase, respectively, are essential for stomach colonization. Here, the molecular basis of proline transport in H. pylori by HpPutP was investigated experimentally for the first time. Measuring radiolabeled substrate transport in H. pylori and E. coli heterologously expressing HpputP as well as in proteoliposomes reconstituted with HpPutP, we demonstrate that the observed proline transport in H. pylori is mediated by HpPutP. HpPutP is specific and exhibits a high affinity for L-proline. Notably, L-proline transport is exclusively dependent on Na+ as coupling ion, i.e., Na+/L-proline symport, reminiscent to the properties of PutP of E. coli even though H. pylori lives in a more acidic environment. Homology model-based structural comparisons and substitution analyses identified amino acids crucial for function. HpPutP-catalyzed proline uptake was efficiently inhibited by the known proline analogs 3,4-dehydro-D, L-proline and L-azetidine-2-carboxylic acid.	[Rivera-Ordaz, Araceli; Bracher, Susanne; Sarrach, Sannia; Hilger, Daniel; Jung, Heinrich] Univ Munich, Dept Biol 1, Martinsried, Germany; [Li, Zheng; Shi, Lei] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Shi, Lei] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Haas, Rainer] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany	University of Munich; Cornell University; Cornell University; Columbia University; Columbia University; University of Munich	Jung, H (corresponding author), Univ Munich, Dept Biol 1, Martinsried, Germany.	hjung@lmu.de	Hilger, Daniel/C-7297-2019; Shi, Lei/AAV-1321-2020; Jung, Heinrich/K-3790-2014; Ordaz, Araceli Rivera/AAB-9260-2019	Hilger, Daniel/0000-0001-5179-1357; Shi, Lei/0000-0002-4137-096X; Jung, Heinrich/0000-0002-5450-3063; 	Deutsche Forschungsgemeinschaft [JU333/3-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft grant JU333/3-3 to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Aslan M, 2007, CLIN BIOCHEM, V40, P37, DOI 10.1016/j.clinbiochem.2006.08.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CC, 1985, J MEMBRANE BIOL, V84, P157, DOI 10.1007/BF01872213; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Jung H, 1998, BBA-BIOENERGETICS, V1365, P60, DOI 10.1016/S0005-2728(98)00044-9; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jung H, 2001, MICROBIAL TRANSPORT, P47; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Liao MK, 2001, AMINO ACIDS, V21, P161, DOI 10.1007/s007260170023; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; MARSHALL BJ, 1984, LANCET, V1, P1311; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mazier S, 2011, J BIOL CHEM, V286, P29347, DOI 10.1074/jbc.M111.263327; McNamara D, 2008, DIGEST LIVER DIS, V40, P504, DOI 10.1016/j.dld.2008.02.031; Nagata K, 2003, MICROBIOL-SGM, V149, P2023, DOI 10.1099/mic.0.26203-0; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Petzold K, 2009, J AM CHEM SOC, V131, P14150, DOI 10.1021/ja905282h; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; POWELL JJ, 1992, GUT, V33, P1617, DOI 10.1136/gut.33.12.1617; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shimomura H, 2012, J BACTERIOL, V194, P2658, DOI 10.1128/JB.00105-12; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2004, HELICOBACTER, V9, P614, DOI 10.1111/j.1083-4389.2004.00272.x; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; WOOD JM, 1979, CAN J BIOCHEM CELL B, V57, P1191, DOI 10.1139/o79-155; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83576	10.1371/journal.pone.0083576	http://dx.doi.org/10.1371/journal.pone.0083576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358297	gold, Green Published, Green Submitted			2022-12-25	WOS:000328737700062
J	Yeheskely-Hayon, D; Kotler, A; Stark, M; Hashimshony, T; Sagee, S; Kassir, Y				Yeheskely-Hayon, Daniella; Kotler, Anat; Stark, Michal; Hashimshony, Tamar; Sagee, Shira; Kassir, Yona			The Roles of the Catalytic and Noncatalytic Activities of Rpd3L and Rpd3S in the Regulation of Gene Transcription in Yeast	PLOS ONE			English	Article							MEIOTIC RECOMBINATION CHECKPOINT; HISTONE DEACETYLASE COMPLEX; MEIOSIS-SPECIFIC GENES; BIDIRECTIONAL PROMOTERS; NEGATIVE REGULATOR; POSITIVE REGULATOR; SPORE FORMATION; ACETYLATION; EXPRESSION; REPRESSION	In budding yeasts, the histone deacetylase Rpd3 resides in two different complexes called Rpd3L (large) and Rpd3S (small) that exert opposing effects on the transcription of meiosis-specific genes. By introducing mutations that disrupt the integrity and function of either Rpd3L or Rpd3S, we show here that Rpd3 function is determined by its association with either of these complexes. Specifically, the catalytic activity of Rpd3S activates the transcription of the two major positive regulators of meiosis, IME1 and IME2, under all growth conditions and activates the transcription of NDT80 only during vegetative growth. In contrast, the effects of Rpd3L depends on nutrients; it represses or activates transcription in the presence or absence of a nitrogen source, respectively. Further, we show that transcriptional activation does not correlate with histone H4 deacetylation, suggesting an effect on a nonhistone protein. Comparison of rpd3-null and catalytic-site point mutants revealed an inhibitory activity that is independent of either the catalytic activity of Rpd3 or the integrity of Rpd3L and Rpd3S.	[Yeheskely-Hayon, Daniella; Kotler, Anat; Stark, Michal; Hashimshony, Tamar; Sagee, Shira; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Kassir, Y (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il	Stark, Michal/AAH-1763-2022; Stark, Michal/AFL-9651-2022	Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696	ISF - Israel Science Foundation	ISF - Israel Science Foundation(Israel Science Foundation)	ISF - Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; BOWDISH KS, 1993, MOL CELL BIOL, V13, P2172, DOI 10.1128/MCB.13.4.2172; Burgess SM, 1999, P NATL ACAD SCI USA, V96, P6835, DOI 10.1073/pnas.96.12.6835; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen XF, 2012, CURR BIOL, V22, P56, DOI 10.1016/j.cub.2011.11.042; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Collart MA, 2001, CURRENT PROTOCOLS MO, V12; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kahana S, 2010, GENETICS, V186, P829, DOI 10.1534/genetics.110.122200; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Rose MD., 1990, METHODS YEAST GENETI; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; SMITH HE, 1989, MOL CELL BIOL, V9, P2142, DOI 10.1128/MCB.9.5.2142; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	66	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e85088	10.1371/journal.pone.0085088	http://dx.doi.org/10.1371/journal.pone.0085088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358376	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700110
J	Dong, GF; Wang, CZ; Wu, YH; Cong, JB; Cheng, L; Wang, MQ; Zhao, PK; Tang, L; Zhang, CG; Wu, K				Dong, Guofu; Wang, Changzhen; Wu, Yonghong; Cong, Jianbo; Cheng, Li; Wang, Mingqun; Zhao, Pengkai; Tang, Li; Zhang, Chenggang; Wu, Ke			Tat Peptide-Mediated Soluble Expression of the Membrane Protein LSECtin-CRD in Escherichia coli	PLOS ONE			English	Article							C-TYPE LECTIN; DC-SIGN; FAMILY-MEMBER; BINDING; TRANSDUCTION; GLYCOPROTEIN; MECHANISM; FUSION; CELLS	The human liver and lymph node sinusoidal endothelial cell C-type lectin (hLSECtin), a type II integral membrane protein, containing a Ca2+-dependent carbohydrate recognition domain (CRD), has a well-established biological activity, yet its three-dimensional structure is unknown due to low expression yields and aggregation into inclusion bodies. Previous study has demonstrated that the HIV-1 virus-encoded Tat peptide ('YGRKKRRQRRR') can increase the yields and the solubility of heterologous proteins. However, whether the Tat peptide could promote the high-yield and soluble expression of membrane proteins in Escherichia coli is not known. Therefore, the prokaryotic expression vector pET28b-Tat-hLSECtin-CRD (using pET28b and pET28b-hLSECtin-CRD as controls) was constructed, and transformed into E. coli BL21 (DE3) cells and induced with isopropyl-beta-d-thiogalactoside (IPTG) followed with identifying by SDS-PAGE and Western blot. Subsequently, the bacterial subcellular structure, in which overexpressed the heterologous proteins Tat-hLSECtin-CRD and Tat-free hLSECtin-CRD, was analyzed by transmission electron microscope (TEM) respectively, and the mannose-binding activity of Tat-hLSECtin-CRD was also determined. Expectedly, the solubility of Tat-LSECtin-CRD significantly increased compared to Tat-free LSECtin-CRD (**p < 0.01) with prolonged time, and the Tat-LSECtin-CRD had a significant mannose-binding activity. The subcellular structure analysis indicated that the bacterial cells overexpressed Tat-hLSECtin-CRD exhibited denser region compared with controls, while dot denser region aggregated in the two ends of bacterial cells overexpressed Tat-free hLSECtin-CRD. This study provided a novel method for improving the soluble expression of membrane proteins in prokaryotic systems by fusion with the Tat peptide, which may be potentially expanded to the expression of other membrane proteins.	[Dong, Guofu; Wang, Changzhen; Cong, Jianbo; Cheng, Li; Wang, Mingqun; Zhao, Pengkai; Wu, Ke] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wu, Yonghong; Zhang, Chenggang] Cognit & Mental Hlth Res Ctr PLA, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Tang, Li] Chinese Human Genome Ctr, Beijing Inst Radiat Med, Dept Genom & Prote, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Tang, L (corresponding author), Chinese Human Genome Ctr, Beijing Inst Radiat Med, Dept Genom & Prote, Beijing, Peoples R China.	tangli08@yahoo.com.cn; zcgweb@126.com; wuke315@126.com	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	National Science Funds of China [31170714, 30970693]; Beijing Municipal Natural Science Foundation [7132134]	National Science Funds of China; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Science Funds of China (Nos. 31170714 and 30970693), and Beijing Municipal Natural Science Foundation (No. 7132134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; Dominguez-Soto A, 2009, HEPATOLOGY, V49, P287, DOI 10.1002/hep.22678; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Farrokhi Naser, 2009, V513, P175, DOI 10.1007/978-1-59745-427-8_10; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Glatz JFC, 2001, J MOL NEUROSCI, V16, P123, DOI 10.1385/JMN:16:2-3:123; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Granseth E, 2007, MOL MEMBR BIOL, V24, P329, DOI 10.1080/09687680701413882; Heinke F, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/790281; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Huang YW, 2009, DEV COMP IMMUNOL, V33, P747, DOI 10.1016/j.dci.2008.12.007; Jimonet P, 2004, CURR OPIN DRUG DISC, V7, P325; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kim RB, 2006, MOL PHARMACEUT, V3, P26, DOI 10.1021/mp050084o; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Le YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018489; Li Y, 2009, MOL CELL BIOCHEM, V327, P183, DOI 10.1007/s11010-009-0056-y; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Mazzuchelli-De-Souza J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421398; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Sanchez L, 1999, J BIOTECHNOL, V72, P13, DOI 10.1016/S0168-1656(99)00036-X; Tang L, 2010, EUR J IMMUNOL, V40, P1185, DOI 10.1002/eji.200939936; Tang L, 2009, GASTROENTEROLOGY, V137, P1498, DOI 10.1053/j.gastro.2009.07.051; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang CZ, 2012, APPL BIOCHEM BIOTECH, V167, P2295, DOI 10.1007/s12010-012-9766-9; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9; Wu YH, 2010, AMINO ACIDS, V39, P811, DOI 10.1007/s00726-010-0534-2; Yabe R, 2010, FEBS J, V277, P4010, DOI 10.1111/j.1742-4658.2010.07792.x; Zhao DY, 2013, IMMUNOBIOLOGY, V218, P602, DOI 10.1016/j.imbio.2012.07.017	48	3	4	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83579	10.1371/journal.pone.0083579	http://dx.doi.org/10.1371/journal.pone.0083579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358298	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700134
J	Fajardo, VA; Bombardier, E; Vigna, C; Devji, T; Bloemberg, D; Gamu, D; Gramolini, AO; Quadrilatero, J; Tupling, AR				Fajardo, Val A.; Bombardier, Eric; Vigna, Chris; Devji, Tahira; Bloemberg, Darin; Gamu, Daniel; Gramolini, Anthony O.; Quadrilatero, Joe; Tupling, A. Russell			Co-Expression of SERCA Isoforms, Phospholamban and Sarcolipin in Human Skeletal Muscle Fibers	PLOS ONE			English	Article							RETICULUM CA2+ ATPASE; SLOW-TWITCH MUSCLE; SARCOPLASMIC-RETICULUM; PROTEIN EXPRESSION; GENE; TRANSPORT; ABLATION; MYOSIN; CA2+-ATPASES; ADAPTATIONS	Sarcolipin (SLN) and phospholamban (PLN) inhibit the activity of sarco(endo) plasmic reticulum Ca2+- ATPases (SERCAs) by reducing their apparent affinity for Ca2+. A ternary complex between SLN, PLN, and SERCAs results in super- inhibition of SERCA activity. Analysis of skeletal muscle homogenate has limited our current understanding of whether SLN and PLN regulate SERCA1a, SERCA2a, or both in skeletal muscle and whether SLN and PLN are coexpressed in skeletal muscle fibers. Biopsies from human vastus lateralis were analyzed through single fiber Western blotting and immunohisto/fluorescence staining to circumvent this limitation. With a newly generated SLN antibody, we report for the first time that SLN protein is present in human skeletal muscle. Addition of the SLN antibody (50 mu g) to vastus lateralis homogenates increased the apparent Ca2+ affinity of SERCA (KCa, pCa units) (- Ab, 5.85 +/- 0.02 vs. +Ab, 5.95 +/- 0.02) and maximal SERCA activity (mu mol/g protein/min) (K-ca, Ab, 122 +/- 6.4 vs. + Ab, 159 +/- 11) demonstrating a functional interaction between SLN and SERCAs in human vastus lateralis. Specifically, our results suggest that although SLN and PLN may preferentially regulate SERCA1a, and SERCA2a, respectively, physiologically they both may regulate either SERCA isoform. Furthermore, we show that SLN and PLN co- immunoprecipitate in human vastus lateralis homogenate and are simultaneously expressed in 81% of the fibers analyzed with Western blotting which implies that super- inhibition of SERCA may exist in human skeletal muscle. Finally, we demonstrate unequivocally that mouse soleus contains PLN protein suggesting that super- inhibition of SERCA may also be important physiologically in rodent skeletal muscle.	[Fajardo, Val A.; Bombardier, Eric; Vigna, Chris; Devji, Tahira; Bloemberg, Darin; Gamu, Daniel; Quadrilatero, Joe; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Waterloo; University of Toronto	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca		Tupling, A. Russell/0000-0002-3895-6767	Natural Sciences and Engineering Research Council of Canada [RGPIN 311922]; Canadian Institutes of Health Research [MOP 106566]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada [RGPIN 311922) and the Canadian Institutes of Health Research (MOP 106566) to AR Tupling. VAF was supported by a doctoral award from the Canadian Institutes of Health Research. EB and CV were supported by post-graduate scholarship doctoral awards from the Natural Sciences and Engineering Research Council of Canada. A O Gramolini is a New Investigator of HSF Canada and holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Damiani E, 2000, BBA-BIOMEMBRANES, V1464, P231, DOI 10.1016/S0005-2736(00)00153-X; Duhamel TA, 2007, J APPL PHYSIOL, V103, P1986, DOI 10.1152/japplphysiol.01440.2006; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Fajardo VA, 2013, LIPIDS, V48, P421, DOI 10.1007/s11745-013-3770-x; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Hamalainen N, 2001, J MUSCLE RES CELL M, V22, P453, DOI 10.1023/A:1014543507149; Holloway GP, 2005, J APPL PHYSIOL, V99, P836, DOI 10.1152/japplphysiol.01407.2004; Kargacin ME, 1998, BIOCHEM J, V331, P245, DOI 10.1042/bj3310245; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MacLennan DH, 1972, COLD SPRING HARB SYM, V37, P469; McMillan EM, 2011, AM J PHYSIOL-REG I, V300, pR531, DOI 10.1152/ajpregu.00488.2010; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Murphy RM, 2011, J APPL PHYSIOL, V110, P820, DOI 10.1152/japplphysiol.01082.2010; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Salanova M, 2009, HISTOCHEM CELL BIOL, V132, P383, DOI 10.1007/s00418-009-0624-y; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Slack JP, 1997, AM J PHYSIOL-CELL PH, V273, pC1, DOI 10.1152/ajpcell.1997.273.1.C1; Talmadge RJ, 2002, J APPL PHYSIOL, V92, P147, DOI 10.1152/japplphysiol.000247.2001; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tupling AR, 2007, J APPL PHYSIOL, V103, P2105, DOI 10.1152/japplphysiol.00771.2007; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2004, CAN J APPL PHYSIOL, V29, P308, DOI 10.1139/h04-021; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Zubrzycka-Gaarn E, 1984, Prog Clin Biol Res, V168, P19	50	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84304	10.1371/journal.pone.0084304	http://dx.doi.org/10.1371/journal.pone.0084304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358354	Green Published, Green Submitted, gold			2022-12-25	WOS:000328735700162
J	Hou, JM; Song, LH; Zhang, W; Wu, WJ; Wang, J; Zhou, DQ; Qu, W; Guo, JW; Gu, SS; He, M; Xie, B; Li, HT				Hou, Jingming; Song, Lingheng; Zhang, Wei; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Qu, Wei; Guo, Junwei; Gu, Shanshan; He, Mei; Xie, Bing; Li, Haitao			Morphologic and Functional Connectivity Alterations of Corticostriatal and Default Mode Network in Treatment-Naive Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							GLUCOSE METABOLIC-RATE; CEREBRAL BLOOD-FLOW; RESTING-STATE; ORBITOFRONTAL CORTEX; UNMEDICATED PATIENTS; BEHAVIOR-THERAPY; MATTER CHANGES; GLOBAL SIGNAL; BRAIN; METAANALYSIS	Background: Previous studies have demonstrated that structural deficits and functional connectivity imbalances might underlie the pathophysiology of obsessive-compulsive disorder (OCD). The purpose of the present study was to investigate gray matter deficits and abnormal resting-state networks in patients with OCD and further investigate the association between the anatomic and functional alterations and clinical symptoms. Methods: Participants were 33 treatment-nave OCD patients and 33 matched healthy controls. Voxel-based morphometry was used to investigate the regions with gray matter abnormalities and resting-state functional connectivity analysis was further conducted between each gray matter abnormal region and the remaining voxels in the brain. Results: Compared with healthy controls, patients with OCD showed significantly increased gray matter volume in the left caudate, left thalamus, and posterior cingulate cortex, as well as decreased gray matter volume in the bilateral medial orbitofrontal cortex, left anterior cingulate cortex, and left inferior frontal gyrus. By using the above morphologic deficits areas as seed regions, functional connectivity analysis found abnormal functional integration in the cortical-striatum-thalamic-cortical (CSTC) circuits and default mode network. Subsequent correlation analyses revealed that morphologic deficits in the left thalamus and increased functional connectivity within the CSTC circuits positively correlated with the total Y-BOCS score. Conclusion: This study provides evidence that morphologic and functional alterations are seen in CSTC circuits and default mode network in treatment-nave OCD patients. The association between symptom severity and the CSTC circuits suggests that anatomic and functional alterations in CSTC circuits are especially important in the pathophysiology of OCD.	[Hou, Jingming; Song, Lingheng; Zhang, Wei; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Xie, Bing; Li, Haitao] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Qu, Wei; Guo, Junwei; Gu, Shanshan; He, Mei] Third Mil Med Univ, Southwest Hosp, Dept Clin Psychol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xie, B (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	xiebing6@gmail.com; liihaitao@163.com	guo, junwei/GSI-5525-2022	Hou, Jing-ming/0000-0002-8964-0359; Hou, Jingming/0000-0002-4991-7587	National Nature Science Foundation of China [81171283]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (grant no. 81171283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Brody AL, 1998, PSYCHIAT RES-NEUROIM, V84, P1, DOI 10.1016/S0925-4927(98)00041-9; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cavallaro R, 2003, BIOL PSYCHIAT, V54, P437, DOI 10.1016/S0006-3223(02)01814-0; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Cheng YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067478; Deckersbach T, 2006, J NEUROIMAGING, V16, P1, DOI 10.1177/1051228405001474; Deckersbach T, 2002, AM J PSYCHIAT, V159, P1780, DOI 10.1176/appi.ajp.159.10.1780; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Exner C, 2012, PSYCHIAT RES-NEUROIM, V202, P74, DOI 10.1016/j.pscychresns.2011.10.007; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoexter MQ, 2012, NEUROPSYCHOPHARMACOL, V37, P734, DOI 10.1038/npp.2011.250; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Hou JM, 2012, J AFFECT DISORDERS, V138, P313, DOI 10.1016/j.jad.2012.01.022; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kwon JS, 2003, PSYCHIAT RES-NEUROIM, V122, P37, DOI 10.1016/S0925-4927(02)00104-X; MACHLIN SR, 1991, AM J PSYCHIAT, V148, P1240; Maltby N, 2005, NEUROIMAGE, V24, P495, DOI 10.1016/j.neuroimage.2004.08.041; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; Rauch SL, 2001, BIOL PSYCHIAT, V50, P659, DOI 10.1016/S0006-3223(01)01188-X; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Rotge Jean-Yves, 2010, Biol Psychiatry, V67, pe37, DOI 10.1016/j.biopsych.2009.10.007; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; Stern ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036356; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; Togao O, 2010, PSYCHIAT RES-NEUROIM, V184, P29, DOI 10.1016/j.pscychresns.2010.06.011; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; WANG L, 2013, HUM BRAIN MAPP, P8420; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; ZALD DH, 2012, CORTEX CEREB CORTEX, P13934; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	84	41	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83931	10.1371/journal.pone.0083931	http://dx.doi.org/10.1371/journal.pone.0083931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358320	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700145
J	Nishizawa, M; Hattori, J; Shiino, T; Matano, T; Heneine, W; Johnson, JA; Sugiura, W				Nishizawa, Masako; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru			Highly-Sensitive Allele-Specific PCR Testing Identifies a Greater Prevalence of Transmitted HIV Drug Resistance in Japan	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; IN-VIVO; MUTATIONS; FITNESS; NEVIRAPINE; POPULATIONS; THERAPY; IMPACT	Background: The transmission of drug-resistant HIV in newly identified infected populations has become an underlying epidemic which can be better assessed with sensitive resistance testing. Since minority drug resistant variants cannot be detected by bulk sequencing, methods with improved sensitivity are required. Thus, the goal of this study was to evaluate if transmitted drug resistance mutations at minority levels in Japanese patients could be identified using highly sensitive allele-specific PCR (AS-PCR). Materials and Methods: Samples were taken from newly diagnosed HIV/AIDS cases at the National Nagoya Hospital from January 2008 to December 2009. All samples were bulk sequenced for HIV protease and reverse transcriptase. To detect minority populations with drug resistance, we used AS-PCR with mutation-specific primers designed for seven reverse transcriptase inhibitor resistance mutations, M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y, and for three protease inhibitor resistance mutations, M46I/L and L90M. Results: We studied 149 newly identified HIV cases. Bulk sequencing detected 8 cases with NRTI resistance mutations (one with A62V, one D67E, one T215D, one T215E, two with T215L and two T215S) and 15 with PI resistance mutations (one with N88D and 14 with M46I). Results obtained by AS-PCR and bulk sequencing demonstrated good concordance but the AS-PCR enabled the detection of seven additional drug-resistant cases (one M41L, two with K65R, two with K70R, and one M184V) in the RT region. Additionally, AS-PCR assays identified 15 additional cases with M46I, five with M46L and four cases with L90M in the protease region. Conclusions: Using AS-PCR substantially increased the detection of transmitted drug resistance in this population from 15.4% to 26.8%, further supporting the benefit of sensitive testing among drug-naive populations. Since the clinical impact of minority drug-resistant populations is not fully comprehended for all mutations, follow-up studies are needed to understand their significance for treatment.	[Nishizawa, Masako; Shiino, Teiichiro; Matano, Tetsuro; Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Hattori, Junko; Sugiura, Wataru] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Heneine, Walid; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; Centers for Disease Control & Prevention - USA; Nagoya University	Sugiura, W (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	wsugiura@nnh.hosp.go.jp			Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Boltz VF, 2010, J VIROL METHODS, V164, P122, DOI 10.1016/j.jviromet.2009.11.025; Borroto-Esoda Katyna, 2007, Antiviral Chemistry & Chemotherapy, V18, P297; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins JA, 2004, J VIROL, V78, P603, DOI 10.1128/JVI.78.2.603-611.2004; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Goudsmit J, 1996, J VIROL, V70, P5662, DOI 10.1128/JVI.70.8.5662-5664.1996; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Ly John K., 2007, Antiviral Chemistry & Chemotherapy, V18, P307; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Martinez-Picado J, 2000, VIROLOGY, V275, P318, DOI 10.1006/viro.2000.0527; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Shi CJ, 2004, NAT METHODS, V1, P141, DOI 10.1038/NMETH713; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sturmer M, 2002, J CLIN VIROL, V25, pS65; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Maarseveen NM, 2007, J INFECT DIS, V195, P399, DOI 10.1086/510533; Villahermosa ML, 2001, J HUMAN VIROL, V4, P238; Wainberg MA, 2004, JAIDS-J ACQ IMM DEF, V37, pS36, DOI 10.1097/01.qai.0000137005.63376.6e; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83150	10.1371/journal.pone.0083150	http://dx.doi.org/10.1371/journal.pone.0083150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358257	Green Submitted, Green Published, gold			2022-12-25	WOS:000328735700106
J	Licata, SC; Shinday, NM; Huizenga, MN; Darnell, SB; Sangrey, GR; Rudolph, U; Rowlett, JK; Sadri-Vakili, G				Licata, Stephanie C.; Shinday, Nina M.; Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Rudolph, Uwe; Rowlett, James K.; Sadri-Vakili, Ghazaleh			Alterations in Brain-Derived Neurotrophic Factor in the Mouse Hippocampus Following Acute but Not Repeated Benzodiazepine Treatment	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; C-FOS EXPRESSION; BDNF GENE; GABA(A) RECEPTORS; RAT HIPPOCAMPUS; MESSENGER-RNA; IMMUNOCYTOCHEMICAL DISTRIBUTION; HISTONE ACETYLATION; DIAZEPAM	Benzodiazepines (BZs) are safe drugs for treating anxiety, sleep, and seizure disorders, but their use also results in unwanted effects including memory impairment, abuse, and dependence. The present study aimed to reveal the molecular mechanisms that may contribute to the effects of BZs in the hippocampus (HIP), an area involved in drug-related plasticity, by investigating the regulation of immediate early genes following BZ administration. Previous studies have demonstrated that both brain derived neurotrophic factor (BDNF) and c-Fos contribute to memory-and abuse-related processes that occur within the HIP, and their expression is altered in response to BZ exposure. In the current study, mice received acute or repeated administration of BZs and HIP tissue was analyzed for alterations in BDNF and c-Fos expression. Although no significant changes in BDNF or c-Fos were observed in response to twice-daily intraperitoneal (i.p.) injections of diazepam (10 mg/kg + 5 mg/kg) or zolpidem (ZP; 2.5 mg/kg + 2.5 mg/kg), acute i.p. administration of both triazolam (0.03 mg/kg) and ZP (1.0 mg/kg) decreased BDNF protein levels within the HIP relative to vehicle, without any effect on c-Fos. ZP specifically reduced exon IV-containing BDNF transcripts with a concomitant increase in the association of methyl-CpG binding protein 2 (MeCP2) with BDNF promoter IV, suggesting that MeCP2 activity at this promoter may represent a ZP-specific mechanism for reducing BDNF expression. ZP also increased the association of phosphorylated cAMP response element binding protein (pCREB) with BDNF promoter I. Future work should examine the interaction between ZP and DNA as the cause for altered gene expression in the HIP, given that BZs can enter the nucleus and intercalate into DNA directly.	[Licata, Stephanie C.; Rudolph, Uwe] McLean Hosp, Belmont, MA 02178 USA; [Shinday, Nina M.; Rowlett, James K.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Charlestown, MA 02114 USA; [Licata, Stephanie C.; Shinday, Nina M.; Huizenga, Megan N.; Darnell, Shayna B.; Sangrey, Gavin R.; Rudolph, Uwe; Rowlett, James K.; Sadri-Vakili, Ghazaleh] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02114 USA.	gsadrivakili@partners.org			National Institutes of Health [DA011792, AG035361, RR000168/OD011103, DA015036, DA033795]; NATIONAL INSTITUTE ON AGING [R01AG035361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033795, T32DA015036, R01DA011792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded collectively by the National Institutes of Health (http://www.nih.gov/) grants DA011792, AG035361, RR000168/OD011103, DA015036, and DA033795. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alme Maria Nordheim, 2007, Neural Plast, V2007, P26496, DOI 10.1155/2007/26496; BABA A, 1983, J NEUROCHEM, V40, P280, DOI 10.1111/j.1471-4159.1983.tb12683.x; BALKIN TJ, 1992, PSYCHOPHARMACOLOGY, V107, P83, DOI 10.1007/BF02244970; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOSMANN HB, 1980, P NATL ACAD SCI-BIOL, V77, P1195, DOI 10.1073/pnas.77.2.1195; Bozas E, 1997, CELL MOL NEUROBIOL, V17, P157, DOI 10.1023/A:1026309727518; Braveman Melissa W., 2004, V277, P261; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; CHANG SL, 1988, BIOCHEM BIOPH RES CO, V157, P698, DOI 10.1016/S0006-291X(88)80306-1; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; DALEZIOS Y, 1993, NEUROCHEM RES, V18, P305, DOI 10.1007/BF00969087; DELCERRO S, 1992, NEUROSCIENCE, V49, P1, DOI 10.1016/0306-4522(92)90071-9; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Elliot EE, 2000, PHARMACOL BIOCHEM BE, V66, P361, DOI 10.1016/S0091-3057(00)00176-3; EVANS SM, 1990, J PHARMACOL EXP THER, V255, P1246; Fedele E, 2000, J NEUROCHEM, V75, P782, DOI 10.1046/j.1471-4159.2000.0750782.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fuchikami M, 2010, PSYCHIAT INVEST, V7, P251, DOI 10.4306/pi.2010.7.4.251; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; Fukuda K, 2002, ANESTH ANALG, V95, P373, DOI 10.1097/00000539-200208000-00024; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Huang TL, 2009, PROG NEURO-PSYCHOPH, V33, P158, DOI 10.1016/j.pnpbp.2008.10.016; Huopaniemi L, 2004, J NEUROCHEM, V88, P1059, DOI 10.1046/j.1471-4159.2003.02216.x; Ichisaka S, 2003, NEUROSCIENCE, V117, P361, DOI 10.1016/S0306-4522(02)00771-6; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kellogg CK, 2000, DEV BRAIN RES, V121, P157, DOI 10.1016/S0165-3806(00)00039-0; Khan GM, 2000, EUR J PHARMACOL, V407, P139, DOI 10.1016/S0014-2999(00)00720-2; Kim DH, 2009, BRIT J PHARMACOL, V158, P1131, DOI 10.1111/j.1476-5381.2009.00378.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; Malkani S, 2000, BRAIN RES, V860, P53, DOI 10.1016/S0006-8993(00)01976-4; Marie-Claire C, 2003, NEUROSCI LETT, V345, P77, DOI 10.1016/S0304-3940(03)00307-0; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maubach KA, 2004, NEUROREPORT, V15, P1145, DOI 10.1097/00001756-200405190-00013; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Mikkelsen JD, 2005, EUR J PHARMACOL, V519, P223, DOI 10.1016/j.ejphar.2005.06.049; Mikkelsen JD, 2008, ANN NY ACAD SCI, V1148, P384, DOI 10.1196/annals.1410.044; Mintzer MZ, 1999, PSYCHOPHARMACOLOGY, V144, P8, DOI 10.1007/s002130050971; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mori K, 2001, PHARMACOL BIOCHEM BE, V69, P367, DOI 10.1016/S0091-3057(01)00546-9; Niles LP, 1997, NEUROSCI LETT, V236, P5, DOI 10.1016/S0304-3940(97)00755-6; Oliveira DR, 2009, BRAIN RES, V1269, P68, DOI 10.1016/j.brainres.2008.11.105; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; Raivio N, 2012, EUR J PHARMACOL, V687, P9, DOI 10.1016/j.ejphar.2012.04.021; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Saha B, 2009, J BIOMOL STRUCT DYN, V26, P421, DOI 10.1080/07391102.2009.10507257; Salminen O, 1996, PHARMACOL BIOCHEM BE, V54, P241, DOI 10.1016/0091-3057(95)02132-9; SANGER DJ, 1986, PSYCHOPHARMACOLOGY, V90, P207; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Saraf MK, 2008, NEUROSCIENCE, V155, P476, DOI 10.1016/j.neuroscience.2008.05.043; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schmidt HD, 2012, J NEUROCHEM, V120, P202, DOI 10.1111/j.1471-4159.2011.07571.x; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Sun YH, 2013, NEUROPHARMACOLOGY, V72, P20, DOI 10.1016/j.neuropharm.2013.04.021; TALLMAN JF, 1978, NATURE, V274, P383, DOI 10.1038/274383a0; Thompson BL, 2006, NEUROPHARMACOLOGY, V50, P57, DOI 10.1016/j.neuropharm.2005.07.024; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Xu HY, 2006, HIPPOCAMPUS, V16, P551, DOI 10.1002/hipo.20184; Xu JY, 2005, BRAIN RES, V1062, P134, DOI 10.1016/j.brainres.2005.09.008; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	82	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84806	10.1371/journal.pone.0084806	http://dx.doi.org/10.1371/journal.pone.0084806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367698	Green Published, gold, Green Submitted			2022-12-25	WOS:000328741900069
J	Lomtadze, N; Kupreishvili, L; Salakaia, A; Vashakidze, S; Sharvadze, L; Kempker, RR; Magee, MJ; del Rio, C; Blumberg, HM				Lomtadze, Nino; Kupreishvili, Lali; Salakaia, Archil; Vashakidze, Sergo; Sharvadze, Lali; Kempker, Russell R.; Magee, Matthew J.; del Rio, Carlos; Blumberg, Henry M.			Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							INFECTION; PREVALENCE; HIV	Background: The country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection. Purpose: To determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy. Methods: Prospective cohort study; HCV serology was obtained on all study subjects at the time of TB diagnosis; hepatic enzyme tests (serum alanine aminotransferase [ALT] activity) were obtained at baseline and monthly during treatment. Results: Among 326 study patients with culture-confirmed TB, 68 (21%) were HCV co-infected, 14 (4.3%) had chronic hepatitis B virus (HBV) infection (hepatitis B virus surface antigen positive [HBsAg+]), and 6 (1.8%) were HIV co-infected. Overall, 19% of TB patients developed mild to moderate incident hepatotoxicity. In multi-variable analysis, HCV co-infection (adjusted Hazards Ratio [aHR]=3.2, 95% CI=1.6-6.5) was found to be an independent risk factor for incident anti-TB drug-induced hepatotoxicity. Survival analysis showed that HCV co-infected patients developed hepatitis more quickly compared to HCV seronegative patients with TB. Conclusion: A high prevalence of HCV co-infection was found among patients with TB in Georgia. Drug-induced hepatotoxicity was significantly associated with HCV co-infection but severe drug-induced hepatotoxicity (WHO grade III or IV) was rare.	[Lomtadze, Nino; Kupreishvili, Lali; Salakaia, Archil; Vashakidze, Sergo] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Sharvadze, Lali] Infect Dis AIDS & Clin Immunol Res Ctr, Tbilisi, Georgia; [Kempker, Russell R.; del Rio, Carlos; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [del Rio, Carlos; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019; Magee, Matthew/W-1169-2019; del Rio, Carlos/B-3763-2012	Blumberg, Henry/0000-0002-3110-2443; del Rio, Carlos/0000-0002-0153-3517	National Institutes of Health (NIH), Fogarty International Center (FIC) [D43TW007124, D43TW007124-06S1, D43TW001042]; National Institute of Allergy and Immunology (NIAID) [K23 AI103044]; National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute [UL1TR000454]; U.S. Civilian and Research Development Foundation [GEB1-002725-TB-07]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW001042, D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Immunology (NIAID); National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute; U.S. Civilian and Research Development Foundation; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH), Fogarty International Center (FIC) [D43TW007124, D43TW007124-06S1, and D43TW001042], National Institute of Allergy and Immunology (NIAID) [K23 AI103044], National Center for Advancing Translational Sciences (NCATS)/Atlanta Clinical and Translational Science Institute [UL1TR000454], the U.S. Civilian and Research Development Foundation (GEB1-002725-TB-07), and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Butsashvili M, 2001, EUR J EPIDEMIOL, V17, P693, DOI 10.1023/A:1015566132757; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Karchava M, 2009, Georgian Med News, P51; Kwon YS, 2007, CHEST, V131, P803, DOI 10.1378/chest.06-2042; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Park WB, 2010, J INFECTION, V61, P323, DOI 10.1016/j.jinf.2010.07.009; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Richards DC, 2006, INT J TUBERC LUNG D, V10, P396; Shapatava E, 2006, DRUG ALCOHOL DEPEN, V82, pS35, DOI 10.1016/S0376-8716(06)80006-2; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Wang JY, 2011, J INFECTION, V62, P448, DOI 10.1016/j.jinf.2011.04.005; Weinstock DM, 2001, INT J TUBERC LUNG D, V5, P164; WHO, 2009, WHOHTMTB2009422; World Health Organization, 2013, WHOHTMTB201311; World Health Organization, 2010, WHOHTMTB20103; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Zaller N, 2004, EUR J EPIDEMIOL, V19, P547, DOI 10.1023/B:EJEP.0000032352.29173.78	29	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83892	10.1371/journal.pone.0083892	http://dx.doi.org/10.1371/journal.pone.0083892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367617	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900025
J	Purmal, K; Alam, MK; Pohchi, A; Razak, NHA				Purmal, Kathiravan; Alam, Mohammad Khursheed; Pohchi, Abdullah; Razak, Noor Hayati Abdul			3D Mapping of Safe and Danger Zones in the Maxilla and Mandible for the Placement of Intermaxillary Fixation Screws	PLOS ONE			English	Article							CORTICAL-BONE THICKNESS; ALVEOLAR BONE	Intermaxillary (IMF) screws feature several advantages over other devices used for intermaxillary fixation, but using cone beam computed tomography (CBCT) scans to determine the safe and danger zones to place these devices for all patients can be expensive. This study aimed to determine the optimal interradicular and buccopalatal/buccolingual spaces for IMF screw placement in the maxilla and mandible. The CBCT volumetric data of 193 patients was used to generate transaxial slices between the second molar on the right to the second molar on the left in both arches. The mean interradicular and buccopalatal/buccolingual distances and standard deviation values were obtained at heights of 2, 5, 8 and 11 mm from the alveolar bone crest. An IMF screw with a diameter of 1.0 mm and length of 7 mm can be placed distal to the canines (2 -11 mm from the alveolar crest) and less than 8 mm between the molars in the maxilla. In the mandible, the safest position is distal to the first premolar (more than 5 mm) and distal to the second premolar (more than 2 mm). There was a significant difference (p< 0.05) between the right and left quadrants. The colour coding 3D template showed the safe and danger zones based on the mesiodistal, buccopalatal and buccolingual distances in the maxilla and mandible. The safest sites for IMF screw insertion in the maxilla were between the canines and first premolars and between the first and second molars. In the mandible, the safest sites were between the first and second premolars and between the second premolar and first molar. However, the IMF screw should not exceed 1.0 mm in diameter and 7 mm in length.	[Purmal, Kathiravan; Pohchi, Abdullah; Razak, Noor Hayati Abdul] Univ Sains Malaysia, Sch Dent Sci, Dept Oral & Maxillofacial Surg, Kota Baharu, Kelantan, Malaysia; [Alam, Mohammad Khursheed] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; alam, mohammed/GXH-3645-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; 	Short Term Grant [304/PPSG/61312043]; Universiti Sains Malaysia	Short Term Grant; Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was supported by Short Term Grant (304/PPSG/61312043), Universiti Sains Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR G, 1989, J ORAL MAXIL SURG, V47, P1234, DOI 10.1016/0278-2391(89)90024-4; BISHARA SE, 1989, AM J ORTHOD DENTOFAC, V96, P416, DOI 10.1016/0889-5406(89)90326-0; Bittencourt Luiza Paiva, 2011, Rev. odonto ciênc., V26, P133, DOI 10.1590/S1980-65232011000200007; Carano Aldo, 2004, Prog Orthod, V5, P212; Coburn DG, 2002, BRIT J ORAL MAX SURG, V40, P241, DOI 10.1054/bjom.2001.0771; Coletti DP, 2007, J ORAL MAXIL SURG, V65, P1746, DOI 10.1016/j.joms.2007.04.022; Evans CA, 2013, OR SURG OR MED OR PA, V116, P238, DOI 10.1016/j.oooo.2013.06.002; Farnsworth D, 2011, AM J ORTHOD DENTOFAC, V139, P495, DOI 10.1016/j.ajodo.2009.03.057; HARRIS EF, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P121; Hernandez LC, 2008, CLIN ORAL IMPLAN RES, V19, P576, DOI 10.1111/j.1600-0501.2007.01507.x; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kim HJ, 2006, AM J ORTHOD DENTOFAC, V130, P177, DOI 10.1016/j.ajodo.2004.12.024; Kuroda T, 2006, AM J ORTHOD DENTOFAC, V129, P562, DOI 10.1016/j.ajodo.2004.12.020; LAVELLE CLB, 1972, AMER J ORTHODONTICS, V61, P29, DOI 10.1016/0002-9416(72)90173-X; Lee KJ, 2009, AM J ORTHOD DENTOFAC, V135, P486, DOI 10.1016/j.ajodo.2007.05.019; LINDHE J, 1984, TXB CLIN PERIODONTOL; Mah JK, 2010, J AM DENT ASSOC, V141, p7S, DOI 10.14219/jada.archive.2010.0361; Monnerat C, 2009, AM J ORTHOD DENTOFAC, V135, DOI [10.1016/j.ajodo.2008.12.003, 10.1016/j.ajodo.2008.06.024]; Park HS, 2008, AM J ORTHOD DENTOFAC, V133, P30, DOI 10.1016/j.ajodo.2006.01.044; PARK J, 2009, AM J ORTHOD DENTOFAC, V136; PARK J, 2009, AM J ORTHOD DENTOFAC, V136, P14; Poggio PM, 2006, ANGLE ORTHOD, V76, P191; Rai AJ, 2009, BRIT J ORAL MAX SURG, V47, P325, DOI 10.1016/j.bjoms.2008.12.009; Schneider AM, 2000, ANN PLAS SURG, V44, P154, DOI 10.1097/00000637-200044020-00005; Schnelle MA, 2004, ANGLE ORTHOD, V74, P832; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Silvestrini-Biavati A, 2011, ORTHOD CRANIOFAC RES, V14, P88, DOI 10.1111/j.1601-6343.2011.01512.x; Stirrups D R, 1993, Br J Orthod, V20, P359; Thongudomporn U, 2009, ORTHOD CRANIOFAC RES, V12, P1, DOI 10.1111/j.1601-6343.2008.01430.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	30	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84202	10.1371/journal.pone.0084202	http://dx.doi.org/10.1371/journal.pone.0084202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367643	Green Submitted, Green Published, gold			2022-12-25	WOS:000328741900038
J	Naumann, MS; Jantzen, C; Haas, AF; Iglesias-Prieto, R; Wild, C				Naumann, Malik S.; Jantzen, Carin; Haas, Andreas F.; Iglesias-Prieto, Roberto; Wild, Christian			Benthic Primary Production Budget of a Caribbean Reef Lagoon (Puerto Morelos, Mexico)	PLOS ONE			English	Article							CORAL-REEF; FRINGING-REEF; SURFACE-AREA; MARINE; CARBON; RESPIRATION; MORPHOLOGY; QUANTIFICATION; PHOTOSYNTHESIS; METABOLISM	High photosynthetic benthic primary production (P) represents a key ecosystem service provided by tropical coral reef systems. However, benthic P budgets of specific ecosystem compartments such as macrophyte-dominated reef lagoons are still scarce. To address this, we quantified individual and lagoon-wide net (P-n) and gross (P-g) primary production by all dominant functional groups of benthic primary producers in a typical macrophyte-dominated Caribbean reef lagoon near Puerto Morelos (Mexico) via measurement of O-2 fluxes in incubation experiments. The photosynthetically active 3D lagoon surface area was quantified using conversion factors to allow extrapolation to lagoon-wide P budgets. Findings revealed that lagoon 2D benthic cover was primarily composed of sand-associated microphytobenthos (40%), seagrasses (29%) and macroalgae (27%), while seagrasses dominated the lagoon 3D surface area (84%). Individual Pg was highest for macroalgae and scleractinian corals (87 and 86 mmol O-2 m(-2) specimen area d(-1), respectively), however seagrasses contributed highest (59%) to the lagoon-wide P-g. Macroalgae exhibited highest individual P-n rates, but seagrasses generated the largest fraction (51%) of lagoon-wide P-n. Individual R was highest for scleractinian corals and macroalgae, whereas seagrasses again provided the major lagoon-wide share (68%). These findings characterise the investigated lagoon as a net autotrophic coral reef ecosystem compartment revealing similar P compared to other macrophyte-dominated coastal environments such as seagrass meadows and macroalgae beds. Further, high lagoon-wide P (Pg: 488 and P-n: 181 mmol O-2 m(-2) lagoon area d(-1)) and overall P-g:R (1.6) indicate substantial benthic excess production within the Puerto Morelos reef lagoon and suggest the export of newly synthesised organic matter to surrounding ecosystems.	[Naumann, Malik S.; Jantzen, Carin; Haas, Andreas F.; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Iglesias-Prieto, Roberto] UNAM, Unidad Acad Puerto Morelos, Inst Ciencias Mar & Limnol, Cancun, Quintana Roo, Mexico; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; University of Bremen	Naumann, MS (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany.	mnaumann@uni-bremen.de	Naumann, Malik/A-3607-2011	Naumann, Malik/0000-0002-6870-291X	German Research Foundation (DFG) [Wi 2677/2-1, Wi 2677/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by German Research Foundation (DFG) grant Wi 2677/2-1 and Wi 2677/6-1 to C.W., and Bleaching Work Group funding within the CRTR project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D. J., 1983, PERSPECTIVES CORAL R, P209; BOUCHER G, 1990, MAR ECOL PROG SER, V64, P271, DOI 10.3354/meps064271; Bruno JF, 1998, J EXP MAR BIOL ECOL, V229, P187, DOI 10.1016/S0022-0981(98)00050-1; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; CARPENTER RC, 1991, LIMNOL OCEANOGR, V36, P40, DOI 10.4319/lo.1991.36.1.0040; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; COLLADOVIDES L, 1998, HIDROBIOLOGICA, V8, P133; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Coronado C, 2007, CORAL REEFS, V26, P149, DOI 10.1007/s00338-006-0175-9; Cuet P, 2011, CORAL REEFS, V30, P45, DOI 10.1007/s00338-011-0744-4; DAHL AL, 1973, MAR BIOL, V23, P239, DOI 10.1007/BF00389331; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jordan E., 1982, Proceedings of the International Coral Reef Symposium, P303; Kinsey D. W., 1977, Proceedings int Coral Reef Symp, V3, P383; Kinsey D.W., 1985, P 5 INT COR REEF S, V4, P505; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Marba N, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P135; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Mayer FW, 2010, MAR FRESHWATER RES, V61, P1006, DOI 10.1071/MF09250; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Naumann MS, 2012, J MARINE SYST, V105, P20, DOI 10.1016/j.jmarsys.2012.05.007; Naumann MS, 2012, P 12 INT COR REEF S; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; ODUM HT, 1957, LIMNOL OCEANOGR, V2, P85, DOI 10.4319/lo.1957.2.2.0085; POLLARD PC, 1993, AUST J MAR FRESH RES, V44, P155; Richter C, 1999, MAR ECOL PROG SER, V188, P105, DOI 10.3354/meps188105; van Tussenbroek BI, 2007, J PHYCOL, V43, P69, DOI 10.1111/j.1529-8817.2006.00307.x; van Tussenbroek BI, 2011, HIDROBIOLOGICA, V21, P293; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; WANDERS J B W, 1976, Aquatic Botany, V2, P327, DOI 10.1016/0304-3770(76)90030-9; Wild C, 2006, MAR FRESHWATER RES, V57, P415, DOI 10.1071/MF05205; Wild C, 2013, P NATL ACAD SCI USA, V110, P8767, DOI 10.1073/pnas.1306839110; Wild C, 2010, MAR ECOL PROG SER, V411, P61, DOI 10.3354/meps08653; Wild C, 2009, AQUAT BIOL, V6, P133, DOI 10.3354/ab00181; Wilkinson C, 2008, STATUS CORAL REEFS W; Wu EY, 1997, J APPL PHYSIOL, V82, P196, DOI 10.1152/jappl.1997.82.1.196	52	19	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82923	10.1371/journal.pone.0082923	http://dx.doi.org/10.1371/journal.pone.0082923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367570	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300081
J	Prandi, S; Bromke, M; Hubner, S; Voigt, A; Boehm, U; Meyerhof, W; Behrens, M				Prandi, Simone; Bromke, Marta; Huebner, Sandra; Voigt, Anja; Boehm, Ulrich; Meyerhof, Wolfgang; Behrens, Maik			A Subset of Mouse Colonic Goblet Cells Expresses the Bitter Taste Receptor Tas2r131	PLOS ONE			English	Article							ENTEROENDOCRINE STC-1 CELLS; EPITHELIAL-CELLS; ALPHA-GUSTDUCIN; SECRETION; MICE; RAT; INTESTINE; PROTEIN; FAMILY; SWEET	The concept that gut nutrient sensing involves taste receptors has been fueled by recent reports associating the expression of taste receptors and taste-associated signaling molecules in the gut and in gut-derived cell lines with physiological responses induced by known taste stimuli. However, for bitter taste receptors (Tas2rs), direct evidence for their functional role in gut physiology is scarce and their cellular expression pattern remained unknown. We therefore investigated Tas2r expression in mice. RT-PCR experiments assessed the presence of mRNA for Tas2rs and taste signaling molecules in the gut. A gene-targeted mouse strain was established to visualize and identify cell types expressing the bitter receptor Tas2r131. Messenger RNA for various Tas2rs and taste signaling molecules were detected by RT-PCR in the gut. Using our knock-in mouse strain we demonstrate that a subset of colonic goblet cells express Tas2r131. Cells that express this receptor are absent in the upper gut and do not correspond to enteroendocrine and brush cells. Expression in colonic goblet cells is consistent with a role of Tas2rs in defense mechanisms against potentially harmful xenobiotics.	[Prandi, Simone; Bromke, Marta; Huebner, Sandra; Voigt, Anja; Meyerhof, Wolfgang; Behrens, Maik] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Voigt, Anja; Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Saarland University	Behrens, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany.	behrens@dife.de	Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860	German Ministry of Education and Research (BMBF) [0315669]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF, #0315669, to WM and MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2000, EUR J NEUROSCI, V12, P1372, DOI 10.1046/j.1460-9568.2000.00032.x; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GOODWIN EC, 1992, J BIOL CHEM, V267, P16330; Hass N, 2007, HISTOCHEM CELL BIOL, V128, P457, DOI 10.1007/s00418-007-0325-3; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; ROBINE S, 1985, P NATL ACAD SCI USA, V82, P8488, DOI 10.1073/pnas.82.24.8488; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	39	47	47	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82820	10.1371/journal.pone.0082820	http://dx.doi.org/10.1371/journal.pone.0082820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367558	gold, Green Submitted, Green Published			2022-12-25	WOS:000328740300072
J	Rosenkranz, SC; Geissen, M; Harter, K; Szalay, B; Ferrer, I; Vogel, J; Smith, S; Glatzel, M				Rosenkranz, Sina Catherine; Geissen, Markus; Haerter, Kristina; Szalay, Beata; Ferrer, Isidro; Vogel, Jana; Smith, Stephen; Glatzel, Markus			Amyloid-Precursor-Protein-Lowering Small Molecules for Disease Modifying Therapy of Alzheimer's Disease	PLOS ONE			English	Article							BETA; IDENTIFICATION; INHIBITOR; PROMOTER; MUTATION; BRAIN; PRION; GENE; APP	Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cognitive decline and memory loss. According to the amyloid-hypothesis, AD is caused by generation and subsequent cerebral deposition of beta-amyloid (A beta). A beta is generated through sequential cleavage of the transmembrane Amyloid-Precursor-Protein (APP) by two endoproteinases termed beta-and gamma-secretase. Increased APP-expression caused by APP gene dosage effects is a risk factor for the development of AD. Here we carried out a large scale screen for novel compounds aimed at decreasing APP-expression. For this we developed a screening system employing a cell culture model of AD. A total of 10,000 substances selected for their ability of drug-likeness and chemical diversity were tested for their potential to decrease APP-expression resulting in reduced A beta-levels. Positive compounds were further evaluated for their effect at lower concentrations, absence of cytotoxicity and specificity. The six most promising compounds were characterized and structure function relationships were established. The novel compounds presented here provide valuable information for the development of causal therapies for AD.	[Rosenkranz, Sina Catherine; Geissen, Markus; Haerter, Kristina; Szalay, Beata; Vogel, Jana; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Rosenkranz, Sina Catherine] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Geissen, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Vasc Med, Hamburg, Germany; [Ferrer, Isidro] Hosp Univ Bellvitge, Inst Neuropathol, Barcelona, Spain; [Smith, Stephen] European Screening Port GmbH, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Glatzel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.	m.glatzel@uke.de	Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817	DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459; University of Hamburg by their research training group, Inflammation and regeneration	DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459(German Research Foundation (DFG)); University of Hamburg by their research training group, Inflammation and regeneration	This work was funded by the DFG (Deutsche Forschungsgesellschaft) as part of their research training group 1459 and by the University of Hamburg by their research training group, Inflammation and regeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.dfg.de/http://www.uni-hamburg.de/	[Anonymous], Patent US, Patent No. 20100248365; Beyer K, 2004, MOL BRAIN RES, V131, P131, DOI 10.1016/j.molbrainres.2004.08.006; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; DONNELLY RJ, 1990, CELL MOL NEUROBIOL, V10, P485, DOI 10.1007/BF00712843; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Freshney R.I., 2010, CULTURE ANIMAL CELLS; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geissen M, 2011, CHEMMEDCHEM, V6, P1928, DOI 10.1002/cmdc.201100119; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hopkins CR, 2011, ACS CHEM NEUROSCI, V2, P279, DOI 10.1021/cn2000469; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; JACOBSEN JS, 1991, NEUROBIOL AGING, V12, P585, DOI 10.1016/0197-4580(91)90090-7; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Kim W, 2006, NY TIMES BK REV, P1; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; LAHIRI DK, 1991, MOL BRAIN RES, V9, P253, DOI 10.1016/0169-328X(91)90009-M; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Licastro F, 2007, NEUROBIOL AGING, V28, P1637, DOI 10.1016/j.neurobiolaging.2006.07.007; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McNaughton D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.010; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; QUITSCHKE WW, 1992, J BIOL CHEM, V267, P17362; Rinderspacher A, 2009, BIOORG MED CHEM LETT, V19, P1715, DOI 10.1016/j.bmcl.2009.01.087; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Sepulveda-Falla D, 2012, J ALZHEIMERS DIS, V32, P1, DOI 10.3233/JAD-2012-120907; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Troy CM, 2000, J NEUROSCI, V20, P1386; Utsuki T, 2006, J PHARMACOL EXP THER, V318, P855, DOI 10.1124/jpet.106.103309; Verbeek MM, 1997, BIOL CHEM, V378, P937; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303	50	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82255	10.1371/journal.pone.0082255	http://dx.doi.org/10.1371/journal.pone.0082255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367508	Green Published, Green Submitted, gold			2022-12-25	WOS:000328740300024
J	Mohan, S; Huff, E; Wish, J; Lilly, M; Chen, SC; McClellan, WM				Mohan, Sumit; Huff, Edwin; Wish, Jay; Lilly, Michael; Chen, Shu-Cheng; McClellan, William M.		Fistula First Breakthrough Initiat	Recovery of Renal Function among ESRD Patients in the US Medicare Program	PLOS ONE			English	Article							CHRONIC DIALYSIS; SURVIVAL	Background: Patients started on long term hemodialysis have typically had low rates of reported renal recovery with recent estimates ranging from 0.9-2.4% while higher rates of recovery have been reported in cohorts with higher percentages of patients with acute renal failure requiring dialysis. Study Design: Our analysis followed approximately 194,000 patients who were initiated on hemodialysis during a 2-year period (2008 & 2009) with CMS-2728 forms submitted to CMS by dialysis facilities, cross-referenced with patient record updates through the end of 2010, and tracked through December 2010 in the CMS SIMS registry. Results: We report a sustained renal recovery (i.e no return to ESRD during the available follow up period) rate among Medicare ESRD patients of >5% - much higher than previously reported. Recovery occurred primarily in the first 2 months post incident dialysis, and was more likely in cases with renal failure secondary to etiologies associated with acute kidney injury. Patients experiencing sustained recovery were markedly less likely than true long-term ESRD patients to have permanent vascular accesses in place at incident hemodialysis, while non-White patients, and patients with any prior nephrology care appeared to have significantly lower rates of renal recovery. We also found widespread geographic variation in the rates of renal recovery across the United States. Conclusions: Renal recovery rates in the US Medicare ESRD program are higher than previously reported and appear to have significant geographic variation. Patients with diagnoses associated with acute kidney injury who are initiated on long-term hemodialysis have significantly higher rates of renal recovery than the general ESRD population and lower rates of permanent access placement.	[Mohan, Sumit] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA; [Huff, Edwin] Boston Reg Off, Centers Medicare & Medicaid Serv, Div Qual Improvement, Boston, MA USA; [Wish, Jay] Case Western Reserve Univ, Dept Med, Div Nephrol, Cleveland, OH 44106 USA; [Lilly, Michael] Univ Maryland, Baltimore Sch Med, Dept Surg, Div Vasc Surg, Baltimore, MD 21201 USA; [Chen, Shu-Cheng] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA; [McClellan, William M.] Emory Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA	Columbia University; Case Western Reserve University; University System of Maryland; University of Maryland Baltimore; Minneapolis Medical Research Foundation; Emory University	Mohan, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA.	sm2206@columbia.edu	Mohan, Sumit/I-5625-2019	Mohan, Sumit/0000-0002-5305-9685	 [HHSM-500-2010-NW002C]		This study was prepared in part by the IPRO EndStage Renal Disease Network of New York, the ESRD Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U. S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. CMS Contract Number: HHSM-500-2010-NW002C	[Anonymous], 2012, ESRD MED EVIDENCE RE; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Chan KE, 2011, CLIN J AM SOC NEPHRO, V6, P2642, DOI 10.2215/CJN.03680411; Chu JK, 2010, SEMIN DIALYSIS, V23, P606, DOI 10.1111/j.1525-139X.2010.00769.x; Goldstein A, 2003, PERITON DIALYSIS INT, V23, P151; Heung M, 2010, J AM SOC NEPHROL, V21, p717A; U S Renal Data System, 2011, USRDS 2011 ANN DAT R; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909	8	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83447	10.1371/journal.pone.0083447	http://dx.doi.org/10.1371/journal.pone.0083447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358285	Green Published, Green Submitted, gold			2022-12-25	WOS:000328737700058
J	Sommi, P; Necchi, V; Vitali, A; Montagna, D; De Luigi, A; Salmona, M; Ricci, V; Solcia, E				Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Montagna, Daniela; De Luigi, Ada; Salmona, Mario; Ricci, Vittorio; Solcia, Enrico			PaCS Is a Novel Cytoplasmic Structure Containing Functional Proteasome and Inducible by Cytokines/Trophic Factors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; UBIQUITINATED PROTEINS; INHERITED THROMBOCYTOPENIA; MULTICATALYTIC PROTEINASE; MISFOLDED PROTEINS; VIRAL ONCOPROTEIN; BINDING PROTEIN; DENDRITIC CELLS; DEGRADATION	A variety of ubiquitinated protein-containing cytoplasmic structures has been reported, from aggresomes to aggresome-like induced structures/sequestosomes or particle-rich cytoplasmic structures (PaCSs) that we recently observed in some human diseases. Nevertheless, the morphological and cytochemical patterns of the different structures remain largely unknown thus jeopardizing their univocal identification. Here, we show that PaCSs resulted from proteasome and polyubiquitinated protein accumulation into well-demarcated, membrane-free, cytoskeleton-poor areas enriched in glycogen and glycosaminoglycans. A major requirement for PaCS detection by either electron or confocal microscopy was the addition of osmium to aldehyde fixatives. However, by analyzing living cells, we found that proteasome chymotrypsin-like activity concentrated in well-defined cytoplasmic structures identified as PaCSs by ultrastructural morphology and immunocytochemistry of the same cells. PaCSs differed ultrastructurally and cytochemically from sequestosomes which may coexist with PaCSs. In human dendritic or natural killer cells, PaCSs were induced in vitro by cytokines/trophic factors during differentiation/activation from blood progenitors. Our results provide evidence that PaCS is indeed a novel distinctive cytoplasmic structure which may play a critical role in the ubiquitin-proteasome system response to immune, infectious or proneoplastic stimuli.	[Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Ricci, Vittorio; Solcia, Enrico] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Sommi, Patrizia; Necchi, Vittorio; Vitali, Agostina; Montagna, Daniela; Ricci, Vittorio; Solcia, Enrico] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Sommi, Patrizia; Solcia, Enrico] Univ Pavia, Serv Anat Pathol, I-27100 Pavia, Italy; [Necchi, Vittorio] Univ Pavia, Ctr Grandi Strumenti, I-27100 Pavia, Italy; [Montagna, Daniela] Univ Pavia, Pediat Hematol Oncol Serv, I-27100 Pavia, Italy; [De Luigi, Ada; Salmona, Mario] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Pavia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Ricci, V (corresponding author), Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	vricci@unipv.it; solciae@smatteo.pv.it	De Luigi, Ada/ABF-7913-2020; salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020; Montagna, Daniela/AAK-9380-2020	De Luigi, Ada/0000-0001-7907-7139; salmona, mario/0000-0002-9098-9873; MONTAGNA, DANIELA/0000-0002-1533-579X	Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo [RF-20102310098]; Italian Ministry for University and Research [2009A37C8C_002]; Fondazione Cariplo [2009-2532, 2011-0485]	Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo (Ricerca Finalizzata RF-20102310098), from the Italian Ministry for University and Research (Progetto di Ricerca di Interesse Nazionale 2009A37C8C_002 to VR) and from Fondazione Cariplo (grants n. 2009-2532 to ES and n. 2011-0485 to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Chiozzi V, 2009, J PHYSIOL PHARMACOL, V60, P23; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Fassbender M, 2008, MED MICROBIOL IMMUN, V197, P185, DOI 10.1007/s00430-008-0091-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; HIRSCH JG, 1968, J CELL BIOL, V38, P615, DOI 10.1083/jcb.38.3.615; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuboki Y, 2010, MODERN PATHOL, V23, P1127, DOI 10.1038/modpathol.2010.97; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Montagna D, 2003, EXP HEMATOL, V31, P1031, DOI 10.1016/S0301-472X(03)00230-3; Nannmark U, 1996, EUR J CELL BIOL, V71, P402; Necchi V, 2013, THROMB HAEMOSTASIS, V109, P263, DOI 10.1160/TH12-07-0497; Necchi V, 2012, HAEMATOL-HEMATOL J, V97, P1057, DOI 10.3324/haematol.2011.048462; Necchi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021317; Necchi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009716; Nishimura A, 2006, MICROBES INFECT, V8, P984, DOI 10.1016/j.micinf.2005.10.015; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; OHKAWA K, 1977, CANCER-AM CANCER SOC, V40, P3019, DOI 10.1002/1097-0142(197712)40:6<3019::AID-CNCR2820400639>3.0.CO;2-M; OHKUBO I, 1991, BIOCHEM BIOPH RES CO, V174, P1133, DOI 10.1016/0006-291X(91)91538-N; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pearse AGE, 1985, ANAL TECHNOLOGY, V2; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pierre P, 2005, IMMUNOL REV, V207, P184, DOI 10.1111/j.0105-2896.2005.00300.x; Pippucci T, 2011, AM J HUM GENET, V88, P115, DOI 10.1016/j.ajhg.2010.12.006; Pitzer F, 1996, FEBS LETT, V394, P47, DOI 10.1016/0014-5793(96)00920-9; Puri R, 2011, FEBS J, V278, P3688, DOI 10.1111/j.1742-4658.2011.08287.x; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shearer J, 2002, CAN J APPL PHYSIOL, V27, P179, DOI 10.1139/h02-012; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; WASSERMAN K, 1994, J CELL BIOCHEM, V55, P133, DOI 10.1002/jcb.240550115; Wenger T, 2012, AUTOPHAGY, V8, P350, DOI [10.4161/auto.8.3.18806, 10.4161/auto.18806]; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	89	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82560	10.1371/journal.pone.0082560	http://dx.doi.org/10.1371/journal.pone.0082560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358206	Green Published, gold, Green Submitted			2022-12-25	WOS:000328737700023
J	Chen, WB; Guo, W; Li, M; Shi, DB; Tian, Y; Li, ZL; Wang, JS; Fu, LY; Xiao, XS; Liu, QQ; Wang, SS; Huang, WL; Deng, WG				Chen, Wangbing; Guo, Wei; Li, Mei; Shi, Dingbo; Tian, Yun; Li, Zhenlin; Wang, Jingshu; Fu, Lingyi; Xiao, Xiangsheng; Liu, Quentin Qiang; Wang, Shusen; Huang, Wenlin; Deng, Wuguo			Upregulation of Cleavage and Polyadenylation Specific Factor 4 in Lung Adenocarcinoma and Its Critical Role for Cancer Cell Survival and Proliferation	PLOS ONE			English	Article							CHRONIC EOSINOPHILIC LEUKEMIA; HYPEREOSINOPHILIC SYNDROME; TUMOR SUPPRESSION; RNA; POLYMERASE; SUBUNIT; KINASE; CPSF; CHEMOTHERAPY; ACTIVATION	Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays a key role in mRNA polyadenylation and mRNA 39 ends maturation. However, its possible role in lung cancer pathogenesis is unknown. In this study, we investigated the biological role and clinical significance of CPSF4 in lung cancer growth and survival and elucidated its underlying molecular mechanisms. We found that CPSF4 was highly expressed in lung adenocarcinoma cell lines and tumor tissue but was undetectable in 8 normal human tissues. We also found that CPSF4 overexpression was correlated with poor overall survival in patients with lung adenocarcinomas (P<0.001). Multivariate survival analyses revealed that higher CPSF4 expression was an independent prognostic factor for overall survival of the patients with lung adenocarcinomas. Suppression of CPSF4 by siRNA inhibited lung cancer cells proliferation, colony formation, and induced apoptosis. Mechanism studies revealed that these effects were achieved through simultaneous modulation of multiple signaling pathways. Knockdown of CPSF4 expression by siRNA markedly inhibited the phosphorylation of PI3K, AKT and ERK1/2 and JNK proteins. In contrast, the ectopic expression of CPSF4 had the opposite effects. Moreover, CPSF4 knockdown also induced the cleavage of caspase-3 and caspse-9 proteins. Collectively, these results demonstrate that CPSF4 plays a critical role in regulating lung cancer cell proliferation and survival and may be a potential prognostic biomarker and therapeutic target for lung adenocarcinoma.	[Chen, Wangbing; Li, Mei; Shi, Dingbo; Tian, Yun; Wang, Jingshu; Fu, Lingyi; Xiao, Xiangsheng; Liu, Quentin Qiang; Wang, Shusen; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Wei; Li, Zhenlin; Liu, Quentin Qiang] Dalian Med Univ Canc Ctr, Inst Canc Stem Cell, Dalian, Peoples R China; [Huang, Wenlin; Deng, Wuguo] Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University	Wang, SS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	wangshs@sysucc.org.cn; dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022	Chen, Wangbing/0000-0002-9469-1337	National Natural Science Foundation of China [81272195, 81071687, 81372133]; State "863 Program'' of China [SS2012AA020403]; State "973 Program'' of China [2014CB542005]; Doctoral Programs Foundation of Ministry of Education of China [20110171110077]; State Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State "863 Program'' of China(National High Technology Research and Development Program of China); State "973 Program'' of China(National Basic Research Program of China); Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in South China	This research was supported by funds from the National Natural Science Foundation of China (81272195, 81071687, 81071687, 81372133), the State "863 Program'' of China (SS2012AA020403), the State "973 Program'' of China (2014CB542005), the Doctoral Programs Foundation of Ministry of Education of China (20110171110077), and the State Key Laboratory of Oncology in South China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragaki M, 2011, CLIN CANCER RES, V17, P5889, DOI 10.1158/1078-0432.CCR-11-0240; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Berger N, 2001, INT J PHARM, V223, P55, DOI 10.1016/S0378-5173(01)00721-9; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Cools J, 2004, CURR OPIN HEMATOL, V11, P51, DOI 10.1097/00062752-200401000-00008; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Gotlib J, 2004, BLOOD, V103, P2879, DOI 10.1182/blood-2003-06-1824; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Papadimitrakopoulou V, 2012, J THORAC ONCOL, V7, P1315, DOI 10.1097/JTO.0b013e31825493eb; Pupo E, 2005, J CONTROL RELEASE, V104, P379, DOI 10.1016/j.jconrel.2005.02.001; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tabuse M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-60; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Travis WD, 2004, SEM RESP CRIT CARE M, V25, P475, DOI 10.1055/s-2004-836141; Ueda K, 2006, CANCER RES, V66, P9682, DOI 10.1158/0008-5472.CAN-06-1483; Wang GD, 2004, ONCOL REP, V12, P955; Xue MZ, 2012, CURR PHARM DESIGN, V18, P2901, DOI 10.2174/138161212800672723	29	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82728	10.1371/journal.pone.0082728	http://dx.doi.org/10.1371/journal.pone.0082728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358221	gold, Green Published, Green Submitted			2022-12-25	WOS:000328735700091
J	Ma, XT; Zhang, HT; Pan, QW; Zhao, YH; Chen, J; Zhao, B; Chen, YF				Ma, Xiaotang; Zhang, Huiting; Pan, Qunwen; Zhao, Yuhui; Chen, Ji; Zhao, Bin; Chen, Yanfang			Hypoxia/Aglycemia-Induced Endothelial Barrier Dysfunction and Tight Junction Protein Downregulation Can Be Ameliorated by Citicoline	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ACUTE ISCHEMIC-STROKE; CDP-CHOLINE; IN-VITRO; CELLS; EXPRESSION; HYPOXIA; NEUROPROTECTION; PERMEABILITY; INVOLVEMENT	This study explores the effect of citicoline on the permeability and expression of tight junction proteins (TJPs) in endothelial cells under hypoxia/aglycemia conditions. Hypoxia or oxygen and glucose deprivation (OGD) was utilized to induce endothelial barrier breakdown model on human umbilical vein endothelial cells (HUVECs) and mouse brain microvascular endothelial cells (bEnd.3s). The effect of citicoline on endothelial barrier breakdown models was determined at either low or high concentrations. FITC-Dextran flux was used to examine the endothelial permeability. The expression of TJPs was measured by immunofluorescence, Real-time PCR and Western Blot methods. Results showed that hypoxia or OGD increased the permeability of HUVECs accompanied with down-regulation of occludens-1 (ZO-1) and occludin at both mRNA and protein levels. Similarly in bEnd.3s, hypoxia increased the permeability and decreased the expression of ZO-1 and claudin-5. Citicoline treatment dose-dependently decreased the permeability in these two models, which paralleled with elevated expression of TJPs. The data demonstrate that citicoline restores the barrier function of endothelial cells compromised by hypoxia/aglycemia probably via up-regulating the expression of TJPs.	[Ma, Xiaotang; Zhang, Huiting; Pan, Qunwen; Chen, Ji; Zhao, Bin; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China; [Zhao, Yuhui; Chen, Ji; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Guangdong Medical University; University System of Ohio; Wright State University Dayton	Zhao, B (corresponding author), Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China.	zhaobine@163.net; yanfang.chen@wright.edu	pan, qunwen/Y-1522-2019	Bihl, Ji/0000-0003-2404-1782	National Nature Science Foundation of China [81271214, 81270195]; National Heart, Lung, and Blood Institute [HL-098637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Nature Science Foundation of China (# 81271214, #81270195) and the National Heart, Lung, and Blood Institute (HL-098637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al Ahmad A, 2012, MICROVASC RES, V84, P222, DOI 10.1016/j.mvr.2012.05.008; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Bala K, 2012, MOL BIOSYST, V8, P2657, DOI 10.1039/c2mb25156f; Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123; Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89; Chen Z., 2013, PROG NEUROBIOL; Cho HJ, 2009, METHOD FIND EXP CLIN, V31, P171, DOI 10.1358/mf.2009.31.3.1364241; Coskun C, 2010, J PHARM PHARMACOL, V62, P497, DOI 10.1211/jpp.62.04.0013; Cotroneo AM, 2013, CLIN INTERV AGING, V8, P131, DOI 10.2147/CIA.S38420; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Horiuchi T, 2009, PERITON DIALYSIS INT, V29, P217; Huang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062164; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Ilcol YO, 2009, SHOCK, V32, P286, DOI 10.1097/SHK.0b013e3181971b02; Inamura A, 2013, NEUROCHEM RES, V38, P1641, DOI 10.1007/s11064-013-1066-4; Kohnke R, 2007, NUTR NEUROSCI, V10, P273, DOI 10.1080/10284150701745910; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Rajadas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058194; Rao AM, 1999, J NEUROSCI RES, V58, P697, DOI 10.1002/(SICI)1097-4547(19991201)58:5<697::AID-JNR11>3.3.CO;2-2; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shakir Taner, 2013, Am J Neurodegener Dis, V2, P70; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Takizawa Y, 2013, EUR J DRUG METAB PHA; Tam SJ, 2010, ANNU REV NEUROSCI, V33, P379, DOI 10.1146/annurev-neuro-060909-152829; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang WM, 2007, PUBLIC HLTH SUPERVIS, V8, P1006; Zhu HY, 2012, J ETHNOPHARMACOL, V141, P714, DOI 10.1016/j.jep.2011.08.063	36	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e82604	10.1371/journal.pone.0082604	http://dx.doi.org/10.1371/journal.pone.0082604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358213	Green Published, gold			2022-12-25	WOS:000328735700086
J	Negandhi, PH; Ghouri, N; Colhoun, HM; Fischbacher, CM; Lindsay, RS; McKnight, JA; Petrie, J; Philip, S; Sattar, N; Wild, SH				Negandhi, Preeti H.; Ghouri, Nazim; Colhoun, Helen M.; Fischbacher, Colin M.; Lindsay, Robert S.; McKnight, John A.; Petrie, John; Philip, Sam; Sattar, Naveed; Wild, Sarah H.		Scottish Diabet Res Network	Ethnic Differences in Glycaemic Control in People with Type 2 Diabetes Mellitus Living in Scotland	PLOS ONE			English	Article							INTERMEDIATE OUTCOMES; EUROPEAN PATIENTS; SOUTH ASIANS; POPULATION; RISK; BANGLADESHI; DISPARITIES; PREVALENCE; MORTALITY; PAKISTANI	Background and Aims: Previous studies have investigated the association between ethnicity and processes of care and intermediate outcomes of diabetes, but there are limited population-based studies available. The aim of this study was to use population-based data to investigate the relationships between ethnicity and glycaemic control in men and women with diabetes mellitus living in Scotland Methods: We used a 2008 extract from the population-based national electronic diabetes database of Scotland. The association between ethnicity with mean glycaemic control in type 2 diabetes mellitus was examined in a retrospective cohort study, including adjustment for a number of variables including age, sex, socioeconomic status, body mass index (BMI), prescribed treatment and duration of diabetes. Results: Complete data for analyses were available for 56,333 White Scottish adults, 2,535 Pakistanis, 857 Indians, 427 Chinese and 223 African-Caribbeans. All other ethnic groups had significantly (p<0.05) greater proportions of people with suboptimal glycaemic control (HbA1c >58 mmol/mol, 7.5%) compared to the White Scottish group, despite generally younger mean age and lower BMI. Fully adjusted odds ratios for suboptimal glycaemic control were significantly higher among Pakistanis and Indians (1.85, 95% CI: 1.68-2.04, and 1.62,95% CI: 1.38-1.89) respectively. Conclusions: Pakistanis and Indians with type 2 diabetes mellitus were more likely to have suboptimal glycaemic control than the white Scottish population. Further research on health services and self-management are needed to understand the association between ethnicity and glycaemic control to address ethnic disparities in glycaemic control.	[Negandhi, Preeti H.] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurgaon, Haryana, India; [Ghouri, Nazim; Lindsay, Robert S.; Petrie, John; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Colhoun, Helen M.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Fischbacher, Colin M.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [McKnight, John A.] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Philip, Sam] Aberdeen Royal Infirm, Dept Endocrinol & Diabet, Aberdeen, Scotland; [Wild, Sarah H.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Public Health Foundation of India; University of Glasgow; University of Dundee; NHS National Services Scotland; University of Edinburgh; University of Aberdeen; University of Edinburgh	Ghouri, N (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	nazim.ghouri@glasgow.ac.uk	Philip, Sam/AAE-3349-2021	Philip, Sam/0000-0001-6164-211X; Fischbacher, Colin/0000-0003-3090-1857; Lindsay, Robert/0000-0002-9868-5217; Ghouri, Noushima/0000-0002-8202-3913; , SDRN-NDS (Scottish Diabetes Research Network National Diabetes Research Dataset)/0000-0002-3365-3441; Colhoun, Helen/0000-0002-8345-3288	Pfizer; Roche; Boehringer Ingelheim; Astra Zeneca	Pfizer(Pfizer); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Astra Zeneca(AstraZeneca)	HMC received monies from Pfizer for attending symposia, a speaker's bureau, as a member of staff and for consultancy. HMC has received research funds from Pfizer, Roche, Eli-Lilly, Boehringer Ingelheim (BI) and Astra Zeneca. HMC has shares in Roche. JAM is the PI for drug studies for Novo Nordisk, Eli Lilly and BI (contracts relating to this work are through JAM's NHS employer R&D department). JAM received monies 2 years ago from BI for organising the ethics application for their study and attending the meeting relating to this. JAM has received support to attend meetings from the above companies as well as from Takeda. This does not alter the authors' adherence to all PLOS ONE policies on sharing materials.	Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; Ahmed US, 2010, DIABETIC MED, V27, P169, DOI 10.1111/j.1464-5491.2009.02904.x; [Anonymous], MAN DIAB; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Choudhury SM, 2009, DIABETIC MED, V26, P636, DOI 10.1111/j.1464-5491.2009.02741.x; Fischbacher CM, 2009, J PUBLIC HEALTH-UK, V31, P239, DOI 10.1093/pubmed/fdp003; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; James GD, 2012, J ROY SOC MED, V105, P300, DOI 10.1258/jrsm.2012.110289; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; McElduff P, 2005, DIABETIC MED, V22, P1226, DOI 10.1111/j.1464-5491.2005.01614.x; McKnight JA, 2008, DIABETIC MED, V25, P743, DOI 10.1111/j.1464-5491.2008.02453.x; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; Mir G, 2010, ETHNIC HEALTH, V15, P327, DOI 10.1080/13557851003624273; Mukhopadhyay B, 2006, DIABETIC MED, V23, P94, DOI 10.1111/j.1464-5491.2005.01735.x; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Scottish Diabetes Survey Monitoring Group, 2012, SCOTT DIAB SURV 2010; Scottish Diabetes Survey Monitoring Group, 2013, SCOTT DIAB SURV 2011; Scottish Executive, 2012, AN ETHN 2001 CENS SU; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Verma A, 2010, J PUBLIC HEALTH-UK, V32, P250, DOI 10.1093/pubmed/fdp114; Walker JJ, 2011, DIABETES CARE, V34, P1127, DOI 10.2337/dc10-1862; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zoppini G, 2008, DIABETES-METAB RES, V24, P624, DOI 10.1002/dmrr.897	26	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e83292	10.1371/journal.pone.0083292	http://dx.doi.org/10.1371/journal.pone.0083292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358273	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000328735700116
J	Yusop, NBM; Mun, CY; Shariff, ZM; Huat, CB				Yusop, Nor Baizura Md; Mun, Chan Yoke; Shariff, Zalilah Mohd; Huat, Choo Beng			Factors Associated with Quality of Life among Hemodialysis Patients in Malaysia	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; NUTRITIONAL-STATUS; KIDNEY-DISEASE; RENAL-FAILURE; BODY-FAT; MAINTENANCE HEMODIALYSIS; DIALYSIS ADEQUACY; DIABETIC-PATIENTS; DIETARY-INTAKE; MENTAL-HEALTH	Although hemodialysis treatment has greatly increased the life expectancy of end stage renal disease patients, low quality of life among hemodialysis patients is frequently reported. This cross-sectional study aimed to determine the relationship between medical history, hemodialysis treatment and nutritional status with the mental and physical components of quality of life in hemodialysis patients. Respondents (n=90) were recruited from Hospital Kuala Lumpur and dialysis centres of the National Kidney Foundation of Malaysia. Data obtained included socio-demography, medical history, hemodialysis treatment and nutritional status. Mental and physical quality of life were measured using the Mental Composite Summary (MCS) and Physical Composite Summary (PCS) of the Short-Form Health Survey 36-items, a generic core of the Kidney Disease Quality of Life Short Form. Two summary measures and total SF-36 was scored as 0-100, with a higher score indicating better quality of life. Approximately 26 (30%) of respondents achieved the body mass index (24 kg/m(2)) and more than 80% (n=77) achieved serum albumin level (>35.0 mg/dL) recommended for hemodialysis patients. The majority of respondents did not meet the energy (n=72, 80%) and protein (n=68,75%) recommendations. The total score of SF-36 was 54.1 +/- 19.2, while the score for the mental and physical components were 45.0 +/- 8.6 and 39.6 +/- 8.6, respectively. Factors associated with a higher MCS score were absence of diabetes mellitus (p=0.000) and lower serum calcium (p=0.004), while higher blood flow (p=0.000), higher serum creatinine (p=0.000) and lower protein intake (p= 0.006) were associated with a higher PCS score. To improve the overall quality of life of hemodialysis patients, a multidisciplinary intervention that includes medical, dietetic and psychosocial strategies that address factors associated with mental and physical quality of life are warranted to reduce further health complications and to improve quality of life.	[Yusop, Nor Baizura Md; Mun, Chan Yoke; Shariff, Zalilah Mohd] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia; [Huat, Choo Beng] Manipal Med Collage, Dept Med, Melaka, Malaysia	Universiti Putra Malaysia	Shariff, ZM (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia.	zalilahms@upm.edu.my						Abbas Tarek M, 2005, Hemodial Int, V9, P153, DOI 10.1111/j.1492-7535.2005.01126.x; Abu Bakar A, 2000, TOTAL QUAL MANAGE, V11, pS788; Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; Allen KL, 2002, J RENAL NUTR, V12, P160, DOI 10.1053/jren.2002.33512; Anees M, 2011, IRAN J KIDNEY DIS, V5, P9; [Anonymous], 2006, DIAL REG PAK 2005 20; Borzou SR, 2009, SAUDI J KIDNEY DIS T, V20, P639; Bossola M, 2005, J RENAL NUTR, V15, P244, DOI 10.1053/j.jrn.2005.01.004; BROZEK J, 1951, BRIT J NUTR, V5, P194, DOI 10.1079/BJN19510025; Buckner S, 2003, J RENAL NUTR, V13, P295, DOI 10.1016/S1051-2276(03)00119-5; Chiang CK, 2004, BLOOD PURIFICAT, V22, P490, DOI 10.1159/000081730; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Durose CL, 2004, J AM DIET ASSOC, V104, P35, DOI 10.1016/j.jada.2003.10.016; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; FAO/WHO/UNU, 2004, FOOD NUTR TECHN REP FOOD NUTR TECHN REP; Germin-Petrovic D, 2011, COLLEGIUM ANTROPOL, V35, P687; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P290; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Hooi L S, 2006, Med J Malaysia, V61, P513; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Ishimura E, 2001, J AM SOC NEPHROL, V12, P1921, DOI 10.1681/ASN.V1291921; Ismail A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-39; Johansen KL, 2003, AM J CLIN NUTR, V77, P842, DOI 10.1093/ajcn/77.4.842; Jones CH, 2004, J RENAL NUTR, V14, P26, DOI 10.1053/j.jrn.2003.09.006; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kloppenburg WD, 1999, KIDNEY INT, V55, P1961, DOI 10.1046/j.1523-1755.1999.00412.x; Kovesdy CP, 2010, CLIN J AM SOC NEPHRO, V5, P468, DOI 10.2215/CJN.06040809; Kugler C, 2005, J NURS SCHOLARSHIP, V37, P25, DOI 10.1111/j.1547-5069.2005.00009.x; Lim YN, 2005, 13 MAL DIAL TRANSP R; Lim YN, 2011, 18 MAL DIAL TRANSP; Lim YN, 2004, 11 MAL DIAL TRANSP; Liu W J, 2006, Med J Malaysia, V61, P540; Lou LM, 2007, NEFROLOGIA, V27, P38; Manns BJ, 2002, ASAIO J, V48, P565, DOI 10.1097/00002480-200209000-00021; Medical Nutrition Therapy Guidelines for Chronic, 2005, KIDN DIS; Mehrotra R, 2002, AM J KIDNEY DIS, V40, P133, DOI 10.1053/ajkd.2002.33922; Miller JE, 2010, AM J NEPHROL, V32, P403, DOI 10.1159/000319861; Morais Alvaro A. C., 2005, Clinics, V60, P185, DOI 10.1590/S1807-59322005000300002; Morsch CM, 2006, J CLIN NURS, V15, P498, DOI 10.1111/j.1365-2702.2006.01349.x; National Kidney Foundation, 2000, AM J KIDNEY DIS, V35; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; Ohkawa S, 2005, NEPHROL DIAL TRANSPL, V20, P945, DOI 10.1093/ndt/gfh643; Ohri-Vachaspati P, 1999, J Ren Nutr, V9, P9; Piperi C, 2004, MOL CELL BIOCHEM, V265, P57, DOI 10.1023/B:MCBI.0000044315.74038.78; Pupim LB, 2002, AM J KIDNEY DIS, V40, P143, DOI 10.1053/ajkd.2002.33923; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; Rutledge C, 2000, NEPHROLOGY, V5, P27, DOI 10.1046/j.1440-1797.2000.00510.x; Sararaks S, 2001, Med J Malaysia, V56, P350; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Sorensen VR, 2007, DIABETOLOGIA, V50, P2254, DOI 10.1007/s00125-007-0810-1; Streja E, 2011, CLIN J AM SOC NEPHRO, V6, P1463, DOI 10.2215/CJN.09131010; Suzana S, 2002, ATLAS FOOD EXCHANGES; Tanaka M, 2007, NEPHROL DIAL TRANSPL, V22, P1658, DOI 10.1093/ndt/gfm008; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Wang VV, 2012, INT J ARTIF ORGANS, V35, P217, DOI 10.5301/ijao.5000014; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong J S, 2005, Med J Malaysia, V60, P146; Wu AW, 2004, J AM SOC NEPHROL, V15, P743, DOI 10.1097/01.ASN.0000113315.81448.CA; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Zyga S, 2005, J RENAL CARE, V31, P24, DOI 10.1111/j.1755-6686.2005.tb00385.x	65	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e84152	10.1371/journal.pone.0084152	http://dx.doi.org/10.1371/journal.pone.0084152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358336	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000328735700153
J	Boch, S; Muller, J; Pratil, D; Blaserl, S; Fischer, M				Boch, Steffen; Mueller, Joerg; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus			Up in the Tree - The Overlooked Richness of Bryophytes and Lichens in Tree Crowns	PLOS ONE			English	Article							EPIPHYTIC BRYOPHYTES; VERTICAL-DISTRIBUTION; STAND STRUCTURE; SPECIES COMPOSITION; BEECH FORESTS; DIVERSITY; BIODIVERSITY; ECOLOGY	Assessing diversity is among the major tasks in ecology and conservation science. In ecological and conservation studies, epiphytic cryptogams are usually sampled up to accessible heights in forests. Thus, their diversity, especially of canopy specialists, likely is underestimated. If the proportion of those species differs among forest types, plot-based diversity assessments are biased and may result in misleading conservation recommendations. We sampled bryophytes and lichens in 30 forest plots of 20 m x 20 m in three German regions, considering all substrates, and including epiphytic litter fall. First, the sampling of epiphytic species was restricted to the lower 2 m of trees and shrubs. Then, on one representative tree per plot, we additionally recorded epiphytic species in the crown, using tree climbing techniques. Per tree, on average 54% of lichen and 20% of bryophyte species were overlooked if the crown was not been included. After sampling all substrates per plot, including the bark of all shrubs and trees, still 38% of the lichen and 4% of the bryophyte species were overlooked if the tree crown of the sampled tree was not included. The number of overlooked lichen species varied strongly among regions. Furthermore, the number of overlooked bryophyte and lichen species per plot was higher in European beech than in coniferous stands and increased with increasing diameter at breast height of the sampled tree. Thus, our results indicate a bias of comparative studies which might have led to misleading conservation recommendations of plot-based diversity assessments.	[Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	University of Bern; University of Bern; University of Potsdam	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Fischer, Markus/C-6411-2008; Schulze, Ernst-Detlef/K-9627-2014	Fischer, Markus/0000-0002-5589-5900; 	DFG (German Research Foundation); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"(FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptroot A., 1997, V68, P203; Barkman J.J., 1958, BRYOLOGIST; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bohn U., 2000, KARTE NATURLICHEN VE; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Diaz IA, 2010, FOREST ECOL MANAG, V259, P1490, DOI 10.1016/j.foreco.2010.01.025; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2009, BIODIVERS CONSERV, V18, P289, DOI 10.1007/s10531-008-9483-4; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; HARRIS GP, 1971, J ECOL, V59, P431, DOI 10.2307/2258323; Holz I, 2002, BRYOLOGIST, V105, P334, DOI 10.1639/0007-2745(2002)105[0334:BDMDAD]2.0.CO;2; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; JARMAN SJ, 1995, NEW ZEAL J BOT, V33, P65, DOI 10.1080/0028825X.1995.10412944; Jonsson MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045701; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; MAZIMPAKA V, 1995, NOVA HEDWIGIA, V61, P431; McCune B, 1997, NORTHWEST SCI, V71, P145; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milne J, 1999, OERST HIKOBIA, V13, P23; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Nascimbene J, 2013, FOREST ECOL MANAG, V298, P27, DOI 10.1016/j.foreco.2013.03.008; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nebel, 2000, MOOSE BADEN WURTTEMB; Nebel M, 2005, MOOSE BADEN WURTTEMB, V3; Nebel M, 2001, MOOSE BADEN WURTTEMB, V2; Nimis PL, 2002, EARTH ENV SCI, V7; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Porley R., 2005, MOSSES LIVERWORTS; R Core Team, 2016, R FDN STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Redei K, 2001, LESNICKY CASOPIS, V47, P135; Romanski J, 2011, BRYOLOGIST, V114, P720, DOI 10.1639/0007-2745-114.4.720; Sillett SC, 2000, NORTHWEST SCI, V74, P44; SILLETT SC, 1995, BRYOLOGIST, V98, P251, DOI 10.2307/3243312; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Sporn SG, 2010, BIODIVERS CONSERV, V19, P745, DOI 10.1007/s10531-009-9731-2; Svensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062825; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; Will-Wolf S, 2002, NATO SCI S SS IV EAR, V7, P203; WIRTH V., 2013, FLECHTEN DTSCH; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; [No title captured]	53	62	69	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84913	10.1371/journal.pone.0084913	http://dx.doi.org/10.1371/journal.pone.0084913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358373	gold, Green Submitted, Green Published			2022-12-25	WOS:000328737700107
J	Chung, Y; Fu, E				Chung, Yi; Fu, Earl			Crosstalk between Shh and TGF-beta Signaling in Cyclosporine-Enhanced Cell Proliferation in Human Gingival Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SONIC HEDGEHOG; TRANSFORMING GROWTH-FACTOR-BETA-1; PROSTATE-CANCER; UP-REGULATION; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION; PATHWAY	Background: Immunosuppressant cyclosporine-A induces gingival hyperplasia, which is characterized by increased fibroblast proliferation and overproduction of extracellular matrix components and regulated by transforming growth factor-beta (TGF-beta). The TGF-beta and Sonic hedgehog (Shh) pathways both mediate cell proliferation. Crosstalk between these pathways in cancer has recently been proposed, but the hierarchical pattern of this crosstalk remains unclear. In normal fibroblasts, a TGF-beta-stimulating Shh pattern was observed in induced fibrosis. However, Shh pathway involvement in cyclosporine-enhanced gingival proliferation and the existence of crosstalk with the TGF-beta pathway remain unclear. Methodology/Principal Findings: Cyclosporine enhanced mRNA and protein levels of TGF-beta and Shh in human gingival fibroblasts (RT-PCR and western blotting). A TGF-beta pathway inhibitor mitigated cyclosporine-enhanced cell proliferation and an Shh pathway inhibitor attenuated cyclosporine-enhanced proliferation in fibroblasts (MTS assay and/or RT-PCR of PCNA). Exogenous TGF-beta increased Shh expression; however, exogenous Shh did not alter TGF-beta expression. The TGF-beta pathway inhibitor mitigated cyclosporine-upregulated Shh expression, but the Shh pathway inhibitor did not alter cyclosporineupregulated TGF-beta expression. Conclusions/Significance: The TGF-beta and Shh pathways mediate cyclosporine-enhanced gingival fibroblast proliferation. Exogenous TGF-beta increased Shh expression, and inhibition of TGF-beta signaling abrogated the cyclosporine-induced upregulation of Shh expression; however, TGF-beta expression appeared unchanged by enhanced or inhibited Shh signaling. This is the first study demonstrating the role of Shh in cyclosporine-enhanced gingival cell proliferation; moreover, it defines a hierarchical crosstalk pattern in which TGF-beta regulates Shh in gingival fibroblasts. Understanding the regulation of cyclosporine-related Shh and TGF-beta signaling and crosstalk in gingival overgrowth will clarify the mechanism of cyclosporine-induced gingival enlargement and help develop targeted therapeutics for blocking these pathways, which can be applied in pre-clinical and clinical settings.	[Chung, Yi; Fu, Earl] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Natl Def Med Ctr, Dept Periodontol, Sch Dent, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Tri Serv Gen Hosp, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Fu, E (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	dentalab@tpts5.seed.net.tw	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	Tri-Service General Hospital [TSGH-C98-29]; National Science Council [NSC-100-2314-B-016-022-MY3]; C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	Tri-Service General Hospital; National Science Council(Ministry of Science and Technology, Taiwan); C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by research grants from Tri-Service General Hospital (TSGH-C98-29), National Science Council (NSC-100-2314-B-016-022-MY3), and C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 1998, J CLIN PERIODONTOL, V25, P48, DOI 10.1111/j.1600-051X.1998.tb02363.x; BARTOLD PM, 1989, J PERIODONTAL RES, V24, P314, DOI 10.1111/j.1600-0765.1989.tb00876.x; Buduneli N, 2001, J PERIODONTOL, V72, P526, DOI 10.1902/jop.2001.72.4.526; Chae HJ, 2006, J DENT RES, V85, P515, DOI 10.1177/154405910608500607; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chen YT, 2005, J PERIODONTOL, V76, P2267, DOI 10.1902/jop.2005.76.12.2267; Chiang CY, 2007, J PERIODONTAL RES, V42, P443, DOI 10.1111/j.1600-0765.2006.00967.x; Chiang CY, 2011, J PERIODONTAL RES, V46, P158, DOI 10.1111/j.1600-0765.2010.01312.x; Chiu HC, 2009, J PERIODONTAL RES, V44, P338, DOI 10.1111/j.1600-0765.2008.01126.x; Cotrim P, 2003, J PERIODONTOL, V74, P1625, DOI 10.1902/jop.2003.74.11.1625; Cotrim P, 2002, J PERIODONTOL, V73, P1313, DOI 10.1902/jop.2002.73.11.1313; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KHANNA A, 1994, BIOCHEM BIOPH RES CO, V204, P1061, DOI 10.1006/bbrc.1994.2570; KHANNA A, 1994, TRANSPLANTATION, V57, P577; Kiefer JC, 2010, DEV DYNAM, V239, P1255, DOI 10.1002/dvdy.22278; King PJ, 2008, J ENDOCRINOL, V198, P439, DOI 10.1677/JOE-08-0161; Kuo PJ, 2012, J PERIODONTAL RES, V47, P431, DOI 10.1111/j.1600-0765.2011.01450.x; Lal BK, 2003, J VASC SURG, V37, P1285, DOI 10.1016/S0741-5214(02)75295-6; Lin YT, 2010, J PERIODONTOL, V81, P1250, DOI 10.1902/jop.2010.090743; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; SCHINCAGLIA GP, 1992, J ORAL PATHOL MED, V21, P181, DOI 10.1111/j.1600-0714.1992.tb00098.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TIPTON DA, 1990, J CELL BIOCHEM, V44, P253, DOI 10.1002/jcb.240440407; TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209; Tu HP, 2006, J PERIODONTOL, V77, P832, DOI 10.1902/jop.2006.050316; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yoshida T, 2005, J PERIODONTAL RES, V40, P11, DOI 10.1111/j.1600-0765.2004.00762.x; ZEBROWSKI EJ, 1994, J PERIODONTOL, V65, P565, DOI 10.1902/jop.1994.65.6.565	45	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70128	10.1371/journal.pone.0070128	http://dx.doi.org/10.1371/journal.pone.0070128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922933	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900150
J	Singh, NK; Kumar, KRR; Kumar, D; Shukla, P; Kirti, PB				Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.			Characterization of a Pathogen Induced Thaumatin-Like Protein Gene AdTLP from Arachis diogoi, a Wild Peanut	PLOS ONE			English	Article							OSMOTIN-LIKE PROTEIN; ANTIFREEZE PROTEINS; ANTIFUNGAL PROTEIN; ENHANCES RESISTANCE; BINDING PROTEINS; EXPRESSION; WHEAT; OVEREXPRESSION; INHIBITOR; TOLERANCE	Peanut (Arachis hypogaea L) is one of the widely cultivated and leading oilseed crops of the world and its yields are greatly affected by various biotic and abiotic stresses. Arachis diogoi, a wild relative of peanut, is an important source of genes for resistance against various stresses that affect peanut. In our previous study a thaumatin-like protein gene was found to be upregulated in a differential expression reverse transcription PCR (DDRT-PCR) study using the conidial spray of the late leaf spot pathogen, Phaeoisariopsis personata. In the present study, the corresponding full length cDNA was cloned using RACE-PCR and has been designated as AdTLP. It carried an open reading frame of 726 bp potentially capable of encoding a polypeptide of 241 amino acids with 16 conserved cysteine residues. The semi-quantitative RT-PCR analysis showed that the transcript level of AdTLP increased upon treatment with the late leaf spot pathogen of peanut, P. personata and various hormone treatments indicating its involvement in both, biotic and abiotic stresses. The antifungal activity of the purified recombinant protein was checked against different fungal pathogens, which showed enhanced anti-fungal activity compared to many other reported TLP proteins. The recombinant AdTLP-GFP fusion protein was found to be predominantly localized to extracellular spaces. Transgenic tobacco plants ectopically expressing AdTLP showed enhanced resistance to fungal pathogen, Rhizoctonia solani. The seedling assays showed enhanced tolerance of AdTLP transgenic plants against salt and oxidative stress. The transcript analysis of various defense related genes highlighted constitutively higher level expression of PR1a, PI-I and PI-II genes in transgenic plants. These results suggest that the AdTLP is a good candidate gene for enhancing stress resistance in crop plants.	[Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Singh, NK (corresponding author), Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	naveenks11@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Council of Scientific and Industrial Research [38-1290/11/EMR-II]; Government of India; UGC	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Government of India; UGC(University Grants Commission, India)	This work was supported by a grant from the Council of Scientific and Industrial Research (grant no. 38-1290/11/EMR-II), Government of India. KRRK was supported by Dr. D. S. Kothari postdoctoral fellowship from UGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2013, MOL BIOTECHNOL, V54, P609, DOI 10.1007/s12033-012-9603-y; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chu KT, 2003, BIOCHEM BIOPH RES CO, V301, P364, DOI 10.1016/S0006-291X(02)02998-4; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Dafoe NJ, 2009, J PROTEOME RES, V8, P2341, DOI 10.1021/pr800968r; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Doxey AC, 2006, NAT BIOTECHNOL, V24, P852, DOI 10.1038/nbt1224; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI [10.1111/j.1364-3703.2007.00419.x, 10.1111/J.1364-3703.2007.00419.X]; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Fierens E, 2009, J ENZYM INHIB MED CH, V24, P646, DOI 10.1080/14756360802321831; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; Fu DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/j.plantsci.2004.09.032; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Garcia-Casado C, 2000, PHYSIOL PLANTARUM, V110, P172; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Gomez-Leyva JF, 2001, J PLANT PHYSIOL, V158, P177, DOI 10.1078/0176-1617-00191; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ho VSM, 2007, PEPTIDES, V28, P760, DOI 10.1016/j.peptides.2007.01.005; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jami SK, 2007, J PLANT PHYSIOL, V164, P238, DOI 10.1016/j.jplph.2006.01.006; Johnson ET, 2011, MOL GENET GENOMICS, V285, P517, DOI 10.1007/s00438-011-0626-z; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kim BG, 2009, PHYSIOL MOL PLANT P, V74, P3, DOI 10.1016/j.pmpp.2009.07.001; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kobayashi K, 2000, PLANT CELL PHYSIOL, V41, P148, DOI 10.1093/pcp/41.2.148; Kombrink E., 1997, PLANT RELATIONSHIPS, DOI [10.1007/978-3-662-10370-8_7, DOI 10.1007/978-3-662-10370-8_7]; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Ladyzhenskaia E P, 2006, Prikl Biokhim Mikrobiol, V42, P462; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Looze Y, 2009, PHYTOCHEMISTRY, V70, P970, DOI 10.1016/j.phytochem.2009.05.005; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Ogoshi A, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P1; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; Rajam MV, 2007, BIOL PLANTARUM, V51, P135, DOI 10.1007/s10535-007-0026-8; Rao NK, 2003, GENET RESOUR CROP EV, V50, P707, DOI 10.1023/A:1025055018954; ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Song XM, 2005, PLANT MOL BIOL, V57, P13, DOI 10.1007/s11103-004-6637-y; Tachi H, 2009, PLANT PHYSIOL BIOCH, V47, P73, DOI 10.1016/j.plaphy.2008.09.012; Takemoto D, 1997, PLANT CELL PHYSIOL, V38, P441, DOI 10.1093/oxfordjournals.pcp.a029187; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Velazhahan R, 2003, BIOL PLANTARUM, V47, P347, DOI 10.1023/B:BIOP.0000023876.55053.5e; Velazhahan R, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P107; Vijayan S, 2008, APPL MICROBIOL BIOT, V80, P1023, DOI 10.1007/s00253-008-1648-2; Vitali A, 2006, PLANT PHYSIOL BIOCH, V44, P604, DOI 10.1016/j.plaphy.2006.09.008; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wang XJ, 2010, PHYSIOL PLANTARUM, V139, P27, DOI 10.1111/j.1399-3054.2009.01338.x; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P130, DOI 10.1006/bbrc.1999.1166; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035	61	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83963	10.1371/journal.pone.0083963	http://dx.doi.org/10.1371/journal.pone.0083963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367621	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900026
J	Zhang, Q; Sun, J; Liu, SZ; Wei, QP				Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping			Manure Refinement Affects Apple Rhizosphere Bacterial Community Structure: A Study in Sandy Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PYROSEQUENCING REVEALS; LOESS PLATEAU; LAND-USE; DIVERSITY; LANDSCAPE; ROOTS; CHINA; SCALE	We used DNA-based pyrosequencing to characterize the bacterial community structure of the sandy soil of an apple orchard with different manure ratios. Five manure percentages (5%, 10%, 15%, 20% and 25%) were examined. More than 10,000 valid reads were obtained for each replicate. The communities were composed of five dominant groups (Proteobacteria, Actinobacteria, Chloroflexi, Acidobacteria and Bacteroidetes), of which Proteobacteria content gradually decreased from 41.38% to 37.29% as manure ratio increased from 0% to 25%, respectively. Redundancy analysis showed that 37 classes were highly correlated with manure ratio, 18 of which were positively correlated. Clustering revealed that the rhizosphere samples were grouped into three components: low manure (control, 5%) treatment, medium manure (10%, 15%) treatment and high manure (20%, 25%) treatment. Venn analysis of species types of these three groups revealed that the bacteria community difference was primarily reflected by quantity ratio rather than species variety. Although greater manure content led to higher soil organic matter content, the medium manure improved soil showed the highest urease activity and saccharase activity, while 5% to 20% manure ratio improvement also resulted in higher bacteria diversity than control and 25% manure ratio treatment. Our experimental results suggest that the use of a proper manure ratio results in significantly higher soil enzyme activity and different bacteria community patterns, whereas the use of excessive manure amounts has negative effect on soil quality.	[Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]	China Agriculture Research System	China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), http://english.agri.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alkorta Itziar, 2003, Rev Environ Health, V18, P65; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bougnom B. P., 2012, Organic Agriculture, V2, P1, DOI 10.1007/s13165-012-0020-0; Bougnom B.P., 2009, BODENKULT, V60, P5; Chenu C, 2000, SOIL SCI SOC AM J, V64, P1479, DOI 10.2136/sssaj2000.6441479x; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Feris K, 2003, APPL ENVIRON MICROB, V69, P5563, DOI 10.1128/AEM.69.9.5563-5573.2003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kindler R, 2006, SOIL BIOL BIOCHEM, V38, P2860, DOI 10.1016/j.soilbio.2006.04.047; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwon S, 2010, J MICROBIOL BIOTECHN, V20, P1717, DOI 10.4014/jmb.1007.07012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Makhalanyane TP, 2012, ENV MICROBIOLOGY REP; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Militon C, 2010, FEMS MICROBIOL ECOL, V74, P669, DOI 10.1111/j.1574-6941.2010.00982.x; MILLER S.S., 2002, J TREE FRUIT PRODUCT, V31, P11, DOI DOI 10.1300/J072V03N01_; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Francisco SS, 2011, J SCI FOOD AGR, V91, P1569, DOI 10.1002/jsfa.4349; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tekere M, 2012, AFR J MICROBIOL RES, V6, P4993, DOI 10.5897/AJMR12.250; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; WU QT, 1994, CAN J MICROBIOL, V40, P916, DOI 10.1139/m94-147	43	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76937	10.1371/journal.pone.0076937	http://dx.doi.org/10.1371/journal.pone.0076937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155909	gold, Green Published, Green Submitted			2022-12-25	WOS:000325887300043
J	Singh, NK; Pakkianathan, BC; Kumar, M; Prasad, T; Kannan, M; Konig, S; Krishnan, M				Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kumar, Manish; Prasad, Tulika; Kannan, Mani; Koenig, Simone; Krishnan, Muthukalingan			Vitellogenin from the Silkworm, Bombyx mori: An Effective Anti-Bacterial Agent	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; PURIFICATION; PROTEIN; HEMOLYMPH; BINDING; IDENTIFICATION; LIPOPROTEINS; LEPIDOPTERA; EXPRESSION; PHOSVITIN	Silkworm, Bombyx mori, vitellogenin (Vg) was isolated from perivisceral fat body of day 3 of pupa. Both Vg subunits were co-purified as verified by mass spectrometry and immunoblot. Purified Vg responded to specific tests for major posttranslational modifications on native gels indicating its nature as lipo-glyco-phosphoprotein. The Vg fraction had strong antibacterial activity against Gram negative bacterium Escherichia coli and Gram positive bacterium Bacillus subtilis. Microscopic images showed binding of Vg to bacterial cells and their destruction. When infected silkworm larvae were treated with purified Vg they survived the full life cycle in contrast to untreated animals. This result showed that Vg has the ability to inhibit the proliferation of bacteria in the silkworm fluid system without disturbing the regular metabolism of the host.	[Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kannan, Mani; Krishnan, Muthukalingan] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Kumar, Manish; Prasad, Tulika] Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India; [Koenig, Simone] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany	Bharathidasan University; Jawaharlal Nehru University, New Delhi; University of Munster	Krishnan, M (corresponding author), Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India.	profmkrish@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology; University Grant Commission (UGC); DST-FIST, New Delhi, India; BRNS Mumbai	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); University Grant Commission (UGC)(University Grants Commission, India); DST-FIST, New Delhi, India(Department of Science & Technology (India)); BRNS Mumbai(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This project was made possible by funding of the Indo-German Academic Exchange Service PPP program. The authors are highly thankful to Department of Biotechnology, Department of Science and Technology, University Grant Commission (UGC), DST-FIST, New Delhi, India, and BRNS Mumbai for providing the financial support to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyodi KG, 2002, ENFIELD REPROD BIO A, P70; Almenara DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053460; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Choi So Joung, 1997, Korean Journal of Entomology, V27, P53; CUTTING JA, 1973, ANAL BIOCHEM, V54, P386, DOI 10.1016/0003-2697(73)90367-9; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; HAGEDORN HH, 1979, ANNU REV ENTOMOL, V24, P475, DOI 10.1146/annurev.en.24.010179.002355; HARNISH DG, 1982, J EXP ZOOL, V220, P1, DOI 10.1002/jez.1402200102; HAUNERLAND NH, 1987, ANAL BIOCHEM, V161, P307, DOI 10.1016/0003-2697(87)90455-6; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hyrsl P, 2005, BIOLOGIA, V60, P207; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Khan MAS, 2000, J AGR FOOD CHEM, V48, P1503, DOI 10.1021/jf990700r; Krishnan M., 2010, MASS SPECTROM, V2, P179; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liu Chao Liang, 2001, Journal of Insect Biotechnology and Sericology, V70, P95; Liu QH, 2009, IMMUNOBIOLOGY, V214, P257, DOI 10.1016/j.imbio.2008.10.003; Magalhaes I, 2004, J CHROMATOGR B, V799, P87, DOI 10.1016/j.jchromb.2003.10.026; Maltais D, 2009, FISH PHYSIOL BIOCHEM, V35, P241, DOI 10.1007/s10695-008-9205-6; Maruta K, 2002, ARCH INSECT BIOCHEM, V50, P97, DOI 10.1002/arch.10035; Meng Yan, 2008, Journal of Insect Biotechnology and Sericology, V77, P35; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MUNDALL EC, 1979, COMP BIOCHEM PHYS B, V63, P459, DOI 10.1016/0305-0491(79)90047-6; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Pakkianathan BC, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-5; PAN ML, 1971, J INSECT PHYSIOL, V17, P677, DOI 10.1016/0022-1910(71)90116-8; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Rosenberg IM, 1996, PROTEIN ANAL PURIFIC, P265; Sambook J, 1989, MOL CLONING LAB MANU; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; STIFANI S, 1990, BIOCHIM BIOPHYS ACTA, V1045, P271, DOI 10.1016/0005-2760(90)90130-P; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tufail M, 2000, ARCH INSECT BIOCHEM, V45, P37, DOI 10.1002/1520-6327(200009)45:1&lt;37::AID-ARCH4&gt;3.0.CO;2-8; Vanishree V, 1998, THESIS BHARATHIDASAN; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Warrier S, 2002, MOL REPROD DEV, V61, P536, DOI 10.1002/mrd.10106; WHEELER DE, 1990, ARCH INSECT BIOCHEM, V14, P253, DOI 10.1002/arch.940140405; YANO K, 1994, BBA-GENE STRUCT EXPR, V1218, P1, DOI 10.1016/0167-4781(94)90094-9; YANO K, 1994, FEBS LETT, V356, P207, DOI 10.1016/0014-5793(94)01265-2; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	50	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73005	10.1371/journal.pone.0073005	http://dx.doi.org/10.1371/journal.pone.0073005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24367621	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400013
J	Lim, L; Marquand, A; Cubillo, AA; Smith, AB; Chantiluke, K; Simmons, A; Mehta, M; Rubia, K				Lim, Lena; Marquand, Andre; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Simmons, Andrew; Mehta, Mitul; Rubia, Katya			Disorder-Specific Predictive Classification of Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Relative to Autism Using Structural Magnetic Resonance Imaging	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; SPECTRUM DISORDER; ALZHEIMERS-DISEASE; BRAIN STRUCTURE; METAANALYSIS; MRI; CHILDREN; ABNORMALITIES; NEUROANATOMY; PREVALENCE	Objective: Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder, but diagnosed by subjective clinical and rating measures. The study's aim was to apply Gaussian process classification (GPC) to grey matter (GM) volumetric data, to assess whether individual ADHD adolescents can be accurately differentiated from healthy controls based on objective, brain structure measures and whether this is disorder-specific relative to autism spectrum disorder (ASD). Method: Twenty-nine adolescent ADHD boys and 29 age-matched healthy and 19 boys with ASD were scanned. GPC was applied to make disorder-specific predictions of ADHD diagnostic status based on individual brain structure patterns. In addition, voxel-based morphometry (VBM) analysis tested for traditional univariate group level differences in GM. Results: The pattern of GM correctly classified 75.9% of patients and 82.8% of controls, achieving an overall classification accuracy of 79.3%. Furthermore, classification was disorder-specific relative to ASD. The discriminating GM patterns showed higher classification weights for ADHD in earlier developing ventrolateral/premotor fronto-temporo-limbic and stronger classification weights for healthy controls in later developing dorsolateral fronto-striato-parieto-cerebellar networks. Several regions were also decreased in GM in ADHD relative to healthy controls in the univariate VBM analysis, suggesting they are GM deficit areas. Conclusions: The study provides evidence that pattern recognition analysis can provide significant individual diagnostic classification of ADHD patients and healthy controls based on distributed GM patterns with 79.3% accuracy and that this is disorder-specific relative to ASD. Findings are a promising first step towards finding an objective differential diagnostic tool based on brain imaging measures to aid with the subjective clinical diagnosis of ADHD.	[Lim, Lena; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Rubia, Katya] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England; [Lim, Lena] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore; [Marquand, Andre; Simmons, Andrew; Mehta, Mitul] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Simmons, Andrew] South London & Maudsley Fdn NHS Trust, NIHR Biomed Res Ctr, London, England; [Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London; National University of Singapore; University of London; King's College London; University of London; King's College London	Rubia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England.	katya.rubia@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Mehta, Mitul/F-3960-2010; Hassan, Randa/AAW-3624-2021; Marquand, Andre F/B-6050-2012; Cubillo, Ana I/J-6822-2019; Cubillo, Ana I/AAC-5908-2022; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Marquand, Andre F/0000-0001-5903-203X; Cubillo, Ana I/0000-0001-5657-7341; Smith, Anna Belinda/0000-0001-5493-9089; Lim, Lena/0000-0002-3301-923X; Wah, Win/0000-0002-4242-5651; Hsu, Li Yang/0000-0002-0396-066X; Rubia, Katya/0000-0002-1410-7701	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT088641/Z/09/Z]; Medical Research Council [G0300155] Funding Source: researchfish; MRC [G0300155] Funding Source: UKRI	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore)(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data collection was supported by grants by the NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London and Lilly Pharmaceuticals. LL was supported by the National Medical Research Council (Singapore). A, Smith, AC, A. Simmonds and KC were supported by the NIHR BRC. AM was supported by the King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and EPSRC under grant no. WT088641/Z/09/Z. Lilly Pharmaceuticals had no input into the design, analysis, data interpretation or write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; [Anonymous], 1994, ICD 10 CLASS MENT BE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bledsoe J, 2009, BIOL PSYCHIAT, V65, P620, DOI 10.1016/j.biopsych.2008.11.030; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Cheng W, 2012, FRONT SYST NEUROSCI, P6; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Colby JB, 2012, FRONT SYST NEUROSCI, P6; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Eloyan A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00061; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Goldberg D. P, 2002, MAUDSLEY HDB PRACTIC; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hahn T, 2013, HUM BRAIN MAPP, V34, P1102, DOI 10.1002/hbm.21497; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; Marquand A, 2010, INT C PATT REC IST T; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pliszka SR, 2006, NEUROLOGY, V67, P1023, DOI 10.1212/01.wnl.0000237385.84037.3c; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rubia K, 2007, P NATL ACAD SCI USA, V104, P19663, DOI 10.1073/pnas.0710329105; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rutter M., 2003, SOCIAL COMMUNICATION; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sobel LJ, 2010, AM J PSYCHIAT, V167, P977, DOI 10.1176/appi.ajp.2010.09091259; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Wechsler D., 1999, WECHSLER ABBREVIATED; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58	65	63	65	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63660	10.1371/journal.pone.0063660	http://dx.doi.org/10.1371/journal.pone.0063660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696841	Green Published, gold			2022-12-25	WOS:000319081900048
J	Chung, YT; Zhang, N; Wooten, RM				Chung, Yutein; Zhang, Nan; Wooten, R. Mark			Borrelia burgdorferi Elicited-IL-10 Suppresses the Production of Inflammatory Mediators, Phagocytosis, and Expression of Co-Stimulatory Receptors by Murine Macrophages and/or Dendritic Cells	PLOS ONE			English	Article							OUTER SURFACE LIPOPROTEINS; HOST-PATHOGEN INTERACTIONS; LYME-DISEASE SPIROCHETE; TOLL-LIKE RECEPTOR-2; FACTOR-KAPPA-B; GENE-EXPRESSION; INTERLEUKIN-10 PRODUCTION; ARTHRITIS DEVELOPMENT; INNATE; MICE	Borrelia burgdorferi (Bb) is a tick-borne spirochete that is the causative agent for Lyme disease. Our previous studies indicate that virulent Bb can potently enhance IL-10 production by macrophages (MOs) and that blocking IL-10 production significantly enhances bacterial clearance. We hypothesize that skin-associated APC types, such as MOs and dendritic cells (DCs) are potent producers of IL-10 in response to Bb, which may act in autocrine fashion to suppress APC responses critical for efficient Bb clearance. Our goal is to delineate which APC immune functions are dysregulated by Bb-elicited IL-10 using a murine model of Lyme disease. Our in vitro studies indicated that both APCs rapidly produce IL-10 upon exposure to Bb, that these levels inversely correlate with the production of many Lyme-relevant proinflammatory cytokines and chemokines, and that APCs derived from IL-10(-/-) mice produced greater amounts of these proinflammatory mediators than wild-type APCs. Phagocytosis assays determined that Bb-elicited IL-10 levels can diminish Bb uptake and trafficking by MOs, suppresses ROS production, but does not affect NO production; Bb-elicited IL-10 had little effect on phagocytosis, ROS, and NO production by DCs. In general, Bb exposure caused little-to-no upregulation of several critical surface co-stimulatory markers by MOs and DCs, however eliminating Bb-elicited IL-10 allowed a significant upregulation in many of these co-stimulatory receptors. These data indicate that IL-10 elicited from Bb-stimulated MOs and DCs results in decreased production of proinflammatory mediators and co-stimulatory molecules, and suppress phagocytosis-associated events that are important for mediating both innate and adaptive immune responses by APCs.	[Chung, Yutein; Zhang, Nan; Wooten, R. Mark] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Wooten, RM (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	r.mark.wooten@utoledo.edu	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	NIH [R01 AI073452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding for this study was NIH grant R01 AI073452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S. W., 1996, Journal of Spirochetal and Tick-borne Diseases, V3, P22; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Behera AK, 2006, INFECT IMMUN, V74, P1462, DOI 10.1128/IAI.74.3.1462-1470.2006; BENACH JL, 1984, YALE J BIOL MED, V57, P599; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bouis DA, 2001, INFECT IMMUN, V69, P518, DOI 10.1128/IAI.69.1.518-528.2001; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Boylan Julie A., 2008, V431, P213; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Cortez-Retamozo V, 2012, J INNATE IMMUN, V4, P411, DOI 10.1159/000335733; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; DING AH, 1988, J IMMUNOL, V141, P2407; Ebnet K, 1997, J IMMUNOL, V158, P3285; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gautam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043860; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; HASTEY CJ, 2012, INFECT J IMMUNOL; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Iliopoulou BP, 2010, CURR OPIN RHEUMATOL, V22, P451, DOI 10.1097/BOR.0b013e328338f73f; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; MA Y, 1993, INFECT IMMUN, V61, P3843, DOI 10.1128/IAI.61.9.3843-3853.1993; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; Marietta EV, 1997, J IMMUNOL, V159, P2840; Matsushima H, 2009, BLOOD, V114, P64, DOI 10.1182/blood-2009-02-204297; Miller JC, 2006, MICROB PATHOGENESIS, V41, P43, DOI 10.1016/j.micpath.2006.04.004; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; MONTGOMERY RR, 1994, J INFECT DIS, V170, P890, DOI 10.1093/infdis/170.4.890; Montgomery RR, 1996, INFECT IMMUN, V64, P2867, DOI 10.1128/IAI.64.7.2867-2872.1996; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; Morrison TB, 1997, J IMMUNOL, V158, P4838; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SELLER KP, 1995, INFECT IMMUN, V63, P3886, DOI 10.1128/IAI.63.10.3886-3895.1995; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Shanafelt MC, 1998, INFECT IMMUN, V66, P266, DOI 10.1128/IAI.66.1.266-271.1998; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Singh SK, 2006, CLIN MICROBIOL INFEC, V12, P705, DOI 10.1111/j.1469-0691.2006.01440.x; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Weis J.J., 2010, BORRELIA MOL BIOL HO, P413; Weis JJ, 2002, CURR OPIN RHEUMATOL, V14, P399, DOI 10.1097/00002281-200207000-00011; Wooten RM, 1996, J IMMUNOL, V157, P4584; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Wooten RM, 1998, J IMMUNOL, V160, P5485; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109; Yoder A, 2003, INFECT IMMUN, V71, P3894, DOI 10.1128/IAI.71.7.3894-3900.2003	88	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84980	10.1371/journal.pone.0084980	http://dx.doi.org/10.1371/journal.pone.0084980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	23922933	Green Published, Green Submitted, gold			2022-12-25	WOS:000328741900074
J	Anderson, KE; Kielkowska, A; Durrant, TN; Juvin, V; Clark, J; Stephens, LR; Hawkins, PT				Anderson, Karen E.; Kielkowska, Anna; Durrant, Tom N.; Juvin, Veronique; Clark, Jonathan; Stephens, Len R.; Hawkins, Phillip T.			Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASES; CAENORHABDITIS-ELEGANS; PHOSPHATIDYLINOSITOL; MEMBRANE; PHOSPHOINOSITIDES; TISSUES; MBOA-7; MICE	We disrupted the gene encoding lysophosphatidylinositol-acyltransferase-1 (LPIAT1) in the mouse with the aim of understanding its role in determining cellular phosphoinositide content. LPIAT1(-/-) mice were born at lower than Mendelian ratios and exhibited a severe developmental brain defect. We compared the phospholipid content of livers and brains from LPIAT1(-/-) and LPIAT1(+/+) littermates by LC-ESI/MS. In accord with previous studies, the most abundant molecular species of each phosphoinositide class (PtdIns, PtdInsP, PtdInsP(2) and PtdInsP(3)) possessed a C38:4 complement of fatty-acyl esters (C18:0 and C20:4 are usually assigned to the sn-1 and sn-2 positions, respectively). LPIAT1(-/-) liver and brain contained relatively less of the C38:4 species of PtdIns, PtdInsP and PtdInsP(2) (dropping from 95-97% to 75-85% of the total species measured for each lipid class) and relatively more of the less abundant species (PtdInsP(3) less abundant species were below our quantification levels). The increases in the less abundant PtdIns and PtdInsP(2) species did not compensate for the loss in C38:4 species, resulting in a 26-44% reduction in total PtdIns and PtdInsP(2) levels in both brain and liver. LPIAT1(-/-) brain and liver also contained increased levels of C18:0 lyso-PtdIns (300% and 525% respectively) indicating a defect in the reacylation of this molecule. LPIAT1(-/-) brain additionally contained significantly reduced C38:4 PC and PE levels (by 47% and 55% respectively), possibly contributing to the phenotype in this organ. The levels of all other molecular species of PC, PE, PS and PA measured in the brain and liver were very similar between LPIAT1(-/-) and LPIAT1(+/+) samples. These results suggest LPIAT1 activity plays a non-redundant role in maintaining physiological levels of PtdIns within an active deacylation/reacylation cycle in mouse tissues. They also suggest that this pathway must act in concert with other, as yet unidentified, mechanisms to achieve the enrichment observed in C38:4 molecular species of phosphoinositides.	[Anderson, Karen E.; Durrant, Tom N.; Juvin, Veronique; Stephens, Len R.; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stephens, LR (corresponding author), Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge, England.	len.stephens@babraham.ac.uk; phillip.hawkins@babraham.ac.uk	Walton, Alexander/W-5786-2019; Jones, Beryl/N-5842-2019	Walton, Alexander/0000-0001-8635-873X; Jones, Beryl/0000-0003-2925-0807; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364; Anderson, Karen/0000-0002-7394-6660; Corby-Harris, Vanessa/0000-0001-7680-0328	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG [BB/J004456/1]; Biotechnology and Biological Sciences Research Council [BB/I003916/1, BBS/E/B/000C0415, BBS/E/B/000C0413] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG BB/J004456/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER A, 1990, LIPIDS, V25, P473, DOI 10.1007/BF02538091; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; PALMER FBS, 1986, BIOCHEM CELL BIOL, V64, P117, DOI 10.1139/o86-019; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shulga YV, 2010, BIOCHEMISTRY-US, V49, P312, DOI 10.1021/bi901551e; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; VADNAL RE, 1989, BIOCHEM BIOPH RES CO, V163, P995, DOI 10.1016/0006-291X(89)92320-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708	27	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58425	10.1371/journal.pone.0058425	http://dx.doi.org/10.1371/journal.pone.0058425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	24358254	Green Published, gold			2022-12-25	WOS:000315637900141
J	Hung, CJ; Wu, CC; Chen, WY; Chang, CY; Kuan, YH; Pan, HC; Liao, SL; Chen, CJ				Hung, Chih-Jen; Wu, Chih-Cheng; Chen, Wen-Ying; Chang, Cheng-Yi; Kuan, Yu-Hsiang; Pan, Hung-Chuan; Liao, Su-Lan; Chen, Chun-Jung			Depression-Like Effect of Prenatal Buprenorphine Exposure in Rats	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; METHADONE TREATMENT; PREFRONTAL CORTEX; POSTMORTEM BRAIN; OPIOID RECEPTOR; GENE-EXPRESSION; SUICIDE VICTIMS; MECHANISMS; INCREASES	Studies indicate that perinatal opioid exposure produces a variety of short-and long-term neurobehavioral consequences. However, the precise modes of action are incompletely understood. Buprenorphine, a mixed agonist/antagonist at the opioid receptors, is currently being used in clinical trials for managing pregnant opioid addicts. This study provides evidence of depression-like consequence following prenatal exposure to supra-therapeutic dose of buprenorphine and sheds light on potential mechanisms of action in a rat model involving administration of intraperitoneal injection to pregnant Sprague-Dawley rats starting from gestation day 7 and lasting for 14 days. Results showed that pups at postnatal day 21 but not the dams had worse parameters of depression-like neurobehaviors using a forced swimming test and tail suspension test, independent of gender. Neurobehavioral changes were accompanied by elevation of oxidative stress, reduction of plasma levels of brain-derived neurotrophic factor (BDNF) and serotonin, and attenuation of tropomyosin-related kinase receptor type B (TrkB) phosphorylation, extracellular signal-regulated kinase (ERK) phosphorylation, protein kinase A activity, cAMP response element-binding protein (CREB) phosphorylation, and CREB DNA-binding activity. Since BDNF/serotonin and CREB signaling could orchestrate a positive feedback loop, our findings suggest that the induction of oxidative stress, reduction of BDNF and serotonin expression, and attenuation of CREB signaling induced by prenatal exposure to supra-therapeutic dose of buprenorphine provide evidence of potential mechanism for the development of depression-like neurobehavior.	[Hung, Chih-Jen; Wu, Chih-Cheng] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Hung, Chih-Jen; Chen, Chun-Jung] HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Wu, Chih-Cheng] Providence Univ, Dept Financial & Computat Math, Taichung, Taiwan; [Chen, Wen-Ying] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chang, Cheng-Yi] Fong Yuan Hosp, Dept Surg, Taichung, Taiwan; [Kuan, Yu-Hsiang] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Liao, Su-Lan; Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan	Taichung Veterans General Hospital; Hungkuang University; Providence University - Taiwan; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Tunghai University	Chen, CJ (corresponding author), HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan.	cjchen@vghtc.gov.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	Taichung Veterans General Hospital [TCVGH-1007306C]; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China [CI-98-10]	Taichung Veterans General Hospital; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China	This study was supported by grants from Taichung Veterans General Hospital [TCVGH-1007306C] and the Yen Tjing Ling Medical Foundation [CI-98-10], Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blandthorn J, 2011, WOMEN BIRTH, V24, P32, DOI 10.1016/j.wombi.2010.07.001; Chung CP, 2013, PSYCHIAT RES, V206, P213, DOI 10.1016/j.psychres.2012.10.018; Coyle MG, 2012, ADDICTION, V107, P63, DOI 10.1111/j.1360-0443.2012.04040.x; Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Englberger W, 2006, EUR J PHARMACOL, V534, P95, DOI 10.1016/j.ejphar.2006.01.022; Farid WO, 2008, CURR NEUROPHARMACOL, V6, P125, DOI 10.2174/157015908784533842; Guzman DC, 2006, NEUROCHEM RES, V31, P549, DOI 10.1007/s11064-006-9053-7; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Jansson LM, 2011, NEUROTOXICOL TERATOL, V33, P240, DOI 10.1016/j.ntt.2010.09.003; JARVIS MAE, 1994, J PSYCHOACTIVE DRUGS, V26, P155, DOI 10.1080/02791072.1994.10472263; Kakko J, 2008, DRUG ALCOHOL DEPEN, V96, P69, DOI 10.1016/j.drugalcdep.2008.01.025; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lesch KP, 2001, J AFFECT DISORDERS, V62, P57, DOI 10.1016/S0165-0327(00)00351-7; Li J, 2013, EUR J PHARMACOL, V707, P112, DOI 10.1016/j.ejphar.2013.03.010; Liebenberg N, 2011, NEUROSCI LETT, V498, P158, DOI 10.1016/j.neulet.2011.05.004; Lund IO, 2013, SUBST ABUS-RES TREAT, V7, P61, DOI 10.4137/SART.S10955; Malanga CJ, 1999, CLIN PERINATOL, V26, P17, DOI 10.1016/S0095-5108(18)30070-8; Marquez P, 2007, NEUROPHARMACOLOGY, V52, P1336, DOI 10.1016/j.neuropharm.2007.01.005; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pandey GN, 2007, INT J NEUROPSYCHOPH, V10, P621, DOI 10.1017/S1461145706007231; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pettit AS, 2012, NEUROSCIENCE, V200, P211, DOI 10.1016/j.neuroscience.2011.10.039; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Reus GZ, 2011, BEHAV BRAIN RES, V221, P166, DOI 10.1016/j.bbr.2011.02.024; Robinson SE, 2002, NEUROTOXICOL TERATOL, V24, P137, DOI 10.1016/S0892-0362(01)00185-4; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Sanchez ES, 2008, GLIA, V56, P1017, DOI 10.1002/glia.20675; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; Walsh SL, 2003, DRUG ALCOHOL DEPEN, V70, pS13, DOI 10.1016/S0376-8716(03)00056-5; Wu VW, 2001, EUR J PHARMACOL, V414, P211, DOI 10.1016/S0014-2999(01)00807-X; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	41	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82262	10.1371/journal.pone.0082262	http://dx.doi.org/10.1371/journal.pone.0082262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367510	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300026
J	Yu, Y; Wang, R; Nan, YC; Zhang, LS; Zhang, YJ				Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Linsheng; Zhang, Yanjin			Induction of STAT1 Phosphorylation at Serine 727 and Expression of Proinflammatory Cytokines by Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							MORPHOLINO OLIGOMERS; TARGETED DISRUPTION; SIGNALING PATHWAY; PRRS VIRUS; TRANSCRIPTION; PROTEIN; REPLICATION; INFECTION; INTERLEUKIN-8; MACROPHAGES	Porcine reproductive and respiratory syndrome virus (PRRSV) is a viral pathogen that causes acute respiratory illnesses in young pigs. Since 1987, PRRSV has contributed substantial economic losses to the swine industry. Elevation of proinflammatory cytokines in PRRSV-infected pigs is thought to contribute to PRRSV pathogenesis. In this study, PRRSV VR-2385, a Type 2 strain with moderate virulence, was found to induce phosphorylation of signal transducer and activator of transcription 1 (STAT1) at serine 727 (pSTAT1-S727) in MARC-145 cells. No phosphorylated STAT1 at tyrosine 701 was detected, which indicates that the pSTAT1-S727 elevation was interferon-independent. The PRRSV-induced pSTAT1-S727, however, was dose-dependent and its levels increased with infection time. IngelVac PRRS MLV strain had a minimal effect on pSTAT1-S727. Compared to MLV-infected cells, VR-2385 infection caused significantly higher level of expression of proinflammatory cytokines, including interleukin 1 beta (IL-1beta) and IL-8. The VR-2385-induced pSTAT1-S727 and cytokine expression were reduced after SB203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK), or methylthioadenosine (MTA), a methyl transferase inhibitor, was added to the cells. The SB203580 and MTA-mediated inhibition suggested that the virus-induced pSTAT1-S727 was dependent on p38 MAPK pathway. In primary porcine alveolar macrophages (PAMs), VR-2385 also induced pSTAT1-S727 and expression of proinflammatory cytokines and chemokines, including IL-1beta, IL-8, chemokine ligand 2 (CCL2) and chemokine (C-X-C motif) ligand 10 (CXCL10). Similarly, SB203580 treatment of PAM cells blocked the elevation of pSTAT1-S727 and cytokine expression. Overexpression of individual viral proteins showed that non-structural protein 12 (nsp12) was able to induce elevation of pSTAT1-S727 and the expression of IL-1 beta and IL-8. These results indicated that PRRSV VR-2385 induces pSTAT1-S727 and the expression of proinflammatory cytokines, which contributes to the insight of PRRSV pathogenesis.	[Yu, Ying; Zhang, Linsheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Mol Virol Lab, VA MD Reg Coll Vet Med, College Pk, MD 20742 USA; [Yu, Ying; Wang, Rong; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Zhang, LS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	linszhang@nwsuaf.edu.cn; zhangyj@umd.edu	Nan, Yuchen/ABF-3746-2021; Zhang, Yanjin/H-5035-2019; Nan, Yuchen/F-9917-2014; Schneider, Harald/B-6681-2008	Nan, Yuchen/0000-0002-4442-8004; Wang, Rong/0000-0002-9947-4307; Schneider, Harald/0000-0002-4548-7268; Zhang, Yanjin/0000-0002-5847-3260	China Scholarship Council; National Pork Board	China Scholarship Council(China Scholarship Council); National Pork Board	This study was partially supported by National Pork Board. Y. Yu, R. Wang, and Y. Nan were partially supported by China Scholarship Council. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Faaberg K.S., 2011, VIRUS TAXONOMY; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gomez-Laguna J, 2010, J COMP PATHOL, V142, P51, DOI 10.1016/j.jcpa.2009.07.004; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Hou J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-165; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lunney JK, 2010, VIRAL IMMUNOL, V23, P127, DOI 10.1089/vim.2009.0087; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Miguel JC, 2010, VET IMMUNOL IMMUNOP, V135, P314, DOI 10.1016/j.vetimm.2010.01.002; Moreno B, 2010, MULT SCLER J, V16, P1102, DOI 10.1177/1352458510375968; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nan YC, 2012, VIROLOGY, V432, P261, DOI 10.1016/j.virol.2012.05.015; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Patel D, 2009, ANTIVIR THER, V14, P899, DOI 10.3851/IMP1409; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; ROSSOW KD, 1995, VET PATHOL, V32, P361, DOI 10.1177/030098589503200404; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Zhang YJ, 2007, ANTIVIR RES, V73, P12, DOI 10.1016/j.antiviral.2006.05.017	39	36	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61967	10.1371/journal.pone.0061967	http://dx.doi.org/10.1371/journal.pone.0061967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	24367634	Green Published, gold, Green Submitted			2022-12-25	WOS:000318340400062
J	Ghosh, A; Sarkar, S; Mandal, AK; Das, N				Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu			Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged Rats	PLOS ONE			English	Article							DRUG-DELIVERY; NITRIC-OXIDE; LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; BRAIN; DEATH; FLAVONOIDS; NANOPARTICLES; ANTIOXIDANTS; MEMBRANE	Cerebral stroke is the leading cause of death and permanent disability among elderly people. In both humans and animals, cerebral ischemia damages the nerve cells in vulnerable regions of the brain, viz., hippocampus, cerebral cortex, cerebellum, and hypothalamus. The present study was conducted to evaluate the therapeutic efficacy of nanoencapsulated quercetin (QC) in combating ischemia-reperfusion-induced neuronal damage in young and aged Swiss Albino rats. Cerebral ischemia was induced by occlusion of the common carotid arteries of both young and aged rats followed by reperfusion. Nanoencapsulated quercetin (2.7 mg/kg b wt) was administered to both groups of animals via oral gavage two hours prior to ischemic insults as well as post-operation till day 3. Cerebral ischemia and 30 min consecutive reperfusion caused a substantial increase in lipid peroxidation, decreased antioxidant enzyme activities and tissue osmolality in different brain regions of both groups of animals. It also decreased mitochondrial membrane microviscosity and increased reactive oxygen species (ROS) generation in different brain regions of young and aged rats. Among the brain regions studied, the hippocampus appeared to be the worst affected region showing increased upregulation of iNOS and caspase-3 activity with decreased neuronal count in the CA1 and CA3 subfields of both young and aged rats. Furthermore, three days of continuous reperfusion after ischemia caused massive damage to neuronal cells. However, it was observed that oral treatment of nanoencapsulated quercetin (2.7 mg/kg b wt) resulted in downregulation of iNOS and caspase-3 activities and improved neuronal count in the hippocampal subfields even 3 days after reperfusion. Moreover, the nanoformulation imparted a significant level of protection in the antioxidant status in different brain regions, thus contributing to a better understanding of the given pathophysiological processes causing ischemic neuronal damage.	[Ghosh, Aparajita; Sarkar, Sibani; Mandal, Ardhendu K.; Das, Nirmalendu] Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India; [Ghosh, Aparajita] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Das, N (corresponding author), Indian Inst Chem Biol, Biomembrane Div, Kolkata, W Bengal, India.	dasnirmalendu@hotmail.com	; Jabgunde, Amit/I-8155-2018; Ghosh, Sougata/GOH-0726-2022; Mandal, Ardhendu Kumar/R-3694-2018; Pardesi, Karishma/D-5827-2012; Ghosh, Sougata/C-6409-2018	Dhavale, Dilip/0000-0001-8221-6347; Jabgunde, Amit/0000-0002-9324-8552; Jagtap, Soham/0000-0002-8687-7326; Ghosh, Sougata/0000-0001-8631-0357; Mandal, Ardhendu Kumar/0000-0001-8336-1220; Shinde, Vaishali/0000-0001-8800-7247; Patil, Ajay B./0000-0003-0509-4926; Pardesi, Karishma/0000-0001-7535-6317; Ghosh, Sougata/0000-0003-0077-1318	Indian Council of Medical Research (ICMR), Government of India [58/17/2003-BMS]; Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Indian Council of Medical Research (ICMR), Adhoc Project number 58/17/2003-BMS, Government of India, and the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Aebi H, 1984, Methods Enzymol, V105, P121; Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; BORS W, 1990, METHOD ENZYMOL, V186, P343; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Changtam C, 2010, EUR J MED CHEM, V45, P941, DOI 10.1016/j.ejmech.2009.11.035; Chen J, 1997, J NEUROCHEM, V69, P232; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GINSBERG MD, 1994, ANN NEUROL, V36, P553, DOI 10.1002/ana.410360402; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Harry GJ, 2003, NEUROTOXICOLOGY, V24, P343, DOI 10.1016/S0161-813X(03)00039-1; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; ISSA AM, 1990, J NEUROSCI, V10, P3247; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kong LD, 2000, CELL MOL LIFE SCI, V57, P500, DOI 10.1007/PL00000710; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lee JC, 2003, EXP CELL RES, V291, P386, DOI 10.1016/S0014-4827(03)00410-5; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; RECKNAGEL RO, 1984, METHOD ENZYMOL, V105, P331; Rodriguez RJ, 2001, FOOD CHEM TOXICOL, V39, P437, DOI 10.1016/S0278-6915(00)00159-9; Ruozi B, 2007, TALANTA, V73, P12, DOI 10.1016/j.talanta.2007.03.031; Sarkar A, 1995, CANCER BIOCHEM BIOPH, V15, P111; Sarkar S, 2002, J DRUG TARGET, V10, P573, DOI 10.1080/106118021000072681; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Taylor CP, 1999, J NEUROSCI, V19, P619; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	52	114	119	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2013	8	4							e57735	10.1371/journal.pone.0057735	http://dx.doi.org/10.1371/journal.pone.0057735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JA	24367520	gold, Green Published, Green Submitted			2022-12-25	WOS:000317909500001
J	Boch, S; Prati, D; Hessenmoller, D; Schulze, ED; Fischer, M				Boch, Steffen; Prati, Daniel; Hessenmoeller, Dominik; Schulze, Ernst-Detlef; Fischer, Markus			Richness of Lichen Species, Especially of Threatened Ones, Is Promoted by Management Methods Furthering Stand Continuity	PLOS ONE			English	Article							EPIPHYTIC LICHENS; OLD-GROWTH; BRYOPHYTE COMMUNITIES; BEECH FORESTS; DIVERSITY; CONSERVATION; BIODIVERSITY; DISPERSAL; INDICATOR; QUALITY	Lichens are a key component of forest biodiversity. However, a comprehensive study analyzing lichen species richness in relation to several management types, extending over different regions and forest stages and including information on site conditions is missing for temperate European forests. In three German regions (Schwabische Alb, Hainich-Dun, Schorfheide-Chorin), the so-called Biodiversity Exploratories, we studied lichen species richness in 631 forest plots of 400 m(2) comprising different management types (unmanaged, selection cutting, deciduous and coniferous age-class forests resulting from clear cutting or shelterwood logging), various stand ages, and site conditions, typical for large parts of temperate Europe. We analyzed how lichen species richness responds to management and habitat variables (standing biomass, cover of deadwood, cover of rocks). We found strong regional differences with highest lichen species richness in the Schwabische Alb, probably driven by regional differences in former air pollution, and in precipitation and habitat variables. Overall, unmanaged forests harbored 22% more threatened lichen species than managed age-class forests. In general, total, corticolous, and threatened lichen species richness did not differ among management types of deciduous forests. However, in the Schwabische-Alb region, deciduous forests had 61% more lichen species than coniferous forests and they had 279% more threatened and 76% more corticolous lichen species. Old deciduous age classes were richer in corticolous lichen species than young ones, while old coniferous age-classes were poorer than young ones. Overall, our findings highlight the importance of stand continuity for conservation. To increase total and threatened lichen species richness we suggest (1) conserving unmanaged forests, (2) promoting silvicultural methods assuring stand continuity, (3) conserving old trees in managed forests, (4) promoting stands of native deciduous tree species instead of coniferous plantations, and (5) increasing the amount of deadwood in forests.	[Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Bot Gardens, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Hessenmoeller, Dominik; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Bern; University of Bern; University of Bern; Max Planck Society	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Fischer, Markus/C-6411-2008; Schulze, Ernst-Detlef/K-9627-2014	Fischer, Markus/0000-0002-5589-5900; 	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories" [SSP 1374, FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories"(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Berge E, 1998, TELLUS B, V50, P205, DOI 10.1034/j.1600-0889.1998.t01-2-00001.x; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Edman M, 2008, J APPL ECOL, V45, P26, DOI 10.1111/j.1365-2664.2007.01354.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; Gilbert Oliver L., 1992, P159; Graae BJ, 1997, FOREST ECOL MANAG, V96, P111, DOI 10.1016/S0378-1127(97)00046-7; Gustafsson L, 2004, BASIC APPL ECOL, V5, P123, DOI 10.1078/1439-1791-00223; Hessenmoller D., 2011, Forstarchiv, V82, P171; Horstkotte T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028779; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Kirschbaum U, 2006, GEFAHRST REINHALT L, V66, P272; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Moning C, 2009, ECOL INDIC, V9, P922, DOI 10.1016/j.ecolind.2008.11.002; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Nascimbene J, 2007, FOREST ECOL MANAG, V247, P43, DOI 10.1016/j.foreco.2007.04.011; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Neitlich PN, 1997, CONSERV BIOL, V11, P172, DOI 10.1046/j.1523-1739.1997.95492.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parviainen J, 2003, J ENVIRON MANAGE, V67, P27, DOI 10.1016/S0301-4797(02)00185-8; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Purvis OW, 2010, SYST BIODIVERS, V8, P193, DOI 10.1080/14772001003782088; PYKALA J, 2006, BASIC APPL ECOL, V223, P84, DOI DOI 10.1016/J.FORECO.2005.10.059; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rolstad J, 2001, ECOL APPL, V11, P421, DOI 10.1890/1051-0761(2001)011[0421:ELINCS]2.0.CO;2; Rose Francis, 1992, P211; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Svoboda D, 2010, ENVIRON POLLUT, V158, P812, DOI 10.1016/j.envpol.2009.10.001; Thor Goran, 1995, Mitteilungen der Eidgenoessischen Forschungsanstalt fuer Wald Schnee und Landschaft, V70, P29; Uliczka H, 2000, BIOL CONSERV, V95, P343, DOI 10.1016/S0006-3207(00)00022-7; Umweltbundesamt, 2005, DAT UMW ZUST UMW DEU; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Wolseley PA, 2006, LICHENOLOGIST, V38, P307, DOI 10.1017/S0024282906006190	53	62	69	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55461	10.1371/journal.pone.0055461	http://dx.doi.org/10.1371/journal.pone.0055461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	24358373	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200052
J	Hung, CM; Lin, RC; Chu, JH; Yeh, CF; Yao, CJ; Li, SH				Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Yao, Chiou-Ju; Li, Shou-Hsien			The De Novo Assembly of Mitochondrial Genomes of the Extinct Passenger Pigeon (Ectopistes migratorius) with Next Generation Sequencing	PLOS ONE			English	Article							ANCIENT DNA; NUCLEAR GENOME; AMPLIFICATION; MTDNA	The information from ancient DNA (aDNA) provides an unparalleled opportunity to infer phylogenetic relationships and population history of extinct species and to investigate genetic evolution directly. However, the degraded and fragmented nature of aDNA has posed technical challenges for studies based on conventional PCR amplification. In this study, we present an approach based on next generation sequencing to efficiently sequence the complete mitochondrial genome (mitogenome) of two extinct passenger pigeons (Ectopistes migratorius) using de novo assembly of massive short (90 bp), paired-end or single-end reads. Although varying levels of human contamination and low levels of postmortem nucleotide lesion were observed, they did not impact sequencing accuracy. Our results demonstrated that the de novo assembly of shotgun sequence reads could be a potent approach to sequence mitogenomes, and offered an efficient way to infer evolutionary history of extinct species.	[Hung, Chih-Ming] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Hung, Chih-Ming] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yao, Chiou-Ju] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan Normal University	Li, SH (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43028@ntnu.edu.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This project is funded by the National Science Council of Taiwan to SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cassista S, 2009, UNDERGRADUATE J ANTH, V1, P141; Catling Paul M., 2001, Biodiversity, V2, P2; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schorger A, 1955, PASSENGER PIGEON; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109	42	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56301	10.1371/journal.pone.0056301	http://dx.doi.org/10.1371/journal.pone.0056301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24367510	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200057
J	Anderson, KE; Sheehan, TH; Mott, BM; Maes, P; Snyder, L; Schwan, MR; Walton, A; Jones, BM; Corby-Harris, V				Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa			Microbial Ecology of the Hive and Pollination Landscape: Bacterial Associates from Floral Nectar, the Alimentary Tract and Stored Food of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT BACTERIA; SYMBIONTS; COMMUNITIES; EVOLUTION; MICROFLORA; DIVERSITY; POLLEN; ANTS; MICROORGANISMS	Nearly all eukaryotes are host to beneficial or benign bacteria in their gut lumen, either vertically inherited, or acquired from the environment. While bacteria core to the honey bee gut are becoming evident, the influence of the hive and pollination environment on honey bee microbial health is largely unexplored. Here we compare bacteria from floral nectar in the immediate pollination environment, different segments of the honey bee (Apis mellifera) alimentary tract, and food stored in the hive (honey and packed pollen or "beebread''). We used cultivation and sequencing to explore bacterial communities in all sample types, coupled with culture-independent analysis of beebread. We compare our results from the alimentary tract with both culture-dependent and culture-independent analyses from previous studies. Culturing the foregut (crop), midgut and hindgut with standard media produced many identical or highly similar 16S rDNA sequences found with 16S rDNA clone libraries and next generation sequencing of 16S rDNA amplicons. Despite extensive culturing with identical media, our results do not support the core crop bacterial community hypothesized by recent studies. We cultured a wide variety of bacterial strains from 6 of 7 phylogenetic groups considered core to the honey bee hindgut. Our results reveal that many bacteria prevalent in beebread and the crop are also found in floral nectar, suggesting frequent horizontal transmission. From beebread we uncovered a variety of bacterial phylotypes, including many possible pathogens and food spoilage organisms, and potentially beneficial bacteria including Lactobacillus kunkeei, Acetobacteraceae and many different groups of Actinobacteria. Contributions of these bacteria to colony health may include general hygiene, fungal and pathogen inhibition and beebread preservation. Our results are important for understanding the contribution to pollinator health of both environmentally vectored and core microbiota, and the identification of factors that may affect bacterial detection and transmission, colony food storage and disease susceptibility.	[Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa] USDA ARS Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Sheehan, Timothy H.; Maes, Patrick] Univ Arizona, Dept Microbiol, Tucson, AZ USA; [Mott, Brendon M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Walton, Alexander] Iowa State Univ, Dept Ecol & Evolut, Ames, IA USA; [Jones, Beryl M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Arizona; University of Arizona; Arizona State University; Arizona State University-Tempe; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Anderson, KE (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	kirk.anderson@ars.usda.gov	Walton, Alexander/W-5786-2019; Jones, Beryl/N-5842-2019	Walton, Alexander/0000-0001-8635-873X; Jones, Beryl/0000-0003-2925-0807; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364; Anderson, Karen/0000-0002-7394-6660; Corby-Harris, Vanessa/0000-0001-7680-0328	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council [BB/I003916/1, BBS/E/B/000C0415, BBS/E/B/000C0413] Funding Source: researchfish	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided entirely by the USA tax-payer supported operating budget of the Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Aween MM, 2012, J FOOD SCI, V77, pM364, DOI 10.1111/j.1750-3841.2012.02776.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Bution ML, 2008, MICRON, V39, P897, DOI 10.1016/j.micron.2007.11.008; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1988, J INSECT PHYSIOL, V34, P85, DOI 10.1016/0022-1910(88)90158-8; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; DAESCHEL MA, 1987, FEMS MICROBIOL LETT, V46, P357, DOI 10.1111/j.1574-6968.1987.tb02472.x; Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; DeSantis TZ, 2006, APPL ENV MICROBIOL; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2011, INT J SYST EVOL MICR; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel, 2013, INT J SYST EVOL MICR, DOI 10.109.; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Feldhaar Heike, 2009, Journal of Biology (London), V8, P31, DOI 10.1186/jbiol129; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1983, J INVERTEBR PATHOL, V42, P187, DOI 10.1016/0022-2011(83)90061-7; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; GOTELLI NJ, 2002, ECOSIM NULL MODELS S; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Holldobler B, 2008, SUPERORGANISM BEAUTY; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; INGLIS GD, 1993, MICROBIAL ECOL, V26, P125, DOI 10.1007/BF00177048; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; Judd T. M., 2011, SOCIAL INSECTS STRUC; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Microbiome F, 2013, UNEXPECTED DIVERSITY, DOI [10.1128/mBio.00602-12, DOI 10.1128/MBI0.00602-12.EDIT0R]; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neveling DP, 2012, CURR MICROBIOL; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Ohkuma M., 2001, RIKEN REV, V41, P69; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rangberg A, 2012, INTEGR COMP BIOL, V52, P89, DOI 10.1093/icb/ics089; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosengaus RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.31; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; SUZUKI I, 1991, MILCHWISSENSCHAFT, V46, P635; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Turner J. Scott, 2005, American Entomologist, V51, P36; Turner JS, 2004, BIOL PHILOS, V19, P327, DOI 10.1023/B:BIPH.0000036115.65522.a1; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VIDAVER AK, 1982, ANNU REV MICROBIOL, V36, P495, DOI 10.1146/annurev.mi.36.100182.002431; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	106	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83125	10.1371/journal.pone.0083125	http://dx.doi.org/10.1371/journal.pone.0083125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358254	Green Submitted, Green Published, gold			2022-12-25	WOS:000328737700049
